data_1oww_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1oww _Structure_validation_residue.Date_analyzed 2016-10-06 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 2' ' ' GLY . . . . . 0.499 ' H ' ' HG3' ' A' ' 83' ' ' GLU . . . . . . . . 0 N--CA 1.441 -0.984 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 95.9 Cg_exo -62.21 133.11 41.98 Favored 'Trans proline' 0 N--CA 1.445 -1.367 0 C-N-CA 123.592 2.861 . . . . 0.0 112.342 -178.504 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 4.3 t -80.98 155.33 4.26 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.924 0 C-N-CA 127.32 2.248 . . . . 0.0 107.424 -175.429 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 53.0 mt-10 -94.49 89.04 5.68 Favored 'General case' 0 CA--C 1.493 -1.25 0 C-N-CA 124.337 1.055 . . . . 0.0 108.426 -177.5 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 3.7 p -115.64 140.24 38.25 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.105 0 N-CA-C 105.497 -2.038 . . . . 0.0 105.497 -169.411 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 93.3 m-85 . . . . . 0 CA--C 1.493 -1.221 0 N-CA-C 107.28 -1.378 . . . . 0.0 107.28 -172.112 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_endo . . . . . 0 CA--C 1.509 -0.753 0 N-CA-C 110.003 -0.806 . . . . 0.0 110.003 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -91.16 -15.4 29.43 Favored 'General case' 0 CA--C 1.498 -1.041 0 C-N-CA 125.438 1.495 . . . . 0.0 108.222 177.663 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' SER . . . . . 0.44 ' HG ' ' HG2' ' A' ' 61' ' ' LYS . 50.1 m -102.58 149.96 23.89 Favored 'General case' 0 N--CA 1.437 -1.101 0 N-CA-C 107.094 -1.446 . . . . 0.0 107.094 175.425 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 60.0 t-80 -139.28 94.45 9.65 Favored Pre-proline 0 N--CA 1.442 -0.855 0 N-CA-C 107.526 -1.287 . . . . 0.0 107.526 175.729 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -78.21 101.36 1.46 Allowed 'Trans proline' 0 N--CA 1.447 -1.235 0 C-N-CA 123.144 2.562 . . . . 0.0 110.043 174.338 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 11.8 tt -90.58 156.69 3.01 Favored 'Isoleucine or valine' 0 N--CA 1.408 -2.532 0 C-N-CA 126.945 2.098 . . . . 0.0 106.042 176.308 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 25.4 tt0 -139.77 146.45 39.51 Favored 'General case' 0 N--CA 1.432 -1.334 0 N-CA-C 103.662 -2.718 . . . . 0.0 103.662 175.125 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 49.3 p90 -135.08 161.69 34.61 Favored 'General case' 0 N--CA 1.431 -1.379 0 N-CA-C 105.045 -2.205 . . . . 0.0 105.045 178.558 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 3.9 m120 -132.65 127.73 35.54 Favored 'General case' 0 CA--C 1.491 -1.325 0 N-CA-C 105.909 -1.886 . . . . 0.0 105.909 -178.884 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -81.18 159.99 66.59 Favored Pre-proline 0 N--CA 1.441 -0.901 0 C-N-CA 123.533 0.733 . . . . 0.0 111.254 -167.119 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_exo -67.29 173.87 7.99 Favored 'Trans proline' 0 N--CA 1.456 -0.718 0 C-N-CA 123.7 2.933 . . . . 0.0 111.738 166.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 49.4 tt0 -80.24 -42.38 1.37 Allowed Pre-proline 0 N--CA 1.444 -0.756 0 CA-C-O 115.63 -2.128 . . . . 0.0 111.522 -177.339 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 74.7 Cg_exo -66.59 148.13 82.93 Favored 'Trans proline' 0 CA--C 1.507 -0.849 0 CA-C-N 125.62 3.043 . . . . 0.0 112.061 177.039 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 24.6 p -98.99 58.52 1.13 Allowed 'General case' 0 C--N 1.355 0.844 0 N-CA-C 107.592 -1.262 . . . . 0.0 107.592 178.46 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 21.1 t-160 -104.38 -5.88 21.29 Favored 'General case' 0 N--CA 1.439 -1.001 0 C-N-CA 125.046 1.338 . . . . 0.0 107.784 178.104 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 56.7 mt -106.73 131.26 57.05 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.21 0 N-CA-C 105.2 -2.148 . . . . 0.0 105.2 178.498 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 75.2 m -104.01 -84.24 0.48 Allowed 'General case' 0 N--CA 1.43 -1.443 0 N-CA-C 106.203 -1.777 . . . . 0.0 106.203 -179.667 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 54.0 mtmt -88.9 167.26 13.37 Favored 'General case' 0 CA--C 1.492 -1.281 0 C-N-CA 123.687 0.795 . . . . 0.0 109.61 -168.801 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 90.0 m-85 -126.04 139.27 53.55 Favored 'General case' 0 N--CA 1.435 -1.196 0 N-CA-C 104.494 -2.41 . . . . 0.0 104.494 165.703 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 1.7 mp -115.03 136.34 52.05 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.132 1 N-CA-C 100.177 -4.009 . . . . 0.0 100.177 167.634 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 3.0 mt -111.53 133.63 53.67 Favored 'General case' 0 CA--C 1.472 -2.052 0 N-CA-C 103.837 -2.653 . . . . 0.0 103.837 164.588 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 16.7 ptp180 -128.73 154.84 45.94 Favored 'General case' 0 N--CA 1.432 -1.345 0 N-CA-C 106.301 -1.74 . . . . 0.0 106.301 169.107 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 48.3 p90 -153.44 144.53 22.94 Favored 'General case' 0 N--CA 1.436 -1.161 0 N-CA-C 106.987 -1.486 . . . . 0.0 106.987 -173.834 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 36.2 ttp180 -142.55 134.04 13.04 Favored Pre-proline 0 CA--C 1.497 -1.09 0 N-CA-C 104.783 -2.303 . . . . 0.0 104.783 -177.859 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 29.8 Cg_endo -72.31 116.71 4.81 Favored 'Trans proline' 0 CA--C 1.505 -0.947 0 C-N-CA 122.928 2.418 . . . . 0.0 108.156 178.364 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 5.5 tmtm? -69.86 85.02 0.49 Allowed 'General case' 0 C--N 1.359 1.011 0 C-N-CA 126.523 1.929 . . . . 0.0 110.242 -174.283 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 33.1 m120 -147.52 -67.78 0.25 Allowed 'General case' 0 N--CA 1.433 -1.286 0 N-CA-C 101.568 -3.493 . . . . 0.0 101.568 -178.71 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 50.8 p -103.28 170.27 8.06 Favored 'General case' 0 N--CA 1.441 -0.918 0 N-CA-C 107.072 -1.455 . . . . 0.0 107.072 171.617 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 3.7 m -119.82 53.42 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.841 0 N-CA-C 106.125 -1.806 . . . . 0.0 106.125 176.45 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -100.32 -131.55 7.41 Favored Glycine 0 C--N 1.356 1.641 0 N-CA-C 109.916 -1.273 . . . . 0.0 109.916 -175.452 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 56.1 ttp180 -79.78 148.51 31.42 Favored 'General case' 0 C--N 1.357 0.9 0 C-N-CA 124.727 1.211 . . . . 0.0 108.694 -175.026 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -148.5 169.86 19.32 Favored 'General case' 0 CA--C 1.494 -1.174 0 CA-C-O 121.468 0.651 . . . . 0.0 110.616 -171.952 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 62.3 mttp -112.3 159.07 19.01 Favored 'General case' 0 CA--C 1.491 -1.292 0 N-CA-C 107.774 -1.195 . . . . 0.0 107.774 -168.849 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 16.2 pt-20 -151.63 160.65 43.55 Favored 'General case' 0 N--CA 1.436 -1.141 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 172.287 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -137.38 163.69 30.42 Favored 'General case' 0 CA--C 1.501 -0.942 0 N-CA-C 106.063 -1.829 . . . . 0.0 106.063 171.68 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 89.4 m -120.41 125.25 47.49 Favored 'General case' 0 CA--C 1.501 -0.913 0 N-CA-C 104.957 -2.238 . . . . 0.0 104.957 175.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 5.3 mp -114.11 136.48 22.21 Favored Pre-proline 0 N--CA 1.437 -1.102 0 N-CA-C 105.196 -2.15 . . . . 0.0 105.196 -175.608 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_exo -64.19 163.72 25.09 Favored 'Trans proline' 0 CA--C 1.51 -0.723 0 C-N-CA 123.378 2.719 . . . . 0.0 113.774 176.624 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -76.26 -18.44 79.27 Favored Glycine 0 C--N 1.353 1.49 0 C-N-CA 124.149 0.881 . . . . 0.0 114.244 -174.03 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 52.4 p-80 -83.28 -25.17 31.82 Favored 'General case' 0 C--N 1.355 0.837 0 CA-C-N 117.951 0.876 . . . . 0.0 109.945 -179.044 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 89.0 mt -88.43 131.57 34.81 Favored 'General case' 0 CA--C 1.5 -0.955 0 N-CA-C 107.712 -1.218 . . . . 0.0 107.712 176.797 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 8.6 p-10 -113.74 8.82 17.59 Favored 'General case' 0 CA--C 1.502 -0.89 0 C-N-CA 124.457 1.103 . . . . 0.0 109.631 -174.916 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 33.5 p -146.39 157.73 43.81 Favored 'General case' 0 CA--C 1.498 -1.055 0 N-CA-C 106.633 -1.617 . . . . 0.0 106.633 -177.463 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 35.4 t80 -154.14 151.27 29.06 Favored 'General case' 0 CA--C 1.487 -1.444 0 N-CA-C 108.07 -1.085 . . . . 0.0 108.07 178.236 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 16.9 m -108.64 113.99 27.43 Favored 'General case' 0 N--CA 1.439 -0.979 0 N-CA-C 105.951 -1.87 . . . . 0.0 105.951 174.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 45.5 mt -91.95 102.28 13.39 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.89 0 N-CA-C 105.242 -2.132 . . . . 0.0 105.242 178.117 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . 0.44 ' HG2' ' HG ' ' A' ' 17' ' ' SER . 35.1 mtmm -106.48 162.32 13.82 Favored 'General case' 0 CA--C 1.497 -1.096 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 -175.785 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 79.93 52.51 4.61 Favored Glycine 0 C--N 1.351 1.365 0 N-CA-C 109.099 -1.6 . . . . 0.0 109.099 178.434 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 89.5 mt -118.12 173.12 6.97 Favored 'General case' 0 CA--C 1.498 -1.023 0 N-CA-C 106.87 -1.53 . . . . 0.0 106.87 -178.778 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 51.6 mtmt -98.14 147.28 32.87 Favored Pre-proline 0 N--CA 1.438 -1.063 0 N-CA-C 105.786 -1.931 . . . . 0.0 105.786 178.666 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -78.56 160.99 28.32 Favored 'Trans proline' 0 N--CA 1.452 -0.93 0 C-N-CA 123.043 2.496 . . . . 0.0 109.997 173.515 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 59.6 30.33 68.52 Favored Glycine 0 C--N 1.356 1.65 0 C-N-CA 126.626 2.06 . . . . 0.0 116.24 169.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 6.4 p -128.45 154.62 39.47 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.85 0 N-CA-C 107.813 -1.18 . . . . 0.0 107.813 -176.002 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 4.8 p -96.53 135.69 29.81 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.9 0 N-CA-C 106.769 -1.567 . . . . 0.0 106.769 175.554 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 81.9 m-85 -113.89 147.44 38.48 Favored 'General case' 0 CA--C 1.497 -1.078 0 N-CA-C 105.382 -2.081 . . . . 0.0 105.382 171.432 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 15.2 pt-20 -95.92 136.53 36.23 Favored 'General case' 0 CA--C 1.498 -1.027 0 N-CA-C 103.457 -2.794 . . . . 0.0 103.457 162.016 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -132.62 146.38 18.18 Favored Glycine 0 CA--C 1.485 -1.784 0 N-CA-C 107.679 -2.168 . . . . 0.0 107.679 -172.332 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 25.2 mt-30 -136.74 133.46 36.07 Favored 'General case' 0 CA--C 1.482 -1.65 0 N-CA-C 105.746 -1.946 . . . . 0.0 105.746 178.627 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 49.6 tp -112.63 100.1 8.45 Favored 'General case' 0 N--CA 1.437 -1.108 0 N-CA-C 103.393 -2.817 . . . . 0.0 103.393 179.535 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 21.7 mt -94.83 129.33 45.15 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.915 0 N-CA-C 104.696 -2.335 . . . . 0.0 104.696 -176.797 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 69.2 m -113.5 113.79 25.62 Favored 'General case' 0 CA--C 1.497 -1.092 0 N-CA-C 107.668 -1.234 . . . . 0.0 107.668 -175.276 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 18.5 mm -89.36 142.73 12.47 Favored 'Isoleucine or valine' 0 CA--C 1.49 -1.349 0 N-CA-C 105.514 -2.032 . . . . 0.0 105.514 -173.441 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 83.0 mt-30 -92.5 -175.62 4.04 Favored 'General case' 0 CA--C 1.502 -0.897 0 CA-C-N 114.766 -1.106 . . . . 0.0 109.203 -175.569 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 73.2 mt-30 -74.79 78.22 2.09 Favored 'General case' 0 N--CA 1.442 -0.863 0 C-N-CA 125.84 1.656 . . . . 0.0 112.347 -177.612 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 65.8 m-85 60.06 21.8 10.98 Favored 'General case' 0 C--N 1.358 0.977 0 C-N-CA 127.322 2.249 . . . . 0.0 112.777 178.623 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -119.28 -118.95 2.78 Favored Glycine 0 C--N 1.355 1.597 0 N-CA-C 108.695 -1.762 . . . . 0.0 108.695 -173.847 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' HIS . . . . . 0.597 ' CG ' ' H ' ' A' ' 82' ' ' GLN . 12.5 t-160 -81.34 -171.56 3.34 Favored 'General case' 0 CA--C 1.497 -1.065 0 C-N-CA 125.386 1.475 . . . . 0.0 108.902 -177.852 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . 0.597 ' H ' ' CG ' ' A' ' 81' ' ' HIS . 5.9 pt20 -144.66 146.48 32.27 Favored 'General case' 0 N--CA 1.434 -1.274 0 N-CA-C 106.067 -1.827 . . . . 0.0 106.067 170.127 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . 0.499 ' HG3' ' H ' ' A' ' 2' ' ' GLY . 46.9 mm-40 -105.19 156.22 18.31 Favored 'General case' 0 CA--C 1.494 -1.178 0 N-CA-C 105.897 -1.89 . . . . 0.0 105.897 179.735 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 7.4 p -129.51 135.76 60.83 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.924 0 N-CA-C 107.308 -1.367 . . . . 0.0 107.308 179.741 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 24.7 m -118.62 133.38 55.9 Favored 'General case' 0 N--CA 1.439 -1.001 0 N-CA-C 102.006 -3.331 . . . . 0.0 102.006 175.467 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 78.6 mtm180 -129.17 147.83 51.05 Favored 'General case' 0 CA--C 1.497 -1.081 0 CA-C-N 119.303 0.956 . . . . 0.0 109.187 -177.698 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 18.5 p90 -166.07 -176.1 3.61 Favored 'General case' 0 CA--C 1.498 -1.025 0 N-CA-C 106.826 -1.546 . . . . 0.0 106.826 -174.79 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -134.58 156.72 48.19 Favored 'General case' 0 N--CA 1.44 -0.962 0 N-CA-C 105.596 -2.001 . . . . 0.0 105.596 164.371 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 23.7 p90 -138.13 165.17 27.3 Favored 'General case' 0 CA--C 1.483 -1.629 0 N-CA-C 107.227 -1.397 . . . . 0.0 107.227 169.449 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 29.4 p -119.67 143.89 47.48 Favored 'General case' 0 N--CA 1.439 -1.004 0 N-CA-C 107.374 -1.343 . . . . 0.0 107.374 176.381 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 19.6 p -108.99 135.06 50.78 Favored 'General case' 0 N--CA 1.439 -1.012 0 N-CA-C 103.613 -2.736 . . . . 0.0 103.613 164.608 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 15.2 t -139.72 149.49 43.69 Favored 'General case' 0 N--CA 1.439 -1.005 0 N-CA-C 106.332 -1.729 . . . . 0.0 106.332 -173.742 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 35.4 t . . . . . 0 C--O 1.261 1.685 0 N-CA-C 105.396 -2.076 . . . . 0.0 105.396 177.99 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.442 -0.938 0 N-CA-C 109.136 -1.586 . . . . 0.0 109.136 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 64.4 Cg_exo -61.48 138.23 74.7 Favored 'Trans proline' 0 N--CA 1.442 -1.508 0 C-N-CA 123.241 2.628 . . . . 0.0 112.957 179.643 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 2.8 t -77.45 153.8 5.42 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.728 0 C-N-CA 127.785 2.434 . . . . 0.0 106.339 -178.527 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 48.7 mm-40 -99.03 88.76 4.05 Favored 'General case' 0 CA--C 1.488 -1.405 0 CA-C-O 122.829 1.3 . . . . 0.0 109.14 -170.133 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 2.4 p -105.66 128.01 60.12 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.07 0 CA-C-N 113.43 -1.714 . . . . 0.0 108.685 -164.376 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 27.5 p90 . . . . . 0 N--CA 1.44 -0.97 0 N-CA-C 106.703 -1.592 . . . . 0.0 106.703 -174.584 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 82.0 Cg_endo . . . . . 0 CA--C 1.505 -0.952 0 CA-C-O 117.82 -0.992 . . . . 0.0 111.544 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 4.1 t30 -124.95 -31.99 3.08 Favored 'General case' 0 CA--C 1.488 -1.42 0 CA-C-N 118.637 0.653 . . . . 0.0 109.78 -165.741 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 13.5 p -106.63 141.85 37.24 Favored 'General case' 0 CA--C 1.493 -1.238 0 N-CA-C 107.44 -1.319 . . . . 0.0 107.44 179.22 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 63.0 t60 -141.89 98.22 6.33 Favored Pre-proline 0 N--CA 1.439 -1.024 0 N-CA-C 107.603 -1.258 . . . . 0.0 107.603 176.531 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -78.32 139.11 16.37 Favored 'Trans proline' 0 N--CA 1.449 -1.092 0 C-N-CA 122.814 2.343 . . . . 0.0 110.785 -177.14 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 21.6 mm -106.87 136.27 42.4 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.958 0 N-CA-C 103.104 -2.924 . . . . 0.0 103.104 174.287 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 40.7 mt-30 -138.76 141.28 38.84 Favored 'General case' 0 CA--C 1.491 -1.318 0 N-CA-C 103.494 -2.78 . . . . 0.0 103.494 -178.048 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 46.1 p90 -148.77 167.23 26.14 Favored 'General case' 0 CA--C 1.498 -1.048 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 -170.609 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 9.5 m120 -131.19 129.53 41.82 Favored 'General case' 0 CA--C 1.492 -1.259 0 N-CA-C 107.441 -1.318 . . . . 0.0 107.441 178.868 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -94.71 170.58 7.85 Favored Pre-proline 0 N--CA 1.439 -0.999 0 C-N-CA 124.468 1.107 . . . . 0.0 109.879 -170.97 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 80.2 Cg_exo -66.06 164.13 28.77 Favored 'Trans proline' 0 CA--C 1.508 -0.807 0 C-N-CA 123.633 2.888 . . . . 0.0 112.222 168.929 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 17.4 mp0 -83.3 -57.34 0.43 Allowed Pre-proline 0 N--CA 1.442 -0.826 0 CA-C-O 115.844 -2.027 . . . . 0.0 110.402 -177.132 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -74.87 171.88 17.42 Favored 'Trans proline' 0 CA--C 1.509 -0.743 0 CA-C-N 125.499 3.0 . . . . 0.0 110.349 177.702 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 66.0 m -75.93 125.86 29.9 Favored 'General case' 0 CA--C 1.501 -0.933 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 -179.635 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 74.8 t60 -162.37 -49.89 0.04 OUTLIER 'General case' 0 N--CA 1.436 -1.17 0 N-CA-C 106.202 -1.777 . . . . 0.0 106.202 -172.813 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 54.0 mt -113.06 136.53 49.08 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.142 0 N-CA-C 105.203 -2.147 . . . . 0.0 105.203 -177.109 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 32.1 t -110.53 -87.5 0.52 Allowed 'General case' 0 N--CA 1.43 -1.474 0 N-CA-C 106.717 -1.586 . . . . 0.0 106.717 179.028 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.411 ' HB3' ' HZ2' ' A' ' 32' ' ' LYS . 6.7 ttpm? -91.86 160.49 15.27 Favored 'General case' 0 CA--C 1.492 -1.262 0 C-N-CA 125.667 1.587 . . . . 0.0 107.649 -160.155 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 92.0 m-85 -125.58 138.91 53.96 Favored 'General case' 0 CA--C 1.494 -1.185 0 N-CA-C 106.277 -1.749 . . . . 0.0 106.277 176.072 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 53.5 mt -116.92 126.82 74.55 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.152 0 N-CA-C 102.592 -3.114 . . . . 0.0 102.592 168.483 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 5.0 mt -102.2 128.65 48.61 Favored 'General case' 0 CA--C 1.475 -1.912 0 N-CA-C 104.894 -2.261 . . . . 0.0 104.894 170.556 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 42.4 ttp85 -132.47 122.0 24.23 Favored 'General case' 0 N--CA 1.437 -1.115 0 N-CA-C 106.097 -1.816 . . . . 0.0 106.097 -178.71 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 42.3 p90 -138.06 151.1 47.52 Favored 'General case' 0 N--CA 1.444 -0.757 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 -169.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 33.2 ptt180 -155.92 164.47 21.25 Favored Pre-proline 0 CA--C 1.502 -0.897 0 N-CA-C 106.605 -1.628 . . . . 0.0 106.605 171.384 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -75.69 127.27 10.09 Favored 'Trans proline' 0 N--CA 1.452 -0.932 0 C-N-CA 122.344 2.029 . . . . 0.0 108.983 179.141 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 64.0 tttm -69.75 83.07 0.45 Allowed 'General case' 0 C--N 1.357 0.921 0 C-N-CA 127.349 2.259 . . . . 0.0 110.821 -177.588 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 29.1 m120 -145.9 -89.81 0.1 Allowed 'General case' 0 N--CA 1.437 -1.091 0 N-CA-C 105.054 -2.202 . . . . 0.0 105.054 -175.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' SER . . . . . 0.612 ' HG ' ' H ' ' A' ' 43' ' ' VAL . 3.7 t -94.31 -164.95 1.23 Allowed 'General case' 0 C--N 1.355 0.819 0 C-N-CA 124.032 0.933 . . . . 0.0 108.924 -172.641 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.612 ' H ' ' HG ' ' A' ' 42' ' ' SER . 4.2 m -121.17 54.51 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.439 -1.003 0 N-CA-C 106.307 -1.738 . . . . 0.0 106.307 -176.648 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -89.8 -140.2 7.93 Favored Glycine 0 C--N 1.355 1.595 0 N-CA-C 110.281 -1.128 . . . . 0.0 110.281 -178.179 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -99.33 165.01 11.88 Favored 'General case' 0 CA--C 1.503 -0.831 0 N-CA-C 106.484 -1.672 . . . . 0.0 106.484 -178.332 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 47.3 m95 -112.34 156.73 21.98 Favored 'General case' 0 N--CA 1.441 -0.912 0 N-CA-C 108.071 -1.085 . . . . 0.0 108.071 -179.09 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 67.9 mttm -97.46 152.25 19.17 Favored 'General case' 0 CA--C 1.49 -1.352 0 N-CA-C 104.779 -2.304 . . . . 0.0 104.779 163.824 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -153.18 156.62 38.91 Favored 'General case' 0 CA--C 1.494 -1.191 0 N-CA-C 107.833 -1.173 . . . . 0.0 107.833 178.854 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -141.07 162.93 34.32 Favored 'General case' 0 CA--C 1.496 -1.132 0 N-CA-C 106.349 -1.723 . . . . 0.0 106.349 175.876 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 88.1 m -122.36 127.24 49.51 Favored 'General case' 0 CA--C 1.501 -0.933 0 N-CA-C 105.242 -2.133 . . . . 0.0 105.242 -179.705 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 4.8 mp -117.38 133.88 23.17 Favored Pre-proline 0 N--CA 1.437 -1.106 0 N-CA-C 104.613 -2.366 . . . . 0.0 104.613 -174.725 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_exo -63.32 166.19 15.6 Favored 'Trans proline' 0 CA--C 1.509 -0.742 0 C-N-CA 123.344 2.696 . . . . 0.0 113.616 176.677 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -81.14 -17.18 72.59 Favored Glycine 0 C--N 1.351 1.405 0 C-N-CA 123.557 0.598 . . . . 0.0 113.099 -172.073 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 52.2 p-80 -83.66 -24.8 31.19 Favored 'General case' 0 C--N 1.355 0.841 0 CA-C-N 117.889 0.845 . . . . 0.0 109.862 179.88 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 87.4 mt -88.18 130.67 34.99 Favored 'General case' 0 CA--C 1.501 -0.94 0 N-CA-C 107.645 -1.243 . . . . 0.0 107.645 177.139 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 8.1 p30 -110.15 7.95 23.59 Favored 'General case' 0 N--CA 1.441 -0.881 0 C-N-CA 124.708 1.203 . . . . 0.0 109.758 -174.937 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 42.1 p -146.5 167.03 24.69 Favored 'General case' 0 N--CA 1.439 -1.0 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 -178.14 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 9.3 t80 -153.29 178.37 9.84 Favored 'General case' 0 N--CA 1.439 -1.023 0 N-CA-C 107.1 -1.444 . . . . 0.0 107.1 -178.275 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 70.0 m -142.0 116.22 9.47 Favored 'General case' 0 N--CA 1.43 -1.459 0 N-CA-C 104.812 -2.292 . . . . 0.0 104.812 176.632 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 12.7 mm -85.75 140.18 16.3 Favored 'Isoleucine or valine' 0 C--N 1.358 0.964 0 N-CA-C 103.856 -2.646 . . . . 0.0 103.856 170.332 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 7.9 mtpm? -141.7 164.65 29.64 Favored 'General case' 0 CA--C 1.497 -1.063 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 178.938 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 85.86 49.49 4.28 Favored Glycine 0 CA--C 1.487 -1.669 0 N-CA-C 108.931 -1.668 . . . . 0.0 108.931 174.843 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 58.1 mt -118.77 170.15 9.24 Favored 'General case' 0 CA--C 1.497 -1.071 0 N-CA-C 108.528 -0.916 . . . . 0.0 108.528 -169.864 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 60.6 mtpt -110.46 155.16 42.51 Favored Pre-proline 0 N--CA 1.44 -0.929 0 N-CA-C 106.942 -1.503 . . . . 0.0 106.942 -176.478 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 63.9 Cg_endo -78.94 161.04 27.1 Favored 'Trans proline' 0 N--CA 1.452 -0.966 0 C-N-CA 122.91 2.407 . . . . 0.0 110.308 172.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 59.47 26.27 61.8 Favored Glycine 0 C--N 1.355 1.586 0 C-N-CA 127.673 2.559 . . . . 0.0 116.378 171.29 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 10.7 p -121.77 147.45 25.76 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.992 0 N-CA-C 107.362 -1.348 . . . . 0.0 107.362 -177.203 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 4.0 p -96.73 129.15 47.19 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.951 0 N-CA-C 106.93 -1.507 . . . . 0.0 106.93 177.125 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 93.4 m-85 -111.18 144.84 39.7 Favored 'General case' 0 CA--C 1.496 -1.113 0 N-CA-C 106.043 -1.836 . . . . 0.0 106.043 173.124 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -96.72 145.12 26.09 Favored 'General case' 0 CA--C 1.496 -1.128 0 N-CA-C 104.475 -2.417 . . . . 0.0 104.475 166.103 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -140.97 155.77 25.16 Favored Glycine 0 CA--C 1.486 -1.731 0 N-CA-C 108.624 -1.791 . . . . 0.0 108.624 -176.275 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 86.8 mt-30 -142.9 134.39 26.34 Favored 'General case' 0 CA--C 1.479 -1.782 0 N-CA-C 104.456 -2.424 . . . . 0.0 104.456 -179.333 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 35.6 tp -114.77 96.17 5.59 Favored 'General case' 0 N--CA 1.437 -1.102 0 N-CA-C 103.659 -2.719 . . . . 0.0 103.659 176.468 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 21.8 mt -88.76 135.37 25.92 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.048 0 N-CA-C 104.213 -2.514 . . . . 0.0 104.213 -177.275 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 14.2 p -124.96 112.14 16.24 Favored 'General case' 0 N--CA 1.435 -1.212 0 N-CA-C 107.777 -1.194 . . . . 0.0 107.777 -171.771 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 2.0 mp -93.48 134.84 29.87 Favored 'Isoleucine or valine' 0 CA--C 1.488 -1.41 0 N-CA-C 104.506 -2.405 . . . . 0.0 104.506 -165.703 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 74.4 mt-30 -92.66 149.9 21.04 Favored 'General case' 0 CA--C 1.493 -1.249 0 N-CA-C 106.522 -1.659 . . . . 0.0 106.522 -178.687 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 44.6 tt0 -70.46 105.71 3.16 Favored 'General case' 0 N--CA 1.441 -0.894 0 C-N-CA 123.44 0.696 . . . . 0.0 110.408 -177.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 31.6 m-85 59.94 41.03 18.29 Favored 'General case' 0 C--N 1.356 0.883 0 C-N-CA 127.094 2.157 . . . . 0.0 112.469 -178.626 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -149.94 -126.11 1.39 Allowed Glycine 0 C--N 1.358 1.752 0 N-CA-C 109.283 -1.527 . . . . 0.0 109.283 178.738 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 47.1 m80 -85.11 -176.26 6.1 Favored 'General case' 0 CA--C 1.497 -1.071 0 C-N-CA 126.107 1.763 . . . . 0.0 111.436 -165.555 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 70.1 mt-30 -130.42 144.47 51.41 Favored 'General case' 0 CA--C 1.496 -1.101 0 N-CA-C 103.975 -2.602 . . . . 0.0 103.975 168.659 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 57.3 mt-10 -131.28 131.32 43.77 Favored 'General case' 0 CA--C 1.491 -1.304 0 N-CA-C 105.312 -2.107 . . . . 0.0 105.312 179.721 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 12.4 p -104.48 134.82 44.78 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.799 0 N-CA-C 108.137 -1.06 . . . . 0.0 108.137 -174.914 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 40.0 m -109.11 131.71 54.81 Favored 'General case' 0 N--CA 1.44 -0.926 0 N-CA-C 101.831 -3.396 . . . . 0.0 101.831 171.403 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 87.5 mtt180 -123.75 149.01 46.11 Favored 'General case' 0 CA--C 1.494 -1.174 0 CA-C-N 119.491 1.041 . . . . 0.0 109.901 -177.92 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 14.8 p90 -163.25 -179.61 6.73 Favored 'General case' 0 CA--C 1.499 -0.988 0 N-CA-C 107.209 -1.404 . . . . 0.0 107.209 -179.149 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 9.3 p-10 -141.31 160.16 40.7 Favored 'General case' 0 N--CA 1.44 -0.963 0 N-CA-C 105.865 -1.902 . . . . 0.0 105.865 167.005 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 23.4 p90 -148.3 170.17 18.5 Favored 'General case' 0 CA--C 1.49 -1.358 0 N-CA-C 107.332 -1.358 . . . . 0.0 107.332 177.294 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 23.9 p -119.25 142.53 47.97 Favored 'General case' 0 CA--C 1.498 -1.024 0 N-CA-C 105.696 -1.965 . . . . 0.0 105.696 171.458 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 45.0 m -115.7 119.83 37.35 Favored 'General case' 0 CA--C 1.495 -1.143 0 N-CA-C 102.614 -3.106 . . . . 0.0 102.614 170.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 14.1 t -154.38 159.19 41.0 Favored 'General case' 0 N--CA 1.436 -1.144 0 N-CA-C 105.901 -1.888 . . . . 0.0 105.901 -173.205 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 9.4 t . . . . . 0 C--O 1.262 1.714 0 N-CA-C 106.356 -1.72 . . . . 0.0 106.356 175.042 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.438 -1.206 0 N-CA-C 106.767 -2.533 . . . . 0.0 106.767 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_exo -61.2 142.47 96.63 Favored 'Trans proline' 0 N--CA 1.446 -1.307 0 C-N-CA 122.837 2.358 . . . . 0.0 114.523 -171.68 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 4.4 t -76.27 154.29 5.89 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.83 0 C-N-CA 127.889 2.476 . . . . 0.0 106.608 -179.06 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 56.6 mm-40 -99.81 92.88 5.51 Favored 'General case' 0 CA--C 1.49 -1.357 0 N-CA-C 107.412 -1.329 . . . . 0.0 107.412 -177.613 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 1.3 p -108.1 131.32 58.82 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.067 0 CA-C-N 113.15 -1.841 . . . . 0.0 108.684 -164.512 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 40.0 m-85 . . . . . 0 CA--C 1.498 -1.027 0 N-CA-C 106.611 -1.626 . . . . 0.0 106.611 173.823 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 95.7 Cg_endo . . . . . 0 N--CA 1.452 -0.928 0 CA-C-O 118.115 -0.869 . . . . 0.0 110.596 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 48.5 m-20 -125.02 -20.92 4.8 Favored 'General case' 0 N--CA 1.434 -1.25 0 C-N-CA 123.617 0.767 . . . . 0.0 109.938 -171.791 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 19.4 m -103.8 142.0 35.13 Favored 'General case' 0 CA--C 1.494 -1.192 0 N-CA-C 106.993 -1.484 . . . . 0.0 106.993 178.677 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 61.6 t-80 -139.29 98.0 8.37 Favored Pre-proline 0 N--CA 1.434 -1.273 0 N-CA-C 105.513 -2.032 . . . . 0.0 105.513 176.819 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -80.55 148.86 18.45 Favored 'Trans proline' 0 N--CA 1.445 -1.327 0 C-N-CA 122.468 2.112 . . . . 0.0 109.403 174.315 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 5.0 pt -124.38 170.72 14.19 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.031 0 N-CA-C 107.525 -1.287 . . . . 0.0 107.525 172.324 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 32.5 mt-30 -139.04 161.17 38.04 Favored 'General case' 0 CA--C 1.501 -0.926 0 N-CA-C 105.161 -2.163 . . . . 0.0 105.161 167.884 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 49.5 p90 -148.56 169.39 20.41 Favored 'General case' 0 CA--C 1.497 -1.089 0 N-CA-C 108.136 -1.061 . . . . 0.0 108.136 175.679 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 20.8 m-80 -134.12 126.04 29.21 Favored 'General case' 0 CA--C 1.491 -1.308 0 N-CA-C 105.573 -2.01 . . . . 0.0 105.573 173.965 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -105.75 175.96 1.9 Allowed Pre-proline 0 N--CA 1.44 -0.969 0 C-N-CA 125.823 1.649 . . . . 0.0 107.647 -169.967 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_exo -61.6 144.86 97.92 Favored 'Trans proline' 0 N--CA 1.455 -0.766 0 C-N-CA 123.174 2.583 . . . . 0.0 113.151 176.488 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 22.0 tt0 -82.8 -39.98 0.83 Allowed Pre-proline 0 N--CA 1.443 -0.818 0 CA-C-O 115.564 -2.16 . . . . 0.0 112.726 -173.034 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 76.2 Cg_exo -72.18 4.65 3.15 Favored 'Trans proline' 0 C--N 1.349 0.561 0 CA-C-N 125.687 3.067 . . . . 0.0 114.679 -178.234 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 34.7 m 71.89 64.66 0.14 Allowed 'General case' 0 CA--C 1.499 -0.984 0 C-N-CA 126.464 1.905 . . . . 0.0 109.06 -178.432 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 55.9 t-80 -87.0 -28.11 22.83 Favored 'General case' 0 N--CA 1.44 -0.957 0 C-N-CA 125.127 1.371 . . . . 0.0 108.25 178.772 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 8.2 mm -119.29 147.61 22.76 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.15 0 N-CA-C 106.395 -1.706 . . . . 0.0 106.395 -170.959 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 74.5 m -99.35 -83.9 0.42 Allowed 'General case' 0 N--CA 1.43 -1.45 0 N-CA-C 106.406 -1.701 . . . . 0.0 106.406 175.896 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 45.5 mtpt -90.0 170.48 10.32 Favored 'General case' 0 CA--C 1.49 -1.349 0 C-N-CA 125.259 1.424 . . . . 0.0 109.198 -164.242 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 42.2 m-85 -131.39 145.4 51.8 Favored 'General case' 0 CA--C 1.498 -1.032 0 N-CA-C 104.589 -2.374 . . . . 0.0 104.589 166.624 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 33.1 mt -123.34 137.37 56.89 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.188 0 N-CA-C 101.792 -3.41 . . . . 0.0 101.792 170.248 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 4.7 mt -114.09 134.47 54.86 Favored 'General case' 0 CA--C 1.467 -2.214 0 N-CA-C 104.64 -2.356 . . . . 0.0 104.64 168.764 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 49.0 mtp180 -118.05 158.74 24.44 Favored 'General case' 0 N--CA 1.431 -1.417 0 N-CA-C 105.381 -2.081 . . . . 0.0 105.381 167.301 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 49.5 p90 -152.63 158.29 42.21 Favored 'General case' 0 N--CA 1.435 -1.21 0 N-CA-C 105.981 -1.859 . . . . 0.0 105.981 173.033 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 46.9 ttp180 -165.08 135.99 3.14 Favored Pre-proline 0 CA--C 1.497 -1.078 0 N-CA-C 104.783 -2.303 . . . . 0.0 104.783 -174.168 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -73.06 117.06 4.95 Favored 'Trans proline' 0 CA--C 1.505 -0.969 0 C-N-CA 122.766 2.311 . . . . 0.0 109.132 -176.829 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 37.9 ttpt -70.71 88.0 0.7 Allowed 'General case' 0 CA--C 1.499 -0.982 0 C-N-CA 126.414 1.886 . . . . 0.0 109.621 -179.939 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 -154.32 -58.55 0.12 Allowed 'General case' 0 N--CA 1.431 -1.401 0 N-CA-C 103.447 -2.797 . . . . 0.0 103.447 -178.521 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' SER . . . . . 0.577 ' HG ' ' H ' ' A' ' 43' ' ' VAL . 6.4 t -107.32 -167.53 1.28 Allowed 'General case' 0 N--CA 1.439 -0.977 0 N-CA-C 105.228 -2.138 . . . . 0.0 105.228 169.376 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.577 ' H ' ' HG ' ' A' ' 42' ' ' SER . 2.7 m -134.84 63.44 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.44 -0.957 0 N-CA-C 104.823 -2.288 . . . . 0.0 104.823 179.18 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -91.23 -134.71 6.21 Favored Glycine 0 C--N 1.354 1.545 0 N-CA-C 109.819 -1.312 . . . . 0.0 109.819 -176.415 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -94.37 149.57 21.12 Favored 'General case' 0 CA--C 1.499 -1.003 0 N-CA-C 106.871 -1.529 . . . . 0.0 106.871 -176.498 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 64.2 m95 -93.84 151.42 19.61 Favored 'General case' 0 N--CA 1.439 -1.022 0 N-CA-C 107.703 -1.221 . . . . 0.0 107.703 178.825 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 61.9 mttp -96.99 152.32 18.84 Favored 'General case' 0 CA--C 1.488 -1.433 0 N-CA-C 104.105 -2.554 . . . . 0.0 104.105 161.073 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -152.69 155.44 37.27 Favored 'General case' 0 N--CA 1.435 -1.204 0 N-CA-C 108.23 -1.026 . . . . 0.0 108.23 -178.073 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -140.85 161.48 37.72 Favored 'General case' 0 CA--C 1.498 -1.028 0 N-CA-C 106.556 -1.646 . . . . 0.0 106.556 174.74 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 87.0 m -118.83 124.82 48.12 Favored 'General case' 0 CA--C 1.5 -0.954 0 N-CA-C 105.517 -2.031 . . . . 0.0 105.517 178.807 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 3.9 mp -106.13 134.37 19.8 Favored Pre-proline 0 N--CA 1.437 -1.099 0 N-CA-C 105.279 -2.119 . . . . 0.0 105.279 -177.468 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_exo -63.93 163.07 26.53 Favored 'Trans proline' 0 CA--C 1.507 -0.833 0 C-N-CA 123.491 2.794 . . . . 0.0 113.146 176.115 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -74.49 -17.14 79.82 Favored Glycine 0 C--N 1.351 1.41 0 C-N-CA 124.006 0.812 . . . . 0.0 114.477 -173.68 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 49.1 p-80 -84.04 -28.69 27.45 Favored 'General case' 0 C--N 1.355 0.826 0 CA-C-N 118.144 0.972 . . . . 0.0 110.22 -179.69 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 89.1 mt -88.74 130.83 35.26 Favored 'General case' 0 CA--C 1.5 -0.961 0 N-CA-C 107.94 -1.133 . . . . 0.0 107.94 178.07 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 7.7 p30 -117.1 11.37 14.18 Favored 'General case' 0 CA--C 1.503 -0.835 0 C-N-CA 124.225 1.01 . . . . 0.0 109.774 -173.563 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 28.1 p -141.02 159.83 41.38 Favored 'General case' 0 CA--C 1.497 -1.081 0 N-CA-C 106.583 -1.636 . . . . 0.0 106.583 179.427 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 7.9 t80 -135.65 172.95 12.27 Favored 'General case' 0 C--N 1.359 1.003 0 CA-C-O 121.829 0.823 . . . . 0.0 109.254 178.84 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 98.8 m -137.18 110.79 8.04 Favored 'General case' 0 N--CA 1.434 -1.257 0 N-CA-C 104.425 -2.435 . . . . 0.0 104.425 173.77 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 24.9 mt -89.28 143.39 11.27 Favored 'Isoleucine or valine' 0 C--N 1.358 0.945 0 N-CA-C 103.662 -2.718 . . . . 0.0 103.662 169.854 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -149.55 158.1 43.87 Favored 'General case' 0 CA--C 1.491 -1.302 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 -178.85 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 77.75 56.58 3.79 Favored Glycine 0 C--N 1.354 1.561 0 N-CA-C 108.984 -1.646 . . . . 0.0 108.984 -179.904 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 69.1 mt -117.08 -160.83 0.78 Allowed 'General case' 0 CA--C 1.5 -0.944 0 N-CA-C 106.584 -1.636 . . . . 0.0 106.584 -179.012 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -131.39 153.42 81.62 Favored Pre-proline 0 N--CA 1.443 -0.811 0 N-CA-C 106.067 -1.827 . . . . 0.0 106.067 -177.78 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 67.6 Cg_endo -79.4 162.45 25.12 Favored 'Trans proline' 0 N--CA 1.453 -0.886 0 C-N-CA 122.858 2.372 . . . . 0.0 109.925 171.893 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 61.17 26.96 66.62 Favored Glycine 0 N--CA 1.431 -1.646 0 C-N-CA 127.27 2.367 . . . . 0.0 115.972 171.509 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 9.1 p -127.59 142.92 42.31 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.116 0 N-CA-C 108.28 -1.007 . . . . 0.0 108.28 -177.83 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 7.5 p -95.58 128.41 46.79 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.929 0 N-CA-C 107.463 -1.31 . . . . 0.0 107.463 177.029 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 91.5 m-85 -107.73 148.46 29.42 Favored 'General case' 0 CA--C 1.498 -1.039 0 N-CA-C 106.382 -1.71 . . . . 0.0 106.382 174.235 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -98.98 140.04 33.73 Favored 'General case' 0 CA--C 1.496 -1.121 0 N-CA-C 104.397 -2.445 . . . . 0.0 104.397 161.826 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -131.96 153.29 20.45 Favored Glycine 0 CA--C 1.484 -1.848 0 N-CA-C 107.688 -2.165 . . . . 0.0 107.688 -175.807 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 36.7 mt-30 -135.58 136.18 40.88 Favored 'General case' 0 CA--C 1.478 -1.791 0 N-CA-C 105.935 -1.876 . . . . 0.0 105.935 175.166 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 27.1 tp -114.39 103.31 10.94 Favored 'General case' 0 N--CA 1.438 -1.063 0 N-CA-C 104.179 -2.526 . . . . 0.0 104.179 176.456 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 24.4 mt -103.25 125.11 57.77 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.973 0 N-CA-C 104.068 -2.568 . . . . 0.0 104.068 -174.23 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 74.2 m -110.28 120.75 43.45 Favored 'General case' 0 CA--C 1.497 -1.091 0 N-CA-C 108.251 -1.018 . . . . 0.0 108.251 -175.653 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 1.8 mp -99.85 138.38 24.38 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.123 0 N-CA-C 104.647 -2.353 . . . . 0.0 104.647 -170.798 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 16.3 tt0 -105.09 127.84 53.07 Favored 'General case' 0 CA--C 1.494 -1.207 0 N-CA-C 102.02 -3.326 . . . . 0.0 102.02 170.692 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 63.5 tp60 -68.38 114.68 7.03 Favored 'General case' 0 C--N 1.355 0.825 0 C-N-CA 123.117 0.567 . . . . 0.0 111.163 -168.77 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 44.4 m-85 59.33 51.68 6.57 Favored 'General case' 0 C--N 1.358 0.936 0 C-N-CA 126.917 2.087 . . . . 0.0 111.703 -175.498 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -164.73 -117.29 0.4 Allowed Glycine 0 N--CA 1.434 -1.464 0 N-CA-C 108.503 -1.839 . . . . 0.0 108.503 178.042 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 24.0 t-80 -82.08 165.52 20.52 Favored 'General case' 0 N--CA 1.441 -0.919 0 C-N-CA 125.706 1.603 . . . . 0.0 110.795 -169.097 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 41.6 mt-30 -139.96 128.67 23.14 Favored 'General case' 0 CA--C 1.495 -1.151 0 N-CA-C 104.192 -2.521 . . . . 0.0 104.192 169.044 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -99.82 154.31 18.44 Favored 'General case' 0 CA--C 1.498 -1.033 0 N-CA-C 105.363 -2.088 . . . . 0.0 105.363 175.598 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 7.6 p -135.26 135.71 51.93 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.885 0 N-CA-C 107.929 -1.137 . . . . 0.0 107.929 177.533 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 48.6 m -122.01 141.5 51.28 Favored 'General case' 0 N--CA 1.44 -0.939 0 N-CA-C 103.143 -2.91 . . . . 0.0 103.143 175.742 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 32.2 ttm180 -131.72 139.42 49.0 Favored 'General case' 0 CA--C 1.502 -0.891 0 N-CA-C 107.805 -1.183 . . . . 0.0 107.805 170.346 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 8.2 p90 -146.25 179.58 7.41 Favored 'General case' 0 N--CA 1.439 -0.979 0 N-CA-C 105.807 -1.923 . . . . 0.0 105.807 177.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 52.9 m-20 -128.09 152.95 47.37 Favored 'General case' 0 CA--C 1.5 -0.96 0 N-CA-C 105.757 -1.942 . . . . 0.0 105.757 169.481 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 21.8 p90 -143.56 166.37 25.02 Favored 'General case' 0 CA--C 1.485 -1.548 0 N-CA-C 107.498 -1.297 . . . . 0.0 107.498 170.42 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 27.8 p -118.56 143.3 46.86 Favored 'General case' 0 CA--C 1.497 -1.082 0 N-CA-C 106.051 -1.833 . . . . 0.0 106.051 173.672 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 30.3 m -118.39 113.18 21.0 Favored 'General case' 0 CA--C 1.494 -1.185 0 N-CA-C 101.576 -3.49 . . . . 0.0 101.576 170.068 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 10.0 t -157.57 -37.37 0.07 Allowed 'General case' 0 N--CA 1.437 -1.088 0 N-CA-C 107.819 -1.178 . . . . 0.0 107.819 -169.088 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 89.4 p . . . . . 0 C--O 1.259 1.592 0 C-N-CA 126.962 2.105 . . . . 0.0 112.192 -174.66 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.436 -1.353 0 N-CA-C 107.075 -2.41 . . . . 0.0 107.075 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_exo -60.23 146.8 95.62 Favored 'Trans proline' 0 N--CA 1.446 -1.309 0 C-N-CA 123.151 2.567 . . . . 0.0 115.553 -169.676 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 6.7 t -77.42 153.12 5.44 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.773 0 C-N-CA 127.631 2.372 . . . . 0.0 105.424 174.309 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 94.7 mt-10 -100.27 95.26 6.67 Favored 'General case' 0 CA--C 1.494 -1.19 0 CA-C-O 121.885 0.85 . . . . 0.0 108.742 -170.621 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 1.8 p -115.3 136.05 53.32 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.999 0 C-N-CA 124.938 1.295 . . . . 0.0 108.365 -164.777 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 83.3 m-85 . . . . . 0 CA--C 1.498 -1.03 0 C-N-CA 125.063 1.345 . . . . 0.0 108.589 -179.14 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo . . . . . 0 N--CA 1.449 -1.089 0 CA-C-O 118.293 -0.794 . . . . 0.0 110.565 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -165.8 -39.22 0.03 OUTLIER 'General case' 0 CA--C 1.488 -1.412 0 O-C-N 123.711 0.632 . . . . 0.0 110.469 -174.854 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 15.5 p -126.42 138.22 53.51 Favored 'General case' 0 CA--C 1.489 -1.371 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 -169.078 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 67.7 t60 -117.56 113.75 38.34 Favored Pre-proline 0 N--CA 1.438 -1.027 0 CA-C-N 114.238 -1.346 . . . . 0.0 107.878 -175.377 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 62.5 Cg_endo -78.28 128.6 9.02 Favored 'Trans proline' 0 N--CA 1.45 -1.04 0 C-N-CA 122.949 2.433 . . . . 0.0 110.405 175.813 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 9.6 mm -105.92 136.08 41.65 Favored 'Isoleucine or valine' 0 C--N 1.354 0.792 0 N-CA-C 103.485 -2.783 . . . . 0.0 103.485 169.833 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 67.5 mt-30 -136.41 147.8 47.46 Favored 'General case' 0 CA--C 1.495 -1.148 0 N-CA-C 104.562 -2.384 . . . . 0.0 104.562 174.18 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 45.9 p90 -147.15 170.04 18.03 Favored 'General case' 0 CA--C 1.494 -1.186 0 N-CA-C 108.002 -1.11 . . . . 0.0 108.002 -175.673 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 26.6 m-80 -136.01 131.82 35.5 Favored 'General case' 0 CA--C 1.49 -1.354 0 N-CA-C 105.377 -2.083 . . . . 0.0 105.377 177.635 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -101.2 170.91 5.94 Favored Pre-proline 0 N--CA 1.439 -0.992 0 C-N-CA 124.541 1.136 . . . . 0.0 108.402 -172.651 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_exo -64.9 165.32 21.63 Favored 'Trans proline' 0 CA--C 1.51 -0.694 0 C-N-CA 123.701 2.934 . . . . 0.0 112.83 173.712 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 79.8 mt-30 -81.51 -55.61 0.62 Allowed Pre-proline 0 N--CA 1.442 -0.829 0 CA-C-O 115.612 -2.137 . . . . 0.0 112.042 -175.58 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_endo -75.29 173.56 14.3 Favored 'Trans proline' 0 CA--C 1.509 -0.726 0 CA-C-N 125.797 3.106 . . . . 0.0 110.431 -179.581 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 52.3 p -73.1 123.83 24.35 Favored 'General case' 0 C--N 1.355 0.845 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 179.014 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 58.7 t60 -160.85 -50.78 0.05 OUTLIER 'General case' 0 CA--C 1.492 -1.253 0 N-CA-C 106.639 -1.615 . . . . 0.0 106.639 -165.143 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 35.5 mt -116.7 140.3 39.73 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.169 0 N-CA-C 105.217 -2.142 . . . . 0.0 105.217 -175.625 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 72.8 m -106.06 -87.55 0.46 Allowed 'General case' 0 N--CA 1.429 -1.484 0 N-CA-C 105.916 -1.883 . . . . 0.0 105.916 178.605 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 53.9 mtmt -91.41 172.33 8.6 Favored 'General case' 0 CA--C 1.485 -1.547 0 C-N-CA 124.927 1.291 . . . . 0.0 108.235 -166.838 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 36.1 m-85 -131.5 151.91 51.17 Favored 'General case' 0 CA--C 1.496 -1.11 0 N-CA-C 105.071 -2.196 . . . . 0.0 105.071 169.164 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 24.6 mt -121.28 134.23 65.3 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.162 0 N-CA-C 101.939 -3.356 . . . . 0.0 101.939 164.941 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 6.5 mt -105.93 123.6 48.23 Favored 'General case' 0 CA--C 1.48 -1.748 0 N-CA-C 104.011 -2.589 . . . . 0.0 104.011 166.669 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 42.8 ttp85 -127.7 123.5 35.58 Favored 'General case' 0 N--CA 1.436 -1.128 0 N-CA-C 105.515 -2.032 . . . . 0.0 105.515 -179.094 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 41.6 p90 -136.86 150.29 48.19 Favored 'General case' 0 CA--C 1.503 -0.841 0 N-CA-C 107.681 -1.229 . . . . 0.0 107.681 -170.89 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 43.3 ptt85 -141.33 158.4 63.99 Favored Pre-proline 0 CA--C 1.499 -1.0 0 N-CA-C 105.754 -1.943 . . . . 0.0 105.754 168.713 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -72.3 164.96 34.04 Favored 'Trans proline' 0 N--CA 1.453 -0.856 0 C-N-CA 123.306 2.671 . . . . 0.0 107.811 162.45 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 5.4 ptmm? -63.66 88.02 0.04 OUTLIER 'General case' 0 C--N 1.357 0.914 0 CA-C-O 122.584 1.183 . . . . 0.0 112.592 172.402 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 31.5 m120 -130.39 -132.09 0.21 Allowed 'General case' 0 N--CA 1.44 -0.952 0 N-CA-C 104.593 -2.373 . . . . 0.0 104.593 176.302 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 57.0 p -99.44 174.24 6.37 Favored 'General case' 0 C--N 1.355 0.811 0 N-CA-C 107.671 -1.233 . . . . 0.0 107.671 176.388 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 9.5 m -100.6 41.63 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.354 0.772 0 C-N-CA 124.758 1.223 . . . . 0.0 108.142 179.128 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -85.13 -99.62 0.68 Allowed Glycine 0 C--N 1.355 1.587 0 N-CA-C 108.532 -1.827 . . . . 0.0 108.532 -179.618 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 96.3 mtm-85 -97.93 141.55 30.76 Favored 'General case' 0 CA--C 1.499 -1.012 0 N-CA-C 107.204 -1.406 . . . . 0.0 107.204 176.278 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 14.6 m95 -121.63 171.78 8.59 Favored 'General case' 0 N--CA 1.439 -1.014 0 N-CA-C 105.413 -2.069 . . . . 0.0 105.413 -177.366 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -101.72 150.27 23.3 Favored 'General case' 0 CA--C 1.486 -1.491 0 N-CA-C 105.072 -2.196 . . . . 0.0 105.072 169.167 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -153.96 158.18 40.27 Favored 'General case' 0 CA--C 1.495 -1.171 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 179.841 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -138.59 160.12 40.39 Favored 'General case' 0 N--CA 1.438 -1.068 0 N-CA-C 105.186 -2.153 . . . . 0.0 105.186 173.94 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 81.6 m -115.88 123.15 47.4 Favored 'General case' 0 CA--C 1.496 -1.12 0 N-CA-C 104.775 -2.306 . . . . 0.0 104.775 177.895 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 3.8 mm -101.18 135.59 19.88 Favored Pre-proline 0 N--CA 1.437 -1.095 0 N-CA-C 105.669 -1.975 . . . . 0.0 105.669 -176.349 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 95.4 Cg_exo -63.69 161.02 33.81 Favored 'Trans proline' 0 CA--C 1.508 -0.805 0 C-N-CA 123.354 2.703 . . . . 0.0 112.257 172.093 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -78.38 -18.25 76.39 Favored Glycine 0 C--N 1.352 1.448 0 C-N-CA 123.439 0.543 . . . . 0.0 113.491 -172.685 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 48.0 p-80 -83.78 -27.18 29.02 Favored 'General case' 0 C--N 1.355 0.838 0 CA-C-N 117.695 0.747 . . . . 0.0 109.923 179.737 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 88.3 mt -88.74 130.43 35.34 Favored 'General case' 0 CA--C 1.498 -1.043 0 N-CA-C 107.977 -1.119 . . . . 0.0 107.977 177.539 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 7.7 p30 -117.98 16.67 14.23 Favored 'General case' 0 CA--C 1.501 -0.929 0 C-N-CA 124.359 1.064 . . . . 0.0 108.935 -177.026 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 35.9 p -144.53 161.77 38.24 Favored 'General case' 0 N--CA 1.438 -1.039 0 N-CA-C 107.204 -1.406 . . . . 0.0 107.204 -179.796 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 12.0 t80 -152.83 178.65 9.42 Favored 'General case' 0 N--CA 1.438 -1.032 0 N-CA-C 106.955 -1.498 . . . . 0.0 106.955 179.687 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 80.8 m -144.34 115.59 7.98 Favored 'General case' 0 N--CA 1.426 -1.633 0 N-CA-C 103.752 -2.684 . . . . 0.0 103.752 174.421 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 53.9 mt -92.58 108.38 20.18 Favored 'Isoleucine or valine' 0 C--N 1.354 0.767 0 N-CA-C 105.236 -2.135 . . . . 0.0 105.236 175.906 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 10.0 mtmp? -108.23 163.74 12.91 Favored 'General case' 0 CA--C 1.498 -1.054 0 CA-C-O 121.547 0.689 . . . . 0.0 109.143 -175.531 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 80.37 50.67 5.28 Favored Glycine 0 CA--C 1.489 -1.552 0 N-CA-C 108.713 -1.755 . . . . 0.0 108.713 174.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 75.7 mt -121.72 163.81 18.45 Favored 'General case' 0 CA--C 1.498 -1.027 0 N-CA-C 106.954 -1.499 . . . . 0.0 106.954 -175.748 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 53.2 mtmt -98.78 147.83 33.73 Favored Pre-proline 0 N--CA 1.44 -0.926 0 N-CA-C 107.026 -1.472 . . . . 0.0 107.026 -177.096 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -76.58 162.66 32.82 Favored 'Trans proline' 0 N--CA 1.451 -1.025 0 C-N-CA 122.95 2.433 . . . . 0.0 109.85 169.832 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 63.34 23.44 66.49 Favored Glycine 0 N--CA 1.428 -1.84 0 C-N-CA 127.417 2.437 . . . . 0.0 116.619 174.905 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 6.5 p -128.84 145.39 35.76 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.857 0 N-CA-C 107.966 -1.124 . . . . 0.0 107.966 -179.684 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 10.7 p -96.83 129.94 46.15 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.857 0 CA-C-O 123.187 1.47 . . . . 0.0 108.537 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 80.0 m-85 -104.65 145.11 30.79 Favored 'General case' 0 N--CA 1.432 -1.373 0 N-CA-C 106.435 -1.691 . . . . 0.0 106.435 176.563 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -91.02 133.1 35.58 Favored 'General case' 0 N--CA 1.442 -0.855 0 N-CA-C 105.336 -2.098 . . . . 0.0 105.336 159.502 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -130.26 158.69 22.51 Favored Glycine 0 C--N 1.355 1.61 0 N-CA-C 108.229 -1.948 . . . . 0.0 108.229 -179.897 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 32.0 mt-30 -149.77 138.57 20.96 Favored 'General case' 0 CA--C 1.484 -1.561 0 N-CA-C 105.422 -2.066 . . . . 0.0 105.422 -178.717 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 52.7 tp -117.47 98.21 6.28 Favored 'General case' 0 N--CA 1.437 -1.08 0 N-CA-C 104.846 -2.279 . . . . 0.0 104.846 179.436 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 48.0 mt -89.63 133.98 30.13 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.962 0 N-CA-C 104.558 -2.386 . . . . 0.0 104.558 -179.585 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 12.1 p -117.13 117.4 29.49 Favored 'General case' 0 N--CA 1.438 -1.075 0 N-CA-C 107.728 -1.212 . . . . 0.0 107.728 -178.427 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 2.6 mp -94.07 130.67 42.66 Favored 'Isoleucine or valine' 0 CA--C 1.487 -1.478 0 N-CA-C 103.455 -2.795 . . . . 0.0 103.455 -172.677 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 21.5 mt-30 -101.84 161.89 13.32 Favored 'General case' 0 CA--C 1.491 -1.295 0 CA-C-N 114.849 -1.069 . . . . 0.0 108.817 -169.845 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 14.4 pt20 -76.29 34.0 0.13 Allowed 'General case' 0 C--N 1.354 0.794 0 C-N-CA 126.537 1.935 . . . . 0.0 113.186 173.943 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 6.4 t80 -148.67 14.13 0.94 Allowed 'General case' 0 N--CA 1.437 -1.095 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 178.366 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 80.26 1.84 88.57 Favored Glycine 0 C--N 1.351 1.412 0 C-N-CA 123.897 0.761 . . . . 0.0 112.732 176.864 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 86.2 t60 -81.9 158.47 23.96 Favored 'General case' 0 N--CA 1.44 -0.953 0 N-CA-C 107.842 -1.17 . . . . 0.0 107.842 -178.918 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 71.7 mt-30 -138.33 110.29 7.24 Favored 'General case' 0 CA--C 1.491 -1.322 0 N-CA-C 102.854 -3.017 . . . . 0.0 102.854 178.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 16.8 tp10 -100.76 132.1 46.32 Favored 'General case' 0 CA--C 1.495 -1.153 0 N-CA-C 105.215 -2.143 . . . . 0.0 105.215 -179.94 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 6.6 p -109.25 134.94 49.69 Favored 'Isoleucine or valine' 0 C--N 1.355 0.818 0 N-CA-C 107.58 -1.267 . . . . 0.0 107.58 -174.061 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 90.8 m -110.66 138.61 46.83 Favored 'General case' 0 N--CA 1.44 -0.927 0 N-CA-C 102.477 -3.157 . . . . 0.0 102.477 171.272 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 16.7 ptm180 -129.67 152.39 49.23 Favored 'General case' 0 CA--C 1.499 -1.011 0 CA-C-N 118.84 0.745 . . . . 0.0 110.025 176.918 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 18.5 p90 -165.53 -177.95 4.67 Favored 'General case' 0 CA--C 1.5 -0.956 0 N-CA-C 106.323 -1.732 . . . . 0.0 106.323 -175.731 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 45.7 p-10 -134.22 158.16 44.42 Favored 'General case' 0 N--CA 1.44 -0.945 0 N-CA-C 106.286 -1.746 . . . . 0.0 106.286 166.608 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 24.3 p90 -143.1 164.61 29.67 Favored 'General case' 0 CA--C 1.482 -1.641 0 N-CA-C 106.785 -1.561 . . . . 0.0 106.785 170.838 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 38.4 p -113.73 141.61 47.05 Favored 'General case' 0 CA--C 1.498 -1.042 0 N-CA-C 105.919 -1.882 . . . . 0.0 105.919 172.749 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 97.5 m -109.57 112.84 25.16 Favored 'General case' 0 CA--C 1.491 -1.325 1 N-CA-C 100.189 -4.004 . . . . 0.0 100.189 168.041 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 11.9 t -159.24 149.79 19.49 Favored 'General case' 0 N--CA 1.437 -1.113 0 N-CA-C 105.375 -2.083 . . . . 0.0 105.375 -174.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 25.7 t . . . . . 0 C--O 1.261 1.708 0 N-CA-C 104.89 -2.263 . . . . 0.0 104.89 171.411 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.435 -1.383 0 N-CA-C 106.309 -2.716 . . . . 0.0 106.309 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . 0.423 ' HA ' ' HG1' ' A' ' 85' ' ' THR . 92.5 Cg_exo -62.37 138.14 69.46 Favored 'Trans proline' 0 N--CA 1.445 -1.356 0 C-N-CA 122.923 2.416 . . . . 0.0 112.973 -171.282 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 2.9 t -77.76 152.65 5.35 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.672 0 C-N-CA 126.443 1.897 . . . . 0.0 106.098 -179.805 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 52.7 mt-10 -96.16 91.34 5.87 Favored 'General case' 0 CA--C 1.494 -1.201 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 -173.335 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 2.1 p -110.22 129.43 65.27 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.075 0 N-CA-C 107.438 -1.319 . . . . 0.0 107.438 -164.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 75.6 m-85 . . . . . 0 CA--C 1.496 -1.109 0 N-CA-C 106.043 -1.836 . . . . 0.0 106.043 -175.035 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 98.7 Cg_endo . . . . . 0 N--CA 1.453 -0.874 0 CA-C-O 118.392 -0.753 . . . . 0.0 110.156 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 6.9 p-10 -102.79 -40.96 6.35 Favored 'General case' 0 CA--C 1.49 -1.356 0 C-N-CA 123.583 0.753 . . . . 0.0 109.61 -172.633 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 35.0 p -110.31 153.62 24.63 Favored 'General case' 0 CA--C 1.495 -1.154 0 N-CA-C 107.081 -1.452 . . . . 0.0 107.081 176.189 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 45.0 t-80 -136.85 98.83 10.47 Favored Pre-proline 0 N--CA 1.435 -1.224 0 N-CA-C 106.778 -1.564 . . . . 0.0 106.778 178.695 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -76.51 130.41 11.76 Favored 'Trans proline' 0 N--CA 1.447 -1.252 0 C-N-CA 122.76 2.307 . . . . 0.0 110.005 -177.441 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 14.5 mm -107.69 148.06 12.18 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.017 0 N-CA-C 103.088 -2.93 . . . . 0.0 103.088 176.127 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 4.4 pt20 -149.68 152.3 35.14 Favored 'General case' 0 CA--C 1.489 -1.377 0 N-CA-C 104.299 -2.482 . . . . 0.0 104.299 167.183 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 44.6 p90 -147.15 166.98 25.31 Favored 'General case' 0 N--CA 1.436 -1.142 0 N-CA-C 106.595 -1.632 . . . . 0.0 106.595 -169.755 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 40.9 m-80 -138.81 132.5 30.68 Favored 'General case' 0 CA--C 1.49 -1.335 0 N-CA-C 107.487 -1.301 . . . . 0.0 107.487 -179.051 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -92.69 175.53 3.18 Favored Pre-proline 0 N--CA 1.44 -0.947 0 C-N-CA 125.696 1.599 . . . . 0.0 109.865 -167.122 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 78.6 Cg_exo -63.94 164.87 20.51 Favored 'Trans proline' 0 N--CA 1.455 -0.757 0 C-N-CA 123.672 2.914 . . . . 0.0 112.491 169.7 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 71.1 tp60 -80.92 -42.42 1.2 Allowed Pre-proline 0 N--CA 1.444 -0.759 0 CA-C-O 115.911 -1.995 . . . . 0.0 110.758 -175.799 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -70.02 -16.49 36.49 Favored 'Trans proline' 0 CA--C 1.512 -0.623 0 CA-C-N 125.382 2.958 . . . . 0.0 112.418 172.505 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 10.4 t 64.95 78.73 0.27 Allowed 'General case' 0 C--N 1.358 0.969 0 C-N-CA 126.545 1.938 . . . . 0.0 109.652 -176.799 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 20.1 t-160 -91.6 -6.68 51.9 Favored 'General case' 0 N--CA 1.442 -0.857 0 C-N-CA 124.755 1.222 . . . . 0.0 109.319 -177.466 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 84.5 mt -113.74 145.55 19.47 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.99 0 N-CA-C 104.736 -2.32 . . . . 0.0 104.736 -173.251 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 25.2 t -103.95 -87.49 0.43 Allowed 'General case' 0 N--CA 1.43 -1.464 0 N-CA-C 105.96 -1.867 . . . . 0.0 105.96 177.241 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 27.4 mtpp -89.58 167.45 12.94 Favored 'General case' 0 CA--C 1.486 -1.504 0 C-N-CA 125.693 1.597 . . . . 0.0 108.94 -163.546 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 90.9 m-85 -134.53 142.72 47.1 Favored 'General case' 0 CA--C 1.493 -1.244 0 N-CA-C 105.072 -2.196 . . . . 0.0 105.072 172.445 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 16.5 mt -123.04 134.45 66.13 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.178 0 N-CA-C 101.786 -3.413 . . . . 0.0 101.786 171.765 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 2.7 mt -110.8 131.48 55.02 Favored 'General case' 0 CA--C 1.473 -1.982 0 N-CA-C 105.715 -1.957 . . . . 0.0 105.715 173.416 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 2.2 mpt_? -115.65 157.72 23.8 Favored 'General case' 0 N--CA 1.428 -1.529 0 N-CA-C 104.981 -2.229 . . . . 0.0 104.981 172.506 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 37.5 p90 -151.01 136.26 17.64 Favored 'General case' 0 N--CA 1.432 -1.363 0 N-CA-C 105.695 -1.965 . . . . 0.0 105.695 171.204 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 15.3 ttp180 -137.39 135.79 19.81 Favored Pre-proline 0 CA--C 1.498 -1.038 0 N-CA-C 103.413 -2.81 . . . . 0.0 103.413 -178.716 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -77.33 155.15 32.48 Favored 'Trans proline' 0 CA--C 1.502 -1.086 0 CA-C-N 123.292 2.211 . . . . 0.0 108.686 179.563 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 70.8 mmtt -73.14 60.71 0.58 Allowed 'General case' 0 C--N 1.356 0.88 0 C-N-CA 125.704 1.601 . . . . 0.0 110.465 170.157 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 29.0 m120 -154.57 -56.93 0.11 Allowed 'General case' 0 N--CA 1.436 -1.17 0 N-CA-C 102.888 -3.004 . . . . 0.0 102.888 -173.163 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 34.8 m -85.31 160.75 19.75 Favored 'General case' 0 N--CA 1.44 -0.941 0 N-CA-C 108.374 -0.973 . . . . 0.0 108.374 178.181 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 17.4 m -131.69 -5.48 1.97 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.784 0 C-N-CA 124.522 1.129 . . . . 0.0 108.821 -173.827 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -142.85 -43.48 0.05 OUTLIER Glycine 0 C--N 1.356 1.644 0 N-CA-C 109.311 -1.516 . . . . 0.0 109.311 -172.656 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 79.7 ttt180 -80.92 126.16 31.02 Favored 'General case' 0 CA--C 1.502 -0.887 0 C-N-CA 124.183 0.993 . . . . 0.0 108.685 -176.89 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -155.97 -177.75 6.8 Favored 'General case' 0 CA--C 1.492 -1.269 0 CA-C-O 121.426 0.632 . . . . 0.0 109.825 -179.681 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 66.7 mttm -130.76 159.91 35.91 Favored 'General case' 0 N--CA 1.435 -1.211 0 N-CA-C 105.402 -2.074 . . . . 0.0 105.402 -175.698 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -149.44 159.84 43.95 Favored 'General case' 0 N--CA 1.434 -1.246 0 N-CA-C 107.691 -1.225 . . . . 0.0 107.691 175.947 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -141.29 157.97 44.51 Favored 'General case' 0 CA--C 1.496 -1.115 0 N-CA-C 106.398 -1.705 . . . . 0.0 106.398 170.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 89.0 m -118.84 127.06 53.16 Favored 'General case' 0 CA--C 1.5 -0.972 0 N-CA-C 105.954 -1.869 . . . . 0.0 105.954 -178.331 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 5.3 mp -114.39 133.91 22.38 Favored Pre-proline 0 N--CA 1.438 -1.072 0 N-CA-C 104.893 -2.262 . . . . 0.0 104.893 -175.695 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 62.6 Cg_exo -63.89 169.07 10.87 Favored 'Trans proline' 0 CA--C 1.508 -0.807 0 C-N-CA 123.387 2.724 . . . . 0.0 113.376 177.155 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -78.42 -19.74 73.39 Favored Glycine 0 C--N 1.351 1.398 0 C-N-CA 123.171 0.415 . . . . 0.0 113.559 -173.851 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 48.8 p-80 -83.84 -28.15 28.22 Favored 'General case' 0 C--N 1.356 0.887 0 CA-C-N 117.755 0.778 . . . . 0.0 109.962 -179.418 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 84.4 mt -88.77 130.49 35.35 Favored 'General case' 0 CA--C 1.501 -0.917 0 N-CA-C 107.723 -1.214 . . . . 0.0 107.723 177.162 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 8.0 p-10 -116.87 10.2 14.06 Favored 'General case' 0 CA--C 1.501 -0.912 0 C-N-CA 123.994 0.918 . . . . 0.0 110.098 -172.203 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 60.1 p -143.03 167.76 21.31 Favored 'General case' 0 N--CA 1.44 -0.942 0 N-CA-C 107.854 -1.165 . . . . 0.0 107.854 -178.631 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 8.3 t80 -155.48 178.27 10.42 Favored 'General case' 0 N--CA 1.441 -0.921 0 N-CA-C 108.023 -1.103 . . . . 0.0 108.023 -176.851 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 97.2 m -145.01 114.91 7.36 Favored 'General case' 0 N--CA 1.432 -1.34 0 N-CA-C 103.859 -2.645 . . . . 0.0 103.859 177.347 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 54.0 mt -97.02 96.68 5.59 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.822 0 N-CA-C 105.767 -1.938 . . . . 0.0 105.767 175.566 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.94 161.76 13.41 Favored 'General case' 0 CA--C 1.498 -1.031 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 -178.381 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 83.7 52.47 3.69 Favored Glycine 0 C--N 1.353 1.501 0 N-CA-C 108.866 -1.694 . . . . 0.0 108.866 177.637 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 76.3 mt -119.19 166.04 13.46 Favored 'General case' 0 CA--C 1.496 -1.11 0 N-CA-C 106.736 -1.579 . . . . 0.0 106.736 -179.51 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 61.1 mttp -97.66 156.59 35.91 Favored Pre-proline 0 N--CA 1.441 -0.898 0 N-CA-C 106.859 -1.534 . . . . 0.0 106.859 -175.666 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 66.2 Cg_endo -77.45 155.63 32.19 Favored 'Trans proline' 0 N--CA 1.451 -0.987 0 C-N-CA 122.808 2.339 . . . . 0.0 109.844 172.063 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 60.15 29.12 67.75 Favored Glycine 0 C--N 1.355 1.584 0 C-N-CA 126.674 2.083 . . . . 0.0 116.628 170.507 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 10.6 p -122.35 138.99 50.65 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.122 0 N-CA-C 107.747 -1.205 . . . . 0.0 107.747 179.472 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 2.4 p -97.74 134.99 33.83 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.818 0 N-CA-C 106.663 -1.606 . . . . 0.0 106.663 177.946 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 94.4 m-85 -114.23 154.4 27.98 Favored 'General case' 0 CA--C 1.502 -0.878 0 C-N-CA 124.97 1.308 . . . . 0.0 107.617 179.492 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -95.18 142.13 27.98 Favored 'General case' 0 CA--C 1.505 -0.787 0 N-CA-C 105.516 -2.031 . . . . 0.0 105.516 155.815 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -132.52 143.66 15.33 Favored Glycine 0 CA--C 1.487 -1.683 0 N-CA-C 107.565 -2.214 . . . . 0.0 107.565 -177.614 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 32.3 mt-30 -135.94 132.59 36.62 Favored 'General case' 0 CA--C 1.489 -1.375 0 N-CA-C 106.361 -1.718 . . . . 0.0 106.361 -178.189 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 47.2 tp -113.9 97.72 6.56 Favored 'General case' 0 N--CA 1.438 -1.042 0 N-CA-C 104.408 -2.441 . . . . 0.0 104.408 -176.757 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 1.8 mp -88.7 125.34 41.88 Favored 'Isoleucine or valine' 0 CA--C 1.499 -1.013 0 N-CA-C 103.585 -2.746 . . . . 0.0 103.585 -176.781 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 12.8 p -121.1 109.27 14.82 Favored 'General case' 0 N--CA 1.436 -1.129 0 N-CA-C 108.214 -1.032 . . . . 0.0 108.214 -170.405 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 29.7 mt -102.1 140.79 19.71 Favored 'Isoleucine or valine' 0 CA--C 1.487 -1.453 0 N-CA-C 105.787 -1.931 . . . . 0.0 105.787 -165.183 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 72.1 mt-30 -87.97 -178.86 6.1 Favored 'General case' 0 CA--C 1.505 -0.753 0 C-N-CA 123.49 0.716 . . . . 0.0 109.47 -177.374 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 85.2 mt-30 -74.3 84.03 1.91 Allowed 'General case' 0 C--N 1.357 0.928 0 C-N-CA 124.779 1.232 . . . . 0.0 110.753 175.465 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 82.6 m-85 58.5 28.38 16.88 Favored 'General case' 0 C--N 1.359 1.006 0 C-N-CA 126.75 2.02 . . . . 0.0 112.27 -177.682 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -112.53 -118.71 3.61 Favored Glycine 0 C--N 1.356 1.683 0 N-CA-C 108.88 -1.688 . . . . 0.0 108.88 -173.729 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' HIS . . . . . 0.43 ' CD2' ' H ' ' A' ' 82' ' ' GLN . 10.1 t-160 -80.9 169.11 17.96 Favored 'General case' 0 N--CA 1.441 -0.89 0 C-N-CA 125.005 1.322 . . . . 0.0 109.323 -174.761 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . 0.43 ' H ' ' CD2' ' A' ' 81' ' ' HIS . 22.3 tt0 -127.47 109.3 11.61 Favored 'General case' 0 N--CA 1.434 -1.229 0 N-CA-C 101.842 -3.392 . . . . 0.0 101.842 170.377 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 4.3 tm-20 -102.83 153.94 19.69 Favored 'General case' 0 CA--C 1.506 -0.748 0 N-CA-C 105.721 -1.955 . . . . 0.0 105.721 -171.938 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 4.4 p -127.94 128.89 69.54 Favored 'Isoleucine or valine' 0 C--N 1.354 0.771 0 N-CA-C 108.274 -1.01 . . . . 0.0 108.274 179.874 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' THR . . . . . 0.423 ' HG1' ' HA ' ' A' ' 3' ' ' PRO . 52.1 m -109.83 139.09 45.29 Favored 'General case' 0 N--CA 1.443 -0.807 0 N-CA-C 102.432 -3.173 . . . . 0.0 102.432 171.694 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 51.6 ttt85 -130.99 142.8 50.37 Favored 'General case' 0 CA--C 1.502 -0.866 0 N-CA-C 108.428 -0.953 . . . . 0.0 108.428 -179.076 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 15.7 p90 -157.07 -176.39 5.95 Favored 'General case' 0 N--CA 1.439 -1.003 0 N-CA-C 105.78 -1.933 . . . . 0.0 105.78 178.769 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 1.4 p30 -136.15 157.02 47.82 Favored 'General case' 0 N--CA 1.439 -0.999 0 N-CA-C 106.296 -1.742 . . . . 0.0 106.296 167.571 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 36.9 p90 -144.45 174.51 10.87 Favored 'General case' 0 CA--C 1.487 -1.469 0 N-CA-C 106.03 -1.841 . . . . 0.0 106.03 171.759 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 10.1 t -142.31 154.37 44.64 Favored 'General case' 0 N--CA 1.439 -0.988 0 N-CA-C 106.7 -1.592 . . . . 0.0 106.7 176.789 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 4.3 p -113.27 120.94 42.89 Favored 'General case' 0 N--CA 1.436 -1.16 0 N-CA-C 101.264 -3.606 . . . . 0.0 101.264 168.184 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 15.0 t -157.71 21.47 0.27 Allowed 'General case' 0 N--CA 1.442 -0.85 0 N-CA-C 106.451 -1.685 . . . . 0.0 106.451 -173.049 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 19.7 m . . . . . 0 C--O 1.26 1.611 0 C-N-CA 123.356 0.662 . . . . 0.0 109.671 -175.77 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.436 -1.317 0 N-CA-C 105.79 -2.924 . . . . 0.0 105.79 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 8.8 Cg_exo -54.61 146.05 55.89 Favored 'Trans proline' 0 N--CA 1.449 -1.133 0 C-N-CA 124.329 3.353 . . . . 0.0 114.898 -168.241 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 5.5 t -77.46 152.5 5.48 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.716 0 N-CA-C 105.436 -2.061 . . . . 0.0 105.436 -177.904 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 92.8 mt-10 -98.54 89.44 4.4 Favored 'General case' 0 CA--C 1.493 -1.234 0 CA-C-O 122.13 0.967 . . . . 0.0 108.666 -169.729 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 2.4 p -111.52 132.33 60.39 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.08 0 N-CA-C 106.979 -1.489 . . . . 0.0 106.979 -166.946 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 67.9 m-85 . . . . . 0 CA--C 1.498 -1.055 0 N-CA-C 106.125 -1.805 . . . . 0.0 106.125 -174.61 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo . . . . . 0 CA--C 1.504 -1.008 0 CA-C-O 118.738 -0.609 . . . . 0.0 110.97 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 1.9 p30 -100.16 -45.43 5.64 Favored 'General case' 0 CA--C 1.488 -1.417 0 C-N-CA 123.596 0.759 . . . . 0.0 109.985 -166.516 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 75.2 m -107.63 158.65 17.08 Favored 'General case' 0 CA--C 1.496 -1.106 0 N-CA-C 107.794 -1.187 . . . . 0.0 107.794 -179.346 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 11.7 t-160 -135.74 85.15 30.87 Favored Pre-proline 0 N--CA 1.438 -1.048 0 N-CA-C 105.593 -2.003 . . . . 0.0 105.593 172.884 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 64.7 Cg_endo -81.78 98.1 0.96 Allowed 'Trans proline' 0 N--CA 1.451 -0.987 0 C-N-CA 123.325 2.683 . . . . 0.0 110.156 -174.713 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 3.0 pt -97.6 173.21 1.0 Allowed 'Isoleucine or valine' 0 CA--C 1.499 -0.99 0 CA-C-O 121.181 0.515 . . . . 0.0 109.992 -173.497 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 1.9 pt20 -151.53 161.58 42.45 Favored 'General case' 0 CA--C 1.496 -1.099 0 N-CA-C 105.699 -1.963 . . . . 0.0 105.699 164.079 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 42.4 p90 -139.62 162.82 34.17 Favored 'General case' 0 CA--C 1.496 -1.122 0 N-CA-C 106.285 -1.746 . . . . 0.0 106.285 -177.679 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 3.1 m120 -127.94 124.48 37.43 Favored 'General case' 0 CA--C 1.491 -1.3 0 N-CA-C 106.183 -1.784 . . . . 0.0 106.183 -179.505 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -105.65 173.38 3.27 Favored Pre-proline 0 N--CA 1.439 -1.012 0 C-N-CA 125.536 1.535 . . . . 0.0 108.181 -169.71 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_exo -63.63 151.2 86.17 Favored 'Trans proline' 0 N--CA 1.455 -0.76 0 C-N-CA 123.732 2.955 . . . . 0.0 112.266 173.532 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 64.8 tt0 -82.05 -40.64 0.96 Allowed Pre-proline 0 N--CA 1.444 -0.76 0 CA-C-O 115.832 -2.033 . . . . 0.0 111.837 -174.742 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 77.1 Cg_exo -70.77 -3.52 12.85 Favored 'Trans proline' 0 CA--C 1.514 -0.481 0 CA-C-N 125.403 2.965 . . . . 0.0 113.818 177.175 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 10.0 t 71.33 78.08 0.17 Allowed 'General case' 0 C--N 1.358 0.937 0 C-N-CA 126.38 1.872 . . . . 0.0 109.252 -179.423 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 82.1 t60 -89.23 -30.15 18.73 Favored 'General case' 0 N--CA 1.441 -0.906 0 C-N-CA 124.696 1.198 . . . . 0.0 108.289 178.166 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 90.3 mt -108.83 146.41 14.52 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.107 0 N-CA-C 105.164 -2.162 . . . . 0.0 105.164 -171.204 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 32.9 t -102.69 -87.77 0.41 Allowed 'General case' 0 N--CA 1.428 -1.572 0 N-CA-C 104.531 -2.396 . . . . 0.0 104.531 176.891 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 50.3 mtpt -89.46 167.07 13.28 Favored 'General case' 0 CA--C 1.489 -1.4 0 C-N-CA 124.91 1.284 . . . . 0.0 108.85 -164.418 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 63.1 m-85 -132.09 142.62 49.58 Favored 'General case' 0 CA--C 1.497 -1.081 0 N-CA-C 105.035 -2.209 . . . . 0.0 105.035 170.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 53.7 mt -119.68 136.12 57.84 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.189 0 N-CA-C 101.156 -3.646 . . . . 0.0 101.156 170.503 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 5.9 mt -110.42 132.53 54.1 Favored 'General case' 0 CA--C 1.47 -2.132 0 N-CA-C 103.823 -2.658 . . . . 0.0 103.823 166.644 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 17.0 ptp180 -132.88 152.04 51.93 Favored 'General case' 0 CA--C 1.49 -1.363 0 N-CA-C 106.787 -1.561 . . . . 0.0 106.787 170.701 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 49.2 p90 -155.19 151.79 28.59 Favored 'General case' 0 N--CA 1.438 -1.04 0 N-CA-C 107.585 -1.265 . . . . 0.0 107.585 -171.22 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 2.8 ptt180 -155.68 153.5 26.31 Favored Pre-proline 0 CA--C 1.497 -1.062 0 N-CA-C 106.466 -1.679 . . . . 0.0 106.466 168.065 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -76.86 156.56 34.85 Favored 'Trans proline' 0 CA--C 1.501 -1.141 0 C-N-CA 122.547 2.165 . . . . 0.0 109.071 -178.231 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 71.4 mmtt -70.35 79.95 0.54 Allowed 'General case' 0 C--N 1.354 0.8 0 C-N-CA 125.065 1.346 . . . . 0.0 110.635 174.598 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 58.9 m-80 -152.01 -81.62 0.1 Allowed 'General case' 0 N--CA 1.437 -1.111 0 N-CA-C 103.43 -2.804 . . . . 0.0 103.43 -179.249 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 50.2 m -93.39 166.14 12.43 Favored 'General case' 0 CA--C 1.5 -0.978 0 C-N-CA 124.055 0.942 . . . . 0.0 108.531 -178.228 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 12.6 m -134.57 25.54 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.754 0 N-CA-C 106.623 -1.621 . . . . 0.0 106.623 178.167 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -89.72 -94.48 1.14 Allowed Glycine 0 C--N 1.356 1.681 0 N-CA-C 109.554 -1.418 . . . . 0.0 109.554 -174.797 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -95.5 166.29 11.93 Favored 'General case' 0 CA--C 1.5 -0.945 0 N-CA-C 107.584 -1.265 . . . . 0.0 107.584 179.418 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -158.29 173.87 16.03 Favored 'General case' 0 CA--C 1.493 -1.238 0 CA-C-O 121.17 0.509 . . . . 0.0 110.142 -177.7 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 8.6 mtpm? -106.53 155.07 19.98 Favored 'General case' 0 CA--C 1.484 -1.565 0 N-CA-C 106.877 -1.527 . . . . 0.0 106.877 -175.404 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 15.6 pt-20 -151.72 161.26 42.96 Favored 'General case' 0 N--CA 1.435 -1.193 0 CA-C-O 121.827 0.823 . . . . 0.0 109.064 173.699 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -138.66 162.39 34.77 Favored 'General case' 0 N--CA 1.44 -0.967 0 N-CA-C 105.765 -1.939 . . . . 0.0 105.765 170.275 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 77.8 m -121.64 126.56 49.32 Favored 'General case' 0 CA--C 1.502 -0.896 0 N-CA-C 105.389 -2.078 . . . . 0.0 105.389 178.233 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 4.2 mp -110.91 133.76 21.17 Favored Pre-proline 0 N--CA 1.436 -1.147 0 N-CA-C 105.12 -2.178 . . . . 0.0 105.12 -176.088 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_exo -63.85 165.15 19.46 Favored 'Trans proline' 0 CA--C 1.507 -0.828 0 C-N-CA 123.519 2.813 . . . . 0.0 113.187 176.743 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -76.52 -18.21 79.27 Favored Glycine 0 C--N 1.351 1.409 0 C-N-CA 123.627 0.632 . . . . 0.0 113.938 -173.933 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 49.8 p-80 -84.02 -28.45 27.66 Favored 'General case' 0 C--N 1.355 0.845 0 CA-C-N 117.992 0.896 . . . . 0.0 110.133 -179.826 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 88.0 mt -88.78 130.76 35.3 Favored 'General case' 0 CA--C 1.499 -0.991 0 N-CA-C 107.911 -1.144 . . . . 0.0 107.911 177.463 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 47.1 p-10 -117.78 12.44 13.89 Favored 'General case' 0 CA--C 1.502 -0.873 0 C-N-CA 123.879 0.872 . . . . 0.0 110.368 -174.887 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 58.0 p -136.8 161.57 35.61 Favored 'General case' 0 CA--C 1.498 -1.052 0 N-CA-C 107.795 -1.187 . . . . 0.0 107.795 -178.379 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 5.2 t80 -147.55 179.51 7.63 Favored 'General case' 0 C--N 1.357 0.933 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 177.198 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 80.2 m -144.92 112.4 6.16 Favored 'General case' 0 N--CA 1.433 -1.295 0 N-CA-C 104.178 -2.527 . . . . 0.0 104.178 174.002 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 50.6 mt -95.18 97.33 6.66 Favored 'Isoleucine or valine' 0 C--N 1.357 0.918 0 N-CA-C 105.333 -2.099 . . . . 0.0 105.333 174.763 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 22.6 pttp -103.82 159.81 15.32 Favored 'General case' 0 CA--C 1.501 -0.919 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 -176.489 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 87.75 51.69 3.17 Favored Glycine 0 C--N 1.354 1.579 0 N-CA-C 109.337 -1.505 . . . . 0.0 109.337 179.187 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 70.7 mt -119.78 171.11 8.63 Favored 'General case' 0 CA--C 1.504 -0.806 0 N-CA-C 107.398 -1.334 . . . . 0.0 107.398 -177.393 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 67.5 mttm -107.09 155.69 38.81 Favored Pre-proline 0 N--CA 1.442 -0.86 0 C-N-CA 124.984 1.313 . . . . 0.0 107.656 -172.338 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -75.82 151.53 36.03 Favored 'Trans proline' 0 N--CA 1.454 -0.853 0 C-N-CA 123.024 2.482 . . . . 0.0 110.811 177.054 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 56.05 36.55 67.95 Favored Glycine 0 C--N 1.355 1.605 0 C-N-CA 127.377 2.418 . . . . 0.0 116.06 169.623 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 9.8 p -124.11 143.56 36.98 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.998 0 N-CA-C 108.088 -1.078 . . . . 0.0 108.088 -177.498 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 7.7 p -98.61 128.4 50.19 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.96 0 N-CA-C 107.747 -1.205 . . . . 0.0 107.747 -179.543 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 68.8 m-85 -111.4 151.62 28.28 Favored 'General case' 0 CA--C 1.497 -1.082 0 C-N-CA 124.814 1.245 . . . . 0.0 108.809 -179.863 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 35.9 tp10 -93.61 137.04 33.28 Favored 'General case' 0 N--CA 1.44 -0.953 0 N-CA-C 104.578 -2.379 . . . . 0.0 104.578 160.017 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -135.33 156.62 22.75 Favored Glycine 0 CA--C 1.489 -1.553 0 N-CA-C 108.511 -1.836 . . . . 0.0 108.511 174.356 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 85.6 mt-30 -144.58 138.95 27.81 Favored 'General case' 0 CA--C 1.483 -1.598 0 N-CA-C 105.986 -1.857 . . . . 0.0 105.986 179.262 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 57.1 tp -115.73 97.32 6.05 Favored 'General case' 0 N--CA 1.435 -1.189 0 N-CA-C 103.892 -2.633 . . . . 0.0 103.892 178.248 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 9.4 mt -89.52 128.87 41.28 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.942 0 N-CA-C 105.356 -2.09 . . . . 0.0 105.356 -178.248 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 3.5 p -117.93 118.86 33.13 Favored 'General case' 0 N--CA 1.438 -1.058 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 -171.71 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 2.0 mp -94.08 131.68 40.31 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.222 0 N-CA-C 105.02 -2.215 . . . . 0.0 105.02 -173.149 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 19.4 mp0 -93.87 143.36 26.41 Favored 'General case' 0 CA--C 1.498 -1.033 0 N-CA-C 104.93 -2.248 . . . . 0.0 104.93 177.218 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 21.4 tt0 -69.12 112.4 5.7 Favored 'General case' 0 C--N 1.356 0.855 0 C-N-CA 123.858 0.863 . . . . 0.0 111.343 -172.585 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 33.7 m-85 56.32 44.81 24.07 Favored 'General case' 0 C--N 1.357 0.917 0 C-N-CA 126.983 2.113 . . . . 0.0 112.173 -179.007 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -156.73 -119.16 0.6 Allowed Glycine 0 CA--C 1.489 -1.577 0 N-CA-C 109.008 -1.637 . . . . 0.0 109.008 -177.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 69.2 m80 -82.68 176.77 9.09 Favored 'General case' 0 CA--C 1.501 -0.939 0 C-N-CA 124.9 1.28 . . . . 0.0 111.288 -166.477 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 22.8 tt0 -137.91 115.96 11.67 Favored 'General case' 0 N--CA 1.435 -1.197 0 N-CA-C 103.819 -2.66 . . . . 0.0 103.819 170.761 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 29.5 tt0 -104.77 147.97 27.12 Favored 'General case' 0 CA--C 1.5 -0.949 0 N-CA-C 106.089 -1.819 . . . . 0.0 106.089 -174.739 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 4.0 p -119.35 134.05 64.2 Favored 'Isoleucine or valine' 0 C--N 1.356 0.85 0 N-CA-C 107.796 -1.187 . . . . 0.0 107.796 178.272 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 65.1 m -110.93 138.44 47.33 Favored 'General case' 0 C--N 1.354 0.791 0 N-CA-C 102.518 -3.142 . . . . 0.0 102.518 168.326 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 27.8 ptt-85 -132.21 150.32 52.18 Favored 'General case' 0 CA--C 1.5 -0.971 0 N-CA-C 109.213 -0.662 . . . . 0.0 109.213 179.485 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 20.2 p90 -163.82 173.8 12.33 Favored 'General case' 0 N--CA 1.441 -0.901 0 N-CA-C 107.947 -1.131 . . . . 0.0 107.947 -174.874 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -125.62 146.05 49.88 Favored 'General case' 0 N--CA 1.438 -1.05 0 N-CA-C 103.816 -2.661 . . . . 0.0 103.816 173.628 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 28.5 p90 -139.51 168.1 20.59 Favored 'General case' 0 CA--C 1.485 -1.526 0 N-CA-C 107.572 -1.269 . . . . 0.0 107.572 167.882 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 60.6 m -130.44 141.93 50.51 Favored 'General case' 0 N--CA 1.44 -0.937 0 N-CA-C 104.832 -2.285 . . . . 0.0 104.832 176.795 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 23.9 p -111.6 136.94 50.11 Favored 'General case' 0 CA--C 1.501 -0.936 0 N-CA-C 103.851 -2.648 . . . . 0.0 103.851 170.486 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 10.5 t -146.22 156.7 43.57 Favored 'General case' 0 N--CA 1.44 -0.967 0 N-CA-C 106.716 -1.587 . . . . 0.0 106.716 -175.072 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 16.9 p . . . . . 0 C--O 1.261 1.684 0 CA-C-O 117.709 -1.139 . . . . 0.0 108.944 -178.336 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.44 -1.055 0 N-CA-C 106.913 -2.475 . . . . 0.0 106.913 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 79.3 Cg_exo -60.67 135.07 57.98 Favored 'Trans proline' 0 CA--C 1.497 -1.369 0 C-N-CA 123.388 2.725 . . . . 0.0 112.185 -173.359 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 16.1 t -84.07 155.24 3.67 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.017 0 C-N-CA 126.468 1.907 . . . . 0.0 106.167 -175.196 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 54.6 mt-10 -104.5 102.86 12.49 Favored 'General case' 0 CA--C 1.492 -1.273 0 N-CA-C 105.772 -1.936 . . . . 0.0 105.772 179.498 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 1.5 p -126.05 141.37 45.88 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.985 0 N-CA-C 105.623 -1.991 . . . . 0.0 105.623 -169.796 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 18.8 p90 . . . . . 0 N--CA 1.436 -1.144 0 N-CA-C 107.716 -1.216 . . . . 0.0 107.716 -162.728 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo . . . . . 0 CA--C 1.508 -0.822 0 CA-C-O 118.582 -0.674 . . . . 0.0 111.115 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 6.8 t-20 -135.78 -23.88 1.35 Allowed 'General case' 0 CA--C 1.495 -1.169 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 -168.709 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 23.0 p -97.64 156.19 16.64 Favored 'General case' 0 N--CA 1.439 -1.02 0 N-CA-C 107.605 -1.257 . . . . 0.0 107.605 177.483 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 79.8 t60 -139.44 86.43 14.28 Favored Pre-proline 0 N--CA 1.439 -1.011 0 N-CA-C 106.348 -1.723 . . . . 0.0 106.348 167.568 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -82.92 100.54 0.96 Allowed 'Trans proline' 0 N--CA 1.453 -0.887 0 C-N-CA 123.574 2.849 . . . . 0.0 110.369 -176.187 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.6 pt -94.38 166.59 1.77 Allowed 'Isoleucine or valine' 0 CA--C 1.501 -0.934 0 C-N-CA 122.715 0.406 . . . . 0.0 110.156 -173.609 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 48.0 tt0 -143.15 147.66 35.3 Favored 'General case' 0 N--CA 1.439 -0.995 0 N-CA-C 105.005 -2.22 . . . . 0.0 105.005 168.547 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 30.9 p90 -130.23 159.85 35.62 Favored 'General case' 0 CA--C 1.495 -1.167 0 N-CA-C 105.599 -2.0 . . . . 0.0 105.599 176.701 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 72.3 m-20 -130.83 132.7 45.38 Favored 'General case' 0 CA--C 1.488 -1.417 0 N-CA-C 104.997 -2.223 . . . . 0.0 104.997 171.837 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -85.77 164.36 40.01 Favored Pre-proline 0 N--CA 1.441 -0.908 0 C-N-CA 124.589 1.155 . . . . 0.0 110.675 -166.175 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_exo -67.23 -179.29 1.75 Allowed 'Trans proline' 0 N--CA 1.457 -0.675 0 C-N-CA 123.775 2.983 . . . . 0.0 112.548 169.072 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? -79.84 -50.85 1.19 Allowed Pre-proline 0 N--CA 1.443 -0.782 0 CA-C-O 115.02 -2.419 . . . . 0.0 111.157 -174.706 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -68.68 147.14 69.11 Favored 'Trans proline' 0 CA--C 1.508 -0.811 0 CA-C-N 126.305 3.288 . . . . 0.0 111.863 -173.056 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 29.4 p -99.0 58.59 1.14 Allowed 'General case' 0 C--N 1.355 0.83 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 -178.605 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 42.6 t60 -116.23 1.37 13.12 Favored 'General case' 0 N--CA 1.438 -1.043 0 C-N-CA 125.217 1.407 . . . . 0.0 107.425 175.857 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 31.2 mt -101.67 131.93 48.58 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.054 0 N-CA-C 104.263 -2.495 . . . . 0.0 104.263 171.017 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 4.4 p -110.52 -84.65 0.56 Allowed 'General case' 0 N--CA 1.432 -1.345 0 N-CA-C 107.028 -1.471 . . . . 0.0 107.028 179.515 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 53.2 mtmt -89.91 171.85 9.3 Favored 'General case' 0 CA--C 1.488 -1.439 0 C-N-CA 124.232 1.013 . . . . 0.0 108.785 -166.413 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 86.8 m-85 -129.34 147.66 51.19 Favored 'General case' 0 CA--C 1.496 -1.115 0 N-CA-C 105.362 -2.088 . . . . 0.0 105.362 168.435 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 61.9 mt -120.41 131.04 73.69 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.249 0 N-CA-C 101.207 -3.627 . . . . 0.0 101.207 165.683 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 2.9 mt -110.49 132.72 53.94 Favored 'General case' 0 CA--C 1.473 -1.997 0 N-CA-C 104.822 -2.288 . . . . 0.0 104.822 170.741 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -129.97 158.94 38.17 Favored 'General case' 0 CA--C 1.493 -1.241 0 N-CA-C 107.308 -1.367 . . . . 0.0 107.308 170.082 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 46.4 p90 -155.15 141.28 18.42 Favored 'General case' 0 N--CA 1.434 -1.232 0 N-CA-C 106.635 -1.617 . . . . 0.0 106.635 -177.908 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 27.0 ttp180 -137.89 142.65 36.94 Favored Pre-proline 0 CA--C 1.502 -0.902 0 N-CA-C 104.902 -2.258 . . . . 0.0 104.902 -179.359 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_exo -65.11 116.97 4.15 Favored 'Trans proline' 0 N--CA 1.455 -0.754 0 C-N-CA 123.024 2.482 . . . . 0.0 109.721 169.133 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 26.7 ttpp -71.96 83.87 0.96 Allowed 'General case' 0 C--N 1.359 0.993 0 C-N-CA 125.306 1.443 . . . . 0.0 110.096 179.933 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 33.1 m120 -150.58 -69.18 0.19 Allowed 'General case' 0 N--CA 1.434 -1.245 0 N-CA-C 102.321 -3.214 . . . . 0.0 102.321 -175.526 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 56.4 p -109.23 175.32 5.5 Favored 'General case' 0 N--CA 1.44 -0.97 0 N-CA-C 107.334 -1.358 . . . . 0.0 107.334 175.171 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 4.2 m -115.69 51.36 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.836 0 N-CA-C 106.241 -1.763 . . . . 0.0 106.241 176.009 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -94.81 -136.1 8.28 Favored Glycine 0 C--N 1.356 1.68 0 N-CA-C 109.739 -1.345 . . . . 0.0 109.739 -175.57 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 39.9 mmt180 -81.18 155.58 26.1 Favored 'General case' 0 CA--C 1.501 -0.939 0 C-N-CA 123.79 0.836 . . . . 0.0 109.108 -176.534 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -159.36 168.89 25.22 Favored 'General case' 0 CA--C 1.493 -1.225 0 CA-C-O 121.385 0.612 . . . . 0.0 109.832 -169.259 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -113.49 156.68 23.12 Favored 'General case' 0 CA--C 1.491 -1.293 0 N-CA-C 107.889 -1.152 . . . . 0.0 107.889 -169.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 23.5 pt-20 -151.37 161.27 43.0 Favored 'General case' 0 N--CA 1.435 -1.191 0 N-CA-C 107.765 -1.198 . . . . 0.0 107.765 172.125 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -139.62 164.71 29.2 Favored 'General case' 0 N--CA 1.438 -1.051 0 N-CA-C 105.603 -1.999 . . . . 0.0 105.603 171.222 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 88.8 m -118.51 122.65 43.21 Favored 'General case' 0 CA--C 1.498 -1.021 0 N-CA-C 104.333 -2.469 . . . . 0.0 104.333 176.056 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 3.7 mm -103.62 138.64 19.59 Favored Pre-proline 0 N--CA 1.438 -1.029 0 N-CA-C 105.808 -1.923 . . . . 0.0 105.808 -174.909 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_exo -63.91 161.15 34.11 Favored 'Trans proline' 0 N--CA 1.455 -0.784 0 C-N-CA 123.378 2.719 . . . . 0.0 112.562 170.817 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -78.22 -19.26 74.87 Favored Glycine 0 C--N 1.353 1.492 0 C-N-CA 123.843 0.735 . . . . 0.0 113.344 -172.485 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 50.3 p-80 -83.61 -24.97 31.24 Favored 'General case' 0 C--N 1.356 0.85 0 CA-C-N 117.68 0.74 . . . . 0.0 110.158 -178.802 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 88.7 mt -88.22 129.77 35.26 Favored 'General case' 0 CA--C 1.498 -1.024 0 N-CA-C 107.913 -1.143 . . . . 0.0 107.913 177.655 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 7.5 p30 -116.66 10.72 14.45 Favored 'General case' 0 CA--C 1.501 -0.93 0 C-N-CA 124.59 1.156 . . . . 0.0 109.662 -174.554 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 31.3 p -141.79 154.42 45.21 Favored 'General case' 0 N--CA 1.44 -0.974 0 N-CA-C 106.863 -1.532 . . . . 0.0 106.863 -179.237 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 9.8 t80 -137.55 170.7 15.62 Favored 'General case' 0 N--CA 1.441 -0.914 0 N-CA-C 107.91 -1.144 . . . . 0.0 107.91 178.606 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 89.2 m -133.93 110.01 9.42 Favored 'General case' 0 N--CA 1.429 -1.517 0 N-CA-C 104.424 -2.436 . . . . 0.0 104.424 172.773 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 45.2 mt -88.37 144.06 9.94 Favored 'Isoleucine or valine' 0 C--N 1.355 0.846 0 N-CA-C 103.663 -2.717 . . . . 0.0 103.663 172.051 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 56.7 mtmt -144.29 165.51 27.69 Favored 'General case' 0 CA--C 1.498 -1.04 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 175.929 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 88.7 48.3 3.97 Favored Glycine 0 CA--C 1.485 -1.832 0 N-CA-C 108.99 -1.644 . . . . 0.0 108.99 174.575 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 51.9 mt -120.79 171.22 8.76 Favored 'General case' 0 CA--C 1.498 -1.025 0 N-CA-C 107.604 -1.258 . . . . 0.0 107.604 -170.22 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt -113.66 150.87 44.0 Favored Pre-proline 0 N--CA 1.44 -0.93 0 N-CA-C 107.363 -1.347 . . . . 0.0 107.363 -174.247 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 78.5 Cg_exo -68.14 153.85 73.81 Favored 'Trans proline' 0 N--CA 1.453 -0.873 0 C-N-CA 123.37 2.714 . . . . 0.0 112.028 168.338 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . 0.48 ' H ' ' HA ' ' A' ' 92' ' ' THR . . . 58.95 30.28 66.29 Favored Glycine 0 N--CA 1.432 -1.604 0 C-N-CA 127.545 2.498 . . . . 0.0 116.478 170.37 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 4.9 p -126.92 142.13 44.27 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.029 0 N-CA-C 108.577 -0.898 . . . . 0.0 108.577 179.316 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 9.3 p -94.62 130.77 42.99 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.837 0 C-N-CA 124.641 1.176 . . . . 0.0 107.959 -178.816 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 88.8 m-85 -110.62 154.91 23.11 Favored 'General case' 0 N--CA 1.437 -1.085 0 C-N-CA 124.79 1.236 . . . . 0.0 108.011 177.854 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 15.3 tp10 -98.53 132.17 44.17 Favored 'General case' 0 N--CA 1.437 -1.099 0 N-CA-C 103.578 -2.749 . . . . 0.0 103.578 164.148 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -129.67 148.82 18.53 Favored Glycine 0 CA--C 1.489 -1.544 0 N-CA-C 107.667 -2.173 . . . . 0.0 107.667 175.786 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 34.6 mt-30 -141.47 137.05 31.86 Favored 'General case' 0 CA--C 1.484 -1.582 0 N-CA-C 106.549 -1.649 . . . . 0.0 106.549 178.4 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 27.6 tp -117.93 97.17 5.69 Favored 'General case' 0 N--CA 1.435 -1.202 0 N-CA-C 104.03 -2.581 . . . . 0.0 104.03 -178.721 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 20.3 mt -92.17 129.01 43.44 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.865 0 N-CA-C 104.947 -2.242 . . . . 0.0 104.947 -179.84 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 49.8 m -110.06 117.84 34.82 Favored 'General case' 0 CA--C 1.497 -1.061 0 N-CA-C 106.814 -1.55 . . . . 0.0 106.814 -175.784 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 1.7 mp -88.2 131.94 34.5 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.302 0 N-CA-C 104.348 -2.464 . . . . 0.0 104.348 -170.455 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 76.0 mt-30 -96.78 157.1 16.06 Favored 'General case' 0 N--CA 1.434 -1.269 0 N-CA-C 107.167 -1.42 . . . . 0.0 107.167 -176.787 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 32.3 mt-30 -69.48 118.2 12.06 Favored 'General case' 0 N--CA 1.438 -1.026 0 C-N-CA 123.919 0.888 . . . . 0.0 112.544 -168.503 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 49.0 m-85 61.68 35.58 16.93 Favored 'General case' 0 C--N 1.355 0.833 0 C-N-CA 127.117 2.167 . . . . 0.0 113.136 170.558 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 179.38 -93.31 0.09 OUTLIER Glycine 0 C--N 1.354 1.53 0 C-N-CA 118.294 -1.907 . . . . 0.0 111.416 177.73 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 74.1 m-70 -78.59 -178.74 6.03 Favored 'General case' 0 CA--C 1.498 -1.047 0 C-N-CA 124.797 1.239 . . . . 0.0 111.747 -163.602 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 4.4 pt20 -153.32 146.56 24.75 Favored 'General case' 0 N--CA 1.434 -1.245 0 N-CA-C 106.484 -1.672 . . . . 0.0 106.484 170.2 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 17.4 tp10 -104.87 146.28 29.22 Favored 'General case' 0 CA--C 1.496 -1.124 0 N-CA-C 105.575 -2.009 . . . . 0.0 105.575 179.855 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 3.0 p -117.76 131.59 70.06 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.824 0 N-CA-C 107.204 -1.406 . . . . 0.0 107.204 177.391 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 40.4 m -113.58 138.36 50.28 Favored 'General case' 0 N--CA 1.441 -0.9 0 N-CA-C 102.871 -3.011 . . . . 0.0 102.871 170.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 7.6 ptp85 -131.58 150.86 52.0 Favored 'General case' 0 CA--C 1.498 -1.025 0 CA-C-O 121.466 0.651 . . . . 0.0 109.594 178.86 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 30.0 p90 -164.2 178.2 7.77 Favored 'General case' 0 N--CA 1.44 -0.97 0 N-CA-C 106.959 -1.497 . . . . 0.0 106.959 -174.617 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 1.5 p30 -137.44 157.71 45.99 Favored 'General case' 0 N--CA 1.44 -0.928 0 N-CA-C 105.844 -1.91 . . . . 0.0 105.844 169.416 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 26.6 p90 -145.73 170.75 15.89 Favored 'General case' 0 CA--C 1.486 -1.497 0 N-CA-C 107.367 -1.346 . . . . 0.0 107.367 174.949 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 24.8 p -121.55 145.33 48.07 Favored 'General case' 0 CA--C 1.5 -0.954 0 N-CA-C 106.006 -1.85 . . . . 0.0 106.006 172.078 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 75.4 m -119.57 113.48 20.77 Favored 'General case' 0 CA--C 1.496 -1.111 0 N-CA-C 102.103 -3.295 . . . . 0.0 102.103 170.287 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' THR . . . . . 0.48 ' HA ' ' H ' ' A' ' 66' ' ' GLY . 15.3 m -143.41 149.74 38.08 Favored 'General case' 0 C--N 1.356 0.87 0 N-CA-C 105.705 -1.961 . . . . 0.0 105.705 -171.934 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 8.7 t . . . . . 0 C--O 1.261 1.662 0 C-N-CA 124.632 1.173 . . . . 0.0 109.497 -176.01 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.439 -1.153 0 N-CA-C 106.077 -2.809 . . . . 0.0 106.077 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_exo -61.0 135.78 61.31 Favored 'Trans proline' 0 N--CA 1.445 -1.342 0 C-N-CA 123.3 2.666 . . . . 0.0 112.37 -173.176 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 8.4 t -78.57 154.05 5.0 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.88 0 C-N-CA 126.738 2.015 . . . . 0.0 106.214 -175.948 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -96.66 90.73 5.42 Favored 'General case' 0 CA--C 1.493 -1.242 0 N-CA-C 107.66 -1.237 . . . . 0.0 107.66 -175.04 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 2.6 p -114.33 133.92 58.89 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.175 0 N-CA-C 107.032 -1.47 . . . . 0.0 107.032 -166.86 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 75.3 m-85 . . . . . 0 N--CA 1.435 -1.188 0 N-CA-C 106.208 -1.775 . . . . 0.0 106.208 -173.776 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_endo . . . . . 0 N--CA 1.457 -0.644 0 N-CA-C 109.903 -0.845 . . . . 0.0 109.903 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 2.3 t30 -89.18 -14.44 36.06 Favored 'General case' 0 N--CA 1.439 -0.994 0 C-N-CA 126.088 1.755 . . . . 0.0 107.403 172.697 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 68.2 m -113.32 150.3 32.73 Favored 'General case' 0 CA--C 1.497 -1.093 0 CA-C-O 122.16 0.981 . . . . 0.0 108.803 175.784 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 26.0 t-80 -124.41 98.54 37.89 Favored Pre-proline 0 N--CA 1.439 -1.014 0 N-CA-C 105.343 -2.095 . . . . 0.0 105.343 166.901 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -74.72 115.2 4.22 Favored 'Trans proline' 0 N--CA 1.448 -1.177 0 C-N-CA 123.017 2.478 . . . . 0.0 108.635 170.492 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 11.1 tt -108.92 148.79 12.53 Favored 'Isoleucine or valine' 0 N--CA 1.406 -2.639 0 C-N-CA 127.053 2.141 . . . . 0.0 106.05 -178.521 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 23.5 tt0 -135.64 145.42 46.8 Favored 'General case' 0 N--CA 1.435 -1.189 0 N-CA-C 104.337 -2.468 . . . . 0.0 104.337 170.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 49.1 p90 -135.46 165.56 25.22 Favored 'General case' 0 N--CA 1.438 -1.054 0 N-CA-C 105.337 -2.097 . . . . 0.0 105.337 175.211 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 39.6 m-80 -140.8 132.04 26.55 Favored 'General case' 0 CA--C 1.489 -1.368 0 N-CA-C 106.136 -1.802 . . . . 0.0 106.136 -179.708 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -96.85 168.59 10.09 Favored Pre-proline 0 N--CA 1.439 -1.006 0 CA-C-N 114.792 -1.095 . . . . 0.0 110.37 -163.797 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 81.1 Cg_exo -66.43 167.69 18.13 Favored 'Trans proline' 0 N--CA 1.456 -0.716 0 C-N-CA 123.821 3.014 . . . . 0.0 111.776 166.731 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 10.2 tm0? -81.95 -52.66 0.74 Allowed Pre-proline 0 N--CA 1.444 -0.774 0 CA-C-O 115.317 -2.278 . . . . 0.0 111.279 -175.232 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -71.26 166.01 30.61 Favored 'Trans proline' 0 CA--C 1.507 -0.829 0 CA-C-N 126.065 3.202 . . . . 0.0 112.45 -172.77 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 28.1 p -77.97 118.29 20.12 Favored 'General case' 0 C--N 1.358 0.94 0 N-CA-C 106.915 -1.513 . . . . 0.0 106.915 173.449 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 8.4 t-160 -169.73 -44.84 0.02 OUTLIER 'General case' 0 CA--C 1.497 -1.063 0 N-CA-C 107.214 -1.402 . . . . 0.0 107.214 -164.099 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 37.2 mt -112.2 137.36 45.27 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.014 0 N-CA-C 104.175 -2.528 . . . . 0.0 104.175 176.615 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 33.5 t -113.06 -87.29 0.56 Allowed 'General case' 0 N--CA 1.43 -1.437 0 N-CA-C 106.494 -1.669 . . . . 0.0 106.494 179.548 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 35.9 ttpt -89.18 163.31 15.48 Favored 'General case' 0 CA--C 1.491 -1.303 0 C-N-CA 125.686 1.594 . . . . 0.0 108.104 -159.202 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 90.6 m-85 -128.88 139.07 52.31 Favored 'General case' 0 CA--C 1.492 -1.257 0 N-CA-C 105.649 -1.982 . . . . 0.0 105.649 175.56 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 55.3 mt -119.42 131.09 73.04 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.121 0 N-CA-C 101.694 -3.447 . . . . 0.0 101.694 171.113 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 3.2 mt -110.47 135.63 50.85 Favored 'General case' 0 CA--C 1.473 -1.982 0 N-CA-C 105.02 -2.215 . . . . 0.0 105.02 171.899 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -131.35 156.51 45.39 Favored 'General case' 0 CA--C 1.493 -1.247 0 N-CA-C 106.889 -1.523 . . . . 0.0 106.889 167.555 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 49.6 p90 -154.18 145.47 22.96 Favored 'General case' 0 N--CA 1.434 -1.257 0 N-CA-C 106.757 -1.572 . . . . 0.0 106.757 -175.94 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 8.6 ttm180 -138.18 139.57 26.01 Favored Pre-proline 0 CA--C 1.499 -0.982 0 N-CA-C 104.605 -2.368 . . . . 0.0 104.605 -179.907 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -72.89 116.06 4.58 Favored 'Trans proline' 0 N--CA 1.454 -0.843 0 C-N-CA 122.739 2.293 . . . . 0.0 108.824 174.713 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 3.0 tmtp? -70.22 81.49 0.53 Allowed 'General case' 0 C--N 1.358 0.97 0 C-N-CA 126.858 2.063 . . . . 0.0 111.029 -176.047 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 1.5 p30 -164.65 -50.06 0.03 OUTLIER 'General case' 0 N--CA 1.435 -1.176 0 N-CA-C 103.676 -2.713 . . . . 0.0 103.676 175.868 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 46.5 p -97.63 163.89 12.65 Favored 'General case' 0 N--CA 1.44 -0.968 0 C-N-CA 124.922 1.289 . . . . 0.0 108.01 178.135 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 4.8 m -125.92 46.18 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.849 0 N-CA-C 105.838 -1.912 . . . . 0.0 105.838 176.455 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -94.89 -154.06 30.66 Favored Glycine 0 C--N 1.356 1.656 0 N-CA-C 109.808 -1.317 . . . . 0.0 109.808 -175.64 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 80.4 ttt180 -78.9 126.76 31.12 Favored 'General case' 0 C--N 1.356 0.86 0 N-CA-C 108.142 -1.059 . . . . 0.0 108.142 -178.59 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -105.24 172.56 6.73 Favored 'General case' 0 CA--C 1.497 -1.061 0 C-N-CA 123.825 0.85 . . . . 0.0 110.377 -172.782 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 63.0 mttp -112.11 157.07 21.25 Favored 'General case' 0 CA--C 1.489 -1.403 0 N-CA-C 107.773 -1.195 . . . . 0.0 107.773 -170.717 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 15.7 pt-20 -151.21 159.73 44.23 Favored 'General case' 0 N--CA 1.437 -1.09 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 173.57 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -138.2 164.03 30.24 Favored 'General case' 0 N--CA 1.44 -0.935 0 N-CA-C 105.851 -1.907 . . . . 0.0 105.851 170.436 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 88.8 m -124.51 127.67 47.8 Favored 'General case' 0 CA--C 1.5 -0.947 0 N-CA-C 105.3 -2.111 . . . . 0.0 105.3 179.053 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 5.2 mp -117.27 135.93 23.29 Favored Pre-proline 0 N--CA 1.438 -1.034 0 N-CA-C 105.213 -2.143 . . . . 0.0 105.213 -172.111 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_exo -63.06 166.82 13.53 Favored 'Trans proline' 0 CA--C 1.509 -0.762 0 C-N-CA 123.54 2.826 . . . . 0.0 113.748 176.582 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -81.09 -16.82 73.62 Favored Glycine 0 C--N 1.353 1.473 0 C-N-CA 123.457 0.551 . . . . 0.0 113.249 -171.95 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 50.8 p-80 -83.83 -25.82 30.02 Favored 'General case' 0 C--N 1.357 0.901 0 CA-C-N 117.831 0.816 . . . . 0.0 109.999 179.899 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 92.4 mt -88.32 131.03 34.97 Favored 'General case' 0 CA--C 1.501 -0.922 0 N-CA-C 107.84 -1.17 . . . . 0.0 107.84 177.46 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 8.3 p-10 -112.95 8.35 18.51 Favored 'General case' 0 CA--C 1.503 -0.863 0 C-N-CA 124.666 1.186 . . . . 0.0 109.667 -174.421 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 32.9 p -146.75 160.92 41.64 Favored 'General case' 0 CA--C 1.499 -1.005 0 N-CA-C 106.484 -1.673 . . . . 0.0 106.484 -177.248 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 19.2 t80 -148.45 160.26 43.23 Favored 'General case' 0 CA--C 1.497 -1.093 0 N-CA-C 108.083 -1.08 . . . . 0.0 108.083 178.575 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 82.8 m -114.43 109.47 18.36 Favored 'General case' 0 N--CA 1.436 -1.14 0 N-CA-C 104.491 -2.411 . . . . 0.0 104.491 168.9 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 65.7 mt -82.94 137.79 20.41 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.902 0 N-CA-C 103.086 -2.931 . . . . 0.0 103.086 169.83 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 17.8 ptpt -147.84 160.62 42.56 Favored 'General case' 0 CA--C 1.495 -1.151 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 -177.709 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 89.82 52.67 2.56 Favored Glycine 0 CA--C 1.489 -1.555 0 N-CA-C 108.586 -1.806 . . . . 0.0 108.586 179.827 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 63.8 mt -120.47 170.63 9.2 Favored 'General case' 0 CA--C 1.498 -1.023 0 N-CA-C 107.377 -1.342 . . . . 0.0 107.377 -171.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 28.9 mtpp -101.59 153.75 37.7 Favored Pre-proline 0 N--CA 1.439 -1.012 0 N-CA-C 106.507 -1.664 . . . . 0.0 106.507 -179.775 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 70.6 Cg_endo -77.6 156.8 32.09 Favored 'Trans proline' 0 N--CA 1.452 -0.964 0 C-N-CA 122.936 2.424 . . . . 0.0 110.342 174.88 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 57.74 32.68 65.99 Favored Glycine 0 C--N 1.355 1.635 0 C-N-CA 126.904 2.192 . . . . 0.0 116.44 169.854 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 5.8 p -129.16 144.39 38.3 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.903 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 -177.009 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 3.5 p -95.4 135.49 29.31 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.918 0 N-CA-C 107.292 -1.373 . . . . 0.0 107.292 -179.693 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 94.8 m-85 -113.67 150.99 32.43 Favored 'General case' 0 CA--C 1.499 -1.011 0 N-CA-C 106.815 -1.55 . . . . 0.0 106.815 177.379 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -94.94 145.29 25.02 Favored 'General case' 0 CA--C 1.501 -0.928 0 N-CA-C 104.155 -2.535 . . . . 0.0 104.155 161.109 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -138.39 149.5 20.56 Favored Glycine 0 CA--C 1.487 -1.678 0 N-CA-C 108.599 -1.801 . . . . 0.0 108.599 -177.413 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 26.2 mt-30 -138.59 135.66 35.19 Favored 'General case' 0 CA--C 1.483 -1.608 0 N-CA-C 105.599 -2.0 . . . . 0.0 105.599 177.064 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 40.9 tp -116.72 99.36 7.07 Favored 'General case' 0 N--CA 1.435 -1.178 0 N-CA-C 103.787 -2.672 . . . . 0.0 103.787 179.075 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 33.0 mt -89.21 127.68 41.75 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.883 0 N-CA-C 104.762 -2.311 . . . . 0.0 104.762 177.702 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 13.3 p -112.03 115.98 29.8 Favored 'General case' 0 N--CA 1.434 -1.26 0 N-CA-C 106.565 -1.642 . . . . 0.0 106.565 -176.619 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 23.1 mm -90.68 138.63 19.13 Favored 'Isoleucine or valine' 0 CA--C 1.483 -1.603 0 N-CA-C 106.154 -1.795 . . . . 0.0 106.154 -167.468 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 36.2 mt-30 -101.24 153.6 19.48 Favored 'General case' 0 CA--C 1.494 -1.198 0 CA-C-N 113.851 -1.522 . . . . 0.0 107.569 -173.313 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 32.8 mt-30 -68.44 101.16 1.19 Allowed 'General case' 0 CA--C 1.5 -0.948 0 C-N-CA 124.939 1.295 . . . . 0.0 112.497 -166.165 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 85.7 m-85 52.99 39.99 30.38 Favored 'General case' 0 C--N 1.359 1.008 0 C-N-CA 127.296 2.238 . . . . 0.0 112.214 -179.825 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -149.64 -118.83 0.93 Allowed Glycine 0 C--N 1.354 1.545 0 N-CA-C 108.851 -1.7 . . . . 0.0 108.851 -175.294 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 64.4 m-70 -81.93 -175.68 5.73 Favored 'General case' 0 CA--C 1.496 -1.113 0 C-N-CA 124.757 1.223 . . . . 0.0 111.528 -167.858 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 40.1 mt-30 -134.0 137.47 44.77 Favored 'General case' 0 N--CA 1.436 -1.132 0 N-CA-C 103.536 -2.765 . . . . 0.0 103.536 171.595 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 16.7 tp10 -118.05 137.02 53.18 Favored 'General case' 0 CA--C 1.495 -1.146 0 N-CA-C 105.174 -2.158 . . . . 0.0 105.174 179.873 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 7.1 p -111.35 139.12 36.9 Favored 'Isoleucine or valine' 0 C--N 1.354 0.797 0 N-CA-C 107.618 -1.253 . . . . 0.0 107.618 -177.414 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 38.2 m -120.49 134.17 55.31 Favored 'General case' 0 N--CA 1.441 -0.886 0 N-CA-C 102.345 -3.206 . . . . 0.0 102.345 174.114 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 83.1 mtm180 -125.82 149.75 48.36 Favored 'General case' 0 CA--C 1.5 -0.954 0 CA-C-N 119.177 0.898 . . . . 0.0 109.479 -176.638 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 19.2 p90 -165.96 -176.59 3.85 Favored 'General case' 0 CA--C 1.501 -0.92 0 N-CA-C 107.382 -1.34 . . . . 0.0 107.382 -178.357 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 44.7 p30 -135.79 158.05 45.34 Favored 'General case' 0 N--CA 1.442 -0.858 0 N-CA-C 107.24 -1.393 . . . . 0.0 107.24 164.626 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 25.4 p90 -142.38 172.88 12.09 Favored 'General case' 0 CA--C 1.485 -1.53 0 N-CA-C 106.018 -1.845 . . . . 0.0 106.018 170.252 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 8.9 t -141.41 152.98 44.77 Favored 'General case' 0 CA--C 1.499 -0.996 0 N-CA-C 105.713 -1.958 . . . . 0.0 105.713 173.77 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 29.8 p -113.95 131.94 56.13 Favored 'General case' 0 N--CA 1.437 -1.104 0 N-CA-C 103.432 -2.803 . . . . 0.0 103.432 171.745 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 25.0 p -130.5 145.83 51.93 Favored 'General case' 0 CA--C 1.5 -0.968 0 N-CA-C 105.654 -1.98 . . . . 0.0 105.654 179.632 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 42.9 p . . . . . 0 C--O 1.26 1.65 0 N-CA-C 109.206 -0.664 . . . . 0.0 109.206 -177.575 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.437 -1.249 0 N-CA-C 105.516 -3.034 . . . . 0.0 105.516 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 90.4 Cg_exo -61.17 134.27 51.51 Favored 'Trans proline' 0 CA--C 1.5 -1.177 0 C-N-CA 123.17 2.58 . . . . 0.0 112.255 -171.018 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 3.1 t -79.39 150.31 5.15 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.79 0 C-N-CA 126.313 1.845 . . . . 0.0 106.039 -176.442 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 54.5 mm-40 -100.1 89.46 4.04 Favored 'General case' 0 CA--C 1.485 -1.527 0 CA-C-O 122.776 1.274 . . . . 0.0 108.36 -170.262 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 2.3 p -104.06 127.24 58.42 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.136 0 CA-C-N 113.421 -1.718 . . . . 0.0 107.661 -166.879 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 59.2 m-85 . . . . . 0 CA--C 1.495 -1.135 0 C-N-CA 123.935 0.894 . . . . 0.0 110.444 -169.501 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo . . . . . 0 N--CA 1.45 -1.056 0 CA-C-O 119.004 -0.498 . . . . 0.0 111.75 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 36.6 m-20 -141.97 -12.39 0.85 Allowed 'General case' 0 N--CA 1.435 -1.191 0 C-N-CA 124.82 1.248 . . . . 0.0 110.228 -163.649 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 23.6 p -98.11 161.39 13.74 Favored 'General case' 0 CA--C 1.503 -0.846 0 O-C-N 120.739 -1.226 . . . . 0.0 107.701 -179.516 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 40.3 t-80 -151.52 104.26 2.91 Favored Pre-proline 0 N--CA 1.443 -0.816 0 CA-C-O 118.359 -0.829 . . . . 0.0 108.934 173.088 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -75.73 123.11 7.25 Favored 'Trans proline' 0 N--CA 1.452 -0.949 0 C-N-CA 123.199 2.599 . . . . 0.0 109.71 175.282 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 10.9 mt -111.6 136.56 47.35 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.947 0 N-CA-C 104.586 -2.375 . . . . 0.0 104.586 -178.639 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 35.7 mt-30 -140.3 146.93 39.17 Favored 'General case' 0 CA--C 1.494 -1.19 0 N-CA-C 104.668 -2.345 . . . . 0.0 104.668 179.387 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 42.7 p90 -147.48 169.63 19.14 Favored 'General case' 0 CA--C 1.499 -1.015 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 -174.072 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 5.7 m120 -131.24 127.57 38.1 Favored 'General case' 0 CA--C 1.492 -1.252 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 179.624 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -92.26 175.78 3.11 Favored Pre-proline 0 N--CA 1.439 -0.993 0 C-N-CA 125.989 1.716 . . . . 0.0 108.946 -174.323 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_exo -63.16 159.58 38.45 Favored 'Trans proline' 0 CA--C 1.508 -0.823 0 C-N-CA 123.743 2.962 . . . . 0.0 112.297 171.095 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 35.9 mt-30 -81.57 -37.12 0.86 Allowed Pre-proline 0 N--CA 1.443 -0.795 0 CA-C-O 115.962 -1.971 . . . . 0.0 111.281 -177.414 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_exo -70.17 -8.26 23.16 Favored 'Trans proline' 0 CA--C 1.512 -0.625 0 CA-C-N 124.878 2.778 . . . . 0.0 112.905 169.526 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . 0.28 80.5 p 54.09 71.81 0.49 Allowed 'General case' 0 C--N 1.36 1.046 0 C-N-CA 127.609 2.363 . . . . 0.0 112.022 -177.254 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 49.8 t-80 -88.74 -10.57 47.85 Favored 'General case' 0 N--CA 1.441 -0.885 0 C-N-CA 124.473 1.109 . . . . 0.0 109.768 -176.329 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 84.7 mt -93.88 145.03 8.4 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.976 0 N-CA-C 105.434 -2.061 . . . . 0.0 105.434 -179.846 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 35.6 t -99.09 -86.78 0.36 Allowed 'General case' 0 N--CA 1.43 -1.445 0 N-CA-C 103.857 -2.646 . . . . 0.0 103.857 174.537 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 46.0 mtpt -89.16 165.94 14.15 Favored 'General case' 0 CA--C 1.492 -1.266 0 C-N-CA 124.854 1.262 . . . . 0.0 109.097 -168.359 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 64.0 m-85 -125.63 142.34 51.56 Favored 'General case' 0 CA--C 1.495 -1.137 0 N-CA-C 104.547 -2.39 . . . . 0.0 104.547 164.641 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 54.7 mt -119.56 132.24 69.9 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.302 0 N-CA-C 101.141 -3.651 . . . . 0.0 101.141 168.796 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 3.0 mt -106.38 128.96 54.43 Favored 'General case' 0 CA--C 1.473 -2.017 0 N-CA-C 103.95 -2.611 . . . . 0.0 103.95 166.766 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 79.3 mtt180 -112.56 157.09 21.59 Favored 'General case' 0 N--CA 1.43 -1.442 0 N-CA-C 105.266 -2.124 . . . . 0.0 105.266 164.248 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 48.6 p90 -156.12 147.42 22.5 Favored 'General case' 0 N--CA 1.43 -1.44 0 N-CA-C 105.934 -1.876 . . . . 0.0 105.934 176.513 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 39.0 ptt180 -157.52 161.07 29.86 Favored Pre-proline 0 N--CA 1.438 -1.028 0 N-CA-C 105.41 -2.071 . . . . 0.0 105.41 170.189 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_exo -66.06 149.77 85.68 Favored 'Trans proline' 0 CA--C 1.503 -1.029 0 C-N-CA 123.367 2.711 . . . . 0.0 109.828 176.572 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 4.1 tmtp? -75.7 70.93 2.54 Favored 'General case' 0 C--N 1.358 0.947 0 C-N-CA 123.643 0.777 . . . . 0.0 109.587 175.731 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 30.4 m120 -158.67 -52.55 0.06 Allowed 'General case' 0 N--CA 1.437 -1.083 0 N-CA-C 103.671 -2.714 . . . . 0.0 103.671 -170.609 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 32.3 t -79.24 151.45 31.17 Favored 'General case' 0 CA--C 1.497 -1.096 0 CA-C-O 122.783 1.277 . . . . 0.0 110.064 -174.73 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 16.1 m -134.34 -0.54 1.24 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.894 0 CA-C-N 112.42 -2.173 . . . . 0.0 108.425 -174.514 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -98.2 -100.21 2.13 Favored Glycine 0 C--N 1.356 1.67 0 N-CA-C 109.355 -1.498 . . . . 0.0 109.355 -174.63 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 77.0 mtp85 -93.95 168.21 11.11 Favored 'General case' 0 CA--C 1.501 -0.908 0 C-N-CA 123.588 0.755 . . . . 0.0 109.559 -173.716 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 60.3 m95 -122.53 163.22 20.32 Favored 'General case' 0 N--CA 1.439 -0.996 0 N-CA-C 106.273 -1.751 . . . . 0.0 106.273 178.591 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -96.77 151.26 19.82 Favored 'General case' 0 CA--C 1.489 -1.392 0 N-CA-C 103.858 -2.645 . . . . 0.0 103.858 158.796 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 16.1 pt-20 -152.31 158.88 43.38 Favored 'General case' 0 CA--C 1.496 -1.12 0 CA-C-O 121.8 0.81 . . . . 0.0 109.559 -178.113 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -142.73 162.25 35.97 Favored 'General case' 0 CA--C 1.498 -1.036 0 N-CA-C 106.051 -1.833 . . . . 0.0 106.051 174.066 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 78.4 m -120.35 125.63 48.49 Favored 'General case' 0 CA--C 1.5 -0.945 0 N-CA-C 105.228 -2.138 . . . . 0.0 105.228 178.713 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 5.3 mp -109.43 133.3 20.87 Favored Pre-proline 0 N--CA 1.437 -1.107 0 N-CA-C 104.313 -2.476 . . . . 0.0 104.313 -177.929 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 65.3 Cg_exo -63.88 165.06 19.74 Favored 'Trans proline' 0 CA--C 1.507 -0.847 0 C-N-CA 123.393 2.729 . . . . 0.0 113.054 178.277 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -75.05 -18.04 80.2 Favored Glycine 0 C--N 1.351 1.403 0 N-CA-C 114.604 0.602 . . . . 0.0 114.604 -174.084 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 47.7 p-80 -83.71 -29.52 27.47 Favored 'General case' 0 C--N 1.356 0.864 0 CA-C-N 118.016 0.908 . . . . 0.0 109.826 179.832 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 89.6 mt -89.14 134.26 34.08 Favored 'General case' 0 CA--C 1.5 -0.972 0 N-CA-C 107.721 -1.215 . . . . 0.0 107.721 176.563 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 6.5 p-10 -123.53 25.01 8.4 Favored 'General case' 0 CA--C 1.498 -1.023 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 -177.541 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 33.9 p -146.79 163.22 36.72 Favored 'General case' 0 N--CA 1.439 -1.021 0 N-CA-C 107.59 -1.263 . . . . 0.0 107.59 -179.248 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 7.4 t80 -154.25 178.4 10.05 Favored 'General case' 0 N--CA 1.44 -0.936 0 N-CA-C 107.903 -1.147 . . . . 0.0 107.903 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 96.1 m -144.09 117.99 9.36 Favored 'General case' 0 N--CA 1.43 -1.44 0 N-CA-C 104.995 -2.224 . . . . 0.0 104.995 176.072 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 13.4 mm -87.22 144.38 9.4 Favored 'Isoleucine or valine' 0 C--N 1.354 0.768 0 N-CA-C 104.3 -2.481 . . . . 0.0 104.3 171.004 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 95.8 mttt -145.27 162.22 37.69 Favored 'General case' 0 CA--C 1.493 -1.225 0 N-CA-C 107.491 -1.3 . . . . 0.0 107.491 170.07 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 79.31 54.56 4.0 Favored Glycine 0 CA--C 1.488 -1.596 0 N-CA-C 108.968 -1.653 . . . . 0.0 108.968 175.249 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 85.3 mt -108.34 -153.87 0.52 Allowed 'General case' 0 CA--C 1.504 -0.799 0 N-CA-C 106.822 -1.547 . . . . 0.0 106.822 178.854 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 90.6 mttt -132.18 156.3 80.27 Favored Pre-proline 0 N--CA 1.44 -0.928 0 N-CA-C 105.74 -1.948 . . . . 0.0 105.74 -170.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_endo -74.09 135.78 21.44 Favored 'Trans proline' 0 N--CA 1.451 -0.993 0 C-N-CA 122.905 2.403 . . . . 0.0 110.45 173.202 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 57.25 49.74 70.09 Favored Glycine 0 C--N 1.355 1.612 0 C-N-CA 126.852 2.167 . . . . 0.0 115.823 170.417 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 27.8 t -118.13 133.58 64.49 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.102 0 N-CA-C 105.951 -1.87 . . . . 0.0 105.951 173.51 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 5.3 p -84.33 119.97 34.27 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.961 0 N-CA-C 105.48 -2.044 . . . . 0.0 105.48 164.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 83.0 m-85 -99.5 149.24 23.42 Favored 'General case' 0 CA--C 1.496 -1.13 0 C-N-CA 125.716 1.606 . . . . 0.0 107.354 -179.477 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 17.9 pt-20 -108.67 133.46 52.73 Favored 'General case' 0 CA--C 1.499 -0.984 0 N-CA-C 105.01 -2.219 . . . . 0.0 105.01 167.912 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -128.45 165.08 21.48 Favored Glycine 0 CA--C 1.484 -1.895 0 N-CA-C 107.688 -2.165 . . . . 0.0 107.688 -174.206 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 83.8 mt-30 -137.3 133.84 35.42 Favored 'General case' 0 CA--C 1.482 -1.667 0 N-CA-C 104.557 -2.386 . . . . 0.0 104.557 169.688 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 27.2 tp -110.54 90.77 3.42 Favored 'General case' 0 N--CA 1.435 -1.221 0 N-CA-C 103.335 -2.839 . . . . 0.0 103.335 174.383 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 13.2 mt -91.58 131.34 38.95 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.927 0 N-CA-C 105.492 -2.04 . . . . 0.0 105.492 -174.373 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 58.5 m -118.47 115.3 24.33 Favored 'General case' 0 N--CA 1.436 -1.164 0 N-CA-C 107.685 -1.228 . . . . 0.0 107.685 -173.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 1.7 mp -91.54 135.97 25.62 Favored 'Isoleucine or valine' 0 CA--C 1.499 -1.0 0 N-CA-C 105.163 -2.162 . . . . 0.0 105.163 -172.175 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 15.6 mp0 -99.17 122.07 41.88 Favored 'General case' 0 CA--C 1.498 -1.034 0 N-CA-C 102.582 -3.118 . . . . 0.0 102.582 170.174 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 16.7 tt0 -68.03 126.02 28.18 Favored 'General case' 0 N--CA 1.443 -0.789 0 C-N-CA 123.26 0.624 . . . . 0.0 111.629 -166.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 21.5 m-85 66.42 43.83 2.55 Favored 'General case' 0 C--N 1.357 0.902 0 C-N-CA 126.746 2.018 . . . . 0.0 111.912 179.787 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -171.95 -115.77 0.37 Allowed Glycine 0 N--CA 1.432 -1.587 0 N-CA-C 108.145 -1.982 . . . . 0.0 108.145 175.714 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 87.7 m-70 -84.71 178.53 7.63 Favored 'General case' 0 CA--C 1.498 -1.023 0 C-N-CA 125.182 1.393 . . . . 0.0 111.103 -169.302 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 5.3 pt20 -145.9 143.89 29.85 Favored 'General case' 0 N--CA 1.436 -1.138 0 N-CA-C 106.156 -1.794 . . . . 0.0 106.156 165.104 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 9.3 tm-20 -106.39 141.76 37.18 Favored 'General case' 0 N--CA 1.438 -1.064 0 N-CA-C 104.44 -2.43 . . . . 0.0 104.44 -177.351 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 3.2 p -121.96 120.43 61.43 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.804 0 N-CA-C 108.195 -1.039 . . . . 0.0 108.195 -179.467 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 83.9 m -97.15 129.09 44.57 Favored 'General case' 0 C--N 1.355 0.844 0 N-CA-C 102.622 -3.103 . . . . 0.0 102.622 169.822 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 55.3 ttt85 -115.17 137.66 51.77 Favored 'General case' 0 CA--C 1.498 -1.04 0 N-CA-C 106.358 -1.719 . . . . 0.0 106.358 175.45 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -150.86 176.76 10.77 Favored 'General case' 0 CA--C 1.494 -1.185 0 N-CA-C 107.657 -1.238 . . . . 0.0 107.657 -177.477 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 38.9 p-10 -139.39 151.25 46.16 Favored 'General case' 0 N--CA 1.438 -1.047 0 N-CA-C 106.0 -1.852 . . . . 0.0 106.0 171.21 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 18.5 p90 -144.43 170.51 15.89 Favored 'General case' 0 CA--C 1.489 -1.387 0 N-CA-C 105.801 -1.926 . . . . 0.0 105.801 176.433 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 55.2 m -122.19 142.98 49.86 Favored 'General case' 0 CA--C 1.5 -0.956 0 N-CA-C 105.564 -2.014 . . . . 0.0 105.564 -179.557 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 86.6 m -120.41 120.97 37.49 Favored 'General case' 0 CA--C 1.498 -1.056 0 N-CA-C 101.971 -3.344 . . . . 0.0 101.971 167.292 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 76.9 p -88.73 -168.46 2.2 Favored 'General case' 0 C--N 1.353 0.723 0 C-N-CA 123.654 0.781 . . . . 0.0 109.422 -169.527 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 32.3 t . . . . . 0 C--O 1.26 1.64 0 N-CA-C 106.768 -1.567 . . . . 0.0 106.768 -179.609 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.436 -1.36 0 N-CA-C 107.62 -2.192 . . . . 0.0 107.62 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 79.4 Cg_exo -61.83 137.5 68.31 Favored 'Trans proline' 0 N--CA 1.444 -1.412 0 C-N-CA 123.359 2.706 . . . . 0.0 113.06 -177.389 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 3.5 t -77.37 152.53 5.51 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.915 0 C-N-CA 127.993 2.517 . . . . 0.0 107.006 -178.86 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 91.4 mt-10 -94.35 86.99 5.05 Favored 'General case' 0 CA--C 1.493 -1.23 0 CA-C-O 122.73 1.252 . . . . 0.0 108.721 -174.547 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 2.1 p -88.98 154.32 3.18 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.077 0 N-CA-C 105.822 -1.918 . . . . 0.0 105.822 -171.293 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 36.8 t80 . . . . . 0 N--CA 1.429 -1.497 0 N-CA-C 104.458 -2.423 . . . . 0.0 104.458 -148.199 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 64.1 Cg_endo . . . . . 0 CA--C 1.504 -1.003 0 CA-C-O 118.494 -0.711 . . . . 0.0 112.052 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 1.4 p30 -120.75 -38.89 2.79 Favored 'General case' 0 CA--C 1.482 -1.654 0 C-N-CA 123.82 0.848 . . . . 0.0 109.198 -173.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 48.5 p -100.54 165.63 11.32 Favored 'General case' 0 N--CA 1.435 -1.22 0 N-CA-C 107.987 -1.116 . . . . 0.0 107.987 -174.956 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 63.7 t-80 -143.31 97.44 5.63 Favored Pre-proline 0 N--CA 1.435 -1.185 0 N-CA-C 104.501 -2.407 . . . . 0.0 104.501 162.434 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -71.18 133.83 23.76 Favored 'Trans proline' 0 N--CA 1.447 -1.258 0 C-N-CA 122.558 2.172 . . . . 0.0 110.167 172.061 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 14.7 mm -104.46 138.63 28.29 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.062 0 N-CA-C 102.928 -2.99 . . . . 0.0 102.928 176.664 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 73.1 mt-30 -128.31 149.66 50.41 Favored 'General case' 0 CA--C 1.493 -1.244 0 N-CA-C 103.909 -2.626 . . . . 0.0 103.909 172.609 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 49.1 p90 -149.49 167.69 25.54 Favored 'General case' 0 CA--C 1.491 -1.307 0 N-CA-C 107.947 -1.131 . . . . 0.0 107.947 -179.125 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 1.8 m120 -130.92 128.44 40.52 Favored 'General case' 0 CA--C 1.489 -1.374 0 N-CA-C 105.382 -2.081 . . . . 0.0 105.382 -179.751 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -87.02 143.79 35.5 Favored Pre-proline 0 N--CA 1.44 -0.927 0 CA-C-O 118.693 -0.67 . . . . 0.0 110.504 -170.622 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_endo -76.76 166.09 27.62 Favored 'Trans proline' 0 N--CA 1.452 -0.917 0 C-N-CA 122.716 2.277 . . . . 0.0 108.214 159.381 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 22.3 tt0 -129.73 84.44 61.19 Favored Pre-proline 0 N--CA 1.442 -0.861 0 N-CA-C 108.323 -0.991 . . . . 0.0 108.323 176.683 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 90.9 Cg_endo -82.31 -8.2 11.76 Favored 'Trans proline' 0 N--CA 1.453 -0.865 0 C-N-CA 123.148 2.565 . . . . 0.0 109.599 163.051 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 21.4 m 59.45 44.21 15.28 Favored 'General case' 0 C--N 1.36 1.028 0 C-N-CA 127.573 2.349 . . . . 0.0 111.222 -171.328 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 15.4 t-160 -140.57 -10.84 1.05 Allowed 'General case' 0 N--CA 1.438 -1.031 0 CA-C-N 113.947 -1.479 . . . . 0.0 108.92 -174.935 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 38.4 mt -111.11 130.7 64.09 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.094 0 N-CA-C 105.423 -2.066 . . . . 0.0 105.423 -173.408 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 32.0 t -112.91 -84.82 0.59 Allowed 'General case' 0 N--CA 1.433 -1.283 0 N-CA-C 107.806 -1.183 . . . . 0.0 107.806 -176.242 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 51.4 mtmt -87.68 168.87 12.62 Favored 'General case' 0 CA--C 1.485 -1.539 0 C-N-CA 124.009 0.924 . . . . 0.0 109.097 -161.313 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 86.8 m-85 -129.46 140.07 51.41 Favored 'General case' 0 CA--C 1.493 -1.238 0 N-CA-C 105.049 -2.204 . . . . 0.0 105.049 170.32 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 35.8 mt -117.24 131.08 71.0 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.203 0 N-CA-C 101.567 -3.494 . . . . 0.0 101.567 169.511 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 4.8 mt -106.65 128.68 54.37 Favored 'General case' 0 CA--C 1.473 -1.985 0 N-CA-C 104.389 -2.448 . . . . 0.0 104.389 168.182 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 65.5 mtt180 -113.97 157.97 21.75 Favored 'General case' 0 N--CA 1.431 -1.377 0 N-CA-C 105.644 -1.984 . . . . 0.0 105.644 167.082 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 36.0 p90 -147.07 130.41 16.63 Favored 'General case' 0 N--CA 1.432 -1.362 0 N-CA-C 104.359 -2.46 . . . . 0.0 104.359 174.16 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 20.0 ttp180 -122.94 138.78 30.2 Favored Pre-proline 0 CA--C 1.498 -1.046 0 N-CA-C 104.087 -2.56 . . . . 0.0 104.087 177.437 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 68.4 Cg_exo -66.26 130.14 23.3 Favored 'Trans proline' 0 CA--C 1.503 -1.037 0 CA-C-N 123.798 2.392 . . . . 0.0 109.122 169.395 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 39.9 ttmt -73.07 69.56 1.02 Allowed 'General case' 0 C--N 1.357 0.929 0 C-N-CA 124.716 1.206 . . . . 0.0 109.899 173.939 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 69.6 m-80 -160.65 -57.05 0.05 Allowed 'General case' 0 N--CA 1.434 -1.26 0 N-CA-C 102.18 -3.267 . . . . 0.0 102.18 -170.866 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 53.4 p -85.29 165.52 17.24 Favored 'General case' 0 N--CA 1.439 -1.021 0 C-N-CA 125.333 1.453 . . . . 0.0 109.109 179.565 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 19.2 m -113.73 -13.04 11.58 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.811 0 C-N-CA 124.254 1.022 . . . . 0.0 110.144 -172.31 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -175.81 38.61 0.1 Allowed Glycine 0 C--N 1.354 1.55 0 N-CA-C 110.359 -1.097 . . . . 0.0 110.359 -178.19 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -119.85 105.51 11.17 Favored 'General case' 0 CA--C 1.492 -1.257 0 N-CA-C 102.271 -3.233 . . . . 0.0 102.271 171.149 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -157.75 165.74 34.59 Favored 'General case' 0 CA--C 1.49 -1.33 0 CA-C-O 122.16 0.981 . . . . 0.0 112.161 -172.618 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 63.2 mttp -121.57 161.41 22.43 Favored 'General case' 0 CA--C 1.492 -1.257 0 CA-C-N 113.688 -1.596 . . . . 0.0 106.79 -169.777 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 15.8 pt-20 -151.92 160.71 43.43 Favored 'General case' 0 N--CA 1.435 -1.199 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 174.315 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -140.5 162.25 35.79 Favored 'General case' 0 CA--C 1.5 -0.961 0 N-CA-C 106.283 -1.747 . . . . 0.0 106.283 174.69 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 59.5 m -120.36 126.04 49.52 Favored 'General case' 0 CA--C 1.499 -0.982 0 N-CA-C 105.175 -2.157 . . . . 0.0 105.175 178.06 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 5.3 mp -112.7 135.94 21.57 Favored Pre-proline 0 N--CA 1.437 -1.098 0 N-CA-C 104.516 -2.401 . . . . 0.0 104.516 -177.346 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 63.2 Cg_exo -63.6 168.06 12.26 Favored 'Trans proline' 0 CA--C 1.51 -0.723 0 C-N-CA 123.45 2.766 . . . . 0.0 113.618 177.466 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -78.49 -20.01 72.65 Favored Glycine 0 C--N 1.351 1.383 0 C-N-CA 123.398 0.523 . . . . 0.0 113.26 -173.885 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 49.7 p-80 -84.27 -27.48 27.85 Favored 'General case' 0 C--N 1.355 0.836 0 CA-C-N 117.713 0.756 . . . . 0.0 110.022 -179.393 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 87.5 mt -88.52 130.64 35.18 Favored 'General case' 0 CA--C 1.5 -0.981 0 N-CA-C 107.541 -1.281 . . . . 0.0 107.541 177.264 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 7.6 p30 -118.88 13.05 13.05 Favored 'General case' 0 CA--C 1.501 -0.921 0 C-N-CA 124.113 0.965 . . . . 0.0 109.645 -173.311 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 46.9 p -142.93 166.6 24.19 Favored 'General case' 0 N--CA 1.44 -0.959 0 N-CA-C 107.282 -1.377 . . . . 0.0 107.282 179.169 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 9.9 t80 -154.87 176.74 12.1 Favored 'General case' 0 N--CA 1.44 -0.938 0 N-CA-C 107.788 -1.19 . . . . 0.0 107.788 -177.161 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 57.2 m -142.57 114.72 8.3 Favored 'General case' 0 N--CA 1.432 -1.367 0 N-CA-C 105.114 -2.18 . . . . 0.0 105.114 176.882 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 50.8 mt -98.84 98.09 6.73 Favored 'Isoleucine or valine' 0 C--N 1.36 1.044 0 N-CA-C 106.137 -1.801 . . . . 0.0 106.137 175.823 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 93.4 mttt -94.97 163.65 13.23 Favored 'General case' 0 CA--C 1.499 -0.988 0 CA-C-O 121.591 0.71 . . . . 0.0 109.341 178.453 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 84.03 49.51 4.73 Favored Glycine 0 CA--C 1.49 -1.471 0 N-CA-C 109.134 -1.586 . . . . 0.0 109.134 174.453 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 68.3 mt -121.63 162.73 20.16 Favored 'General case' 0 CA--C 1.497 -1.078 0 N-CA-C 106.171 -1.789 . . . . 0.0 106.171 -179.144 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -99.57 157.34 34.13 Favored Pre-proline 0 N--CA 1.44 -0.944 0 N-CA-C 107.257 -1.386 . . . . 0.0 107.257 -177.276 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -78.65 165.88 24.38 Favored 'Trans proline' 0 N--CA 1.451 -1.005 0 C-N-CA 123.074 2.516 . . . . 0.0 109.575 165.521 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . 0.441 ' H ' ' HA ' ' A' ' 92' ' ' THR . . . 64.67 18.77 64.26 Favored Glycine 0 N--CA 1.43 -1.736 0 C-N-CA 127.223 2.344 . . . . 0.0 116.415 173.178 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 13.9 p -123.99 140.36 47.66 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.024 0 N-CA-C 107.942 -1.133 . . . . 0.0 107.942 -176.338 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 2.8 p -96.34 129.48 46.35 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.842 0 N-CA-C 107.391 -1.337 . . . . 0.0 107.391 178.671 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 82.6 m-85 -109.56 155.17 21.73 Favored 'General case' 0 N--CA 1.438 -1.04 0 C-N-CA 124.672 1.189 . . . . 0.0 108.436 177.375 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 19.3 tt0 -92.63 139.04 30.98 Favored 'General case' 0 N--CA 1.437 -1.108 0 N-CA-C 104.044 -2.576 . . . . 0.0 104.044 159.074 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -132.31 146.07 17.82 Favored Glycine 0 CA--C 1.49 -1.488 0 N-CA-C 107.575 -2.21 . . . . 0.0 107.575 171.679 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 32.4 mt-30 -138.57 136.02 35.6 Favored 'General case' 0 CA--C 1.479 -1.759 0 N-CA-C 106.321 -1.733 . . . . 0.0 106.321 177.834 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 45.2 tp -117.54 95.53 4.99 Favored 'General case' 0 N--CA 1.439 -1.011 0 N-CA-C 104.423 -2.436 . . . . 0.0 104.423 -178.281 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 12.5 mt -90.92 131.7 37.4 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.85 0 N-CA-C 105.167 -2.16 . . . . 0.0 105.167 -176.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 26.0 p -112.18 115.05 28.21 Favored 'General case' 0 N--CA 1.441 -0.882 0 N-CA-C 107.592 -1.262 . . . . 0.0 107.592 -176.257 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 5.8 mm -94.03 151.56 3.71 Favored 'Isoleucine or valine' 0 CA--C 1.49 -1.347 0 N-CA-C 106.282 -1.747 . . . . 0.0 106.282 -165.142 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . 0.528 HE21 ' HB2' ' A' ' 81' ' ' HIS . 15.6 mt-30 -119.1 145.66 45.74 Favored 'General case' 0 CA--C 1.49 -1.344 0 N-CA-C 105.154 -2.165 . . . . 0.0 105.154 176.879 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 36.1 mt-30 -77.27 35.31 0.17 Allowed 'General case' 0 C--N 1.356 0.856 0 C-N-CA 125.182 1.393 . . . . 0.0 112.917 179.322 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -138.54 13.33 2.76 Favored 'General case' 0 CA--C 1.499 -1.017 0 C-N-CA 124.754 1.222 . . . . 0.0 107.747 -179.436 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 92.51 -13.64 66.81 Favored Glycine 0 C--N 1.352 1.419 0 C-N-CA 124.298 0.952 . . . . 0.0 112.511 173.423 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' HIS . . . . . 0.528 ' HB2' HE21 ' A' ' 77' ' ' GLN . 65.4 m80 -80.74 161.99 24.31 Favored 'General case' 0 CA--C 1.502 -0.897 0 CA-C-N 118.045 0.922 . . . . 0.0 109.692 -174.81 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 80.7 mt-30 -145.45 137.34 25.44 Favored 'General case' 0 N--CA 1.437 -1.104 0 N-CA-C 104.606 -2.368 . . . . 0.0 104.606 -178.148 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 9.6 mp0 -118.36 131.37 56.31 Favored 'General case' 0 CA--C 1.494 -1.199 0 N-CA-C 104.074 -2.565 . . . . 0.0 104.074 173.155 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 5.6 p -106.91 132.72 53.52 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.864 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 -172.104 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 21.5 m -104.86 137.52 42.52 Favored 'General case' 0 N--CA 1.442 -0.873 0 N-CA-C 102.383 -3.192 . . . . 0.0 102.383 168.947 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 31.5 ptt-85 -134.38 145.95 49.44 Favored 'General case' 0 CA--C 1.496 -1.112 0 CA-C-O 121.588 0.708 . . . . 0.0 109.143 179.831 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 20.0 p90 -164.78 -178.9 5.52 Favored 'General case' 0 CA--C 1.499 -0.999 0 N-CA-C 106.376 -1.713 . . . . 0.0 106.376 -173.296 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -137.06 157.76 45.98 Favored 'General case' 0 N--CA 1.437 -1.094 0 N-CA-C 106.212 -1.773 . . . . 0.0 106.212 170.155 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 25.5 p90 -143.58 170.72 15.3 Favored 'General case' 0 CA--C 1.487 -1.453 0 N-CA-C 106.256 -1.757 . . . . 0.0 106.256 169.497 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 9.7 m -126.49 140.3 52.57 Favored 'General case' 0 CA--C 1.499 -1.001 0 N-CA-C 103.678 -2.712 . . . . 0.0 103.678 175.827 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 86.1 m -112.71 114.15 26.6 Favored 'General case' 0 CA--C 1.497 -1.09 0 N-CA-C 102.137 -3.283 . . . . 0.0 102.137 176.58 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' THR . . . . . 0.441 ' HA ' ' H ' ' A' ' 66' ' ' GLY . 23.7 p -125.21 168.5 13.38 Favored 'General case' 0 CA--C 1.5 -0.952 0 N-CA-C 106.438 -1.69 . . . . 0.0 106.438 -179.128 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 15.1 t . . . . . 0 C--O 1.258 1.546 0 N-CA-C 108.014 -1.106 . . . . 0.0 108.014 -178.399 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.437 -1.265 0 N-CA-C 106.748 -2.541 . . . . 0.0 106.748 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 66.6 Cg_exo -60.1 138.86 84.44 Favored 'Trans proline' 0 N--CA 1.447 -1.214 0 C-N-CA 123.396 2.73 . . . . 0.0 113.493 -170.79 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 21.5 t -77.77 156.55 5.23 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.9 0 C-N-CA 128.277 2.631 . . . . 0.0 105.354 178.483 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 59.4 mm-40 -109.73 98.67 7.97 Favored 'General case' 0 CA--C 1.487 -1.478 0 N-CA-C 106.947 -1.501 . . . . 0.0 106.947 -174.442 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 2.2 p -123.27 139.3 50.38 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.108 0 N-CA-C 106.248 -1.76 . . . . 0.0 106.248 -169.163 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 75.1 m-85 . . . . . 0 CA--C 1.494 -1.184 0 N-CA-C 105.179 -2.156 . . . . 0.0 105.179 -172.403 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo . . . . . 0 CA--C 1.505 -0.943 0 CA-C-O 118.206 -0.831 . . . . 0.0 112.005 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 5.8 p-10 -114.28 -39.46 3.86 Favored 'General case' 0 CA--C 1.491 -1.321 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 -164.701 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 66.5 m -104.31 154.33 19.95 Favored 'General case' 0 CA--C 1.494 -1.181 0 N-CA-C 106.599 -1.63 . . . . 0.0 106.599 176.285 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . 0.486 ' CD2' ' HG1' ' A' ' 91' ' ' THR . 37.0 t-80 -139.95 89.58 11.24 Favored Pre-proline 0 N--CA 1.438 -1.033 0 N-CA-C 107.188 -1.412 . . . . 0.0 107.188 172.917 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -82.96 120.05 2.96 Favored 'Trans proline' 0 N--CA 1.447 -1.219 0 C-N-CA 123.11 2.54 . . . . 0.0 110.463 179.593 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 3.9 pt -104.85 173.84 1.35 Allowed 'Isoleucine or valine' 0 CA--C 1.497 -1.083 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 -177.486 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 2.4 pt20 -149.82 149.43 30.5 Favored 'General case' 0 N--CA 1.44 -0.967 0 N-CA-C 106.421 -1.696 . . . . 0.0 106.421 173.52 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 23.8 p90 -134.44 157.14 47.21 Favored 'General case' 0 CA--C 1.499 -0.983 0 N-CA-C 106.632 -1.618 . . . . 0.0 106.632 -177.808 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 59.8 t30 -99.71 -177.81 3.68 Favored 'General case' 0 CA--C 1.492 -1.272 0 N-CA-C 102.683 -3.08 . . . . 0.0 102.683 168.152 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -155.63 170.49 8.66 Favored Pre-proline 0 N--CA 1.438 -1.043 0 N-CA-C 106.334 -1.728 . . . . 0.0 106.334 176.325 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 63.5 Cg_exo -63.65 164.16 22.06 Favored 'Trans proline' 0 N--CA 1.456 -0.695 0 C-N-CA 123.267 2.645 . . . . 0.0 112.635 173.176 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 17.9 mp0 -80.48 -53.83 0.85 Allowed Pre-proline 0 N--CA 1.443 -0.818 0 CA-C-O 115.579 -2.153 . . . . 0.0 111.617 -167.919 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -74.03 172.26 16.29 Favored 'Trans proline' 0 CA--C 1.51 -0.699 0 CA-C-N 125.871 3.132 . . . . 0.0 109.95 174.221 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 22.8 t -83.79 87.01 7.07 Favored 'General case' 0 C--N 1.357 0.907 0 N-CA-C 107.237 -1.394 . . . . 0.0 107.237 178.563 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 22.5 t-160 -112.56 -32.86 6.33 Favored 'General case' 0 N--CA 1.436 -1.145 0 N-CA-C 106.938 -1.504 . . . . 0.0 106.938 -177.084 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 1.8 mp -108.62 134.55 50.2 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.946 0 N-CA-C 103.315 -2.846 . . . . 0.0 103.315 -178.179 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 5.9 p -100.77 -82.01 0.46 Allowed 'General case' 0 N--CA 1.434 -1.26 0 N-CA-C 107.875 -1.158 . . . . 0.0 107.875 175.108 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.407 ' HZ1' ' HB3' ' A' ' 32' ' ' LYS . 6.5 ttpm? -94.35 161.27 14.31 Favored 'General case' 0 CA--C 1.495 -1.136 0 C-N-CA 124.7 1.2 . . . . 0.0 108.029 -165.733 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 85.5 m-85 -125.9 138.14 53.77 Favored 'General case' 0 N--CA 1.437 -1.079 0 N-CA-C 105.111 -2.181 . . . . 0.0 105.111 171.733 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 34.3 mm -109.25 129.18 64.43 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.155 0 N-CA-C 101.03 -3.692 . . . . 0.0 101.03 165.831 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 3.8 mt -109.02 135.8 49.6 Favored 'General case' 0 CA--C 1.478 -1.796 0 N-CA-C 106.543 -1.651 . . . . 0.0 106.543 169.721 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 84.1 mtt180 -125.09 158.23 34.35 Favored 'General case' 0 N--CA 1.43 -1.446 0 N-CA-C 107.123 -1.436 . . . . 0.0 107.123 173.191 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 48.0 p90 -150.5 145.21 25.85 Favored 'General case' 0 N--CA 1.437 -1.091 0 N-CA-C 105.86 -1.904 . . . . 0.0 105.86 173.381 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 46.9 ttp180 -153.44 137.57 10.73 Favored Pre-proline 0 CA--C 1.498 -1.032 0 N-CA-C 105.324 -2.102 . . . . 0.0 105.324 -176.411 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -72.74 120.75 6.86 Favored 'Trans proline' 0 N--CA 1.451 -1.021 0 CA-C-N 123.485 2.28 . . . . 0.0 109.034 -177.369 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 58.5 tttm -73.48 65.06 0.89 Allowed 'General case' 0 C--N 1.358 0.962 0 C-N-CA 127.078 2.151 . . . . 0.0 110.554 177.514 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 6.4 t-20 -161.77 -53.0 0.04 OUTLIER 'General case' 0 N--CA 1.432 -1.358 0 N-CA-C 104.003 -2.592 . . . . 0.0 104.003 -169.735 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 50.3 m -88.36 166.0 14.57 Favored 'General case' 0 N--CA 1.438 -1.052 0 C-N-CA 124.431 1.092 . . . . 0.0 108.218 177.991 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 10.9 m -116.0 41.37 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.795 0 N-CA-C 106.938 -1.505 . . . . 0.0 106.938 -178.998 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -92.54 -156.38 32.72 Favored Glycine 0 C--N 1.354 1.559 0 N-CA-C 109.61 -1.396 . . . . 0.0 109.61 -177.494 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 39.6 mmt180 -101.87 172.2 7.07 Favored 'General case' 0 CA--C 1.499 -0.999 0 N-CA-C 107.324 -1.362 . . . . 0.0 107.324 -179.999 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 47.9 m95 -87.12 164.28 16.5 Favored 'General case' 0 N--CA 1.441 -0.88 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 -177.681 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 96.2 mttt -108.77 155.64 20.54 Favored 'General case' 0 CA--C 1.489 -1.366 0 N-CA-C 102.237 -3.246 . . . . 0.0 102.237 161.462 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -151.32 159.07 44.49 Favored 'General case' 0 CA--C 1.494 -1.209 0 CA-C-O 122.021 0.915 . . . . 0.0 109.794 -178.048 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -133.88 159.21 41.36 Favored 'General case' 0 N--CA 1.434 -1.241 0 N-CA-C 106.057 -1.831 . . . . 0.0 106.057 172.68 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 93.8 m -119.86 125.63 48.99 Favored 'General case' 0 CA--C 1.499 -1.006 0 N-CA-C 104.277 -2.49 . . . . 0.0 104.277 178.178 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 34.0 mt -123.79 122.79 26.35 Favored Pre-proline 0 N--CA 1.439 -0.984 0 N-CA-C 105.038 -2.208 . . . . 0.0 105.038 -171.602 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . 0.505 ' HB2' ' CE1' ' A' ' 54' ' ' HIS . 50.7 Cg_exo -67.25 169.21 15.78 Favored 'Trans proline' 0 CA--C 1.512 -0.612 0 C-N-CA 123.279 2.653 . . . . 0.0 111.301 175.757 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -86.71 83.21 1.6 Allowed Glycine 0 C--N 1.352 1.441 0 N-CA-C 110.121 -1.191 . . . . 0.0 110.121 -177.728 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . 0.505 ' CE1' ' HB2' ' A' ' 52' ' ' PRO . 0.5 OUTLIER -157.54 -44.11 0.07 Allowed 'General case' 0 CA--C 1.497 -1.079 0 N-CA-C 107.279 -1.378 . . . . 0.0 107.279 -179.795 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 92.2 mt -89.62 136.49 33.0 Favored 'General case' 0 CA--C 1.495 -1.148 0 N-CA-C 107.832 -1.173 . . . . 0.0 107.832 179.522 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 8.6 p30 -112.67 5.34 17.68 Favored 'General case' 0 N--CA 1.44 -0.926 0 C-N-CA 124.875 1.27 . . . . 0.0 109.119 -179.392 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 45.3 p -142.98 150.28 39.45 Favored 'General case' 0 CA--C 1.499 -1.012 0 N-CA-C 107.171 -1.418 . . . . 0.0 107.171 -178.519 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 7.5 t80 -126.36 174.08 8.85 Favored 'General case' 0 C--N 1.357 0.924 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 -179.087 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 88.0 m -138.74 109.44 6.64 Favored 'General case' 0 N--CA 1.43 -1.425 0 N-CA-C 104.618 -2.364 . . . . 0.0 104.618 172.205 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 28.3 mt -88.15 147.17 5.42 Favored 'Isoleucine or valine' 0 C--N 1.358 0.965 0 N-CA-C 104.271 -2.492 . . . . 0.0 104.271 171.447 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 94.0 mttt -141.08 162.65 34.97 Favored 'General case' 0 CA--C 1.5 -0.976 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 177.131 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 82.61 48.96 5.35 Favored Glycine 0 C--N 1.353 1.487 0 N-CA-C 109.838 -1.305 . . . . 0.0 109.838 173.758 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 58.0 mt -119.71 173.34 7.08 Favored 'General case' 0 CA--C 1.5 -0.958 0 N-CA-C 107.886 -1.153 . . . . 0.0 107.886 -173.654 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 67.8 mttm -110.36 157.15 38.96 Favored Pre-proline 0 N--CA 1.441 -0.876 0 N-CA-C 107.419 -1.326 . . . . 0.0 107.419 -176.113 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 67.5 Cg_endo -78.65 161.3 27.86 Favored 'Trans proline' 0 N--CA 1.451 -0.986 0 C-N-CA 123.168 2.579 . . . . 0.0 109.785 168.247 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 59.59 26.21 61.99 Favored Glycine 0 C--N 1.355 1.621 0 C-N-CA 127.261 2.363 . . . . 0.0 116.337 171.59 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 13.2 p -120.24 148.3 23.46 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.995 0 N-CA-C 106.837 -1.542 . . . . 0.0 106.837 -177.595 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 4.0 p -99.76 130.93 48.1 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.907 0 N-CA-C 106.626 -1.62 . . . . 0.0 106.626 176.137 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 93.5 m-85 -112.16 148.42 34.04 Favored 'General case' 0 CA--C 1.494 -1.189 0 N-CA-C 105.537 -2.023 . . . . 0.0 105.537 172.246 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -97.91 134.69 40.7 Favored 'General case' 0 CA--C 1.496 -1.11 0 N-CA-C 103.576 -2.75 . . . . 0.0 103.576 161.68 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -117.6 152.58 17.62 Favored Glycine 0 CA--C 1.486 -1.75 0 N-CA-C 106.065 -2.814 . . . . 0.0 106.065 -178.054 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 35.3 tt0 -145.64 130.1 17.82 Favored 'General case' 0 CA--C 1.48 -1.735 0 N-CA-C 106.623 -1.621 . . . . 0.0 106.623 -177.226 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 38.9 tp -118.14 99.8 7.11 Favored 'General case' 0 N--CA 1.437 -1.081 0 N-CA-C 104.151 -2.537 . . . . 0.0 104.151 -174.534 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 26.8 mt -91.99 131.56 38.75 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.865 0 N-CA-C 103.603 -2.74 . . . . 0.0 103.603 176.481 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 20.9 p -117.08 115.74 25.97 Favored 'General case' 0 N--CA 1.436 -1.166 0 N-CA-C 106.962 -1.495 . . . . 0.0 106.962 -177.33 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 1.7 mp -89.58 132.52 34.07 Favored 'Isoleucine or valine' 0 CA--C 1.483 -1.6 0 N-CA-C 102.543 -3.132 . . . . 0.0 102.543 -173.131 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 82.0 mt-30 -101.83 152.65 20.64 Favored 'General case' 0 CA--C 1.489 -1.393 0 N-CA-C 106.951 -1.5 . . . . 0.0 106.951 -174.97 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 11.8 tt0 -77.53 41.48 0.33 Allowed 'General case' 0 N--CA 1.443 -0.818 0 C-N-CA 125.858 1.663 . . . . 0.0 112.419 -179.668 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 8.5 t80 -151.78 16.7 0.68 Allowed 'General case' 0 N--CA 1.436 -1.128 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 178.315 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 86.99 -11.75 63.97 Favored Glycine 0 C--N 1.353 1.526 0 C-N-CA 123.73 0.681 . . . . 0.0 112.496 176.901 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 44.6 t-80 -78.65 160.38 27.56 Favored 'General case' 0 N--CA 1.441 -0.888 0 C-N-CA 124.68 1.192 . . . . 0.0 109.011 -176.767 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 83.2 mt-30 -136.22 136.2 39.71 Favored 'General case' 0 CA--C 1.491 -1.318 0 N-CA-C 104.579 -2.378 . . . . 0.0 104.579 175.14 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 16.8 tp10 -120.49 131.47 54.74 Favored 'General case' 0 CA--C 1.495 -1.171 0 N-CA-C 104.753 -2.314 . . . . 0.0 104.753 178.0 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 7.2 p -108.94 139.25 32.33 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.83 0 N-CA-C 107.561 -1.274 . . . . 0.0 107.561 -174.298 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 89.1 m -125.32 131.22 53.07 Favored 'General case' 0 N--CA 1.44 -0.953 0 N-CA-C 102.804 -3.036 . . . . 0.0 102.804 178.51 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 40.5 ttp180 -130.51 145.53 51.88 Favored 'General case' 0 C--N 1.356 0.882 0 CA-C-N 119.492 1.042 . . . . 0.0 109.031 178.459 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 17.8 p90 -156.35 -179.89 8.59 Favored 'General case' 0 CA--C 1.498 -1.026 0 N-CA-C 105.987 -1.857 . . . . 0.0 105.987 -171.245 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 1.6 p30 -141.05 157.72 44.93 Favored 'General case' 0 N--CA 1.442 -0.873 0 N-CA-C 108.117 -1.068 . . . . 0.0 108.117 169.153 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 21.8 p90 -144.66 170.71 15.56 Favored 'General case' 0 CA--C 1.493 -1.226 0 N-CA-C 106.921 -1.511 . . . . 0.0 106.921 173.597 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 24.7 p -117.51 138.6 51.78 Favored 'General case' 0 CA--C 1.501 -0.934 0 N-CA-C 106.175 -1.787 . . . . 0.0 106.175 171.491 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' THR . . . . . 0.486 ' HG1' ' CD2' ' A' ' 18' ' ' HIS . 56.0 m -108.07 113.49 26.69 Favored 'General case' 0 CA--C 1.495 -1.149 0 N-CA-C 103.009 -2.96 . . . . 0.0 103.009 172.076 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 15.0 t -161.86 165.36 27.85 Favored 'General case' 0 N--CA 1.436 -1.171 0 N-CA-C 104.731 -2.322 . . . . 0.0 104.731 -174.653 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 75.2 p . . . . . 0 C--O 1.261 1.687 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 173.587 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.438 -1.201 0 N-CA-C 108.593 -1.803 . . . . 0.0 108.593 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_exo -64.79 146.29 88.0 Favored 'Trans proline' 0 N--CA 1.442 -1.529 0 C-N-CA 123.157 2.571 . . . . 0.0 115.287 -161.042 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 4.6 m -83.0 169.28 1.6 Allowed 'Isoleucine or valine' 0 N--CA 1.432 -1.336 0 C-N-CA 126.641 1.977 . . . . 0.0 107.168 171.063 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 -101.81 100.35 10.67 Favored 'General case' 0 CA--C 1.495 -1.164 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 -176.678 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 4.2 p -107.77 137.62 38.16 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.138 0 N-CA-C 107.474 -1.306 . . . . 0.0 107.474 -174.016 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 1.6 t80 . . . . . 0 N--CA 1.433 -1.323 0 N-CA-C 106.975 -1.491 . . . . 0.0 106.975 -170.669 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_exo . . . . . 0 CA--C 1.507 -0.83 0 N-CA-C 110.722 -0.53 . . . . 0.0 110.722 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 1.9 p30 -96.87 -30.81 12.92 Favored 'General case' 0 CA--C 1.486 -1.485 0 C-N-CA 125.508 1.523 . . . . 0.0 110.638 -172.783 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 22.9 t -119.54 156.71 29.78 Favored 'General case' 0 CA--C 1.498 -1.037 0 CA-C-O 122.223 1.011 . . . . 0.0 108.915 -172.47 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 59.7 t-80 -140.39 98.75 7.26 Favored Pre-proline 0 N--CA 1.438 -1.056 0 N-CA-C 106.735 -1.58 . . . . 0.0 106.735 172.783 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -80.86 137.31 11.04 Favored 'Trans proline' 0 N--CA 1.447 -1.216 0 C-N-CA 123.019 2.479 . . . . 0.0 110.17 176.104 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 2.4 pt -118.64 172.77 5.59 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.07 0 N-CA-C 107.747 -1.205 . . . . 0.0 107.747 178.794 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 3.6 pt20 -150.79 158.34 44.03 Favored 'General case' 0 CA--C 1.492 -1.287 0 N-CA-C 105.706 -1.961 . . . . 0.0 105.706 168.947 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 43.7 p90 -142.97 164.49 29.94 Favored 'General case' 0 CA--C 1.493 -1.231 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 -175.409 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 81.1 m-20 -109.39 177.1 4.85 Favored 'General case' 0 CA--C 1.494 -1.2 0 N-CA-C 104.297 -2.482 . . . . 0.0 104.297 168.839 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -161.23 173.83 4.36 Favored Pre-proline 0 N--CA 1.435 -1.22 0 N-CA-C 104.788 -2.301 . . . . 0.0 104.788 -176.138 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 67.1 Cg_exo -63.1 153.49 73.55 Favored 'Trans proline' 0 N--CA 1.455 -0.742 0 C-N-CA 123.786 2.991 . . . . 0.0 112.758 175.563 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 26.1 tt0 -82.17 -40.36 0.93 Allowed Pre-proline 0 N--CA 1.443 -0.813 0 CA-C-O 115.574 -2.155 . . . . 0.0 112.071 -174.558 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_exo -69.49 -8.9 24.83 Favored 'Trans proline' 0 CA--C 1.512 -0.59 0 CA-C-N 125.674 3.062 . . . . 0.0 114.037 179.906 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 8.9 t 67.86 66.65 0.36 Allowed 'General case' 0 C--N 1.357 0.91 0 C-N-CA 126.107 1.763 . . . . 0.0 110.038 178.939 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 76.6 t60 -97.49 -2.27 42.33 Favored 'General case' 0 N--CA 1.441 -0.876 0 C-N-CA 124.517 1.127 . . . . 0.0 108.307 175.411 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 9.7 mt -111.16 135.8 49.21 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.071 0 N-CA-C 105.131 -2.174 . . . . 0.0 105.131 -179.669 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 4.6 p -98.13 -84.45 0.39 Allowed 'General case' 0 N--CA 1.428 -1.565 0 N-CA-C 106.518 -1.66 . . . . 0.0 106.518 178.282 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 52.7 mtmt -90.57 170.65 10.0 Favored 'General case' 0 CA--C 1.487 -1.448 0 C-N-CA 123.857 0.863 . . . . 0.0 109.086 -165.134 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 87.4 m-85 -132.43 140.05 48.28 Favored 'General case' 0 N--CA 1.436 -1.141 0 N-CA-C 103.837 -2.653 . . . . 0.0 103.837 167.568 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 41.8 mt -121.73 135.2 62.64 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.204 0 N-CA-C 101.632 -3.47 . . . . 0.0 101.632 173.66 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 4.5 mt -113.07 136.98 52.11 Favored 'General case' 0 CA--C 1.467 -2.233 0 N-CA-C 104.848 -2.278 . . . . 0.0 104.848 169.54 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 1.1 ptm180 -131.51 152.31 50.84 Favored 'General case' 0 N--CA 1.43 -1.472 0 N-CA-C 105.678 -1.971 . . . . 0.0 105.678 168.632 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 48.6 p90 -155.0 152.28 29.48 Favored 'General case' 0 N--CA 1.436 -1.158 0 N-CA-C 106.841 -1.54 . . . . 0.0 106.841 -175.034 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 36.4 ptt180 -158.14 157.37 29.18 Favored Pre-proline 0 CA--C 1.5 -0.949 0 N-CA-C 105.881 -1.896 . . . . 0.0 105.881 171.989 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_endo -76.43 124.33 7.65 Favored 'Trans proline' 0 CA--C 1.503 -1.067 0 C-N-CA 122.652 2.234 . . . . 0.0 108.968 -175.209 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 85.1 tttt -71.19 79.58 0.7 Allowed 'General case' 0 C--N 1.358 0.943 0 C-N-CA 126.296 1.839 . . . . 0.0 110.497 178.753 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 67.7 m-80 -154.28 -69.57 0.13 Allowed 'General case' 0 N--CA 1.436 -1.167 0 N-CA-C 101.531 -3.507 . . . . 0.0 101.531 -176.313 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 55.1 m -96.79 167.03 11.35 Favored 'General case' 0 N--CA 1.44 -0.925 0 N-CA-C 106.746 -1.575 . . . . 0.0 106.746 171.55 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 2.6 m -132.82 62.59 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.439 -0.988 0 N-CA-C 105.285 -2.117 . . . . 0.0 105.285 179.892 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -93.1 -111.83 2.09 Favored Glycine 0 C--N 1.353 1.521 0 N-CA-C 108.838 -1.705 . . . . 0.0 108.838 -178.916 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 86.7 mtm180 -97.66 169.66 9.55 Favored 'General case' 0 CA--C 1.501 -0.92 0 N-CA-C 107.973 -1.121 . . . . 0.0 107.973 -179.367 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 70.6 m95 -112.16 167.17 10.62 Favored 'General case' 0 N--CA 1.44 -0.957 0 N-CA-C 107.615 -1.254 . . . . 0.0 107.615 178.53 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -114.51 152.89 30.97 Favored 'General case' 0 CA--C 1.487 -1.46 0 N-CA-C 102.537 -3.135 . . . . 0.0 102.537 163.245 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 16.2 pt-20 -152.35 159.04 43.51 Favored 'General case' 0 N--CA 1.437 -1.094 0 CA-C-O 121.749 0.785 . . . . 0.0 109.106 178.507 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -140.03 162.68 34.62 Favored 'General case' 0 CA--C 1.499 -0.998 0 N-CA-C 106.553 -1.647 . . . . 0.0 106.553 172.488 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 90.0 m -119.34 125.32 48.75 Favored 'General case' 0 CA--C 1.5 -0.969 0 N-CA-C 105.127 -2.175 . . . . 0.0 105.127 176.981 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 4.5 mp -109.03 133.64 20.65 Favored Pre-proline 0 N--CA 1.437 -1.117 0 N-CA-C 105.239 -2.134 . . . . 0.0 105.239 -175.928 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 68.7 Cg_exo -64.27 164.1 24.04 Favored 'Trans proline' 0 CA--C 1.508 -0.802 0 C-N-CA 123.312 2.675 . . . . 0.0 113.369 176.193 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -75.37 -16.63 80.5 Favored Glycine 0 C--N 1.352 1.418 0 C-N-CA 123.977 0.799 . . . . 0.0 114.497 -174.421 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 52.6 p-80 -83.52 -27.15 29.57 Favored 'General case' 0 C--N 1.357 0.903 0 CA-C-N 118.144 0.972 . . . . 0.0 110.105 -179.617 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 88.4 mt -88.65 131.18 35.1 Favored 'General case' 0 CA--C 1.501 -0.908 0 N-CA-C 107.945 -1.131 . . . . 0.0 107.945 177.161 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 8.5 p30 -114.17 7.87 16.73 Favored 'General case' 0 CA--C 1.504 -0.797 0 C-N-CA 124.521 1.128 . . . . 0.0 109.858 -174.753 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 36.9 p -139.23 160.49 39.68 Favored 'General case' 0 CA--C 1.497 -1.093 0 N-CA-C 107.163 -1.421 . . . . 0.0 107.163 -177.519 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 4.1 t80 -138.87 178.77 6.91 Favored 'General case' 0 C--N 1.36 1.064 0 CA-C-O 121.672 0.748 . . . . 0.0 109.171 175.729 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 89.4 m -144.49 103.62 3.97 Favored 'General case' 0 N--CA 1.432 -1.339 0 N-CA-C 103.689 -2.708 . . . . 0.0 103.689 -178.502 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 55.8 mt -95.37 106.51 18.33 Favored 'Isoleucine or valine' 0 C--N 1.358 0.969 0 N-CA-C 106.239 -1.763 . . . . 0.0 106.239 179.541 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 63.7 mttm -103.64 163.76 12.11 Favored 'General case' 0 CA--C 1.502 -0.897 0 CA-C-O 121.739 0.78 . . . . 0.0 109.542 178.814 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 90.85 45.5 4.2 Favored Glycine 0 CA--C 1.49 -1.474 0 N-CA-C 109.285 -1.526 . . . . 0.0 109.285 172.907 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 61.7 mt -119.92 176.67 5.3 Favored 'General case' 0 N--CA 1.44 -0.931 0 N-CA-C 106.909 -1.515 . . . . 0.0 106.909 -174.643 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -120.89 157.79 53.94 Favored Pre-proline 0 N--CA 1.44 -0.93 0 N-CA-C 106.704 -1.591 . . . . 0.0 106.704 -175.684 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 64.8 Cg_endo -78.63 164.54 25.76 Favored 'Trans proline' 0 N--CA 1.452 -0.956 0 C-N-CA 123.065 2.51 . . . . 0.0 110.559 170.252 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . 0.459 ' H ' ' HA ' ' A' ' 92' ' ' THR . . . 60.94 25.2 63.76 Favored Glycine 0 N--CA 1.431 -1.679 0 C-N-CA 128.006 2.717 . . . . 0.0 116.124 171.256 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 8.5 p -130.54 146.83 33.42 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.15 0 N-CA-C 108.188 -1.041 . . . . 0.0 108.188 -176.124 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 4.2 p -95.88 133.66 36.23 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.907 0 N-CA-C 107.377 -1.342 . . . . 0.0 107.377 178.157 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 93.8 m-85 -112.9 149.48 33.12 Favored 'General case' 0 CA--C 1.498 -1.057 0 N-CA-C 106.161 -1.792 . . . . 0.0 106.161 174.299 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -101.1 140.0 36.01 Favored 'General case' 0 CA--C 1.497 -1.094 0 N-CA-C 104.561 -2.385 . . . . 0.0 104.561 164.827 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -137.15 148.98 20.08 Favored Glycine 0 CA--C 1.486 -1.723 0 N-CA-C 108.101 -2.0 . . . . 0.0 108.101 -175.035 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 84.5 mt-30 -138.79 135.77 34.97 Favored 'General case' 0 CA--C 1.484 -1.58 0 N-CA-C 105.585 -2.006 . . . . 0.0 105.585 178.477 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 46.0 tp -114.71 103.29 10.84 Favored 'General case' 0 N--CA 1.434 -1.271 0 N-CA-C 103.847 -2.649 . . . . 0.0 103.847 179.247 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 38.1 mt -91.94 122.02 42.99 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.898 0 N-CA-C 103.852 -2.647 . . . . 0.0 103.852 177.723 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 15.4 p -113.92 115.1 27.15 Favored 'General case' 0 N--CA 1.441 -0.884 0 N-CA-C 107.156 -1.424 . . . . 0.0 107.156 -175.316 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 1.8 mp -90.36 131.94 36.26 Favored 'Isoleucine or valine' 0 CA--C 1.482 -1.659 0 N-CA-C 104.805 -2.294 . . . . 0.0 104.805 -162.817 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 76.4 mt-30 -84.3 147.91 26.95 Favored 'General case' 0 CA--C 1.491 -1.298 0 N-CA-C 107.994 -1.113 . . . . 0.0 107.994 -178.882 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 20.2 tt0 -76.5 41.75 0.26 Allowed 'General case' 0 N--CA 1.442 -0.862 0 C-N-CA 126.331 1.852 . . . . 0.0 110.545 170.739 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 8.2 t80 -153.07 15.9 0.55 Allowed 'General case' 0 N--CA 1.434 -1.265 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 -176.528 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 89.25 -19.03 41.62 Favored Glycine 0 C--N 1.353 1.506 0 C-N-CA 123.72 0.676 . . . . 0.0 112.601 174.358 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 36.7 m170 -81.7 173.48 12.28 Favored 'General case' 0 CA--C 1.495 -1.153 0 C-N-CA 124.446 1.098 . . . . 0.0 109.274 -176.308 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 77.1 mt-30 -138.7 145.55 40.47 Favored 'General case' 0 CA--C 1.495 -1.154 0 N-CA-C 105.527 -2.027 . . . . 0.0 105.527 176.495 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -111.23 153.72 25.44 Favored 'General case' 0 CA--C 1.493 -1.215 0 N-CA-C 105.415 -2.068 . . . . 0.0 105.415 171.06 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 14.8 p -126.92 137.46 57.78 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.897 0 N-CA-C 106.523 -1.658 . . . . 0.0 106.523 173.325 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 91.4 m -127.08 131.01 50.98 Favored 'General case' 0 N--CA 1.438 -1.066 0 N-CA-C 101.973 -3.343 . . . . 0.0 101.973 179.055 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 88.8 mtt180 -127.08 148.92 50.13 Favored 'General case' 0 CA--C 1.495 -1.15 0 CA-C-N 118.804 0.729 . . . . 0.0 109.487 -173.154 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 19.6 p90 -164.82 178.26 7.32 Favored 'General case' 0 CA--C 1.502 -0.9 0 N-CA-C 108.156 -1.053 . . . . 0.0 108.156 -175.287 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 51.4 m-20 -132.52 154.06 50.33 Favored 'General case' 0 N--CA 1.442 -0.872 0 N-CA-C 105.507 -2.034 . . . . 0.0 105.507 168.743 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 20.9 p90 -142.5 166.84 23.57 Favored 'General case' 0 CA--C 1.488 -1.424 0 N-CA-C 107.41 -1.33 . . . . 0.0 107.41 169.708 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 25.0 p -120.02 141.65 49.53 Favored 'General case' 0 CA--C 1.5 -0.981 0 N-CA-C 106.21 -1.774 . . . . 0.0 106.21 174.919 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 45.4 m -115.74 120.16 38.39 Favored 'General case' 0 CA--C 1.493 -1.245 0 N-CA-C 102.137 -3.283 . . . . 0.0 102.137 171.706 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' THR . . . . . 0.459 ' HA ' ' H ' ' A' ' 66' ' ' GLY . 5.3 t -145.92 -66.95 0.29 Allowed 'General case' 0 N--CA 1.436 -1.132 0 N-CA-C 106.093 -1.817 . . . . 0.0 106.093 -175.626 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 19.8 m . . . . . 0 C--O 1.261 1.659 0 C-N-CA 125.505 1.522 . . . . 0.0 110.355 178.379 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.436 -1.346 0 N-CA-C 106.717 -2.553 . . . . 0.0 106.717 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 22.8 Cg_exo -59.09 145.6 97.14 Favored 'Trans proline' 0 N--CA 1.448 -1.188 0 C-N-CA 123.058 2.505 . . . . 0.0 116.054 -164.598 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 48.9 t -79.17 158.96 4.63 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.94 0 C-N-CA 127.707 2.403 . . . . 0.0 106.991 179.575 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -103.86 106.3 16.76 Favored 'General case' 0 CA--C 1.494 -1.184 0 N-CA-C 104.853 -2.277 . . . . 0.0 104.853 175.052 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 2.1 p -130.4 141.64 45.77 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.1 0 N-CA-C 105.349 -2.093 . . . . 0.0 105.349 -169.632 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 1.8 p90 . . . . . 0 N--CA 1.438 -1.055 0 N-CA-C 105.933 -1.877 . . . . 0.0 105.933 -166.854 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_endo . . . . . 0 N--CA 1.454 -0.845 0 N-CA-C 110.259 -0.708 . . . . 0.0 110.259 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 1.3 p30 -107.79 -42.09 4.82 Favored 'General case' 0 CA--C 1.492 -1.255 0 C-N-CA 124.725 1.21 . . . . 0.0 109.488 -169.069 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 32.8 t -117.06 157.02 26.55 Favored 'General case' 0 CA--C 1.496 -1.134 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 -172.558 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 23.7 m-70 -146.99 98.66 4.05 Favored Pre-proline 0 N--CA 1.437 -1.111 0 N-CA-C 106.516 -1.661 . . . . 0.0 106.516 169.235 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -76.59 100.03 1.35 Allowed 'Trans proline' 0 N--CA 1.447 -1.222 0 C-N-CA 123.654 2.902 . . . . 0.0 109.407 171.746 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 13.4 tt -90.28 149.42 4.05 Favored 'Isoleucine or valine' 0 N--CA 1.408 -2.574 0 C-N-CA 128.834 2.854 . . . . 0.0 106.786 -177.41 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 57.3 mt-30 -141.03 151.06 43.76 Favored 'General case' 0 N--CA 1.434 -1.248 0 N-CA-C 104.225 -2.509 . . . . 0.0 104.225 175.724 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 34.0 p90 -138.98 156.82 46.93 Favored 'General case' 0 N--CA 1.437 -1.081 0 N-CA-C 107.794 -1.187 . . . . 0.0 107.794 -176.815 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 61.3 t30 -94.42 -173.65 3.12 Favored 'General case' 0 CA--C 1.49 -1.336 0 N-CA-C 103.531 -2.766 . . . . 0.0 103.531 169.898 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -155.97 169.21 10.81 Favored Pre-proline 0 N--CA 1.44 -0.96 0 N-CA-C 107.284 -1.376 . . . . 0.0 107.284 172.36 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 98.0 Cg_exo -64.39 167.34 15.05 Favored 'Trans proline' 0 CA--C 1.51 -0.683 0 C-N-CA 123.559 2.839 . . . . 0.0 112.447 170.686 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 71.4 tp60 -80.03 -42.68 1.44 Allowed Pre-proline 0 N--CA 1.444 -0.741 0 CA-C-O 115.586 -2.149 . . . . 0.0 112.026 -172.016 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_exo -66.78 152.72 79.98 Favored 'Trans proline' 0 CA--C 1.507 -0.864 0 CA-C-N 125.773 3.097 . . . . 0.0 112.171 177.936 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 27.2 p -99.58 58.01 1.04 Allowed 'General case' 0 C--N 1.353 0.754 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 179.739 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 76.3 t60 -106.21 -4.65 19.97 Favored 'General case' 0 N--CA 1.441 -0.92 0 C-N-CA 125.273 1.429 . . . . 0.0 107.595 175.67 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 41.8 mt -105.44 129.07 58.89 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.248 0 N-CA-C 105.037 -2.209 . . . . 0.0 105.037 178.167 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 5.2 p -104.36 -84.34 0.48 Allowed 'General case' 0 N--CA 1.43 -1.449 0 N-CA-C 107.459 -1.311 . . . . 0.0 107.459 -178.591 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 55.1 mtmt -89.7 168.83 11.81 Favored 'General case' 0 CA--C 1.488 -1.432 0 N-CA-C 108.544 -0.909 . . . . 0.0 108.544 -164.277 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 93.7 m-85 -129.79 138.34 51.0 Favored 'General case' 0 N--CA 1.434 -1.266 0 N-CA-C 103.861 -2.644 . . . . 0.0 103.861 168.297 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 57.3 mt -114.88 130.61 69.05 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.296 0 N-CA-C 101.01 -3.7 . . . . 0.0 101.01 169.885 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 3.1 mt -110.26 129.9 55.65 Favored 'General case' 0 CA--C 1.469 -2.144 0 N-CA-C 104.034 -2.58 . . . . 0.0 104.034 167.635 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 6.5 ptm180 -132.63 154.48 50.04 Favored 'General case' 0 N--CA 1.431 -1.399 0 N-CA-C 107.035 -1.468 . . . . 0.0 107.035 176.062 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 47.8 p90 -155.18 142.44 19.42 Favored 'General case' 0 N--CA 1.435 -1.176 0 N-CA-C 106.877 -1.527 . . . . 0.0 106.877 -173.328 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 30.7 ttp180 -139.54 140.88 26.61 Favored Pre-proline 0 CA--C 1.499 -1.017 0 N-CA-C 104.528 -2.397 . . . . 0.0 104.528 -177.777 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 26.7 Cg_endo -72.14 120.17 6.63 Favored 'Trans proline' 0 N--CA 1.452 -0.934 0 C-N-CA 122.827 2.351 . . . . 0.0 108.472 174.663 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 23.0 ttmm -68.06 85.2 0.24 Allowed 'General case' 0 C--N 1.359 1.005 0 C-N-CA 127.34 2.256 . . . . 0.0 109.733 -178.641 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 31.2 m120 -150.77 -72.41 0.17 Allowed 'General case' 0 N--CA 1.435 -1.209 0 N-CA-C 102.006 -3.331 . . . . 0.0 102.006 -178.075 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 53.7 p -105.55 172.1 6.98 Favored 'General case' 0 N--CA 1.441 -0.909 0 N-CA-C 107.374 -1.343 . . . . 0.0 107.374 174.61 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 4.0 m -116.21 52.27 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.863 0 N-CA-C 106.011 -1.848 . . . . 0.0 106.011 175.022 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -98.15 -129.08 6.27 Favored Glycine 0 C--N 1.355 1.597 0 N-CA-C 109.421 -1.472 . . . . 0.0 109.421 -176.031 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 17.5 ptm180 -80.09 160.06 25.89 Favored 'General case' 0 C--N 1.357 0.906 0 C-N-CA 123.942 0.897 . . . . 0.0 109.685 -176.925 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -162.49 169.91 19.56 Favored 'General case' 0 CA--C 1.493 -1.212 0 CA-C-O 121.445 0.64 . . . . 0.0 110.298 -171.217 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 95.6 mttt -111.06 155.89 22.12 Favored 'General case' 0 CA--C 1.488 -1.408 0 N-CA-C 107.485 -1.302 . . . . 0.0 107.485 -172.612 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 24.5 pt-20 -152.25 160.15 43.41 Favored 'General case' 0 N--CA 1.434 -1.27 0 N-CA-C 107.972 -1.121 . . . . 0.0 107.972 171.142 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -137.76 159.48 41.88 Favored 'General case' 0 N--CA 1.437 -1.102 0 N-CA-C 105.396 -2.075 . . . . 0.0 105.396 173.785 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 73.3 m -120.41 125.9 49.12 Favored 'General case' 0 CA--C 1.498 -1.036 0 N-CA-C 104.533 -2.395 . . . . 0.0 104.533 177.393 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 5.3 mp -114.73 136.03 22.43 Favored Pre-proline 0 N--CA 1.435 -1.188 0 N-CA-C 104.6 -2.37 . . . . 0.0 104.6 -174.255 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 62.0 Cg_exo -64.3 166.85 15.97 Favored 'Trans proline' 0 CA--C 1.508 -0.78 0 C-N-CA 123.528 2.818 . . . . 0.0 113.519 176.794 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -77.06 -19.23 77.63 Favored Glycine 0 C--N 1.353 1.507 0 C-N-CA 123.797 0.713 . . . . 0.0 114.242 -175.149 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 51.7 p-80 -83.23 -26.79 30.43 Favored 'General case' 0 C--N 1.355 0.838 0 CA-C-N 117.963 0.881 . . . . 0.0 109.788 -179.278 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 89.0 mt -88.84 132.92 34.45 Favored 'General case' 0 CA--C 1.501 -0.93 0 N-CA-C 107.37 -1.345 . . . . 0.0 107.37 175.407 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 7.8 p30 -121.33 15.0 11.31 Favored 'General case' 0 CA--C 1.5 -0.946 0 C-N-CA 124.19 0.996 . . . . 0.0 108.816 -175.501 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 32.9 p -144.73 155.47 43.57 Favored 'General case' 0 N--CA 1.438 -1.074 0 N-CA-C 106.928 -1.508 . . . . 0.0 106.928 -178.721 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 23.0 t80 -150.64 157.76 43.35 Favored 'General case' 0 CA--C 1.497 -1.093 0 N-CA-C 107.965 -1.124 . . . . 0.0 107.965 178.188 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 48.2 m -108.78 112.37 24.61 Favored 'General case' 0 CA--C 1.5 -0.945 0 N-CA-C 106.197 -1.779 . . . . 0.0 106.197 173.536 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 55.3 mt -97.19 91.83 2.76 Favored 'Isoleucine or valine' 0 C--N 1.359 0.982 0 N-CA-C 105.084 -2.191 . . . . 0.0 105.084 174.146 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . 0.468 ' HD3' ' H ' ' A' ' 61' ' ' LYS . 0.3 OUTLIER -105.18 160.52 15.01 Favored 'General case' 0 CA--C 1.498 -1.022 0 N-CA-C 107.67 -1.233 . . . . 0.0 107.67 178.412 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 88.74 52.85 2.7 Favored Glycine 0 C--N 1.353 1.504 0 N-CA-C 108.75 -1.74 . . . . 0.0 108.75 179.796 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 60.7 mt -115.54 158.55 22.46 Favored 'General case' 0 CA--C 1.501 -0.91 0 N-CA-C 107.087 -1.449 . . . . 0.0 107.087 178.961 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 29.1 mtpp -95.35 155.71 38.48 Favored Pre-proline 0 N--CA 1.441 -0.925 0 N-CA-C 106.97 -1.492 . . . . 0.0 106.97 -178.442 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 69.0 Cg_endo -80.31 162.87 22.46 Favored 'Trans proline' 0 N--CA 1.454 -0.852 0 C-N-CA 122.988 2.459 . . . . 0.0 110.903 177.249 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 60.93 26.67 65.78 Favored Glycine 0 C--N 1.356 1.669 0 C-N-CA 127.819 2.628 . . . . 0.0 116.814 166.095 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 7.2 p -131.43 145.61 34.95 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.846 0 CA-C-N 117.701 0.75 . . . . 0.0 109.325 -173.211 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 2.9 p -90.46 127.29 43.05 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.863 0 N-CA-C 107.208 -1.405 . . . . 0.0 107.208 176.332 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 84.0 m-85 -107.3 147.77 29.85 Favored 'General case' 0 CA--C 1.498 -1.044 0 N-CA-C 106.814 -1.551 . . . . 0.0 106.814 172.842 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -95.87 143.98 26.61 Favored 'General case' 0 N--CA 1.439 -0.993 0 N-CA-C 105.132 -2.173 . . . . 0.0 105.132 160.918 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -133.42 155.13 21.56 Favored Glycine 0 CA--C 1.488 -1.637 0 N-CA-C 107.727 -2.149 . . . . 0.0 107.727 -178.962 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 32.0 mt-30 -143.13 138.25 29.68 Favored 'General case' 0 CA--C 1.482 -1.667 0 N-CA-C 105.959 -1.867 . . . . 0.0 105.959 176.345 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 42.8 tp -113.69 103.77 11.56 Favored 'General case' 0 N--CA 1.436 -1.175 0 N-CA-C 103.76 -2.682 . . . . 0.0 103.76 175.75 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 13.6 mt -98.19 128.45 49.63 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.786 0 N-CA-C 104.32 -2.474 . . . . 0.0 104.32 179.664 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 43.8 m -112.41 112.43 23.99 Favored 'General case' 0 N--CA 1.441 -0.923 0 N-CA-C 106.992 -1.484 . . . . 0.0 106.992 -175.189 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 1.7 mp -87.85 136.35 23.36 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.217 0 N-CA-C 104.712 -2.329 . . . . 0.0 104.712 -166.822 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 78.2 mt-30 -95.84 141.69 28.98 Favored 'General case' 0 N--CA 1.436 -1.154 0 N-CA-C 106.042 -1.836 . . . . 0.0 106.042 -179.068 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 7.8 tp-100 -69.04 117.02 10.16 Favored 'General case' 0 N--CA 1.441 -0.882 0 C-N-CA 124.129 0.972 . . . . 0.0 111.395 -170.554 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 31.9 m-85 58.09 45.39 17.81 Favored 'General case' 0 C--N 1.358 0.972 0 C-N-CA 127.325 2.25 . . . . 0.0 112.816 179.653 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -170.33 -114.46 0.31 Allowed Glycine 0 C--N 1.354 1.554 0 C-N-CA 118.663 -1.732 . . . . 0.0 109.704 174.847 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 52.2 m80 -83.24 -171.67 3.7 Favored 'General case' 0 CA--C 1.495 -1.165 0 C-N-CA 125.714 1.606 . . . . 0.0 110.425 -167.715 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -146.66 145.46 30.04 Favored 'General case' 0 N--CA 1.433 -1.281 0 N-CA-C 106.509 -1.663 . . . . 0.0 106.509 169.507 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -101.72 145.45 29.11 Favored 'General case' 0 N--CA 1.44 -0.957 0 N-CA-C 104.645 -2.354 . . . . 0.0 104.645 -179.907 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 6.6 p -124.99 137.96 55.86 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.775 0 N-CA-C 108.104 -1.073 . . . . 0.0 108.104 -177.569 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 61.0 m -125.85 137.13 53.74 Favored 'General case' 0 N--CA 1.439 -0.98 0 N-CA-C 103.232 -2.877 . . . . 0.0 103.232 175.922 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 54.6 ttp180 -130.15 144.6 51.45 Favored 'General case' 0 CA--C 1.502 -0.873 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 -179.309 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 23.6 p90 -156.48 -178.19 7.16 Favored 'General case' 0 CA--C 1.5 -0.962 0 N-CA-C 106.263 -1.754 . . . . 0.0 106.263 -178.216 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 47.7 p-10 -140.43 160.79 39.21 Favored 'General case' 0 N--CA 1.441 -0.877 0 N-CA-C 107.412 -1.329 . . . . 0.0 107.412 168.116 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 24.5 p90 -147.21 170.31 17.51 Favored 'General case' 0 CA--C 1.49 -1.365 0 N-CA-C 107.033 -1.469 . . . . 0.0 107.033 173.785 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 33.0 p -124.74 147.13 48.81 Favored 'General case' 0 CA--C 1.499 -0.994 0 N-CA-C 107.319 -1.363 . . . . 0.0 107.319 178.036 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 4.4 p -109.09 130.12 55.48 Favored 'General case' 0 N--CA 1.439 -1.012 0 N-CA-C 102.525 -3.139 . . . . 0.0 102.525 164.047 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 42.9 p -90.73 -179.17 5.46 Favored 'General case' 0 N--CA 1.444 -0.732 0 N-CA-C 106.931 -1.507 . . . . 0.0 106.931 179.54 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 31.5 t . . . . . 0 C--O 1.262 1.729 0 N-CA-C 105.186 -2.153 . . . . 0.0 105.186 176.695 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.435 -1.403 0 N-CA-C 105.795 -2.922 . . . . 0.0 105.795 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_exo -61.65 139.45 81.11 Favored 'Trans proline' 0 N--CA 1.442 -1.527 0 C-N-CA 122.865 2.377 . . . . 0.0 113.694 -175.62 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 4.1 t -79.46 154.26 4.7 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.932 0 C-N-CA 127.202 2.201 . . . . 0.0 106.383 -179.14 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 55.6 mm-40 -101.43 96.11 6.93 Favored 'General case' 0 CA--C 1.49 -1.338 0 N-CA-C 107.643 -1.244 . . . . 0.0 107.643 -175.267 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 2.4 p -120.52 143.14 33.43 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.103 0 CA-C-N 113.459 -1.701 . . . . 0.0 107.802 -165.033 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.438 -1.036 0 C-N-CA 125.762 1.625 . . . . 0.0 112.494 -169.271 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 75.0 Cg_endo . . . . . 0 CA--C 1.504 -0.978 0 CA-C-O 118.328 -0.78 . . . . 0.0 111.04 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 4.7 p-10 -122.66 -36.11 2.96 Favored 'General case' 0 CA--C 1.486 -1.499 0 O-C-N 123.821 0.7 . . . . 0.0 110.744 -162.988 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 30.3 p -117.58 151.54 36.96 Favored 'General case' 0 CA--C 1.496 -1.127 0 CA-C-O 121.79 0.805 . . . . 0.0 108.896 -173.122 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 81.0 t60 -145.77 106.37 4.28 Favored Pre-proline 0 N--CA 1.433 -1.28 0 N-CA-C 106.228 -1.767 . . . . 0.0 106.228 167.43 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -77.74 142.49 20.33 Favored 'Trans proline' 0 N--CA 1.447 -1.249 0 C-N-CA 122.578 2.186 . . . . 0.0 109.732 173.092 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 18.2 mm -102.9 140.09 22.1 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.919 0 N-CA-C 103.434 -2.802 . . . . 0.0 103.434 174.121 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 1.4 tm0? -130.32 138.04 50.24 Favored 'General case' 0 CA--C 1.498 -1.045 0 N-CA-C 102.801 -3.036 . . . . 0.0 102.801 176.5 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 49.5 p90 -140.64 166.38 24.9 Favored 'General case' 0 CA--C 1.497 -1.067 0 N-CA-C 106.913 -1.514 . . . . 0.0 106.913 -178.786 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 36.7 m-80 -136.91 132.42 34.46 Favored 'General case' 0 CA--C 1.488 -1.404 0 N-CA-C 105.469 -2.049 . . . . 0.0 105.469 177.198 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -104.0 167.61 9.79 Favored Pre-proline 0 N--CA 1.44 -0.972 0 C-N-CA 124.515 1.126 . . . . 0.0 109.378 -166.809 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_exo -66.23 158.48 54.62 Favored 'Trans proline' 0 CA--C 1.508 -0.78 0 C-N-CA 123.359 2.706 . . . . 0.0 111.926 171.207 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 24.4 tt0 -82.95 -45.12 0.88 Allowed Pre-proline 0 N--CA 1.443 -0.781 0 CA-C-O 115.54 -2.172 . . . . 0.0 111.691 -177.618 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 74.7 Cg_exo -68.57 164.55 32.53 Favored 'Trans proline' 0 CA--C 1.509 -0.77 0 CA-C-N 125.65 3.054 . . . . 0.0 112.717 -178.002 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 35.8 p -76.78 124.51 27.79 Favored 'General case' 0 C--N 1.355 0.847 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 179.323 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . 0.51 ' HD1' HG13 ' A' ' 30' ' ' ILE . 64.2 t-80 -174.69 -42.78 0.01 OUTLIER 'General case' 0 CA--C 1.496 -1.098 0 N-CA-C 106.559 -1.645 . . . . 0.0 106.559 -171.192 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.51 HG13 ' HD1' ' A' ' 29' ' ' HIS . 36.1 mt -118.18 136.42 55.43 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.132 0 N-CA-C 106.331 -1.729 . . . . 0.0 106.331 -171.948 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' SER . . . . . 0.464 ' HG ' ' H ' ' A' ' 32' ' ' LYS . 5.9 p -114.29 -85.39 0.6 Allowed 'General case' 0 N--CA 1.431 -1.399 0 N-CA-C 106.188 -1.782 . . . . 0.0 106.188 177.361 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.464 ' H ' ' HG ' ' A' ' 31' ' ' SER . 52.0 mtmt -86.03 167.48 14.98 Favored 'General case' 0 CA--C 1.485 -1.527 0 C-N-CA 124.799 1.239 . . . . 0.0 109.224 -164.387 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 81.4 m-85 -132.02 133.43 44.42 Favored 'General case' 0 CA--C 1.49 -1.362 0 N-CA-C 104.044 -2.576 . . . . 0.0 104.044 177.504 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 28.2 mt -122.41 127.87 75.24 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.326 0 N-CA-C 101.921 -3.363 . . . . 0.0 101.921 178.338 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 5.2 mt -110.51 133.46 53.27 Favored 'General case' 0 CA--C 1.475 -1.916 0 N-CA-C 106.151 -1.796 . . . . 0.0 106.151 177.531 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 2.4 mpt_? -112.45 155.46 24.21 Favored 'General case' 0 N--CA 1.432 -1.373 0 N-CA-C 104.62 -2.363 . . . . 0.0 104.62 166.961 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 47.8 p90 -155.32 150.73 27.15 Favored 'General case' 0 N--CA 1.438 -1.042 0 N-CA-C 107.729 -1.211 . . . . 0.0 107.729 170.196 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 11.2 ptp180 -150.88 148.87 24.0 Favored Pre-proline 0 CA--C 1.499 -0.982 0 N-CA-C 106.777 -1.564 . . . . 0.0 106.777 166.863 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -75.96 144.84 27.63 Favored 'Trans proline' 0 CA--C 1.503 -1.048 0 C-N-CA 122.763 2.309 . . . . 0.0 107.86 171.619 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -70.69 80.2 0.6 Allowed 'General case' 0 C--N 1.354 0.797 0 C-N-CA 125.085 1.354 . . . . 0.0 110.915 177.157 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 8.9 t-20 -161.97 -54.8 0.04 OUTLIER 'General case' 0 N--CA 1.431 -1.399 0 N-CA-C 102.917 -2.994 . . . . 0.0 102.917 -178.158 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 34.3 p -83.82 143.79 29.7 Favored 'General case' 0 N--CA 1.438 -1.065 0 N-CA-C 107.299 -1.371 . . . . 0.0 107.299 173.226 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 14.3 m -136.81 14.96 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.803 0 N-CA-C 106.677 -1.601 . . . . 0.0 106.677 177.614 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -101.44 -93.98 2.2 Favored Glycine 0 C--N 1.356 1.658 0 N-CA-C 108.043 -2.023 . . . . 0.0 108.043 -175.067 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 17.5 ptm180 -91.13 171.16 9.44 Favored 'General case' 0 CA--C 1.503 -0.864 0 N-CA-C 108.108 -1.071 . . . . 0.0 108.108 177.255 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -159.52 179.38 8.96 Favored 'General case' 0 CA--C 1.494 -1.192 0 N-CA-C 109.606 -0.516 . . . . 0.0 109.606 -178.657 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -110.04 152.63 25.7 Favored 'General case' 0 CA--C 1.489 -1.387 0 N-CA-C 106.755 -1.572 . . . . 0.0 106.755 -175.818 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -154.8 156.95 37.18 Favored 'General case' 0 N--CA 1.433 -1.284 0 N-CA-C 106.957 -1.497 . . . . 0.0 106.957 -178.953 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -146.05 164.03 33.4 Favored 'General case' 0 CA--C 1.502 -0.885 0 N-CA-C 107.793 -1.188 . . . . 0.0 107.793 175.13 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 96.9 m -120.98 126.57 50.29 Favored 'General case' 0 CA--C 1.502 -0.867 0 N-CA-C 105.542 -2.022 . . . . 0.0 105.542 178.382 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 5.0 mp -114.07 136.13 22.16 Favored Pre-proline 0 N--CA 1.439 -0.992 0 N-CA-C 105.296 -2.113 . . . . 0.0 105.296 -175.823 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_exo -63.06 165.66 16.22 Favored 'Trans proline' 0 CA--C 1.508 -0.81 0 C-N-CA 123.734 2.956 . . . . 0.0 113.799 176.823 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -82.2 -13.68 78.46 Favored Glycine 0 C--N 1.351 1.403 0 C-N-CA 123.507 0.575 . . . . 0.0 113.451 -171.682 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 50.5 p-80 -84.66 -27.16 27.29 Favored 'General case' 0 C--N 1.356 0.872 0 CA-C-N 117.945 0.872 . . . . 0.0 109.862 178.572 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 88.5 mt -88.52 130.39 35.24 Favored 'General case' 0 CA--C 1.498 -1.027 0 N-CA-C 108.536 -0.912 . . . . 0.0 108.536 178.678 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 8.4 p-10 -108.8 10.84 26.55 Favored 'General case' 0 N--CA 1.442 -0.845 0 C-N-CA 124.574 1.15 . . . . 0.0 109.921 -177.484 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 39.2 p -146.43 162.5 38.12 Favored 'General case' 0 N--CA 1.439 -1.003 0 N-CA-C 107.534 -1.284 . . . . 0.0 107.534 -178.598 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 10.7 t80 -140.21 174.63 10.33 Favored 'General case' 0 N--CA 1.444 -0.728 0 N-CA-C 107.122 -1.436 . . . . 0.0 107.122 -179.789 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 55.4 m -137.82 111.41 8.13 Favored 'General case' 0 N--CA 1.433 -1.317 0 N-CA-C 104.689 -2.337 . . . . 0.0 104.689 174.064 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 43.5 mt -91.43 138.72 19.09 Favored 'Isoleucine or valine' 0 C--N 1.358 0.95 0 N-CA-C 104.346 -2.464 . . . . 0.0 104.346 172.361 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 6.9 mtpm? -139.56 162.11 35.88 Favored 'General case' 0 CA--C 1.499 -0.994 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 -179.12 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 82.99 51.37 4.23 Favored Glycine 0 C--N 1.354 1.546 0 N-CA-C 109.429 -1.468 . . . . 0.0 109.429 176.862 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 80.5 mt -117.67 172.03 7.63 Favored 'General case' 0 CA--C 1.501 -0.932 0 N-CA-C 108.071 -1.085 . . . . 0.0 108.071 -170.869 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 10.4 mptt -102.97 151.21 38.37 Favored Pre-proline 0 N--CA 1.442 -0.828 0 N-CA-C 107.572 -1.27 . . . . 0.0 107.572 -172.479 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 64.2 Cg_exo -66.66 135.4 38.59 Favored 'Trans proline' 0 N--CA 1.453 -0.911 0 C-N-CA 123.62 2.88 . . . . 0.0 112.226 171.56 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 54.66 50.01 59.22 Favored Glycine 0 C--N 1.355 1.599 0 C-N-CA 127.256 2.36 . . . . 0.0 115.415 167.334 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 4.3 p -128.94 149.49 33.7 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.007 0 N-CA-C 107.597 -1.26 . . . . 0.0 107.597 178.871 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 7.6 p -95.23 135.5 29.11 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.959 0 N-CA-C 107.644 -1.243 . . . . 0.0 107.644 -178.256 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 83.6 m-85 -117.1 151.28 37.14 Favored 'General case' 0 CA--C 1.496 -1.121 0 N-CA-C 106.395 -1.706 . . . . 0.0 106.395 177.364 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -98.44 142.46 30.03 Favored 'General case' 0 CA--C 1.5 -0.97 0 N-CA-C 104.908 -2.256 . . . . 0.0 104.908 159.476 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -133.23 149.88 19.72 Favored Glycine 0 CA--C 1.49 -1.525 0 N-CA-C 107.693 -2.163 . . . . 0.0 107.693 179.938 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 33.7 mt-30 -136.49 136.24 39.25 Favored 'General case' 0 CA--C 1.484 -1.56 0 N-CA-C 106.581 -1.637 . . . . 0.0 106.581 176.173 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 15.0 tp -119.92 106.75 12.35 Favored 'General case' 0 CA--C 1.499 -1.007 0 N-CA-C 105.778 -1.934 . . . . 0.0 105.778 -176.851 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 5.9 mt -100.15 129.32 51.05 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.113 0 N-CA-C 105.036 -2.209 . . . . 0.0 105.036 -178.81 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 12.6 p -115.72 114.4 24.77 Favored 'General case' 0 N--CA 1.443 -0.823 0 N-CA-C 108.108 -1.071 . . . . 0.0 108.108 -176.418 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 1.7 mp -94.94 143.05 12.57 Favored 'Isoleucine or valine' 0 C--N 1.358 0.941 0 N-CA-C 106.045 -1.835 . . . . 0.0 106.045 -163.808 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 16.7 tt0 -102.3 140.95 35.9 Favored 'General case' 0 CA--C 1.498 -1.031 0 N-CA-C 105.116 -2.179 . . . . 0.0 105.116 171.342 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 75.4 mt-30 -67.19 115.21 6.61 Favored 'General case' 0 C--N 1.358 0.955 0 C-N-CA 123.319 0.648 . . . . 0.0 111.075 -176.038 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 58.4 m-85 60.12 40.03 18.84 Favored 'General case' 0 C--N 1.355 0.848 0 C-N-CA 126.523 1.929 . . . . 0.0 112.143 176.324 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -158.85 -118.61 0.53 Allowed Glycine 0 C--N 1.355 1.623 0 N-CA-C 108.779 -1.728 . . . . 0.0 108.779 -178.361 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 78.4 m-70 -82.84 179.98 7.61 Favored 'General case' 0 CA--C 1.501 -0.928 0 C-N-CA 124.657 1.183 . . . . 0.0 111.178 -168.38 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 10.9 pt20 -157.16 133.5 9.78 Favored 'General case' 0 N--CA 1.434 -1.258 0 N-CA-C 106.076 -1.824 . . . . 0.0 106.076 167.391 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 31.5 mm-40 -100.91 146.43 27.36 Favored 'General case' 0 CA--C 1.498 -1.031 0 N-CA-C 105.531 -2.026 . . . . 0.0 105.531 -178.231 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 7.6 p -122.3 141.55 42.27 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.721 0 N-CA-C 108.004 -1.109 . . . . 0.0 108.004 -174.444 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 23.2 m -125.79 145.45 50.21 Favored 'General case' 0 N--CA 1.442 -0.872 0 N-CA-C 104.398 -2.445 . . . . 0.0 104.398 -179.711 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 38.9 ttm180 -133.85 143.46 48.33 Favored 'General case' 0 CA--C 1.504 -0.81 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 173.32 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 28.9 p90 -155.67 175.68 13.6 Favored 'General case' 0 CA--C 1.5 -0.974 0 N-CA-C 106.905 -1.517 . . . . 0.0 106.905 -178.424 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 52.2 m-20 -133.47 153.86 51.28 Favored 'General case' 0 CA--C 1.504 -0.81 0 N-CA-C 106.018 -1.845 . . . . 0.0 106.018 170.334 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 17.1 p90 -151.28 175.64 12.01 Favored 'General case' 0 CA--C 1.493 -1.23 0 N-CA-C 106.678 -1.601 . . . . 0.0 106.678 173.222 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 31.4 p -122.6 147.02 46.9 Favored 'General case' 0 CA--C 1.504 -0.813 0 N-CA-C 107.533 -1.284 . . . . 0.0 107.533 174.276 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 94.3 m -99.52 121.65 41.47 Favored 'General case' 0 CA--C 1.496 -1.125 0 N-CA-C 102.721 -3.066 . . . . 0.0 102.721 165.583 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 2.3 m 68.13 -128.34 0.13 Allowed 'General case' 0 C--N 1.36 1.028 0 C-N-CA 126.573 1.949 . . . . 0.0 106.481 -165.346 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 26.8 p . . . . . 0 C--O 1.261 1.69 0 N-CA-C 106.168 -1.79 . . . . 0.0 106.168 174.124 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.438 -1.182 0 N-CA-C 106.138 -2.785 . . . . 0.0 106.138 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_exo -58.4 140.93 96.46 Favored 'Trans proline' 0 N--CA 1.445 -1.35 0 C-N-CA 123.749 2.966 . . . . 0.0 113.319 -175.783 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 7.3 t -79.0 155.31 4.83 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.892 0 C-N-CA 127.014 2.126 . . . . 0.0 106.569 -175.345 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 93.4 mt-10 -97.35 87.98 4.29 Favored 'General case' 0 CA--C 1.493 -1.224 0 CA-C-O 122.377 1.084 . . . . 0.0 108.181 -173.1 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 2.7 p -110.77 134.93 51.45 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.146 0 CA-C-N 114.319 -1.31 . . . . 0.0 107.868 -166.179 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 23.8 p90 . . . . . 0 N--CA 1.434 -1.246 0 N-CA-C 104.072 -2.566 . . . . 0.0 104.072 178.131 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo . . . . . 0 CA--C 1.507 -0.84 0 CA-C-O 118.19 -0.838 . . . . 0.0 110.917 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 7.0 p-10 -104.18 -42.34 5.55 Favored 'General case' 0 CA--C 1.494 -1.199 0 O-C-N 123.716 0.635 . . . . 0.0 110.417 -165.72 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 10.9 p -120.1 143.98 47.86 Favored 'General case' 0 CA--C 1.488 -1.432 0 N-CA-C 107.98 -1.118 . . . . 0.0 107.98 -178.43 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . 0.448 ' CE1' HG23 ' A' ' 91' ' ' THR . 0.1 OUTLIER -135.12 92.75 17.8 Favored Pre-proline 0 N--CA 1.441 -0.905 0 N-CA-C 105.657 -1.979 . . . . 0.0 105.657 174.322 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_endo -74.9 127.87 11.11 Favored 'Trans proline' 0 N--CA 1.443 -1.447 0 C-N-CA 123.007 2.471 . . . . 0.0 109.442 170.492 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 28.3 mm -104.86 149.82 8.1 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.081 0 N-CA-C 104.231 -2.507 . . . . 0.0 104.231 -174.277 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 65.4 tt0 -140.24 142.84 35.77 Favored 'General case' 0 N--CA 1.438 -1.066 0 N-CA-C 104.205 -2.517 . . . . 0.0 104.205 168.587 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 37.8 p90 -136.27 164.2 28.63 Favored 'General case' 0 N--CA 1.439 -0.987 0 N-CA-C 106.226 -1.768 . . . . 0.0 106.226 -175.176 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 5.8 m120 -131.24 127.71 38.41 Favored 'General case' 0 CA--C 1.492 -1.286 0 N-CA-C 106.353 -1.721 . . . . 0.0 106.353 -179.948 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -84.61 161.77 52.67 Favored Pre-proline 0 N--CA 1.442 -0.857 0 C-N-CA 123.663 0.785 . . . . 0.0 110.541 -168.381 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_exo -67.23 172.72 9.62 Favored 'Trans proline' 0 CA--C 1.51 -0.717 0 C-N-CA 123.498 2.798 . . . . 0.0 112.295 170.766 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 1.4 tm0? -80.74 -46.99 1.23 Allowed Pre-proline 0 N--CA 1.443 -0.795 0 CA-C-O 115.569 -2.158 . . . . 0.0 110.429 -176.86 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 63.3 Cg_exo -68.25 164.78 31.02 Favored 'Trans proline' 0 CA--C 1.509 -0.75 0 CA-C-N 125.784 3.101 . . . . 0.0 112.086 176.999 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 22.6 t -88.07 85.88 7.03 Favored 'General case' 0 C--N 1.356 0.862 0 N-CA-C 106.412 -1.699 . . . . 0.0 106.412 176.258 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . 0.478 ' HD1' HG13 ' A' ' 30' ' ' ILE . 59.9 t-80 -116.16 -28.85 6.45 Favored 'General case' 0 N--CA 1.437 -1.124 0 C-N-CA 125.585 1.554 . . . . 0.0 107.076 -175.01 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.478 HG13 ' HD1' ' A' ' 29' ' ' HIS . 42.6 mt -126.35 137.03 59.05 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.056 0 N-CA-C 106.916 -1.513 . . . . 0.0 106.916 -169.041 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 32.9 t -113.56 -85.72 0.59 Allowed 'General case' 0 N--CA 1.432 -1.348 0 N-CA-C 106.328 -1.731 . . . . 0.0 106.328 178.073 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 37.0 ttpt -88.43 160.67 17.44 Favored 'General case' 0 CA--C 1.493 -1.241 0 C-N-CA 125.859 1.664 . . . . 0.0 107.906 -165.04 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 92.8 m-85 -127.47 139.97 52.46 Favored 'General case' 0 CA--C 1.492 -1.28 0 N-CA-C 105.377 -2.083 . . . . 0.0 105.377 177.941 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 13.9 mt -124.95 131.09 73.03 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.151 0 N-CA-C 101.958 -3.349 . . . . 0.0 101.958 172.898 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 3.5 mt -109.23 127.55 54.34 Favored 'General case' 0 CA--C 1.475 -1.936 0 N-CA-C 104.975 -2.232 . . . . 0.0 104.975 174.303 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -116.63 158.33 23.91 Favored 'General case' 0 N--CA 1.434 -1.257 0 N-CA-C 104.636 -2.357 . . . . 0.0 104.636 174.375 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 48.4 p90 -157.29 142.29 16.94 Favored 'General case' 0 N--CA 1.437 -1.081 0 N-CA-C 107.018 -1.475 . . . . 0.0 107.018 175.079 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 13.4 ttm180 -131.68 125.2 20.35 Favored Pre-proline 0 CA--C 1.503 -0.853 0 N-CA-C 106.261 -1.755 . . . . 0.0 106.261 179.006 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 4.8 Cg_endo -73.35 118.93 5.72 Favored 'Trans proline' 0 N--CA 1.45 -1.066 0 CA-C-N 123.388 2.246 . . . . 0.0 109.033 168.969 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 32.3 mmmt -70.98 88.7 0.77 Allowed 'General case' 0 N--CA 1.44 -0.937 0 C-N-CA 125.644 1.578 . . . . 0.0 111.133 179.214 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 70.5 m-80 -135.57 -68.02 0.52 Allowed 'General case' 0 N--CA 1.436 -1.148 0 N-CA-C 102.244 -3.243 . . . . 0.0 102.244 172.729 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 57.8 m -102.98 168.28 9.3 Favored 'General case' 0 N--CA 1.44 -0.945 0 N-CA-C 106.674 -1.602 . . . . 0.0 106.674 172.234 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 3.6 m -122.15 55.53 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.88 0 N-CA-C 105.752 -1.944 . . . . 0.0 105.752 177.581 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -104.01 -109.4 3.38 Favored Glycine 0 C--N 1.353 1.479 0 N-CA-C 107.78 -2.128 . . . . 0.0 107.78 -177.221 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 82.4 mtt85 -91.24 172.3 8.64 Favored 'General case' 0 CA--C 1.502 -0.883 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 -178.534 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -153.69 176.27 12.3 Favored 'General case' 0 N--CA 1.437 -1.097 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 -179.964 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 59.5 mttp -112.42 156.98 21.63 Favored 'General case' 0 CA--C 1.49 -1.356 0 N-CA-C 107.782 -1.192 . . . . 0.0 107.782 -174.767 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 1.1 pp20? -151.42 162.37 41.05 Favored 'General case' 0 N--CA 1.434 -1.24 0 N-CA-C 107.966 -1.124 . . . . 0.0 107.966 171.014 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -144.49 159.73 42.27 Favored 'General case' 0 CA--C 1.497 -1.062 0 N-CA-C 105.857 -1.905 . . . . 0.0 105.857 172.072 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 91.4 m -121.28 130.01 53.43 Favored 'General case' 0 CA--C 1.502 -0.896 0 N-CA-C 106.576 -1.638 . . . . 0.0 106.576 -173.892 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 4.1 mp -116.64 134.79 22.86 Favored Pre-proline 0 N--CA 1.438 -1.066 0 N-CA-C 105.386 -2.079 . . . . 0.0 105.386 -175.054 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 66.0 Cg_exo -62.88 164.55 18.71 Favored 'Trans proline' 0 N--CA 1.455 -0.736 0 C-N-CA 123.498 2.799 . . . . 0.0 113.351 174.954 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -81.88 -14.87 76.59 Favored Glycine 0 C--N 1.352 1.422 0 O-C-N 123.48 0.487 . . . . 0.0 113.297 -170.717 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 50.1 p-80 -83.87 -25.5 30.21 Favored 'General case' 0 C--N 1.356 0.852 0 CA-C-N 117.846 0.823 . . . . 0.0 109.828 179.173 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 89.9 mt -88.41 133.17 34.18 Favored 'General case' 0 CA--C 1.5 -0.959 0 N-CA-C 107.876 -1.157 . . . . 0.0 107.876 177.633 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 7.9 p30 -110.41 9.03 23.44 Favored 'General case' 0 CA--C 1.504 -0.821 0 C-N-CA 124.654 1.181 . . . . 0.0 109.802 -175.436 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 37.2 p -145.81 162.98 36.42 Favored 'General case' 0 N--CA 1.438 -1.051 0 N-CA-C 107.395 -1.335 . . . . 0.0 107.395 -177.477 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 8.3 t80 -141.8 174.94 10.11 Favored 'General case' 0 N--CA 1.441 -0.878 0 N-CA-C 108.009 -1.108 . . . . 0.0 108.009 179.765 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 89.6 m -135.45 109.98 8.54 Favored 'General case' 0 N--CA 1.432 -1.337 0 N-CA-C 104.19 -2.522 . . . . 0.0 104.19 171.202 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 58.3 mt -87.5 143.83 10.49 Favored 'Isoleucine or valine' 0 C--N 1.36 1.022 0 N-CA-C 103.943 -2.614 . . . . 0.0 103.943 169.977 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -147.07 160.58 42.24 Favored 'General case' 0 CA--C 1.498 -1.054 0 N-CA-C 108.054 -1.091 . . . . 0.0 108.054 173.865 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 86.83 51.83 3.3 Favored Glycine 0 C--N 1.353 1.484 0 N-CA-C 109.006 -1.638 . . . . 0.0 109.006 177.004 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 48.2 mt -112.1 175.29 5.49 Favored 'General case' 0 CA--C 1.502 -0.867 0 N-CA-C 107.013 -1.477 . . . . 0.0 107.013 -178.353 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 57.6 mttp -115.99 152.59 47.79 Favored Pre-proline 0 N--CA 1.444 -0.757 0 N-CA-C 106.526 -1.657 . . . . 0.0 106.526 -168.395 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_endo -79.5 155.36 24.59 Favored 'Trans proline' 0 N--CA 1.454 -0.835 0 C-N-CA 122.719 2.279 . . . . 0.0 110.838 175.883 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 59.01 29.8 65.76 Favored Glycine 0 C--N 1.354 1.566 0 C-N-CA 127.747 2.594 . . . . 0.0 116.883 167.288 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 9.0 p -127.4 148.24 32.14 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.847 0 N-CA-C 108.715 -0.846 . . . . 0.0 108.715 -177.581 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 6.7 p -92.8 124.17 45.14 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.765 0 N-CA-C 107.804 -1.184 . . . . 0.0 107.804 175.614 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 51.0 m-85 -101.48 150.41 23.07 Favored 'General case' 0 N--CA 1.439 -1.004 0 N-CA-C 107.629 -1.249 . . . . 0.0 107.629 173.403 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 12.4 tp10 -93.7 136.18 34.24 Favored 'General case' 0 CA--C 1.498 -1.044 0 N-CA-C 103.762 -2.681 . . . . 0.0 103.762 163.914 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -134.43 145.32 17.41 Favored Glycine 0 CA--C 1.488 -1.64 0 N-CA-C 107.547 -2.221 . . . . 0.0 107.547 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 35.2 mt-30 -140.75 136.81 32.9 Favored 'General case' 0 CA--C 1.485 -1.52 0 N-CA-C 105.718 -1.956 . . . . 0.0 105.718 -177.677 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 40.9 tp -115.01 98.21 6.67 Favored 'General case' 0 N--CA 1.437 -1.124 0 N-CA-C 103.453 -2.795 . . . . 0.0 103.453 179.297 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 39.7 mm -92.88 125.96 45.39 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.942 0 N-CA-C 103.704 -2.702 . . . . 0.0 103.704 -178.08 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 49.2 m -120.72 112.29 18.67 Favored 'General case' 0 N--CA 1.438 -1.069 0 N-CA-C 107.632 -1.247 . . . . 0.0 107.632 -169.261 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 39.3 mm -88.15 139.87 16.68 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.323 0 N-CA-C 106.894 -1.521 . . . . 0.0 106.894 -163.188 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 15.3 tt0 -101.93 132.34 47.8 Favored 'General case' 0 CA--C 1.495 -1.171 0 N-CA-C 104.953 -2.24 . . . . 0.0 104.953 178.776 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 17.8 tt0 -77.08 42.56 0.33 Allowed 'General case' 0 C--N 1.355 0.813 0 C-N-CA 125.339 1.456 . . . . 0.0 113.168 -177.761 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 61.6 m-85 -140.42 19.59 2.39 Favored 'General case' 0 N--CA 1.442 -0.872 0 N-CA-C 107.094 -1.447 . . . . 0.0 107.094 173.251 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 96.55 -21.57 44.95 Favored Glycine 0 C--N 1.354 1.582 0 C-N-CA 123.94 0.781 . . . . 0.0 111.395 174.598 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 77.9 m-70 -81.71 178.91 8.06 Favored 'General case' 0 CA--C 1.498 -1.032 0 C-N-CA 124.621 1.168 . . . . 0.0 109.508 -177.016 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 5.0 pt20 -159.02 163.53 36.32 Favored 'General case' 0 N--CA 1.439 -1.024 0 CA-C-O 122.027 0.917 . . . . 0.0 108.721 174.78 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 16.6 tp10 -117.37 154.2 31.73 Favored 'General case' 0 N--CA 1.437 -1.078 0 N-CA-C 105.631 -1.989 . . . . 0.0 105.631 179.604 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 1.9 p -126.0 134.31 66.84 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.86 0 N-CA-C 106.9 -1.519 . . . . 0.0 106.9 176.75 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 38.8 m -122.54 131.96 54.09 Favored 'General case' 0 N--CA 1.439 -0.996 0 N-CA-C 102.211 -3.255 . . . . 0.0 102.211 172.595 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 22.9 ttt180 -130.27 143.5 50.81 Favored 'General case' 0 CA--C 1.504 -0.803 0 CA-C-N 118.784 0.72 . . . . 0.0 109.444 -172.691 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 18.0 p90 -162.06 -177.18 5.6 Favored 'General case' 0 C--N 1.359 1.007 0 N-CA-C 106.829 -1.545 . . . . 0.0 106.829 -175.316 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 43.6 p-10 -136.63 160.91 37.38 Favored 'General case' 0 N--CA 1.442 -0.831 0 N-CA-C 106.018 -1.845 . . . . 0.0 106.018 168.836 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . 0.413 ' CD1' ' CD2' ' A' ' 18' ' ' HIS . 22.3 p90 -143.61 164.82 29.32 Favored 'General case' 0 CA--C 1.488 -1.428 0 N-CA-C 107.254 -1.388 . . . . 0.0 107.254 170.065 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 22.8 p -117.88 137.96 52.45 Favored 'General case' 0 CA--C 1.499 -1.005 0 N-CA-C 106.337 -1.727 . . . . 0.0 106.337 177.433 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' THR . . . . . 0.448 HG23 ' CE1' ' A' ' 18' ' ' HIS . 7.0 p -107.97 128.77 54.93 Favored 'General case' 0 CA--C 1.5 -0.977 0 N-CA-C 103.061 -2.94 . . . . 0.0 103.061 172.788 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 15.1 t -158.41 152.21 23.6 Favored 'General case' 0 N--CA 1.437 -1.08 0 N-CA-C 105.944 -1.873 . . . . 0.0 105.944 -178.11 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 33.8 p . . . . . 0 C--O 1.26 1.625 0 N-CA-C 107.189 -1.411 . . . . 0.0 107.189 174.714 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.443 -0.886 0 N-CA-C 108.616 -1.793 . . . . 0.0 108.616 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_exo -60.46 140.55 92.07 Favored 'Trans proline' 0 N--CA 1.443 -1.461 0 C-N-CA 123.137 2.558 . . . . 0.0 113.484 -177.385 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 7.6 t -78.57 149.77 5.58 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.947 0 C-N-CA 127.775 2.43 . . . . 0.0 105.461 179.112 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 90.0 mt-10 -103.71 94.29 5.37 Favored 'General case' 0 CA--C 1.493 -1.23 0 C-N-CA 123.849 0.86 . . . . 0.0 108.726 -168.282 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 2.5 p -121.83 142.47 38.0 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.983 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 -161.936 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 18.1 p90 . . . . . 0 N--CA 1.435 -1.192 0 N-CA-C 106.923 -1.51 . . . . 0.0 106.923 -168.158 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo . . . . . 0 CA--C 1.502 -1.076 0 CA-C-O 118.75 -0.604 . . . . 0.0 111.06 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 1.7 p30 -103.2 -40.05 6.59 Favored 'General case' 0 CA--C 1.484 -1.596 0 O-C-N 124.09 0.869 . . . . 0.0 110.455 -166.593 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 73.1 m -116.18 156.7 26.03 Favored 'General case' 0 CA--C 1.497 -1.083 0 CA-C-O 121.871 0.843 . . . . 0.0 108.797 -178.532 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 21.1 t-80 -132.96 89.88 33.12 Favored Pre-proline 0 N--CA 1.438 -1.03 0 N-CA-C 106.167 -1.79 . . . . 0.0 106.167 169.414 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 65.5 Cg_endo -84.24 103.38 0.96 Allowed 'Trans proline' 0 N--CA 1.453 -0.871 0 C-N-CA 123.27 2.647 . . . . 0.0 110.449 -175.072 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.7 pt -94.39 168.29 1.53 Allowed 'Isoleucine or valine' 0 C--N 1.356 0.864 0 N-CA-C 109.925 -0.398 . . . . 0.0 109.925 -173.608 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 28.1 tt0 -144.35 147.83 33.95 Favored 'General case' 0 N--CA 1.438 -1.033 0 N-CA-C 104.974 -2.232 . . . . 0.0 104.974 169.97 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 40.9 p90 -129.81 156.6 44.08 Favored 'General case' 0 CA--C 1.496 -1.103 0 N-CA-C 106.859 -1.534 . . . . 0.0 106.859 177.535 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 8.2 t-20 -110.92 149.2 30.97 Favored 'General case' 0 CA--C 1.489 -1.373 0 N-CA-C 102.186 -3.265 . . . . 0.0 102.186 173.211 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -115.82 170.37 5.8 Favored Pre-proline 0 N--CA 1.441 -0.895 0 C-N-CA 124.161 0.984 . . . . 0.0 108.521 -166.369 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 94.8 Cg_exo -65.18 169.53 12.04 Favored 'Trans proline' 0 CA--C 1.511 -0.668 0 C-N-CA 123.613 2.875 . . . . 0.0 112.323 166.918 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 64.7 mt-30 -80.51 -56.1 0.7 Allowed Pre-proline 0 N--CA 1.442 -0.831 0 CA-C-O 115.505 -2.188 . . . . 0.0 112.454 -172.903 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -75.31 169.78 21.74 Favored 'Trans proline' 0 CA--C 1.511 -0.655 0 CA-C-N 125.923 3.151 . . . . 0.0 110.671 -177.073 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 67.3 m -87.09 86.16 7.28 Favored 'General case' 0 CA--C 1.502 -0.901 0 N-CA-C 106.708 -1.59 . . . . 0.0 106.708 175.975 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 11.9 t-160 -122.78 -26.05 4.54 Favored 'General case' 0 N--CA 1.436 -1.129 0 C-N-CA 124.972 1.309 . . . . 0.0 107.792 -171.673 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 1.7 mp -103.16 136.7 34.57 Favored 'Isoleucine or valine' 0 C--N 1.355 0.824 0 N-CA-C 103.885 -2.635 . . . . 0.0 103.885 -171.919 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 34.5 t -96.29 -85.99 0.33 Allowed 'General case' 0 N--CA 1.43 -1.468 0 N-CA-C 104.791 -2.3 . . . . 0.0 104.791 174.473 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 50.8 mtmt -90.67 170.97 9.7 Favored 'General case' 0 CA--C 1.493 -1.226 0 C-N-CA 123.884 0.874 . . . . 0.0 110.096 -168.01 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 96.4 m-85 -125.69 140.37 52.76 Favored 'General case' 0 CA--C 1.496 -1.101 0 N-CA-C 103.948 -2.612 . . . . 0.0 103.948 162.132 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 54.0 mt -120.9 127.85 75.99 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.12 0 N-CA-C 101.828 -3.397 . . . . 0.0 101.828 170.976 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 4.5 mt -106.91 137.15 45.52 Favored 'General case' 0 CA--C 1.476 -1.898 0 N-CA-C 105.384 -2.08 . . . . 0.0 105.384 171.611 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -131.83 156.02 46.78 Favored 'General case' 0 N--CA 1.434 -1.242 0 N-CA-C 106.878 -1.526 . . . . 0.0 106.878 166.258 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 49.4 p90 -155.27 145.76 22.07 Favored 'General case' 0 N--CA 1.435 -1.209 0 N-CA-C 106.517 -1.66 . . . . 0.0 106.517 -176.384 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 45.5 ttm-85 -135.87 140.67 34.15 Favored Pre-proline 0 N--CA 1.441 -0.88 0 N-CA-C 104.575 -2.38 . . . . 0.0 104.575 178.254 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -72.95 116.55 4.76 Favored 'Trans proline' 0 CA--C 1.504 -0.992 0 C-N-CA 122.735 2.29 . . . . 0.0 108.594 166.284 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 82.5 tttt -73.87 83.85 1.69 Allowed 'General case' 0 C--N 1.355 0.843 0 C-N-CA 125.537 1.535 . . . . 0.0 110.199 -174.252 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 33.1 m120 -147.51 -73.04 0.21 Allowed 'General case' 0 N--CA 1.435 -1.186 0 N-CA-C 102.354 -3.202 . . . . 0.0 102.354 -175.785 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 50.8 p -96.73 168.4 10.53 Favored 'General case' 0 N--CA 1.442 -0.867 0 N-CA-C 107.454 -1.313 . . . . 0.0 107.454 173.351 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 3.6 m -125.98 55.16 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.849 0 N-CA-C 105.821 -1.918 . . . . 0.0 105.821 177.192 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -93.19 -106.05 1.74 Allowed Glycine 0 C--N 1.355 1.611 0 N-CA-C 108.415 -1.874 . . . . 0.0 108.415 -177.247 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 5.6 mmp_? -105.12 170.01 8.12 Favored 'General case' 0 CA--C 1.499 -1.017 0 N-CA-C 107.042 -1.466 . . . . 0.0 107.042 176.729 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -151.23 173.01 14.95 Favored 'General case' 0 N--CA 1.436 -1.137 0 N-CA-C 108.728 -0.841 . . . . 0.0 108.728 -177.943 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 67.8 mttm -111.68 155.76 22.93 Favored 'General case' 0 CA--C 1.49 -1.357 0 N-CA-C 107.774 -1.195 . . . . 0.0 107.774 -172.13 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 15.4 pt-20 -151.49 160.67 43.6 Favored 'General case' 0 N--CA 1.435 -1.211 0 N-CA-C 108.247 -1.02 . . . . 0.0 108.247 172.565 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -137.37 156.76 47.84 Favored 'General case' 0 CA--C 1.497 -1.064 0 N-CA-C 105.938 -1.875 . . . . 0.0 105.938 171.532 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 95.2 m -117.85 123.29 45.52 Favored 'General case' 0 CA--C 1.499 -0.982 0 N-CA-C 104.134 -2.543 . . . . 0.0 104.134 176.398 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 65.9 mt -118.73 137.67 25.15 Favored Pre-proline 0 N--CA 1.437 -1.08 0 N-CA-C 105.984 -1.858 . . . . 0.0 105.984 -164.867 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 75.3 Cg_exo -65.05 163.87 27.08 Favored 'Trans proline' 0 N--CA 1.455 -0.749 0 C-N-CA 123.295 2.663 . . . . 0.0 113.545 176.491 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -78.68 -17.27 77.78 Favored Glycine 0 C--N 1.352 1.456 0 C-N-CA 124.042 0.83 . . . . 0.0 113.807 -174.87 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 54.3 p-80 -83.45 -23.81 32.09 Favored 'General case' 0 C--N 1.357 0.893 0 CA-C-N 117.936 0.868 . . . . 0.0 109.963 -179.602 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 80.8 mt -87.93 125.24 34.4 Favored 'General case' 0 CA--C 1.497 -1.093 0 N-CA-C 107.975 -1.12 . . . . 0.0 107.975 176.721 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 8.1 p30 -112.25 6.69 19.09 Favored 'General case' 0 N--CA 1.442 -0.848 0 C-N-CA 124.741 1.216 . . . . 0.0 109.783 -174.845 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 28.7 p -142.06 154.96 45.35 Favored 'General case' 0 CA--C 1.498 -1.043 0 N-CA-C 106.684 -1.598 . . . . 0.0 106.684 -177.977 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 10.8 t80 -133.84 171.33 14.3 Favored 'General case' 0 CA--C 1.502 -0.869 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 178.423 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 94.4 m -131.8 109.09 9.88 Favored 'General case' 0 N--CA 1.43 -1.433 0 N-CA-C 103.929 -2.619 . . . . 0.0 103.929 170.545 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 42.6 mt -84.09 139.48 17.54 Favored 'Isoleucine or valine' 0 C--N 1.358 0.969 0 N-CA-C 103.123 -2.917 . . . . 0.0 103.123 169.433 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 18.0 ptpt -147.74 160.05 43.14 Favored 'General case' 0 CA--C 1.497 -1.085 0 N-CA-C 109.068 -0.716 . . . . 0.0 109.068 -176.261 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 81.2 53.96 3.72 Favored Glycine 0 C--N 1.355 1.586 0 N-CA-C 108.816 -1.714 . . . . 0.0 108.816 -179.946 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 84.6 mt -117.14 172.6 7.17 Favored 'General case' 0 CA--C 1.496 -1.113 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 -173.019 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 65.7 tttp -124.43 139.56 33.26 Favored Pre-proline 0 N--CA 1.434 -1.259 0 N-CA-C 104.97 -2.233 . . . . 0.0 104.97 -175.342 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -74.9 163.97 34.4 Favored 'Trans proline' 0 N--CA 1.455 -0.789 0 C-N-CA 123.058 2.505 . . . . 0.0 110.089 174.98 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 62.63 44.07 98.07 Favored Glycine 0 N--CA 1.429 -1.824 0 C-N-CA 125.946 1.736 . . . . 0.0 112.756 -178.803 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 20.5 t -134.95 127.19 48.15 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.09 0 N-CA-C 104.325 -2.472 . . . . 0.0 104.325 173.078 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 4.4 p -83.8 116.72 28.21 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.928 0 N-CA-C 105.061 -2.2 . . . . 0.0 105.061 162.521 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 80.8 m-85 -97.64 147.04 24.72 Favored 'General case' 0 CA--C 1.495 -1.153 0 N-CA-C 105.817 -1.919 . . . . 0.0 105.817 178.71 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 14.6 pt-20 -95.37 140.76 29.79 Favored 'General case' 0 CA--C 1.501 -0.934 0 N-CA-C 105.168 -2.16 . . . . 0.0 105.168 164.288 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -134.33 151.89 20.45 Favored Glycine 0 CA--C 1.49 -1.521 0 N-CA-C 107.633 -2.187 . . . . 0.0 107.633 -178.972 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 31.9 mt-30 -143.65 135.71 26.67 Favored 'General case' 0 CA--C 1.488 -1.425 0 N-CA-C 105.699 -1.963 . . . . 0.0 105.699 179.171 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 15.4 tp -120.01 100.98 7.54 Favored 'General case' 0 CA--C 1.499 -0.983 0 N-CA-C 105.482 -2.044 . . . . 0.0 105.482 -177.453 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 18.7 mt -94.02 131.29 41.34 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.889 0 N-CA-C 105.072 -2.196 . . . . 0.0 105.072 178.143 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 23.3 p -108.38 125.87 52.22 Favored 'General case' 0 N--CA 1.44 -0.972 0 N-CA-C 106.088 -1.819 . . . . 0.0 106.088 173.163 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 1.7 mp -92.33 137.04 23.07 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.181 0 N-CA-C 103.427 -2.805 . . . . 0.0 103.427 -179.346 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 4.8 mp0 -92.25 153.48 19.23 Favored 'General case' 0 CA--C 1.497 -1.091 0 N-CA-C 107.032 -1.47 . . . . 0.0 107.032 177.701 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 9.0 tt0 -77.52 32.53 0.16 Allowed 'General case' 0 C--N 1.356 0.854 0 C-N-CA 125.5 1.52 . . . . 0.0 112.385 173.766 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 88.4 m-85 -143.9 14.26 1.7 Allowed 'General case' 0 CA--C 1.498 -1.027 0 C-N-CA 124.119 0.968 . . . . 0.0 108.687 -173.96 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 90.14 -17.94 50.91 Favored Glycine 0 C--N 1.35 1.357 0 C-N-CA 124.131 0.872 . . . . 0.0 112.433 173.835 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 78.4 m-70 -81.48 173.84 12.02 Favored 'General case' 0 CA--C 1.496 -1.109 0 C-N-CA 124.691 1.196 . . . . 0.0 109.17 -177.365 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 5.1 pt20 -155.03 142.41 19.56 Favored 'General case' 0 N--CA 1.438 -1.042 0 N-CA-C 107.778 -1.193 . . . . 0.0 107.778 171.715 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 67.7 mt-10 -108.24 140.22 41.8 Favored 'General case' 0 CA--C 1.496 -1.1 0 N-CA-C 105.191 -2.152 . . . . 0.0 105.191 178.97 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 3.3 p -117.81 137.39 51.9 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.823 0 N-CA-C 107.544 -1.28 . . . . 0.0 107.544 -175.377 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 24.9 m -117.33 140.57 49.4 Favored 'General case' 0 N--CA 1.441 -0.898 0 N-CA-C 104.015 -2.587 . . . . 0.0 104.015 174.84 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -126.46 153.88 44.46 Favored 'General case' 0 CA--C 1.498 -1.04 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 170.331 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 29.5 p90 -166.46 -179.1 4.77 Favored 'General case' 0 CA--C 1.5 -0.948 0 N-CA-C 106.888 -1.523 . . . . 0.0 106.888 -178.093 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 1.7 p30 -139.11 159.51 41.98 Favored 'General case' 0 N--CA 1.438 -1.038 0 N-CA-C 106.436 -1.691 . . . . 0.0 106.436 166.132 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 20.5 p90 -142.42 172.88 12.09 Favored 'General case' 0 CA--C 1.488 -1.411 0 N-CA-C 105.814 -1.921 . . . . 0.0 105.814 171.867 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 16.2 m -130.39 143.48 50.79 Favored 'General case' 0 CA--C 1.501 -0.915 0 N-CA-C 104.697 -2.334 . . . . 0.0 104.697 176.76 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 58.8 m -120.48 124.83 46.35 Favored 'General case' 0 N--CA 1.441 -0.918 0 N-CA-C 102.973 -2.973 . . . . 0.0 102.973 176.758 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 33.0 p -134.24 167.8 20.03 Favored 'General case' 0 C--N 1.357 0.894 0 N-CA-C 107.459 -1.311 . . . . 0.0 107.459 -177.738 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 56.8 p . . . . . 0 C--O 1.26 1.61 0 C-N-CA 124.431 1.092 . . . . 0.0 108.844 178.02 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.437 -1.288 0 N-CA-C 107.82 -2.112 . . . . 0.0 107.82 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 70.7 Cg_exo -65.5 142.15 70.43 Favored 'Trans proline' 0 N--CA 1.444 -1.425 0 C-N-CA 122.257 1.971 . . . . 0.0 115.2 -169.913 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 12.9 t -78.29 154.36 5.1 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.807 0 C-N-CA 128.645 2.778 . . . . 0.0 104.776 168.287 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 57.8 mm-40 -109.35 99.88 9.06 Favored 'General case' 0 CA--C 1.488 -1.437 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 -172.249 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 2.4 p -119.23 141.29 39.86 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.012 0 N-CA-C 106.413 -1.699 . . . . 0.0 106.413 -172.087 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 15.4 p90 . . . . . 0 N--CA 1.436 -1.154 0 N-CA-C 107.078 -1.453 . . . . 0.0 107.078 -169.005 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_exo . . . . . 0 CA--C 1.509 -0.769 0 N-CA-C 110.705 -0.536 . . . . 0.0 110.705 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -102.31 -45.36 5.13 Favored 'General case' 0 CA--C 1.492 -1.251 0 C-N-CA 125.132 1.373 . . . . 0.0 110.342 -168.033 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 73.5 m -110.85 158.16 19.02 Favored 'General case' 0 CA--C 1.493 -1.234 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 -176.219 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 18.7 t-160 -148.63 95.65 3.96 Favored Pre-proline 0 N--CA 1.44 -0.962 0 N-CA-C 107.651 -1.24 . . . . 0.0 107.651 165.575 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 70.2 Cg_endo -74.61 134.18 18.17 Favored 'Trans proline' 0 N--CA 1.446 -1.268 0 C-N-CA 122.903 2.402 . . . . 0.0 109.246 170.264 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 7.5 pt -116.08 168.39 7.77 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.047 0 N-CA-C 107.006 -1.479 . . . . 0.0 107.006 179.762 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 23.2 tt0 -148.9 147.7 28.98 Favored 'General case' 0 N--CA 1.438 -1.072 0 N-CA-C 105.068 -2.197 . . . . 0.0 105.068 172.27 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 39.5 p90 -131.5 160.95 33.7 Favored 'General case' 0 N--CA 1.438 -1.061 0 N-CA-C 107.069 -1.456 . . . . 0.0 107.069 -178.879 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 83.8 m-20 -103.92 -179.62 4.0 Favored 'General case' 0 CA--C 1.488 -1.407 0 N-CA-C 103.721 -2.696 . . . . 0.0 103.721 170.865 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -157.29 173.07 5.34 Favored Pre-proline 0 N--CA 1.44 -0.963 0 N-CA-C 106.696 -1.594 . . . . 0.0 106.696 177.317 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 79.8 Cg_exo -63.99 161.31 33.75 Favored 'Trans proline' 0 N--CA 1.455 -0.74 0 C-N-CA 123.761 2.974 . . . . 0.0 113.082 173.129 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 70.8 tp60 -82.71 -45.03 0.92 Allowed Pre-proline 0 N--CA 1.444 -0.746 0 CA-C-O 115.519 -2.181 . . . . 0.0 111.925 -175.375 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_exo -70.87 -15.51 32.92 Favored 'Trans proline' 0 CA--C 1.509 -0.727 0 CA-C-N 125.897 3.142 . . . . 0.0 113.342 -176.114 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 9.1 t 66.33 73.06 0.38 Allowed 'General case' 0 C--N 1.357 0.925 0 C-N-CA 126.153 1.781 . . . . 0.0 110.54 179.159 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 23.6 t-160 -97.55 -3.49 39.63 Favored 'General case' 0 N--CA 1.444 -0.752 0 C-N-CA 125.002 1.321 . . . . 0.0 107.976 174.311 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 33.5 mt -106.08 136.65 39.69 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.128 0 N-CA-C 104.516 -2.401 . . . . 0.0 104.516 -176.739 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 4.9 p -99.52 -85.01 0.4 Allowed 'General case' 0 N--CA 1.43 -1.442 0 N-CA-C 105.687 -1.968 . . . . 0.0 105.687 176.962 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 54.2 mtmt -89.76 167.39 12.91 Favored 'General case' 0 CA--C 1.488 -1.436 0 C-N-CA 123.423 0.689 . . . . 0.0 109.253 -164.992 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 93.8 m-85 -126.96 133.15 50.66 Favored 'General case' 0 CA--C 1.493 -1.239 0 N-CA-C 103.219 -2.882 . . . . 0.0 103.219 165.75 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 1.6 mp -107.6 136.26 43.48 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.195 1 N-CA-C 99.078 -4.416 . . . . 0.0 99.078 166.686 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 46.9 tp -119.72 137.08 54.15 Favored 'General case' 0 N--CA 1.397 -3.092 0 N-CA-C 101.36 -3.57 . . . . 0.0 101.36 172.664 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 14.9 ptp180 -133.94 155.3 50.17 Favored 'General case' 0 CA--C 1.488 -1.417 0 N-CA-C 107.072 -1.455 . . . . 0.0 107.072 174.168 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 47.0 p90 -152.67 139.13 18.59 Favored 'General case' 0 N--CA 1.43 -1.465 0 N-CA-C 105.778 -1.934 . . . . 0.0 105.778 -175.889 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 46.1 ttp85 -145.87 145.04 23.67 Favored Pre-proline 0 N--CA 1.442 -0.843 0 N-CA-C 104.871 -2.27 . . . . 0.0 104.871 -177.17 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 63.6 Cg_exo -64.21 122.8 10.89 Favored 'Trans proline' 0 CA--C 1.505 -0.975 0 C-N-CA 123.09 2.527 . . . . 0.0 111.06 174.7 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 49.9 tttp -71.95 75.65 0.91 Allowed 'General case' 0 C--N 1.358 0.956 0 C-N-CA 125.897 1.679 . . . . 0.0 110.449 176.475 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 29.8 m120 -151.35 -74.73 0.15 Allowed 'General case' 0 N--CA 1.435 -1.212 0 N-CA-C 102.407 -3.183 . . . . 0.0 102.407 -172.541 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 39.1 p -97.44 161.08 13.95 Favored 'General case' 0 C--N 1.356 0.88 0 N-CA-C 106.856 -1.535 . . . . 0.0 106.856 172.332 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 3.7 m -115.61 52.76 0.21 Allowed 'Isoleucine or valine' 0 CA--C 1.504 -0.81 0 N-CA-C 106.526 -1.657 . . . . 0.0 106.526 -179.236 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -88.59 -137.31 5.88 Favored Glycine 0 C--N 1.355 1.59 0 N-CA-C 109.722 -1.351 . . . . 0.0 109.722 -179.872 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 96.4 mtt-85 -85.05 155.78 21.38 Favored 'General case' 0 CA--C 1.499 -0.981 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 -177.596 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 49.0 m95 -105.19 159.33 15.95 Favored 'General case' 0 N--CA 1.436 -1.146 0 N-CA-C 107.552 -1.277 . . . . 0.0 107.552 -175.102 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 64.3 mttp -98.76 150.31 21.96 Favored 'General case' 0 CA--C 1.488 -1.416 0 N-CA-C 104.232 -2.507 . . . . 0.0 104.232 161.801 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -153.12 157.91 41.08 Favored 'General case' 0 CA--C 1.494 -1.173 0 CA-C-O 121.787 0.803 . . . . 0.0 108.867 -176.768 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -140.89 165.81 26.49 Favored 'General case' 0 N--CA 1.437 -1.114 0 N-CA-C 106.119 -1.808 . . . . 0.0 106.119 173.505 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 98.9 m -121.6 127.22 50.66 Favored 'General case' 0 CA--C 1.5 -0.952 0 N-CA-C 104.8 -2.296 . . . . 0.0 104.8 175.87 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 5.3 mp -114.97 134.35 22.51 Favored Pre-proline 0 N--CA 1.435 -1.203 0 N-CA-C 104.871 -2.27 . . . . 0.0 104.871 -176.014 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 68.7 Cg_exo -64.67 165.95 19.28 Favored 'Trans proline' 0 CA--C 1.508 -0.811 0 C-N-CA 123.354 2.703 . . . . 0.0 113.391 177.019 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -73.96 -20.57 79.71 Favored Glycine 0 C--N 1.351 1.376 0 C-N-CA 123.906 0.765 . . . . 0.0 114.141 -174.891 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 52.2 p-80 -83.56 -27.06 29.54 Favored 'General case' 0 C--N 1.354 0.793 0 CA-C-N 117.872 0.836 . . . . 0.0 110.243 -178.72 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 85.0 mt -88.65 126.25 35.21 Favored 'General case' 0 CA--C 1.501 -0.938 0 N-CA-C 107.894 -1.15 . . . . 0.0 107.894 177.283 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 7.8 p-10 -108.65 8.18 26.88 Favored 'General case' 0 CA--C 1.503 -0.843 0 C-N-CA 124.391 1.076 . . . . 0.0 110.634 -170.526 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 5.8 p -142.62 168.08 20.57 Favored 'General case' 0 CA--C 1.491 -1.297 0 N-CA-C 108.106 -1.072 . . . . 0.0 108.106 -177.802 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 8.5 t80 -139.6 175.86 9.22 Favored 'General case' 0 N--CA 1.441 -0.908 0 N-CA-C 107.81 -1.181 . . . . 0.0 107.81 174.365 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 99.3 m -140.05 112.2 7.65 Favored 'General case' 0 N--CA 1.435 -1.208 0 N-CA-C 104.924 -2.25 . . . . 0.0 104.924 178.573 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 17.3 mm -90.25 145.27 7.61 Favored 'Isoleucine or valine' 0 C--N 1.356 0.856 0 N-CA-C 105.013 -2.217 . . . . 0.0 105.013 171.261 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . 0.437 ' HB3' ' HZ1' ' A' ' 61' ' ' LYS . 0.4 OUTLIER -149.83 161.58 41.97 Favored 'General case' 0 N--CA 1.438 -1.057 0 N-CA-C 107.841 -1.17 . . . . 0.0 107.841 167.662 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 85.88 52.3 3.34 Favored Glycine 0 C--N 1.354 1.543 0 N-CA-C 109.303 -1.519 . . . . 0.0 109.303 177.654 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 78.0 mt -115.18 165.62 12.73 Favored 'General case' 0 CA--C 1.5 -0.967 0 N-CA-C 108.142 -1.059 . . . . 0.0 108.142 -179.141 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt -103.58 154.93 37.53 Favored Pre-proline 0 N--CA 1.44 -0.952 0 N-CA-C 107.068 -1.456 . . . . 0.0 107.068 -176.068 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -76.96 152.52 31.91 Favored 'Trans proline' 0 N--CA 1.452 -0.966 0 C-N-CA 122.829 2.353 . . . . 0.0 111.127 -178.515 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 55.17 40.42 74.72 Favored Glycine 0 C--N 1.356 1.686 0 C-N-CA 127.567 2.508 . . . . 0.0 115.636 170.518 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 5.5 p -129.87 138.08 54.99 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.165 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 -177.169 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 3.2 p -91.76 127.59 43.96 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.884 0 C-N-CA 125.119 1.368 . . . . 0.0 107.681 -178.197 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 82.7 m-85 -107.71 153.24 23.23 Favored 'General case' 0 N--CA 1.438 -1.07 0 C-N-CA 125.12 1.368 . . . . 0.0 108.382 178.036 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 21.4 tp10 -97.55 136.51 37.85 Favored 'General case' 0 N--CA 1.434 -1.242 0 N-CA-C 104.027 -2.582 . . . . 0.0 104.027 165.354 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -131.0 144.11 15.58 Favored Glycine 0 CA--C 1.492 -1.36 0 N-CA-C 107.681 -2.168 . . . . 0.0 107.681 174.325 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 25.9 mt-30 -133.67 134.37 43.04 Favored 'General case' 0 CA--C 1.486 -1.485 0 N-CA-C 107.109 -1.441 . . . . 0.0 107.109 174.858 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 66.6 tp -109.97 101.46 10.28 Favored 'General case' 0 CA--C 1.502 -0.874 0 N-CA-C 104.499 -2.408 . . . . 0.0 104.499 178.493 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 32.4 mt -97.78 123.39 50.2 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.868 0 N-CA-C 104.102 -2.555 . . . . 0.0 104.102 -176.612 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 32.8 p -118.24 120.06 36.56 Favored 'General case' 0 CA--C 1.505 -0.769 0 N-CA-C 108.72 -0.844 . . . . 0.0 108.72 -172.25 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 1.8 mp -93.64 136.24 25.9 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.301 0 N-CA-C 104.581 -2.377 . . . . 0.0 104.581 -170.243 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 84.7 mt-30 -93.68 152.8 18.73 Favored 'General case' 0 CA--C 1.493 -1.224 0 N-CA-C 106.903 -1.517 . . . . 0.0 106.903 176.91 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 9.0 pt20 -69.14 99.56 1.15 Allowed 'General case' 0 N--CA 1.44 -0.926 0 C-N-CA 124.871 1.268 . . . . 0.0 111.458 -176.296 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 69.1 m-85 57.1 39.4 29.11 Favored 'General case' 0 C--N 1.358 0.946 0 C-N-CA 127.248 2.219 . . . . 0.0 112.16 -179.402 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -141.04 -124.32 2.02 Favored Glycine 0 C--N 1.357 1.708 0 N-CA-C 108.497 -1.841 . . . . 0.0 108.497 -177.4 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 59.1 m80 -83.82 -179.75 7.36 Favored 'General case' 0 CA--C 1.499 -1.019 0 C-N-CA 125.193 1.397 . . . . 0.0 110.302 -170.982 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 21.4 tt0 -139.26 119.15 13.31 Favored 'General case' 0 N--CA 1.434 -1.258 0 N-CA-C 104.781 -2.303 . . . . 0.0 104.781 175.993 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 88.0 mt-10 -99.11 154.23 18.28 Favored 'General case' 0 CA--C 1.499 -1.005 0 N-CA-C 107.37 -1.345 . . . . 0.0 107.37 -178.435 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 7.7 p -128.78 134.97 63.39 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.776 0 N-CA-C 107.598 -1.26 . . . . 0.0 107.598 175.082 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 95.2 m -119.84 137.0 54.26 Favored 'General case' 0 CA--C 1.498 -1.044 0 N-CA-C 102.623 -3.103 . . . . 0.0 102.623 175.098 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 83.0 mtm-85 -126.69 150.67 48.89 Favored 'General case' 0 CA--C 1.5 -0.964 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 -178.531 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 32.7 p90 -165.33 178.81 6.61 Favored 'General case' 0 CA--C 1.5 -0.98 0 N-CA-C 107.234 -1.395 . . . . 0.0 107.234 -177.993 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -139.43 157.85 45.14 Favored 'General case' 0 N--CA 1.441 -0.913 0 N-CA-C 106.441 -1.689 . . . . 0.0 106.441 169.472 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 24.0 p90 -144.83 175.59 10.08 Favored 'General case' 0 CA--C 1.488 -1.442 0 N-CA-C 105.271 -2.122 . . . . 0.0 105.271 172.375 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 8.9 t -143.9 154.94 43.86 Favored 'General case' 0 N--CA 1.44 -0.968 0 N-CA-C 105.439 -2.06 . . . . 0.0 105.439 173.631 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 54.8 p -121.95 138.93 54.23 Favored 'General case' 0 CA--C 1.497 -1.086 0 N-CA-C 104.242 -2.503 . . . . 0.0 104.242 177.144 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 12.3 t -165.89 172.9 11.08 Favored 'General case' 0 N--CA 1.44 -0.944 0 N-CA-C 105.134 -2.173 . . . . 0.0 105.134 -175.625 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 10.0 p . . . . . 0 C--O 1.261 1.678 0 N-CA-C 105.144 -2.169 . . . . 0.0 105.144 164.327 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.441 -1.004 0 N-CA-C 107.731 -2.148 . . . . 0.0 107.731 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -61.6 138.6 76.42 Favored 'Trans proline' 0 N--CA 1.441 -1.567 0 C-N-CA 123.115 2.543 . . . . 0.0 112.973 178.993 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 14.5 t -77.62 161.26 4.52 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.882 0 C-N-CA 129.005 2.922 . . . . 0.0 105.732 179.03 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 59.1 mm-40 -110.87 100.43 9.16 Favored 'General case' 0 CA--C 1.49 -1.361 0 N-CA-C 106.564 -1.643 . . . . 0.0 106.564 -179.449 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 1.5 p -120.85 141.17 42.48 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.041 0 N-CA-C 106.191 -1.781 . . . . 0.0 106.191 -169.531 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 30.6 p90 . . . . . 0 N--CA 1.434 -1.241 0 N-CA-C 107.015 -1.476 . . . . 0.0 107.015 -169.289 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 66.5 Cg_endo . . . . . 0 N--CA 1.454 -0.831 0 N-CA-C 109.45 -1.019 . . . . 0.0 109.45 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 5.8 p-10 -116.44 -35.95 4.13 Favored 'General case' 0 CA--C 1.491 -1.321 0 C-N-CA 124.328 1.051 . . . . 0.0 109.344 -172.581 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 30.3 p -130.22 151.95 50.18 Favored 'General case' 0 CA--C 1.499 -1.0 0 CA-C-O 122.151 0.977 . . . . 0.0 110.004 -175.42 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . 0.614 ' CD2' ' HG1' ' A' ' 91' ' ' THR . 35.7 m-70 -142.87 98.99 5.62 Favored Pre-proline 0 N--CA 1.438 -1.069 0 N-CA-C 107.145 -1.428 . . . . 0.0 107.145 175.668 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -79.1 114.04 3.3 Favored 'Trans proline' 0 N--CA 1.445 -1.339 0 C-N-CA 123.074 2.516 . . . . 0.0 110.178 175.953 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 3.9 pt -93.93 166.53 1.77 Allowed 'Isoleucine or valine' 0 CA--C 1.498 -1.05 0 N-CA-C 107.825 -1.176 . . . . 0.0 107.825 -178.251 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 17.6 mp0 -139.69 151.46 45.92 Favored 'General case' 0 CA--C 1.499 -1.002 0 N-CA-C 105.496 -2.038 . . . . 0.0 105.496 174.815 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 42.3 p90 -136.33 156.71 48.25 Favored 'General case' 0 CA--C 1.496 -1.113 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 175.666 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 83.2 m-20 -97.35 -175.71 3.3 Favored 'General case' 0 CA--C 1.486 -1.487 0 N-CA-C 104.31 -2.478 . . . . 0.0 104.31 171.29 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -157.59 173.79 4.65 Favored Pre-proline 0 N--CA 1.44 -0.93 0 N-CA-C 106.828 -1.545 . . . . 0.0 106.828 176.458 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_exo -63.96 162.52 28.78 Favored 'Trans proline' 0 CA--C 1.51 -0.724 0 C-N-CA 123.678 2.919 . . . . 0.0 112.209 169.169 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 1.2 tm0? -81.26 -60.09 0.43 Allowed Pre-proline 0 C--N 1.353 0.744 0 CA-C-O 115.705 -2.093 . . . . 0.0 110.671 -174.193 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_endo -75.42 174.43 12.81 Favored 'Trans proline' 0 CA--C 1.511 -0.645 0 CA-C-N 125.688 3.067 . . . . 0.0 110.161 -179.694 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 52.2 p -72.58 126.26 29.44 Favored 'General case' 0 C--N 1.357 0.919 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 177.787 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 16.2 t-160 -160.9 -51.66 0.05 OUTLIER 'General case' 0 CA--C 1.493 -1.229 0 N-CA-C 106.566 -1.642 . . . . 0.0 106.566 -166.646 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 35.1 mt -111.81 132.64 59.87 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.1 0 N-CA-C 105.487 -2.042 . . . . 0.0 105.487 -174.154 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 30.0 t -102.77 -84.79 0.45 Allowed 'General case' 0 N--CA 1.431 -1.41 0 N-CA-C 107.586 -1.264 . . . . 0.0 107.586 -178.146 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 23.1 ttmm -91.42 149.51 21.68 Favored 'General case' 0 CA--C 1.493 -1.244 0 N-CA-C 106.829 -1.545 . . . . 0.0 106.829 -161.278 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 97.4 m-85 -117.49 128.84 55.38 Favored 'General case' 0 CA--C 1.496 -1.129 0 N-CA-C 104.725 -2.324 . . . . 0.0 104.725 168.785 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 60.9 mt -106.48 117.44 52.27 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.075 0 N-CA-C 102.188 -3.264 . . . . 0.0 102.188 169.604 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -95.33 125.35 39.89 Favored 'General case' 0 CA--C 1.48 -1.745 0 N-CA-C 106.972 -1.492 . . . . 0.0 106.972 176.813 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 97.0 mtt180 -120.74 147.12 45.74 Favored 'General case' 0 CA--C 1.49 -1.333 0 N-CA-C 105.972 -1.862 . . . . 0.0 105.972 171.75 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 40.3 p90 -151.99 173.55 14.72 Favored 'General case' 0 CA--C 1.487 -1.479 0 N-CA-C 106.199 -1.778 . . . . 0.0 106.199 169.982 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 36.0 ptt180 -170.96 158.83 5.38 Favored Pre-proline 0 CA--C 1.499 -1.009 0 N-CA-C 106.284 -1.747 . . . . 0.0 106.284 177.004 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . 0.423 ' HB2' HD21 ' A' ' 41' ' ' ASN . 60.4 Cg_endo -74.51 140.86 27.44 Favored 'Trans proline' 0 N--CA 1.448 -1.181 0 C-N-CA 122.065 1.843 . . . . 0.0 107.839 168.062 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 57.7 tttp -71.18 78.42 0.7 Allowed 'General case' 0 C--N 1.355 0.806 0 C-N-CA 125.344 1.458 . . . . 0.0 110.784 179.947 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . 0.423 HD21 ' HB2' ' A' ' 39' ' ' PRO . 60.1 m-80 -161.11 -46.73 0.04 OUTLIER 'General case' 0 N--CA 1.438 -1.044 0 N-CA-C 104.966 -2.235 . . . . 0.0 104.966 -170.668 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 27.8 m -77.68 161.01 28.09 Favored 'General case' 0 C--N 1.359 0.995 0 C-N-CA 124.19 0.996 . . . . 0.0 110.503 -170.926 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 20.2 m -102.01 -26.93 3.4 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.879 0 C-N-CA 124.83 1.252 . . . . 0.0 109.887 -170.608 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -173.17 27.17 0.09 OUTLIER Glycine 0 CA--C 1.493 -1.339 0 N-CA-C 110.569 -1.012 . . . . 0.0 110.569 179.853 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 54.7 ttp180 -98.62 122.29 41.65 Favored 'General case' 0 CA--C 1.495 -1.15 0 N-CA-C 105.026 -2.213 . . . . 0.0 105.026 172.669 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 83.8 m95 -128.6 138.74 52.36 Favored 'General case' 0 CA--C 1.496 -1.123 0 N-CA-C 106.732 -1.581 . . . . 0.0 106.732 179.665 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 60.9 mttp -96.11 104.47 16.42 Favored 'General case' 0 CA--C 1.491 -1.307 0 N-CA-C 104.332 -2.47 . . . . 0.0 104.332 169.192 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 16.1 pt-20 -107.49 150.96 26.2 Favored 'General case' 0 CA--C 1.498 -1.055 0 CA-C-N 115.033 -0.985 . . . . 0.0 109.532 -176.475 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -136.74 154.51 50.56 Favored 'General case' 0 N--CA 1.438 -1.055 0 N-CA-C 105.917 -1.883 . . . . 0.0 105.917 178.089 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 92.4 m -121.71 125.1 45.82 Favored 'General case' 0 CA--C 1.501 -0.91 0 N-CA-C 104.292 -2.485 . . . . 0.0 104.292 178.317 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 63.6 mt -128.86 137.39 30.87 Favored Pre-proline 0 N--CA 1.44 -0.961 0 N-CA-C 105.154 -2.165 . . . . 0.0 105.154 -166.29 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -74.56 171.13 18.76 Favored 'Trans proline' 0 CA--C 1.508 -0.8 0 C-N-CA 123.44 2.76 . . . . 0.0 110.876 178.555 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -77.95 -11.96 84.88 Favored Glycine 0 C--N 1.352 1.463 0 C-N-CA 123.808 0.718 . . . . 0.0 114.117 -178.742 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 9.2 p-80 -83.01 -25.37 32.27 Favored 'General case' 0 C--N 1.357 0.931 0 CA-C-N 118.321 1.061 . . . . 0.0 110.236 -178.937 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 87.2 mt -89.09 128.26 35.74 Favored 'General case' 0 CA--C 1.501 -0.929 0 N-CA-C 107.316 -1.364 . . . . 0.0 107.316 173.412 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 8.4 p30 -112.91 1.05 15.32 Favored 'General case' 0 N--CA 1.443 -0.8 0 C-N-CA 124.762 1.225 . . . . 0.0 109.814 -173.146 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 25.7 p -145.71 160.18 42.09 Favored 'General case' 0 CA--C 1.498 -1.025 0 N-CA-C 106.331 -1.729 . . . . 0.0 106.331 -177.33 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 5.1 t80 -131.89 177.89 7.19 Favored 'General case' 0 C--N 1.358 0.942 0 CA-C-O 121.684 0.754 . . . . 0.0 109.366 178.808 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 97.7 m -133.72 105.78 7.01 Favored 'General case' 0 N--CA 1.431 -1.393 0 N-CA-C 103.302 -2.851 . . . . 0.0 103.302 171.613 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 59.5 mt -86.83 140.22 16.14 Favored 'Isoleucine or valine' 0 C--N 1.359 0.993 0 N-CA-C 103.938 -2.615 . . . . 0.0 103.938 171.326 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -147.26 160.46 42.47 Favored 'General case' 0 N--CA 1.438 -1.071 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 -176.866 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 84.42 52.6 3.51 Favored Glycine 0 C--N 1.354 1.565 0 N-CA-C 109.208 -1.557 . . . . 0.0 109.208 178.672 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 47.9 mt -114.9 168.59 9.77 Favored 'General case' 0 CA--C 1.501 -0.924 0 N-CA-C 107.591 -1.263 . . . . 0.0 107.591 -173.631 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -119.67 150.48 50.32 Favored Pre-proline 0 N--CA 1.442 -0.872 0 N-CA-C 106.775 -1.565 . . . . 0.0 106.775 -173.624 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -77.18 165.7 27.54 Favored 'Trans proline' 0 N--CA 1.454 -0.827 0 C-N-CA 123.129 2.552 . . . . 0.0 110.806 175.263 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . 0.499 ' H ' ' HA ' ' A' ' 92' ' ' THR . . . 64.18 19.18 63.65 Favored Glycine 0 N--CA 1.429 -1.828 0 C-N-CA 128.209 2.814 . . . . 0.0 116.575 173.212 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 9.9 p -134.21 145.9 32.22 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.108 0 CA-C-N 118.636 1.218 . . . . 0.0 108.073 -174.713 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 7.3 p -90.33 128.2 42.38 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.959 0 N-CA-C 106.97 -1.492 . . . . 0.0 106.97 177.523 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 49.0 m-85 -101.0 137.33 39.51 Favored 'General case' 0 CA--C 1.493 -1.233 0 N-CA-C 105.575 -2.009 . . . . 0.0 105.575 174.3 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 18.9 pt-20 -112.35 158.63 19.55 Favored 'General case' 0 N--CA 1.437 -1.096 0 N-CA-C 105.956 -1.868 . . . . 0.0 105.956 173.044 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -169.57 -172.38 36.12 Favored Glycine 0 N--CA 1.415 -2.726 0 C-N-CA 120.578 -0.82 . . . . 0.0 114.879 175.447 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 32.0 mt-30 -148.24 139.88 23.71 Favored 'General case' 0 CA--C 1.486 -1.518 0 N-CA-C 105.997 -1.853 . . . . 0.0 105.997 -166.878 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 59.5 tp -116.47 96.41 5.51 Favored 'General case' 0 CA--C 1.499 -0.997 0 N-CA-C 104.015 -2.587 . . . . 0.0 104.015 174.958 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 27.3 mt -88.49 134.79 27.27 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.919 0 N-CA-C 104.05 -2.574 . . . . 0.0 104.05 -178.313 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 25.2 p -129.5 104.62 7.57 Favored 'General case' 0 N--CA 1.438 -1.066 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 -169.326 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 3.7 mp -93.51 136.42 25.31 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.312 0 N-CA-C 104.062 -2.57 . . . . 0.0 104.062 -167.07 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 80.5 mt-30 -88.24 177.29 6.92 Favored 'General case' 0 CA--C 1.496 -1.132 0 C-N-CA 123.712 0.805 . . . . 0.0 108.968 -171.304 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 35.3 mt-30 -71.52 96.04 1.47 Allowed 'General case' 0 CA--C 1.501 -0.921 0 C-N-CA 124.597 1.159 . . . . 0.0 109.459 176.46 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . 0.301 41.3 p90 47.65 33.0 2.76 Favored 'General case' 0 C--N 1.36 1.035 0 C-N-CA 128.126 2.57 . . . . 0.0 114.438 -174.815 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -125.29 -125.89 2.95 Favored Glycine 0 C--N 1.358 1.78 0 N-CA-C 109.456 -1.458 . . . . 0.0 109.456 -174.119 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 52.3 m80 -84.1 -178.02 6.83 Favored 'General case' 0 CA--C 1.498 -1.027 0 C-N-CA 125.614 1.566 . . . . 0.0 111.044 -167.818 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 35.7 mt-30 -125.29 146.25 49.64 Favored 'General case' 0 CA--C 1.494 -1.188 0 N-CA-C 103.459 -2.793 . . . . 0.0 103.459 167.806 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 54.6 mt-10 -138.14 121.48 17.06 Favored 'General case' 0 CA--C 1.492 -1.281 0 N-CA-C 105.372 -2.084 . . . . 0.0 105.372 -177.114 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 7.5 p -99.4 134.97 36.62 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.79 0 N-CA-C 108.151 -1.055 . . . . 0.0 108.151 -172.624 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 26.7 m -115.2 158.96 21.53 Favored 'General case' 0 N--CA 1.443 -0.802 0 N-CA-C 103.81 -2.663 . . . . 0.0 103.81 175.915 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 38.8 ptt180 -126.32 154.71 43.1 Favored 'General case' 0 CA--C 1.501 -0.915 0 CA-C-O 121.32 0.581 . . . . 0.0 109.8 178.126 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 29.4 p90 -157.45 165.43 35.69 Favored 'General case' 0 CA--C 1.502 -0.866 0 N-CA-C 107.274 -1.38 . . . . 0.0 107.274 173.486 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -145.57 156.82 43.93 Favored 'General case' 0 N--CA 1.441 -0.885 0 N-CA-C 106.314 -1.736 . . . . 0.0 106.314 159.997 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 27.4 p90 -146.37 168.23 21.62 Favored 'General case' 0 CA--C 1.492 -1.254 0 N-CA-C 106.404 -1.702 . . . . 0.0 106.404 171.046 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 26.6 p -110.86 140.36 45.39 Favored 'General case' 0 CA--C 1.5 -0.944 0 N-CA-C 106.957 -1.497 . . . . 0.0 106.957 178.668 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' THR . . . . . 0.614 ' HG1' ' CD2' ' A' ' 18' ' ' HIS . 89.7 m -116.45 109.14 16.91 Favored 'General case' 0 CA--C 1.489 -1.394 0 N-CA-C 102.106 -3.294 . . . . 0.0 102.106 174.037 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' THR . . . . . 0.499 ' HA ' ' H ' ' A' ' 66' ' ' GLY . 86.9 m -147.28 -55.69 0.24 Allowed 'General case' 0 CA--C 1.498 -1.034 0 N-CA-C 106.645 -1.613 . . . . 0.0 106.645 -171.686 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 8.9 t . . . . . 0 C--O 1.26 1.653 0 CA-C-O 118.078 -0.963 . . . . 0.0 110.049 -165.25 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.443 -0.847 0 N-CA-C 109.104 -1.598 . . . . 0.0 109.104 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_exo -61.55 136.12 61.15 Favored 'Trans proline' 0 N--CA 1.443 -1.472 0 C-N-CA 123.088 2.526 . . . . 0.0 113.624 -178.357 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.52 HG22 ' HG ' ' A' ' 75' ' ' SER . 24.6 t -84.59 161.92 3.08 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.048 0 C-N-CA 129.202 3.001 . . . . 0.0 106.424 -178.196 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -108.38 108.9 20.06 Favored 'General case' 0 CA--C 1.496 -1.107 0 N-CA-C 105.876 -1.898 . . . . 0.0 105.876 175.927 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 1.5 p -129.3 142.04 45.01 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.894 0 N-CA-C 105.687 -1.968 . . . . 0.0 105.687 -170.101 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 33.1 p90 . . . . . 0 N--CA 1.438 -1.026 0 CA-C-O 121.876 0.846 . . . . 0.0 109.302 -162.184 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_exo . . . . . 0 CA--C 1.506 -0.882 0 CA-C-O 119.118 -0.451 . . . . 0.0 111.291 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 1.6 p30 -102.46 -42.44 5.97 Favored 'General case' 0 CA--C 1.489 -1.368 0 C-N-CA 124.215 1.006 . . . . 0.0 111.029 -165.188 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 56.6 p -110.48 156.0 21.46 Favored 'General case' 0 CA--C 1.497 -1.06 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 -175.634 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 86.3 t60 -131.57 98.72 17.8 Favored Pre-proline 0 N--CA 1.439 -0.989 0 N-CA-C 106.128 -1.804 . . . . 0.0 106.128 172.493 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -80.13 128.99 7.58 Favored 'Trans proline' 0 N--CA 1.451 -0.972 0 C-N-CA 123.26 2.64 . . . . 0.0 109.836 177.231 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 3.7 mp -111.9 149.04 14.67 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.183 0 N-CA-C 104.881 -2.266 . . . . 0.0 104.881 -179.62 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 31.2 mt-30 -138.7 152.94 48.44 Favored 'General case' 0 CA--C 1.497 -1.092 0 N-CA-C 104.578 -2.378 . . . . 0.0 104.578 164.57 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 37.2 p90 -136.02 158.5 44.26 Favored 'General case' 0 CA--C 1.501 -0.916 0 N-CA-C 107.065 -1.457 . . . . 0.0 107.065 -178.595 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 84.2 m-20 -96.4 -176.92 3.78 Favored 'General case' 0 CA--C 1.488 -1.407 0 N-CA-C 103.934 -2.617 . . . . 0.0 103.934 169.045 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -157.35 171.85 6.91 Favored Pre-proline 0 N--CA 1.44 -0.933 0 N-CA-C 106.579 -1.637 . . . . 0.0 106.579 173.188 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 68.5 Cg_exo -63.74 154.46 69.28 Favored 'Trans proline' 0 CA--C 1.508 -0.814 0 C-N-CA 123.51 2.807 . . . . 0.0 112.842 174.59 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 24.0 tt0 -82.43 -41.93 0.94 Allowed Pre-proline 0 N--CA 1.443 -0.798 0 CA-C-O 115.697 -2.097 . . . . 0.0 112.031 -175.134 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_exo -71.71 -3.74 13.71 Favored 'Trans proline' 0 CA--C 1.514 -0.521 0 CA-C-N 125.574 3.026 . . . . 0.0 113.851 -179.867 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 10.3 t 71.0 75.93 0.19 Allowed 'General case' 0 C--N 1.357 0.903 0 C-N-CA 126.381 1.873 . . . . 0.0 108.812 -176.71 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 57.8 t-80 -90.95 -20.18 22.46 Favored 'General case' 0 N--CA 1.439 -0.977 0 C-N-CA 125.27 1.428 . . . . 0.0 108.455 179.969 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 22.9 mt -125.38 147.47 30.07 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.105 0 N-CA-C 105.396 -2.075 . . . . 0.0 105.396 -168.578 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 9.2 p -107.29 -84.13 0.53 Allowed 'General case' 0 N--CA 1.432 -1.328 0 N-CA-C 106.879 -1.526 . . . . 0.0 106.879 174.554 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 51.7 mtmt -89.2 167.57 12.98 Favored 'General case' 0 CA--C 1.486 -1.493 0 C-N-CA 124.683 1.193 . . . . 0.0 108.782 -165.274 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 90.4 m-85 -132.31 138.24 47.74 Favored 'General case' 0 CA--C 1.495 -1.142 0 N-CA-C 105.329 -2.1 . . . . 0.0 105.329 176.033 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 51.8 mt -118.42 131.55 70.85 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.111 0 N-CA-C 101.074 -3.676 . . . . 0.0 101.074 170.652 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 6.8 mt -111.01 128.13 55.75 Favored 'General case' 0 CA--C 1.477 -1.854 0 N-CA-C 104.739 -2.319 . . . . 0.0 104.739 170.104 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 3.2 mmm180 -107.51 160.11 15.91 Favored 'General case' 0 N--CA 1.432 -1.348 0 N-CA-C 104.737 -2.32 . . . . 0.0 104.737 171.077 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 48.5 p90 -159.18 152.82 22.89 Favored 'General case' 0 N--CA 1.437 -1.085 0 N-CA-C 107.801 -1.185 . . . . 0.0 107.801 171.093 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 13.1 ptp180 -154.61 158.05 32.2 Favored Pre-proline 0 CA--C 1.501 -0.932 0 N-CA-C 105.661 -1.978 . . . . 0.0 105.661 163.946 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -72.52 129.01 14.16 Favored 'Trans proline' 0 N--CA 1.451 -0.977 0 C-N-CA 122.637 2.225 . . . . 0.0 107.752 170.191 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 48.2 tttp -67.6 81.82 0.17 Allowed 'General case' 0 C--N 1.357 0.912 0 C-N-CA 127.781 2.433 . . . . 0.0 111.473 -170.761 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 4.7 t-20 -162.17 -51.05 0.04 OUTLIER 'General case' 0 N--CA 1.432 -1.335 0 N-CA-C 105.562 -2.014 . . . . 0.0 105.562 -173.607 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 37.9 p -80.63 155.7 26.72 Favored 'General case' 0 N--CA 1.438 -1.059 0 C-N-CA 124.567 1.147 . . . . 0.0 109.685 -176.891 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 17.3 m -130.44 10.67 2.14 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.811 0 C-N-CA 125.061 1.344 . . . . 0.0 107.888 -177.427 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -94.27 -113.18 2.45 Favored Glycine 0 C--N 1.356 1.694 0 N-CA-C 109.489 -1.444 . . . . 0.0 109.489 -174.534 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 85.6 mtm180 -92.66 175.95 6.63 Favored 'General case' 0 CA--C 1.503 -0.863 0 N-CA-C 108.191 -1.04 . . . . 0.0 108.191 -178.538 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -155.41 -178.41 7.25 Favored 'General case' 0 CA--C 1.495 -1.171 0 CA-C-O 121.221 0.534 . . . . 0.0 109.839 178.565 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 96.0 mttt -109.21 156.55 19.76 Favored 'General case' 0 CA--C 1.489 -1.396 0 N-CA-C 106.451 -1.685 . . . . 0.0 106.451 -176.724 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 1.1 pp20? -152.08 163.12 39.99 Favored 'General case' 0 N--CA 1.432 -1.363 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 176.252 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -139.97 160.79 39.14 Favored 'General case' 0 CA--C 1.495 -1.136 0 N-CA-C 105.663 -1.977 . . . . 0.0 105.663 169.596 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 77.6 m -120.62 125.96 49.07 Favored 'General case' 0 CA--C 1.499 -1.014 0 N-CA-C 104.732 -2.322 . . . . 0.0 104.732 176.446 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 4.9 mp -114.04 134.41 22.17 Favored Pre-proline 0 N--CA 1.435 -1.186 0 N-CA-C 104.84 -2.281 . . . . 0.0 104.84 -175.545 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 67.5 Cg_exo -63.89 167.6 13.62 Favored 'Trans proline' 0 CA--C 1.509 -0.761 0 C-N-CA 123.595 2.863 . . . . 0.0 113.406 177.227 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -77.75 -19.02 76.43 Favored Glycine 0 C--N 1.352 1.439 0 C-N-CA 123.583 0.611 . . . . 0.0 113.425 -173.488 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 50.9 p-80 -84.08 -27.88 27.95 Favored 'General case' 0 C--N 1.357 0.906 0 CA-C-N 117.757 0.779 . . . . 0.0 110.172 -179.471 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 86.4 mt -88.56 128.97 35.58 Favored 'General case' 0 CA--C 1.5 -0.943 0 N-CA-C 107.881 -1.155 . . . . 0.0 107.881 177.653 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 8.7 p30 -110.98 8.33 21.96 Favored 'General case' 0 CA--C 1.5 -0.946 0 C-N-CA 124.498 1.119 . . . . 0.0 110.543 -171.806 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 46.6 p -142.03 160.16 40.77 Favored 'General case' 0 N--CA 1.439 -0.988 0 N-CA-C 108.107 -1.071 . . . . 0.0 108.107 -175.713 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 12.3 t80 -143.63 176.72 9.0 Favored 'General case' 0 C--N 1.355 0.822 0 N-CA-C 107.328 -1.36 . . . . 0.0 107.328 176.953 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 97.6 m -147.06 116.96 7.2 Favored 'General case' 0 N--CA 1.429 -1.509 0 N-CA-C 104.851 -2.277 . . . . 0.0 104.851 176.101 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 79.7 mt -91.24 147.06 5.5 Favored 'Isoleucine or valine' 0 C--N 1.355 0.804 0 N-CA-C 103.555 -2.757 . . . . 0.0 103.555 169.364 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 67.6 mttm -140.38 166.37 24.89 Favored 'General case' 0 CA--C 1.5 -0.954 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 178.149 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 83.16 49.39 5.01 Favored Glycine 0 C--N 1.354 1.577 0 N-CA-C 109.211 -1.556 . . . . 0.0 109.211 174.787 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 63.9 mt -118.78 169.4 9.88 Favored 'General case' 0 CA--C 1.498 -1.023 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 -170.576 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -116.76 144.74 33.95 Favored Pre-proline 0 N--CA 1.439 -1.008 0 N-CA-C 105.679 -1.971 . . . . 0.0 105.679 -173.764 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -77.33 161.75 31.59 Favored 'Trans proline' 0 N--CA 1.452 -0.934 0 C-N-CA 122.788 2.325 . . . . 0.0 110.996 174.466 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . 0.483 ' H ' ' HA ' ' A' ' 92' ' ' THR . . . 62.54 26.66 68.54 Favored Glycine 0 N--CA 1.428 -1.856 0 C-N-CA 127.617 2.532 . . . . 0.0 115.765 174.225 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 9.8 p -126.65 145.59 33.95 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.928 0 N-CA-C 107.596 -1.261 . . . . 0.0 107.596 179.408 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 4.2 p -92.61 135.75 26.7 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.824 0 N-CA-C 107.214 -1.402 . . . . 0.0 107.214 179.945 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 91.1 m-85 -116.79 149.27 40.23 Favored 'General case' 0 CA--C 1.494 -1.193 0 N-CA-C 105.607 -1.997 . . . . 0.0 105.607 175.278 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -96.7 139.93 32.04 Favored 'General case' 0 CA--C 1.499 -1.009 0 N-CA-C 104.367 -2.457 . . . . 0.0 104.367 162.773 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -132.66 154.14 20.97 Favored Glycine 0 CA--C 1.483 -1.925 0 N-CA-C 106.951 -2.46 . . . . 0.0 106.951 179.849 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 29.2 tt0 -146.94 135.61 22.09 Favored 'General case' 0 CA--C 1.483 -1.627 0 N-CA-C 106.949 -1.5 . . . . 0.0 106.949 -178.625 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 21.8 tp -115.79 100.55 8.09 Favored 'General case' 0 N--CA 1.438 -1.074 0 N-CA-C 104.45 -2.426 . . . . 0.0 104.45 -177.355 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 21.2 mt -93.16 126.61 45.57 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.917 0 N-CA-C 104.032 -2.581 . . . . 0.0 104.032 177.572 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' SER . . . . . 0.52 ' HG ' HG22 ' A' ' 4' ' ' VAL . 74.2 m -117.98 111.32 18.8 Favored 'General case' 0 N--CA 1.436 -1.173 0 N-CA-C 107.746 -1.205 . . . . 0.0 107.746 -170.413 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 31.0 mm -91.22 144.01 10.05 Favored 'Isoleucine or valine' 0 CA--C 1.49 -1.365 0 N-CA-C 106.519 -1.66 . . . . 0.0 106.519 -165.799 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 17.1 tt0 -110.81 107.18 16.6 Favored 'General case' 0 CA--C 1.495 -1.135 0 N-CA-C 103.036 -2.95 . . . . 0.0 103.036 171.452 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 19.7 pt20 -67.25 138.46 56.91 Favored 'General case' 0 C--N 1.356 0.866 0 CA-C-O 121.232 0.539 . . . . 0.0 111.68 -167.148 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 55.0 m-85 68.05 32.15 5.14 Favored 'General case' 0 C--N 1.355 0.821 0 C-N-CA 126.695 1.998 . . . . 0.0 111.764 -176.1 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -174.97 -112.86 0.31 Allowed Glycine 0 C--N 1.355 1.613 0 C-N-CA 119.349 -1.405 . . . . 0.0 109.749 176.922 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 66.4 m80 -83.43 -178.73 7.15 Favored 'General case' 0 CA--C 1.5 -0.954 0 C-N-CA 125.242 1.417 . . . . 0.0 111.269 -164.595 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 5.9 pt20 -154.51 148.77 26.0 Favored 'General case' 0 N--CA 1.435 -1.216 0 N-CA-C 106.621 -1.622 . . . . 0.0 106.621 166.506 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 8.4 mp0 -109.81 155.93 21.0 Favored 'General case' 0 N--CA 1.437 -1.085 0 N-CA-C 104.869 -2.271 . . . . 0.0 104.869 -178.116 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 12.4 p -131.45 139.17 51.4 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.838 0 N-CA-C 107.772 -1.196 . . . . 0.0 107.772 -179.739 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 41.8 m -133.28 122.69 24.25 Favored 'General case' 0 N--CA 1.438 -1.074 0 N-CA-C 103.261 -2.866 . . . . 0.0 103.261 -178.669 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 52.8 ttt85 -119.75 144.15 47.42 Favored 'General case' 0 CA--C 1.504 -0.794 0 N-CA-C 108.174 -1.047 . . . . 0.0 108.174 -176.011 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 29.0 p90 -155.06 -179.59 8.21 Favored 'General case' 0 CA--C 1.499 -0.981 0 N-CA-C 107.547 -1.279 . . . . 0.0 107.547 -177.182 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -138.82 156.31 47.44 Favored 'General case' 0 N--CA 1.44 -0.961 0 N-CA-C 105.811 -1.922 . . . . 0.0 105.811 167.169 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 22.2 p90 -142.61 171.79 13.57 Favored 'General case' 0 CA--C 1.487 -1.477 0 N-CA-C 106.83 -1.544 . . . . 0.0 106.83 175.001 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 25.5 p -120.37 143.88 48.19 Favored 'General case' 0 CA--C 1.499 -0.993 0 N-CA-C 105.526 -2.027 . . . . 0.0 105.526 169.364 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 57.3 m -109.05 126.06 52.76 Favored 'General case' 0 CA--C 1.493 -1.244 0 N-CA-C 101.36 -3.57 . . . . 0.0 101.36 164.764 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' THR . . . . . 0.483 ' HA ' ' H ' ' A' ' 66' ' ' GLY . 12.4 t -146.01 172.46 13.35 Favored 'General case' 0 N--CA 1.435 -1.177 0 N-CA-C 105.264 -2.125 . . . . 0.0 105.264 -173.751 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 69.5 m . . . . . 0 C--O 1.26 1.629 0 N-CA-C 106.8 -1.556 . . . . 0.0 106.8 173.197 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.437 -1.285 0 N-CA-C 106.705 -2.558 . . . . 0.0 106.705 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 8.9 Cg_exo -55.42 148.57 51.36 Favored 'Trans proline' 0 N--CA 1.45 -1.078 0 C-N-CA 124.11 3.207 . . . . 0.0 116.463 -161.995 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 17.5 t -76.88 156.21 5.54 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.806 0 C-N-CA 128.29 2.636 . . . . 0.0 105.036 175.021 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 55.2 mt-10 -107.15 105.81 15.98 Favored 'General case' 0 CA--C 1.494 -1.18 0 N-CA-C 106.512 -1.662 . . . . 0.0 106.512 -176.478 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 1.7 p -127.49 141.83 45.26 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.981 0 N-CA-C 106.172 -1.788 . . . . 0.0 106.172 -169.808 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 21.2 p90 . . . . . 0 N--CA 1.436 -1.13 0 N-CA-C 106.95 -1.5 . . . . 0.0 106.95 -162.589 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo . . . . . 0 CA--C 1.504 -0.987 0 CA-C-O 118.17 -0.846 . . . . 0.0 111.267 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 4.1 t30 -117.73 -33.67 4.45 Favored 'General case' 0 CA--C 1.487 -1.459 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 -170.849 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 67.8 m -103.63 152.12 22.14 Favored 'General case' 0 CA--C 1.495 -1.163 0 N-CA-C 107.092 -1.448 . . . . 0.0 107.092 178.854 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 82.7 t60 -144.61 84.17 9.27 Favored Pre-proline 0 N--CA 1.437 -1.123 0 N-CA-C 106.559 -1.645 . . . . 0.0 106.559 174.651 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -81.75 123.19 4.13 Favored 'Trans proline' 0 N--CA 1.446 -1.294 0 C-N-CA 123.286 2.657 . . . . 0.0 109.765 179.882 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 3.4 pt -109.81 170.86 2.96 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.069 0 N-CA-C 108.466 -0.939 . . . . 0.0 108.466 -174.962 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 33.6 tt0 -145.92 148.03 32.38 Favored 'General case' 0 N--CA 1.437 -1.076 0 N-CA-C 105.459 -2.052 . . . . 0.0 105.459 172.247 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 19.6 p90 -130.75 158.04 41.18 Favored 'General case' 0 CA--C 1.499 -1.001 0 N-CA-C 106.27 -1.752 . . . . 0.0 106.27 179.491 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 89.6 m-20 -95.47 -179.46 4.77 Favored 'General case' 0 CA--C 1.488 -1.433 0 N-CA-C 103.647 -2.723 . . . . 0.0 103.647 168.89 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -160.08 165.37 17.9 Favored Pre-proline 0 N--CA 1.439 -0.982 0 N-CA-C 104.966 -2.235 . . . . 0.0 104.966 176.851 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -74.63 154.86 44.68 Favored 'Trans proline' 0 N--CA 1.453 -0.874 0 C-N-CA 122.546 2.164 . . . . 0.0 109.711 179.244 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 11.8 tp-100 -82.85 -43.41 0.9 Allowed Pre-proline 0 N--CA 1.443 -0.799 0 CA-C-O 115.924 -1.989 . . . . 0.0 111.219 -174.777 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 70.5 Cg_exo -67.89 167.94 20.09 Favored 'Trans proline' 0 CA--C 1.508 -0.778 0 CA-C-N 125.347 2.945 . . . . 0.0 111.976 174.213 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 34.8 p -72.94 123.18 22.94 Favored 'General case' 0 C--N 1.355 0.836 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 178.949 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 20.0 t-160 -159.58 -51.54 0.06 Allowed 'General case' 0 CA--C 1.493 -1.248 0 N-CA-C 106.729 -1.582 . . . . 0.0 106.729 -169.83 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 48.9 mt -121.6 137.88 53.78 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.119 0 N-CA-C 106.425 -1.695 . . . . 0.0 106.425 -168.842 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 73.5 m -107.33 -82.26 0.55 Allowed 'General case' 0 N--CA 1.432 -1.345 0 C-N-CA 125.025 1.33 . . . . 0.0 108.131 179.953 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 35.0 ttpt -92.25 161.74 14.58 Favored 'General case' 0 CA--C 1.494 -1.196 0 C-N-CA 125.47 1.508 . . . . 0.0 107.731 -165.477 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 90.2 m-85 -128.92 137.01 51.17 Favored 'General case' 0 CA--C 1.497 -1.089 0 N-CA-C 104.686 -2.338 . . . . 0.0 104.686 173.367 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 62.0 mt -116.73 128.81 74.01 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.213 0 N-CA-C 101.611 -3.477 . . . . 0.0 101.611 171.725 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 3.1 mt -109.02 133.35 53.1 Favored 'General case' 0 CA--C 1.475 -1.908 0 N-CA-C 105.766 -1.939 . . . . 0.0 105.766 171.784 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 16.3 ptp180 -135.96 152.6 51.14 Favored 'General case' 0 N--CA 1.434 -1.259 0 N-CA-C 107.31 -1.367 . . . . 0.0 107.31 173.928 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 48.6 p90 -156.73 153.57 28.62 Favored 'General case' 0 N--CA 1.438 -1.039 0 N-CA-C 107.766 -1.198 . . . . 0.0 107.766 -172.736 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 10.6 ptp180 -149.02 155.78 40.38 Favored Pre-proline 0 CA--C 1.499 -0.988 0 N-CA-C 105.696 -1.964 . . . . 0.0 105.696 168.393 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -72.17 121.25 7.37 Favored 'Trans proline' 0 N--CA 1.452 -0.958 0 C-N-CA 122.876 2.384 . . . . 0.0 108.327 169.797 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 57.5 tttp -70.3 80.01 0.53 Allowed 'General case' 0 C--N 1.357 0.924 0 C-N-CA 126.918 2.087 . . . . 0.0 110.446 -178.182 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 29.9 m120 -155.4 -70.41 0.12 Allowed 'General case' 0 N--CA 1.435 -1.215 0 N-CA-C 102.046 -3.316 . . . . 0.0 102.046 -173.209 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 37.2 p -96.22 157.89 15.69 Favored 'General case' 0 N--CA 1.439 -0.993 0 N-CA-C 107.555 -1.276 . . . . 0.0 107.555 175.139 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 3.3 m -130.62 53.68 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.918 0 N-CA-C 105.789 -1.93 . . . . 0.0 105.789 178.24 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -94.61 -107.73 2.08 Favored Glycine 0 C--N 1.355 1.625 0 N-CA-C 108.017 -2.033 . . . . 0.0 108.017 -179.092 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 8.3 ptm180 -88.8 175.29 7.54 Favored 'General case' 0 CA--C 1.502 -0.874 0 N-CA-C 107.625 -1.25 . . . . 0.0 107.625 174.822 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -157.24 171.3 20.66 Favored 'General case' 0 CA--C 1.492 -1.262 0 CA-C-O 121.393 0.616 . . . . 0.0 110.191 175.199 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 64.9 mttp -109.45 152.29 25.59 Favored 'General case' 0 CA--C 1.486 -1.503 0 N-CA-C 107.469 -1.308 . . . . 0.0 107.469 -172.551 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -152.99 155.42 36.9 Favored 'General case' 0 N--CA 1.434 -1.252 0 N-CA-C 107.74 -1.208 . . . . 0.0 107.74 177.727 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -137.3 156.96 47.64 Favored 'General case' 0 N--CA 1.437 -1.107 0 N-CA-C 105.816 -1.92 . . . . 0.0 105.816 173.539 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 87.3 m -121.12 125.32 46.92 Favored 'General case' 0 CA--C 1.501 -0.93 0 N-CA-C 104.784 -2.302 . . . . 0.0 104.784 -179.585 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 58.5 mt -124.02 132.32 24.29 Favored Pre-proline 0 N--CA 1.439 -1.024 0 N-CA-C 105.039 -2.208 . . . . 0.0 105.039 -164.672 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo -77.95 172.51 15.47 Favored 'Trans proline' 0 N--CA 1.455 -0.794 0 C-N-CA 122.717 2.278 . . . . 0.0 110.558 -179.516 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -96.75 69.56 0.84 Allowed Glycine 0 C--N 1.353 1.486 0 N-CA-C 109.34 -1.504 . . . . 0.0 109.34 178.602 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . 0.416 ' HB2' HD11 ' A' ' 55' ' ' LEU . 27.3 m170 -120.55 -66.43 1.06 Allowed 'General case' 0 CA--C 1.499 -0.986 0 N-CA-C 103.265 -2.865 . . . . 0.0 103.265 174.357 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.528 ' H ' HD21 ' A' ' 55' ' ' LEU . 0.0 OUTLIER -89.69 164.08 14.85 Favored 'General case' 0 N--CA 1.43 -1.471 0 C-N-CA 129.17 2.988 . . . . 0.0 106.856 177.765 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 7.1 p30 -140.11 30.34 2.0 Favored 'General case' 0 N--CA 1.431 -1.399 0 N-CA-C 107.125 -1.435 . . . . 0.0 107.125 -177.567 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 36.5 p -139.8 149.12 43.13 Favored 'General case' 0 CA--C 1.501 -0.937 0 N-CA-C 106.809 -1.552 . . . . 0.0 106.809 177.321 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 10.3 t80 -128.37 175.99 8.06 Favored 'General case' 0 C--N 1.358 0.973 0 N-CA-C 107.92 -1.141 . . . . 0.0 107.92 179.764 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 97.7 m -138.5 109.25 6.65 Favored 'General case' 0 N--CA 1.432 -1.344 0 N-CA-C 104.081 -2.562 . . . . 0.0 104.081 173.113 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 27.4 mt -87.9 147.54 5.19 Favored 'Isoleucine or valine' 0 C--N 1.358 0.969 0 N-CA-C 103.427 -2.805 . . . . 0.0 103.427 169.696 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 8.7 ptpp? -150.1 162.83 39.66 Favored 'General case' 0 CA--C 1.497 -1.067 0 N-CA-C 108.169 -1.048 . . . . 0.0 108.169 179.366 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 83.63 51.03 4.21 Favored Glycine 0 C--N 1.354 1.575 0 N-CA-C 109.367 -1.493 . . . . 0.0 109.367 177.768 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.403 HD11 ' HG1' ' A' ' 91' ' ' THR . 62.7 mt -120.34 177.44 5.03 Favored 'General case' 0 CA--C 1.5 -0.954 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 -171.59 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -122.79 152.88 63.1 Favored Pre-proline 0 N--CA 1.44 -0.952 0 N-CA-C 106.46 -1.681 . . . . 0.0 106.46 -175.765 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -79.72 163.74 23.59 Favored 'Trans proline' 0 N--CA 1.451 -0.992 0 C-N-CA 122.976 2.451 . . . . 0.0 110.62 175.312 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . 0.487 ' H ' ' HA ' ' A' ' 92' ' ' THR . . . 58.64 26.16 59.57 Favored Glycine 0 C--N 1.356 1.657 0 C-N-CA 128.207 2.813 . . . . 0.0 116.28 171.966 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 8.6 p -126.41 147.5 31.24 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.977 0 N-CA-C 107.625 -1.25 . . . . 0.0 107.625 -176.988 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 5.1 p -96.02 138.14 22.2 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.945 0 N-CA-C 107.323 -1.362 . . . . 0.0 107.323 -178.114 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 88.6 m-85 -119.13 151.63 37.95 Favored 'General case' 0 N--CA 1.436 -1.157 0 N-CA-C 105.638 -1.986 . . . . 0.0 105.638 175.335 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -101.53 141.72 33.98 Favored 'General case' 0 CA--C 1.497 -1.095 0 N-CA-C 104.743 -2.317 . . . . 0.0 104.743 162.114 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -135.88 150.01 20.23 Favored Glycine 0 CA--C 1.488 -1.608 0 N-CA-C 107.701 -2.16 . . . . 0.0 107.701 -179.576 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 31.1 mt-30 -141.6 133.43 27.31 Favored 'General case' 0 CA--C 1.485 -1.545 0 N-CA-C 106.019 -1.845 . . . . 0.0 106.019 -177.628 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 23.2 tp -115.33 99.77 7.63 Favored 'General case' 0 N--CA 1.439 -1.01 0 N-CA-C 104.249 -2.5 . . . . 0.0 104.249 -178.339 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 11.7 mt -92.43 127.33 44.68 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.812 0 N-CA-C 104.502 -2.407 . . . . 0.0 104.502 179.767 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 10.3 p -114.98 111.66 21.49 Favored 'General case' 0 N--CA 1.436 -1.141 0 N-CA-C 107.593 -1.262 . . . . 0.0 107.593 -173.904 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 10.4 mm -94.79 150.81 3.96 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.298 0 N-CA-C 106.116 -1.809 . . . . 0.0 106.116 -167.195 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 6.4 pt20 -117.69 137.27 52.78 Favored 'General case' 0 CA--C 1.495 -1.155 0 N-CA-C 105.467 -2.049 . . . . 0.0 105.467 169.654 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 63.4 tp60 -69.02 117.89 11.23 Favored 'General case' 0 N--CA 1.441 -0.918 0 C-N-CA 124.107 0.963 . . . . 0.0 111.566 -167.019 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 36.1 m-85 59.09 49.95 8.73 Favored 'General case' 0 C--N 1.357 0.902 0 C-N-CA 126.971 2.108 . . . . 0.0 112.013 -177.918 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -158.72 -122.53 0.68 Allowed Glycine 0 N--CA 1.432 -1.623 0 N-CA-C 108.193 -1.963 . . . . 0.0 108.193 177.499 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 79.8 m-70 -86.58 177.87 7.25 Favored 'General case' 0 CA--C 1.498 -1.035 0 C-N-CA 125.34 1.456 . . . . 0.0 111.07 -169.479 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 26.6 mp0 -133.31 140.21 47.31 Favored 'General case' 0 N--CA 1.436 -1.173 0 N-CA-C 103.608 -2.738 . . . . 0.0 103.608 168.898 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 30.6 tt0 -119.25 137.73 53.47 Favored 'General case' 0 CA--C 1.496 -1.102 0 N-CA-C 103.948 -2.612 . . . . 0.0 103.948 177.915 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 6.3 p -117.1 136.01 55.63 Favored 'Isoleucine or valine' 0 C--N 1.354 0.775 0 N-CA-C 107.914 -1.143 . . . . 0.0 107.914 -177.065 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 63.6 m -116.73 140.15 49.75 Favored 'General case' 0 N--CA 1.441 -0.921 0 N-CA-C 103.067 -2.938 . . . . 0.0 103.067 173.464 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 79.2 mtt85 -128.09 152.05 48.46 Favored 'General case' 0 CA--C 1.5 -0.953 0 N-CA-C 109.195 -0.669 . . . . 0.0 109.195 177.331 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 30.7 p90 -163.81 175.79 10.13 Favored 'General case' 0 C--N 1.355 0.82 0 N-CA-C 107.796 -1.187 . . . . 0.0 107.796 -178.445 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 51.5 m-20 -133.53 154.11 51.1 Favored 'General case' 0 CA--C 1.502 -0.875 0 N-CA-C 105.715 -1.957 . . . . 0.0 105.715 169.553 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 22.1 p90 -142.94 169.36 17.72 Favored 'General case' 0 CA--C 1.487 -1.454 0 N-CA-C 107.765 -1.198 . . . . 0.0 107.765 171.095 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 27.5 p -121.89 143.26 49.54 Favored 'General case' 0 CA--C 1.501 -0.934 0 N-CA-C 105.733 -1.951 . . . . 0.0 105.733 170.754 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' THR . . . . . 0.403 ' HG1' HD11 ' A' ' 63' ' ' LEU . 45.1 m -114.02 125.63 54.21 Favored 'General case' 0 CA--C 1.497 -1.059 0 N-CA-C 102.499 -3.148 . . . . 0.0 102.499 170.953 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' THR . . . . . 0.487 ' HA ' ' H ' ' A' ' 66' ' ' GLY . 13.2 t -143.86 161.61 38.23 Favored 'General case' 0 N--CA 1.441 -0.907 0 N-CA-C 107.365 -1.346 . . . . 0.0 107.365 -171.523 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 50.8 p . . . . . 0 C--O 1.261 1.686 0 C-N-CA 124.837 1.255 . . . . 0.0 109.361 -179.103 . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.436 -1.355 0 N-CA-C 105.702 -2.959 . . . . 0.0 105.702 . . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_exo -60.34 132.22 42.61 Favored 'Trans proline' 0 N--CA 1.447 -1.264 0 C-N-CA 123.601 2.867 . . . . 0.0 111.125 -178.05 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 20.2 t -77.95 153.98 5.23 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.925 0 C-N-CA 127.095 2.158 . . . . 0.0 106.273 -172.792 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -96.12 85.67 4.07 Favored 'General case' 0 CA--C 1.49 -1.328 0 N-CA-C 107.377 -1.342 . . . . 0.0 107.377 -176.887 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 1.8 p -100.06 120.73 49.88 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.169 0 N-CA-C 106.484 -1.673 . . . . 0.0 106.484 -170.578 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 48.4 m-85 . . . . . 0 CA--C 1.495 -1.161 0 N-CA-C 106.923 -1.51 . . . . 0.0 106.923 -168.318 . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 64.6 Cg_endo . . . . . 0 CA--C 1.506 -0.919 0 CA-C-O 118.656 -0.643 . . . . 0.0 111.792 . . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 1.9 m-80 -124.53 -20.22 5.19 Favored 'General case' 0 CA--C 1.491 -1.292 0 C-N-CA 124.128 0.971 . . . . 0.0 109.284 -169.016 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 5.7 p -108.52 134.91 50.64 Favored 'General case' 0 CA--C 1.495 -1.172 0 N-CA-C 107.714 -1.217 . . . . 0.0 107.714 -176.563 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 58.7 t-80 -122.8 98.2 43.15 Favored Pre-proline 0 N--CA 1.441 -0.906 0 N-CA-C 106.978 -1.49 . . . . 0.0 106.978 178.027 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 63.4 Cg_endo -80.05 127.15 6.72 Favored 'Trans proline' 0 N--CA 1.449 -1.107 0 C-N-CA 123.073 2.515 . . . . 0.0 109.873 177.635 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 2.1 pt -110.74 166.26 5.56 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.031 0 N-CA-C 107.153 -1.425 . . . . 0.0 107.153 174.365 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 32.3 mt-30 -138.51 160.09 40.45 Favored 'General case' 0 CA--C 1.497 -1.084 0 N-CA-C 105.286 -2.116 . . . . 0.0 105.286 167.68 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 48.8 p90 -145.1 169.57 17.89 Favored 'General case' 0 CA--C 1.498 -1.054 0 N-CA-C 107.488 -1.301 . . . . 0.0 107.488 173.209 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 44.8 t30 -146.69 136.49 23.21 Favored 'General case' 0 CA--C 1.484 -1.575 0 N-CA-C 106.548 -1.649 . . . . 0.0 106.548 174.449 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -82.78 167.64 28.37 Favored Pre-proline 0 N--CA 1.439 -0.991 0 CA-C-N 112.793 -2.003 . . . . 0.0 111.681 -160.944 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 76.7 Cg_exo -66.16 176.29 4.04 Favored 'Trans proline' 0 N--CA 1.456 -0.68 0 C-N-CA 123.826 3.017 . . . . 0.0 111.752 165.107 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 1.3 tm0? -79.18 -46.04 1.68 Allowed Pre-proline 0 N--CA 1.443 -0.805 0 CA-C-O 115.544 -2.17 . . . . 0.0 110.496 -175.728 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 75.6 Cg_exo -66.53 148.0 83.02 Favored 'Trans proline' 0 CA--C 1.51 -0.721 0 CA-C-N 125.792 3.104 . . . . 0.0 111.969 177.147 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 69.6 m -100.85 63.19 1.03 Allowed 'General case' 0 CA--C 1.502 -0.889 0 N-CA-C 106.778 -1.564 . . . . 0.0 106.778 178.554 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 79.8 t60 -110.36 -1.59 17.09 Favored 'General case' 0 N--CA 1.44 -0.962 0 C-N-CA 125.322 1.449 . . . . 0.0 107.844 179.57 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 3.7 mp -100.16 126.28 53.71 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.115 0 N-CA-C 103.807 -2.664 . . . . 0.0 103.807 -177.639 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 60.5 m -95.43 -84.25 0.34 Allowed 'General case' 0 N--CA 1.431 -1.417 0 N-CA-C 106.153 -1.795 . . . . 0.0 106.153 177.232 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 53.7 mtmt -91.05 169.19 11.08 Favored 'General case' 0 CA--C 1.49 -1.358 0 C-N-CA 123.419 0.687 . . . . 0.0 109.24 -167.871 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 97.4 m-85 -126.87 133.82 50.62 Favored 'General case' 0 N--CA 1.435 -1.222 0 N-CA-C 103.048 -2.945 . . . . 0.0 103.048 164.108 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 51.1 mt -118.31 126.95 75.42 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.179 0 N-CA-C 102.398 -3.186 . . . . 0.0 102.398 173.804 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 7.0 mt -105.99 137.85 43.19 Favored 'General case' 0 CA--C 1.473 -2.003 0 N-CA-C 105.326 -2.101 . . . . 0.0 105.326 173.716 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -132.96 155.64 48.76 Favored 'General case' 0 N--CA 1.431 -1.422 0 N-CA-C 106.808 -1.553 . . . . 0.0 106.808 166.881 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 48.4 p90 -152.19 142.36 22.33 Favored 'General case' 0 N--CA 1.436 -1.132 0 N-CA-C 105.999 -1.852 . . . . 0.0 105.999 -177.352 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 45.4 ttm-85 -132.69 141.88 42.74 Favored Pre-proline 0 CA--C 1.5 -0.974 0 N-CA-C 103.991 -2.596 . . . . 0.0 103.991 179.578 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_endo -71.65 122.78 8.87 Favored 'Trans proline' 0 N--CA 1.452 -0.947 0 CA-C-N 123.683 2.351 . . . . 0.0 108.523 171.917 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 19.6 ttmm -71.58 63.92 0.43 Allowed 'General case' 0 C--N 1.358 0.963 0 C-N-CA 127.319 2.248 . . . . 0.0 111.767 -179.071 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 7.7 p30 -161.43 15.48 0.1 Allowed 'General case' 0 N--CA 1.438 -1.045 0 C-N-CA 125.292 1.437 . . . . 0.0 107.881 177.069 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 43.0 p -160.46 165.72 30.49 Favored 'General case' 0 N--CA 1.437 -1.102 0 N-CA-C 106.458 -1.682 . . . . 0.0 106.458 -175.897 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 4.9 m -137.73 40.73 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.845 0 N-CA-C 105.808 -1.923 . . . . 0.0 105.808 176.026 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -91.4 -114.92 1.92 Allowed Glycine 0 C--N 1.356 1.661 0 N-CA-C 109.071 -1.612 . . . . 0.0 109.071 -175.494 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 11.9 ptm180 -97.99 178.96 4.94 Favored 'General case' 0 CA--C 1.503 -0.861 0 N-CA-C 107.198 -1.408 . . . . 0.0 107.198 174.234 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -153.83 171.7 18.52 Favored 'General case' 0 N--CA 1.435 -1.206 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 176.363 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 96.7 mttt -110.34 157.13 19.84 Favored 'General case' 0 CA--C 1.489 -1.401 0 N-CA-C 107.291 -1.374 . . . . 0.0 107.291 -172.06 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 1.2 pp20? -150.64 160.62 43.7 Favored 'General case' 0 N--CA 1.437 -1.098 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 173.929 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -138.1 159.86 40.92 Favored 'General case' 0 N--CA 1.439 -0.98 0 N-CA-C 106.191 -1.781 . . . . 0.0 106.191 171.086 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 85.7 m -117.61 123.39 46.07 Favored 'General case' 0 CA--C 1.501 -0.933 0 N-CA-C 104.642 -2.355 . . . . 0.0 104.642 176.218 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 5.4 mp -112.8 133.59 21.9 Favored Pre-proline 0 N--CA 1.438 -1.063 0 N-CA-C 104.837 -2.283 . . . . 0.0 104.837 -174.076 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 64.3 Cg_exo -65.3 166.27 19.75 Favored 'Trans proline' 0 CA--C 1.509 -0.749 0 C-N-CA 123.185 2.59 . . . . 0.0 113.512 176.86 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -75.76 -19.18 79.23 Favored Glycine 0 C--N 1.353 1.491 0 C-N-CA 123.876 0.75 . . . . 0.0 114.245 -175.195 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 53.2 p-80 -83.05 -26.27 31.3 Favored 'General case' 0 C--N 1.356 0.851 0 CA-C-N 118.012 0.906 . . . . 0.0 109.835 -178.846 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 85.1 mt -88.58 128.92 35.58 Favored 'General case' 0 CA--C 1.5 -0.978 0 N-CA-C 107.441 -1.318 . . . . 0.0 107.441 175.605 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 8.0 p30 -117.46 10.61 13.62 Favored 'General case' 0 CA--C 1.502 -0.88 0 C-N-CA 124.083 0.953 . . . . 0.0 109.713 -173.313 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 29.1 p -142.17 161.35 38.24 Favored 'General case' 0 CA--C 1.498 -1.029 0 N-CA-C 106.537 -1.653 . . . . 0.0 106.537 179.291 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 11.1 t80 -140.56 162.2 35.93 Favored 'General case' 0 CA--C 1.499 -0.996 0 CA-C-O 121.849 0.833 . . . . 0.0 108.99 177.805 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 37.8 m -126.1 111.97 15.29 Favored 'General case' 0 N--CA 1.434 -1.243 0 N-CA-C 105.499 -2.037 . . . . 0.0 105.499 169.842 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 37.9 mt -84.75 140.71 15.64 Favored 'Isoleucine or valine' 0 C--N 1.357 0.897 0 N-CA-C 103.67 -2.715 . . . . 0.0 103.67 172.791 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 94.3 mttt -141.4 162.13 36.24 Favored 'General case' 0 CA--C 1.491 -1.3 0 CA-C-O 121.859 0.838 . . . . 0.0 108.881 -177.451 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 75.27 55.09 5.31 Favored Glycine 0 CA--C 1.489 -1.574 0 N-CA-C 108.937 -1.665 . . . . 0.0 108.937 176.63 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 62.3 mt -115.49 -174.22 2.48 Favored 'General case' 0 CA--C 1.5 -0.96 0 N-CA-C 107.547 -1.279 . . . . 0.0 107.547 -176.124 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 94.0 mttt -109.38 160.88 26.05 Favored Pre-proline 0 N--CA 1.441 -0.886 0 N-CA-C 106.091 -1.818 . . . . 0.0 106.091 -177.366 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -81.38 158.0 19.65 Favored 'Trans proline' 0 N--CA 1.45 -1.062 0 C-N-CA 122.764 2.309 . . . . 0.0 109.538 165.472 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 59.18 28.24 63.85 Favored Glycine 0 C--N 1.358 1.752 0 C-N-CA 126.947 2.213 . . . . 0.0 116.273 171.794 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 7.1 p -115.48 142.82 27.04 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.963 0 N-CA-C 107.803 -1.184 . . . . 0.0 107.803 -173.286 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 3.5 p -100.86 131.52 48.32 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.894 0 N-CA-C 106.423 -1.695 . . . . 0.0 106.423 173.594 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 90.0 m-85 -114.31 150.68 34.11 Favored 'General case' 0 N--CA 1.44 -0.946 0 N-CA-C 106.537 -1.653 . . . . 0.0 106.537 174.414 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -94.29 145.37 24.78 Favored 'General case' 0 CA--C 1.5 -0.961 0 N-CA-C 104.369 -2.456 . . . . 0.0 104.369 159.728 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -137.32 155.23 22.8 Favored Glycine 0 CA--C 1.485 -1.844 0 N-CA-C 108.192 -1.963 . . . . 0.0 108.192 -177.518 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 27.5 tt0 -151.34 135.13 16.43 Favored 'General case' 0 CA--C 1.485 -1.532 0 N-CA-C 106.478 -1.675 . . . . 0.0 106.478 -176.791 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 25.2 tp -123.87 97.86 5.55 Favored 'General case' 0 N--CA 1.434 -1.245 0 N-CA-C 104.556 -2.387 . . . . 0.0 104.556 -172.927 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 10.5 mt -91.83 138.63 19.39 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.853 0 N-CA-C 105.252 -2.129 . . . . 0.0 105.252 177.666 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 75.0 m -112.59 112.07 23.34 Favored 'General case' 0 N--CA 1.434 -1.233 0 N-CA-C 106.313 -1.736 . . . . 0.0 106.313 178.935 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 1.7 mp -89.49 134.17 29.47 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.217 0 N-CA-C 103.645 -2.724 . . . . 0.0 103.645 -173.058 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 79.0 mt-30 -99.37 160.13 14.5 Favored 'General case' 0 CA--C 1.494 -1.197 0 N-CA-C 106.704 -1.591 . . . . 0.0 106.704 -174.087 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 5.6 pt20 -69.09 110.27 4.43 Favored 'General case' 0 N--CA 1.441 -0.904 0 CA-C-O 121.982 0.896 . . . . 0.0 112.761 -170.947 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 75.6 m-85 53.95 40.86 32.04 Favored 'General case' 0 C--N 1.358 0.949 0 C-N-CA 127.834 2.454 . . . . 0.0 112.925 175.094 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -163.17 -114.94 0.32 Allowed Glycine 0 C--N 1.353 1.502 0 C-N-CA 119.324 -1.417 . . . . 0.0 109.808 -179.304 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 38.5 m170 -81.61 -175.85 5.75 Favored 'General case' 0 CA--C 1.498 -1.052 0 C-N-CA 125.05 1.34 . . . . 0.0 110.745 -167.324 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 4.8 pt20 -147.85 142.06 26.15 Favored 'General case' 0 N--CA 1.434 -1.238 0 N-CA-C 106.192 -1.781 . . . . 0.0 106.192 171.826 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 16.7 tp10 -110.7 139.46 45.97 Favored 'General case' 0 CA--C 1.496 -1.099 0 N-CA-C 105.823 -1.917 . . . . 0.0 105.823 -177.762 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 8.2 p -110.64 141.61 25.47 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.745 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 -174.48 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 36.2 m -130.15 129.24 43.22 Favored 'General case' 0 C--N 1.355 0.831 0 N-CA-C 102.832 -3.025 . . . . 0.0 102.832 175.67 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 18.7 ptp180 -134.71 154.48 51.54 Favored 'General case' 0 C--N 1.355 0.819 0 CA-C-N 119.912 1.233 . . . . 0.0 111.25 -176.256 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 18.7 p90 -165.26 -175.22 3.53 Favored 'General case' 0 C--N 1.359 1.0 0 N-CA-C 107.064 -1.458 . . . . 0.0 107.064 -169.517 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -140.15 159.46 42.14 Favored 'General case' 0 N--CA 1.443 -0.795 0 N-CA-C 107.029 -1.471 . . . . 0.0 107.029 166.735 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 20.7 p90 -144.83 169.23 18.43 Favored 'General case' 0 CA--C 1.492 -1.276 0 N-CA-C 107.723 -1.214 . . . . 0.0 107.723 174.103 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 88.7 m -126.49 135.74 51.73 Favored 'General case' 0 CA--C 1.5 -0.971 0 N-CA-C 104.004 -2.591 . . . . 0.0 104.004 176.194 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 76.9 m -107.56 107.53 18.41 Favored 'General case' 0 CA--C 1.497 -1.064 0 N-CA-C 105.126 -2.176 . . . . 0.0 105.126 178.699 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 5.7 m 75.91 145.01 0.08 Allowed 'General case' 0 C--N 1.359 1.006 0 C-N-CA 127.213 2.205 . . . . 0.0 110.387 173.515 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 24.3 m . . . . . 0 C--O 1.259 1.604 0 C-N-CA 125.597 1.559 . . . . 0.0 109.785 -178.825 . . . . . . . . 0 0 . 1 . 022 nuclear orig core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.438 -1.227 0 N-CA-C 106.902 -2.479 . . . . 0.0 106.902 . . . . . . . . . 0 0 . 1 . 022 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 74.8 Cg_exo -60.93 135.82 61.84 Favored 'Trans proline' 0 N--CA 1.445 -1.33 0 C-N-CA 123.401 2.734 . . . . 0.0 112.865 -176.638 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 32.1 t -79.12 157.46 4.75 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.06 0 C-N-CA 128.078 2.551 . . . . 0.0 107.348 -175.891 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 -105.48 102.26 11.74 Favored 'General case' 0 CA--C 1.491 -1.295 0 N-CA-C 105.197 -2.149 . . . . 0.0 105.197 176.78 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 1.7 p -117.46 134.66 60.33 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.114 0 N-CA-C 106.509 -1.663 . . . . 0.0 106.509 -166.762 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 1.5 t80 . . . . . 0 N--CA 1.434 -1.234 0 N-CA-C 106.975 -1.491 . . . . 0.0 106.975 -169.022 . . . . . . . . 0 0 . 1 . 022 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.427 ' HG2' ' H ' ' A' ' 16' ' ' ASN . 56.3 Cg_endo . . . . . 0 N--CA 1.45 -1.074 0 N-CA-C 109.224 -1.106 . . . . 0.0 109.224 . . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . 0.427 ' H ' ' HG2' ' A' ' 15' ' ' PRO . 58.1 m-20 -133.37 -6.14 2.96 Favored 'General case' 0 N--CA 1.434 -1.259 0 C-N-CA 127.256 2.223 . . . . 0.0 108.63 -171.965 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 70.9 m -92.57 154.64 18.29 Favored 'General case' 0 CA--C 1.496 -1.128 0 N-CA-C 105.793 -1.928 . . . . 0.0 105.793 174.777 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 46.7 t-80 -147.3 90.72 5.23 Favored Pre-proline 0 N--CA 1.437 -1.099 0 N-CA-C 107.436 -1.32 . . . . 0.0 107.436 172.769 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -80.42 139.47 12.96 Favored 'Trans proline' 0 N--CA 1.446 -1.295 0 C-N-CA 122.705 2.27 . . . . 0.0 110.135 177.594 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 4.4 pt -122.49 175.24 5.83 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.055 0 N-CA-C 108.147 -1.057 . . . . 0.0 108.147 177.871 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 2.7 pt20 -151.31 155.23 38.31 Favored 'General case' 0 CA--C 1.498 -1.045 0 N-CA-C 105.733 -1.951 . . . . 0.0 105.733 176.27 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 33.5 p90 -142.31 162.52 35.26 Favored 'General case' 0 CA--C 1.501 -0.915 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 -175.872 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 61.8 t30 -98.94 -172.51 2.3 Favored 'General case' 0 CA--C 1.493 -1.222 0 N-CA-C 103.658 -2.719 . . . . 0.0 103.658 169.486 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -158.0 168.46 12.41 Favored Pre-proline 0 N--CA 1.44 -0.974 0 N-CA-C 106.471 -1.677 . . . . 0.0 106.471 168.694 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_exo -63.39 154.33 68.97 Favored 'Trans proline' 0 N--CA 1.454 -0.816 0 C-N-CA 123.244 2.63 . . . . 0.0 112.506 173.487 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 90.4 mm-40 -81.77 -35.51 0.75 Allowed Pre-proline 0 N--CA 1.443 -0.799 0 CA-C-O 115.148 -2.358 . . . . 0.0 114.208 -168.096 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_exo -70.83 -4.2 14.26 Favored 'Trans proline' 0 CA--C 1.512 -0.619 0 CA-C-N 126.1 3.214 . . . . 0.0 114.615 -177.809 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 8.7 t 68.38 59.55 0.41 Allowed 'General case' 0 C--N 1.359 0.986 0 C-N-CA 126.121 1.768 . . . . 0.0 108.886 -177.345 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 12.7 t-160 -94.41 -11.28 30.17 Favored 'General case' 0 N--CA 1.439 -0.991 0 C-N-CA 125.133 1.373 . . . . 0.0 108.034 -179.332 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 1.8 mp -111.56 137.36 44.46 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.949 0 N-CA-C 104.473 -2.417 . . . . 0.0 104.473 -175.099 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 62.2 m -100.06 -84.4 0.42 Allowed 'General case' 0 N--CA 1.432 -1.331 0 N-CA-C 106.823 -1.547 . . . . 0.0 106.823 171.093 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 55.4 mtmt -88.64 168.71 12.3 Favored 'General case' 0 CA--C 1.487 -1.457 0 C-N-CA 124.335 1.054 . . . . 0.0 109.447 -164.531 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 85.0 m-85 -130.26 135.0 47.65 Favored 'General case' 0 CA--C 1.495 -1.14 0 N-CA-C 103.978 -2.601 . . . . 0.0 103.978 170.252 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 42.0 mt -119.35 128.69 75.84 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.162 0 N-CA-C 101.913 -3.365 . . . . 0.0 101.913 174.515 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 4.2 mt -110.02 143.75 39.57 Favored 'General case' 0 CA--C 1.471 -2.084 0 N-CA-C 106.906 -1.516 . . . . 0.0 106.906 175.275 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 2.6 mpt_? -125.86 157.19 38.24 Favored 'General case' 0 N--CA 1.425 -1.705 0 N-CA-C 106.456 -1.683 . . . . 0.0 106.456 168.592 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 45.1 p90 -149.12 139.03 21.99 Favored 'General case' 0 N--CA 1.433 -1.321 0 N-CA-C 106.291 -1.744 . . . . 0.0 106.291 169.224 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 19.1 ttm180 -133.26 136.57 27.51 Favored Pre-proline 0 CA--C 1.495 -1.156 0 N-CA-C 104.206 -2.516 . . . . 0.0 104.206 179.103 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -71.0 114.72 3.99 Favored 'Trans proline' 0 N--CA 1.454 -0.846 0 CA-C-N 124.581 2.672 . . . . 0.0 108.495 175.02 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 54.4 tttp -70.89 72.26 0.55 Allowed 'General case' 0 C--N 1.359 0.992 0 C-N-CA 127.609 2.364 . . . . 0.0 111.467 -174.724 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 70.4 m-80 -154.05 -60.95 0.13 Allowed 'General case' 0 N--CA 1.434 -1.245 0 N-CA-C 101.532 -3.507 . . . . 0.0 101.532 -172.176 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 42.5 p -93.4 160.19 14.92 Favored 'General case' 0 N--CA 1.439 -0.99 0 C-N-CA 124.854 1.262 . . . . 0.0 107.65 173.175 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 5.9 m -126.33 44.87 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.842 0 N-CA-C 106.183 -1.784 . . . . 0.0 106.183 177.975 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -99.4 -128.54 6.27 Favored Glycine 0 C--N 1.355 1.593 0 N-CA-C 108.704 -1.759 . . . . 0.0 108.704 -177.547 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 83.9 mtt85 -84.51 168.18 15.67 Favored 'General case' 0 CA--C 1.502 -0.885 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 -179.072 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -151.83 173.26 14.99 Favored 'General case' 0 CA--C 1.494 -1.205 0 CA-C-O 121.506 0.669 . . . . 0.0 110.051 -172.981 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 36.9 mtmt -112.62 156.85 22.02 Favored 'General case' 0 CA--C 1.488 -1.427 0 N-CA-C 106.789 -1.56 . . . . 0.0 106.789 -173.001 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 16.3 pt-20 -152.28 160.66 43.31 Favored 'General case' 0 N--CA 1.436 -1.17 0 N-CA-C 108.666 -0.865 . . . . 0.0 108.666 178.698 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -140.19 163.02 33.87 Favored 'General case' 0 CA--C 1.498 -1.021 0 N-CA-C 107.102 -1.444 . . . . 0.0 107.102 171.434 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 90.5 m -121.31 126.23 48.98 Favored 'General case' 0 CA--C 1.501 -0.912 0 N-CA-C 104.691 -2.336 . . . . 0.0 104.691 175.344 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 5.2 mp -114.86 133.76 22.56 Favored Pre-proline 0 N--CA 1.437 -1.081 0 N-CA-C 105.121 -2.178 . . . . 0.0 105.121 -174.055 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_exo -64.09 165.59 18.89 Favored 'Trans proline' 0 CA--C 1.509 -0.759 0 C-N-CA 123.39 2.727 . . . . 0.0 113.812 177.127 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -77.71 -16.99 79.46 Favored Glycine 0 C--N 1.353 1.483 0 C-N-CA 123.869 0.747 . . . . 0.0 113.884 -172.887 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 51.8 p-80 -83.98 -24.98 30.37 Favored 'General case' 0 C--N 1.356 0.857 0 CA-C-N 117.975 0.887 . . . . 0.0 110.32 -179.643 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 88.2 mt -88.29 129.36 35.4 Favored 'General case' 0 CA--C 1.5 -0.955 0 N-CA-C 108.299 -1.0 . . . . 0.0 108.299 178.906 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 8.6 p30 -105.23 -1.09 25.77 Favored 'General case' 0 N--CA 1.442 -0.837 0 C-N-CA 124.909 1.284 . . . . 0.0 110.782 -173.918 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 30.5 p -139.42 159.29 42.5 Favored 'General case' 0 CA--C 1.497 -1.069 0 N-CA-C 107.575 -1.269 . . . . 0.0 107.575 -174.974 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 6.1 t80 -128.75 174.5 9.39 Favored 'General case' 0 C--N 1.36 1.055 0 N-CA-C 107.858 -1.164 . . . . 0.0 107.858 175.94 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 99.9 m -140.15 110.74 6.75 Favored 'General case' 0 N--CA 1.431 -1.406 0 N-CA-C 103.923 -2.621 . . . . 0.0 103.923 171.466 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 25.4 mt -87.5 148.74 4.39 Favored 'Isoleucine or valine' 0 C--N 1.358 0.958 0 N-CA-C 103.878 -2.638 . . . . 0.0 103.878 170.3 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 8.4 ptpp? -150.02 159.51 44.34 Favored 'General case' 0 CA--C 1.492 -1.255 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 178.18 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 78.94 54.87 3.98 Favored Glycine 0 C--N 1.355 1.591 0 N-CA-C 109.184 -1.566 . . . . 0.0 109.184 178.841 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 58.8 mt -116.11 -161.11 0.78 Allowed 'General case' 0 CA--C 1.502 -0.888 0 N-CA-C 106.84 -1.541 . . . . 0.0 106.84 -177.322 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 10.7 mptt -125.12 160.99 52.14 Favored Pre-proline 0 N--CA 1.442 -0.874 0 N-CA-C 105.684 -1.969 . . . . 0.0 105.684 -176.361 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -79.57 156.2 24.7 Favored 'Trans proline' 0 N--CA 1.452 -0.918 0 C-N-CA 123.035 2.49 . . . . 0.0 109.567 165.273 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 55.32 33.24 58.11 Favored Glycine 0 C--N 1.356 1.656 0 C-N-CA 127.514 2.483 . . . . 0.0 116.512 172.276 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 7.9 p -115.04 147.3 18.53 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.014 0 N-CA-C 107.282 -1.377 . . . . 0.0 107.282 -176.366 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 4.7 p -102.47 134.12 44.21 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.778 0 N-CA-C 106.636 -1.616 . . . . 0.0 106.636 174.577 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 81.8 m-85 -116.9 150.51 38.35 Favored 'General case' 0 N--CA 1.44 -0.936 0 N-CA-C 107.225 -1.398 . . . . 0.0 107.225 174.323 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 13.1 tp10 -95.95 128.88 43.23 Favored 'General case' 0 CA--C 1.492 -1.254 0 N-CA-C 102.089 -3.301 . . . . 0.0 102.089 165.821 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -125.91 140.83 12.43 Favored Glycine 0 CA--C 1.491 -1.468 0 N-CA-C 107.862 -2.095 . . . . 0.0 107.862 -179.205 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 28.7 tt0 -134.14 130.82 37.9 Favored 'General case' 0 CA--C 1.482 -1.64 0 N-CA-C 106.213 -1.773 . . . . 0.0 106.213 -178.496 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 43.2 tp -117.42 102.98 9.67 Favored 'General case' 0 N--CA 1.437 -1.09 0 N-CA-C 104.626 -2.361 . . . . 0.0 104.626 -176.516 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 11.9 mt -93.99 130.36 43.04 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.888 0 N-CA-C 104.287 -2.486 . . . . 0.0 104.287 174.878 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 25.2 p -112.75 114.11 26.52 Favored 'General case' 0 N--CA 1.438 -1.069 0 N-CA-C 106.683 -1.599 . . . . 0.0 106.683 -179.857 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 22.5 mm -90.03 142.0 13.54 Favored 'Isoleucine or valine' 0 CA--C 1.485 -1.529 0 N-CA-C 105.606 -1.998 . . . . 0.0 105.606 -167.985 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 78.0 mt-30 -104.57 152.42 22.44 Favored 'General case' 0 CA--C 1.493 -1.244 0 CA-C-N 114.548 -1.206 . . . . 0.0 107.904 -174.478 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 24.5 tt0 -77.49 35.09 0.18 Allowed 'General case' 0 C--N 1.355 0.841 0 C-N-CA 125.882 1.673 . . . . 0.0 113.41 -178.579 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 98.5 m-85 -143.63 11.74 1.67 Allowed 'General case' 0 CA--C 1.498 -1.057 0 N-CA-C 109.068 -0.715 . . . . 0.0 109.068 -175.719 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 88.91 -20.62 31.46 Favored Glycine 0 C--N 1.351 1.374 0 C-N-CA 124.097 0.856 . . . . 0.0 111.207 179.739 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 85.6 m-70 -81.04 173.9 12.14 Favored 'General case' 0 CA--C 1.496 -1.1 0 C-N-CA 125.362 1.465 . . . . 0.0 108.683 -178.673 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 9.9 pt20 -162.38 145.12 11.25 Favored 'General case' 0 N--CA 1.437 -1.117 0 N-CA-C 107.875 -1.157 . . . . 0.0 107.875 -176.102 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 48.0 mm-40 -110.21 147.89 32.9 Favored 'General case' 0 CA--C 1.496 -1.127 0 N-CA-C 106.351 -1.722 . . . . 0.0 106.351 179.237 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 8.7 p -118.74 143.0 31.02 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.746 0 N-CA-C 107.626 -1.249 . . . . 0.0 107.626 -175.773 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 28.1 m -131.72 131.94 43.47 Favored 'General case' 0 N--CA 1.441 -0.898 0 N-CA-C 103.275 -2.861 . . . . 0.0 103.275 179.748 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 88.2 mtm180 -125.46 148.47 48.83 Favored 'General case' 0 CA--C 1.501 -0.924 0 CA-C-N 119.011 0.823 . . . . 0.0 108.826 -179.699 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 23.0 p90 -163.38 179.82 7.07 Favored 'General case' 0 CA--C 1.501 -0.926 0 N-CA-C 106.804 -1.554 . . . . 0.0 106.804 -177.779 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 41.6 p30 -136.96 156.34 48.58 Favored 'General case' 0 N--CA 1.443 -0.824 0 N-CA-C 106.488 -1.671 . . . . 0.0 106.488 167.457 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 23.3 p90 -142.94 170.67 15.26 Favored 'General case' 0 CA--C 1.488 -1.439 0 N-CA-C 106.505 -1.665 . . . . 0.0 106.505 172.318 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 36.0 p -120.9 139.7 52.84 Favored 'General case' 0 CA--C 1.502 -0.897 0 N-CA-C 106.443 -1.688 . . . . 0.0 106.443 174.014 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 71.1 m -108.41 88.13 2.66 Favored 'General case' 0 CA--C 1.497 -1.094 0 N-CA-C 102.948 -2.982 . . . . 0.0 102.948 171.793 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 42.6 p -89.79 -178.42 5.5 Favored 'General case' 0 N--CA 1.443 -0.8 0 N-CA-C 106.998 -1.482 . . . . 0.0 106.998 178.977 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 22.7 t . . . . . 0 C--O 1.26 1.626 0 N-CA-C 104.923 -2.251 . . . . 0.0 104.923 175.385 . . . . . . . . 0 0 . 1 . 023 nuclear orig core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.436 -1.313 0 N-CA-C 106.243 -2.743 . . . . 0.0 106.243 . . . . . . . . . 0 0 . 1 . 023 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 77.5 Cg_exo -61.51 133.47 45.95 Favored 'Trans proline' 0 N--CA 1.446 -1.301 0 C-N-CA 122.742 2.295 . . . . 0.0 113.844 -171.579 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.403 ' H ' ' HG1' ' A' ' 85' ' ' THR . 38.6 t -85.71 161.78 2.96 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.085 0 C-N-CA 128.454 2.702 . . . . 0.0 107.513 -172.37 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -106.26 106.09 16.44 Favored 'General case' 0 CA--C 1.493 -1.249 0 N-CA-C 105.06 -2.2 . . . . 0.0 105.06 176.733 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 1.5 p -127.21 140.41 49.17 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.086 0 N-CA-C 104.958 -2.238 . . . . 0.0 104.958 -170.31 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 16.5 p90 . . . . . 0 N--CA 1.436 -1.169 0 N-CA-C 107.071 -1.455 . . . . 0.0 107.071 -166.674 . . . . . . . . 0 0 . 1 . 023 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_endo . . . . . 0 CA--C 1.501 -1.152 0 N-CA-C 110.906 -0.459 . . . . 0.0 110.906 . . . . . . . . . 0 0 . 1 . 023 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 2.1 m-80 -118.87 -20.31 8.23 Favored 'General case' 0 CA--C 1.49 -1.328 0 C-N-CA 124.857 1.263 . . . . 0.0 109.242 -168.821 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 15.0 p -97.86 148.2 23.66 Favored 'General case' 0 CA--C 1.493 -1.235 0 N-CA-C 107.444 -1.317 . . . . 0.0 107.444 -177.514 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 28.1 t60 -150.54 97.04 3.33 Favored Pre-proline 0 N--CA 1.438 -1.053 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 170.403 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -80.06 139.5 13.56 Favored 'Trans proline' 0 N--CA 1.447 -1.24 0 C-N-CA 122.35 2.033 . . . . 0.0 110.408 178.759 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 18.7 mm -113.62 146.21 18.5 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.937 0 N-CA-C 104.429 -2.434 . . . . 0.0 104.429 -178.051 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 35.0 mt-30 -136.42 149.95 48.53 Favored 'General case' 0 CA--C 1.502 -0.879 0 N-CA-C 105.326 -2.101 . . . . 0.0 105.326 168.904 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 42.0 p90 -141.48 161.97 36.61 Favored 'General case' 0 CA--C 1.502 -0.873 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 -175.169 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 81.2 m-20 -100.98 -172.39 2.16 Favored 'General case' 0 CA--C 1.485 -1.543 0 N-CA-C 103.851 -2.648 . . . . 0.0 103.851 171.389 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -150.45 163.14 25.26 Favored Pre-proline 0 N--CA 1.444 -0.771 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 169.93 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 80.4 Cg_exo -67.32 170.16 13.98 Favored 'Trans proline' 0 N--CA 1.456 -0.704 0 C-N-CA 123.38 2.72 . . . . 0.0 112.319 169.682 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 24.0 mm100 -82.42 -56.01 0.53 Allowed Pre-proline 0 N--CA 1.442 -0.869 0 CA-C-O 115.578 -2.153 . . . . 0.0 113.644 -172.328 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 82.6 Cg_endo -75.77 170.04 21.0 Favored 'Trans proline' 0 CA--C 1.509 -0.773 0 CA-C-N 125.774 3.098 . . . . 0.0 111.085 -169.228 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 69.4 m -76.83 113.27 14.33 Favored 'General case' 0 CA--C 1.5 -0.955 0 N-CA-C 107.717 -1.216 . . . . 0.0 107.717 179.031 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . 0.422 ' HD1' HG13 ' A' ' 30' ' ' ILE . 61.4 t-80 -167.59 -49.95 0.02 OUTLIER 'General case' 0 N--CA 1.435 -1.193 0 N-CA-C 105.441 -2.059 . . . . 0.0 105.441 -170.559 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.422 HG13 ' HD1' ' A' ' 29' ' ' HIS . 26.6 mt -105.69 126.62 60.99 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.145 0 N-CA-C 106.429 -1.693 . . . . 0.0 106.429 -176.668 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 74.3 m -116.35 -84.35 0.63 Allowed 'General case' 0 N--CA 1.433 -1.278 0 N-CA-C 107.828 -1.175 . . . . 0.0 107.828 -174.714 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 38.8 ttpt -89.27 156.43 18.75 Favored 'General case' 0 CA--C 1.493 -1.22 0 C-N-CA 126.197 1.799 . . . . 0.0 106.888 -164.641 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 90.7 m-85 -126.86 135.89 51.6 Favored 'General case' 0 CA--C 1.488 -1.417 0 N-CA-C 105.304 -2.11 . . . . 0.0 105.304 179.474 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 1.5 mp -112.65 135.69 51.26 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.231 0 N-CA-C 100.473 -3.899 . . . . 0.0 100.473 170.239 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 3.1 mt -106.49 124.78 50.11 Favored 'General case' 0 CA--C 1.479 -1.788 0 N-CA-C 104.676 -2.342 . . . . 0.0 104.676 166.436 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -106.58 154.01 21.51 Favored 'General case' 0 N--CA 1.431 -1.375 0 N-CA-C 104.483 -2.414 . . . . 0.0 104.483 170.771 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 48.2 p90 -154.79 141.64 19.11 Favored 'General case' 0 N--CA 1.433 -1.292 0 N-CA-C 106.344 -1.725 . . . . 0.0 106.344 168.171 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 5.3 ptp180 -133.74 153.99 80.34 Favored Pre-proline 0 CA--C 1.497 -1.064 0 N-CA-C 103.751 -2.685 . . . . 0.0 103.751 168.695 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 68.8 Cg_endo -75.22 164.8 32.26 Favored 'Trans proline' 0 CA--C 1.506 -0.921 0 C-N-CA 122.789 2.326 . . . . 0.0 106.765 164.711 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 5.5 ptmm? -64.92 93.8 0.12 Allowed 'General case' 0 C--N 1.352 0.678 0 CA-C-N 119.976 1.262 . . . . 0.0 113.048 176.658 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -128.3 -136.28 0.23 Allowed 'General case' 0 N--CA 1.44 -0.953 0 N-CA-C 104.974 -2.232 . . . . 0.0 104.974 167.427 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 42.4 m -97.17 -154.28 0.45 Allowed 'General case' 0 N--CA 1.44 -0.954 0 C-N-CA 125.607 1.563 . . . . 0.0 107.121 179.313 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 9.2 m -94.85 42.69 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.445 -0.711 0 C-N-CA 126.627 1.971 . . . . 0.0 107.284 176.322 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -90.19 -146.33 15.22 Favored Glycine 0 C--N 1.353 1.478 0 C-N-CA 124.184 0.897 . . . . 0.0 110.998 -171.947 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 17.1 tpt180 -75.95 135.2 40.05 Favored 'General case' 0 CA--C 1.502 -0.881 0 C-N-CA 124.267 1.027 . . . . 0.0 108.332 -177.01 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -146.95 174.65 11.32 Favored 'General case' 0 N--CA 1.434 -1.27 0 N-CA-C 109.395 -0.594 . . . . 0.0 109.395 -174.261 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 64.3 mttp -112.3 155.74 23.58 Favored 'General case' 0 CA--C 1.489 -1.403 0 N-CA-C 107.347 -1.353 . . . . 0.0 107.347 -171.482 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 15.4 pt-20 -150.68 158.89 44.68 Favored 'General case' 0 N--CA 1.433 -1.284 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 179.784 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -136.7 160.45 38.8 Favored 'General case' 0 CA--C 1.497 -1.065 0 N-CA-C 106.509 -1.663 . . . . 0.0 106.509 171.754 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 77.3 m -122.8 126.54 47.63 Favored 'General case' 0 CA--C 1.501 -0.924 0 N-CA-C 104.956 -2.238 . . . . 0.0 104.956 175.335 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 5.2 mp -117.56 135.33 23.22 Favored Pre-proline 0 N--CA 1.437 -1.099 0 N-CA-C 104.753 -2.314 . . . . 0.0 104.753 -177.26 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_exo -63.48 167.13 13.71 Favored 'Trans proline' 0 CA--C 1.51 -0.71 0 C-N-CA 123.558 2.839 . . . . 0.0 113.477 177.101 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -79.49 -18.84 72.7 Favored Glycine 0 C--N 1.352 1.464 0 C-N-CA 123.344 0.497 . . . . 0.0 113.363 -172.59 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 47.7 p-80 -84.18 -27.01 28.36 Favored 'General case' 0 C--N 1.354 0.794 0 CA-C-N 117.743 0.771 . . . . 0.0 109.968 179.774 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 88.5 mt -88.57 132.58 34.47 Favored 'General case' 0 CA--C 1.502 -0.893 0 N-CA-C 107.789 -1.189 . . . . 0.0 107.789 177.722 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 7.6 p-10 -114.98 9.88 16.16 Favored 'General case' 0 CA--C 1.502 -0.897 0 C-N-CA 124.287 1.035 . . . . 0.0 110.169 -171.669 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 53.4 p -144.55 165.81 26.92 Favored 'General case' 0 N--CA 1.44 -0.958 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 -175.267 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 11.2 t80 -151.98 174.72 13.3 Favored 'General case' 0 N--CA 1.441 -0.908 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 -179.162 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 87.7 m -139.1 113.13 8.63 Favored 'General case' 0 N--CA 1.431 -1.409 0 N-CA-C 105.078 -2.193 . . . . 0.0 105.078 172.775 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 54.2 mt -87.08 142.93 12.32 Favored 'Isoleucine or valine' 0 C--N 1.359 0.979 0 N-CA-C 104.217 -2.512 . . . . 0.0 104.217 172.604 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 60.7 mttp -141.41 162.42 35.53 Favored 'General case' 0 CA--C 1.495 -1.138 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 179.195 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 78.84 53.05 4.72 Favored Glycine 0 CA--C 1.488 -1.609 0 N-CA-C 109.094 -1.602 . . . . 0.0 109.094 174.949 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 78.7 mt -113.46 -166.06 1.05 Allowed 'General case' 0 CA--C 1.503 -0.855 0 N-CA-C 107.279 -1.378 . . . . 0.0 107.279 -176.589 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 11.0 mptt -132.29 148.67 70.63 Favored Pre-proline 0 N--CA 1.442 -0.859 0 N-CA-C 104.993 -2.225 . . . . 0.0 104.993 -177.517 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -78.97 162.54 26.28 Favored 'Trans proline' 0 N--CA 1.45 -1.055 0 C-N-CA 122.772 2.315 . . . . 0.0 109.761 173.772 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . 0.402 ' H ' ' HA ' ' A' ' 92' ' ' THR . . . 63.63 24.0 67.55 Favored Glycine 0 N--CA 1.428 -1.851 0 C-N-CA 127.377 2.418 . . . . 0.0 116.063 172.886 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 9.6 p -129.7 143.13 42.02 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.02 0 N-CA-C 107.484 -1.302 . . . . 0.0 107.484 -178.037 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 11.5 p -95.65 127.56 47.58 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.011 0 CA-C-O 123.289 1.519 . . . . 0.0 107.571 178.258 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 87.3 m-85 -100.44 144.34 29.55 Favored 'General case' 0 N--CA 1.431 -1.41 0 N-CA-C 106.235 -1.765 . . . . 0.0 106.235 176.339 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 33.6 tp10 -90.57 132.66 35.59 Favored 'General case' 0 N--CA 1.439 -0.981 0 N-CA-C 104.205 -2.517 . . . . 0.0 104.205 163.064 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -129.3 152.43 19.5 Favored Glycine 0 CA--C 1.489 -1.547 0 N-CA-C 108.283 -1.927 . . . . 0.0 108.283 -179.136 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 26.7 mt-30 -138.19 137.8 37.95 Favored 'General case' 0 CA--C 1.485 -1.548 0 N-CA-C 106.347 -1.723 . . . . 0.0 106.347 174.849 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 62.7 tp -109.72 97.92 7.36 Favored 'General case' 0 CA--C 1.499 -1.014 0 N-CA-C 102.898 -3.001 . . . . 0.0 102.898 174.542 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 9.1 mt -94.86 124.61 47.43 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.054 0 N-CA-C 104.026 -2.583 . . . . 0.0 104.026 -174.21 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 74.6 m -112.89 108.9 18.02 Favored 'General case' 0 CA--C 1.5 -0.959 0 N-CA-C 107.826 -1.176 . . . . 0.0 107.826 -168.03 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 1.8 mp -93.17 136.9 23.76 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.226 0 N-CA-C 105.2 -2.148 . . . . 0.0 105.2 -167.241 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 14.0 tt0 -97.96 111.25 23.63 Favored 'General case' 0 N--CA 1.431 -1.377 0 N-CA-C 101.706 -3.442 . . . . 0.0 101.706 169.508 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 41.8 mt-30 -69.25 125.03 25.42 Favored 'General case' 0 CA--C 1.5 -0.975 0 CA-C-O 120.846 0.355 . . . . 0.0 110.218 -170.587 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 52.7 m-85 68.71 39.1 2.06 Favored 'General case' 0 C--N 1.356 0.872 0 C-N-CA 126.492 1.917 . . . . 0.0 110.996 -176.172 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -166.68 -116.22 0.35 Allowed Glycine 0 C--N 1.357 1.721 0 N-CA-C 109.288 -1.525 . . . . 0.0 109.288 179.144 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 29.3 m170 -82.51 -179.73 7.52 Favored 'General case' 0 CA--C 1.502 -0.874 0 C-N-CA 125.606 1.563 . . . . 0.0 111.259 -168.504 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 25.7 tt0 -147.44 123.58 10.81 Favored 'General case' 0 N--CA 1.436 -1.167 0 N-CA-C 105.591 -2.003 . . . . 0.0 105.591 170.686 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 47.8 mm-40 -104.68 160.63 14.81 Favored 'General case' 0 CA--C 1.501 -0.931 0 N-CA-C 106.243 -1.762 . . . . 0.0 106.243 176.558 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 10.9 p -135.84 138.55 47.53 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.842 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 -178.233 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 85' ' ' THR . . . . . 0.403 ' HG1' ' H ' ' A' ' 4' ' ' VAL . 24.9 m -122.35 139.45 53.81 Favored 'General case' 0 N--CA 1.442 -0.833 0 N-CA-C 103.124 -2.917 . . . . 0.0 103.124 173.05 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 55.9 ttp180 -135.03 143.16 46.59 Favored 'General case' 0 CA--C 1.505 -0.77 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 -174.13 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 21.1 p90 -164.0 -175.81 4.22 Favored 'General case' 0 C--N 1.358 0.97 0 N-CA-C 106.891 -1.522 . . . . 0.0 106.891 -174.519 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 44.4 p-10 -136.5 158.34 44.67 Favored 'General case' 0 N--CA 1.442 -0.838 0 N-CA-C 107.093 -1.447 . . . . 0.0 107.093 166.748 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 25.2 p90 -143.75 164.12 31.37 Favored 'General case' 0 CA--C 1.486 -1.49 0 N-CA-C 106.821 -1.548 . . . . 0.0 106.821 169.769 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 43.8 m -118.42 137.77 52.92 Favored 'General case' 0 CA--C 1.498 -1.051 0 N-CA-C 105.336 -2.098 . . . . 0.0 105.336 179.186 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 61.3 m -115.75 115.67 26.73 Favored 'General case' 0 CA--C 1.493 -1.213 0 N-CA-C 101.866 -3.383 . . . . 0.0 101.866 174.722 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 92' ' ' THR . . . . . 0.402 ' HA ' ' H ' ' A' ' 66' ' ' GLY . 15.1 t -155.29 148.23 24.51 Favored 'General case' 0 N--CA 1.437 -1.103 0 N-CA-C 107.315 -1.365 . . . . 0.0 107.315 -174.227 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 67.7 m . . . . . 0 C--O 1.26 1.615 0 N-CA-C 106.467 -1.679 . . . . 0.0 106.467 175.214 . . . . . . . . 0 0 . 1 . 024 nuclear orig core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.438 -1.23 0 N-CA-C 106.728 -2.549 . . . . 0.0 106.728 . . . . . . . . . 0 0 . 1 . 024 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 29.8 Cg_exo -59.04 139.78 92.28 Favored 'Trans proline' 0 N--CA 1.446 -1.293 0 C-N-CA 123.649 2.899 . . . . 0.0 113.559 -175.168 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 41.9 t -79.83 160.15 4.28 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.996 0 C-N-CA 128.552 2.741 . . . . 0.0 106.282 -179.002 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 55.2 mt-10 -108.13 106.74 17.09 Favored 'General case' 0 CA--C 1.493 -1.215 0 N-CA-C 105.998 -1.853 . . . . 0.0 105.998 -179.638 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 1.5 p -124.18 140.07 48.66 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.914 0 N-CA-C 106.142 -1.799 . . . . 0.0 106.142 -172.367 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 16.5 p90 . . . . . 0 N--CA 1.438 -1.032 0 N-CA-C 105.968 -1.864 . . . . 0.0 105.968 -168.589 . . . . . . . . 0 0 . 1 . 024 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo . . . . . 0 CA--C 1.505 -0.952 0 CA-C-O 118.39 -0.754 . . . . 0.0 111.372 . . . . . . . . . 0 0 . 1 . 024 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 6.2 p-10 -104.37 -41.32 5.79 Favored 'General case' 0 CA--C 1.489 -1.369 0 C-N-CA 123.167 0.587 . . . . 0.0 109.622 -167.103 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 12.0 p -110.5 150.72 28.49 Favored 'General case' 0 CA--C 1.494 -1.202 0 N-CA-C 107.399 -1.334 . . . . 0.0 107.399 -179.095 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . 0.431 ' CD2' ' HG1' ' A' ' 91' ' ' THR . 58.6 t-80 -143.37 93.61 6.37 Favored Pre-proline 0 N--CA 1.437 -1.087 0 N-CA-C 106.892 -1.522 . . . . 0.0 106.892 173.656 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -82.02 146.17 14.32 Favored 'Trans proline' 0 N--CA 1.445 -1.332 0 C-N-CA 123.436 2.757 . . . . 0.0 109.948 175.958 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 7.4 pt -126.3 173.44 12.04 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.985 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 178.217 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 49.2 tt0 -148.49 149.34 31.48 Favored 'General case' 0 N--CA 1.44 -0.95 0 N-CA-C 105.192 -2.151 . . . . 0.0 105.192 170.684 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 27.7 p90 -130.51 161.25 31.89 Favored 'General case' 0 N--CA 1.44 -0.959 0 N-CA-C 106.296 -1.742 . . . . 0.0 106.296 -179.696 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 61.1 t30 -96.61 -176.25 3.55 Favored 'General case' 0 CA--C 1.491 -1.327 0 N-CA-C 103.33 -2.841 . . . . 0.0 103.33 169.372 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -156.43 166.96 15.37 Favored Pre-proline 0 N--CA 1.44 -0.938 0 N-CA-C 106.621 -1.622 . . . . 0.0 106.621 172.888 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 99.6 Cg_exo -65.39 162.17 34.82 Favored 'Trans proline' 0 CA--C 1.508 -0.775 0 C-N-CA 123.486 2.791 . . . . 0.0 112.978 175.838 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 1.2 tm0? -82.08 -58.75 0.45 Allowed Pre-proline 0 N--CA 1.442 -0.845 0 CA-C-O 115.7 -2.095 . . . . 0.0 110.686 -177.46 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo -74.95 175.54 11.09 Favored 'Trans proline' 0 CA--C 1.51 -0.696 0 CA-C-N 125.67 3.061 . . . . 0.0 110.548 -177.168 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 44.2 p -69.18 124.5 23.98 Favored 'General case' 0 C--N 1.356 0.891 0 C-N-CA 123.824 0.85 . . . . 0.0 109.785 -178.239 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 61.0 t60 -168.12 -42.82 0.02 OUTLIER 'General case' 0 CA--C 1.494 -1.199 0 N-CA-C 106.598 -1.63 . . . . 0.0 106.598 -170.747 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 33.4 mt -132.56 140.42 47.62 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.895 0 N-CA-C 107.68 -1.23 . . . . 0.0 107.68 -173.604 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 31.8 p -123.18 -71.22 0.73 Allowed 'General case' 0 C--N 1.359 0.985 0 C-N-CA 124.219 1.008 . . . . 0.0 109.536 172.875 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 44.6 mtpt -86.44 166.58 15.41 Favored 'General case' 0 CA--C 1.488 -1.439 0 C-N-CA 126.899 2.08 . . . . 0.0 107.219 -171.029 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 83.4 m-85 -134.31 148.61 50.79 Favored 'General case' 0 CA--C 1.493 -1.248 0 N-CA-C 104.855 -2.276 . . . . 0.0 104.855 175.369 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 4.4 mt -123.54 139.47 50.05 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.315 0 N-CA-C 101.402 -3.555 . . . . 0.0 101.402 171.361 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 12.0 mt -116.02 135.36 54.03 Favored 'General case' 0 CA--C 1.477 -1.852 0 N-CA-C 106.717 -1.586 . . . . 0.0 106.717 166.681 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 9.0 mpt_? -110.58 153.12 25.6 Favored 'General case' 0 N--CA 1.429 -1.48 0 N-CA-C 104.491 -2.411 . . . . 0.0 104.491 166.559 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 48.9 p90 -154.15 146.59 24.0 Favored 'General case' 0 N--CA 1.441 -0.905 0 N-CA-C 108.099 -1.075 . . . . 0.0 108.099 168.969 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 43.9 ttm-85 -142.08 143.9 29.75 Favored Pre-proline 0 CA--C 1.503 -0.844 0 N-CA-C 104.693 -2.336 . . . . 0.0 104.693 179.876 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -71.42 115.22 4.2 Favored 'Trans proline' 0 N--CA 1.454 -0.808 0 C-N-CA 122.878 2.386 . . . . 0.0 108.845 167.151 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 64.3 tttm -70.33 77.87 0.54 Allowed 'General case' 0 C--N 1.358 0.955 0 C-N-CA 126.979 2.112 . . . . 0.0 111.084 -177.179 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 68.7 m-80 -151.77 -73.26 0.15 Allowed 'General case' 0 N--CA 1.435 -1.218 0 N-CA-C 102.653 -3.091 . . . . 0.0 102.653 -173.436 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 60.8 m -96.5 168.38 10.58 Favored 'General case' 0 C--N 1.356 0.874 0 N-CA-C 107.19 -1.411 . . . . 0.0 107.19 175.028 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 2.6 m -130.91 62.27 0.3 Allowed 'Isoleucine or valine' 0 CA--C 1.501 -0.913 0 N-CA-C 105.436 -2.061 . . . . 0.0 105.436 179.759 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -93.18 -110.53 2.01 Favored Glycine 0 C--N 1.353 1.503 0 N-CA-C 107.969 -2.052 . . . . 0.0 107.969 -179.818 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 80.2 mtp180 -105.88 175.66 5.42 Favored 'General case' 0 CA--C 1.502 -0.884 0 N-CA-C 106.338 -1.727 . . . . 0.0 106.338 173.564 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -152.05 172.63 15.99 Favored 'General case' 0 CA--C 1.495 -1.168 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 -176.676 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 94.6 mttt -108.02 154.16 22.05 Favored 'General case' 0 CA--C 1.487 -1.456 0 N-CA-C 107.313 -1.366 . . . . 0.0 107.313 -173.984 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -152.19 153.03 33.01 Favored 'General case' 0 N--CA 1.431 -1.391 0 N-CA-C 107.542 -1.281 . . . . 0.0 107.542 -177.738 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -146.48 160.62 41.87 Favored 'General case' 0 CA--C 1.499 -1.018 0 N-CA-C 107.667 -1.235 . . . . 0.0 107.667 177.665 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 91.6 m -121.7 126.76 49.69 Favored 'General case' 0 CA--C 1.5 -0.956 0 N-CA-C 105.176 -2.157 . . . . 0.0 105.176 177.734 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 52.5 mt -117.58 136.92 23.75 Favored Pre-proline 0 N--CA 1.436 -1.164 0 N-CA-C 105.639 -1.985 . . . . 0.0 105.639 -166.635 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 76.1 Cg_exo -65.26 168.46 14.21 Favored 'Trans proline' 0 CA--C 1.51 -0.692 0 C-N-CA 123.214 2.609 . . . . 0.0 113.284 177.702 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -96.38 7.68 66.41 Favored Glycine 0 C--N 1.352 1.428 0 CA-C-O 118.951 -0.916 . . . . 0.0 113.013 -178.038 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 44.3 p-80 -83.93 -47.45 11.02 Favored 'General case' 0 C--N 1.362 1.146 0 CA-C-N 119.206 1.503 . . . . 0.0 109.186 178.869 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -87.95 165.76 14.99 Favored 'General case' 0 CA--C 1.489 -1.381 0 CA-C-O 122.934 1.35 . . . . 0.0 108.271 170.921 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 6.0 p-10 -140.54 24.53 2.25 Favored 'General case' 0 N--CA 1.424 -1.761 0 CA-C-N 112.974 -1.921 . . . . 0.0 106.987 -178.506 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 57.1 p -132.14 158.49 41.53 Favored 'General case' 0 CA--C 1.501 -0.91 0 N-CA-C 107.788 -1.19 . . . . 0.0 107.788 176.387 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 7.7 t80 -133.21 175.79 9.09 Favored 'General case' 0 C--N 1.359 1.002 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 175.463 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 93.3 m -142.4 110.84 6.1 Favored 'General case' 0 N--CA 1.431 -1.404 0 N-CA-C 104.409 -2.441 . . . . 0.0 104.409 173.985 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 26.3 mt -90.85 147.32 5.3 Favored 'Isoleucine or valine' 0 C--N 1.358 0.952 0 N-CA-C 104.293 -2.484 . . . . 0.0 104.293 172.443 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 67.3 mttm -142.46 164.62 29.63 Favored 'General case' 0 CA--C 1.5 -0.946 0 N-CA-C 108.717 -0.845 . . . . 0.0 108.717 177.549 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 82.02 50.01 5.07 Favored Glycine 0 C--N 1.356 1.663 0 C-N-CA 125.357 1.456 . . . . 0.0 109.562 175.153 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 49.5 mt -119.25 172.97 7.23 Favored 'General case' 0 CA--C 1.5 -0.97 0 N-CA-C 108.22 -1.03 . . . . 0.0 108.22 -170.998 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -114.61 160.91 31.38 Favored Pre-proline 0 N--CA 1.442 -0.872 0 N-CA-C 106.856 -1.535 . . . . 0.0 106.856 -176.937 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -79.75 163.12 23.88 Favored 'Trans proline' 0 N--CA 1.452 -0.944 0 C-N-CA 123.192 2.595 . . . . 0.0 109.83 166.131 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 60.9 24.65 62.92 Favored Glycine 0 C--N 1.355 1.638 0 C-N-CA 127.778 2.609 . . . . 0.0 116.496 172.1 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 7.7 p -118.9 146.14 23.94 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.063 0 N-CA-C 107.529 -1.286 . . . . 0.0 107.529 -174.56 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 4.2 p -100.31 129.9 50.36 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.906 0 N-CA-C 106.665 -1.606 . . . . 0.0 106.665 176.013 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 94.1 m-85 -113.44 150.01 33.38 Favored 'General case' 0 N--CA 1.439 -1.016 0 N-CA-C 105.923 -1.88 . . . . 0.0 105.923 173.508 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -100.61 144.58 29.42 Favored 'General case' 0 CA--C 1.496 -1.119 0 N-CA-C 104.327 -2.471 . . . . 0.0 104.327 162.546 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -126.99 157.76 20.74 Favored Glycine 0 CA--C 1.489 -1.584 0 N-CA-C 108.016 -2.034 . . . . 0.0 108.016 174.663 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 23.7 tt0 -142.7 131.48 22.76 Favored 'General case' 0 CA--C 1.482 -1.671 0 N-CA-C 106.004 -1.85 . . . . 0.0 106.004 176.53 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 39.8 tp -113.5 104.76 12.59 Favored 'General case' 0 N--CA 1.437 -1.112 0 N-CA-C 104.6 -2.371 . . . . 0.0 104.6 -174.878 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 21.8 mt -100.48 126.69 54.03 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.866 0 N-CA-C 103.192 -2.892 . . . . 0.0 103.192 -179.29 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 50.5 m -118.36 115.9 25.63 Favored 'General case' 0 N--CA 1.444 -0.74 0 CA-C-N 119.24 0.927 . . . . 0.0 109.154 -171.32 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 2.4 mp -104.3 141.11 20.55 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.982 0 N-CA-C 105.779 -1.934 . . . . 0.0 105.779 -162.824 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 12.0 tp-100 -103.89 125.95 50.66 Favored 'General case' 0 CA--C 1.493 -1.25 0 N-CA-C 102.458 -3.164 . . . . 0.0 102.458 161.293 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 18.5 tt0 -68.35 117.89 10.72 Favored 'General case' 0 N--CA 1.443 -0.808 0 C-N-CA 123.036 0.534 . . . . 0.0 110.558 -170.428 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 24.8 m-85 64.44 53.96 1.58 Allowed 'General case' 0 C--N 1.358 0.957 0 C-N-CA 126.597 1.959 . . . . 0.0 110.686 -175.256 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -172.47 -110.86 0.25 Allowed Glycine 0 C--N 1.352 1.421 0 N-CA-C 109.021 -1.632 . . . . 0.0 109.021 -178.696 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 27.9 m170 -80.2 164.92 22.9 Favored 'General case' 0 CA--C 1.503 -0.861 0 C-N-CA 125.066 1.347 . . . . 0.0 111.436 -168.792 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 44.8 tt0 -151.0 111.27 4.15 Favored 'General case' 0 N--CA 1.435 -1.181 0 N-CA-C 105.539 -2.023 . . . . 0.0 105.539 169.806 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 17.2 tp10 -99.82 151.95 20.69 Favored 'General case' 0 N--CA 1.441 -0.901 0 N-CA-C 105.799 -1.926 . . . . 0.0 105.799 179.267 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 11.3 p -130.85 139.91 49.98 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.774 0 N-CA-C 107.324 -1.362 . . . . 0.0 107.324 177.849 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 85.8 m -138.51 133.85 33.17 Favored 'General case' 0 N--CA 1.441 -0.922 0 N-CA-C 102.901 -3.0 . . . . 0.0 102.901 -177.969 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 8.1 ptm180 -113.79 165.1 12.9 Favored 'General case' 0 C--N 1.357 0.915 0 CA-C-N 119.822 1.192 . . . . 0.0 109.667 174.506 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 43.0 p90 -163.99 174.6 11.2 Favored 'General case' 0 CA--C 1.5 -0.975 0 N-CA-C 106.919 -1.512 . . . . 0.0 106.919 177.163 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 1.4 p30 -143.97 156.55 44.45 Favored 'General case' 0 N--CA 1.441 -0.885 0 N-CA-C 106.965 -1.494 . . . . 0.0 106.965 166.459 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 6.6 p90 -148.36 173.27 13.23 Favored 'General case' 0 CA--C 1.488 -1.434 0 N-CA-C 107.661 -1.237 . . . . 0.0 107.661 -179.881 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 32.0 p -122.97 143.99 49.54 Favored 'General case' 0 CA--C 1.499 -0.99 0 N-CA-C 106.308 -1.738 . . . . 0.0 106.308 171.633 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 91' ' ' THR . . . . . 0.431 ' HG1' ' CD2' ' A' ' 18' ' ' HIS . 68.3 m -110.07 87.23 2.47 Favored 'General case' 0 CA--C 1.495 -1.137 0 N-CA-C 100.579 -3.86 . . . . 0.0 100.579 166.27 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 10.2 t -97.41 -50.88 4.36 Favored 'General case' 0 N--CA 1.441 -0.908 0 N-CA-C 108.293 -1.002 . . . . 0.0 108.293 -168.33 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 11.4 t . . . . . 0 C--O 1.26 1.638 0 C-N-CA 126.118 1.767 . . . . 0.0 110.256 -175.475 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 17.0 t . . . . . 0 N--CA 1.484 1.258 0 CA-C-O 121.288 0.566 . . . . 0.0 110.538 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . 0.499 ' H ' ' HG3' ' A' ' 83' ' ' GLU . . . 100.89 -179.48 28.82 Favored Glycine 0 C--N 1.354 1.544 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 174.599 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 95.9 Cg_exo -62.21 133.11 41.98 Favored 'Trans proline' 0 N--CA 1.445 -1.367 0 C-N-CA 123.592 2.861 . . . . 0.0 112.342 -178.504 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 4.3 t -80.98 155.33 4.26 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.924 0 C-N-CA 127.32 2.248 . . . . 0.0 107.424 -175.429 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 53.0 mt-10 -94.49 89.04 5.68 Favored 'General case' 0 CA--C 1.493 -1.25 0 C-N-CA 124.337 1.055 . . . . 0.0 108.426 -177.5 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 3.7 p -115.64 140.24 38.25 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.105 0 N-CA-C 105.497 -2.038 . . . . 0.0 105.497 -169.411 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 93.3 m-85 -130.46 166.12 21.18 Favored 'General case' 0 CA--C 1.493 -1.221 0 N-CA-C 107.28 -1.378 . . . . 0.0 107.28 -172.112 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 58.6 mt -91.05 90.5 3.32 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.931 0 N-CA-C 104.596 -2.372 . . . . 0.0 104.596 176.798 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 24.8 p -106.41 154.85 20.23 Favored 'General case' 0 CA--C 1.5 -0.945 0 N-CA-C 105.204 -2.147 . . . . 0.0 105.204 175.736 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -169.15 82.66 0.13 Allowed 'General case' 0 N--CA 1.431 -1.419 0 N-CA-C 102.091 -3.3 . . . . 0.0 102.091 -178.009 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 45.8 p -80.81 166.69 37.62 Favored Pre-proline 0 N--CA 1.444 -0.755 0 CA-C-O 116.972 -1.49 . . . . 0.0 107.222 -178.256 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_exo -61.13 106.11 0.37 Allowed 'Trans proline' 0 CA--C 1.509 -0.774 0 C-N-CA 123.085 2.523 . . . . 0.0 113.82 -168.622 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 67.8 m -151.19 -163.92 1.88 Allowed 'General case' 0 N--CA 1.421 -1.925 0 N-CA-C 101.025 -3.694 . . . . 0.0 101.025 -174.619 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 37.4 mt-30 -83.38 157.36 65.15 Favored Pre-proline 0 N--CA 1.44 -0.967 0 C-N-CA 126.32 1.848 . . . . 0.0 107.801 178.411 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_endo -82.19 -5.61 12.0 Favored 'Trans proline' 0 CA--C 1.509 -0.753 0 C-N-CA 123.409 2.739 . . . . 0.0 110.003 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -91.16 -15.4 29.43 Favored 'General case' 0 CA--C 1.498 -1.041 0 C-N-CA 125.438 1.495 . . . . 0.0 108.222 177.663 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' SER . . . . . 0.44 ' HG ' ' HG2' ' A' ' 61' ' ' LYS . 50.1 m -102.58 149.96 23.89 Favored 'General case' 0 N--CA 1.437 -1.101 0 N-CA-C 107.094 -1.446 . . . . 0.0 107.094 175.425 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 60.0 t-80 -139.28 94.45 9.65 Favored Pre-proline 0 N--CA 1.442 -0.855 0 N-CA-C 107.526 -1.287 . . . . 0.0 107.526 175.729 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -78.21 101.36 1.46 Allowed 'Trans proline' 0 N--CA 1.447 -1.235 0 C-N-CA 123.144 2.562 . . . . 0.0 110.043 174.338 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 11.8 tt -90.58 156.69 3.01 Favored 'Isoleucine or valine' 0 N--CA 1.408 -2.532 0 C-N-CA 126.945 2.098 . . . . 0.0 106.042 176.308 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 25.4 tt0 -139.77 146.45 39.51 Favored 'General case' 0 N--CA 1.432 -1.334 0 N-CA-C 103.662 -2.718 . . . . 0.0 103.662 175.125 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 49.3 p90 -135.08 161.69 34.61 Favored 'General case' 0 N--CA 1.431 -1.379 0 N-CA-C 105.045 -2.205 . . . . 0.0 105.045 178.558 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 3.9 m120 -132.65 127.73 35.54 Favored 'General case' 0 CA--C 1.491 -1.325 0 N-CA-C 105.909 -1.886 . . . . 0.0 105.909 -178.884 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -81.18 159.99 66.59 Favored Pre-proline 0 N--CA 1.441 -0.901 0 C-N-CA 123.533 0.733 . . . . 0.0 111.254 -167.119 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_exo -67.29 173.87 7.99 Favored 'Trans proline' 0 N--CA 1.456 -0.718 0 C-N-CA 123.7 2.933 . . . . 0.0 111.738 166.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 49.4 tt0 -80.24 -42.38 1.37 Allowed Pre-proline 0 N--CA 1.444 -0.756 0 CA-C-O 115.63 -2.128 . . . . 0.0 111.522 -177.339 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 74.7 Cg_exo -66.59 148.13 82.93 Favored 'Trans proline' 0 CA--C 1.507 -0.849 0 CA-C-N 125.62 3.043 . . . . 0.0 112.061 177.039 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 24.6 p -98.99 58.52 1.13 Allowed 'General case' 0 C--N 1.355 0.844 0 N-CA-C 107.592 -1.262 . . . . 0.0 107.592 178.46 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 21.1 t-160 -104.38 -5.88 21.29 Favored 'General case' 0 N--CA 1.439 -1.001 0 C-N-CA 125.046 1.338 . . . . 0.0 107.784 178.104 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 56.7 mt -106.73 131.26 57.05 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.21 0 N-CA-C 105.2 -2.148 . . . . 0.0 105.2 178.498 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 75.2 m -104.01 -84.24 0.48 Allowed 'General case' 0 N--CA 1.43 -1.443 0 N-CA-C 106.203 -1.777 . . . . 0.0 106.203 -179.667 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 54.0 mtmt -88.9 167.26 13.37 Favored 'General case' 0 CA--C 1.492 -1.281 0 C-N-CA 123.687 0.795 . . . . 0.0 109.61 -168.801 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 90.0 m-85 -126.04 139.27 53.55 Favored 'General case' 0 N--CA 1.435 -1.196 0 N-CA-C 104.494 -2.41 . . . . 0.0 104.494 165.703 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 1.7 mp -115.03 136.34 52.05 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.132 1 N-CA-C 100.177 -4.009 . . . . 0.0 100.177 167.634 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 3.0 mt -111.53 133.63 53.67 Favored 'General case' 0 CA--C 1.472 -2.052 0 N-CA-C 103.837 -2.653 . . . . 0.0 103.837 164.588 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 16.7 ptp180 -128.73 154.84 45.94 Favored 'General case' 0 N--CA 1.432 -1.345 0 N-CA-C 106.301 -1.74 . . . . 0.0 106.301 169.107 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 48.3 p90 -153.44 144.53 22.94 Favored 'General case' 0 N--CA 1.436 -1.161 0 N-CA-C 106.987 -1.486 . . . . 0.0 106.987 -173.834 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 36.2 ttp180 -142.55 134.04 13.04 Favored Pre-proline 0 CA--C 1.497 -1.09 0 N-CA-C 104.783 -2.303 . . . . 0.0 104.783 -177.859 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 29.8 Cg_endo -72.31 116.71 4.81 Favored 'Trans proline' 0 CA--C 1.505 -0.947 0 C-N-CA 122.928 2.418 . . . . 0.0 108.156 178.364 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 5.5 tmtm? -69.86 85.02 0.49 Allowed 'General case' 0 C--N 1.359 1.011 0 C-N-CA 126.523 1.929 . . . . 0.0 110.242 -174.283 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 33.1 m120 -147.52 -67.78 0.25 Allowed 'General case' 0 N--CA 1.433 -1.286 0 N-CA-C 101.568 -3.493 . . . . 0.0 101.568 -178.71 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 50.8 p -103.28 170.27 8.06 Favored 'General case' 0 N--CA 1.441 -0.918 0 N-CA-C 107.072 -1.455 . . . . 0.0 107.072 171.617 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 3.7 m -119.82 53.42 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.841 0 N-CA-C 106.125 -1.806 . . . . 0.0 106.125 176.45 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -100.32 -131.55 7.41 Favored Glycine 0 C--N 1.356 1.641 0 N-CA-C 109.916 -1.273 . . . . 0.0 109.916 -175.452 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 56.1 ttp180 -79.78 148.51 31.42 Favored 'General case' 0 C--N 1.357 0.9 0 C-N-CA 124.727 1.211 . . . . 0.0 108.694 -175.026 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -148.5 169.86 19.32 Favored 'General case' 0 CA--C 1.494 -1.174 0 CA-C-O 121.468 0.651 . . . . 0.0 110.616 -171.952 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 62.3 mttp -112.3 159.07 19.01 Favored 'General case' 0 CA--C 1.491 -1.292 0 N-CA-C 107.774 -1.195 . . . . 0.0 107.774 -168.849 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 16.2 pt-20 -151.63 160.65 43.55 Favored 'General case' 0 N--CA 1.436 -1.141 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 172.287 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -137.38 163.69 30.42 Favored 'General case' 0 CA--C 1.501 -0.942 0 N-CA-C 106.063 -1.829 . . . . 0.0 106.063 171.68 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 89.4 m -120.41 125.25 47.49 Favored 'General case' 0 CA--C 1.501 -0.913 0 N-CA-C 104.957 -2.238 . . . . 0.0 104.957 175.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 5.3 mp -114.11 136.48 22.21 Favored Pre-proline 0 N--CA 1.437 -1.102 0 N-CA-C 105.196 -2.15 . . . . 0.0 105.196 -175.608 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_exo -64.19 163.72 25.09 Favored 'Trans proline' 0 CA--C 1.51 -0.723 0 C-N-CA 123.378 2.719 . . . . 0.0 113.774 176.624 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -76.26 -18.44 79.27 Favored Glycine 0 C--N 1.353 1.49 0 C-N-CA 124.149 0.881 . . . . 0.0 114.244 -174.03 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 52.4 p-80 -83.28 -25.17 31.82 Favored 'General case' 0 C--N 1.355 0.837 0 CA-C-N 117.951 0.876 . . . . 0.0 109.945 -179.044 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 89.0 mt -88.43 131.57 34.81 Favored 'General case' 0 CA--C 1.5 -0.955 0 N-CA-C 107.712 -1.218 . . . . 0.0 107.712 176.797 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 8.6 p-10 -113.74 8.82 17.59 Favored 'General case' 0 CA--C 1.502 -0.89 0 C-N-CA 124.457 1.103 . . . . 0.0 109.631 -174.916 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 33.5 p -146.39 157.73 43.81 Favored 'General case' 0 CA--C 1.498 -1.055 0 N-CA-C 106.633 -1.617 . . . . 0.0 106.633 -177.463 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 35.4 t80 -154.14 151.27 29.06 Favored 'General case' 0 CA--C 1.487 -1.444 0 N-CA-C 108.07 -1.085 . . . . 0.0 108.07 178.236 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 16.9 m -108.64 113.99 27.43 Favored 'General case' 0 N--CA 1.439 -0.979 0 N-CA-C 105.951 -1.87 . . . . 0.0 105.951 174.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 45.5 mt -91.95 102.28 13.39 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.89 0 N-CA-C 105.242 -2.132 . . . . 0.0 105.242 178.117 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . 0.44 ' HG2' ' HG ' ' A' ' 17' ' ' SER . 35.1 mtmm -106.48 162.32 13.82 Favored 'General case' 0 CA--C 1.497 -1.096 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 -175.785 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 79.93 52.51 4.61 Favored Glycine 0 C--N 1.351 1.365 0 N-CA-C 109.099 -1.6 . . . . 0.0 109.099 178.434 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 89.5 mt -118.12 173.12 6.97 Favored 'General case' 0 CA--C 1.498 -1.023 0 N-CA-C 106.87 -1.53 . . . . 0.0 106.87 -178.778 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 51.6 mtmt -98.14 147.28 32.87 Favored Pre-proline 0 N--CA 1.438 -1.063 0 N-CA-C 105.786 -1.931 . . . . 0.0 105.786 178.666 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -78.56 160.99 28.32 Favored 'Trans proline' 0 N--CA 1.452 -0.93 0 C-N-CA 123.043 2.496 . . . . 0.0 109.997 173.515 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 59.6 30.33 68.52 Favored Glycine 0 C--N 1.356 1.65 0 C-N-CA 126.626 2.06 . . . . 0.0 116.24 169.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 6.4 p -128.45 154.62 39.47 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.85 0 N-CA-C 107.813 -1.18 . . . . 0.0 107.813 -176.002 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 4.8 p -96.53 135.69 29.81 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.9 0 N-CA-C 106.769 -1.567 . . . . 0.0 106.769 175.554 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 81.9 m-85 -113.89 147.44 38.48 Favored 'General case' 0 CA--C 1.497 -1.078 0 N-CA-C 105.382 -2.081 . . . . 0.0 105.382 171.432 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 15.2 pt-20 -95.92 136.53 36.23 Favored 'General case' 0 CA--C 1.498 -1.027 0 N-CA-C 103.457 -2.794 . . . . 0.0 103.457 162.016 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -132.62 146.38 18.18 Favored Glycine 0 CA--C 1.485 -1.784 0 N-CA-C 107.679 -2.168 . . . . 0.0 107.679 -172.332 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 25.2 mt-30 -136.74 133.46 36.07 Favored 'General case' 0 CA--C 1.482 -1.65 0 N-CA-C 105.746 -1.946 . . . . 0.0 105.746 178.627 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 49.6 tp -112.63 100.1 8.45 Favored 'General case' 0 N--CA 1.437 -1.108 0 N-CA-C 103.393 -2.817 . . . . 0.0 103.393 179.535 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 21.7 mt -94.83 129.33 45.15 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.915 0 N-CA-C 104.696 -2.335 . . . . 0.0 104.696 -176.797 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 69.2 m -113.5 113.79 25.62 Favored 'General case' 0 CA--C 1.497 -1.092 0 N-CA-C 107.668 -1.234 . . . . 0.0 107.668 -175.276 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 18.5 mm -89.36 142.73 12.47 Favored 'Isoleucine or valine' 0 CA--C 1.49 -1.349 0 N-CA-C 105.514 -2.032 . . . . 0.0 105.514 -173.441 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 83.0 mt-30 -92.5 -175.62 4.04 Favored 'General case' 0 CA--C 1.502 -0.897 0 CA-C-N 114.766 -1.106 . . . . 0.0 109.203 -175.569 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 73.2 mt-30 -74.79 78.22 2.09 Favored 'General case' 0 N--CA 1.442 -0.863 0 C-N-CA 125.84 1.656 . . . . 0.0 112.347 -177.612 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 65.8 m-85 60.06 21.8 10.98 Favored 'General case' 0 C--N 1.358 0.977 0 C-N-CA 127.322 2.249 . . . . 0.0 112.777 178.623 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -119.28 -118.95 2.78 Favored Glycine 0 C--N 1.355 1.597 0 N-CA-C 108.695 -1.762 . . . . 0.0 108.695 -173.847 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . 0.597 ' CG ' ' H ' ' A' ' 82' ' ' GLN . 12.5 t-160 -81.34 -171.56 3.34 Favored 'General case' 0 CA--C 1.497 -1.065 0 C-N-CA 125.386 1.475 . . . . 0.0 108.902 -177.852 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . 0.597 ' H ' ' CG ' ' A' ' 81' ' ' HIS . 5.9 pt20 -144.66 146.48 32.27 Favored 'General case' 0 N--CA 1.434 -1.274 0 N-CA-C 106.067 -1.827 . . . . 0.0 106.067 170.127 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 0.499 ' HG3' ' H ' ' A' ' 2' ' ' GLY . 46.9 mm-40 -105.19 156.22 18.31 Favored 'General case' 0 CA--C 1.494 -1.178 0 N-CA-C 105.897 -1.89 . . . . 0.0 105.897 179.735 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 7.4 p -129.51 135.76 60.83 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.924 0 N-CA-C 107.308 -1.367 . . . . 0.0 107.308 179.741 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 24.7 m -118.62 133.38 55.9 Favored 'General case' 0 N--CA 1.439 -1.001 0 N-CA-C 102.006 -3.331 . . . . 0.0 102.006 175.467 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 78.6 mtm180 -129.17 147.83 51.05 Favored 'General case' 0 CA--C 1.497 -1.081 0 CA-C-N 119.303 0.956 . . . . 0.0 109.187 -177.698 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 18.5 p90 -166.07 -176.1 3.61 Favored 'General case' 0 CA--C 1.498 -1.025 0 N-CA-C 106.826 -1.546 . . . . 0.0 106.826 -174.79 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -134.58 156.72 48.19 Favored 'General case' 0 N--CA 1.44 -0.962 0 N-CA-C 105.596 -2.001 . . . . 0.0 105.596 164.371 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 23.7 p90 -138.13 165.17 27.3 Favored 'General case' 0 CA--C 1.483 -1.629 0 N-CA-C 107.227 -1.397 . . . . 0.0 107.227 169.449 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 29.4 p -119.67 143.89 47.48 Favored 'General case' 0 N--CA 1.439 -1.004 0 N-CA-C 107.374 -1.343 . . . . 0.0 107.374 176.381 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 19.6 p -108.99 135.06 50.78 Favored 'General case' 0 N--CA 1.439 -1.012 0 N-CA-C 103.613 -2.736 . . . . 0.0 103.613 164.608 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 15.2 t -139.72 149.49 43.69 Favored 'General case' 0 N--CA 1.439 -1.005 0 N-CA-C 106.332 -1.729 . . . . 0.0 106.332 -173.742 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 35.4 t . . . . . 0 C--O 1.261 1.685 0 N-CA-C 105.396 -2.076 . . . . 0.0 105.396 177.99 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 87.8 p . . . . . 0 N--CA 1.489 1.488 0 CA-C-O 121.46 0.648 . . . . 0.0 111.982 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 84.53 -151.16 26.34 Favored Glycine 0 C--N 1.356 1.671 0 N-CA-C 109.136 -1.586 . . . . 0.0 109.136 176.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 64.4 Cg_exo -61.48 138.23 74.7 Favored 'Trans proline' 0 N--CA 1.442 -1.508 0 C-N-CA 123.241 2.628 . . . . 0.0 112.957 179.643 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 2.8 t -77.45 153.8 5.42 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.728 0 C-N-CA 127.785 2.434 . . . . 0.0 106.339 -178.527 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 48.7 mm-40 -99.03 88.76 4.05 Favored 'General case' 0 CA--C 1.488 -1.405 0 CA-C-O 122.829 1.3 . . . . 0.0 109.14 -170.133 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 2.4 p -105.66 128.01 60.12 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.07 0 CA-C-N 113.43 -1.714 . . . . 0.0 108.685 -164.376 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 27.5 p90 -130.28 154.35 47.69 Favored 'General case' 0 N--CA 1.44 -0.97 0 N-CA-C 106.703 -1.592 . . . . 0.0 106.703 -174.584 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 40.6 mm -123.99 109.34 22.69 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.236 0 N-CA-C 105.276 -2.12 . . . . 0.0 105.276 -179.666 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 40.5 p -132.58 -152.43 0.5 Allowed 'General case' 0 N--CA 1.444 -0.739 0 N-CA-C 104.451 -2.426 . . . . 0.0 104.451 171.367 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 80.0 tt0 79.51 -18.89 0.47 Allowed 'General case' 0 C--N 1.362 1.149 0 C-N-CA 128.445 2.698 . . . . 0.0 112.35 169.551 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 14.9 p -139.99 109.46 7.07 Favored Pre-proline 0 N--CA 1.446 -0.653 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 -170.418 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -72.17 -31.53 11.87 Favored 'Trans proline' 0 N--CA 1.455 -0.77 0 C-N-CA 122.843 2.362 . . . . 0.0 110.697 164.696 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 11.9 p -169.02 119.47 0.72 Allowed 'General case' 0 N--CA 1.437 -1.076 0 N-CA-C 107.085 -1.45 . . . . 0.0 107.085 -176.12 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 23.9 mm100 -150.57 128.05 5.61 Favored Pre-proline 0 N--CA 1.443 -0.791 0 N-CA-C 104.834 -2.284 . . . . 0.0 104.834 170.418 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 82.0 Cg_endo -84.41 -16.17 5.99 Favored 'Trans proline' 0 CA--C 1.505 -0.952 0 C-N-CA 123.039 2.492 . . . . 0.0 111.544 -173.862 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 4.1 t30 -124.95 -31.99 3.08 Favored 'General case' 0 CA--C 1.488 -1.42 0 CA-C-N 118.637 0.653 . . . . 0.0 109.78 -165.741 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 13.5 p -106.63 141.85 37.24 Favored 'General case' 0 CA--C 1.493 -1.238 0 N-CA-C 107.44 -1.319 . . . . 0.0 107.44 179.22 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 63.0 t60 -141.89 98.22 6.33 Favored Pre-proline 0 N--CA 1.439 -1.024 0 N-CA-C 107.603 -1.258 . . . . 0.0 107.603 176.531 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -78.32 139.11 16.37 Favored 'Trans proline' 0 N--CA 1.449 -1.092 0 C-N-CA 122.814 2.343 . . . . 0.0 110.785 -177.14 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 21.6 mm -106.87 136.27 42.4 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.958 0 N-CA-C 103.104 -2.924 . . . . 0.0 103.104 174.287 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 40.7 mt-30 -138.76 141.28 38.84 Favored 'General case' 0 CA--C 1.491 -1.318 0 N-CA-C 103.494 -2.78 . . . . 0.0 103.494 -178.048 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 46.1 p90 -148.77 167.23 26.14 Favored 'General case' 0 CA--C 1.498 -1.048 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 -170.609 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 9.5 m120 -131.19 129.53 41.82 Favored 'General case' 0 CA--C 1.492 -1.259 0 N-CA-C 107.441 -1.318 . . . . 0.0 107.441 178.868 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -94.71 170.58 7.85 Favored Pre-proline 0 N--CA 1.439 -0.999 0 C-N-CA 124.468 1.107 . . . . 0.0 109.879 -170.97 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 80.2 Cg_exo -66.06 164.13 28.77 Favored 'Trans proline' 0 CA--C 1.508 -0.807 0 C-N-CA 123.633 2.888 . . . . 0.0 112.222 168.929 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 17.4 mp0 -83.3 -57.34 0.43 Allowed Pre-proline 0 N--CA 1.442 -0.826 0 CA-C-O 115.844 -2.027 . . . . 0.0 110.402 -177.132 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -74.87 171.88 17.42 Favored 'Trans proline' 0 CA--C 1.509 -0.743 0 CA-C-N 125.499 3.0 . . . . 0.0 110.349 177.702 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 66.0 m -75.93 125.86 29.9 Favored 'General case' 0 CA--C 1.501 -0.933 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 -179.635 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 74.8 t60 -162.37 -49.89 0.04 OUTLIER 'General case' 0 N--CA 1.436 -1.17 0 N-CA-C 106.202 -1.777 . . . . 0.0 106.202 -172.813 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 54.0 mt -113.06 136.53 49.08 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.142 0 N-CA-C 105.203 -2.147 . . . . 0.0 105.203 -177.109 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 32.1 t -110.53 -87.5 0.52 Allowed 'General case' 0 N--CA 1.43 -1.474 0 N-CA-C 106.717 -1.586 . . . . 0.0 106.717 179.028 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.411 ' HB3' ' HZ2' ' A' ' 32' ' ' LYS . 6.7 ttpm? -91.86 160.49 15.27 Favored 'General case' 0 CA--C 1.492 -1.262 0 C-N-CA 125.667 1.587 . . . . 0.0 107.649 -160.155 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 92.0 m-85 -125.58 138.91 53.96 Favored 'General case' 0 CA--C 1.494 -1.185 0 N-CA-C 106.277 -1.749 . . . . 0.0 106.277 176.072 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 53.5 mt -116.92 126.82 74.55 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.152 0 N-CA-C 102.592 -3.114 . . . . 0.0 102.592 168.483 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 5.0 mt -102.2 128.65 48.61 Favored 'General case' 0 CA--C 1.475 -1.912 0 N-CA-C 104.894 -2.261 . . . . 0.0 104.894 170.556 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 42.4 ttp85 -132.47 122.0 24.23 Favored 'General case' 0 N--CA 1.437 -1.115 0 N-CA-C 106.097 -1.816 . . . . 0.0 106.097 -178.71 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 42.3 p90 -138.06 151.1 47.52 Favored 'General case' 0 N--CA 1.444 -0.757 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 -169.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 33.2 ptt180 -155.92 164.47 21.25 Favored Pre-proline 0 CA--C 1.502 -0.897 0 N-CA-C 106.605 -1.628 . . . . 0.0 106.605 171.384 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -75.69 127.27 10.09 Favored 'Trans proline' 0 N--CA 1.452 -0.932 0 C-N-CA 122.344 2.029 . . . . 0.0 108.983 179.141 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 64.0 tttm -69.75 83.07 0.45 Allowed 'General case' 0 C--N 1.357 0.921 0 C-N-CA 127.349 2.259 . . . . 0.0 110.821 -177.588 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 29.1 m120 -145.9 -89.81 0.1 Allowed 'General case' 0 N--CA 1.437 -1.091 0 N-CA-C 105.054 -2.202 . . . . 0.0 105.054 -175.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' SER . . . . . 0.612 ' HG ' ' H ' ' A' ' 43' ' ' VAL . 3.7 t -94.31 -164.95 1.23 Allowed 'General case' 0 C--N 1.355 0.819 0 C-N-CA 124.032 0.933 . . . . 0.0 108.924 -172.641 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.612 ' H ' ' HG ' ' A' ' 42' ' ' SER . 4.2 m -121.17 54.51 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.439 -1.003 0 N-CA-C 106.307 -1.738 . . . . 0.0 106.307 -176.648 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -89.8 -140.2 7.93 Favored Glycine 0 C--N 1.355 1.595 0 N-CA-C 110.281 -1.128 . . . . 0.0 110.281 -178.179 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -99.33 165.01 11.88 Favored 'General case' 0 CA--C 1.503 -0.831 0 N-CA-C 106.484 -1.672 . . . . 0.0 106.484 -178.332 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 47.3 m95 -112.34 156.73 21.98 Favored 'General case' 0 N--CA 1.441 -0.912 0 N-CA-C 108.071 -1.085 . . . . 0.0 108.071 -179.09 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 67.9 mttm -97.46 152.25 19.17 Favored 'General case' 0 CA--C 1.49 -1.352 0 N-CA-C 104.779 -2.304 . . . . 0.0 104.779 163.824 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -153.18 156.62 38.91 Favored 'General case' 0 CA--C 1.494 -1.191 0 N-CA-C 107.833 -1.173 . . . . 0.0 107.833 178.854 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -141.07 162.93 34.32 Favored 'General case' 0 CA--C 1.496 -1.132 0 N-CA-C 106.349 -1.723 . . . . 0.0 106.349 175.876 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 88.1 m -122.36 127.24 49.51 Favored 'General case' 0 CA--C 1.501 -0.933 0 N-CA-C 105.242 -2.133 . . . . 0.0 105.242 -179.705 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 4.8 mp -117.38 133.88 23.17 Favored Pre-proline 0 N--CA 1.437 -1.106 0 N-CA-C 104.613 -2.366 . . . . 0.0 104.613 -174.725 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_exo -63.32 166.19 15.6 Favored 'Trans proline' 0 CA--C 1.509 -0.742 0 C-N-CA 123.344 2.696 . . . . 0.0 113.616 176.677 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -81.14 -17.18 72.59 Favored Glycine 0 C--N 1.351 1.405 0 C-N-CA 123.557 0.598 . . . . 0.0 113.099 -172.073 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 52.2 p-80 -83.66 -24.8 31.19 Favored 'General case' 0 C--N 1.355 0.841 0 CA-C-N 117.889 0.845 . . . . 0.0 109.862 179.88 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 87.4 mt -88.18 130.67 34.99 Favored 'General case' 0 CA--C 1.501 -0.94 0 N-CA-C 107.645 -1.243 . . . . 0.0 107.645 177.139 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 8.1 p30 -110.15 7.95 23.59 Favored 'General case' 0 N--CA 1.441 -0.881 0 C-N-CA 124.708 1.203 . . . . 0.0 109.758 -174.937 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 42.1 p -146.5 167.03 24.69 Favored 'General case' 0 N--CA 1.439 -1.0 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 -178.14 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 9.3 t80 -153.29 178.37 9.84 Favored 'General case' 0 N--CA 1.439 -1.023 0 N-CA-C 107.1 -1.444 . . . . 0.0 107.1 -178.275 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 70.0 m -142.0 116.22 9.47 Favored 'General case' 0 N--CA 1.43 -1.459 0 N-CA-C 104.812 -2.292 . . . . 0.0 104.812 176.632 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 12.7 mm -85.75 140.18 16.3 Favored 'Isoleucine or valine' 0 C--N 1.358 0.964 0 N-CA-C 103.856 -2.646 . . . . 0.0 103.856 170.332 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 7.9 mtpm? -141.7 164.65 29.64 Favored 'General case' 0 CA--C 1.497 -1.063 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 178.938 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 85.86 49.49 4.28 Favored Glycine 0 CA--C 1.487 -1.669 0 N-CA-C 108.931 -1.668 . . . . 0.0 108.931 174.843 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 58.1 mt -118.77 170.15 9.24 Favored 'General case' 0 CA--C 1.497 -1.071 0 N-CA-C 108.528 -0.916 . . . . 0.0 108.528 -169.864 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 60.6 mtpt -110.46 155.16 42.51 Favored Pre-proline 0 N--CA 1.44 -0.929 0 N-CA-C 106.942 -1.503 . . . . 0.0 106.942 -176.478 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 63.9 Cg_endo -78.94 161.04 27.1 Favored 'Trans proline' 0 N--CA 1.452 -0.966 0 C-N-CA 122.91 2.407 . . . . 0.0 110.308 172.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 59.47 26.27 61.8 Favored Glycine 0 C--N 1.355 1.586 0 C-N-CA 127.673 2.559 . . . . 0.0 116.378 171.29 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 10.7 p -121.77 147.45 25.76 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.992 0 N-CA-C 107.362 -1.348 . . . . 0.0 107.362 -177.203 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 4.0 p -96.73 129.15 47.19 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.951 0 N-CA-C 106.93 -1.507 . . . . 0.0 106.93 177.125 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 93.4 m-85 -111.18 144.84 39.7 Favored 'General case' 0 CA--C 1.496 -1.113 0 N-CA-C 106.043 -1.836 . . . . 0.0 106.043 173.124 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -96.72 145.12 26.09 Favored 'General case' 0 CA--C 1.496 -1.128 0 N-CA-C 104.475 -2.417 . . . . 0.0 104.475 166.103 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -140.97 155.77 25.16 Favored Glycine 0 CA--C 1.486 -1.731 0 N-CA-C 108.624 -1.791 . . . . 0.0 108.624 -176.275 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 86.8 mt-30 -142.9 134.39 26.34 Favored 'General case' 0 CA--C 1.479 -1.782 0 N-CA-C 104.456 -2.424 . . . . 0.0 104.456 -179.333 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 35.6 tp -114.77 96.17 5.59 Favored 'General case' 0 N--CA 1.437 -1.102 0 N-CA-C 103.659 -2.719 . . . . 0.0 103.659 176.468 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 21.8 mt -88.76 135.37 25.92 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.048 0 N-CA-C 104.213 -2.514 . . . . 0.0 104.213 -177.275 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 14.2 p -124.96 112.14 16.24 Favored 'General case' 0 N--CA 1.435 -1.212 0 N-CA-C 107.777 -1.194 . . . . 0.0 107.777 -171.771 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 2.0 mp -93.48 134.84 29.87 Favored 'Isoleucine or valine' 0 CA--C 1.488 -1.41 0 N-CA-C 104.506 -2.405 . . . . 0.0 104.506 -165.703 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 74.4 mt-30 -92.66 149.9 21.04 Favored 'General case' 0 CA--C 1.493 -1.249 0 N-CA-C 106.522 -1.659 . . . . 0.0 106.522 -178.687 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 44.6 tt0 -70.46 105.71 3.16 Favored 'General case' 0 N--CA 1.441 -0.894 0 C-N-CA 123.44 0.696 . . . . 0.0 110.408 -177.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 31.6 m-85 59.94 41.03 18.29 Favored 'General case' 0 C--N 1.356 0.883 0 C-N-CA 127.094 2.157 . . . . 0.0 112.469 -178.626 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -149.94 -126.11 1.39 Allowed Glycine 0 C--N 1.358 1.752 0 N-CA-C 109.283 -1.527 . . . . 0.0 109.283 178.738 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 47.1 m80 -85.11 -176.26 6.1 Favored 'General case' 0 CA--C 1.497 -1.071 0 C-N-CA 126.107 1.763 . . . . 0.0 111.436 -165.555 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 70.1 mt-30 -130.42 144.47 51.41 Favored 'General case' 0 CA--C 1.496 -1.101 0 N-CA-C 103.975 -2.602 . . . . 0.0 103.975 168.659 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 57.3 mt-10 -131.28 131.32 43.77 Favored 'General case' 0 CA--C 1.491 -1.304 0 N-CA-C 105.312 -2.107 . . . . 0.0 105.312 179.721 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 12.4 p -104.48 134.82 44.78 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.799 0 N-CA-C 108.137 -1.06 . . . . 0.0 108.137 -174.914 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 40.0 m -109.11 131.71 54.81 Favored 'General case' 0 N--CA 1.44 -0.926 0 N-CA-C 101.831 -3.396 . . . . 0.0 101.831 171.403 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 87.5 mtt180 -123.75 149.01 46.11 Favored 'General case' 0 CA--C 1.494 -1.174 0 CA-C-N 119.491 1.041 . . . . 0.0 109.901 -177.92 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 14.8 p90 -163.25 -179.61 6.73 Favored 'General case' 0 CA--C 1.499 -0.988 0 N-CA-C 107.209 -1.404 . . . . 0.0 107.209 -179.149 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 9.3 p-10 -141.31 160.16 40.7 Favored 'General case' 0 N--CA 1.44 -0.963 0 N-CA-C 105.865 -1.902 . . . . 0.0 105.865 167.005 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 23.4 p90 -148.3 170.17 18.5 Favored 'General case' 0 CA--C 1.49 -1.358 0 N-CA-C 107.332 -1.358 . . . . 0.0 107.332 177.294 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 23.9 p -119.25 142.53 47.97 Favored 'General case' 0 CA--C 1.498 -1.024 0 N-CA-C 105.696 -1.965 . . . . 0.0 105.696 171.458 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 45.0 m -115.7 119.83 37.35 Favored 'General case' 0 CA--C 1.495 -1.143 0 N-CA-C 102.614 -3.106 . . . . 0.0 102.614 170.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 14.1 t -154.38 159.19 41.0 Favored 'General case' 0 N--CA 1.436 -1.144 0 N-CA-C 105.901 -1.888 . . . . 0.0 105.901 -173.205 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 9.4 t . . . . . 0 C--O 1.262 1.714 0 N-CA-C 106.356 -1.72 . . . . 0.0 106.356 175.042 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 18.7 t . . . . . 0 N--CA 1.483 1.192 0 N-CA-C 109.395 -0.595 . . . . 0.0 109.395 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 155.93 -161.62 30.8 Favored Glycine 0 C--N 1.351 1.382 0 N-CA-C 106.767 -2.533 . . . . 0.0 106.767 -178.324 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_exo -61.2 142.47 96.63 Favored 'Trans proline' 0 N--CA 1.446 -1.307 0 C-N-CA 122.837 2.358 . . . . 0.0 114.523 -171.68 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 4.4 t -76.27 154.29 5.89 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.83 0 C-N-CA 127.889 2.476 . . . . 0.0 106.608 -179.06 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 56.6 mm-40 -99.81 92.88 5.51 Favored 'General case' 0 CA--C 1.49 -1.357 0 N-CA-C 107.412 -1.329 . . . . 0.0 107.412 -177.613 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 1.3 p -108.1 131.32 58.82 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.067 0 CA-C-N 113.15 -1.841 . . . . 0.0 108.684 -164.512 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 40.0 m-85 -94.08 144.42 25.5 Favored 'General case' 0 CA--C 1.498 -1.027 0 N-CA-C 106.611 -1.626 . . . . 0.0 106.611 173.823 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 36.0 mm -114.56 96.26 4.49 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.235 0 N-CA-C 102.911 -2.996 . . . . 0.0 102.911 178.245 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 40.6 p -88.44 98.58 11.71 Favored 'General case' 0 N--CA 1.443 -0.805 0 CA-C-O 122.401 1.096 . . . . 0.0 109.776 -172.336 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 92.3 mt-10 -107.08 40.73 1.6 Allowed 'General case' 0 N--CA 1.443 -0.786 0 N-CA-C 105.874 -1.898 . . . . 0.0 105.874 173.595 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 48.3 m -85.74 -57.27 0.36 Allowed Pre-proline 0 N--CA 1.441 -0.913 0 CA-C-O 115.828 -2.034 . . . . 0.0 108.862 178.36 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_endo -74.69 171.8 17.5 Favored 'Trans proline' 0 CA--C 1.512 -0.596 0 CA-C-N 125.39 2.961 . . . . 0.0 110.381 177.242 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 73.3 m -123.15 103.24 8.43 Favored 'General case' 0 N--CA 1.433 -1.306 0 N-CA-C 106.107 -1.812 . . . . 0.0 106.107 -172.959 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 26.9 mp0 -140.71 134.22 14.91 Favored Pre-proline 0 N--CA 1.442 -0.831 0 N-CA-C 104.084 -2.562 . . . . 0.0 104.084 169.495 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 95.7 Cg_endo -81.91 -11.56 11.2 Favored 'Trans proline' 0 N--CA 1.452 -0.928 0 C-N-CA 123.012 2.475 . . . . 0.0 110.596 -175.762 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 48.5 m-20 -125.02 -20.92 4.8 Favored 'General case' 0 N--CA 1.434 -1.25 0 C-N-CA 123.617 0.767 . . . . 0.0 109.938 -171.791 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 19.4 m -103.8 142.0 35.13 Favored 'General case' 0 CA--C 1.494 -1.192 0 N-CA-C 106.993 -1.484 . . . . 0.0 106.993 178.677 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 61.6 t-80 -139.29 98.0 8.37 Favored Pre-proline 0 N--CA 1.434 -1.273 0 N-CA-C 105.513 -2.032 . . . . 0.0 105.513 176.819 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -80.55 148.86 18.45 Favored 'Trans proline' 0 N--CA 1.445 -1.327 0 C-N-CA 122.468 2.112 . . . . 0.0 109.403 174.315 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 5.0 pt -124.38 170.72 14.19 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.031 0 N-CA-C 107.525 -1.287 . . . . 0.0 107.525 172.324 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 32.5 mt-30 -139.04 161.17 38.04 Favored 'General case' 0 CA--C 1.501 -0.926 0 N-CA-C 105.161 -2.163 . . . . 0.0 105.161 167.884 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 49.5 p90 -148.56 169.39 20.41 Favored 'General case' 0 CA--C 1.497 -1.089 0 N-CA-C 108.136 -1.061 . . . . 0.0 108.136 175.679 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 20.8 m-80 -134.12 126.04 29.21 Favored 'General case' 0 CA--C 1.491 -1.308 0 N-CA-C 105.573 -2.01 . . . . 0.0 105.573 173.965 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -105.75 175.96 1.9 Allowed Pre-proline 0 N--CA 1.44 -0.969 0 C-N-CA 125.823 1.649 . . . . 0.0 107.647 -169.967 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_exo -61.6 144.86 97.92 Favored 'Trans proline' 0 N--CA 1.455 -0.766 0 C-N-CA 123.174 2.583 . . . . 0.0 113.151 176.488 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 22.0 tt0 -82.8 -39.98 0.83 Allowed Pre-proline 0 N--CA 1.443 -0.818 0 CA-C-O 115.564 -2.16 . . . . 0.0 112.726 -173.034 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 76.2 Cg_exo -72.18 4.65 3.15 Favored 'Trans proline' 0 C--N 1.349 0.561 0 CA-C-N 125.687 3.067 . . . . 0.0 114.679 -178.234 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 34.7 m 71.89 64.66 0.14 Allowed 'General case' 0 CA--C 1.499 -0.984 0 C-N-CA 126.464 1.905 . . . . 0.0 109.06 -178.432 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 55.9 t-80 -87.0 -28.11 22.83 Favored 'General case' 0 N--CA 1.44 -0.957 0 C-N-CA 125.127 1.371 . . . . 0.0 108.25 178.772 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 8.2 mm -119.29 147.61 22.76 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.15 0 N-CA-C 106.395 -1.706 . . . . 0.0 106.395 -170.959 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 74.5 m -99.35 -83.9 0.42 Allowed 'General case' 0 N--CA 1.43 -1.45 0 N-CA-C 106.406 -1.701 . . . . 0.0 106.406 175.896 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 45.5 mtpt -90.0 170.48 10.32 Favored 'General case' 0 CA--C 1.49 -1.349 0 C-N-CA 125.259 1.424 . . . . 0.0 109.198 -164.242 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 42.2 m-85 -131.39 145.4 51.8 Favored 'General case' 0 CA--C 1.498 -1.032 0 N-CA-C 104.589 -2.374 . . . . 0.0 104.589 166.624 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 33.1 mt -123.34 137.37 56.89 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.188 0 N-CA-C 101.792 -3.41 . . . . 0.0 101.792 170.248 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 4.7 mt -114.09 134.47 54.86 Favored 'General case' 0 CA--C 1.467 -2.214 0 N-CA-C 104.64 -2.356 . . . . 0.0 104.64 168.764 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 49.0 mtp180 -118.05 158.74 24.44 Favored 'General case' 0 N--CA 1.431 -1.417 0 N-CA-C 105.381 -2.081 . . . . 0.0 105.381 167.301 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 49.5 p90 -152.63 158.29 42.21 Favored 'General case' 0 N--CA 1.435 -1.21 0 N-CA-C 105.981 -1.859 . . . . 0.0 105.981 173.033 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 46.9 ttp180 -165.08 135.99 3.14 Favored Pre-proline 0 CA--C 1.497 -1.078 0 N-CA-C 104.783 -2.303 . . . . 0.0 104.783 -174.168 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -73.06 117.06 4.95 Favored 'Trans proline' 0 CA--C 1.505 -0.969 0 C-N-CA 122.766 2.311 . . . . 0.0 109.132 -176.829 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 37.9 ttpt -70.71 88.0 0.7 Allowed 'General case' 0 CA--C 1.499 -0.982 0 C-N-CA 126.414 1.886 . . . . 0.0 109.621 -179.939 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 -154.32 -58.55 0.12 Allowed 'General case' 0 N--CA 1.431 -1.401 0 N-CA-C 103.447 -2.797 . . . . 0.0 103.447 -178.521 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' SER . . . . . 0.577 ' HG ' ' H ' ' A' ' 43' ' ' VAL . 6.4 t -107.32 -167.53 1.28 Allowed 'General case' 0 N--CA 1.439 -0.977 0 N-CA-C 105.228 -2.138 . . . . 0.0 105.228 169.376 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.577 ' H ' ' HG ' ' A' ' 42' ' ' SER . 2.7 m -134.84 63.44 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.44 -0.957 0 N-CA-C 104.823 -2.288 . . . . 0.0 104.823 179.18 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -91.23 -134.71 6.21 Favored Glycine 0 C--N 1.354 1.545 0 N-CA-C 109.819 -1.312 . . . . 0.0 109.819 -176.415 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -94.37 149.57 21.12 Favored 'General case' 0 CA--C 1.499 -1.003 0 N-CA-C 106.871 -1.529 . . . . 0.0 106.871 -176.498 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 64.2 m95 -93.84 151.42 19.61 Favored 'General case' 0 N--CA 1.439 -1.022 0 N-CA-C 107.703 -1.221 . . . . 0.0 107.703 178.825 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 61.9 mttp -96.99 152.32 18.84 Favored 'General case' 0 CA--C 1.488 -1.433 0 N-CA-C 104.105 -2.554 . . . . 0.0 104.105 161.073 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -152.69 155.44 37.27 Favored 'General case' 0 N--CA 1.435 -1.204 0 N-CA-C 108.23 -1.026 . . . . 0.0 108.23 -178.073 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -140.85 161.48 37.72 Favored 'General case' 0 CA--C 1.498 -1.028 0 N-CA-C 106.556 -1.646 . . . . 0.0 106.556 174.74 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 87.0 m -118.83 124.82 48.12 Favored 'General case' 0 CA--C 1.5 -0.954 0 N-CA-C 105.517 -2.031 . . . . 0.0 105.517 178.807 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 3.9 mp -106.13 134.37 19.8 Favored Pre-proline 0 N--CA 1.437 -1.099 0 N-CA-C 105.279 -2.119 . . . . 0.0 105.279 -177.468 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_exo -63.93 163.07 26.53 Favored 'Trans proline' 0 CA--C 1.507 -0.833 0 C-N-CA 123.491 2.794 . . . . 0.0 113.146 176.115 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -74.49 -17.14 79.82 Favored Glycine 0 C--N 1.351 1.41 0 C-N-CA 124.006 0.812 . . . . 0.0 114.477 -173.68 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 49.1 p-80 -84.04 -28.69 27.45 Favored 'General case' 0 C--N 1.355 0.826 0 CA-C-N 118.144 0.972 . . . . 0.0 110.22 -179.69 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 89.1 mt -88.74 130.83 35.26 Favored 'General case' 0 CA--C 1.5 -0.961 0 N-CA-C 107.94 -1.133 . . . . 0.0 107.94 178.07 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 7.7 p30 -117.1 11.37 14.18 Favored 'General case' 0 CA--C 1.503 -0.835 0 C-N-CA 124.225 1.01 . . . . 0.0 109.774 -173.563 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 28.1 p -141.02 159.83 41.38 Favored 'General case' 0 CA--C 1.497 -1.081 0 N-CA-C 106.583 -1.636 . . . . 0.0 106.583 179.427 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 7.9 t80 -135.65 172.95 12.27 Favored 'General case' 0 C--N 1.359 1.003 0 CA-C-O 121.829 0.823 . . . . 0.0 109.254 178.84 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 98.8 m -137.18 110.79 8.04 Favored 'General case' 0 N--CA 1.434 -1.257 0 N-CA-C 104.425 -2.435 . . . . 0.0 104.425 173.77 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 24.9 mt -89.28 143.39 11.27 Favored 'Isoleucine or valine' 0 C--N 1.358 0.945 0 N-CA-C 103.662 -2.718 . . . . 0.0 103.662 169.854 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -149.55 158.1 43.87 Favored 'General case' 0 CA--C 1.491 -1.302 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 -178.85 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 77.75 56.58 3.79 Favored Glycine 0 C--N 1.354 1.561 0 N-CA-C 108.984 -1.646 . . . . 0.0 108.984 -179.904 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 69.1 mt -117.08 -160.83 0.78 Allowed 'General case' 0 CA--C 1.5 -0.944 0 N-CA-C 106.584 -1.636 . . . . 0.0 106.584 -179.012 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -131.39 153.42 81.62 Favored Pre-proline 0 N--CA 1.443 -0.811 0 N-CA-C 106.067 -1.827 . . . . 0.0 106.067 -177.78 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 67.6 Cg_endo -79.4 162.45 25.12 Favored 'Trans proline' 0 N--CA 1.453 -0.886 0 C-N-CA 122.858 2.372 . . . . 0.0 109.925 171.893 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 61.17 26.96 66.62 Favored Glycine 0 N--CA 1.431 -1.646 0 C-N-CA 127.27 2.367 . . . . 0.0 115.972 171.509 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 9.1 p -127.59 142.92 42.31 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.116 0 N-CA-C 108.28 -1.007 . . . . 0.0 108.28 -177.83 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 7.5 p -95.58 128.41 46.79 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.929 0 N-CA-C 107.463 -1.31 . . . . 0.0 107.463 177.029 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 91.5 m-85 -107.73 148.46 29.42 Favored 'General case' 0 CA--C 1.498 -1.039 0 N-CA-C 106.382 -1.71 . . . . 0.0 106.382 174.235 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -98.98 140.04 33.73 Favored 'General case' 0 CA--C 1.496 -1.121 0 N-CA-C 104.397 -2.445 . . . . 0.0 104.397 161.826 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -131.96 153.29 20.45 Favored Glycine 0 CA--C 1.484 -1.848 0 N-CA-C 107.688 -2.165 . . . . 0.0 107.688 -175.807 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 36.7 mt-30 -135.58 136.18 40.88 Favored 'General case' 0 CA--C 1.478 -1.791 0 N-CA-C 105.935 -1.876 . . . . 0.0 105.935 175.166 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 27.1 tp -114.39 103.31 10.94 Favored 'General case' 0 N--CA 1.438 -1.063 0 N-CA-C 104.179 -2.526 . . . . 0.0 104.179 176.456 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 24.4 mt -103.25 125.11 57.77 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.973 0 N-CA-C 104.068 -2.568 . . . . 0.0 104.068 -174.23 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 74.2 m -110.28 120.75 43.45 Favored 'General case' 0 CA--C 1.497 -1.091 0 N-CA-C 108.251 -1.018 . . . . 0.0 108.251 -175.653 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 1.8 mp -99.85 138.38 24.38 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.123 0 N-CA-C 104.647 -2.353 . . . . 0.0 104.647 -170.798 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 16.3 tt0 -105.09 127.84 53.07 Favored 'General case' 0 CA--C 1.494 -1.207 0 N-CA-C 102.02 -3.326 . . . . 0.0 102.02 170.692 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 63.5 tp60 -68.38 114.68 7.03 Favored 'General case' 0 C--N 1.355 0.825 0 C-N-CA 123.117 0.567 . . . . 0.0 111.163 -168.77 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 44.4 m-85 59.33 51.68 6.57 Favored 'General case' 0 C--N 1.358 0.936 0 C-N-CA 126.917 2.087 . . . . 0.0 111.703 -175.498 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -164.73 -117.29 0.4 Allowed Glycine 0 N--CA 1.434 -1.464 0 N-CA-C 108.503 -1.839 . . . . 0.0 108.503 178.042 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 24.0 t-80 -82.08 165.52 20.52 Favored 'General case' 0 N--CA 1.441 -0.919 0 C-N-CA 125.706 1.603 . . . . 0.0 110.795 -169.097 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 41.6 mt-30 -139.96 128.67 23.14 Favored 'General case' 0 CA--C 1.495 -1.151 0 N-CA-C 104.192 -2.521 . . . . 0.0 104.192 169.044 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -99.82 154.31 18.44 Favored 'General case' 0 CA--C 1.498 -1.033 0 N-CA-C 105.363 -2.088 . . . . 0.0 105.363 175.598 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 7.6 p -135.26 135.71 51.93 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.885 0 N-CA-C 107.929 -1.137 . . . . 0.0 107.929 177.533 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 48.6 m -122.01 141.5 51.28 Favored 'General case' 0 N--CA 1.44 -0.939 0 N-CA-C 103.143 -2.91 . . . . 0.0 103.143 175.742 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 32.2 ttm180 -131.72 139.42 49.0 Favored 'General case' 0 CA--C 1.502 -0.891 0 N-CA-C 107.805 -1.183 . . . . 0.0 107.805 170.346 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 8.2 p90 -146.25 179.58 7.41 Favored 'General case' 0 N--CA 1.439 -0.979 0 N-CA-C 105.807 -1.923 . . . . 0.0 105.807 177.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 52.9 m-20 -128.09 152.95 47.37 Favored 'General case' 0 CA--C 1.5 -0.96 0 N-CA-C 105.757 -1.942 . . . . 0.0 105.757 169.481 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 21.8 p90 -143.56 166.37 25.02 Favored 'General case' 0 CA--C 1.485 -1.548 0 N-CA-C 107.498 -1.297 . . . . 0.0 107.498 170.42 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 27.8 p -118.56 143.3 46.86 Favored 'General case' 0 CA--C 1.497 -1.082 0 N-CA-C 106.051 -1.833 . . . . 0.0 106.051 173.672 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 30.3 m -118.39 113.18 21.0 Favored 'General case' 0 CA--C 1.494 -1.185 0 N-CA-C 101.576 -3.49 . . . . 0.0 101.576 170.068 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 10.0 t -157.57 -37.37 0.07 Allowed 'General case' 0 N--CA 1.437 -1.088 0 N-CA-C 107.819 -1.178 . . . . 0.0 107.819 -169.088 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 89.4 p . . . . . 0 C--O 1.259 1.592 0 C-N-CA 126.962 2.105 . . . . 0.0 112.192 -174.66 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 85.1 p . . . . . 0 N--CA 1.487 1.416 0 CA-C-O 121.632 0.729 . . . . 0.0 111.89 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 173.97 179.0 44.32 Favored Glycine 0 N--CA 1.436 -1.353 0 N-CA-C 107.075 -2.41 . . . . 0.0 107.075 178.825 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_exo -60.23 146.8 95.62 Favored 'Trans proline' 0 N--CA 1.446 -1.309 0 C-N-CA 123.151 2.567 . . . . 0.0 115.553 -169.676 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 6.7 t -77.42 153.12 5.44 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.773 0 C-N-CA 127.631 2.372 . . . . 0.0 105.424 174.309 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 94.7 mt-10 -100.27 95.26 6.67 Favored 'General case' 0 CA--C 1.494 -1.19 0 CA-C-O 121.885 0.85 . . . . 0.0 108.742 -170.621 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 1.8 p -115.3 136.05 53.32 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.999 0 C-N-CA 124.938 1.295 . . . . 0.0 108.365 -164.777 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 83.3 m-85 -86.74 148.78 25.28 Favored 'General case' 0 CA--C 1.498 -1.03 0 C-N-CA 125.063 1.345 . . . . 0.0 108.589 -179.14 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 45.2 mt -120.04 144.22 29.38 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.973 0 N-CA-C 102.826 -3.027 . . . . 0.0 102.826 179.377 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 24.9 p -126.89 99.89 5.93 Favored 'General case' 0 C--N 1.356 0.85 0 N-CA-C 105.897 -1.89 . . . . 0.0 105.897 176.209 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -106.73 34.22 3.53 Favored 'General case' 0 C--N 1.356 0.878 0 N-CA-C 108.025 -1.102 . . . . 0.0 108.025 177.284 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 33.1 p -89.45 157.96 46.52 Favored Pre-proline 0 N--CA 1.443 -0.817 0 N-CA-C 106.365 -1.717 . . . . 0.0 106.365 175.713 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 63.9 Cg_endo -78.36 84.04 2.1 Favored 'Trans proline' 0 N--CA 1.45 -1.042 0 C-N-CA 122.878 2.385 . . . . 0.0 109.178 169.306 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 63.0 m -157.54 32.29 0.27 Allowed 'General case' 0 CA--C 1.498 -1.048 0 CA-C-O 122.473 1.13 . . . . 0.0 110.514 -178.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 14.0 mp0 -138.39 86.85 16.17 Favored Pre-proline 0 CA--C 1.507 -0.692 0 CA-C-N 114.183 -1.371 . . . . 0.0 108.588 -178.894 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -86.9 -2.85 8.15 Favored 'Trans proline' 0 N--CA 1.449 -1.089 0 C-N-CA 122.478 2.119 . . . . 0.0 110.565 -177.578 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -165.8 -39.22 0.03 OUTLIER 'General case' 0 CA--C 1.488 -1.412 0 O-C-N 123.711 0.632 . . . . 0.0 110.469 -174.854 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 15.5 p -126.42 138.22 53.51 Favored 'General case' 0 CA--C 1.489 -1.371 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 -169.078 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 67.7 t60 -117.56 113.75 38.34 Favored Pre-proline 0 N--CA 1.438 -1.027 0 CA-C-N 114.238 -1.346 . . . . 0.0 107.878 -175.377 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 62.5 Cg_endo -78.28 128.6 9.02 Favored 'Trans proline' 0 N--CA 1.45 -1.04 0 C-N-CA 122.949 2.433 . . . . 0.0 110.405 175.813 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 9.6 mm -105.92 136.08 41.65 Favored 'Isoleucine or valine' 0 C--N 1.354 0.792 0 N-CA-C 103.485 -2.783 . . . . 0.0 103.485 169.833 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 67.5 mt-30 -136.41 147.8 47.46 Favored 'General case' 0 CA--C 1.495 -1.148 0 N-CA-C 104.562 -2.384 . . . . 0.0 104.562 174.18 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 45.9 p90 -147.15 170.04 18.03 Favored 'General case' 0 CA--C 1.494 -1.186 0 N-CA-C 108.002 -1.11 . . . . 0.0 108.002 -175.673 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 26.6 m-80 -136.01 131.82 35.5 Favored 'General case' 0 CA--C 1.49 -1.354 0 N-CA-C 105.377 -2.083 . . . . 0.0 105.377 177.635 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -101.2 170.91 5.94 Favored Pre-proline 0 N--CA 1.439 -0.992 0 C-N-CA 124.541 1.136 . . . . 0.0 108.402 -172.651 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_exo -64.9 165.32 21.63 Favored 'Trans proline' 0 CA--C 1.51 -0.694 0 C-N-CA 123.701 2.934 . . . . 0.0 112.83 173.712 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 79.8 mt-30 -81.51 -55.61 0.62 Allowed Pre-proline 0 N--CA 1.442 -0.829 0 CA-C-O 115.612 -2.137 . . . . 0.0 112.042 -175.58 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_endo -75.29 173.56 14.3 Favored 'Trans proline' 0 CA--C 1.509 -0.726 0 CA-C-N 125.797 3.106 . . . . 0.0 110.431 -179.581 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 52.3 p -73.1 123.83 24.35 Favored 'General case' 0 C--N 1.355 0.845 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 179.014 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 58.7 t60 -160.85 -50.78 0.05 OUTLIER 'General case' 0 CA--C 1.492 -1.253 0 N-CA-C 106.639 -1.615 . . . . 0.0 106.639 -165.143 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 35.5 mt -116.7 140.3 39.73 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.169 0 N-CA-C 105.217 -2.142 . . . . 0.0 105.217 -175.625 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 72.8 m -106.06 -87.55 0.46 Allowed 'General case' 0 N--CA 1.429 -1.484 0 N-CA-C 105.916 -1.883 . . . . 0.0 105.916 178.605 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 53.9 mtmt -91.41 172.33 8.6 Favored 'General case' 0 CA--C 1.485 -1.547 0 C-N-CA 124.927 1.291 . . . . 0.0 108.235 -166.838 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 36.1 m-85 -131.5 151.91 51.17 Favored 'General case' 0 CA--C 1.496 -1.11 0 N-CA-C 105.071 -2.196 . . . . 0.0 105.071 169.164 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 24.6 mt -121.28 134.23 65.3 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.162 0 N-CA-C 101.939 -3.356 . . . . 0.0 101.939 164.941 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 6.5 mt -105.93 123.6 48.23 Favored 'General case' 0 CA--C 1.48 -1.748 0 N-CA-C 104.011 -2.589 . . . . 0.0 104.011 166.669 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 42.8 ttp85 -127.7 123.5 35.58 Favored 'General case' 0 N--CA 1.436 -1.128 0 N-CA-C 105.515 -2.032 . . . . 0.0 105.515 -179.094 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 41.6 p90 -136.86 150.29 48.19 Favored 'General case' 0 CA--C 1.503 -0.841 0 N-CA-C 107.681 -1.229 . . . . 0.0 107.681 -170.89 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 43.3 ptt85 -141.33 158.4 63.99 Favored Pre-proline 0 CA--C 1.499 -1.0 0 N-CA-C 105.754 -1.943 . . . . 0.0 105.754 168.713 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -72.3 164.96 34.04 Favored 'Trans proline' 0 N--CA 1.453 -0.856 0 C-N-CA 123.306 2.671 . . . . 0.0 107.811 162.45 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 5.4 ptmm? -63.66 88.02 0.04 OUTLIER 'General case' 0 C--N 1.357 0.914 0 CA-C-O 122.584 1.183 . . . . 0.0 112.592 172.402 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 31.5 m120 -130.39 -132.09 0.21 Allowed 'General case' 0 N--CA 1.44 -0.952 0 N-CA-C 104.593 -2.373 . . . . 0.0 104.593 176.302 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 57.0 p -99.44 174.24 6.37 Favored 'General case' 0 C--N 1.355 0.811 0 N-CA-C 107.671 -1.233 . . . . 0.0 107.671 176.388 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 9.5 m -100.6 41.63 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.354 0.772 0 C-N-CA 124.758 1.223 . . . . 0.0 108.142 179.128 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -85.13 -99.62 0.68 Allowed Glycine 0 C--N 1.355 1.587 0 N-CA-C 108.532 -1.827 . . . . 0.0 108.532 -179.618 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 96.3 mtm-85 -97.93 141.55 30.76 Favored 'General case' 0 CA--C 1.499 -1.012 0 N-CA-C 107.204 -1.406 . . . . 0.0 107.204 176.278 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 14.6 m95 -121.63 171.78 8.59 Favored 'General case' 0 N--CA 1.439 -1.014 0 N-CA-C 105.413 -2.069 . . . . 0.0 105.413 -177.366 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -101.72 150.27 23.3 Favored 'General case' 0 CA--C 1.486 -1.491 0 N-CA-C 105.072 -2.196 . . . . 0.0 105.072 169.167 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -153.96 158.18 40.27 Favored 'General case' 0 CA--C 1.495 -1.171 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 179.841 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -138.59 160.12 40.39 Favored 'General case' 0 N--CA 1.438 -1.068 0 N-CA-C 105.186 -2.153 . . . . 0.0 105.186 173.94 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 81.6 m -115.88 123.15 47.4 Favored 'General case' 0 CA--C 1.496 -1.12 0 N-CA-C 104.775 -2.306 . . . . 0.0 104.775 177.895 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 3.8 mm -101.18 135.59 19.88 Favored Pre-proline 0 N--CA 1.437 -1.095 0 N-CA-C 105.669 -1.975 . . . . 0.0 105.669 -176.349 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 95.4 Cg_exo -63.69 161.02 33.81 Favored 'Trans proline' 0 CA--C 1.508 -0.805 0 C-N-CA 123.354 2.703 . . . . 0.0 112.257 172.093 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -78.38 -18.25 76.39 Favored Glycine 0 C--N 1.352 1.448 0 C-N-CA 123.439 0.543 . . . . 0.0 113.491 -172.685 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 48.0 p-80 -83.78 -27.18 29.02 Favored 'General case' 0 C--N 1.355 0.838 0 CA-C-N 117.695 0.747 . . . . 0.0 109.923 179.737 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 88.3 mt -88.74 130.43 35.34 Favored 'General case' 0 CA--C 1.498 -1.043 0 N-CA-C 107.977 -1.119 . . . . 0.0 107.977 177.539 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 7.7 p30 -117.98 16.67 14.23 Favored 'General case' 0 CA--C 1.501 -0.929 0 C-N-CA 124.359 1.064 . . . . 0.0 108.935 -177.026 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 35.9 p -144.53 161.77 38.24 Favored 'General case' 0 N--CA 1.438 -1.039 0 N-CA-C 107.204 -1.406 . . . . 0.0 107.204 -179.796 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 12.0 t80 -152.83 178.65 9.42 Favored 'General case' 0 N--CA 1.438 -1.032 0 N-CA-C 106.955 -1.498 . . . . 0.0 106.955 179.687 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 80.8 m -144.34 115.59 7.98 Favored 'General case' 0 N--CA 1.426 -1.633 0 N-CA-C 103.752 -2.684 . . . . 0.0 103.752 174.421 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 53.9 mt -92.58 108.38 20.18 Favored 'Isoleucine or valine' 0 C--N 1.354 0.767 0 N-CA-C 105.236 -2.135 . . . . 0.0 105.236 175.906 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 10.0 mtmp? -108.23 163.74 12.91 Favored 'General case' 0 CA--C 1.498 -1.054 0 CA-C-O 121.547 0.689 . . . . 0.0 109.143 -175.531 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 80.37 50.67 5.28 Favored Glycine 0 CA--C 1.489 -1.552 0 N-CA-C 108.713 -1.755 . . . . 0.0 108.713 174.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 75.7 mt -121.72 163.81 18.45 Favored 'General case' 0 CA--C 1.498 -1.027 0 N-CA-C 106.954 -1.499 . . . . 0.0 106.954 -175.748 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 53.2 mtmt -98.78 147.83 33.73 Favored Pre-proline 0 N--CA 1.44 -0.926 0 N-CA-C 107.026 -1.472 . . . . 0.0 107.026 -177.096 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -76.58 162.66 32.82 Favored 'Trans proline' 0 N--CA 1.451 -1.025 0 C-N-CA 122.95 2.433 . . . . 0.0 109.85 169.832 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 63.34 23.44 66.49 Favored Glycine 0 N--CA 1.428 -1.84 0 C-N-CA 127.417 2.437 . . . . 0.0 116.619 174.905 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 6.5 p -128.84 145.39 35.76 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.857 0 N-CA-C 107.966 -1.124 . . . . 0.0 107.966 -179.684 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 10.7 p -96.83 129.94 46.15 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.857 0 CA-C-O 123.187 1.47 . . . . 0.0 108.537 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 80.0 m-85 -104.65 145.11 30.79 Favored 'General case' 0 N--CA 1.432 -1.373 0 N-CA-C 106.435 -1.691 . . . . 0.0 106.435 176.563 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -91.02 133.1 35.58 Favored 'General case' 0 N--CA 1.442 -0.855 0 N-CA-C 105.336 -2.098 . . . . 0.0 105.336 159.502 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -130.26 158.69 22.51 Favored Glycine 0 C--N 1.355 1.61 0 N-CA-C 108.229 -1.948 . . . . 0.0 108.229 -179.897 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 32.0 mt-30 -149.77 138.57 20.96 Favored 'General case' 0 CA--C 1.484 -1.561 0 N-CA-C 105.422 -2.066 . . . . 0.0 105.422 -178.717 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 52.7 tp -117.47 98.21 6.28 Favored 'General case' 0 N--CA 1.437 -1.08 0 N-CA-C 104.846 -2.279 . . . . 0.0 104.846 179.436 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 48.0 mt -89.63 133.98 30.13 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.962 0 N-CA-C 104.558 -2.386 . . . . 0.0 104.558 -179.585 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 12.1 p -117.13 117.4 29.49 Favored 'General case' 0 N--CA 1.438 -1.075 0 N-CA-C 107.728 -1.212 . . . . 0.0 107.728 -178.427 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 2.6 mp -94.07 130.67 42.66 Favored 'Isoleucine or valine' 0 CA--C 1.487 -1.478 0 N-CA-C 103.455 -2.795 . . . . 0.0 103.455 -172.677 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 21.5 mt-30 -101.84 161.89 13.32 Favored 'General case' 0 CA--C 1.491 -1.295 0 CA-C-N 114.849 -1.069 . . . . 0.0 108.817 -169.845 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 14.4 pt20 -76.29 34.0 0.13 Allowed 'General case' 0 C--N 1.354 0.794 0 C-N-CA 126.537 1.935 . . . . 0.0 113.186 173.943 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 6.4 t80 -148.67 14.13 0.94 Allowed 'General case' 0 N--CA 1.437 -1.095 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 178.366 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 80.26 1.84 88.57 Favored Glycine 0 C--N 1.351 1.412 0 C-N-CA 123.897 0.761 . . . . 0.0 112.732 176.864 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 86.2 t60 -81.9 158.47 23.96 Favored 'General case' 0 N--CA 1.44 -0.953 0 N-CA-C 107.842 -1.17 . . . . 0.0 107.842 -178.918 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 71.7 mt-30 -138.33 110.29 7.24 Favored 'General case' 0 CA--C 1.491 -1.322 0 N-CA-C 102.854 -3.017 . . . . 0.0 102.854 178.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 16.8 tp10 -100.76 132.1 46.32 Favored 'General case' 0 CA--C 1.495 -1.153 0 N-CA-C 105.215 -2.143 . . . . 0.0 105.215 -179.94 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 6.6 p -109.25 134.94 49.69 Favored 'Isoleucine or valine' 0 C--N 1.355 0.818 0 N-CA-C 107.58 -1.267 . . . . 0.0 107.58 -174.061 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 90.8 m -110.66 138.61 46.83 Favored 'General case' 0 N--CA 1.44 -0.927 0 N-CA-C 102.477 -3.157 . . . . 0.0 102.477 171.272 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 16.7 ptm180 -129.67 152.39 49.23 Favored 'General case' 0 CA--C 1.499 -1.011 0 CA-C-N 118.84 0.745 . . . . 0.0 110.025 176.918 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 18.5 p90 -165.53 -177.95 4.67 Favored 'General case' 0 CA--C 1.5 -0.956 0 N-CA-C 106.323 -1.732 . . . . 0.0 106.323 -175.731 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 45.7 p-10 -134.22 158.16 44.42 Favored 'General case' 0 N--CA 1.44 -0.945 0 N-CA-C 106.286 -1.746 . . . . 0.0 106.286 166.608 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 24.3 p90 -143.1 164.61 29.67 Favored 'General case' 0 CA--C 1.482 -1.641 0 N-CA-C 106.785 -1.561 . . . . 0.0 106.785 170.838 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 38.4 p -113.73 141.61 47.05 Favored 'General case' 0 CA--C 1.498 -1.042 0 N-CA-C 105.919 -1.882 . . . . 0.0 105.919 172.749 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 97.5 m -109.57 112.84 25.16 Favored 'General case' 0 CA--C 1.491 -1.325 1 N-CA-C 100.189 -4.004 . . . . 0.0 100.189 168.041 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 11.9 t -159.24 149.79 19.49 Favored 'General case' 0 N--CA 1.437 -1.113 0 N-CA-C 105.375 -2.083 . . . . 0.0 105.375 -174.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 25.7 t . . . . . 0 C--O 1.261 1.708 0 N-CA-C 104.89 -2.263 . . . . 0.0 104.89 171.411 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' SER . . . . . 0.65 ' HG ' HE21 ' A' ' 77' ' ' GLN . 99.8 p . . . . . 0 N--CA 1.488 1.468 0 CA-C-O 121.471 0.653 . . . . 0.0 111.185 . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -158.24 -168.6 20.72 Favored Glycine 0 N--CA 1.435 -1.383 0 N-CA-C 106.309 -2.716 . . . . 0.0 106.309 179.854 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . 0.423 ' HA ' ' HG1' ' A' ' 85' ' ' THR . 92.5 Cg_exo -62.37 138.14 69.46 Favored 'Trans proline' 0 N--CA 1.445 -1.356 0 C-N-CA 122.923 2.416 . . . . 0.0 112.973 -171.282 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 2.9 t -77.76 152.65 5.35 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.672 0 C-N-CA 126.443 1.897 . . . . 0.0 106.098 -179.805 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 52.7 mt-10 -96.16 91.34 5.87 Favored 'General case' 0 CA--C 1.494 -1.201 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 -173.335 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 2.1 p -110.22 129.43 65.27 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.075 0 N-CA-C 107.438 -1.319 . . . . 0.0 107.438 -164.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 75.6 m-85 -133.55 155.81 48.95 Favored 'General case' 0 CA--C 1.496 -1.109 0 N-CA-C 106.043 -1.836 . . . . 0.0 106.043 -175.035 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 50.3 mm -110.56 102.49 14.05 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.262 0 N-CA-C 105.689 -1.967 . . . . 0.0 105.689 -178.336 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 14.8 t -158.37 159.76 36.18 Favored 'General case' 0 N--CA 1.437 -1.079 0 N-CA-C 105.04 -2.207 . . . . 0.0 105.04 174.128 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 149.21 -64.91 0.0 OUTLIER 'General case' 0 CA--C 1.494 -1.19 0 N-CA-C 102.702 -3.073 . . . . 0.0 102.702 171.947 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 5.3 t -155.08 87.45 3.28 Favored Pre-proline 0 N--CA 1.439 -0.996 0 N-CA-C 105.504 -2.036 . . . . 0.0 105.504 175.919 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 70.0 Cg_endo -86.32 34.87 0.46 Allowed 'Trans proline' 0 N--CA 1.457 -0.625 0 C-N-CA 123.472 2.781 . . . . 0.0 110.281 174.547 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 68.6 m -122.62 42.41 3.18 Favored 'General case' 0 CA--C 1.499 -1.012 0 N-CA-C 106.781 -1.563 . . . . 0.0 106.781 178.535 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 99.1 mm-40 -136.47 113.15 10.17 Favored Pre-proline 0 N--CA 1.439 -0.997 0 CA-C-N 113.024 -1.898 . . . . 0.0 106.882 -175.094 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 98.7 Cg_endo -89.6 -7.41 4.8 Favored 'Trans proline' 0 N--CA 1.453 -0.874 0 C-N-CA 122.76 2.306 . . . . 0.0 110.156 175.347 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 6.9 p-10 -102.79 -40.96 6.35 Favored 'General case' 0 CA--C 1.49 -1.356 0 C-N-CA 123.583 0.753 . . . . 0.0 109.61 -172.633 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 35.0 p -110.31 153.62 24.63 Favored 'General case' 0 CA--C 1.495 -1.154 0 N-CA-C 107.081 -1.452 . . . . 0.0 107.081 176.189 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 45.0 t-80 -136.85 98.83 10.47 Favored Pre-proline 0 N--CA 1.435 -1.224 0 N-CA-C 106.778 -1.564 . . . . 0.0 106.778 178.695 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -76.51 130.41 11.76 Favored 'Trans proline' 0 N--CA 1.447 -1.252 0 C-N-CA 122.76 2.307 . . . . 0.0 110.005 -177.441 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 14.5 mm -107.69 148.06 12.18 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.017 0 N-CA-C 103.088 -2.93 . . . . 0.0 103.088 176.127 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 4.4 pt20 -149.68 152.3 35.14 Favored 'General case' 0 CA--C 1.489 -1.377 0 N-CA-C 104.299 -2.482 . . . . 0.0 104.299 167.183 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 44.6 p90 -147.15 166.98 25.31 Favored 'General case' 0 N--CA 1.436 -1.142 0 N-CA-C 106.595 -1.632 . . . . 0.0 106.595 -169.755 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 40.9 m-80 -138.81 132.5 30.68 Favored 'General case' 0 CA--C 1.49 -1.335 0 N-CA-C 107.487 -1.301 . . . . 0.0 107.487 -179.051 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -92.69 175.53 3.18 Favored Pre-proline 0 N--CA 1.44 -0.947 0 C-N-CA 125.696 1.599 . . . . 0.0 109.865 -167.122 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 78.6 Cg_exo -63.94 164.87 20.51 Favored 'Trans proline' 0 N--CA 1.455 -0.757 0 C-N-CA 123.672 2.914 . . . . 0.0 112.491 169.7 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 71.1 tp60 -80.92 -42.42 1.2 Allowed Pre-proline 0 N--CA 1.444 -0.759 0 CA-C-O 115.911 -1.995 . . . . 0.0 110.758 -175.799 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -70.02 -16.49 36.49 Favored 'Trans proline' 0 CA--C 1.512 -0.623 0 CA-C-N 125.382 2.958 . . . . 0.0 112.418 172.505 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 10.4 t 64.95 78.73 0.27 Allowed 'General case' 0 C--N 1.358 0.969 0 C-N-CA 126.545 1.938 . . . . 0.0 109.652 -176.799 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 20.1 t-160 -91.6 -6.68 51.9 Favored 'General case' 0 N--CA 1.442 -0.857 0 C-N-CA 124.755 1.222 . . . . 0.0 109.319 -177.466 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 84.5 mt -113.74 145.55 19.47 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.99 0 N-CA-C 104.736 -2.32 . . . . 0.0 104.736 -173.251 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 25.2 t -103.95 -87.49 0.43 Allowed 'General case' 0 N--CA 1.43 -1.464 0 N-CA-C 105.96 -1.867 . . . . 0.0 105.96 177.241 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 27.4 mtpp -89.58 167.45 12.94 Favored 'General case' 0 CA--C 1.486 -1.504 0 C-N-CA 125.693 1.597 . . . . 0.0 108.94 -163.546 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 90.9 m-85 -134.53 142.72 47.1 Favored 'General case' 0 CA--C 1.493 -1.244 0 N-CA-C 105.072 -2.196 . . . . 0.0 105.072 172.445 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 16.5 mt -123.04 134.45 66.13 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.178 0 N-CA-C 101.786 -3.413 . . . . 0.0 101.786 171.765 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 2.7 mt -110.8 131.48 55.02 Favored 'General case' 0 CA--C 1.473 -1.982 0 N-CA-C 105.715 -1.957 . . . . 0.0 105.715 173.416 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 2.2 mpt_? -115.65 157.72 23.8 Favored 'General case' 0 N--CA 1.428 -1.529 0 N-CA-C 104.981 -2.229 . . . . 0.0 104.981 172.506 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 37.5 p90 -151.01 136.26 17.64 Favored 'General case' 0 N--CA 1.432 -1.363 0 N-CA-C 105.695 -1.965 . . . . 0.0 105.695 171.204 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 15.3 ttp180 -137.39 135.79 19.81 Favored Pre-proline 0 CA--C 1.498 -1.038 0 N-CA-C 103.413 -2.81 . . . . 0.0 103.413 -178.716 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -77.33 155.15 32.48 Favored 'Trans proline' 0 CA--C 1.502 -1.086 0 CA-C-N 123.292 2.211 . . . . 0.0 108.686 179.563 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 70.8 mmtt -73.14 60.71 0.58 Allowed 'General case' 0 C--N 1.356 0.88 0 C-N-CA 125.704 1.601 . . . . 0.0 110.465 170.157 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 29.0 m120 -154.57 -56.93 0.11 Allowed 'General case' 0 N--CA 1.436 -1.17 0 N-CA-C 102.888 -3.004 . . . . 0.0 102.888 -173.163 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 34.8 m -85.31 160.75 19.75 Favored 'General case' 0 N--CA 1.44 -0.941 0 N-CA-C 108.374 -0.973 . . . . 0.0 108.374 178.181 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 17.4 m -131.69 -5.48 1.97 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.784 0 C-N-CA 124.522 1.129 . . . . 0.0 108.821 -173.827 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -142.85 -43.48 0.05 OUTLIER Glycine 0 C--N 1.356 1.644 0 N-CA-C 109.311 -1.516 . . . . 0.0 109.311 -172.656 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 79.7 ttt180 -80.92 126.16 31.02 Favored 'General case' 0 CA--C 1.502 -0.887 0 C-N-CA 124.183 0.993 . . . . 0.0 108.685 -176.89 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -155.97 -177.75 6.8 Favored 'General case' 0 CA--C 1.492 -1.269 0 CA-C-O 121.426 0.632 . . . . 0.0 109.825 -179.681 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 66.7 mttm -130.76 159.91 35.91 Favored 'General case' 0 N--CA 1.435 -1.211 0 N-CA-C 105.402 -2.074 . . . . 0.0 105.402 -175.698 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -149.44 159.84 43.95 Favored 'General case' 0 N--CA 1.434 -1.246 0 N-CA-C 107.691 -1.225 . . . . 0.0 107.691 175.947 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -141.29 157.97 44.51 Favored 'General case' 0 CA--C 1.496 -1.115 0 N-CA-C 106.398 -1.705 . . . . 0.0 106.398 170.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 89.0 m -118.84 127.06 53.16 Favored 'General case' 0 CA--C 1.5 -0.972 0 N-CA-C 105.954 -1.869 . . . . 0.0 105.954 -178.331 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 5.3 mp -114.39 133.91 22.38 Favored Pre-proline 0 N--CA 1.438 -1.072 0 N-CA-C 104.893 -2.262 . . . . 0.0 104.893 -175.695 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 62.6 Cg_exo -63.89 169.07 10.87 Favored 'Trans proline' 0 CA--C 1.508 -0.807 0 C-N-CA 123.387 2.724 . . . . 0.0 113.376 177.155 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -78.42 -19.74 73.39 Favored Glycine 0 C--N 1.351 1.398 0 C-N-CA 123.171 0.415 . . . . 0.0 113.559 -173.851 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 48.8 p-80 -83.84 -28.15 28.22 Favored 'General case' 0 C--N 1.356 0.887 0 CA-C-N 117.755 0.778 . . . . 0.0 109.962 -179.418 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 84.4 mt -88.77 130.49 35.35 Favored 'General case' 0 CA--C 1.501 -0.917 0 N-CA-C 107.723 -1.214 . . . . 0.0 107.723 177.162 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 8.0 p-10 -116.87 10.2 14.06 Favored 'General case' 0 CA--C 1.501 -0.912 0 C-N-CA 123.994 0.918 . . . . 0.0 110.098 -172.203 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 60.1 p -143.03 167.76 21.31 Favored 'General case' 0 N--CA 1.44 -0.942 0 N-CA-C 107.854 -1.165 . . . . 0.0 107.854 -178.631 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 8.3 t80 -155.48 178.27 10.42 Favored 'General case' 0 N--CA 1.441 -0.921 0 N-CA-C 108.023 -1.103 . . . . 0.0 108.023 -176.851 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 97.2 m -145.01 114.91 7.36 Favored 'General case' 0 N--CA 1.432 -1.34 0 N-CA-C 103.859 -2.645 . . . . 0.0 103.859 177.347 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 54.0 mt -97.02 96.68 5.59 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.822 0 N-CA-C 105.767 -1.938 . . . . 0.0 105.767 175.566 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.94 161.76 13.41 Favored 'General case' 0 CA--C 1.498 -1.031 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 -178.381 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 83.7 52.47 3.69 Favored Glycine 0 C--N 1.353 1.501 0 N-CA-C 108.866 -1.694 . . . . 0.0 108.866 177.637 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 76.3 mt -119.19 166.04 13.46 Favored 'General case' 0 CA--C 1.496 -1.11 0 N-CA-C 106.736 -1.579 . . . . 0.0 106.736 -179.51 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 61.1 mttp -97.66 156.59 35.91 Favored Pre-proline 0 N--CA 1.441 -0.898 0 N-CA-C 106.859 -1.534 . . . . 0.0 106.859 -175.666 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 66.2 Cg_endo -77.45 155.63 32.19 Favored 'Trans proline' 0 N--CA 1.451 -0.987 0 C-N-CA 122.808 2.339 . . . . 0.0 109.844 172.063 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 60.15 29.12 67.75 Favored Glycine 0 C--N 1.355 1.584 0 C-N-CA 126.674 2.083 . . . . 0.0 116.628 170.507 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 10.6 p -122.35 138.99 50.65 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.122 0 N-CA-C 107.747 -1.205 . . . . 0.0 107.747 179.472 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 2.4 p -97.74 134.99 33.83 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.818 0 N-CA-C 106.663 -1.606 . . . . 0.0 106.663 177.946 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 94.4 m-85 -114.23 154.4 27.98 Favored 'General case' 0 CA--C 1.502 -0.878 0 C-N-CA 124.97 1.308 . . . . 0.0 107.617 179.492 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -95.18 142.13 27.98 Favored 'General case' 0 CA--C 1.505 -0.787 0 N-CA-C 105.516 -2.031 . . . . 0.0 105.516 155.815 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -132.52 143.66 15.33 Favored Glycine 0 CA--C 1.487 -1.683 0 N-CA-C 107.565 -2.214 . . . . 0.0 107.565 -177.614 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 32.3 mt-30 -135.94 132.59 36.62 Favored 'General case' 0 CA--C 1.489 -1.375 0 N-CA-C 106.361 -1.718 . . . . 0.0 106.361 -178.189 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 47.2 tp -113.9 97.72 6.56 Favored 'General case' 0 N--CA 1.438 -1.042 0 N-CA-C 104.408 -2.441 . . . . 0.0 104.408 -176.757 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 1.8 mp -88.7 125.34 41.88 Favored 'Isoleucine or valine' 0 CA--C 1.499 -1.013 0 N-CA-C 103.585 -2.746 . . . . 0.0 103.585 -176.781 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 12.8 p -121.1 109.27 14.82 Favored 'General case' 0 N--CA 1.436 -1.129 0 N-CA-C 108.214 -1.032 . . . . 0.0 108.214 -170.405 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 29.7 mt -102.1 140.79 19.71 Favored 'Isoleucine or valine' 0 CA--C 1.487 -1.453 0 N-CA-C 105.787 -1.931 . . . . 0.0 105.787 -165.183 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . 0.65 HE21 ' HG ' ' A' ' 1' ' ' SER . 72.1 mt-30 -87.97 -178.86 6.1 Favored 'General case' 0 CA--C 1.505 -0.753 0 C-N-CA 123.49 0.716 . . . . 0.0 109.47 -177.374 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 85.2 mt-30 -74.3 84.03 1.91 Allowed 'General case' 0 C--N 1.357 0.928 0 C-N-CA 124.779 1.232 . . . . 0.0 110.753 175.465 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 82.6 m-85 58.5 28.38 16.88 Favored 'General case' 0 C--N 1.359 1.006 0 C-N-CA 126.75 2.02 . . . . 0.0 112.27 -177.682 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -112.53 -118.71 3.61 Favored Glycine 0 C--N 1.356 1.683 0 N-CA-C 108.88 -1.688 . . . . 0.0 108.88 -173.729 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . 0.43 ' CD2' ' H ' ' A' ' 82' ' ' GLN . 10.1 t-160 -80.9 169.11 17.96 Favored 'General case' 0 N--CA 1.441 -0.89 0 C-N-CA 125.005 1.322 . . . . 0.0 109.323 -174.761 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . 0.43 ' H ' ' CD2' ' A' ' 81' ' ' HIS . 22.3 tt0 -127.47 109.3 11.61 Favored 'General case' 0 N--CA 1.434 -1.229 0 N-CA-C 101.842 -3.392 . . . . 0.0 101.842 170.377 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 4.3 tm-20 -102.83 153.94 19.69 Favored 'General case' 0 CA--C 1.506 -0.748 0 N-CA-C 105.721 -1.955 . . . . 0.0 105.721 -171.938 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 4.4 p -127.94 128.89 69.54 Favored 'Isoleucine or valine' 0 C--N 1.354 0.771 0 N-CA-C 108.274 -1.01 . . . . 0.0 108.274 179.874 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' THR . . . . . 0.423 ' HG1' ' HA ' ' A' ' 3' ' ' PRO . 52.1 m -109.83 139.09 45.29 Favored 'General case' 0 N--CA 1.443 -0.807 0 N-CA-C 102.432 -3.173 . . . . 0.0 102.432 171.694 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 51.6 ttt85 -130.99 142.8 50.37 Favored 'General case' 0 CA--C 1.502 -0.866 0 N-CA-C 108.428 -0.953 . . . . 0.0 108.428 -179.076 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 15.7 p90 -157.07 -176.39 5.95 Favored 'General case' 0 N--CA 1.439 -1.003 0 N-CA-C 105.78 -1.933 . . . . 0.0 105.78 178.769 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 1.4 p30 -136.15 157.02 47.82 Favored 'General case' 0 N--CA 1.439 -0.999 0 N-CA-C 106.296 -1.742 . . . . 0.0 106.296 167.571 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 36.9 p90 -144.45 174.51 10.87 Favored 'General case' 0 CA--C 1.487 -1.469 0 N-CA-C 106.03 -1.841 . . . . 0.0 106.03 171.759 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 10.1 t -142.31 154.37 44.64 Favored 'General case' 0 N--CA 1.439 -0.988 0 N-CA-C 106.7 -1.592 . . . . 0.0 106.7 176.789 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 4.3 p -113.27 120.94 42.89 Favored 'General case' 0 N--CA 1.436 -1.16 0 N-CA-C 101.264 -3.606 . . . . 0.0 101.264 168.184 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 15.0 t -157.71 21.47 0.27 Allowed 'General case' 0 N--CA 1.442 -0.85 0 N-CA-C 106.451 -1.685 . . . . 0.0 106.451 -173.049 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 19.7 m . . . . . 0 C--O 1.26 1.611 0 C-N-CA 123.356 0.662 . . . . 0.0 109.671 -175.77 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 98.8 p . . . . . 0 N--CA 1.487 1.414 0 CA-C-O 121.639 0.733 . . . . 0.0 111.649 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 162.11 -171.4 38.0 Favored Glycine 0 N--CA 1.436 -1.317 0 N-CA-C 105.79 -2.924 . . . . 0.0 105.79 -179.253 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 8.8 Cg_exo -54.61 146.05 55.89 Favored 'Trans proline' 0 N--CA 1.449 -1.133 0 C-N-CA 124.329 3.353 . . . . 0.0 114.898 -168.241 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 5.5 t -77.46 152.5 5.48 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.716 0 N-CA-C 105.436 -2.061 . . . . 0.0 105.436 -177.904 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 92.8 mt-10 -98.54 89.44 4.4 Favored 'General case' 0 CA--C 1.493 -1.234 0 CA-C-O 122.13 0.967 . . . . 0.0 108.666 -169.729 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 2.4 p -111.52 132.33 60.39 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.08 0 N-CA-C 106.979 -1.489 . . . . 0.0 106.979 -166.946 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 67.9 m-85 -144.77 174.83 10.65 Favored 'General case' 0 CA--C 1.498 -1.055 0 N-CA-C 106.125 -1.805 . . . . 0.0 106.125 -174.61 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 19.3 tt -136.43 131.2 48.03 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.047 0 N-CA-C 103.275 -2.861 . . . . 0.0 103.275 159.951 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 15.1 t -143.63 10.92 1.64 Allowed 'General case' 0 N--CA 1.439 -0.995 0 N-CA-C 106.588 -1.634 . . . . 0.0 106.588 -177.733 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 6.8 mp0 -85.82 -69.74 0.64 Allowed 'General case' 0 CA--C 1.497 -1.084 0 N-CA-C 107.696 -1.224 . . . . 0.0 107.696 -175.25 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' THR . . . . . 0.428 HG22 HE21 ' A' ' 14' ' ' GLN . 43.4 p -101.98 130.1 25.08 Favored Pre-proline 0 N--CA 1.442 -0.869 0 N-CA-C 107.639 -1.245 . . . . 0.0 107.639 -175.734 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -81.37 -16.27 9.58 Favored 'Trans proline' 0 N--CA 1.453 -0.872 0 C-N-CA 122.863 2.376 . . . . 0.0 110.009 171.464 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 65.8 m -156.12 122.94 5.24 Favored 'General case' 0 N--CA 1.432 -1.344 0 N-CA-C 104.01 -2.589 . . . . 0.0 104.01 -177.594 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . 0.428 HE21 HG22 ' A' ' 11' ' ' THR . 7.5 tp-100 -157.43 111.36 1.86 Allowed Pre-proline 0 N--CA 1.437 -1.121 0 N-CA-C 105.834 -1.913 . . . . 0.0 105.834 171.695 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -83.46 -25.83 2.41 Favored 'Trans proline' 0 CA--C 1.504 -1.008 0 C-N-CA 122.213 1.942 . . . . 0.0 110.97 -169.567 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 1.9 p30 -100.16 -45.43 5.64 Favored 'General case' 0 CA--C 1.488 -1.417 0 C-N-CA 123.596 0.759 . . . . 0.0 109.985 -166.516 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 75.2 m -107.63 158.65 17.08 Favored 'General case' 0 CA--C 1.496 -1.106 0 N-CA-C 107.794 -1.187 . . . . 0.0 107.794 -179.346 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 11.7 t-160 -135.74 85.15 30.87 Favored Pre-proline 0 N--CA 1.438 -1.048 0 N-CA-C 105.593 -2.003 . . . . 0.0 105.593 172.884 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 64.7 Cg_endo -81.78 98.1 0.96 Allowed 'Trans proline' 0 N--CA 1.451 -0.987 0 C-N-CA 123.325 2.683 . . . . 0.0 110.156 -174.713 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 3.0 pt -97.6 173.21 1.0 Allowed 'Isoleucine or valine' 0 CA--C 1.499 -0.99 0 CA-C-O 121.181 0.515 . . . . 0.0 109.992 -173.497 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 1.9 pt20 -151.53 161.58 42.45 Favored 'General case' 0 CA--C 1.496 -1.099 0 N-CA-C 105.699 -1.963 . . . . 0.0 105.699 164.079 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 42.4 p90 -139.62 162.82 34.17 Favored 'General case' 0 CA--C 1.496 -1.122 0 N-CA-C 106.285 -1.746 . . . . 0.0 106.285 -177.679 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 3.1 m120 -127.94 124.48 37.43 Favored 'General case' 0 CA--C 1.491 -1.3 0 N-CA-C 106.183 -1.784 . . . . 0.0 106.183 -179.505 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -105.65 173.38 3.27 Favored Pre-proline 0 N--CA 1.439 -1.012 0 C-N-CA 125.536 1.535 . . . . 0.0 108.181 -169.71 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_exo -63.63 151.2 86.17 Favored 'Trans proline' 0 N--CA 1.455 -0.76 0 C-N-CA 123.732 2.955 . . . . 0.0 112.266 173.532 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 64.8 tt0 -82.05 -40.64 0.96 Allowed Pre-proline 0 N--CA 1.444 -0.76 0 CA-C-O 115.832 -2.033 . . . . 0.0 111.837 -174.742 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 77.1 Cg_exo -70.77 -3.52 12.85 Favored 'Trans proline' 0 CA--C 1.514 -0.481 0 CA-C-N 125.403 2.965 . . . . 0.0 113.818 177.175 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 10.0 t 71.33 78.08 0.17 Allowed 'General case' 0 C--N 1.358 0.937 0 C-N-CA 126.38 1.872 . . . . 0.0 109.252 -179.423 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 82.1 t60 -89.23 -30.15 18.73 Favored 'General case' 0 N--CA 1.441 -0.906 0 C-N-CA 124.696 1.198 . . . . 0.0 108.289 178.166 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 90.3 mt -108.83 146.41 14.52 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.107 0 N-CA-C 105.164 -2.162 . . . . 0.0 105.164 -171.204 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 32.9 t -102.69 -87.77 0.41 Allowed 'General case' 0 N--CA 1.428 -1.572 0 N-CA-C 104.531 -2.396 . . . . 0.0 104.531 176.891 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 50.3 mtpt -89.46 167.07 13.28 Favored 'General case' 0 CA--C 1.489 -1.4 0 C-N-CA 124.91 1.284 . . . . 0.0 108.85 -164.418 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 63.1 m-85 -132.09 142.62 49.58 Favored 'General case' 0 CA--C 1.497 -1.081 0 N-CA-C 105.035 -2.209 . . . . 0.0 105.035 170.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 53.7 mt -119.68 136.12 57.84 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.189 0 N-CA-C 101.156 -3.646 . . . . 0.0 101.156 170.503 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 5.9 mt -110.42 132.53 54.1 Favored 'General case' 0 CA--C 1.47 -2.132 0 N-CA-C 103.823 -2.658 . . . . 0.0 103.823 166.644 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 17.0 ptp180 -132.88 152.04 51.93 Favored 'General case' 0 CA--C 1.49 -1.363 0 N-CA-C 106.787 -1.561 . . . . 0.0 106.787 170.701 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 49.2 p90 -155.19 151.79 28.59 Favored 'General case' 0 N--CA 1.438 -1.04 0 N-CA-C 107.585 -1.265 . . . . 0.0 107.585 -171.22 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 2.8 ptt180 -155.68 153.5 26.31 Favored Pre-proline 0 CA--C 1.497 -1.062 0 N-CA-C 106.466 -1.679 . . . . 0.0 106.466 168.065 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -76.86 156.56 34.85 Favored 'Trans proline' 0 CA--C 1.501 -1.141 0 C-N-CA 122.547 2.165 . . . . 0.0 109.071 -178.231 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 71.4 mmtt -70.35 79.95 0.54 Allowed 'General case' 0 C--N 1.354 0.8 0 C-N-CA 125.065 1.346 . . . . 0.0 110.635 174.598 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 58.9 m-80 -152.01 -81.62 0.1 Allowed 'General case' 0 N--CA 1.437 -1.111 0 N-CA-C 103.43 -2.804 . . . . 0.0 103.43 -179.249 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 50.2 m -93.39 166.14 12.43 Favored 'General case' 0 CA--C 1.5 -0.978 0 C-N-CA 124.055 0.942 . . . . 0.0 108.531 -178.228 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 12.6 m -134.57 25.54 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.754 0 N-CA-C 106.623 -1.621 . . . . 0.0 106.623 178.167 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -89.72 -94.48 1.14 Allowed Glycine 0 C--N 1.356 1.681 0 N-CA-C 109.554 -1.418 . . . . 0.0 109.554 -174.797 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -95.5 166.29 11.93 Favored 'General case' 0 CA--C 1.5 -0.945 0 N-CA-C 107.584 -1.265 . . . . 0.0 107.584 179.418 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -158.29 173.87 16.03 Favored 'General case' 0 CA--C 1.493 -1.238 0 CA-C-O 121.17 0.509 . . . . 0.0 110.142 -177.7 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 8.6 mtpm? -106.53 155.07 19.98 Favored 'General case' 0 CA--C 1.484 -1.565 0 N-CA-C 106.877 -1.527 . . . . 0.0 106.877 -175.404 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 15.6 pt-20 -151.72 161.26 42.96 Favored 'General case' 0 N--CA 1.435 -1.193 0 CA-C-O 121.827 0.823 . . . . 0.0 109.064 173.699 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -138.66 162.39 34.77 Favored 'General case' 0 N--CA 1.44 -0.967 0 N-CA-C 105.765 -1.939 . . . . 0.0 105.765 170.275 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 77.8 m -121.64 126.56 49.32 Favored 'General case' 0 CA--C 1.502 -0.896 0 N-CA-C 105.389 -2.078 . . . . 0.0 105.389 178.233 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 4.2 mp -110.91 133.76 21.17 Favored Pre-proline 0 N--CA 1.436 -1.147 0 N-CA-C 105.12 -2.178 . . . . 0.0 105.12 -176.088 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_exo -63.85 165.15 19.46 Favored 'Trans proline' 0 CA--C 1.507 -0.828 0 C-N-CA 123.519 2.813 . . . . 0.0 113.187 176.743 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -76.52 -18.21 79.27 Favored Glycine 0 C--N 1.351 1.409 0 C-N-CA 123.627 0.632 . . . . 0.0 113.938 -173.933 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 49.8 p-80 -84.02 -28.45 27.66 Favored 'General case' 0 C--N 1.355 0.845 0 CA-C-N 117.992 0.896 . . . . 0.0 110.133 -179.826 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 88.0 mt -88.78 130.76 35.3 Favored 'General case' 0 CA--C 1.499 -0.991 0 N-CA-C 107.911 -1.144 . . . . 0.0 107.911 177.463 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 47.1 p-10 -117.78 12.44 13.89 Favored 'General case' 0 CA--C 1.502 -0.873 0 C-N-CA 123.879 0.872 . . . . 0.0 110.368 -174.887 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 58.0 p -136.8 161.57 35.61 Favored 'General case' 0 CA--C 1.498 -1.052 0 N-CA-C 107.795 -1.187 . . . . 0.0 107.795 -178.379 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 5.2 t80 -147.55 179.51 7.63 Favored 'General case' 0 C--N 1.357 0.933 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 177.198 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 80.2 m -144.92 112.4 6.16 Favored 'General case' 0 N--CA 1.433 -1.295 0 N-CA-C 104.178 -2.527 . . . . 0.0 104.178 174.002 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 50.6 mt -95.18 97.33 6.66 Favored 'Isoleucine or valine' 0 C--N 1.357 0.918 0 N-CA-C 105.333 -2.099 . . . . 0.0 105.333 174.763 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 22.6 pttp -103.82 159.81 15.32 Favored 'General case' 0 CA--C 1.501 -0.919 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 -176.489 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 87.75 51.69 3.17 Favored Glycine 0 C--N 1.354 1.579 0 N-CA-C 109.337 -1.505 . . . . 0.0 109.337 179.187 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 70.7 mt -119.78 171.11 8.63 Favored 'General case' 0 CA--C 1.504 -0.806 0 N-CA-C 107.398 -1.334 . . . . 0.0 107.398 -177.393 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 67.5 mttm -107.09 155.69 38.81 Favored Pre-proline 0 N--CA 1.442 -0.86 0 C-N-CA 124.984 1.313 . . . . 0.0 107.656 -172.338 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -75.82 151.53 36.03 Favored 'Trans proline' 0 N--CA 1.454 -0.853 0 C-N-CA 123.024 2.482 . . . . 0.0 110.811 177.054 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 56.05 36.55 67.95 Favored Glycine 0 C--N 1.355 1.605 0 C-N-CA 127.377 2.418 . . . . 0.0 116.06 169.623 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 9.8 p -124.11 143.56 36.98 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.998 0 N-CA-C 108.088 -1.078 . . . . 0.0 108.088 -177.498 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 7.7 p -98.61 128.4 50.19 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.96 0 N-CA-C 107.747 -1.205 . . . . 0.0 107.747 -179.543 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 68.8 m-85 -111.4 151.62 28.28 Favored 'General case' 0 CA--C 1.497 -1.082 0 C-N-CA 124.814 1.245 . . . . 0.0 108.809 -179.863 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 35.9 tp10 -93.61 137.04 33.28 Favored 'General case' 0 N--CA 1.44 -0.953 0 N-CA-C 104.578 -2.379 . . . . 0.0 104.578 160.017 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -135.33 156.62 22.75 Favored Glycine 0 CA--C 1.489 -1.553 0 N-CA-C 108.511 -1.836 . . . . 0.0 108.511 174.356 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 85.6 mt-30 -144.58 138.95 27.81 Favored 'General case' 0 CA--C 1.483 -1.598 0 N-CA-C 105.986 -1.857 . . . . 0.0 105.986 179.262 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 57.1 tp -115.73 97.32 6.05 Favored 'General case' 0 N--CA 1.435 -1.189 0 N-CA-C 103.892 -2.633 . . . . 0.0 103.892 178.248 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 9.4 mt -89.52 128.87 41.28 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.942 0 N-CA-C 105.356 -2.09 . . . . 0.0 105.356 -178.248 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 3.5 p -117.93 118.86 33.13 Favored 'General case' 0 N--CA 1.438 -1.058 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 -171.71 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 2.0 mp -94.08 131.68 40.31 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.222 0 N-CA-C 105.02 -2.215 . . . . 0.0 105.02 -173.149 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 19.4 mp0 -93.87 143.36 26.41 Favored 'General case' 0 CA--C 1.498 -1.033 0 N-CA-C 104.93 -2.248 . . . . 0.0 104.93 177.218 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 21.4 tt0 -69.12 112.4 5.7 Favored 'General case' 0 C--N 1.356 0.855 0 C-N-CA 123.858 0.863 . . . . 0.0 111.343 -172.585 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 33.7 m-85 56.32 44.81 24.07 Favored 'General case' 0 C--N 1.357 0.917 0 C-N-CA 126.983 2.113 . . . . 0.0 112.173 -179.007 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -156.73 -119.16 0.6 Allowed Glycine 0 CA--C 1.489 -1.577 0 N-CA-C 109.008 -1.637 . . . . 0.0 109.008 -177.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 69.2 m80 -82.68 176.77 9.09 Favored 'General case' 0 CA--C 1.501 -0.939 0 C-N-CA 124.9 1.28 . . . . 0.0 111.288 -166.477 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 22.8 tt0 -137.91 115.96 11.67 Favored 'General case' 0 N--CA 1.435 -1.197 0 N-CA-C 103.819 -2.66 . . . . 0.0 103.819 170.761 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 29.5 tt0 -104.77 147.97 27.12 Favored 'General case' 0 CA--C 1.5 -0.949 0 N-CA-C 106.089 -1.819 . . . . 0.0 106.089 -174.739 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 4.0 p -119.35 134.05 64.2 Favored 'Isoleucine or valine' 0 C--N 1.356 0.85 0 N-CA-C 107.796 -1.187 . . . . 0.0 107.796 178.272 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 65.1 m -110.93 138.44 47.33 Favored 'General case' 0 C--N 1.354 0.791 0 N-CA-C 102.518 -3.142 . . . . 0.0 102.518 168.326 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 27.8 ptt-85 -132.21 150.32 52.18 Favored 'General case' 0 CA--C 1.5 -0.971 0 N-CA-C 109.213 -0.662 . . . . 0.0 109.213 179.485 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 20.2 p90 -163.82 173.8 12.33 Favored 'General case' 0 N--CA 1.441 -0.901 0 N-CA-C 107.947 -1.131 . . . . 0.0 107.947 -174.874 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -125.62 146.05 49.88 Favored 'General case' 0 N--CA 1.438 -1.05 0 N-CA-C 103.816 -2.661 . . . . 0.0 103.816 173.628 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 28.5 p90 -139.51 168.1 20.59 Favored 'General case' 0 CA--C 1.485 -1.526 0 N-CA-C 107.572 -1.269 . . . . 0.0 107.572 167.882 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 60.6 m -130.44 141.93 50.51 Favored 'General case' 0 N--CA 1.44 -0.937 0 N-CA-C 104.832 -2.285 . . . . 0.0 104.832 176.795 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 23.9 p -111.6 136.94 50.11 Favored 'General case' 0 CA--C 1.501 -0.936 0 N-CA-C 103.851 -2.648 . . . . 0.0 103.851 170.486 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 10.5 t -146.22 156.7 43.57 Favored 'General case' 0 N--CA 1.44 -0.967 0 N-CA-C 106.716 -1.587 . . . . 0.0 106.716 -175.072 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 16.9 p . . . . . 0 C--O 1.261 1.684 0 CA-C-O 117.709 -1.139 . . . . 0.0 108.944 -178.336 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 72.2 m . . . . . 0 N--CA 1.486 1.355 0 N-CA-C 108.358 -0.978 . . . . 0.0 108.358 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -160.42 -179.92 35.51 Favored Glycine 0 C--N 1.352 1.434 0 N-CA-C 106.913 -2.475 . . . . 0.0 106.913 177.969 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 79.3 Cg_exo -60.67 135.07 57.98 Favored 'Trans proline' 0 CA--C 1.497 -1.369 0 C-N-CA 123.388 2.725 . . . . 0.0 112.185 -173.359 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 16.1 t -84.07 155.24 3.67 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.017 0 C-N-CA 126.468 1.907 . . . . 0.0 106.167 -175.196 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 54.6 mt-10 -104.5 102.86 12.49 Favored 'General case' 0 CA--C 1.492 -1.273 0 N-CA-C 105.772 -1.936 . . . . 0.0 105.772 179.498 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 1.5 p -126.05 141.37 45.88 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.985 0 N-CA-C 105.623 -1.991 . . . . 0.0 105.623 -169.796 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 18.8 p90 -161.69 170.3 19.93 Favored 'General case' 0 N--CA 1.436 -1.144 0 N-CA-C 107.716 -1.216 . . . . 0.0 107.716 -162.728 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -124.19 133.49 69.17 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.823 0 N-CA-C 102.482 -3.155 . . . . 0.0 102.482 160.809 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 10.4 p -131.27 124.2 29.99 Favored 'General case' 0 CA--C 1.5 -0.964 0 N-CA-C 106.418 -1.697 . . . . 0.0 106.418 179.922 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 23.8 tt0 68.15 48.72 0.91 Allowed 'General case' 0 C--N 1.356 0.86 0 C-N-CA 126.44 1.896 . . . . 0.0 110.914 175.586 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 15.4 p -104.19 102.9 35.4 Favored Pre-proline 0 C--N 1.353 0.746 0 N-CA-C 106.113 -1.81 . . . . 0.0 106.113 172.175 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 31.0 Cg_endo -74.97 -69.02 0.02 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.768 0 C-N-CA 122.425 2.083 . . . . 0.0 110.607 -175.737 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 10.2 p -141.07 107.68 5.33 Favored 'General case' 0 N--CA 1.432 -1.349 0 N-CA-C 105.711 -1.959 . . . . 0.0 105.711 -179.742 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 91.3 mm-40 -120.83 105.74 40.25 Favored Pre-proline 0 N--CA 1.436 -1.145 0 N-CA-C 103.87 -2.641 . . . . 0.0 103.87 178.379 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -84.61 -25.48 1.97 Allowed 'Trans proline' 0 CA--C 1.508 -0.822 0 C-N-CA 122.289 1.993 . . . . 0.0 111.115 -167.426 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 6.8 t-20 -135.78 -23.88 1.35 Allowed 'General case' 0 CA--C 1.495 -1.169 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 -168.709 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 23.0 p -97.64 156.19 16.64 Favored 'General case' 0 N--CA 1.439 -1.02 0 N-CA-C 107.605 -1.257 . . . . 0.0 107.605 177.483 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 79.8 t60 -139.44 86.43 14.28 Favored Pre-proline 0 N--CA 1.439 -1.011 0 N-CA-C 106.348 -1.723 . . . . 0.0 106.348 167.568 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -82.92 100.54 0.96 Allowed 'Trans proline' 0 N--CA 1.453 -0.887 0 C-N-CA 123.574 2.849 . . . . 0.0 110.369 -176.187 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.6 pt -94.38 166.59 1.77 Allowed 'Isoleucine or valine' 0 CA--C 1.501 -0.934 0 C-N-CA 122.715 0.406 . . . . 0.0 110.156 -173.609 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 48.0 tt0 -143.15 147.66 35.3 Favored 'General case' 0 N--CA 1.439 -0.995 0 N-CA-C 105.005 -2.22 . . . . 0.0 105.005 168.547 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 30.9 p90 -130.23 159.85 35.62 Favored 'General case' 0 CA--C 1.495 -1.167 0 N-CA-C 105.599 -2.0 . . . . 0.0 105.599 176.701 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 72.3 m-20 -130.83 132.7 45.38 Favored 'General case' 0 CA--C 1.488 -1.417 0 N-CA-C 104.997 -2.223 . . . . 0.0 104.997 171.837 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -85.77 164.36 40.01 Favored Pre-proline 0 N--CA 1.441 -0.908 0 C-N-CA 124.589 1.155 . . . . 0.0 110.675 -166.175 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_exo -67.23 -179.29 1.75 Allowed 'Trans proline' 0 N--CA 1.457 -0.675 0 C-N-CA 123.775 2.983 . . . . 0.0 112.548 169.072 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? -79.84 -50.85 1.19 Allowed Pre-proline 0 N--CA 1.443 -0.782 0 CA-C-O 115.02 -2.419 . . . . 0.0 111.157 -174.706 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -68.68 147.14 69.11 Favored 'Trans proline' 0 CA--C 1.508 -0.811 0 CA-C-N 126.305 3.288 . . . . 0.0 111.863 -173.056 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 29.4 p -99.0 58.59 1.14 Allowed 'General case' 0 C--N 1.355 0.83 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 -178.605 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 42.6 t60 -116.23 1.37 13.12 Favored 'General case' 0 N--CA 1.438 -1.043 0 C-N-CA 125.217 1.407 . . . . 0.0 107.425 175.857 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 31.2 mt -101.67 131.93 48.58 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.054 0 N-CA-C 104.263 -2.495 . . . . 0.0 104.263 171.017 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 4.4 p -110.52 -84.65 0.56 Allowed 'General case' 0 N--CA 1.432 -1.345 0 N-CA-C 107.028 -1.471 . . . . 0.0 107.028 179.515 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 53.2 mtmt -89.91 171.85 9.3 Favored 'General case' 0 CA--C 1.488 -1.439 0 C-N-CA 124.232 1.013 . . . . 0.0 108.785 -166.413 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 86.8 m-85 -129.34 147.66 51.19 Favored 'General case' 0 CA--C 1.496 -1.115 0 N-CA-C 105.362 -2.088 . . . . 0.0 105.362 168.435 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 61.9 mt -120.41 131.04 73.69 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.249 0 N-CA-C 101.207 -3.627 . . . . 0.0 101.207 165.683 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 2.9 mt -110.49 132.72 53.94 Favored 'General case' 0 CA--C 1.473 -1.997 0 N-CA-C 104.822 -2.288 . . . . 0.0 104.822 170.741 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -129.97 158.94 38.17 Favored 'General case' 0 CA--C 1.493 -1.241 0 N-CA-C 107.308 -1.367 . . . . 0.0 107.308 170.082 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 46.4 p90 -155.15 141.28 18.42 Favored 'General case' 0 N--CA 1.434 -1.232 0 N-CA-C 106.635 -1.617 . . . . 0.0 106.635 -177.908 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 27.0 ttp180 -137.89 142.65 36.94 Favored Pre-proline 0 CA--C 1.502 -0.902 0 N-CA-C 104.902 -2.258 . . . . 0.0 104.902 -179.359 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_exo -65.11 116.97 4.15 Favored 'Trans proline' 0 N--CA 1.455 -0.754 0 C-N-CA 123.024 2.482 . . . . 0.0 109.721 169.133 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 26.7 ttpp -71.96 83.87 0.96 Allowed 'General case' 0 C--N 1.359 0.993 0 C-N-CA 125.306 1.443 . . . . 0.0 110.096 179.933 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 33.1 m120 -150.58 -69.18 0.19 Allowed 'General case' 0 N--CA 1.434 -1.245 0 N-CA-C 102.321 -3.214 . . . . 0.0 102.321 -175.526 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 56.4 p -109.23 175.32 5.5 Favored 'General case' 0 N--CA 1.44 -0.97 0 N-CA-C 107.334 -1.358 . . . . 0.0 107.334 175.171 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 4.2 m -115.69 51.36 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.836 0 N-CA-C 106.241 -1.763 . . . . 0.0 106.241 176.009 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -94.81 -136.1 8.28 Favored Glycine 0 C--N 1.356 1.68 0 N-CA-C 109.739 -1.345 . . . . 0.0 109.739 -175.57 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 39.9 mmt180 -81.18 155.58 26.1 Favored 'General case' 0 CA--C 1.501 -0.939 0 C-N-CA 123.79 0.836 . . . . 0.0 109.108 -176.534 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -159.36 168.89 25.22 Favored 'General case' 0 CA--C 1.493 -1.225 0 CA-C-O 121.385 0.612 . . . . 0.0 109.832 -169.259 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -113.49 156.68 23.12 Favored 'General case' 0 CA--C 1.491 -1.293 0 N-CA-C 107.889 -1.152 . . . . 0.0 107.889 -169.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 23.5 pt-20 -151.37 161.27 43.0 Favored 'General case' 0 N--CA 1.435 -1.191 0 N-CA-C 107.765 -1.198 . . . . 0.0 107.765 172.125 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -139.62 164.71 29.2 Favored 'General case' 0 N--CA 1.438 -1.051 0 N-CA-C 105.603 -1.999 . . . . 0.0 105.603 171.222 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 88.8 m -118.51 122.65 43.21 Favored 'General case' 0 CA--C 1.498 -1.021 0 N-CA-C 104.333 -2.469 . . . . 0.0 104.333 176.056 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 3.7 mm -103.62 138.64 19.59 Favored Pre-proline 0 N--CA 1.438 -1.029 0 N-CA-C 105.808 -1.923 . . . . 0.0 105.808 -174.909 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_exo -63.91 161.15 34.11 Favored 'Trans proline' 0 N--CA 1.455 -0.784 0 C-N-CA 123.378 2.719 . . . . 0.0 112.562 170.817 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -78.22 -19.26 74.87 Favored Glycine 0 C--N 1.353 1.492 0 C-N-CA 123.843 0.735 . . . . 0.0 113.344 -172.485 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 50.3 p-80 -83.61 -24.97 31.24 Favored 'General case' 0 C--N 1.356 0.85 0 CA-C-N 117.68 0.74 . . . . 0.0 110.158 -178.802 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 88.7 mt -88.22 129.77 35.26 Favored 'General case' 0 CA--C 1.498 -1.024 0 N-CA-C 107.913 -1.143 . . . . 0.0 107.913 177.655 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 7.5 p30 -116.66 10.72 14.45 Favored 'General case' 0 CA--C 1.501 -0.93 0 C-N-CA 124.59 1.156 . . . . 0.0 109.662 -174.554 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 31.3 p -141.79 154.42 45.21 Favored 'General case' 0 N--CA 1.44 -0.974 0 N-CA-C 106.863 -1.532 . . . . 0.0 106.863 -179.237 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 9.8 t80 -137.55 170.7 15.62 Favored 'General case' 0 N--CA 1.441 -0.914 0 N-CA-C 107.91 -1.144 . . . . 0.0 107.91 178.606 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 89.2 m -133.93 110.01 9.42 Favored 'General case' 0 N--CA 1.429 -1.517 0 N-CA-C 104.424 -2.436 . . . . 0.0 104.424 172.773 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 45.2 mt -88.37 144.06 9.94 Favored 'Isoleucine or valine' 0 C--N 1.355 0.846 0 N-CA-C 103.663 -2.717 . . . . 0.0 103.663 172.051 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 56.7 mtmt -144.29 165.51 27.69 Favored 'General case' 0 CA--C 1.498 -1.04 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 175.929 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 88.7 48.3 3.97 Favored Glycine 0 CA--C 1.485 -1.832 0 N-CA-C 108.99 -1.644 . . . . 0.0 108.99 174.575 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 51.9 mt -120.79 171.22 8.76 Favored 'General case' 0 CA--C 1.498 -1.025 0 N-CA-C 107.604 -1.258 . . . . 0.0 107.604 -170.22 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt -113.66 150.87 44.0 Favored Pre-proline 0 N--CA 1.44 -0.93 0 N-CA-C 107.363 -1.347 . . . . 0.0 107.363 -174.247 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 78.5 Cg_exo -68.14 153.85 73.81 Favored 'Trans proline' 0 N--CA 1.453 -0.873 0 C-N-CA 123.37 2.714 . . . . 0.0 112.028 168.338 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . 0.48 ' H ' ' HA ' ' A' ' 92' ' ' THR . . . 58.95 30.28 66.29 Favored Glycine 0 N--CA 1.432 -1.604 0 C-N-CA 127.545 2.498 . . . . 0.0 116.478 170.37 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 4.9 p -126.92 142.13 44.27 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.029 0 N-CA-C 108.577 -0.898 . . . . 0.0 108.577 179.316 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 9.3 p -94.62 130.77 42.99 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.837 0 C-N-CA 124.641 1.176 . . . . 0.0 107.959 -178.816 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 88.8 m-85 -110.62 154.91 23.11 Favored 'General case' 0 N--CA 1.437 -1.085 0 C-N-CA 124.79 1.236 . . . . 0.0 108.011 177.854 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 15.3 tp10 -98.53 132.17 44.17 Favored 'General case' 0 N--CA 1.437 -1.099 0 N-CA-C 103.578 -2.749 . . . . 0.0 103.578 164.148 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -129.67 148.82 18.53 Favored Glycine 0 CA--C 1.489 -1.544 0 N-CA-C 107.667 -2.173 . . . . 0.0 107.667 175.786 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 34.6 mt-30 -141.47 137.05 31.86 Favored 'General case' 0 CA--C 1.484 -1.582 0 N-CA-C 106.549 -1.649 . . . . 0.0 106.549 178.4 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 27.6 tp -117.93 97.17 5.69 Favored 'General case' 0 N--CA 1.435 -1.202 0 N-CA-C 104.03 -2.581 . . . . 0.0 104.03 -178.721 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 20.3 mt -92.17 129.01 43.44 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.865 0 N-CA-C 104.947 -2.242 . . . . 0.0 104.947 -179.84 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 49.8 m -110.06 117.84 34.82 Favored 'General case' 0 CA--C 1.497 -1.061 0 N-CA-C 106.814 -1.55 . . . . 0.0 106.814 -175.784 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 1.7 mp -88.2 131.94 34.5 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.302 0 N-CA-C 104.348 -2.464 . . . . 0.0 104.348 -170.455 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 76.0 mt-30 -96.78 157.1 16.06 Favored 'General case' 0 N--CA 1.434 -1.269 0 N-CA-C 107.167 -1.42 . . . . 0.0 107.167 -176.787 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 32.3 mt-30 -69.48 118.2 12.06 Favored 'General case' 0 N--CA 1.438 -1.026 0 C-N-CA 123.919 0.888 . . . . 0.0 112.544 -168.503 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 49.0 m-85 61.68 35.58 16.93 Favored 'General case' 0 C--N 1.355 0.833 0 C-N-CA 127.117 2.167 . . . . 0.0 113.136 170.558 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 179.38 -93.31 0.09 OUTLIER Glycine 0 C--N 1.354 1.53 0 C-N-CA 118.294 -1.907 . . . . 0.0 111.416 177.73 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 74.1 m-70 -78.59 -178.74 6.03 Favored 'General case' 0 CA--C 1.498 -1.047 0 C-N-CA 124.797 1.239 . . . . 0.0 111.747 -163.602 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 4.4 pt20 -153.32 146.56 24.75 Favored 'General case' 0 N--CA 1.434 -1.245 0 N-CA-C 106.484 -1.672 . . . . 0.0 106.484 170.2 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 17.4 tp10 -104.87 146.28 29.22 Favored 'General case' 0 CA--C 1.496 -1.124 0 N-CA-C 105.575 -2.009 . . . . 0.0 105.575 179.855 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 3.0 p -117.76 131.59 70.06 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.824 0 N-CA-C 107.204 -1.406 . . . . 0.0 107.204 177.391 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 40.4 m -113.58 138.36 50.28 Favored 'General case' 0 N--CA 1.441 -0.9 0 N-CA-C 102.871 -3.011 . . . . 0.0 102.871 170.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 7.6 ptp85 -131.58 150.86 52.0 Favored 'General case' 0 CA--C 1.498 -1.025 0 CA-C-O 121.466 0.651 . . . . 0.0 109.594 178.86 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 30.0 p90 -164.2 178.2 7.77 Favored 'General case' 0 N--CA 1.44 -0.97 0 N-CA-C 106.959 -1.497 . . . . 0.0 106.959 -174.617 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 1.5 p30 -137.44 157.71 45.99 Favored 'General case' 0 N--CA 1.44 -0.928 0 N-CA-C 105.844 -1.91 . . . . 0.0 105.844 169.416 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 26.6 p90 -145.73 170.75 15.89 Favored 'General case' 0 CA--C 1.486 -1.497 0 N-CA-C 107.367 -1.346 . . . . 0.0 107.367 174.949 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 24.8 p -121.55 145.33 48.07 Favored 'General case' 0 CA--C 1.5 -0.954 0 N-CA-C 106.006 -1.85 . . . . 0.0 106.006 172.078 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 75.4 m -119.57 113.48 20.77 Favored 'General case' 0 CA--C 1.496 -1.111 0 N-CA-C 102.103 -3.295 . . . . 0.0 102.103 170.287 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' THR . . . . . 0.48 ' HA ' ' H ' ' A' ' 66' ' ' GLY . 15.3 m -143.41 149.74 38.08 Favored 'General case' 0 C--N 1.356 0.87 0 N-CA-C 105.705 -1.961 . . . . 0.0 105.705 -171.934 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 8.7 t . . . . . 0 C--O 1.261 1.662 0 C-N-CA 124.632 1.173 . . . . 0.0 109.497 -176.01 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 20.4 t . . . . . 0 N--CA 1.48 1.034 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -151.8 -173.18 21.28 Favored Glycine 0 C--N 1.351 1.393 0 N-CA-C 106.077 -2.809 . . . . 0.0 106.077 179.766 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_exo -61.0 135.78 61.31 Favored 'Trans proline' 0 N--CA 1.445 -1.342 0 C-N-CA 123.3 2.666 . . . . 0.0 112.37 -173.176 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 8.4 t -78.57 154.05 5.0 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.88 0 C-N-CA 126.738 2.015 . . . . 0.0 106.214 -175.948 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -96.66 90.73 5.42 Favored 'General case' 0 CA--C 1.493 -1.242 0 N-CA-C 107.66 -1.237 . . . . 0.0 107.66 -175.04 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 2.6 p -114.33 133.92 58.89 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.175 0 N-CA-C 107.032 -1.47 . . . . 0.0 107.032 -166.86 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 75.3 m-85 -134.07 173.4 11.62 Favored 'General case' 0 N--CA 1.435 -1.188 0 N-CA-C 106.208 -1.775 . . . . 0.0 106.208 -173.776 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 79.5 mt -98.92 141.72 16.03 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.021 0 N-CA-C 103.423 -2.806 . . . . 0.0 103.423 173.42 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 37.0 p -114.13 134.97 54.53 Favored 'General case' 0 CA--C 1.501 -0.916 0 N-CA-C 103.377 -2.823 . . . . 0.0 103.377 169.798 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 54.4 mt-10 -117.93 50.28 1.16 Allowed 'General case' 0 CA--C 1.495 -1.166 0 N-CA-C 104.54 -2.393 . . . . 0.0 104.54 -173.351 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 11.0 t -82.89 150.7 62.55 Favored Pre-proline 0 N--CA 1.44 -0.961 0 N-CA-C 105.677 -1.971 . . . . 0.0 105.677 175.531 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_exo -64.77 117.54 4.61 Favored 'Trans proline' 0 CA--C 1.507 -0.839 0 C-N-CA 122.544 2.163 . . . . 0.0 113.275 -171.617 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' SER . . . . . 0.419 ' HG ' ' H ' ' A' ' 14' ' ' GLN . 5.7 t -154.49 -170.13 3.44 Favored 'General case' 0 N--CA 1.416 -2.156 0 N-CA-C 101.105 -3.665 . . . . 0.0 101.105 179.242 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . 0.419 ' H ' ' HG ' ' A' ' 13' ' ' SER . 38.2 mt-30 -82.7 162.14 56.43 Favored Pre-proline 0 N--CA 1.442 -0.868 0 C-N-CA 126.6 1.96 . . . . 0.0 109.389 -174.971 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_endo -80.88 -2.58 11.89 Favored 'Trans proline' 0 N--CA 1.457 -0.644 0 C-N-CA 123.813 3.008 . . . . 0.0 109.903 165.419 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 2.3 t30 -89.18 -14.44 36.06 Favored 'General case' 0 N--CA 1.439 -0.994 0 C-N-CA 126.088 1.755 . . . . 0.0 107.403 172.697 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 68.2 m -113.32 150.3 32.73 Favored 'General case' 0 CA--C 1.497 -1.093 0 CA-C-O 122.16 0.981 . . . . 0.0 108.803 175.784 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 26.0 t-80 -124.41 98.54 37.89 Favored Pre-proline 0 N--CA 1.439 -1.014 0 N-CA-C 105.343 -2.095 . . . . 0.0 105.343 166.901 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -74.72 115.2 4.22 Favored 'Trans proline' 0 N--CA 1.448 -1.177 0 C-N-CA 123.017 2.478 . . . . 0.0 108.635 170.492 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 11.1 tt -108.92 148.79 12.53 Favored 'Isoleucine or valine' 0 N--CA 1.406 -2.639 0 C-N-CA 127.053 2.141 . . . . 0.0 106.05 -178.521 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 23.5 tt0 -135.64 145.42 46.8 Favored 'General case' 0 N--CA 1.435 -1.189 0 N-CA-C 104.337 -2.468 . . . . 0.0 104.337 170.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 49.1 p90 -135.46 165.56 25.22 Favored 'General case' 0 N--CA 1.438 -1.054 0 N-CA-C 105.337 -2.097 . . . . 0.0 105.337 175.211 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 39.6 m-80 -140.8 132.04 26.55 Favored 'General case' 0 CA--C 1.489 -1.368 0 N-CA-C 106.136 -1.802 . . . . 0.0 106.136 -179.708 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -96.85 168.59 10.09 Favored Pre-proline 0 N--CA 1.439 -1.006 0 CA-C-N 114.792 -1.095 . . . . 0.0 110.37 -163.797 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 81.1 Cg_exo -66.43 167.69 18.13 Favored 'Trans proline' 0 N--CA 1.456 -0.716 0 C-N-CA 123.821 3.014 . . . . 0.0 111.776 166.731 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 10.2 tm0? -81.95 -52.66 0.74 Allowed Pre-proline 0 N--CA 1.444 -0.774 0 CA-C-O 115.317 -2.278 . . . . 0.0 111.279 -175.232 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -71.26 166.01 30.61 Favored 'Trans proline' 0 CA--C 1.507 -0.829 0 CA-C-N 126.065 3.202 . . . . 0.0 112.45 -172.77 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 28.1 p -77.97 118.29 20.12 Favored 'General case' 0 C--N 1.358 0.94 0 N-CA-C 106.915 -1.513 . . . . 0.0 106.915 173.449 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 8.4 t-160 -169.73 -44.84 0.02 OUTLIER 'General case' 0 CA--C 1.497 -1.063 0 N-CA-C 107.214 -1.402 . . . . 0.0 107.214 -164.099 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 37.2 mt -112.2 137.36 45.27 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.014 0 N-CA-C 104.175 -2.528 . . . . 0.0 104.175 176.615 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 33.5 t -113.06 -87.29 0.56 Allowed 'General case' 0 N--CA 1.43 -1.437 0 N-CA-C 106.494 -1.669 . . . . 0.0 106.494 179.548 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 35.9 ttpt -89.18 163.31 15.48 Favored 'General case' 0 CA--C 1.491 -1.303 0 C-N-CA 125.686 1.594 . . . . 0.0 108.104 -159.202 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 90.6 m-85 -128.88 139.07 52.31 Favored 'General case' 0 CA--C 1.492 -1.257 0 N-CA-C 105.649 -1.982 . . . . 0.0 105.649 175.56 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 55.3 mt -119.42 131.09 73.04 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.121 0 N-CA-C 101.694 -3.447 . . . . 0.0 101.694 171.113 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 3.2 mt -110.47 135.63 50.85 Favored 'General case' 0 CA--C 1.473 -1.982 0 N-CA-C 105.02 -2.215 . . . . 0.0 105.02 171.899 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -131.35 156.51 45.39 Favored 'General case' 0 CA--C 1.493 -1.247 0 N-CA-C 106.889 -1.523 . . . . 0.0 106.889 167.555 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 49.6 p90 -154.18 145.47 22.96 Favored 'General case' 0 N--CA 1.434 -1.257 0 N-CA-C 106.757 -1.572 . . . . 0.0 106.757 -175.94 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 8.6 ttm180 -138.18 139.57 26.01 Favored Pre-proline 0 CA--C 1.499 -0.982 0 N-CA-C 104.605 -2.368 . . . . 0.0 104.605 -179.907 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -72.89 116.06 4.58 Favored 'Trans proline' 0 N--CA 1.454 -0.843 0 C-N-CA 122.739 2.293 . . . . 0.0 108.824 174.713 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 3.0 tmtp? -70.22 81.49 0.53 Allowed 'General case' 0 C--N 1.358 0.97 0 C-N-CA 126.858 2.063 . . . . 0.0 111.029 -176.047 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 1.5 p30 -164.65 -50.06 0.03 OUTLIER 'General case' 0 N--CA 1.435 -1.176 0 N-CA-C 103.676 -2.713 . . . . 0.0 103.676 175.868 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 46.5 p -97.63 163.89 12.65 Favored 'General case' 0 N--CA 1.44 -0.968 0 C-N-CA 124.922 1.289 . . . . 0.0 108.01 178.135 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 4.8 m -125.92 46.18 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.849 0 N-CA-C 105.838 -1.912 . . . . 0.0 105.838 176.455 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -94.89 -154.06 30.66 Favored Glycine 0 C--N 1.356 1.656 0 N-CA-C 109.808 -1.317 . . . . 0.0 109.808 -175.64 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 80.4 ttt180 -78.9 126.76 31.12 Favored 'General case' 0 C--N 1.356 0.86 0 N-CA-C 108.142 -1.059 . . . . 0.0 108.142 -178.59 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -105.24 172.56 6.73 Favored 'General case' 0 CA--C 1.497 -1.061 0 C-N-CA 123.825 0.85 . . . . 0.0 110.377 -172.782 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 63.0 mttp -112.11 157.07 21.25 Favored 'General case' 0 CA--C 1.489 -1.403 0 N-CA-C 107.773 -1.195 . . . . 0.0 107.773 -170.717 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 15.7 pt-20 -151.21 159.73 44.23 Favored 'General case' 0 N--CA 1.437 -1.09 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 173.57 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -138.2 164.03 30.24 Favored 'General case' 0 N--CA 1.44 -0.935 0 N-CA-C 105.851 -1.907 . . . . 0.0 105.851 170.436 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 88.8 m -124.51 127.67 47.8 Favored 'General case' 0 CA--C 1.5 -0.947 0 N-CA-C 105.3 -2.111 . . . . 0.0 105.3 179.053 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 5.2 mp -117.27 135.93 23.29 Favored Pre-proline 0 N--CA 1.438 -1.034 0 N-CA-C 105.213 -2.143 . . . . 0.0 105.213 -172.111 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_exo -63.06 166.82 13.53 Favored 'Trans proline' 0 CA--C 1.509 -0.762 0 C-N-CA 123.54 2.826 . . . . 0.0 113.748 176.582 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -81.09 -16.82 73.62 Favored Glycine 0 C--N 1.353 1.473 0 C-N-CA 123.457 0.551 . . . . 0.0 113.249 -171.95 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 50.8 p-80 -83.83 -25.82 30.02 Favored 'General case' 0 C--N 1.357 0.901 0 CA-C-N 117.831 0.816 . . . . 0.0 109.999 179.899 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 92.4 mt -88.32 131.03 34.97 Favored 'General case' 0 CA--C 1.501 -0.922 0 N-CA-C 107.84 -1.17 . . . . 0.0 107.84 177.46 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 8.3 p-10 -112.95 8.35 18.51 Favored 'General case' 0 CA--C 1.503 -0.863 0 C-N-CA 124.666 1.186 . . . . 0.0 109.667 -174.421 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 32.9 p -146.75 160.92 41.64 Favored 'General case' 0 CA--C 1.499 -1.005 0 N-CA-C 106.484 -1.673 . . . . 0.0 106.484 -177.248 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 19.2 t80 -148.45 160.26 43.23 Favored 'General case' 0 CA--C 1.497 -1.093 0 N-CA-C 108.083 -1.08 . . . . 0.0 108.083 178.575 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 82.8 m -114.43 109.47 18.36 Favored 'General case' 0 N--CA 1.436 -1.14 0 N-CA-C 104.491 -2.411 . . . . 0.0 104.491 168.9 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 65.7 mt -82.94 137.79 20.41 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.902 0 N-CA-C 103.086 -2.931 . . . . 0.0 103.086 169.83 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 17.8 ptpt -147.84 160.62 42.56 Favored 'General case' 0 CA--C 1.495 -1.151 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 -177.709 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 89.82 52.67 2.56 Favored Glycine 0 CA--C 1.489 -1.555 0 N-CA-C 108.586 -1.806 . . . . 0.0 108.586 179.827 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 63.8 mt -120.47 170.63 9.2 Favored 'General case' 0 CA--C 1.498 -1.023 0 N-CA-C 107.377 -1.342 . . . . 0.0 107.377 -171.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 28.9 mtpp -101.59 153.75 37.7 Favored Pre-proline 0 N--CA 1.439 -1.012 0 N-CA-C 106.507 -1.664 . . . . 0.0 106.507 -179.775 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 70.6 Cg_endo -77.6 156.8 32.09 Favored 'Trans proline' 0 N--CA 1.452 -0.964 0 C-N-CA 122.936 2.424 . . . . 0.0 110.342 174.88 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 57.74 32.68 65.99 Favored Glycine 0 C--N 1.355 1.635 0 C-N-CA 126.904 2.192 . . . . 0.0 116.44 169.854 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 5.8 p -129.16 144.39 38.3 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.903 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 -177.009 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 3.5 p -95.4 135.49 29.31 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.918 0 N-CA-C 107.292 -1.373 . . . . 0.0 107.292 -179.693 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 94.8 m-85 -113.67 150.99 32.43 Favored 'General case' 0 CA--C 1.499 -1.011 0 N-CA-C 106.815 -1.55 . . . . 0.0 106.815 177.379 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -94.94 145.29 25.02 Favored 'General case' 0 CA--C 1.501 -0.928 0 N-CA-C 104.155 -2.535 . . . . 0.0 104.155 161.109 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -138.39 149.5 20.56 Favored Glycine 0 CA--C 1.487 -1.678 0 N-CA-C 108.599 -1.801 . . . . 0.0 108.599 -177.413 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 26.2 mt-30 -138.59 135.66 35.19 Favored 'General case' 0 CA--C 1.483 -1.608 0 N-CA-C 105.599 -2.0 . . . . 0.0 105.599 177.064 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 40.9 tp -116.72 99.36 7.07 Favored 'General case' 0 N--CA 1.435 -1.178 0 N-CA-C 103.787 -2.672 . . . . 0.0 103.787 179.075 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 33.0 mt -89.21 127.68 41.75 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.883 0 N-CA-C 104.762 -2.311 . . . . 0.0 104.762 177.702 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 13.3 p -112.03 115.98 29.8 Favored 'General case' 0 N--CA 1.434 -1.26 0 N-CA-C 106.565 -1.642 . . . . 0.0 106.565 -176.619 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 23.1 mm -90.68 138.63 19.13 Favored 'Isoleucine or valine' 0 CA--C 1.483 -1.603 0 N-CA-C 106.154 -1.795 . . . . 0.0 106.154 -167.468 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 36.2 mt-30 -101.24 153.6 19.48 Favored 'General case' 0 CA--C 1.494 -1.198 0 CA-C-N 113.851 -1.522 . . . . 0.0 107.569 -173.313 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 32.8 mt-30 -68.44 101.16 1.19 Allowed 'General case' 0 CA--C 1.5 -0.948 0 C-N-CA 124.939 1.295 . . . . 0.0 112.497 -166.165 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 85.7 m-85 52.99 39.99 30.38 Favored 'General case' 0 C--N 1.359 1.008 0 C-N-CA 127.296 2.238 . . . . 0.0 112.214 -179.825 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -149.64 -118.83 0.93 Allowed Glycine 0 C--N 1.354 1.545 0 N-CA-C 108.851 -1.7 . . . . 0.0 108.851 -175.294 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 64.4 m-70 -81.93 -175.68 5.73 Favored 'General case' 0 CA--C 1.496 -1.113 0 C-N-CA 124.757 1.223 . . . . 0.0 111.528 -167.858 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 40.1 mt-30 -134.0 137.47 44.77 Favored 'General case' 0 N--CA 1.436 -1.132 0 N-CA-C 103.536 -2.765 . . . . 0.0 103.536 171.595 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 16.7 tp10 -118.05 137.02 53.18 Favored 'General case' 0 CA--C 1.495 -1.146 0 N-CA-C 105.174 -2.158 . . . . 0.0 105.174 179.873 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 7.1 p -111.35 139.12 36.9 Favored 'Isoleucine or valine' 0 C--N 1.354 0.797 0 N-CA-C 107.618 -1.253 . . . . 0.0 107.618 -177.414 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 38.2 m -120.49 134.17 55.31 Favored 'General case' 0 N--CA 1.441 -0.886 0 N-CA-C 102.345 -3.206 . . . . 0.0 102.345 174.114 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 83.1 mtm180 -125.82 149.75 48.36 Favored 'General case' 0 CA--C 1.5 -0.954 0 CA-C-N 119.177 0.898 . . . . 0.0 109.479 -176.638 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 19.2 p90 -165.96 -176.59 3.85 Favored 'General case' 0 CA--C 1.501 -0.92 0 N-CA-C 107.382 -1.34 . . . . 0.0 107.382 -178.357 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 44.7 p30 -135.79 158.05 45.34 Favored 'General case' 0 N--CA 1.442 -0.858 0 N-CA-C 107.24 -1.393 . . . . 0.0 107.24 164.626 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 25.4 p90 -142.38 172.88 12.09 Favored 'General case' 0 CA--C 1.485 -1.53 0 N-CA-C 106.018 -1.845 . . . . 0.0 106.018 170.252 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 8.9 t -141.41 152.98 44.77 Favored 'General case' 0 CA--C 1.499 -0.996 0 N-CA-C 105.713 -1.958 . . . . 0.0 105.713 173.77 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 29.8 p -113.95 131.94 56.13 Favored 'General case' 0 N--CA 1.437 -1.104 0 N-CA-C 103.432 -2.803 . . . . 0.0 103.432 171.745 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 25.0 p -130.5 145.83 51.93 Favored 'General case' 0 CA--C 1.5 -0.968 0 N-CA-C 105.654 -1.98 . . . . 0.0 105.654 179.632 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 42.9 p . . . . . 0 C--O 1.26 1.65 0 N-CA-C 109.206 -0.664 . . . . 0.0 109.206 -177.575 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 65.2 m . . . . . 0 N--CA 1.49 1.553 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -160.97 178.99 36.71 Favored Glycine 0 C--N 1.351 1.386 0 N-CA-C 105.516 -3.034 . . . . 0.0 105.516 173.566 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 90.4 Cg_exo -61.17 134.27 51.51 Favored 'Trans proline' 0 CA--C 1.5 -1.177 0 C-N-CA 123.17 2.58 . . . . 0.0 112.255 -171.018 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 3.1 t -79.39 150.31 5.15 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.79 0 C-N-CA 126.313 1.845 . . . . 0.0 106.039 -176.442 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 54.5 mm-40 -100.1 89.46 4.04 Favored 'General case' 0 CA--C 1.485 -1.527 0 CA-C-O 122.776 1.274 . . . . 0.0 108.36 -170.262 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 2.3 p -104.06 127.24 58.42 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.136 0 CA-C-N 113.421 -1.718 . . . . 0.0 107.661 -166.879 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 59.2 m-85 -85.67 138.27 32.25 Favored 'General case' 0 CA--C 1.495 -1.135 0 C-N-CA 123.935 0.894 . . . . 0.0 110.444 -169.501 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 35.2 mt -131.82 62.21 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.438 -1.052 0 N-CA-C 100.615 -3.846 . . . . 0.0 100.615 163.057 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 88.2 m -111.76 100.31 8.84 Favored 'General case' 0 CA--C 1.498 -1.033 0 N-CA-C 104.941 -2.244 . . . . 0.0 104.941 -172.635 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 11.8 tp10 54.89 42.19 31.3 Favored 'General case' 0 C--N 1.358 0.975 0 C-N-CA 126.859 2.064 . . . . 0.0 111.138 -176.949 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 30.7 m -92.53 -55.21 0.25 Allowed Pre-proline 0 N--CA 1.442 -0.826 0 CA-C-O 113.992 -2.909 . . . . 0.0 109.936 -174.546 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_exo -71.46 87.47 0.78 Allowed 'Trans proline' 0 C--N 1.349 0.584 0 CA-C-N 126.435 3.334 . . . . 0.0 115.415 -164.664 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 11.1 p -159.73 82.11 0.73 Allowed 'General case' 0 CA--C 1.492 -1.268 0 N-CA-C 105.803 -1.925 . . . . 0.0 105.803 168.831 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 2.7 mp0 -156.02 157.52 31.32 Favored Pre-proline 0 N--CA 1.441 -0.92 0 N-CA-C 104.54 -2.393 . . . . 0.0 104.54 -176.405 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -80.01 -50.79 0.06 OUTLIER 'Trans proline' 0 N--CA 1.45 -1.056 0 C-N-CA 122.647 2.231 . . . . 0.0 111.75 172.861 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 36.6 m-20 -141.97 -12.39 0.85 Allowed 'General case' 0 N--CA 1.435 -1.191 0 C-N-CA 124.82 1.248 . . . . 0.0 110.228 -163.649 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 23.6 p -98.11 161.39 13.74 Favored 'General case' 0 CA--C 1.503 -0.846 0 O-C-N 120.739 -1.226 . . . . 0.0 107.701 -179.516 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 40.3 t-80 -151.52 104.26 2.91 Favored Pre-proline 0 N--CA 1.443 -0.816 0 CA-C-O 118.359 -0.829 . . . . 0.0 108.934 173.088 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -75.73 123.11 7.25 Favored 'Trans proline' 0 N--CA 1.452 -0.949 0 C-N-CA 123.199 2.599 . . . . 0.0 109.71 175.282 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 10.9 mt -111.6 136.56 47.35 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.947 0 N-CA-C 104.586 -2.375 . . . . 0.0 104.586 -178.639 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 35.7 mt-30 -140.3 146.93 39.17 Favored 'General case' 0 CA--C 1.494 -1.19 0 N-CA-C 104.668 -2.345 . . . . 0.0 104.668 179.387 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 42.7 p90 -147.48 169.63 19.14 Favored 'General case' 0 CA--C 1.499 -1.015 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 -174.072 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 5.7 m120 -131.24 127.57 38.1 Favored 'General case' 0 CA--C 1.492 -1.252 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 179.624 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -92.26 175.78 3.11 Favored Pre-proline 0 N--CA 1.439 -0.993 0 C-N-CA 125.989 1.716 . . . . 0.0 108.946 -174.323 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_exo -63.16 159.58 38.45 Favored 'Trans proline' 0 CA--C 1.508 -0.823 0 C-N-CA 123.743 2.962 . . . . 0.0 112.297 171.095 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 35.9 mt-30 -81.57 -37.12 0.86 Allowed Pre-proline 0 N--CA 1.443 -0.795 0 CA-C-O 115.962 -1.971 . . . . 0.0 111.281 -177.414 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_exo -70.17 -8.26 23.16 Favored 'Trans proline' 0 CA--C 1.512 -0.625 0 CA-C-N 124.878 2.778 . . . . 0.0 112.905 169.526 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . 0.28 80.5 p 54.09 71.81 0.49 Allowed 'General case' 0 C--N 1.36 1.046 0 C-N-CA 127.609 2.363 . . . . 0.0 112.022 -177.254 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 49.8 t-80 -88.74 -10.57 47.85 Favored 'General case' 0 N--CA 1.441 -0.885 0 C-N-CA 124.473 1.109 . . . . 0.0 109.768 -176.329 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 84.7 mt -93.88 145.03 8.4 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.976 0 N-CA-C 105.434 -2.061 . . . . 0.0 105.434 -179.846 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 35.6 t -99.09 -86.78 0.36 Allowed 'General case' 0 N--CA 1.43 -1.445 0 N-CA-C 103.857 -2.646 . . . . 0.0 103.857 174.537 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 46.0 mtpt -89.16 165.94 14.15 Favored 'General case' 0 CA--C 1.492 -1.266 0 C-N-CA 124.854 1.262 . . . . 0.0 109.097 -168.359 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 64.0 m-85 -125.63 142.34 51.56 Favored 'General case' 0 CA--C 1.495 -1.137 0 N-CA-C 104.547 -2.39 . . . . 0.0 104.547 164.641 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 54.7 mt -119.56 132.24 69.9 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.302 0 N-CA-C 101.141 -3.651 . . . . 0.0 101.141 168.796 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 3.0 mt -106.38 128.96 54.43 Favored 'General case' 0 CA--C 1.473 -2.017 0 N-CA-C 103.95 -2.611 . . . . 0.0 103.95 166.766 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 79.3 mtt180 -112.56 157.09 21.59 Favored 'General case' 0 N--CA 1.43 -1.442 0 N-CA-C 105.266 -2.124 . . . . 0.0 105.266 164.248 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 48.6 p90 -156.12 147.42 22.5 Favored 'General case' 0 N--CA 1.43 -1.44 0 N-CA-C 105.934 -1.876 . . . . 0.0 105.934 176.513 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 39.0 ptt180 -157.52 161.07 29.86 Favored Pre-proline 0 N--CA 1.438 -1.028 0 N-CA-C 105.41 -2.071 . . . . 0.0 105.41 170.189 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_exo -66.06 149.77 85.68 Favored 'Trans proline' 0 CA--C 1.503 -1.029 0 C-N-CA 123.367 2.711 . . . . 0.0 109.828 176.572 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 4.1 tmtp? -75.7 70.93 2.54 Favored 'General case' 0 C--N 1.358 0.947 0 C-N-CA 123.643 0.777 . . . . 0.0 109.587 175.731 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 30.4 m120 -158.67 -52.55 0.06 Allowed 'General case' 0 N--CA 1.437 -1.083 0 N-CA-C 103.671 -2.714 . . . . 0.0 103.671 -170.609 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 32.3 t -79.24 151.45 31.17 Favored 'General case' 0 CA--C 1.497 -1.096 0 CA-C-O 122.783 1.277 . . . . 0.0 110.064 -174.73 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 16.1 m -134.34 -0.54 1.24 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.894 0 CA-C-N 112.42 -2.173 . . . . 0.0 108.425 -174.514 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -98.2 -100.21 2.13 Favored Glycine 0 C--N 1.356 1.67 0 N-CA-C 109.355 -1.498 . . . . 0.0 109.355 -174.63 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 77.0 mtp85 -93.95 168.21 11.11 Favored 'General case' 0 CA--C 1.501 -0.908 0 C-N-CA 123.588 0.755 . . . . 0.0 109.559 -173.716 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 60.3 m95 -122.53 163.22 20.32 Favored 'General case' 0 N--CA 1.439 -0.996 0 N-CA-C 106.273 -1.751 . . . . 0.0 106.273 178.591 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -96.77 151.26 19.82 Favored 'General case' 0 CA--C 1.489 -1.392 0 N-CA-C 103.858 -2.645 . . . . 0.0 103.858 158.796 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 16.1 pt-20 -152.31 158.88 43.38 Favored 'General case' 0 CA--C 1.496 -1.12 0 CA-C-O 121.8 0.81 . . . . 0.0 109.559 -178.113 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -142.73 162.25 35.97 Favored 'General case' 0 CA--C 1.498 -1.036 0 N-CA-C 106.051 -1.833 . . . . 0.0 106.051 174.066 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 78.4 m -120.35 125.63 48.49 Favored 'General case' 0 CA--C 1.5 -0.945 0 N-CA-C 105.228 -2.138 . . . . 0.0 105.228 178.713 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 5.3 mp -109.43 133.3 20.87 Favored Pre-proline 0 N--CA 1.437 -1.107 0 N-CA-C 104.313 -2.476 . . . . 0.0 104.313 -177.929 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 65.3 Cg_exo -63.88 165.06 19.74 Favored 'Trans proline' 0 CA--C 1.507 -0.847 0 C-N-CA 123.393 2.729 . . . . 0.0 113.054 178.277 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -75.05 -18.04 80.2 Favored Glycine 0 C--N 1.351 1.403 0 N-CA-C 114.604 0.602 . . . . 0.0 114.604 -174.084 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 47.7 p-80 -83.71 -29.52 27.47 Favored 'General case' 0 C--N 1.356 0.864 0 CA-C-N 118.016 0.908 . . . . 0.0 109.826 179.832 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 89.6 mt -89.14 134.26 34.08 Favored 'General case' 0 CA--C 1.5 -0.972 0 N-CA-C 107.721 -1.215 . . . . 0.0 107.721 176.563 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 6.5 p-10 -123.53 25.01 8.4 Favored 'General case' 0 CA--C 1.498 -1.023 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 -177.541 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 33.9 p -146.79 163.22 36.72 Favored 'General case' 0 N--CA 1.439 -1.021 0 N-CA-C 107.59 -1.263 . . . . 0.0 107.59 -179.248 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 7.4 t80 -154.25 178.4 10.05 Favored 'General case' 0 N--CA 1.44 -0.936 0 N-CA-C 107.903 -1.147 . . . . 0.0 107.903 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 96.1 m -144.09 117.99 9.36 Favored 'General case' 0 N--CA 1.43 -1.44 0 N-CA-C 104.995 -2.224 . . . . 0.0 104.995 176.072 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 13.4 mm -87.22 144.38 9.4 Favored 'Isoleucine or valine' 0 C--N 1.354 0.768 0 N-CA-C 104.3 -2.481 . . . . 0.0 104.3 171.004 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 95.8 mttt -145.27 162.22 37.69 Favored 'General case' 0 CA--C 1.493 -1.225 0 N-CA-C 107.491 -1.3 . . . . 0.0 107.491 170.07 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 79.31 54.56 4.0 Favored Glycine 0 CA--C 1.488 -1.596 0 N-CA-C 108.968 -1.653 . . . . 0.0 108.968 175.249 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 85.3 mt -108.34 -153.87 0.52 Allowed 'General case' 0 CA--C 1.504 -0.799 0 N-CA-C 106.822 -1.547 . . . . 0.0 106.822 178.854 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 90.6 mttt -132.18 156.3 80.27 Favored Pre-proline 0 N--CA 1.44 -0.928 0 N-CA-C 105.74 -1.948 . . . . 0.0 105.74 -170.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_endo -74.09 135.78 21.44 Favored 'Trans proline' 0 N--CA 1.451 -0.993 0 C-N-CA 122.905 2.403 . . . . 0.0 110.45 173.202 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 57.25 49.74 70.09 Favored Glycine 0 C--N 1.355 1.612 0 C-N-CA 126.852 2.167 . . . . 0.0 115.823 170.417 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 27.8 t -118.13 133.58 64.49 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.102 0 N-CA-C 105.951 -1.87 . . . . 0.0 105.951 173.51 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 5.3 p -84.33 119.97 34.27 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.961 0 N-CA-C 105.48 -2.044 . . . . 0.0 105.48 164.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 83.0 m-85 -99.5 149.24 23.42 Favored 'General case' 0 CA--C 1.496 -1.13 0 C-N-CA 125.716 1.606 . . . . 0.0 107.354 -179.477 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 17.9 pt-20 -108.67 133.46 52.73 Favored 'General case' 0 CA--C 1.499 -0.984 0 N-CA-C 105.01 -2.219 . . . . 0.0 105.01 167.912 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -128.45 165.08 21.48 Favored Glycine 0 CA--C 1.484 -1.895 0 N-CA-C 107.688 -2.165 . . . . 0.0 107.688 -174.206 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 83.8 mt-30 -137.3 133.84 35.42 Favored 'General case' 0 CA--C 1.482 -1.667 0 N-CA-C 104.557 -2.386 . . . . 0.0 104.557 169.688 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 27.2 tp -110.54 90.77 3.42 Favored 'General case' 0 N--CA 1.435 -1.221 0 N-CA-C 103.335 -2.839 . . . . 0.0 103.335 174.383 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 13.2 mt -91.58 131.34 38.95 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.927 0 N-CA-C 105.492 -2.04 . . . . 0.0 105.492 -174.373 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 58.5 m -118.47 115.3 24.33 Favored 'General case' 0 N--CA 1.436 -1.164 0 N-CA-C 107.685 -1.228 . . . . 0.0 107.685 -173.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 1.7 mp -91.54 135.97 25.62 Favored 'Isoleucine or valine' 0 CA--C 1.499 -1.0 0 N-CA-C 105.163 -2.162 . . . . 0.0 105.163 -172.175 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 15.6 mp0 -99.17 122.07 41.88 Favored 'General case' 0 CA--C 1.498 -1.034 0 N-CA-C 102.582 -3.118 . . . . 0.0 102.582 170.174 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 16.7 tt0 -68.03 126.02 28.18 Favored 'General case' 0 N--CA 1.443 -0.789 0 C-N-CA 123.26 0.624 . . . . 0.0 111.629 -166.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 21.5 m-85 66.42 43.83 2.55 Favored 'General case' 0 C--N 1.357 0.902 0 C-N-CA 126.746 2.018 . . . . 0.0 111.912 179.787 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -171.95 -115.77 0.37 Allowed Glycine 0 N--CA 1.432 -1.587 0 N-CA-C 108.145 -1.982 . . . . 0.0 108.145 175.714 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 87.7 m-70 -84.71 178.53 7.63 Favored 'General case' 0 CA--C 1.498 -1.023 0 C-N-CA 125.182 1.393 . . . . 0.0 111.103 -169.302 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 5.3 pt20 -145.9 143.89 29.85 Favored 'General case' 0 N--CA 1.436 -1.138 0 N-CA-C 106.156 -1.794 . . . . 0.0 106.156 165.104 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 9.3 tm-20 -106.39 141.76 37.18 Favored 'General case' 0 N--CA 1.438 -1.064 0 N-CA-C 104.44 -2.43 . . . . 0.0 104.44 -177.351 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 3.2 p -121.96 120.43 61.43 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.804 0 N-CA-C 108.195 -1.039 . . . . 0.0 108.195 -179.467 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 83.9 m -97.15 129.09 44.57 Favored 'General case' 0 C--N 1.355 0.844 0 N-CA-C 102.622 -3.103 . . . . 0.0 102.622 169.822 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 55.3 ttt85 -115.17 137.66 51.77 Favored 'General case' 0 CA--C 1.498 -1.04 0 N-CA-C 106.358 -1.719 . . . . 0.0 106.358 175.45 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -150.86 176.76 10.77 Favored 'General case' 0 CA--C 1.494 -1.185 0 N-CA-C 107.657 -1.238 . . . . 0.0 107.657 -177.477 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 38.9 p-10 -139.39 151.25 46.16 Favored 'General case' 0 N--CA 1.438 -1.047 0 N-CA-C 106.0 -1.852 . . . . 0.0 106.0 171.21 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 18.5 p90 -144.43 170.51 15.89 Favored 'General case' 0 CA--C 1.489 -1.387 0 N-CA-C 105.801 -1.926 . . . . 0.0 105.801 176.433 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 55.2 m -122.19 142.98 49.86 Favored 'General case' 0 CA--C 1.5 -0.956 0 N-CA-C 105.564 -2.014 . . . . 0.0 105.564 -179.557 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 86.6 m -120.41 120.97 37.49 Favored 'General case' 0 CA--C 1.498 -1.056 0 N-CA-C 101.971 -3.344 . . . . 0.0 101.971 167.292 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 76.9 p -88.73 -168.46 2.2 Favored 'General case' 0 C--N 1.353 0.723 0 C-N-CA 123.654 0.781 . . . . 0.0 109.422 -169.527 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 32.3 t . . . . . 0 C--O 1.26 1.64 0 N-CA-C 106.768 -1.567 . . . . 0.0 106.768 -179.609 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 60.2 m . . . . . 0 N--CA 1.489 1.475 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 167.6 -162.79 36.59 Favored Glycine 0 N--CA 1.436 -1.36 0 N-CA-C 107.62 -2.192 . . . . 0.0 107.62 -179.931 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 79.4 Cg_exo -61.83 137.5 68.31 Favored 'Trans proline' 0 N--CA 1.444 -1.412 0 C-N-CA 123.359 2.706 . . . . 0.0 113.06 -177.389 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 3.5 t -77.37 152.53 5.51 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.915 0 C-N-CA 127.993 2.517 . . . . 0.0 107.006 -178.86 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 91.4 mt-10 -94.35 86.99 5.05 Favored 'General case' 0 CA--C 1.493 -1.23 0 CA-C-O 122.73 1.252 . . . . 0.0 108.721 -174.547 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 2.1 p -88.98 154.32 3.18 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.077 0 N-CA-C 105.822 -1.918 . . . . 0.0 105.822 -171.293 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 36.8 t80 -146.57 66.06 1.18 Allowed 'General case' 0 N--CA 1.429 -1.497 0 N-CA-C 104.458 -2.423 . . . . 0.0 104.458 -148.199 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 61.2 mt -98.94 95.7 4.49 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.96 0 N-CA-C 104.166 -2.531 . . . . 0.0 104.166 176.118 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 14.7 t -157.66 -26.44 0.09 Allowed 'General case' 0 N--CA 1.442 -0.854 0 CA-C-N 113.756 -1.565 . . . . 0.0 110.149 -172.19 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 31.9 tt0 -100.96 2.38 40.65 Favored 'General case' 0 N--CA 1.438 -1.051 0 C-N-CA 125.661 1.585 . . . . 0.0 107.537 -176.238 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 20.5 p -134.61 73.55 67.43 Favored Pre-proline 0 C--N 1.358 0.976 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 -177.297 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -75.44 -52.5 0.1 Allowed 'Trans proline' 0 N--CA 1.453 -0.891 0 C-N-CA 122.585 2.19 . . . . 0.0 110.523 176.354 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 18.7 p -139.36 110.23 6.78 Favored 'General case' 0 N--CA 1.425 -1.686 0 N-CA-C 104.497 -2.409 . . . . 0.0 104.497 -172.979 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 29.0 mm100 -129.37 132.3 24.18 Favored Pre-proline 0 N--CA 1.438 -1.042 0 N-CA-C 101.657 -3.46 . . . . 0.0 101.657 168.486 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 64.1 Cg_endo -82.46 -27.38 2.25 Favored 'Trans proline' 0 CA--C 1.504 -1.003 0 C-N-CA 122.085 1.856 . . . . 0.0 112.052 -154.763 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 1.4 p30 -120.75 -38.89 2.79 Favored 'General case' 0 CA--C 1.482 -1.654 0 C-N-CA 123.82 0.848 . . . . 0.0 109.198 -173.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 48.5 p -100.54 165.63 11.32 Favored 'General case' 0 N--CA 1.435 -1.22 0 N-CA-C 107.987 -1.116 . . . . 0.0 107.987 -174.956 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 63.7 t-80 -143.31 97.44 5.63 Favored Pre-proline 0 N--CA 1.435 -1.185 0 N-CA-C 104.501 -2.407 . . . . 0.0 104.501 162.434 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -71.18 133.83 23.76 Favored 'Trans proline' 0 N--CA 1.447 -1.258 0 C-N-CA 122.558 2.172 . . . . 0.0 110.167 172.061 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 14.7 mm -104.46 138.63 28.29 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.062 0 N-CA-C 102.928 -2.99 . . . . 0.0 102.928 176.664 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 73.1 mt-30 -128.31 149.66 50.41 Favored 'General case' 0 CA--C 1.493 -1.244 0 N-CA-C 103.909 -2.626 . . . . 0.0 103.909 172.609 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 49.1 p90 -149.49 167.69 25.54 Favored 'General case' 0 CA--C 1.491 -1.307 0 N-CA-C 107.947 -1.131 . . . . 0.0 107.947 -179.125 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 1.8 m120 -130.92 128.44 40.52 Favored 'General case' 0 CA--C 1.489 -1.374 0 N-CA-C 105.382 -2.081 . . . . 0.0 105.382 -179.751 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -87.02 143.79 35.5 Favored Pre-proline 0 N--CA 1.44 -0.927 0 CA-C-O 118.693 -0.67 . . . . 0.0 110.504 -170.622 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_endo -76.76 166.09 27.62 Favored 'Trans proline' 0 N--CA 1.452 -0.917 0 C-N-CA 122.716 2.277 . . . . 0.0 108.214 159.381 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 22.3 tt0 -129.73 84.44 61.19 Favored Pre-proline 0 N--CA 1.442 -0.861 0 N-CA-C 108.323 -0.991 . . . . 0.0 108.323 176.683 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 90.9 Cg_endo -82.31 -8.2 11.76 Favored 'Trans proline' 0 N--CA 1.453 -0.865 0 C-N-CA 123.148 2.565 . . . . 0.0 109.599 163.051 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 21.4 m 59.45 44.21 15.28 Favored 'General case' 0 C--N 1.36 1.028 0 C-N-CA 127.573 2.349 . . . . 0.0 111.222 -171.328 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 15.4 t-160 -140.57 -10.84 1.05 Allowed 'General case' 0 N--CA 1.438 -1.031 0 CA-C-N 113.947 -1.479 . . . . 0.0 108.92 -174.935 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 38.4 mt -111.11 130.7 64.09 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.094 0 N-CA-C 105.423 -2.066 . . . . 0.0 105.423 -173.408 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 32.0 t -112.91 -84.82 0.59 Allowed 'General case' 0 N--CA 1.433 -1.283 0 N-CA-C 107.806 -1.183 . . . . 0.0 107.806 -176.242 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 51.4 mtmt -87.68 168.87 12.62 Favored 'General case' 0 CA--C 1.485 -1.539 0 C-N-CA 124.009 0.924 . . . . 0.0 109.097 -161.313 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 86.8 m-85 -129.46 140.07 51.41 Favored 'General case' 0 CA--C 1.493 -1.238 0 N-CA-C 105.049 -2.204 . . . . 0.0 105.049 170.32 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 35.8 mt -117.24 131.08 71.0 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.203 0 N-CA-C 101.567 -3.494 . . . . 0.0 101.567 169.511 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 4.8 mt -106.65 128.68 54.37 Favored 'General case' 0 CA--C 1.473 -1.985 0 N-CA-C 104.389 -2.448 . . . . 0.0 104.389 168.182 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 65.5 mtt180 -113.97 157.97 21.75 Favored 'General case' 0 N--CA 1.431 -1.377 0 N-CA-C 105.644 -1.984 . . . . 0.0 105.644 167.082 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 36.0 p90 -147.07 130.41 16.63 Favored 'General case' 0 N--CA 1.432 -1.362 0 N-CA-C 104.359 -2.46 . . . . 0.0 104.359 174.16 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 20.0 ttp180 -122.94 138.78 30.2 Favored Pre-proline 0 CA--C 1.498 -1.046 0 N-CA-C 104.087 -2.56 . . . . 0.0 104.087 177.437 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 68.4 Cg_exo -66.26 130.14 23.3 Favored 'Trans proline' 0 CA--C 1.503 -1.037 0 CA-C-N 123.798 2.392 . . . . 0.0 109.122 169.395 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 39.9 ttmt -73.07 69.56 1.02 Allowed 'General case' 0 C--N 1.357 0.929 0 C-N-CA 124.716 1.206 . . . . 0.0 109.899 173.939 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 69.6 m-80 -160.65 -57.05 0.05 Allowed 'General case' 0 N--CA 1.434 -1.26 0 N-CA-C 102.18 -3.267 . . . . 0.0 102.18 -170.866 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 53.4 p -85.29 165.52 17.24 Favored 'General case' 0 N--CA 1.439 -1.021 0 C-N-CA 125.333 1.453 . . . . 0.0 109.109 179.565 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 19.2 m -113.73 -13.04 11.58 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.811 0 C-N-CA 124.254 1.022 . . . . 0.0 110.144 -172.31 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -175.81 38.61 0.1 Allowed Glycine 0 C--N 1.354 1.55 0 N-CA-C 110.359 -1.097 . . . . 0.0 110.359 -178.19 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -119.85 105.51 11.17 Favored 'General case' 0 CA--C 1.492 -1.257 0 N-CA-C 102.271 -3.233 . . . . 0.0 102.271 171.149 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -157.75 165.74 34.59 Favored 'General case' 0 CA--C 1.49 -1.33 0 CA-C-O 122.16 0.981 . . . . 0.0 112.161 -172.618 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 63.2 mttp -121.57 161.41 22.43 Favored 'General case' 0 CA--C 1.492 -1.257 0 CA-C-N 113.688 -1.596 . . . . 0.0 106.79 -169.777 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 15.8 pt-20 -151.92 160.71 43.43 Favored 'General case' 0 N--CA 1.435 -1.199 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 174.315 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -140.5 162.25 35.79 Favored 'General case' 0 CA--C 1.5 -0.961 0 N-CA-C 106.283 -1.747 . . . . 0.0 106.283 174.69 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 59.5 m -120.36 126.04 49.52 Favored 'General case' 0 CA--C 1.499 -0.982 0 N-CA-C 105.175 -2.157 . . . . 0.0 105.175 178.06 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 5.3 mp -112.7 135.94 21.57 Favored Pre-proline 0 N--CA 1.437 -1.098 0 N-CA-C 104.516 -2.401 . . . . 0.0 104.516 -177.346 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 63.2 Cg_exo -63.6 168.06 12.26 Favored 'Trans proline' 0 CA--C 1.51 -0.723 0 C-N-CA 123.45 2.766 . . . . 0.0 113.618 177.466 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -78.49 -20.01 72.65 Favored Glycine 0 C--N 1.351 1.383 0 C-N-CA 123.398 0.523 . . . . 0.0 113.26 -173.885 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 49.7 p-80 -84.27 -27.48 27.85 Favored 'General case' 0 C--N 1.355 0.836 0 CA-C-N 117.713 0.756 . . . . 0.0 110.022 -179.393 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 87.5 mt -88.52 130.64 35.18 Favored 'General case' 0 CA--C 1.5 -0.981 0 N-CA-C 107.541 -1.281 . . . . 0.0 107.541 177.264 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 7.6 p30 -118.88 13.05 13.05 Favored 'General case' 0 CA--C 1.501 -0.921 0 C-N-CA 124.113 0.965 . . . . 0.0 109.645 -173.311 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 46.9 p -142.93 166.6 24.19 Favored 'General case' 0 N--CA 1.44 -0.959 0 N-CA-C 107.282 -1.377 . . . . 0.0 107.282 179.169 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 9.9 t80 -154.87 176.74 12.1 Favored 'General case' 0 N--CA 1.44 -0.938 0 N-CA-C 107.788 -1.19 . . . . 0.0 107.788 -177.161 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 57.2 m -142.57 114.72 8.3 Favored 'General case' 0 N--CA 1.432 -1.367 0 N-CA-C 105.114 -2.18 . . . . 0.0 105.114 176.882 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 50.8 mt -98.84 98.09 6.73 Favored 'Isoleucine or valine' 0 C--N 1.36 1.044 0 N-CA-C 106.137 -1.801 . . . . 0.0 106.137 175.823 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 93.4 mttt -94.97 163.65 13.23 Favored 'General case' 0 CA--C 1.499 -0.988 0 CA-C-O 121.591 0.71 . . . . 0.0 109.341 178.453 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 84.03 49.51 4.73 Favored Glycine 0 CA--C 1.49 -1.471 0 N-CA-C 109.134 -1.586 . . . . 0.0 109.134 174.453 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 68.3 mt -121.63 162.73 20.16 Favored 'General case' 0 CA--C 1.497 -1.078 0 N-CA-C 106.171 -1.789 . . . . 0.0 106.171 -179.144 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -99.57 157.34 34.13 Favored Pre-proline 0 N--CA 1.44 -0.944 0 N-CA-C 107.257 -1.386 . . . . 0.0 107.257 -177.276 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -78.65 165.88 24.38 Favored 'Trans proline' 0 N--CA 1.451 -1.005 0 C-N-CA 123.074 2.516 . . . . 0.0 109.575 165.521 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . 0.441 ' H ' ' HA ' ' A' ' 92' ' ' THR . . . 64.67 18.77 64.26 Favored Glycine 0 N--CA 1.43 -1.736 0 C-N-CA 127.223 2.344 . . . . 0.0 116.415 173.178 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 13.9 p -123.99 140.36 47.66 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.024 0 N-CA-C 107.942 -1.133 . . . . 0.0 107.942 -176.338 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 2.8 p -96.34 129.48 46.35 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.842 0 N-CA-C 107.391 -1.337 . . . . 0.0 107.391 178.671 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 82.6 m-85 -109.56 155.17 21.73 Favored 'General case' 0 N--CA 1.438 -1.04 0 C-N-CA 124.672 1.189 . . . . 0.0 108.436 177.375 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 19.3 tt0 -92.63 139.04 30.98 Favored 'General case' 0 N--CA 1.437 -1.108 0 N-CA-C 104.044 -2.576 . . . . 0.0 104.044 159.074 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -132.31 146.07 17.82 Favored Glycine 0 CA--C 1.49 -1.488 0 N-CA-C 107.575 -2.21 . . . . 0.0 107.575 171.679 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 32.4 mt-30 -138.57 136.02 35.6 Favored 'General case' 0 CA--C 1.479 -1.759 0 N-CA-C 106.321 -1.733 . . . . 0.0 106.321 177.834 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 45.2 tp -117.54 95.53 4.99 Favored 'General case' 0 N--CA 1.439 -1.011 0 N-CA-C 104.423 -2.436 . . . . 0.0 104.423 -178.281 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 12.5 mt -90.92 131.7 37.4 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.85 0 N-CA-C 105.167 -2.16 . . . . 0.0 105.167 -176.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 26.0 p -112.18 115.05 28.21 Favored 'General case' 0 N--CA 1.441 -0.882 0 N-CA-C 107.592 -1.262 . . . . 0.0 107.592 -176.257 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 5.8 mm -94.03 151.56 3.71 Favored 'Isoleucine or valine' 0 CA--C 1.49 -1.347 0 N-CA-C 106.282 -1.747 . . . . 0.0 106.282 -165.142 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . 0.528 HE21 ' HB2' ' A' ' 81' ' ' HIS . 15.6 mt-30 -119.1 145.66 45.74 Favored 'General case' 0 CA--C 1.49 -1.344 0 N-CA-C 105.154 -2.165 . . . . 0.0 105.154 176.879 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 36.1 mt-30 -77.27 35.31 0.17 Allowed 'General case' 0 C--N 1.356 0.856 0 C-N-CA 125.182 1.393 . . . . 0.0 112.917 179.322 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -138.54 13.33 2.76 Favored 'General case' 0 CA--C 1.499 -1.017 0 C-N-CA 124.754 1.222 . . . . 0.0 107.747 -179.436 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 92.51 -13.64 66.81 Favored Glycine 0 C--N 1.352 1.419 0 C-N-CA 124.298 0.952 . . . . 0.0 112.511 173.423 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . 0.528 ' HB2' HE21 ' A' ' 77' ' ' GLN . 65.4 m80 -80.74 161.99 24.31 Favored 'General case' 0 CA--C 1.502 -0.897 0 CA-C-N 118.045 0.922 . . . . 0.0 109.692 -174.81 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 80.7 mt-30 -145.45 137.34 25.44 Favored 'General case' 0 N--CA 1.437 -1.104 0 N-CA-C 104.606 -2.368 . . . . 0.0 104.606 -178.148 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 9.6 mp0 -118.36 131.37 56.31 Favored 'General case' 0 CA--C 1.494 -1.199 0 N-CA-C 104.074 -2.565 . . . . 0.0 104.074 173.155 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 5.6 p -106.91 132.72 53.52 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.864 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 -172.104 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 21.5 m -104.86 137.52 42.52 Favored 'General case' 0 N--CA 1.442 -0.873 0 N-CA-C 102.383 -3.192 . . . . 0.0 102.383 168.947 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 31.5 ptt-85 -134.38 145.95 49.44 Favored 'General case' 0 CA--C 1.496 -1.112 0 CA-C-O 121.588 0.708 . . . . 0.0 109.143 179.831 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 20.0 p90 -164.78 -178.9 5.52 Favored 'General case' 0 CA--C 1.499 -0.999 0 N-CA-C 106.376 -1.713 . . . . 0.0 106.376 -173.296 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -137.06 157.76 45.98 Favored 'General case' 0 N--CA 1.437 -1.094 0 N-CA-C 106.212 -1.773 . . . . 0.0 106.212 170.155 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 25.5 p90 -143.58 170.72 15.3 Favored 'General case' 0 CA--C 1.487 -1.453 0 N-CA-C 106.256 -1.757 . . . . 0.0 106.256 169.497 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 9.7 m -126.49 140.3 52.57 Favored 'General case' 0 CA--C 1.499 -1.001 0 N-CA-C 103.678 -2.712 . . . . 0.0 103.678 175.827 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 86.1 m -112.71 114.15 26.6 Favored 'General case' 0 CA--C 1.497 -1.09 0 N-CA-C 102.137 -3.283 . . . . 0.0 102.137 176.58 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' THR . . . . . 0.441 ' HA ' ' H ' ' A' ' 66' ' ' GLY . 23.7 p -125.21 168.5 13.38 Favored 'General case' 0 CA--C 1.5 -0.952 0 N-CA-C 106.438 -1.69 . . . . 0.0 106.438 -179.128 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 15.1 t . . . . . 0 C--O 1.258 1.546 0 N-CA-C 108.014 -1.106 . . . . 0.0 108.014 -178.399 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 23.3 t . . . . . 0 N--CA 1.482 1.171 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 169.4 174.62 37.96 Favored Glycine 0 C--N 1.349 1.286 0 N-CA-C 106.748 -2.541 . . . . 0.0 106.748 178.13 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 66.6 Cg_exo -60.1 138.86 84.44 Favored 'Trans proline' 0 N--CA 1.447 -1.214 0 C-N-CA 123.396 2.73 . . . . 0.0 113.493 -170.79 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 21.5 t -77.77 156.55 5.23 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.9 0 C-N-CA 128.277 2.631 . . . . 0.0 105.354 178.483 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 59.4 mm-40 -109.73 98.67 7.97 Favored 'General case' 0 CA--C 1.487 -1.478 0 N-CA-C 106.947 -1.501 . . . . 0.0 106.947 -174.442 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 2.2 p -123.27 139.3 50.38 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.108 0 N-CA-C 106.248 -1.76 . . . . 0.0 106.248 -169.163 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 75.1 m-85 -144.9 179.69 7.17 Favored 'General case' 0 CA--C 1.494 -1.184 0 N-CA-C 105.179 -2.156 . . . . 0.0 105.179 -172.403 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.404 HG13 ' CE1' ' A' ' 18' ' ' HIS . 0.0 OUTLIER -135.92 127.89 45.27 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.094 0 N-CA-C 104.182 -2.525 . . . . 0.0 104.182 161.865 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 14.8 t -154.73 9.28 0.33 Allowed 'General case' 0 N--CA 1.437 -1.084 0 N-CA-C 107.274 -1.38 . . . . 0.0 107.274 -178.441 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 26.6 tt0 -83.05 -29.86 28.5 Favored 'General case' 0 C--N 1.359 0.98 0 O-C-N 121.102 -0.999 . . . . 0.0 111.097 -167.047 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 13.0 t -139.72 140.53 25.08 Favored Pre-proline 0 N--CA 1.442 -0.846 0 N-CA-C 104.41 -2.441 . . . . 0.0 104.41 175.178 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 69.7 Cg_endo -84.24 -20.25 4.24 Favored 'Trans proline' 0 N--CA 1.453 -0.882 0 C-N-CA 122.37 2.047 . . . . 0.0 110.729 178.88 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 47.6 m -158.0 113.71 2.75 Favored 'General case' 0 CA--C 1.495 -1.14 0 N-CA-C 105.762 -1.94 . . . . 0.0 105.762 -169.792 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 66.7 tp60 -157.03 119.08 2.14 Favored Pre-proline 0 N--CA 1.441 -0.899 0 N-CA-C 105.54 -2.022 . . . . 0.0 105.54 174.368 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -88.07 -20.72 1.78 Allowed 'Trans proline' 0 CA--C 1.505 -0.943 0 C-N-CA 122.262 1.975 . . . . 0.0 112.005 -167.282 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 5.8 p-10 -114.28 -39.46 3.86 Favored 'General case' 0 CA--C 1.491 -1.321 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 -164.701 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 66.5 m -104.31 154.33 19.95 Favored 'General case' 0 CA--C 1.494 -1.181 0 N-CA-C 106.599 -1.63 . . . . 0.0 106.599 176.285 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . 0.486 ' CD2' ' HG1' ' A' ' 91' ' ' THR . 37.0 t-80 -139.95 89.58 11.24 Favored Pre-proline 0 N--CA 1.438 -1.033 0 N-CA-C 107.188 -1.412 . . . . 0.0 107.188 172.917 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -82.96 120.05 2.96 Favored 'Trans proline' 0 N--CA 1.447 -1.219 0 C-N-CA 123.11 2.54 . . . . 0.0 110.463 179.593 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 3.9 pt -104.85 173.84 1.35 Allowed 'Isoleucine or valine' 0 CA--C 1.497 -1.083 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 -177.486 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 2.4 pt20 -149.82 149.43 30.5 Favored 'General case' 0 N--CA 1.44 -0.967 0 N-CA-C 106.421 -1.696 . . . . 0.0 106.421 173.52 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 23.8 p90 -134.44 157.14 47.21 Favored 'General case' 0 CA--C 1.499 -0.983 0 N-CA-C 106.632 -1.618 . . . . 0.0 106.632 -177.808 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 59.8 t30 -99.71 -177.81 3.68 Favored 'General case' 0 CA--C 1.492 -1.272 0 N-CA-C 102.683 -3.08 . . . . 0.0 102.683 168.152 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -155.63 170.49 8.66 Favored Pre-proline 0 N--CA 1.438 -1.043 0 N-CA-C 106.334 -1.728 . . . . 0.0 106.334 176.325 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 63.5 Cg_exo -63.65 164.16 22.06 Favored 'Trans proline' 0 N--CA 1.456 -0.695 0 C-N-CA 123.267 2.645 . . . . 0.0 112.635 173.176 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 17.9 mp0 -80.48 -53.83 0.85 Allowed Pre-proline 0 N--CA 1.443 -0.818 0 CA-C-O 115.579 -2.153 . . . . 0.0 111.617 -167.919 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -74.03 172.26 16.29 Favored 'Trans proline' 0 CA--C 1.51 -0.699 0 CA-C-N 125.871 3.132 . . . . 0.0 109.95 174.221 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 22.8 t -83.79 87.01 7.07 Favored 'General case' 0 C--N 1.357 0.907 0 N-CA-C 107.237 -1.394 . . . . 0.0 107.237 178.563 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 22.5 t-160 -112.56 -32.86 6.33 Favored 'General case' 0 N--CA 1.436 -1.145 0 N-CA-C 106.938 -1.504 . . . . 0.0 106.938 -177.084 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 1.8 mp -108.62 134.55 50.2 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.946 0 N-CA-C 103.315 -2.846 . . . . 0.0 103.315 -178.179 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 5.9 p -100.77 -82.01 0.46 Allowed 'General case' 0 N--CA 1.434 -1.26 0 N-CA-C 107.875 -1.158 . . . . 0.0 107.875 175.108 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.407 ' HZ1' ' HB3' ' A' ' 32' ' ' LYS . 6.5 ttpm? -94.35 161.27 14.31 Favored 'General case' 0 CA--C 1.495 -1.136 0 C-N-CA 124.7 1.2 . . . . 0.0 108.029 -165.733 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 85.5 m-85 -125.9 138.14 53.77 Favored 'General case' 0 N--CA 1.437 -1.079 0 N-CA-C 105.111 -2.181 . . . . 0.0 105.111 171.733 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 34.3 mm -109.25 129.18 64.43 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.155 0 N-CA-C 101.03 -3.692 . . . . 0.0 101.03 165.831 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 3.8 mt -109.02 135.8 49.6 Favored 'General case' 0 CA--C 1.478 -1.796 0 N-CA-C 106.543 -1.651 . . . . 0.0 106.543 169.721 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 84.1 mtt180 -125.09 158.23 34.35 Favored 'General case' 0 N--CA 1.43 -1.446 0 N-CA-C 107.123 -1.436 . . . . 0.0 107.123 173.191 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 48.0 p90 -150.5 145.21 25.85 Favored 'General case' 0 N--CA 1.437 -1.091 0 N-CA-C 105.86 -1.904 . . . . 0.0 105.86 173.381 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 46.9 ttp180 -153.44 137.57 10.73 Favored Pre-proline 0 CA--C 1.498 -1.032 0 N-CA-C 105.324 -2.102 . . . . 0.0 105.324 -176.411 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -72.74 120.75 6.86 Favored 'Trans proline' 0 N--CA 1.451 -1.021 0 CA-C-N 123.485 2.28 . . . . 0.0 109.034 -177.369 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 58.5 tttm -73.48 65.06 0.89 Allowed 'General case' 0 C--N 1.358 0.962 0 C-N-CA 127.078 2.151 . . . . 0.0 110.554 177.514 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 6.4 t-20 -161.77 -53.0 0.04 OUTLIER 'General case' 0 N--CA 1.432 -1.358 0 N-CA-C 104.003 -2.592 . . . . 0.0 104.003 -169.735 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 50.3 m -88.36 166.0 14.57 Favored 'General case' 0 N--CA 1.438 -1.052 0 C-N-CA 124.431 1.092 . . . . 0.0 108.218 177.991 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 10.9 m -116.0 41.37 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.795 0 N-CA-C 106.938 -1.505 . . . . 0.0 106.938 -178.998 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -92.54 -156.38 32.72 Favored Glycine 0 C--N 1.354 1.559 0 N-CA-C 109.61 -1.396 . . . . 0.0 109.61 -177.494 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 39.6 mmt180 -101.87 172.2 7.07 Favored 'General case' 0 CA--C 1.499 -0.999 0 N-CA-C 107.324 -1.362 . . . . 0.0 107.324 -179.999 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 47.9 m95 -87.12 164.28 16.5 Favored 'General case' 0 N--CA 1.441 -0.88 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 -177.681 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 96.2 mttt -108.77 155.64 20.54 Favored 'General case' 0 CA--C 1.489 -1.366 0 N-CA-C 102.237 -3.246 . . . . 0.0 102.237 161.462 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -151.32 159.07 44.49 Favored 'General case' 0 CA--C 1.494 -1.209 0 CA-C-O 122.021 0.915 . . . . 0.0 109.794 -178.048 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -133.88 159.21 41.36 Favored 'General case' 0 N--CA 1.434 -1.241 0 N-CA-C 106.057 -1.831 . . . . 0.0 106.057 172.68 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 93.8 m -119.86 125.63 48.99 Favored 'General case' 0 CA--C 1.499 -1.006 0 N-CA-C 104.277 -2.49 . . . . 0.0 104.277 178.178 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 34.0 mt -123.79 122.79 26.35 Favored Pre-proline 0 N--CA 1.439 -0.984 0 N-CA-C 105.038 -2.208 . . . . 0.0 105.038 -171.602 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . 0.505 ' HB2' ' CE1' ' A' ' 54' ' ' HIS . 50.7 Cg_exo -67.25 169.21 15.78 Favored 'Trans proline' 0 CA--C 1.512 -0.612 0 C-N-CA 123.279 2.653 . . . . 0.0 111.301 175.757 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -86.71 83.21 1.6 Allowed Glycine 0 C--N 1.352 1.441 0 N-CA-C 110.121 -1.191 . . . . 0.0 110.121 -177.728 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . 0.505 ' CE1' ' HB2' ' A' ' 52' ' ' PRO . 0.5 OUTLIER -157.54 -44.11 0.07 Allowed 'General case' 0 CA--C 1.497 -1.079 0 N-CA-C 107.279 -1.378 . . . . 0.0 107.279 -179.795 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 92.2 mt -89.62 136.49 33.0 Favored 'General case' 0 CA--C 1.495 -1.148 0 N-CA-C 107.832 -1.173 . . . . 0.0 107.832 179.522 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 8.6 p30 -112.67 5.34 17.68 Favored 'General case' 0 N--CA 1.44 -0.926 0 C-N-CA 124.875 1.27 . . . . 0.0 109.119 -179.392 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 45.3 p -142.98 150.28 39.45 Favored 'General case' 0 CA--C 1.499 -1.012 0 N-CA-C 107.171 -1.418 . . . . 0.0 107.171 -178.519 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 7.5 t80 -126.36 174.08 8.85 Favored 'General case' 0 C--N 1.357 0.924 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 -179.087 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 88.0 m -138.74 109.44 6.64 Favored 'General case' 0 N--CA 1.43 -1.425 0 N-CA-C 104.618 -2.364 . . . . 0.0 104.618 172.205 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 28.3 mt -88.15 147.17 5.42 Favored 'Isoleucine or valine' 0 C--N 1.358 0.965 0 N-CA-C 104.271 -2.492 . . . . 0.0 104.271 171.447 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 94.0 mttt -141.08 162.65 34.97 Favored 'General case' 0 CA--C 1.5 -0.976 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 177.131 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 82.61 48.96 5.35 Favored Glycine 0 C--N 1.353 1.487 0 N-CA-C 109.838 -1.305 . . . . 0.0 109.838 173.758 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 58.0 mt -119.71 173.34 7.08 Favored 'General case' 0 CA--C 1.5 -0.958 0 N-CA-C 107.886 -1.153 . . . . 0.0 107.886 -173.654 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 67.8 mttm -110.36 157.15 38.96 Favored Pre-proline 0 N--CA 1.441 -0.876 0 N-CA-C 107.419 -1.326 . . . . 0.0 107.419 -176.113 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 67.5 Cg_endo -78.65 161.3 27.86 Favored 'Trans proline' 0 N--CA 1.451 -0.986 0 C-N-CA 123.168 2.579 . . . . 0.0 109.785 168.247 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 59.59 26.21 61.99 Favored Glycine 0 C--N 1.355 1.621 0 C-N-CA 127.261 2.363 . . . . 0.0 116.337 171.59 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 13.2 p -120.24 148.3 23.46 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.995 0 N-CA-C 106.837 -1.542 . . . . 0.0 106.837 -177.595 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 4.0 p -99.76 130.93 48.1 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.907 0 N-CA-C 106.626 -1.62 . . . . 0.0 106.626 176.137 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 93.5 m-85 -112.16 148.42 34.04 Favored 'General case' 0 CA--C 1.494 -1.189 0 N-CA-C 105.537 -2.023 . . . . 0.0 105.537 172.246 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -97.91 134.69 40.7 Favored 'General case' 0 CA--C 1.496 -1.11 0 N-CA-C 103.576 -2.75 . . . . 0.0 103.576 161.68 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -117.6 152.58 17.62 Favored Glycine 0 CA--C 1.486 -1.75 0 N-CA-C 106.065 -2.814 . . . . 0.0 106.065 -178.054 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 35.3 tt0 -145.64 130.1 17.82 Favored 'General case' 0 CA--C 1.48 -1.735 0 N-CA-C 106.623 -1.621 . . . . 0.0 106.623 -177.226 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 38.9 tp -118.14 99.8 7.11 Favored 'General case' 0 N--CA 1.437 -1.081 0 N-CA-C 104.151 -2.537 . . . . 0.0 104.151 -174.534 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 26.8 mt -91.99 131.56 38.75 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.865 0 N-CA-C 103.603 -2.74 . . . . 0.0 103.603 176.481 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 20.9 p -117.08 115.74 25.97 Favored 'General case' 0 N--CA 1.436 -1.166 0 N-CA-C 106.962 -1.495 . . . . 0.0 106.962 -177.33 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 1.7 mp -89.58 132.52 34.07 Favored 'Isoleucine or valine' 0 CA--C 1.483 -1.6 0 N-CA-C 102.543 -3.132 . . . . 0.0 102.543 -173.131 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 82.0 mt-30 -101.83 152.65 20.64 Favored 'General case' 0 CA--C 1.489 -1.393 0 N-CA-C 106.951 -1.5 . . . . 0.0 106.951 -174.97 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 11.8 tt0 -77.53 41.48 0.33 Allowed 'General case' 0 N--CA 1.443 -0.818 0 C-N-CA 125.858 1.663 . . . . 0.0 112.419 -179.668 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 8.5 t80 -151.78 16.7 0.68 Allowed 'General case' 0 N--CA 1.436 -1.128 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 178.315 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 86.99 -11.75 63.97 Favored Glycine 0 C--N 1.353 1.526 0 C-N-CA 123.73 0.681 . . . . 0.0 112.496 176.901 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 44.6 t-80 -78.65 160.38 27.56 Favored 'General case' 0 N--CA 1.441 -0.888 0 C-N-CA 124.68 1.192 . . . . 0.0 109.011 -176.767 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 83.2 mt-30 -136.22 136.2 39.71 Favored 'General case' 0 CA--C 1.491 -1.318 0 N-CA-C 104.579 -2.378 . . . . 0.0 104.579 175.14 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 16.8 tp10 -120.49 131.47 54.74 Favored 'General case' 0 CA--C 1.495 -1.171 0 N-CA-C 104.753 -2.314 . . . . 0.0 104.753 178.0 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 7.2 p -108.94 139.25 32.33 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.83 0 N-CA-C 107.561 -1.274 . . . . 0.0 107.561 -174.298 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 89.1 m -125.32 131.22 53.07 Favored 'General case' 0 N--CA 1.44 -0.953 0 N-CA-C 102.804 -3.036 . . . . 0.0 102.804 178.51 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 40.5 ttp180 -130.51 145.53 51.88 Favored 'General case' 0 C--N 1.356 0.882 0 CA-C-N 119.492 1.042 . . . . 0.0 109.031 178.459 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 17.8 p90 -156.35 -179.89 8.59 Favored 'General case' 0 CA--C 1.498 -1.026 0 N-CA-C 105.987 -1.857 . . . . 0.0 105.987 -171.245 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 1.6 p30 -141.05 157.72 44.93 Favored 'General case' 0 N--CA 1.442 -0.873 0 N-CA-C 108.117 -1.068 . . . . 0.0 108.117 169.153 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 21.8 p90 -144.66 170.71 15.56 Favored 'General case' 0 CA--C 1.493 -1.226 0 N-CA-C 106.921 -1.511 . . . . 0.0 106.921 173.597 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 24.7 p -117.51 138.6 51.78 Favored 'General case' 0 CA--C 1.501 -0.934 0 N-CA-C 106.175 -1.787 . . . . 0.0 106.175 171.491 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' THR . . . . . 0.486 ' HG1' ' CD2' ' A' ' 18' ' ' HIS . 56.0 m -108.07 113.49 26.69 Favored 'General case' 0 CA--C 1.495 -1.149 0 N-CA-C 103.009 -2.96 . . . . 0.0 103.009 172.076 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 15.0 t -161.86 165.36 27.85 Favored 'General case' 0 N--CA 1.436 -1.171 0 N-CA-C 104.731 -2.322 . . . . 0.0 104.731 -174.653 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 75.2 p . . . . . 0 C--O 1.261 1.687 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 173.587 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 70.1 m . . . . . 0 N--CA 1.488 1.456 0 CA-C-O 121.431 0.634 . . . . 0.0 110.88 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -178.29 104.07 0.18 Allowed Glycine 0 C--N 1.351 1.404 0 N-CA-C 108.593 -1.803 . . . . 0.0 108.593 176.544 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_exo -64.79 146.29 88.0 Favored 'Trans proline' 0 N--CA 1.442 -1.529 0 C-N-CA 123.157 2.571 . . . . 0.0 115.287 -161.042 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 4.6 m -83.0 169.28 1.6 Allowed 'Isoleucine or valine' 0 N--CA 1.432 -1.336 0 C-N-CA 126.641 1.977 . . . . 0.0 107.168 171.063 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 -101.81 100.35 10.67 Favored 'General case' 0 CA--C 1.495 -1.164 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 -176.678 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 4.2 p -107.77 137.62 38.16 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.138 0 N-CA-C 107.474 -1.306 . . . . 0.0 107.474 -174.016 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -145.19 133.48 21.71 Favored 'General case' 0 N--CA 1.433 -1.323 0 N-CA-C 106.975 -1.491 . . . . 0.0 106.975 -170.669 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 35.6 pt -89.13 162.27 2.57 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.295 0 N-CA-C 105.465 -2.05 . . . . 0.0 105.465 171.132 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 9.8 m -80.1 -105.84 0.02 OUTLIER 'General case' 0 C--N 1.354 0.769 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 -170.832 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 3.2 tm-20 -116.5 -87.74 0.6 Allowed 'General case' 0 CA--C 1.495 -1.156 0 N-CA-C 103.69 -2.707 . . . . 0.0 103.69 177.908 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 14.6 t -153.63 142.95 14.88 Favored Pre-proline 0 N--CA 1.438 -1.034 0 N-CA-C 101.136 -3.653 . . . . 0.0 101.136 162.452 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -77.97 -171.94 1.34 Allowed 'Trans proline' 0 N--CA 1.457 -0.674 0 C-N-CA 122.769 2.313 . . . . 0.0 109.48 179.667 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 11.5 t -114.36 36.2 3.86 Favored 'General case' 0 CA--C 1.499 -0.986 0 N-CA-C 106.221 -1.77 . . . . 0.0 106.221 173.82 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 37.2 mt-30 -125.37 101.65 30.88 Favored Pre-proline 0 N--CA 1.435 -1.21 0 CA-C-N 111.912 -2.404 . . . . 0.0 106.311 -176.808 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_exo -74.88 -11.36 21.7 Favored 'Trans proline' 0 CA--C 1.507 -0.83 0 C-N-CA 122.979 2.453 . . . . 0.0 110.722 177.293 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 1.9 p30 -96.87 -30.81 12.92 Favored 'General case' 0 CA--C 1.486 -1.485 0 C-N-CA 125.508 1.523 . . . . 0.0 110.638 -172.783 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 22.9 t -119.54 156.71 29.78 Favored 'General case' 0 CA--C 1.498 -1.037 0 CA-C-O 122.223 1.011 . . . . 0.0 108.915 -172.47 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 59.7 t-80 -140.39 98.75 7.26 Favored Pre-proline 0 N--CA 1.438 -1.056 0 N-CA-C 106.735 -1.58 . . . . 0.0 106.735 172.783 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -80.86 137.31 11.04 Favored 'Trans proline' 0 N--CA 1.447 -1.216 0 C-N-CA 123.019 2.479 . . . . 0.0 110.17 176.104 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 2.4 pt -118.64 172.77 5.59 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.07 0 N-CA-C 107.747 -1.205 . . . . 0.0 107.747 178.794 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 3.6 pt20 -150.79 158.34 44.03 Favored 'General case' 0 CA--C 1.492 -1.287 0 N-CA-C 105.706 -1.961 . . . . 0.0 105.706 168.947 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 43.7 p90 -142.97 164.49 29.94 Favored 'General case' 0 CA--C 1.493 -1.231 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 -175.409 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 81.1 m-20 -109.39 177.1 4.85 Favored 'General case' 0 CA--C 1.494 -1.2 0 N-CA-C 104.297 -2.482 . . . . 0.0 104.297 168.839 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -161.23 173.83 4.36 Favored Pre-proline 0 N--CA 1.435 -1.22 0 N-CA-C 104.788 -2.301 . . . . 0.0 104.788 -176.138 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 67.1 Cg_exo -63.1 153.49 73.55 Favored 'Trans proline' 0 N--CA 1.455 -0.742 0 C-N-CA 123.786 2.991 . . . . 0.0 112.758 175.563 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 26.1 tt0 -82.17 -40.36 0.93 Allowed Pre-proline 0 N--CA 1.443 -0.813 0 CA-C-O 115.574 -2.155 . . . . 0.0 112.071 -174.558 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_exo -69.49 -8.9 24.83 Favored 'Trans proline' 0 CA--C 1.512 -0.59 0 CA-C-N 125.674 3.062 . . . . 0.0 114.037 179.906 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 8.9 t 67.86 66.65 0.36 Allowed 'General case' 0 C--N 1.357 0.91 0 C-N-CA 126.107 1.763 . . . . 0.0 110.038 178.939 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 76.6 t60 -97.49 -2.27 42.33 Favored 'General case' 0 N--CA 1.441 -0.876 0 C-N-CA 124.517 1.127 . . . . 0.0 108.307 175.411 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 9.7 mt -111.16 135.8 49.21 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.071 0 N-CA-C 105.131 -2.174 . . . . 0.0 105.131 -179.669 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 4.6 p -98.13 -84.45 0.39 Allowed 'General case' 0 N--CA 1.428 -1.565 0 N-CA-C 106.518 -1.66 . . . . 0.0 106.518 178.282 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 52.7 mtmt -90.57 170.65 10.0 Favored 'General case' 0 CA--C 1.487 -1.448 0 C-N-CA 123.857 0.863 . . . . 0.0 109.086 -165.134 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 87.4 m-85 -132.43 140.05 48.28 Favored 'General case' 0 N--CA 1.436 -1.141 0 N-CA-C 103.837 -2.653 . . . . 0.0 103.837 167.568 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 41.8 mt -121.73 135.2 62.64 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.204 0 N-CA-C 101.632 -3.47 . . . . 0.0 101.632 173.66 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 4.5 mt -113.07 136.98 52.11 Favored 'General case' 0 CA--C 1.467 -2.233 0 N-CA-C 104.848 -2.278 . . . . 0.0 104.848 169.54 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 1.1 ptm180 -131.51 152.31 50.84 Favored 'General case' 0 N--CA 1.43 -1.472 0 N-CA-C 105.678 -1.971 . . . . 0.0 105.678 168.632 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 48.6 p90 -155.0 152.28 29.48 Favored 'General case' 0 N--CA 1.436 -1.158 0 N-CA-C 106.841 -1.54 . . . . 0.0 106.841 -175.034 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 36.4 ptt180 -158.14 157.37 29.18 Favored Pre-proline 0 CA--C 1.5 -0.949 0 N-CA-C 105.881 -1.896 . . . . 0.0 105.881 171.989 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_endo -76.43 124.33 7.65 Favored 'Trans proline' 0 CA--C 1.503 -1.067 0 C-N-CA 122.652 2.234 . . . . 0.0 108.968 -175.209 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 85.1 tttt -71.19 79.58 0.7 Allowed 'General case' 0 C--N 1.358 0.943 0 C-N-CA 126.296 1.839 . . . . 0.0 110.497 178.753 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 67.7 m-80 -154.28 -69.57 0.13 Allowed 'General case' 0 N--CA 1.436 -1.167 0 N-CA-C 101.531 -3.507 . . . . 0.0 101.531 -176.313 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 55.1 m -96.79 167.03 11.35 Favored 'General case' 0 N--CA 1.44 -0.925 0 N-CA-C 106.746 -1.575 . . . . 0.0 106.746 171.55 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 2.6 m -132.82 62.59 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.439 -0.988 0 N-CA-C 105.285 -2.117 . . . . 0.0 105.285 179.892 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -93.1 -111.83 2.09 Favored Glycine 0 C--N 1.353 1.521 0 N-CA-C 108.838 -1.705 . . . . 0.0 108.838 -178.916 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 86.7 mtm180 -97.66 169.66 9.55 Favored 'General case' 0 CA--C 1.501 -0.92 0 N-CA-C 107.973 -1.121 . . . . 0.0 107.973 -179.367 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 70.6 m95 -112.16 167.17 10.62 Favored 'General case' 0 N--CA 1.44 -0.957 0 N-CA-C 107.615 -1.254 . . . . 0.0 107.615 178.53 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -114.51 152.89 30.97 Favored 'General case' 0 CA--C 1.487 -1.46 0 N-CA-C 102.537 -3.135 . . . . 0.0 102.537 163.245 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 16.2 pt-20 -152.35 159.04 43.51 Favored 'General case' 0 N--CA 1.437 -1.094 0 CA-C-O 121.749 0.785 . . . . 0.0 109.106 178.507 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -140.03 162.68 34.62 Favored 'General case' 0 CA--C 1.499 -0.998 0 N-CA-C 106.553 -1.647 . . . . 0.0 106.553 172.488 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 90.0 m -119.34 125.32 48.75 Favored 'General case' 0 CA--C 1.5 -0.969 0 N-CA-C 105.127 -2.175 . . . . 0.0 105.127 176.981 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 4.5 mp -109.03 133.64 20.65 Favored Pre-proline 0 N--CA 1.437 -1.117 0 N-CA-C 105.239 -2.134 . . . . 0.0 105.239 -175.928 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 68.7 Cg_exo -64.27 164.1 24.04 Favored 'Trans proline' 0 CA--C 1.508 -0.802 0 C-N-CA 123.312 2.675 . . . . 0.0 113.369 176.193 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -75.37 -16.63 80.5 Favored Glycine 0 C--N 1.352 1.418 0 C-N-CA 123.977 0.799 . . . . 0.0 114.497 -174.421 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 52.6 p-80 -83.52 -27.15 29.57 Favored 'General case' 0 C--N 1.357 0.903 0 CA-C-N 118.144 0.972 . . . . 0.0 110.105 -179.617 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 88.4 mt -88.65 131.18 35.1 Favored 'General case' 0 CA--C 1.501 -0.908 0 N-CA-C 107.945 -1.131 . . . . 0.0 107.945 177.161 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 8.5 p30 -114.17 7.87 16.73 Favored 'General case' 0 CA--C 1.504 -0.797 0 C-N-CA 124.521 1.128 . . . . 0.0 109.858 -174.753 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 36.9 p -139.23 160.49 39.68 Favored 'General case' 0 CA--C 1.497 -1.093 0 N-CA-C 107.163 -1.421 . . . . 0.0 107.163 -177.519 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 4.1 t80 -138.87 178.77 6.91 Favored 'General case' 0 C--N 1.36 1.064 0 CA-C-O 121.672 0.748 . . . . 0.0 109.171 175.729 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 89.4 m -144.49 103.62 3.97 Favored 'General case' 0 N--CA 1.432 -1.339 0 N-CA-C 103.689 -2.708 . . . . 0.0 103.689 -178.502 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 55.8 mt -95.37 106.51 18.33 Favored 'Isoleucine or valine' 0 C--N 1.358 0.969 0 N-CA-C 106.239 -1.763 . . . . 0.0 106.239 179.541 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 63.7 mttm -103.64 163.76 12.11 Favored 'General case' 0 CA--C 1.502 -0.897 0 CA-C-O 121.739 0.78 . . . . 0.0 109.542 178.814 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 90.85 45.5 4.2 Favored Glycine 0 CA--C 1.49 -1.474 0 N-CA-C 109.285 -1.526 . . . . 0.0 109.285 172.907 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 61.7 mt -119.92 176.67 5.3 Favored 'General case' 0 N--CA 1.44 -0.931 0 N-CA-C 106.909 -1.515 . . . . 0.0 106.909 -174.643 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -120.89 157.79 53.94 Favored Pre-proline 0 N--CA 1.44 -0.93 0 N-CA-C 106.704 -1.591 . . . . 0.0 106.704 -175.684 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 64.8 Cg_endo -78.63 164.54 25.76 Favored 'Trans proline' 0 N--CA 1.452 -0.956 0 C-N-CA 123.065 2.51 . . . . 0.0 110.559 170.252 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . 0.459 ' H ' ' HA ' ' A' ' 92' ' ' THR . . . 60.94 25.2 63.76 Favored Glycine 0 N--CA 1.431 -1.679 0 C-N-CA 128.006 2.717 . . . . 0.0 116.124 171.256 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 8.5 p -130.54 146.83 33.42 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.15 0 N-CA-C 108.188 -1.041 . . . . 0.0 108.188 -176.124 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 4.2 p -95.88 133.66 36.23 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.907 0 N-CA-C 107.377 -1.342 . . . . 0.0 107.377 178.157 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 93.8 m-85 -112.9 149.48 33.12 Favored 'General case' 0 CA--C 1.498 -1.057 0 N-CA-C 106.161 -1.792 . . . . 0.0 106.161 174.299 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -101.1 140.0 36.01 Favored 'General case' 0 CA--C 1.497 -1.094 0 N-CA-C 104.561 -2.385 . . . . 0.0 104.561 164.827 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -137.15 148.98 20.08 Favored Glycine 0 CA--C 1.486 -1.723 0 N-CA-C 108.101 -2.0 . . . . 0.0 108.101 -175.035 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 84.5 mt-30 -138.79 135.77 34.97 Favored 'General case' 0 CA--C 1.484 -1.58 0 N-CA-C 105.585 -2.006 . . . . 0.0 105.585 178.477 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 46.0 tp -114.71 103.29 10.84 Favored 'General case' 0 N--CA 1.434 -1.271 0 N-CA-C 103.847 -2.649 . . . . 0.0 103.847 179.247 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 38.1 mt -91.94 122.02 42.99 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.898 0 N-CA-C 103.852 -2.647 . . . . 0.0 103.852 177.723 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 15.4 p -113.92 115.1 27.15 Favored 'General case' 0 N--CA 1.441 -0.884 0 N-CA-C 107.156 -1.424 . . . . 0.0 107.156 -175.316 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 1.8 mp -90.36 131.94 36.26 Favored 'Isoleucine or valine' 0 CA--C 1.482 -1.659 0 N-CA-C 104.805 -2.294 . . . . 0.0 104.805 -162.817 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 76.4 mt-30 -84.3 147.91 26.95 Favored 'General case' 0 CA--C 1.491 -1.298 0 N-CA-C 107.994 -1.113 . . . . 0.0 107.994 -178.882 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 20.2 tt0 -76.5 41.75 0.26 Allowed 'General case' 0 N--CA 1.442 -0.862 0 C-N-CA 126.331 1.852 . . . . 0.0 110.545 170.739 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 8.2 t80 -153.07 15.9 0.55 Allowed 'General case' 0 N--CA 1.434 -1.265 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 -176.528 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 89.25 -19.03 41.62 Favored Glycine 0 C--N 1.353 1.506 0 C-N-CA 123.72 0.676 . . . . 0.0 112.601 174.358 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 36.7 m170 -81.7 173.48 12.28 Favored 'General case' 0 CA--C 1.495 -1.153 0 C-N-CA 124.446 1.098 . . . . 0.0 109.274 -176.308 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 77.1 mt-30 -138.7 145.55 40.47 Favored 'General case' 0 CA--C 1.495 -1.154 0 N-CA-C 105.527 -2.027 . . . . 0.0 105.527 176.495 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -111.23 153.72 25.44 Favored 'General case' 0 CA--C 1.493 -1.215 0 N-CA-C 105.415 -2.068 . . . . 0.0 105.415 171.06 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 14.8 p -126.92 137.46 57.78 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.897 0 N-CA-C 106.523 -1.658 . . . . 0.0 106.523 173.325 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 91.4 m -127.08 131.01 50.98 Favored 'General case' 0 N--CA 1.438 -1.066 0 N-CA-C 101.973 -3.343 . . . . 0.0 101.973 179.055 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 88.8 mtt180 -127.08 148.92 50.13 Favored 'General case' 0 CA--C 1.495 -1.15 0 CA-C-N 118.804 0.729 . . . . 0.0 109.487 -173.154 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 19.6 p90 -164.82 178.26 7.32 Favored 'General case' 0 CA--C 1.502 -0.9 0 N-CA-C 108.156 -1.053 . . . . 0.0 108.156 -175.287 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 51.4 m-20 -132.52 154.06 50.33 Favored 'General case' 0 N--CA 1.442 -0.872 0 N-CA-C 105.507 -2.034 . . . . 0.0 105.507 168.743 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 20.9 p90 -142.5 166.84 23.57 Favored 'General case' 0 CA--C 1.488 -1.424 0 N-CA-C 107.41 -1.33 . . . . 0.0 107.41 169.708 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 25.0 p -120.02 141.65 49.53 Favored 'General case' 0 CA--C 1.5 -0.981 0 N-CA-C 106.21 -1.774 . . . . 0.0 106.21 174.919 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 45.4 m -115.74 120.16 38.39 Favored 'General case' 0 CA--C 1.493 -1.245 0 N-CA-C 102.137 -3.283 . . . . 0.0 102.137 171.706 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' THR . . . . . 0.459 ' HA ' ' H ' ' A' ' 66' ' ' GLY . 5.3 t -145.92 -66.95 0.29 Allowed 'General case' 0 N--CA 1.436 -1.132 0 N-CA-C 106.093 -1.817 . . . . 0.0 106.093 -175.626 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 19.8 m . . . . . 0 C--O 1.261 1.659 0 C-N-CA 125.505 1.522 . . . . 0.0 110.355 178.379 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 22.7 t . . . . . 0 N--CA 1.483 1.214 0 CA-C-O 121.259 0.552 . . . . 0.0 109.799 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 169.62 170.41 34.06 Favored Glycine 0 N--CA 1.436 -1.346 0 N-CA-C 106.717 -2.553 . . . . 0.0 106.717 176.699 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 22.8 Cg_exo -59.09 145.6 97.14 Favored 'Trans proline' 0 N--CA 1.448 -1.188 0 C-N-CA 123.058 2.505 . . . . 0.0 116.054 -164.598 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 48.9 t -79.17 158.96 4.63 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.94 0 C-N-CA 127.707 2.403 . . . . 0.0 106.991 179.575 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -103.86 106.3 16.76 Favored 'General case' 0 CA--C 1.494 -1.184 0 N-CA-C 104.853 -2.277 . . . . 0.0 104.853 175.052 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 2.1 p -130.4 141.64 45.77 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.1 0 N-CA-C 105.349 -2.093 . . . . 0.0 105.349 -169.632 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 1.8 p90 -154.0 149.23 27.0 Favored 'General case' 0 N--CA 1.438 -1.055 0 N-CA-C 105.933 -1.877 . . . . 0.0 105.933 -166.854 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 41.9 mt -109.06 119.76 59.18 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.059 0 N-CA-C 104.899 -2.26 . . . . 0.0 104.899 178.214 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 27.8 p -117.9 -176.8 3.12 Favored 'General case' 0 N--CA 1.442 -0.872 0 N-CA-C 106.937 -1.505 . . . . 0.0 106.937 -177.157 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 17.2 tt0 60.49 24.05 13.69 Favored 'General case' 0 C--N 1.359 0.986 0 C-N-CA 127.69 2.396 . . . . 0.0 112.925 173.367 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 9.6 t -125.06 94.53 43.62 Favored Pre-proline 0 C--N 1.352 0.689 0 N-CA-C 107.957 -1.127 . . . . 0.0 107.957 -176.113 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -78.37 -27.43 5.32 Favored 'Trans proline' 0 N--CA 1.455 -0.771 0 C-N-CA 122.442 2.095 . . . . 0.0 109.5 167.598 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 9.7 p 179.92 108.19 0.04 OUTLIER 'General case' 0 N--CA 1.438 -1.075 0 N-CA-C 104.89 -2.263 . . . . 0.0 104.89 178.306 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 39.1 mt-30 -146.44 103.58 4.01 Favored Pre-proline 0 N--CA 1.441 -0.908 0 N-CA-C 104.836 -2.283 . . . . 0.0 104.836 175.806 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_endo -83.19 -8.71 10.74 Favored 'Trans proline' 0 N--CA 1.454 -0.845 0 C-N-CA 123.273 2.649 . . . . 0.0 110.259 -177.501 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 1.3 p30 -107.79 -42.09 4.82 Favored 'General case' 0 CA--C 1.492 -1.255 0 C-N-CA 124.725 1.21 . . . . 0.0 109.488 -169.069 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 32.8 t -117.06 157.02 26.55 Favored 'General case' 0 CA--C 1.496 -1.134 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 -172.558 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 23.7 m-70 -146.99 98.66 4.05 Favored Pre-proline 0 N--CA 1.437 -1.111 0 N-CA-C 106.516 -1.661 . . . . 0.0 106.516 169.235 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -76.59 100.03 1.35 Allowed 'Trans proline' 0 N--CA 1.447 -1.222 0 C-N-CA 123.654 2.902 . . . . 0.0 109.407 171.746 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 13.4 tt -90.28 149.42 4.05 Favored 'Isoleucine or valine' 0 N--CA 1.408 -2.574 0 C-N-CA 128.834 2.854 . . . . 0.0 106.786 -177.41 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 57.3 mt-30 -141.03 151.06 43.76 Favored 'General case' 0 N--CA 1.434 -1.248 0 N-CA-C 104.225 -2.509 . . . . 0.0 104.225 175.724 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 34.0 p90 -138.98 156.82 46.93 Favored 'General case' 0 N--CA 1.437 -1.081 0 N-CA-C 107.794 -1.187 . . . . 0.0 107.794 -176.815 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 61.3 t30 -94.42 -173.65 3.12 Favored 'General case' 0 CA--C 1.49 -1.336 0 N-CA-C 103.531 -2.766 . . . . 0.0 103.531 169.898 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -155.97 169.21 10.81 Favored Pre-proline 0 N--CA 1.44 -0.96 0 N-CA-C 107.284 -1.376 . . . . 0.0 107.284 172.36 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 98.0 Cg_exo -64.39 167.34 15.05 Favored 'Trans proline' 0 CA--C 1.51 -0.683 0 C-N-CA 123.559 2.839 . . . . 0.0 112.447 170.686 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 71.4 tp60 -80.03 -42.68 1.44 Allowed Pre-proline 0 N--CA 1.444 -0.741 0 CA-C-O 115.586 -2.149 . . . . 0.0 112.026 -172.016 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_exo -66.78 152.72 79.98 Favored 'Trans proline' 0 CA--C 1.507 -0.864 0 CA-C-N 125.773 3.097 . . . . 0.0 112.171 177.936 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 27.2 p -99.58 58.01 1.04 Allowed 'General case' 0 C--N 1.353 0.754 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 179.739 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 76.3 t60 -106.21 -4.65 19.97 Favored 'General case' 0 N--CA 1.441 -0.92 0 C-N-CA 125.273 1.429 . . . . 0.0 107.595 175.67 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 41.8 mt -105.44 129.07 58.89 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.248 0 N-CA-C 105.037 -2.209 . . . . 0.0 105.037 178.167 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 5.2 p -104.36 -84.34 0.48 Allowed 'General case' 0 N--CA 1.43 -1.449 0 N-CA-C 107.459 -1.311 . . . . 0.0 107.459 -178.591 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 55.1 mtmt -89.7 168.83 11.81 Favored 'General case' 0 CA--C 1.488 -1.432 0 N-CA-C 108.544 -0.909 . . . . 0.0 108.544 -164.277 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 93.7 m-85 -129.79 138.34 51.0 Favored 'General case' 0 N--CA 1.434 -1.266 0 N-CA-C 103.861 -2.644 . . . . 0.0 103.861 168.297 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 57.3 mt -114.88 130.61 69.05 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.296 0 N-CA-C 101.01 -3.7 . . . . 0.0 101.01 169.885 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 3.1 mt -110.26 129.9 55.65 Favored 'General case' 0 CA--C 1.469 -2.144 0 N-CA-C 104.034 -2.58 . . . . 0.0 104.034 167.635 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 6.5 ptm180 -132.63 154.48 50.04 Favored 'General case' 0 N--CA 1.431 -1.399 0 N-CA-C 107.035 -1.468 . . . . 0.0 107.035 176.062 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 47.8 p90 -155.18 142.44 19.42 Favored 'General case' 0 N--CA 1.435 -1.176 0 N-CA-C 106.877 -1.527 . . . . 0.0 106.877 -173.328 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 30.7 ttp180 -139.54 140.88 26.61 Favored Pre-proline 0 CA--C 1.499 -1.017 0 N-CA-C 104.528 -2.397 . . . . 0.0 104.528 -177.777 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 26.7 Cg_endo -72.14 120.17 6.63 Favored 'Trans proline' 0 N--CA 1.452 -0.934 0 C-N-CA 122.827 2.351 . . . . 0.0 108.472 174.663 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 23.0 ttmm -68.06 85.2 0.24 Allowed 'General case' 0 C--N 1.359 1.005 0 C-N-CA 127.34 2.256 . . . . 0.0 109.733 -178.641 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 31.2 m120 -150.77 -72.41 0.17 Allowed 'General case' 0 N--CA 1.435 -1.209 0 N-CA-C 102.006 -3.331 . . . . 0.0 102.006 -178.075 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 53.7 p -105.55 172.1 6.98 Favored 'General case' 0 N--CA 1.441 -0.909 0 N-CA-C 107.374 -1.343 . . . . 0.0 107.374 174.61 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 4.0 m -116.21 52.27 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.863 0 N-CA-C 106.011 -1.848 . . . . 0.0 106.011 175.022 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -98.15 -129.08 6.27 Favored Glycine 0 C--N 1.355 1.597 0 N-CA-C 109.421 -1.472 . . . . 0.0 109.421 -176.031 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 17.5 ptm180 -80.09 160.06 25.89 Favored 'General case' 0 C--N 1.357 0.906 0 C-N-CA 123.942 0.897 . . . . 0.0 109.685 -176.925 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -162.49 169.91 19.56 Favored 'General case' 0 CA--C 1.493 -1.212 0 CA-C-O 121.445 0.64 . . . . 0.0 110.298 -171.217 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 95.6 mttt -111.06 155.89 22.12 Favored 'General case' 0 CA--C 1.488 -1.408 0 N-CA-C 107.485 -1.302 . . . . 0.0 107.485 -172.612 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 24.5 pt-20 -152.25 160.15 43.41 Favored 'General case' 0 N--CA 1.434 -1.27 0 N-CA-C 107.972 -1.121 . . . . 0.0 107.972 171.142 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -137.76 159.48 41.88 Favored 'General case' 0 N--CA 1.437 -1.102 0 N-CA-C 105.396 -2.075 . . . . 0.0 105.396 173.785 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 73.3 m -120.41 125.9 49.12 Favored 'General case' 0 CA--C 1.498 -1.036 0 N-CA-C 104.533 -2.395 . . . . 0.0 104.533 177.393 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 5.3 mp -114.73 136.03 22.43 Favored Pre-proline 0 N--CA 1.435 -1.188 0 N-CA-C 104.6 -2.37 . . . . 0.0 104.6 -174.255 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 62.0 Cg_exo -64.3 166.85 15.97 Favored 'Trans proline' 0 CA--C 1.508 -0.78 0 C-N-CA 123.528 2.818 . . . . 0.0 113.519 176.794 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -77.06 -19.23 77.63 Favored Glycine 0 C--N 1.353 1.507 0 C-N-CA 123.797 0.713 . . . . 0.0 114.242 -175.149 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 51.7 p-80 -83.23 -26.79 30.43 Favored 'General case' 0 C--N 1.355 0.838 0 CA-C-N 117.963 0.881 . . . . 0.0 109.788 -179.278 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 89.0 mt -88.84 132.92 34.45 Favored 'General case' 0 CA--C 1.501 -0.93 0 N-CA-C 107.37 -1.345 . . . . 0.0 107.37 175.407 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 7.8 p30 -121.33 15.0 11.31 Favored 'General case' 0 CA--C 1.5 -0.946 0 C-N-CA 124.19 0.996 . . . . 0.0 108.816 -175.501 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 32.9 p -144.73 155.47 43.57 Favored 'General case' 0 N--CA 1.438 -1.074 0 N-CA-C 106.928 -1.508 . . . . 0.0 106.928 -178.721 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 23.0 t80 -150.64 157.76 43.35 Favored 'General case' 0 CA--C 1.497 -1.093 0 N-CA-C 107.965 -1.124 . . . . 0.0 107.965 178.188 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 48.2 m -108.78 112.37 24.61 Favored 'General case' 0 CA--C 1.5 -0.945 0 N-CA-C 106.197 -1.779 . . . . 0.0 106.197 173.536 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 55.3 mt -97.19 91.83 2.76 Favored 'Isoleucine or valine' 0 C--N 1.359 0.982 0 N-CA-C 105.084 -2.191 . . . . 0.0 105.084 174.146 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . 0.468 ' HD3' ' H ' ' A' ' 61' ' ' LYS . 0.3 OUTLIER -105.18 160.52 15.01 Favored 'General case' 0 CA--C 1.498 -1.022 0 N-CA-C 107.67 -1.233 . . . . 0.0 107.67 178.412 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 88.74 52.85 2.7 Favored Glycine 0 C--N 1.353 1.504 0 N-CA-C 108.75 -1.74 . . . . 0.0 108.75 179.796 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 60.7 mt -115.54 158.55 22.46 Favored 'General case' 0 CA--C 1.501 -0.91 0 N-CA-C 107.087 -1.449 . . . . 0.0 107.087 178.961 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 29.1 mtpp -95.35 155.71 38.48 Favored Pre-proline 0 N--CA 1.441 -0.925 0 N-CA-C 106.97 -1.492 . . . . 0.0 106.97 -178.442 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 69.0 Cg_endo -80.31 162.87 22.46 Favored 'Trans proline' 0 N--CA 1.454 -0.852 0 C-N-CA 122.988 2.459 . . . . 0.0 110.903 177.249 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 60.93 26.67 65.78 Favored Glycine 0 C--N 1.356 1.669 0 C-N-CA 127.819 2.628 . . . . 0.0 116.814 166.095 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 7.2 p -131.43 145.61 34.95 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.846 0 CA-C-N 117.701 0.75 . . . . 0.0 109.325 -173.211 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 2.9 p -90.46 127.29 43.05 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.863 0 N-CA-C 107.208 -1.405 . . . . 0.0 107.208 176.332 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 84.0 m-85 -107.3 147.77 29.85 Favored 'General case' 0 CA--C 1.498 -1.044 0 N-CA-C 106.814 -1.551 . . . . 0.0 106.814 172.842 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -95.87 143.98 26.61 Favored 'General case' 0 N--CA 1.439 -0.993 0 N-CA-C 105.132 -2.173 . . . . 0.0 105.132 160.918 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -133.42 155.13 21.56 Favored Glycine 0 CA--C 1.488 -1.637 0 N-CA-C 107.727 -2.149 . . . . 0.0 107.727 -178.962 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 32.0 mt-30 -143.13 138.25 29.68 Favored 'General case' 0 CA--C 1.482 -1.667 0 N-CA-C 105.959 -1.867 . . . . 0.0 105.959 176.345 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 42.8 tp -113.69 103.77 11.56 Favored 'General case' 0 N--CA 1.436 -1.175 0 N-CA-C 103.76 -2.682 . . . . 0.0 103.76 175.75 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 13.6 mt -98.19 128.45 49.63 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.786 0 N-CA-C 104.32 -2.474 . . . . 0.0 104.32 179.664 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 43.8 m -112.41 112.43 23.99 Favored 'General case' 0 N--CA 1.441 -0.923 0 N-CA-C 106.992 -1.484 . . . . 0.0 106.992 -175.189 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 1.7 mp -87.85 136.35 23.36 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.217 0 N-CA-C 104.712 -2.329 . . . . 0.0 104.712 -166.822 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 78.2 mt-30 -95.84 141.69 28.98 Favored 'General case' 0 N--CA 1.436 -1.154 0 N-CA-C 106.042 -1.836 . . . . 0.0 106.042 -179.068 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 7.8 tp-100 -69.04 117.02 10.16 Favored 'General case' 0 N--CA 1.441 -0.882 0 C-N-CA 124.129 0.972 . . . . 0.0 111.395 -170.554 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 31.9 m-85 58.09 45.39 17.81 Favored 'General case' 0 C--N 1.358 0.972 0 C-N-CA 127.325 2.25 . . . . 0.0 112.816 179.653 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -170.33 -114.46 0.31 Allowed Glycine 0 C--N 1.354 1.554 0 C-N-CA 118.663 -1.732 . . . . 0.0 109.704 174.847 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 52.2 m80 -83.24 -171.67 3.7 Favored 'General case' 0 CA--C 1.495 -1.165 0 C-N-CA 125.714 1.606 . . . . 0.0 110.425 -167.715 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -146.66 145.46 30.04 Favored 'General case' 0 N--CA 1.433 -1.281 0 N-CA-C 106.509 -1.663 . . . . 0.0 106.509 169.507 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -101.72 145.45 29.11 Favored 'General case' 0 N--CA 1.44 -0.957 0 N-CA-C 104.645 -2.354 . . . . 0.0 104.645 -179.907 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 6.6 p -124.99 137.96 55.86 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.775 0 N-CA-C 108.104 -1.073 . . . . 0.0 108.104 -177.569 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 61.0 m -125.85 137.13 53.74 Favored 'General case' 0 N--CA 1.439 -0.98 0 N-CA-C 103.232 -2.877 . . . . 0.0 103.232 175.922 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 54.6 ttp180 -130.15 144.6 51.45 Favored 'General case' 0 CA--C 1.502 -0.873 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 -179.309 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 23.6 p90 -156.48 -178.19 7.16 Favored 'General case' 0 CA--C 1.5 -0.962 0 N-CA-C 106.263 -1.754 . . . . 0.0 106.263 -178.216 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 47.7 p-10 -140.43 160.79 39.21 Favored 'General case' 0 N--CA 1.441 -0.877 0 N-CA-C 107.412 -1.329 . . . . 0.0 107.412 168.116 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 24.5 p90 -147.21 170.31 17.51 Favored 'General case' 0 CA--C 1.49 -1.365 0 N-CA-C 107.033 -1.469 . . . . 0.0 107.033 173.785 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 33.0 p -124.74 147.13 48.81 Favored 'General case' 0 CA--C 1.499 -0.994 0 N-CA-C 107.319 -1.363 . . . . 0.0 107.319 178.036 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 4.4 p -109.09 130.12 55.48 Favored 'General case' 0 N--CA 1.439 -1.012 0 N-CA-C 102.525 -3.139 . . . . 0.0 102.525 164.047 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 42.9 p -90.73 -179.17 5.46 Favored 'General case' 0 N--CA 1.444 -0.732 0 N-CA-C 106.931 -1.507 . . . . 0.0 106.931 179.54 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 31.5 t . . . . . 0 C--O 1.262 1.729 0 N-CA-C 105.186 -2.153 . . . . 0.0 105.186 176.695 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 68.0 m . . . . . 0 N--CA 1.484 1.275 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 167.75 -154.81 25.19 Favored Glycine 0 N--CA 1.435 -1.403 0 N-CA-C 105.795 -2.922 . . . . 0.0 105.795 -176.631 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_exo -61.65 139.45 81.11 Favored 'Trans proline' 0 N--CA 1.442 -1.527 0 C-N-CA 122.865 2.377 . . . . 0.0 113.694 -175.62 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 4.1 t -79.46 154.26 4.7 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.932 0 C-N-CA 127.202 2.201 . . . . 0.0 106.383 -179.14 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 55.6 mm-40 -101.43 96.11 6.93 Favored 'General case' 0 CA--C 1.49 -1.338 0 N-CA-C 107.643 -1.244 . . . . 0.0 107.643 -175.267 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 2.4 p -120.52 143.14 33.43 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.103 0 CA-C-N 113.459 -1.701 . . . . 0.0 107.802 -165.033 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -73.65 171.54 13.07 Favored 'General case' 0 N--CA 1.438 -1.036 0 C-N-CA 125.762 1.625 . . . . 0.0 112.494 -169.271 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.472 HG13 ' H ' ' A' ' 9' ' ' THR . 5.5 tp -89.7 -152.24 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.438 -1.048 0 C-N-CA 128.172 2.589 . . . . 0.0 106.285 175.18 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.491 ' HB ' ' H ' ' A' ' 90' ' ' THR . 4.3 t -72.46 92.2 1.44 Allowed 'General case' 0 N--CA 1.442 -0.848 0 C-N-CA 127.278 2.231 . . . . 0.0 108.85 172.541 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -85.99 0.02 54.34 Favored 'General case' 0 C--N 1.355 0.837 0 C-N-CA 124.617 1.167 . . . . 0.0 111.528 179.847 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 20.9 p -84.53 135.0 41.4 Favored Pre-proline 0 C--N 1.356 0.864 0 N-CA-C 107.958 -1.127 . . . . 0.0 107.958 177.181 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_endo -72.1 -69.85 0.02 OUTLIER 'Trans proline' 0 N--CA 1.45 -1.047 0 C-N-CA 122.998 2.465 . . . . 0.0 108.525 166.805 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 65.8 m -143.87 112.88 6.74 Favored 'General case' 0 N--CA 1.434 -1.232 0 N-CA-C 103.843 -2.651 . . . . 0.0 103.843 169.481 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 30.0 mm100 -140.16 113.66 7.53 Favored Pre-proline 0 N--CA 1.442 -0.836 0 N-CA-C 104.405 -2.442 . . . . 0.0 104.405 176.086 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 75.0 Cg_endo -82.63 -14.98 8.77 Favored 'Trans proline' 0 CA--C 1.504 -0.978 0 C-N-CA 123.024 2.483 . . . . 0.0 111.04 -169.408 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 4.7 p-10 -122.66 -36.11 2.96 Favored 'General case' 0 CA--C 1.486 -1.499 0 O-C-N 123.821 0.7 . . . . 0.0 110.744 -162.988 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 30.3 p -117.58 151.54 36.96 Favored 'General case' 0 CA--C 1.496 -1.127 0 CA-C-O 121.79 0.805 . . . . 0.0 108.896 -173.122 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . 0.44 ' HE1' ' HA ' ' A' ' 9' ' ' THR . 81.0 t60 -145.77 106.37 4.28 Favored Pre-proline 0 N--CA 1.433 -1.28 0 N-CA-C 106.228 -1.767 . . . . 0.0 106.228 167.43 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -77.74 142.49 20.33 Favored 'Trans proline' 0 N--CA 1.447 -1.249 0 C-N-CA 122.578 2.186 . . . . 0.0 109.732 173.092 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 18.2 mm -102.9 140.09 22.1 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.919 0 N-CA-C 103.434 -2.802 . . . . 0.0 103.434 174.121 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 1.4 tm0? -130.32 138.04 50.24 Favored 'General case' 0 CA--C 1.498 -1.045 0 N-CA-C 102.801 -3.036 . . . . 0.0 102.801 176.5 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 49.5 p90 -140.64 166.38 24.9 Favored 'General case' 0 CA--C 1.497 -1.067 0 N-CA-C 106.913 -1.514 . . . . 0.0 106.913 -178.786 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 36.7 m-80 -136.91 132.42 34.46 Favored 'General case' 0 CA--C 1.488 -1.404 0 N-CA-C 105.469 -2.049 . . . . 0.0 105.469 177.198 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -104.0 167.61 9.79 Favored Pre-proline 0 N--CA 1.44 -0.972 0 C-N-CA 124.515 1.126 . . . . 0.0 109.378 -166.809 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_exo -66.23 158.48 54.62 Favored 'Trans proline' 0 CA--C 1.508 -0.78 0 C-N-CA 123.359 2.706 . . . . 0.0 111.926 171.207 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 24.4 tt0 -82.95 -45.12 0.88 Allowed Pre-proline 0 N--CA 1.443 -0.781 0 CA-C-O 115.54 -2.172 . . . . 0.0 111.691 -177.618 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 74.7 Cg_exo -68.57 164.55 32.53 Favored 'Trans proline' 0 CA--C 1.509 -0.77 0 CA-C-N 125.65 3.054 . . . . 0.0 112.717 -178.002 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 35.8 p -76.78 124.51 27.79 Favored 'General case' 0 C--N 1.355 0.847 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 179.323 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . 0.51 ' HD1' HG13 ' A' ' 30' ' ' ILE . 64.2 t-80 -174.69 -42.78 0.01 OUTLIER 'General case' 0 CA--C 1.496 -1.098 0 N-CA-C 106.559 -1.645 . . . . 0.0 106.559 -171.192 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.51 HG13 ' HD1' ' A' ' 29' ' ' HIS . 36.1 mt -118.18 136.42 55.43 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.132 0 N-CA-C 106.331 -1.729 . . . . 0.0 106.331 -171.948 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' SER . . . . . 0.464 ' HG ' ' H ' ' A' ' 32' ' ' LYS . 5.9 p -114.29 -85.39 0.6 Allowed 'General case' 0 N--CA 1.431 -1.399 0 N-CA-C 106.188 -1.782 . . . . 0.0 106.188 177.361 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.464 ' H ' ' HG ' ' A' ' 31' ' ' SER . 52.0 mtmt -86.03 167.48 14.98 Favored 'General case' 0 CA--C 1.485 -1.527 0 C-N-CA 124.799 1.239 . . . . 0.0 109.224 -164.387 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 81.4 m-85 -132.02 133.43 44.42 Favored 'General case' 0 CA--C 1.49 -1.362 0 N-CA-C 104.044 -2.576 . . . . 0.0 104.044 177.504 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 28.2 mt -122.41 127.87 75.24 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.326 0 N-CA-C 101.921 -3.363 . . . . 0.0 101.921 178.338 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 5.2 mt -110.51 133.46 53.27 Favored 'General case' 0 CA--C 1.475 -1.916 0 N-CA-C 106.151 -1.796 . . . . 0.0 106.151 177.531 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 2.4 mpt_? -112.45 155.46 24.21 Favored 'General case' 0 N--CA 1.432 -1.373 0 N-CA-C 104.62 -2.363 . . . . 0.0 104.62 166.961 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 47.8 p90 -155.32 150.73 27.15 Favored 'General case' 0 N--CA 1.438 -1.042 0 N-CA-C 107.729 -1.211 . . . . 0.0 107.729 170.196 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 11.2 ptp180 -150.88 148.87 24.0 Favored Pre-proline 0 CA--C 1.499 -0.982 0 N-CA-C 106.777 -1.564 . . . . 0.0 106.777 166.863 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -75.96 144.84 27.63 Favored 'Trans proline' 0 CA--C 1.503 -1.048 0 C-N-CA 122.763 2.309 . . . . 0.0 107.86 171.619 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -70.69 80.2 0.6 Allowed 'General case' 0 C--N 1.354 0.797 0 C-N-CA 125.085 1.354 . . . . 0.0 110.915 177.157 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 8.9 t-20 -161.97 -54.8 0.04 OUTLIER 'General case' 0 N--CA 1.431 -1.399 0 N-CA-C 102.917 -2.994 . . . . 0.0 102.917 -178.158 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 34.3 p -83.82 143.79 29.7 Favored 'General case' 0 N--CA 1.438 -1.065 0 N-CA-C 107.299 -1.371 . . . . 0.0 107.299 173.226 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 14.3 m -136.81 14.96 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.803 0 N-CA-C 106.677 -1.601 . . . . 0.0 106.677 177.614 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -101.44 -93.98 2.2 Favored Glycine 0 C--N 1.356 1.658 0 N-CA-C 108.043 -2.023 . . . . 0.0 108.043 -175.067 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 17.5 ptm180 -91.13 171.16 9.44 Favored 'General case' 0 CA--C 1.503 -0.864 0 N-CA-C 108.108 -1.071 . . . . 0.0 108.108 177.255 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -159.52 179.38 8.96 Favored 'General case' 0 CA--C 1.494 -1.192 0 N-CA-C 109.606 -0.516 . . . . 0.0 109.606 -178.657 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -110.04 152.63 25.7 Favored 'General case' 0 CA--C 1.489 -1.387 0 N-CA-C 106.755 -1.572 . . . . 0.0 106.755 -175.818 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -154.8 156.95 37.18 Favored 'General case' 0 N--CA 1.433 -1.284 0 N-CA-C 106.957 -1.497 . . . . 0.0 106.957 -178.953 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -146.05 164.03 33.4 Favored 'General case' 0 CA--C 1.502 -0.885 0 N-CA-C 107.793 -1.188 . . . . 0.0 107.793 175.13 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 96.9 m -120.98 126.57 50.29 Favored 'General case' 0 CA--C 1.502 -0.867 0 N-CA-C 105.542 -2.022 . . . . 0.0 105.542 178.382 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 5.0 mp -114.07 136.13 22.16 Favored Pre-proline 0 N--CA 1.439 -0.992 0 N-CA-C 105.296 -2.113 . . . . 0.0 105.296 -175.823 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_exo -63.06 165.66 16.22 Favored 'Trans proline' 0 CA--C 1.508 -0.81 0 C-N-CA 123.734 2.956 . . . . 0.0 113.799 176.823 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -82.2 -13.68 78.46 Favored Glycine 0 C--N 1.351 1.403 0 C-N-CA 123.507 0.575 . . . . 0.0 113.451 -171.682 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 50.5 p-80 -84.66 -27.16 27.29 Favored 'General case' 0 C--N 1.356 0.872 0 CA-C-N 117.945 0.872 . . . . 0.0 109.862 178.572 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 88.5 mt -88.52 130.39 35.24 Favored 'General case' 0 CA--C 1.498 -1.027 0 N-CA-C 108.536 -0.912 . . . . 0.0 108.536 178.678 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 8.4 p-10 -108.8 10.84 26.55 Favored 'General case' 0 N--CA 1.442 -0.845 0 C-N-CA 124.574 1.15 . . . . 0.0 109.921 -177.484 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 39.2 p -146.43 162.5 38.12 Favored 'General case' 0 N--CA 1.439 -1.003 0 N-CA-C 107.534 -1.284 . . . . 0.0 107.534 -178.598 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 10.7 t80 -140.21 174.63 10.33 Favored 'General case' 0 N--CA 1.444 -0.728 0 N-CA-C 107.122 -1.436 . . . . 0.0 107.122 -179.789 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 55.4 m -137.82 111.41 8.13 Favored 'General case' 0 N--CA 1.433 -1.317 0 N-CA-C 104.689 -2.337 . . . . 0.0 104.689 174.064 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 43.5 mt -91.43 138.72 19.09 Favored 'Isoleucine or valine' 0 C--N 1.358 0.95 0 N-CA-C 104.346 -2.464 . . . . 0.0 104.346 172.361 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 6.9 mtpm? -139.56 162.11 35.88 Favored 'General case' 0 CA--C 1.499 -0.994 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 -179.12 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 82.99 51.37 4.23 Favored Glycine 0 C--N 1.354 1.546 0 N-CA-C 109.429 -1.468 . . . . 0.0 109.429 176.862 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 80.5 mt -117.67 172.03 7.63 Favored 'General case' 0 CA--C 1.501 -0.932 0 N-CA-C 108.071 -1.085 . . . . 0.0 108.071 -170.869 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 10.4 mptt -102.97 151.21 38.37 Favored Pre-proline 0 N--CA 1.442 -0.828 0 N-CA-C 107.572 -1.27 . . . . 0.0 107.572 -172.479 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 64.2 Cg_exo -66.66 135.4 38.59 Favored 'Trans proline' 0 N--CA 1.453 -0.911 0 C-N-CA 123.62 2.88 . . . . 0.0 112.226 171.56 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 54.66 50.01 59.22 Favored Glycine 0 C--N 1.355 1.599 0 C-N-CA 127.256 2.36 . . . . 0.0 115.415 167.334 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 4.3 p -128.94 149.49 33.7 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.007 0 N-CA-C 107.597 -1.26 . . . . 0.0 107.597 178.871 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 7.6 p -95.23 135.5 29.11 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.959 0 N-CA-C 107.644 -1.243 . . . . 0.0 107.644 -178.256 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 83.6 m-85 -117.1 151.28 37.14 Favored 'General case' 0 CA--C 1.496 -1.121 0 N-CA-C 106.395 -1.706 . . . . 0.0 106.395 177.364 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -98.44 142.46 30.03 Favored 'General case' 0 CA--C 1.5 -0.97 0 N-CA-C 104.908 -2.256 . . . . 0.0 104.908 159.476 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -133.23 149.88 19.72 Favored Glycine 0 CA--C 1.49 -1.525 0 N-CA-C 107.693 -2.163 . . . . 0.0 107.693 179.938 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 33.7 mt-30 -136.49 136.24 39.25 Favored 'General case' 0 CA--C 1.484 -1.56 0 N-CA-C 106.581 -1.637 . . . . 0.0 106.581 176.173 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 15.0 tp -119.92 106.75 12.35 Favored 'General case' 0 CA--C 1.499 -1.007 0 N-CA-C 105.778 -1.934 . . . . 0.0 105.778 -176.851 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 5.9 mt -100.15 129.32 51.05 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.113 0 N-CA-C 105.036 -2.209 . . . . 0.0 105.036 -178.81 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 12.6 p -115.72 114.4 24.77 Favored 'General case' 0 N--CA 1.443 -0.823 0 N-CA-C 108.108 -1.071 . . . . 0.0 108.108 -176.418 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 1.7 mp -94.94 143.05 12.57 Favored 'Isoleucine or valine' 0 C--N 1.358 0.941 0 N-CA-C 106.045 -1.835 . . . . 0.0 106.045 -163.808 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 16.7 tt0 -102.3 140.95 35.9 Favored 'General case' 0 CA--C 1.498 -1.031 0 N-CA-C 105.116 -2.179 . . . . 0.0 105.116 171.342 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 75.4 mt-30 -67.19 115.21 6.61 Favored 'General case' 0 C--N 1.358 0.955 0 C-N-CA 123.319 0.648 . . . . 0.0 111.075 -176.038 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 58.4 m-85 60.12 40.03 18.84 Favored 'General case' 0 C--N 1.355 0.848 0 C-N-CA 126.523 1.929 . . . . 0.0 112.143 176.324 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -158.85 -118.61 0.53 Allowed Glycine 0 C--N 1.355 1.623 0 N-CA-C 108.779 -1.728 . . . . 0.0 108.779 -178.361 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 78.4 m-70 -82.84 179.98 7.61 Favored 'General case' 0 CA--C 1.501 -0.928 0 C-N-CA 124.657 1.183 . . . . 0.0 111.178 -168.38 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 10.9 pt20 -157.16 133.5 9.78 Favored 'General case' 0 N--CA 1.434 -1.258 0 N-CA-C 106.076 -1.824 . . . . 0.0 106.076 167.391 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 31.5 mm-40 -100.91 146.43 27.36 Favored 'General case' 0 CA--C 1.498 -1.031 0 N-CA-C 105.531 -2.026 . . . . 0.0 105.531 -178.231 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 7.6 p -122.3 141.55 42.27 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.721 0 N-CA-C 108.004 -1.109 . . . . 0.0 108.004 -174.444 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 23.2 m -125.79 145.45 50.21 Favored 'General case' 0 N--CA 1.442 -0.872 0 N-CA-C 104.398 -2.445 . . . . 0.0 104.398 -179.711 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 38.9 ttm180 -133.85 143.46 48.33 Favored 'General case' 0 CA--C 1.504 -0.81 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 173.32 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 28.9 p90 -155.67 175.68 13.6 Favored 'General case' 0 CA--C 1.5 -0.974 0 N-CA-C 106.905 -1.517 . . . . 0.0 106.905 -178.424 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 52.2 m-20 -133.47 153.86 51.28 Favored 'General case' 0 CA--C 1.504 -0.81 0 N-CA-C 106.018 -1.845 . . . . 0.0 106.018 170.334 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 17.1 p90 -151.28 175.64 12.01 Favored 'General case' 0 CA--C 1.493 -1.23 0 N-CA-C 106.678 -1.601 . . . . 0.0 106.678 173.222 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' THR . . . . . 0.491 ' H ' ' HB ' ' A' ' 9' ' ' THR . 31.4 p -122.6 147.02 46.9 Favored 'General case' 0 CA--C 1.504 -0.813 0 N-CA-C 107.533 -1.284 . . . . 0.0 107.533 174.276 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 94.3 m -99.52 121.65 41.47 Favored 'General case' 0 CA--C 1.496 -1.125 0 N-CA-C 102.721 -3.066 . . . . 0.0 102.721 165.583 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 2.3 m 68.13 -128.34 0.13 Allowed 'General case' 0 C--N 1.36 1.028 0 C-N-CA 126.573 1.949 . . . . 0.0 106.481 -165.346 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 26.8 p . . . . . 0 C--O 1.261 1.69 0 N-CA-C 106.168 -1.79 . . . . 0.0 106.168 174.124 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 24.1 t . . . . . 0 N--CA 1.48 1.037 0 N-CA-C 108.752 -0.833 . . . . 0.0 108.752 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -142.89 -147.74 4.82 Favored Glycine 0 C--N 1.352 1.439 0 N-CA-C 106.138 -2.785 . . . . 0.0 106.138 -176.917 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_exo -58.4 140.93 96.46 Favored 'Trans proline' 0 N--CA 1.445 -1.35 0 C-N-CA 123.749 2.966 . . . . 0.0 113.319 -175.783 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 7.3 t -79.0 155.31 4.83 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.892 0 C-N-CA 127.014 2.126 . . . . 0.0 106.569 -175.345 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 93.4 mt-10 -97.35 87.98 4.29 Favored 'General case' 0 CA--C 1.493 -1.224 0 CA-C-O 122.377 1.084 . . . . 0.0 108.181 -173.1 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 2.7 p -110.77 134.93 51.45 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.146 0 CA-C-N 114.319 -1.31 . . . . 0.0 107.868 -166.179 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 23.8 p90 -135.81 175.67 9.38 Favored 'General case' 0 N--CA 1.434 -1.246 0 N-CA-C 104.072 -2.566 . . . . 0.0 104.072 178.131 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 17.9 tt -112.74 123.53 68.5 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.952 0 N-CA-C 107.343 -1.355 . . . . 0.0 107.343 175.756 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 8.1 t -101.05 155.9 17.72 Favored 'General case' 0 N--CA 1.44 -0.931 0 N-CA-C 107.904 -1.147 . . . . 0.0 107.904 -177.209 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 58.17 37.46 26.29 Favored 'General case' 0 C--N 1.358 0.973 0 C-N-CA 127.465 2.306 . . . . 0.0 113.48 167.431 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 16.2 p -126.2 87.23 56.58 Favored Pre-proline 0 C--N 1.35 0.616 0 N-CA-C 109.217 -0.66 . . . . 0.0 109.217 178.47 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 68.6 Cg_endo -77.73 -25.8 7.5 Favored 'Trans proline' 0 N--CA 1.453 -0.861 0 C-N-CA 122.574 2.183 . . . . 0.0 109.512 162.369 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 9.1 p 172.18 109.98 0.01 OUTLIER 'General case' 0 N--CA 1.439 -1.002 0 N-CA-C 104.887 -2.264 . . . . 0.0 104.887 -179.975 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 92.1 mt-30 -151.56 105.61 2.9 Favored Pre-proline 0 N--CA 1.442 -0.834 0 N-CA-C 105.666 -1.976 . . . . 0.0 105.666 178.798 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -83.67 -14.14 7.93 Favored 'Trans proline' 0 CA--C 1.507 -0.84 0 C-N-CA 122.936 2.424 . . . . 0.0 110.917 -179.002 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 7.0 p-10 -104.18 -42.34 5.55 Favored 'General case' 0 CA--C 1.494 -1.199 0 O-C-N 123.716 0.635 . . . . 0.0 110.417 -165.72 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 10.9 p -120.1 143.98 47.86 Favored 'General case' 0 CA--C 1.488 -1.432 0 N-CA-C 107.98 -1.118 . . . . 0.0 107.98 -178.43 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . 0.448 ' CE1' HG23 ' A' ' 91' ' ' THR . 0.1 OUTLIER -135.12 92.75 17.8 Favored Pre-proline 0 N--CA 1.441 -0.905 0 N-CA-C 105.657 -1.979 . . . . 0.0 105.657 174.322 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_endo -74.9 127.87 11.11 Favored 'Trans proline' 0 N--CA 1.443 -1.447 0 C-N-CA 123.007 2.471 . . . . 0.0 109.442 170.492 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 28.3 mm -104.86 149.82 8.1 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.081 0 N-CA-C 104.231 -2.507 . . . . 0.0 104.231 -174.277 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 65.4 tt0 -140.24 142.84 35.77 Favored 'General case' 0 N--CA 1.438 -1.066 0 N-CA-C 104.205 -2.517 . . . . 0.0 104.205 168.587 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 37.8 p90 -136.27 164.2 28.63 Favored 'General case' 0 N--CA 1.439 -0.987 0 N-CA-C 106.226 -1.768 . . . . 0.0 106.226 -175.176 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 5.8 m120 -131.24 127.71 38.41 Favored 'General case' 0 CA--C 1.492 -1.286 0 N-CA-C 106.353 -1.721 . . . . 0.0 106.353 -179.948 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -84.61 161.77 52.67 Favored Pre-proline 0 N--CA 1.442 -0.857 0 C-N-CA 123.663 0.785 . . . . 0.0 110.541 -168.381 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_exo -67.23 172.72 9.62 Favored 'Trans proline' 0 CA--C 1.51 -0.717 0 C-N-CA 123.498 2.798 . . . . 0.0 112.295 170.766 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 1.4 tm0? -80.74 -46.99 1.23 Allowed Pre-proline 0 N--CA 1.443 -0.795 0 CA-C-O 115.569 -2.158 . . . . 0.0 110.429 -176.86 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 63.3 Cg_exo -68.25 164.78 31.02 Favored 'Trans proline' 0 CA--C 1.509 -0.75 0 CA-C-N 125.784 3.101 . . . . 0.0 112.086 176.999 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 22.6 t -88.07 85.88 7.03 Favored 'General case' 0 C--N 1.356 0.862 0 N-CA-C 106.412 -1.699 . . . . 0.0 106.412 176.258 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . 0.478 ' HD1' HG13 ' A' ' 30' ' ' ILE . 59.9 t-80 -116.16 -28.85 6.45 Favored 'General case' 0 N--CA 1.437 -1.124 0 C-N-CA 125.585 1.554 . . . . 0.0 107.076 -175.01 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.478 HG13 ' HD1' ' A' ' 29' ' ' HIS . 42.6 mt -126.35 137.03 59.05 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.056 0 N-CA-C 106.916 -1.513 . . . . 0.0 106.916 -169.041 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 32.9 t -113.56 -85.72 0.59 Allowed 'General case' 0 N--CA 1.432 -1.348 0 N-CA-C 106.328 -1.731 . . . . 0.0 106.328 178.073 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 37.0 ttpt -88.43 160.67 17.44 Favored 'General case' 0 CA--C 1.493 -1.241 0 C-N-CA 125.859 1.664 . . . . 0.0 107.906 -165.04 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 92.8 m-85 -127.47 139.97 52.46 Favored 'General case' 0 CA--C 1.492 -1.28 0 N-CA-C 105.377 -2.083 . . . . 0.0 105.377 177.941 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 13.9 mt -124.95 131.09 73.03 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.151 0 N-CA-C 101.958 -3.349 . . . . 0.0 101.958 172.898 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 3.5 mt -109.23 127.55 54.34 Favored 'General case' 0 CA--C 1.475 -1.936 0 N-CA-C 104.975 -2.232 . . . . 0.0 104.975 174.303 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -116.63 158.33 23.91 Favored 'General case' 0 N--CA 1.434 -1.257 0 N-CA-C 104.636 -2.357 . . . . 0.0 104.636 174.375 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 48.4 p90 -157.29 142.29 16.94 Favored 'General case' 0 N--CA 1.437 -1.081 0 N-CA-C 107.018 -1.475 . . . . 0.0 107.018 175.079 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 13.4 ttm180 -131.68 125.2 20.35 Favored Pre-proline 0 CA--C 1.503 -0.853 0 N-CA-C 106.261 -1.755 . . . . 0.0 106.261 179.006 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 4.8 Cg_endo -73.35 118.93 5.72 Favored 'Trans proline' 0 N--CA 1.45 -1.066 0 CA-C-N 123.388 2.246 . . . . 0.0 109.033 168.969 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 32.3 mmmt -70.98 88.7 0.77 Allowed 'General case' 0 N--CA 1.44 -0.937 0 C-N-CA 125.644 1.578 . . . . 0.0 111.133 179.214 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 70.5 m-80 -135.57 -68.02 0.52 Allowed 'General case' 0 N--CA 1.436 -1.148 0 N-CA-C 102.244 -3.243 . . . . 0.0 102.244 172.729 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 57.8 m -102.98 168.28 9.3 Favored 'General case' 0 N--CA 1.44 -0.945 0 N-CA-C 106.674 -1.602 . . . . 0.0 106.674 172.234 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 3.6 m -122.15 55.53 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.88 0 N-CA-C 105.752 -1.944 . . . . 0.0 105.752 177.581 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -104.01 -109.4 3.38 Favored Glycine 0 C--N 1.353 1.479 0 N-CA-C 107.78 -2.128 . . . . 0.0 107.78 -177.221 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 82.4 mtt85 -91.24 172.3 8.64 Favored 'General case' 0 CA--C 1.502 -0.883 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 -178.534 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -153.69 176.27 12.3 Favored 'General case' 0 N--CA 1.437 -1.097 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 -179.964 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 59.5 mttp -112.42 156.98 21.63 Favored 'General case' 0 CA--C 1.49 -1.356 0 N-CA-C 107.782 -1.192 . . . . 0.0 107.782 -174.767 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 1.1 pp20? -151.42 162.37 41.05 Favored 'General case' 0 N--CA 1.434 -1.24 0 N-CA-C 107.966 -1.124 . . . . 0.0 107.966 171.014 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -144.49 159.73 42.27 Favored 'General case' 0 CA--C 1.497 -1.062 0 N-CA-C 105.857 -1.905 . . . . 0.0 105.857 172.072 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 91.4 m -121.28 130.01 53.43 Favored 'General case' 0 CA--C 1.502 -0.896 0 N-CA-C 106.576 -1.638 . . . . 0.0 106.576 -173.892 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 4.1 mp -116.64 134.79 22.86 Favored Pre-proline 0 N--CA 1.438 -1.066 0 N-CA-C 105.386 -2.079 . . . . 0.0 105.386 -175.054 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 66.0 Cg_exo -62.88 164.55 18.71 Favored 'Trans proline' 0 N--CA 1.455 -0.736 0 C-N-CA 123.498 2.799 . . . . 0.0 113.351 174.954 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -81.88 -14.87 76.59 Favored Glycine 0 C--N 1.352 1.422 0 O-C-N 123.48 0.487 . . . . 0.0 113.297 -170.717 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 50.1 p-80 -83.87 -25.5 30.21 Favored 'General case' 0 C--N 1.356 0.852 0 CA-C-N 117.846 0.823 . . . . 0.0 109.828 179.173 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 89.9 mt -88.41 133.17 34.18 Favored 'General case' 0 CA--C 1.5 -0.959 0 N-CA-C 107.876 -1.157 . . . . 0.0 107.876 177.633 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 7.9 p30 -110.41 9.03 23.44 Favored 'General case' 0 CA--C 1.504 -0.821 0 C-N-CA 124.654 1.181 . . . . 0.0 109.802 -175.436 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 37.2 p -145.81 162.98 36.42 Favored 'General case' 0 N--CA 1.438 -1.051 0 N-CA-C 107.395 -1.335 . . . . 0.0 107.395 -177.477 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 8.3 t80 -141.8 174.94 10.11 Favored 'General case' 0 N--CA 1.441 -0.878 0 N-CA-C 108.009 -1.108 . . . . 0.0 108.009 179.765 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 89.6 m -135.45 109.98 8.54 Favored 'General case' 0 N--CA 1.432 -1.337 0 N-CA-C 104.19 -2.522 . . . . 0.0 104.19 171.202 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 58.3 mt -87.5 143.83 10.49 Favored 'Isoleucine or valine' 0 C--N 1.36 1.022 0 N-CA-C 103.943 -2.614 . . . . 0.0 103.943 169.977 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -147.07 160.58 42.24 Favored 'General case' 0 CA--C 1.498 -1.054 0 N-CA-C 108.054 -1.091 . . . . 0.0 108.054 173.865 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 86.83 51.83 3.3 Favored Glycine 0 C--N 1.353 1.484 0 N-CA-C 109.006 -1.638 . . . . 0.0 109.006 177.004 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 48.2 mt -112.1 175.29 5.49 Favored 'General case' 0 CA--C 1.502 -0.867 0 N-CA-C 107.013 -1.477 . . . . 0.0 107.013 -178.353 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 57.6 mttp -115.99 152.59 47.79 Favored Pre-proline 0 N--CA 1.444 -0.757 0 N-CA-C 106.526 -1.657 . . . . 0.0 106.526 -168.395 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_endo -79.5 155.36 24.59 Favored 'Trans proline' 0 N--CA 1.454 -0.835 0 C-N-CA 122.719 2.279 . . . . 0.0 110.838 175.883 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 59.01 29.8 65.76 Favored Glycine 0 C--N 1.354 1.566 0 C-N-CA 127.747 2.594 . . . . 0.0 116.883 167.288 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 9.0 p -127.4 148.24 32.14 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.847 0 N-CA-C 108.715 -0.846 . . . . 0.0 108.715 -177.581 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 6.7 p -92.8 124.17 45.14 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.765 0 N-CA-C 107.804 -1.184 . . . . 0.0 107.804 175.614 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 51.0 m-85 -101.48 150.41 23.07 Favored 'General case' 0 N--CA 1.439 -1.004 0 N-CA-C 107.629 -1.249 . . . . 0.0 107.629 173.403 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 12.4 tp10 -93.7 136.18 34.24 Favored 'General case' 0 CA--C 1.498 -1.044 0 N-CA-C 103.762 -2.681 . . . . 0.0 103.762 163.914 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -134.43 145.32 17.41 Favored Glycine 0 CA--C 1.488 -1.64 0 N-CA-C 107.547 -2.221 . . . . 0.0 107.547 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 35.2 mt-30 -140.75 136.81 32.9 Favored 'General case' 0 CA--C 1.485 -1.52 0 N-CA-C 105.718 -1.956 . . . . 0.0 105.718 -177.677 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 40.9 tp -115.01 98.21 6.67 Favored 'General case' 0 N--CA 1.437 -1.124 0 N-CA-C 103.453 -2.795 . . . . 0.0 103.453 179.297 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 39.7 mm -92.88 125.96 45.39 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.942 0 N-CA-C 103.704 -2.702 . . . . 0.0 103.704 -178.08 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 49.2 m -120.72 112.29 18.67 Favored 'General case' 0 N--CA 1.438 -1.069 0 N-CA-C 107.632 -1.247 . . . . 0.0 107.632 -169.261 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 39.3 mm -88.15 139.87 16.68 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.323 0 N-CA-C 106.894 -1.521 . . . . 0.0 106.894 -163.188 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 15.3 tt0 -101.93 132.34 47.8 Favored 'General case' 0 CA--C 1.495 -1.171 0 N-CA-C 104.953 -2.24 . . . . 0.0 104.953 178.776 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 17.8 tt0 -77.08 42.56 0.33 Allowed 'General case' 0 C--N 1.355 0.813 0 C-N-CA 125.339 1.456 . . . . 0.0 113.168 -177.761 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 61.6 m-85 -140.42 19.59 2.39 Favored 'General case' 0 N--CA 1.442 -0.872 0 N-CA-C 107.094 -1.447 . . . . 0.0 107.094 173.251 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 96.55 -21.57 44.95 Favored Glycine 0 C--N 1.354 1.582 0 C-N-CA 123.94 0.781 . . . . 0.0 111.395 174.598 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 77.9 m-70 -81.71 178.91 8.06 Favored 'General case' 0 CA--C 1.498 -1.032 0 C-N-CA 124.621 1.168 . . . . 0.0 109.508 -177.016 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 5.0 pt20 -159.02 163.53 36.32 Favored 'General case' 0 N--CA 1.439 -1.024 0 CA-C-O 122.027 0.917 . . . . 0.0 108.721 174.78 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 16.6 tp10 -117.37 154.2 31.73 Favored 'General case' 0 N--CA 1.437 -1.078 0 N-CA-C 105.631 -1.989 . . . . 0.0 105.631 179.604 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 1.9 p -126.0 134.31 66.84 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.86 0 N-CA-C 106.9 -1.519 . . . . 0.0 106.9 176.75 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 38.8 m -122.54 131.96 54.09 Favored 'General case' 0 N--CA 1.439 -0.996 0 N-CA-C 102.211 -3.255 . . . . 0.0 102.211 172.595 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 22.9 ttt180 -130.27 143.5 50.81 Favored 'General case' 0 CA--C 1.504 -0.803 0 CA-C-N 118.784 0.72 . . . . 0.0 109.444 -172.691 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 18.0 p90 -162.06 -177.18 5.6 Favored 'General case' 0 C--N 1.359 1.007 0 N-CA-C 106.829 -1.545 . . . . 0.0 106.829 -175.316 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 43.6 p-10 -136.63 160.91 37.38 Favored 'General case' 0 N--CA 1.442 -0.831 0 N-CA-C 106.018 -1.845 . . . . 0.0 106.018 168.836 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.413 ' CD1' ' CD2' ' A' ' 18' ' ' HIS . 22.3 p90 -143.61 164.82 29.32 Favored 'General case' 0 CA--C 1.488 -1.428 0 N-CA-C 107.254 -1.388 . . . . 0.0 107.254 170.065 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 22.8 p -117.88 137.96 52.45 Favored 'General case' 0 CA--C 1.499 -1.005 0 N-CA-C 106.337 -1.727 . . . . 0.0 106.337 177.433 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' THR . . . . . 0.448 HG23 ' CE1' ' A' ' 18' ' ' HIS . 7.0 p -107.97 128.77 54.93 Favored 'General case' 0 CA--C 1.5 -0.977 0 N-CA-C 103.061 -2.94 . . . . 0.0 103.061 172.788 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 15.1 t -158.41 152.21 23.6 Favored 'General case' 0 N--CA 1.437 -1.08 0 N-CA-C 105.944 -1.873 . . . . 0.0 105.944 -178.11 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 33.8 p . . . . . 0 C--O 1.26 1.625 0 N-CA-C 107.189 -1.411 . . . . 0.0 107.189 174.714 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 89.9 p . . . . . 0 N--CA 1.487 1.403 0 CA-C-O 121.467 0.651 . . . . 0.0 111.889 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 85.66 -157.81 31.63 Favored Glycine 0 C--N 1.355 1.588 0 N-CA-C 108.616 -1.793 . . . . 0.0 108.616 -178.911 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_exo -60.46 140.55 92.07 Favored 'Trans proline' 0 N--CA 1.443 -1.461 0 C-N-CA 123.137 2.558 . . . . 0.0 113.484 -177.385 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 7.6 t -78.57 149.77 5.58 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.947 0 C-N-CA 127.775 2.43 . . . . 0.0 105.461 179.112 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 90.0 mt-10 -103.71 94.29 5.37 Favored 'General case' 0 CA--C 1.493 -1.23 0 C-N-CA 123.849 0.86 . . . . 0.0 108.726 -168.282 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 2.5 p -121.83 142.47 38.0 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.983 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 -161.936 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 18.1 p90 -154.83 177.77 10.9 Favored 'General case' 0 N--CA 1.435 -1.192 0 N-CA-C 106.923 -1.51 . . . . 0.0 106.923 -168.158 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 19.4 tt -139.27 132.93 38.82 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.958 0 N-CA-C 102.662 -3.088 . . . . 0.0 102.662 160.314 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 12.3 p -127.29 125.72 41.38 Favored 'General case' 0 CA--C 1.502 -0.898 0 N-CA-C 108.093 -1.077 . . . . 0.0 108.093 -174.632 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 49.8 tt0 67.0 53.13 0.83 Allowed 'General case' 0 N--CA 1.442 -0.846 0 C-N-CA 126.679 1.992 . . . . 0.0 112.664 168.054 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 10.2 t -98.76 123.31 50.09 Favored Pre-proline 0 C--N 1.355 0.847 0 N-CA-C 104.458 -2.423 . . . . 0.0 104.458 166.146 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_endo -78.61 -41.94 0.23 Allowed 'Trans proline' 0 N--CA 1.453 -0.858 0 C-N-CA 122.145 1.897 . . . . 0.0 109.637 -179.858 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 8.8 p -179.8 130.72 0.1 Allowed 'General case' 0 N--CA 1.433 -1.306 0 N-CA-C 103.042 -2.947 . . . . 0.0 103.042 -178.309 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 25.4 tp60 -155.88 100.56 2.17 Favored Pre-proline 0 N--CA 1.437 -1.097 0 N-CA-C 105.069 -2.197 . . . . 0.0 105.069 179.729 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -82.94 -19.16 5.99 Favored 'Trans proline' 0 CA--C 1.502 -1.076 0 C-N-CA 122.884 2.39 . . . . 0.0 111.06 -169.053 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 1.7 p30 -103.2 -40.05 6.59 Favored 'General case' 0 CA--C 1.484 -1.596 0 O-C-N 124.09 0.869 . . . . 0.0 110.455 -166.593 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 73.1 m -116.18 156.7 26.03 Favored 'General case' 0 CA--C 1.497 -1.083 0 CA-C-O 121.871 0.843 . . . . 0.0 108.797 -178.532 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 21.1 t-80 -132.96 89.88 33.12 Favored Pre-proline 0 N--CA 1.438 -1.03 0 N-CA-C 106.167 -1.79 . . . . 0.0 106.167 169.414 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 65.5 Cg_endo -84.24 103.38 0.96 Allowed 'Trans proline' 0 N--CA 1.453 -0.871 0 C-N-CA 123.27 2.647 . . . . 0.0 110.449 -175.072 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.7 pt -94.39 168.29 1.53 Allowed 'Isoleucine or valine' 0 C--N 1.356 0.864 0 N-CA-C 109.925 -0.398 . . . . 0.0 109.925 -173.608 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 28.1 tt0 -144.35 147.83 33.95 Favored 'General case' 0 N--CA 1.438 -1.033 0 N-CA-C 104.974 -2.232 . . . . 0.0 104.974 169.97 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 40.9 p90 -129.81 156.6 44.08 Favored 'General case' 0 CA--C 1.496 -1.103 0 N-CA-C 106.859 -1.534 . . . . 0.0 106.859 177.535 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 8.2 t-20 -110.92 149.2 30.97 Favored 'General case' 0 CA--C 1.489 -1.373 0 N-CA-C 102.186 -3.265 . . . . 0.0 102.186 173.211 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -115.82 170.37 5.8 Favored Pre-proline 0 N--CA 1.441 -0.895 0 C-N-CA 124.161 0.984 . . . . 0.0 108.521 -166.369 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 94.8 Cg_exo -65.18 169.53 12.04 Favored 'Trans proline' 0 CA--C 1.511 -0.668 0 C-N-CA 123.613 2.875 . . . . 0.0 112.323 166.918 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 64.7 mt-30 -80.51 -56.1 0.7 Allowed Pre-proline 0 N--CA 1.442 -0.831 0 CA-C-O 115.505 -2.188 . . . . 0.0 112.454 -172.903 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -75.31 169.78 21.74 Favored 'Trans proline' 0 CA--C 1.511 -0.655 0 CA-C-N 125.923 3.151 . . . . 0.0 110.671 -177.073 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 67.3 m -87.09 86.16 7.28 Favored 'General case' 0 CA--C 1.502 -0.901 0 N-CA-C 106.708 -1.59 . . . . 0.0 106.708 175.975 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 11.9 t-160 -122.78 -26.05 4.54 Favored 'General case' 0 N--CA 1.436 -1.129 0 C-N-CA 124.972 1.309 . . . . 0.0 107.792 -171.673 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 1.7 mp -103.16 136.7 34.57 Favored 'Isoleucine or valine' 0 C--N 1.355 0.824 0 N-CA-C 103.885 -2.635 . . . . 0.0 103.885 -171.919 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 34.5 t -96.29 -85.99 0.33 Allowed 'General case' 0 N--CA 1.43 -1.468 0 N-CA-C 104.791 -2.3 . . . . 0.0 104.791 174.473 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 50.8 mtmt -90.67 170.97 9.7 Favored 'General case' 0 CA--C 1.493 -1.226 0 C-N-CA 123.884 0.874 . . . . 0.0 110.096 -168.01 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 96.4 m-85 -125.69 140.37 52.76 Favored 'General case' 0 CA--C 1.496 -1.101 0 N-CA-C 103.948 -2.612 . . . . 0.0 103.948 162.132 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 54.0 mt -120.9 127.85 75.99 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.12 0 N-CA-C 101.828 -3.397 . . . . 0.0 101.828 170.976 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 4.5 mt -106.91 137.15 45.52 Favored 'General case' 0 CA--C 1.476 -1.898 0 N-CA-C 105.384 -2.08 . . . . 0.0 105.384 171.611 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -131.83 156.02 46.78 Favored 'General case' 0 N--CA 1.434 -1.242 0 N-CA-C 106.878 -1.526 . . . . 0.0 106.878 166.258 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 49.4 p90 -155.27 145.76 22.07 Favored 'General case' 0 N--CA 1.435 -1.209 0 N-CA-C 106.517 -1.66 . . . . 0.0 106.517 -176.384 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 45.5 ttm-85 -135.87 140.67 34.15 Favored Pre-proline 0 N--CA 1.441 -0.88 0 N-CA-C 104.575 -2.38 . . . . 0.0 104.575 178.254 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -72.95 116.55 4.76 Favored 'Trans proline' 0 CA--C 1.504 -0.992 0 C-N-CA 122.735 2.29 . . . . 0.0 108.594 166.284 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 82.5 tttt -73.87 83.85 1.69 Allowed 'General case' 0 C--N 1.355 0.843 0 C-N-CA 125.537 1.535 . . . . 0.0 110.199 -174.252 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 33.1 m120 -147.51 -73.04 0.21 Allowed 'General case' 0 N--CA 1.435 -1.186 0 N-CA-C 102.354 -3.202 . . . . 0.0 102.354 -175.785 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 50.8 p -96.73 168.4 10.53 Favored 'General case' 0 N--CA 1.442 -0.867 0 N-CA-C 107.454 -1.313 . . . . 0.0 107.454 173.351 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 3.6 m -125.98 55.16 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.849 0 N-CA-C 105.821 -1.918 . . . . 0.0 105.821 177.192 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -93.19 -106.05 1.74 Allowed Glycine 0 C--N 1.355 1.611 0 N-CA-C 108.415 -1.874 . . . . 0.0 108.415 -177.247 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 5.6 mmp_? -105.12 170.01 8.12 Favored 'General case' 0 CA--C 1.499 -1.017 0 N-CA-C 107.042 -1.466 . . . . 0.0 107.042 176.729 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -151.23 173.01 14.95 Favored 'General case' 0 N--CA 1.436 -1.137 0 N-CA-C 108.728 -0.841 . . . . 0.0 108.728 -177.943 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 67.8 mttm -111.68 155.76 22.93 Favored 'General case' 0 CA--C 1.49 -1.357 0 N-CA-C 107.774 -1.195 . . . . 0.0 107.774 -172.13 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 15.4 pt-20 -151.49 160.67 43.6 Favored 'General case' 0 N--CA 1.435 -1.211 0 N-CA-C 108.247 -1.02 . . . . 0.0 108.247 172.565 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -137.37 156.76 47.84 Favored 'General case' 0 CA--C 1.497 -1.064 0 N-CA-C 105.938 -1.875 . . . . 0.0 105.938 171.532 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 95.2 m -117.85 123.29 45.52 Favored 'General case' 0 CA--C 1.499 -0.982 0 N-CA-C 104.134 -2.543 . . . . 0.0 104.134 176.398 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 65.9 mt -118.73 137.67 25.15 Favored Pre-proline 0 N--CA 1.437 -1.08 0 N-CA-C 105.984 -1.858 . . . . 0.0 105.984 -164.867 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 75.3 Cg_exo -65.05 163.87 27.08 Favored 'Trans proline' 0 N--CA 1.455 -0.749 0 C-N-CA 123.295 2.663 . . . . 0.0 113.545 176.491 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -78.68 -17.27 77.78 Favored Glycine 0 C--N 1.352 1.456 0 C-N-CA 124.042 0.83 . . . . 0.0 113.807 -174.87 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 54.3 p-80 -83.45 -23.81 32.09 Favored 'General case' 0 C--N 1.357 0.893 0 CA-C-N 117.936 0.868 . . . . 0.0 109.963 -179.602 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 80.8 mt -87.93 125.24 34.4 Favored 'General case' 0 CA--C 1.497 -1.093 0 N-CA-C 107.975 -1.12 . . . . 0.0 107.975 176.721 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 8.1 p30 -112.25 6.69 19.09 Favored 'General case' 0 N--CA 1.442 -0.848 0 C-N-CA 124.741 1.216 . . . . 0.0 109.783 -174.845 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 28.7 p -142.06 154.96 45.35 Favored 'General case' 0 CA--C 1.498 -1.043 0 N-CA-C 106.684 -1.598 . . . . 0.0 106.684 -177.977 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 10.8 t80 -133.84 171.33 14.3 Favored 'General case' 0 CA--C 1.502 -0.869 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 178.423 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 94.4 m -131.8 109.09 9.88 Favored 'General case' 0 N--CA 1.43 -1.433 0 N-CA-C 103.929 -2.619 . . . . 0.0 103.929 170.545 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 42.6 mt -84.09 139.48 17.54 Favored 'Isoleucine or valine' 0 C--N 1.358 0.969 0 N-CA-C 103.123 -2.917 . . . . 0.0 103.123 169.433 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 18.0 ptpt -147.74 160.05 43.14 Favored 'General case' 0 CA--C 1.497 -1.085 0 N-CA-C 109.068 -0.716 . . . . 0.0 109.068 -176.261 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 81.2 53.96 3.72 Favored Glycine 0 C--N 1.355 1.586 0 N-CA-C 108.816 -1.714 . . . . 0.0 108.816 -179.946 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 84.6 mt -117.14 172.6 7.17 Favored 'General case' 0 CA--C 1.496 -1.113 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 -173.019 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 65.7 tttp -124.43 139.56 33.26 Favored Pre-proline 0 N--CA 1.434 -1.259 0 N-CA-C 104.97 -2.233 . . . . 0.0 104.97 -175.342 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -74.9 163.97 34.4 Favored 'Trans proline' 0 N--CA 1.455 -0.789 0 C-N-CA 123.058 2.505 . . . . 0.0 110.089 174.98 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 62.63 44.07 98.07 Favored Glycine 0 N--CA 1.429 -1.824 0 C-N-CA 125.946 1.736 . . . . 0.0 112.756 -178.803 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 20.5 t -134.95 127.19 48.15 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.09 0 N-CA-C 104.325 -2.472 . . . . 0.0 104.325 173.078 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 4.4 p -83.8 116.72 28.21 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.928 0 N-CA-C 105.061 -2.2 . . . . 0.0 105.061 162.521 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 80.8 m-85 -97.64 147.04 24.72 Favored 'General case' 0 CA--C 1.495 -1.153 0 N-CA-C 105.817 -1.919 . . . . 0.0 105.817 178.71 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 14.6 pt-20 -95.37 140.76 29.79 Favored 'General case' 0 CA--C 1.501 -0.934 0 N-CA-C 105.168 -2.16 . . . . 0.0 105.168 164.288 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -134.33 151.89 20.45 Favored Glycine 0 CA--C 1.49 -1.521 0 N-CA-C 107.633 -2.187 . . . . 0.0 107.633 -178.972 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 31.9 mt-30 -143.65 135.71 26.67 Favored 'General case' 0 CA--C 1.488 -1.425 0 N-CA-C 105.699 -1.963 . . . . 0.0 105.699 179.171 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 15.4 tp -120.01 100.98 7.54 Favored 'General case' 0 CA--C 1.499 -0.983 0 N-CA-C 105.482 -2.044 . . . . 0.0 105.482 -177.453 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 18.7 mt -94.02 131.29 41.34 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.889 0 N-CA-C 105.072 -2.196 . . . . 0.0 105.072 178.143 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 23.3 p -108.38 125.87 52.22 Favored 'General case' 0 N--CA 1.44 -0.972 0 N-CA-C 106.088 -1.819 . . . . 0.0 106.088 173.163 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 1.7 mp -92.33 137.04 23.07 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.181 0 N-CA-C 103.427 -2.805 . . . . 0.0 103.427 -179.346 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 4.8 mp0 -92.25 153.48 19.23 Favored 'General case' 0 CA--C 1.497 -1.091 0 N-CA-C 107.032 -1.47 . . . . 0.0 107.032 177.701 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 9.0 tt0 -77.52 32.53 0.16 Allowed 'General case' 0 C--N 1.356 0.854 0 C-N-CA 125.5 1.52 . . . . 0.0 112.385 173.766 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 88.4 m-85 -143.9 14.26 1.7 Allowed 'General case' 0 CA--C 1.498 -1.027 0 C-N-CA 124.119 0.968 . . . . 0.0 108.687 -173.96 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 90.14 -17.94 50.91 Favored Glycine 0 C--N 1.35 1.357 0 C-N-CA 124.131 0.872 . . . . 0.0 112.433 173.835 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 78.4 m-70 -81.48 173.84 12.02 Favored 'General case' 0 CA--C 1.496 -1.109 0 C-N-CA 124.691 1.196 . . . . 0.0 109.17 -177.365 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 5.1 pt20 -155.03 142.41 19.56 Favored 'General case' 0 N--CA 1.438 -1.042 0 N-CA-C 107.778 -1.193 . . . . 0.0 107.778 171.715 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 67.7 mt-10 -108.24 140.22 41.8 Favored 'General case' 0 CA--C 1.496 -1.1 0 N-CA-C 105.191 -2.152 . . . . 0.0 105.191 178.97 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 3.3 p -117.81 137.39 51.9 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.823 0 N-CA-C 107.544 -1.28 . . . . 0.0 107.544 -175.377 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 24.9 m -117.33 140.57 49.4 Favored 'General case' 0 N--CA 1.441 -0.898 0 N-CA-C 104.015 -2.587 . . . . 0.0 104.015 174.84 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -126.46 153.88 44.46 Favored 'General case' 0 CA--C 1.498 -1.04 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 170.331 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 29.5 p90 -166.46 -179.1 4.77 Favored 'General case' 0 CA--C 1.5 -0.948 0 N-CA-C 106.888 -1.523 . . . . 0.0 106.888 -178.093 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 1.7 p30 -139.11 159.51 41.98 Favored 'General case' 0 N--CA 1.438 -1.038 0 N-CA-C 106.436 -1.691 . . . . 0.0 106.436 166.132 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 20.5 p90 -142.42 172.88 12.09 Favored 'General case' 0 CA--C 1.488 -1.411 0 N-CA-C 105.814 -1.921 . . . . 0.0 105.814 171.867 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 16.2 m -130.39 143.48 50.79 Favored 'General case' 0 CA--C 1.501 -0.915 0 N-CA-C 104.697 -2.334 . . . . 0.0 104.697 176.76 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 58.8 m -120.48 124.83 46.35 Favored 'General case' 0 N--CA 1.441 -0.918 0 N-CA-C 102.973 -2.973 . . . . 0.0 102.973 176.758 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 33.0 p -134.24 167.8 20.03 Favored 'General case' 0 C--N 1.357 0.894 0 N-CA-C 107.459 -1.311 . . . . 0.0 107.459 -177.738 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 56.8 p . . . . . 0 C--O 1.26 1.61 0 C-N-CA 124.431 1.092 . . . . 0.0 108.844 178.02 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 22.7 t . . . . . 0 N--CA 1.484 1.264 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -177.49 154.32 15.26 Favored Glycine 0 C--N 1.352 1.471 0 N-CA-C 107.82 -2.112 . . . . 0.0 107.82 175.663 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 70.7 Cg_exo -65.5 142.15 70.43 Favored 'Trans proline' 0 N--CA 1.444 -1.425 0 C-N-CA 122.257 1.971 . . . . 0.0 115.2 -169.913 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 12.9 t -78.29 154.36 5.1 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.807 0 C-N-CA 128.645 2.778 . . . . 0.0 104.776 168.287 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 57.8 mm-40 -109.35 99.88 9.06 Favored 'General case' 0 CA--C 1.488 -1.437 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 -172.249 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 2.4 p -119.23 141.29 39.86 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.012 0 N-CA-C 106.413 -1.699 . . . . 0.0 106.413 -172.087 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 15.4 p90 -142.69 162.24 35.99 Favored 'General case' 0 N--CA 1.436 -1.154 0 N-CA-C 107.078 -1.453 . . . . 0.0 107.078 -169.005 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 39.8 pt -94.98 157.92 3.01 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.365 0 N-CA-C 107.399 -1.334 . . . . 0.0 107.399 177.782 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 41.3 p -79.53 -169.37 1.89 Allowed 'General case' 0 C--N 1.354 0.8 0 C-N-CA 123.881 0.872 . . . . 0.0 111.167 -175.797 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -89.29 -11.38 43.64 Favored 'General case' 0 N--CA 1.443 -0.801 0 C-N-CA 125.136 1.374 . . . . 0.0 110.812 -170.701 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 5.0 t -114.17 94.98 37.14 Favored Pre-proline 0 N--CA 1.44 -0.952 0 N-CA-C 107.265 -1.383 . . . . 0.0 107.265 -177.478 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 93.7 Cg_endo -81.03 -9.36 12.94 Favored 'Trans proline' 0 N--CA 1.451 -0.977 0 C-N-CA 122.775 2.317 . . . . 0.0 109.649 167.072 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 49.2 m -95.17 76.8 3.47 Favored 'General case' 0 CA--C 1.493 -1.223 0 CA-C-O 123.391 1.567 . . . . 0.0 108.903 -177.502 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 80.7 mt-30 -156.34 99.38 2.12 Favored Pre-proline 0 N--CA 1.433 -1.306 0 N-CA-C 100.979 -3.711 . . . . 0.0 100.979 173.995 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_exo -76.66 -14.29 17.72 Favored 'Trans proline' 0 CA--C 1.509 -0.769 0 C-N-CA 122.494 2.13 . . . . 0.0 110.705 -178.258 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -102.31 -45.36 5.13 Favored 'General case' 0 CA--C 1.492 -1.251 0 C-N-CA 125.132 1.373 . . . . 0.0 110.342 -168.033 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 73.5 m -110.85 158.16 19.02 Favored 'General case' 0 CA--C 1.493 -1.234 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 -176.219 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 18.7 t-160 -148.63 95.65 3.96 Favored Pre-proline 0 N--CA 1.44 -0.962 0 N-CA-C 107.651 -1.24 . . . . 0.0 107.651 165.575 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 70.2 Cg_endo -74.61 134.18 18.17 Favored 'Trans proline' 0 N--CA 1.446 -1.268 0 C-N-CA 122.903 2.402 . . . . 0.0 109.246 170.264 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 7.5 pt -116.08 168.39 7.77 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.047 0 N-CA-C 107.006 -1.479 . . . . 0.0 107.006 179.762 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 23.2 tt0 -148.9 147.7 28.98 Favored 'General case' 0 N--CA 1.438 -1.072 0 N-CA-C 105.068 -2.197 . . . . 0.0 105.068 172.27 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 39.5 p90 -131.5 160.95 33.7 Favored 'General case' 0 N--CA 1.438 -1.061 0 N-CA-C 107.069 -1.456 . . . . 0.0 107.069 -178.879 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 83.8 m-20 -103.92 -179.62 4.0 Favored 'General case' 0 CA--C 1.488 -1.407 0 N-CA-C 103.721 -2.696 . . . . 0.0 103.721 170.865 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -157.29 173.07 5.34 Favored Pre-proline 0 N--CA 1.44 -0.963 0 N-CA-C 106.696 -1.594 . . . . 0.0 106.696 177.317 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 79.8 Cg_exo -63.99 161.31 33.75 Favored 'Trans proline' 0 N--CA 1.455 -0.74 0 C-N-CA 123.761 2.974 . . . . 0.0 113.082 173.129 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 70.8 tp60 -82.71 -45.03 0.92 Allowed Pre-proline 0 N--CA 1.444 -0.746 0 CA-C-O 115.519 -2.181 . . . . 0.0 111.925 -175.375 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_exo -70.87 -15.51 32.92 Favored 'Trans proline' 0 CA--C 1.509 -0.727 0 CA-C-N 125.897 3.142 . . . . 0.0 113.342 -176.114 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 9.1 t 66.33 73.06 0.38 Allowed 'General case' 0 C--N 1.357 0.925 0 C-N-CA 126.153 1.781 . . . . 0.0 110.54 179.159 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 23.6 t-160 -97.55 -3.49 39.63 Favored 'General case' 0 N--CA 1.444 -0.752 0 C-N-CA 125.002 1.321 . . . . 0.0 107.976 174.311 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 33.5 mt -106.08 136.65 39.69 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.128 0 N-CA-C 104.516 -2.401 . . . . 0.0 104.516 -176.739 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 4.9 p -99.52 -85.01 0.4 Allowed 'General case' 0 N--CA 1.43 -1.442 0 N-CA-C 105.687 -1.968 . . . . 0.0 105.687 176.962 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 54.2 mtmt -89.76 167.39 12.91 Favored 'General case' 0 CA--C 1.488 -1.436 0 C-N-CA 123.423 0.689 . . . . 0.0 109.253 -164.992 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 93.8 m-85 -126.96 133.15 50.66 Favored 'General case' 0 CA--C 1.493 -1.239 0 N-CA-C 103.219 -2.882 . . . . 0.0 103.219 165.75 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 1.6 mp -107.6 136.26 43.48 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.195 1 N-CA-C 99.078 -4.416 . . . . 0.0 99.078 166.686 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 46.9 tp -119.72 137.08 54.15 Favored 'General case' 0 N--CA 1.397 -3.092 0 N-CA-C 101.36 -3.57 . . . . 0.0 101.36 172.664 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 14.9 ptp180 -133.94 155.3 50.17 Favored 'General case' 0 CA--C 1.488 -1.417 0 N-CA-C 107.072 -1.455 . . . . 0.0 107.072 174.168 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 47.0 p90 -152.67 139.13 18.59 Favored 'General case' 0 N--CA 1.43 -1.465 0 N-CA-C 105.778 -1.934 . . . . 0.0 105.778 -175.889 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 46.1 ttp85 -145.87 145.04 23.67 Favored Pre-proline 0 N--CA 1.442 -0.843 0 N-CA-C 104.871 -2.27 . . . . 0.0 104.871 -177.17 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 63.6 Cg_exo -64.21 122.8 10.89 Favored 'Trans proline' 0 CA--C 1.505 -0.975 0 C-N-CA 123.09 2.527 . . . . 0.0 111.06 174.7 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 49.9 tttp -71.95 75.65 0.91 Allowed 'General case' 0 C--N 1.358 0.956 0 C-N-CA 125.897 1.679 . . . . 0.0 110.449 176.475 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 29.8 m120 -151.35 -74.73 0.15 Allowed 'General case' 0 N--CA 1.435 -1.212 0 N-CA-C 102.407 -3.183 . . . . 0.0 102.407 -172.541 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 39.1 p -97.44 161.08 13.95 Favored 'General case' 0 C--N 1.356 0.88 0 N-CA-C 106.856 -1.535 . . . . 0.0 106.856 172.332 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 3.7 m -115.61 52.76 0.21 Allowed 'Isoleucine or valine' 0 CA--C 1.504 -0.81 0 N-CA-C 106.526 -1.657 . . . . 0.0 106.526 -179.236 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -88.59 -137.31 5.88 Favored Glycine 0 C--N 1.355 1.59 0 N-CA-C 109.722 -1.351 . . . . 0.0 109.722 -179.872 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 96.4 mtt-85 -85.05 155.78 21.38 Favored 'General case' 0 CA--C 1.499 -0.981 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 -177.596 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 49.0 m95 -105.19 159.33 15.95 Favored 'General case' 0 N--CA 1.436 -1.146 0 N-CA-C 107.552 -1.277 . . . . 0.0 107.552 -175.102 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 64.3 mttp -98.76 150.31 21.96 Favored 'General case' 0 CA--C 1.488 -1.416 0 N-CA-C 104.232 -2.507 . . . . 0.0 104.232 161.801 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -153.12 157.91 41.08 Favored 'General case' 0 CA--C 1.494 -1.173 0 CA-C-O 121.787 0.803 . . . . 0.0 108.867 -176.768 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -140.89 165.81 26.49 Favored 'General case' 0 N--CA 1.437 -1.114 0 N-CA-C 106.119 -1.808 . . . . 0.0 106.119 173.505 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 98.9 m -121.6 127.22 50.66 Favored 'General case' 0 CA--C 1.5 -0.952 0 N-CA-C 104.8 -2.296 . . . . 0.0 104.8 175.87 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 5.3 mp -114.97 134.35 22.51 Favored Pre-proline 0 N--CA 1.435 -1.203 0 N-CA-C 104.871 -2.27 . . . . 0.0 104.871 -176.014 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 68.7 Cg_exo -64.67 165.95 19.28 Favored 'Trans proline' 0 CA--C 1.508 -0.811 0 C-N-CA 123.354 2.703 . . . . 0.0 113.391 177.019 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -73.96 -20.57 79.71 Favored Glycine 0 C--N 1.351 1.376 0 C-N-CA 123.906 0.765 . . . . 0.0 114.141 -174.891 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 52.2 p-80 -83.56 -27.06 29.54 Favored 'General case' 0 C--N 1.354 0.793 0 CA-C-N 117.872 0.836 . . . . 0.0 110.243 -178.72 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 85.0 mt -88.65 126.25 35.21 Favored 'General case' 0 CA--C 1.501 -0.938 0 N-CA-C 107.894 -1.15 . . . . 0.0 107.894 177.283 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 7.8 p-10 -108.65 8.18 26.88 Favored 'General case' 0 CA--C 1.503 -0.843 0 C-N-CA 124.391 1.076 . . . . 0.0 110.634 -170.526 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 5.8 p -142.62 168.08 20.57 Favored 'General case' 0 CA--C 1.491 -1.297 0 N-CA-C 108.106 -1.072 . . . . 0.0 108.106 -177.802 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 8.5 t80 -139.6 175.86 9.22 Favored 'General case' 0 N--CA 1.441 -0.908 0 N-CA-C 107.81 -1.181 . . . . 0.0 107.81 174.365 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 99.3 m -140.05 112.2 7.65 Favored 'General case' 0 N--CA 1.435 -1.208 0 N-CA-C 104.924 -2.25 . . . . 0.0 104.924 178.573 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 17.3 mm -90.25 145.27 7.61 Favored 'Isoleucine or valine' 0 C--N 1.356 0.856 0 N-CA-C 105.013 -2.217 . . . . 0.0 105.013 171.261 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . 0.437 ' HB3' ' HZ1' ' A' ' 61' ' ' LYS . 0.4 OUTLIER -149.83 161.58 41.97 Favored 'General case' 0 N--CA 1.438 -1.057 0 N-CA-C 107.841 -1.17 . . . . 0.0 107.841 167.662 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 85.88 52.3 3.34 Favored Glycine 0 C--N 1.354 1.543 0 N-CA-C 109.303 -1.519 . . . . 0.0 109.303 177.654 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 78.0 mt -115.18 165.62 12.73 Favored 'General case' 0 CA--C 1.5 -0.967 0 N-CA-C 108.142 -1.059 . . . . 0.0 108.142 -179.141 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt -103.58 154.93 37.53 Favored Pre-proline 0 N--CA 1.44 -0.952 0 N-CA-C 107.068 -1.456 . . . . 0.0 107.068 -176.068 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -76.96 152.52 31.91 Favored 'Trans proline' 0 N--CA 1.452 -0.966 0 C-N-CA 122.829 2.353 . . . . 0.0 111.127 -178.515 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 55.17 40.42 74.72 Favored Glycine 0 C--N 1.356 1.686 0 C-N-CA 127.567 2.508 . . . . 0.0 115.636 170.518 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 5.5 p -129.87 138.08 54.99 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.165 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 -177.169 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 3.2 p -91.76 127.59 43.96 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.884 0 C-N-CA 125.119 1.368 . . . . 0.0 107.681 -178.197 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 82.7 m-85 -107.71 153.24 23.23 Favored 'General case' 0 N--CA 1.438 -1.07 0 C-N-CA 125.12 1.368 . . . . 0.0 108.382 178.036 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 21.4 tp10 -97.55 136.51 37.85 Favored 'General case' 0 N--CA 1.434 -1.242 0 N-CA-C 104.027 -2.582 . . . . 0.0 104.027 165.354 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -131.0 144.11 15.58 Favored Glycine 0 CA--C 1.492 -1.36 0 N-CA-C 107.681 -2.168 . . . . 0.0 107.681 174.325 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 25.9 mt-30 -133.67 134.37 43.04 Favored 'General case' 0 CA--C 1.486 -1.485 0 N-CA-C 107.109 -1.441 . . . . 0.0 107.109 174.858 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 66.6 tp -109.97 101.46 10.28 Favored 'General case' 0 CA--C 1.502 -0.874 0 N-CA-C 104.499 -2.408 . . . . 0.0 104.499 178.493 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 32.4 mt -97.78 123.39 50.2 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.868 0 N-CA-C 104.102 -2.555 . . . . 0.0 104.102 -176.612 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 32.8 p -118.24 120.06 36.56 Favored 'General case' 0 CA--C 1.505 -0.769 0 N-CA-C 108.72 -0.844 . . . . 0.0 108.72 -172.25 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 1.8 mp -93.64 136.24 25.9 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.301 0 N-CA-C 104.581 -2.377 . . . . 0.0 104.581 -170.243 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 84.7 mt-30 -93.68 152.8 18.73 Favored 'General case' 0 CA--C 1.493 -1.224 0 N-CA-C 106.903 -1.517 . . . . 0.0 106.903 176.91 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 9.0 pt20 -69.14 99.56 1.15 Allowed 'General case' 0 N--CA 1.44 -0.926 0 C-N-CA 124.871 1.268 . . . . 0.0 111.458 -176.296 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 69.1 m-85 57.1 39.4 29.11 Favored 'General case' 0 C--N 1.358 0.946 0 C-N-CA 127.248 2.219 . . . . 0.0 112.16 -179.402 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -141.04 -124.32 2.02 Favored Glycine 0 C--N 1.357 1.708 0 N-CA-C 108.497 -1.841 . . . . 0.0 108.497 -177.4 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 59.1 m80 -83.82 -179.75 7.36 Favored 'General case' 0 CA--C 1.499 -1.019 0 C-N-CA 125.193 1.397 . . . . 0.0 110.302 -170.982 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 21.4 tt0 -139.26 119.15 13.31 Favored 'General case' 0 N--CA 1.434 -1.258 0 N-CA-C 104.781 -2.303 . . . . 0.0 104.781 175.993 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 88.0 mt-10 -99.11 154.23 18.28 Favored 'General case' 0 CA--C 1.499 -1.005 0 N-CA-C 107.37 -1.345 . . . . 0.0 107.37 -178.435 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 7.7 p -128.78 134.97 63.39 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.776 0 N-CA-C 107.598 -1.26 . . . . 0.0 107.598 175.082 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 95.2 m -119.84 137.0 54.26 Favored 'General case' 0 CA--C 1.498 -1.044 0 N-CA-C 102.623 -3.103 . . . . 0.0 102.623 175.098 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 83.0 mtm-85 -126.69 150.67 48.89 Favored 'General case' 0 CA--C 1.5 -0.964 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 -178.531 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 32.7 p90 -165.33 178.81 6.61 Favored 'General case' 0 CA--C 1.5 -0.98 0 N-CA-C 107.234 -1.395 . . . . 0.0 107.234 -177.993 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -139.43 157.85 45.14 Favored 'General case' 0 N--CA 1.441 -0.913 0 N-CA-C 106.441 -1.689 . . . . 0.0 106.441 169.472 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 24.0 p90 -144.83 175.59 10.08 Favored 'General case' 0 CA--C 1.488 -1.442 0 N-CA-C 105.271 -2.122 . . . . 0.0 105.271 172.375 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 8.9 t -143.9 154.94 43.86 Favored 'General case' 0 N--CA 1.44 -0.968 0 N-CA-C 105.439 -2.06 . . . . 0.0 105.439 173.631 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 54.8 p -121.95 138.93 54.23 Favored 'General case' 0 CA--C 1.497 -1.086 0 N-CA-C 104.242 -2.503 . . . . 0.0 104.242 177.144 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 12.3 t -165.89 172.9 11.08 Favored 'General case' 0 N--CA 1.44 -0.944 0 N-CA-C 105.134 -2.173 . . . . 0.0 105.134 -175.625 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 10.0 p . . . . . 0 C--O 1.261 1.678 0 N-CA-C 105.144 -2.169 . . . . 0.0 105.144 164.327 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' SER . . . . . 0.435 ' HG ' ' HE1' ' A' ' 29' ' ' HIS . 15.1 t . . . . . 0 N--CA 1.485 1.297 0 CA-C-O 121.381 0.61 . . . . 0.0 110.258 . . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 90.97 -150.5 20.57 Favored Glycine 0 C--N 1.353 1.518 0 N-CA-C 107.731 -2.148 . . . . 0.0 107.731 179.773 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -61.6 138.6 76.42 Favored 'Trans proline' 0 N--CA 1.441 -1.567 0 C-N-CA 123.115 2.543 . . . . 0.0 112.973 178.993 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 14.5 t -77.62 161.26 4.52 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.882 0 C-N-CA 129.005 2.922 . . . . 0.0 105.732 179.03 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 59.1 mm-40 -110.87 100.43 9.16 Favored 'General case' 0 CA--C 1.49 -1.361 0 N-CA-C 106.564 -1.643 . . . . 0.0 106.564 -179.449 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 1.5 p -120.85 141.17 42.48 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.041 0 N-CA-C 106.191 -1.781 . . . . 0.0 106.191 -169.531 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 30.6 p90 -153.32 172.61 16.77 Favored 'General case' 0 N--CA 1.434 -1.241 0 N-CA-C 107.015 -1.476 . . . . 0.0 107.015 -169.289 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 19.1 tt -146.72 136.28 16.87 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.177 0 N-CA-C 103.512 -2.773 . . . . 0.0 103.512 165.495 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 35.9 m -151.45 139.67 20.28 Favored 'General case' 0 CA--C 1.501 -0.917 0 N-CA-C 104.051 -2.574 . . . . 0.0 104.051 -175.796 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 29.6 tt0 67.65 59.4 0.48 Allowed 'General case' 0 CA--C 1.479 -1.78 0 C-N-CA 125.299 1.44 . . . . 0.0 108.878 162.186 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 66.0 m -85.12 136.47 38.18 Favored Pre-proline 0 N--CA 1.446 -0.657 0 N-CA-C 105.053 -2.202 . . . . 0.0 105.053 173.914 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 76.4 Cg_exo -75.97 45.63 1.55 Allowed 'Trans proline' 0 CA--C 1.519 -0.25 0 C-N-CA 123.342 2.695 . . . . 0.0 113.946 177.081 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 30.0 m 46.75 94.46 0.01 OUTLIER 'General case' 0 CA--C 1.499 -0.981 0 C-N-CA 128.203 2.601 . . . . 0.0 114.192 -174.375 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 34.9 mt-30 -137.59 108.64 8.57 Favored Pre-proline 0 N--CA 1.434 -1.255 0 N-CA-C 104.581 -2.377 . . . . 0.0 104.581 -172.906 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 66.5 Cg_endo -85.92 5.66 5.92 Favored 'Trans proline' 0 N--CA 1.454 -0.831 0 C-N-CA 123.611 2.874 . . . . 0.0 109.45 -177.886 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 5.8 p-10 -116.44 -35.95 4.13 Favored 'General case' 0 CA--C 1.491 -1.321 0 C-N-CA 124.328 1.051 . . . . 0.0 109.344 -172.581 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 30.3 p -130.22 151.95 50.18 Favored 'General case' 0 CA--C 1.499 -1.0 0 CA-C-O 122.151 0.977 . . . . 0.0 110.004 -175.42 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . 0.614 ' CD2' ' HG1' ' A' ' 91' ' ' THR . 35.7 m-70 -142.87 98.99 5.62 Favored Pre-proline 0 N--CA 1.438 -1.069 0 N-CA-C 107.145 -1.428 . . . . 0.0 107.145 175.668 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -79.1 114.04 3.3 Favored 'Trans proline' 0 N--CA 1.445 -1.339 0 C-N-CA 123.074 2.516 . . . . 0.0 110.178 175.953 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 3.9 pt -93.93 166.53 1.77 Allowed 'Isoleucine or valine' 0 CA--C 1.498 -1.05 0 N-CA-C 107.825 -1.176 . . . . 0.0 107.825 -178.251 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 17.6 mp0 -139.69 151.46 45.92 Favored 'General case' 0 CA--C 1.499 -1.002 0 N-CA-C 105.496 -2.038 . . . . 0.0 105.496 174.815 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 42.3 p90 -136.33 156.71 48.25 Favored 'General case' 0 CA--C 1.496 -1.113 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 175.666 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 83.2 m-20 -97.35 -175.71 3.3 Favored 'General case' 0 CA--C 1.486 -1.487 0 N-CA-C 104.31 -2.478 . . . . 0.0 104.31 171.29 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -157.59 173.79 4.65 Favored Pre-proline 0 N--CA 1.44 -0.93 0 N-CA-C 106.828 -1.545 . . . . 0.0 106.828 176.458 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_exo -63.96 162.52 28.78 Favored 'Trans proline' 0 CA--C 1.51 -0.724 0 C-N-CA 123.678 2.919 . . . . 0.0 112.209 169.169 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 1.2 tm0? -81.26 -60.09 0.43 Allowed Pre-proline 0 C--N 1.353 0.744 0 CA-C-O 115.705 -2.093 . . . . 0.0 110.671 -174.193 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_endo -75.42 174.43 12.81 Favored 'Trans proline' 0 CA--C 1.511 -0.645 0 CA-C-N 125.688 3.067 . . . . 0.0 110.161 -179.694 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 52.2 p -72.58 126.26 29.44 Favored 'General case' 0 C--N 1.357 0.919 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 177.787 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . 0.435 ' HE1' ' HG ' ' A' ' 1' ' ' SER . 16.2 t-160 -160.9 -51.66 0.05 OUTLIER 'General case' 0 CA--C 1.493 -1.229 0 N-CA-C 106.566 -1.642 . . . . 0.0 106.566 -166.646 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 35.1 mt -111.81 132.64 59.87 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.1 0 N-CA-C 105.487 -2.042 . . . . 0.0 105.487 -174.154 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 30.0 t -102.77 -84.79 0.45 Allowed 'General case' 0 N--CA 1.431 -1.41 0 N-CA-C 107.586 -1.264 . . . . 0.0 107.586 -178.146 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 23.1 ttmm -91.42 149.51 21.68 Favored 'General case' 0 CA--C 1.493 -1.244 0 N-CA-C 106.829 -1.545 . . . . 0.0 106.829 -161.278 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 97.4 m-85 -117.49 128.84 55.38 Favored 'General case' 0 CA--C 1.496 -1.129 0 N-CA-C 104.725 -2.324 . . . . 0.0 104.725 168.785 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 60.9 mt -106.48 117.44 52.27 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.075 0 N-CA-C 102.188 -3.264 . . . . 0.0 102.188 169.604 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -95.33 125.35 39.89 Favored 'General case' 0 CA--C 1.48 -1.745 0 N-CA-C 106.972 -1.492 . . . . 0.0 106.972 176.813 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 97.0 mtt180 -120.74 147.12 45.74 Favored 'General case' 0 CA--C 1.49 -1.333 0 N-CA-C 105.972 -1.862 . . . . 0.0 105.972 171.75 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 40.3 p90 -151.99 173.55 14.72 Favored 'General case' 0 CA--C 1.487 -1.479 0 N-CA-C 106.199 -1.778 . . . . 0.0 106.199 169.982 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 36.0 ptt180 -170.96 158.83 5.38 Favored Pre-proline 0 CA--C 1.499 -1.009 0 N-CA-C 106.284 -1.747 . . . . 0.0 106.284 177.004 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . 0.423 ' HB2' HD21 ' A' ' 41' ' ' ASN . 60.4 Cg_endo -74.51 140.86 27.44 Favored 'Trans proline' 0 N--CA 1.448 -1.181 0 C-N-CA 122.065 1.843 . . . . 0.0 107.839 168.062 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 57.7 tttp -71.18 78.42 0.7 Allowed 'General case' 0 C--N 1.355 0.806 0 C-N-CA 125.344 1.458 . . . . 0.0 110.784 179.947 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . 0.423 HD21 ' HB2' ' A' ' 39' ' ' PRO . 60.1 m-80 -161.11 -46.73 0.04 OUTLIER 'General case' 0 N--CA 1.438 -1.044 0 N-CA-C 104.966 -2.235 . . . . 0.0 104.966 -170.668 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 27.8 m -77.68 161.01 28.09 Favored 'General case' 0 C--N 1.359 0.995 0 C-N-CA 124.19 0.996 . . . . 0.0 110.503 -170.926 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 20.2 m -102.01 -26.93 3.4 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.879 0 C-N-CA 124.83 1.252 . . . . 0.0 109.887 -170.608 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -173.17 27.17 0.09 OUTLIER Glycine 0 CA--C 1.493 -1.339 0 N-CA-C 110.569 -1.012 . . . . 0.0 110.569 179.853 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 54.7 ttp180 -98.62 122.29 41.65 Favored 'General case' 0 CA--C 1.495 -1.15 0 N-CA-C 105.026 -2.213 . . . . 0.0 105.026 172.669 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 83.8 m95 -128.6 138.74 52.36 Favored 'General case' 0 CA--C 1.496 -1.123 0 N-CA-C 106.732 -1.581 . . . . 0.0 106.732 179.665 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 60.9 mttp -96.11 104.47 16.42 Favored 'General case' 0 CA--C 1.491 -1.307 0 N-CA-C 104.332 -2.47 . . . . 0.0 104.332 169.192 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 16.1 pt-20 -107.49 150.96 26.2 Favored 'General case' 0 CA--C 1.498 -1.055 0 CA-C-N 115.033 -0.985 . . . . 0.0 109.532 -176.475 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -136.74 154.51 50.56 Favored 'General case' 0 N--CA 1.438 -1.055 0 N-CA-C 105.917 -1.883 . . . . 0.0 105.917 178.089 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 92.4 m -121.71 125.1 45.82 Favored 'General case' 0 CA--C 1.501 -0.91 0 N-CA-C 104.292 -2.485 . . . . 0.0 104.292 178.317 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 63.6 mt -128.86 137.39 30.87 Favored Pre-proline 0 N--CA 1.44 -0.961 0 N-CA-C 105.154 -2.165 . . . . 0.0 105.154 -166.29 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -74.56 171.13 18.76 Favored 'Trans proline' 0 CA--C 1.508 -0.8 0 C-N-CA 123.44 2.76 . . . . 0.0 110.876 178.555 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -77.95 -11.96 84.88 Favored Glycine 0 C--N 1.352 1.463 0 C-N-CA 123.808 0.718 . . . . 0.0 114.117 -178.742 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 9.2 p-80 -83.01 -25.37 32.27 Favored 'General case' 0 C--N 1.357 0.931 0 CA-C-N 118.321 1.061 . . . . 0.0 110.236 -178.937 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 87.2 mt -89.09 128.26 35.74 Favored 'General case' 0 CA--C 1.501 -0.929 0 N-CA-C 107.316 -1.364 . . . . 0.0 107.316 173.412 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 8.4 p30 -112.91 1.05 15.32 Favored 'General case' 0 N--CA 1.443 -0.8 0 C-N-CA 124.762 1.225 . . . . 0.0 109.814 -173.146 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 25.7 p -145.71 160.18 42.09 Favored 'General case' 0 CA--C 1.498 -1.025 0 N-CA-C 106.331 -1.729 . . . . 0.0 106.331 -177.33 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 5.1 t80 -131.89 177.89 7.19 Favored 'General case' 0 C--N 1.358 0.942 0 CA-C-O 121.684 0.754 . . . . 0.0 109.366 178.808 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 97.7 m -133.72 105.78 7.01 Favored 'General case' 0 N--CA 1.431 -1.393 0 N-CA-C 103.302 -2.851 . . . . 0.0 103.302 171.613 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 59.5 mt -86.83 140.22 16.14 Favored 'Isoleucine or valine' 0 C--N 1.359 0.993 0 N-CA-C 103.938 -2.615 . . . . 0.0 103.938 171.326 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -147.26 160.46 42.47 Favored 'General case' 0 N--CA 1.438 -1.071 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 -176.866 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 84.42 52.6 3.51 Favored Glycine 0 C--N 1.354 1.565 0 N-CA-C 109.208 -1.557 . . . . 0.0 109.208 178.672 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 47.9 mt -114.9 168.59 9.77 Favored 'General case' 0 CA--C 1.501 -0.924 0 N-CA-C 107.591 -1.263 . . . . 0.0 107.591 -173.631 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -119.67 150.48 50.32 Favored Pre-proline 0 N--CA 1.442 -0.872 0 N-CA-C 106.775 -1.565 . . . . 0.0 106.775 -173.624 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -77.18 165.7 27.54 Favored 'Trans proline' 0 N--CA 1.454 -0.827 0 C-N-CA 123.129 2.552 . . . . 0.0 110.806 175.263 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . 0.499 ' H ' ' HA ' ' A' ' 92' ' ' THR . . . 64.18 19.18 63.65 Favored Glycine 0 N--CA 1.429 -1.828 0 C-N-CA 128.209 2.814 . . . . 0.0 116.575 173.212 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 9.9 p -134.21 145.9 32.22 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.108 0 CA-C-N 118.636 1.218 . . . . 0.0 108.073 -174.713 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 7.3 p -90.33 128.2 42.38 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.959 0 N-CA-C 106.97 -1.492 . . . . 0.0 106.97 177.523 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 49.0 m-85 -101.0 137.33 39.51 Favored 'General case' 0 CA--C 1.493 -1.233 0 N-CA-C 105.575 -2.009 . . . . 0.0 105.575 174.3 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 18.9 pt-20 -112.35 158.63 19.55 Favored 'General case' 0 N--CA 1.437 -1.096 0 N-CA-C 105.956 -1.868 . . . . 0.0 105.956 173.044 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -169.57 -172.38 36.12 Favored Glycine 0 N--CA 1.415 -2.726 0 C-N-CA 120.578 -0.82 . . . . 0.0 114.879 175.447 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 32.0 mt-30 -148.24 139.88 23.71 Favored 'General case' 0 CA--C 1.486 -1.518 0 N-CA-C 105.997 -1.853 . . . . 0.0 105.997 -166.878 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 59.5 tp -116.47 96.41 5.51 Favored 'General case' 0 CA--C 1.499 -0.997 0 N-CA-C 104.015 -2.587 . . . . 0.0 104.015 174.958 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 27.3 mt -88.49 134.79 27.27 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.919 0 N-CA-C 104.05 -2.574 . . . . 0.0 104.05 -178.313 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 25.2 p -129.5 104.62 7.57 Favored 'General case' 0 N--CA 1.438 -1.066 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 -169.326 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 3.7 mp -93.51 136.42 25.31 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.312 0 N-CA-C 104.062 -2.57 . . . . 0.0 104.062 -167.07 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 80.5 mt-30 -88.24 177.29 6.92 Favored 'General case' 0 CA--C 1.496 -1.132 0 C-N-CA 123.712 0.805 . . . . 0.0 108.968 -171.304 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 35.3 mt-30 -71.52 96.04 1.47 Allowed 'General case' 0 CA--C 1.501 -0.921 0 C-N-CA 124.597 1.159 . . . . 0.0 109.459 176.46 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . 0.301 41.3 p90 47.65 33.0 2.76 Favored 'General case' 0 C--N 1.36 1.035 0 C-N-CA 128.126 2.57 . . . . 0.0 114.438 -174.815 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -125.29 -125.89 2.95 Favored Glycine 0 C--N 1.358 1.78 0 N-CA-C 109.456 -1.458 . . . . 0.0 109.456 -174.119 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 52.3 m80 -84.1 -178.02 6.83 Favored 'General case' 0 CA--C 1.498 -1.027 0 C-N-CA 125.614 1.566 . . . . 0.0 111.044 -167.818 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 35.7 mt-30 -125.29 146.25 49.64 Favored 'General case' 0 CA--C 1.494 -1.188 0 N-CA-C 103.459 -2.793 . . . . 0.0 103.459 167.806 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 54.6 mt-10 -138.14 121.48 17.06 Favored 'General case' 0 CA--C 1.492 -1.281 0 N-CA-C 105.372 -2.084 . . . . 0.0 105.372 -177.114 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 7.5 p -99.4 134.97 36.62 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.79 0 N-CA-C 108.151 -1.055 . . . . 0.0 108.151 -172.624 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 26.7 m -115.2 158.96 21.53 Favored 'General case' 0 N--CA 1.443 -0.802 0 N-CA-C 103.81 -2.663 . . . . 0.0 103.81 175.915 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 38.8 ptt180 -126.32 154.71 43.1 Favored 'General case' 0 CA--C 1.501 -0.915 0 CA-C-O 121.32 0.581 . . . . 0.0 109.8 178.126 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 29.4 p90 -157.45 165.43 35.69 Favored 'General case' 0 CA--C 1.502 -0.866 0 N-CA-C 107.274 -1.38 . . . . 0.0 107.274 173.486 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -145.57 156.82 43.93 Favored 'General case' 0 N--CA 1.441 -0.885 0 N-CA-C 106.314 -1.736 . . . . 0.0 106.314 159.997 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 27.4 p90 -146.37 168.23 21.62 Favored 'General case' 0 CA--C 1.492 -1.254 0 N-CA-C 106.404 -1.702 . . . . 0.0 106.404 171.046 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 26.6 p -110.86 140.36 45.39 Favored 'General case' 0 CA--C 1.5 -0.944 0 N-CA-C 106.957 -1.497 . . . . 0.0 106.957 178.668 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' THR . . . . . 0.614 ' HG1' ' CD2' ' A' ' 18' ' ' HIS . 89.7 m -116.45 109.14 16.91 Favored 'General case' 0 CA--C 1.489 -1.394 0 N-CA-C 102.106 -3.294 . . . . 0.0 102.106 174.037 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' THR . . . . . 0.499 ' HA ' ' H ' ' A' ' 66' ' ' GLY . 86.9 m -147.28 -55.69 0.24 Allowed 'General case' 0 CA--C 1.498 -1.034 0 N-CA-C 106.645 -1.613 . . . . 0.0 106.645 -171.686 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 8.9 t . . . . . 0 C--O 1.26 1.653 0 CA-C-O 118.078 -0.963 . . . . 0.0 110.049 -165.25 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 88.8 p . . . . . 0 N--CA 1.489 1.489 0 CA-C-O 121.348 0.594 . . . . 0.0 111.823 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 83.76 -149.25 25.46 Favored Glycine 0 C--N 1.355 1.635 0 N-CA-C 109.104 -1.598 . . . . 0.0 109.104 176.882 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_exo -61.55 136.12 61.15 Favored 'Trans proline' 0 N--CA 1.443 -1.472 0 C-N-CA 123.088 2.526 . . . . 0.0 113.624 -178.357 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.52 HG22 ' HG ' ' A' ' 75' ' ' SER . 24.6 t -84.59 161.92 3.08 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.048 0 C-N-CA 129.202 3.001 . . . . 0.0 106.424 -178.196 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -108.38 108.9 20.06 Favored 'General case' 0 CA--C 1.496 -1.107 0 N-CA-C 105.876 -1.898 . . . . 0.0 105.876 175.927 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 1.5 p -129.3 142.04 45.01 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.894 0 N-CA-C 105.687 -1.968 . . . . 0.0 105.687 -170.101 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 33.1 p90 -155.51 171.04 20.58 Favored 'General case' 0 N--CA 1.438 -1.026 0 CA-C-O 121.876 0.846 . . . . 0.0 109.302 -162.184 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 14.5 tt -134.76 134.7 53.82 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.973 0 N-CA-C 102.014 -3.328 . . . . 0.0 102.014 162.742 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 93.6 m -146.62 128.39 15.29 Favored 'General case' 0 CA--C 1.504 -0.813 0 N-CA-C 106.702 -1.592 . . . . 0.0 106.702 -173.598 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 19.4 tt0 61.71 42.2 11.08 Favored 'General case' 0 C--N 1.358 0.974 0 C-N-CA 127.305 2.242 . . . . 0.0 113.202 165.936 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 99.7 m -87.6 122.9 70.24 Favored Pre-proline 0 N--CA 1.445 -0.694 0 N-CA-C 107.215 -1.402 . . . . 0.0 107.215 177.589 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 98.4 Cg_endo -85.06 80.27 2.15 Favored 'Trans proline' 0 N--CA 1.456 -0.717 0 C-N-CA 123.195 2.597 . . . . 0.0 110.947 -174.915 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . 0.264 80.7 p 51.1 99.38 0.01 OUTLIER 'General case' 0 C--N 1.357 0.913 0 C-N-CA 127.883 2.473 . . . . 0.0 115.547 174.007 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 99.6 mm-40 -129.56 102.81 17.99 Favored Pre-proline 0 N--CA 1.442 -0.831 0 N-CA-C 106.18 -1.785 . . . . 0.0 106.18 178.528 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_exo -74.66 -21.31 16.83 Favored 'Trans proline' 0 CA--C 1.506 -0.882 0 C-N-CA 123.2 2.6 . . . . 0.0 111.291 178.017 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 1.6 p30 -102.46 -42.44 5.97 Favored 'General case' 0 CA--C 1.489 -1.368 0 C-N-CA 124.215 1.006 . . . . 0.0 111.029 -165.188 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 56.6 p -110.48 156.0 21.46 Favored 'General case' 0 CA--C 1.497 -1.06 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 -175.634 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 86.3 t60 -131.57 98.72 17.8 Favored Pre-proline 0 N--CA 1.439 -0.989 0 N-CA-C 106.128 -1.804 . . . . 0.0 106.128 172.493 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -80.13 128.99 7.58 Favored 'Trans proline' 0 N--CA 1.451 -0.972 0 C-N-CA 123.26 2.64 . . . . 0.0 109.836 177.231 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 3.7 mp -111.9 149.04 14.67 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.183 0 N-CA-C 104.881 -2.266 . . . . 0.0 104.881 -179.62 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 31.2 mt-30 -138.7 152.94 48.44 Favored 'General case' 0 CA--C 1.497 -1.092 0 N-CA-C 104.578 -2.378 . . . . 0.0 104.578 164.57 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 37.2 p90 -136.02 158.5 44.26 Favored 'General case' 0 CA--C 1.501 -0.916 0 N-CA-C 107.065 -1.457 . . . . 0.0 107.065 -178.595 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 84.2 m-20 -96.4 -176.92 3.78 Favored 'General case' 0 CA--C 1.488 -1.407 0 N-CA-C 103.934 -2.617 . . . . 0.0 103.934 169.045 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -157.35 171.85 6.91 Favored Pre-proline 0 N--CA 1.44 -0.933 0 N-CA-C 106.579 -1.637 . . . . 0.0 106.579 173.188 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 68.5 Cg_exo -63.74 154.46 69.28 Favored 'Trans proline' 0 CA--C 1.508 -0.814 0 C-N-CA 123.51 2.807 . . . . 0.0 112.842 174.59 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 24.0 tt0 -82.43 -41.93 0.94 Allowed Pre-proline 0 N--CA 1.443 -0.798 0 CA-C-O 115.697 -2.097 . . . . 0.0 112.031 -175.134 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_exo -71.71 -3.74 13.71 Favored 'Trans proline' 0 CA--C 1.514 -0.521 0 CA-C-N 125.574 3.026 . . . . 0.0 113.851 -179.867 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 10.3 t 71.0 75.93 0.19 Allowed 'General case' 0 C--N 1.357 0.903 0 C-N-CA 126.381 1.873 . . . . 0.0 108.812 -176.71 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 57.8 t-80 -90.95 -20.18 22.46 Favored 'General case' 0 N--CA 1.439 -0.977 0 C-N-CA 125.27 1.428 . . . . 0.0 108.455 179.969 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 22.9 mt -125.38 147.47 30.07 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.105 0 N-CA-C 105.396 -2.075 . . . . 0.0 105.396 -168.578 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 9.2 p -107.29 -84.13 0.53 Allowed 'General case' 0 N--CA 1.432 -1.328 0 N-CA-C 106.879 -1.526 . . . . 0.0 106.879 174.554 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 51.7 mtmt -89.2 167.57 12.98 Favored 'General case' 0 CA--C 1.486 -1.493 0 C-N-CA 124.683 1.193 . . . . 0.0 108.782 -165.274 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 90.4 m-85 -132.31 138.24 47.74 Favored 'General case' 0 CA--C 1.495 -1.142 0 N-CA-C 105.329 -2.1 . . . . 0.0 105.329 176.033 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 51.8 mt -118.42 131.55 70.85 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.111 0 N-CA-C 101.074 -3.676 . . . . 0.0 101.074 170.652 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 6.8 mt -111.01 128.13 55.75 Favored 'General case' 0 CA--C 1.477 -1.854 0 N-CA-C 104.739 -2.319 . . . . 0.0 104.739 170.104 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 3.2 mmm180 -107.51 160.11 15.91 Favored 'General case' 0 N--CA 1.432 -1.348 0 N-CA-C 104.737 -2.32 . . . . 0.0 104.737 171.077 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 48.5 p90 -159.18 152.82 22.89 Favored 'General case' 0 N--CA 1.437 -1.085 0 N-CA-C 107.801 -1.185 . . . . 0.0 107.801 171.093 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 13.1 ptp180 -154.61 158.05 32.2 Favored Pre-proline 0 CA--C 1.501 -0.932 0 N-CA-C 105.661 -1.978 . . . . 0.0 105.661 163.946 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -72.52 129.01 14.16 Favored 'Trans proline' 0 N--CA 1.451 -0.977 0 C-N-CA 122.637 2.225 . . . . 0.0 107.752 170.191 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 48.2 tttp -67.6 81.82 0.17 Allowed 'General case' 0 C--N 1.357 0.912 0 C-N-CA 127.781 2.433 . . . . 0.0 111.473 -170.761 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 4.7 t-20 -162.17 -51.05 0.04 OUTLIER 'General case' 0 N--CA 1.432 -1.335 0 N-CA-C 105.562 -2.014 . . . . 0.0 105.562 -173.607 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 37.9 p -80.63 155.7 26.72 Favored 'General case' 0 N--CA 1.438 -1.059 0 C-N-CA 124.567 1.147 . . . . 0.0 109.685 -176.891 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 17.3 m -130.44 10.67 2.14 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.811 0 C-N-CA 125.061 1.344 . . . . 0.0 107.888 -177.427 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -94.27 -113.18 2.45 Favored Glycine 0 C--N 1.356 1.694 0 N-CA-C 109.489 -1.444 . . . . 0.0 109.489 -174.534 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 85.6 mtm180 -92.66 175.95 6.63 Favored 'General case' 0 CA--C 1.503 -0.863 0 N-CA-C 108.191 -1.04 . . . . 0.0 108.191 -178.538 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -155.41 -178.41 7.25 Favored 'General case' 0 CA--C 1.495 -1.171 0 CA-C-O 121.221 0.534 . . . . 0.0 109.839 178.565 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 96.0 mttt -109.21 156.55 19.76 Favored 'General case' 0 CA--C 1.489 -1.396 0 N-CA-C 106.451 -1.685 . . . . 0.0 106.451 -176.724 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 1.1 pp20? -152.08 163.12 39.99 Favored 'General case' 0 N--CA 1.432 -1.363 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 176.252 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -139.97 160.79 39.14 Favored 'General case' 0 CA--C 1.495 -1.136 0 N-CA-C 105.663 -1.977 . . . . 0.0 105.663 169.596 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 77.6 m -120.62 125.96 49.07 Favored 'General case' 0 CA--C 1.499 -1.014 0 N-CA-C 104.732 -2.322 . . . . 0.0 104.732 176.446 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 4.9 mp -114.04 134.41 22.17 Favored Pre-proline 0 N--CA 1.435 -1.186 0 N-CA-C 104.84 -2.281 . . . . 0.0 104.84 -175.545 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 67.5 Cg_exo -63.89 167.6 13.62 Favored 'Trans proline' 0 CA--C 1.509 -0.761 0 C-N-CA 123.595 2.863 . . . . 0.0 113.406 177.227 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -77.75 -19.02 76.43 Favored Glycine 0 C--N 1.352 1.439 0 C-N-CA 123.583 0.611 . . . . 0.0 113.425 -173.488 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 50.9 p-80 -84.08 -27.88 27.95 Favored 'General case' 0 C--N 1.357 0.906 0 CA-C-N 117.757 0.779 . . . . 0.0 110.172 -179.471 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 86.4 mt -88.56 128.97 35.58 Favored 'General case' 0 CA--C 1.5 -0.943 0 N-CA-C 107.881 -1.155 . . . . 0.0 107.881 177.653 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 8.7 p30 -110.98 8.33 21.96 Favored 'General case' 0 CA--C 1.5 -0.946 0 C-N-CA 124.498 1.119 . . . . 0.0 110.543 -171.806 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 46.6 p -142.03 160.16 40.77 Favored 'General case' 0 N--CA 1.439 -0.988 0 N-CA-C 108.107 -1.071 . . . . 0.0 108.107 -175.713 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 12.3 t80 -143.63 176.72 9.0 Favored 'General case' 0 C--N 1.355 0.822 0 N-CA-C 107.328 -1.36 . . . . 0.0 107.328 176.953 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 97.6 m -147.06 116.96 7.2 Favored 'General case' 0 N--CA 1.429 -1.509 0 N-CA-C 104.851 -2.277 . . . . 0.0 104.851 176.101 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 79.7 mt -91.24 147.06 5.5 Favored 'Isoleucine or valine' 0 C--N 1.355 0.804 0 N-CA-C 103.555 -2.757 . . . . 0.0 103.555 169.364 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 67.6 mttm -140.38 166.37 24.89 Favored 'General case' 0 CA--C 1.5 -0.954 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 178.149 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 83.16 49.39 5.01 Favored Glycine 0 C--N 1.354 1.577 0 N-CA-C 109.211 -1.556 . . . . 0.0 109.211 174.787 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 63.9 mt -118.78 169.4 9.88 Favored 'General case' 0 CA--C 1.498 -1.023 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 -170.576 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -116.76 144.74 33.95 Favored Pre-proline 0 N--CA 1.439 -1.008 0 N-CA-C 105.679 -1.971 . . . . 0.0 105.679 -173.764 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -77.33 161.75 31.59 Favored 'Trans proline' 0 N--CA 1.452 -0.934 0 C-N-CA 122.788 2.325 . . . . 0.0 110.996 174.466 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . 0.483 ' H ' ' HA ' ' A' ' 92' ' ' THR . . . 62.54 26.66 68.54 Favored Glycine 0 N--CA 1.428 -1.856 0 C-N-CA 127.617 2.532 . . . . 0.0 115.765 174.225 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 9.8 p -126.65 145.59 33.95 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.928 0 N-CA-C 107.596 -1.261 . . . . 0.0 107.596 179.408 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 4.2 p -92.61 135.75 26.7 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.824 0 N-CA-C 107.214 -1.402 . . . . 0.0 107.214 179.945 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 91.1 m-85 -116.79 149.27 40.23 Favored 'General case' 0 CA--C 1.494 -1.193 0 N-CA-C 105.607 -1.997 . . . . 0.0 105.607 175.278 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -96.7 139.93 32.04 Favored 'General case' 0 CA--C 1.499 -1.009 0 N-CA-C 104.367 -2.457 . . . . 0.0 104.367 162.773 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -132.66 154.14 20.97 Favored Glycine 0 CA--C 1.483 -1.925 0 N-CA-C 106.951 -2.46 . . . . 0.0 106.951 179.849 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 29.2 tt0 -146.94 135.61 22.09 Favored 'General case' 0 CA--C 1.483 -1.627 0 N-CA-C 106.949 -1.5 . . . . 0.0 106.949 -178.625 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 21.8 tp -115.79 100.55 8.09 Favored 'General case' 0 N--CA 1.438 -1.074 0 N-CA-C 104.45 -2.426 . . . . 0.0 104.45 -177.355 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 21.2 mt -93.16 126.61 45.57 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.917 0 N-CA-C 104.032 -2.581 . . . . 0.0 104.032 177.572 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' SER . . . . . 0.52 ' HG ' HG22 ' A' ' 4' ' ' VAL . 74.2 m -117.98 111.32 18.8 Favored 'General case' 0 N--CA 1.436 -1.173 0 N-CA-C 107.746 -1.205 . . . . 0.0 107.746 -170.413 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 31.0 mm -91.22 144.01 10.05 Favored 'Isoleucine or valine' 0 CA--C 1.49 -1.365 0 N-CA-C 106.519 -1.66 . . . . 0.0 106.519 -165.799 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 17.1 tt0 -110.81 107.18 16.6 Favored 'General case' 0 CA--C 1.495 -1.135 0 N-CA-C 103.036 -2.95 . . . . 0.0 103.036 171.452 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 19.7 pt20 -67.25 138.46 56.91 Favored 'General case' 0 C--N 1.356 0.866 0 CA-C-O 121.232 0.539 . . . . 0.0 111.68 -167.148 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 55.0 m-85 68.05 32.15 5.14 Favored 'General case' 0 C--N 1.355 0.821 0 C-N-CA 126.695 1.998 . . . . 0.0 111.764 -176.1 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -174.97 -112.86 0.31 Allowed Glycine 0 C--N 1.355 1.613 0 C-N-CA 119.349 -1.405 . . . . 0.0 109.749 176.922 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 66.4 m80 -83.43 -178.73 7.15 Favored 'General case' 0 CA--C 1.5 -0.954 0 C-N-CA 125.242 1.417 . . . . 0.0 111.269 -164.595 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 5.9 pt20 -154.51 148.77 26.0 Favored 'General case' 0 N--CA 1.435 -1.216 0 N-CA-C 106.621 -1.622 . . . . 0.0 106.621 166.506 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 8.4 mp0 -109.81 155.93 21.0 Favored 'General case' 0 N--CA 1.437 -1.085 0 N-CA-C 104.869 -2.271 . . . . 0.0 104.869 -178.116 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 12.4 p -131.45 139.17 51.4 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.838 0 N-CA-C 107.772 -1.196 . . . . 0.0 107.772 -179.739 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 41.8 m -133.28 122.69 24.25 Favored 'General case' 0 N--CA 1.438 -1.074 0 N-CA-C 103.261 -2.866 . . . . 0.0 103.261 -178.669 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 52.8 ttt85 -119.75 144.15 47.42 Favored 'General case' 0 CA--C 1.504 -0.794 0 N-CA-C 108.174 -1.047 . . . . 0.0 108.174 -176.011 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 29.0 p90 -155.06 -179.59 8.21 Favored 'General case' 0 CA--C 1.499 -0.981 0 N-CA-C 107.547 -1.279 . . . . 0.0 107.547 -177.182 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -138.82 156.31 47.44 Favored 'General case' 0 N--CA 1.44 -0.961 0 N-CA-C 105.811 -1.922 . . . . 0.0 105.811 167.169 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 22.2 p90 -142.61 171.79 13.57 Favored 'General case' 0 CA--C 1.487 -1.477 0 N-CA-C 106.83 -1.544 . . . . 0.0 106.83 175.001 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 25.5 p -120.37 143.88 48.19 Favored 'General case' 0 CA--C 1.499 -0.993 0 N-CA-C 105.526 -2.027 . . . . 0.0 105.526 169.364 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 57.3 m -109.05 126.06 52.76 Favored 'General case' 0 CA--C 1.493 -1.244 0 N-CA-C 101.36 -3.57 . . . . 0.0 101.36 164.764 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' THR . . . . . 0.483 ' HA ' ' H ' ' A' ' 66' ' ' GLY . 12.4 t -146.01 172.46 13.35 Favored 'General case' 0 N--CA 1.435 -1.177 0 N-CA-C 105.264 -2.125 . . . . 0.0 105.264 -173.751 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 69.5 m . . . . . 0 C--O 1.26 1.629 0 N-CA-C 106.8 -1.556 . . . . 0.0 106.8 173.197 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 23.3 t . . . . . 0 N--CA 1.483 1.211 0 N-CA-C 109.581 -0.526 . . . . 0.0 109.581 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 166.66 176.83 38.07 Favored Glycine 0 N--CA 1.437 -1.285 0 N-CA-C 106.705 -2.558 . . . . 0.0 106.705 178.375 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 8.9 Cg_exo -55.42 148.57 51.36 Favored 'Trans proline' 0 N--CA 1.45 -1.078 0 C-N-CA 124.11 3.207 . . . . 0.0 116.463 -161.995 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 17.5 t -76.88 156.21 5.54 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.806 0 C-N-CA 128.29 2.636 . . . . 0.0 105.036 175.021 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 55.2 mt-10 -107.15 105.81 15.98 Favored 'General case' 0 CA--C 1.494 -1.18 0 N-CA-C 106.512 -1.662 . . . . 0.0 106.512 -176.478 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 1.7 p -127.49 141.83 45.26 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.981 0 N-CA-C 106.172 -1.788 . . . . 0.0 106.172 -169.808 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 21.2 p90 -156.67 170.79 21.61 Favored 'General case' 0 N--CA 1.436 -1.13 0 N-CA-C 106.95 -1.5 . . . . 0.0 106.95 -162.589 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.414 HG21 ' CE1' ' A' ' 18' ' ' HIS . 0.0 OUTLIER -129.21 120.04 50.36 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.661 0 N-CA-C 103.772 -2.677 . . . . 0.0 103.772 165.461 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 84.9 m -122.87 -21.89 5.43 Favored 'General case' 0 N--CA 1.443 -0.802 0 N-CA-C 106.663 -1.606 . . . . 0.0 106.663 176.912 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -104.38 7.3 35.59 Favored 'General case' 0 N--CA 1.438 -1.066 0 C-N-CA 125.08 1.352 . . . . 0.0 110.23 -168.026 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 30.6 m -108.87 100.35 39.2 Favored Pre-proline 0 C--N 1.36 1.027 0 N-CA-C 107.188 -1.412 . . . . 0.0 107.188 178.107 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -76.53 -80.26 0.01 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.884 0 C-N-CA 123.021 2.481 . . . . 0.0 109.727 170.186 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 10.7 p -140.02 108.23 5.79 Favored 'General case' 0 N--CA 1.433 -1.287 0 N-CA-C 104.617 -2.364 . . . . 0.0 104.617 -179.748 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 73.2 mt-30 -143.79 110.59 5.23 Favored Pre-proline 0 N--CA 1.438 -1.05 0 N-CA-C 104.166 -2.531 . . . . 0.0 104.166 -179.597 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -85.43 -19.1 3.72 Favored 'Trans proline' 0 CA--C 1.504 -0.987 0 C-N-CA 122.722 2.281 . . . . 0.0 111.267 -167.425 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 4.1 t30 -117.73 -33.67 4.45 Favored 'General case' 0 CA--C 1.487 -1.459 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 -170.849 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 67.8 m -103.63 152.12 22.14 Favored 'General case' 0 CA--C 1.495 -1.163 0 N-CA-C 107.092 -1.448 . . . . 0.0 107.092 178.854 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . 0.414 ' CE1' HG21 ' A' ' 8' ' ' ILE . 82.7 t60 -144.61 84.17 9.27 Favored Pre-proline 0 N--CA 1.437 -1.123 0 N-CA-C 106.559 -1.645 . . . . 0.0 106.559 174.651 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -81.75 123.19 4.13 Favored 'Trans proline' 0 N--CA 1.446 -1.294 0 C-N-CA 123.286 2.657 . . . . 0.0 109.765 179.882 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 3.4 pt -109.81 170.86 2.96 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.069 0 N-CA-C 108.466 -0.939 . . . . 0.0 108.466 -174.962 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 33.6 tt0 -145.92 148.03 32.38 Favored 'General case' 0 N--CA 1.437 -1.076 0 N-CA-C 105.459 -2.052 . . . . 0.0 105.459 172.247 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 19.6 p90 -130.75 158.04 41.18 Favored 'General case' 0 CA--C 1.499 -1.001 0 N-CA-C 106.27 -1.752 . . . . 0.0 106.27 179.491 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 89.6 m-20 -95.47 -179.46 4.77 Favored 'General case' 0 CA--C 1.488 -1.433 0 N-CA-C 103.647 -2.723 . . . . 0.0 103.647 168.89 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -160.08 165.37 17.9 Favored Pre-proline 0 N--CA 1.439 -0.982 0 N-CA-C 104.966 -2.235 . . . . 0.0 104.966 176.851 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -74.63 154.86 44.68 Favored 'Trans proline' 0 N--CA 1.453 -0.874 0 C-N-CA 122.546 2.164 . . . . 0.0 109.711 179.244 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 11.8 tp-100 -82.85 -43.41 0.9 Allowed Pre-proline 0 N--CA 1.443 -0.799 0 CA-C-O 115.924 -1.989 . . . . 0.0 111.219 -174.777 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 70.5 Cg_exo -67.89 167.94 20.09 Favored 'Trans proline' 0 CA--C 1.508 -0.778 0 CA-C-N 125.347 2.945 . . . . 0.0 111.976 174.213 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 34.8 p -72.94 123.18 22.94 Favored 'General case' 0 C--N 1.355 0.836 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 178.949 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 20.0 t-160 -159.58 -51.54 0.06 Allowed 'General case' 0 CA--C 1.493 -1.248 0 N-CA-C 106.729 -1.582 . . . . 0.0 106.729 -169.83 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 48.9 mt -121.6 137.88 53.78 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.119 0 N-CA-C 106.425 -1.695 . . . . 0.0 106.425 -168.842 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 73.5 m -107.33 -82.26 0.55 Allowed 'General case' 0 N--CA 1.432 -1.345 0 C-N-CA 125.025 1.33 . . . . 0.0 108.131 179.953 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 35.0 ttpt -92.25 161.74 14.58 Favored 'General case' 0 CA--C 1.494 -1.196 0 C-N-CA 125.47 1.508 . . . . 0.0 107.731 -165.477 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 90.2 m-85 -128.92 137.01 51.17 Favored 'General case' 0 CA--C 1.497 -1.089 0 N-CA-C 104.686 -2.338 . . . . 0.0 104.686 173.367 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 62.0 mt -116.73 128.81 74.01 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.213 0 N-CA-C 101.611 -3.477 . . . . 0.0 101.611 171.725 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 3.1 mt -109.02 133.35 53.1 Favored 'General case' 0 CA--C 1.475 -1.908 0 N-CA-C 105.766 -1.939 . . . . 0.0 105.766 171.784 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 16.3 ptp180 -135.96 152.6 51.14 Favored 'General case' 0 N--CA 1.434 -1.259 0 N-CA-C 107.31 -1.367 . . . . 0.0 107.31 173.928 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 48.6 p90 -156.73 153.57 28.62 Favored 'General case' 0 N--CA 1.438 -1.039 0 N-CA-C 107.766 -1.198 . . . . 0.0 107.766 -172.736 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 10.6 ptp180 -149.02 155.78 40.38 Favored Pre-proline 0 CA--C 1.499 -0.988 0 N-CA-C 105.696 -1.964 . . . . 0.0 105.696 168.393 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -72.17 121.25 7.37 Favored 'Trans proline' 0 N--CA 1.452 -0.958 0 C-N-CA 122.876 2.384 . . . . 0.0 108.327 169.797 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 57.5 tttp -70.3 80.01 0.53 Allowed 'General case' 0 C--N 1.357 0.924 0 C-N-CA 126.918 2.087 . . . . 0.0 110.446 -178.182 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 29.9 m120 -155.4 -70.41 0.12 Allowed 'General case' 0 N--CA 1.435 -1.215 0 N-CA-C 102.046 -3.316 . . . . 0.0 102.046 -173.209 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 37.2 p -96.22 157.89 15.69 Favored 'General case' 0 N--CA 1.439 -0.993 0 N-CA-C 107.555 -1.276 . . . . 0.0 107.555 175.139 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 3.3 m -130.62 53.68 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.918 0 N-CA-C 105.789 -1.93 . . . . 0.0 105.789 178.24 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -94.61 -107.73 2.08 Favored Glycine 0 C--N 1.355 1.625 0 N-CA-C 108.017 -2.033 . . . . 0.0 108.017 -179.092 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 8.3 ptm180 -88.8 175.29 7.54 Favored 'General case' 0 CA--C 1.502 -0.874 0 N-CA-C 107.625 -1.25 . . . . 0.0 107.625 174.822 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -157.24 171.3 20.66 Favored 'General case' 0 CA--C 1.492 -1.262 0 CA-C-O 121.393 0.616 . . . . 0.0 110.191 175.199 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 64.9 mttp -109.45 152.29 25.59 Favored 'General case' 0 CA--C 1.486 -1.503 0 N-CA-C 107.469 -1.308 . . . . 0.0 107.469 -172.551 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -152.99 155.42 36.9 Favored 'General case' 0 N--CA 1.434 -1.252 0 N-CA-C 107.74 -1.208 . . . . 0.0 107.74 177.727 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -137.3 156.96 47.64 Favored 'General case' 0 N--CA 1.437 -1.107 0 N-CA-C 105.816 -1.92 . . . . 0.0 105.816 173.539 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 87.3 m -121.12 125.32 46.92 Favored 'General case' 0 CA--C 1.501 -0.93 0 N-CA-C 104.784 -2.302 . . . . 0.0 104.784 -179.585 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 58.5 mt -124.02 132.32 24.29 Favored Pre-proline 0 N--CA 1.439 -1.024 0 N-CA-C 105.039 -2.208 . . . . 0.0 105.039 -164.672 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo -77.95 172.51 15.47 Favored 'Trans proline' 0 N--CA 1.455 -0.794 0 C-N-CA 122.717 2.278 . . . . 0.0 110.558 -179.516 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -96.75 69.56 0.84 Allowed Glycine 0 C--N 1.353 1.486 0 N-CA-C 109.34 -1.504 . . . . 0.0 109.34 178.602 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . 0.416 ' HB2' HD11 ' A' ' 55' ' ' LEU . 27.3 m170 -120.55 -66.43 1.06 Allowed 'General case' 0 CA--C 1.499 -0.986 0 N-CA-C 103.265 -2.865 . . . . 0.0 103.265 174.357 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.528 ' H ' HD21 ' A' ' 55' ' ' LEU . 0.0 OUTLIER -89.69 164.08 14.85 Favored 'General case' 0 N--CA 1.43 -1.471 0 C-N-CA 129.17 2.988 . . . . 0.0 106.856 177.765 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 7.1 p30 -140.11 30.34 2.0 Favored 'General case' 0 N--CA 1.431 -1.399 0 N-CA-C 107.125 -1.435 . . . . 0.0 107.125 -177.567 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 36.5 p -139.8 149.12 43.13 Favored 'General case' 0 CA--C 1.501 -0.937 0 N-CA-C 106.809 -1.552 . . . . 0.0 106.809 177.321 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 10.3 t80 -128.37 175.99 8.06 Favored 'General case' 0 C--N 1.358 0.973 0 N-CA-C 107.92 -1.141 . . . . 0.0 107.92 179.764 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 97.7 m -138.5 109.25 6.65 Favored 'General case' 0 N--CA 1.432 -1.344 0 N-CA-C 104.081 -2.562 . . . . 0.0 104.081 173.113 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 27.4 mt -87.9 147.54 5.19 Favored 'Isoleucine or valine' 0 C--N 1.358 0.969 0 N-CA-C 103.427 -2.805 . . . . 0.0 103.427 169.696 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 8.7 ptpp? -150.1 162.83 39.66 Favored 'General case' 0 CA--C 1.497 -1.067 0 N-CA-C 108.169 -1.048 . . . . 0.0 108.169 179.366 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 83.63 51.03 4.21 Favored Glycine 0 C--N 1.354 1.575 0 N-CA-C 109.367 -1.493 . . . . 0.0 109.367 177.768 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.403 HD11 ' HG1' ' A' ' 91' ' ' THR . 62.7 mt -120.34 177.44 5.03 Favored 'General case' 0 CA--C 1.5 -0.954 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 -171.59 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -122.79 152.88 63.1 Favored Pre-proline 0 N--CA 1.44 -0.952 0 N-CA-C 106.46 -1.681 . . . . 0.0 106.46 -175.765 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -79.72 163.74 23.59 Favored 'Trans proline' 0 N--CA 1.451 -0.992 0 C-N-CA 122.976 2.451 . . . . 0.0 110.62 175.312 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . 0.487 ' H ' ' HA ' ' A' ' 92' ' ' THR . . . 58.64 26.16 59.57 Favored Glycine 0 C--N 1.356 1.657 0 C-N-CA 128.207 2.813 . . . . 0.0 116.28 171.966 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 8.6 p -126.41 147.5 31.24 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.977 0 N-CA-C 107.625 -1.25 . . . . 0.0 107.625 -176.988 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 5.1 p -96.02 138.14 22.2 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.945 0 N-CA-C 107.323 -1.362 . . . . 0.0 107.323 -178.114 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 88.6 m-85 -119.13 151.63 37.95 Favored 'General case' 0 N--CA 1.436 -1.157 0 N-CA-C 105.638 -1.986 . . . . 0.0 105.638 175.335 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -101.53 141.72 33.98 Favored 'General case' 0 CA--C 1.497 -1.095 0 N-CA-C 104.743 -2.317 . . . . 0.0 104.743 162.114 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -135.88 150.01 20.23 Favored Glycine 0 CA--C 1.488 -1.608 0 N-CA-C 107.701 -2.16 . . . . 0.0 107.701 -179.576 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 31.1 mt-30 -141.6 133.43 27.31 Favored 'General case' 0 CA--C 1.485 -1.545 0 N-CA-C 106.019 -1.845 . . . . 0.0 106.019 -177.628 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 23.2 tp -115.33 99.77 7.63 Favored 'General case' 0 N--CA 1.439 -1.01 0 N-CA-C 104.249 -2.5 . . . . 0.0 104.249 -178.339 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 11.7 mt -92.43 127.33 44.68 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.812 0 N-CA-C 104.502 -2.407 . . . . 0.0 104.502 179.767 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 10.3 p -114.98 111.66 21.49 Favored 'General case' 0 N--CA 1.436 -1.141 0 N-CA-C 107.593 -1.262 . . . . 0.0 107.593 -173.904 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 10.4 mm -94.79 150.81 3.96 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.298 0 N-CA-C 106.116 -1.809 . . . . 0.0 106.116 -167.195 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 6.4 pt20 -117.69 137.27 52.78 Favored 'General case' 0 CA--C 1.495 -1.155 0 N-CA-C 105.467 -2.049 . . . . 0.0 105.467 169.654 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 63.4 tp60 -69.02 117.89 11.23 Favored 'General case' 0 N--CA 1.441 -0.918 0 C-N-CA 124.107 0.963 . . . . 0.0 111.566 -167.019 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 36.1 m-85 59.09 49.95 8.73 Favored 'General case' 0 C--N 1.357 0.902 0 C-N-CA 126.971 2.108 . . . . 0.0 112.013 -177.918 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -158.72 -122.53 0.68 Allowed Glycine 0 N--CA 1.432 -1.623 0 N-CA-C 108.193 -1.963 . . . . 0.0 108.193 177.499 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 79.8 m-70 -86.58 177.87 7.25 Favored 'General case' 0 CA--C 1.498 -1.035 0 C-N-CA 125.34 1.456 . . . . 0.0 111.07 -169.479 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 26.6 mp0 -133.31 140.21 47.31 Favored 'General case' 0 N--CA 1.436 -1.173 0 N-CA-C 103.608 -2.738 . . . . 0.0 103.608 168.898 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 30.6 tt0 -119.25 137.73 53.47 Favored 'General case' 0 CA--C 1.496 -1.102 0 N-CA-C 103.948 -2.612 . . . . 0.0 103.948 177.915 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 6.3 p -117.1 136.01 55.63 Favored 'Isoleucine or valine' 0 C--N 1.354 0.775 0 N-CA-C 107.914 -1.143 . . . . 0.0 107.914 -177.065 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 63.6 m -116.73 140.15 49.75 Favored 'General case' 0 N--CA 1.441 -0.921 0 N-CA-C 103.067 -2.938 . . . . 0.0 103.067 173.464 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 79.2 mtt85 -128.09 152.05 48.46 Favored 'General case' 0 CA--C 1.5 -0.953 0 N-CA-C 109.195 -0.669 . . . . 0.0 109.195 177.331 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 30.7 p90 -163.81 175.79 10.13 Favored 'General case' 0 C--N 1.355 0.82 0 N-CA-C 107.796 -1.187 . . . . 0.0 107.796 -178.445 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 51.5 m-20 -133.53 154.11 51.1 Favored 'General case' 0 CA--C 1.502 -0.875 0 N-CA-C 105.715 -1.957 . . . . 0.0 105.715 169.553 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 22.1 p90 -142.94 169.36 17.72 Favored 'General case' 0 CA--C 1.487 -1.454 0 N-CA-C 107.765 -1.198 . . . . 0.0 107.765 171.095 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 27.5 p -121.89 143.26 49.54 Favored 'General case' 0 CA--C 1.501 -0.934 0 N-CA-C 105.733 -1.951 . . . . 0.0 105.733 170.754 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' THR . . . . . 0.403 ' HG1' HD11 ' A' ' 63' ' ' LEU . 45.1 m -114.02 125.63 54.21 Favored 'General case' 0 CA--C 1.497 -1.059 0 N-CA-C 102.499 -3.148 . . . . 0.0 102.499 170.953 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' THR . . . . . 0.487 ' HA ' ' H ' ' A' ' 66' ' ' GLY . 13.2 t -143.86 161.61 38.23 Favored 'General case' 0 N--CA 1.441 -0.907 0 N-CA-C 107.365 -1.346 . . . . 0.0 107.365 -171.523 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 50.8 p . . . . . 0 C--O 1.261 1.686 0 C-N-CA 124.837 1.255 . . . . 0.0 109.361 -179.103 . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 22.4 t . . . . . 0 N--CA 1.484 1.244 0 CA-C-O 121.64 0.733 . . . . 0.0 110.315 . . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -164.07 -169.66 27.9 Favored Glycine 0 N--CA 1.436 -1.355 0 N-CA-C 105.702 -2.959 . . . . 0.0 105.702 177.652 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_exo -60.34 132.22 42.61 Favored 'Trans proline' 0 N--CA 1.447 -1.264 0 C-N-CA 123.601 2.867 . . . . 0.0 111.125 -178.05 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 20.2 t -77.95 153.98 5.23 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.925 0 C-N-CA 127.095 2.158 . . . . 0.0 106.273 -172.792 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -96.12 85.67 4.07 Favored 'General case' 0 CA--C 1.49 -1.328 0 N-CA-C 107.377 -1.342 . . . . 0.0 107.377 -176.887 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 1.8 p -100.06 120.73 49.88 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.169 0 N-CA-C 106.484 -1.673 . . . . 0.0 106.484 -170.578 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 48.4 m-85 -94.57 96.38 9.41 Favored 'General case' 0 CA--C 1.495 -1.161 0 N-CA-C 106.923 -1.51 . . . . 0.0 106.923 -168.318 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 32.0 mm -103.04 96.36 4.57 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.264 0 N-CA-C 103.502 -2.777 . . . . 0.0 103.502 176.357 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 40.5 p -78.82 -32.79 46.39 Favored 'General case' 0 N--CA 1.442 -0.833 0 CA-C-N 114.501 -1.227 . . . . 0.0 108.567 178.501 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . 0.475 ' HG3' ' H ' ' A' ' 90' ' ' THR . 25.8 tt0 67.35 54.05 0.73 Allowed 'General case' 0 C--N 1.358 0.956 0 C-N-CA 126.369 1.867 . . . . 0.0 109.726 175.608 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 2.2 p -152.07 81.45 5.67 Favored Pre-proline 0 N--CA 1.441 -0.885 0 N-CA-C 103.469 -2.789 . . . . 0.0 103.469 177.096 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -75.0 -39.24 1.26 Allowed 'Trans proline' 0 N--CA 1.453 -0.903 0 C-N-CA 122.183 1.922 . . . . 0.0 110.536 -176.595 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 23.1 m 60.92 29.21 18.88 Favored 'General case' 0 C--N 1.361 1.071 0 C-N-CA 127.323 2.249 . . . . 0.0 112.904 -179.767 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 83.5 mt-30 -150.23 141.0 14.45 Favored Pre-proline 0 N--CA 1.44 -0.969 0 N-CA-C 105.004 -2.221 . . . . 0.0 105.004 -175.69 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 64.6 Cg_endo -82.47 -29.14 1.55 Allowed 'Trans proline' 0 CA--C 1.506 -0.919 0 C-N-CA 122.584 2.19 . . . . 0.0 111.792 -161.648 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 1.9 m-80 -124.53 -20.22 5.19 Favored 'General case' 0 CA--C 1.491 -1.292 0 C-N-CA 124.128 0.971 . . . . 0.0 109.284 -169.016 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 5.7 p -108.52 134.91 50.64 Favored 'General case' 0 CA--C 1.495 -1.172 0 N-CA-C 107.714 -1.217 . . . . 0.0 107.714 -176.563 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 58.7 t-80 -122.8 98.2 43.15 Favored Pre-proline 0 N--CA 1.441 -0.906 0 N-CA-C 106.978 -1.49 . . . . 0.0 106.978 178.027 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 63.4 Cg_endo -80.05 127.15 6.72 Favored 'Trans proline' 0 N--CA 1.449 -1.107 0 C-N-CA 123.073 2.515 . . . . 0.0 109.873 177.635 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 2.1 pt -110.74 166.26 5.56 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.031 0 N-CA-C 107.153 -1.425 . . . . 0.0 107.153 174.365 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 32.3 mt-30 -138.51 160.09 40.45 Favored 'General case' 0 CA--C 1.497 -1.084 0 N-CA-C 105.286 -2.116 . . . . 0.0 105.286 167.68 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 48.8 p90 -145.1 169.57 17.89 Favored 'General case' 0 CA--C 1.498 -1.054 0 N-CA-C 107.488 -1.301 . . . . 0.0 107.488 173.209 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 44.8 t30 -146.69 136.49 23.21 Favored 'General case' 0 CA--C 1.484 -1.575 0 N-CA-C 106.548 -1.649 . . . . 0.0 106.548 174.449 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -82.78 167.64 28.37 Favored Pre-proline 0 N--CA 1.439 -0.991 0 CA-C-N 112.793 -2.003 . . . . 0.0 111.681 -160.944 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 76.7 Cg_exo -66.16 176.29 4.04 Favored 'Trans proline' 0 N--CA 1.456 -0.68 0 C-N-CA 123.826 3.017 . . . . 0.0 111.752 165.107 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 1.3 tm0? -79.18 -46.04 1.68 Allowed Pre-proline 0 N--CA 1.443 -0.805 0 CA-C-O 115.544 -2.17 . . . . 0.0 110.496 -175.728 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 75.6 Cg_exo -66.53 148.0 83.02 Favored 'Trans proline' 0 CA--C 1.51 -0.721 0 CA-C-N 125.792 3.104 . . . . 0.0 111.969 177.147 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 69.6 m -100.85 63.19 1.03 Allowed 'General case' 0 CA--C 1.502 -0.889 0 N-CA-C 106.778 -1.564 . . . . 0.0 106.778 178.554 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 79.8 t60 -110.36 -1.59 17.09 Favored 'General case' 0 N--CA 1.44 -0.962 0 C-N-CA 125.322 1.449 . . . . 0.0 107.844 179.57 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 3.7 mp -100.16 126.28 53.71 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.115 0 N-CA-C 103.807 -2.664 . . . . 0.0 103.807 -177.639 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 60.5 m -95.43 -84.25 0.34 Allowed 'General case' 0 N--CA 1.431 -1.417 0 N-CA-C 106.153 -1.795 . . . . 0.0 106.153 177.232 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 53.7 mtmt -91.05 169.19 11.08 Favored 'General case' 0 CA--C 1.49 -1.358 0 C-N-CA 123.419 0.687 . . . . 0.0 109.24 -167.871 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 97.4 m-85 -126.87 133.82 50.62 Favored 'General case' 0 N--CA 1.435 -1.222 0 N-CA-C 103.048 -2.945 . . . . 0.0 103.048 164.108 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 51.1 mt -118.31 126.95 75.42 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.179 0 N-CA-C 102.398 -3.186 . . . . 0.0 102.398 173.804 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 7.0 mt -105.99 137.85 43.19 Favored 'General case' 0 CA--C 1.473 -2.003 0 N-CA-C 105.326 -2.101 . . . . 0.0 105.326 173.716 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -132.96 155.64 48.76 Favored 'General case' 0 N--CA 1.431 -1.422 0 N-CA-C 106.808 -1.553 . . . . 0.0 106.808 166.881 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 48.4 p90 -152.19 142.36 22.33 Favored 'General case' 0 N--CA 1.436 -1.132 0 N-CA-C 105.999 -1.852 . . . . 0.0 105.999 -177.352 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 45.4 ttm-85 -132.69 141.88 42.74 Favored Pre-proline 0 CA--C 1.5 -0.974 0 N-CA-C 103.991 -2.596 . . . . 0.0 103.991 179.578 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_endo -71.65 122.78 8.87 Favored 'Trans proline' 0 N--CA 1.452 -0.947 0 CA-C-N 123.683 2.351 . . . . 0.0 108.523 171.917 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 19.6 ttmm -71.58 63.92 0.43 Allowed 'General case' 0 C--N 1.358 0.963 0 C-N-CA 127.319 2.248 . . . . 0.0 111.767 -179.071 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 7.7 p30 -161.43 15.48 0.1 Allowed 'General case' 0 N--CA 1.438 -1.045 0 C-N-CA 125.292 1.437 . . . . 0.0 107.881 177.069 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 43.0 p -160.46 165.72 30.49 Favored 'General case' 0 N--CA 1.437 -1.102 0 N-CA-C 106.458 -1.682 . . . . 0.0 106.458 -175.897 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 4.9 m -137.73 40.73 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.845 0 N-CA-C 105.808 -1.923 . . . . 0.0 105.808 176.026 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -91.4 -114.92 1.92 Allowed Glycine 0 C--N 1.356 1.661 0 N-CA-C 109.071 -1.612 . . . . 0.0 109.071 -175.494 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 11.9 ptm180 -97.99 178.96 4.94 Favored 'General case' 0 CA--C 1.503 -0.861 0 N-CA-C 107.198 -1.408 . . . . 0.0 107.198 174.234 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -153.83 171.7 18.52 Favored 'General case' 0 N--CA 1.435 -1.206 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 176.363 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 96.7 mttt -110.34 157.13 19.84 Favored 'General case' 0 CA--C 1.489 -1.401 0 N-CA-C 107.291 -1.374 . . . . 0.0 107.291 -172.06 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 1.2 pp20? -150.64 160.62 43.7 Favored 'General case' 0 N--CA 1.437 -1.098 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 173.929 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -138.1 159.86 40.92 Favored 'General case' 0 N--CA 1.439 -0.98 0 N-CA-C 106.191 -1.781 . . . . 0.0 106.191 171.086 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 85.7 m -117.61 123.39 46.07 Favored 'General case' 0 CA--C 1.501 -0.933 0 N-CA-C 104.642 -2.355 . . . . 0.0 104.642 176.218 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 5.4 mp -112.8 133.59 21.9 Favored Pre-proline 0 N--CA 1.438 -1.063 0 N-CA-C 104.837 -2.283 . . . . 0.0 104.837 -174.076 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 64.3 Cg_exo -65.3 166.27 19.75 Favored 'Trans proline' 0 CA--C 1.509 -0.749 0 C-N-CA 123.185 2.59 . . . . 0.0 113.512 176.86 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -75.76 -19.18 79.23 Favored Glycine 0 C--N 1.353 1.491 0 C-N-CA 123.876 0.75 . . . . 0.0 114.245 -175.195 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 53.2 p-80 -83.05 -26.27 31.3 Favored 'General case' 0 C--N 1.356 0.851 0 CA-C-N 118.012 0.906 . . . . 0.0 109.835 -178.846 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 85.1 mt -88.58 128.92 35.58 Favored 'General case' 0 CA--C 1.5 -0.978 0 N-CA-C 107.441 -1.318 . . . . 0.0 107.441 175.605 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 8.0 p30 -117.46 10.61 13.62 Favored 'General case' 0 CA--C 1.502 -0.88 0 C-N-CA 124.083 0.953 . . . . 0.0 109.713 -173.313 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 29.1 p -142.17 161.35 38.24 Favored 'General case' 0 CA--C 1.498 -1.029 0 N-CA-C 106.537 -1.653 . . . . 0.0 106.537 179.291 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 11.1 t80 -140.56 162.2 35.93 Favored 'General case' 0 CA--C 1.499 -0.996 0 CA-C-O 121.849 0.833 . . . . 0.0 108.99 177.805 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 37.8 m -126.1 111.97 15.29 Favored 'General case' 0 N--CA 1.434 -1.243 0 N-CA-C 105.499 -2.037 . . . . 0.0 105.499 169.842 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 37.9 mt -84.75 140.71 15.64 Favored 'Isoleucine or valine' 0 C--N 1.357 0.897 0 N-CA-C 103.67 -2.715 . . . . 0.0 103.67 172.791 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 94.3 mttt -141.4 162.13 36.24 Favored 'General case' 0 CA--C 1.491 -1.3 0 CA-C-O 121.859 0.838 . . . . 0.0 108.881 -177.451 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 75.27 55.09 5.31 Favored Glycine 0 CA--C 1.489 -1.574 0 N-CA-C 108.937 -1.665 . . . . 0.0 108.937 176.63 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 62.3 mt -115.49 -174.22 2.48 Favored 'General case' 0 CA--C 1.5 -0.96 0 N-CA-C 107.547 -1.279 . . . . 0.0 107.547 -176.124 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 94.0 mttt -109.38 160.88 26.05 Favored Pre-proline 0 N--CA 1.441 -0.886 0 N-CA-C 106.091 -1.818 . . . . 0.0 106.091 -177.366 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -81.38 158.0 19.65 Favored 'Trans proline' 0 N--CA 1.45 -1.062 0 C-N-CA 122.764 2.309 . . . . 0.0 109.538 165.472 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 59.18 28.24 63.85 Favored Glycine 0 C--N 1.358 1.752 0 C-N-CA 126.947 2.213 . . . . 0.0 116.273 171.794 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 7.1 p -115.48 142.82 27.04 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.963 0 N-CA-C 107.803 -1.184 . . . . 0.0 107.803 -173.286 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 3.5 p -100.86 131.52 48.32 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.894 0 N-CA-C 106.423 -1.695 . . . . 0.0 106.423 173.594 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 90.0 m-85 -114.31 150.68 34.11 Favored 'General case' 0 N--CA 1.44 -0.946 0 N-CA-C 106.537 -1.653 . . . . 0.0 106.537 174.414 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -94.29 145.37 24.78 Favored 'General case' 0 CA--C 1.5 -0.961 0 N-CA-C 104.369 -2.456 . . . . 0.0 104.369 159.728 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -137.32 155.23 22.8 Favored Glycine 0 CA--C 1.485 -1.844 0 N-CA-C 108.192 -1.963 . . . . 0.0 108.192 -177.518 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 27.5 tt0 -151.34 135.13 16.43 Favored 'General case' 0 CA--C 1.485 -1.532 0 N-CA-C 106.478 -1.675 . . . . 0.0 106.478 -176.791 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 25.2 tp -123.87 97.86 5.55 Favored 'General case' 0 N--CA 1.434 -1.245 0 N-CA-C 104.556 -2.387 . . . . 0.0 104.556 -172.927 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 10.5 mt -91.83 138.63 19.39 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.853 0 N-CA-C 105.252 -2.129 . . . . 0.0 105.252 177.666 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 75.0 m -112.59 112.07 23.34 Favored 'General case' 0 N--CA 1.434 -1.233 0 N-CA-C 106.313 -1.736 . . . . 0.0 106.313 178.935 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 1.7 mp -89.49 134.17 29.47 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.217 0 N-CA-C 103.645 -2.724 . . . . 0.0 103.645 -173.058 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 79.0 mt-30 -99.37 160.13 14.5 Favored 'General case' 0 CA--C 1.494 -1.197 0 N-CA-C 106.704 -1.591 . . . . 0.0 106.704 -174.087 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 5.6 pt20 -69.09 110.27 4.43 Favored 'General case' 0 N--CA 1.441 -0.904 0 CA-C-O 121.982 0.896 . . . . 0.0 112.761 -170.947 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 75.6 m-85 53.95 40.86 32.04 Favored 'General case' 0 C--N 1.358 0.949 0 C-N-CA 127.834 2.454 . . . . 0.0 112.925 175.094 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -163.17 -114.94 0.32 Allowed Glycine 0 C--N 1.353 1.502 0 C-N-CA 119.324 -1.417 . . . . 0.0 109.808 -179.304 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 38.5 m170 -81.61 -175.85 5.75 Favored 'General case' 0 CA--C 1.498 -1.052 0 C-N-CA 125.05 1.34 . . . . 0.0 110.745 -167.324 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 4.8 pt20 -147.85 142.06 26.15 Favored 'General case' 0 N--CA 1.434 -1.238 0 N-CA-C 106.192 -1.781 . . . . 0.0 106.192 171.826 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 16.7 tp10 -110.7 139.46 45.97 Favored 'General case' 0 CA--C 1.496 -1.099 0 N-CA-C 105.823 -1.917 . . . . 0.0 105.823 -177.762 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 8.2 p -110.64 141.61 25.47 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.745 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 -174.48 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 36.2 m -130.15 129.24 43.22 Favored 'General case' 0 C--N 1.355 0.831 0 N-CA-C 102.832 -3.025 . . . . 0.0 102.832 175.67 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 18.7 ptp180 -134.71 154.48 51.54 Favored 'General case' 0 C--N 1.355 0.819 0 CA-C-N 119.912 1.233 . . . . 0.0 111.25 -176.256 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 18.7 p90 -165.26 -175.22 3.53 Favored 'General case' 0 C--N 1.359 1.0 0 N-CA-C 107.064 -1.458 . . . . 0.0 107.064 -169.517 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -140.15 159.46 42.14 Favored 'General case' 0 N--CA 1.443 -0.795 0 N-CA-C 107.029 -1.471 . . . . 0.0 107.029 166.735 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 20.7 p90 -144.83 169.23 18.43 Favored 'General case' 0 CA--C 1.492 -1.276 0 N-CA-C 107.723 -1.214 . . . . 0.0 107.723 174.103 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 90' ' ' THR . . . . . 0.475 ' H ' ' HG3' ' A' ' 10' ' ' GLU . 88.7 m -126.49 135.74 51.73 Favored 'General case' 0 CA--C 1.5 -0.971 0 N-CA-C 104.004 -2.591 . . . . 0.0 104.004 176.194 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 76.9 m -107.56 107.53 18.41 Favored 'General case' 0 CA--C 1.497 -1.064 0 N-CA-C 105.126 -2.176 . . . . 0.0 105.126 178.699 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 5.7 m 75.91 145.01 0.08 Allowed 'General case' 0 C--N 1.359 1.006 0 C-N-CA 127.213 2.205 . . . . 0.0 110.387 173.515 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 24.3 m . . . . . 0 C--O 1.259 1.604 0 C-N-CA 125.597 1.559 . . . . 0.0 109.785 -178.825 . . . . . . . . 0 0 . 1 . 022 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 22.8 t . . . . . 0 N--CA 1.481 1.108 0 N-CA-C 109.214 -0.662 . . . . 0.0 109.214 . . . . . . . . . 0 0 . 1 . 022 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -160.96 -153.52 7.02 Favored Glycine 0 C--N 1.352 1.462 0 N-CA-C 106.902 -2.479 . . . . 0.0 106.902 -176.832 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 74.8 Cg_exo -60.93 135.82 61.84 Favored 'Trans proline' 0 N--CA 1.445 -1.33 0 C-N-CA 123.401 2.734 . . . . 0.0 112.865 -176.638 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 32.1 t -79.12 157.46 4.75 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.06 0 C-N-CA 128.078 2.551 . . . . 0.0 107.348 -175.891 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 -105.48 102.26 11.74 Favored 'General case' 0 CA--C 1.491 -1.295 0 N-CA-C 105.197 -2.149 . . . . 0.0 105.197 176.78 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 1.7 p -117.46 134.66 60.33 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.114 0 N-CA-C 106.509 -1.663 . . . . 0.0 106.509 -166.762 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -121.04 170.34 9.62 Favored 'General case' 0 N--CA 1.434 -1.234 0 N-CA-C 106.975 -1.491 . . . . 0.0 106.975 -169.022 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.487 HD13 ' HE1' ' A' ' 18' ' ' HIS . 42.1 mm -118.82 152.56 21.06 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.903 0 N-CA-C 103.114 -2.921 . . . . 0.0 103.114 176.745 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 56.8 p -74.88 -176.45 2.9 Favored 'General case' 0 N--CA 1.446 -0.654 0 C-N-CA 124.688 1.195 . . . . 0.0 111.438 -171.325 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 22.3 pt-20 -102.49 24.41 10.44 Favored 'General case' 0 N--CA 1.44 -0.945 0 C-N-CA 124.898 1.279 . . . . 0.0 110.167 -169.605 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 25.7 p -83.58 120.93 76.14 Favored Pre-proline 0 C--N 1.357 0.897 0 N-CA-C 107.43 -1.322 . . . . 0.0 107.43 179.489 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_endo -77.99 -36.94 0.94 Allowed 'Trans proline' 0 CA--C 1.508 -0.817 0 C-N-CA 122.56 2.173 . . . . 0.0 110.535 -170.652 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 62.4 m -144.65 110.28 5.3 Favored 'General case' 0 CA--C 1.491 -1.303 0 N-CA-C 104.023 -2.584 . . . . 0.0 104.023 177.552 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 2.7 pm0 -98.36 153.79 37.88 Favored Pre-proline 0 N--CA 1.437 -1.082 0 N-CA-C 105.562 -2.014 . . . . 0.0 105.562 177.628 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.427 ' HG2' ' H ' ' A' ' 16' ' ' ASN . 56.3 Cg_endo -83.42 -76.09 0.0 OUTLIER 'Trans proline' 0 N--CA 1.45 -1.074 0 CA-C-N 122.764 2.023 . . . . 0.0 109.224 -177.326 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . 0.427 ' H ' ' HG2' ' A' ' 15' ' ' PRO . 58.1 m-20 -133.37 -6.14 2.96 Favored 'General case' 0 N--CA 1.434 -1.259 0 C-N-CA 127.256 2.223 . . . . 0.0 108.63 -171.965 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 70.9 m -92.57 154.64 18.29 Favored 'General case' 0 CA--C 1.496 -1.128 0 N-CA-C 105.793 -1.928 . . . . 0.0 105.793 174.777 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . 0.487 ' HE1' HD13 ' A' ' 8' ' ' ILE . 46.7 t-80 -147.3 90.72 5.23 Favored Pre-proline 0 N--CA 1.437 -1.099 0 N-CA-C 107.436 -1.32 . . . . 0.0 107.436 172.769 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -80.42 139.47 12.96 Favored 'Trans proline' 0 N--CA 1.446 -1.295 0 C-N-CA 122.705 2.27 . . . . 0.0 110.135 177.594 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 4.4 pt -122.49 175.24 5.83 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.055 0 N-CA-C 108.147 -1.057 . . . . 0.0 108.147 177.871 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 2.7 pt20 -151.31 155.23 38.31 Favored 'General case' 0 CA--C 1.498 -1.045 0 N-CA-C 105.733 -1.951 . . . . 0.0 105.733 176.27 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 33.5 p90 -142.31 162.52 35.26 Favored 'General case' 0 CA--C 1.501 -0.915 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 -175.872 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 61.8 t30 -98.94 -172.51 2.3 Favored 'General case' 0 CA--C 1.493 -1.222 0 N-CA-C 103.658 -2.719 . . . . 0.0 103.658 169.486 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -158.0 168.46 12.41 Favored Pre-proline 0 N--CA 1.44 -0.974 0 N-CA-C 106.471 -1.677 . . . . 0.0 106.471 168.694 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_exo -63.39 154.33 68.97 Favored 'Trans proline' 0 N--CA 1.454 -0.816 0 C-N-CA 123.244 2.63 . . . . 0.0 112.506 173.487 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 90.4 mm-40 -81.77 -35.51 0.75 Allowed Pre-proline 0 N--CA 1.443 -0.799 0 CA-C-O 115.148 -2.358 . . . . 0.0 114.208 -168.096 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_exo -70.83 -4.2 14.26 Favored 'Trans proline' 0 CA--C 1.512 -0.619 0 CA-C-N 126.1 3.214 . . . . 0.0 114.615 -177.809 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 8.7 t 68.38 59.55 0.41 Allowed 'General case' 0 C--N 1.359 0.986 0 C-N-CA 126.121 1.768 . . . . 0.0 108.886 -177.345 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 12.7 t-160 -94.41 -11.28 30.17 Favored 'General case' 0 N--CA 1.439 -0.991 0 C-N-CA 125.133 1.373 . . . . 0.0 108.034 -179.332 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 1.8 mp -111.56 137.36 44.46 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.949 0 N-CA-C 104.473 -2.417 . . . . 0.0 104.473 -175.099 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 62.2 m -100.06 -84.4 0.42 Allowed 'General case' 0 N--CA 1.432 -1.331 0 N-CA-C 106.823 -1.547 . . . . 0.0 106.823 171.093 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 55.4 mtmt -88.64 168.71 12.3 Favored 'General case' 0 CA--C 1.487 -1.457 0 C-N-CA 124.335 1.054 . . . . 0.0 109.447 -164.531 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 85.0 m-85 -130.26 135.0 47.65 Favored 'General case' 0 CA--C 1.495 -1.14 0 N-CA-C 103.978 -2.601 . . . . 0.0 103.978 170.252 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 42.0 mt -119.35 128.69 75.84 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.162 0 N-CA-C 101.913 -3.365 . . . . 0.0 101.913 174.515 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 4.2 mt -110.02 143.75 39.57 Favored 'General case' 0 CA--C 1.471 -2.084 0 N-CA-C 106.906 -1.516 . . . . 0.0 106.906 175.275 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 2.6 mpt_? -125.86 157.19 38.24 Favored 'General case' 0 N--CA 1.425 -1.705 0 N-CA-C 106.456 -1.683 . . . . 0.0 106.456 168.592 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 45.1 p90 -149.12 139.03 21.99 Favored 'General case' 0 N--CA 1.433 -1.321 0 N-CA-C 106.291 -1.744 . . . . 0.0 106.291 169.224 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 19.1 ttm180 -133.26 136.57 27.51 Favored Pre-proline 0 CA--C 1.495 -1.156 0 N-CA-C 104.206 -2.516 . . . . 0.0 104.206 179.103 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -71.0 114.72 3.99 Favored 'Trans proline' 0 N--CA 1.454 -0.846 0 CA-C-N 124.581 2.672 . . . . 0.0 108.495 175.02 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 54.4 tttp -70.89 72.26 0.55 Allowed 'General case' 0 C--N 1.359 0.992 0 C-N-CA 127.609 2.364 . . . . 0.0 111.467 -174.724 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 70.4 m-80 -154.05 -60.95 0.13 Allowed 'General case' 0 N--CA 1.434 -1.245 0 N-CA-C 101.532 -3.507 . . . . 0.0 101.532 -172.176 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 42.5 p -93.4 160.19 14.92 Favored 'General case' 0 N--CA 1.439 -0.99 0 C-N-CA 124.854 1.262 . . . . 0.0 107.65 173.175 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 5.9 m -126.33 44.87 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.842 0 N-CA-C 106.183 -1.784 . . . . 0.0 106.183 177.975 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -99.4 -128.54 6.27 Favored Glycine 0 C--N 1.355 1.593 0 N-CA-C 108.704 -1.759 . . . . 0.0 108.704 -177.547 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 83.9 mtt85 -84.51 168.18 15.67 Favored 'General case' 0 CA--C 1.502 -0.885 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 -179.072 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -151.83 173.26 14.99 Favored 'General case' 0 CA--C 1.494 -1.205 0 CA-C-O 121.506 0.669 . . . . 0.0 110.051 -172.981 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 36.9 mtmt -112.62 156.85 22.02 Favored 'General case' 0 CA--C 1.488 -1.427 0 N-CA-C 106.789 -1.56 . . . . 0.0 106.789 -173.001 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 16.3 pt-20 -152.28 160.66 43.31 Favored 'General case' 0 N--CA 1.436 -1.17 0 N-CA-C 108.666 -0.865 . . . . 0.0 108.666 178.698 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -140.19 163.02 33.87 Favored 'General case' 0 CA--C 1.498 -1.021 0 N-CA-C 107.102 -1.444 . . . . 0.0 107.102 171.434 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 90.5 m -121.31 126.23 48.98 Favored 'General case' 0 CA--C 1.501 -0.912 0 N-CA-C 104.691 -2.336 . . . . 0.0 104.691 175.344 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 5.2 mp -114.86 133.76 22.56 Favored Pre-proline 0 N--CA 1.437 -1.081 0 N-CA-C 105.121 -2.178 . . . . 0.0 105.121 -174.055 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_exo -64.09 165.59 18.89 Favored 'Trans proline' 0 CA--C 1.509 -0.759 0 C-N-CA 123.39 2.727 . . . . 0.0 113.812 177.127 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -77.71 -16.99 79.46 Favored Glycine 0 C--N 1.353 1.483 0 C-N-CA 123.869 0.747 . . . . 0.0 113.884 -172.887 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 51.8 p-80 -83.98 -24.98 30.37 Favored 'General case' 0 C--N 1.356 0.857 0 CA-C-N 117.975 0.887 . . . . 0.0 110.32 -179.643 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 88.2 mt -88.29 129.36 35.4 Favored 'General case' 0 CA--C 1.5 -0.955 0 N-CA-C 108.299 -1.0 . . . . 0.0 108.299 178.906 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 8.6 p30 -105.23 -1.09 25.77 Favored 'General case' 0 N--CA 1.442 -0.837 0 C-N-CA 124.909 1.284 . . . . 0.0 110.782 -173.918 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 30.5 p -139.42 159.29 42.5 Favored 'General case' 0 CA--C 1.497 -1.069 0 N-CA-C 107.575 -1.269 . . . . 0.0 107.575 -174.974 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 6.1 t80 -128.75 174.5 9.39 Favored 'General case' 0 C--N 1.36 1.055 0 N-CA-C 107.858 -1.164 . . . . 0.0 107.858 175.94 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 99.9 m -140.15 110.74 6.75 Favored 'General case' 0 N--CA 1.431 -1.406 0 N-CA-C 103.923 -2.621 . . . . 0.0 103.923 171.466 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 25.4 mt -87.5 148.74 4.39 Favored 'Isoleucine or valine' 0 C--N 1.358 0.958 0 N-CA-C 103.878 -2.638 . . . . 0.0 103.878 170.3 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 8.4 ptpp? -150.02 159.51 44.34 Favored 'General case' 0 CA--C 1.492 -1.255 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 178.18 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 78.94 54.87 3.98 Favored Glycine 0 C--N 1.355 1.591 0 N-CA-C 109.184 -1.566 . . . . 0.0 109.184 178.841 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 58.8 mt -116.11 -161.11 0.78 Allowed 'General case' 0 CA--C 1.502 -0.888 0 N-CA-C 106.84 -1.541 . . . . 0.0 106.84 -177.322 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 10.7 mptt -125.12 160.99 52.14 Favored Pre-proline 0 N--CA 1.442 -0.874 0 N-CA-C 105.684 -1.969 . . . . 0.0 105.684 -176.361 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -79.57 156.2 24.7 Favored 'Trans proline' 0 N--CA 1.452 -0.918 0 C-N-CA 123.035 2.49 . . . . 0.0 109.567 165.273 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 55.32 33.24 58.11 Favored Glycine 0 C--N 1.356 1.656 0 C-N-CA 127.514 2.483 . . . . 0.0 116.512 172.276 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 7.9 p -115.04 147.3 18.53 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.014 0 N-CA-C 107.282 -1.377 . . . . 0.0 107.282 -176.366 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 4.7 p -102.47 134.12 44.21 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.778 0 N-CA-C 106.636 -1.616 . . . . 0.0 106.636 174.577 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 81.8 m-85 -116.9 150.51 38.35 Favored 'General case' 0 N--CA 1.44 -0.936 0 N-CA-C 107.225 -1.398 . . . . 0.0 107.225 174.323 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 13.1 tp10 -95.95 128.88 43.23 Favored 'General case' 0 CA--C 1.492 -1.254 0 N-CA-C 102.089 -3.301 . . . . 0.0 102.089 165.821 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -125.91 140.83 12.43 Favored Glycine 0 CA--C 1.491 -1.468 0 N-CA-C 107.862 -2.095 . . . . 0.0 107.862 -179.205 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 28.7 tt0 -134.14 130.82 37.9 Favored 'General case' 0 CA--C 1.482 -1.64 0 N-CA-C 106.213 -1.773 . . . . 0.0 106.213 -178.496 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 43.2 tp -117.42 102.98 9.67 Favored 'General case' 0 N--CA 1.437 -1.09 0 N-CA-C 104.626 -2.361 . . . . 0.0 104.626 -176.516 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 11.9 mt -93.99 130.36 43.04 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.888 0 N-CA-C 104.287 -2.486 . . . . 0.0 104.287 174.878 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 25.2 p -112.75 114.11 26.52 Favored 'General case' 0 N--CA 1.438 -1.069 0 N-CA-C 106.683 -1.599 . . . . 0.0 106.683 -179.857 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 22.5 mm -90.03 142.0 13.54 Favored 'Isoleucine or valine' 0 CA--C 1.485 -1.529 0 N-CA-C 105.606 -1.998 . . . . 0.0 105.606 -167.985 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 78.0 mt-30 -104.57 152.42 22.44 Favored 'General case' 0 CA--C 1.493 -1.244 0 CA-C-N 114.548 -1.206 . . . . 0.0 107.904 -174.478 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 24.5 tt0 -77.49 35.09 0.18 Allowed 'General case' 0 C--N 1.355 0.841 0 C-N-CA 125.882 1.673 . . . . 0.0 113.41 -178.579 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 98.5 m-85 -143.63 11.74 1.67 Allowed 'General case' 0 CA--C 1.498 -1.057 0 N-CA-C 109.068 -0.715 . . . . 0.0 109.068 -175.719 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 88.91 -20.62 31.46 Favored Glycine 0 C--N 1.351 1.374 0 C-N-CA 124.097 0.856 . . . . 0.0 111.207 179.739 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 85.6 m-70 -81.04 173.9 12.14 Favored 'General case' 0 CA--C 1.496 -1.1 0 C-N-CA 125.362 1.465 . . . . 0.0 108.683 -178.673 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 9.9 pt20 -162.38 145.12 11.25 Favored 'General case' 0 N--CA 1.437 -1.117 0 N-CA-C 107.875 -1.157 . . . . 0.0 107.875 -176.102 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 48.0 mm-40 -110.21 147.89 32.9 Favored 'General case' 0 CA--C 1.496 -1.127 0 N-CA-C 106.351 -1.722 . . . . 0.0 106.351 179.237 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 8.7 p -118.74 143.0 31.02 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.746 0 N-CA-C 107.626 -1.249 . . . . 0.0 107.626 -175.773 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 28.1 m -131.72 131.94 43.47 Favored 'General case' 0 N--CA 1.441 -0.898 0 N-CA-C 103.275 -2.861 . . . . 0.0 103.275 179.748 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 88.2 mtm180 -125.46 148.47 48.83 Favored 'General case' 0 CA--C 1.501 -0.924 0 CA-C-N 119.011 0.823 . . . . 0.0 108.826 -179.699 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 23.0 p90 -163.38 179.82 7.07 Favored 'General case' 0 CA--C 1.501 -0.926 0 N-CA-C 106.804 -1.554 . . . . 0.0 106.804 -177.779 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 41.6 p30 -136.96 156.34 48.58 Favored 'General case' 0 N--CA 1.443 -0.824 0 N-CA-C 106.488 -1.671 . . . . 0.0 106.488 167.457 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 23.3 p90 -142.94 170.67 15.26 Favored 'General case' 0 CA--C 1.488 -1.439 0 N-CA-C 106.505 -1.665 . . . . 0.0 106.505 172.318 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 36.0 p -120.9 139.7 52.84 Favored 'General case' 0 CA--C 1.502 -0.897 0 N-CA-C 106.443 -1.688 . . . . 0.0 106.443 174.014 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 71.1 m -108.41 88.13 2.66 Favored 'General case' 0 CA--C 1.497 -1.094 0 N-CA-C 102.948 -2.982 . . . . 0.0 102.948 171.793 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 42.6 p -89.79 -178.42 5.5 Favored 'General case' 0 N--CA 1.443 -0.8 0 N-CA-C 106.998 -1.482 . . . . 0.0 106.998 178.977 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 22.7 t . . . . . 0 C--O 1.26 1.626 0 N-CA-C 104.923 -2.251 . . . . 0.0 104.923 175.385 . . . . . . . . 0 0 . 1 . 023 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 72.5 m . . . . . 0 N--CA 1.484 1.263 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 . . . . . . . . . 0 0 . 1 . 023 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -156.97 -143.1 3.57 Favored Glycine 0 C--N 1.352 1.421 0 N-CA-C 106.243 -2.743 . . . . 0.0 106.243 -175.666 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 77.5 Cg_exo -61.51 133.47 45.95 Favored 'Trans proline' 0 N--CA 1.446 -1.301 0 C-N-CA 122.742 2.295 . . . . 0.0 113.844 -171.579 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.403 ' H ' ' HG1' ' A' ' 85' ' ' THR . 38.6 t -85.71 161.78 2.96 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.085 0 C-N-CA 128.454 2.702 . . . . 0.0 107.513 -172.37 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -106.26 106.09 16.44 Favored 'General case' 0 CA--C 1.493 -1.249 0 N-CA-C 105.06 -2.2 . . . . 0.0 105.06 176.733 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 1.5 p -127.21 140.41 49.17 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.086 0 N-CA-C 104.958 -2.238 . . . . 0.0 104.958 -170.31 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 16.5 p90 -142.68 159.23 42.63 Favored 'General case' 0 N--CA 1.436 -1.169 0 N-CA-C 107.071 -1.455 . . . . 0.0 107.071 -166.674 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 38.2 pt -92.26 157.71 2.93 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.403 0 N-CA-C 107.09 -1.448 . . . . 0.0 107.09 176.885 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 25.2 p -75.96 -42.68 47.79 Favored 'General case' 0 CA--C 1.503 -0.848 0 C-N-CA 123.445 0.698 . . . . 0.0 112.204 -169.973 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 79.46 84.93 0.06 Allowed 'General case' 0 CA--C 1.496 -1.103 0 C-N-CA 126.714 2.005 . . . . 0.0 106.592 -175.324 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 15.9 p -113.02 142.61 27.61 Favored Pre-proline 0 N--CA 1.444 -0.737 0 N-CA-C 105.34 -2.096 . . . . 0.0 105.34 176.527 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -78.66 100.03 1.32 Allowed 'Trans proline' 0 N--CA 1.454 -0.797 0 C-N-CA 123.177 2.585 . . . . 0.0 109.921 177.494 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 20.1 m 73.25 122.17 0.04 OUTLIER 'General case' 0 C--N 1.359 1.003 0 C-N-CA 126.638 1.975 . . . . 0.0 111.119 179.159 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 5.6 pm0 -146.79 115.01 4.38 Favored Pre-proline 0 N--CA 1.44 -0.965 0 N-CA-C 106.54 -1.652 . . . . 0.0 106.54 -179.527 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_endo -84.2 -55.47 0.03 OUTLIER 'Trans proline' 0 CA--C 1.501 -1.152 0 C-N-CA 121.919 1.746 . . . . 0.0 110.906 -170.395 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 2.1 m-80 -118.87 -20.31 8.23 Favored 'General case' 0 CA--C 1.49 -1.328 0 C-N-CA 124.857 1.263 . . . . 0.0 109.242 -168.821 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 15.0 p -97.86 148.2 23.66 Favored 'General case' 0 CA--C 1.493 -1.235 0 N-CA-C 107.444 -1.317 . . . . 0.0 107.444 -177.514 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 28.1 t60 -150.54 97.04 3.33 Favored Pre-proline 0 N--CA 1.438 -1.053 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 170.403 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -80.06 139.5 13.56 Favored 'Trans proline' 0 N--CA 1.447 -1.24 0 C-N-CA 122.35 2.033 . . . . 0.0 110.408 178.759 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 18.7 mm -113.62 146.21 18.5 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.937 0 N-CA-C 104.429 -2.434 . . . . 0.0 104.429 -178.051 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 35.0 mt-30 -136.42 149.95 48.53 Favored 'General case' 0 CA--C 1.502 -0.879 0 N-CA-C 105.326 -2.101 . . . . 0.0 105.326 168.904 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 42.0 p90 -141.48 161.97 36.61 Favored 'General case' 0 CA--C 1.502 -0.873 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 -175.169 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 81.2 m-20 -100.98 -172.39 2.16 Favored 'General case' 0 CA--C 1.485 -1.543 0 N-CA-C 103.851 -2.648 . . . . 0.0 103.851 171.389 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -150.45 163.14 25.26 Favored Pre-proline 0 N--CA 1.444 -0.771 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 169.93 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 80.4 Cg_exo -67.32 170.16 13.98 Favored 'Trans proline' 0 N--CA 1.456 -0.704 0 C-N-CA 123.38 2.72 . . . . 0.0 112.319 169.682 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 24.0 mm100 -82.42 -56.01 0.53 Allowed Pre-proline 0 N--CA 1.442 -0.869 0 CA-C-O 115.578 -2.153 . . . . 0.0 113.644 -172.328 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 82.6 Cg_endo -75.77 170.04 21.0 Favored 'Trans proline' 0 CA--C 1.509 -0.773 0 CA-C-N 125.774 3.098 . . . . 0.0 111.085 -169.228 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 69.4 m -76.83 113.27 14.33 Favored 'General case' 0 CA--C 1.5 -0.955 0 N-CA-C 107.717 -1.216 . . . . 0.0 107.717 179.031 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . 0.422 ' HD1' HG13 ' A' ' 30' ' ' ILE . 61.4 t-80 -167.59 -49.95 0.02 OUTLIER 'General case' 0 N--CA 1.435 -1.193 0 N-CA-C 105.441 -2.059 . . . . 0.0 105.441 -170.559 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.422 HG13 ' HD1' ' A' ' 29' ' ' HIS . 26.6 mt -105.69 126.62 60.99 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.145 0 N-CA-C 106.429 -1.693 . . . . 0.0 106.429 -176.668 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 74.3 m -116.35 -84.35 0.63 Allowed 'General case' 0 N--CA 1.433 -1.278 0 N-CA-C 107.828 -1.175 . . . . 0.0 107.828 -174.714 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 38.8 ttpt -89.27 156.43 18.75 Favored 'General case' 0 CA--C 1.493 -1.22 0 C-N-CA 126.197 1.799 . . . . 0.0 106.888 -164.641 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 90.7 m-85 -126.86 135.89 51.6 Favored 'General case' 0 CA--C 1.488 -1.417 0 N-CA-C 105.304 -2.11 . . . . 0.0 105.304 179.474 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 1.5 mp -112.65 135.69 51.26 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.231 0 N-CA-C 100.473 -3.899 . . . . 0.0 100.473 170.239 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 3.1 mt -106.49 124.78 50.11 Favored 'General case' 0 CA--C 1.479 -1.788 0 N-CA-C 104.676 -2.342 . . . . 0.0 104.676 166.436 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -106.58 154.01 21.51 Favored 'General case' 0 N--CA 1.431 -1.375 0 N-CA-C 104.483 -2.414 . . . . 0.0 104.483 170.771 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 48.2 p90 -154.79 141.64 19.11 Favored 'General case' 0 N--CA 1.433 -1.292 0 N-CA-C 106.344 -1.725 . . . . 0.0 106.344 168.171 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 5.3 ptp180 -133.74 153.99 80.34 Favored Pre-proline 0 CA--C 1.497 -1.064 0 N-CA-C 103.751 -2.685 . . . . 0.0 103.751 168.695 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 68.8 Cg_endo -75.22 164.8 32.26 Favored 'Trans proline' 0 CA--C 1.506 -0.921 0 C-N-CA 122.789 2.326 . . . . 0.0 106.765 164.711 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 5.5 ptmm? -64.92 93.8 0.12 Allowed 'General case' 0 C--N 1.352 0.678 0 CA-C-N 119.976 1.262 . . . . 0.0 113.048 176.658 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -128.3 -136.28 0.23 Allowed 'General case' 0 N--CA 1.44 -0.953 0 N-CA-C 104.974 -2.232 . . . . 0.0 104.974 167.427 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 42.4 m -97.17 -154.28 0.45 Allowed 'General case' 0 N--CA 1.44 -0.954 0 C-N-CA 125.607 1.563 . . . . 0.0 107.121 179.313 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 9.2 m -94.85 42.69 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.445 -0.711 0 C-N-CA 126.627 1.971 . . . . 0.0 107.284 176.322 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -90.19 -146.33 15.22 Favored Glycine 0 C--N 1.353 1.478 0 C-N-CA 124.184 0.897 . . . . 0.0 110.998 -171.947 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 17.1 tpt180 -75.95 135.2 40.05 Favored 'General case' 0 CA--C 1.502 -0.881 0 C-N-CA 124.267 1.027 . . . . 0.0 108.332 -177.01 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -146.95 174.65 11.32 Favored 'General case' 0 N--CA 1.434 -1.27 0 N-CA-C 109.395 -0.594 . . . . 0.0 109.395 -174.261 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 64.3 mttp -112.3 155.74 23.58 Favored 'General case' 0 CA--C 1.489 -1.403 0 N-CA-C 107.347 -1.353 . . . . 0.0 107.347 -171.482 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 15.4 pt-20 -150.68 158.89 44.68 Favored 'General case' 0 N--CA 1.433 -1.284 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 179.784 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -136.7 160.45 38.8 Favored 'General case' 0 CA--C 1.497 -1.065 0 N-CA-C 106.509 -1.663 . . . . 0.0 106.509 171.754 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 77.3 m -122.8 126.54 47.63 Favored 'General case' 0 CA--C 1.501 -0.924 0 N-CA-C 104.956 -2.238 . . . . 0.0 104.956 175.335 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 5.2 mp -117.56 135.33 23.22 Favored Pre-proline 0 N--CA 1.437 -1.099 0 N-CA-C 104.753 -2.314 . . . . 0.0 104.753 -177.26 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_exo -63.48 167.13 13.71 Favored 'Trans proline' 0 CA--C 1.51 -0.71 0 C-N-CA 123.558 2.839 . . . . 0.0 113.477 177.101 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -79.49 -18.84 72.7 Favored Glycine 0 C--N 1.352 1.464 0 C-N-CA 123.344 0.497 . . . . 0.0 113.363 -172.59 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 47.7 p-80 -84.18 -27.01 28.36 Favored 'General case' 0 C--N 1.354 0.794 0 CA-C-N 117.743 0.771 . . . . 0.0 109.968 179.774 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 88.5 mt -88.57 132.58 34.47 Favored 'General case' 0 CA--C 1.502 -0.893 0 N-CA-C 107.789 -1.189 . . . . 0.0 107.789 177.722 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 7.6 p-10 -114.98 9.88 16.16 Favored 'General case' 0 CA--C 1.502 -0.897 0 C-N-CA 124.287 1.035 . . . . 0.0 110.169 -171.669 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 53.4 p -144.55 165.81 26.92 Favored 'General case' 0 N--CA 1.44 -0.958 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 -175.267 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 11.2 t80 -151.98 174.72 13.3 Favored 'General case' 0 N--CA 1.441 -0.908 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 -179.162 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 87.7 m -139.1 113.13 8.63 Favored 'General case' 0 N--CA 1.431 -1.409 0 N-CA-C 105.078 -2.193 . . . . 0.0 105.078 172.775 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 54.2 mt -87.08 142.93 12.32 Favored 'Isoleucine or valine' 0 C--N 1.359 0.979 0 N-CA-C 104.217 -2.512 . . . . 0.0 104.217 172.604 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 60.7 mttp -141.41 162.42 35.53 Favored 'General case' 0 CA--C 1.495 -1.138 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 179.195 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 78.84 53.05 4.72 Favored Glycine 0 CA--C 1.488 -1.609 0 N-CA-C 109.094 -1.602 . . . . 0.0 109.094 174.949 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 78.7 mt -113.46 -166.06 1.05 Allowed 'General case' 0 CA--C 1.503 -0.855 0 N-CA-C 107.279 -1.378 . . . . 0.0 107.279 -176.589 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 11.0 mptt -132.29 148.67 70.63 Favored Pre-proline 0 N--CA 1.442 -0.859 0 N-CA-C 104.993 -2.225 . . . . 0.0 104.993 -177.517 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -78.97 162.54 26.28 Favored 'Trans proline' 0 N--CA 1.45 -1.055 0 C-N-CA 122.772 2.315 . . . . 0.0 109.761 173.772 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . 0.402 ' H ' ' HA ' ' A' ' 92' ' ' THR . . . 63.63 24.0 67.55 Favored Glycine 0 N--CA 1.428 -1.851 0 C-N-CA 127.377 2.418 . . . . 0.0 116.063 172.886 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 9.6 p -129.7 143.13 42.02 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.02 0 N-CA-C 107.484 -1.302 . . . . 0.0 107.484 -178.037 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 11.5 p -95.65 127.56 47.58 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.011 0 CA-C-O 123.289 1.519 . . . . 0.0 107.571 178.258 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 87.3 m-85 -100.44 144.34 29.55 Favored 'General case' 0 N--CA 1.431 -1.41 0 N-CA-C 106.235 -1.765 . . . . 0.0 106.235 176.339 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 33.6 tp10 -90.57 132.66 35.59 Favored 'General case' 0 N--CA 1.439 -0.981 0 N-CA-C 104.205 -2.517 . . . . 0.0 104.205 163.064 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -129.3 152.43 19.5 Favored Glycine 0 CA--C 1.489 -1.547 0 N-CA-C 108.283 -1.927 . . . . 0.0 108.283 -179.136 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 26.7 mt-30 -138.19 137.8 37.95 Favored 'General case' 0 CA--C 1.485 -1.548 0 N-CA-C 106.347 -1.723 . . . . 0.0 106.347 174.849 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 62.7 tp -109.72 97.92 7.36 Favored 'General case' 0 CA--C 1.499 -1.014 0 N-CA-C 102.898 -3.001 . . . . 0.0 102.898 174.542 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 9.1 mt -94.86 124.61 47.43 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.054 0 N-CA-C 104.026 -2.583 . . . . 0.0 104.026 -174.21 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 74.6 m -112.89 108.9 18.02 Favored 'General case' 0 CA--C 1.5 -0.959 0 N-CA-C 107.826 -1.176 . . . . 0.0 107.826 -168.03 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 1.8 mp -93.17 136.9 23.76 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.226 0 N-CA-C 105.2 -2.148 . . . . 0.0 105.2 -167.241 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 14.0 tt0 -97.96 111.25 23.63 Favored 'General case' 0 N--CA 1.431 -1.377 0 N-CA-C 101.706 -3.442 . . . . 0.0 101.706 169.508 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 41.8 mt-30 -69.25 125.03 25.42 Favored 'General case' 0 CA--C 1.5 -0.975 0 CA-C-O 120.846 0.355 . . . . 0.0 110.218 -170.587 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 52.7 m-85 68.71 39.1 2.06 Favored 'General case' 0 C--N 1.356 0.872 0 C-N-CA 126.492 1.917 . . . . 0.0 110.996 -176.172 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -166.68 -116.22 0.35 Allowed Glycine 0 C--N 1.357 1.721 0 N-CA-C 109.288 -1.525 . . . . 0.0 109.288 179.144 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 29.3 m170 -82.51 -179.73 7.52 Favored 'General case' 0 CA--C 1.502 -0.874 0 C-N-CA 125.606 1.563 . . . . 0.0 111.259 -168.504 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 25.7 tt0 -147.44 123.58 10.81 Favored 'General case' 0 N--CA 1.436 -1.167 0 N-CA-C 105.591 -2.003 . . . . 0.0 105.591 170.686 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 47.8 mm-40 -104.68 160.63 14.81 Favored 'General case' 0 CA--C 1.501 -0.931 0 N-CA-C 106.243 -1.762 . . . . 0.0 106.243 176.558 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 10.9 p -135.84 138.55 47.53 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.842 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 -178.233 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 85' ' ' THR . . . . . 0.403 ' HG1' ' H ' ' A' ' 4' ' ' VAL . 24.9 m -122.35 139.45 53.81 Favored 'General case' 0 N--CA 1.442 -0.833 0 N-CA-C 103.124 -2.917 . . . . 0.0 103.124 173.05 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 55.9 ttp180 -135.03 143.16 46.59 Favored 'General case' 0 CA--C 1.505 -0.77 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 -174.13 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 21.1 p90 -164.0 -175.81 4.22 Favored 'General case' 0 C--N 1.358 0.97 0 N-CA-C 106.891 -1.522 . . . . 0.0 106.891 -174.519 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 44.4 p-10 -136.5 158.34 44.67 Favored 'General case' 0 N--CA 1.442 -0.838 0 N-CA-C 107.093 -1.447 . . . . 0.0 107.093 166.748 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 25.2 p90 -143.75 164.12 31.37 Favored 'General case' 0 CA--C 1.486 -1.49 0 N-CA-C 106.821 -1.548 . . . . 0.0 106.821 169.769 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 43.8 m -118.42 137.77 52.92 Favored 'General case' 0 CA--C 1.498 -1.051 0 N-CA-C 105.336 -2.098 . . . . 0.0 105.336 179.186 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 61.3 m -115.75 115.67 26.73 Favored 'General case' 0 CA--C 1.493 -1.213 0 N-CA-C 101.866 -3.383 . . . . 0.0 101.866 174.722 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 92' ' ' THR . . . . . 0.402 ' HA ' ' H ' ' A' ' 66' ' ' GLY . 15.1 t -155.29 148.23 24.51 Favored 'General case' 0 N--CA 1.437 -1.103 0 N-CA-C 107.315 -1.365 . . . . 0.0 107.315 -174.227 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 67.7 m . . . . . 0 C--O 1.26 1.615 0 N-CA-C 106.467 -1.679 . . . . 0.0 106.467 175.214 . . . . . . . . 0 0 . 1 . 024 nuclear orig full ' A' A ' 1' ' ' SER . . . . . 0.403 ' H ' ' CE1' ' A' ' 29' ' ' HIS . 66.7 m . . . . . 0 N--CA 1.486 1.353 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 . . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 174.73 -160.73 30.05 Favored Glycine 0 C--N 1.35 1.308 0 N-CA-C 106.728 -2.549 . . . . 0.0 106.728 -178.313 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 29.8 Cg_exo -59.04 139.78 92.28 Favored 'Trans proline' 0 N--CA 1.446 -1.293 0 C-N-CA 123.649 2.899 . . . . 0.0 113.559 -175.168 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 41.9 t -79.83 160.15 4.28 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.996 0 C-N-CA 128.552 2.741 . . . . 0.0 106.282 -179.002 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 55.2 mt-10 -108.13 106.74 17.09 Favored 'General case' 0 CA--C 1.493 -1.215 0 N-CA-C 105.998 -1.853 . . . . 0.0 105.998 -179.638 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 1.5 p -124.18 140.07 48.66 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.914 0 N-CA-C 106.142 -1.799 . . . . 0.0 106.142 -172.367 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 16.5 p90 -146.09 165.18 29.85 Favored 'General case' 0 N--CA 1.438 -1.032 0 N-CA-C 105.968 -1.864 . . . . 0.0 105.968 -168.589 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 7.8 pt -110.51 113.99 45.8 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.557 0 N-CA-C 107.653 -1.24 . . . . 0.0 107.653 -178.515 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 9.4 t -121.92 170.42 9.82 Favored 'General case' 0 N--CA 1.445 -0.717 0 N-CA-C 107.028 -1.471 . . . . 0.0 107.028 -179.172 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 11.9 tp10 68.1 16.42 9.47 Favored 'General case' 0 C--N 1.36 1.035 0 C-N-CA 126.731 2.012 . . . . 0.0 112.863 171.657 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 5.7 t -143.75 94.59 5.96 Favored Pre-proline 0 N--CA 1.444 -0.73 0 N-CA-C 108.126 -1.065 . . . . 0.0 108.126 177.421 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -77.23 -32.63 2.98 Favored 'Trans proline' 0 N--CA 1.452 -0.95 0 C-N-CA 122.514 2.143 . . . . 0.0 109.453 162.062 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 12.3 p -168.03 109.41 0.58 Allowed 'General case' 0 N--CA 1.437 -1.111 0 N-CA-C 106.698 -1.593 . . . . 0.0 106.698 -179.438 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 90.5 mt-30 -151.65 114.72 3.02 Favored Pre-proline 0 C--N 1.353 0.729 0 N-CA-C 104.833 -2.284 . . . . 0.0 104.833 177.837 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -86.17 -21.76 2.41 Favored 'Trans proline' 0 CA--C 1.505 -0.952 0 C-N-CA 122.464 2.109 . . . . 0.0 111.372 -170.113 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 6.2 p-10 -104.37 -41.32 5.79 Favored 'General case' 0 CA--C 1.489 -1.369 0 C-N-CA 123.167 0.587 . . . . 0.0 109.622 -167.103 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 12.0 p -110.5 150.72 28.49 Favored 'General case' 0 CA--C 1.494 -1.202 0 N-CA-C 107.399 -1.334 . . . . 0.0 107.399 -179.095 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . 0.431 ' CD2' ' HG1' ' A' ' 91' ' ' THR . 58.6 t-80 -143.37 93.61 6.37 Favored Pre-proline 0 N--CA 1.437 -1.087 0 N-CA-C 106.892 -1.522 . . . . 0.0 106.892 173.656 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -82.02 146.17 14.32 Favored 'Trans proline' 0 N--CA 1.445 -1.332 0 C-N-CA 123.436 2.757 . . . . 0.0 109.948 175.958 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 7.4 pt -126.3 173.44 12.04 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.985 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 178.217 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 49.2 tt0 -148.49 149.34 31.48 Favored 'General case' 0 N--CA 1.44 -0.95 0 N-CA-C 105.192 -2.151 . . . . 0.0 105.192 170.684 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 27.7 p90 -130.51 161.25 31.89 Favored 'General case' 0 N--CA 1.44 -0.959 0 N-CA-C 106.296 -1.742 . . . . 0.0 106.296 -179.696 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 61.1 t30 -96.61 -176.25 3.55 Favored 'General case' 0 CA--C 1.491 -1.327 0 N-CA-C 103.33 -2.841 . . . . 0.0 103.33 169.372 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -156.43 166.96 15.37 Favored Pre-proline 0 N--CA 1.44 -0.938 0 N-CA-C 106.621 -1.622 . . . . 0.0 106.621 172.888 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 99.6 Cg_exo -65.39 162.17 34.82 Favored 'Trans proline' 0 CA--C 1.508 -0.775 0 C-N-CA 123.486 2.791 . . . . 0.0 112.978 175.838 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 1.2 tm0? -82.08 -58.75 0.45 Allowed Pre-proline 0 N--CA 1.442 -0.845 0 CA-C-O 115.7 -2.095 . . . . 0.0 110.686 -177.46 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo -74.95 175.54 11.09 Favored 'Trans proline' 0 CA--C 1.51 -0.696 0 CA-C-N 125.67 3.061 . . . . 0.0 110.548 -177.168 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 44.2 p -69.18 124.5 23.98 Favored 'General case' 0 C--N 1.356 0.891 0 C-N-CA 123.824 0.85 . . . . 0.0 109.785 -178.239 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . 0.403 ' CE1' ' H ' ' A' ' 1' ' ' SER . 61.0 t60 -168.12 -42.82 0.02 OUTLIER 'General case' 0 CA--C 1.494 -1.199 0 N-CA-C 106.598 -1.63 . . . . 0.0 106.598 -170.747 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 33.4 mt -132.56 140.42 47.62 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.895 0 N-CA-C 107.68 -1.23 . . . . 0.0 107.68 -173.604 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 31.8 p -123.18 -71.22 0.73 Allowed 'General case' 0 C--N 1.359 0.985 0 C-N-CA 124.219 1.008 . . . . 0.0 109.536 172.875 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 44.6 mtpt -86.44 166.58 15.41 Favored 'General case' 0 CA--C 1.488 -1.439 0 C-N-CA 126.899 2.08 . . . . 0.0 107.219 -171.029 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 83.4 m-85 -134.31 148.61 50.79 Favored 'General case' 0 CA--C 1.493 -1.248 0 N-CA-C 104.855 -2.276 . . . . 0.0 104.855 175.369 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 4.4 mt -123.54 139.47 50.05 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.315 0 N-CA-C 101.402 -3.555 . . . . 0.0 101.402 171.361 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 12.0 mt -116.02 135.36 54.03 Favored 'General case' 0 CA--C 1.477 -1.852 0 N-CA-C 106.717 -1.586 . . . . 0.0 106.717 166.681 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 9.0 mpt_? -110.58 153.12 25.6 Favored 'General case' 0 N--CA 1.429 -1.48 0 N-CA-C 104.491 -2.411 . . . . 0.0 104.491 166.559 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 48.9 p90 -154.15 146.59 24.0 Favored 'General case' 0 N--CA 1.441 -0.905 0 N-CA-C 108.099 -1.075 . . . . 0.0 108.099 168.969 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 43.9 ttm-85 -142.08 143.9 29.75 Favored Pre-proline 0 CA--C 1.503 -0.844 0 N-CA-C 104.693 -2.336 . . . . 0.0 104.693 179.876 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -71.42 115.22 4.2 Favored 'Trans proline' 0 N--CA 1.454 -0.808 0 C-N-CA 122.878 2.386 . . . . 0.0 108.845 167.151 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 64.3 tttm -70.33 77.87 0.54 Allowed 'General case' 0 C--N 1.358 0.955 0 C-N-CA 126.979 2.112 . . . . 0.0 111.084 -177.179 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 68.7 m-80 -151.77 -73.26 0.15 Allowed 'General case' 0 N--CA 1.435 -1.218 0 N-CA-C 102.653 -3.091 . . . . 0.0 102.653 -173.436 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 60.8 m -96.5 168.38 10.58 Favored 'General case' 0 C--N 1.356 0.874 0 N-CA-C 107.19 -1.411 . . . . 0.0 107.19 175.028 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 2.6 m -130.91 62.27 0.3 Allowed 'Isoleucine or valine' 0 CA--C 1.501 -0.913 0 N-CA-C 105.436 -2.061 . . . . 0.0 105.436 179.759 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -93.18 -110.53 2.01 Favored Glycine 0 C--N 1.353 1.503 0 N-CA-C 107.969 -2.052 . . . . 0.0 107.969 -179.818 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 80.2 mtp180 -105.88 175.66 5.42 Favored 'General case' 0 CA--C 1.502 -0.884 0 N-CA-C 106.338 -1.727 . . . . 0.0 106.338 173.564 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -152.05 172.63 15.99 Favored 'General case' 0 CA--C 1.495 -1.168 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 -176.676 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 94.6 mttt -108.02 154.16 22.05 Favored 'General case' 0 CA--C 1.487 -1.456 0 N-CA-C 107.313 -1.366 . . . . 0.0 107.313 -173.984 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -152.19 153.03 33.01 Favored 'General case' 0 N--CA 1.431 -1.391 0 N-CA-C 107.542 -1.281 . . . . 0.0 107.542 -177.738 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -146.48 160.62 41.87 Favored 'General case' 0 CA--C 1.499 -1.018 0 N-CA-C 107.667 -1.235 . . . . 0.0 107.667 177.665 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 91.6 m -121.7 126.76 49.69 Favored 'General case' 0 CA--C 1.5 -0.956 0 N-CA-C 105.176 -2.157 . . . . 0.0 105.176 177.734 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 52.5 mt -117.58 136.92 23.75 Favored Pre-proline 0 N--CA 1.436 -1.164 0 N-CA-C 105.639 -1.985 . . . . 0.0 105.639 -166.635 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 76.1 Cg_exo -65.26 168.46 14.21 Favored 'Trans proline' 0 CA--C 1.51 -0.692 0 C-N-CA 123.214 2.609 . . . . 0.0 113.284 177.702 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -96.38 7.68 66.41 Favored Glycine 0 C--N 1.352 1.428 0 CA-C-O 118.951 -0.916 . . . . 0.0 113.013 -178.038 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 44.3 p-80 -83.93 -47.45 11.02 Favored 'General case' 0 C--N 1.362 1.146 0 CA-C-N 119.206 1.503 . . . . 0.0 109.186 178.869 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -87.95 165.76 14.99 Favored 'General case' 0 CA--C 1.489 -1.381 0 CA-C-O 122.934 1.35 . . . . 0.0 108.271 170.921 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 6.0 p-10 -140.54 24.53 2.25 Favored 'General case' 0 N--CA 1.424 -1.761 0 CA-C-N 112.974 -1.921 . . . . 0.0 106.987 -178.506 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 57.1 p -132.14 158.49 41.53 Favored 'General case' 0 CA--C 1.501 -0.91 0 N-CA-C 107.788 -1.19 . . . . 0.0 107.788 176.387 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 7.7 t80 -133.21 175.79 9.09 Favored 'General case' 0 C--N 1.359 1.002 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 175.463 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 93.3 m -142.4 110.84 6.1 Favored 'General case' 0 N--CA 1.431 -1.404 0 N-CA-C 104.409 -2.441 . . . . 0.0 104.409 173.985 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 26.3 mt -90.85 147.32 5.3 Favored 'Isoleucine or valine' 0 C--N 1.358 0.952 0 N-CA-C 104.293 -2.484 . . . . 0.0 104.293 172.443 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 67.3 mttm -142.46 164.62 29.63 Favored 'General case' 0 CA--C 1.5 -0.946 0 N-CA-C 108.717 -0.845 . . . . 0.0 108.717 177.549 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 82.02 50.01 5.07 Favored Glycine 0 C--N 1.356 1.663 0 C-N-CA 125.357 1.456 . . . . 0.0 109.562 175.153 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 49.5 mt -119.25 172.97 7.23 Favored 'General case' 0 CA--C 1.5 -0.97 0 N-CA-C 108.22 -1.03 . . . . 0.0 108.22 -170.998 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -114.61 160.91 31.38 Favored Pre-proline 0 N--CA 1.442 -0.872 0 N-CA-C 106.856 -1.535 . . . . 0.0 106.856 -176.937 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -79.75 163.12 23.88 Favored 'Trans proline' 0 N--CA 1.452 -0.944 0 C-N-CA 123.192 2.595 . . . . 0.0 109.83 166.131 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 60.9 24.65 62.92 Favored Glycine 0 C--N 1.355 1.638 0 C-N-CA 127.778 2.609 . . . . 0.0 116.496 172.1 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 7.7 p -118.9 146.14 23.94 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.063 0 N-CA-C 107.529 -1.286 . . . . 0.0 107.529 -174.56 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 4.2 p -100.31 129.9 50.36 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.906 0 N-CA-C 106.665 -1.606 . . . . 0.0 106.665 176.013 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 94.1 m-85 -113.44 150.01 33.38 Favored 'General case' 0 N--CA 1.439 -1.016 0 N-CA-C 105.923 -1.88 . . . . 0.0 105.923 173.508 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -100.61 144.58 29.42 Favored 'General case' 0 CA--C 1.496 -1.119 0 N-CA-C 104.327 -2.471 . . . . 0.0 104.327 162.546 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -126.99 157.76 20.74 Favored Glycine 0 CA--C 1.489 -1.584 0 N-CA-C 108.016 -2.034 . . . . 0.0 108.016 174.663 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 23.7 tt0 -142.7 131.48 22.76 Favored 'General case' 0 CA--C 1.482 -1.671 0 N-CA-C 106.004 -1.85 . . . . 0.0 106.004 176.53 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 39.8 tp -113.5 104.76 12.59 Favored 'General case' 0 N--CA 1.437 -1.112 0 N-CA-C 104.6 -2.371 . . . . 0.0 104.6 -174.878 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 21.8 mt -100.48 126.69 54.03 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.866 0 N-CA-C 103.192 -2.892 . . . . 0.0 103.192 -179.29 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 50.5 m -118.36 115.9 25.63 Favored 'General case' 0 N--CA 1.444 -0.74 0 CA-C-N 119.24 0.927 . . . . 0.0 109.154 -171.32 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 2.4 mp -104.3 141.11 20.55 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.982 0 N-CA-C 105.779 -1.934 . . . . 0.0 105.779 -162.824 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 12.0 tp-100 -103.89 125.95 50.66 Favored 'General case' 0 CA--C 1.493 -1.25 0 N-CA-C 102.458 -3.164 . . . . 0.0 102.458 161.293 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 18.5 tt0 -68.35 117.89 10.72 Favored 'General case' 0 N--CA 1.443 -0.808 0 C-N-CA 123.036 0.534 . . . . 0.0 110.558 -170.428 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 24.8 m-85 64.44 53.96 1.58 Allowed 'General case' 0 C--N 1.358 0.957 0 C-N-CA 126.597 1.959 . . . . 0.0 110.686 -175.256 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -172.47 -110.86 0.25 Allowed Glycine 0 C--N 1.352 1.421 0 N-CA-C 109.021 -1.632 . . . . 0.0 109.021 -178.696 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 27.9 m170 -80.2 164.92 22.9 Favored 'General case' 0 CA--C 1.503 -0.861 0 C-N-CA 125.066 1.347 . . . . 0.0 111.436 -168.792 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 44.8 tt0 -151.0 111.27 4.15 Favored 'General case' 0 N--CA 1.435 -1.181 0 N-CA-C 105.539 -2.023 . . . . 0.0 105.539 169.806 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 17.2 tp10 -99.82 151.95 20.69 Favored 'General case' 0 N--CA 1.441 -0.901 0 N-CA-C 105.799 -1.926 . . . . 0.0 105.799 179.267 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 11.3 p -130.85 139.91 49.98 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.774 0 N-CA-C 107.324 -1.362 . . . . 0.0 107.324 177.849 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 85.8 m -138.51 133.85 33.17 Favored 'General case' 0 N--CA 1.441 -0.922 0 N-CA-C 102.901 -3.0 . . . . 0.0 102.901 -177.969 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 8.1 ptm180 -113.79 165.1 12.9 Favored 'General case' 0 C--N 1.357 0.915 0 CA-C-N 119.822 1.192 . . . . 0.0 109.667 174.506 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 43.0 p90 -163.99 174.6 11.2 Favored 'General case' 0 CA--C 1.5 -0.975 0 N-CA-C 106.919 -1.512 . . . . 0.0 106.919 177.163 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 1.4 p30 -143.97 156.55 44.45 Favored 'General case' 0 N--CA 1.441 -0.885 0 N-CA-C 106.965 -1.494 . . . . 0.0 106.965 166.459 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 6.6 p90 -148.36 173.27 13.23 Favored 'General case' 0 CA--C 1.488 -1.434 0 N-CA-C 107.661 -1.237 . . . . 0.0 107.661 -179.881 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 32.0 p -122.97 143.99 49.54 Favored 'General case' 0 CA--C 1.499 -0.99 0 N-CA-C 106.308 -1.738 . . . . 0.0 106.308 171.633 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 91' ' ' THR . . . . . 0.431 ' HG1' ' CD2' ' A' ' 18' ' ' HIS . 68.3 m -110.07 87.23 2.47 Favored 'General case' 0 CA--C 1.495 -1.137 0 N-CA-C 100.579 -3.86 . . . . 0.0 100.579 166.27 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 10.2 t -97.41 -50.88 4.36 Favored 'General case' 0 N--CA 1.441 -0.908 0 N-CA-C 108.293 -1.002 . . . . 0.0 108.293 -168.33 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 11.4 t . . . . . 0 C--O 1.26 1.638 0 C-N-CA 126.118 1.767 . . . . 0.0 110.256 -175.475 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.441 -0.984 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 95.9 Cg_exo -62.21 133.11 41.98 Favored 'Trans proline' 0 N--CA 1.445 -1.367 0 C-N-CA 123.592 2.861 . . . . 0.0 112.342 -178.504 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 4.3 t -80.98 155.33 4.26 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.924 0 C-N-CA 127.32 2.248 . . . . 0.0 107.424 -175.429 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 53.0 mt-10 -94.49 89.04 5.68 Favored 'General case' 0 CA--C 1.493 -1.25 0 C-N-CA 124.337 1.055 . . . . 0.0 108.426 -177.5 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 3.7 p -115.64 140.24 38.25 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.105 0 N-CA-C 105.497 -2.038 . . . . 0.0 105.497 -169.411 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 93.3 m-85 . . . . . 0 CA--C 1.493 -1.221 0 N-CA-C 107.28 -1.378 . . . . 0.0 107.28 -172.112 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_endo . . . . . 0 CA--C 1.509 -0.753 0 N-CA-C 110.003 -0.806 . . . . 0.0 110.003 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 3.4 p30 -91.16 -15.4 29.43 Favored 'General case' 0 CA--C 1.498 -1.041 0 C-N-CA 125.438 1.495 . . . . 0.0 108.222 177.663 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 50.1 m -102.58 149.96 23.89 Favored 'General case' 0 N--CA 1.437 -1.101 0 N-CA-C 107.094 -1.446 . . . . 0.0 107.094 175.425 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 60.0 t-80 -139.28 94.45 9.65 Favored Pre-proline 0 N--CA 1.442 -0.855 0 N-CA-C 107.526 -1.287 . . . . 0.0 107.526 175.729 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -78.21 101.36 1.46 Allowed 'Trans proline' 0 N--CA 1.447 -1.235 0 C-N-CA 123.144 2.562 . . . . 0.0 110.043 174.338 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 11.8 tt -90.58 156.69 3.01 Favored 'Isoleucine or valine' 0 N--CA 1.408 -2.532 0 C-N-CA 126.945 2.098 . . . . 0.0 106.042 176.308 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 25.4 tt0 -139.77 146.45 39.51 Favored 'General case' 0 N--CA 1.432 -1.334 0 N-CA-C 103.662 -2.718 . . . . 0.0 103.662 175.125 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 49.3 p90 -135.08 161.69 34.61 Favored 'General case' 0 N--CA 1.431 -1.379 0 N-CA-C 105.045 -2.205 . . . . 0.0 105.045 178.558 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 3.9 m120 -132.65 127.73 35.54 Favored 'General case' 0 CA--C 1.491 -1.325 0 N-CA-C 105.909 -1.886 . . . . 0.0 105.909 -178.884 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -81.18 159.99 66.59 Favored Pre-proline 0 N--CA 1.441 -0.901 0 C-N-CA 123.533 0.733 . . . . 0.0 111.254 -167.119 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_exo -67.29 173.87 7.99 Favored 'Trans proline' 0 N--CA 1.456 -0.718 0 C-N-CA 123.7 2.933 . . . . 0.0 111.738 166.987 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 49.4 tt0 -80.24 -42.38 1.37 Allowed Pre-proline 0 N--CA 1.444 -0.756 0 CA-C-O 115.63 -2.128 . . . . 0.0 111.522 -177.339 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 74.7 Cg_exo -66.59 148.13 82.93 Favored 'Trans proline' 0 CA--C 1.507 -0.849 0 CA-C-N 125.62 3.043 . . . . 0.0 112.061 177.039 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 24.6 p -98.99 58.52 1.13 Allowed 'General case' 0 C--N 1.355 0.844 0 N-CA-C 107.592 -1.262 . . . . 0.0 107.592 178.46 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 21.1 t-160 -104.38 -5.88 21.29 Favored 'General case' 0 N--CA 1.439 -1.001 0 C-N-CA 125.046 1.338 . . . . 0.0 107.784 178.104 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 56.7 mt -106.73 131.26 57.05 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.21 0 N-CA-C 105.2 -2.148 . . . . 0.0 105.2 178.498 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 75.2 m -104.01 -84.24 0.48 Allowed 'General case' 0 N--CA 1.43 -1.443 0 N-CA-C 106.203 -1.777 . . . . 0.0 106.203 -179.667 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 54.0 mtmt -88.9 167.26 13.37 Favored 'General case' 0 CA--C 1.492 -1.281 0 C-N-CA 123.687 0.795 . . . . 0.0 109.61 -168.801 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 90.0 m-85 -126.04 139.27 53.55 Favored 'General case' 0 N--CA 1.435 -1.196 0 N-CA-C 104.494 -2.41 . . . . 0.0 104.494 165.703 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 1.7 mp -115.03 136.34 52.05 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.132 1 N-CA-C 100.177 -4.009 . . . . 0.0 100.177 167.634 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 3.0 mt -111.53 133.63 53.67 Favored 'General case' 0 CA--C 1.472 -2.052 0 N-CA-C 103.837 -2.653 . . . . 0.0 103.837 164.588 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 16.7 ptp180 -128.73 154.84 45.94 Favored 'General case' 0 N--CA 1.432 -1.345 0 N-CA-C 106.301 -1.74 . . . . 0.0 106.301 169.107 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 48.3 p90 -153.44 144.53 22.94 Favored 'General case' 0 N--CA 1.436 -1.161 0 N-CA-C 106.987 -1.486 . . . . 0.0 106.987 -173.834 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 36.2 ttp180 -142.55 134.04 13.04 Favored Pre-proline 0 CA--C 1.497 -1.09 0 N-CA-C 104.783 -2.303 . . . . 0.0 104.783 -177.859 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 29.8 Cg_endo -72.31 116.71 4.81 Favored 'Trans proline' 0 CA--C 1.505 -0.947 0 C-N-CA 122.928 2.418 . . . . 0.0 108.156 178.364 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 5.5 tmtm? -69.86 85.02 0.49 Allowed 'General case' 0 C--N 1.359 1.011 0 C-N-CA 126.523 1.929 . . . . 0.0 110.242 -174.283 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 33.1 m120 -147.52 -67.78 0.25 Allowed 'General case' 0 N--CA 1.433 -1.286 0 N-CA-C 101.568 -3.493 . . . . 0.0 101.568 -178.71 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 50.8 p -103.28 170.27 8.06 Favored 'General case' 0 N--CA 1.441 -0.918 0 N-CA-C 107.072 -1.455 . . . . 0.0 107.072 171.617 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 3.7 m -119.82 53.42 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.841 0 N-CA-C 106.125 -1.806 . . . . 0.0 106.125 176.45 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -100.32 -131.55 7.41 Favored Glycine 0 C--N 1.356 1.641 0 N-CA-C 109.916 -1.273 . . . . 0.0 109.916 -175.452 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 56.1 ttp180 -79.78 148.51 31.42 Favored 'General case' 0 C--N 1.357 0.9 0 C-N-CA 124.727 1.211 . . . . 0.0 108.694 -175.026 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -148.5 169.86 19.32 Favored 'General case' 0 CA--C 1.494 -1.174 0 CA-C-O 121.468 0.651 . . . . 0.0 110.616 -171.952 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 62.3 mttp -112.3 159.07 19.01 Favored 'General case' 0 CA--C 1.491 -1.292 0 N-CA-C 107.774 -1.195 . . . . 0.0 107.774 -168.849 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 16.2 pt-20 -151.63 160.65 43.55 Favored 'General case' 0 N--CA 1.436 -1.141 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 172.287 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -137.38 163.69 30.42 Favored 'General case' 0 CA--C 1.501 -0.942 0 N-CA-C 106.063 -1.829 . . . . 0.0 106.063 171.68 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 89.4 m -120.41 125.25 47.49 Favored 'General case' 0 CA--C 1.501 -0.913 0 N-CA-C 104.957 -2.238 . . . . 0.0 104.957 175.992 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 5.3 mp -114.11 136.48 22.21 Favored Pre-proline 0 N--CA 1.437 -1.102 0 N-CA-C 105.196 -2.15 . . . . 0.0 105.196 -175.608 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_exo -64.19 163.72 25.09 Favored 'Trans proline' 0 CA--C 1.51 -0.723 0 C-N-CA 123.378 2.719 . . . . 0.0 113.774 176.624 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -76.26 -18.44 79.27 Favored Glycine 0 C--N 1.353 1.49 0 C-N-CA 124.149 0.881 . . . . 0.0 114.244 -174.03 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 52.4 p-80 -83.28 -25.17 31.82 Favored 'General case' 0 C--N 1.355 0.837 0 CA-C-N 117.951 0.876 . . . . 0.0 109.945 -179.044 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 89.0 mt -88.43 131.57 34.81 Favored 'General case' 0 CA--C 1.5 -0.955 0 N-CA-C 107.712 -1.218 . . . . 0.0 107.712 176.797 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 8.6 p-10 -113.74 8.82 17.59 Favored 'General case' 0 CA--C 1.502 -0.89 0 C-N-CA 124.457 1.103 . . . . 0.0 109.631 -174.916 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 33.5 p -146.39 157.73 43.81 Favored 'General case' 0 CA--C 1.498 -1.055 0 N-CA-C 106.633 -1.617 . . . . 0.0 106.633 -177.463 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 35.4 t80 -154.14 151.27 29.06 Favored 'General case' 0 CA--C 1.487 -1.444 0 N-CA-C 108.07 -1.085 . . . . 0.0 108.07 178.236 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 16.9 m -108.64 113.99 27.43 Favored 'General case' 0 N--CA 1.439 -0.979 0 N-CA-C 105.951 -1.87 . . . . 0.0 105.951 174.954 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 45.5 mt -91.95 102.28 13.39 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.89 0 N-CA-C 105.242 -2.132 . . . . 0.0 105.242 178.117 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 35.1 mtmm -106.48 162.32 13.82 Favored 'General case' 0 CA--C 1.497 -1.096 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 -175.785 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 79.93 52.51 4.61 Favored Glycine 0 C--N 1.351 1.365 0 N-CA-C 109.099 -1.6 . . . . 0.0 109.099 178.434 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 89.5 mt -118.12 173.12 6.97 Favored 'General case' 0 CA--C 1.498 -1.023 0 N-CA-C 106.87 -1.53 . . . . 0.0 106.87 -178.778 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 51.6 mtmt -98.14 147.28 32.87 Favored Pre-proline 0 N--CA 1.438 -1.063 0 N-CA-C 105.786 -1.931 . . . . 0.0 105.786 178.666 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -78.56 160.99 28.32 Favored 'Trans proline' 0 N--CA 1.452 -0.93 0 C-N-CA 123.043 2.496 . . . . 0.0 109.997 173.515 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 59.6 30.33 68.52 Favored Glycine 0 C--N 1.356 1.65 0 C-N-CA 126.626 2.06 . . . . 0.0 116.24 169.964 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 6.4 p -128.45 154.62 39.47 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.85 0 N-CA-C 107.813 -1.18 . . . . 0.0 107.813 -176.002 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 4.8 p -96.53 135.69 29.81 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.9 0 N-CA-C 106.769 -1.567 . . . . 0.0 106.769 175.554 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 81.9 m-85 -113.89 147.44 38.48 Favored 'General case' 0 CA--C 1.497 -1.078 0 N-CA-C 105.382 -2.081 . . . . 0.0 105.382 171.432 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 15.2 pt-20 -95.92 136.53 36.23 Favored 'General case' 0 CA--C 1.498 -1.027 0 N-CA-C 103.457 -2.794 . . . . 0.0 103.457 162.016 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -132.62 146.38 18.18 Favored Glycine 0 CA--C 1.485 -1.784 0 N-CA-C 107.679 -2.168 . . . . 0.0 107.679 -172.332 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 83.0 mt-30 -136.74 133.46 36.07 Favored 'General case' 0 CA--C 1.482 -1.65 0 N-CA-C 105.746 -1.946 . . . . 0.0 105.746 178.627 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 49.6 tp -112.63 100.1 8.45 Favored 'General case' 0 N--CA 1.437 -1.108 0 N-CA-C 103.393 -2.817 . . . . 0.0 103.393 179.535 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 21.7 mt -94.83 129.33 45.15 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.915 0 N-CA-C 104.696 -2.335 . . . . 0.0 104.696 -176.797 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 69.2 m -113.5 113.79 25.62 Favored 'General case' 0 CA--C 1.497 -1.092 0 N-CA-C 107.668 -1.234 . . . . 0.0 107.668 -175.276 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 18.5 mm -89.36 142.73 12.47 Favored 'Isoleucine or valine' 0 CA--C 1.49 -1.349 0 N-CA-C 105.514 -2.032 . . . . 0.0 105.514 -173.441 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 83.0 mt-30 -92.5 -175.62 4.04 Favored 'General case' 0 CA--C 1.502 -0.897 0 CA-C-N 114.766 -1.106 . . . . 0.0 109.203 -175.569 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 73.2 mt-30 -74.79 78.22 2.09 Favored 'General case' 0 N--CA 1.442 -0.863 0 C-N-CA 125.84 1.656 . . . . 0.0 112.347 -177.612 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 65.8 m-85 60.06 21.8 10.98 Favored 'General case' 0 C--N 1.358 0.977 0 C-N-CA 127.322 2.249 . . . . 0.0 112.777 178.623 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -119.28 -118.95 2.78 Favored Glycine 0 C--N 1.355 1.597 0 N-CA-C 108.695 -1.762 . . . . 0.0 108.695 -173.847 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' HIS . . . . . 0.518 ' CG ' ' H ' ' A' ' 82' ' ' GLN . 2.4 t60 -81.34 -171.56 3.34 Favored 'General case' 0 CA--C 1.497 -1.065 0 C-N-CA 125.386 1.475 . . . . 0.0 108.902 -177.852 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 82' ' ' GLN . . . . . 0.518 ' H ' ' CG ' ' A' ' 81' ' ' HIS . 5.9 pt20 -144.66 146.48 32.27 Favored 'General case' 0 N--CA 1.434 -1.274 0 N-CA-C 106.067 -1.827 . . . . 0.0 106.067 170.127 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 46.9 mm-40 -105.19 156.22 18.31 Favored 'General case' 0 CA--C 1.494 -1.178 0 N-CA-C 105.897 -1.89 . . . . 0.0 105.897 179.735 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 7.4 p -129.51 135.76 60.83 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.924 0 N-CA-C 107.308 -1.367 . . . . 0.0 107.308 179.741 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 24.7 m -118.62 133.38 55.9 Favored 'General case' 0 N--CA 1.439 -1.001 0 N-CA-C 102.006 -3.331 . . . . 0.0 102.006 175.467 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 78.6 mtm180 -129.17 147.83 51.05 Favored 'General case' 0 CA--C 1.497 -1.081 0 CA-C-N 119.303 0.956 . . . . 0.0 109.187 -177.698 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 18.5 p90 -166.07 -176.1 3.61 Favored 'General case' 0 CA--C 1.498 -1.025 0 N-CA-C 106.826 -1.546 . . . . 0.0 106.826 -174.79 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -134.58 156.72 48.19 Favored 'General case' 0 N--CA 1.44 -0.962 0 N-CA-C 105.596 -2.001 . . . . 0.0 105.596 164.371 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 23.7 p90 -138.13 165.17 27.3 Favored 'General case' 0 CA--C 1.483 -1.629 0 N-CA-C 107.227 -1.397 . . . . 0.0 107.227 169.449 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 29.4 p -119.67 143.89 47.48 Favored 'General case' 0 N--CA 1.439 -1.004 0 N-CA-C 107.374 -1.343 . . . . 0.0 107.374 176.381 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 19.6 p -108.99 135.06 50.78 Favored 'General case' 0 N--CA 1.439 -1.012 0 N-CA-C 103.613 -2.736 . . . . 0.0 103.613 164.608 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 15.2 t -139.72 149.49 43.69 Favored 'General case' 0 N--CA 1.439 -1.005 0 N-CA-C 106.332 -1.729 . . . . 0.0 106.332 -173.742 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 35.4 t . . . . . 0 C--O 1.261 1.685 0 N-CA-C 105.396 -2.076 . . . . 0.0 105.396 177.99 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.442 -0.938 0 N-CA-C 109.136 -1.586 . . . . 0.0 109.136 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 64.4 Cg_exo -61.48 138.23 74.7 Favored 'Trans proline' 0 N--CA 1.442 -1.508 0 C-N-CA 123.241 2.628 . . . . 0.0 112.957 179.643 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 2.8 t -77.45 153.8 5.42 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.728 0 C-N-CA 127.785 2.434 . . . . 0.0 106.339 -178.527 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 48.7 mm-40 -99.03 88.76 4.05 Favored 'General case' 0 CA--C 1.488 -1.405 0 CA-C-O 122.829 1.3 . . . . 0.0 109.14 -170.133 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 2.4 p -105.66 128.01 60.12 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.07 0 CA-C-N 113.43 -1.714 . . . . 0.0 108.685 -164.376 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 27.5 p90 . . . . . 0 N--CA 1.44 -0.97 0 N-CA-C 106.703 -1.592 . . . . 0.0 106.703 -174.584 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 82.0 Cg_endo . . . . . 0 CA--C 1.505 -0.952 0 CA-C-O 117.82 -0.992 . . . . 0.0 111.544 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 4.1 t30 -124.95 -31.99 3.08 Favored 'General case' 0 CA--C 1.488 -1.42 0 CA-C-N 118.637 0.653 . . . . 0.0 109.78 -165.741 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 13.5 p -106.63 141.85 37.24 Favored 'General case' 0 CA--C 1.493 -1.238 0 N-CA-C 107.44 -1.319 . . . . 0.0 107.44 179.22 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 63.0 t60 -141.89 98.22 6.33 Favored Pre-proline 0 N--CA 1.439 -1.024 0 N-CA-C 107.603 -1.258 . . . . 0.0 107.603 176.531 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -78.32 139.11 16.37 Favored 'Trans proline' 0 N--CA 1.449 -1.092 0 C-N-CA 122.814 2.343 . . . . 0.0 110.785 -177.14 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 21.6 mm -106.87 136.27 42.4 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.958 0 N-CA-C 103.104 -2.924 . . . . 0.0 103.104 174.287 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 40.7 mt-30 -138.76 141.28 38.84 Favored 'General case' 0 CA--C 1.491 -1.318 0 N-CA-C 103.494 -2.78 . . . . 0.0 103.494 -178.048 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 46.1 p90 -148.77 167.23 26.14 Favored 'General case' 0 CA--C 1.498 -1.048 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 -170.609 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 9.5 m120 -131.19 129.53 41.82 Favored 'General case' 0 CA--C 1.492 -1.259 0 N-CA-C 107.441 -1.318 . . . . 0.0 107.441 178.868 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -94.71 170.58 7.85 Favored Pre-proline 0 N--CA 1.439 -0.999 0 C-N-CA 124.468 1.107 . . . . 0.0 109.879 -170.97 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 80.2 Cg_exo -66.06 164.13 28.77 Favored 'Trans proline' 0 CA--C 1.508 -0.807 0 C-N-CA 123.633 2.888 . . . . 0.0 112.222 168.929 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 17.4 mp0 -83.3 -57.34 0.43 Allowed Pre-proline 0 N--CA 1.442 -0.826 0 CA-C-O 115.844 -2.027 . . . . 0.0 110.402 -177.132 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -74.87 171.88 17.42 Favored 'Trans proline' 0 CA--C 1.509 -0.743 0 CA-C-N 125.499 3.0 . . . . 0.0 110.349 177.702 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 66.0 m -75.93 125.86 29.9 Favored 'General case' 0 CA--C 1.501 -0.933 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 -179.635 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 26.7 t-80 -162.37 -49.89 0.04 OUTLIER 'General case' 0 N--CA 1.436 -1.17 0 N-CA-C 106.202 -1.777 . . . . 0.0 106.202 -172.813 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 54.0 mt -113.06 136.53 49.08 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.142 0 N-CA-C 105.203 -2.147 . . . . 0.0 105.203 -177.109 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 32.1 t -110.53 -87.5 0.52 Allowed 'General case' 0 N--CA 1.43 -1.474 0 N-CA-C 106.717 -1.586 . . . . 0.0 106.717 179.028 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 6.7 ttpm? -91.86 160.49 15.27 Favored 'General case' 0 CA--C 1.492 -1.262 0 C-N-CA 125.667 1.587 . . . . 0.0 107.649 -160.155 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 92.0 m-85 -125.58 138.91 53.96 Favored 'General case' 0 CA--C 1.494 -1.185 0 N-CA-C 106.277 -1.749 . . . . 0.0 106.277 176.072 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 53.5 mt -116.92 126.82 74.55 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.152 0 N-CA-C 102.592 -3.114 . . . . 0.0 102.592 168.483 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 5.0 mt -102.2 128.65 48.61 Favored 'General case' 0 CA--C 1.475 -1.912 0 N-CA-C 104.894 -2.261 . . . . 0.0 104.894 170.556 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 42.4 ttp85 -132.47 122.0 24.23 Favored 'General case' 0 N--CA 1.437 -1.115 0 N-CA-C 106.097 -1.816 . . . . 0.0 106.097 -178.71 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 42.3 p90 -138.06 151.1 47.52 Favored 'General case' 0 N--CA 1.444 -0.757 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 -169.994 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 33.2 ptt180 -155.92 164.47 21.25 Favored Pre-proline 0 CA--C 1.502 -0.897 0 N-CA-C 106.605 -1.628 . . . . 0.0 106.605 171.384 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' PRO . . . . . 0.416 ' HA ' ' HA ' ' A' ' 69' ' ' TYR . 37.7 Cg_endo -75.69 127.27 10.09 Favored 'Trans proline' 0 N--CA 1.452 -0.932 0 C-N-CA 122.344 2.029 . . . . 0.0 108.983 179.141 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 64.0 tttm -69.75 83.07 0.45 Allowed 'General case' 0 C--N 1.357 0.921 0 C-N-CA 127.349 2.259 . . . . 0.0 110.821 -177.588 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 29.1 m120 -145.9 -89.81 0.1 Allowed 'General case' 0 N--CA 1.437 -1.091 0 N-CA-C 105.054 -2.202 . . . . 0.0 105.054 -175.958 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 3.7 t -94.31 -164.95 1.23 Allowed 'General case' 0 C--N 1.355 0.819 0 C-N-CA 124.032 0.933 . . . . 0.0 108.924 -172.641 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 4.2 m -121.17 54.51 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.439 -1.003 0 N-CA-C 106.307 -1.738 . . . . 0.0 106.307 -176.648 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -89.8 -140.2 7.93 Favored Glycine 0 C--N 1.355 1.595 0 N-CA-C 110.281 -1.128 . . . . 0.0 110.281 -178.179 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -99.33 165.01 11.88 Favored 'General case' 0 CA--C 1.503 -0.831 0 N-CA-C 106.484 -1.672 . . . . 0.0 106.484 -178.332 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 47.3 m95 -112.34 156.73 21.98 Favored 'General case' 0 N--CA 1.441 -0.912 0 N-CA-C 108.071 -1.085 . . . . 0.0 108.071 -179.09 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 67.9 mttm -97.46 152.25 19.17 Favored 'General case' 0 CA--C 1.49 -1.352 0 N-CA-C 104.779 -2.304 . . . . 0.0 104.779 163.824 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -153.18 156.62 38.91 Favored 'General case' 0 CA--C 1.494 -1.191 0 N-CA-C 107.833 -1.173 . . . . 0.0 107.833 178.854 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -141.07 162.93 34.32 Favored 'General case' 0 CA--C 1.496 -1.132 0 N-CA-C 106.349 -1.723 . . . . 0.0 106.349 175.876 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 88.1 m -122.36 127.24 49.51 Favored 'General case' 0 CA--C 1.501 -0.933 0 N-CA-C 105.242 -2.133 . . . . 0.0 105.242 -179.705 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 4.8 mp -117.38 133.88 23.17 Favored Pre-proline 0 N--CA 1.437 -1.106 0 N-CA-C 104.613 -2.366 . . . . 0.0 104.613 -174.725 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_exo -63.32 166.19 15.6 Favored 'Trans proline' 0 CA--C 1.509 -0.742 0 C-N-CA 123.344 2.696 . . . . 0.0 113.616 176.677 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -81.14 -17.18 72.59 Favored Glycine 0 C--N 1.351 1.405 0 C-N-CA 123.557 0.598 . . . . 0.0 113.099 -172.073 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 52.2 p-80 -83.66 -24.8 31.19 Favored 'General case' 0 C--N 1.355 0.841 0 CA-C-N 117.889 0.845 . . . . 0.0 109.862 179.88 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 87.4 mt -88.18 130.67 34.99 Favored 'General case' 0 CA--C 1.501 -0.94 0 N-CA-C 107.645 -1.243 . . . . 0.0 107.645 177.139 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 8.1 p30 -110.15 7.95 23.59 Favored 'General case' 0 N--CA 1.441 -0.881 0 C-N-CA 124.708 1.203 . . . . 0.0 109.758 -174.937 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 42.1 p -146.5 167.03 24.69 Favored 'General case' 0 N--CA 1.439 -1.0 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 -178.14 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 9.3 t80 -153.29 178.37 9.84 Favored 'General case' 0 N--CA 1.439 -1.023 0 N-CA-C 107.1 -1.444 . . . . 0.0 107.1 -178.275 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 70.0 m -142.0 116.22 9.47 Favored 'General case' 0 N--CA 1.43 -1.459 0 N-CA-C 104.812 -2.292 . . . . 0.0 104.812 176.632 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 12.7 mm -85.75 140.18 16.3 Favored 'Isoleucine or valine' 0 C--N 1.358 0.964 0 N-CA-C 103.856 -2.646 . . . . 0.0 103.856 170.332 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 7.9 mtpm? -141.7 164.65 29.64 Favored 'General case' 0 CA--C 1.497 -1.063 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 178.938 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 85.86 49.49 4.28 Favored Glycine 0 CA--C 1.487 -1.669 0 N-CA-C 108.931 -1.668 . . . . 0.0 108.931 174.843 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 58.1 mt -118.77 170.15 9.24 Favored 'General case' 0 CA--C 1.497 -1.071 0 N-CA-C 108.528 -0.916 . . . . 0.0 108.528 -169.864 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 60.6 mtpt -110.46 155.16 42.51 Favored Pre-proline 0 N--CA 1.44 -0.929 0 N-CA-C 106.942 -1.503 . . . . 0.0 106.942 -176.478 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 63.9 Cg_endo -78.94 161.04 27.1 Favored 'Trans proline' 0 N--CA 1.452 -0.966 0 C-N-CA 122.91 2.407 . . . . 0.0 110.308 172.982 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' GLY . . . . . 0.438 ' H ' ' HA ' ' A' ' 92' ' ' THR . . . 59.47 26.27 61.8 Favored Glycine 0 C--N 1.355 1.586 0 C-N-CA 127.673 2.559 . . . . 0.0 116.378 171.29 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 10.7 p -121.77 147.45 25.76 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.992 0 N-CA-C 107.362 -1.348 . . . . 0.0 107.362 -177.203 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 4.0 p -96.73 129.15 47.19 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.951 0 N-CA-C 106.93 -1.507 . . . . 0.0 106.93 177.125 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' TYR . . . . . 0.416 ' HA ' ' HA ' ' A' ' 39' ' ' PRO . 93.4 m-85 -111.18 144.84 39.7 Favored 'General case' 0 CA--C 1.496 -1.113 0 N-CA-C 106.043 -1.836 . . . . 0.0 106.043 173.124 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -96.72 145.12 26.09 Favored 'General case' 0 CA--C 1.496 -1.128 0 N-CA-C 104.475 -2.417 . . . . 0.0 104.475 166.103 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -140.97 155.77 25.16 Favored Glycine 0 CA--C 1.486 -1.731 0 N-CA-C 108.624 -1.791 . . . . 0.0 108.624 -176.275 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 86.8 mt-30 -142.9 134.39 26.34 Favored 'General case' 0 CA--C 1.479 -1.782 0 N-CA-C 104.456 -2.424 . . . . 0.0 104.456 -179.333 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 35.6 tp -114.77 96.17 5.59 Favored 'General case' 0 N--CA 1.437 -1.102 0 N-CA-C 103.659 -2.719 . . . . 0.0 103.659 176.468 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 21.8 mt -88.76 135.37 25.92 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.048 0 N-CA-C 104.213 -2.514 . . . . 0.0 104.213 -177.275 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 14.2 p -124.96 112.14 16.24 Favored 'General case' 0 N--CA 1.435 -1.212 0 N-CA-C 107.777 -1.194 . . . . 0.0 107.777 -171.771 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 2.0 mp -93.48 134.84 29.87 Favored 'Isoleucine or valine' 0 CA--C 1.488 -1.41 0 N-CA-C 104.506 -2.405 . . . . 0.0 104.506 -165.703 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 74.4 mt-30 -92.66 149.9 21.04 Favored 'General case' 0 CA--C 1.493 -1.249 0 N-CA-C 106.522 -1.659 . . . . 0.0 106.522 -178.687 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 44.6 tt0 -70.46 105.71 3.16 Favored 'General case' 0 N--CA 1.441 -0.894 0 C-N-CA 123.44 0.696 . . . . 0.0 110.408 -177.997 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 31.6 m-85 59.94 41.03 18.29 Favored 'General case' 0 C--N 1.356 0.883 0 C-N-CA 127.094 2.157 . . . . 0.0 112.469 -178.626 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -149.94 -126.11 1.39 Allowed Glycine 0 C--N 1.358 1.752 0 N-CA-C 109.283 -1.527 . . . . 0.0 109.283 178.738 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 47.1 m80 -85.11 -176.26 6.1 Favored 'General case' 0 CA--C 1.497 -1.071 0 C-N-CA 126.107 1.763 . . . . 0.0 111.436 -165.555 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 36.7 mt-30 -130.42 144.47 51.41 Favored 'General case' 0 CA--C 1.496 -1.101 0 N-CA-C 103.975 -2.602 . . . . 0.0 103.975 168.659 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 57.3 mt-10 -131.28 131.32 43.77 Favored 'General case' 0 CA--C 1.491 -1.304 0 N-CA-C 105.312 -2.107 . . . . 0.0 105.312 179.721 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 12.4 p -104.48 134.82 44.78 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.799 0 N-CA-C 108.137 -1.06 . . . . 0.0 108.137 -174.914 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 40.0 m -109.11 131.71 54.81 Favored 'General case' 0 N--CA 1.44 -0.926 0 N-CA-C 101.831 -3.396 . . . . 0.0 101.831 171.403 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 87.5 mtt180 -123.75 149.01 46.11 Favored 'General case' 0 CA--C 1.494 -1.174 0 CA-C-N 119.491 1.041 . . . . 0.0 109.901 -177.92 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 14.8 p90 -163.25 -179.61 6.73 Favored 'General case' 0 CA--C 1.499 -0.988 0 N-CA-C 107.209 -1.404 . . . . 0.0 107.209 -179.149 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 9.3 p-10 -141.31 160.16 40.7 Favored 'General case' 0 N--CA 1.44 -0.963 0 N-CA-C 105.865 -1.902 . . . . 0.0 105.865 167.005 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 23.4 p90 -148.3 170.17 18.5 Favored 'General case' 0 CA--C 1.49 -1.358 0 N-CA-C 107.332 -1.358 . . . . 0.0 107.332 177.294 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 23.9 p -119.25 142.53 47.97 Favored 'General case' 0 CA--C 1.498 -1.024 0 N-CA-C 105.696 -1.965 . . . . 0.0 105.696 171.458 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 45.0 m -115.7 119.83 37.35 Favored 'General case' 0 CA--C 1.495 -1.143 0 N-CA-C 102.614 -3.106 . . . . 0.0 102.614 170.989 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 92' ' ' THR . . . . . 0.438 ' HA ' ' H ' ' A' ' 66' ' ' GLY . 14.1 t -154.38 159.19 41.0 Favored 'General case' 0 N--CA 1.436 -1.144 0 N-CA-C 105.901 -1.888 . . . . 0.0 105.901 -173.205 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 9.4 t . . . . . 0 C--O 1.262 1.714 0 N-CA-C 106.356 -1.72 . . . . 0.0 106.356 175.042 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.438 -1.206 0 N-CA-C 106.767 -2.533 . . . . 0.0 106.767 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_exo -61.2 142.47 96.63 Favored 'Trans proline' 0 N--CA 1.446 -1.307 0 C-N-CA 122.837 2.358 . . . . 0.0 114.523 -171.68 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 4.4 t -76.27 154.29 5.89 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.83 0 C-N-CA 127.889 2.476 . . . . 0.0 106.608 -179.06 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 56.6 mm-40 -99.81 92.88 5.51 Favored 'General case' 0 CA--C 1.49 -1.357 0 N-CA-C 107.412 -1.329 . . . . 0.0 107.412 -177.613 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 1.3 p -108.1 131.32 58.82 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.067 0 CA-C-N 113.15 -1.841 . . . . 0.0 108.684 -164.512 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 40.0 m-85 . . . . . 0 CA--C 1.498 -1.027 0 N-CA-C 106.611 -1.626 . . . . 0.0 106.611 173.823 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 95.7 Cg_endo . . . . . 0 N--CA 1.452 -0.928 0 CA-C-O 118.115 -0.869 . . . . 0.0 110.596 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 48.5 m-20 -125.02 -20.92 4.8 Favored 'General case' 0 N--CA 1.434 -1.25 0 C-N-CA 123.617 0.767 . . . . 0.0 109.938 -171.791 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 19.4 m -103.8 142.0 35.13 Favored 'General case' 0 CA--C 1.494 -1.192 0 N-CA-C 106.993 -1.484 . . . . 0.0 106.993 178.677 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 61.6 t-80 -139.29 98.0 8.37 Favored Pre-proline 0 N--CA 1.434 -1.273 0 N-CA-C 105.513 -2.032 . . . . 0.0 105.513 176.819 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -80.55 148.86 18.45 Favored 'Trans proline' 0 N--CA 1.445 -1.327 0 C-N-CA 122.468 2.112 . . . . 0.0 109.403 174.315 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.414 HD11 HD11 ' A' ' 35' ' ' LEU . 5.0 pt -124.38 170.72 14.19 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.031 0 N-CA-C 107.525 -1.287 . . . . 0.0 107.525 172.324 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 32.5 mt-30 -139.04 161.17 38.04 Favored 'General case' 0 CA--C 1.501 -0.926 0 N-CA-C 105.161 -2.163 . . . . 0.0 105.161 167.884 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 49.5 p90 -148.56 169.39 20.41 Favored 'General case' 0 CA--C 1.497 -1.089 0 N-CA-C 108.136 -1.061 . . . . 0.0 108.136 175.679 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 20.8 m-80 -134.12 126.04 29.21 Favored 'General case' 0 CA--C 1.491 -1.308 0 N-CA-C 105.573 -2.01 . . . . 0.0 105.573 173.965 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -105.75 175.96 1.9 Allowed Pre-proline 0 N--CA 1.44 -0.969 0 C-N-CA 125.823 1.649 . . . . 0.0 107.647 -169.967 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_exo -61.6 144.86 97.92 Favored 'Trans proline' 0 N--CA 1.455 -0.766 0 C-N-CA 123.174 2.583 . . . . 0.0 113.151 176.488 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 22.0 tt0 -82.8 -39.98 0.83 Allowed Pre-proline 0 N--CA 1.443 -0.818 0 CA-C-O 115.564 -2.16 . . . . 0.0 112.726 -173.034 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 76.2 Cg_exo -72.18 4.65 3.15 Favored 'Trans proline' 0 C--N 1.349 0.561 0 CA-C-N 125.687 3.067 . . . . 0.0 114.679 -178.234 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 34.7 m 71.89 64.66 0.14 Allowed 'General case' 0 CA--C 1.499 -0.984 0 C-N-CA 126.464 1.905 . . . . 0.0 109.06 -178.432 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 55.9 t-80 -87.0 -28.11 22.83 Favored 'General case' 0 N--CA 1.44 -0.957 0 C-N-CA 125.127 1.371 . . . . 0.0 108.25 178.772 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 8.2 mm -119.29 147.61 22.76 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.15 0 N-CA-C 106.395 -1.706 . . . . 0.0 106.395 -170.959 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 74.5 m -99.35 -83.9 0.42 Allowed 'General case' 0 N--CA 1.43 -1.45 0 N-CA-C 106.406 -1.701 . . . . 0.0 106.406 175.896 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 45.5 mtpt -90.0 170.48 10.32 Favored 'General case' 0 CA--C 1.49 -1.349 0 C-N-CA 125.259 1.424 . . . . 0.0 109.198 -164.242 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 42.2 m-85 -131.39 145.4 51.8 Favored 'General case' 0 CA--C 1.498 -1.032 0 N-CA-C 104.589 -2.374 . . . . 0.0 104.589 166.624 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 33.1 mt -123.34 137.37 56.89 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.188 0 N-CA-C 101.792 -3.41 . . . . 0.0 101.792 170.248 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.414 HD11 HD11 ' A' ' 20' ' ' ILE . 4.7 mt -114.09 134.47 54.86 Favored 'General case' 0 CA--C 1.467 -2.214 0 N-CA-C 104.64 -2.356 . . . . 0.0 104.64 168.764 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 49.0 mtp180 -118.05 158.74 24.44 Favored 'General case' 0 N--CA 1.431 -1.417 0 N-CA-C 105.381 -2.081 . . . . 0.0 105.381 167.301 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 49.5 p90 -152.63 158.29 42.21 Favored 'General case' 0 N--CA 1.435 -1.21 0 N-CA-C 105.981 -1.859 . . . . 0.0 105.981 173.033 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 46.9 ttp180 -165.08 135.99 3.14 Favored Pre-proline 0 CA--C 1.497 -1.078 0 N-CA-C 104.783 -2.303 . . . . 0.0 104.783 -174.168 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -73.06 117.06 4.95 Favored 'Trans proline' 0 CA--C 1.505 -0.969 0 C-N-CA 122.766 2.311 . . . . 0.0 109.132 -176.829 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 37.9 ttpt -70.71 88.0 0.7 Allowed 'General case' 0 CA--C 1.499 -0.982 0 C-N-CA 126.414 1.886 . . . . 0.0 109.621 -179.939 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 -154.32 -58.55 0.12 Allowed 'General case' 0 N--CA 1.431 -1.401 0 N-CA-C 103.447 -2.797 . . . . 0.0 103.447 -178.521 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 6.4 t -107.32 -167.53 1.28 Allowed 'General case' 0 N--CA 1.439 -0.977 0 N-CA-C 105.228 -2.138 . . . . 0.0 105.228 169.376 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 2.7 m -134.84 63.44 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.44 -0.957 0 N-CA-C 104.823 -2.288 . . . . 0.0 104.823 179.18 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -91.23 -134.71 6.21 Favored Glycine 0 C--N 1.354 1.545 0 N-CA-C 109.819 -1.312 . . . . 0.0 109.819 -176.415 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -94.37 149.57 21.12 Favored 'General case' 0 CA--C 1.499 -1.003 0 N-CA-C 106.871 -1.529 . . . . 0.0 106.871 -176.498 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 64.2 m95 -93.84 151.42 19.61 Favored 'General case' 0 N--CA 1.439 -1.022 0 N-CA-C 107.703 -1.221 . . . . 0.0 107.703 178.825 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 61.9 mttp -96.99 152.32 18.84 Favored 'General case' 0 CA--C 1.488 -1.433 0 N-CA-C 104.105 -2.554 . . . . 0.0 104.105 161.073 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -152.69 155.44 37.27 Favored 'General case' 0 N--CA 1.435 -1.204 0 N-CA-C 108.23 -1.026 . . . . 0.0 108.23 -178.073 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -140.85 161.48 37.72 Favored 'General case' 0 CA--C 1.498 -1.028 0 N-CA-C 106.556 -1.646 . . . . 0.0 106.556 174.74 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 87.0 m -118.83 124.82 48.12 Favored 'General case' 0 CA--C 1.5 -0.954 0 N-CA-C 105.517 -2.031 . . . . 0.0 105.517 178.807 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 3.9 mp -106.13 134.37 19.8 Favored Pre-proline 0 N--CA 1.437 -1.099 0 N-CA-C 105.279 -2.119 . . . . 0.0 105.279 -177.468 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_exo -63.93 163.07 26.53 Favored 'Trans proline' 0 CA--C 1.507 -0.833 0 C-N-CA 123.491 2.794 . . . . 0.0 113.146 176.115 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -74.49 -17.14 79.82 Favored Glycine 0 C--N 1.351 1.41 0 C-N-CA 124.006 0.812 . . . . 0.0 114.477 -173.68 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 49.1 p-80 -84.04 -28.69 27.45 Favored 'General case' 0 C--N 1.355 0.826 0 CA-C-N 118.144 0.972 . . . . 0.0 110.22 -179.69 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 89.1 mt -88.74 130.83 35.26 Favored 'General case' 0 CA--C 1.5 -0.961 0 N-CA-C 107.94 -1.133 . . . . 0.0 107.94 178.07 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 7.7 p30 -117.1 11.37 14.18 Favored 'General case' 0 CA--C 1.503 -0.835 0 C-N-CA 124.225 1.01 . . . . 0.0 109.774 -173.563 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 28.1 p -141.02 159.83 41.38 Favored 'General case' 0 CA--C 1.497 -1.081 0 N-CA-C 106.583 -1.636 . . . . 0.0 106.583 179.427 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 7.9 t80 -135.65 172.95 12.27 Favored 'General case' 0 C--N 1.359 1.003 0 CA-C-O 121.829 0.823 . . . . 0.0 109.254 178.84 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 98.8 m -137.18 110.79 8.04 Favored 'General case' 0 N--CA 1.434 -1.257 0 N-CA-C 104.425 -2.435 . . . . 0.0 104.425 173.77 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 24.9 mt -89.28 143.39 11.27 Favored 'Isoleucine or valine' 0 C--N 1.358 0.945 0 N-CA-C 103.662 -2.718 . . . . 0.0 103.662 169.854 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -149.55 158.1 43.87 Favored 'General case' 0 CA--C 1.491 -1.302 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 -178.85 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 77.75 56.58 3.79 Favored Glycine 0 C--N 1.354 1.561 0 N-CA-C 108.984 -1.646 . . . . 0.0 108.984 -179.904 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 69.1 mt -117.08 -160.83 0.78 Allowed 'General case' 0 CA--C 1.5 -0.944 0 N-CA-C 106.584 -1.636 . . . . 0.0 106.584 -179.012 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -131.39 153.42 81.62 Favored Pre-proline 0 N--CA 1.443 -0.811 0 N-CA-C 106.067 -1.827 . . . . 0.0 106.067 -177.78 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 67.6 Cg_endo -79.4 162.45 25.12 Favored 'Trans proline' 0 N--CA 1.453 -0.886 0 C-N-CA 122.858 2.372 . . . . 0.0 109.925 171.893 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' GLY . . . . . 0.504 ' H ' ' HA ' ' A' ' 92' ' ' THR . . . 61.17 26.96 66.62 Favored Glycine 0 N--CA 1.431 -1.646 0 C-N-CA 127.27 2.367 . . . . 0.0 115.972 171.509 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 9.1 p -127.59 142.92 42.31 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.116 0 N-CA-C 108.28 -1.007 . . . . 0.0 108.28 -177.83 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 7.5 p -95.58 128.41 46.79 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.929 0 N-CA-C 107.463 -1.31 . . . . 0.0 107.463 177.029 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 91.5 m-85 -107.73 148.46 29.42 Favored 'General case' 0 CA--C 1.498 -1.039 0 N-CA-C 106.382 -1.71 . . . . 0.0 106.382 174.235 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -98.98 140.04 33.73 Favored 'General case' 0 CA--C 1.496 -1.121 0 N-CA-C 104.397 -2.445 . . . . 0.0 104.397 161.826 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -131.96 153.29 20.45 Favored Glycine 0 CA--C 1.484 -1.848 0 N-CA-C 107.688 -2.165 . . . . 0.0 107.688 -175.807 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 36.7 mt-30 -135.58 136.18 40.88 Favored 'General case' 0 CA--C 1.478 -1.791 0 N-CA-C 105.935 -1.876 . . . . 0.0 105.935 175.166 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 27.1 tp -114.39 103.31 10.94 Favored 'General case' 0 N--CA 1.438 -1.063 0 N-CA-C 104.179 -2.526 . . . . 0.0 104.179 176.456 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 24.4 mt -103.25 125.11 57.77 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.973 0 N-CA-C 104.068 -2.568 . . . . 0.0 104.068 -174.23 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 74.2 m -110.28 120.75 43.45 Favored 'General case' 0 CA--C 1.497 -1.091 0 N-CA-C 108.251 -1.018 . . . . 0.0 108.251 -175.653 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 1.8 mp -99.85 138.38 24.38 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.123 0 N-CA-C 104.647 -2.353 . . . . 0.0 104.647 -170.798 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 16.3 tt0 -105.09 127.84 53.07 Favored 'General case' 0 CA--C 1.494 -1.207 0 N-CA-C 102.02 -3.326 . . . . 0.0 102.02 170.692 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 63.5 tp60 -68.38 114.68 7.03 Favored 'General case' 0 C--N 1.355 0.825 0 C-N-CA 123.117 0.567 . . . . 0.0 111.163 -168.77 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 44.4 m-85 59.33 51.68 6.57 Favored 'General case' 0 C--N 1.358 0.936 0 C-N-CA 126.917 2.087 . . . . 0.0 111.703 -175.498 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -164.73 -117.29 0.4 Allowed Glycine 0 N--CA 1.434 -1.464 0 N-CA-C 108.503 -1.839 . . . . 0.0 108.503 178.042 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 24.0 t-80 -82.08 165.52 20.52 Favored 'General case' 0 N--CA 1.441 -0.919 0 C-N-CA 125.706 1.603 . . . . 0.0 110.795 -169.097 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 41.6 mt-30 -139.96 128.67 23.14 Favored 'General case' 0 CA--C 1.495 -1.151 0 N-CA-C 104.192 -2.521 . . . . 0.0 104.192 169.044 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -99.82 154.31 18.44 Favored 'General case' 0 CA--C 1.498 -1.033 0 N-CA-C 105.363 -2.088 . . . . 0.0 105.363 175.598 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 7.6 p -135.26 135.71 51.93 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.885 0 N-CA-C 107.929 -1.137 . . . . 0.0 107.929 177.533 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 48.6 m -122.01 141.5 51.28 Favored 'General case' 0 N--CA 1.44 -0.939 0 N-CA-C 103.143 -2.91 . . . . 0.0 103.143 175.742 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 32.2 ttm180 -131.72 139.42 49.0 Favored 'General case' 0 CA--C 1.502 -0.891 0 N-CA-C 107.805 -1.183 . . . . 0.0 107.805 170.346 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 8.2 p90 -146.25 179.58 7.41 Favored 'General case' 0 N--CA 1.439 -0.979 0 N-CA-C 105.807 -1.923 . . . . 0.0 105.807 177.985 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 52.9 m-20 -128.09 152.95 47.37 Favored 'General case' 0 CA--C 1.5 -0.96 0 N-CA-C 105.757 -1.942 . . . . 0.0 105.757 169.481 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 21.8 p90 -143.56 166.37 25.02 Favored 'General case' 0 CA--C 1.485 -1.548 0 N-CA-C 107.498 -1.297 . . . . 0.0 107.498 170.42 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 27.8 p -118.56 143.3 46.86 Favored 'General case' 0 CA--C 1.497 -1.082 0 N-CA-C 106.051 -1.833 . . . . 0.0 106.051 173.672 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 30.3 m -118.39 113.18 21.0 Favored 'General case' 0 CA--C 1.494 -1.185 0 N-CA-C 101.576 -3.49 . . . . 0.0 101.576 170.068 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 92' ' ' THR . . . . . 0.504 ' HA ' ' H ' ' A' ' 66' ' ' GLY . 10.0 t -157.57 -37.37 0.07 Allowed 'General case' 0 N--CA 1.437 -1.088 0 N-CA-C 107.819 -1.178 . . . . 0.0 107.819 -169.088 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 89.4 p . . . . . 0 C--O 1.259 1.592 0 C-N-CA 126.962 2.105 . . . . 0.0 112.192 -174.66 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.436 -1.353 0 N-CA-C 107.075 -2.41 . . . . 0.0 107.075 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_exo -60.23 146.8 95.62 Favored 'Trans proline' 0 N--CA 1.446 -1.309 0 C-N-CA 123.151 2.567 . . . . 0.0 115.553 -169.676 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 6.7 t -77.42 153.12 5.44 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.773 0 C-N-CA 127.631 2.372 . . . . 0.0 105.424 174.309 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 94.7 mt-10 -100.27 95.26 6.67 Favored 'General case' 0 CA--C 1.494 -1.19 0 CA-C-O 121.885 0.85 . . . . 0.0 108.742 -170.621 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 1.8 p -115.3 136.05 53.32 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.999 0 C-N-CA 124.938 1.295 . . . . 0.0 108.365 -164.777 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 83.3 m-85 . . . . . 0 CA--C 1.498 -1.03 0 C-N-CA 125.063 1.345 . . . . 0.0 108.589 -179.14 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo . . . . . 0 N--CA 1.449 -1.089 0 CA-C-O 118.293 -0.794 . . . . 0.0 110.565 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 10.0 p-10 -165.8 -39.22 0.03 OUTLIER 'General case' 0 CA--C 1.488 -1.412 0 O-C-N 123.711 0.632 . . . . 0.0 110.469 -174.854 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 15.5 p -126.42 138.22 53.51 Favored 'General case' 0 CA--C 1.489 -1.371 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 -169.078 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 57.5 t-80 -117.56 113.75 38.34 Favored Pre-proline 0 N--CA 1.438 -1.027 0 CA-C-N 114.238 -1.346 . . . . 0.0 107.878 -175.377 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 62.5 Cg_endo -78.28 128.6 9.02 Favored 'Trans proline' 0 N--CA 1.45 -1.04 0 C-N-CA 122.949 2.433 . . . . 0.0 110.405 175.813 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 9.6 mm -105.92 136.08 41.65 Favored 'Isoleucine or valine' 0 C--N 1.354 0.792 0 N-CA-C 103.485 -2.783 . . . . 0.0 103.485 169.833 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 67.5 mt-30 -136.41 147.8 47.46 Favored 'General case' 0 CA--C 1.495 -1.148 0 N-CA-C 104.562 -2.384 . . . . 0.0 104.562 174.18 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 45.9 p90 -147.15 170.04 18.03 Favored 'General case' 0 CA--C 1.494 -1.186 0 N-CA-C 108.002 -1.11 . . . . 0.0 108.002 -175.673 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 26.6 m-80 -136.01 131.82 35.5 Favored 'General case' 0 CA--C 1.49 -1.354 0 N-CA-C 105.377 -2.083 . . . . 0.0 105.377 177.635 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -101.2 170.91 5.94 Favored Pre-proline 0 N--CA 1.439 -0.992 0 C-N-CA 124.541 1.136 . . . . 0.0 108.402 -172.651 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_exo -64.9 165.32 21.63 Favored 'Trans proline' 0 CA--C 1.51 -0.694 0 C-N-CA 123.701 2.934 . . . . 0.0 112.83 173.712 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 79.8 mt-30 -81.51 -55.61 0.62 Allowed Pre-proline 0 N--CA 1.442 -0.829 0 CA-C-O 115.612 -2.137 . . . . 0.0 112.042 -175.58 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_endo -75.29 173.56 14.3 Favored 'Trans proline' 0 CA--C 1.509 -0.726 0 CA-C-N 125.797 3.106 . . . . 0.0 110.431 -179.581 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 52.3 p -73.1 123.83 24.35 Favored 'General case' 0 C--N 1.355 0.845 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 179.014 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 17.7 t-80 -160.85 -50.78 0.05 OUTLIER 'General case' 0 CA--C 1.492 -1.253 0 N-CA-C 106.639 -1.615 . . . . 0.0 106.639 -165.143 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 35.5 mt -116.7 140.3 39.73 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.169 0 N-CA-C 105.217 -2.142 . . . . 0.0 105.217 -175.625 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 72.8 m -106.06 -87.55 0.46 Allowed 'General case' 0 N--CA 1.429 -1.484 0 N-CA-C 105.916 -1.883 . . . . 0.0 105.916 178.605 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 53.9 mtmt -91.41 172.33 8.6 Favored 'General case' 0 CA--C 1.485 -1.547 0 C-N-CA 124.927 1.291 . . . . 0.0 108.235 -166.838 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 36.1 m-85 -131.5 151.91 51.17 Favored 'General case' 0 CA--C 1.496 -1.11 0 N-CA-C 105.071 -2.196 . . . . 0.0 105.071 169.164 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 24.6 mt -121.28 134.23 65.3 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.162 0 N-CA-C 101.939 -3.356 . . . . 0.0 101.939 164.941 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 6.5 mt -105.93 123.6 48.23 Favored 'General case' 0 CA--C 1.48 -1.748 0 N-CA-C 104.011 -2.589 . . . . 0.0 104.011 166.669 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 42.8 ttp85 -127.7 123.5 35.58 Favored 'General case' 0 N--CA 1.436 -1.128 0 N-CA-C 105.515 -2.032 . . . . 0.0 105.515 -179.094 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 41.6 p90 -136.86 150.29 48.19 Favored 'General case' 0 CA--C 1.503 -0.841 0 N-CA-C 107.681 -1.229 . . . . 0.0 107.681 -170.89 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 43.3 ptt85 -141.33 158.4 63.99 Favored Pre-proline 0 CA--C 1.499 -1.0 0 N-CA-C 105.754 -1.943 . . . . 0.0 105.754 168.713 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -72.3 164.96 34.04 Favored 'Trans proline' 0 N--CA 1.453 -0.856 0 C-N-CA 123.306 2.671 . . . . 0.0 107.811 162.45 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 5.4 ptmm? -63.66 88.02 0.04 OUTLIER 'General case' 0 C--N 1.357 0.914 0 CA-C-O 122.584 1.183 . . . . 0.0 112.592 172.402 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 31.5 m120 -130.39 -132.09 0.21 Allowed 'General case' 0 N--CA 1.44 -0.952 0 N-CA-C 104.593 -2.373 . . . . 0.0 104.593 176.302 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 57.0 p -99.44 174.24 6.37 Favored 'General case' 0 C--N 1.355 0.811 0 N-CA-C 107.671 -1.233 . . . . 0.0 107.671 176.388 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 9.5 m -100.6 41.63 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.354 0.772 0 C-N-CA 124.758 1.223 . . . . 0.0 108.142 179.128 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -85.13 -99.62 0.68 Allowed Glycine 0 C--N 1.355 1.587 0 N-CA-C 108.532 -1.827 . . . . 0.0 108.532 -179.618 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 96.3 mtm-85 -97.93 141.55 30.76 Favored 'General case' 0 CA--C 1.499 -1.012 0 N-CA-C 107.204 -1.406 . . . . 0.0 107.204 176.278 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 14.6 m95 -121.63 171.78 8.59 Favored 'General case' 0 N--CA 1.439 -1.014 0 N-CA-C 105.413 -2.069 . . . . 0.0 105.413 -177.366 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -101.72 150.27 23.3 Favored 'General case' 0 CA--C 1.486 -1.491 0 N-CA-C 105.072 -2.196 . . . . 0.0 105.072 169.167 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -153.96 158.18 40.27 Favored 'General case' 0 CA--C 1.495 -1.171 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 179.841 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -138.59 160.12 40.39 Favored 'General case' 0 N--CA 1.438 -1.068 0 N-CA-C 105.186 -2.153 . . . . 0.0 105.186 173.94 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 81.6 m -115.88 123.15 47.4 Favored 'General case' 0 CA--C 1.496 -1.12 0 N-CA-C 104.775 -2.306 . . . . 0.0 104.775 177.895 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 3.8 mm -101.18 135.59 19.88 Favored Pre-proline 0 N--CA 1.437 -1.095 0 N-CA-C 105.669 -1.975 . . . . 0.0 105.669 -176.349 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 95.4 Cg_exo -63.69 161.02 33.81 Favored 'Trans proline' 0 CA--C 1.508 -0.805 0 C-N-CA 123.354 2.703 . . . . 0.0 112.257 172.093 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -78.38 -18.25 76.39 Favored Glycine 0 C--N 1.352 1.448 0 C-N-CA 123.439 0.543 . . . . 0.0 113.491 -172.685 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 48.0 p-80 -83.78 -27.18 29.02 Favored 'General case' 0 C--N 1.355 0.838 0 CA-C-N 117.695 0.747 . . . . 0.0 109.923 179.737 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 88.3 mt -88.74 130.43 35.34 Favored 'General case' 0 CA--C 1.498 -1.043 0 N-CA-C 107.977 -1.119 . . . . 0.0 107.977 177.539 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 7.7 p30 -117.98 16.67 14.23 Favored 'General case' 0 CA--C 1.501 -0.929 0 C-N-CA 124.359 1.064 . . . . 0.0 108.935 -177.026 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 35.9 p -144.53 161.77 38.24 Favored 'General case' 0 N--CA 1.438 -1.039 0 N-CA-C 107.204 -1.406 . . . . 0.0 107.204 -179.796 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 12.0 t80 -152.83 178.65 9.42 Favored 'General case' 0 N--CA 1.438 -1.032 0 N-CA-C 106.955 -1.498 . . . . 0.0 106.955 179.687 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 80.8 m -144.34 115.59 7.98 Favored 'General case' 0 N--CA 1.426 -1.633 0 N-CA-C 103.752 -2.684 . . . . 0.0 103.752 174.421 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 53.9 mt -92.58 108.38 20.18 Favored 'Isoleucine or valine' 0 C--N 1.354 0.767 0 N-CA-C 105.236 -2.135 . . . . 0.0 105.236 175.906 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 10.0 mtmp? -108.23 163.74 12.91 Favored 'General case' 0 CA--C 1.498 -1.054 0 CA-C-O 121.547 0.689 . . . . 0.0 109.143 -175.531 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 80.37 50.67 5.28 Favored Glycine 0 CA--C 1.489 -1.552 0 N-CA-C 108.713 -1.755 . . . . 0.0 108.713 174.987 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 75.7 mt -121.72 163.81 18.45 Favored 'General case' 0 CA--C 1.498 -1.027 0 N-CA-C 106.954 -1.499 . . . . 0.0 106.954 -175.748 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 53.2 mtmt -98.78 147.83 33.73 Favored Pre-proline 0 N--CA 1.44 -0.926 0 N-CA-C 107.026 -1.472 . . . . 0.0 107.026 -177.096 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -76.58 162.66 32.82 Favored 'Trans proline' 0 N--CA 1.451 -1.025 0 C-N-CA 122.95 2.433 . . . . 0.0 109.85 169.832 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' GLY . . . . . 0.444 ' H ' ' HA ' ' A' ' 92' ' ' THR . . . 63.34 23.44 66.49 Favored Glycine 0 N--CA 1.428 -1.84 0 C-N-CA 127.417 2.437 . . . . 0.0 116.619 174.905 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 6.5 p -128.84 145.39 35.76 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.857 0 N-CA-C 107.966 -1.124 . . . . 0.0 107.966 -179.684 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 10.7 p -96.83 129.94 46.15 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.857 0 CA-C-O 123.187 1.47 . . . . 0.0 108.537 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 80.0 m-85 -104.65 145.11 30.79 Favored 'General case' 0 N--CA 1.432 -1.373 0 N-CA-C 106.435 -1.691 . . . . 0.0 106.435 176.563 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -91.02 133.1 35.58 Favored 'General case' 0 N--CA 1.442 -0.855 0 N-CA-C 105.336 -2.098 . . . . 0.0 105.336 159.502 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -130.26 158.69 22.51 Favored Glycine 0 C--N 1.355 1.61 0 N-CA-C 108.229 -1.948 . . . . 0.0 108.229 -179.897 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 32.0 mt-30 -149.77 138.57 20.96 Favored 'General case' 0 CA--C 1.484 -1.561 0 N-CA-C 105.422 -2.066 . . . . 0.0 105.422 -178.717 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 52.7 tp -117.47 98.21 6.28 Favored 'General case' 0 N--CA 1.437 -1.08 0 N-CA-C 104.846 -2.279 . . . . 0.0 104.846 179.436 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 48.0 mt -89.63 133.98 30.13 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.962 0 N-CA-C 104.558 -2.386 . . . . 0.0 104.558 -179.585 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 12.1 p -117.13 117.4 29.49 Favored 'General case' 0 N--CA 1.438 -1.075 0 N-CA-C 107.728 -1.212 . . . . 0.0 107.728 -178.427 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 2.6 mp -94.07 130.67 42.66 Favored 'Isoleucine or valine' 0 CA--C 1.487 -1.478 0 N-CA-C 103.455 -2.795 . . . . 0.0 103.455 -172.677 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 71.4 mt-30 -101.84 161.89 13.32 Favored 'General case' 0 CA--C 1.491 -1.295 0 CA-C-N 114.849 -1.069 . . . . 0.0 108.817 -169.845 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 14.4 pt20 -76.29 34.0 0.13 Allowed 'General case' 0 C--N 1.354 0.794 0 C-N-CA 126.537 1.935 . . . . 0.0 113.186 173.943 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 6.4 t80 -148.67 14.13 0.94 Allowed 'General case' 0 N--CA 1.437 -1.095 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 178.366 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 80.26 1.84 88.57 Favored Glycine 0 C--N 1.351 1.412 0 C-N-CA 123.897 0.761 . . . . 0.0 112.732 176.864 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 48.8 t-80 -81.9 158.47 23.96 Favored 'General case' 0 N--CA 1.44 -0.953 0 N-CA-C 107.842 -1.17 . . . . 0.0 107.842 -178.918 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 71.7 mt-30 -138.33 110.29 7.24 Favored 'General case' 0 CA--C 1.491 -1.322 0 N-CA-C 102.854 -3.017 . . . . 0.0 102.854 178.976 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 16.8 tp10 -100.76 132.1 46.32 Favored 'General case' 0 CA--C 1.495 -1.153 0 N-CA-C 105.215 -2.143 . . . . 0.0 105.215 -179.94 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 6.6 p -109.25 134.94 49.69 Favored 'Isoleucine or valine' 0 C--N 1.355 0.818 0 N-CA-C 107.58 -1.267 . . . . 0.0 107.58 -174.061 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 90.8 m -110.66 138.61 46.83 Favored 'General case' 0 N--CA 1.44 -0.927 0 N-CA-C 102.477 -3.157 . . . . 0.0 102.477 171.272 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 16.7 ptm180 -129.67 152.39 49.23 Favored 'General case' 0 CA--C 1.499 -1.011 0 CA-C-N 118.84 0.745 . . . . 0.0 110.025 176.918 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 18.5 p90 -165.53 -177.95 4.67 Favored 'General case' 0 CA--C 1.5 -0.956 0 N-CA-C 106.323 -1.732 . . . . 0.0 106.323 -175.731 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 45.7 p-10 -134.22 158.16 44.42 Favored 'General case' 0 N--CA 1.44 -0.945 0 N-CA-C 106.286 -1.746 . . . . 0.0 106.286 166.608 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 24.3 p90 -143.1 164.61 29.67 Favored 'General case' 0 CA--C 1.482 -1.641 0 N-CA-C 106.785 -1.561 . . . . 0.0 106.785 170.838 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 38.4 p -113.73 141.61 47.05 Favored 'General case' 0 CA--C 1.498 -1.042 0 N-CA-C 105.919 -1.882 . . . . 0.0 105.919 172.749 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 97.5 m -109.57 112.84 25.16 Favored 'General case' 0 CA--C 1.491 -1.325 1 N-CA-C 100.189 -4.004 . . . . 0.0 100.189 168.041 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 92' ' ' THR . . . . . 0.444 ' HA ' ' H ' ' A' ' 66' ' ' GLY . 11.9 t -159.24 149.79 19.49 Favored 'General case' 0 N--CA 1.437 -1.113 0 N-CA-C 105.375 -2.083 . . . . 0.0 105.375 -174.981 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 25.7 t . . . . . 0 C--O 1.261 1.708 0 N-CA-C 104.89 -2.263 . . . . 0.0 104.89 171.411 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.435 -1.383 0 N-CA-C 106.309 -2.716 . . . . 0.0 106.309 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 92.5 Cg_exo -62.37 138.14 69.46 Favored 'Trans proline' 0 N--CA 1.445 -1.356 0 C-N-CA 122.923 2.416 . . . . 0.0 112.973 -171.282 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 2.9 t -77.76 152.65 5.35 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.672 0 C-N-CA 126.443 1.897 . . . . 0.0 106.098 -179.805 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 52.7 mt-10 -96.16 91.34 5.87 Favored 'General case' 0 CA--C 1.494 -1.201 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 -173.335 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.409 ' HA ' ' HA ' ' A' ' 22' ' ' TRP . 2.1 p -110.22 129.43 65.27 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.075 0 N-CA-C 107.438 -1.319 . . . . 0.0 107.438 -164.967 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 75.6 m-85 . . . . . 0 CA--C 1.496 -1.109 0 N-CA-C 106.043 -1.836 . . . . 0.0 106.043 -175.035 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 98.7 Cg_endo . . . . . 0 N--CA 1.453 -0.874 0 CA-C-O 118.392 -0.753 . . . . 0.0 110.156 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 6.9 p-10 -102.79 -40.96 6.35 Favored 'General case' 0 CA--C 1.49 -1.356 0 C-N-CA 123.583 0.753 . . . . 0.0 109.61 -172.633 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 35.0 p -110.31 153.62 24.63 Favored 'General case' 0 CA--C 1.495 -1.154 0 N-CA-C 107.081 -1.452 . . . . 0.0 107.081 176.189 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 45.0 t-80 -136.85 98.83 10.47 Favored Pre-proline 0 N--CA 1.435 -1.224 0 N-CA-C 106.778 -1.564 . . . . 0.0 106.778 178.695 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -76.51 130.41 11.76 Favored 'Trans proline' 0 N--CA 1.447 -1.252 0 C-N-CA 122.76 2.307 . . . . 0.0 110.005 -177.441 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 14.5 mm -107.69 148.06 12.18 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.017 0 N-CA-C 103.088 -2.93 . . . . 0.0 103.088 176.127 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 4.4 pt20 -149.68 152.3 35.14 Favored 'General case' 0 CA--C 1.489 -1.377 0 N-CA-C 104.299 -2.482 . . . . 0.0 104.299 167.183 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' TRP . . . . . 0.409 ' HA ' ' HA ' ' A' ' 6' ' ' VAL . 44.6 p90 -147.15 166.98 25.31 Favored 'General case' 0 N--CA 1.436 -1.142 0 N-CA-C 106.595 -1.632 . . . . 0.0 106.595 -169.755 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 40.9 m-80 -138.81 132.5 30.68 Favored 'General case' 0 CA--C 1.49 -1.335 0 N-CA-C 107.487 -1.301 . . . . 0.0 107.487 -179.051 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -92.69 175.53 3.18 Favored Pre-proline 0 N--CA 1.44 -0.947 0 C-N-CA 125.696 1.599 . . . . 0.0 109.865 -167.122 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 78.6 Cg_exo -63.94 164.87 20.51 Favored 'Trans proline' 0 N--CA 1.455 -0.757 0 C-N-CA 123.672 2.914 . . . . 0.0 112.491 169.7 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 71.1 tp60 -80.92 -42.42 1.2 Allowed Pre-proline 0 N--CA 1.444 -0.759 0 CA-C-O 115.911 -1.995 . . . . 0.0 110.758 -175.799 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -70.02 -16.49 36.49 Favored 'Trans proline' 0 CA--C 1.512 -0.623 0 CA-C-N 125.382 2.958 . . . . 0.0 112.418 172.505 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 10.4 t 64.95 78.73 0.27 Allowed 'General case' 0 C--N 1.358 0.969 0 C-N-CA 126.545 1.938 . . . . 0.0 109.652 -176.799 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 20.1 t-160 -91.6 -6.68 51.9 Favored 'General case' 0 N--CA 1.442 -0.857 0 C-N-CA 124.755 1.222 . . . . 0.0 109.319 -177.466 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 84.5 mt -113.74 145.55 19.47 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.99 0 N-CA-C 104.736 -2.32 . . . . 0.0 104.736 -173.251 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 25.2 t -103.95 -87.49 0.43 Allowed 'General case' 0 N--CA 1.43 -1.464 0 N-CA-C 105.96 -1.867 . . . . 0.0 105.96 177.241 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 27.4 mtpp -89.58 167.45 12.94 Favored 'General case' 0 CA--C 1.486 -1.504 0 C-N-CA 125.693 1.597 . . . . 0.0 108.94 -163.546 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 90.9 m-85 -134.53 142.72 47.1 Favored 'General case' 0 CA--C 1.493 -1.244 0 N-CA-C 105.072 -2.196 . . . . 0.0 105.072 172.445 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 16.5 mt -123.04 134.45 66.13 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.178 0 N-CA-C 101.786 -3.413 . . . . 0.0 101.786 171.765 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 2.7 mt -110.8 131.48 55.02 Favored 'General case' 0 CA--C 1.473 -1.982 0 N-CA-C 105.715 -1.957 . . . . 0.0 105.715 173.416 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 2.2 mpt_? -115.65 157.72 23.8 Favored 'General case' 0 N--CA 1.428 -1.529 0 N-CA-C 104.981 -2.229 . . . . 0.0 104.981 172.506 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 37.5 p90 -151.01 136.26 17.64 Favored 'General case' 0 N--CA 1.432 -1.363 0 N-CA-C 105.695 -1.965 . . . . 0.0 105.695 171.204 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 15.3 ttp180 -137.39 135.79 19.81 Favored Pre-proline 0 CA--C 1.498 -1.038 0 N-CA-C 103.413 -2.81 . . . . 0.0 103.413 -178.716 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -77.33 155.15 32.48 Favored 'Trans proline' 0 CA--C 1.502 -1.086 0 CA-C-N 123.292 2.211 . . . . 0.0 108.686 179.563 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 70.8 mmtt -73.14 60.71 0.58 Allowed 'General case' 0 C--N 1.356 0.88 0 C-N-CA 125.704 1.601 . . . . 0.0 110.465 170.157 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 29.0 m120 -154.57 -56.93 0.11 Allowed 'General case' 0 N--CA 1.436 -1.17 0 N-CA-C 102.888 -3.004 . . . . 0.0 102.888 -173.163 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 34.8 m -85.31 160.75 19.75 Favored 'General case' 0 N--CA 1.44 -0.941 0 N-CA-C 108.374 -0.973 . . . . 0.0 108.374 178.181 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 17.4 m -131.69 -5.48 1.97 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.784 0 C-N-CA 124.522 1.129 . . . . 0.0 108.821 -173.827 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -142.85 -43.48 0.05 OUTLIER Glycine 0 C--N 1.356 1.644 0 N-CA-C 109.311 -1.516 . . . . 0.0 109.311 -172.656 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 79.7 ttt180 -80.92 126.16 31.02 Favored 'General case' 0 CA--C 1.502 -0.887 0 C-N-CA 124.183 0.993 . . . . 0.0 108.685 -176.89 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -155.97 -177.75 6.8 Favored 'General case' 0 CA--C 1.492 -1.269 0 CA-C-O 121.426 0.632 . . . . 0.0 109.825 -179.681 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 66.7 mttm -130.76 159.91 35.91 Favored 'General case' 0 N--CA 1.435 -1.211 0 N-CA-C 105.402 -2.074 . . . . 0.0 105.402 -175.698 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -149.44 159.84 43.95 Favored 'General case' 0 N--CA 1.434 -1.246 0 N-CA-C 107.691 -1.225 . . . . 0.0 107.691 175.947 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -141.29 157.97 44.51 Favored 'General case' 0 CA--C 1.496 -1.115 0 N-CA-C 106.398 -1.705 . . . . 0.0 106.398 170.999 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 89.0 m -118.84 127.06 53.16 Favored 'General case' 0 CA--C 1.5 -0.972 0 N-CA-C 105.954 -1.869 . . . . 0.0 105.954 -178.331 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 5.3 mp -114.39 133.91 22.38 Favored Pre-proline 0 N--CA 1.438 -1.072 0 N-CA-C 104.893 -2.262 . . . . 0.0 104.893 -175.695 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 62.6 Cg_exo -63.89 169.07 10.87 Favored 'Trans proline' 0 CA--C 1.508 -0.807 0 C-N-CA 123.387 2.724 . . . . 0.0 113.376 177.155 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -78.42 -19.74 73.39 Favored Glycine 0 C--N 1.351 1.398 0 C-N-CA 123.171 0.415 . . . . 0.0 113.559 -173.851 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 48.8 p-80 -83.84 -28.15 28.22 Favored 'General case' 0 C--N 1.356 0.887 0 CA-C-N 117.755 0.778 . . . . 0.0 109.962 -179.418 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 84.4 mt -88.77 130.49 35.35 Favored 'General case' 0 CA--C 1.501 -0.917 0 N-CA-C 107.723 -1.214 . . . . 0.0 107.723 177.162 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 8.0 p-10 -116.87 10.2 14.06 Favored 'General case' 0 CA--C 1.501 -0.912 0 C-N-CA 123.994 0.918 . . . . 0.0 110.098 -172.203 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 60.1 p -143.03 167.76 21.31 Favored 'General case' 0 N--CA 1.44 -0.942 0 N-CA-C 107.854 -1.165 . . . . 0.0 107.854 -178.631 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 8.3 t80 -155.48 178.27 10.42 Favored 'General case' 0 N--CA 1.441 -0.921 0 N-CA-C 108.023 -1.103 . . . . 0.0 108.023 -176.851 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 97.2 m -145.01 114.91 7.36 Favored 'General case' 0 N--CA 1.432 -1.34 0 N-CA-C 103.859 -2.645 . . . . 0.0 103.859 177.347 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 54.0 mt -97.02 96.68 5.59 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.822 0 N-CA-C 105.767 -1.938 . . . . 0.0 105.767 175.566 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.94 161.76 13.41 Favored 'General case' 0 CA--C 1.498 -1.031 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 -178.381 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 83.7 52.47 3.69 Favored Glycine 0 C--N 1.353 1.501 0 N-CA-C 108.866 -1.694 . . . . 0.0 108.866 177.637 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 76.3 mt -119.19 166.04 13.46 Favored 'General case' 0 CA--C 1.496 -1.11 0 N-CA-C 106.736 -1.579 . . . . 0.0 106.736 -179.51 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 61.1 mttp -97.66 156.59 35.91 Favored Pre-proline 0 N--CA 1.441 -0.898 0 N-CA-C 106.859 -1.534 . . . . 0.0 106.859 -175.666 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 66.2 Cg_endo -77.45 155.63 32.19 Favored 'Trans proline' 0 N--CA 1.451 -0.987 0 C-N-CA 122.808 2.339 . . . . 0.0 109.844 172.063 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 60.15 29.12 67.75 Favored Glycine 0 C--N 1.355 1.584 0 C-N-CA 126.674 2.083 . . . . 0.0 116.628 170.507 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 10.6 p -122.35 138.99 50.65 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.122 0 N-CA-C 107.747 -1.205 . . . . 0.0 107.747 179.472 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 2.4 p -97.74 134.99 33.83 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.818 0 N-CA-C 106.663 -1.606 . . . . 0.0 106.663 177.946 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 94.4 m-85 -114.23 154.4 27.98 Favored 'General case' 0 CA--C 1.502 -0.878 0 C-N-CA 124.97 1.308 . . . . 0.0 107.617 179.492 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -95.18 142.13 27.98 Favored 'General case' 0 CA--C 1.505 -0.787 0 N-CA-C 105.516 -2.031 . . . . 0.0 105.516 155.815 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -132.52 143.66 15.33 Favored Glycine 0 CA--C 1.487 -1.683 0 N-CA-C 107.565 -2.214 . . . . 0.0 107.565 -177.614 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 32.3 mt-30 -135.94 132.59 36.62 Favored 'General case' 0 CA--C 1.489 -1.375 0 N-CA-C 106.361 -1.718 . . . . 0.0 106.361 -178.189 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 47.2 tp -113.9 97.72 6.56 Favored 'General case' 0 N--CA 1.438 -1.042 0 N-CA-C 104.408 -2.441 . . . . 0.0 104.408 -176.757 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 1.8 mp -88.7 125.34 41.88 Favored 'Isoleucine or valine' 0 CA--C 1.499 -1.013 0 N-CA-C 103.585 -2.746 . . . . 0.0 103.585 -176.781 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 12.8 p -121.1 109.27 14.82 Favored 'General case' 0 N--CA 1.436 -1.129 0 N-CA-C 108.214 -1.032 . . . . 0.0 108.214 -170.405 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 29.7 mt -102.1 140.79 19.71 Favored 'Isoleucine or valine' 0 CA--C 1.487 -1.453 0 N-CA-C 105.787 -1.931 . . . . 0.0 105.787 -165.183 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 72.1 mt-30 -87.97 -178.86 6.1 Favored 'General case' 0 CA--C 1.505 -0.753 0 C-N-CA 123.49 0.716 . . . . 0.0 109.47 -177.374 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 85.2 mt-30 -74.3 84.03 1.91 Allowed 'General case' 0 C--N 1.357 0.928 0 C-N-CA 124.779 1.232 . . . . 0.0 110.753 175.465 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 82.6 m-85 58.5 28.38 16.88 Favored 'General case' 0 C--N 1.359 1.006 0 C-N-CA 126.75 2.02 . . . . 0.0 112.27 -177.682 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -112.53 -118.71 3.61 Favored Glycine 0 C--N 1.356 1.683 0 N-CA-C 108.88 -1.688 . . . . 0.0 108.88 -173.729 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 19.0 t60 -80.9 169.11 17.96 Favored 'General case' 0 N--CA 1.441 -0.89 0 C-N-CA 125.005 1.322 . . . . 0.0 109.323 -174.761 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 22.3 tt0 -127.47 109.3 11.61 Favored 'General case' 0 N--CA 1.434 -1.229 0 N-CA-C 101.842 -3.392 . . . . 0.0 101.842 170.377 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 4.3 tm-20 -102.83 153.94 19.69 Favored 'General case' 0 CA--C 1.506 -0.748 0 N-CA-C 105.721 -1.955 . . . . 0.0 105.721 -171.938 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 4.4 p -127.94 128.89 69.54 Favored 'Isoleucine or valine' 0 C--N 1.354 0.771 0 N-CA-C 108.274 -1.01 . . . . 0.0 108.274 179.874 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 52.1 m -109.83 139.09 45.29 Favored 'General case' 0 N--CA 1.443 -0.807 0 N-CA-C 102.432 -3.173 . . . . 0.0 102.432 171.694 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 51.6 ttt85 -130.99 142.8 50.37 Favored 'General case' 0 CA--C 1.502 -0.866 0 N-CA-C 108.428 -0.953 . . . . 0.0 108.428 -179.076 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 15.7 p90 -157.07 -176.39 5.95 Favored 'General case' 0 N--CA 1.439 -1.003 0 N-CA-C 105.78 -1.933 . . . . 0.0 105.78 178.769 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 1.4 p30 -136.15 157.02 47.82 Favored 'General case' 0 N--CA 1.439 -0.999 0 N-CA-C 106.296 -1.742 . . . . 0.0 106.296 167.571 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 36.9 p90 -144.45 174.51 10.87 Favored 'General case' 0 CA--C 1.487 -1.469 0 N-CA-C 106.03 -1.841 . . . . 0.0 106.03 171.759 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 10.1 t -142.31 154.37 44.64 Favored 'General case' 0 N--CA 1.439 -0.988 0 N-CA-C 106.7 -1.592 . . . . 0.0 106.7 176.789 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 4.3 p -113.27 120.94 42.89 Favored 'General case' 0 N--CA 1.436 -1.16 0 N-CA-C 101.264 -3.606 . . . . 0.0 101.264 168.184 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 15.0 t -157.71 21.47 0.27 Allowed 'General case' 0 N--CA 1.442 -0.85 0 N-CA-C 106.451 -1.685 . . . . 0.0 106.451 -173.049 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 19.7 m . . . . . 0 C--O 1.26 1.611 0 C-N-CA 123.356 0.662 . . . . 0.0 109.671 -175.77 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.436 -1.317 0 N-CA-C 105.79 -2.924 . . . . 0.0 105.79 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 8.8 Cg_exo -54.61 146.05 55.89 Favored 'Trans proline' 0 N--CA 1.449 -1.133 0 C-N-CA 124.329 3.353 . . . . 0.0 114.898 -168.241 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 5.5 t -77.46 152.5 5.48 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.716 0 N-CA-C 105.436 -2.061 . . . . 0.0 105.436 -177.904 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 92.8 mt-10 -98.54 89.44 4.4 Favored 'General case' 0 CA--C 1.493 -1.234 0 CA-C-O 122.13 0.967 . . . . 0.0 108.666 -169.729 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 2.4 p -111.52 132.33 60.39 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.08 0 N-CA-C 106.979 -1.489 . . . . 0.0 106.979 -166.946 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 67.9 m-85 . . . . . 0 CA--C 1.498 -1.055 0 N-CA-C 106.125 -1.805 . . . . 0.0 106.125 -174.61 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo . . . . . 0 CA--C 1.504 -1.008 0 CA-C-O 118.738 -0.609 . . . . 0.0 110.97 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 1.9 p30 -100.16 -45.43 5.64 Favored 'General case' 0 CA--C 1.488 -1.417 0 C-N-CA 123.596 0.759 . . . . 0.0 109.985 -166.516 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 75.2 m -107.63 158.65 17.08 Favored 'General case' 0 CA--C 1.496 -1.106 0 N-CA-C 107.794 -1.187 . . . . 0.0 107.794 -179.346 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 11.7 t-160 -135.74 85.15 30.87 Favored Pre-proline 0 N--CA 1.438 -1.048 0 N-CA-C 105.593 -2.003 . . . . 0.0 105.593 172.884 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 64.7 Cg_endo -81.78 98.1 0.96 Allowed 'Trans proline' 0 N--CA 1.451 -0.987 0 C-N-CA 123.325 2.683 . . . . 0.0 110.156 -174.713 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.51 HD11 HD11 ' A' ' 35' ' ' LEU . 3.0 pt -97.6 173.21 1.0 Allowed 'Isoleucine or valine' 0 CA--C 1.499 -0.99 0 CA-C-O 121.181 0.515 . . . . 0.0 109.992 -173.497 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 21' ' ' GLN . . . . . 0.448 ' HA ' ' HA ' ' A' ' 57' ' ' SER . 1.9 pt20 -151.53 161.58 42.45 Favored 'General case' 0 CA--C 1.496 -1.099 0 N-CA-C 105.699 -1.963 . . . . 0.0 105.699 164.079 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 42.4 p90 -139.62 162.82 34.17 Favored 'General case' 0 CA--C 1.496 -1.122 0 N-CA-C 106.285 -1.746 . . . . 0.0 106.285 -177.679 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 3.1 m120 -127.94 124.48 37.43 Favored 'General case' 0 CA--C 1.491 -1.3 0 N-CA-C 106.183 -1.784 . . . . 0.0 106.183 -179.505 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -105.65 173.38 3.27 Favored Pre-proline 0 N--CA 1.439 -1.012 0 C-N-CA 125.536 1.535 . . . . 0.0 108.181 -169.71 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_exo -63.63 151.2 86.17 Favored 'Trans proline' 0 N--CA 1.455 -0.76 0 C-N-CA 123.732 2.955 . . . . 0.0 112.266 173.532 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 64.8 tt0 -82.05 -40.64 0.96 Allowed Pre-proline 0 N--CA 1.444 -0.76 0 CA-C-O 115.832 -2.033 . . . . 0.0 111.837 -174.742 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 77.1 Cg_exo -70.77 -3.52 12.85 Favored 'Trans proline' 0 CA--C 1.514 -0.481 0 CA-C-N 125.403 2.965 . . . . 0.0 113.818 177.175 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 10.0 t 71.33 78.08 0.17 Allowed 'General case' 0 C--N 1.358 0.937 0 C-N-CA 126.38 1.872 . . . . 0.0 109.252 -179.423 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 82.1 t60 -89.23 -30.15 18.73 Favored 'General case' 0 N--CA 1.441 -0.906 0 C-N-CA 124.696 1.198 . . . . 0.0 108.289 178.166 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 90.3 mt -108.83 146.41 14.52 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.107 0 N-CA-C 105.164 -2.162 . . . . 0.0 105.164 -171.204 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 32.9 t -102.69 -87.77 0.41 Allowed 'General case' 0 N--CA 1.428 -1.572 0 N-CA-C 104.531 -2.396 . . . . 0.0 104.531 176.891 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 50.3 mtpt -89.46 167.07 13.28 Favored 'General case' 0 CA--C 1.489 -1.4 0 C-N-CA 124.91 1.284 . . . . 0.0 108.85 -164.418 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 63.1 m-85 -132.09 142.62 49.58 Favored 'General case' 0 CA--C 1.497 -1.081 0 N-CA-C 105.035 -2.209 . . . . 0.0 105.035 170.987 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 53.7 mt -119.68 136.12 57.84 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.189 0 N-CA-C 101.156 -3.646 . . . . 0.0 101.156 170.503 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.51 HD11 HD11 ' A' ' 20' ' ' ILE . 5.9 mt -110.42 132.53 54.1 Favored 'General case' 0 CA--C 1.47 -2.132 0 N-CA-C 103.823 -2.658 . . . . 0.0 103.823 166.644 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 17.0 ptp180 -132.88 152.04 51.93 Favored 'General case' 0 CA--C 1.49 -1.363 0 N-CA-C 106.787 -1.561 . . . . 0.0 106.787 170.701 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 49.2 p90 -155.19 151.79 28.59 Favored 'General case' 0 N--CA 1.438 -1.04 0 N-CA-C 107.585 -1.265 . . . . 0.0 107.585 -171.22 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 2.8 ptt180 -155.68 153.5 26.31 Favored Pre-proline 0 CA--C 1.497 -1.062 0 N-CA-C 106.466 -1.679 . . . . 0.0 106.466 168.065 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -76.86 156.56 34.85 Favored 'Trans proline' 0 CA--C 1.501 -1.141 0 C-N-CA 122.547 2.165 . . . . 0.0 109.071 -178.231 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 71.4 mmtt -70.35 79.95 0.54 Allowed 'General case' 0 C--N 1.354 0.8 0 C-N-CA 125.065 1.346 . . . . 0.0 110.635 174.598 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 58.9 m-80 -152.01 -81.62 0.1 Allowed 'General case' 0 N--CA 1.437 -1.111 0 N-CA-C 103.43 -2.804 . . . . 0.0 103.43 -179.249 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 50.2 m -93.39 166.14 12.43 Favored 'General case' 0 CA--C 1.5 -0.978 0 C-N-CA 124.055 0.942 . . . . 0.0 108.531 -178.228 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 12.6 m -134.57 25.54 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.754 0 N-CA-C 106.623 -1.621 . . . . 0.0 106.623 178.167 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -89.72 -94.48 1.14 Allowed Glycine 0 C--N 1.356 1.681 0 N-CA-C 109.554 -1.418 . . . . 0.0 109.554 -174.797 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -95.5 166.29 11.93 Favored 'General case' 0 CA--C 1.5 -0.945 0 N-CA-C 107.584 -1.265 . . . . 0.0 107.584 179.418 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -158.29 173.87 16.03 Favored 'General case' 0 CA--C 1.493 -1.238 0 CA-C-O 121.17 0.509 . . . . 0.0 110.142 -177.7 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 8.6 mtpm? -106.53 155.07 19.98 Favored 'General case' 0 CA--C 1.484 -1.565 0 N-CA-C 106.877 -1.527 . . . . 0.0 106.877 -175.404 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 15.6 pt-20 -151.72 161.26 42.96 Favored 'General case' 0 N--CA 1.435 -1.193 0 CA-C-O 121.827 0.823 . . . . 0.0 109.064 173.699 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -138.66 162.39 34.77 Favored 'General case' 0 N--CA 1.44 -0.967 0 N-CA-C 105.765 -1.939 . . . . 0.0 105.765 170.275 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 77.8 m -121.64 126.56 49.32 Favored 'General case' 0 CA--C 1.502 -0.896 0 N-CA-C 105.389 -2.078 . . . . 0.0 105.389 178.233 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 4.2 mp -110.91 133.76 21.17 Favored Pre-proline 0 N--CA 1.436 -1.147 0 N-CA-C 105.12 -2.178 . . . . 0.0 105.12 -176.088 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_exo -63.85 165.15 19.46 Favored 'Trans proline' 0 CA--C 1.507 -0.828 0 C-N-CA 123.519 2.813 . . . . 0.0 113.187 176.743 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -76.52 -18.21 79.27 Favored Glycine 0 C--N 1.351 1.409 0 C-N-CA 123.627 0.632 . . . . 0.0 113.938 -173.933 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 49.8 p-80 -84.02 -28.45 27.66 Favored 'General case' 0 C--N 1.355 0.845 0 CA-C-N 117.992 0.896 . . . . 0.0 110.133 -179.826 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 88.0 mt -88.78 130.76 35.3 Favored 'General case' 0 CA--C 1.499 -0.991 0 N-CA-C 107.911 -1.144 . . . . 0.0 107.911 177.463 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 47.1 p-10 -117.78 12.44 13.89 Favored 'General case' 0 CA--C 1.502 -0.873 0 C-N-CA 123.879 0.872 . . . . 0.0 110.368 -174.887 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' SER . . . . . 0.448 ' HA ' ' HA ' ' A' ' 21' ' ' GLN . 58.0 p -136.8 161.57 35.61 Favored 'General case' 0 CA--C 1.498 -1.052 0 N-CA-C 107.795 -1.187 . . . . 0.0 107.795 -178.379 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 5.2 t80 -147.55 179.51 7.63 Favored 'General case' 0 C--N 1.357 0.933 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 177.198 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 80.2 m -144.92 112.4 6.16 Favored 'General case' 0 N--CA 1.433 -1.295 0 N-CA-C 104.178 -2.527 . . . . 0.0 104.178 174.002 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 50.6 mt -95.18 97.33 6.66 Favored 'Isoleucine or valine' 0 C--N 1.357 0.918 0 N-CA-C 105.333 -2.099 . . . . 0.0 105.333 174.763 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 22.6 pttp -103.82 159.81 15.32 Favored 'General case' 0 CA--C 1.501 -0.919 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 -176.489 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 87.75 51.69 3.17 Favored Glycine 0 C--N 1.354 1.579 0 N-CA-C 109.337 -1.505 . . . . 0.0 109.337 179.187 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 70.7 mt -119.78 171.11 8.63 Favored 'General case' 0 CA--C 1.504 -0.806 0 N-CA-C 107.398 -1.334 . . . . 0.0 107.398 -177.393 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 67.5 mttm -107.09 155.69 38.81 Favored Pre-proline 0 N--CA 1.442 -0.86 0 C-N-CA 124.984 1.313 . . . . 0.0 107.656 -172.338 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -75.82 151.53 36.03 Favored 'Trans proline' 0 N--CA 1.454 -0.853 0 C-N-CA 123.024 2.482 . . . . 0.0 110.811 177.054 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 56.05 36.55 67.95 Favored Glycine 0 C--N 1.355 1.605 0 C-N-CA 127.377 2.418 . . . . 0.0 116.06 169.623 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 9.8 p -124.11 143.56 36.98 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.998 0 N-CA-C 108.088 -1.078 . . . . 0.0 108.088 -177.498 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 7.7 p -98.61 128.4 50.19 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.96 0 N-CA-C 107.747 -1.205 . . . . 0.0 107.747 -179.543 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 68.8 m-85 -111.4 151.62 28.28 Favored 'General case' 0 CA--C 1.497 -1.082 0 C-N-CA 124.814 1.245 . . . . 0.0 108.809 -179.863 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 35.9 tp10 -93.61 137.04 33.28 Favored 'General case' 0 N--CA 1.44 -0.953 0 N-CA-C 104.578 -2.379 . . . . 0.0 104.578 160.017 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -135.33 156.62 22.75 Favored Glycine 0 CA--C 1.489 -1.553 0 N-CA-C 108.511 -1.836 . . . . 0.0 108.511 174.356 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 85.6 mt-30 -144.58 138.95 27.81 Favored 'General case' 0 CA--C 1.483 -1.598 0 N-CA-C 105.986 -1.857 . . . . 0.0 105.986 179.262 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 57.1 tp -115.73 97.32 6.05 Favored 'General case' 0 N--CA 1.435 -1.189 0 N-CA-C 103.892 -2.633 . . . . 0.0 103.892 178.248 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 9.4 mt -89.52 128.87 41.28 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.942 0 N-CA-C 105.356 -2.09 . . . . 0.0 105.356 -178.248 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 3.5 p -117.93 118.86 33.13 Favored 'General case' 0 N--CA 1.438 -1.058 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 -171.71 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 2.0 mp -94.08 131.68 40.31 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.222 0 N-CA-C 105.02 -2.215 . . . . 0.0 105.02 -173.149 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 19.4 mp0 -93.87 143.36 26.41 Favored 'General case' 0 CA--C 1.498 -1.033 0 N-CA-C 104.93 -2.248 . . . . 0.0 104.93 177.218 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 21.4 tt0 -69.12 112.4 5.7 Favored 'General case' 0 C--N 1.356 0.855 0 C-N-CA 123.858 0.863 . . . . 0.0 111.343 -172.585 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 33.7 m-85 56.32 44.81 24.07 Favored 'General case' 0 C--N 1.357 0.917 0 C-N-CA 126.983 2.113 . . . . 0.0 112.173 -179.007 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -156.73 -119.16 0.6 Allowed Glycine 0 CA--C 1.489 -1.577 0 N-CA-C 109.008 -1.637 . . . . 0.0 109.008 -177.98 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 69.2 m80 -82.68 176.77 9.09 Favored 'General case' 0 CA--C 1.501 -0.939 0 C-N-CA 124.9 1.28 . . . . 0.0 111.288 -166.477 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 22.8 tt0 -137.91 115.96 11.67 Favored 'General case' 0 N--CA 1.435 -1.197 0 N-CA-C 103.819 -2.66 . . . . 0.0 103.819 170.761 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 29.5 tt0 -104.77 147.97 27.12 Favored 'General case' 0 CA--C 1.5 -0.949 0 N-CA-C 106.089 -1.819 . . . . 0.0 106.089 -174.739 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 4.0 p -119.35 134.05 64.2 Favored 'Isoleucine or valine' 0 C--N 1.356 0.85 0 N-CA-C 107.796 -1.187 . . . . 0.0 107.796 178.272 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 65.1 m -110.93 138.44 47.33 Favored 'General case' 0 C--N 1.354 0.791 0 N-CA-C 102.518 -3.142 . . . . 0.0 102.518 168.326 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 27.8 ptt-85 -132.21 150.32 52.18 Favored 'General case' 0 CA--C 1.5 -0.971 0 N-CA-C 109.213 -0.662 . . . . 0.0 109.213 179.485 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 20.2 p90 -163.82 173.8 12.33 Favored 'General case' 0 N--CA 1.441 -0.901 0 N-CA-C 107.947 -1.131 . . . . 0.0 107.947 -174.874 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -125.62 146.05 49.88 Favored 'General case' 0 N--CA 1.438 -1.05 0 N-CA-C 103.816 -2.661 . . . . 0.0 103.816 173.628 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 28.5 p90 -139.51 168.1 20.59 Favored 'General case' 0 CA--C 1.485 -1.526 0 N-CA-C 107.572 -1.269 . . . . 0.0 107.572 167.882 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 60.6 m -130.44 141.93 50.51 Favored 'General case' 0 N--CA 1.44 -0.937 0 N-CA-C 104.832 -2.285 . . . . 0.0 104.832 176.795 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 23.9 p -111.6 136.94 50.11 Favored 'General case' 0 CA--C 1.501 -0.936 0 N-CA-C 103.851 -2.648 . . . . 0.0 103.851 170.486 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 10.5 t -146.22 156.7 43.57 Favored 'General case' 0 N--CA 1.44 -0.967 0 N-CA-C 106.716 -1.587 . . . . 0.0 106.716 -175.072 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 16.9 p . . . . . 0 C--O 1.261 1.684 0 CA-C-O 117.709 -1.139 . . . . 0.0 108.944 -178.336 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.44 -1.055 0 N-CA-C 106.913 -2.475 . . . . 0.0 106.913 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 79.3 Cg_exo -60.67 135.07 57.98 Favored 'Trans proline' 0 CA--C 1.497 -1.369 0 C-N-CA 123.388 2.725 . . . . 0.0 112.185 -173.359 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 16.1 t -84.07 155.24 3.67 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.017 0 C-N-CA 126.468 1.907 . . . . 0.0 106.167 -175.196 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 54.6 mt-10 -104.5 102.86 12.49 Favored 'General case' 0 CA--C 1.492 -1.273 0 N-CA-C 105.772 -1.936 . . . . 0.0 105.772 179.498 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 1.5 p -126.05 141.37 45.88 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.985 0 N-CA-C 105.623 -1.991 . . . . 0.0 105.623 -169.796 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 18.8 p90 . . . . . 0 N--CA 1.436 -1.144 0 N-CA-C 107.716 -1.216 . . . . 0.0 107.716 -162.728 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo . . . . . 0 CA--C 1.508 -0.822 0 CA-C-O 118.582 -0.674 . . . . 0.0 111.115 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 6.8 t-20 -135.78 -23.88 1.35 Allowed 'General case' 0 CA--C 1.495 -1.169 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 -168.709 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 23.0 p -97.64 156.19 16.64 Favored 'General case' 0 N--CA 1.439 -1.02 0 N-CA-C 107.605 -1.257 . . . . 0.0 107.605 177.483 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 79.8 t60 -139.44 86.43 14.28 Favored Pre-proline 0 N--CA 1.439 -1.011 0 N-CA-C 106.348 -1.723 . . . . 0.0 106.348 167.568 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -82.92 100.54 0.96 Allowed 'Trans proline' 0 N--CA 1.453 -0.887 0 C-N-CA 123.574 2.849 . . . . 0.0 110.369 -176.187 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.53 HD11 HD11 ' A' ' 35' ' ' LEU . 1.6 pt -94.38 166.59 1.77 Allowed 'Isoleucine or valine' 0 CA--C 1.501 -0.934 0 C-N-CA 122.715 0.406 . . . . 0.0 110.156 -173.609 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 48.0 tt0 -143.15 147.66 35.3 Favored 'General case' 0 N--CA 1.439 -0.995 0 N-CA-C 105.005 -2.22 . . . . 0.0 105.005 168.547 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 30.9 p90 -130.23 159.85 35.62 Favored 'General case' 0 CA--C 1.495 -1.167 0 N-CA-C 105.599 -2.0 . . . . 0.0 105.599 176.701 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 72.3 m-20 -130.83 132.7 45.38 Favored 'General case' 0 CA--C 1.488 -1.417 0 N-CA-C 104.997 -2.223 . . . . 0.0 104.997 171.837 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -85.77 164.36 40.01 Favored Pre-proline 0 N--CA 1.441 -0.908 0 C-N-CA 124.589 1.155 . . . . 0.0 110.675 -166.175 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_exo -67.23 -179.29 1.75 Allowed 'Trans proline' 0 N--CA 1.457 -0.675 0 C-N-CA 123.775 2.983 . . . . 0.0 112.548 169.072 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? -79.84 -50.85 1.19 Allowed Pre-proline 0 N--CA 1.443 -0.782 0 CA-C-O 115.02 -2.419 . . . . 0.0 111.157 -174.706 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -68.68 147.14 69.11 Favored 'Trans proline' 0 CA--C 1.508 -0.811 0 CA-C-N 126.305 3.288 . . . . 0.0 111.863 -173.056 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 29.4 p -99.0 58.59 1.14 Allowed 'General case' 0 C--N 1.355 0.83 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 -178.605 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 42.6 t60 -116.23 1.37 13.12 Favored 'General case' 0 N--CA 1.438 -1.043 0 C-N-CA 125.217 1.407 . . . . 0.0 107.425 175.857 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 31.2 mt -101.67 131.93 48.58 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.054 0 N-CA-C 104.263 -2.495 . . . . 0.0 104.263 171.017 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 4.4 p -110.52 -84.65 0.56 Allowed 'General case' 0 N--CA 1.432 -1.345 0 N-CA-C 107.028 -1.471 . . . . 0.0 107.028 179.515 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 53.2 mtmt -89.91 171.85 9.3 Favored 'General case' 0 CA--C 1.488 -1.439 0 C-N-CA 124.232 1.013 . . . . 0.0 108.785 -166.413 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 86.8 m-85 -129.34 147.66 51.19 Favored 'General case' 0 CA--C 1.496 -1.115 0 N-CA-C 105.362 -2.088 . . . . 0.0 105.362 168.435 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 61.9 mt -120.41 131.04 73.69 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.249 0 N-CA-C 101.207 -3.627 . . . . 0.0 101.207 165.683 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.53 HD11 HD11 ' A' ' 20' ' ' ILE . 2.9 mt -110.49 132.72 53.94 Favored 'General case' 0 CA--C 1.473 -1.997 0 N-CA-C 104.822 -2.288 . . . . 0.0 104.822 170.741 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -129.97 158.94 38.17 Favored 'General case' 0 CA--C 1.493 -1.241 0 N-CA-C 107.308 -1.367 . . . . 0.0 107.308 170.082 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 46.4 p90 -155.15 141.28 18.42 Favored 'General case' 0 N--CA 1.434 -1.232 0 N-CA-C 106.635 -1.617 . . . . 0.0 106.635 -177.908 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 27.0 ttp180 -137.89 142.65 36.94 Favored Pre-proline 0 CA--C 1.502 -0.902 0 N-CA-C 104.902 -2.258 . . . . 0.0 104.902 -179.359 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_exo -65.11 116.97 4.15 Favored 'Trans proline' 0 N--CA 1.455 -0.754 0 C-N-CA 123.024 2.482 . . . . 0.0 109.721 169.133 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 26.7 ttpp -71.96 83.87 0.96 Allowed 'General case' 0 C--N 1.359 0.993 0 C-N-CA 125.306 1.443 . . . . 0.0 110.096 179.933 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 33.1 m120 -150.58 -69.18 0.19 Allowed 'General case' 0 N--CA 1.434 -1.245 0 N-CA-C 102.321 -3.214 . . . . 0.0 102.321 -175.526 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 56.4 p -109.23 175.32 5.5 Favored 'General case' 0 N--CA 1.44 -0.97 0 N-CA-C 107.334 -1.358 . . . . 0.0 107.334 175.171 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 4.2 m -115.69 51.36 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.836 0 N-CA-C 106.241 -1.763 . . . . 0.0 106.241 176.009 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -94.81 -136.1 8.28 Favored Glycine 0 C--N 1.356 1.68 0 N-CA-C 109.739 -1.345 . . . . 0.0 109.739 -175.57 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 39.9 mmt180 -81.18 155.58 26.1 Favored 'General case' 0 CA--C 1.501 -0.939 0 C-N-CA 123.79 0.836 . . . . 0.0 109.108 -176.534 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -159.36 168.89 25.22 Favored 'General case' 0 CA--C 1.493 -1.225 0 CA-C-O 121.385 0.612 . . . . 0.0 109.832 -169.259 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -113.49 156.68 23.12 Favored 'General case' 0 CA--C 1.491 -1.293 0 N-CA-C 107.889 -1.152 . . . . 0.0 107.889 -169.975 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 23.5 pt-20 -151.37 161.27 43.0 Favored 'General case' 0 N--CA 1.435 -1.191 0 N-CA-C 107.765 -1.198 . . . . 0.0 107.765 172.125 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -139.62 164.71 29.2 Favored 'General case' 0 N--CA 1.438 -1.051 0 N-CA-C 105.603 -1.999 . . . . 0.0 105.603 171.222 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 88.8 m -118.51 122.65 43.21 Favored 'General case' 0 CA--C 1.498 -1.021 0 N-CA-C 104.333 -2.469 . . . . 0.0 104.333 176.056 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 3.7 mm -103.62 138.64 19.59 Favored Pre-proline 0 N--CA 1.438 -1.029 0 N-CA-C 105.808 -1.923 . . . . 0.0 105.808 -174.909 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_exo -63.91 161.15 34.11 Favored 'Trans proline' 0 N--CA 1.455 -0.784 0 C-N-CA 123.378 2.719 . . . . 0.0 112.562 170.817 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -78.22 -19.26 74.87 Favored Glycine 0 C--N 1.353 1.492 0 C-N-CA 123.843 0.735 . . . . 0.0 113.344 -172.485 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 50.3 p-80 -83.61 -24.97 31.24 Favored 'General case' 0 C--N 1.356 0.85 0 CA-C-N 117.68 0.74 . . . . 0.0 110.158 -178.802 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 88.7 mt -88.22 129.77 35.26 Favored 'General case' 0 CA--C 1.498 -1.024 0 N-CA-C 107.913 -1.143 . . . . 0.0 107.913 177.655 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 7.5 p30 -116.66 10.72 14.45 Favored 'General case' 0 CA--C 1.501 -0.93 0 C-N-CA 124.59 1.156 . . . . 0.0 109.662 -174.554 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 31.3 p -141.79 154.42 45.21 Favored 'General case' 0 N--CA 1.44 -0.974 0 N-CA-C 106.863 -1.532 . . . . 0.0 106.863 -179.237 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 9.8 t80 -137.55 170.7 15.62 Favored 'General case' 0 N--CA 1.441 -0.914 0 N-CA-C 107.91 -1.144 . . . . 0.0 107.91 178.606 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 89.2 m -133.93 110.01 9.42 Favored 'General case' 0 N--CA 1.429 -1.517 0 N-CA-C 104.424 -2.436 . . . . 0.0 104.424 172.773 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 45.2 mt -88.37 144.06 9.94 Favored 'Isoleucine or valine' 0 C--N 1.355 0.846 0 N-CA-C 103.663 -2.717 . . . . 0.0 103.663 172.051 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 56.7 mtmt -144.29 165.51 27.69 Favored 'General case' 0 CA--C 1.498 -1.04 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 175.929 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 88.7 48.3 3.97 Favored Glycine 0 CA--C 1.485 -1.832 0 N-CA-C 108.99 -1.644 . . . . 0.0 108.99 174.575 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 51.9 mt -120.79 171.22 8.76 Favored 'General case' 0 CA--C 1.498 -1.025 0 N-CA-C 107.604 -1.258 . . . . 0.0 107.604 -170.22 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt -113.66 150.87 44.0 Favored Pre-proline 0 N--CA 1.44 -0.93 0 N-CA-C 107.363 -1.347 . . . . 0.0 107.363 -174.247 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 78.5 Cg_exo -68.14 153.85 73.81 Favored 'Trans proline' 0 N--CA 1.453 -0.873 0 C-N-CA 123.37 2.714 . . . . 0.0 112.028 168.338 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' GLY . . . . . 0.603 ' H ' ' HA ' ' A' ' 92' ' ' THR . . . 58.95 30.28 66.29 Favored Glycine 0 N--CA 1.432 -1.604 0 C-N-CA 127.545 2.498 . . . . 0.0 116.478 170.37 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 4.9 p -126.92 142.13 44.27 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.029 0 N-CA-C 108.577 -0.898 . . . . 0.0 108.577 179.316 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 9.3 p -94.62 130.77 42.99 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.837 0 C-N-CA 124.641 1.176 . . . . 0.0 107.959 -178.816 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 88.8 m-85 -110.62 154.91 23.11 Favored 'General case' 0 N--CA 1.437 -1.085 0 C-N-CA 124.79 1.236 . . . . 0.0 108.011 177.854 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 15.3 tp10 -98.53 132.17 44.17 Favored 'General case' 0 N--CA 1.437 -1.099 0 N-CA-C 103.578 -2.749 . . . . 0.0 103.578 164.148 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -129.67 148.82 18.53 Favored Glycine 0 CA--C 1.489 -1.544 0 N-CA-C 107.667 -2.173 . . . . 0.0 107.667 175.786 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 34.6 mt-30 -141.47 137.05 31.86 Favored 'General case' 0 CA--C 1.484 -1.582 0 N-CA-C 106.549 -1.649 . . . . 0.0 106.549 178.4 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 27.6 tp -117.93 97.17 5.69 Favored 'General case' 0 N--CA 1.435 -1.202 0 N-CA-C 104.03 -2.581 . . . . 0.0 104.03 -178.721 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 20.3 mt -92.17 129.01 43.44 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.865 0 N-CA-C 104.947 -2.242 . . . . 0.0 104.947 -179.84 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 49.8 m -110.06 117.84 34.82 Favored 'General case' 0 CA--C 1.497 -1.061 0 N-CA-C 106.814 -1.55 . . . . 0.0 106.814 -175.784 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 1.7 mp -88.2 131.94 34.5 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.302 0 N-CA-C 104.348 -2.464 . . . . 0.0 104.348 -170.455 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 76.0 mt-30 -96.78 157.1 16.06 Favored 'General case' 0 N--CA 1.434 -1.269 0 N-CA-C 107.167 -1.42 . . . . 0.0 107.167 -176.787 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 32.3 mt-30 -69.48 118.2 12.06 Favored 'General case' 0 N--CA 1.438 -1.026 0 C-N-CA 123.919 0.888 . . . . 0.0 112.544 -168.503 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 49.0 m-85 61.68 35.58 16.93 Favored 'General case' 0 C--N 1.355 0.833 0 C-N-CA 127.117 2.167 . . . . 0.0 113.136 170.558 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 179.38 -93.31 0.09 OUTLIER Glycine 0 C--N 1.354 1.53 0 C-N-CA 118.294 -1.907 . . . . 0.0 111.416 177.73 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 74.1 m-70 -78.59 -178.74 6.03 Favored 'General case' 0 CA--C 1.498 -1.047 0 C-N-CA 124.797 1.239 . . . . 0.0 111.747 -163.602 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 4.4 pt20 -153.32 146.56 24.75 Favored 'General case' 0 N--CA 1.434 -1.245 0 N-CA-C 106.484 -1.672 . . . . 0.0 106.484 170.2 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 17.4 tp10 -104.87 146.28 29.22 Favored 'General case' 0 CA--C 1.496 -1.124 0 N-CA-C 105.575 -2.009 . . . . 0.0 105.575 179.855 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 3.0 p -117.76 131.59 70.06 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.824 0 N-CA-C 107.204 -1.406 . . . . 0.0 107.204 177.391 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 40.4 m -113.58 138.36 50.28 Favored 'General case' 0 N--CA 1.441 -0.9 0 N-CA-C 102.871 -3.011 . . . . 0.0 102.871 170.962 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 7.6 ptp85 -131.58 150.86 52.0 Favored 'General case' 0 CA--C 1.498 -1.025 0 CA-C-O 121.466 0.651 . . . . 0.0 109.594 178.86 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 30.0 p90 -164.2 178.2 7.77 Favored 'General case' 0 N--CA 1.44 -0.97 0 N-CA-C 106.959 -1.497 . . . . 0.0 106.959 -174.617 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 1.5 p30 -137.44 157.71 45.99 Favored 'General case' 0 N--CA 1.44 -0.928 0 N-CA-C 105.844 -1.91 . . . . 0.0 105.844 169.416 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 26.6 p90 -145.73 170.75 15.89 Favored 'General case' 0 CA--C 1.486 -1.497 0 N-CA-C 107.367 -1.346 . . . . 0.0 107.367 174.949 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 24.8 p -121.55 145.33 48.07 Favored 'General case' 0 CA--C 1.5 -0.954 0 N-CA-C 106.006 -1.85 . . . . 0.0 106.006 172.078 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 75.4 m -119.57 113.48 20.77 Favored 'General case' 0 CA--C 1.496 -1.111 0 N-CA-C 102.103 -3.295 . . . . 0.0 102.103 170.287 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 92' ' ' THR . . . . . 0.603 ' HA ' ' H ' ' A' ' 66' ' ' GLY . 15.3 m -143.41 149.74 38.08 Favored 'General case' 0 C--N 1.356 0.87 0 N-CA-C 105.705 -1.961 . . . . 0.0 105.705 -171.934 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 8.7 t . . . . . 0 C--O 1.261 1.662 0 C-N-CA 124.632 1.173 . . . . 0.0 109.497 -176.01 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.439 -1.153 0 N-CA-C 106.077 -2.809 . . . . 0.0 106.077 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_exo -61.0 135.78 61.31 Favored 'Trans proline' 0 N--CA 1.445 -1.342 0 C-N-CA 123.3 2.666 . . . . 0.0 112.37 -173.176 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 8.4 t -78.57 154.05 5.0 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.88 0 C-N-CA 126.738 2.015 . . . . 0.0 106.214 -175.948 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -96.66 90.73 5.42 Favored 'General case' 0 CA--C 1.493 -1.242 0 N-CA-C 107.66 -1.237 . . . . 0.0 107.66 -175.04 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.425 ' HA ' ' HA ' ' A' ' 22' ' ' TRP . 2.6 p -114.33 133.92 58.89 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.175 0 N-CA-C 107.032 -1.47 . . . . 0.0 107.032 -166.86 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 75.3 m-85 . . . . . 0 N--CA 1.435 -1.188 0 N-CA-C 106.208 -1.775 . . . . 0.0 106.208 -173.776 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_endo . . . . . 0 N--CA 1.457 -0.644 0 N-CA-C 109.903 -0.845 . . . . 0.0 109.903 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 2.3 t30 -89.18 -14.44 36.06 Favored 'General case' 0 N--CA 1.439 -0.994 0 C-N-CA 126.088 1.755 . . . . 0.0 107.403 172.697 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 68.2 m -113.32 150.3 32.73 Favored 'General case' 0 CA--C 1.497 -1.093 0 CA-C-O 122.16 0.981 . . . . 0.0 108.803 175.784 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 26.0 t-80 -124.41 98.54 37.89 Favored Pre-proline 0 N--CA 1.439 -1.014 0 N-CA-C 105.343 -2.095 . . . . 0.0 105.343 166.901 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -74.72 115.2 4.22 Favored 'Trans proline' 0 N--CA 1.448 -1.177 0 C-N-CA 123.017 2.478 . . . . 0.0 108.635 170.492 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 11.1 tt -108.92 148.79 12.53 Favored 'Isoleucine or valine' 0 N--CA 1.406 -2.639 0 C-N-CA 127.053 2.141 . . . . 0.0 106.05 -178.521 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 23.5 tt0 -135.64 145.42 46.8 Favored 'General case' 0 N--CA 1.435 -1.189 0 N-CA-C 104.337 -2.468 . . . . 0.0 104.337 170.967 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' TRP . . . . . 0.425 ' HA ' ' HA ' ' A' ' 6' ' ' VAL . 49.1 p90 -135.46 165.56 25.22 Favored 'General case' 0 N--CA 1.438 -1.054 0 N-CA-C 105.337 -2.097 . . . . 0.0 105.337 175.211 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 39.6 m-80 -140.8 132.04 26.55 Favored 'General case' 0 CA--C 1.489 -1.368 0 N-CA-C 106.136 -1.802 . . . . 0.0 106.136 -179.708 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -96.85 168.59 10.09 Favored Pre-proline 0 N--CA 1.439 -1.006 0 CA-C-N 114.792 -1.095 . . . . 0.0 110.37 -163.797 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 81.1 Cg_exo -66.43 167.69 18.13 Favored 'Trans proline' 0 N--CA 1.456 -0.716 0 C-N-CA 123.821 3.014 . . . . 0.0 111.776 166.731 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 10.2 tm0? -81.95 -52.66 0.74 Allowed Pre-proline 0 N--CA 1.444 -0.774 0 CA-C-O 115.317 -2.278 . . . . 0.0 111.279 -175.232 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -71.26 166.01 30.61 Favored 'Trans proline' 0 CA--C 1.507 -0.829 0 CA-C-N 126.065 3.202 . . . . 0.0 112.45 -172.77 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 28.1 p -77.97 118.29 20.12 Favored 'General case' 0 C--N 1.358 0.94 0 N-CA-C 106.915 -1.513 . . . . 0.0 106.915 173.449 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 8.4 t-160 -169.73 -44.84 0.02 OUTLIER 'General case' 0 CA--C 1.497 -1.063 0 N-CA-C 107.214 -1.402 . . . . 0.0 107.214 -164.099 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 37.2 mt -112.2 137.36 45.27 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.014 0 N-CA-C 104.175 -2.528 . . . . 0.0 104.175 176.615 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 33.5 t -113.06 -87.29 0.56 Allowed 'General case' 0 N--CA 1.43 -1.437 0 N-CA-C 106.494 -1.669 . . . . 0.0 106.494 179.548 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 35.9 ttpt -89.18 163.31 15.48 Favored 'General case' 0 CA--C 1.491 -1.303 0 C-N-CA 125.686 1.594 . . . . 0.0 108.104 -159.202 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 90.6 m-85 -128.88 139.07 52.31 Favored 'General case' 0 CA--C 1.492 -1.257 0 N-CA-C 105.649 -1.982 . . . . 0.0 105.649 175.56 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 55.3 mt -119.42 131.09 73.04 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.121 0 N-CA-C 101.694 -3.447 . . . . 0.0 101.694 171.113 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 3.2 mt -110.47 135.63 50.85 Favored 'General case' 0 CA--C 1.473 -1.982 0 N-CA-C 105.02 -2.215 . . . . 0.0 105.02 171.899 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -131.35 156.51 45.39 Favored 'General case' 0 CA--C 1.493 -1.247 0 N-CA-C 106.889 -1.523 . . . . 0.0 106.889 167.555 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 49.6 p90 -154.18 145.47 22.96 Favored 'General case' 0 N--CA 1.434 -1.257 0 N-CA-C 106.757 -1.572 . . . . 0.0 106.757 -175.94 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 8.6 ttm180 -138.18 139.57 26.01 Favored Pre-proline 0 CA--C 1.499 -0.982 0 N-CA-C 104.605 -2.368 . . . . 0.0 104.605 -179.907 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -72.89 116.06 4.58 Favored 'Trans proline' 0 N--CA 1.454 -0.843 0 C-N-CA 122.739 2.293 . . . . 0.0 108.824 174.713 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 3.0 tmtp? -70.22 81.49 0.53 Allowed 'General case' 0 C--N 1.358 0.97 0 C-N-CA 126.858 2.063 . . . . 0.0 111.029 -176.047 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 1.5 p30 -164.65 -50.06 0.03 OUTLIER 'General case' 0 N--CA 1.435 -1.176 0 N-CA-C 103.676 -2.713 . . . . 0.0 103.676 175.868 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 46.5 p -97.63 163.89 12.65 Favored 'General case' 0 N--CA 1.44 -0.968 0 C-N-CA 124.922 1.289 . . . . 0.0 108.01 178.135 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 4.8 m -125.92 46.18 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.849 0 N-CA-C 105.838 -1.912 . . . . 0.0 105.838 176.455 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -94.89 -154.06 30.66 Favored Glycine 0 C--N 1.356 1.656 0 N-CA-C 109.808 -1.317 . . . . 0.0 109.808 -175.64 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 80.4 ttt180 -78.9 126.76 31.12 Favored 'General case' 0 C--N 1.356 0.86 0 N-CA-C 108.142 -1.059 . . . . 0.0 108.142 -178.59 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -105.24 172.56 6.73 Favored 'General case' 0 CA--C 1.497 -1.061 0 C-N-CA 123.825 0.85 . . . . 0.0 110.377 -172.782 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 63.0 mttp -112.11 157.07 21.25 Favored 'General case' 0 CA--C 1.489 -1.403 0 N-CA-C 107.773 -1.195 . . . . 0.0 107.773 -170.717 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 15.7 pt-20 -151.21 159.73 44.23 Favored 'General case' 0 N--CA 1.437 -1.09 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 173.57 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -138.2 164.03 30.24 Favored 'General case' 0 N--CA 1.44 -0.935 0 N-CA-C 105.851 -1.907 . . . . 0.0 105.851 170.436 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 88.8 m -124.51 127.67 47.8 Favored 'General case' 0 CA--C 1.5 -0.947 0 N-CA-C 105.3 -2.111 . . . . 0.0 105.3 179.053 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 5.2 mp -117.27 135.93 23.29 Favored Pre-proline 0 N--CA 1.438 -1.034 0 N-CA-C 105.213 -2.143 . . . . 0.0 105.213 -172.111 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_exo -63.06 166.82 13.53 Favored 'Trans proline' 0 CA--C 1.509 -0.762 0 C-N-CA 123.54 2.826 . . . . 0.0 113.748 176.582 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -81.09 -16.82 73.62 Favored Glycine 0 C--N 1.353 1.473 0 C-N-CA 123.457 0.551 . . . . 0.0 113.249 -171.95 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 50.8 p-80 -83.83 -25.82 30.02 Favored 'General case' 0 C--N 1.357 0.901 0 CA-C-N 117.831 0.816 . . . . 0.0 109.999 179.899 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 92.4 mt -88.32 131.03 34.97 Favored 'General case' 0 CA--C 1.501 -0.922 0 N-CA-C 107.84 -1.17 . . . . 0.0 107.84 177.46 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 8.3 p-10 -112.95 8.35 18.51 Favored 'General case' 0 CA--C 1.503 -0.863 0 C-N-CA 124.666 1.186 . . . . 0.0 109.667 -174.421 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 32.9 p -146.75 160.92 41.64 Favored 'General case' 0 CA--C 1.499 -1.005 0 N-CA-C 106.484 -1.673 . . . . 0.0 106.484 -177.248 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 19.2 t80 -148.45 160.26 43.23 Favored 'General case' 0 CA--C 1.497 -1.093 0 N-CA-C 108.083 -1.08 . . . . 0.0 108.083 178.575 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 82.8 m -114.43 109.47 18.36 Favored 'General case' 0 N--CA 1.436 -1.14 0 N-CA-C 104.491 -2.411 . . . . 0.0 104.491 168.9 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 65.7 mt -82.94 137.79 20.41 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.902 0 N-CA-C 103.086 -2.931 . . . . 0.0 103.086 169.83 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 17.8 ptpt -147.84 160.62 42.56 Favored 'General case' 0 CA--C 1.495 -1.151 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 -177.709 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 89.82 52.67 2.56 Favored Glycine 0 CA--C 1.489 -1.555 0 N-CA-C 108.586 -1.806 . . . . 0.0 108.586 179.827 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 63.8 mt -120.47 170.63 9.2 Favored 'General case' 0 CA--C 1.498 -1.023 0 N-CA-C 107.377 -1.342 . . . . 0.0 107.377 -171.986 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 28.9 mtpp -101.59 153.75 37.7 Favored Pre-proline 0 N--CA 1.439 -1.012 0 N-CA-C 106.507 -1.664 . . . . 0.0 106.507 -179.775 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 70.6 Cg_endo -77.6 156.8 32.09 Favored 'Trans proline' 0 N--CA 1.452 -0.964 0 C-N-CA 122.936 2.424 . . . . 0.0 110.342 174.88 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 57.74 32.68 65.99 Favored Glycine 0 C--N 1.355 1.635 0 C-N-CA 126.904 2.192 . . . . 0.0 116.44 169.854 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 5.8 p -129.16 144.39 38.3 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.903 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 -177.009 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 3.5 p -95.4 135.49 29.31 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.918 0 N-CA-C 107.292 -1.373 . . . . 0.0 107.292 -179.693 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 94.8 m-85 -113.67 150.99 32.43 Favored 'General case' 0 CA--C 1.499 -1.011 0 N-CA-C 106.815 -1.55 . . . . 0.0 106.815 177.379 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -94.94 145.29 25.02 Favored 'General case' 0 CA--C 1.501 -0.928 0 N-CA-C 104.155 -2.535 . . . . 0.0 104.155 161.109 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -138.39 149.5 20.56 Favored Glycine 0 CA--C 1.487 -1.678 0 N-CA-C 108.599 -1.801 . . . . 0.0 108.599 -177.413 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 84.8 mt-30 -138.59 135.66 35.19 Favored 'General case' 0 CA--C 1.483 -1.608 0 N-CA-C 105.599 -2.0 . . . . 0.0 105.599 177.064 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 40.9 tp -116.72 99.36 7.07 Favored 'General case' 0 N--CA 1.435 -1.178 0 N-CA-C 103.787 -2.672 . . . . 0.0 103.787 179.075 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 33.0 mt -89.21 127.68 41.75 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.883 0 N-CA-C 104.762 -2.311 . . . . 0.0 104.762 177.702 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 13.3 p -112.03 115.98 29.8 Favored 'General case' 0 N--CA 1.434 -1.26 0 N-CA-C 106.565 -1.642 . . . . 0.0 106.565 -176.619 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 23.1 mm -90.68 138.63 19.13 Favored 'Isoleucine or valine' 0 CA--C 1.483 -1.603 0 N-CA-C 106.154 -1.795 . . . . 0.0 106.154 -167.468 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 36.2 mt-30 -101.24 153.6 19.48 Favored 'General case' 0 CA--C 1.494 -1.198 0 CA-C-N 113.851 -1.522 . . . . 0.0 107.569 -173.313 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 32.8 mt-30 -68.44 101.16 1.19 Allowed 'General case' 0 CA--C 1.5 -0.948 0 C-N-CA 124.939 1.295 . . . . 0.0 112.497 -166.165 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 85.7 m-85 52.99 39.99 30.38 Favored 'General case' 0 C--N 1.359 1.008 0 C-N-CA 127.296 2.238 . . . . 0.0 112.214 -179.825 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -149.64 -118.83 0.93 Allowed Glycine 0 C--N 1.354 1.545 0 N-CA-C 108.851 -1.7 . . . . 0.0 108.851 -175.294 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 64.4 m-70 -81.93 -175.68 5.73 Favored 'General case' 0 CA--C 1.496 -1.113 0 C-N-CA 124.757 1.223 . . . . 0.0 111.528 -167.858 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 40.1 mt-30 -134.0 137.47 44.77 Favored 'General case' 0 N--CA 1.436 -1.132 0 N-CA-C 103.536 -2.765 . . . . 0.0 103.536 171.595 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 16.7 tp10 -118.05 137.02 53.18 Favored 'General case' 0 CA--C 1.495 -1.146 0 N-CA-C 105.174 -2.158 . . . . 0.0 105.174 179.873 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 7.1 p -111.35 139.12 36.9 Favored 'Isoleucine or valine' 0 C--N 1.354 0.797 0 N-CA-C 107.618 -1.253 . . . . 0.0 107.618 -177.414 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 38.2 m -120.49 134.17 55.31 Favored 'General case' 0 N--CA 1.441 -0.886 0 N-CA-C 102.345 -3.206 . . . . 0.0 102.345 174.114 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 83.1 mtm180 -125.82 149.75 48.36 Favored 'General case' 0 CA--C 1.5 -0.954 0 CA-C-N 119.177 0.898 . . . . 0.0 109.479 -176.638 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 19.2 p90 -165.96 -176.59 3.85 Favored 'General case' 0 CA--C 1.501 -0.92 0 N-CA-C 107.382 -1.34 . . . . 0.0 107.382 -178.357 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 44.7 p30 -135.79 158.05 45.34 Favored 'General case' 0 N--CA 1.442 -0.858 0 N-CA-C 107.24 -1.393 . . . . 0.0 107.24 164.626 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 25.4 p90 -142.38 172.88 12.09 Favored 'General case' 0 CA--C 1.485 -1.53 0 N-CA-C 106.018 -1.845 . . . . 0.0 106.018 170.252 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 8.9 t -141.41 152.98 44.77 Favored 'General case' 0 CA--C 1.499 -0.996 0 N-CA-C 105.713 -1.958 . . . . 0.0 105.713 173.77 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 29.8 p -113.95 131.94 56.13 Favored 'General case' 0 N--CA 1.437 -1.104 0 N-CA-C 103.432 -2.803 . . . . 0.0 103.432 171.745 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 25.0 p -130.5 145.83 51.93 Favored 'General case' 0 CA--C 1.5 -0.968 0 N-CA-C 105.654 -1.98 . . . . 0.0 105.654 179.632 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 42.9 p . . . . . 0 C--O 1.26 1.65 0 N-CA-C 109.206 -0.664 . . . . 0.0 109.206 -177.575 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.437 -1.249 0 N-CA-C 105.516 -3.034 . . . . 0.0 105.516 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 90.4 Cg_exo -61.17 134.27 51.51 Favored 'Trans proline' 0 CA--C 1.5 -1.177 0 C-N-CA 123.17 2.58 . . . . 0.0 112.255 -171.018 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 3.1 t -79.39 150.31 5.15 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.79 0 C-N-CA 126.313 1.845 . . . . 0.0 106.039 -176.442 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 54.5 mm-40 -100.1 89.46 4.04 Favored 'General case' 0 CA--C 1.485 -1.527 0 CA-C-O 122.776 1.274 . . . . 0.0 108.36 -170.262 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 2.3 p -104.06 127.24 58.42 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.136 0 CA-C-N 113.421 -1.718 . . . . 0.0 107.661 -166.879 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 59.2 m-85 . . . . . 0 CA--C 1.495 -1.135 0 C-N-CA 123.935 0.894 . . . . 0.0 110.444 -169.501 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo . . . . . 0 N--CA 1.45 -1.056 0 CA-C-O 119.004 -0.498 . . . . 0.0 111.75 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 36.6 m-20 -141.97 -12.39 0.85 Allowed 'General case' 0 N--CA 1.435 -1.191 0 C-N-CA 124.82 1.248 . . . . 0.0 110.228 -163.649 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 23.6 p -98.11 161.39 13.74 Favored 'General case' 0 CA--C 1.503 -0.846 0 O-C-N 120.739 -1.226 . . . . 0.0 107.701 -179.516 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 40.3 t-80 -151.52 104.26 2.91 Favored Pre-proline 0 N--CA 1.443 -0.816 0 CA-C-O 118.359 -0.829 . . . . 0.0 108.934 173.088 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -75.73 123.11 7.25 Favored 'Trans proline' 0 N--CA 1.452 -0.949 0 C-N-CA 123.199 2.599 . . . . 0.0 109.71 175.282 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 10.9 mt -111.6 136.56 47.35 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.947 0 N-CA-C 104.586 -2.375 . . . . 0.0 104.586 -178.639 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 35.7 mt-30 -140.3 146.93 39.17 Favored 'General case' 0 CA--C 1.494 -1.19 0 N-CA-C 104.668 -2.345 . . . . 0.0 104.668 179.387 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 42.7 p90 -147.48 169.63 19.14 Favored 'General case' 0 CA--C 1.499 -1.015 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 -174.072 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 8.1 m-80 -131.24 127.57 38.1 Favored 'General case' 0 CA--C 1.492 -1.252 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 179.624 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -92.26 175.78 3.11 Favored Pre-proline 0 N--CA 1.439 -0.993 0 C-N-CA 125.989 1.716 . . . . 0.0 108.946 -174.323 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_exo -63.16 159.58 38.45 Favored 'Trans proline' 0 CA--C 1.508 -0.823 0 C-N-CA 123.743 2.962 . . . . 0.0 112.297 171.095 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 35.9 mt-30 -81.57 -37.12 0.86 Allowed Pre-proline 0 N--CA 1.443 -0.795 0 CA-C-O 115.962 -1.971 . . . . 0.0 111.281 -177.414 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_exo -70.17 -8.26 23.16 Favored 'Trans proline' 0 CA--C 1.512 -0.625 0 CA-C-N 124.878 2.778 . . . . 0.0 112.905 169.526 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . 0.28 80.5 p 54.09 71.81 0.49 Allowed 'General case' 0 C--N 1.36 1.046 0 C-N-CA 127.609 2.363 . . . . 0.0 112.022 -177.254 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 49.8 t-80 -88.74 -10.57 47.85 Favored 'General case' 0 N--CA 1.441 -0.885 0 C-N-CA 124.473 1.109 . . . . 0.0 109.768 -176.329 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.408 HG21 ' CE1' ' A' ' 33' ' ' TYR . 84.7 mt -93.88 145.03 8.4 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.976 0 N-CA-C 105.434 -2.061 . . . . 0.0 105.434 -179.846 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 35.6 t -99.09 -86.78 0.36 Allowed 'General case' 0 N--CA 1.43 -1.445 0 N-CA-C 103.857 -2.646 . . . . 0.0 103.857 174.537 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 46.0 mtpt -89.16 165.94 14.15 Favored 'General case' 0 CA--C 1.492 -1.266 0 C-N-CA 124.854 1.262 . . . . 0.0 109.097 -168.359 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' TYR . . . . . 0.408 ' CE1' HG21 ' A' ' 30' ' ' ILE . 64.0 m-85 -125.63 142.34 51.56 Favored 'General case' 0 CA--C 1.495 -1.137 0 N-CA-C 104.547 -2.39 . . . . 0.0 104.547 164.641 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 54.7 mt -119.56 132.24 69.9 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.302 0 N-CA-C 101.141 -3.651 . . . . 0.0 101.141 168.796 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 3.0 mt -106.38 128.96 54.43 Favored 'General case' 0 CA--C 1.473 -2.017 0 N-CA-C 103.95 -2.611 . . . . 0.0 103.95 166.766 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 79.3 mtt180 -112.56 157.09 21.59 Favored 'General case' 0 N--CA 1.43 -1.442 0 N-CA-C 105.266 -2.124 . . . . 0.0 105.266 164.248 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 48.6 p90 -156.12 147.42 22.5 Favored 'General case' 0 N--CA 1.43 -1.44 0 N-CA-C 105.934 -1.876 . . . . 0.0 105.934 176.513 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 39.0 ptt180 -157.52 161.07 29.86 Favored Pre-proline 0 N--CA 1.438 -1.028 0 N-CA-C 105.41 -2.071 . . . . 0.0 105.41 170.189 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_exo -66.06 149.77 85.68 Favored 'Trans proline' 0 CA--C 1.503 -1.029 0 C-N-CA 123.367 2.711 . . . . 0.0 109.828 176.572 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 4.1 tmtp? -75.7 70.93 2.54 Favored 'General case' 0 C--N 1.358 0.947 0 C-N-CA 123.643 0.777 . . . . 0.0 109.587 175.731 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 30.4 m120 -158.67 -52.55 0.06 Allowed 'General case' 0 N--CA 1.437 -1.083 0 N-CA-C 103.671 -2.714 . . . . 0.0 103.671 -170.609 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 32.3 t -79.24 151.45 31.17 Favored 'General case' 0 CA--C 1.497 -1.096 0 CA-C-O 122.783 1.277 . . . . 0.0 110.064 -174.73 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 16.1 m -134.34 -0.54 1.24 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.894 0 CA-C-N 112.42 -2.173 . . . . 0.0 108.425 -174.514 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -98.2 -100.21 2.13 Favored Glycine 0 C--N 1.356 1.67 0 N-CA-C 109.355 -1.498 . . . . 0.0 109.355 -174.63 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 77.0 mtp85 -93.95 168.21 11.11 Favored 'General case' 0 CA--C 1.501 -0.908 0 C-N-CA 123.588 0.755 . . . . 0.0 109.559 -173.716 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 60.3 m95 -122.53 163.22 20.32 Favored 'General case' 0 N--CA 1.439 -0.996 0 N-CA-C 106.273 -1.751 . . . . 0.0 106.273 178.591 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -96.77 151.26 19.82 Favored 'General case' 0 CA--C 1.489 -1.392 0 N-CA-C 103.858 -2.645 . . . . 0.0 103.858 158.796 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 16.1 pt-20 -152.31 158.88 43.38 Favored 'General case' 0 CA--C 1.496 -1.12 0 CA-C-O 121.8 0.81 . . . . 0.0 109.559 -178.113 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -142.73 162.25 35.97 Favored 'General case' 0 CA--C 1.498 -1.036 0 N-CA-C 106.051 -1.833 . . . . 0.0 106.051 174.066 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 78.4 m -120.35 125.63 48.49 Favored 'General case' 0 CA--C 1.5 -0.945 0 N-CA-C 105.228 -2.138 . . . . 0.0 105.228 178.713 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 5.3 mp -109.43 133.3 20.87 Favored Pre-proline 0 N--CA 1.437 -1.107 0 N-CA-C 104.313 -2.476 . . . . 0.0 104.313 -177.929 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 65.3 Cg_exo -63.88 165.06 19.74 Favored 'Trans proline' 0 CA--C 1.507 -0.847 0 C-N-CA 123.393 2.729 . . . . 0.0 113.054 178.277 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -75.05 -18.04 80.2 Favored Glycine 0 C--N 1.351 1.403 0 N-CA-C 114.604 0.602 . . . . 0.0 114.604 -174.084 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 47.7 p-80 -83.71 -29.52 27.47 Favored 'General case' 0 C--N 1.356 0.864 0 CA-C-N 118.016 0.908 . . . . 0.0 109.826 179.832 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 89.6 mt -89.14 134.26 34.08 Favored 'General case' 0 CA--C 1.5 -0.972 0 N-CA-C 107.721 -1.215 . . . . 0.0 107.721 176.563 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 6.5 p-10 -123.53 25.01 8.4 Favored 'General case' 0 CA--C 1.498 -1.023 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 -177.541 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 33.9 p -146.79 163.22 36.72 Favored 'General case' 0 N--CA 1.439 -1.021 0 N-CA-C 107.59 -1.263 . . . . 0.0 107.59 -179.248 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 7.4 t80 -154.25 178.4 10.05 Favored 'General case' 0 N--CA 1.44 -0.936 0 N-CA-C 107.903 -1.147 . . . . 0.0 107.903 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 96.1 m -144.09 117.99 9.36 Favored 'General case' 0 N--CA 1.43 -1.44 0 N-CA-C 104.995 -2.224 . . . . 0.0 104.995 176.072 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 13.4 mm -87.22 144.38 9.4 Favored 'Isoleucine or valine' 0 C--N 1.354 0.768 0 N-CA-C 104.3 -2.481 . . . . 0.0 104.3 171.004 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 95.8 mttt -145.27 162.22 37.69 Favored 'General case' 0 CA--C 1.493 -1.225 0 N-CA-C 107.491 -1.3 . . . . 0.0 107.491 170.07 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 79.31 54.56 4.0 Favored Glycine 0 CA--C 1.488 -1.596 0 N-CA-C 108.968 -1.653 . . . . 0.0 108.968 175.249 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 85.3 mt -108.34 -153.87 0.52 Allowed 'General case' 0 CA--C 1.504 -0.799 0 N-CA-C 106.822 -1.547 . . . . 0.0 106.822 178.854 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 90.6 mttt -132.18 156.3 80.27 Favored Pre-proline 0 N--CA 1.44 -0.928 0 N-CA-C 105.74 -1.948 . . . . 0.0 105.74 -170.997 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_endo -74.09 135.78 21.44 Favored 'Trans proline' 0 N--CA 1.451 -0.993 0 C-N-CA 122.905 2.403 . . . . 0.0 110.45 173.202 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 57.25 49.74 70.09 Favored Glycine 0 C--N 1.355 1.612 0 C-N-CA 126.852 2.167 . . . . 0.0 115.823 170.417 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 27.8 t -118.13 133.58 64.49 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.102 0 N-CA-C 105.951 -1.87 . . . . 0.0 105.951 173.51 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 5.3 p -84.33 119.97 34.27 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.961 0 N-CA-C 105.48 -2.044 . . . . 0.0 105.48 164.947 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 83.0 m-85 -99.5 149.24 23.42 Favored 'General case' 0 CA--C 1.496 -1.13 0 C-N-CA 125.716 1.606 . . . . 0.0 107.354 -179.477 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 17.9 pt-20 -108.67 133.46 52.73 Favored 'General case' 0 CA--C 1.499 -0.984 0 N-CA-C 105.01 -2.219 . . . . 0.0 105.01 167.912 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -128.45 165.08 21.48 Favored Glycine 0 CA--C 1.484 -1.895 0 N-CA-C 107.688 -2.165 . . . . 0.0 107.688 -174.206 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 83.8 mt-30 -137.3 133.84 35.42 Favored 'General case' 0 CA--C 1.482 -1.667 0 N-CA-C 104.557 -2.386 . . . . 0.0 104.557 169.688 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 27.2 tp -110.54 90.77 3.42 Favored 'General case' 0 N--CA 1.435 -1.221 0 N-CA-C 103.335 -2.839 . . . . 0.0 103.335 174.383 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 13.2 mt -91.58 131.34 38.95 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.927 0 N-CA-C 105.492 -2.04 . . . . 0.0 105.492 -174.373 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 58.5 m -118.47 115.3 24.33 Favored 'General case' 0 N--CA 1.436 -1.164 0 N-CA-C 107.685 -1.228 . . . . 0.0 107.685 -173.998 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 1.7 mp -91.54 135.97 25.62 Favored 'Isoleucine or valine' 0 CA--C 1.499 -1.0 0 N-CA-C 105.163 -2.162 . . . . 0.0 105.163 -172.175 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 15.6 mp0 -99.17 122.07 41.88 Favored 'General case' 0 CA--C 1.498 -1.034 0 N-CA-C 102.582 -3.118 . . . . 0.0 102.582 170.174 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 16.7 tt0 -68.03 126.02 28.18 Favored 'General case' 0 N--CA 1.443 -0.789 0 C-N-CA 123.26 0.624 . . . . 0.0 111.629 -166.995 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 21.5 m-85 66.42 43.83 2.55 Favored 'General case' 0 C--N 1.357 0.902 0 C-N-CA 126.746 2.018 . . . . 0.0 111.912 179.787 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -171.95 -115.77 0.37 Allowed Glycine 0 N--CA 1.432 -1.587 0 N-CA-C 108.145 -1.982 . . . . 0.0 108.145 175.714 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 87.7 m-70 -84.71 178.53 7.63 Favored 'General case' 0 CA--C 1.498 -1.023 0 C-N-CA 125.182 1.393 . . . . 0.0 111.103 -169.302 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 5.3 pt20 -145.9 143.89 29.85 Favored 'General case' 0 N--CA 1.436 -1.138 0 N-CA-C 106.156 -1.794 . . . . 0.0 106.156 165.104 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 9.3 tm-20 -106.39 141.76 37.18 Favored 'General case' 0 N--CA 1.438 -1.064 0 N-CA-C 104.44 -2.43 . . . . 0.0 104.44 -177.351 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 3.2 p -121.96 120.43 61.43 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.804 0 N-CA-C 108.195 -1.039 . . . . 0.0 108.195 -179.467 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 83.9 m -97.15 129.09 44.57 Favored 'General case' 0 C--N 1.355 0.844 0 N-CA-C 102.622 -3.103 . . . . 0.0 102.622 169.822 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 55.3 ttt85 -115.17 137.66 51.77 Favored 'General case' 0 CA--C 1.498 -1.04 0 N-CA-C 106.358 -1.719 . . . . 0.0 106.358 175.45 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -150.86 176.76 10.77 Favored 'General case' 0 CA--C 1.494 -1.185 0 N-CA-C 107.657 -1.238 . . . . 0.0 107.657 -177.477 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 38.9 p-10 -139.39 151.25 46.16 Favored 'General case' 0 N--CA 1.438 -1.047 0 N-CA-C 106.0 -1.852 . . . . 0.0 106.0 171.21 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 18.5 p90 -144.43 170.51 15.89 Favored 'General case' 0 CA--C 1.489 -1.387 0 N-CA-C 105.801 -1.926 . . . . 0.0 105.801 176.433 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 55.2 m -122.19 142.98 49.86 Favored 'General case' 0 CA--C 1.5 -0.956 0 N-CA-C 105.564 -2.014 . . . . 0.0 105.564 -179.557 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 86.6 m -120.41 120.97 37.49 Favored 'General case' 0 CA--C 1.498 -1.056 0 N-CA-C 101.971 -3.344 . . . . 0.0 101.971 167.292 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 76.9 p -88.73 -168.46 2.2 Favored 'General case' 0 C--N 1.353 0.723 0 C-N-CA 123.654 0.781 . . . . 0.0 109.422 -169.527 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 32.3 t . . . . . 0 C--O 1.26 1.64 0 N-CA-C 106.768 -1.567 . . . . 0.0 106.768 -179.609 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.436 -1.36 0 N-CA-C 107.62 -2.192 . . . . 0.0 107.62 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 79.4 Cg_exo -61.83 137.5 68.31 Favored 'Trans proline' 0 N--CA 1.444 -1.412 0 C-N-CA 123.359 2.706 . . . . 0.0 113.06 -177.389 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 3.5 t -77.37 152.53 5.51 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.915 0 C-N-CA 127.993 2.517 . . . . 0.0 107.006 -178.86 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 91.4 mt-10 -94.35 86.99 5.05 Favored 'General case' 0 CA--C 1.493 -1.23 0 CA-C-O 122.73 1.252 . . . . 0.0 108.721 -174.547 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.417 HG12 ' H ' ' A' ' 6' ' ' VAL . 2.1 p -88.98 154.32 3.18 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.077 0 N-CA-C 105.822 -1.918 . . . . 0.0 105.822 -171.293 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 36.8 t80 . . . . . 0 N--CA 1.429 -1.497 0 N-CA-C 104.458 -2.423 . . . . 0.0 104.458 -148.199 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 64.1 Cg_endo . . . . . 0 CA--C 1.504 -1.003 0 CA-C-O 118.494 -0.711 . . . . 0.0 112.052 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 12.4 p-10 -120.75 -38.89 2.79 Favored 'General case' 0 CA--C 1.482 -1.654 0 C-N-CA 123.82 0.848 . . . . 0.0 109.198 -173.989 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 48.5 p -100.54 165.63 11.32 Favored 'General case' 0 N--CA 1.435 -1.22 0 N-CA-C 107.987 -1.116 . . . . 0.0 107.987 -174.956 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 63.7 t-80 -143.31 97.44 5.63 Favored Pre-proline 0 N--CA 1.435 -1.185 0 N-CA-C 104.501 -2.407 . . . . 0.0 104.501 162.434 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -71.18 133.83 23.76 Favored 'Trans proline' 0 N--CA 1.447 -1.258 0 C-N-CA 122.558 2.172 . . . . 0.0 110.167 172.061 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 14.7 mm -104.46 138.63 28.29 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.062 0 N-CA-C 102.928 -2.99 . . . . 0.0 102.928 176.664 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 73.1 mt-30 -128.31 149.66 50.41 Favored 'General case' 0 CA--C 1.493 -1.244 0 N-CA-C 103.909 -2.626 . . . . 0.0 103.909 172.609 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 49.1 p90 -149.49 167.69 25.54 Favored 'General case' 0 CA--C 1.491 -1.307 0 N-CA-C 107.947 -1.131 . . . . 0.0 107.947 -179.125 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 1.8 m120 -130.92 128.44 40.52 Favored 'General case' 0 CA--C 1.489 -1.374 0 N-CA-C 105.382 -2.081 . . . . 0.0 105.382 -179.751 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -87.02 143.79 35.5 Favored Pre-proline 0 N--CA 1.44 -0.927 0 CA-C-O 118.693 -0.67 . . . . 0.0 110.504 -170.622 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_endo -76.76 166.09 27.62 Favored 'Trans proline' 0 N--CA 1.452 -0.917 0 C-N-CA 122.716 2.277 . . . . 0.0 108.214 159.381 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 22.3 tt0 -129.73 84.44 61.19 Favored Pre-proline 0 N--CA 1.442 -0.861 0 N-CA-C 108.323 -0.991 . . . . 0.0 108.323 176.683 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 90.9 Cg_endo -82.31 -8.2 11.76 Favored 'Trans proline' 0 N--CA 1.453 -0.865 0 C-N-CA 123.148 2.565 . . . . 0.0 109.599 163.051 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 21.4 m 59.45 44.21 15.28 Favored 'General case' 0 C--N 1.36 1.028 0 C-N-CA 127.573 2.349 . . . . 0.0 111.222 -171.328 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 15.4 t-160 -140.57 -10.84 1.05 Allowed 'General case' 0 N--CA 1.438 -1.031 0 CA-C-N 113.947 -1.479 . . . . 0.0 108.92 -174.935 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 38.4 mt -111.11 130.7 64.09 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.094 0 N-CA-C 105.423 -2.066 . . . . 0.0 105.423 -173.408 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 32.0 t -112.91 -84.82 0.59 Allowed 'General case' 0 N--CA 1.433 -1.283 0 N-CA-C 107.806 -1.183 . . . . 0.0 107.806 -176.242 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 51.4 mtmt -87.68 168.87 12.62 Favored 'General case' 0 CA--C 1.485 -1.539 0 C-N-CA 124.009 0.924 . . . . 0.0 109.097 -161.313 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 86.8 m-85 -129.46 140.07 51.41 Favored 'General case' 0 CA--C 1.493 -1.238 0 N-CA-C 105.049 -2.204 . . . . 0.0 105.049 170.32 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 35.8 mt -117.24 131.08 71.0 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.203 0 N-CA-C 101.567 -3.494 . . . . 0.0 101.567 169.511 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 4.8 mt -106.65 128.68 54.37 Favored 'General case' 0 CA--C 1.473 -1.985 0 N-CA-C 104.389 -2.448 . . . . 0.0 104.389 168.182 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 65.5 mtt180 -113.97 157.97 21.75 Favored 'General case' 0 N--CA 1.431 -1.377 0 N-CA-C 105.644 -1.984 . . . . 0.0 105.644 167.082 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 36.0 p90 -147.07 130.41 16.63 Favored 'General case' 0 N--CA 1.432 -1.362 0 N-CA-C 104.359 -2.46 . . . . 0.0 104.359 174.16 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 20.0 ttp180 -122.94 138.78 30.2 Favored Pre-proline 0 CA--C 1.498 -1.046 0 N-CA-C 104.087 -2.56 . . . . 0.0 104.087 177.437 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 68.4 Cg_exo -66.26 130.14 23.3 Favored 'Trans proline' 0 CA--C 1.503 -1.037 0 CA-C-N 123.798 2.392 . . . . 0.0 109.122 169.395 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 39.9 ttmt -73.07 69.56 1.02 Allowed 'General case' 0 C--N 1.357 0.929 0 C-N-CA 124.716 1.206 . . . . 0.0 109.899 173.939 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 69.6 m-80 -160.65 -57.05 0.05 Allowed 'General case' 0 N--CA 1.434 -1.26 0 N-CA-C 102.18 -3.267 . . . . 0.0 102.18 -170.866 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 53.4 p -85.29 165.52 17.24 Favored 'General case' 0 N--CA 1.439 -1.021 0 C-N-CA 125.333 1.453 . . . . 0.0 109.109 179.565 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 19.2 m -113.73 -13.04 11.58 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.811 0 C-N-CA 124.254 1.022 . . . . 0.0 110.144 -172.31 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -175.81 38.61 0.1 Allowed Glycine 0 C--N 1.354 1.55 0 N-CA-C 110.359 -1.097 . . . . 0.0 110.359 -178.19 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -119.85 105.51 11.17 Favored 'General case' 0 CA--C 1.492 -1.257 0 N-CA-C 102.271 -3.233 . . . . 0.0 102.271 171.149 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -157.75 165.74 34.59 Favored 'General case' 0 CA--C 1.49 -1.33 0 CA-C-O 122.16 0.981 . . . . 0.0 112.161 -172.618 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 63.2 mttp -121.57 161.41 22.43 Favored 'General case' 0 CA--C 1.492 -1.257 0 CA-C-N 113.688 -1.596 . . . . 0.0 106.79 -169.777 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 15.8 pt-20 -151.92 160.71 43.43 Favored 'General case' 0 N--CA 1.435 -1.199 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 174.315 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -140.5 162.25 35.79 Favored 'General case' 0 CA--C 1.5 -0.961 0 N-CA-C 106.283 -1.747 . . . . 0.0 106.283 174.69 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 59.5 m -120.36 126.04 49.52 Favored 'General case' 0 CA--C 1.499 -0.982 0 N-CA-C 105.175 -2.157 . . . . 0.0 105.175 178.06 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 5.3 mp -112.7 135.94 21.57 Favored Pre-proline 0 N--CA 1.437 -1.098 0 N-CA-C 104.516 -2.401 . . . . 0.0 104.516 -177.346 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 63.2 Cg_exo -63.6 168.06 12.26 Favored 'Trans proline' 0 CA--C 1.51 -0.723 0 C-N-CA 123.45 2.766 . . . . 0.0 113.618 177.466 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -78.49 -20.01 72.65 Favored Glycine 0 C--N 1.351 1.383 0 C-N-CA 123.398 0.523 . . . . 0.0 113.26 -173.885 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 49.7 p-80 -84.27 -27.48 27.85 Favored 'General case' 0 C--N 1.355 0.836 0 CA-C-N 117.713 0.756 . . . . 0.0 110.022 -179.393 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 87.5 mt -88.52 130.64 35.18 Favored 'General case' 0 CA--C 1.5 -0.981 0 N-CA-C 107.541 -1.281 . . . . 0.0 107.541 177.264 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 7.6 p30 -118.88 13.05 13.05 Favored 'General case' 0 CA--C 1.501 -0.921 0 C-N-CA 124.113 0.965 . . . . 0.0 109.645 -173.311 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 46.9 p -142.93 166.6 24.19 Favored 'General case' 0 N--CA 1.44 -0.959 0 N-CA-C 107.282 -1.377 . . . . 0.0 107.282 179.169 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 9.9 t80 -154.87 176.74 12.1 Favored 'General case' 0 N--CA 1.44 -0.938 0 N-CA-C 107.788 -1.19 . . . . 0.0 107.788 -177.161 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 57.2 m -142.57 114.72 8.3 Favored 'General case' 0 N--CA 1.432 -1.367 0 N-CA-C 105.114 -2.18 . . . . 0.0 105.114 176.882 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 50.8 mt -98.84 98.09 6.73 Favored 'Isoleucine or valine' 0 C--N 1.36 1.044 0 N-CA-C 106.137 -1.801 . . . . 0.0 106.137 175.823 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 93.4 mttt -94.97 163.65 13.23 Favored 'General case' 0 CA--C 1.499 -0.988 0 CA-C-O 121.591 0.71 . . . . 0.0 109.341 178.453 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 84.03 49.51 4.73 Favored Glycine 0 CA--C 1.49 -1.471 0 N-CA-C 109.134 -1.586 . . . . 0.0 109.134 174.453 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 68.3 mt -121.63 162.73 20.16 Favored 'General case' 0 CA--C 1.497 -1.078 0 N-CA-C 106.171 -1.789 . . . . 0.0 106.171 -179.144 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -99.57 157.34 34.13 Favored Pre-proline 0 N--CA 1.44 -0.944 0 N-CA-C 107.257 -1.386 . . . . 0.0 107.257 -177.276 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -78.65 165.88 24.38 Favored 'Trans proline' 0 N--CA 1.451 -1.005 0 C-N-CA 123.074 2.516 . . . . 0.0 109.575 165.521 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' GLY . . . . . 0.515 ' H ' ' HA ' ' A' ' 92' ' ' THR . . . 64.67 18.77 64.26 Favored Glycine 0 N--CA 1.43 -1.736 0 C-N-CA 127.223 2.344 . . . . 0.0 116.415 173.178 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 13.9 p -123.99 140.36 47.66 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.024 0 N-CA-C 107.942 -1.133 . . . . 0.0 107.942 -176.338 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 2.8 p -96.34 129.48 46.35 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.842 0 N-CA-C 107.391 -1.337 . . . . 0.0 107.391 178.671 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 82.6 m-85 -109.56 155.17 21.73 Favored 'General case' 0 N--CA 1.438 -1.04 0 C-N-CA 124.672 1.189 . . . . 0.0 108.436 177.375 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 19.3 tt0 -92.63 139.04 30.98 Favored 'General case' 0 N--CA 1.437 -1.108 0 N-CA-C 104.044 -2.576 . . . . 0.0 104.044 159.074 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -132.31 146.07 17.82 Favored Glycine 0 CA--C 1.49 -1.488 0 N-CA-C 107.575 -2.21 . . . . 0.0 107.575 171.679 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 32.4 mt-30 -138.57 136.02 35.6 Favored 'General case' 0 CA--C 1.479 -1.759 0 N-CA-C 106.321 -1.733 . . . . 0.0 106.321 177.834 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 45.2 tp -117.54 95.53 4.99 Favored 'General case' 0 N--CA 1.439 -1.011 0 N-CA-C 104.423 -2.436 . . . . 0.0 104.423 -178.281 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 12.5 mt -90.92 131.7 37.4 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.85 0 N-CA-C 105.167 -2.16 . . . . 0.0 105.167 -176.994 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 26.0 p -112.18 115.05 28.21 Favored 'General case' 0 N--CA 1.441 -0.882 0 N-CA-C 107.592 -1.262 . . . . 0.0 107.592 -176.257 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 5.8 mm -94.03 151.56 3.71 Favored 'Isoleucine or valine' 0 CA--C 1.49 -1.347 0 N-CA-C 106.282 -1.747 . . . . 0.0 106.282 -165.142 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 37.4 mt-30 -119.1 145.66 45.74 Favored 'General case' 0 CA--C 1.49 -1.344 0 N-CA-C 105.154 -2.165 . . . . 0.0 105.154 176.879 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 36.1 mt-30 -77.27 35.31 0.17 Allowed 'General case' 0 C--N 1.356 0.856 0 C-N-CA 125.182 1.393 . . . . 0.0 112.917 179.322 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -138.54 13.33 2.76 Favored 'General case' 0 CA--C 1.499 -1.017 0 C-N-CA 124.754 1.222 . . . . 0.0 107.747 -179.436 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 92.51 -13.64 66.81 Favored Glycine 0 C--N 1.352 1.419 0 C-N-CA 124.298 0.952 . . . . 0.0 112.511 173.423 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 65.4 m80 -80.74 161.99 24.31 Favored 'General case' 0 CA--C 1.502 -0.897 0 CA-C-N 118.045 0.922 . . . . 0.0 109.692 -174.81 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 80.7 mt-30 -145.45 137.34 25.44 Favored 'General case' 0 N--CA 1.437 -1.104 0 N-CA-C 104.606 -2.368 . . . . 0.0 104.606 -178.148 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 9.6 mp0 -118.36 131.37 56.31 Favored 'General case' 0 CA--C 1.494 -1.199 0 N-CA-C 104.074 -2.565 . . . . 0.0 104.074 173.155 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 5.6 p -106.91 132.72 53.52 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.864 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 -172.104 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 21.5 m -104.86 137.52 42.52 Favored 'General case' 0 N--CA 1.442 -0.873 0 N-CA-C 102.383 -3.192 . . . . 0.0 102.383 168.947 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 31.5 ptt-85 -134.38 145.95 49.44 Favored 'General case' 0 CA--C 1.496 -1.112 0 CA-C-O 121.588 0.708 . . . . 0.0 109.143 179.831 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 20.0 p90 -164.78 -178.9 5.52 Favored 'General case' 0 CA--C 1.499 -0.999 0 N-CA-C 106.376 -1.713 . . . . 0.0 106.376 -173.296 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -137.06 157.76 45.98 Favored 'General case' 0 N--CA 1.437 -1.094 0 N-CA-C 106.212 -1.773 . . . . 0.0 106.212 170.155 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 25.5 p90 -143.58 170.72 15.3 Favored 'General case' 0 CA--C 1.487 -1.453 0 N-CA-C 106.256 -1.757 . . . . 0.0 106.256 169.497 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 9.7 m -126.49 140.3 52.57 Favored 'General case' 0 CA--C 1.499 -1.001 0 N-CA-C 103.678 -2.712 . . . . 0.0 103.678 175.827 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 86.1 m -112.71 114.15 26.6 Favored 'General case' 0 CA--C 1.497 -1.09 0 N-CA-C 102.137 -3.283 . . . . 0.0 102.137 176.58 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 92' ' ' THR . . . . . 0.515 ' HA ' ' H ' ' A' ' 66' ' ' GLY . 23.7 p -125.21 168.5 13.38 Favored 'General case' 0 CA--C 1.5 -0.952 0 N-CA-C 106.438 -1.69 . . . . 0.0 106.438 -179.128 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 15.1 t . . . . . 0 C--O 1.258 1.546 0 N-CA-C 108.014 -1.106 . . . . 0.0 108.014 -178.399 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.437 -1.265 0 N-CA-C 106.748 -2.541 . . . . 0.0 106.748 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 66.6 Cg_exo -60.1 138.86 84.44 Favored 'Trans proline' 0 N--CA 1.447 -1.214 0 C-N-CA 123.396 2.73 . . . . 0.0 113.493 -170.79 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 21.5 t -77.77 156.55 5.23 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.9 0 C-N-CA 128.277 2.631 . . . . 0.0 105.354 178.483 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 59.4 mm-40 -109.73 98.67 7.97 Favored 'General case' 0 CA--C 1.487 -1.478 0 N-CA-C 106.947 -1.501 . . . . 0.0 106.947 -174.442 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 2.2 p -123.27 139.3 50.38 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.108 0 N-CA-C 106.248 -1.76 . . . . 0.0 106.248 -169.163 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 75.1 m-85 . . . . . 0 CA--C 1.494 -1.184 0 N-CA-C 105.179 -2.156 . . . . 0.0 105.179 -172.403 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo . . . . . 0 CA--C 1.505 -0.943 0 CA-C-O 118.206 -0.831 . . . . 0.0 112.005 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 5.8 p-10 -114.28 -39.46 3.86 Favored 'General case' 0 CA--C 1.491 -1.321 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 -164.701 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 66.5 m -104.31 154.33 19.95 Favored 'General case' 0 CA--C 1.494 -1.181 0 N-CA-C 106.599 -1.63 . . . . 0.0 106.599 176.285 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 18.3 t60 -139.95 89.58 11.24 Favored Pre-proline 0 N--CA 1.438 -1.033 0 N-CA-C 107.188 -1.412 . . . . 0.0 107.188 172.917 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -82.96 120.05 2.96 Favored 'Trans proline' 0 N--CA 1.447 -1.219 0 C-N-CA 123.11 2.54 . . . . 0.0 110.463 179.593 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.485 HD11 HD11 ' A' ' 35' ' ' LEU . 3.9 pt -104.85 173.84 1.35 Allowed 'Isoleucine or valine' 0 CA--C 1.497 -1.083 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 -177.486 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 2.4 pt20 -149.82 149.43 30.5 Favored 'General case' 0 N--CA 1.44 -0.967 0 N-CA-C 106.421 -1.696 . . . . 0.0 106.421 173.52 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 23.8 p90 -134.44 157.14 47.21 Favored 'General case' 0 CA--C 1.499 -0.983 0 N-CA-C 106.632 -1.618 . . . . 0.0 106.632 -177.808 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 59.8 t30 -99.71 -177.81 3.68 Favored 'General case' 0 CA--C 1.492 -1.272 0 N-CA-C 102.683 -3.08 . . . . 0.0 102.683 168.152 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -155.63 170.49 8.66 Favored Pre-proline 0 N--CA 1.438 -1.043 0 N-CA-C 106.334 -1.728 . . . . 0.0 106.334 176.325 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 63.5 Cg_exo -63.65 164.16 22.06 Favored 'Trans proline' 0 N--CA 1.456 -0.695 0 C-N-CA 123.267 2.645 . . . . 0.0 112.635 173.176 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 17.9 mp0 -80.48 -53.83 0.85 Allowed Pre-proline 0 N--CA 1.443 -0.818 0 CA-C-O 115.579 -2.153 . . . . 0.0 111.617 -167.919 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -74.03 172.26 16.29 Favored 'Trans proline' 0 CA--C 1.51 -0.699 0 CA-C-N 125.871 3.132 . . . . 0.0 109.95 174.221 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 22.8 t -83.79 87.01 7.07 Favored 'General case' 0 C--N 1.357 0.907 0 N-CA-C 107.237 -1.394 . . . . 0.0 107.237 178.563 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 22.5 t-160 -112.56 -32.86 6.33 Favored 'General case' 0 N--CA 1.436 -1.145 0 N-CA-C 106.938 -1.504 . . . . 0.0 106.938 -177.084 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 1.8 mp -108.62 134.55 50.2 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.946 0 N-CA-C 103.315 -2.846 . . . . 0.0 103.315 -178.179 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 5.9 p -100.77 -82.01 0.46 Allowed 'General case' 0 N--CA 1.434 -1.26 0 N-CA-C 107.875 -1.158 . . . . 0.0 107.875 175.108 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 6.5 ttpm? -94.35 161.27 14.31 Favored 'General case' 0 CA--C 1.495 -1.136 0 C-N-CA 124.7 1.2 . . . . 0.0 108.029 -165.733 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 85.5 m-85 -125.9 138.14 53.77 Favored 'General case' 0 N--CA 1.437 -1.079 0 N-CA-C 105.111 -2.181 . . . . 0.0 105.111 171.733 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 34.3 mm -109.25 129.18 64.43 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.155 0 N-CA-C 101.03 -3.692 . . . . 0.0 101.03 165.831 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.485 HD11 HD11 ' A' ' 20' ' ' ILE . 3.8 mt -109.02 135.8 49.6 Favored 'General case' 0 CA--C 1.478 -1.796 0 N-CA-C 106.543 -1.651 . . . . 0.0 106.543 169.721 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 84.1 mtt180 -125.09 158.23 34.35 Favored 'General case' 0 N--CA 1.43 -1.446 0 N-CA-C 107.123 -1.436 . . . . 0.0 107.123 173.191 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 48.0 p90 -150.5 145.21 25.85 Favored 'General case' 0 N--CA 1.437 -1.091 0 N-CA-C 105.86 -1.904 . . . . 0.0 105.86 173.381 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 46.9 ttp180 -153.44 137.57 10.73 Favored Pre-proline 0 CA--C 1.498 -1.032 0 N-CA-C 105.324 -2.102 . . . . 0.0 105.324 -176.411 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -72.74 120.75 6.86 Favored 'Trans proline' 0 N--CA 1.451 -1.021 0 CA-C-N 123.485 2.28 . . . . 0.0 109.034 -177.369 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 58.5 tttm -73.48 65.06 0.89 Allowed 'General case' 0 C--N 1.358 0.962 0 C-N-CA 127.078 2.151 . . . . 0.0 110.554 177.514 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 6.4 t-20 -161.77 -53.0 0.04 OUTLIER 'General case' 0 N--CA 1.432 -1.358 0 N-CA-C 104.003 -2.592 . . . . 0.0 104.003 -169.735 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 50.3 m -88.36 166.0 14.57 Favored 'General case' 0 N--CA 1.438 -1.052 0 C-N-CA 124.431 1.092 . . . . 0.0 108.218 177.991 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 10.9 m -116.0 41.37 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.795 0 N-CA-C 106.938 -1.505 . . . . 0.0 106.938 -178.998 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -92.54 -156.38 32.72 Favored Glycine 0 C--N 1.354 1.559 0 N-CA-C 109.61 -1.396 . . . . 0.0 109.61 -177.494 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 39.6 mmt180 -101.87 172.2 7.07 Favored 'General case' 0 CA--C 1.499 -0.999 0 N-CA-C 107.324 -1.362 . . . . 0.0 107.324 -179.999 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 47.9 m95 -87.12 164.28 16.5 Favored 'General case' 0 N--CA 1.441 -0.88 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 -177.681 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 96.2 mttt -108.77 155.64 20.54 Favored 'General case' 0 CA--C 1.489 -1.366 0 N-CA-C 102.237 -3.246 . . . . 0.0 102.237 161.462 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -151.32 159.07 44.49 Favored 'General case' 0 CA--C 1.494 -1.209 0 CA-C-O 122.021 0.915 . . . . 0.0 109.794 -178.048 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -133.88 159.21 41.36 Favored 'General case' 0 N--CA 1.434 -1.241 0 N-CA-C 106.057 -1.831 . . . . 0.0 106.057 172.68 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 93.8 m -119.86 125.63 48.99 Favored 'General case' 0 CA--C 1.499 -1.006 0 N-CA-C 104.277 -2.49 . . . . 0.0 104.277 178.178 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 34.0 mt -123.79 122.79 26.35 Favored Pre-proline 0 N--CA 1.439 -0.984 0 N-CA-C 105.038 -2.208 . . . . 0.0 105.038 -171.602 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' PRO . . . . . 0.462 ' HB2' ' CE1' ' A' ' 54' ' ' HIS . 50.7 Cg_exo -67.25 169.21 15.78 Favored 'Trans proline' 0 CA--C 1.512 -0.612 0 C-N-CA 123.279 2.653 . . . . 0.0 111.301 175.757 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -86.71 83.21 1.6 Allowed Glycine 0 C--N 1.352 1.441 0 N-CA-C 110.121 -1.191 . . . . 0.0 110.121 -177.728 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 54' ' ' HIS . . . . . 0.462 ' CE1' ' HB2' ' A' ' 52' ' ' PRO . 0.5 OUTLIER -157.54 -44.11 0.07 Allowed 'General case' 0 CA--C 1.497 -1.079 0 N-CA-C 107.279 -1.378 . . . . 0.0 107.279 -179.795 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 92.2 mt -89.62 136.49 33.0 Favored 'General case' 0 CA--C 1.495 -1.148 0 N-CA-C 107.832 -1.173 . . . . 0.0 107.832 179.522 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 8.6 p30 -112.67 5.34 17.68 Favored 'General case' 0 N--CA 1.44 -0.926 0 C-N-CA 124.875 1.27 . . . . 0.0 109.119 -179.392 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 45.3 p -142.98 150.28 39.45 Favored 'General case' 0 CA--C 1.499 -1.012 0 N-CA-C 107.171 -1.418 . . . . 0.0 107.171 -178.519 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 7.5 t80 -126.36 174.08 8.85 Favored 'General case' 0 C--N 1.357 0.924 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 -179.087 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 88.0 m -138.74 109.44 6.64 Favored 'General case' 0 N--CA 1.43 -1.425 0 N-CA-C 104.618 -2.364 . . . . 0.0 104.618 172.205 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 28.3 mt -88.15 147.17 5.42 Favored 'Isoleucine or valine' 0 C--N 1.358 0.965 0 N-CA-C 104.271 -2.492 . . . . 0.0 104.271 171.447 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 94.0 mttt -141.08 162.65 34.97 Favored 'General case' 0 CA--C 1.5 -0.976 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 177.131 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 82.61 48.96 5.35 Favored Glycine 0 C--N 1.353 1.487 0 N-CA-C 109.838 -1.305 . . . . 0.0 109.838 173.758 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 58.0 mt -119.71 173.34 7.08 Favored 'General case' 0 CA--C 1.5 -0.958 0 N-CA-C 107.886 -1.153 . . . . 0.0 107.886 -173.654 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 67.8 mttm -110.36 157.15 38.96 Favored Pre-proline 0 N--CA 1.441 -0.876 0 N-CA-C 107.419 -1.326 . . . . 0.0 107.419 -176.113 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 67.5 Cg_endo -78.65 161.3 27.86 Favored 'Trans proline' 0 N--CA 1.451 -0.986 0 C-N-CA 123.168 2.579 . . . . 0.0 109.785 168.247 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 59.59 26.21 61.99 Favored Glycine 0 C--N 1.355 1.621 0 C-N-CA 127.261 2.363 . . . . 0.0 116.337 171.59 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 13.2 p -120.24 148.3 23.46 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.995 0 N-CA-C 106.837 -1.542 . . . . 0.0 106.837 -177.595 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 4.0 p -99.76 130.93 48.1 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.907 0 N-CA-C 106.626 -1.62 . . . . 0.0 106.626 176.137 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 93.5 m-85 -112.16 148.42 34.04 Favored 'General case' 0 CA--C 1.494 -1.189 0 N-CA-C 105.537 -2.023 . . . . 0.0 105.537 172.246 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -97.91 134.69 40.7 Favored 'General case' 0 CA--C 1.496 -1.11 0 N-CA-C 103.576 -2.75 . . . . 0.0 103.576 161.68 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -117.6 152.58 17.62 Favored Glycine 0 CA--C 1.486 -1.75 0 N-CA-C 106.065 -2.814 . . . . 0.0 106.065 -178.054 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 35.3 tt0 -145.64 130.1 17.82 Favored 'General case' 0 CA--C 1.48 -1.735 0 N-CA-C 106.623 -1.621 . . . . 0.0 106.623 -177.226 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 38.9 tp -118.14 99.8 7.11 Favored 'General case' 0 N--CA 1.437 -1.081 0 N-CA-C 104.151 -2.537 . . . . 0.0 104.151 -174.534 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 26.8 mt -91.99 131.56 38.75 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.865 0 N-CA-C 103.603 -2.74 . . . . 0.0 103.603 176.481 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 20.9 p -117.08 115.74 25.97 Favored 'General case' 0 N--CA 1.436 -1.166 0 N-CA-C 106.962 -1.495 . . . . 0.0 106.962 -177.33 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 1.7 mp -89.58 132.52 34.07 Favored 'Isoleucine or valine' 0 CA--C 1.483 -1.6 0 N-CA-C 102.543 -3.132 . . . . 0.0 102.543 -173.131 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 82.0 mt-30 -101.83 152.65 20.64 Favored 'General case' 0 CA--C 1.489 -1.393 0 N-CA-C 106.951 -1.5 . . . . 0.0 106.951 -174.97 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 11.8 tt0 -77.53 41.48 0.33 Allowed 'General case' 0 N--CA 1.443 -0.818 0 C-N-CA 125.858 1.663 . . . . 0.0 112.419 -179.668 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 8.5 t80 -151.78 16.7 0.68 Allowed 'General case' 0 N--CA 1.436 -1.128 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 178.315 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 86.99 -11.75 63.97 Favored Glycine 0 C--N 1.353 1.526 0 C-N-CA 123.73 0.681 . . . . 0.0 112.496 176.901 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 44.6 t-80 -78.65 160.38 27.56 Favored 'General case' 0 N--CA 1.441 -0.888 0 C-N-CA 124.68 1.192 . . . . 0.0 109.011 -176.767 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 83.2 mt-30 -136.22 136.2 39.71 Favored 'General case' 0 CA--C 1.491 -1.318 0 N-CA-C 104.579 -2.378 . . . . 0.0 104.579 175.14 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 16.8 tp10 -120.49 131.47 54.74 Favored 'General case' 0 CA--C 1.495 -1.171 0 N-CA-C 104.753 -2.314 . . . . 0.0 104.753 178.0 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 7.2 p -108.94 139.25 32.33 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.83 0 N-CA-C 107.561 -1.274 . . . . 0.0 107.561 -174.298 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 89.1 m -125.32 131.22 53.07 Favored 'General case' 0 N--CA 1.44 -0.953 0 N-CA-C 102.804 -3.036 . . . . 0.0 102.804 178.51 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 40.5 ttp180 -130.51 145.53 51.88 Favored 'General case' 0 C--N 1.356 0.882 0 CA-C-N 119.492 1.042 . . . . 0.0 109.031 178.459 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 17.8 p90 -156.35 -179.89 8.59 Favored 'General case' 0 CA--C 1.498 -1.026 0 N-CA-C 105.987 -1.857 . . . . 0.0 105.987 -171.245 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 1.6 p30 -141.05 157.72 44.93 Favored 'General case' 0 N--CA 1.442 -0.873 0 N-CA-C 108.117 -1.068 . . . . 0.0 108.117 169.153 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 21.8 p90 -144.66 170.71 15.56 Favored 'General case' 0 CA--C 1.493 -1.226 0 N-CA-C 106.921 -1.511 . . . . 0.0 106.921 173.597 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 24.7 p -117.51 138.6 51.78 Favored 'General case' 0 CA--C 1.501 -0.934 0 N-CA-C 106.175 -1.787 . . . . 0.0 106.175 171.491 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 56.0 m -108.07 113.49 26.69 Favored 'General case' 0 CA--C 1.495 -1.149 0 N-CA-C 103.009 -2.96 . . . . 0.0 103.009 172.076 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 15.0 t -161.86 165.36 27.85 Favored 'General case' 0 N--CA 1.436 -1.171 0 N-CA-C 104.731 -2.322 . . . . 0.0 104.731 -174.653 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 75.2 p . . . . . 0 C--O 1.261 1.687 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 173.587 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.438 -1.201 0 N-CA-C 108.593 -1.803 . . . . 0.0 108.593 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_exo -64.79 146.29 88.0 Favored 'Trans proline' 0 N--CA 1.442 -1.529 0 C-N-CA 123.157 2.571 . . . . 0.0 115.287 -161.042 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 4.6 m -83.0 169.28 1.6 Allowed 'Isoleucine or valine' 0 N--CA 1.432 -1.336 0 C-N-CA 126.641 1.977 . . . . 0.0 107.168 171.063 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 -101.81 100.35 10.67 Favored 'General case' 0 CA--C 1.495 -1.164 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 -176.678 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 4.2 p -107.77 137.62 38.16 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.138 0 N-CA-C 107.474 -1.306 . . . . 0.0 107.474 -174.016 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 1.6 t80 . . . . . 0 N--CA 1.433 -1.323 0 N-CA-C 106.975 -1.491 . . . . 0.0 106.975 -170.669 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_exo . . . . . 0 CA--C 1.507 -0.83 0 N-CA-C 110.722 -0.53 . . . . 0.0 110.722 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 8.6 p-10 -96.87 -30.81 12.92 Favored 'General case' 0 CA--C 1.486 -1.485 0 C-N-CA 125.508 1.523 . . . . 0.0 110.638 -172.783 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 22.9 t -119.54 156.71 29.78 Favored 'General case' 0 CA--C 1.498 -1.037 0 CA-C-O 122.223 1.011 . . . . 0.0 108.915 -172.47 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 59.7 t-80 -140.39 98.75 7.26 Favored Pre-proline 0 N--CA 1.438 -1.056 0 N-CA-C 106.735 -1.58 . . . . 0.0 106.735 172.783 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -80.86 137.31 11.04 Favored 'Trans proline' 0 N--CA 1.447 -1.216 0 C-N-CA 123.019 2.479 . . . . 0.0 110.17 176.104 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 2.4 pt -118.64 172.77 5.59 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.07 0 N-CA-C 107.747 -1.205 . . . . 0.0 107.747 178.794 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' GLN . . . . . 0.448 ' HA ' ' HA ' ' A' ' 57' ' ' SER . 3.6 pt20 -150.79 158.34 44.03 Favored 'General case' 0 CA--C 1.492 -1.287 0 N-CA-C 105.706 -1.961 . . . . 0.0 105.706 168.947 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 43.7 p90 -142.97 164.49 29.94 Favored 'General case' 0 CA--C 1.493 -1.231 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 -175.409 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 81.1 m-20 -109.39 177.1 4.85 Favored 'General case' 0 CA--C 1.494 -1.2 0 N-CA-C 104.297 -2.482 . . . . 0.0 104.297 168.839 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -161.23 173.83 4.36 Favored Pre-proline 0 N--CA 1.435 -1.22 0 N-CA-C 104.788 -2.301 . . . . 0.0 104.788 -176.138 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' PRO . . . . . 0.432 ' HD2' HD12 ' A' ' 30' ' ' ILE . 67.1 Cg_exo -63.1 153.49 73.55 Favored 'Trans proline' 0 N--CA 1.455 -0.742 0 C-N-CA 123.786 2.991 . . . . 0.0 112.758 175.563 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 26.1 tt0 -82.17 -40.36 0.93 Allowed Pre-proline 0 N--CA 1.443 -0.813 0 CA-C-O 115.574 -2.155 . . . . 0.0 112.071 -174.558 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_exo -69.49 -8.9 24.83 Favored 'Trans proline' 0 CA--C 1.512 -0.59 0 CA-C-N 125.674 3.062 . . . . 0.0 114.037 179.906 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 8.9 t 67.86 66.65 0.36 Allowed 'General case' 0 C--N 1.357 0.91 0 C-N-CA 126.107 1.763 . . . . 0.0 110.038 178.939 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 76.6 t60 -97.49 -2.27 42.33 Favored 'General case' 0 N--CA 1.441 -0.876 0 C-N-CA 124.517 1.127 . . . . 0.0 108.307 175.411 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.432 HD12 ' HD2' ' A' ' 25' ' ' PRO . 9.7 mt -111.16 135.8 49.21 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.071 0 N-CA-C 105.131 -2.174 . . . . 0.0 105.131 -179.669 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 4.6 p -98.13 -84.45 0.39 Allowed 'General case' 0 N--CA 1.428 -1.565 0 N-CA-C 106.518 -1.66 . . . . 0.0 106.518 178.282 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 52.7 mtmt -90.57 170.65 10.0 Favored 'General case' 0 CA--C 1.487 -1.448 0 C-N-CA 123.857 0.863 . . . . 0.0 109.086 -165.134 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 87.4 m-85 -132.43 140.05 48.28 Favored 'General case' 0 N--CA 1.436 -1.141 0 N-CA-C 103.837 -2.653 . . . . 0.0 103.837 167.568 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 41.8 mt -121.73 135.2 62.64 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.204 0 N-CA-C 101.632 -3.47 . . . . 0.0 101.632 173.66 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 4.5 mt -113.07 136.98 52.11 Favored 'General case' 0 CA--C 1.467 -2.233 0 N-CA-C 104.848 -2.278 . . . . 0.0 104.848 169.54 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 1.1 ptm180 -131.51 152.31 50.84 Favored 'General case' 0 N--CA 1.43 -1.472 0 N-CA-C 105.678 -1.971 . . . . 0.0 105.678 168.632 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 48.6 p90 -155.0 152.28 29.48 Favored 'General case' 0 N--CA 1.436 -1.158 0 N-CA-C 106.841 -1.54 . . . . 0.0 106.841 -175.034 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 36.4 ptt180 -158.14 157.37 29.18 Favored Pre-proline 0 CA--C 1.5 -0.949 0 N-CA-C 105.881 -1.896 . . . . 0.0 105.881 171.989 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_endo -76.43 124.33 7.65 Favored 'Trans proline' 0 CA--C 1.503 -1.067 0 C-N-CA 122.652 2.234 . . . . 0.0 108.968 -175.209 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 85.1 tttt -71.19 79.58 0.7 Allowed 'General case' 0 C--N 1.358 0.943 0 C-N-CA 126.296 1.839 . . . . 0.0 110.497 178.753 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 26.1 m120 -154.28 -69.57 0.13 Allowed 'General case' 0 N--CA 1.436 -1.167 0 N-CA-C 101.531 -3.507 . . . . 0.0 101.531 -176.313 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 55.1 m -96.79 167.03 11.35 Favored 'General case' 0 N--CA 1.44 -0.925 0 N-CA-C 106.746 -1.575 . . . . 0.0 106.746 171.55 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 2.6 m -132.82 62.59 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.439 -0.988 0 N-CA-C 105.285 -2.117 . . . . 0.0 105.285 179.892 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -93.1 -111.83 2.09 Favored Glycine 0 C--N 1.353 1.521 0 N-CA-C 108.838 -1.705 . . . . 0.0 108.838 -178.916 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 86.7 mtm180 -97.66 169.66 9.55 Favored 'General case' 0 CA--C 1.501 -0.92 0 N-CA-C 107.973 -1.121 . . . . 0.0 107.973 -179.367 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 70.6 m95 -112.16 167.17 10.62 Favored 'General case' 0 N--CA 1.44 -0.957 0 N-CA-C 107.615 -1.254 . . . . 0.0 107.615 178.53 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -114.51 152.89 30.97 Favored 'General case' 0 CA--C 1.487 -1.46 0 N-CA-C 102.537 -3.135 . . . . 0.0 102.537 163.245 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 16.2 pt-20 -152.35 159.04 43.51 Favored 'General case' 0 N--CA 1.437 -1.094 0 CA-C-O 121.749 0.785 . . . . 0.0 109.106 178.507 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -140.03 162.68 34.62 Favored 'General case' 0 CA--C 1.499 -0.998 0 N-CA-C 106.553 -1.647 . . . . 0.0 106.553 172.488 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 90.0 m -119.34 125.32 48.75 Favored 'General case' 0 CA--C 1.5 -0.969 0 N-CA-C 105.127 -2.175 . . . . 0.0 105.127 176.981 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 4.5 mp -109.03 133.64 20.65 Favored Pre-proline 0 N--CA 1.437 -1.117 0 N-CA-C 105.239 -2.134 . . . . 0.0 105.239 -175.928 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 68.7 Cg_exo -64.27 164.1 24.04 Favored 'Trans proline' 0 CA--C 1.508 -0.802 0 C-N-CA 123.312 2.675 . . . . 0.0 113.369 176.193 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -75.37 -16.63 80.5 Favored Glycine 0 C--N 1.352 1.418 0 C-N-CA 123.977 0.799 . . . . 0.0 114.497 -174.421 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 52.6 p-80 -83.52 -27.15 29.57 Favored 'General case' 0 C--N 1.357 0.903 0 CA-C-N 118.144 0.972 . . . . 0.0 110.105 -179.617 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 88.4 mt -88.65 131.18 35.1 Favored 'General case' 0 CA--C 1.501 -0.908 0 N-CA-C 107.945 -1.131 . . . . 0.0 107.945 177.161 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 8.5 p30 -114.17 7.87 16.73 Favored 'General case' 0 CA--C 1.504 -0.797 0 C-N-CA 124.521 1.128 . . . . 0.0 109.858 -174.753 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 57' ' ' SER . . . . . 0.448 ' HA ' ' HA ' ' A' ' 21' ' ' GLN . 36.9 p -139.23 160.49 39.68 Favored 'General case' 0 CA--C 1.497 -1.093 0 N-CA-C 107.163 -1.421 . . . . 0.0 107.163 -177.519 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 4.1 t80 -138.87 178.77 6.91 Favored 'General case' 0 C--N 1.36 1.064 0 CA-C-O 121.672 0.748 . . . . 0.0 109.171 175.729 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 89.4 m -144.49 103.62 3.97 Favored 'General case' 0 N--CA 1.432 -1.339 0 N-CA-C 103.689 -2.708 . . . . 0.0 103.689 -178.502 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 55.8 mt -95.37 106.51 18.33 Favored 'Isoleucine or valine' 0 C--N 1.358 0.969 0 N-CA-C 106.239 -1.763 . . . . 0.0 106.239 179.541 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 63.7 mttm -103.64 163.76 12.11 Favored 'General case' 0 CA--C 1.502 -0.897 0 CA-C-O 121.739 0.78 . . . . 0.0 109.542 178.814 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 90.85 45.5 4.2 Favored Glycine 0 CA--C 1.49 -1.474 0 N-CA-C 109.285 -1.526 . . . . 0.0 109.285 172.907 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 61.7 mt -119.92 176.67 5.3 Favored 'General case' 0 N--CA 1.44 -0.931 0 N-CA-C 106.909 -1.515 . . . . 0.0 106.909 -174.643 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -120.89 157.79 53.94 Favored Pre-proline 0 N--CA 1.44 -0.93 0 N-CA-C 106.704 -1.591 . . . . 0.0 106.704 -175.684 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 64.8 Cg_endo -78.63 164.54 25.76 Favored 'Trans proline' 0 N--CA 1.452 -0.956 0 C-N-CA 123.065 2.51 . . . . 0.0 110.559 170.252 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 66' ' ' GLY . . . . . 0.585 ' H ' ' HA ' ' A' ' 92' ' ' THR . . . 60.94 25.2 63.76 Favored Glycine 0 N--CA 1.431 -1.679 0 C-N-CA 128.006 2.717 . . . . 0.0 116.124 171.256 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 8.5 p -130.54 146.83 33.42 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.15 0 N-CA-C 108.188 -1.041 . . . . 0.0 108.188 -176.124 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 4.2 p -95.88 133.66 36.23 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.907 0 N-CA-C 107.377 -1.342 . . . . 0.0 107.377 178.157 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 93.8 m-85 -112.9 149.48 33.12 Favored 'General case' 0 CA--C 1.498 -1.057 0 N-CA-C 106.161 -1.792 . . . . 0.0 106.161 174.299 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -101.1 140.0 36.01 Favored 'General case' 0 CA--C 1.497 -1.094 0 N-CA-C 104.561 -2.385 . . . . 0.0 104.561 164.827 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -137.15 148.98 20.08 Favored Glycine 0 CA--C 1.486 -1.723 0 N-CA-C 108.101 -2.0 . . . . 0.0 108.101 -175.035 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 84.5 mt-30 -138.79 135.77 34.97 Favored 'General case' 0 CA--C 1.484 -1.58 0 N-CA-C 105.585 -2.006 . . . . 0.0 105.585 178.477 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 46.0 tp -114.71 103.29 10.84 Favored 'General case' 0 N--CA 1.434 -1.271 0 N-CA-C 103.847 -2.649 . . . . 0.0 103.847 179.247 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 38.1 mt -91.94 122.02 42.99 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.898 0 N-CA-C 103.852 -2.647 . . . . 0.0 103.852 177.723 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 15.4 p -113.92 115.1 27.15 Favored 'General case' 0 N--CA 1.441 -0.884 0 N-CA-C 107.156 -1.424 . . . . 0.0 107.156 -175.316 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 1.8 mp -90.36 131.94 36.26 Favored 'Isoleucine or valine' 0 CA--C 1.482 -1.659 0 N-CA-C 104.805 -2.294 . . . . 0.0 104.805 -162.817 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 76.4 mt-30 -84.3 147.91 26.95 Favored 'General case' 0 CA--C 1.491 -1.298 0 N-CA-C 107.994 -1.113 . . . . 0.0 107.994 -178.882 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 20.2 tt0 -76.5 41.75 0.26 Allowed 'General case' 0 N--CA 1.442 -0.862 0 C-N-CA 126.331 1.852 . . . . 0.0 110.545 170.739 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 8.2 t80 -153.07 15.9 0.55 Allowed 'General case' 0 N--CA 1.434 -1.265 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 -176.528 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 89.25 -19.03 41.62 Favored Glycine 0 C--N 1.353 1.506 0 C-N-CA 123.72 0.676 . . . . 0.0 112.601 174.358 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 36.7 m170 -81.7 173.48 12.28 Favored 'General case' 0 CA--C 1.495 -1.153 0 C-N-CA 124.446 1.098 . . . . 0.0 109.274 -176.308 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 32.0 mt-30 -138.7 145.55 40.47 Favored 'General case' 0 CA--C 1.495 -1.154 0 N-CA-C 105.527 -2.027 . . . . 0.0 105.527 176.495 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -111.23 153.72 25.44 Favored 'General case' 0 CA--C 1.493 -1.215 0 N-CA-C 105.415 -2.068 . . . . 0.0 105.415 171.06 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 14.8 p -126.92 137.46 57.78 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.897 0 N-CA-C 106.523 -1.658 . . . . 0.0 106.523 173.325 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 91.4 m -127.08 131.01 50.98 Favored 'General case' 0 N--CA 1.438 -1.066 0 N-CA-C 101.973 -3.343 . . . . 0.0 101.973 179.055 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 88.8 mtt180 -127.08 148.92 50.13 Favored 'General case' 0 CA--C 1.495 -1.15 0 CA-C-N 118.804 0.729 . . . . 0.0 109.487 -173.154 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 19.6 p90 -164.82 178.26 7.32 Favored 'General case' 0 CA--C 1.502 -0.9 0 N-CA-C 108.156 -1.053 . . . . 0.0 108.156 -175.287 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 51.4 m-20 -132.52 154.06 50.33 Favored 'General case' 0 N--CA 1.442 -0.872 0 N-CA-C 105.507 -2.034 . . . . 0.0 105.507 168.743 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 20.9 p90 -142.5 166.84 23.57 Favored 'General case' 0 CA--C 1.488 -1.424 0 N-CA-C 107.41 -1.33 . . . . 0.0 107.41 169.708 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 25.0 p -120.02 141.65 49.53 Favored 'General case' 0 CA--C 1.5 -0.981 0 N-CA-C 106.21 -1.774 . . . . 0.0 106.21 174.919 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 45.4 m -115.74 120.16 38.39 Favored 'General case' 0 CA--C 1.493 -1.245 0 N-CA-C 102.137 -3.283 . . . . 0.0 102.137 171.706 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 92' ' ' THR . . . . . 0.585 ' HA ' ' H ' ' A' ' 66' ' ' GLY . 5.3 t -145.92 -66.95 0.29 Allowed 'General case' 0 N--CA 1.436 -1.132 0 N-CA-C 106.093 -1.817 . . . . 0.0 106.093 -175.626 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 93' ' ' SER . . . . . 0.436 ' H ' HG23 ' A' ' 92' ' ' THR . 19.8 m . . . . . 0 C--O 1.261 1.659 0 C-N-CA 125.505 1.522 . . . . 0.0 110.355 178.379 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.436 -1.346 0 N-CA-C 106.717 -2.553 . . . . 0.0 106.717 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 22.8 Cg_exo -59.09 145.6 97.14 Favored 'Trans proline' 0 N--CA 1.448 -1.188 0 C-N-CA 123.058 2.505 . . . . 0.0 116.054 -164.598 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 48.9 t -79.17 158.96 4.63 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.94 0 C-N-CA 127.707 2.403 . . . . 0.0 106.991 179.575 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -103.86 106.3 16.76 Favored 'General case' 0 CA--C 1.494 -1.184 0 N-CA-C 104.853 -2.277 . . . . 0.0 104.853 175.052 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 2.1 p -130.4 141.64 45.77 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.1 0 N-CA-C 105.349 -2.093 . . . . 0.0 105.349 -169.632 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 1.8 p90 . . . . . 0 N--CA 1.438 -1.055 0 N-CA-C 105.933 -1.877 . . . . 0.0 105.933 -166.854 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_endo . . . . . 0 N--CA 1.454 -0.845 0 N-CA-C 110.259 -0.708 . . . . 0.0 110.259 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 12.3 p-10 -107.79 -42.09 4.82 Favored 'General case' 0 CA--C 1.492 -1.255 0 C-N-CA 124.725 1.21 . . . . 0.0 109.488 -169.069 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 32.8 t -117.06 157.02 26.55 Favored 'General case' 0 CA--C 1.496 -1.134 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 -172.558 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 23.7 m-70 -146.99 98.66 4.05 Favored Pre-proline 0 N--CA 1.437 -1.111 0 N-CA-C 106.516 -1.661 . . . . 0.0 106.516 169.235 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -76.59 100.03 1.35 Allowed 'Trans proline' 0 N--CA 1.447 -1.222 0 C-N-CA 123.654 2.902 . . . . 0.0 109.407 171.746 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.438 HG22 ' H ' ' A' ' 20' ' ' ILE . 13.4 tt -90.28 149.42 4.05 Favored 'Isoleucine or valine' 0 N--CA 1.408 -2.574 0 C-N-CA 128.834 2.854 . . . . 0.0 106.786 -177.41 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 57.3 mt-30 -141.03 151.06 43.76 Favored 'General case' 0 N--CA 1.434 -1.248 0 N-CA-C 104.225 -2.509 . . . . 0.0 104.225 175.724 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 34.0 p90 -138.98 156.82 46.93 Favored 'General case' 0 N--CA 1.437 -1.081 0 N-CA-C 107.794 -1.187 . . . . 0.0 107.794 -176.815 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 61.3 t30 -94.42 -173.65 3.12 Favored 'General case' 0 CA--C 1.49 -1.336 0 N-CA-C 103.531 -2.766 . . . . 0.0 103.531 169.898 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -155.97 169.21 10.81 Favored Pre-proline 0 N--CA 1.44 -0.96 0 N-CA-C 107.284 -1.376 . . . . 0.0 107.284 172.36 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 98.0 Cg_exo -64.39 167.34 15.05 Favored 'Trans proline' 0 CA--C 1.51 -0.683 0 C-N-CA 123.559 2.839 . . . . 0.0 112.447 170.686 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 71.4 tp60 -80.03 -42.68 1.44 Allowed Pre-proline 0 N--CA 1.444 -0.741 0 CA-C-O 115.586 -2.149 . . . . 0.0 112.026 -172.016 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_exo -66.78 152.72 79.98 Favored 'Trans proline' 0 CA--C 1.507 -0.864 0 CA-C-N 125.773 3.097 . . . . 0.0 112.171 177.936 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 27.2 p -99.58 58.01 1.04 Allowed 'General case' 0 C--N 1.353 0.754 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 179.739 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 76.3 t60 -106.21 -4.65 19.97 Favored 'General case' 0 N--CA 1.441 -0.92 0 C-N-CA 125.273 1.429 . . . . 0.0 107.595 175.67 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 41.8 mt -105.44 129.07 58.89 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.248 0 N-CA-C 105.037 -2.209 . . . . 0.0 105.037 178.167 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 5.2 p -104.36 -84.34 0.48 Allowed 'General case' 0 N--CA 1.43 -1.449 0 N-CA-C 107.459 -1.311 . . . . 0.0 107.459 -178.591 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 55.1 mtmt -89.7 168.83 11.81 Favored 'General case' 0 CA--C 1.488 -1.432 0 N-CA-C 108.544 -0.909 . . . . 0.0 108.544 -164.277 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 93.7 m-85 -129.79 138.34 51.0 Favored 'General case' 0 N--CA 1.434 -1.266 0 N-CA-C 103.861 -2.644 . . . . 0.0 103.861 168.297 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 57.3 mt -114.88 130.61 69.05 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.296 0 N-CA-C 101.01 -3.7 . . . . 0.0 101.01 169.885 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 3.1 mt -110.26 129.9 55.65 Favored 'General case' 0 CA--C 1.469 -2.144 0 N-CA-C 104.034 -2.58 . . . . 0.0 104.034 167.635 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 6.5 ptm180 -132.63 154.48 50.04 Favored 'General case' 0 N--CA 1.431 -1.399 0 N-CA-C 107.035 -1.468 . . . . 0.0 107.035 176.062 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 47.8 p90 -155.18 142.44 19.42 Favored 'General case' 0 N--CA 1.435 -1.176 0 N-CA-C 106.877 -1.527 . . . . 0.0 106.877 -173.328 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 30.7 ttp180 -139.54 140.88 26.61 Favored Pre-proline 0 CA--C 1.499 -1.017 0 N-CA-C 104.528 -2.397 . . . . 0.0 104.528 -177.777 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 26.7 Cg_endo -72.14 120.17 6.63 Favored 'Trans proline' 0 N--CA 1.452 -0.934 0 C-N-CA 122.827 2.351 . . . . 0.0 108.472 174.663 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 23.0 ttmm -68.06 85.2 0.24 Allowed 'General case' 0 C--N 1.359 1.005 0 C-N-CA 127.34 2.256 . . . . 0.0 109.733 -178.641 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 31.2 m120 -150.77 -72.41 0.17 Allowed 'General case' 0 N--CA 1.435 -1.209 0 N-CA-C 102.006 -3.331 . . . . 0.0 102.006 -178.075 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 53.7 p -105.55 172.1 6.98 Favored 'General case' 0 N--CA 1.441 -0.909 0 N-CA-C 107.374 -1.343 . . . . 0.0 107.374 174.61 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 4.0 m -116.21 52.27 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.863 0 N-CA-C 106.011 -1.848 . . . . 0.0 106.011 175.022 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -98.15 -129.08 6.27 Favored Glycine 0 C--N 1.355 1.597 0 N-CA-C 109.421 -1.472 . . . . 0.0 109.421 -176.031 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 17.5 ptm180 -80.09 160.06 25.89 Favored 'General case' 0 C--N 1.357 0.906 0 C-N-CA 123.942 0.897 . . . . 0.0 109.685 -176.925 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -162.49 169.91 19.56 Favored 'General case' 0 CA--C 1.493 -1.212 0 CA-C-O 121.445 0.64 . . . . 0.0 110.298 -171.217 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 95.6 mttt -111.06 155.89 22.12 Favored 'General case' 0 CA--C 1.488 -1.408 0 N-CA-C 107.485 -1.302 . . . . 0.0 107.485 -172.612 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 24.5 pt-20 -152.25 160.15 43.41 Favored 'General case' 0 N--CA 1.434 -1.27 0 N-CA-C 107.972 -1.121 . . . . 0.0 107.972 171.142 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -137.76 159.48 41.88 Favored 'General case' 0 N--CA 1.437 -1.102 0 N-CA-C 105.396 -2.075 . . . . 0.0 105.396 173.785 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 73.3 m -120.41 125.9 49.12 Favored 'General case' 0 CA--C 1.498 -1.036 0 N-CA-C 104.533 -2.395 . . . . 0.0 104.533 177.393 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 5.3 mp -114.73 136.03 22.43 Favored Pre-proline 0 N--CA 1.435 -1.188 0 N-CA-C 104.6 -2.37 . . . . 0.0 104.6 -174.255 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 62.0 Cg_exo -64.3 166.85 15.97 Favored 'Trans proline' 0 CA--C 1.508 -0.78 0 C-N-CA 123.528 2.818 . . . . 0.0 113.519 176.794 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -77.06 -19.23 77.63 Favored Glycine 0 C--N 1.353 1.507 0 C-N-CA 123.797 0.713 . . . . 0.0 114.242 -175.149 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 51.7 p-80 -83.23 -26.79 30.43 Favored 'General case' 0 C--N 1.355 0.838 0 CA-C-N 117.963 0.881 . . . . 0.0 109.788 -179.278 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 89.0 mt -88.84 132.92 34.45 Favored 'General case' 0 CA--C 1.501 -0.93 0 N-CA-C 107.37 -1.345 . . . . 0.0 107.37 175.407 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 7.8 p30 -121.33 15.0 11.31 Favored 'General case' 0 CA--C 1.5 -0.946 0 C-N-CA 124.19 0.996 . . . . 0.0 108.816 -175.501 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 32.9 p -144.73 155.47 43.57 Favored 'General case' 0 N--CA 1.438 -1.074 0 N-CA-C 106.928 -1.508 . . . . 0.0 106.928 -178.721 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 23.0 t80 -150.64 157.76 43.35 Favored 'General case' 0 CA--C 1.497 -1.093 0 N-CA-C 107.965 -1.124 . . . . 0.0 107.965 178.188 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 48.2 m -108.78 112.37 24.61 Favored 'General case' 0 CA--C 1.5 -0.945 0 N-CA-C 106.197 -1.779 . . . . 0.0 106.197 173.536 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 55.3 mt -97.19 91.83 2.76 Favored 'Isoleucine or valine' 0 C--N 1.359 0.982 0 N-CA-C 105.084 -2.191 . . . . 0.0 105.084 174.146 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 61' ' ' LYS . . . . . 0.517 ' HD3' ' H ' ' A' ' 61' ' ' LYS . 0.3 OUTLIER -105.18 160.52 15.01 Favored 'General case' 0 CA--C 1.498 -1.022 0 N-CA-C 107.67 -1.233 . . . . 0.0 107.67 178.412 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 88.74 52.85 2.7 Favored Glycine 0 C--N 1.353 1.504 0 N-CA-C 108.75 -1.74 . . . . 0.0 108.75 179.796 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 60.7 mt -115.54 158.55 22.46 Favored 'General case' 0 CA--C 1.501 -0.91 0 N-CA-C 107.087 -1.449 . . . . 0.0 107.087 178.961 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 29.1 mtpp -95.35 155.71 38.48 Favored Pre-proline 0 N--CA 1.441 -0.925 0 N-CA-C 106.97 -1.492 . . . . 0.0 106.97 -178.442 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 69.0 Cg_endo -80.31 162.87 22.46 Favored 'Trans proline' 0 N--CA 1.454 -0.852 0 C-N-CA 122.988 2.459 . . . . 0.0 110.903 177.249 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 60.93 26.67 65.78 Favored Glycine 0 C--N 1.356 1.669 0 C-N-CA 127.819 2.628 . . . . 0.0 116.814 166.095 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 7.2 p -131.43 145.61 34.95 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.846 0 CA-C-N 117.701 0.75 . . . . 0.0 109.325 -173.211 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 2.9 p -90.46 127.29 43.05 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.863 0 N-CA-C 107.208 -1.405 . . . . 0.0 107.208 176.332 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 84.0 m-85 -107.3 147.77 29.85 Favored 'General case' 0 CA--C 1.498 -1.044 0 N-CA-C 106.814 -1.551 . . . . 0.0 106.814 172.842 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -95.87 143.98 26.61 Favored 'General case' 0 N--CA 1.439 -0.993 0 N-CA-C 105.132 -2.173 . . . . 0.0 105.132 160.918 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -133.42 155.13 21.56 Favored Glycine 0 CA--C 1.488 -1.637 0 N-CA-C 107.727 -2.149 . . . . 0.0 107.727 -178.962 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 32.0 mt-30 -143.13 138.25 29.68 Favored 'General case' 0 CA--C 1.482 -1.667 0 N-CA-C 105.959 -1.867 . . . . 0.0 105.959 176.345 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 42.8 tp -113.69 103.77 11.56 Favored 'General case' 0 N--CA 1.436 -1.175 0 N-CA-C 103.76 -2.682 . . . . 0.0 103.76 175.75 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 13.6 mt -98.19 128.45 49.63 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.786 0 N-CA-C 104.32 -2.474 . . . . 0.0 104.32 179.664 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 43.8 m -112.41 112.43 23.99 Favored 'General case' 0 N--CA 1.441 -0.923 0 N-CA-C 106.992 -1.484 . . . . 0.0 106.992 -175.189 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 1.7 mp -87.85 136.35 23.36 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.217 0 N-CA-C 104.712 -2.329 . . . . 0.0 104.712 -166.822 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 78.2 mt-30 -95.84 141.69 28.98 Favored 'General case' 0 N--CA 1.436 -1.154 0 N-CA-C 106.042 -1.836 . . . . 0.0 106.042 -179.068 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 7.8 tp-100 -69.04 117.02 10.16 Favored 'General case' 0 N--CA 1.441 -0.882 0 C-N-CA 124.129 0.972 . . . . 0.0 111.395 -170.554 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 31.9 m-85 58.09 45.39 17.81 Favored 'General case' 0 C--N 1.358 0.972 0 C-N-CA 127.325 2.25 . . . . 0.0 112.816 179.653 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -170.33 -114.46 0.31 Allowed Glycine 0 C--N 1.354 1.554 0 C-N-CA 118.663 -1.732 . . . . 0.0 109.704 174.847 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 52.2 m80 -83.24 -171.67 3.7 Favored 'General case' 0 CA--C 1.495 -1.165 0 C-N-CA 125.714 1.606 . . . . 0.0 110.425 -167.715 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -146.66 145.46 30.04 Favored 'General case' 0 N--CA 1.433 -1.281 0 N-CA-C 106.509 -1.663 . . . . 0.0 106.509 169.507 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -101.72 145.45 29.11 Favored 'General case' 0 N--CA 1.44 -0.957 0 N-CA-C 104.645 -2.354 . . . . 0.0 104.645 -179.907 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 6.6 p -124.99 137.96 55.86 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.775 0 N-CA-C 108.104 -1.073 . . . . 0.0 108.104 -177.569 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 61.0 m -125.85 137.13 53.74 Favored 'General case' 0 N--CA 1.439 -0.98 0 N-CA-C 103.232 -2.877 . . . . 0.0 103.232 175.922 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 54.6 ttp180 -130.15 144.6 51.45 Favored 'General case' 0 CA--C 1.502 -0.873 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 -179.309 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 23.6 p90 -156.48 -178.19 7.16 Favored 'General case' 0 CA--C 1.5 -0.962 0 N-CA-C 106.263 -1.754 . . . . 0.0 106.263 -178.216 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 47.7 p-10 -140.43 160.79 39.21 Favored 'General case' 0 N--CA 1.441 -0.877 0 N-CA-C 107.412 -1.329 . . . . 0.0 107.412 168.116 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 24.5 p90 -147.21 170.31 17.51 Favored 'General case' 0 CA--C 1.49 -1.365 0 N-CA-C 107.033 -1.469 . . . . 0.0 107.033 173.785 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 33.0 p -124.74 147.13 48.81 Favored 'General case' 0 CA--C 1.499 -0.994 0 N-CA-C 107.319 -1.363 . . . . 0.0 107.319 178.036 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 4.4 p -109.09 130.12 55.48 Favored 'General case' 0 N--CA 1.439 -1.012 0 N-CA-C 102.525 -3.139 . . . . 0.0 102.525 164.047 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 42.9 p -90.73 -179.17 5.46 Favored 'General case' 0 N--CA 1.444 -0.732 0 N-CA-C 106.931 -1.507 . . . . 0.0 106.931 179.54 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 31.5 t . . . . . 0 C--O 1.262 1.729 0 N-CA-C 105.186 -2.153 . . . . 0.0 105.186 176.695 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.435 -1.403 0 N-CA-C 105.795 -2.922 . . . . 0.0 105.795 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_exo -61.65 139.45 81.11 Favored 'Trans proline' 0 N--CA 1.442 -1.527 0 C-N-CA 122.865 2.377 . . . . 0.0 113.694 -175.62 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 4.1 t -79.46 154.26 4.7 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.932 0 C-N-CA 127.202 2.201 . . . . 0.0 106.383 -179.14 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 55.6 mm-40 -101.43 96.11 6.93 Favored 'General case' 0 CA--C 1.49 -1.338 0 N-CA-C 107.643 -1.244 . . . . 0.0 107.643 -175.267 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 2.4 p -120.52 143.14 33.43 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.103 0 CA-C-N 113.459 -1.701 . . . . 0.0 107.802 -165.033 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.438 -1.036 0 C-N-CA 125.762 1.625 . . . . 0.0 112.494 -169.271 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 75.0 Cg_endo . . . . . 0 CA--C 1.504 -0.978 0 CA-C-O 118.328 -0.78 . . . . 0.0 111.04 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 4.7 p-10 -122.66 -36.11 2.96 Favored 'General case' 0 CA--C 1.486 -1.499 0 O-C-N 123.821 0.7 . . . . 0.0 110.744 -162.988 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 30.3 p -117.58 151.54 36.96 Favored 'General case' 0 CA--C 1.496 -1.127 0 CA-C-O 121.79 0.805 . . . . 0.0 108.896 -173.122 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 58.6 t-80 -145.77 106.37 4.28 Favored Pre-proline 0 N--CA 1.433 -1.28 0 N-CA-C 106.228 -1.767 . . . . 0.0 106.228 167.43 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -77.74 142.49 20.33 Favored 'Trans proline' 0 N--CA 1.447 -1.249 0 C-N-CA 122.578 2.186 . . . . 0.0 109.732 173.092 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 18.2 mm -102.9 140.09 22.1 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.919 0 N-CA-C 103.434 -2.802 . . . . 0.0 103.434 174.121 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 14.6 tm0? -130.32 138.04 50.24 Favored 'General case' 0 CA--C 1.498 -1.045 0 N-CA-C 102.801 -3.036 . . . . 0.0 102.801 176.5 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 49.5 p90 -140.64 166.38 24.9 Favored 'General case' 0 CA--C 1.497 -1.067 0 N-CA-C 106.913 -1.514 . . . . 0.0 106.913 -178.786 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 36.7 m-80 -136.91 132.42 34.46 Favored 'General case' 0 CA--C 1.488 -1.404 0 N-CA-C 105.469 -2.049 . . . . 0.0 105.469 177.198 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -104.0 167.61 9.79 Favored Pre-proline 0 N--CA 1.44 -0.972 0 C-N-CA 124.515 1.126 . . . . 0.0 109.378 -166.809 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_exo -66.23 158.48 54.62 Favored 'Trans proline' 0 CA--C 1.508 -0.78 0 C-N-CA 123.359 2.706 . . . . 0.0 111.926 171.207 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 24.4 tt0 -82.95 -45.12 0.88 Allowed Pre-proline 0 N--CA 1.443 -0.781 0 CA-C-O 115.54 -2.172 . . . . 0.0 111.691 -177.618 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 74.7 Cg_exo -68.57 164.55 32.53 Favored 'Trans proline' 0 CA--C 1.509 -0.77 0 CA-C-N 125.65 3.054 . . . . 0.0 112.717 -178.002 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 35.8 p -76.78 124.51 27.79 Favored 'General case' 0 C--N 1.355 0.847 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 179.323 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 64.2 t-80 -174.69 -42.78 0.01 OUTLIER 'General case' 0 CA--C 1.496 -1.098 0 N-CA-C 106.559 -1.645 . . . . 0.0 106.559 -171.192 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 36.1 mt -118.18 136.42 55.43 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.132 0 N-CA-C 106.331 -1.729 . . . . 0.0 106.331 -171.948 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 5.9 p -114.29 -85.39 0.6 Allowed 'General case' 0 N--CA 1.431 -1.399 0 N-CA-C 106.188 -1.782 . . . . 0.0 106.188 177.361 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 52.0 mtmt -86.03 167.48 14.98 Favored 'General case' 0 CA--C 1.485 -1.527 0 C-N-CA 124.799 1.239 . . . . 0.0 109.224 -164.387 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 81.4 m-85 -132.02 133.43 44.42 Favored 'General case' 0 CA--C 1.49 -1.362 0 N-CA-C 104.044 -2.576 . . . . 0.0 104.044 177.504 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 28.2 mt -122.41 127.87 75.24 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.326 0 N-CA-C 101.921 -3.363 . . . . 0.0 101.921 178.338 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 5.2 mt -110.51 133.46 53.27 Favored 'General case' 0 CA--C 1.475 -1.916 0 N-CA-C 106.151 -1.796 . . . . 0.0 106.151 177.531 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 2.4 mpt_? -112.45 155.46 24.21 Favored 'General case' 0 N--CA 1.432 -1.373 0 N-CA-C 104.62 -2.363 . . . . 0.0 104.62 166.961 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 47.8 p90 -155.32 150.73 27.15 Favored 'General case' 0 N--CA 1.438 -1.042 0 N-CA-C 107.729 -1.211 . . . . 0.0 107.729 170.196 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 11.2 ptp180 -150.88 148.87 24.0 Favored Pre-proline 0 CA--C 1.499 -0.982 0 N-CA-C 106.777 -1.564 . . . . 0.0 106.777 166.863 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -75.96 144.84 27.63 Favored 'Trans proline' 0 CA--C 1.503 -1.048 0 C-N-CA 122.763 2.309 . . . . 0.0 107.86 171.619 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -70.69 80.2 0.6 Allowed 'General case' 0 C--N 1.354 0.797 0 C-N-CA 125.085 1.354 . . . . 0.0 110.915 177.157 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 8.9 t-20 -161.97 -54.8 0.04 OUTLIER 'General case' 0 N--CA 1.431 -1.399 0 N-CA-C 102.917 -2.994 . . . . 0.0 102.917 -178.158 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 34.3 p -83.82 143.79 29.7 Favored 'General case' 0 N--CA 1.438 -1.065 0 N-CA-C 107.299 -1.371 . . . . 0.0 107.299 173.226 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 14.3 m -136.81 14.96 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.803 0 N-CA-C 106.677 -1.601 . . . . 0.0 106.677 177.614 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -101.44 -93.98 2.2 Favored Glycine 0 C--N 1.356 1.658 0 N-CA-C 108.043 -2.023 . . . . 0.0 108.043 -175.067 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 17.5 ptm180 -91.13 171.16 9.44 Favored 'General case' 0 CA--C 1.503 -0.864 0 N-CA-C 108.108 -1.071 . . . . 0.0 108.108 177.255 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -159.52 179.38 8.96 Favored 'General case' 0 CA--C 1.494 -1.192 0 N-CA-C 109.606 -0.516 . . . . 0.0 109.606 -178.657 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -110.04 152.63 25.7 Favored 'General case' 0 CA--C 1.489 -1.387 0 N-CA-C 106.755 -1.572 . . . . 0.0 106.755 -175.818 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -154.8 156.95 37.18 Favored 'General case' 0 N--CA 1.433 -1.284 0 N-CA-C 106.957 -1.497 . . . . 0.0 106.957 -178.953 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -146.05 164.03 33.4 Favored 'General case' 0 CA--C 1.502 -0.885 0 N-CA-C 107.793 -1.188 . . . . 0.0 107.793 175.13 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 96.9 m -120.98 126.57 50.29 Favored 'General case' 0 CA--C 1.502 -0.867 0 N-CA-C 105.542 -2.022 . . . . 0.0 105.542 178.382 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 5.0 mp -114.07 136.13 22.16 Favored Pre-proline 0 N--CA 1.439 -0.992 0 N-CA-C 105.296 -2.113 . . . . 0.0 105.296 -175.823 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_exo -63.06 165.66 16.22 Favored 'Trans proline' 0 CA--C 1.508 -0.81 0 C-N-CA 123.734 2.956 . . . . 0.0 113.799 176.823 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -82.2 -13.68 78.46 Favored Glycine 0 C--N 1.351 1.403 0 C-N-CA 123.507 0.575 . . . . 0.0 113.451 -171.682 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 50.5 p-80 -84.66 -27.16 27.29 Favored 'General case' 0 C--N 1.356 0.872 0 CA-C-N 117.945 0.872 . . . . 0.0 109.862 178.572 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 88.5 mt -88.52 130.39 35.24 Favored 'General case' 0 CA--C 1.498 -1.027 0 N-CA-C 108.536 -0.912 . . . . 0.0 108.536 178.678 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 8.4 p-10 -108.8 10.84 26.55 Favored 'General case' 0 N--CA 1.442 -0.845 0 C-N-CA 124.574 1.15 . . . . 0.0 109.921 -177.484 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 39.2 p -146.43 162.5 38.12 Favored 'General case' 0 N--CA 1.439 -1.003 0 N-CA-C 107.534 -1.284 . . . . 0.0 107.534 -178.598 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 10.7 t80 -140.21 174.63 10.33 Favored 'General case' 0 N--CA 1.444 -0.728 0 N-CA-C 107.122 -1.436 . . . . 0.0 107.122 -179.789 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 55.4 m -137.82 111.41 8.13 Favored 'General case' 0 N--CA 1.433 -1.317 0 N-CA-C 104.689 -2.337 . . . . 0.0 104.689 174.064 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 43.5 mt -91.43 138.72 19.09 Favored 'Isoleucine or valine' 0 C--N 1.358 0.95 0 N-CA-C 104.346 -2.464 . . . . 0.0 104.346 172.361 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 6.9 mtpm? -139.56 162.11 35.88 Favored 'General case' 0 CA--C 1.499 -0.994 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 -179.12 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 82.99 51.37 4.23 Favored Glycine 0 C--N 1.354 1.546 0 N-CA-C 109.429 -1.468 . . . . 0.0 109.429 176.862 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 80.5 mt -117.67 172.03 7.63 Favored 'General case' 0 CA--C 1.501 -0.932 0 N-CA-C 108.071 -1.085 . . . . 0.0 108.071 -170.869 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 10.4 mptt -102.97 151.21 38.37 Favored Pre-proline 0 N--CA 1.442 -0.828 0 N-CA-C 107.572 -1.27 . . . . 0.0 107.572 -172.479 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 64.2 Cg_exo -66.66 135.4 38.59 Favored 'Trans proline' 0 N--CA 1.453 -0.911 0 C-N-CA 123.62 2.88 . . . . 0.0 112.226 171.56 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 54.66 50.01 59.22 Favored Glycine 0 C--N 1.355 1.599 0 C-N-CA 127.256 2.36 . . . . 0.0 115.415 167.334 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 4.3 p -128.94 149.49 33.7 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.007 0 N-CA-C 107.597 -1.26 . . . . 0.0 107.597 178.871 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 7.6 p -95.23 135.5 29.11 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.959 0 N-CA-C 107.644 -1.243 . . . . 0.0 107.644 -178.256 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 83.6 m-85 -117.1 151.28 37.14 Favored 'General case' 0 CA--C 1.496 -1.121 0 N-CA-C 106.395 -1.706 . . . . 0.0 106.395 177.364 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -98.44 142.46 30.03 Favored 'General case' 0 CA--C 1.5 -0.97 0 N-CA-C 104.908 -2.256 . . . . 0.0 104.908 159.476 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -133.23 149.88 19.72 Favored Glycine 0 CA--C 1.49 -1.525 0 N-CA-C 107.693 -2.163 . . . . 0.0 107.693 179.938 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 33.7 mt-30 -136.49 136.24 39.25 Favored 'General case' 0 CA--C 1.484 -1.56 0 N-CA-C 106.581 -1.637 . . . . 0.0 106.581 176.173 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 15.0 tp -119.92 106.75 12.35 Favored 'General case' 0 CA--C 1.499 -1.007 0 N-CA-C 105.778 -1.934 . . . . 0.0 105.778 -176.851 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 5.9 mt -100.15 129.32 51.05 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.113 0 N-CA-C 105.036 -2.209 . . . . 0.0 105.036 -178.81 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 12.6 p -115.72 114.4 24.77 Favored 'General case' 0 N--CA 1.443 -0.823 0 N-CA-C 108.108 -1.071 . . . . 0.0 108.108 -176.418 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 1.7 mp -94.94 143.05 12.57 Favored 'Isoleucine or valine' 0 C--N 1.358 0.941 0 N-CA-C 106.045 -1.835 . . . . 0.0 106.045 -163.808 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 16.7 tt0 -102.3 140.95 35.9 Favored 'General case' 0 CA--C 1.498 -1.031 0 N-CA-C 105.116 -2.179 . . . . 0.0 105.116 171.342 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 75.4 mt-30 -67.19 115.21 6.61 Favored 'General case' 0 C--N 1.358 0.955 0 C-N-CA 123.319 0.648 . . . . 0.0 111.075 -176.038 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 58.4 m-85 60.12 40.03 18.84 Favored 'General case' 0 C--N 1.355 0.848 0 C-N-CA 126.523 1.929 . . . . 0.0 112.143 176.324 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -158.85 -118.61 0.53 Allowed Glycine 0 C--N 1.355 1.623 0 N-CA-C 108.779 -1.728 . . . . 0.0 108.779 -178.361 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 78.4 m-70 -82.84 179.98 7.61 Favored 'General case' 0 CA--C 1.501 -0.928 0 C-N-CA 124.657 1.183 . . . . 0.0 111.178 -168.38 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 13.7 pt20 -157.16 133.5 9.78 Favored 'General case' 0 N--CA 1.434 -1.258 0 N-CA-C 106.076 -1.824 . . . . 0.0 106.076 167.391 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 31.5 mm-40 -100.91 146.43 27.36 Favored 'General case' 0 CA--C 1.498 -1.031 0 N-CA-C 105.531 -2.026 . . . . 0.0 105.531 -178.231 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 7.6 p -122.3 141.55 42.27 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.721 0 N-CA-C 108.004 -1.109 . . . . 0.0 108.004 -174.444 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 23.2 m -125.79 145.45 50.21 Favored 'General case' 0 N--CA 1.442 -0.872 0 N-CA-C 104.398 -2.445 . . . . 0.0 104.398 -179.711 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 38.9 ttm180 -133.85 143.46 48.33 Favored 'General case' 0 CA--C 1.504 -0.81 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 173.32 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 28.9 p90 -155.67 175.68 13.6 Favored 'General case' 0 CA--C 1.5 -0.974 0 N-CA-C 106.905 -1.517 . . . . 0.0 106.905 -178.424 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 52.2 m-20 -133.47 153.86 51.28 Favored 'General case' 0 CA--C 1.504 -0.81 0 N-CA-C 106.018 -1.845 . . . . 0.0 106.018 170.334 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 17.1 p90 -151.28 175.64 12.01 Favored 'General case' 0 CA--C 1.493 -1.23 0 N-CA-C 106.678 -1.601 . . . . 0.0 106.678 173.222 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 31.4 p -122.6 147.02 46.9 Favored 'General case' 0 CA--C 1.504 -0.813 0 N-CA-C 107.533 -1.284 . . . . 0.0 107.533 174.276 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 94.3 m -99.52 121.65 41.47 Favored 'General case' 0 CA--C 1.496 -1.125 0 N-CA-C 102.721 -3.066 . . . . 0.0 102.721 165.583 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 2.3 m 68.13 -128.34 0.13 Allowed 'General case' 0 C--N 1.36 1.028 0 C-N-CA 126.573 1.949 . . . . 0.0 106.481 -165.346 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 26.8 p . . . . . 0 C--O 1.261 1.69 0 N-CA-C 106.168 -1.79 . . . . 0.0 106.168 174.124 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.438 -1.182 0 N-CA-C 106.138 -2.785 . . . . 0.0 106.138 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_exo -58.4 140.93 96.46 Favored 'Trans proline' 0 N--CA 1.445 -1.35 0 C-N-CA 123.749 2.966 . . . . 0.0 113.319 -175.783 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 7.3 t -79.0 155.31 4.83 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.892 0 C-N-CA 127.014 2.126 . . . . 0.0 106.569 -175.345 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 93.4 mt-10 -97.35 87.98 4.29 Favored 'General case' 0 CA--C 1.493 -1.224 0 CA-C-O 122.377 1.084 . . . . 0.0 108.181 -173.1 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 2.7 p -110.77 134.93 51.45 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.146 0 CA-C-N 114.319 -1.31 . . . . 0.0 107.868 -166.179 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 23.8 p90 . . . . . 0 N--CA 1.434 -1.246 0 N-CA-C 104.072 -2.566 . . . . 0.0 104.072 178.131 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo . . . . . 0 CA--C 1.507 -0.84 0 CA-C-O 118.19 -0.838 . . . . 0.0 110.917 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 7.0 p-10 -104.18 -42.34 5.55 Favored 'General case' 0 CA--C 1.494 -1.199 0 O-C-N 123.716 0.635 . . . . 0.0 110.417 -165.72 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 10.9 p -120.1 143.98 47.86 Favored 'General case' 0 CA--C 1.488 -1.432 0 N-CA-C 107.98 -1.118 . . . . 0.0 107.98 -178.43 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' HIS . . . . . 0.515 ' CE1' HG22 ' A' ' 91' ' ' THR . 0.1 OUTLIER -135.12 92.75 17.8 Favored Pre-proline 0 N--CA 1.441 -0.905 0 N-CA-C 105.657 -1.979 . . . . 0.0 105.657 174.322 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_endo -74.9 127.87 11.11 Favored 'Trans proline' 0 N--CA 1.443 -1.447 0 C-N-CA 123.007 2.471 . . . . 0.0 109.442 170.492 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 28.3 mm -104.86 149.82 8.1 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.081 0 N-CA-C 104.231 -2.507 . . . . 0.0 104.231 -174.277 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 65.4 tt0 -140.24 142.84 35.77 Favored 'General case' 0 N--CA 1.438 -1.066 0 N-CA-C 104.205 -2.517 . . . . 0.0 104.205 168.587 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 37.8 p90 -136.27 164.2 28.63 Favored 'General case' 0 N--CA 1.439 -0.987 0 N-CA-C 106.226 -1.768 . . . . 0.0 106.226 -175.176 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 5.8 m120 -131.24 127.71 38.41 Favored 'General case' 0 CA--C 1.492 -1.286 0 N-CA-C 106.353 -1.721 . . . . 0.0 106.353 -179.948 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -84.61 161.77 52.67 Favored Pre-proline 0 N--CA 1.442 -0.857 0 C-N-CA 123.663 0.785 . . . . 0.0 110.541 -168.381 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_exo -67.23 172.72 9.62 Favored 'Trans proline' 0 CA--C 1.51 -0.717 0 C-N-CA 123.498 2.798 . . . . 0.0 112.295 170.766 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 1.4 tm0? -80.74 -46.99 1.23 Allowed Pre-proline 0 N--CA 1.443 -0.795 0 CA-C-O 115.569 -2.158 . . . . 0.0 110.429 -176.86 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 63.3 Cg_exo -68.25 164.78 31.02 Favored 'Trans proline' 0 CA--C 1.509 -0.75 0 CA-C-N 125.784 3.101 . . . . 0.0 112.086 176.999 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 22.6 t -88.07 85.88 7.03 Favored 'General case' 0 C--N 1.356 0.862 0 N-CA-C 106.412 -1.699 . . . . 0.0 106.412 176.258 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 59.9 t-80 -116.16 -28.85 6.45 Favored 'General case' 0 N--CA 1.437 -1.124 0 C-N-CA 125.585 1.554 . . . . 0.0 107.076 -175.01 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 42.6 mt -126.35 137.03 59.05 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.056 0 N-CA-C 106.916 -1.513 . . . . 0.0 106.916 -169.041 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 32.9 t -113.56 -85.72 0.59 Allowed 'General case' 0 N--CA 1.432 -1.348 0 N-CA-C 106.328 -1.731 . . . . 0.0 106.328 178.073 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 37.0 ttpt -88.43 160.67 17.44 Favored 'General case' 0 CA--C 1.493 -1.241 0 C-N-CA 125.859 1.664 . . . . 0.0 107.906 -165.04 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 92.8 m-85 -127.47 139.97 52.46 Favored 'General case' 0 CA--C 1.492 -1.28 0 N-CA-C 105.377 -2.083 . . . . 0.0 105.377 177.941 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 13.9 mt -124.95 131.09 73.03 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.151 0 N-CA-C 101.958 -3.349 . . . . 0.0 101.958 172.898 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 3.5 mt -109.23 127.55 54.34 Favored 'General case' 0 CA--C 1.475 -1.936 0 N-CA-C 104.975 -2.232 . . . . 0.0 104.975 174.303 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -116.63 158.33 23.91 Favored 'General case' 0 N--CA 1.434 -1.257 0 N-CA-C 104.636 -2.357 . . . . 0.0 104.636 174.375 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 48.4 p90 -157.29 142.29 16.94 Favored 'General case' 0 N--CA 1.437 -1.081 0 N-CA-C 107.018 -1.475 . . . . 0.0 107.018 175.079 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 13.4 ttm180 -131.68 125.2 20.35 Favored Pre-proline 0 CA--C 1.503 -0.853 0 N-CA-C 106.261 -1.755 . . . . 0.0 106.261 179.006 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 4.8 Cg_endo -73.35 118.93 5.72 Favored 'Trans proline' 0 N--CA 1.45 -1.066 0 CA-C-N 123.388 2.246 . . . . 0.0 109.033 168.969 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 32.3 mmmt -70.98 88.7 0.77 Allowed 'General case' 0 N--CA 1.44 -0.937 0 C-N-CA 125.644 1.578 . . . . 0.0 111.133 179.214 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 31.4 m120 -135.57 -68.02 0.52 Allowed 'General case' 0 N--CA 1.436 -1.148 0 N-CA-C 102.244 -3.243 . . . . 0.0 102.244 172.729 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 57.8 m -102.98 168.28 9.3 Favored 'General case' 0 N--CA 1.44 -0.945 0 N-CA-C 106.674 -1.602 . . . . 0.0 106.674 172.234 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 3.6 m -122.15 55.53 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.88 0 N-CA-C 105.752 -1.944 . . . . 0.0 105.752 177.581 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -104.01 -109.4 3.38 Favored Glycine 0 C--N 1.353 1.479 0 N-CA-C 107.78 -2.128 . . . . 0.0 107.78 -177.221 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 82.4 mtt85 -91.24 172.3 8.64 Favored 'General case' 0 CA--C 1.502 -0.883 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 -178.534 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -153.69 176.27 12.3 Favored 'General case' 0 N--CA 1.437 -1.097 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 -179.964 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 59.5 mttp -112.42 156.98 21.63 Favored 'General case' 0 CA--C 1.49 -1.356 0 N-CA-C 107.782 -1.192 . . . . 0.0 107.782 -174.767 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 1.1 pp20? -151.42 162.37 41.05 Favored 'General case' 0 N--CA 1.434 -1.24 0 N-CA-C 107.966 -1.124 . . . . 0.0 107.966 171.014 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -144.49 159.73 42.27 Favored 'General case' 0 CA--C 1.497 -1.062 0 N-CA-C 105.857 -1.905 . . . . 0.0 105.857 172.072 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 91.4 m -121.28 130.01 53.43 Favored 'General case' 0 CA--C 1.502 -0.896 0 N-CA-C 106.576 -1.638 . . . . 0.0 106.576 -173.892 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 4.1 mp -116.64 134.79 22.86 Favored Pre-proline 0 N--CA 1.438 -1.066 0 N-CA-C 105.386 -2.079 . . . . 0.0 105.386 -175.054 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 66.0 Cg_exo -62.88 164.55 18.71 Favored 'Trans proline' 0 N--CA 1.455 -0.736 0 C-N-CA 123.498 2.799 . . . . 0.0 113.351 174.954 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -81.88 -14.87 76.59 Favored Glycine 0 C--N 1.352 1.422 0 O-C-N 123.48 0.487 . . . . 0.0 113.297 -170.717 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 50.1 p-80 -83.87 -25.5 30.21 Favored 'General case' 0 C--N 1.356 0.852 0 CA-C-N 117.846 0.823 . . . . 0.0 109.828 179.173 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 89.9 mt -88.41 133.17 34.18 Favored 'General case' 0 CA--C 1.5 -0.959 0 N-CA-C 107.876 -1.157 . . . . 0.0 107.876 177.633 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 7.9 p30 -110.41 9.03 23.44 Favored 'General case' 0 CA--C 1.504 -0.821 0 C-N-CA 124.654 1.181 . . . . 0.0 109.802 -175.436 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 37.2 p -145.81 162.98 36.42 Favored 'General case' 0 N--CA 1.438 -1.051 0 N-CA-C 107.395 -1.335 . . . . 0.0 107.395 -177.477 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 8.3 t80 -141.8 174.94 10.11 Favored 'General case' 0 N--CA 1.441 -0.878 0 N-CA-C 108.009 -1.108 . . . . 0.0 108.009 179.765 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 89.6 m -135.45 109.98 8.54 Favored 'General case' 0 N--CA 1.432 -1.337 0 N-CA-C 104.19 -2.522 . . . . 0.0 104.19 171.202 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 58.3 mt -87.5 143.83 10.49 Favored 'Isoleucine or valine' 0 C--N 1.36 1.022 0 N-CA-C 103.943 -2.614 . . . . 0.0 103.943 169.977 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -147.07 160.58 42.24 Favored 'General case' 0 CA--C 1.498 -1.054 0 N-CA-C 108.054 -1.091 . . . . 0.0 108.054 173.865 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 86.83 51.83 3.3 Favored Glycine 0 C--N 1.353 1.484 0 N-CA-C 109.006 -1.638 . . . . 0.0 109.006 177.004 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 48.2 mt -112.1 175.29 5.49 Favored 'General case' 0 CA--C 1.502 -0.867 0 N-CA-C 107.013 -1.477 . . . . 0.0 107.013 -178.353 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 57.6 mttp -115.99 152.59 47.79 Favored Pre-proline 0 N--CA 1.444 -0.757 0 N-CA-C 106.526 -1.657 . . . . 0.0 106.526 -168.395 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_endo -79.5 155.36 24.59 Favored 'Trans proline' 0 N--CA 1.454 -0.835 0 C-N-CA 122.719 2.279 . . . . 0.0 110.838 175.883 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 59.01 29.8 65.76 Favored Glycine 0 C--N 1.354 1.566 0 C-N-CA 127.747 2.594 . . . . 0.0 116.883 167.288 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 9.0 p -127.4 148.24 32.14 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.847 0 N-CA-C 108.715 -0.846 . . . . 0.0 108.715 -177.581 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 6.7 p -92.8 124.17 45.14 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.765 0 N-CA-C 107.804 -1.184 . . . . 0.0 107.804 175.614 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 51.0 m-85 -101.48 150.41 23.07 Favored 'General case' 0 N--CA 1.439 -1.004 0 N-CA-C 107.629 -1.249 . . . . 0.0 107.629 173.403 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 12.4 tp10 -93.7 136.18 34.24 Favored 'General case' 0 CA--C 1.498 -1.044 0 N-CA-C 103.762 -2.681 . . . . 0.0 103.762 163.914 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -134.43 145.32 17.41 Favored Glycine 0 CA--C 1.488 -1.64 0 N-CA-C 107.547 -2.221 . . . . 0.0 107.547 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 35.2 mt-30 -140.75 136.81 32.9 Favored 'General case' 0 CA--C 1.485 -1.52 0 N-CA-C 105.718 -1.956 . . . . 0.0 105.718 -177.677 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 40.9 tp -115.01 98.21 6.67 Favored 'General case' 0 N--CA 1.437 -1.124 0 N-CA-C 103.453 -2.795 . . . . 0.0 103.453 179.297 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 39.7 mm -92.88 125.96 45.39 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.942 0 N-CA-C 103.704 -2.702 . . . . 0.0 103.704 -178.08 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 49.2 m -120.72 112.29 18.67 Favored 'General case' 0 N--CA 1.438 -1.069 0 N-CA-C 107.632 -1.247 . . . . 0.0 107.632 -169.261 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 39.3 mm -88.15 139.87 16.68 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.323 0 N-CA-C 106.894 -1.521 . . . . 0.0 106.894 -163.188 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 15.3 tt0 -101.93 132.34 47.8 Favored 'General case' 0 CA--C 1.495 -1.171 0 N-CA-C 104.953 -2.24 . . . . 0.0 104.953 178.776 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 17.8 tt0 -77.08 42.56 0.33 Allowed 'General case' 0 C--N 1.355 0.813 0 C-N-CA 125.339 1.456 . . . . 0.0 113.168 -177.761 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 61.6 m-85 -140.42 19.59 2.39 Favored 'General case' 0 N--CA 1.442 -0.872 0 N-CA-C 107.094 -1.447 . . . . 0.0 107.094 173.251 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 96.55 -21.57 44.95 Favored Glycine 0 C--N 1.354 1.582 0 C-N-CA 123.94 0.781 . . . . 0.0 111.395 174.598 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 77.9 m-70 -81.71 178.91 8.06 Favored 'General case' 0 CA--C 1.498 -1.032 0 C-N-CA 124.621 1.168 . . . . 0.0 109.508 -177.016 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 5.0 pt20 -159.02 163.53 36.32 Favored 'General case' 0 N--CA 1.439 -1.024 0 CA-C-O 122.027 0.917 . . . . 0.0 108.721 174.78 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 16.6 tp10 -117.37 154.2 31.73 Favored 'General case' 0 N--CA 1.437 -1.078 0 N-CA-C 105.631 -1.989 . . . . 0.0 105.631 179.604 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 1.9 p -126.0 134.31 66.84 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.86 0 N-CA-C 106.9 -1.519 . . . . 0.0 106.9 176.75 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 38.8 m -122.54 131.96 54.09 Favored 'General case' 0 N--CA 1.439 -0.996 0 N-CA-C 102.211 -3.255 . . . . 0.0 102.211 172.595 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 22.9 ttt180 -130.27 143.5 50.81 Favored 'General case' 0 CA--C 1.504 -0.803 0 CA-C-N 118.784 0.72 . . . . 0.0 109.444 -172.691 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 18.0 p90 -162.06 -177.18 5.6 Favored 'General case' 0 C--N 1.359 1.007 0 N-CA-C 106.829 -1.545 . . . . 0.0 106.829 -175.316 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 43.6 p-10 -136.63 160.91 37.38 Favored 'General case' 0 N--CA 1.442 -0.831 0 N-CA-C 106.018 -1.845 . . . . 0.0 106.018 168.836 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.413 ' CD1' ' CD2' ' A' ' 18' ' ' HIS . 22.3 p90 -143.61 164.82 29.32 Favored 'General case' 0 CA--C 1.488 -1.428 0 N-CA-C 107.254 -1.388 . . . . 0.0 107.254 170.065 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 22.8 p -117.88 137.96 52.45 Favored 'General case' 0 CA--C 1.499 -1.005 0 N-CA-C 106.337 -1.727 . . . . 0.0 106.337 177.433 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 91' ' ' THR . . . . . 0.515 HG22 ' CE1' ' A' ' 18' ' ' HIS . 7.0 p -107.97 128.77 54.93 Favored 'General case' 0 CA--C 1.5 -0.977 0 N-CA-C 103.061 -2.94 . . . . 0.0 103.061 172.788 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 15.1 t -158.41 152.21 23.6 Favored 'General case' 0 N--CA 1.437 -1.08 0 N-CA-C 105.944 -1.873 . . . . 0.0 105.944 -178.11 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 33.8 p . . . . . 0 C--O 1.26 1.625 0 N-CA-C 107.189 -1.411 . . . . 0.0 107.189 174.714 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.443 -0.886 0 N-CA-C 108.616 -1.793 . . . . 0.0 108.616 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_exo -60.46 140.55 92.07 Favored 'Trans proline' 0 N--CA 1.443 -1.461 0 C-N-CA 123.137 2.558 . . . . 0.0 113.484 -177.385 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 7.6 t -78.57 149.77 5.58 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.947 0 C-N-CA 127.775 2.43 . . . . 0.0 105.461 179.112 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 90.0 mt-10 -103.71 94.29 5.37 Favored 'General case' 0 CA--C 1.493 -1.23 0 C-N-CA 123.849 0.86 . . . . 0.0 108.726 -168.282 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 2.5 p -121.83 142.47 38.0 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.983 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 -161.936 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 18.1 p90 . . . . . 0 N--CA 1.435 -1.192 0 N-CA-C 106.923 -1.51 . . . . 0.0 106.923 -168.158 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo . . . . . 0 CA--C 1.502 -1.076 0 CA-C-O 118.75 -0.604 . . . . 0.0 111.06 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 1.7 p30 -103.2 -40.05 6.59 Favored 'General case' 0 CA--C 1.484 -1.596 0 O-C-N 124.09 0.869 . . . . 0.0 110.455 -166.593 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 73.1 m -116.18 156.7 26.03 Favored 'General case' 0 CA--C 1.497 -1.083 0 CA-C-O 121.871 0.843 . . . . 0.0 108.797 -178.532 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 21.1 t-80 -132.96 89.88 33.12 Favored Pre-proline 0 N--CA 1.438 -1.03 0 N-CA-C 106.167 -1.79 . . . . 0.0 106.167 169.414 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 65.5 Cg_endo -84.24 103.38 0.96 Allowed 'Trans proline' 0 N--CA 1.453 -0.871 0 C-N-CA 123.27 2.647 . . . . 0.0 110.449 -175.072 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.583 HD11 HD11 ' A' ' 35' ' ' LEU . 1.7 pt -94.39 168.29 1.53 Allowed 'Isoleucine or valine' 0 C--N 1.356 0.864 0 N-CA-C 109.925 -0.398 . . . . 0.0 109.925 -173.608 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 28.1 tt0 -144.35 147.83 33.95 Favored 'General case' 0 N--CA 1.438 -1.033 0 N-CA-C 104.974 -2.232 . . . . 0.0 104.974 169.97 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 40.9 p90 -129.81 156.6 44.08 Favored 'General case' 0 CA--C 1.496 -1.103 0 N-CA-C 106.859 -1.534 . . . . 0.0 106.859 177.535 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 8.2 t-20 -110.92 149.2 30.97 Favored 'General case' 0 CA--C 1.489 -1.373 0 N-CA-C 102.186 -3.265 . . . . 0.0 102.186 173.211 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -115.82 170.37 5.8 Favored Pre-proline 0 N--CA 1.441 -0.895 0 C-N-CA 124.161 0.984 . . . . 0.0 108.521 -166.369 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 94.8 Cg_exo -65.18 169.53 12.04 Favored 'Trans proline' 0 CA--C 1.511 -0.668 0 C-N-CA 123.613 2.875 . . . . 0.0 112.323 166.918 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 64.7 mt-30 -80.51 -56.1 0.7 Allowed Pre-proline 0 N--CA 1.442 -0.831 0 CA-C-O 115.505 -2.188 . . . . 0.0 112.454 -172.903 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -75.31 169.78 21.74 Favored 'Trans proline' 0 CA--C 1.511 -0.655 0 CA-C-N 125.923 3.151 . . . . 0.0 110.671 -177.073 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 67.3 m -87.09 86.16 7.28 Favored 'General case' 0 CA--C 1.502 -0.901 0 N-CA-C 106.708 -1.59 . . . . 0.0 106.708 175.975 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 11.9 t-160 -122.78 -26.05 4.54 Favored 'General case' 0 N--CA 1.436 -1.129 0 C-N-CA 124.972 1.309 . . . . 0.0 107.792 -171.673 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 1.7 mp -103.16 136.7 34.57 Favored 'Isoleucine or valine' 0 C--N 1.355 0.824 0 N-CA-C 103.885 -2.635 . . . . 0.0 103.885 -171.919 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 34.5 t -96.29 -85.99 0.33 Allowed 'General case' 0 N--CA 1.43 -1.468 0 N-CA-C 104.791 -2.3 . . . . 0.0 104.791 174.473 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 50.8 mtmt -90.67 170.97 9.7 Favored 'General case' 0 CA--C 1.493 -1.226 0 C-N-CA 123.884 0.874 . . . . 0.0 110.096 -168.01 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 96.4 m-85 -125.69 140.37 52.76 Favored 'General case' 0 CA--C 1.496 -1.101 0 N-CA-C 103.948 -2.612 . . . . 0.0 103.948 162.132 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 54.0 mt -120.9 127.85 75.99 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.12 0 N-CA-C 101.828 -3.397 . . . . 0.0 101.828 170.976 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.583 HD11 HD11 ' A' ' 20' ' ' ILE . 4.5 mt -106.91 137.15 45.52 Favored 'General case' 0 CA--C 1.476 -1.898 0 N-CA-C 105.384 -2.08 . . . . 0.0 105.384 171.611 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -131.83 156.02 46.78 Favored 'General case' 0 N--CA 1.434 -1.242 0 N-CA-C 106.878 -1.526 . . . . 0.0 106.878 166.258 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 49.4 p90 -155.27 145.76 22.07 Favored 'General case' 0 N--CA 1.435 -1.209 0 N-CA-C 106.517 -1.66 . . . . 0.0 106.517 -176.384 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 45.5 ttm-85 -135.87 140.67 34.15 Favored Pre-proline 0 N--CA 1.441 -0.88 0 N-CA-C 104.575 -2.38 . . . . 0.0 104.575 178.254 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -72.95 116.55 4.76 Favored 'Trans proline' 0 CA--C 1.504 -0.992 0 C-N-CA 122.735 2.29 . . . . 0.0 108.594 166.284 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 82.5 tttt -73.87 83.85 1.69 Allowed 'General case' 0 C--N 1.355 0.843 0 C-N-CA 125.537 1.535 . . . . 0.0 110.199 -174.252 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 33.1 m120 -147.51 -73.04 0.21 Allowed 'General case' 0 N--CA 1.435 -1.186 0 N-CA-C 102.354 -3.202 . . . . 0.0 102.354 -175.785 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 50.8 p -96.73 168.4 10.53 Favored 'General case' 0 N--CA 1.442 -0.867 0 N-CA-C 107.454 -1.313 . . . . 0.0 107.454 173.351 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 3.6 m -125.98 55.16 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.849 0 N-CA-C 105.821 -1.918 . . . . 0.0 105.821 177.192 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -93.19 -106.05 1.74 Allowed Glycine 0 C--N 1.355 1.611 0 N-CA-C 108.415 -1.874 . . . . 0.0 108.415 -177.247 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 5.6 mmp_? -105.12 170.01 8.12 Favored 'General case' 0 CA--C 1.499 -1.017 0 N-CA-C 107.042 -1.466 . . . . 0.0 107.042 176.729 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -151.23 173.01 14.95 Favored 'General case' 0 N--CA 1.436 -1.137 0 N-CA-C 108.728 -0.841 . . . . 0.0 108.728 -177.943 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 67.8 mttm -111.68 155.76 22.93 Favored 'General case' 0 CA--C 1.49 -1.357 0 N-CA-C 107.774 -1.195 . . . . 0.0 107.774 -172.13 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 15.4 pt-20 -151.49 160.67 43.6 Favored 'General case' 0 N--CA 1.435 -1.211 0 N-CA-C 108.247 -1.02 . . . . 0.0 108.247 172.565 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -137.37 156.76 47.84 Favored 'General case' 0 CA--C 1.497 -1.064 0 N-CA-C 105.938 -1.875 . . . . 0.0 105.938 171.532 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 95.2 m -117.85 123.29 45.52 Favored 'General case' 0 CA--C 1.499 -0.982 0 N-CA-C 104.134 -2.543 . . . . 0.0 104.134 176.398 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 65.9 mt -118.73 137.67 25.15 Favored Pre-proline 0 N--CA 1.437 -1.08 0 N-CA-C 105.984 -1.858 . . . . 0.0 105.984 -164.867 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 75.3 Cg_exo -65.05 163.87 27.08 Favored 'Trans proline' 0 N--CA 1.455 -0.749 0 C-N-CA 123.295 2.663 . . . . 0.0 113.545 176.491 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -78.68 -17.27 77.78 Favored Glycine 0 C--N 1.352 1.456 0 C-N-CA 124.042 0.83 . . . . 0.0 113.807 -174.87 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 54.3 p-80 -83.45 -23.81 32.09 Favored 'General case' 0 C--N 1.357 0.893 0 CA-C-N 117.936 0.868 . . . . 0.0 109.963 -179.602 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 80.8 mt -87.93 125.24 34.4 Favored 'General case' 0 CA--C 1.497 -1.093 0 N-CA-C 107.975 -1.12 . . . . 0.0 107.975 176.721 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 8.1 p30 -112.25 6.69 19.09 Favored 'General case' 0 N--CA 1.442 -0.848 0 C-N-CA 124.741 1.216 . . . . 0.0 109.783 -174.845 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 28.7 p -142.06 154.96 45.35 Favored 'General case' 0 CA--C 1.498 -1.043 0 N-CA-C 106.684 -1.598 . . . . 0.0 106.684 -177.977 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 10.8 t80 -133.84 171.33 14.3 Favored 'General case' 0 CA--C 1.502 -0.869 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 178.423 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 94.4 m -131.8 109.09 9.88 Favored 'General case' 0 N--CA 1.43 -1.433 0 N-CA-C 103.929 -2.619 . . . . 0.0 103.929 170.545 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 42.6 mt -84.09 139.48 17.54 Favored 'Isoleucine or valine' 0 C--N 1.358 0.969 0 N-CA-C 103.123 -2.917 . . . . 0.0 103.123 169.433 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 18.0 ptpt -147.74 160.05 43.14 Favored 'General case' 0 CA--C 1.497 -1.085 0 N-CA-C 109.068 -0.716 . . . . 0.0 109.068 -176.261 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 81.2 53.96 3.72 Favored Glycine 0 C--N 1.355 1.586 0 N-CA-C 108.816 -1.714 . . . . 0.0 108.816 -179.946 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 84.6 mt -117.14 172.6 7.17 Favored 'General case' 0 CA--C 1.496 -1.113 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 -173.019 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 65.7 tttp -124.43 139.56 33.26 Favored Pre-proline 0 N--CA 1.434 -1.259 0 N-CA-C 104.97 -2.233 . . . . 0.0 104.97 -175.342 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -74.9 163.97 34.4 Favored 'Trans proline' 0 N--CA 1.455 -0.789 0 C-N-CA 123.058 2.505 . . . . 0.0 110.089 174.98 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 62.63 44.07 98.07 Favored Glycine 0 N--CA 1.429 -1.824 0 C-N-CA 125.946 1.736 . . . . 0.0 112.756 -178.803 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 20.5 t -134.95 127.19 48.15 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.09 0 N-CA-C 104.325 -2.472 . . . . 0.0 104.325 173.078 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 4.4 p -83.8 116.72 28.21 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.928 0 N-CA-C 105.061 -2.2 . . . . 0.0 105.061 162.521 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 80.8 m-85 -97.64 147.04 24.72 Favored 'General case' 0 CA--C 1.495 -1.153 0 N-CA-C 105.817 -1.919 . . . . 0.0 105.817 178.71 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 14.6 pt-20 -95.37 140.76 29.79 Favored 'General case' 0 CA--C 1.501 -0.934 0 N-CA-C 105.168 -2.16 . . . . 0.0 105.168 164.288 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -134.33 151.89 20.45 Favored Glycine 0 CA--C 1.49 -1.521 0 N-CA-C 107.633 -2.187 . . . . 0.0 107.633 -178.972 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 31.9 mt-30 -143.65 135.71 26.67 Favored 'General case' 0 CA--C 1.488 -1.425 0 N-CA-C 105.699 -1.963 . . . . 0.0 105.699 179.171 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 15.4 tp -120.01 100.98 7.54 Favored 'General case' 0 CA--C 1.499 -0.983 0 N-CA-C 105.482 -2.044 . . . . 0.0 105.482 -177.453 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 18.7 mt -94.02 131.29 41.34 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.889 0 N-CA-C 105.072 -2.196 . . . . 0.0 105.072 178.143 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 23.3 p -108.38 125.87 52.22 Favored 'General case' 0 N--CA 1.44 -0.972 0 N-CA-C 106.088 -1.819 . . . . 0.0 106.088 173.163 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 1.7 mp -92.33 137.04 23.07 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.181 0 N-CA-C 103.427 -2.805 . . . . 0.0 103.427 -179.346 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 4.8 mp0 -92.25 153.48 19.23 Favored 'General case' 0 CA--C 1.497 -1.091 0 N-CA-C 107.032 -1.47 . . . . 0.0 107.032 177.701 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 9.0 tt0 -77.52 32.53 0.16 Allowed 'General case' 0 C--N 1.356 0.854 0 C-N-CA 125.5 1.52 . . . . 0.0 112.385 173.766 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 88.4 m-85 -143.9 14.26 1.7 Allowed 'General case' 0 CA--C 1.498 -1.027 0 C-N-CA 124.119 0.968 . . . . 0.0 108.687 -173.96 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 90.14 -17.94 50.91 Favored Glycine 0 C--N 1.35 1.357 0 C-N-CA 124.131 0.872 . . . . 0.0 112.433 173.835 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 78.4 m-70 -81.48 173.84 12.02 Favored 'General case' 0 CA--C 1.496 -1.109 0 C-N-CA 124.691 1.196 . . . . 0.0 109.17 -177.365 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 5.1 pt20 -155.03 142.41 19.56 Favored 'General case' 0 N--CA 1.438 -1.042 0 N-CA-C 107.778 -1.193 . . . . 0.0 107.778 171.715 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 67.7 mt-10 -108.24 140.22 41.8 Favored 'General case' 0 CA--C 1.496 -1.1 0 N-CA-C 105.191 -2.152 . . . . 0.0 105.191 178.97 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 3.3 p -117.81 137.39 51.9 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.823 0 N-CA-C 107.544 -1.28 . . . . 0.0 107.544 -175.377 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 24.9 m -117.33 140.57 49.4 Favored 'General case' 0 N--CA 1.441 -0.898 0 N-CA-C 104.015 -2.587 . . . . 0.0 104.015 174.84 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -126.46 153.88 44.46 Favored 'General case' 0 CA--C 1.498 -1.04 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 170.331 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 29.5 p90 -166.46 -179.1 4.77 Favored 'General case' 0 CA--C 1.5 -0.948 0 N-CA-C 106.888 -1.523 . . . . 0.0 106.888 -178.093 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 1.7 p30 -139.11 159.51 41.98 Favored 'General case' 0 N--CA 1.438 -1.038 0 N-CA-C 106.436 -1.691 . . . . 0.0 106.436 166.132 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 20.5 p90 -142.42 172.88 12.09 Favored 'General case' 0 CA--C 1.488 -1.411 0 N-CA-C 105.814 -1.921 . . . . 0.0 105.814 171.867 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 16.2 m -130.39 143.48 50.79 Favored 'General case' 0 CA--C 1.501 -0.915 0 N-CA-C 104.697 -2.334 . . . . 0.0 104.697 176.76 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 58.8 m -120.48 124.83 46.35 Favored 'General case' 0 N--CA 1.441 -0.918 0 N-CA-C 102.973 -2.973 . . . . 0.0 102.973 176.758 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 33.0 p -134.24 167.8 20.03 Favored 'General case' 0 C--N 1.357 0.894 0 N-CA-C 107.459 -1.311 . . . . 0.0 107.459 -177.738 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 56.8 p . . . . . 0 C--O 1.26 1.61 0 C-N-CA 124.431 1.092 . . . . 0.0 108.844 178.02 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.437 -1.288 0 N-CA-C 107.82 -2.112 . . . . 0.0 107.82 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 70.7 Cg_exo -65.5 142.15 70.43 Favored 'Trans proline' 0 N--CA 1.444 -1.425 0 C-N-CA 122.257 1.971 . . . . 0.0 115.2 -169.913 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 12.9 t -78.29 154.36 5.1 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.807 0 C-N-CA 128.645 2.778 . . . . 0.0 104.776 168.287 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 57.8 mm-40 -109.35 99.88 9.06 Favored 'General case' 0 CA--C 1.488 -1.437 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 -172.249 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 2.4 p -119.23 141.29 39.86 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.012 0 N-CA-C 106.413 -1.699 . . . . 0.0 106.413 -172.087 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 15.4 p90 . . . . . 0 N--CA 1.436 -1.154 0 N-CA-C 107.078 -1.453 . . . . 0.0 107.078 -169.005 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_exo . . . . . 0 CA--C 1.509 -0.769 0 N-CA-C 110.705 -0.536 . . . . 0.0 110.705 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 13.8 p-10 -102.31 -45.36 5.13 Favored 'General case' 0 CA--C 1.492 -1.251 0 C-N-CA 125.132 1.373 . . . . 0.0 110.342 -168.033 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 73.5 m -110.85 158.16 19.02 Favored 'General case' 0 CA--C 1.493 -1.234 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 -176.219 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 18.7 t-160 -148.63 95.65 3.96 Favored Pre-proline 0 N--CA 1.44 -0.962 0 N-CA-C 107.651 -1.24 . . . . 0.0 107.651 165.575 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 70.2 Cg_endo -74.61 134.18 18.17 Favored 'Trans proline' 0 N--CA 1.446 -1.268 0 C-N-CA 122.903 2.402 . . . . 0.0 109.246 170.264 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 7.5 pt -116.08 168.39 7.77 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.047 0 N-CA-C 107.006 -1.479 . . . . 0.0 107.006 179.762 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 23.2 tt0 -148.9 147.7 28.98 Favored 'General case' 0 N--CA 1.438 -1.072 0 N-CA-C 105.068 -2.197 . . . . 0.0 105.068 172.27 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 39.5 p90 -131.5 160.95 33.7 Favored 'General case' 0 N--CA 1.438 -1.061 0 N-CA-C 107.069 -1.456 . . . . 0.0 107.069 -178.879 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 83.8 m-20 -103.92 -179.62 4.0 Favored 'General case' 0 CA--C 1.488 -1.407 0 N-CA-C 103.721 -2.696 . . . . 0.0 103.721 170.865 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -157.29 173.07 5.34 Favored Pre-proline 0 N--CA 1.44 -0.963 0 N-CA-C 106.696 -1.594 . . . . 0.0 106.696 177.317 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 79.8 Cg_exo -63.99 161.31 33.75 Favored 'Trans proline' 0 N--CA 1.455 -0.74 0 C-N-CA 123.761 2.974 . . . . 0.0 113.082 173.129 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 70.8 tp60 -82.71 -45.03 0.92 Allowed Pre-proline 0 N--CA 1.444 -0.746 0 CA-C-O 115.519 -2.181 . . . . 0.0 111.925 -175.375 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_exo -70.87 -15.51 32.92 Favored 'Trans proline' 0 CA--C 1.509 -0.727 0 CA-C-N 125.897 3.142 . . . . 0.0 113.342 -176.114 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 9.1 t 66.33 73.06 0.38 Allowed 'General case' 0 C--N 1.357 0.925 0 C-N-CA 126.153 1.781 . . . . 0.0 110.54 179.159 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 23.6 t-160 -97.55 -3.49 39.63 Favored 'General case' 0 N--CA 1.444 -0.752 0 C-N-CA 125.002 1.321 . . . . 0.0 107.976 174.311 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 33.5 mt -106.08 136.65 39.69 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.128 0 N-CA-C 104.516 -2.401 . . . . 0.0 104.516 -176.739 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 4.9 p -99.52 -85.01 0.4 Allowed 'General case' 0 N--CA 1.43 -1.442 0 N-CA-C 105.687 -1.968 . . . . 0.0 105.687 176.962 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 54.2 mtmt -89.76 167.39 12.91 Favored 'General case' 0 CA--C 1.488 -1.436 0 C-N-CA 123.423 0.689 . . . . 0.0 109.253 -164.992 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 93.8 m-85 -126.96 133.15 50.66 Favored 'General case' 0 CA--C 1.493 -1.239 0 N-CA-C 103.219 -2.882 . . . . 0.0 103.219 165.75 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.451 HD13 HD13 ' A' ' 76' ' ' ILE . 1.6 mp -107.6 136.26 43.48 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.195 1 N-CA-C 99.078 -4.416 . . . . 0.0 99.078 166.686 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 46.9 tp -119.72 137.08 54.15 Favored 'General case' 0 N--CA 1.397 -3.092 0 N-CA-C 101.36 -3.57 . . . . 0.0 101.36 172.664 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 14.9 ptp180 -133.94 155.3 50.17 Favored 'General case' 0 CA--C 1.488 -1.417 0 N-CA-C 107.072 -1.455 . . . . 0.0 107.072 174.168 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 47.0 p90 -152.67 139.13 18.59 Favored 'General case' 0 N--CA 1.43 -1.465 0 N-CA-C 105.778 -1.934 . . . . 0.0 105.778 -175.889 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 46.1 ttp85 -145.87 145.04 23.67 Favored Pre-proline 0 N--CA 1.442 -0.843 0 N-CA-C 104.871 -2.27 . . . . 0.0 104.871 -177.17 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 63.6 Cg_exo -64.21 122.8 10.89 Favored 'Trans proline' 0 CA--C 1.505 -0.975 0 C-N-CA 123.09 2.527 . . . . 0.0 111.06 174.7 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 49.9 tttp -71.95 75.65 0.91 Allowed 'General case' 0 C--N 1.358 0.956 0 C-N-CA 125.897 1.679 . . . . 0.0 110.449 176.475 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 29.8 m120 -151.35 -74.73 0.15 Allowed 'General case' 0 N--CA 1.435 -1.212 0 N-CA-C 102.407 -3.183 . . . . 0.0 102.407 -172.541 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 39.1 p -97.44 161.08 13.95 Favored 'General case' 0 C--N 1.356 0.88 0 N-CA-C 106.856 -1.535 . . . . 0.0 106.856 172.332 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 3.7 m -115.61 52.76 0.21 Allowed 'Isoleucine or valine' 0 CA--C 1.504 -0.81 0 N-CA-C 106.526 -1.657 . . . . 0.0 106.526 -179.236 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -88.59 -137.31 5.88 Favored Glycine 0 C--N 1.355 1.59 0 N-CA-C 109.722 -1.351 . . . . 0.0 109.722 -179.872 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 96.4 mtt-85 -85.05 155.78 21.38 Favored 'General case' 0 CA--C 1.499 -0.981 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 -177.596 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 49.0 m95 -105.19 159.33 15.95 Favored 'General case' 0 N--CA 1.436 -1.146 0 N-CA-C 107.552 -1.277 . . . . 0.0 107.552 -175.102 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 64.3 mttp -98.76 150.31 21.96 Favored 'General case' 0 CA--C 1.488 -1.416 0 N-CA-C 104.232 -2.507 . . . . 0.0 104.232 161.801 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -153.12 157.91 41.08 Favored 'General case' 0 CA--C 1.494 -1.173 0 CA-C-O 121.787 0.803 . . . . 0.0 108.867 -176.768 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -140.89 165.81 26.49 Favored 'General case' 0 N--CA 1.437 -1.114 0 N-CA-C 106.119 -1.808 . . . . 0.0 106.119 173.505 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 98.9 m -121.6 127.22 50.66 Favored 'General case' 0 CA--C 1.5 -0.952 0 N-CA-C 104.8 -2.296 . . . . 0.0 104.8 175.87 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 5.3 mp -114.97 134.35 22.51 Favored Pre-proline 0 N--CA 1.435 -1.203 0 N-CA-C 104.871 -2.27 . . . . 0.0 104.871 -176.014 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 68.7 Cg_exo -64.67 165.95 19.28 Favored 'Trans proline' 0 CA--C 1.508 -0.811 0 C-N-CA 123.354 2.703 . . . . 0.0 113.391 177.019 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -73.96 -20.57 79.71 Favored Glycine 0 C--N 1.351 1.376 0 C-N-CA 123.906 0.765 . . . . 0.0 114.141 -174.891 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 52.2 p-80 -83.56 -27.06 29.54 Favored 'General case' 0 C--N 1.354 0.793 0 CA-C-N 117.872 0.836 . . . . 0.0 110.243 -178.72 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 85.0 mt -88.65 126.25 35.21 Favored 'General case' 0 CA--C 1.501 -0.938 0 N-CA-C 107.894 -1.15 . . . . 0.0 107.894 177.283 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 7.8 p-10 -108.65 8.18 26.88 Favored 'General case' 0 CA--C 1.503 -0.843 0 C-N-CA 124.391 1.076 . . . . 0.0 110.634 -170.526 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 5.8 p -142.62 168.08 20.57 Favored 'General case' 0 CA--C 1.491 -1.297 0 N-CA-C 108.106 -1.072 . . . . 0.0 108.106 -177.802 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 8.5 t80 -139.6 175.86 9.22 Favored 'General case' 0 N--CA 1.441 -0.908 0 N-CA-C 107.81 -1.181 . . . . 0.0 107.81 174.365 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 99.3 m -140.05 112.2 7.65 Favored 'General case' 0 N--CA 1.435 -1.208 0 N-CA-C 104.924 -2.25 . . . . 0.0 104.924 178.573 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 17.3 mm -90.25 145.27 7.61 Favored 'Isoleucine or valine' 0 C--N 1.356 0.856 0 N-CA-C 105.013 -2.217 . . . . 0.0 105.013 171.261 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -149.83 161.58 41.97 Favored 'General case' 0 N--CA 1.438 -1.057 0 N-CA-C 107.841 -1.17 . . . . 0.0 107.841 167.662 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 85.88 52.3 3.34 Favored Glycine 0 C--N 1.354 1.543 0 N-CA-C 109.303 -1.519 . . . . 0.0 109.303 177.654 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 78.0 mt -115.18 165.62 12.73 Favored 'General case' 0 CA--C 1.5 -0.967 0 N-CA-C 108.142 -1.059 . . . . 0.0 108.142 -179.141 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt -103.58 154.93 37.53 Favored Pre-proline 0 N--CA 1.44 -0.952 0 N-CA-C 107.068 -1.456 . . . . 0.0 107.068 -176.068 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -76.96 152.52 31.91 Favored 'Trans proline' 0 N--CA 1.452 -0.966 0 C-N-CA 122.829 2.353 . . . . 0.0 111.127 -178.515 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 55.17 40.42 74.72 Favored Glycine 0 C--N 1.356 1.686 0 C-N-CA 127.567 2.508 . . . . 0.0 115.636 170.518 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 5.5 p -129.87 138.08 54.99 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.165 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 -177.169 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 3.2 p -91.76 127.59 43.96 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.884 0 C-N-CA 125.119 1.368 . . . . 0.0 107.681 -178.197 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 82.7 m-85 -107.71 153.24 23.23 Favored 'General case' 0 N--CA 1.438 -1.07 0 C-N-CA 125.12 1.368 . . . . 0.0 108.382 178.036 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 21.4 tp10 -97.55 136.51 37.85 Favored 'General case' 0 N--CA 1.434 -1.242 0 N-CA-C 104.027 -2.582 . . . . 0.0 104.027 165.354 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -131.0 144.11 15.58 Favored Glycine 0 CA--C 1.492 -1.36 0 N-CA-C 107.681 -2.168 . . . . 0.0 107.681 174.325 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 84.3 mt-30 -133.67 134.37 43.04 Favored 'General case' 0 CA--C 1.486 -1.485 0 N-CA-C 107.109 -1.441 . . . . 0.0 107.109 174.858 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 66.6 tp -109.97 101.46 10.28 Favored 'General case' 0 CA--C 1.502 -0.874 0 N-CA-C 104.499 -2.408 . . . . 0.0 104.499 178.493 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 32.4 mt -97.78 123.39 50.2 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.868 0 N-CA-C 104.102 -2.555 . . . . 0.0 104.102 -176.612 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 32.8 p -118.24 120.06 36.56 Favored 'General case' 0 CA--C 1.505 -0.769 0 N-CA-C 108.72 -0.844 . . . . 0.0 108.72 -172.25 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.451 HD13 HD13 ' A' ' 34' ' ' ILE . 1.8 mp -93.64 136.24 25.9 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.301 0 N-CA-C 104.581 -2.377 . . . . 0.0 104.581 -170.243 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 84.7 mt-30 -93.68 152.8 18.73 Favored 'General case' 0 CA--C 1.493 -1.224 0 N-CA-C 106.903 -1.517 . . . . 0.0 106.903 176.91 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 9.0 pt20 -69.14 99.56 1.15 Allowed 'General case' 0 N--CA 1.44 -0.926 0 C-N-CA 124.871 1.268 . . . . 0.0 111.458 -176.296 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 69.1 m-85 57.1 39.4 29.11 Favored 'General case' 0 C--N 1.358 0.946 0 C-N-CA 127.248 2.219 . . . . 0.0 112.16 -179.402 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -141.04 -124.32 2.02 Favored Glycine 0 C--N 1.357 1.708 0 N-CA-C 108.497 -1.841 . . . . 0.0 108.497 -177.4 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 59.1 m80 -83.82 -179.75 7.36 Favored 'General case' 0 CA--C 1.499 -1.019 0 C-N-CA 125.193 1.397 . . . . 0.0 110.302 -170.982 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 21.4 tt0 -139.26 119.15 13.31 Favored 'General case' 0 N--CA 1.434 -1.258 0 N-CA-C 104.781 -2.303 . . . . 0.0 104.781 175.993 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 88.0 mt-10 -99.11 154.23 18.28 Favored 'General case' 0 CA--C 1.499 -1.005 0 N-CA-C 107.37 -1.345 . . . . 0.0 107.37 -178.435 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 7.7 p -128.78 134.97 63.39 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.776 0 N-CA-C 107.598 -1.26 . . . . 0.0 107.598 175.082 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 95.2 m -119.84 137.0 54.26 Favored 'General case' 0 CA--C 1.498 -1.044 0 N-CA-C 102.623 -3.103 . . . . 0.0 102.623 175.098 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 83.0 mtm-85 -126.69 150.67 48.89 Favored 'General case' 0 CA--C 1.5 -0.964 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 -178.531 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 32.7 p90 -165.33 178.81 6.61 Favored 'General case' 0 CA--C 1.5 -0.98 0 N-CA-C 107.234 -1.395 . . . . 0.0 107.234 -177.993 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -139.43 157.85 45.14 Favored 'General case' 0 N--CA 1.441 -0.913 0 N-CA-C 106.441 -1.689 . . . . 0.0 106.441 169.472 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 24.0 p90 -144.83 175.59 10.08 Favored 'General case' 0 CA--C 1.488 -1.442 0 N-CA-C 105.271 -2.122 . . . . 0.0 105.271 172.375 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 8.9 t -143.9 154.94 43.86 Favored 'General case' 0 N--CA 1.44 -0.968 0 N-CA-C 105.439 -2.06 . . . . 0.0 105.439 173.631 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 54.8 p -121.95 138.93 54.23 Favored 'General case' 0 CA--C 1.497 -1.086 0 N-CA-C 104.242 -2.503 . . . . 0.0 104.242 177.144 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 12.3 t -165.89 172.9 11.08 Favored 'General case' 0 N--CA 1.44 -0.944 0 N-CA-C 105.134 -2.173 . . . . 0.0 105.134 -175.625 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 10.0 p . . . . . 0 C--O 1.261 1.678 0 N-CA-C 105.144 -2.169 . . . . 0.0 105.144 164.327 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.441 -1.004 0 N-CA-C 107.731 -2.148 . . . . 0.0 107.731 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -61.6 138.6 76.42 Favored 'Trans proline' 0 N--CA 1.441 -1.567 0 C-N-CA 123.115 2.543 . . . . 0.0 112.973 178.993 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 14.5 t -77.62 161.26 4.52 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.882 0 C-N-CA 129.005 2.922 . . . . 0.0 105.732 179.03 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 59.1 mm-40 -110.87 100.43 9.16 Favored 'General case' 0 CA--C 1.49 -1.361 0 N-CA-C 106.564 -1.643 . . . . 0.0 106.564 -179.449 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 1.5 p -120.85 141.17 42.48 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.041 0 N-CA-C 106.191 -1.781 . . . . 0.0 106.191 -169.531 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 30.6 p90 . . . . . 0 N--CA 1.434 -1.241 0 N-CA-C 107.015 -1.476 . . . . 0.0 107.015 -169.289 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 66.5 Cg_endo . . . . . 0 N--CA 1.454 -0.831 0 N-CA-C 109.45 -1.019 . . . . 0.0 109.45 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 5.8 p-10 -116.44 -35.95 4.13 Favored 'General case' 0 CA--C 1.491 -1.321 0 C-N-CA 124.328 1.051 . . . . 0.0 109.344 -172.581 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 30.3 p -130.22 151.95 50.18 Favored 'General case' 0 CA--C 1.499 -1.0 0 CA-C-O 122.151 0.977 . . . . 0.0 110.004 -175.42 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 35.7 m-70 -142.87 98.99 5.62 Favored Pre-proline 0 N--CA 1.438 -1.069 0 N-CA-C 107.145 -1.428 . . . . 0.0 107.145 175.668 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -79.1 114.04 3.3 Favored 'Trans proline' 0 N--CA 1.445 -1.339 0 C-N-CA 123.074 2.516 . . . . 0.0 110.178 175.953 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.53 HD11 HD11 ' A' ' 35' ' ' LEU . 3.9 pt -93.93 166.53 1.77 Allowed 'Isoleucine or valine' 0 CA--C 1.498 -1.05 0 N-CA-C 107.825 -1.176 . . . . 0.0 107.825 -178.251 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 17.6 mp0 -139.69 151.46 45.92 Favored 'General case' 0 CA--C 1.499 -1.002 0 N-CA-C 105.496 -2.038 . . . . 0.0 105.496 174.815 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 42.3 p90 -136.33 156.71 48.25 Favored 'General case' 0 CA--C 1.496 -1.113 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 175.666 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 83.2 m-20 -97.35 -175.71 3.3 Favored 'General case' 0 CA--C 1.486 -1.487 0 N-CA-C 104.31 -2.478 . . . . 0.0 104.31 171.29 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -157.59 173.79 4.65 Favored Pre-proline 0 N--CA 1.44 -0.93 0 N-CA-C 106.828 -1.545 . . . . 0.0 106.828 176.458 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_exo -63.96 162.52 28.78 Favored 'Trans proline' 0 CA--C 1.51 -0.724 0 C-N-CA 123.678 2.919 . . . . 0.0 112.209 169.169 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 1.2 tm0? -81.26 -60.09 0.43 Allowed Pre-proline 0 C--N 1.353 0.744 0 CA-C-O 115.705 -2.093 . . . . 0.0 110.671 -174.193 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_endo -75.42 174.43 12.81 Favored 'Trans proline' 0 CA--C 1.511 -0.645 0 CA-C-N 125.688 3.067 . . . . 0.0 110.161 -179.694 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 52.2 p -72.58 126.26 29.44 Favored 'General case' 0 C--N 1.357 0.919 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 177.787 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 16.2 t-160 -160.9 -51.66 0.05 OUTLIER 'General case' 0 CA--C 1.493 -1.229 0 N-CA-C 106.566 -1.642 . . . . 0.0 106.566 -166.646 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 35.1 mt -111.81 132.64 59.87 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.1 0 N-CA-C 105.487 -2.042 . . . . 0.0 105.487 -174.154 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 30.0 t -102.77 -84.79 0.45 Allowed 'General case' 0 N--CA 1.431 -1.41 0 N-CA-C 107.586 -1.264 . . . . 0.0 107.586 -178.146 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 23.1 ttmm -91.42 149.51 21.68 Favored 'General case' 0 CA--C 1.493 -1.244 0 N-CA-C 106.829 -1.545 . . . . 0.0 106.829 -161.278 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 97.4 m-85 -117.49 128.84 55.38 Favored 'General case' 0 CA--C 1.496 -1.129 0 N-CA-C 104.725 -2.324 . . . . 0.0 104.725 168.785 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 60.9 mt -106.48 117.44 52.27 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.075 0 N-CA-C 102.188 -3.264 . . . . 0.0 102.188 169.604 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.53 HD11 HD11 ' A' ' 20' ' ' ILE . 0.9 OUTLIER -95.33 125.35 39.89 Favored 'General case' 0 CA--C 1.48 -1.745 0 N-CA-C 106.972 -1.492 . . . . 0.0 106.972 176.813 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 97.0 mtt180 -120.74 147.12 45.74 Favored 'General case' 0 CA--C 1.49 -1.333 0 N-CA-C 105.972 -1.862 . . . . 0.0 105.972 171.75 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 40.3 p90 -151.99 173.55 14.72 Favored 'General case' 0 CA--C 1.487 -1.479 0 N-CA-C 106.199 -1.778 . . . . 0.0 106.199 169.982 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 36.0 ptt180 -170.96 158.83 5.38 Favored Pre-proline 0 CA--C 1.499 -1.009 0 N-CA-C 106.284 -1.747 . . . . 0.0 106.284 177.004 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -74.51 140.86 27.44 Favored 'Trans proline' 0 N--CA 1.448 -1.181 0 C-N-CA 122.065 1.843 . . . . 0.0 107.839 168.062 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 57.7 tttp -71.18 78.42 0.7 Allowed 'General case' 0 C--N 1.355 0.806 0 C-N-CA 125.344 1.458 . . . . 0.0 110.784 179.947 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 20.9 m120 -161.11 -46.73 0.04 OUTLIER 'General case' 0 N--CA 1.438 -1.044 0 N-CA-C 104.966 -2.235 . . . . 0.0 104.966 -170.668 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 27.8 m -77.68 161.01 28.09 Favored 'General case' 0 C--N 1.359 0.995 0 C-N-CA 124.19 0.996 . . . . 0.0 110.503 -170.926 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 20.2 m -102.01 -26.93 3.4 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.879 0 C-N-CA 124.83 1.252 . . . . 0.0 109.887 -170.608 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -173.17 27.17 0.09 OUTLIER Glycine 0 CA--C 1.493 -1.339 0 N-CA-C 110.569 -1.012 . . . . 0.0 110.569 179.853 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 54.7 ttp180 -98.62 122.29 41.65 Favored 'General case' 0 CA--C 1.495 -1.15 0 N-CA-C 105.026 -2.213 . . . . 0.0 105.026 172.669 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 83.8 m95 -128.6 138.74 52.36 Favored 'General case' 0 CA--C 1.496 -1.123 0 N-CA-C 106.732 -1.581 . . . . 0.0 106.732 179.665 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 60.9 mttp -96.11 104.47 16.42 Favored 'General case' 0 CA--C 1.491 -1.307 0 N-CA-C 104.332 -2.47 . . . . 0.0 104.332 169.192 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 16.1 pt-20 -107.49 150.96 26.2 Favored 'General case' 0 CA--C 1.498 -1.055 0 CA-C-N 115.033 -0.985 . . . . 0.0 109.532 -176.475 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -136.74 154.51 50.56 Favored 'General case' 0 N--CA 1.438 -1.055 0 N-CA-C 105.917 -1.883 . . . . 0.0 105.917 178.089 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 92.4 m -121.71 125.1 45.82 Favored 'General case' 0 CA--C 1.501 -0.91 0 N-CA-C 104.292 -2.485 . . . . 0.0 104.292 178.317 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 63.6 mt -128.86 137.39 30.87 Favored Pre-proline 0 N--CA 1.44 -0.961 0 N-CA-C 105.154 -2.165 . . . . 0.0 105.154 -166.29 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -74.56 171.13 18.76 Favored 'Trans proline' 0 CA--C 1.508 -0.8 0 C-N-CA 123.44 2.76 . . . . 0.0 110.876 178.555 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -77.95 -11.96 84.88 Favored Glycine 0 C--N 1.352 1.463 0 C-N-CA 123.808 0.718 . . . . 0.0 114.117 -178.742 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 9.2 p-80 -83.01 -25.37 32.27 Favored 'General case' 0 C--N 1.357 0.931 0 CA-C-N 118.321 1.061 . . . . 0.0 110.236 -178.937 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 87.2 mt -89.09 128.26 35.74 Favored 'General case' 0 CA--C 1.501 -0.929 0 N-CA-C 107.316 -1.364 . . . . 0.0 107.316 173.412 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 8.4 p30 -112.91 1.05 15.32 Favored 'General case' 0 N--CA 1.443 -0.8 0 C-N-CA 124.762 1.225 . . . . 0.0 109.814 -173.146 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 25.7 p -145.71 160.18 42.09 Favored 'General case' 0 CA--C 1.498 -1.025 0 N-CA-C 106.331 -1.729 . . . . 0.0 106.331 -177.33 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 5.1 t80 -131.89 177.89 7.19 Favored 'General case' 0 C--N 1.358 0.942 0 CA-C-O 121.684 0.754 . . . . 0.0 109.366 178.808 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 97.7 m -133.72 105.78 7.01 Favored 'General case' 0 N--CA 1.431 -1.393 0 N-CA-C 103.302 -2.851 . . . . 0.0 103.302 171.613 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 59.5 mt -86.83 140.22 16.14 Favored 'Isoleucine or valine' 0 C--N 1.359 0.993 0 N-CA-C 103.938 -2.615 . . . . 0.0 103.938 171.326 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -147.26 160.46 42.47 Favored 'General case' 0 N--CA 1.438 -1.071 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 -176.866 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 84.42 52.6 3.51 Favored Glycine 0 C--N 1.354 1.565 0 N-CA-C 109.208 -1.557 . . . . 0.0 109.208 178.672 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 47.9 mt -114.9 168.59 9.77 Favored 'General case' 0 CA--C 1.501 -0.924 0 N-CA-C 107.591 -1.263 . . . . 0.0 107.591 -173.631 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -119.67 150.48 50.32 Favored Pre-proline 0 N--CA 1.442 -0.872 0 N-CA-C 106.775 -1.565 . . . . 0.0 106.775 -173.624 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -77.18 165.7 27.54 Favored 'Trans proline' 0 N--CA 1.454 -0.827 0 C-N-CA 123.129 2.552 . . . . 0.0 110.806 175.263 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 66' ' ' GLY . . . . . 0.609 ' H ' ' HA ' ' A' ' 92' ' ' THR . . . 64.18 19.18 63.65 Favored Glycine 0 N--CA 1.429 -1.828 0 C-N-CA 128.209 2.814 . . . . 0.0 116.575 173.212 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 9.9 p -134.21 145.9 32.22 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.108 0 CA-C-N 118.636 1.218 . . . . 0.0 108.073 -174.713 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 7.3 p -90.33 128.2 42.38 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.959 0 N-CA-C 106.97 -1.492 . . . . 0.0 106.97 177.523 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 49.0 m-85 -101.0 137.33 39.51 Favored 'General case' 0 CA--C 1.493 -1.233 0 N-CA-C 105.575 -2.009 . . . . 0.0 105.575 174.3 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 18.9 pt-20 -112.35 158.63 19.55 Favored 'General case' 0 N--CA 1.437 -1.096 0 N-CA-C 105.956 -1.868 . . . . 0.0 105.956 173.044 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -169.57 -172.38 36.12 Favored Glycine 0 N--CA 1.415 -2.726 0 C-N-CA 120.578 -0.82 . . . . 0.0 114.879 175.447 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 32.0 mt-30 -148.24 139.88 23.71 Favored 'General case' 0 CA--C 1.486 -1.518 0 N-CA-C 105.997 -1.853 . . . . 0.0 105.997 -166.878 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 59.5 tp -116.47 96.41 5.51 Favored 'General case' 0 CA--C 1.499 -0.997 0 N-CA-C 104.015 -2.587 . . . . 0.0 104.015 174.958 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 27.3 mt -88.49 134.79 27.27 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.919 0 N-CA-C 104.05 -2.574 . . . . 0.0 104.05 -178.313 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 25.2 p -129.5 104.62 7.57 Favored 'General case' 0 N--CA 1.438 -1.066 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 -169.326 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 3.7 mp -93.51 136.42 25.31 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.312 0 N-CA-C 104.062 -2.57 . . . . 0.0 104.062 -167.07 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 80.5 mt-30 -88.24 177.29 6.92 Favored 'General case' 0 CA--C 1.496 -1.132 0 C-N-CA 123.712 0.805 . . . . 0.0 108.968 -171.304 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 35.3 mt-30 -71.52 96.04 1.47 Allowed 'General case' 0 CA--C 1.501 -0.921 0 C-N-CA 124.597 1.159 . . . . 0.0 109.459 176.46 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . 0.301 41.3 p90 47.65 33.0 2.76 Favored 'General case' 0 C--N 1.36 1.035 0 C-N-CA 128.126 2.57 . . . . 0.0 114.438 -174.815 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -125.29 -125.89 2.95 Favored Glycine 0 C--N 1.358 1.78 0 N-CA-C 109.456 -1.458 . . . . 0.0 109.456 -174.119 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 52.3 m80 -84.1 -178.02 6.83 Favored 'General case' 0 CA--C 1.498 -1.027 0 C-N-CA 125.614 1.566 . . . . 0.0 111.044 -167.818 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 35.7 mt-30 -125.29 146.25 49.64 Favored 'General case' 0 CA--C 1.494 -1.188 0 N-CA-C 103.459 -2.793 . . . . 0.0 103.459 167.806 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 54.6 mt-10 -138.14 121.48 17.06 Favored 'General case' 0 CA--C 1.492 -1.281 0 N-CA-C 105.372 -2.084 . . . . 0.0 105.372 -177.114 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 7.5 p -99.4 134.97 36.62 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.79 0 N-CA-C 108.151 -1.055 . . . . 0.0 108.151 -172.624 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 26.7 m -115.2 158.96 21.53 Favored 'General case' 0 N--CA 1.443 -0.802 0 N-CA-C 103.81 -2.663 . . . . 0.0 103.81 175.915 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 38.8 ptt180 -126.32 154.71 43.1 Favored 'General case' 0 CA--C 1.501 -0.915 0 CA-C-O 121.32 0.581 . . . . 0.0 109.8 178.126 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 29.4 p90 -157.45 165.43 35.69 Favored 'General case' 0 CA--C 1.502 -0.866 0 N-CA-C 107.274 -1.38 . . . . 0.0 107.274 173.486 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -145.57 156.82 43.93 Favored 'General case' 0 N--CA 1.441 -0.885 0 N-CA-C 106.314 -1.736 . . . . 0.0 106.314 159.997 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 27.4 p90 -146.37 168.23 21.62 Favored 'General case' 0 CA--C 1.492 -1.254 0 N-CA-C 106.404 -1.702 . . . . 0.0 106.404 171.046 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 26.6 p -110.86 140.36 45.39 Favored 'General case' 0 CA--C 1.5 -0.944 0 N-CA-C 106.957 -1.497 . . . . 0.0 106.957 178.668 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 89.7 m -116.45 109.14 16.91 Favored 'General case' 0 CA--C 1.489 -1.394 0 N-CA-C 102.106 -3.294 . . . . 0.0 102.106 174.037 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 92' ' ' THR . . . . . 0.609 ' HA ' ' H ' ' A' ' 66' ' ' GLY . 86.9 m -147.28 -55.69 0.24 Allowed 'General case' 0 CA--C 1.498 -1.034 0 N-CA-C 106.645 -1.613 . . . . 0.0 106.645 -171.686 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 8.9 t . . . . . 0 C--O 1.26 1.653 0 CA-C-O 118.078 -0.963 . . . . 0.0 110.049 -165.25 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.443 -0.847 0 N-CA-C 109.104 -1.598 . . . . 0.0 109.104 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_exo -61.55 136.12 61.15 Favored 'Trans proline' 0 N--CA 1.443 -1.472 0 C-N-CA 123.088 2.526 . . . . 0.0 113.624 -178.357 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 24.6 t -84.59 161.92 3.08 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.048 0 C-N-CA 129.202 3.001 . . . . 0.0 106.424 -178.196 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -108.38 108.9 20.06 Favored 'General case' 0 CA--C 1.496 -1.107 0 N-CA-C 105.876 -1.898 . . . . 0.0 105.876 175.927 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 1.5 p -129.3 142.04 45.01 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.894 0 N-CA-C 105.687 -1.968 . . . . 0.0 105.687 -170.101 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 33.1 p90 . . . . . 0 N--CA 1.438 -1.026 0 CA-C-O 121.876 0.846 . . . . 0.0 109.302 -162.184 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_exo . . . . . 0 CA--C 1.506 -0.882 0 CA-C-O 119.118 -0.451 . . . . 0.0 111.291 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 12.0 p-10 -102.46 -42.44 5.97 Favored 'General case' 0 CA--C 1.489 -1.368 0 C-N-CA 124.215 1.006 . . . . 0.0 111.029 -165.188 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 56.6 p -110.48 156.0 21.46 Favored 'General case' 0 CA--C 1.497 -1.06 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 -175.634 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 52.8 t-80 -131.57 98.72 17.8 Favored Pre-proline 0 N--CA 1.439 -0.989 0 N-CA-C 106.128 -1.804 . . . . 0.0 106.128 172.493 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -80.13 128.99 7.58 Favored 'Trans proline' 0 N--CA 1.451 -0.972 0 C-N-CA 123.26 2.64 . . . . 0.0 109.836 177.231 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 3.7 mp -111.9 149.04 14.67 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.183 0 N-CA-C 104.881 -2.266 . . . . 0.0 104.881 -179.62 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 31.2 mt-30 -138.7 152.94 48.44 Favored 'General case' 0 CA--C 1.497 -1.092 0 N-CA-C 104.578 -2.378 . . . . 0.0 104.578 164.57 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 37.2 p90 -136.02 158.5 44.26 Favored 'General case' 0 CA--C 1.501 -0.916 0 N-CA-C 107.065 -1.457 . . . . 0.0 107.065 -178.595 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 28.1 m120 -96.4 -176.92 3.78 Favored 'General case' 0 CA--C 1.488 -1.407 0 N-CA-C 103.934 -2.617 . . . . 0.0 103.934 169.045 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -157.35 171.85 6.91 Favored Pre-proline 0 N--CA 1.44 -0.933 0 N-CA-C 106.579 -1.637 . . . . 0.0 106.579 173.188 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 68.5 Cg_exo -63.74 154.46 69.28 Favored 'Trans proline' 0 CA--C 1.508 -0.814 0 C-N-CA 123.51 2.807 . . . . 0.0 112.842 174.59 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 24.0 tt0 -82.43 -41.93 0.94 Allowed Pre-proline 0 N--CA 1.443 -0.798 0 CA-C-O 115.697 -2.097 . . . . 0.0 112.031 -175.134 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_exo -71.71 -3.74 13.71 Favored 'Trans proline' 0 CA--C 1.514 -0.521 0 CA-C-N 125.574 3.026 . . . . 0.0 113.851 -179.867 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 10.3 t 71.0 75.93 0.19 Allowed 'General case' 0 C--N 1.357 0.903 0 C-N-CA 126.381 1.873 . . . . 0.0 108.812 -176.71 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 57.8 t-80 -90.95 -20.18 22.46 Favored 'General case' 0 N--CA 1.439 -0.977 0 C-N-CA 125.27 1.428 . . . . 0.0 108.455 179.969 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 22.9 mt -125.38 147.47 30.07 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.105 0 N-CA-C 105.396 -2.075 . . . . 0.0 105.396 -168.578 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 9.2 p -107.29 -84.13 0.53 Allowed 'General case' 0 N--CA 1.432 -1.328 0 N-CA-C 106.879 -1.526 . . . . 0.0 106.879 174.554 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 51.7 mtmt -89.2 167.57 12.98 Favored 'General case' 0 CA--C 1.486 -1.493 0 C-N-CA 124.683 1.193 . . . . 0.0 108.782 -165.274 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 90.4 m-85 -132.31 138.24 47.74 Favored 'General case' 0 CA--C 1.495 -1.142 0 N-CA-C 105.329 -2.1 . . . . 0.0 105.329 176.033 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 51.8 mt -118.42 131.55 70.85 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.111 0 N-CA-C 101.074 -3.676 . . . . 0.0 101.074 170.652 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 6.8 mt -111.01 128.13 55.75 Favored 'General case' 0 CA--C 1.477 -1.854 0 N-CA-C 104.739 -2.319 . . . . 0.0 104.739 170.104 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 3.2 mmm180 -107.51 160.11 15.91 Favored 'General case' 0 N--CA 1.432 -1.348 0 N-CA-C 104.737 -2.32 . . . . 0.0 104.737 171.077 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 48.5 p90 -159.18 152.82 22.89 Favored 'General case' 0 N--CA 1.437 -1.085 0 N-CA-C 107.801 -1.185 . . . . 0.0 107.801 171.093 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 13.1 ptp180 -154.61 158.05 32.2 Favored Pre-proline 0 CA--C 1.501 -0.932 0 N-CA-C 105.661 -1.978 . . . . 0.0 105.661 163.946 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 39' ' ' PRO . . . . . 0.433 ' HA ' ' HA ' ' A' ' 69' ' ' TYR . 37.9 Cg_endo -72.52 129.01 14.16 Favored 'Trans proline' 0 N--CA 1.451 -0.977 0 C-N-CA 122.637 2.225 . . . . 0.0 107.752 170.191 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 48.2 tttp -67.6 81.82 0.17 Allowed 'General case' 0 C--N 1.357 0.912 0 C-N-CA 127.781 2.433 . . . . 0.0 111.473 -170.761 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 4.7 t-20 -162.17 -51.05 0.04 OUTLIER 'General case' 0 N--CA 1.432 -1.335 0 N-CA-C 105.562 -2.014 . . . . 0.0 105.562 -173.607 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 37.9 p -80.63 155.7 26.72 Favored 'General case' 0 N--CA 1.438 -1.059 0 C-N-CA 124.567 1.147 . . . . 0.0 109.685 -176.891 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 17.3 m -130.44 10.67 2.14 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.811 0 C-N-CA 125.061 1.344 . . . . 0.0 107.888 -177.427 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -94.27 -113.18 2.45 Favored Glycine 0 C--N 1.356 1.694 0 N-CA-C 109.489 -1.444 . . . . 0.0 109.489 -174.534 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 85.6 mtm180 -92.66 175.95 6.63 Favored 'General case' 0 CA--C 1.503 -0.863 0 N-CA-C 108.191 -1.04 . . . . 0.0 108.191 -178.538 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -155.41 -178.41 7.25 Favored 'General case' 0 CA--C 1.495 -1.171 0 CA-C-O 121.221 0.534 . . . . 0.0 109.839 178.565 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 96.0 mttt -109.21 156.55 19.76 Favored 'General case' 0 CA--C 1.489 -1.396 0 N-CA-C 106.451 -1.685 . . . . 0.0 106.451 -176.724 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 1.1 pp20? -152.08 163.12 39.99 Favored 'General case' 0 N--CA 1.432 -1.363 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 176.252 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -139.97 160.79 39.14 Favored 'General case' 0 CA--C 1.495 -1.136 0 N-CA-C 105.663 -1.977 . . . . 0.0 105.663 169.596 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 77.6 m -120.62 125.96 49.07 Favored 'General case' 0 CA--C 1.499 -1.014 0 N-CA-C 104.732 -2.322 . . . . 0.0 104.732 176.446 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 4.9 mp -114.04 134.41 22.17 Favored Pre-proline 0 N--CA 1.435 -1.186 0 N-CA-C 104.84 -2.281 . . . . 0.0 104.84 -175.545 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 67.5 Cg_exo -63.89 167.6 13.62 Favored 'Trans proline' 0 CA--C 1.509 -0.761 0 C-N-CA 123.595 2.863 . . . . 0.0 113.406 177.227 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -77.75 -19.02 76.43 Favored Glycine 0 C--N 1.352 1.439 0 C-N-CA 123.583 0.611 . . . . 0.0 113.425 -173.488 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 50.9 p-80 -84.08 -27.88 27.95 Favored 'General case' 0 C--N 1.357 0.906 0 CA-C-N 117.757 0.779 . . . . 0.0 110.172 -179.471 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 86.4 mt -88.56 128.97 35.58 Favored 'General case' 0 CA--C 1.5 -0.943 0 N-CA-C 107.881 -1.155 . . . . 0.0 107.881 177.653 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 8.7 p30 -110.98 8.33 21.96 Favored 'General case' 0 CA--C 1.5 -0.946 0 C-N-CA 124.498 1.119 . . . . 0.0 110.543 -171.806 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 46.6 p -142.03 160.16 40.77 Favored 'General case' 0 N--CA 1.439 -0.988 0 N-CA-C 108.107 -1.071 . . . . 0.0 108.107 -175.713 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 12.3 t80 -143.63 176.72 9.0 Favored 'General case' 0 C--N 1.355 0.822 0 N-CA-C 107.328 -1.36 . . . . 0.0 107.328 176.953 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 97.6 m -147.06 116.96 7.2 Favored 'General case' 0 N--CA 1.429 -1.509 0 N-CA-C 104.851 -2.277 . . . . 0.0 104.851 176.101 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 79.7 mt -91.24 147.06 5.5 Favored 'Isoleucine or valine' 0 C--N 1.355 0.804 0 N-CA-C 103.555 -2.757 . . . . 0.0 103.555 169.364 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 67.6 mttm -140.38 166.37 24.89 Favored 'General case' 0 CA--C 1.5 -0.954 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 178.149 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 83.16 49.39 5.01 Favored Glycine 0 C--N 1.354 1.577 0 N-CA-C 109.211 -1.556 . . . . 0.0 109.211 174.787 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 63.9 mt -118.78 169.4 9.88 Favored 'General case' 0 CA--C 1.498 -1.023 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 -170.576 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -116.76 144.74 33.95 Favored Pre-proline 0 N--CA 1.439 -1.008 0 N-CA-C 105.679 -1.971 . . . . 0.0 105.679 -173.764 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -77.33 161.75 31.59 Favored 'Trans proline' 0 N--CA 1.452 -0.934 0 C-N-CA 122.788 2.325 . . . . 0.0 110.996 174.466 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 66' ' ' GLY . . . . . 0.584 ' H ' ' HA ' ' A' ' 92' ' ' THR . . . 62.54 26.66 68.54 Favored Glycine 0 N--CA 1.428 -1.856 0 C-N-CA 127.617 2.532 . . . . 0.0 115.765 174.225 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 9.8 p -126.65 145.59 33.95 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.928 0 N-CA-C 107.596 -1.261 . . . . 0.0 107.596 179.408 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 4.2 p -92.61 135.75 26.7 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.824 0 N-CA-C 107.214 -1.402 . . . . 0.0 107.214 179.945 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 69' ' ' TYR . . . . . 0.433 ' HA ' ' HA ' ' A' ' 39' ' ' PRO . 91.1 m-85 -116.79 149.27 40.23 Favored 'General case' 0 CA--C 1.494 -1.193 0 N-CA-C 105.607 -1.997 . . . . 0.0 105.607 175.278 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -96.7 139.93 32.04 Favored 'General case' 0 CA--C 1.499 -1.009 0 N-CA-C 104.367 -2.457 . . . . 0.0 104.367 162.773 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -132.66 154.14 20.97 Favored Glycine 0 CA--C 1.483 -1.925 0 N-CA-C 106.951 -2.46 . . . . 0.0 106.951 179.849 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 29.2 tt0 -146.94 135.61 22.09 Favored 'General case' 0 CA--C 1.483 -1.627 0 N-CA-C 106.949 -1.5 . . . . 0.0 106.949 -178.625 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 21.8 tp -115.79 100.55 8.09 Favored 'General case' 0 N--CA 1.438 -1.074 0 N-CA-C 104.45 -2.426 . . . . 0.0 104.45 -177.355 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 21.2 mt -93.16 126.61 45.57 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.917 0 N-CA-C 104.032 -2.581 . . . . 0.0 104.032 177.572 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 74.2 m -117.98 111.32 18.8 Favored 'General case' 0 N--CA 1.436 -1.173 0 N-CA-C 107.746 -1.205 . . . . 0.0 107.746 -170.413 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 31.0 mm -91.22 144.01 10.05 Favored 'Isoleucine or valine' 0 CA--C 1.49 -1.365 0 N-CA-C 106.519 -1.66 . . . . 0.0 106.519 -165.799 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 17.1 tt0 -110.81 107.18 16.6 Favored 'General case' 0 CA--C 1.495 -1.135 0 N-CA-C 103.036 -2.95 . . . . 0.0 103.036 171.452 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 19.7 pt20 -67.25 138.46 56.91 Favored 'General case' 0 C--N 1.356 0.866 0 CA-C-O 121.232 0.539 . . . . 0.0 111.68 -167.148 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 55.0 m-85 68.05 32.15 5.14 Favored 'General case' 0 C--N 1.355 0.821 0 C-N-CA 126.695 1.998 . . . . 0.0 111.764 -176.1 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -174.97 -112.86 0.31 Allowed Glycine 0 C--N 1.355 1.613 0 C-N-CA 119.349 -1.405 . . . . 0.0 109.749 176.922 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 66.4 m80 -83.43 -178.73 7.15 Favored 'General case' 0 CA--C 1.5 -0.954 0 C-N-CA 125.242 1.417 . . . . 0.0 111.269 -164.595 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 5.9 pt20 -154.51 148.77 26.0 Favored 'General case' 0 N--CA 1.435 -1.216 0 N-CA-C 106.621 -1.622 . . . . 0.0 106.621 166.506 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 8.4 mp0 -109.81 155.93 21.0 Favored 'General case' 0 N--CA 1.437 -1.085 0 N-CA-C 104.869 -2.271 . . . . 0.0 104.869 -178.116 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 12.4 p -131.45 139.17 51.4 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.838 0 N-CA-C 107.772 -1.196 . . . . 0.0 107.772 -179.739 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 41.8 m -133.28 122.69 24.25 Favored 'General case' 0 N--CA 1.438 -1.074 0 N-CA-C 103.261 -2.866 . . . . 0.0 103.261 -178.669 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 52.8 ttt85 -119.75 144.15 47.42 Favored 'General case' 0 CA--C 1.504 -0.794 0 N-CA-C 108.174 -1.047 . . . . 0.0 108.174 -176.011 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 29.0 p90 -155.06 -179.59 8.21 Favored 'General case' 0 CA--C 1.499 -0.981 0 N-CA-C 107.547 -1.279 . . . . 0.0 107.547 -177.182 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -138.82 156.31 47.44 Favored 'General case' 0 N--CA 1.44 -0.961 0 N-CA-C 105.811 -1.922 . . . . 0.0 105.811 167.169 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 22.2 p90 -142.61 171.79 13.57 Favored 'General case' 0 CA--C 1.487 -1.477 0 N-CA-C 106.83 -1.544 . . . . 0.0 106.83 175.001 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 25.5 p -120.37 143.88 48.19 Favored 'General case' 0 CA--C 1.499 -0.993 0 N-CA-C 105.526 -2.027 . . . . 0.0 105.526 169.364 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 57.3 m -109.05 126.06 52.76 Favored 'General case' 0 CA--C 1.493 -1.244 0 N-CA-C 101.36 -3.57 . . . . 0.0 101.36 164.764 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 92' ' ' THR . . . . . 0.584 ' HA ' ' H ' ' A' ' 66' ' ' GLY . 12.4 t -146.01 172.46 13.35 Favored 'General case' 0 N--CA 1.435 -1.177 0 N-CA-C 105.264 -2.125 . . . . 0.0 105.264 -173.751 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 69.5 m . . . . . 0 C--O 1.26 1.629 0 N-CA-C 106.8 -1.556 . . . . 0.0 106.8 173.197 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.437 -1.285 0 N-CA-C 106.705 -2.558 . . . . 0.0 106.705 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 8.9 Cg_exo -55.42 148.57 51.36 Favored 'Trans proline' 0 N--CA 1.45 -1.078 0 C-N-CA 124.11 3.207 . . . . 0.0 116.463 -161.995 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 17.5 t -76.88 156.21 5.54 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.806 0 C-N-CA 128.29 2.636 . . . . 0.0 105.036 175.021 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 55.2 mt-10 -107.15 105.81 15.98 Favored 'General case' 0 CA--C 1.494 -1.18 0 N-CA-C 106.512 -1.662 . . . . 0.0 106.512 -176.478 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 1.7 p -127.49 141.83 45.26 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.981 0 N-CA-C 106.172 -1.788 . . . . 0.0 106.172 -169.808 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 21.2 p90 . . . . . 0 N--CA 1.436 -1.13 0 N-CA-C 106.95 -1.5 . . . . 0.0 106.95 -162.589 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo . . . . . 0 CA--C 1.504 -0.987 0 CA-C-O 118.17 -0.846 . . . . 0.0 111.267 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 4.1 t30 -117.73 -33.67 4.45 Favored 'General case' 0 CA--C 1.487 -1.459 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 -170.849 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 67.8 m -103.63 152.12 22.14 Favored 'General case' 0 CA--C 1.495 -1.163 0 N-CA-C 107.092 -1.448 . . . . 0.0 107.092 178.854 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 82.7 t60 -144.61 84.17 9.27 Favored Pre-proline 0 N--CA 1.437 -1.123 0 N-CA-C 106.559 -1.645 . . . . 0.0 106.559 174.651 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -81.75 123.19 4.13 Favored 'Trans proline' 0 N--CA 1.446 -1.294 0 C-N-CA 123.286 2.657 . . . . 0.0 109.765 179.882 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.577 HD11 HD11 ' A' ' 35' ' ' LEU . 3.4 pt -109.81 170.86 2.96 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.069 0 N-CA-C 108.466 -0.939 . . . . 0.0 108.466 -174.962 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 33.6 tt0 -145.92 148.03 32.38 Favored 'General case' 0 N--CA 1.437 -1.076 0 N-CA-C 105.459 -2.052 . . . . 0.0 105.459 172.247 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 19.6 p90 -130.75 158.04 41.18 Favored 'General case' 0 CA--C 1.499 -1.001 0 N-CA-C 106.27 -1.752 . . . . 0.0 106.27 179.491 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 89.6 m-20 -95.47 -179.46 4.77 Favored 'General case' 0 CA--C 1.488 -1.433 0 N-CA-C 103.647 -2.723 . . . . 0.0 103.647 168.89 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -160.08 165.37 17.9 Favored Pre-proline 0 N--CA 1.439 -0.982 0 N-CA-C 104.966 -2.235 . . . . 0.0 104.966 176.851 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -74.63 154.86 44.68 Favored 'Trans proline' 0 N--CA 1.453 -0.874 0 C-N-CA 122.546 2.164 . . . . 0.0 109.711 179.244 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 11.8 tp-100 -82.85 -43.41 0.9 Allowed Pre-proline 0 N--CA 1.443 -0.799 0 CA-C-O 115.924 -1.989 . . . . 0.0 111.219 -174.777 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 70.5 Cg_exo -67.89 167.94 20.09 Favored 'Trans proline' 0 CA--C 1.508 -0.778 0 CA-C-N 125.347 2.945 . . . . 0.0 111.976 174.213 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 34.8 p -72.94 123.18 22.94 Favored 'General case' 0 C--N 1.355 0.836 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 178.949 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 20.0 t-160 -159.58 -51.54 0.06 Allowed 'General case' 0 CA--C 1.493 -1.248 0 N-CA-C 106.729 -1.582 . . . . 0.0 106.729 -169.83 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 48.9 mt -121.6 137.88 53.78 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.119 0 N-CA-C 106.425 -1.695 . . . . 0.0 106.425 -168.842 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 73.5 m -107.33 -82.26 0.55 Allowed 'General case' 0 N--CA 1.432 -1.345 0 C-N-CA 125.025 1.33 . . . . 0.0 108.131 179.953 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 35.0 ttpt -92.25 161.74 14.58 Favored 'General case' 0 CA--C 1.494 -1.196 0 C-N-CA 125.47 1.508 . . . . 0.0 107.731 -165.477 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 90.2 m-85 -128.92 137.01 51.17 Favored 'General case' 0 CA--C 1.497 -1.089 0 N-CA-C 104.686 -2.338 . . . . 0.0 104.686 173.367 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 62.0 mt -116.73 128.81 74.01 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.213 0 N-CA-C 101.611 -3.477 . . . . 0.0 101.611 171.725 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.577 HD11 HD11 ' A' ' 20' ' ' ILE . 3.1 mt -109.02 133.35 53.1 Favored 'General case' 0 CA--C 1.475 -1.908 0 N-CA-C 105.766 -1.939 . . . . 0.0 105.766 171.784 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 16.3 ptp180 -135.96 152.6 51.14 Favored 'General case' 0 N--CA 1.434 -1.259 0 N-CA-C 107.31 -1.367 . . . . 0.0 107.31 173.928 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 48.6 p90 -156.73 153.57 28.62 Favored 'General case' 0 N--CA 1.438 -1.039 0 N-CA-C 107.766 -1.198 . . . . 0.0 107.766 -172.736 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 10.6 ptp180 -149.02 155.78 40.38 Favored Pre-proline 0 CA--C 1.499 -0.988 0 N-CA-C 105.696 -1.964 . . . . 0.0 105.696 168.393 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -72.17 121.25 7.37 Favored 'Trans proline' 0 N--CA 1.452 -0.958 0 C-N-CA 122.876 2.384 . . . . 0.0 108.327 169.797 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 57.5 tttp -70.3 80.01 0.53 Allowed 'General case' 0 C--N 1.357 0.924 0 C-N-CA 126.918 2.087 . . . . 0.0 110.446 -178.182 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 29.9 m120 -155.4 -70.41 0.12 Allowed 'General case' 0 N--CA 1.435 -1.215 0 N-CA-C 102.046 -3.316 . . . . 0.0 102.046 -173.209 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 37.2 p -96.22 157.89 15.69 Favored 'General case' 0 N--CA 1.439 -0.993 0 N-CA-C 107.555 -1.276 . . . . 0.0 107.555 175.139 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 3.3 m -130.62 53.68 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.918 0 N-CA-C 105.789 -1.93 . . . . 0.0 105.789 178.24 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -94.61 -107.73 2.08 Favored Glycine 0 C--N 1.355 1.625 0 N-CA-C 108.017 -2.033 . . . . 0.0 108.017 -179.092 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 8.3 ptm180 -88.8 175.29 7.54 Favored 'General case' 0 CA--C 1.502 -0.874 0 N-CA-C 107.625 -1.25 . . . . 0.0 107.625 174.822 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -157.24 171.3 20.66 Favored 'General case' 0 CA--C 1.492 -1.262 0 CA-C-O 121.393 0.616 . . . . 0.0 110.191 175.199 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 64.9 mttp -109.45 152.29 25.59 Favored 'General case' 0 CA--C 1.486 -1.503 0 N-CA-C 107.469 -1.308 . . . . 0.0 107.469 -172.551 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -152.99 155.42 36.9 Favored 'General case' 0 N--CA 1.434 -1.252 0 N-CA-C 107.74 -1.208 . . . . 0.0 107.74 177.727 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -137.3 156.96 47.64 Favored 'General case' 0 N--CA 1.437 -1.107 0 N-CA-C 105.816 -1.92 . . . . 0.0 105.816 173.539 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 87.3 m -121.12 125.32 46.92 Favored 'General case' 0 CA--C 1.501 -0.93 0 N-CA-C 104.784 -2.302 . . . . 0.0 104.784 -179.585 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 58.5 mt -124.02 132.32 24.29 Favored Pre-proline 0 N--CA 1.439 -1.024 0 N-CA-C 105.039 -2.208 . . . . 0.0 105.039 -164.672 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo -77.95 172.51 15.47 Favored 'Trans proline' 0 N--CA 1.455 -0.794 0 C-N-CA 122.717 2.278 . . . . 0.0 110.558 -179.516 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -96.75 69.56 0.84 Allowed Glycine 0 C--N 1.353 1.486 0 N-CA-C 109.34 -1.504 . . . . 0.0 109.34 178.602 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 54' ' ' HIS . . . . . 0.646 ' HB2' HD13 ' A' ' 55' ' ' LEU . 27.3 m170 -120.55 -66.43 1.06 Allowed 'General case' 0 CA--C 1.499 -0.986 0 N-CA-C 103.265 -2.865 . . . . 0.0 103.265 174.357 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.647 HD22 ' H ' ' A' ' 55' ' ' LEU . 0.0 OUTLIER -89.69 164.08 14.85 Favored 'General case' 0 N--CA 1.43 -1.471 0 C-N-CA 129.17 2.988 . . . . 0.0 106.856 177.765 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 7.1 p30 -140.11 30.34 2.0 Favored 'General case' 0 N--CA 1.431 -1.399 0 N-CA-C 107.125 -1.435 . . . . 0.0 107.125 -177.567 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 36.5 p -139.8 149.12 43.13 Favored 'General case' 0 CA--C 1.501 -0.937 0 N-CA-C 106.809 -1.552 . . . . 0.0 106.809 177.321 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 10.3 t80 -128.37 175.99 8.06 Favored 'General case' 0 C--N 1.358 0.973 0 N-CA-C 107.92 -1.141 . . . . 0.0 107.92 179.764 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 97.7 m -138.5 109.25 6.65 Favored 'General case' 0 N--CA 1.432 -1.344 0 N-CA-C 104.081 -2.562 . . . . 0.0 104.081 173.113 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 27.4 mt -87.9 147.54 5.19 Favored 'Isoleucine or valine' 0 C--N 1.358 0.969 0 N-CA-C 103.427 -2.805 . . . . 0.0 103.427 169.696 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 8.7 ptpp? -150.1 162.83 39.66 Favored 'General case' 0 CA--C 1.497 -1.067 0 N-CA-C 108.169 -1.048 . . . . 0.0 108.169 179.366 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 83.63 51.03 4.21 Favored Glycine 0 C--N 1.354 1.575 0 N-CA-C 109.367 -1.493 . . . . 0.0 109.367 177.768 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 62.7 mt -120.34 177.44 5.03 Favored 'General case' 0 CA--C 1.5 -0.954 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 -171.59 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -122.79 152.88 63.1 Favored Pre-proline 0 N--CA 1.44 -0.952 0 N-CA-C 106.46 -1.681 . . . . 0.0 106.46 -175.765 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -79.72 163.74 23.59 Favored 'Trans proline' 0 N--CA 1.451 -0.992 0 C-N-CA 122.976 2.451 . . . . 0.0 110.62 175.312 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 66' ' ' GLY . . . . . 0.578 ' H ' ' HA ' ' A' ' 92' ' ' THR . . . 58.64 26.16 59.57 Favored Glycine 0 C--N 1.356 1.657 0 C-N-CA 128.207 2.813 . . . . 0.0 116.28 171.966 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 8.6 p -126.41 147.5 31.24 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.977 0 N-CA-C 107.625 -1.25 . . . . 0.0 107.625 -176.988 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 5.1 p -96.02 138.14 22.2 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.945 0 N-CA-C 107.323 -1.362 . . . . 0.0 107.323 -178.114 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 88.6 m-85 -119.13 151.63 37.95 Favored 'General case' 0 N--CA 1.436 -1.157 0 N-CA-C 105.638 -1.986 . . . . 0.0 105.638 175.335 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -101.53 141.72 33.98 Favored 'General case' 0 CA--C 1.497 -1.095 0 N-CA-C 104.743 -2.317 . . . . 0.0 104.743 162.114 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -135.88 150.01 20.23 Favored Glycine 0 CA--C 1.488 -1.608 0 N-CA-C 107.701 -2.16 . . . . 0.0 107.701 -179.576 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 31.1 mt-30 -141.6 133.43 27.31 Favored 'General case' 0 CA--C 1.485 -1.545 0 N-CA-C 106.019 -1.845 . . . . 0.0 106.019 -177.628 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 23.2 tp -115.33 99.77 7.63 Favored 'General case' 0 N--CA 1.439 -1.01 0 N-CA-C 104.249 -2.5 . . . . 0.0 104.249 -178.339 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 11.7 mt -92.43 127.33 44.68 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.812 0 N-CA-C 104.502 -2.407 . . . . 0.0 104.502 179.767 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 10.3 p -114.98 111.66 21.49 Favored 'General case' 0 N--CA 1.436 -1.141 0 N-CA-C 107.593 -1.262 . . . . 0.0 107.593 -173.904 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 10.4 mm -94.79 150.81 3.96 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.298 0 N-CA-C 106.116 -1.809 . . . . 0.0 106.116 -167.195 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 6.4 pt20 -117.69 137.27 52.78 Favored 'General case' 0 CA--C 1.495 -1.155 0 N-CA-C 105.467 -2.049 . . . . 0.0 105.467 169.654 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 63.4 tp60 -69.02 117.89 11.23 Favored 'General case' 0 N--CA 1.441 -0.918 0 C-N-CA 124.107 0.963 . . . . 0.0 111.566 -167.019 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 36.1 m-85 59.09 49.95 8.73 Favored 'General case' 0 C--N 1.357 0.902 0 C-N-CA 126.971 2.108 . . . . 0.0 112.013 -177.918 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -158.72 -122.53 0.68 Allowed Glycine 0 N--CA 1.432 -1.623 0 N-CA-C 108.193 -1.963 . . . . 0.0 108.193 177.499 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 79.8 m-70 -86.58 177.87 7.25 Favored 'General case' 0 CA--C 1.498 -1.035 0 C-N-CA 125.34 1.456 . . . . 0.0 111.07 -169.479 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 26.6 mp0 -133.31 140.21 47.31 Favored 'General case' 0 N--CA 1.436 -1.173 0 N-CA-C 103.608 -2.738 . . . . 0.0 103.608 168.898 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 30.6 tt0 -119.25 137.73 53.47 Favored 'General case' 0 CA--C 1.496 -1.102 0 N-CA-C 103.948 -2.612 . . . . 0.0 103.948 177.915 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 6.3 p -117.1 136.01 55.63 Favored 'Isoleucine or valine' 0 C--N 1.354 0.775 0 N-CA-C 107.914 -1.143 . . . . 0.0 107.914 -177.065 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 63.6 m -116.73 140.15 49.75 Favored 'General case' 0 N--CA 1.441 -0.921 0 N-CA-C 103.067 -2.938 . . . . 0.0 103.067 173.464 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 79.2 mtt85 -128.09 152.05 48.46 Favored 'General case' 0 CA--C 1.5 -0.953 0 N-CA-C 109.195 -0.669 . . . . 0.0 109.195 177.331 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 30.7 p90 -163.81 175.79 10.13 Favored 'General case' 0 C--N 1.355 0.82 0 N-CA-C 107.796 -1.187 . . . . 0.0 107.796 -178.445 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 51.5 m-20 -133.53 154.11 51.1 Favored 'General case' 0 CA--C 1.502 -0.875 0 N-CA-C 105.715 -1.957 . . . . 0.0 105.715 169.553 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 22.1 p90 -142.94 169.36 17.72 Favored 'General case' 0 CA--C 1.487 -1.454 0 N-CA-C 107.765 -1.198 . . . . 0.0 107.765 171.095 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 27.5 p -121.89 143.26 49.54 Favored 'General case' 0 CA--C 1.501 -0.934 0 N-CA-C 105.733 -1.951 . . . . 0.0 105.733 170.754 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 45.1 m -114.02 125.63 54.21 Favored 'General case' 0 CA--C 1.497 -1.059 0 N-CA-C 102.499 -3.148 . . . . 0.0 102.499 170.953 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 92' ' ' THR . . . . . 0.578 ' HA ' ' H ' ' A' ' 66' ' ' GLY . 13.2 t -143.86 161.61 38.23 Favored 'General case' 0 N--CA 1.441 -0.907 0 N-CA-C 107.365 -1.346 . . . . 0.0 107.365 -171.523 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 50.8 p . . . . . 0 C--O 1.261 1.686 0 C-N-CA 124.837 1.255 . . . . 0.0 109.361 -179.103 . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.436 -1.355 0 N-CA-C 105.702 -2.959 . . . . 0.0 105.702 . . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_exo -60.34 132.22 42.61 Favored 'Trans proline' 0 N--CA 1.447 -1.264 0 C-N-CA 123.601 2.867 . . . . 0.0 111.125 -178.05 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 20.2 t -77.95 153.98 5.23 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.925 0 C-N-CA 127.095 2.158 . . . . 0.0 106.273 -172.792 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -96.12 85.67 4.07 Favored 'General case' 0 CA--C 1.49 -1.328 0 N-CA-C 107.377 -1.342 . . . . 0.0 107.377 -176.887 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.44 ' HA ' ' HA ' ' A' ' 22' ' ' TRP . 1.8 p -100.06 120.73 49.88 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.169 0 N-CA-C 106.484 -1.673 . . . . 0.0 106.484 -170.578 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 48.4 m-85 . . . . . 0 CA--C 1.495 -1.161 0 N-CA-C 106.923 -1.51 . . . . 0.0 106.923 -168.318 . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 64.6 Cg_endo . . . . . 0 CA--C 1.506 -0.919 0 CA-C-O 118.656 -0.643 . . . . 0.0 111.792 . . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 1.9 m-80 -124.53 -20.22 5.19 Favored 'General case' 0 CA--C 1.491 -1.292 0 C-N-CA 124.128 0.971 . . . . 0.0 109.284 -169.016 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 5.7 p -108.52 134.91 50.64 Favored 'General case' 0 CA--C 1.495 -1.172 0 N-CA-C 107.714 -1.217 . . . . 0.0 107.714 -176.563 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 58.7 t-80 -122.8 98.2 43.15 Favored Pre-proline 0 N--CA 1.441 -0.906 0 N-CA-C 106.978 -1.49 . . . . 0.0 106.978 178.027 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 63.4 Cg_endo -80.05 127.15 6.72 Favored 'Trans proline' 0 N--CA 1.449 -1.107 0 C-N-CA 123.073 2.515 . . . . 0.0 109.873 177.635 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 2.1 pt -110.74 166.26 5.56 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.031 0 N-CA-C 107.153 -1.425 . . . . 0.0 107.153 174.365 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 32.3 mt-30 -138.51 160.09 40.45 Favored 'General case' 0 CA--C 1.497 -1.084 0 N-CA-C 105.286 -2.116 . . . . 0.0 105.286 167.68 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 22' ' ' TRP . . . . . 0.44 ' HA ' ' HA ' ' A' ' 6' ' ' VAL . 48.8 p90 -145.1 169.57 17.89 Favored 'General case' 0 CA--C 1.498 -1.054 0 N-CA-C 107.488 -1.301 . . . . 0.0 107.488 173.209 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 44.8 t30 -146.69 136.49 23.21 Favored 'General case' 0 CA--C 1.484 -1.575 0 N-CA-C 106.548 -1.649 . . . . 0.0 106.548 174.449 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -82.78 167.64 28.37 Favored Pre-proline 0 N--CA 1.439 -0.991 0 CA-C-N 112.793 -2.003 . . . . 0.0 111.681 -160.944 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 76.7 Cg_exo -66.16 176.29 4.04 Favored 'Trans proline' 0 N--CA 1.456 -0.68 0 C-N-CA 123.826 3.017 . . . . 0.0 111.752 165.107 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 1.3 tm0? -79.18 -46.04 1.68 Allowed Pre-proline 0 N--CA 1.443 -0.805 0 CA-C-O 115.544 -2.17 . . . . 0.0 110.496 -175.728 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 75.6 Cg_exo -66.53 148.0 83.02 Favored 'Trans proline' 0 CA--C 1.51 -0.721 0 CA-C-N 125.792 3.104 . . . . 0.0 111.969 177.147 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 69.6 m -100.85 63.19 1.03 Allowed 'General case' 0 CA--C 1.502 -0.889 0 N-CA-C 106.778 -1.564 . . . . 0.0 106.778 178.554 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 79.8 t60 -110.36 -1.59 17.09 Favored 'General case' 0 N--CA 1.44 -0.962 0 C-N-CA 125.322 1.449 . . . . 0.0 107.844 179.57 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 3.7 mp -100.16 126.28 53.71 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.115 0 N-CA-C 103.807 -2.664 . . . . 0.0 103.807 -177.639 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 60.5 m -95.43 -84.25 0.34 Allowed 'General case' 0 N--CA 1.431 -1.417 0 N-CA-C 106.153 -1.795 . . . . 0.0 106.153 177.232 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 53.7 mtmt -91.05 169.19 11.08 Favored 'General case' 0 CA--C 1.49 -1.358 0 C-N-CA 123.419 0.687 . . . . 0.0 109.24 -167.871 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 97.4 m-85 -126.87 133.82 50.62 Favored 'General case' 0 N--CA 1.435 -1.222 0 N-CA-C 103.048 -2.945 . . . . 0.0 103.048 164.108 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 51.1 mt -118.31 126.95 75.42 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.179 0 N-CA-C 102.398 -3.186 . . . . 0.0 102.398 173.804 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 7.0 mt -105.99 137.85 43.19 Favored 'General case' 0 CA--C 1.473 -2.003 0 N-CA-C 105.326 -2.101 . . . . 0.0 105.326 173.716 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -132.96 155.64 48.76 Favored 'General case' 0 N--CA 1.431 -1.422 0 N-CA-C 106.808 -1.553 . . . . 0.0 106.808 166.881 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 48.4 p90 -152.19 142.36 22.33 Favored 'General case' 0 N--CA 1.436 -1.132 0 N-CA-C 105.999 -1.852 . . . . 0.0 105.999 -177.352 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 45.4 ttm-85 -132.69 141.88 42.74 Favored Pre-proline 0 CA--C 1.5 -0.974 0 N-CA-C 103.991 -2.596 . . . . 0.0 103.991 179.578 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_endo -71.65 122.78 8.87 Favored 'Trans proline' 0 N--CA 1.452 -0.947 0 CA-C-N 123.683 2.351 . . . . 0.0 108.523 171.917 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 19.6 ttmm -71.58 63.92 0.43 Allowed 'General case' 0 C--N 1.358 0.963 0 C-N-CA 127.319 2.248 . . . . 0.0 111.767 -179.071 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 7.7 p30 -161.43 15.48 0.1 Allowed 'General case' 0 N--CA 1.438 -1.045 0 C-N-CA 125.292 1.437 . . . . 0.0 107.881 177.069 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 43.0 p -160.46 165.72 30.49 Favored 'General case' 0 N--CA 1.437 -1.102 0 N-CA-C 106.458 -1.682 . . . . 0.0 106.458 -175.897 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 4.9 m -137.73 40.73 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.845 0 N-CA-C 105.808 -1.923 . . . . 0.0 105.808 176.026 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -91.4 -114.92 1.92 Allowed Glycine 0 C--N 1.356 1.661 0 N-CA-C 109.071 -1.612 . . . . 0.0 109.071 -175.494 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 11.9 ptm180 -97.99 178.96 4.94 Favored 'General case' 0 CA--C 1.503 -0.861 0 N-CA-C 107.198 -1.408 . . . . 0.0 107.198 174.234 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -153.83 171.7 18.52 Favored 'General case' 0 N--CA 1.435 -1.206 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 176.363 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 96.7 mttt -110.34 157.13 19.84 Favored 'General case' 0 CA--C 1.489 -1.401 0 N-CA-C 107.291 -1.374 . . . . 0.0 107.291 -172.06 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 1.2 pp20? -150.64 160.62 43.7 Favored 'General case' 0 N--CA 1.437 -1.098 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 173.929 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -138.1 159.86 40.92 Favored 'General case' 0 N--CA 1.439 -0.98 0 N-CA-C 106.191 -1.781 . . . . 0.0 106.191 171.086 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 85.7 m -117.61 123.39 46.07 Favored 'General case' 0 CA--C 1.501 -0.933 0 N-CA-C 104.642 -2.355 . . . . 0.0 104.642 176.218 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 5.4 mp -112.8 133.59 21.9 Favored Pre-proline 0 N--CA 1.438 -1.063 0 N-CA-C 104.837 -2.283 . . . . 0.0 104.837 -174.076 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 64.3 Cg_exo -65.3 166.27 19.75 Favored 'Trans proline' 0 CA--C 1.509 -0.749 0 C-N-CA 123.185 2.59 . . . . 0.0 113.512 176.86 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -75.76 -19.18 79.23 Favored Glycine 0 C--N 1.353 1.491 0 C-N-CA 123.876 0.75 . . . . 0.0 114.245 -175.195 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 53.2 p-80 -83.05 -26.27 31.3 Favored 'General case' 0 C--N 1.356 0.851 0 CA-C-N 118.012 0.906 . . . . 0.0 109.835 -178.846 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 85.1 mt -88.58 128.92 35.58 Favored 'General case' 0 CA--C 1.5 -0.978 0 N-CA-C 107.441 -1.318 . . . . 0.0 107.441 175.605 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 8.0 p30 -117.46 10.61 13.62 Favored 'General case' 0 CA--C 1.502 -0.88 0 C-N-CA 124.083 0.953 . . . . 0.0 109.713 -173.313 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 29.1 p -142.17 161.35 38.24 Favored 'General case' 0 CA--C 1.498 -1.029 0 N-CA-C 106.537 -1.653 . . . . 0.0 106.537 179.291 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 11.1 t80 -140.56 162.2 35.93 Favored 'General case' 0 CA--C 1.499 -0.996 0 CA-C-O 121.849 0.833 . . . . 0.0 108.99 177.805 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 37.8 m -126.1 111.97 15.29 Favored 'General case' 0 N--CA 1.434 -1.243 0 N-CA-C 105.499 -2.037 . . . . 0.0 105.499 169.842 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 37.9 mt -84.75 140.71 15.64 Favored 'Isoleucine or valine' 0 C--N 1.357 0.897 0 N-CA-C 103.67 -2.715 . . . . 0.0 103.67 172.791 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 94.3 mttt -141.4 162.13 36.24 Favored 'General case' 0 CA--C 1.491 -1.3 0 CA-C-O 121.859 0.838 . . . . 0.0 108.881 -177.451 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 75.27 55.09 5.31 Favored Glycine 0 CA--C 1.489 -1.574 0 N-CA-C 108.937 -1.665 . . . . 0.0 108.937 176.63 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 62.3 mt -115.49 -174.22 2.48 Favored 'General case' 0 CA--C 1.5 -0.96 0 N-CA-C 107.547 -1.279 . . . . 0.0 107.547 -176.124 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 94.0 mttt -109.38 160.88 26.05 Favored Pre-proline 0 N--CA 1.441 -0.886 0 N-CA-C 106.091 -1.818 . . . . 0.0 106.091 -177.366 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -81.38 158.0 19.65 Favored 'Trans proline' 0 N--CA 1.45 -1.062 0 C-N-CA 122.764 2.309 . . . . 0.0 109.538 165.472 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 59.18 28.24 63.85 Favored Glycine 0 C--N 1.358 1.752 0 C-N-CA 126.947 2.213 . . . . 0.0 116.273 171.794 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 7.1 p -115.48 142.82 27.04 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.963 0 N-CA-C 107.803 -1.184 . . . . 0.0 107.803 -173.286 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 3.5 p -100.86 131.52 48.32 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.894 0 N-CA-C 106.423 -1.695 . . . . 0.0 106.423 173.594 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 90.0 m-85 -114.31 150.68 34.11 Favored 'General case' 0 N--CA 1.44 -0.946 0 N-CA-C 106.537 -1.653 . . . . 0.0 106.537 174.414 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -94.29 145.37 24.78 Favored 'General case' 0 CA--C 1.5 -0.961 0 N-CA-C 104.369 -2.456 . . . . 0.0 104.369 159.728 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -137.32 155.23 22.8 Favored Glycine 0 CA--C 1.485 -1.844 0 N-CA-C 108.192 -1.963 . . . . 0.0 108.192 -177.518 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 40.0 tt0 -151.34 135.13 16.43 Favored 'General case' 0 CA--C 1.485 -1.532 0 N-CA-C 106.478 -1.675 . . . . 0.0 106.478 -176.791 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 25.2 tp -123.87 97.86 5.55 Favored 'General case' 0 N--CA 1.434 -1.245 0 N-CA-C 104.556 -2.387 . . . . 0.0 104.556 -172.927 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 10.5 mt -91.83 138.63 19.39 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.853 0 N-CA-C 105.252 -2.129 . . . . 0.0 105.252 177.666 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 75.0 m -112.59 112.07 23.34 Favored 'General case' 0 N--CA 1.434 -1.233 0 N-CA-C 106.313 -1.736 . . . . 0.0 106.313 178.935 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 1.7 mp -89.49 134.17 29.47 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.217 0 N-CA-C 103.645 -2.724 . . . . 0.0 103.645 -173.058 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 79.0 mt-30 -99.37 160.13 14.5 Favored 'General case' 0 CA--C 1.494 -1.197 0 N-CA-C 106.704 -1.591 . . . . 0.0 106.704 -174.087 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 5.6 pt20 -69.09 110.27 4.43 Favored 'General case' 0 N--CA 1.441 -0.904 0 CA-C-O 121.982 0.896 . . . . 0.0 112.761 -170.947 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 75.6 m-85 53.95 40.86 32.04 Favored 'General case' 0 C--N 1.358 0.949 0 C-N-CA 127.834 2.454 . . . . 0.0 112.925 175.094 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -163.17 -114.94 0.32 Allowed Glycine 0 C--N 1.353 1.502 0 C-N-CA 119.324 -1.417 . . . . 0.0 109.808 -179.304 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 38.5 m170 -81.61 -175.85 5.75 Favored 'General case' 0 CA--C 1.498 -1.052 0 C-N-CA 125.05 1.34 . . . . 0.0 110.745 -167.324 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 4.8 pt20 -147.85 142.06 26.15 Favored 'General case' 0 N--CA 1.434 -1.238 0 N-CA-C 106.192 -1.781 . . . . 0.0 106.192 171.826 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 16.7 tp10 -110.7 139.46 45.97 Favored 'General case' 0 CA--C 1.496 -1.099 0 N-CA-C 105.823 -1.917 . . . . 0.0 105.823 -177.762 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 8.2 p -110.64 141.61 25.47 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.745 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 -174.48 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 36.2 m -130.15 129.24 43.22 Favored 'General case' 0 C--N 1.355 0.831 0 N-CA-C 102.832 -3.025 . . . . 0.0 102.832 175.67 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 18.7 ptp180 -134.71 154.48 51.54 Favored 'General case' 0 C--N 1.355 0.819 0 CA-C-N 119.912 1.233 . . . . 0.0 111.25 -176.256 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 18.7 p90 -165.26 -175.22 3.53 Favored 'General case' 0 C--N 1.359 1.0 0 N-CA-C 107.064 -1.458 . . . . 0.0 107.064 -169.517 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -140.15 159.46 42.14 Favored 'General case' 0 N--CA 1.443 -0.795 0 N-CA-C 107.029 -1.471 . . . . 0.0 107.029 166.735 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 20.7 p90 -144.83 169.23 18.43 Favored 'General case' 0 CA--C 1.492 -1.276 0 N-CA-C 107.723 -1.214 . . . . 0.0 107.723 174.103 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 88.7 m -126.49 135.74 51.73 Favored 'General case' 0 CA--C 1.5 -0.971 0 N-CA-C 104.004 -2.591 . . . . 0.0 104.004 176.194 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 76.9 m -107.56 107.53 18.41 Favored 'General case' 0 CA--C 1.497 -1.064 0 N-CA-C 105.126 -2.176 . . . . 0.0 105.126 178.699 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 5.7 m 75.91 145.01 0.08 Allowed 'General case' 0 C--N 1.359 1.006 0 C-N-CA 127.213 2.205 . . . . 0.0 110.387 173.515 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 24.3 m . . . . . 0 C--O 1.259 1.604 0 C-N-CA 125.597 1.559 . . . . 0.0 109.785 -178.825 . . . . . . . . 0 0 . 1 . 022 nuclear build core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.438 -1.227 0 N-CA-C 106.902 -2.479 . . . . 0.0 106.902 . . . . . . . . . 0 0 . 1 . 022 nuclear build core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 74.8 Cg_exo -60.93 135.82 61.84 Favored 'Trans proline' 0 N--CA 1.445 -1.33 0 C-N-CA 123.401 2.734 . . . . 0.0 112.865 -176.638 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 32.1 t -79.12 157.46 4.75 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.06 0 C-N-CA 128.078 2.551 . . . . 0.0 107.348 -175.891 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 -105.48 102.26 11.74 Favored 'General case' 0 CA--C 1.491 -1.295 0 N-CA-C 105.197 -2.149 . . . . 0.0 105.197 176.78 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 1.7 p -117.46 134.66 60.33 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.114 0 N-CA-C 106.509 -1.663 . . . . 0.0 106.509 -166.762 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 1.5 t80 . . . . . 0 N--CA 1.434 -1.234 0 N-CA-C 106.975 -1.491 . . . . 0.0 106.975 -169.022 . . . . . . . . 0 0 . 1 . 022 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo . . . . . 0 N--CA 1.45 -1.074 0 N-CA-C 109.224 -1.106 . . . . 0.0 109.224 . . . . . . . . . 0 0 . 1 . 022 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 58.1 m-20 -133.37 -6.14 2.96 Favored 'General case' 0 N--CA 1.434 -1.259 0 C-N-CA 127.256 2.223 . . . . 0.0 108.63 -171.965 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 70.9 m -92.57 154.64 18.29 Favored 'General case' 0 CA--C 1.496 -1.128 0 N-CA-C 105.793 -1.928 . . . . 0.0 105.793 174.777 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 10.8 t60 -147.3 90.72 5.23 Favored Pre-proline 0 N--CA 1.437 -1.099 0 N-CA-C 107.436 -1.32 . . . . 0.0 107.436 172.769 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -80.42 139.47 12.96 Favored 'Trans proline' 0 N--CA 1.446 -1.295 0 C-N-CA 122.705 2.27 . . . . 0.0 110.135 177.594 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.447 HD11 HD11 ' A' ' 35' ' ' LEU . 4.4 pt -122.49 175.24 5.83 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.055 0 N-CA-C 108.147 -1.057 . . . . 0.0 108.147 177.871 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 21' ' ' GLN . . . . . 0.425 ' HA ' ' HA ' ' A' ' 57' ' ' SER . 2.7 pt20 -151.31 155.23 38.31 Favored 'General case' 0 CA--C 1.498 -1.045 0 N-CA-C 105.733 -1.951 . . . . 0.0 105.733 176.27 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 33.5 p90 -142.31 162.52 35.26 Favored 'General case' 0 CA--C 1.501 -0.915 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 -175.872 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 61.8 t30 -98.94 -172.51 2.3 Favored 'General case' 0 CA--C 1.493 -1.222 0 N-CA-C 103.658 -2.719 . . . . 0.0 103.658 169.486 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -158.0 168.46 12.41 Favored Pre-proline 0 N--CA 1.44 -0.974 0 N-CA-C 106.471 -1.677 . . . . 0.0 106.471 168.694 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_exo -63.39 154.33 68.97 Favored 'Trans proline' 0 N--CA 1.454 -0.816 0 C-N-CA 123.244 2.63 . . . . 0.0 112.506 173.487 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 90.4 mm-40 -81.77 -35.51 0.75 Allowed Pre-proline 0 N--CA 1.443 -0.799 0 CA-C-O 115.148 -2.358 . . . . 0.0 114.208 -168.096 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_exo -70.83 -4.2 14.26 Favored 'Trans proline' 0 CA--C 1.512 -0.619 0 CA-C-N 126.1 3.214 . . . . 0.0 114.615 -177.809 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 8.7 t 68.38 59.55 0.41 Allowed 'General case' 0 C--N 1.359 0.986 0 C-N-CA 126.121 1.768 . . . . 0.0 108.886 -177.345 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 12.7 t-160 -94.41 -11.28 30.17 Favored 'General case' 0 N--CA 1.439 -0.991 0 C-N-CA 125.133 1.373 . . . . 0.0 108.034 -179.332 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 1.8 mp -111.56 137.36 44.46 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.949 0 N-CA-C 104.473 -2.417 . . . . 0.0 104.473 -175.099 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 62.2 m -100.06 -84.4 0.42 Allowed 'General case' 0 N--CA 1.432 -1.331 0 N-CA-C 106.823 -1.547 . . . . 0.0 106.823 171.093 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 55.4 mtmt -88.64 168.71 12.3 Favored 'General case' 0 CA--C 1.487 -1.457 0 C-N-CA 124.335 1.054 . . . . 0.0 109.447 -164.531 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 85.0 m-85 -130.26 135.0 47.65 Favored 'General case' 0 CA--C 1.495 -1.14 0 N-CA-C 103.978 -2.601 . . . . 0.0 103.978 170.252 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 42.0 mt -119.35 128.69 75.84 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.162 0 N-CA-C 101.913 -3.365 . . . . 0.0 101.913 174.515 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.447 HD11 HD11 ' A' ' 20' ' ' ILE . 4.2 mt -110.02 143.75 39.57 Favored 'General case' 0 CA--C 1.471 -2.084 0 N-CA-C 106.906 -1.516 . . . . 0.0 106.906 175.275 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 2.6 mpt_? -125.86 157.19 38.24 Favored 'General case' 0 N--CA 1.425 -1.705 0 N-CA-C 106.456 -1.683 . . . . 0.0 106.456 168.592 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 45.1 p90 -149.12 139.03 21.99 Favored 'General case' 0 N--CA 1.433 -1.321 0 N-CA-C 106.291 -1.744 . . . . 0.0 106.291 169.224 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 19.1 ttm180 -133.26 136.57 27.51 Favored Pre-proline 0 CA--C 1.495 -1.156 0 N-CA-C 104.206 -2.516 . . . . 0.0 104.206 179.103 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -71.0 114.72 3.99 Favored 'Trans proline' 0 N--CA 1.454 -0.846 0 CA-C-N 124.581 2.672 . . . . 0.0 108.495 175.02 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 54.4 tttp -70.89 72.26 0.55 Allowed 'General case' 0 C--N 1.359 0.992 0 C-N-CA 127.609 2.364 . . . . 0.0 111.467 -174.724 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 70.4 m-80 -154.05 -60.95 0.13 Allowed 'General case' 0 N--CA 1.434 -1.245 0 N-CA-C 101.532 -3.507 . . . . 0.0 101.532 -172.176 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 42.5 p -93.4 160.19 14.92 Favored 'General case' 0 N--CA 1.439 -0.99 0 C-N-CA 124.854 1.262 . . . . 0.0 107.65 173.175 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 5.9 m -126.33 44.87 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.842 0 N-CA-C 106.183 -1.784 . . . . 0.0 106.183 177.975 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -99.4 -128.54 6.27 Favored Glycine 0 C--N 1.355 1.593 0 N-CA-C 108.704 -1.759 . . . . 0.0 108.704 -177.547 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 83.9 mtt85 -84.51 168.18 15.67 Favored 'General case' 0 CA--C 1.502 -0.885 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 -179.072 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -151.83 173.26 14.99 Favored 'General case' 0 CA--C 1.494 -1.205 0 CA-C-O 121.506 0.669 . . . . 0.0 110.051 -172.981 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 36.9 mtmt -112.62 156.85 22.02 Favored 'General case' 0 CA--C 1.488 -1.427 0 N-CA-C 106.789 -1.56 . . . . 0.0 106.789 -173.001 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 16.3 pt-20 -152.28 160.66 43.31 Favored 'General case' 0 N--CA 1.436 -1.17 0 N-CA-C 108.666 -0.865 . . . . 0.0 108.666 178.698 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -140.19 163.02 33.87 Favored 'General case' 0 CA--C 1.498 -1.021 0 N-CA-C 107.102 -1.444 . . . . 0.0 107.102 171.434 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 90.5 m -121.31 126.23 48.98 Favored 'General case' 0 CA--C 1.501 -0.912 0 N-CA-C 104.691 -2.336 . . . . 0.0 104.691 175.344 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 5.2 mp -114.86 133.76 22.56 Favored Pre-proline 0 N--CA 1.437 -1.081 0 N-CA-C 105.121 -2.178 . . . . 0.0 105.121 -174.055 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_exo -64.09 165.59 18.89 Favored 'Trans proline' 0 CA--C 1.509 -0.759 0 C-N-CA 123.39 2.727 . . . . 0.0 113.812 177.127 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -77.71 -16.99 79.46 Favored Glycine 0 C--N 1.353 1.483 0 C-N-CA 123.869 0.747 . . . . 0.0 113.884 -172.887 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 51.8 p-80 -83.98 -24.98 30.37 Favored 'General case' 0 C--N 1.356 0.857 0 CA-C-N 117.975 0.887 . . . . 0.0 110.32 -179.643 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 88.2 mt -88.29 129.36 35.4 Favored 'General case' 0 CA--C 1.5 -0.955 0 N-CA-C 108.299 -1.0 . . . . 0.0 108.299 178.906 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 8.6 p30 -105.23 -1.09 25.77 Favored 'General case' 0 N--CA 1.442 -0.837 0 C-N-CA 124.909 1.284 . . . . 0.0 110.782 -173.918 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 57' ' ' SER . . . . . 0.425 ' HA ' ' HA ' ' A' ' 21' ' ' GLN . 30.5 p -139.42 159.29 42.5 Favored 'General case' 0 CA--C 1.497 -1.069 0 N-CA-C 107.575 -1.269 . . . . 0.0 107.575 -174.974 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 6.1 t80 -128.75 174.5 9.39 Favored 'General case' 0 C--N 1.36 1.055 0 N-CA-C 107.858 -1.164 . . . . 0.0 107.858 175.94 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 99.9 m -140.15 110.74 6.75 Favored 'General case' 0 N--CA 1.431 -1.406 0 N-CA-C 103.923 -2.621 . . . . 0.0 103.923 171.466 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 25.4 mt -87.5 148.74 4.39 Favored 'Isoleucine or valine' 0 C--N 1.358 0.958 0 N-CA-C 103.878 -2.638 . . . . 0.0 103.878 170.3 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 8.4 ptpp? -150.02 159.51 44.34 Favored 'General case' 0 CA--C 1.492 -1.255 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 178.18 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 78.94 54.87 3.98 Favored Glycine 0 C--N 1.355 1.591 0 N-CA-C 109.184 -1.566 . . . . 0.0 109.184 178.841 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 58.8 mt -116.11 -161.11 0.78 Allowed 'General case' 0 CA--C 1.502 -0.888 0 N-CA-C 106.84 -1.541 . . . . 0.0 106.84 -177.322 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 10.7 mptt -125.12 160.99 52.14 Favored Pre-proline 0 N--CA 1.442 -0.874 0 N-CA-C 105.684 -1.969 . . . . 0.0 105.684 -176.361 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -79.57 156.2 24.7 Favored 'Trans proline' 0 N--CA 1.452 -0.918 0 C-N-CA 123.035 2.49 . . . . 0.0 109.567 165.273 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 55.32 33.24 58.11 Favored Glycine 0 C--N 1.356 1.656 0 C-N-CA 127.514 2.483 . . . . 0.0 116.512 172.276 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 7.9 p -115.04 147.3 18.53 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.014 0 N-CA-C 107.282 -1.377 . . . . 0.0 107.282 -176.366 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 4.7 p -102.47 134.12 44.21 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.778 0 N-CA-C 106.636 -1.616 . . . . 0.0 106.636 174.577 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 81.8 m-85 -116.9 150.51 38.35 Favored 'General case' 0 N--CA 1.44 -0.936 0 N-CA-C 107.225 -1.398 . . . . 0.0 107.225 174.323 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 13.1 tp10 -95.95 128.88 43.23 Favored 'General case' 0 CA--C 1.492 -1.254 0 N-CA-C 102.089 -3.301 . . . . 0.0 102.089 165.821 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -125.91 140.83 12.43 Favored Glycine 0 CA--C 1.491 -1.468 0 N-CA-C 107.862 -2.095 . . . . 0.0 107.862 -179.205 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 28.7 tt0 -134.14 130.82 37.9 Favored 'General case' 0 CA--C 1.482 -1.64 0 N-CA-C 106.213 -1.773 . . . . 0.0 106.213 -178.496 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 43.2 tp -117.42 102.98 9.67 Favored 'General case' 0 N--CA 1.437 -1.09 0 N-CA-C 104.626 -2.361 . . . . 0.0 104.626 -176.516 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 11.9 mt -93.99 130.36 43.04 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.888 0 N-CA-C 104.287 -2.486 . . . . 0.0 104.287 174.878 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 25.2 p -112.75 114.11 26.52 Favored 'General case' 0 N--CA 1.438 -1.069 0 N-CA-C 106.683 -1.599 . . . . 0.0 106.683 -179.857 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 22.5 mm -90.03 142.0 13.54 Favored 'Isoleucine or valine' 0 CA--C 1.485 -1.529 0 N-CA-C 105.606 -1.998 . . . . 0.0 105.606 -167.985 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 78.0 mt-30 -104.57 152.42 22.44 Favored 'General case' 0 CA--C 1.493 -1.244 0 CA-C-N 114.548 -1.206 . . . . 0.0 107.904 -174.478 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 24.5 tt0 -77.49 35.09 0.18 Allowed 'General case' 0 C--N 1.355 0.841 0 C-N-CA 125.882 1.673 . . . . 0.0 113.41 -178.579 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 98.5 m-85 -143.63 11.74 1.67 Allowed 'General case' 0 CA--C 1.498 -1.057 0 N-CA-C 109.068 -0.715 . . . . 0.0 109.068 -175.719 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 88.91 -20.62 31.46 Favored Glycine 0 C--N 1.351 1.374 0 C-N-CA 124.097 0.856 . . . . 0.0 111.207 179.739 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 85.6 m-70 -81.04 173.9 12.14 Favored 'General case' 0 CA--C 1.496 -1.1 0 C-N-CA 125.362 1.465 . . . . 0.0 108.683 -178.673 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 5.4 pt20 -162.38 145.12 11.25 Favored 'General case' 0 N--CA 1.437 -1.117 0 N-CA-C 107.875 -1.157 . . . . 0.0 107.875 -176.102 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 48.0 mm-40 -110.21 147.89 32.9 Favored 'General case' 0 CA--C 1.496 -1.127 0 N-CA-C 106.351 -1.722 . . . . 0.0 106.351 179.237 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 8.7 p -118.74 143.0 31.02 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.746 0 N-CA-C 107.626 -1.249 . . . . 0.0 107.626 -175.773 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 28.1 m -131.72 131.94 43.47 Favored 'General case' 0 N--CA 1.441 -0.898 0 N-CA-C 103.275 -2.861 . . . . 0.0 103.275 179.748 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 88.2 mtm180 -125.46 148.47 48.83 Favored 'General case' 0 CA--C 1.501 -0.924 0 CA-C-N 119.011 0.823 . . . . 0.0 108.826 -179.699 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 23.0 p90 -163.38 179.82 7.07 Favored 'General case' 0 CA--C 1.501 -0.926 0 N-CA-C 106.804 -1.554 . . . . 0.0 106.804 -177.779 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 41.6 p30 -136.96 156.34 48.58 Favored 'General case' 0 N--CA 1.443 -0.824 0 N-CA-C 106.488 -1.671 . . . . 0.0 106.488 167.457 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 23.3 p90 -142.94 170.67 15.26 Favored 'General case' 0 CA--C 1.488 -1.439 0 N-CA-C 106.505 -1.665 . . . . 0.0 106.505 172.318 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 36.0 p -120.9 139.7 52.84 Favored 'General case' 0 CA--C 1.502 -0.897 0 N-CA-C 106.443 -1.688 . . . . 0.0 106.443 174.014 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 71.1 m -108.41 88.13 2.66 Favored 'General case' 0 CA--C 1.497 -1.094 0 N-CA-C 102.948 -2.982 . . . . 0.0 102.948 171.793 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 42.6 p -89.79 -178.42 5.5 Favored 'General case' 0 N--CA 1.443 -0.8 0 N-CA-C 106.998 -1.482 . . . . 0.0 106.998 178.977 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 22.7 t . . . . . 0 C--O 1.26 1.626 0 N-CA-C 104.923 -2.251 . . . . 0.0 104.923 175.385 . . . . . . . . 0 0 . 1 . 023 nuclear build core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.436 -1.313 0 N-CA-C 106.243 -2.743 . . . . 0.0 106.243 . . . . . . . . . 0 0 . 1 . 023 nuclear build core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 77.5 Cg_exo -61.51 133.47 45.95 Favored 'Trans proline' 0 N--CA 1.446 -1.301 0 C-N-CA 122.742 2.295 . . . . 0.0 113.844 -171.579 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 38.6 t -85.71 161.78 2.96 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.085 0 C-N-CA 128.454 2.702 . . . . 0.0 107.513 -172.37 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -106.26 106.09 16.44 Favored 'General case' 0 CA--C 1.493 -1.249 0 N-CA-C 105.06 -2.2 . . . . 0.0 105.06 176.733 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 1.5 p -127.21 140.41 49.17 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.086 0 N-CA-C 104.958 -2.238 . . . . 0.0 104.958 -170.31 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 16.5 p90 . . . . . 0 N--CA 1.436 -1.169 0 N-CA-C 107.071 -1.455 . . . . 0.0 107.071 -166.674 . . . . . . . . 0 0 . 1 . 023 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_endo . . . . . 0 CA--C 1.501 -1.152 0 N-CA-C 110.906 -0.459 . . . . 0.0 110.906 . . . . . . . . . 0 0 . 1 . 023 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 2.1 m-80 -118.87 -20.31 8.23 Favored 'General case' 0 CA--C 1.49 -1.328 0 C-N-CA 124.857 1.263 . . . . 0.0 109.242 -168.821 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 15.0 p -97.86 148.2 23.66 Favored 'General case' 0 CA--C 1.493 -1.235 0 N-CA-C 107.444 -1.317 . . . . 0.0 107.444 -177.514 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 30.1 t-80 -150.54 97.04 3.33 Favored Pre-proline 0 N--CA 1.438 -1.053 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 170.403 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -80.06 139.5 13.56 Favored 'Trans proline' 0 N--CA 1.447 -1.24 0 C-N-CA 122.35 2.033 . . . . 0.0 110.408 178.759 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 18.7 mm -113.62 146.21 18.5 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.937 0 N-CA-C 104.429 -2.434 . . . . 0.0 104.429 -178.051 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 35.0 mt-30 -136.42 149.95 48.53 Favored 'General case' 0 CA--C 1.502 -0.879 0 N-CA-C 105.326 -2.101 . . . . 0.0 105.326 168.904 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 42.0 p90 -141.48 161.97 36.61 Favored 'General case' 0 CA--C 1.502 -0.873 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 -175.169 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 81.2 m-20 -100.98 -172.39 2.16 Favored 'General case' 0 CA--C 1.485 -1.543 0 N-CA-C 103.851 -2.648 . . . . 0.0 103.851 171.389 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -150.45 163.14 25.26 Favored Pre-proline 0 N--CA 1.444 -0.771 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 169.93 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 80.4 Cg_exo -67.32 170.16 13.98 Favored 'Trans proline' 0 N--CA 1.456 -0.704 0 C-N-CA 123.38 2.72 . . . . 0.0 112.319 169.682 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 24.0 mm100 -82.42 -56.01 0.53 Allowed Pre-proline 0 N--CA 1.442 -0.869 0 CA-C-O 115.578 -2.153 . . . . 0.0 113.644 -172.328 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 82.6 Cg_endo -75.77 170.04 21.0 Favored 'Trans proline' 0 CA--C 1.509 -0.773 0 CA-C-N 125.774 3.098 . . . . 0.0 111.085 -169.228 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 69.4 m -76.83 113.27 14.33 Favored 'General case' 0 CA--C 1.5 -0.955 0 N-CA-C 107.717 -1.216 . . . . 0.0 107.717 179.031 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 61.4 t-80 -167.59 -49.95 0.02 OUTLIER 'General case' 0 N--CA 1.435 -1.193 0 N-CA-C 105.441 -2.059 . . . . 0.0 105.441 -170.559 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 26.6 mt -105.69 126.62 60.99 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.145 0 N-CA-C 106.429 -1.693 . . . . 0.0 106.429 -176.668 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 74.3 m -116.35 -84.35 0.63 Allowed 'General case' 0 N--CA 1.433 -1.278 0 N-CA-C 107.828 -1.175 . . . . 0.0 107.828 -174.714 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 38.8 ttpt -89.27 156.43 18.75 Favored 'General case' 0 CA--C 1.493 -1.22 0 C-N-CA 126.197 1.799 . . . . 0.0 106.888 -164.641 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 90.7 m-85 -126.86 135.89 51.6 Favored 'General case' 0 CA--C 1.488 -1.417 0 N-CA-C 105.304 -2.11 . . . . 0.0 105.304 179.474 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 1.5 mp -112.65 135.69 51.26 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.231 0 N-CA-C 100.473 -3.899 . . . . 0.0 100.473 170.239 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 3.1 mt -106.49 124.78 50.11 Favored 'General case' 0 CA--C 1.479 -1.788 0 N-CA-C 104.676 -2.342 . . . . 0.0 104.676 166.436 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -106.58 154.01 21.51 Favored 'General case' 0 N--CA 1.431 -1.375 0 N-CA-C 104.483 -2.414 . . . . 0.0 104.483 170.771 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 48.2 p90 -154.79 141.64 19.11 Favored 'General case' 0 N--CA 1.433 -1.292 0 N-CA-C 106.344 -1.725 . . . . 0.0 106.344 168.171 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 5.3 ptp180 -133.74 153.99 80.34 Favored Pre-proline 0 CA--C 1.497 -1.064 0 N-CA-C 103.751 -2.685 . . . . 0.0 103.751 168.695 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 68.8 Cg_endo -75.22 164.8 32.26 Favored 'Trans proline' 0 CA--C 1.506 -0.921 0 C-N-CA 122.789 2.326 . . . . 0.0 106.765 164.711 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 5.5 ptmm? -64.92 93.8 0.12 Allowed 'General case' 0 C--N 1.352 0.678 0 CA-C-N 119.976 1.262 . . . . 0.0 113.048 176.658 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -128.3 -136.28 0.23 Allowed 'General case' 0 N--CA 1.44 -0.953 0 N-CA-C 104.974 -2.232 . . . . 0.0 104.974 167.427 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 42.4 m -97.17 -154.28 0.45 Allowed 'General case' 0 N--CA 1.44 -0.954 0 C-N-CA 125.607 1.563 . . . . 0.0 107.121 179.313 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 9.2 m -94.85 42.69 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.445 -0.711 0 C-N-CA 126.627 1.971 . . . . 0.0 107.284 176.322 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -90.19 -146.33 15.22 Favored Glycine 0 C--N 1.353 1.478 0 C-N-CA 124.184 0.897 . . . . 0.0 110.998 -171.947 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 17.1 tpt180 -75.95 135.2 40.05 Favored 'General case' 0 CA--C 1.502 -0.881 0 C-N-CA 124.267 1.027 . . . . 0.0 108.332 -177.01 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -146.95 174.65 11.32 Favored 'General case' 0 N--CA 1.434 -1.27 0 N-CA-C 109.395 -0.594 . . . . 0.0 109.395 -174.261 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 64.3 mttp -112.3 155.74 23.58 Favored 'General case' 0 CA--C 1.489 -1.403 0 N-CA-C 107.347 -1.353 . . . . 0.0 107.347 -171.482 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 15.4 pt-20 -150.68 158.89 44.68 Favored 'General case' 0 N--CA 1.433 -1.284 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 179.784 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -136.7 160.45 38.8 Favored 'General case' 0 CA--C 1.497 -1.065 0 N-CA-C 106.509 -1.663 . . . . 0.0 106.509 171.754 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 77.3 m -122.8 126.54 47.63 Favored 'General case' 0 CA--C 1.501 -0.924 0 N-CA-C 104.956 -2.238 . . . . 0.0 104.956 175.335 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 5.2 mp -117.56 135.33 23.22 Favored Pre-proline 0 N--CA 1.437 -1.099 0 N-CA-C 104.753 -2.314 . . . . 0.0 104.753 -177.26 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_exo -63.48 167.13 13.71 Favored 'Trans proline' 0 CA--C 1.51 -0.71 0 C-N-CA 123.558 2.839 . . . . 0.0 113.477 177.101 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -79.49 -18.84 72.7 Favored Glycine 0 C--N 1.352 1.464 0 C-N-CA 123.344 0.497 . . . . 0.0 113.363 -172.59 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 47.7 p-80 -84.18 -27.01 28.36 Favored 'General case' 0 C--N 1.354 0.794 0 CA-C-N 117.743 0.771 . . . . 0.0 109.968 179.774 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 88.5 mt -88.57 132.58 34.47 Favored 'General case' 0 CA--C 1.502 -0.893 0 N-CA-C 107.789 -1.189 . . . . 0.0 107.789 177.722 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 7.6 p-10 -114.98 9.88 16.16 Favored 'General case' 0 CA--C 1.502 -0.897 0 C-N-CA 124.287 1.035 . . . . 0.0 110.169 -171.669 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 53.4 p -144.55 165.81 26.92 Favored 'General case' 0 N--CA 1.44 -0.958 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 -175.267 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 11.2 t80 -151.98 174.72 13.3 Favored 'General case' 0 N--CA 1.441 -0.908 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 -179.162 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 87.7 m -139.1 113.13 8.63 Favored 'General case' 0 N--CA 1.431 -1.409 0 N-CA-C 105.078 -2.193 . . . . 0.0 105.078 172.775 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 54.2 mt -87.08 142.93 12.32 Favored 'Isoleucine or valine' 0 C--N 1.359 0.979 0 N-CA-C 104.217 -2.512 . . . . 0.0 104.217 172.604 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 60.7 mttp -141.41 162.42 35.53 Favored 'General case' 0 CA--C 1.495 -1.138 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 179.195 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 78.84 53.05 4.72 Favored Glycine 0 CA--C 1.488 -1.609 0 N-CA-C 109.094 -1.602 . . . . 0.0 109.094 174.949 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 78.7 mt -113.46 -166.06 1.05 Allowed 'General case' 0 CA--C 1.503 -0.855 0 N-CA-C 107.279 -1.378 . . . . 0.0 107.279 -176.589 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 11.0 mptt -132.29 148.67 70.63 Favored Pre-proline 0 N--CA 1.442 -0.859 0 N-CA-C 104.993 -2.225 . . . . 0.0 104.993 -177.517 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -78.97 162.54 26.28 Favored 'Trans proline' 0 N--CA 1.45 -1.055 0 C-N-CA 122.772 2.315 . . . . 0.0 109.761 173.772 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 66' ' ' GLY . . . . . 0.536 ' H ' ' HA ' ' A' ' 92' ' ' THR . . . 63.63 24.0 67.55 Favored Glycine 0 N--CA 1.428 -1.851 0 C-N-CA 127.377 2.418 . . . . 0.0 116.063 172.886 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 9.6 p -129.7 143.13 42.02 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.02 0 N-CA-C 107.484 -1.302 . . . . 0.0 107.484 -178.037 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 11.5 p -95.65 127.56 47.58 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.011 0 CA-C-O 123.289 1.519 . . . . 0.0 107.571 178.258 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 87.3 m-85 -100.44 144.34 29.55 Favored 'General case' 0 N--CA 1.431 -1.41 0 N-CA-C 106.235 -1.765 . . . . 0.0 106.235 176.339 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 33.6 tp10 -90.57 132.66 35.59 Favored 'General case' 0 N--CA 1.439 -0.981 0 N-CA-C 104.205 -2.517 . . . . 0.0 104.205 163.064 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -129.3 152.43 19.5 Favored Glycine 0 CA--C 1.489 -1.547 0 N-CA-C 108.283 -1.927 . . . . 0.0 108.283 -179.136 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 85.4 mt-30 -138.19 137.8 37.95 Favored 'General case' 0 CA--C 1.485 -1.548 0 N-CA-C 106.347 -1.723 . . . . 0.0 106.347 174.849 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 62.7 tp -109.72 97.92 7.36 Favored 'General case' 0 CA--C 1.499 -1.014 0 N-CA-C 102.898 -3.001 . . . . 0.0 102.898 174.542 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 9.1 mt -94.86 124.61 47.43 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.054 0 N-CA-C 104.026 -2.583 . . . . 0.0 104.026 -174.21 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 74.6 m -112.89 108.9 18.02 Favored 'General case' 0 CA--C 1.5 -0.959 0 N-CA-C 107.826 -1.176 . . . . 0.0 107.826 -168.03 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 1.8 mp -93.17 136.9 23.76 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.226 0 N-CA-C 105.2 -2.148 . . . . 0.0 105.2 -167.241 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 14.0 tt0 -97.96 111.25 23.63 Favored 'General case' 0 N--CA 1.431 -1.377 0 N-CA-C 101.706 -3.442 . . . . 0.0 101.706 169.508 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 41.8 mt-30 -69.25 125.03 25.42 Favored 'General case' 0 CA--C 1.5 -0.975 0 CA-C-O 120.846 0.355 . . . . 0.0 110.218 -170.587 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 52.7 m-85 68.71 39.1 2.06 Favored 'General case' 0 C--N 1.356 0.872 0 C-N-CA 126.492 1.917 . . . . 0.0 110.996 -176.172 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -166.68 -116.22 0.35 Allowed Glycine 0 C--N 1.357 1.721 0 N-CA-C 109.288 -1.525 . . . . 0.0 109.288 179.144 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 29.3 m170 -82.51 -179.73 7.52 Favored 'General case' 0 CA--C 1.502 -0.874 0 C-N-CA 125.606 1.563 . . . . 0.0 111.259 -168.504 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 25.7 tt0 -147.44 123.58 10.81 Favored 'General case' 0 N--CA 1.436 -1.167 0 N-CA-C 105.591 -2.003 . . . . 0.0 105.591 170.686 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 47.8 mm-40 -104.68 160.63 14.81 Favored 'General case' 0 CA--C 1.501 -0.931 0 N-CA-C 106.243 -1.762 . . . . 0.0 106.243 176.558 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 10.9 p -135.84 138.55 47.53 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.842 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 -178.233 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 24.9 m -122.35 139.45 53.81 Favored 'General case' 0 N--CA 1.442 -0.833 0 N-CA-C 103.124 -2.917 . . . . 0.0 103.124 173.05 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 55.9 ttp180 -135.03 143.16 46.59 Favored 'General case' 0 CA--C 1.505 -0.77 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 -174.13 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 21.1 p90 -164.0 -175.81 4.22 Favored 'General case' 0 C--N 1.358 0.97 0 N-CA-C 106.891 -1.522 . . . . 0.0 106.891 -174.519 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 44.4 p-10 -136.5 158.34 44.67 Favored 'General case' 0 N--CA 1.442 -0.838 0 N-CA-C 107.093 -1.447 . . . . 0.0 107.093 166.748 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 25.2 p90 -143.75 164.12 31.37 Favored 'General case' 0 CA--C 1.486 -1.49 0 N-CA-C 106.821 -1.548 . . . . 0.0 106.821 169.769 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 43.8 m -118.42 137.77 52.92 Favored 'General case' 0 CA--C 1.498 -1.051 0 N-CA-C 105.336 -2.098 . . . . 0.0 105.336 179.186 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 61.3 m -115.75 115.67 26.73 Favored 'General case' 0 CA--C 1.493 -1.213 0 N-CA-C 101.866 -3.383 . . . . 0.0 101.866 174.722 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 92' ' ' THR . . . . . 0.536 ' HA ' ' H ' ' A' ' 66' ' ' GLY . 15.1 t -155.29 148.23 24.51 Favored 'General case' 0 N--CA 1.437 -1.103 0 N-CA-C 107.315 -1.365 . . . . 0.0 107.315 -174.227 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 67.7 m . . . . . 0 C--O 1.26 1.615 0 N-CA-C 106.467 -1.679 . . . . 0.0 106.467 175.214 . . . . . . . . 0 0 . 1 . 024 nuclear build core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.438 -1.23 0 N-CA-C 106.728 -2.549 . . . . 0.0 106.728 . . . . . . . . . 0 0 . 1 . 024 nuclear build core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 29.8 Cg_exo -59.04 139.78 92.28 Favored 'Trans proline' 0 N--CA 1.446 -1.293 0 C-N-CA 123.649 2.899 . . . . 0.0 113.559 -175.168 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 41.9 t -79.83 160.15 4.28 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.996 0 C-N-CA 128.552 2.741 . . . . 0.0 106.282 -179.002 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 55.2 mt-10 -108.13 106.74 17.09 Favored 'General case' 0 CA--C 1.493 -1.215 0 N-CA-C 105.998 -1.853 . . . . 0.0 105.998 -179.638 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 1.5 p -124.18 140.07 48.66 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.914 0 N-CA-C 106.142 -1.799 . . . . 0.0 106.142 -172.367 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 16.5 p90 . . . . . 0 N--CA 1.438 -1.032 0 N-CA-C 105.968 -1.864 . . . . 0.0 105.968 -168.589 . . . . . . . . 0 0 . 1 . 024 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo . . . . . 0 CA--C 1.505 -0.952 0 CA-C-O 118.39 -0.754 . . . . 0.0 111.372 . . . . . . . . . 0 0 . 1 . 024 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 6.2 p-10 -104.37 -41.32 5.79 Favored 'General case' 0 CA--C 1.489 -1.369 0 C-N-CA 123.167 0.587 . . . . 0.0 109.622 -167.103 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 12.0 p -110.5 150.72 28.49 Favored 'General case' 0 CA--C 1.494 -1.202 0 N-CA-C 107.399 -1.334 . . . . 0.0 107.399 -179.095 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 58.6 t-80 -143.37 93.61 6.37 Favored Pre-proline 0 N--CA 1.437 -1.087 0 N-CA-C 106.892 -1.522 . . . . 0.0 106.892 173.656 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -82.02 146.17 14.32 Favored 'Trans proline' 0 N--CA 1.445 -1.332 0 C-N-CA 123.436 2.757 . . . . 0.0 109.948 175.958 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.491 HD11 HD11 ' A' ' 35' ' ' LEU . 7.4 pt -126.3 173.44 12.04 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.985 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 178.217 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 49.2 tt0 -148.49 149.34 31.48 Favored 'General case' 0 N--CA 1.44 -0.95 0 N-CA-C 105.192 -2.151 . . . . 0.0 105.192 170.684 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 27.7 p90 -130.51 161.25 31.89 Favored 'General case' 0 N--CA 1.44 -0.959 0 N-CA-C 106.296 -1.742 . . . . 0.0 106.296 -179.696 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 61.1 t30 -96.61 -176.25 3.55 Favored 'General case' 0 CA--C 1.491 -1.327 0 N-CA-C 103.33 -2.841 . . . . 0.0 103.33 169.372 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -156.43 166.96 15.37 Favored Pre-proline 0 N--CA 1.44 -0.938 0 N-CA-C 106.621 -1.622 . . . . 0.0 106.621 172.888 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 99.6 Cg_exo -65.39 162.17 34.82 Favored 'Trans proline' 0 CA--C 1.508 -0.775 0 C-N-CA 123.486 2.791 . . . . 0.0 112.978 175.838 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 1.2 tm0? -82.08 -58.75 0.45 Allowed Pre-proline 0 N--CA 1.442 -0.845 0 CA-C-O 115.7 -2.095 . . . . 0.0 110.686 -177.46 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo -74.95 175.54 11.09 Favored 'Trans proline' 0 CA--C 1.51 -0.696 0 CA-C-N 125.67 3.061 . . . . 0.0 110.548 -177.168 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 44.2 p -69.18 124.5 23.98 Favored 'General case' 0 C--N 1.356 0.891 0 C-N-CA 123.824 0.85 . . . . 0.0 109.785 -178.239 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 22.2 t-80 -168.12 -42.82 0.02 OUTLIER 'General case' 0 CA--C 1.494 -1.199 0 N-CA-C 106.598 -1.63 . . . . 0.0 106.598 -170.747 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 33.4 mt -132.56 140.42 47.62 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.895 0 N-CA-C 107.68 -1.23 . . . . 0.0 107.68 -173.604 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 31.8 p -123.18 -71.22 0.73 Allowed 'General case' 0 C--N 1.359 0.985 0 C-N-CA 124.219 1.008 . . . . 0.0 109.536 172.875 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 44.6 mtpt -86.44 166.58 15.41 Favored 'General case' 0 CA--C 1.488 -1.439 0 C-N-CA 126.899 2.08 . . . . 0.0 107.219 -171.029 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 83.4 m-85 -134.31 148.61 50.79 Favored 'General case' 0 CA--C 1.493 -1.248 0 N-CA-C 104.855 -2.276 . . . . 0.0 104.855 175.369 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 4.4 mt -123.54 139.47 50.05 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.315 0 N-CA-C 101.402 -3.555 . . . . 0.0 101.402 171.361 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.491 HD11 HD11 ' A' ' 20' ' ' ILE . 12.0 mt -116.02 135.36 54.03 Favored 'General case' 0 CA--C 1.477 -1.852 0 N-CA-C 106.717 -1.586 . . . . 0.0 106.717 166.681 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 9.0 mpt_? -110.58 153.12 25.6 Favored 'General case' 0 N--CA 1.429 -1.48 0 N-CA-C 104.491 -2.411 . . . . 0.0 104.491 166.559 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 48.9 p90 -154.15 146.59 24.0 Favored 'General case' 0 N--CA 1.441 -0.905 0 N-CA-C 108.099 -1.075 . . . . 0.0 108.099 168.969 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 43.9 ttm-85 -142.08 143.9 29.75 Favored Pre-proline 0 CA--C 1.503 -0.844 0 N-CA-C 104.693 -2.336 . . . . 0.0 104.693 179.876 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -71.42 115.22 4.2 Favored 'Trans proline' 0 N--CA 1.454 -0.808 0 C-N-CA 122.878 2.386 . . . . 0.0 108.845 167.151 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 64.3 tttm -70.33 77.87 0.54 Allowed 'General case' 0 C--N 1.358 0.955 0 C-N-CA 126.979 2.112 . . . . 0.0 111.084 -177.179 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 68.7 m-80 -151.77 -73.26 0.15 Allowed 'General case' 0 N--CA 1.435 -1.218 0 N-CA-C 102.653 -3.091 . . . . 0.0 102.653 -173.436 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 60.8 m -96.5 168.38 10.58 Favored 'General case' 0 C--N 1.356 0.874 0 N-CA-C 107.19 -1.411 . . . . 0.0 107.19 175.028 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 2.6 m -130.91 62.27 0.3 Allowed 'Isoleucine or valine' 0 CA--C 1.501 -0.913 0 N-CA-C 105.436 -2.061 . . . . 0.0 105.436 179.759 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -93.18 -110.53 2.01 Favored Glycine 0 C--N 1.353 1.503 0 N-CA-C 107.969 -2.052 . . . . 0.0 107.969 -179.818 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 80.2 mtp180 -105.88 175.66 5.42 Favored 'General case' 0 CA--C 1.502 -0.884 0 N-CA-C 106.338 -1.727 . . . . 0.0 106.338 173.564 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -152.05 172.63 15.99 Favored 'General case' 0 CA--C 1.495 -1.168 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 -176.676 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 94.6 mttt -108.02 154.16 22.05 Favored 'General case' 0 CA--C 1.487 -1.456 0 N-CA-C 107.313 -1.366 . . . . 0.0 107.313 -173.984 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -152.19 153.03 33.01 Favored 'General case' 0 N--CA 1.431 -1.391 0 N-CA-C 107.542 -1.281 . . . . 0.0 107.542 -177.738 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -146.48 160.62 41.87 Favored 'General case' 0 CA--C 1.499 -1.018 0 N-CA-C 107.667 -1.235 . . . . 0.0 107.667 177.665 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 91.6 m -121.7 126.76 49.69 Favored 'General case' 0 CA--C 1.5 -0.956 0 N-CA-C 105.176 -2.157 . . . . 0.0 105.176 177.734 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 52.5 mt -117.58 136.92 23.75 Favored Pre-proline 0 N--CA 1.436 -1.164 0 N-CA-C 105.639 -1.985 . . . . 0.0 105.639 -166.635 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 76.1 Cg_exo -65.26 168.46 14.21 Favored 'Trans proline' 0 CA--C 1.51 -0.692 0 C-N-CA 123.214 2.609 . . . . 0.0 113.284 177.702 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -96.38 7.68 66.41 Favored Glycine 0 C--N 1.352 1.428 0 CA-C-O 118.951 -0.916 . . . . 0.0 113.013 -178.038 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 44.3 p-80 -83.93 -47.45 11.02 Favored 'General case' 0 C--N 1.362 1.146 0 CA-C-N 119.206 1.503 . . . . 0.0 109.186 178.869 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -87.95 165.76 14.99 Favored 'General case' 0 CA--C 1.489 -1.381 0 CA-C-O 122.934 1.35 . . . . 0.0 108.271 170.921 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 6.0 p-10 -140.54 24.53 2.25 Favored 'General case' 0 N--CA 1.424 -1.761 0 CA-C-N 112.974 -1.921 . . . . 0.0 106.987 -178.506 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 57.1 p -132.14 158.49 41.53 Favored 'General case' 0 CA--C 1.501 -0.91 0 N-CA-C 107.788 -1.19 . . . . 0.0 107.788 176.387 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 7.7 t80 -133.21 175.79 9.09 Favored 'General case' 0 C--N 1.359 1.002 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 175.463 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 93.3 m -142.4 110.84 6.1 Favored 'General case' 0 N--CA 1.431 -1.404 0 N-CA-C 104.409 -2.441 . . . . 0.0 104.409 173.985 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 26.3 mt -90.85 147.32 5.3 Favored 'Isoleucine or valine' 0 C--N 1.358 0.952 0 N-CA-C 104.293 -2.484 . . . . 0.0 104.293 172.443 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 67.3 mttm -142.46 164.62 29.63 Favored 'General case' 0 CA--C 1.5 -0.946 0 N-CA-C 108.717 -0.845 . . . . 0.0 108.717 177.549 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 82.02 50.01 5.07 Favored Glycine 0 C--N 1.356 1.663 0 C-N-CA 125.357 1.456 . . . . 0.0 109.562 175.153 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 49.5 mt -119.25 172.97 7.23 Favored 'General case' 0 CA--C 1.5 -0.97 0 N-CA-C 108.22 -1.03 . . . . 0.0 108.22 -170.998 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -114.61 160.91 31.38 Favored Pre-proline 0 N--CA 1.442 -0.872 0 N-CA-C 106.856 -1.535 . . . . 0.0 106.856 -176.937 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -79.75 163.12 23.88 Favored 'Trans proline' 0 N--CA 1.452 -0.944 0 C-N-CA 123.192 2.595 . . . . 0.0 109.83 166.131 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 60.9 24.65 62.92 Favored Glycine 0 C--N 1.355 1.638 0 C-N-CA 127.778 2.609 . . . . 0.0 116.496 172.1 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 7.7 p -118.9 146.14 23.94 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.063 0 N-CA-C 107.529 -1.286 . . . . 0.0 107.529 -174.56 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 4.2 p -100.31 129.9 50.36 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.906 0 N-CA-C 106.665 -1.606 . . . . 0.0 106.665 176.013 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 94.1 m-85 -113.44 150.01 33.38 Favored 'General case' 0 N--CA 1.439 -1.016 0 N-CA-C 105.923 -1.88 . . . . 0.0 105.923 173.508 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -100.61 144.58 29.42 Favored 'General case' 0 CA--C 1.496 -1.119 0 N-CA-C 104.327 -2.471 . . . . 0.0 104.327 162.546 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -126.99 157.76 20.74 Favored Glycine 0 CA--C 1.489 -1.584 0 N-CA-C 108.016 -2.034 . . . . 0.0 108.016 174.663 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 23.7 tt0 -142.7 131.48 22.76 Favored 'General case' 0 CA--C 1.482 -1.671 0 N-CA-C 106.004 -1.85 . . . . 0.0 106.004 176.53 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 39.8 tp -113.5 104.76 12.59 Favored 'General case' 0 N--CA 1.437 -1.112 0 N-CA-C 104.6 -2.371 . . . . 0.0 104.6 -174.878 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 21.8 mt -100.48 126.69 54.03 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.866 0 N-CA-C 103.192 -2.892 . . . . 0.0 103.192 -179.29 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 50.5 m -118.36 115.9 25.63 Favored 'General case' 0 N--CA 1.444 -0.74 0 CA-C-N 119.24 0.927 . . . . 0.0 109.154 -171.32 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 2.4 mp -104.3 141.11 20.55 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.982 0 N-CA-C 105.779 -1.934 . . . . 0.0 105.779 -162.824 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 77' ' ' GLN . . . . . 0.442 ' HB3' ' H ' ' A' ' 81' ' ' HIS . 66.2 tp60 -103.89 125.95 50.66 Favored 'General case' 0 CA--C 1.493 -1.25 0 N-CA-C 102.458 -3.164 . . . . 0.0 102.458 161.293 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 18.5 tt0 -68.35 117.89 10.72 Favored 'General case' 0 N--CA 1.443 -0.808 0 C-N-CA 123.036 0.534 . . . . 0.0 110.558 -170.428 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 24.8 m-85 64.44 53.96 1.58 Allowed 'General case' 0 C--N 1.358 0.957 0 C-N-CA 126.597 1.959 . . . . 0.0 110.686 -175.256 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -172.47 -110.86 0.25 Allowed Glycine 0 C--N 1.352 1.421 0 N-CA-C 109.021 -1.632 . . . . 0.0 109.021 -178.696 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 81' ' ' HIS . . . . . 0.442 ' H ' ' HB3' ' A' ' 77' ' ' GLN . 27.9 m170 -80.2 164.92 22.9 Favored 'General case' 0 CA--C 1.503 -0.861 0 C-N-CA 125.066 1.347 . . . . 0.0 111.436 -168.792 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 44.8 tt0 -151.0 111.27 4.15 Favored 'General case' 0 N--CA 1.435 -1.181 0 N-CA-C 105.539 -2.023 . . . . 0.0 105.539 169.806 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 17.2 tp10 -99.82 151.95 20.69 Favored 'General case' 0 N--CA 1.441 -0.901 0 N-CA-C 105.799 -1.926 . . . . 0.0 105.799 179.267 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 11.3 p -130.85 139.91 49.98 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.774 0 N-CA-C 107.324 -1.362 . . . . 0.0 107.324 177.849 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 85.8 m -138.51 133.85 33.17 Favored 'General case' 0 N--CA 1.441 -0.922 0 N-CA-C 102.901 -3.0 . . . . 0.0 102.901 -177.969 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 8.1 ptm180 -113.79 165.1 12.9 Favored 'General case' 0 C--N 1.357 0.915 0 CA-C-N 119.822 1.192 . . . . 0.0 109.667 174.506 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 43.0 p90 -163.99 174.6 11.2 Favored 'General case' 0 CA--C 1.5 -0.975 0 N-CA-C 106.919 -1.512 . . . . 0.0 106.919 177.163 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 1.4 p30 -143.97 156.55 44.45 Favored 'General case' 0 N--CA 1.441 -0.885 0 N-CA-C 106.965 -1.494 . . . . 0.0 106.965 166.459 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 6.6 p90 -148.36 173.27 13.23 Favored 'General case' 0 CA--C 1.488 -1.434 0 N-CA-C 107.661 -1.237 . . . . 0.0 107.661 -179.881 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 32.0 p -122.97 143.99 49.54 Favored 'General case' 0 CA--C 1.499 -0.99 0 N-CA-C 106.308 -1.738 . . . . 0.0 106.308 171.633 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 68.3 m -110.07 87.23 2.47 Favored 'General case' 0 CA--C 1.495 -1.137 0 N-CA-C 100.579 -3.86 . . . . 0.0 100.579 166.27 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 10.2 t -97.41 -50.88 4.36 Favored 'General case' 0 N--CA 1.441 -0.908 0 N-CA-C 108.293 -1.002 . . . . 0.0 108.293 -168.33 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 11.4 t . . . . . 0 C--O 1.26 1.638 0 C-N-CA 126.118 1.767 . . . . 0.0 110.256 -175.475 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 17.0 t . . . . . 0 N--CA 1.484 1.258 0 CA-C-O 121.288 0.566 . . . . 0.0 110.538 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' GLY . . . . . 0.513 ' H ' ' HG3' ' A' ' 83' ' ' GLU . . . 100.89 -179.48 28.82 Favored Glycine 0 C--N 1.354 1.544 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 174.599 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 95.9 Cg_exo -62.21 133.11 41.98 Favored 'Trans proline' 0 N--CA 1.445 -1.367 0 C-N-CA 123.592 2.861 . . . . 0.0 112.342 -178.504 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 4.3 t -80.98 155.33 4.26 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.924 0 C-N-CA 127.32 2.248 . . . . 0.0 107.424 -175.429 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 53.0 mt-10 -94.49 89.04 5.68 Favored 'General case' 0 CA--C 1.493 -1.25 0 C-N-CA 124.337 1.055 . . . . 0.0 108.426 -177.5 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 3.7 p -115.64 140.24 38.25 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.105 0 N-CA-C 105.497 -2.038 . . . . 0.0 105.497 -169.411 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 93.3 m-85 -130.46 166.12 21.18 Favored 'General case' 0 CA--C 1.493 -1.221 0 N-CA-C 107.28 -1.378 . . . . 0.0 107.28 -172.112 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 58.6 mt -91.05 90.5 3.32 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.931 0 N-CA-C 104.596 -2.372 . . . . 0.0 104.596 176.798 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 24.8 p -106.41 154.85 20.23 Favored 'General case' 0 CA--C 1.5 -0.945 0 N-CA-C 105.204 -2.147 . . . . 0.0 105.204 175.736 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -169.15 82.66 0.13 Allowed 'General case' 0 N--CA 1.431 -1.419 0 N-CA-C 102.091 -3.3 . . . . 0.0 102.091 -178.009 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 45.8 p -80.81 166.69 37.62 Favored Pre-proline 0 N--CA 1.444 -0.755 0 CA-C-O 116.972 -1.49 . . . . 0.0 107.222 -178.256 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_exo -61.13 106.11 0.37 Allowed 'Trans proline' 0 CA--C 1.509 -0.774 0 C-N-CA 123.085 2.523 . . . . 0.0 113.82 -168.622 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 67.8 m -151.19 -163.92 1.88 Allowed 'General case' 0 N--CA 1.421 -1.925 0 N-CA-C 101.025 -3.694 . . . . 0.0 101.025 -174.619 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 37.4 mt-30 -83.38 157.36 65.15 Favored Pre-proline 0 N--CA 1.44 -0.967 0 C-N-CA 126.32 1.848 . . . . 0.0 107.801 178.411 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_endo -82.19 -5.61 12.0 Favored 'Trans proline' 0 CA--C 1.509 -0.753 0 C-N-CA 123.409 2.739 . . . . 0.0 110.003 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -91.16 -15.4 29.43 Favored 'General case' 0 CA--C 1.498 -1.041 0 C-N-CA 125.438 1.495 . . . . 0.0 108.222 177.663 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 50.1 m -102.58 149.96 23.89 Favored 'General case' 0 N--CA 1.437 -1.101 0 N-CA-C 107.094 -1.446 . . . . 0.0 107.094 175.425 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 60.0 t-80 -139.28 94.45 9.65 Favored Pre-proline 0 N--CA 1.442 -0.855 0 N-CA-C 107.526 -1.287 . . . . 0.0 107.526 175.729 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -78.21 101.36 1.46 Allowed 'Trans proline' 0 N--CA 1.447 -1.235 0 C-N-CA 123.144 2.562 . . . . 0.0 110.043 174.338 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 11.8 tt -90.58 156.69 3.01 Favored 'Isoleucine or valine' 0 N--CA 1.408 -2.532 0 C-N-CA 126.945 2.098 . . . . 0.0 106.042 176.308 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 25.4 tt0 -139.77 146.45 39.51 Favored 'General case' 0 N--CA 1.432 -1.334 0 N-CA-C 103.662 -2.718 . . . . 0.0 103.662 175.125 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 49.3 p90 -135.08 161.69 34.61 Favored 'General case' 0 N--CA 1.431 -1.379 0 N-CA-C 105.045 -2.205 . . . . 0.0 105.045 178.558 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 3.9 m120 -132.65 127.73 35.54 Favored 'General case' 0 CA--C 1.491 -1.325 0 N-CA-C 105.909 -1.886 . . . . 0.0 105.909 -178.884 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -81.18 159.99 66.59 Favored Pre-proline 0 N--CA 1.441 -0.901 0 C-N-CA 123.533 0.733 . . . . 0.0 111.254 -167.119 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_exo -67.29 173.87 7.99 Favored 'Trans proline' 0 N--CA 1.456 -0.718 0 C-N-CA 123.7 2.933 . . . . 0.0 111.738 166.987 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 49.4 tt0 -80.24 -42.38 1.37 Allowed Pre-proline 0 N--CA 1.444 -0.756 0 CA-C-O 115.63 -2.128 . . . . 0.0 111.522 -177.339 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 74.7 Cg_exo -66.59 148.13 82.93 Favored 'Trans proline' 0 CA--C 1.507 -0.849 0 CA-C-N 125.62 3.043 . . . . 0.0 112.061 177.039 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 24.6 p -98.99 58.52 1.13 Allowed 'General case' 0 C--N 1.355 0.844 0 N-CA-C 107.592 -1.262 . . . . 0.0 107.592 178.46 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 21.1 t-160 -104.38 -5.88 21.29 Favored 'General case' 0 N--CA 1.439 -1.001 0 C-N-CA 125.046 1.338 . . . . 0.0 107.784 178.104 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 56.7 mt -106.73 131.26 57.05 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.21 0 N-CA-C 105.2 -2.148 . . . . 0.0 105.2 178.498 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 75.2 m -104.01 -84.24 0.48 Allowed 'General case' 0 N--CA 1.43 -1.443 0 N-CA-C 106.203 -1.777 . . . . 0.0 106.203 -179.667 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 54.0 mtmt -88.9 167.26 13.37 Favored 'General case' 0 CA--C 1.492 -1.281 0 C-N-CA 123.687 0.795 . . . . 0.0 109.61 -168.801 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 90.0 m-85 -126.04 139.27 53.55 Favored 'General case' 0 N--CA 1.435 -1.196 0 N-CA-C 104.494 -2.41 . . . . 0.0 104.494 165.703 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 1.7 mp -115.03 136.34 52.05 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.132 1 N-CA-C 100.177 -4.009 . . . . 0.0 100.177 167.634 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 3.0 mt -111.53 133.63 53.67 Favored 'General case' 0 CA--C 1.472 -2.052 0 N-CA-C 103.837 -2.653 . . . . 0.0 103.837 164.588 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 16.7 ptp180 -128.73 154.84 45.94 Favored 'General case' 0 N--CA 1.432 -1.345 0 N-CA-C 106.301 -1.74 . . . . 0.0 106.301 169.107 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 48.3 p90 -153.44 144.53 22.94 Favored 'General case' 0 N--CA 1.436 -1.161 0 N-CA-C 106.987 -1.486 . . . . 0.0 106.987 -173.834 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 36.2 ttp180 -142.55 134.04 13.04 Favored Pre-proline 0 CA--C 1.497 -1.09 0 N-CA-C 104.783 -2.303 . . . . 0.0 104.783 -177.859 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 29.8 Cg_endo -72.31 116.71 4.81 Favored 'Trans proline' 0 CA--C 1.505 -0.947 0 C-N-CA 122.928 2.418 . . . . 0.0 108.156 178.364 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 5.5 tmtm? -69.86 85.02 0.49 Allowed 'General case' 0 C--N 1.359 1.011 0 C-N-CA 126.523 1.929 . . . . 0.0 110.242 -174.283 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 33.1 m120 -147.52 -67.78 0.25 Allowed 'General case' 0 N--CA 1.433 -1.286 0 N-CA-C 101.568 -3.493 . . . . 0.0 101.568 -178.71 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 50.8 p -103.28 170.27 8.06 Favored 'General case' 0 N--CA 1.441 -0.918 0 N-CA-C 107.072 -1.455 . . . . 0.0 107.072 171.617 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 3.7 m -119.82 53.42 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.841 0 N-CA-C 106.125 -1.806 . . . . 0.0 106.125 176.45 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -100.32 -131.55 7.41 Favored Glycine 0 C--N 1.356 1.641 0 N-CA-C 109.916 -1.273 . . . . 0.0 109.916 -175.452 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 56.1 ttp180 -79.78 148.51 31.42 Favored 'General case' 0 C--N 1.357 0.9 0 C-N-CA 124.727 1.211 . . . . 0.0 108.694 -175.026 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -148.5 169.86 19.32 Favored 'General case' 0 CA--C 1.494 -1.174 0 CA-C-O 121.468 0.651 . . . . 0.0 110.616 -171.952 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 62.3 mttp -112.3 159.07 19.01 Favored 'General case' 0 CA--C 1.491 -1.292 0 N-CA-C 107.774 -1.195 . . . . 0.0 107.774 -168.849 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 16.2 pt-20 -151.63 160.65 43.55 Favored 'General case' 0 N--CA 1.436 -1.141 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 172.287 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -137.38 163.69 30.42 Favored 'General case' 0 CA--C 1.501 -0.942 0 N-CA-C 106.063 -1.829 . . . . 0.0 106.063 171.68 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 89.4 m -120.41 125.25 47.49 Favored 'General case' 0 CA--C 1.501 -0.913 0 N-CA-C 104.957 -2.238 . . . . 0.0 104.957 175.992 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 5.3 mp -114.11 136.48 22.21 Favored Pre-proline 0 N--CA 1.437 -1.102 0 N-CA-C 105.196 -2.15 . . . . 0.0 105.196 -175.608 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_exo -64.19 163.72 25.09 Favored 'Trans proline' 0 CA--C 1.51 -0.723 0 C-N-CA 123.378 2.719 . . . . 0.0 113.774 176.624 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -76.26 -18.44 79.27 Favored Glycine 0 C--N 1.353 1.49 0 C-N-CA 124.149 0.881 . . . . 0.0 114.244 -174.03 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 52.4 p-80 -83.28 -25.17 31.82 Favored 'General case' 0 C--N 1.355 0.837 0 CA-C-N 117.951 0.876 . . . . 0.0 109.945 -179.044 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 89.0 mt -88.43 131.57 34.81 Favored 'General case' 0 CA--C 1.5 -0.955 0 N-CA-C 107.712 -1.218 . . . . 0.0 107.712 176.797 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 8.6 p-10 -113.74 8.82 17.59 Favored 'General case' 0 CA--C 1.502 -0.89 0 C-N-CA 124.457 1.103 . . . . 0.0 109.631 -174.916 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 33.5 p -146.39 157.73 43.81 Favored 'General case' 0 CA--C 1.498 -1.055 0 N-CA-C 106.633 -1.617 . . . . 0.0 106.633 -177.463 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 35.4 t80 -154.14 151.27 29.06 Favored 'General case' 0 CA--C 1.487 -1.444 0 N-CA-C 108.07 -1.085 . . . . 0.0 108.07 178.236 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 16.9 m -108.64 113.99 27.43 Favored 'General case' 0 N--CA 1.439 -0.979 0 N-CA-C 105.951 -1.87 . . . . 0.0 105.951 174.954 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 45.5 mt -91.95 102.28 13.39 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.89 0 N-CA-C 105.242 -2.132 . . . . 0.0 105.242 178.117 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 35.1 mtmm -106.48 162.32 13.82 Favored 'General case' 0 CA--C 1.497 -1.096 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 -175.785 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 79.93 52.51 4.61 Favored Glycine 0 C--N 1.351 1.365 0 N-CA-C 109.099 -1.6 . . . . 0.0 109.099 178.434 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 89.5 mt -118.12 173.12 6.97 Favored 'General case' 0 CA--C 1.498 -1.023 0 N-CA-C 106.87 -1.53 . . . . 0.0 106.87 -178.778 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 51.6 mtmt -98.14 147.28 32.87 Favored Pre-proline 0 N--CA 1.438 -1.063 0 N-CA-C 105.786 -1.931 . . . . 0.0 105.786 178.666 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -78.56 160.99 28.32 Favored 'Trans proline' 0 N--CA 1.452 -0.93 0 C-N-CA 123.043 2.496 . . . . 0.0 109.997 173.515 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 59.6 30.33 68.52 Favored Glycine 0 C--N 1.356 1.65 0 C-N-CA 126.626 2.06 . . . . 0.0 116.24 169.964 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 6.4 p -128.45 154.62 39.47 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.85 0 N-CA-C 107.813 -1.18 . . . . 0.0 107.813 -176.002 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 4.8 p -96.53 135.69 29.81 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.9 0 N-CA-C 106.769 -1.567 . . . . 0.0 106.769 175.554 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 81.9 m-85 -113.89 147.44 38.48 Favored 'General case' 0 CA--C 1.497 -1.078 0 N-CA-C 105.382 -2.081 . . . . 0.0 105.382 171.432 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 15.2 pt-20 -95.92 136.53 36.23 Favored 'General case' 0 CA--C 1.498 -1.027 0 N-CA-C 103.457 -2.794 . . . . 0.0 103.457 162.016 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -132.62 146.38 18.18 Favored Glycine 0 CA--C 1.485 -1.784 0 N-CA-C 107.679 -2.168 . . . . 0.0 107.679 -172.332 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 83.0 mt-30 -136.74 133.46 36.07 Favored 'General case' 0 CA--C 1.482 -1.65 0 N-CA-C 105.746 -1.946 . . . . 0.0 105.746 178.627 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 49.6 tp -112.63 100.1 8.45 Favored 'General case' 0 N--CA 1.437 -1.108 0 N-CA-C 103.393 -2.817 . . . . 0.0 103.393 179.535 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 21.7 mt -94.83 129.33 45.15 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.915 0 N-CA-C 104.696 -2.335 . . . . 0.0 104.696 -176.797 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 69.2 m -113.5 113.79 25.62 Favored 'General case' 0 CA--C 1.497 -1.092 0 N-CA-C 107.668 -1.234 . . . . 0.0 107.668 -175.276 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 18.5 mm -89.36 142.73 12.47 Favored 'Isoleucine or valine' 0 CA--C 1.49 -1.349 0 N-CA-C 105.514 -2.032 . . . . 0.0 105.514 -173.441 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 83.0 mt-30 -92.5 -175.62 4.04 Favored 'General case' 0 CA--C 1.502 -0.897 0 CA-C-N 114.766 -1.106 . . . . 0.0 109.203 -175.569 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 73.2 mt-30 -74.79 78.22 2.09 Favored 'General case' 0 N--CA 1.442 -0.863 0 C-N-CA 125.84 1.656 . . . . 0.0 112.347 -177.612 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 65.8 m-85 60.06 21.8 10.98 Favored 'General case' 0 C--N 1.358 0.977 0 C-N-CA 127.322 2.249 . . . . 0.0 112.777 178.623 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -119.28 -118.95 2.78 Favored Glycine 0 C--N 1.355 1.597 0 N-CA-C 108.695 -1.762 . . . . 0.0 108.695 -173.847 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' HIS . . . . . 0.518 ' CG ' ' H ' ' A' ' 82' ' ' GLN . 2.4 t60 -81.34 -171.56 3.34 Favored 'General case' 0 CA--C 1.497 -1.065 0 C-N-CA 125.386 1.475 . . . . 0.0 108.902 -177.852 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 82' ' ' GLN . . . . . 0.518 ' H ' ' CG ' ' A' ' 81' ' ' HIS . 5.9 pt20 -144.66 146.48 32.27 Favored 'General case' 0 N--CA 1.434 -1.274 0 N-CA-C 106.067 -1.827 . . . . 0.0 106.067 170.127 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.513 ' HG3' ' H ' ' A' ' 2' ' ' GLY . 46.9 mm-40 -105.19 156.22 18.31 Favored 'General case' 0 CA--C 1.494 -1.178 0 N-CA-C 105.897 -1.89 . . . . 0.0 105.897 179.735 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 7.4 p -129.51 135.76 60.83 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.924 0 N-CA-C 107.308 -1.367 . . . . 0.0 107.308 179.741 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 24.7 m -118.62 133.38 55.9 Favored 'General case' 0 N--CA 1.439 -1.001 0 N-CA-C 102.006 -3.331 . . . . 0.0 102.006 175.467 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 78.6 mtm180 -129.17 147.83 51.05 Favored 'General case' 0 CA--C 1.497 -1.081 0 CA-C-N 119.303 0.956 . . . . 0.0 109.187 -177.698 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 18.5 p90 -166.07 -176.1 3.61 Favored 'General case' 0 CA--C 1.498 -1.025 0 N-CA-C 106.826 -1.546 . . . . 0.0 106.826 -174.79 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -134.58 156.72 48.19 Favored 'General case' 0 N--CA 1.44 -0.962 0 N-CA-C 105.596 -2.001 . . . . 0.0 105.596 164.371 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 23.7 p90 -138.13 165.17 27.3 Favored 'General case' 0 CA--C 1.483 -1.629 0 N-CA-C 107.227 -1.397 . . . . 0.0 107.227 169.449 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 29.4 p -119.67 143.89 47.48 Favored 'General case' 0 N--CA 1.439 -1.004 0 N-CA-C 107.374 -1.343 . . . . 0.0 107.374 176.381 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 19.6 p -108.99 135.06 50.78 Favored 'General case' 0 N--CA 1.439 -1.012 0 N-CA-C 103.613 -2.736 . . . . 0.0 103.613 164.608 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 15.2 t -139.72 149.49 43.69 Favored 'General case' 0 N--CA 1.439 -1.005 0 N-CA-C 106.332 -1.729 . . . . 0.0 106.332 -173.742 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 35.4 t . . . . . 0 C--O 1.261 1.685 0 N-CA-C 105.396 -2.076 . . . . 0.0 105.396 177.99 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 87.8 p . . . . . 0 N--CA 1.489 1.488 0 CA-C-O 121.46 0.648 . . . . 0.0 111.982 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 84.53 -151.16 26.34 Favored Glycine 0 C--N 1.356 1.671 0 N-CA-C 109.136 -1.586 . . . . 0.0 109.136 176.99 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 64.4 Cg_exo -61.48 138.23 74.7 Favored 'Trans proline' 0 N--CA 1.442 -1.508 0 C-N-CA 123.241 2.628 . . . . 0.0 112.957 179.643 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 2.8 t -77.45 153.8 5.42 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.728 0 C-N-CA 127.785 2.434 . . . . 0.0 106.339 -178.527 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 48.7 mm-40 -99.03 88.76 4.05 Favored 'General case' 0 CA--C 1.488 -1.405 0 CA-C-O 122.829 1.3 . . . . 0.0 109.14 -170.133 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 2.4 p -105.66 128.01 60.12 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.07 0 CA-C-N 113.43 -1.714 . . . . 0.0 108.685 -164.376 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 27.5 p90 -130.28 154.35 47.69 Favored 'General case' 0 N--CA 1.44 -0.97 0 N-CA-C 106.703 -1.592 . . . . 0.0 106.703 -174.584 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 40.6 mm -123.99 109.34 22.69 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.236 0 N-CA-C 105.276 -2.12 . . . . 0.0 105.276 -179.666 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 40.5 p -132.58 -152.43 0.5 Allowed 'General case' 0 N--CA 1.444 -0.739 0 N-CA-C 104.451 -2.426 . . . . 0.0 104.451 171.367 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 80.0 tt0 79.51 -18.89 0.47 Allowed 'General case' 0 C--N 1.362 1.149 0 C-N-CA 128.445 2.698 . . . . 0.0 112.35 169.551 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 14.9 p -139.99 109.46 7.07 Favored Pre-proline 0 N--CA 1.446 -0.653 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 -170.418 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -72.17 -31.53 11.87 Favored 'Trans proline' 0 N--CA 1.455 -0.77 0 C-N-CA 122.843 2.362 . . . . 0.0 110.697 164.696 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 11.9 p -169.02 119.47 0.72 Allowed 'General case' 0 N--CA 1.437 -1.076 0 N-CA-C 107.085 -1.45 . . . . 0.0 107.085 -176.12 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 23.9 mm100 -150.57 128.05 5.61 Favored Pre-proline 0 N--CA 1.443 -0.791 0 N-CA-C 104.834 -2.284 . . . . 0.0 104.834 170.418 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 82.0 Cg_endo -84.41 -16.17 5.99 Favored 'Trans proline' 0 CA--C 1.505 -0.952 0 C-N-CA 123.039 2.492 . . . . 0.0 111.544 -173.862 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 4.1 t30 -124.95 -31.99 3.08 Favored 'General case' 0 CA--C 1.488 -1.42 0 CA-C-N 118.637 0.653 . . . . 0.0 109.78 -165.741 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 13.5 p -106.63 141.85 37.24 Favored 'General case' 0 CA--C 1.493 -1.238 0 N-CA-C 107.44 -1.319 . . . . 0.0 107.44 179.22 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 63.0 t60 -141.89 98.22 6.33 Favored Pre-proline 0 N--CA 1.439 -1.024 0 N-CA-C 107.603 -1.258 . . . . 0.0 107.603 176.531 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -78.32 139.11 16.37 Favored 'Trans proline' 0 N--CA 1.449 -1.092 0 C-N-CA 122.814 2.343 . . . . 0.0 110.785 -177.14 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 21.6 mm -106.87 136.27 42.4 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.958 0 N-CA-C 103.104 -2.924 . . . . 0.0 103.104 174.287 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 40.7 mt-30 -138.76 141.28 38.84 Favored 'General case' 0 CA--C 1.491 -1.318 0 N-CA-C 103.494 -2.78 . . . . 0.0 103.494 -178.048 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 46.1 p90 -148.77 167.23 26.14 Favored 'General case' 0 CA--C 1.498 -1.048 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 -170.609 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 9.5 m120 -131.19 129.53 41.82 Favored 'General case' 0 CA--C 1.492 -1.259 0 N-CA-C 107.441 -1.318 . . . . 0.0 107.441 178.868 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -94.71 170.58 7.85 Favored Pre-proline 0 N--CA 1.439 -0.999 0 C-N-CA 124.468 1.107 . . . . 0.0 109.879 -170.97 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 80.2 Cg_exo -66.06 164.13 28.77 Favored 'Trans proline' 0 CA--C 1.508 -0.807 0 C-N-CA 123.633 2.888 . . . . 0.0 112.222 168.929 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 17.4 mp0 -83.3 -57.34 0.43 Allowed Pre-proline 0 N--CA 1.442 -0.826 0 CA-C-O 115.844 -2.027 . . . . 0.0 110.402 -177.132 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -74.87 171.88 17.42 Favored 'Trans proline' 0 CA--C 1.509 -0.743 0 CA-C-N 125.499 3.0 . . . . 0.0 110.349 177.702 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 66.0 m -75.93 125.86 29.9 Favored 'General case' 0 CA--C 1.501 -0.933 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 -179.635 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 26.7 t-80 -162.37 -49.89 0.04 OUTLIER 'General case' 0 N--CA 1.436 -1.17 0 N-CA-C 106.202 -1.777 . . . . 0.0 106.202 -172.813 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 54.0 mt -113.06 136.53 49.08 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.142 0 N-CA-C 105.203 -2.147 . . . . 0.0 105.203 -177.109 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 32.1 t -110.53 -87.5 0.52 Allowed 'General case' 0 N--CA 1.43 -1.474 0 N-CA-C 106.717 -1.586 . . . . 0.0 106.717 179.028 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 6.7 ttpm? -91.86 160.49 15.27 Favored 'General case' 0 CA--C 1.492 -1.262 0 C-N-CA 125.667 1.587 . . . . 0.0 107.649 -160.155 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 92.0 m-85 -125.58 138.91 53.96 Favored 'General case' 0 CA--C 1.494 -1.185 0 N-CA-C 106.277 -1.749 . . . . 0.0 106.277 176.072 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 53.5 mt -116.92 126.82 74.55 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.152 0 N-CA-C 102.592 -3.114 . . . . 0.0 102.592 168.483 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 5.0 mt -102.2 128.65 48.61 Favored 'General case' 0 CA--C 1.475 -1.912 0 N-CA-C 104.894 -2.261 . . . . 0.0 104.894 170.556 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 42.4 ttp85 -132.47 122.0 24.23 Favored 'General case' 0 N--CA 1.437 -1.115 0 N-CA-C 106.097 -1.816 . . . . 0.0 106.097 -178.71 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 42.3 p90 -138.06 151.1 47.52 Favored 'General case' 0 N--CA 1.444 -0.757 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 -169.994 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 33.2 ptt180 -155.92 164.47 21.25 Favored Pre-proline 0 CA--C 1.502 -0.897 0 N-CA-C 106.605 -1.628 . . . . 0.0 106.605 171.384 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' PRO . . . . . 0.416 ' HA ' ' HA ' ' A' ' 69' ' ' TYR . 37.7 Cg_endo -75.69 127.27 10.09 Favored 'Trans proline' 0 N--CA 1.452 -0.932 0 C-N-CA 122.344 2.029 . . . . 0.0 108.983 179.141 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 64.0 tttm -69.75 83.07 0.45 Allowed 'General case' 0 C--N 1.357 0.921 0 C-N-CA 127.349 2.259 . . . . 0.0 110.821 -177.588 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 29.1 m120 -145.9 -89.81 0.1 Allowed 'General case' 0 N--CA 1.437 -1.091 0 N-CA-C 105.054 -2.202 . . . . 0.0 105.054 -175.958 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 3.7 t -94.31 -164.95 1.23 Allowed 'General case' 0 C--N 1.355 0.819 0 C-N-CA 124.032 0.933 . . . . 0.0 108.924 -172.641 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 4.2 m -121.17 54.51 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.439 -1.003 0 N-CA-C 106.307 -1.738 . . . . 0.0 106.307 -176.648 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -89.8 -140.2 7.93 Favored Glycine 0 C--N 1.355 1.595 0 N-CA-C 110.281 -1.128 . . . . 0.0 110.281 -178.179 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -99.33 165.01 11.88 Favored 'General case' 0 CA--C 1.503 -0.831 0 N-CA-C 106.484 -1.672 . . . . 0.0 106.484 -178.332 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 47.3 m95 -112.34 156.73 21.98 Favored 'General case' 0 N--CA 1.441 -0.912 0 N-CA-C 108.071 -1.085 . . . . 0.0 108.071 -179.09 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 67.9 mttm -97.46 152.25 19.17 Favored 'General case' 0 CA--C 1.49 -1.352 0 N-CA-C 104.779 -2.304 . . . . 0.0 104.779 163.824 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -153.18 156.62 38.91 Favored 'General case' 0 CA--C 1.494 -1.191 0 N-CA-C 107.833 -1.173 . . . . 0.0 107.833 178.854 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -141.07 162.93 34.32 Favored 'General case' 0 CA--C 1.496 -1.132 0 N-CA-C 106.349 -1.723 . . . . 0.0 106.349 175.876 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 88.1 m -122.36 127.24 49.51 Favored 'General case' 0 CA--C 1.501 -0.933 0 N-CA-C 105.242 -2.133 . . . . 0.0 105.242 -179.705 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 4.8 mp -117.38 133.88 23.17 Favored Pre-proline 0 N--CA 1.437 -1.106 0 N-CA-C 104.613 -2.366 . . . . 0.0 104.613 -174.725 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_exo -63.32 166.19 15.6 Favored 'Trans proline' 0 CA--C 1.509 -0.742 0 C-N-CA 123.344 2.696 . . . . 0.0 113.616 176.677 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -81.14 -17.18 72.59 Favored Glycine 0 C--N 1.351 1.405 0 C-N-CA 123.557 0.598 . . . . 0.0 113.099 -172.073 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 52.2 p-80 -83.66 -24.8 31.19 Favored 'General case' 0 C--N 1.355 0.841 0 CA-C-N 117.889 0.845 . . . . 0.0 109.862 179.88 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 87.4 mt -88.18 130.67 34.99 Favored 'General case' 0 CA--C 1.501 -0.94 0 N-CA-C 107.645 -1.243 . . . . 0.0 107.645 177.139 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 8.1 p30 -110.15 7.95 23.59 Favored 'General case' 0 N--CA 1.441 -0.881 0 C-N-CA 124.708 1.203 . . . . 0.0 109.758 -174.937 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 42.1 p -146.5 167.03 24.69 Favored 'General case' 0 N--CA 1.439 -1.0 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 -178.14 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 9.3 t80 -153.29 178.37 9.84 Favored 'General case' 0 N--CA 1.439 -1.023 0 N-CA-C 107.1 -1.444 . . . . 0.0 107.1 -178.275 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 70.0 m -142.0 116.22 9.47 Favored 'General case' 0 N--CA 1.43 -1.459 0 N-CA-C 104.812 -2.292 . . . . 0.0 104.812 176.632 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 12.7 mm -85.75 140.18 16.3 Favored 'Isoleucine or valine' 0 C--N 1.358 0.964 0 N-CA-C 103.856 -2.646 . . . . 0.0 103.856 170.332 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 7.9 mtpm? -141.7 164.65 29.64 Favored 'General case' 0 CA--C 1.497 -1.063 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 178.938 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 85.86 49.49 4.28 Favored Glycine 0 CA--C 1.487 -1.669 0 N-CA-C 108.931 -1.668 . . . . 0.0 108.931 174.843 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 58.1 mt -118.77 170.15 9.24 Favored 'General case' 0 CA--C 1.497 -1.071 0 N-CA-C 108.528 -0.916 . . . . 0.0 108.528 -169.864 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 60.6 mtpt -110.46 155.16 42.51 Favored Pre-proline 0 N--CA 1.44 -0.929 0 N-CA-C 106.942 -1.503 . . . . 0.0 106.942 -176.478 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 63.9 Cg_endo -78.94 161.04 27.1 Favored 'Trans proline' 0 N--CA 1.452 -0.966 0 C-N-CA 122.91 2.407 . . . . 0.0 110.308 172.982 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 0.438 ' H ' ' HA ' ' A' ' 92' ' ' THR . . . 59.47 26.27 61.8 Favored Glycine 0 C--N 1.355 1.586 0 C-N-CA 127.673 2.559 . . . . 0.0 116.378 171.29 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 10.7 p -121.77 147.45 25.76 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.992 0 N-CA-C 107.362 -1.348 . . . . 0.0 107.362 -177.203 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 4.0 p -96.73 129.15 47.19 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.951 0 N-CA-C 106.93 -1.507 . . . . 0.0 106.93 177.125 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' TYR . . . . . 0.416 ' HA ' ' HA ' ' A' ' 39' ' ' PRO . 93.4 m-85 -111.18 144.84 39.7 Favored 'General case' 0 CA--C 1.496 -1.113 0 N-CA-C 106.043 -1.836 . . . . 0.0 106.043 173.124 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -96.72 145.12 26.09 Favored 'General case' 0 CA--C 1.496 -1.128 0 N-CA-C 104.475 -2.417 . . . . 0.0 104.475 166.103 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -140.97 155.77 25.16 Favored Glycine 0 CA--C 1.486 -1.731 0 N-CA-C 108.624 -1.791 . . . . 0.0 108.624 -176.275 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 86.8 mt-30 -142.9 134.39 26.34 Favored 'General case' 0 CA--C 1.479 -1.782 0 N-CA-C 104.456 -2.424 . . . . 0.0 104.456 -179.333 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 35.6 tp -114.77 96.17 5.59 Favored 'General case' 0 N--CA 1.437 -1.102 0 N-CA-C 103.659 -2.719 . . . . 0.0 103.659 176.468 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 21.8 mt -88.76 135.37 25.92 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.048 0 N-CA-C 104.213 -2.514 . . . . 0.0 104.213 -177.275 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 14.2 p -124.96 112.14 16.24 Favored 'General case' 0 N--CA 1.435 -1.212 0 N-CA-C 107.777 -1.194 . . . . 0.0 107.777 -171.771 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 2.0 mp -93.48 134.84 29.87 Favored 'Isoleucine or valine' 0 CA--C 1.488 -1.41 0 N-CA-C 104.506 -2.405 . . . . 0.0 104.506 -165.703 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 74.4 mt-30 -92.66 149.9 21.04 Favored 'General case' 0 CA--C 1.493 -1.249 0 N-CA-C 106.522 -1.659 . . . . 0.0 106.522 -178.687 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 44.6 tt0 -70.46 105.71 3.16 Favored 'General case' 0 N--CA 1.441 -0.894 0 C-N-CA 123.44 0.696 . . . . 0.0 110.408 -177.997 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 31.6 m-85 59.94 41.03 18.29 Favored 'General case' 0 C--N 1.356 0.883 0 C-N-CA 127.094 2.157 . . . . 0.0 112.469 -178.626 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -149.94 -126.11 1.39 Allowed Glycine 0 C--N 1.358 1.752 0 N-CA-C 109.283 -1.527 . . . . 0.0 109.283 178.738 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 47.1 m80 -85.11 -176.26 6.1 Favored 'General case' 0 CA--C 1.497 -1.071 0 C-N-CA 126.107 1.763 . . . . 0.0 111.436 -165.555 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 36.7 mt-30 -130.42 144.47 51.41 Favored 'General case' 0 CA--C 1.496 -1.101 0 N-CA-C 103.975 -2.602 . . . . 0.0 103.975 168.659 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 57.3 mt-10 -131.28 131.32 43.77 Favored 'General case' 0 CA--C 1.491 -1.304 0 N-CA-C 105.312 -2.107 . . . . 0.0 105.312 179.721 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 12.4 p -104.48 134.82 44.78 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.799 0 N-CA-C 108.137 -1.06 . . . . 0.0 108.137 -174.914 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 40.0 m -109.11 131.71 54.81 Favored 'General case' 0 N--CA 1.44 -0.926 0 N-CA-C 101.831 -3.396 . . . . 0.0 101.831 171.403 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 87.5 mtt180 -123.75 149.01 46.11 Favored 'General case' 0 CA--C 1.494 -1.174 0 CA-C-N 119.491 1.041 . . . . 0.0 109.901 -177.92 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 14.8 p90 -163.25 -179.61 6.73 Favored 'General case' 0 CA--C 1.499 -0.988 0 N-CA-C 107.209 -1.404 . . . . 0.0 107.209 -179.149 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 9.3 p-10 -141.31 160.16 40.7 Favored 'General case' 0 N--CA 1.44 -0.963 0 N-CA-C 105.865 -1.902 . . . . 0.0 105.865 167.005 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 23.4 p90 -148.3 170.17 18.5 Favored 'General case' 0 CA--C 1.49 -1.358 0 N-CA-C 107.332 -1.358 . . . . 0.0 107.332 177.294 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 23.9 p -119.25 142.53 47.97 Favored 'General case' 0 CA--C 1.498 -1.024 0 N-CA-C 105.696 -1.965 . . . . 0.0 105.696 171.458 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 45.0 m -115.7 119.83 37.35 Favored 'General case' 0 CA--C 1.495 -1.143 0 N-CA-C 102.614 -3.106 . . . . 0.0 102.614 170.989 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' THR . . . . . 0.438 ' HA ' ' H ' ' A' ' 66' ' ' GLY . 14.1 t -154.38 159.19 41.0 Favored 'General case' 0 N--CA 1.436 -1.144 0 N-CA-C 105.901 -1.888 . . . . 0.0 105.901 -173.205 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 9.4 t . . . . . 0 C--O 1.262 1.714 0 N-CA-C 106.356 -1.72 . . . . 0.0 106.356 175.042 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 18.7 t . . . . . 0 N--CA 1.483 1.192 0 N-CA-C 109.395 -0.595 . . . . 0.0 109.395 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 155.93 -161.62 30.8 Favored Glycine 0 C--N 1.351 1.382 0 N-CA-C 106.767 -2.533 . . . . 0.0 106.767 -178.324 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_exo -61.2 142.47 96.63 Favored 'Trans proline' 0 N--CA 1.446 -1.307 0 C-N-CA 122.837 2.358 . . . . 0.0 114.523 -171.68 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 4.4 t -76.27 154.29 5.89 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.83 0 C-N-CA 127.889 2.476 . . . . 0.0 106.608 -179.06 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 56.6 mm-40 -99.81 92.88 5.51 Favored 'General case' 0 CA--C 1.49 -1.357 0 N-CA-C 107.412 -1.329 . . . . 0.0 107.412 -177.613 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 1.3 p -108.1 131.32 58.82 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.067 0 CA-C-N 113.15 -1.841 . . . . 0.0 108.684 -164.512 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 40.0 m-85 -94.08 144.42 25.5 Favored 'General case' 0 CA--C 1.498 -1.027 0 N-CA-C 106.611 -1.626 . . . . 0.0 106.611 173.823 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 36.0 mm -114.56 96.26 4.49 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.235 0 N-CA-C 102.911 -2.996 . . . . 0.0 102.911 178.245 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 40.6 p -88.44 98.58 11.71 Favored 'General case' 0 N--CA 1.443 -0.805 0 CA-C-O 122.401 1.096 . . . . 0.0 109.776 -172.336 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 92.3 mt-10 -107.08 40.73 1.6 Allowed 'General case' 0 N--CA 1.443 -0.786 0 N-CA-C 105.874 -1.898 . . . . 0.0 105.874 173.595 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 48.3 m -85.74 -57.27 0.36 Allowed Pre-proline 0 N--CA 1.441 -0.913 0 CA-C-O 115.828 -2.034 . . . . 0.0 108.862 178.36 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_endo -74.69 171.8 17.5 Favored 'Trans proline' 0 CA--C 1.512 -0.596 0 CA-C-N 125.39 2.961 . . . . 0.0 110.381 177.242 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 73.3 m -123.15 103.24 8.43 Favored 'General case' 0 N--CA 1.433 -1.306 0 N-CA-C 106.107 -1.812 . . . . 0.0 106.107 -172.959 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 26.9 mp0 -140.71 134.22 14.91 Favored Pre-proline 0 N--CA 1.442 -0.831 0 N-CA-C 104.084 -2.562 . . . . 0.0 104.084 169.495 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 95.7 Cg_endo -81.91 -11.56 11.2 Favored 'Trans proline' 0 N--CA 1.452 -0.928 0 C-N-CA 123.012 2.475 . . . . 0.0 110.596 -175.762 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 48.5 m-20 -125.02 -20.92 4.8 Favored 'General case' 0 N--CA 1.434 -1.25 0 C-N-CA 123.617 0.767 . . . . 0.0 109.938 -171.791 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 19.4 m -103.8 142.0 35.13 Favored 'General case' 0 CA--C 1.494 -1.192 0 N-CA-C 106.993 -1.484 . . . . 0.0 106.993 178.677 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 48.5 t60 -139.29 98.0 8.37 Favored Pre-proline 0 N--CA 1.434 -1.273 0 N-CA-C 105.513 -2.032 . . . . 0.0 105.513 176.819 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -80.55 148.86 18.45 Favored 'Trans proline' 0 N--CA 1.445 -1.327 0 C-N-CA 122.468 2.112 . . . . 0.0 109.403 174.315 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.414 HD11 HD11 ' A' ' 35' ' ' LEU . 5.0 pt -124.38 170.72 14.19 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.031 0 N-CA-C 107.525 -1.287 . . . . 0.0 107.525 172.324 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 32.5 mt-30 -139.04 161.17 38.04 Favored 'General case' 0 CA--C 1.501 -0.926 0 N-CA-C 105.161 -2.163 . . . . 0.0 105.161 167.884 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 49.5 p90 -148.56 169.39 20.41 Favored 'General case' 0 CA--C 1.497 -1.089 0 N-CA-C 108.136 -1.061 . . . . 0.0 108.136 175.679 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 20.8 m-80 -134.12 126.04 29.21 Favored 'General case' 0 CA--C 1.491 -1.308 0 N-CA-C 105.573 -2.01 . . . . 0.0 105.573 173.965 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -105.75 175.96 1.9 Allowed Pre-proline 0 N--CA 1.44 -0.969 0 C-N-CA 125.823 1.649 . . . . 0.0 107.647 -169.967 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_exo -61.6 144.86 97.92 Favored 'Trans proline' 0 N--CA 1.455 -0.766 0 C-N-CA 123.174 2.583 . . . . 0.0 113.151 176.488 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 22.0 tt0 -82.8 -39.98 0.83 Allowed Pre-proline 0 N--CA 1.443 -0.818 0 CA-C-O 115.564 -2.16 . . . . 0.0 112.726 -173.034 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 76.2 Cg_exo -72.18 4.65 3.15 Favored 'Trans proline' 0 C--N 1.349 0.561 0 CA-C-N 125.687 3.067 . . . . 0.0 114.679 -178.234 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 34.7 m 71.89 64.66 0.14 Allowed 'General case' 0 CA--C 1.499 -0.984 0 C-N-CA 126.464 1.905 . . . . 0.0 109.06 -178.432 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 55.9 t-80 -87.0 -28.11 22.83 Favored 'General case' 0 N--CA 1.44 -0.957 0 C-N-CA 125.127 1.371 . . . . 0.0 108.25 178.772 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 8.2 mm -119.29 147.61 22.76 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.15 0 N-CA-C 106.395 -1.706 . . . . 0.0 106.395 -170.959 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 74.5 m -99.35 -83.9 0.42 Allowed 'General case' 0 N--CA 1.43 -1.45 0 N-CA-C 106.406 -1.701 . . . . 0.0 106.406 175.896 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 45.5 mtpt -90.0 170.48 10.32 Favored 'General case' 0 CA--C 1.49 -1.349 0 C-N-CA 125.259 1.424 . . . . 0.0 109.198 -164.242 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 42.2 m-85 -131.39 145.4 51.8 Favored 'General case' 0 CA--C 1.498 -1.032 0 N-CA-C 104.589 -2.374 . . . . 0.0 104.589 166.624 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 33.1 mt -123.34 137.37 56.89 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.188 0 N-CA-C 101.792 -3.41 . . . . 0.0 101.792 170.248 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.414 HD11 HD11 ' A' ' 20' ' ' ILE . 4.7 mt -114.09 134.47 54.86 Favored 'General case' 0 CA--C 1.467 -2.214 0 N-CA-C 104.64 -2.356 . . . . 0.0 104.64 168.764 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 49.0 mtp180 -118.05 158.74 24.44 Favored 'General case' 0 N--CA 1.431 -1.417 0 N-CA-C 105.381 -2.081 . . . . 0.0 105.381 167.301 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 49.5 p90 -152.63 158.29 42.21 Favored 'General case' 0 N--CA 1.435 -1.21 0 N-CA-C 105.981 -1.859 . . . . 0.0 105.981 173.033 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 46.9 ttp180 -165.08 135.99 3.14 Favored Pre-proline 0 CA--C 1.497 -1.078 0 N-CA-C 104.783 -2.303 . . . . 0.0 104.783 -174.168 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -73.06 117.06 4.95 Favored 'Trans proline' 0 CA--C 1.505 -0.969 0 C-N-CA 122.766 2.311 . . . . 0.0 109.132 -176.829 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 37.9 ttpt -70.71 88.0 0.7 Allowed 'General case' 0 CA--C 1.499 -0.982 0 C-N-CA 126.414 1.886 . . . . 0.0 109.621 -179.939 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 -154.32 -58.55 0.12 Allowed 'General case' 0 N--CA 1.431 -1.401 0 N-CA-C 103.447 -2.797 . . . . 0.0 103.447 -178.521 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 6.4 t -107.32 -167.53 1.28 Allowed 'General case' 0 N--CA 1.439 -0.977 0 N-CA-C 105.228 -2.138 . . . . 0.0 105.228 169.376 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 2.7 m -134.84 63.44 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.44 -0.957 0 N-CA-C 104.823 -2.288 . . . . 0.0 104.823 179.18 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -91.23 -134.71 6.21 Favored Glycine 0 C--N 1.354 1.545 0 N-CA-C 109.819 -1.312 . . . . 0.0 109.819 -176.415 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -94.37 149.57 21.12 Favored 'General case' 0 CA--C 1.499 -1.003 0 N-CA-C 106.871 -1.529 . . . . 0.0 106.871 -176.498 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 64.2 m95 -93.84 151.42 19.61 Favored 'General case' 0 N--CA 1.439 -1.022 0 N-CA-C 107.703 -1.221 . . . . 0.0 107.703 178.825 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 61.9 mttp -96.99 152.32 18.84 Favored 'General case' 0 CA--C 1.488 -1.433 0 N-CA-C 104.105 -2.554 . . . . 0.0 104.105 161.073 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -152.69 155.44 37.27 Favored 'General case' 0 N--CA 1.435 -1.204 0 N-CA-C 108.23 -1.026 . . . . 0.0 108.23 -178.073 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -140.85 161.48 37.72 Favored 'General case' 0 CA--C 1.498 -1.028 0 N-CA-C 106.556 -1.646 . . . . 0.0 106.556 174.74 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 87.0 m -118.83 124.82 48.12 Favored 'General case' 0 CA--C 1.5 -0.954 0 N-CA-C 105.517 -2.031 . . . . 0.0 105.517 178.807 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 3.9 mp -106.13 134.37 19.8 Favored Pre-proline 0 N--CA 1.437 -1.099 0 N-CA-C 105.279 -2.119 . . . . 0.0 105.279 -177.468 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_exo -63.93 163.07 26.53 Favored 'Trans proline' 0 CA--C 1.507 -0.833 0 C-N-CA 123.491 2.794 . . . . 0.0 113.146 176.115 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -74.49 -17.14 79.82 Favored Glycine 0 C--N 1.351 1.41 0 C-N-CA 124.006 0.812 . . . . 0.0 114.477 -173.68 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 49.1 p-80 -84.04 -28.69 27.45 Favored 'General case' 0 C--N 1.355 0.826 0 CA-C-N 118.144 0.972 . . . . 0.0 110.22 -179.69 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 89.1 mt -88.74 130.83 35.26 Favored 'General case' 0 CA--C 1.5 -0.961 0 N-CA-C 107.94 -1.133 . . . . 0.0 107.94 178.07 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 7.7 p30 -117.1 11.37 14.18 Favored 'General case' 0 CA--C 1.503 -0.835 0 C-N-CA 124.225 1.01 . . . . 0.0 109.774 -173.563 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 28.1 p -141.02 159.83 41.38 Favored 'General case' 0 CA--C 1.497 -1.081 0 N-CA-C 106.583 -1.636 . . . . 0.0 106.583 179.427 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 7.9 t80 -135.65 172.95 12.27 Favored 'General case' 0 C--N 1.359 1.003 0 CA-C-O 121.829 0.823 . . . . 0.0 109.254 178.84 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 98.8 m -137.18 110.79 8.04 Favored 'General case' 0 N--CA 1.434 -1.257 0 N-CA-C 104.425 -2.435 . . . . 0.0 104.425 173.77 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 24.9 mt -89.28 143.39 11.27 Favored 'Isoleucine or valine' 0 C--N 1.358 0.945 0 N-CA-C 103.662 -2.718 . . . . 0.0 103.662 169.854 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -149.55 158.1 43.87 Favored 'General case' 0 CA--C 1.491 -1.302 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 -178.85 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 77.75 56.58 3.79 Favored Glycine 0 C--N 1.354 1.561 0 N-CA-C 108.984 -1.646 . . . . 0.0 108.984 -179.904 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 69.1 mt -117.08 -160.83 0.78 Allowed 'General case' 0 CA--C 1.5 -0.944 0 N-CA-C 106.584 -1.636 . . . . 0.0 106.584 -179.012 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -131.39 153.42 81.62 Favored Pre-proline 0 N--CA 1.443 -0.811 0 N-CA-C 106.067 -1.827 . . . . 0.0 106.067 -177.78 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 67.6 Cg_endo -79.4 162.45 25.12 Favored 'Trans proline' 0 N--CA 1.453 -0.886 0 C-N-CA 122.858 2.372 . . . . 0.0 109.925 171.893 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 0.504 ' H ' ' HA ' ' A' ' 92' ' ' THR . . . 61.17 26.96 66.62 Favored Glycine 0 N--CA 1.431 -1.646 0 C-N-CA 127.27 2.367 . . . . 0.0 115.972 171.509 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 9.1 p -127.59 142.92 42.31 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.116 0 N-CA-C 108.28 -1.007 . . . . 0.0 108.28 -177.83 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 7.5 p -95.58 128.41 46.79 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.929 0 N-CA-C 107.463 -1.31 . . . . 0.0 107.463 177.029 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 91.5 m-85 -107.73 148.46 29.42 Favored 'General case' 0 CA--C 1.498 -1.039 0 N-CA-C 106.382 -1.71 . . . . 0.0 106.382 174.235 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -98.98 140.04 33.73 Favored 'General case' 0 CA--C 1.496 -1.121 0 N-CA-C 104.397 -2.445 . . . . 0.0 104.397 161.826 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -131.96 153.29 20.45 Favored Glycine 0 CA--C 1.484 -1.848 0 N-CA-C 107.688 -2.165 . . . . 0.0 107.688 -175.807 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 36.7 mt-30 -135.58 136.18 40.88 Favored 'General case' 0 CA--C 1.478 -1.791 0 N-CA-C 105.935 -1.876 . . . . 0.0 105.935 175.166 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 27.1 tp -114.39 103.31 10.94 Favored 'General case' 0 N--CA 1.438 -1.063 0 N-CA-C 104.179 -2.526 . . . . 0.0 104.179 176.456 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 24.4 mt -103.25 125.11 57.77 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.973 0 N-CA-C 104.068 -2.568 . . . . 0.0 104.068 -174.23 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 74.2 m -110.28 120.75 43.45 Favored 'General case' 0 CA--C 1.497 -1.091 0 N-CA-C 108.251 -1.018 . . . . 0.0 108.251 -175.653 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 1.8 mp -99.85 138.38 24.38 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.123 0 N-CA-C 104.647 -2.353 . . . . 0.0 104.647 -170.798 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 16.3 tt0 -105.09 127.84 53.07 Favored 'General case' 0 CA--C 1.494 -1.207 0 N-CA-C 102.02 -3.326 . . . . 0.0 102.02 170.692 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 63.5 tp60 -68.38 114.68 7.03 Favored 'General case' 0 C--N 1.355 0.825 0 C-N-CA 123.117 0.567 . . . . 0.0 111.163 -168.77 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 44.4 m-85 59.33 51.68 6.57 Favored 'General case' 0 C--N 1.358 0.936 0 C-N-CA 126.917 2.087 . . . . 0.0 111.703 -175.498 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -164.73 -117.29 0.4 Allowed Glycine 0 N--CA 1.434 -1.464 0 N-CA-C 108.503 -1.839 . . . . 0.0 108.503 178.042 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 24.0 t-80 -82.08 165.52 20.52 Favored 'General case' 0 N--CA 1.441 -0.919 0 C-N-CA 125.706 1.603 . . . . 0.0 110.795 -169.097 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 41.6 mt-30 -139.96 128.67 23.14 Favored 'General case' 0 CA--C 1.495 -1.151 0 N-CA-C 104.192 -2.521 . . . . 0.0 104.192 169.044 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -99.82 154.31 18.44 Favored 'General case' 0 CA--C 1.498 -1.033 0 N-CA-C 105.363 -2.088 . . . . 0.0 105.363 175.598 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 7.6 p -135.26 135.71 51.93 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.885 0 N-CA-C 107.929 -1.137 . . . . 0.0 107.929 177.533 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 48.6 m -122.01 141.5 51.28 Favored 'General case' 0 N--CA 1.44 -0.939 0 N-CA-C 103.143 -2.91 . . . . 0.0 103.143 175.742 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 32.2 ttm180 -131.72 139.42 49.0 Favored 'General case' 0 CA--C 1.502 -0.891 0 N-CA-C 107.805 -1.183 . . . . 0.0 107.805 170.346 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 8.2 p90 -146.25 179.58 7.41 Favored 'General case' 0 N--CA 1.439 -0.979 0 N-CA-C 105.807 -1.923 . . . . 0.0 105.807 177.985 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 52.9 m-20 -128.09 152.95 47.37 Favored 'General case' 0 CA--C 1.5 -0.96 0 N-CA-C 105.757 -1.942 . . . . 0.0 105.757 169.481 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 21.8 p90 -143.56 166.37 25.02 Favored 'General case' 0 CA--C 1.485 -1.548 0 N-CA-C 107.498 -1.297 . . . . 0.0 107.498 170.42 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 27.8 p -118.56 143.3 46.86 Favored 'General case' 0 CA--C 1.497 -1.082 0 N-CA-C 106.051 -1.833 . . . . 0.0 106.051 173.672 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 30.3 m -118.39 113.18 21.0 Favored 'General case' 0 CA--C 1.494 -1.185 0 N-CA-C 101.576 -3.49 . . . . 0.0 101.576 170.068 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' THR . . . . . 0.504 ' HA ' ' H ' ' A' ' 66' ' ' GLY . 10.0 t -157.57 -37.37 0.07 Allowed 'General case' 0 N--CA 1.437 -1.088 0 N-CA-C 107.819 -1.178 . . . . 0.0 107.819 -169.088 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 89.4 p . . . . . 0 C--O 1.259 1.592 0 C-N-CA 126.962 2.105 . . . . 0.0 112.192 -174.66 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 85.1 p . . . . . 0 N--CA 1.487 1.416 0 CA-C-O 121.632 0.729 . . . . 0.0 111.89 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 173.97 179.0 44.32 Favored Glycine 0 N--CA 1.436 -1.353 0 N-CA-C 107.075 -2.41 . . . . 0.0 107.075 178.825 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_exo -60.23 146.8 95.62 Favored 'Trans proline' 0 N--CA 1.446 -1.309 0 C-N-CA 123.151 2.567 . . . . 0.0 115.553 -169.676 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 6.7 t -77.42 153.12 5.44 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.773 0 C-N-CA 127.631 2.372 . . . . 0.0 105.424 174.309 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 94.7 mt-10 -100.27 95.26 6.67 Favored 'General case' 0 CA--C 1.494 -1.19 0 CA-C-O 121.885 0.85 . . . . 0.0 108.742 -170.621 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 1.8 p -115.3 136.05 53.32 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.999 0 C-N-CA 124.938 1.295 . . . . 0.0 108.365 -164.777 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 83.3 m-85 -86.74 148.78 25.28 Favored 'General case' 0 CA--C 1.498 -1.03 0 C-N-CA 125.063 1.345 . . . . 0.0 108.589 -179.14 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 45.2 mt -120.04 144.22 29.38 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.973 0 N-CA-C 102.826 -3.027 . . . . 0.0 102.826 179.377 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 24.9 p -126.89 99.89 5.93 Favored 'General case' 0 C--N 1.356 0.85 0 N-CA-C 105.897 -1.89 . . . . 0.0 105.897 176.209 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -106.73 34.22 3.53 Favored 'General case' 0 C--N 1.356 0.878 0 N-CA-C 108.025 -1.102 . . . . 0.0 108.025 177.284 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 33.1 p -89.45 157.96 46.52 Favored Pre-proline 0 N--CA 1.443 -0.817 0 N-CA-C 106.365 -1.717 . . . . 0.0 106.365 175.713 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 63.9 Cg_endo -78.36 84.04 2.1 Favored 'Trans proline' 0 N--CA 1.45 -1.042 0 C-N-CA 122.878 2.385 . . . . 0.0 109.178 169.306 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 63.0 m -157.54 32.29 0.27 Allowed 'General case' 0 CA--C 1.498 -1.048 0 CA-C-O 122.473 1.13 . . . . 0.0 110.514 -178.969 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 14.0 mp0 -138.39 86.85 16.17 Favored Pre-proline 0 CA--C 1.507 -0.692 0 CA-C-N 114.183 -1.371 . . . . 0.0 108.588 -178.894 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -86.9 -2.85 8.15 Favored 'Trans proline' 0 N--CA 1.449 -1.089 0 C-N-CA 122.478 2.119 . . . . 0.0 110.565 -177.578 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 10.0 p-10 -165.8 -39.22 0.03 OUTLIER 'General case' 0 CA--C 1.488 -1.412 0 O-C-N 123.711 0.632 . . . . 0.0 110.469 -174.854 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 15.5 p -126.42 138.22 53.51 Favored 'General case' 0 CA--C 1.489 -1.371 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 -169.078 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 57.5 t-80 -117.56 113.75 38.34 Favored Pre-proline 0 N--CA 1.438 -1.027 0 CA-C-N 114.238 -1.346 . . . . 0.0 107.878 -175.377 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 62.5 Cg_endo -78.28 128.6 9.02 Favored 'Trans proline' 0 N--CA 1.45 -1.04 0 C-N-CA 122.949 2.433 . . . . 0.0 110.405 175.813 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 9.6 mm -105.92 136.08 41.65 Favored 'Isoleucine or valine' 0 C--N 1.354 0.792 0 N-CA-C 103.485 -2.783 . . . . 0.0 103.485 169.833 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 67.5 mt-30 -136.41 147.8 47.46 Favored 'General case' 0 CA--C 1.495 -1.148 0 N-CA-C 104.562 -2.384 . . . . 0.0 104.562 174.18 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 45.9 p90 -147.15 170.04 18.03 Favored 'General case' 0 CA--C 1.494 -1.186 0 N-CA-C 108.002 -1.11 . . . . 0.0 108.002 -175.673 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 26.6 m-80 -136.01 131.82 35.5 Favored 'General case' 0 CA--C 1.49 -1.354 0 N-CA-C 105.377 -2.083 . . . . 0.0 105.377 177.635 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -101.2 170.91 5.94 Favored Pre-proline 0 N--CA 1.439 -0.992 0 C-N-CA 124.541 1.136 . . . . 0.0 108.402 -172.651 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_exo -64.9 165.32 21.63 Favored 'Trans proline' 0 CA--C 1.51 -0.694 0 C-N-CA 123.701 2.934 . . . . 0.0 112.83 173.712 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 79.8 mt-30 -81.51 -55.61 0.62 Allowed Pre-proline 0 N--CA 1.442 -0.829 0 CA-C-O 115.612 -2.137 . . . . 0.0 112.042 -175.58 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_endo -75.29 173.56 14.3 Favored 'Trans proline' 0 CA--C 1.509 -0.726 0 CA-C-N 125.797 3.106 . . . . 0.0 110.431 -179.581 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 52.3 p -73.1 123.83 24.35 Favored 'General case' 0 C--N 1.355 0.845 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 179.014 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 17.7 t-80 -160.85 -50.78 0.05 OUTLIER 'General case' 0 CA--C 1.492 -1.253 0 N-CA-C 106.639 -1.615 . . . . 0.0 106.639 -165.143 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 35.5 mt -116.7 140.3 39.73 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.169 0 N-CA-C 105.217 -2.142 . . . . 0.0 105.217 -175.625 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 72.8 m -106.06 -87.55 0.46 Allowed 'General case' 0 N--CA 1.429 -1.484 0 N-CA-C 105.916 -1.883 . . . . 0.0 105.916 178.605 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 53.9 mtmt -91.41 172.33 8.6 Favored 'General case' 0 CA--C 1.485 -1.547 0 C-N-CA 124.927 1.291 . . . . 0.0 108.235 -166.838 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 36.1 m-85 -131.5 151.91 51.17 Favored 'General case' 0 CA--C 1.496 -1.11 0 N-CA-C 105.071 -2.196 . . . . 0.0 105.071 169.164 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 24.6 mt -121.28 134.23 65.3 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.162 0 N-CA-C 101.939 -3.356 . . . . 0.0 101.939 164.941 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 6.5 mt -105.93 123.6 48.23 Favored 'General case' 0 CA--C 1.48 -1.748 0 N-CA-C 104.011 -2.589 . . . . 0.0 104.011 166.669 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 42.8 ttp85 -127.7 123.5 35.58 Favored 'General case' 0 N--CA 1.436 -1.128 0 N-CA-C 105.515 -2.032 . . . . 0.0 105.515 -179.094 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 41.6 p90 -136.86 150.29 48.19 Favored 'General case' 0 CA--C 1.503 -0.841 0 N-CA-C 107.681 -1.229 . . . . 0.0 107.681 -170.89 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 43.3 ptt85 -141.33 158.4 63.99 Favored Pre-proline 0 CA--C 1.499 -1.0 0 N-CA-C 105.754 -1.943 . . . . 0.0 105.754 168.713 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -72.3 164.96 34.04 Favored 'Trans proline' 0 N--CA 1.453 -0.856 0 C-N-CA 123.306 2.671 . . . . 0.0 107.811 162.45 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 5.4 ptmm? -63.66 88.02 0.04 OUTLIER 'General case' 0 C--N 1.357 0.914 0 CA-C-O 122.584 1.183 . . . . 0.0 112.592 172.402 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 31.5 m120 -130.39 -132.09 0.21 Allowed 'General case' 0 N--CA 1.44 -0.952 0 N-CA-C 104.593 -2.373 . . . . 0.0 104.593 176.302 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 57.0 p -99.44 174.24 6.37 Favored 'General case' 0 C--N 1.355 0.811 0 N-CA-C 107.671 -1.233 . . . . 0.0 107.671 176.388 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 9.5 m -100.6 41.63 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.354 0.772 0 C-N-CA 124.758 1.223 . . . . 0.0 108.142 179.128 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -85.13 -99.62 0.68 Allowed Glycine 0 C--N 1.355 1.587 0 N-CA-C 108.532 -1.827 . . . . 0.0 108.532 -179.618 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 96.3 mtm-85 -97.93 141.55 30.76 Favored 'General case' 0 CA--C 1.499 -1.012 0 N-CA-C 107.204 -1.406 . . . . 0.0 107.204 176.278 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 14.6 m95 -121.63 171.78 8.59 Favored 'General case' 0 N--CA 1.439 -1.014 0 N-CA-C 105.413 -2.069 . . . . 0.0 105.413 -177.366 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -101.72 150.27 23.3 Favored 'General case' 0 CA--C 1.486 -1.491 0 N-CA-C 105.072 -2.196 . . . . 0.0 105.072 169.167 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -153.96 158.18 40.27 Favored 'General case' 0 CA--C 1.495 -1.171 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 179.841 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -138.59 160.12 40.39 Favored 'General case' 0 N--CA 1.438 -1.068 0 N-CA-C 105.186 -2.153 . . . . 0.0 105.186 173.94 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 81.6 m -115.88 123.15 47.4 Favored 'General case' 0 CA--C 1.496 -1.12 0 N-CA-C 104.775 -2.306 . . . . 0.0 104.775 177.895 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 3.8 mm -101.18 135.59 19.88 Favored Pre-proline 0 N--CA 1.437 -1.095 0 N-CA-C 105.669 -1.975 . . . . 0.0 105.669 -176.349 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 95.4 Cg_exo -63.69 161.02 33.81 Favored 'Trans proline' 0 CA--C 1.508 -0.805 0 C-N-CA 123.354 2.703 . . . . 0.0 112.257 172.093 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -78.38 -18.25 76.39 Favored Glycine 0 C--N 1.352 1.448 0 C-N-CA 123.439 0.543 . . . . 0.0 113.491 -172.685 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 48.0 p-80 -83.78 -27.18 29.02 Favored 'General case' 0 C--N 1.355 0.838 0 CA-C-N 117.695 0.747 . . . . 0.0 109.923 179.737 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 88.3 mt -88.74 130.43 35.34 Favored 'General case' 0 CA--C 1.498 -1.043 0 N-CA-C 107.977 -1.119 . . . . 0.0 107.977 177.539 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 7.7 p30 -117.98 16.67 14.23 Favored 'General case' 0 CA--C 1.501 -0.929 0 C-N-CA 124.359 1.064 . . . . 0.0 108.935 -177.026 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 35.9 p -144.53 161.77 38.24 Favored 'General case' 0 N--CA 1.438 -1.039 0 N-CA-C 107.204 -1.406 . . . . 0.0 107.204 -179.796 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 12.0 t80 -152.83 178.65 9.42 Favored 'General case' 0 N--CA 1.438 -1.032 0 N-CA-C 106.955 -1.498 . . . . 0.0 106.955 179.687 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 80.8 m -144.34 115.59 7.98 Favored 'General case' 0 N--CA 1.426 -1.633 0 N-CA-C 103.752 -2.684 . . . . 0.0 103.752 174.421 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 53.9 mt -92.58 108.38 20.18 Favored 'Isoleucine or valine' 0 C--N 1.354 0.767 0 N-CA-C 105.236 -2.135 . . . . 0.0 105.236 175.906 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 10.0 mtmp? -108.23 163.74 12.91 Favored 'General case' 0 CA--C 1.498 -1.054 0 CA-C-O 121.547 0.689 . . . . 0.0 109.143 -175.531 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 80.37 50.67 5.28 Favored Glycine 0 CA--C 1.489 -1.552 0 N-CA-C 108.713 -1.755 . . . . 0.0 108.713 174.987 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 75.7 mt -121.72 163.81 18.45 Favored 'General case' 0 CA--C 1.498 -1.027 0 N-CA-C 106.954 -1.499 . . . . 0.0 106.954 -175.748 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 53.2 mtmt -98.78 147.83 33.73 Favored Pre-proline 0 N--CA 1.44 -0.926 0 N-CA-C 107.026 -1.472 . . . . 0.0 107.026 -177.096 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -76.58 162.66 32.82 Favored 'Trans proline' 0 N--CA 1.451 -1.025 0 C-N-CA 122.95 2.433 . . . . 0.0 109.85 169.832 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 0.444 ' H ' ' HA ' ' A' ' 92' ' ' THR . . . 63.34 23.44 66.49 Favored Glycine 0 N--CA 1.428 -1.84 0 C-N-CA 127.417 2.437 . . . . 0.0 116.619 174.905 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 6.5 p -128.84 145.39 35.76 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.857 0 N-CA-C 107.966 -1.124 . . . . 0.0 107.966 -179.684 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 10.7 p -96.83 129.94 46.15 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.857 0 CA-C-O 123.187 1.47 . . . . 0.0 108.537 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 80.0 m-85 -104.65 145.11 30.79 Favored 'General case' 0 N--CA 1.432 -1.373 0 N-CA-C 106.435 -1.691 . . . . 0.0 106.435 176.563 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -91.02 133.1 35.58 Favored 'General case' 0 N--CA 1.442 -0.855 0 N-CA-C 105.336 -2.098 . . . . 0.0 105.336 159.502 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -130.26 158.69 22.51 Favored Glycine 0 C--N 1.355 1.61 0 N-CA-C 108.229 -1.948 . . . . 0.0 108.229 -179.897 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 32.0 mt-30 -149.77 138.57 20.96 Favored 'General case' 0 CA--C 1.484 -1.561 0 N-CA-C 105.422 -2.066 . . . . 0.0 105.422 -178.717 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 52.7 tp -117.47 98.21 6.28 Favored 'General case' 0 N--CA 1.437 -1.08 0 N-CA-C 104.846 -2.279 . . . . 0.0 104.846 179.436 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 48.0 mt -89.63 133.98 30.13 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.962 0 N-CA-C 104.558 -2.386 . . . . 0.0 104.558 -179.585 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 12.1 p -117.13 117.4 29.49 Favored 'General case' 0 N--CA 1.438 -1.075 0 N-CA-C 107.728 -1.212 . . . . 0.0 107.728 -178.427 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 2.6 mp -94.07 130.67 42.66 Favored 'Isoleucine or valine' 0 CA--C 1.487 -1.478 0 N-CA-C 103.455 -2.795 . . . . 0.0 103.455 -172.677 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 21.5 mt-30 -101.84 161.89 13.32 Favored 'General case' 0 CA--C 1.491 -1.295 0 CA-C-N 114.849 -1.069 . . . . 0.0 108.817 -169.845 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 14.4 pt20 -76.29 34.0 0.13 Allowed 'General case' 0 C--N 1.354 0.794 0 C-N-CA 126.537 1.935 . . . . 0.0 113.186 173.943 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 6.4 t80 -148.67 14.13 0.94 Allowed 'General case' 0 N--CA 1.437 -1.095 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 178.366 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 80.26 1.84 88.57 Favored Glycine 0 C--N 1.351 1.412 0 C-N-CA 123.897 0.761 . . . . 0.0 112.732 176.864 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 48.8 t-80 -81.9 158.47 23.96 Favored 'General case' 0 N--CA 1.44 -0.953 0 N-CA-C 107.842 -1.17 . . . . 0.0 107.842 -178.918 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 71.7 mt-30 -138.33 110.29 7.24 Favored 'General case' 0 CA--C 1.491 -1.322 0 N-CA-C 102.854 -3.017 . . . . 0.0 102.854 178.976 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 16.8 tp10 -100.76 132.1 46.32 Favored 'General case' 0 CA--C 1.495 -1.153 0 N-CA-C 105.215 -2.143 . . . . 0.0 105.215 -179.94 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 6.6 p -109.25 134.94 49.69 Favored 'Isoleucine or valine' 0 C--N 1.355 0.818 0 N-CA-C 107.58 -1.267 . . . . 0.0 107.58 -174.061 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 90.8 m -110.66 138.61 46.83 Favored 'General case' 0 N--CA 1.44 -0.927 0 N-CA-C 102.477 -3.157 . . . . 0.0 102.477 171.272 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 16.7 ptm180 -129.67 152.39 49.23 Favored 'General case' 0 CA--C 1.499 -1.011 0 CA-C-N 118.84 0.745 . . . . 0.0 110.025 176.918 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 18.5 p90 -165.53 -177.95 4.67 Favored 'General case' 0 CA--C 1.5 -0.956 0 N-CA-C 106.323 -1.732 . . . . 0.0 106.323 -175.731 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 45.7 p-10 -134.22 158.16 44.42 Favored 'General case' 0 N--CA 1.44 -0.945 0 N-CA-C 106.286 -1.746 . . . . 0.0 106.286 166.608 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 24.3 p90 -143.1 164.61 29.67 Favored 'General case' 0 CA--C 1.482 -1.641 0 N-CA-C 106.785 -1.561 . . . . 0.0 106.785 170.838 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 38.4 p -113.73 141.61 47.05 Favored 'General case' 0 CA--C 1.498 -1.042 0 N-CA-C 105.919 -1.882 . . . . 0.0 105.919 172.749 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 97.5 m -109.57 112.84 25.16 Favored 'General case' 0 CA--C 1.491 -1.325 1 N-CA-C 100.189 -4.004 . . . . 0.0 100.189 168.041 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 92' ' ' THR . . . . . 0.444 ' HA ' ' H ' ' A' ' 66' ' ' GLY . 11.9 t -159.24 149.79 19.49 Favored 'General case' 0 N--CA 1.437 -1.113 0 N-CA-C 105.375 -2.083 . . . . 0.0 105.375 -174.981 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 25.7 t . . . . . 0 C--O 1.261 1.708 0 N-CA-C 104.89 -2.263 . . . . 0.0 104.89 171.411 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 99.8 p . . . . . 0 N--CA 1.488 1.468 0 CA-C-O 121.471 0.653 . . . . 0.0 111.185 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -158.24 -168.6 20.72 Favored Glycine 0 N--CA 1.435 -1.383 0 N-CA-C 106.309 -2.716 . . . . 0.0 106.309 179.854 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 92.5 Cg_exo -62.37 138.14 69.46 Favored 'Trans proline' 0 N--CA 1.445 -1.356 0 C-N-CA 122.923 2.416 . . . . 0.0 112.973 -171.282 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 2.9 t -77.76 152.65 5.35 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.672 0 C-N-CA 126.443 1.897 . . . . 0.0 106.098 -179.805 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 52.7 mt-10 -96.16 91.34 5.87 Favored 'General case' 0 CA--C 1.494 -1.201 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 -173.335 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.409 ' HA ' ' HA ' ' A' ' 22' ' ' TRP . 2.1 p -110.22 129.43 65.27 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.075 0 N-CA-C 107.438 -1.319 . . . . 0.0 107.438 -164.967 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 75.6 m-85 -133.55 155.81 48.95 Favored 'General case' 0 CA--C 1.496 -1.109 0 N-CA-C 106.043 -1.836 . . . . 0.0 106.043 -175.035 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 50.3 mm -110.56 102.49 14.05 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.262 0 N-CA-C 105.689 -1.967 . . . . 0.0 105.689 -178.336 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 14.8 t -158.37 159.76 36.18 Favored 'General case' 0 N--CA 1.437 -1.079 0 N-CA-C 105.04 -2.207 . . . . 0.0 105.04 174.128 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 149.21 -64.91 0.0 OUTLIER 'General case' 0 CA--C 1.494 -1.19 0 N-CA-C 102.702 -3.073 . . . . 0.0 102.702 171.947 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 5.3 t -155.08 87.45 3.28 Favored Pre-proline 0 N--CA 1.439 -0.996 0 N-CA-C 105.504 -2.036 . . . . 0.0 105.504 175.919 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 70.0 Cg_endo -86.32 34.87 0.46 Allowed 'Trans proline' 0 N--CA 1.457 -0.625 0 C-N-CA 123.472 2.781 . . . . 0.0 110.281 174.547 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 68.6 m -122.62 42.41 3.18 Favored 'General case' 0 CA--C 1.499 -1.012 0 N-CA-C 106.781 -1.563 . . . . 0.0 106.781 178.535 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 99.1 mm-40 -136.47 113.15 10.17 Favored Pre-proline 0 N--CA 1.439 -0.997 0 CA-C-N 113.024 -1.898 . . . . 0.0 106.882 -175.094 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 98.7 Cg_endo -89.6 -7.41 4.8 Favored 'Trans proline' 0 N--CA 1.453 -0.874 0 C-N-CA 122.76 2.306 . . . . 0.0 110.156 175.347 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 6.9 p-10 -102.79 -40.96 6.35 Favored 'General case' 0 CA--C 1.49 -1.356 0 C-N-CA 123.583 0.753 . . . . 0.0 109.61 -172.633 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 35.0 p -110.31 153.62 24.63 Favored 'General case' 0 CA--C 1.495 -1.154 0 N-CA-C 107.081 -1.452 . . . . 0.0 107.081 176.189 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 14.9 t60 -136.85 98.83 10.47 Favored Pre-proline 0 N--CA 1.435 -1.224 0 N-CA-C 106.778 -1.564 . . . . 0.0 106.778 178.695 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -76.51 130.41 11.76 Favored 'Trans proline' 0 N--CA 1.447 -1.252 0 C-N-CA 122.76 2.307 . . . . 0.0 110.005 -177.441 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 14.5 mm -107.69 148.06 12.18 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.017 0 N-CA-C 103.088 -2.93 . . . . 0.0 103.088 176.127 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 4.4 pt20 -149.68 152.3 35.14 Favored 'General case' 0 CA--C 1.489 -1.377 0 N-CA-C 104.299 -2.482 . . . . 0.0 104.299 167.183 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' TRP . . . . . 0.409 ' HA ' ' HA ' ' A' ' 6' ' ' VAL . 44.6 p90 -147.15 166.98 25.31 Favored 'General case' 0 N--CA 1.436 -1.142 0 N-CA-C 106.595 -1.632 . . . . 0.0 106.595 -169.755 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 40.9 m-80 -138.81 132.5 30.68 Favored 'General case' 0 CA--C 1.49 -1.335 0 N-CA-C 107.487 -1.301 . . . . 0.0 107.487 -179.051 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -92.69 175.53 3.18 Favored Pre-proline 0 N--CA 1.44 -0.947 0 C-N-CA 125.696 1.599 . . . . 0.0 109.865 -167.122 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 78.6 Cg_exo -63.94 164.87 20.51 Favored 'Trans proline' 0 N--CA 1.455 -0.757 0 C-N-CA 123.672 2.914 . . . . 0.0 112.491 169.7 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 71.1 tp60 -80.92 -42.42 1.2 Allowed Pre-proline 0 N--CA 1.444 -0.759 0 CA-C-O 115.911 -1.995 . . . . 0.0 110.758 -175.799 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -70.02 -16.49 36.49 Favored 'Trans proline' 0 CA--C 1.512 -0.623 0 CA-C-N 125.382 2.958 . . . . 0.0 112.418 172.505 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 10.4 t 64.95 78.73 0.27 Allowed 'General case' 0 C--N 1.358 0.969 0 C-N-CA 126.545 1.938 . . . . 0.0 109.652 -176.799 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 20.1 t-160 -91.6 -6.68 51.9 Favored 'General case' 0 N--CA 1.442 -0.857 0 C-N-CA 124.755 1.222 . . . . 0.0 109.319 -177.466 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 84.5 mt -113.74 145.55 19.47 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.99 0 N-CA-C 104.736 -2.32 . . . . 0.0 104.736 -173.251 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 25.2 t -103.95 -87.49 0.43 Allowed 'General case' 0 N--CA 1.43 -1.464 0 N-CA-C 105.96 -1.867 . . . . 0.0 105.96 177.241 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 27.4 mtpp -89.58 167.45 12.94 Favored 'General case' 0 CA--C 1.486 -1.504 0 C-N-CA 125.693 1.597 . . . . 0.0 108.94 -163.546 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 90.9 m-85 -134.53 142.72 47.1 Favored 'General case' 0 CA--C 1.493 -1.244 0 N-CA-C 105.072 -2.196 . . . . 0.0 105.072 172.445 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 16.5 mt -123.04 134.45 66.13 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.178 0 N-CA-C 101.786 -3.413 . . . . 0.0 101.786 171.765 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 2.7 mt -110.8 131.48 55.02 Favored 'General case' 0 CA--C 1.473 -1.982 0 N-CA-C 105.715 -1.957 . . . . 0.0 105.715 173.416 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 2.2 mpt_? -115.65 157.72 23.8 Favored 'General case' 0 N--CA 1.428 -1.529 0 N-CA-C 104.981 -2.229 . . . . 0.0 104.981 172.506 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 37.5 p90 -151.01 136.26 17.64 Favored 'General case' 0 N--CA 1.432 -1.363 0 N-CA-C 105.695 -1.965 . . . . 0.0 105.695 171.204 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 15.3 ttp180 -137.39 135.79 19.81 Favored Pre-proline 0 CA--C 1.498 -1.038 0 N-CA-C 103.413 -2.81 . . . . 0.0 103.413 -178.716 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -77.33 155.15 32.48 Favored 'Trans proline' 0 CA--C 1.502 -1.086 0 CA-C-N 123.292 2.211 . . . . 0.0 108.686 179.563 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 70.8 mmtt -73.14 60.71 0.58 Allowed 'General case' 0 C--N 1.356 0.88 0 C-N-CA 125.704 1.601 . . . . 0.0 110.465 170.157 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 29.0 m120 -154.57 -56.93 0.11 Allowed 'General case' 0 N--CA 1.436 -1.17 0 N-CA-C 102.888 -3.004 . . . . 0.0 102.888 -173.163 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 34.8 m -85.31 160.75 19.75 Favored 'General case' 0 N--CA 1.44 -0.941 0 N-CA-C 108.374 -0.973 . . . . 0.0 108.374 178.181 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 17.4 m -131.69 -5.48 1.97 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.784 0 C-N-CA 124.522 1.129 . . . . 0.0 108.821 -173.827 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -142.85 -43.48 0.05 OUTLIER Glycine 0 C--N 1.356 1.644 0 N-CA-C 109.311 -1.516 . . . . 0.0 109.311 -172.656 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 79.7 ttt180 -80.92 126.16 31.02 Favored 'General case' 0 CA--C 1.502 -0.887 0 C-N-CA 124.183 0.993 . . . . 0.0 108.685 -176.89 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -155.97 -177.75 6.8 Favored 'General case' 0 CA--C 1.492 -1.269 0 CA-C-O 121.426 0.632 . . . . 0.0 109.825 -179.681 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 66.7 mttm -130.76 159.91 35.91 Favored 'General case' 0 N--CA 1.435 -1.211 0 N-CA-C 105.402 -2.074 . . . . 0.0 105.402 -175.698 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -149.44 159.84 43.95 Favored 'General case' 0 N--CA 1.434 -1.246 0 N-CA-C 107.691 -1.225 . . . . 0.0 107.691 175.947 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -141.29 157.97 44.51 Favored 'General case' 0 CA--C 1.496 -1.115 0 N-CA-C 106.398 -1.705 . . . . 0.0 106.398 170.999 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 89.0 m -118.84 127.06 53.16 Favored 'General case' 0 CA--C 1.5 -0.972 0 N-CA-C 105.954 -1.869 . . . . 0.0 105.954 -178.331 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 5.3 mp -114.39 133.91 22.38 Favored Pre-proline 0 N--CA 1.438 -1.072 0 N-CA-C 104.893 -2.262 . . . . 0.0 104.893 -175.695 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 62.6 Cg_exo -63.89 169.07 10.87 Favored 'Trans proline' 0 CA--C 1.508 -0.807 0 C-N-CA 123.387 2.724 . . . . 0.0 113.376 177.155 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -78.42 -19.74 73.39 Favored Glycine 0 C--N 1.351 1.398 0 C-N-CA 123.171 0.415 . . . . 0.0 113.559 -173.851 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 48.8 p-80 -83.84 -28.15 28.22 Favored 'General case' 0 C--N 1.356 0.887 0 CA-C-N 117.755 0.778 . . . . 0.0 109.962 -179.418 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 84.4 mt -88.77 130.49 35.35 Favored 'General case' 0 CA--C 1.501 -0.917 0 N-CA-C 107.723 -1.214 . . . . 0.0 107.723 177.162 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 8.0 p-10 -116.87 10.2 14.06 Favored 'General case' 0 CA--C 1.501 -0.912 0 C-N-CA 123.994 0.918 . . . . 0.0 110.098 -172.203 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 60.1 p -143.03 167.76 21.31 Favored 'General case' 0 N--CA 1.44 -0.942 0 N-CA-C 107.854 -1.165 . . . . 0.0 107.854 -178.631 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 8.3 t80 -155.48 178.27 10.42 Favored 'General case' 0 N--CA 1.441 -0.921 0 N-CA-C 108.023 -1.103 . . . . 0.0 108.023 -176.851 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 97.2 m -145.01 114.91 7.36 Favored 'General case' 0 N--CA 1.432 -1.34 0 N-CA-C 103.859 -2.645 . . . . 0.0 103.859 177.347 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 54.0 mt -97.02 96.68 5.59 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.822 0 N-CA-C 105.767 -1.938 . . . . 0.0 105.767 175.566 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.94 161.76 13.41 Favored 'General case' 0 CA--C 1.498 -1.031 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 -178.381 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 83.7 52.47 3.69 Favored Glycine 0 C--N 1.353 1.501 0 N-CA-C 108.866 -1.694 . . . . 0.0 108.866 177.637 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 76.3 mt -119.19 166.04 13.46 Favored 'General case' 0 CA--C 1.496 -1.11 0 N-CA-C 106.736 -1.579 . . . . 0.0 106.736 -179.51 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 61.1 mttp -97.66 156.59 35.91 Favored Pre-proline 0 N--CA 1.441 -0.898 0 N-CA-C 106.859 -1.534 . . . . 0.0 106.859 -175.666 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 66.2 Cg_endo -77.45 155.63 32.19 Favored 'Trans proline' 0 N--CA 1.451 -0.987 0 C-N-CA 122.808 2.339 . . . . 0.0 109.844 172.063 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 60.15 29.12 67.75 Favored Glycine 0 C--N 1.355 1.584 0 C-N-CA 126.674 2.083 . . . . 0.0 116.628 170.507 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 10.6 p -122.35 138.99 50.65 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.122 0 N-CA-C 107.747 -1.205 . . . . 0.0 107.747 179.472 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 2.4 p -97.74 134.99 33.83 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.818 0 N-CA-C 106.663 -1.606 . . . . 0.0 106.663 177.946 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 94.4 m-85 -114.23 154.4 27.98 Favored 'General case' 0 CA--C 1.502 -0.878 0 C-N-CA 124.97 1.308 . . . . 0.0 107.617 179.492 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -95.18 142.13 27.98 Favored 'General case' 0 CA--C 1.505 -0.787 0 N-CA-C 105.516 -2.031 . . . . 0.0 105.516 155.815 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -132.52 143.66 15.33 Favored Glycine 0 CA--C 1.487 -1.683 0 N-CA-C 107.565 -2.214 . . . . 0.0 107.565 -177.614 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 32.3 mt-30 -135.94 132.59 36.62 Favored 'General case' 0 CA--C 1.489 -1.375 0 N-CA-C 106.361 -1.718 . . . . 0.0 106.361 -178.189 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 47.2 tp -113.9 97.72 6.56 Favored 'General case' 0 N--CA 1.438 -1.042 0 N-CA-C 104.408 -2.441 . . . . 0.0 104.408 -176.757 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 1.8 mp -88.7 125.34 41.88 Favored 'Isoleucine or valine' 0 CA--C 1.499 -1.013 0 N-CA-C 103.585 -2.746 . . . . 0.0 103.585 -176.781 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 12.8 p -121.1 109.27 14.82 Favored 'General case' 0 N--CA 1.436 -1.129 0 N-CA-C 108.214 -1.032 . . . . 0.0 108.214 -170.405 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 29.7 mt -102.1 140.79 19.71 Favored 'Isoleucine or valine' 0 CA--C 1.487 -1.453 0 N-CA-C 105.787 -1.931 . . . . 0.0 105.787 -165.183 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 72.1 mt-30 -87.97 -178.86 6.1 Favored 'General case' 0 CA--C 1.505 -0.753 0 C-N-CA 123.49 0.716 . . . . 0.0 109.47 -177.374 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 85.2 mt-30 -74.3 84.03 1.91 Allowed 'General case' 0 C--N 1.357 0.928 0 C-N-CA 124.779 1.232 . . . . 0.0 110.753 175.465 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 82.6 m-85 58.5 28.38 16.88 Favored 'General case' 0 C--N 1.359 1.006 0 C-N-CA 126.75 2.02 . . . . 0.0 112.27 -177.682 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -112.53 -118.71 3.61 Favored Glycine 0 C--N 1.356 1.683 0 N-CA-C 108.88 -1.688 . . . . 0.0 108.88 -173.729 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 19.0 t60 -80.9 169.11 17.96 Favored 'General case' 0 N--CA 1.441 -0.89 0 C-N-CA 125.005 1.322 . . . . 0.0 109.323 -174.761 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 22.3 tt0 -127.47 109.3 11.61 Favored 'General case' 0 N--CA 1.434 -1.229 0 N-CA-C 101.842 -3.392 . . . . 0.0 101.842 170.377 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 4.3 tm-20 -102.83 153.94 19.69 Favored 'General case' 0 CA--C 1.506 -0.748 0 N-CA-C 105.721 -1.955 . . . . 0.0 105.721 -171.938 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 4.4 p -127.94 128.89 69.54 Favored 'Isoleucine or valine' 0 C--N 1.354 0.771 0 N-CA-C 108.274 -1.01 . . . . 0.0 108.274 179.874 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 52.1 m -109.83 139.09 45.29 Favored 'General case' 0 N--CA 1.443 -0.807 0 N-CA-C 102.432 -3.173 . . . . 0.0 102.432 171.694 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 51.6 ttt85 -130.99 142.8 50.37 Favored 'General case' 0 CA--C 1.502 -0.866 0 N-CA-C 108.428 -0.953 . . . . 0.0 108.428 -179.076 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 15.7 p90 -157.07 -176.39 5.95 Favored 'General case' 0 N--CA 1.439 -1.003 0 N-CA-C 105.78 -1.933 . . . . 0.0 105.78 178.769 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 1.4 p30 -136.15 157.02 47.82 Favored 'General case' 0 N--CA 1.439 -0.999 0 N-CA-C 106.296 -1.742 . . . . 0.0 106.296 167.571 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 36.9 p90 -144.45 174.51 10.87 Favored 'General case' 0 CA--C 1.487 -1.469 0 N-CA-C 106.03 -1.841 . . . . 0.0 106.03 171.759 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 10.1 t -142.31 154.37 44.64 Favored 'General case' 0 N--CA 1.439 -0.988 0 N-CA-C 106.7 -1.592 . . . . 0.0 106.7 176.789 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 4.3 p -113.27 120.94 42.89 Favored 'General case' 0 N--CA 1.436 -1.16 0 N-CA-C 101.264 -3.606 . . . . 0.0 101.264 168.184 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 15.0 t -157.71 21.47 0.27 Allowed 'General case' 0 N--CA 1.442 -0.85 0 N-CA-C 106.451 -1.685 . . . . 0.0 106.451 -173.049 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 19.7 m . . . . . 0 C--O 1.26 1.611 0 C-N-CA 123.356 0.662 . . . . 0.0 109.671 -175.77 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 98.8 p . . . . . 0 N--CA 1.487 1.414 0 CA-C-O 121.639 0.733 . . . . 0.0 111.649 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 162.11 -171.4 38.0 Favored Glycine 0 N--CA 1.436 -1.317 0 N-CA-C 105.79 -2.924 . . . . 0.0 105.79 -179.253 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 8.8 Cg_exo -54.61 146.05 55.89 Favored 'Trans proline' 0 N--CA 1.449 -1.133 0 C-N-CA 124.329 3.353 . . . . 0.0 114.898 -168.241 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 5.5 t -77.46 152.5 5.48 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.716 0 N-CA-C 105.436 -2.061 . . . . 0.0 105.436 -177.904 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 92.8 mt-10 -98.54 89.44 4.4 Favored 'General case' 0 CA--C 1.493 -1.234 0 CA-C-O 122.13 0.967 . . . . 0.0 108.666 -169.729 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 2.4 p -111.52 132.33 60.39 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.08 0 N-CA-C 106.979 -1.489 . . . . 0.0 106.979 -166.946 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 67.9 m-85 -144.77 174.83 10.65 Favored 'General case' 0 CA--C 1.498 -1.055 0 N-CA-C 106.125 -1.805 . . . . 0.0 106.125 -174.61 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 19.3 tt -136.43 131.2 48.03 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.047 0 N-CA-C 103.275 -2.861 . . . . 0.0 103.275 159.951 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 15.1 t -143.63 10.92 1.64 Allowed 'General case' 0 N--CA 1.439 -0.995 0 N-CA-C 106.588 -1.634 . . . . 0.0 106.588 -177.733 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 6.8 mp0 -85.82 -69.74 0.64 Allowed 'General case' 0 CA--C 1.497 -1.084 0 N-CA-C 107.696 -1.224 . . . . 0.0 107.696 -175.25 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 43.4 p -101.98 130.1 25.08 Favored Pre-proline 0 N--CA 1.442 -0.869 0 N-CA-C 107.639 -1.245 . . . . 0.0 107.639 -175.734 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -81.37 -16.27 9.58 Favored 'Trans proline' 0 N--CA 1.453 -0.872 0 C-N-CA 122.863 2.376 . . . . 0.0 110.009 171.464 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 65.8 m -156.12 122.94 5.24 Favored 'General case' 0 N--CA 1.432 -1.344 0 N-CA-C 104.01 -2.589 . . . . 0.0 104.01 -177.594 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 41.1 tp60 -157.43 111.36 1.86 Allowed Pre-proline 0 N--CA 1.437 -1.121 0 N-CA-C 105.834 -1.913 . . . . 0.0 105.834 171.695 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -83.46 -25.83 2.41 Favored 'Trans proline' 0 CA--C 1.504 -1.008 0 C-N-CA 122.213 1.942 . . . . 0.0 110.97 -169.567 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 11.2 p-10 -100.16 -45.43 5.64 Favored 'General case' 0 CA--C 1.488 -1.417 0 C-N-CA 123.596 0.759 . . . . 0.0 109.985 -166.516 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 75.2 m -107.63 158.65 17.08 Favored 'General case' 0 CA--C 1.496 -1.106 0 N-CA-C 107.794 -1.187 . . . . 0.0 107.794 -179.346 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 30.8 t60 -135.74 85.15 30.87 Favored Pre-proline 0 N--CA 1.438 -1.048 0 N-CA-C 105.593 -2.003 . . . . 0.0 105.593 172.884 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 64.7 Cg_endo -81.78 98.1 0.96 Allowed 'Trans proline' 0 N--CA 1.451 -0.987 0 C-N-CA 123.325 2.683 . . . . 0.0 110.156 -174.713 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.51 HD11 HD11 ' A' ' 35' ' ' LEU . 3.0 pt -97.6 173.21 1.0 Allowed 'Isoleucine or valine' 0 CA--C 1.499 -0.99 0 CA-C-O 121.181 0.515 . . . . 0.0 109.992 -173.497 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' GLN . . . . . 0.448 ' HA ' ' HA ' ' A' ' 57' ' ' SER . 1.9 pt20 -151.53 161.58 42.45 Favored 'General case' 0 CA--C 1.496 -1.099 0 N-CA-C 105.699 -1.963 . . . . 0.0 105.699 164.079 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 42.4 p90 -139.62 162.82 34.17 Favored 'General case' 0 CA--C 1.496 -1.122 0 N-CA-C 106.285 -1.746 . . . . 0.0 106.285 -177.679 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 3.1 m120 -127.94 124.48 37.43 Favored 'General case' 0 CA--C 1.491 -1.3 0 N-CA-C 106.183 -1.784 . . . . 0.0 106.183 -179.505 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -105.65 173.38 3.27 Favored Pre-proline 0 N--CA 1.439 -1.012 0 C-N-CA 125.536 1.535 . . . . 0.0 108.181 -169.71 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_exo -63.63 151.2 86.17 Favored 'Trans proline' 0 N--CA 1.455 -0.76 0 C-N-CA 123.732 2.955 . . . . 0.0 112.266 173.532 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 64.8 tt0 -82.05 -40.64 0.96 Allowed Pre-proline 0 N--CA 1.444 -0.76 0 CA-C-O 115.832 -2.033 . . . . 0.0 111.837 -174.742 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 77.1 Cg_exo -70.77 -3.52 12.85 Favored 'Trans proline' 0 CA--C 1.514 -0.481 0 CA-C-N 125.403 2.965 . . . . 0.0 113.818 177.175 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 10.0 t 71.33 78.08 0.17 Allowed 'General case' 0 C--N 1.358 0.937 0 C-N-CA 126.38 1.872 . . . . 0.0 109.252 -179.423 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 82.1 t60 -89.23 -30.15 18.73 Favored 'General case' 0 N--CA 1.441 -0.906 0 C-N-CA 124.696 1.198 . . . . 0.0 108.289 178.166 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 90.3 mt -108.83 146.41 14.52 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.107 0 N-CA-C 105.164 -2.162 . . . . 0.0 105.164 -171.204 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 32.9 t -102.69 -87.77 0.41 Allowed 'General case' 0 N--CA 1.428 -1.572 0 N-CA-C 104.531 -2.396 . . . . 0.0 104.531 176.891 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 50.3 mtpt -89.46 167.07 13.28 Favored 'General case' 0 CA--C 1.489 -1.4 0 C-N-CA 124.91 1.284 . . . . 0.0 108.85 -164.418 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 63.1 m-85 -132.09 142.62 49.58 Favored 'General case' 0 CA--C 1.497 -1.081 0 N-CA-C 105.035 -2.209 . . . . 0.0 105.035 170.987 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 53.7 mt -119.68 136.12 57.84 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.189 0 N-CA-C 101.156 -3.646 . . . . 0.0 101.156 170.503 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.51 HD11 HD11 ' A' ' 20' ' ' ILE . 5.9 mt -110.42 132.53 54.1 Favored 'General case' 0 CA--C 1.47 -2.132 0 N-CA-C 103.823 -2.658 . . . . 0.0 103.823 166.644 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 17.0 ptp180 -132.88 152.04 51.93 Favored 'General case' 0 CA--C 1.49 -1.363 0 N-CA-C 106.787 -1.561 . . . . 0.0 106.787 170.701 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 49.2 p90 -155.19 151.79 28.59 Favored 'General case' 0 N--CA 1.438 -1.04 0 N-CA-C 107.585 -1.265 . . . . 0.0 107.585 -171.22 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 2.8 ptt180 -155.68 153.5 26.31 Favored Pre-proline 0 CA--C 1.497 -1.062 0 N-CA-C 106.466 -1.679 . . . . 0.0 106.466 168.065 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -76.86 156.56 34.85 Favored 'Trans proline' 0 CA--C 1.501 -1.141 0 C-N-CA 122.547 2.165 . . . . 0.0 109.071 -178.231 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 71.4 mmtt -70.35 79.95 0.54 Allowed 'General case' 0 C--N 1.354 0.8 0 C-N-CA 125.065 1.346 . . . . 0.0 110.635 174.598 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 58.9 m-80 -152.01 -81.62 0.1 Allowed 'General case' 0 N--CA 1.437 -1.111 0 N-CA-C 103.43 -2.804 . . . . 0.0 103.43 -179.249 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 50.2 m -93.39 166.14 12.43 Favored 'General case' 0 CA--C 1.5 -0.978 0 C-N-CA 124.055 0.942 . . . . 0.0 108.531 -178.228 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 12.6 m -134.57 25.54 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.754 0 N-CA-C 106.623 -1.621 . . . . 0.0 106.623 178.167 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -89.72 -94.48 1.14 Allowed Glycine 0 C--N 1.356 1.681 0 N-CA-C 109.554 -1.418 . . . . 0.0 109.554 -174.797 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -95.5 166.29 11.93 Favored 'General case' 0 CA--C 1.5 -0.945 0 N-CA-C 107.584 -1.265 . . . . 0.0 107.584 179.418 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -158.29 173.87 16.03 Favored 'General case' 0 CA--C 1.493 -1.238 0 CA-C-O 121.17 0.509 . . . . 0.0 110.142 -177.7 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 8.6 mtpm? -106.53 155.07 19.98 Favored 'General case' 0 CA--C 1.484 -1.565 0 N-CA-C 106.877 -1.527 . . . . 0.0 106.877 -175.404 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 15.6 pt-20 -151.72 161.26 42.96 Favored 'General case' 0 N--CA 1.435 -1.193 0 CA-C-O 121.827 0.823 . . . . 0.0 109.064 173.699 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -138.66 162.39 34.77 Favored 'General case' 0 N--CA 1.44 -0.967 0 N-CA-C 105.765 -1.939 . . . . 0.0 105.765 170.275 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 77.8 m -121.64 126.56 49.32 Favored 'General case' 0 CA--C 1.502 -0.896 0 N-CA-C 105.389 -2.078 . . . . 0.0 105.389 178.233 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 4.2 mp -110.91 133.76 21.17 Favored Pre-proline 0 N--CA 1.436 -1.147 0 N-CA-C 105.12 -2.178 . . . . 0.0 105.12 -176.088 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_exo -63.85 165.15 19.46 Favored 'Trans proline' 0 CA--C 1.507 -0.828 0 C-N-CA 123.519 2.813 . . . . 0.0 113.187 176.743 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -76.52 -18.21 79.27 Favored Glycine 0 C--N 1.351 1.409 0 C-N-CA 123.627 0.632 . . . . 0.0 113.938 -173.933 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 49.8 p-80 -84.02 -28.45 27.66 Favored 'General case' 0 C--N 1.355 0.845 0 CA-C-N 117.992 0.896 . . . . 0.0 110.133 -179.826 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 88.0 mt -88.78 130.76 35.3 Favored 'General case' 0 CA--C 1.499 -0.991 0 N-CA-C 107.911 -1.144 . . . . 0.0 107.911 177.463 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 47.1 p-10 -117.78 12.44 13.89 Favored 'General case' 0 CA--C 1.502 -0.873 0 C-N-CA 123.879 0.872 . . . . 0.0 110.368 -174.887 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.448 ' HA ' ' HA ' ' A' ' 21' ' ' GLN . 58.0 p -136.8 161.57 35.61 Favored 'General case' 0 CA--C 1.498 -1.052 0 N-CA-C 107.795 -1.187 . . . . 0.0 107.795 -178.379 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 5.2 t80 -147.55 179.51 7.63 Favored 'General case' 0 C--N 1.357 0.933 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 177.198 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 80.2 m -144.92 112.4 6.16 Favored 'General case' 0 N--CA 1.433 -1.295 0 N-CA-C 104.178 -2.527 . . . . 0.0 104.178 174.002 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 50.6 mt -95.18 97.33 6.66 Favored 'Isoleucine or valine' 0 C--N 1.357 0.918 0 N-CA-C 105.333 -2.099 . . . . 0.0 105.333 174.763 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 22.6 pttp -103.82 159.81 15.32 Favored 'General case' 0 CA--C 1.501 -0.919 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 -176.489 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 87.75 51.69 3.17 Favored Glycine 0 C--N 1.354 1.579 0 N-CA-C 109.337 -1.505 . . . . 0.0 109.337 179.187 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 70.7 mt -119.78 171.11 8.63 Favored 'General case' 0 CA--C 1.504 -0.806 0 N-CA-C 107.398 -1.334 . . . . 0.0 107.398 -177.393 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 67.5 mttm -107.09 155.69 38.81 Favored Pre-proline 0 N--CA 1.442 -0.86 0 C-N-CA 124.984 1.313 . . . . 0.0 107.656 -172.338 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -75.82 151.53 36.03 Favored 'Trans proline' 0 N--CA 1.454 -0.853 0 C-N-CA 123.024 2.482 . . . . 0.0 110.811 177.054 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 56.05 36.55 67.95 Favored Glycine 0 C--N 1.355 1.605 0 C-N-CA 127.377 2.418 . . . . 0.0 116.06 169.623 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 9.8 p -124.11 143.56 36.98 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.998 0 N-CA-C 108.088 -1.078 . . . . 0.0 108.088 -177.498 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 7.7 p -98.61 128.4 50.19 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.96 0 N-CA-C 107.747 -1.205 . . . . 0.0 107.747 -179.543 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 68.8 m-85 -111.4 151.62 28.28 Favored 'General case' 0 CA--C 1.497 -1.082 0 C-N-CA 124.814 1.245 . . . . 0.0 108.809 -179.863 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 35.9 tp10 -93.61 137.04 33.28 Favored 'General case' 0 N--CA 1.44 -0.953 0 N-CA-C 104.578 -2.379 . . . . 0.0 104.578 160.017 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -135.33 156.62 22.75 Favored Glycine 0 CA--C 1.489 -1.553 0 N-CA-C 108.511 -1.836 . . . . 0.0 108.511 174.356 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 85.6 mt-30 -144.58 138.95 27.81 Favored 'General case' 0 CA--C 1.483 -1.598 0 N-CA-C 105.986 -1.857 . . . . 0.0 105.986 179.262 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 57.1 tp -115.73 97.32 6.05 Favored 'General case' 0 N--CA 1.435 -1.189 0 N-CA-C 103.892 -2.633 . . . . 0.0 103.892 178.248 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 9.4 mt -89.52 128.87 41.28 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.942 0 N-CA-C 105.356 -2.09 . . . . 0.0 105.356 -178.248 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 3.5 p -117.93 118.86 33.13 Favored 'General case' 0 N--CA 1.438 -1.058 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 -171.71 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 2.0 mp -94.08 131.68 40.31 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.222 0 N-CA-C 105.02 -2.215 . . . . 0.0 105.02 -173.149 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 19.4 mp0 -93.87 143.36 26.41 Favored 'General case' 0 CA--C 1.498 -1.033 0 N-CA-C 104.93 -2.248 . . . . 0.0 104.93 177.218 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 21.4 tt0 -69.12 112.4 5.7 Favored 'General case' 0 C--N 1.356 0.855 0 C-N-CA 123.858 0.863 . . . . 0.0 111.343 -172.585 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 33.7 m-85 56.32 44.81 24.07 Favored 'General case' 0 C--N 1.357 0.917 0 C-N-CA 126.983 2.113 . . . . 0.0 112.173 -179.007 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -156.73 -119.16 0.6 Allowed Glycine 0 CA--C 1.489 -1.577 0 N-CA-C 109.008 -1.637 . . . . 0.0 109.008 -177.98 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 69.2 m80 -82.68 176.77 9.09 Favored 'General case' 0 CA--C 1.501 -0.939 0 C-N-CA 124.9 1.28 . . . . 0.0 111.288 -166.477 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 22.8 tt0 -137.91 115.96 11.67 Favored 'General case' 0 N--CA 1.435 -1.197 0 N-CA-C 103.819 -2.66 . . . . 0.0 103.819 170.761 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 29.5 tt0 -104.77 147.97 27.12 Favored 'General case' 0 CA--C 1.5 -0.949 0 N-CA-C 106.089 -1.819 . . . . 0.0 106.089 -174.739 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 4.0 p -119.35 134.05 64.2 Favored 'Isoleucine or valine' 0 C--N 1.356 0.85 0 N-CA-C 107.796 -1.187 . . . . 0.0 107.796 178.272 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 65.1 m -110.93 138.44 47.33 Favored 'General case' 0 C--N 1.354 0.791 0 N-CA-C 102.518 -3.142 . . . . 0.0 102.518 168.326 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 27.8 ptt-85 -132.21 150.32 52.18 Favored 'General case' 0 CA--C 1.5 -0.971 0 N-CA-C 109.213 -0.662 . . . . 0.0 109.213 179.485 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 20.2 p90 -163.82 173.8 12.33 Favored 'General case' 0 N--CA 1.441 -0.901 0 N-CA-C 107.947 -1.131 . . . . 0.0 107.947 -174.874 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -125.62 146.05 49.88 Favored 'General case' 0 N--CA 1.438 -1.05 0 N-CA-C 103.816 -2.661 . . . . 0.0 103.816 173.628 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 28.5 p90 -139.51 168.1 20.59 Favored 'General case' 0 CA--C 1.485 -1.526 0 N-CA-C 107.572 -1.269 . . . . 0.0 107.572 167.882 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 60.6 m -130.44 141.93 50.51 Favored 'General case' 0 N--CA 1.44 -0.937 0 N-CA-C 104.832 -2.285 . . . . 0.0 104.832 176.795 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 23.9 p -111.6 136.94 50.11 Favored 'General case' 0 CA--C 1.501 -0.936 0 N-CA-C 103.851 -2.648 . . . . 0.0 103.851 170.486 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 10.5 t -146.22 156.7 43.57 Favored 'General case' 0 N--CA 1.44 -0.967 0 N-CA-C 106.716 -1.587 . . . . 0.0 106.716 -175.072 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 16.9 p . . . . . 0 C--O 1.261 1.684 0 CA-C-O 117.709 -1.139 . . . . 0.0 108.944 -178.336 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 72.2 m . . . . . 0 N--CA 1.486 1.355 0 N-CA-C 108.358 -0.978 . . . . 0.0 108.358 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -160.42 -179.92 35.51 Favored Glycine 0 C--N 1.352 1.434 0 N-CA-C 106.913 -2.475 . . . . 0.0 106.913 177.969 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 79.3 Cg_exo -60.67 135.07 57.98 Favored 'Trans proline' 0 CA--C 1.497 -1.369 0 C-N-CA 123.388 2.725 . . . . 0.0 112.185 -173.359 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 16.1 t -84.07 155.24 3.67 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.017 0 C-N-CA 126.468 1.907 . . . . 0.0 106.167 -175.196 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 54.6 mt-10 -104.5 102.86 12.49 Favored 'General case' 0 CA--C 1.492 -1.273 0 N-CA-C 105.772 -1.936 . . . . 0.0 105.772 179.498 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 1.5 p -126.05 141.37 45.88 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.985 0 N-CA-C 105.623 -1.991 . . . . 0.0 105.623 -169.796 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 18.8 p90 -161.69 170.3 19.93 Favored 'General case' 0 N--CA 1.436 -1.144 0 N-CA-C 107.716 -1.216 . . . . 0.0 107.716 -162.728 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -124.19 133.49 69.17 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.823 0 N-CA-C 102.482 -3.155 . . . . 0.0 102.482 160.809 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 10.4 p -131.27 124.2 29.99 Favored 'General case' 0 CA--C 1.5 -0.964 0 N-CA-C 106.418 -1.697 . . . . 0.0 106.418 179.922 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 23.8 tt0 68.15 48.72 0.91 Allowed 'General case' 0 C--N 1.356 0.86 0 C-N-CA 126.44 1.896 . . . . 0.0 110.914 175.586 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 15.4 p -104.19 102.9 35.4 Favored Pre-proline 0 C--N 1.353 0.746 0 N-CA-C 106.113 -1.81 . . . . 0.0 106.113 172.175 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 31.0 Cg_endo -74.97 -69.02 0.02 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.768 0 C-N-CA 122.425 2.083 . . . . 0.0 110.607 -175.737 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 10.2 p -141.07 107.68 5.33 Favored 'General case' 0 N--CA 1.432 -1.349 0 N-CA-C 105.711 -1.959 . . . . 0.0 105.711 -179.742 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 91.3 mm-40 -120.83 105.74 40.25 Favored Pre-proline 0 N--CA 1.436 -1.145 0 N-CA-C 103.87 -2.641 . . . . 0.0 103.87 178.379 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -84.61 -25.48 1.97 Allowed 'Trans proline' 0 CA--C 1.508 -0.822 0 C-N-CA 122.289 1.993 . . . . 0.0 111.115 -167.426 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 6.8 t-20 -135.78 -23.88 1.35 Allowed 'General case' 0 CA--C 1.495 -1.169 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 -168.709 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 23.0 p -97.64 156.19 16.64 Favored 'General case' 0 N--CA 1.439 -1.02 0 N-CA-C 107.605 -1.257 . . . . 0.0 107.605 177.483 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 29.3 t-80 -139.44 86.43 14.28 Favored Pre-proline 0 N--CA 1.439 -1.011 0 N-CA-C 106.348 -1.723 . . . . 0.0 106.348 167.568 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -82.92 100.54 0.96 Allowed 'Trans proline' 0 N--CA 1.453 -0.887 0 C-N-CA 123.574 2.849 . . . . 0.0 110.369 -176.187 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.53 HD11 HD11 ' A' ' 35' ' ' LEU . 1.6 pt -94.38 166.59 1.77 Allowed 'Isoleucine or valine' 0 CA--C 1.501 -0.934 0 C-N-CA 122.715 0.406 . . . . 0.0 110.156 -173.609 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 48.0 tt0 -143.15 147.66 35.3 Favored 'General case' 0 N--CA 1.439 -0.995 0 N-CA-C 105.005 -2.22 . . . . 0.0 105.005 168.547 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 30.9 p90 -130.23 159.85 35.62 Favored 'General case' 0 CA--C 1.495 -1.167 0 N-CA-C 105.599 -2.0 . . . . 0.0 105.599 176.701 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 72.3 m-20 -130.83 132.7 45.38 Favored 'General case' 0 CA--C 1.488 -1.417 0 N-CA-C 104.997 -2.223 . . . . 0.0 104.997 171.837 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -85.77 164.36 40.01 Favored Pre-proline 0 N--CA 1.441 -0.908 0 C-N-CA 124.589 1.155 . . . . 0.0 110.675 -166.175 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_exo -67.23 -179.29 1.75 Allowed 'Trans proline' 0 N--CA 1.457 -0.675 0 C-N-CA 123.775 2.983 . . . . 0.0 112.548 169.072 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? -79.84 -50.85 1.19 Allowed Pre-proline 0 N--CA 1.443 -0.782 0 CA-C-O 115.02 -2.419 . . . . 0.0 111.157 -174.706 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -68.68 147.14 69.11 Favored 'Trans proline' 0 CA--C 1.508 -0.811 0 CA-C-N 126.305 3.288 . . . . 0.0 111.863 -173.056 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 29.4 p -99.0 58.59 1.14 Allowed 'General case' 0 C--N 1.355 0.83 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 -178.605 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 42.6 t60 -116.23 1.37 13.12 Favored 'General case' 0 N--CA 1.438 -1.043 0 C-N-CA 125.217 1.407 . . . . 0.0 107.425 175.857 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 31.2 mt -101.67 131.93 48.58 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.054 0 N-CA-C 104.263 -2.495 . . . . 0.0 104.263 171.017 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 4.4 p -110.52 -84.65 0.56 Allowed 'General case' 0 N--CA 1.432 -1.345 0 N-CA-C 107.028 -1.471 . . . . 0.0 107.028 179.515 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 53.2 mtmt -89.91 171.85 9.3 Favored 'General case' 0 CA--C 1.488 -1.439 0 C-N-CA 124.232 1.013 . . . . 0.0 108.785 -166.413 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 86.8 m-85 -129.34 147.66 51.19 Favored 'General case' 0 CA--C 1.496 -1.115 0 N-CA-C 105.362 -2.088 . . . . 0.0 105.362 168.435 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 61.9 mt -120.41 131.04 73.69 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.249 0 N-CA-C 101.207 -3.627 . . . . 0.0 101.207 165.683 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.53 HD11 HD11 ' A' ' 20' ' ' ILE . 2.9 mt -110.49 132.72 53.94 Favored 'General case' 0 CA--C 1.473 -1.997 0 N-CA-C 104.822 -2.288 . . . . 0.0 104.822 170.741 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -129.97 158.94 38.17 Favored 'General case' 0 CA--C 1.493 -1.241 0 N-CA-C 107.308 -1.367 . . . . 0.0 107.308 170.082 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 46.4 p90 -155.15 141.28 18.42 Favored 'General case' 0 N--CA 1.434 -1.232 0 N-CA-C 106.635 -1.617 . . . . 0.0 106.635 -177.908 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 27.0 ttp180 -137.89 142.65 36.94 Favored Pre-proline 0 CA--C 1.502 -0.902 0 N-CA-C 104.902 -2.258 . . . . 0.0 104.902 -179.359 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_exo -65.11 116.97 4.15 Favored 'Trans proline' 0 N--CA 1.455 -0.754 0 C-N-CA 123.024 2.482 . . . . 0.0 109.721 169.133 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 26.7 ttpp -71.96 83.87 0.96 Allowed 'General case' 0 C--N 1.359 0.993 0 C-N-CA 125.306 1.443 . . . . 0.0 110.096 179.933 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 33.1 m120 -150.58 -69.18 0.19 Allowed 'General case' 0 N--CA 1.434 -1.245 0 N-CA-C 102.321 -3.214 . . . . 0.0 102.321 -175.526 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 56.4 p -109.23 175.32 5.5 Favored 'General case' 0 N--CA 1.44 -0.97 0 N-CA-C 107.334 -1.358 . . . . 0.0 107.334 175.171 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 4.2 m -115.69 51.36 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.836 0 N-CA-C 106.241 -1.763 . . . . 0.0 106.241 176.009 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -94.81 -136.1 8.28 Favored Glycine 0 C--N 1.356 1.68 0 N-CA-C 109.739 -1.345 . . . . 0.0 109.739 -175.57 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 39.9 mmt180 -81.18 155.58 26.1 Favored 'General case' 0 CA--C 1.501 -0.939 0 C-N-CA 123.79 0.836 . . . . 0.0 109.108 -176.534 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -159.36 168.89 25.22 Favored 'General case' 0 CA--C 1.493 -1.225 0 CA-C-O 121.385 0.612 . . . . 0.0 109.832 -169.259 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -113.49 156.68 23.12 Favored 'General case' 0 CA--C 1.491 -1.293 0 N-CA-C 107.889 -1.152 . . . . 0.0 107.889 -169.975 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 23.5 pt-20 -151.37 161.27 43.0 Favored 'General case' 0 N--CA 1.435 -1.191 0 N-CA-C 107.765 -1.198 . . . . 0.0 107.765 172.125 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -139.62 164.71 29.2 Favored 'General case' 0 N--CA 1.438 -1.051 0 N-CA-C 105.603 -1.999 . . . . 0.0 105.603 171.222 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 88.8 m -118.51 122.65 43.21 Favored 'General case' 0 CA--C 1.498 -1.021 0 N-CA-C 104.333 -2.469 . . . . 0.0 104.333 176.056 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 3.7 mm -103.62 138.64 19.59 Favored Pre-proline 0 N--CA 1.438 -1.029 0 N-CA-C 105.808 -1.923 . . . . 0.0 105.808 -174.909 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_exo -63.91 161.15 34.11 Favored 'Trans proline' 0 N--CA 1.455 -0.784 0 C-N-CA 123.378 2.719 . . . . 0.0 112.562 170.817 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -78.22 -19.26 74.87 Favored Glycine 0 C--N 1.353 1.492 0 C-N-CA 123.843 0.735 . . . . 0.0 113.344 -172.485 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 50.3 p-80 -83.61 -24.97 31.24 Favored 'General case' 0 C--N 1.356 0.85 0 CA-C-N 117.68 0.74 . . . . 0.0 110.158 -178.802 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 88.7 mt -88.22 129.77 35.26 Favored 'General case' 0 CA--C 1.498 -1.024 0 N-CA-C 107.913 -1.143 . . . . 0.0 107.913 177.655 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 7.5 p30 -116.66 10.72 14.45 Favored 'General case' 0 CA--C 1.501 -0.93 0 C-N-CA 124.59 1.156 . . . . 0.0 109.662 -174.554 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 31.3 p -141.79 154.42 45.21 Favored 'General case' 0 N--CA 1.44 -0.974 0 N-CA-C 106.863 -1.532 . . . . 0.0 106.863 -179.237 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 9.8 t80 -137.55 170.7 15.62 Favored 'General case' 0 N--CA 1.441 -0.914 0 N-CA-C 107.91 -1.144 . . . . 0.0 107.91 178.606 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 89.2 m -133.93 110.01 9.42 Favored 'General case' 0 N--CA 1.429 -1.517 0 N-CA-C 104.424 -2.436 . . . . 0.0 104.424 172.773 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 45.2 mt -88.37 144.06 9.94 Favored 'Isoleucine or valine' 0 C--N 1.355 0.846 0 N-CA-C 103.663 -2.717 . . . . 0.0 103.663 172.051 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 56.7 mtmt -144.29 165.51 27.69 Favored 'General case' 0 CA--C 1.498 -1.04 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 175.929 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 88.7 48.3 3.97 Favored Glycine 0 CA--C 1.485 -1.832 0 N-CA-C 108.99 -1.644 . . . . 0.0 108.99 174.575 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 51.9 mt -120.79 171.22 8.76 Favored 'General case' 0 CA--C 1.498 -1.025 0 N-CA-C 107.604 -1.258 . . . . 0.0 107.604 -170.22 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt -113.66 150.87 44.0 Favored Pre-proline 0 N--CA 1.44 -0.93 0 N-CA-C 107.363 -1.347 . . . . 0.0 107.363 -174.247 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 78.5 Cg_exo -68.14 153.85 73.81 Favored 'Trans proline' 0 N--CA 1.453 -0.873 0 C-N-CA 123.37 2.714 . . . . 0.0 112.028 168.338 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 0.603 ' H ' ' HA ' ' A' ' 92' ' ' THR . . . 58.95 30.28 66.29 Favored Glycine 0 N--CA 1.432 -1.604 0 C-N-CA 127.545 2.498 . . . . 0.0 116.478 170.37 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 4.9 p -126.92 142.13 44.27 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.029 0 N-CA-C 108.577 -0.898 . . . . 0.0 108.577 179.316 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 9.3 p -94.62 130.77 42.99 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.837 0 C-N-CA 124.641 1.176 . . . . 0.0 107.959 -178.816 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 88.8 m-85 -110.62 154.91 23.11 Favored 'General case' 0 N--CA 1.437 -1.085 0 C-N-CA 124.79 1.236 . . . . 0.0 108.011 177.854 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 15.3 tp10 -98.53 132.17 44.17 Favored 'General case' 0 N--CA 1.437 -1.099 0 N-CA-C 103.578 -2.749 . . . . 0.0 103.578 164.148 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -129.67 148.82 18.53 Favored Glycine 0 CA--C 1.489 -1.544 0 N-CA-C 107.667 -2.173 . . . . 0.0 107.667 175.786 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 34.6 mt-30 -141.47 137.05 31.86 Favored 'General case' 0 CA--C 1.484 -1.582 0 N-CA-C 106.549 -1.649 . . . . 0.0 106.549 178.4 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 27.6 tp -117.93 97.17 5.69 Favored 'General case' 0 N--CA 1.435 -1.202 0 N-CA-C 104.03 -2.581 . . . . 0.0 104.03 -178.721 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 20.3 mt -92.17 129.01 43.44 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.865 0 N-CA-C 104.947 -2.242 . . . . 0.0 104.947 -179.84 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 49.8 m -110.06 117.84 34.82 Favored 'General case' 0 CA--C 1.497 -1.061 0 N-CA-C 106.814 -1.55 . . . . 0.0 106.814 -175.784 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 1.7 mp -88.2 131.94 34.5 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.302 0 N-CA-C 104.348 -2.464 . . . . 0.0 104.348 -170.455 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 76.0 mt-30 -96.78 157.1 16.06 Favored 'General case' 0 N--CA 1.434 -1.269 0 N-CA-C 107.167 -1.42 . . . . 0.0 107.167 -176.787 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 32.3 mt-30 -69.48 118.2 12.06 Favored 'General case' 0 N--CA 1.438 -1.026 0 C-N-CA 123.919 0.888 . . . . 0.0 112.544 -168.503 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 49.0 m-85 61.68 35.58 16.93 Favored 'General case' 0 C--N 1.355 0.833 0 C-N-CA 127.117 2.167 . . . . 0.0 113.136 170.558 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 179.38 -93.31 0.09 OUTLIER Glycine 0 C--N 1.354 1.53 0 C-N-CA 118.294 -1.907 . . . . 0.0 111.416 177.73 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 74.1 m-70 -78.59 -178.74 6.03 Favored 'General case' 0 CA--C 1.498 -1.047 0 C-N-CA 124.797 1.239 . . . . 0.0 111.747 -163.602 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 4.4 pt20 -153.32 146.56 24.75 Favored 'General case' 0 N--CA 1.434 -1.245 0 N-CA-C 106.484 -1.672 . . . . 0.0 106.484 170.2 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 17.4 tp10 -104.87 146.28 29.22 Favored 'General case' 0 CA--C 1.496 -1.124 0 N-CA-C 105.575 -2.009 . . . . 0.0 105.575 179.855 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 3.0 p -117.76 131.59 70.06 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.824 0 N-CA-C 107.204 -1.406 . . . . 0.0 107.204 177.391 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 40.4 m -113.58 138.36 50.28 Favored 'General case' 0 N--CA 1.441 -0.9 0 N-CA-C 102.871 -3.011 . . . . 0.0 102.871 170.962 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 7.6 ptp85 -131.58 150.86 52.0 Favored 'General case' 0 CA--C 1.498 -1.025 0 CA-C-O 121.466 0.651 . . . . 0.0 109.594 178.86 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 30.0 p90 -164.2 178.2 7.77 Favored 'General case' 0 N--CA 1.44 -0.97 0 N-CA-C 106.959 -1.497 . . . . 0.0 106.959 -174.617 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 1.5 p30 -137.44 157.71 45.99 Favored 'General case' 0 N--CA 1.44 -0.928 0 N-CA-C 105.844 -1.91 . . . . 0.0 105.844 169.416 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 26.6 p90 -145.73 170.75 15.89 Favored 'General case' 0 CA--C 1.486 -1.497 0 N-CA-C 107.367 -1.346 . . . . 0.0 107.367 174.949 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 24.8 p -121.55 145.33 48.07 Favored 'General case' 0 CA--C 1.5 -0.954 0 N-CA-C 106.006 -1.85 . . . . 0.0 106.006 172.078 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 75.4 m -119.57 113.48 20.77 Favored 'General case' 0 CA--C 1.496 -1.111 0 N-CA-C 102.103 -3.295 . . . . 0.0 102.103 170.287 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' THR . . . . . 0.603 ' HA ' ' H ' ' A' ' 66' ' ' GLY . 15.3 m -143.41 149.74 38.08 Favored 'General case' 0 C--N 1.356 0.87 0 N-CA-C 105.705 -1.961 . . . . 0.0 105.705 -171.934 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 8.7 t . . . . . 0 C--O 1.261 1.662 0 C-N-CA 124.632 1.173 . . . . 0.0 109.497 -176.01 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 20.4 t . . . . . 0 N--CA 1.48 1.034 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -151.8 -173.18 21.28 Favored Glycine 0 C--N 1.351 1.393 0 N-CA-C 106.077 -2.809 . . . . 0.0 106.077 179.766 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_exo -61.0 135.78 61.31 Favored 'Trans proline' 0 N--CA 1.445 -1.342 0 C-N-CA 123.3 2.666 . . . . 0.0 112.37 -173.176 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 8.4 t -78.57 154.05 5.0 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.88 0 C-N-CA 126.738 2.015 . . . . 0.0 106.214 -175.948 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -96.66 90.73 5.42 Favored 'General case' 0 CA--C 1.493 -1.242 0 N-CA-C 107.66 -1.237 . . . . 0.0 107.66 -175.04 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.425 ' HA ' ' HA ' ' A' ' 22' ' ' TRP . 2.6 p -114.33 133.92 58.89 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.175 0 N-CA-C 107.032 -1.47 . . . . 0.0 107.032 -166.86 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 75.3 m-85 -134.07 173.4 11.62 Favored 'General case' 0 N--CA 1.435 -1.188 0 N-CA-C 106.208 -1.775 . . . . 0.0 106.208 -173.776 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 79.5 mt -98.92 141.72 16.03 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.021 0 N-CA-C 103.423 -2.806 . . . . 0.0 103.423 173.42 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 37.0 p -114.13 134.97 54.53 Favored 'General case' 0 CA--C 1.501 -0.916 0 N-CA-C 103.377 -2.823 . . . . 0.0 103.377 169.798 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 54.4 mt-10 -117.93 50.28 1.16 Allowed 'General case' 0 CA--C 1.495 -1.166 0 N-CA-C 104.54 -2.393 . . . . 0.0 104.54 -173.351 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 11.0 t -82.89 150.7 62.55 Favored Pre-proline 0 N--CA 1.44 -0.961 0 N-CA-C 105.677 -1.971 . . . . 0.0 105.677 175.531 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_exo -64.77 117.54 4.61 Favored 'Trans proline' 0 CA--C 1.507 -0.839 0 C-N-CA 122.544 2.163 . . . . 0.0 113.275 -171.617 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 5.7 t -154.49 -170.13 3.44 Favored 'General case' 0 N--CA 1.416 -2.156 0 N-CA-C 101.105 -3.665 . . . . 0.0 101.105 179.242 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 38.2 mt-30 -82.7 162.14 56.43 Favored Pre-proline 0 N--CA 1.442 -0.868 0 C-N-CA 126.6 1.96 . . . . 0.0 109.389 -174.971 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_endo -80.88 -2.58 11.89 Favored 'Trans proline' 0 N--CA 1.457 -0.644 0 C-N-CA 123.813 3.008 . . . . 0.0 109.903 165.419 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 2.3 t30 -89.18 -14.44 36.06 Favored 'General case' 0 N--CA 1.439 -0.994 0 C-N-CA 126.088 1.755 . . . . 0.0 107.403 172.697 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 68.2 m -113.32 150.3 32.73 Favored 'General case' 0 CA--C 1.497 -1.093 0 CA-C-O 122.16 0.981 . . . . 0.0 108.803 175.784 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 26.0 t-80 -124.41 98.54 37.89 Favored Pre-proline 0 N--CA 1.439 -1.014 0 N-CA-C 105.343 -2.095 . . . . 0.0 105.343 166.901 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -74.72 115.2 4.22 Favored 'Trans proline' 0 N--CA 1.448 -1.177 0 C-N-CA 123.017 2.478 . . . . 0.0 108.635 170.492 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 11.1 tt -108.92 148.79 12.53 Favored 'Isoleucine or valine' 0 N--CA 1.406 -2.639 0 C-N-CA 127.053 2.141 . . . . 0.0 106.05 -178.521 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 23.5 tt0 -135.64 145.42 46.8 Favored 'General case' 0 N--CA 1.435 -1.189 0 N-CA-C 104.337 -2.468 . . . . 0.0 104.337 170.967 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' TRP . . . . . 0.425 ' HA ' ' HA ' ' A' ' 6' ' ' VAL . 49.1 p90 -135.46 165.56 25.22 Favored 'General case' 0 N--CA 1.438 -1.054 0 N-CA-C 105.337 -2.097 . . . . 0.0 105.337 175.211 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 39.6 m-80 -140.8 132.04 26.55 Favored 'General case' 0 CA--C 1.489 -1.368 0 N-CA-C 106.136 -1.802 . . . . 0.0 106.136 -179.708 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -96.85 168.59 10.09 Favored Pre-proline 0 N--CA 1.439 -1.006 0 CA-C-N 114.792 -1.095 . . . . 0.0 110.37 -163.797 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 81.1 Cg_exo -66.43 167.69 18.13 Favored 'Trans proline' 0 N--CA 1.456 -0.716 0 C-N-CA 123.821 3.014 . . . . 0.0 111.776 166.731 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 10.2 tm0? -81.95 -52.66 0.74 Allowed Pre-proline 0 N--CA 1.444 -0.774 0 CA-C-O 115.317 -2.278 . . . . 0.0 111.279 -175.232 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -71.26 166.01 30.61 Favored 'Trans proline' 0 CA--C 1.507 -0.829 0 CA-C-N 126.065 3.202 . . . . 0.0 112.45 -172.77 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 28.1 p -77.97 118.29 20.12 Favored 'General case' 0 C--N 1.358 0.94 0 N-CA-C 106.915 -1.513 . . . . 0.0 106.915 173.449 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 8.4 t-160 -169.73 -44.84 0.02 OUTLIER 'General case' 0 CA--C 1.497 -1.063 0 N-CA-C 107.214 -1.402 . . . . 0.0 107.214 -164.099 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 37.2 mt -112.2 137.36 45.27 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.014 0 N-CA-C 104.175 -2.528 . . . . 0.0 104.175 176.615 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 33.5 t -113.06 -87.29 0.56 Allowed 'General case' 0 N--CA 1.43 -1.437 0 N-CA-C 106.494 -1.669 . . . . 0.0 106.494 179.548 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 35.9 ttpt -89.18 163.31 15.48 Favored 'General case' 0 CA--C 1.491 -1.303 0 C-N-CA 125.686 1.594 . . . . 0.0 108.104 -159.202 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 90.6 m-85 -128.88 139.07 52.31 Favored 'General case' 0 CA--C 1.492 -1.257 0 N-CA-C 105.649 -1.982 . . . . 0.0 105.649 175.56 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 55.3 mt -119.42 131.09 73.04 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.121 0 N-CA-C 101.694 -3.447 . . . . 0.0 101.694 171.113 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 3.2 mt -110.47 135.63 50.85 Favored 'General case' 0 CA--C 1.473 -1.982 0 N-CA-C 105.02 -2.215 . . . . 0.0 105.02 171.899 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -131.35 156.51 45.39 Favored 'General case' 0 CA--C 1.493 -1.247 0 N-CA-C 106.889 -1.523 . . . . 0.0 106.889 167.555 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 49.6 p90 -154.18 145.47 22.96 Favored 'General case' 0 N--CA 1.434 -1.257 0 N-CA-C 106.757 -1.572 . . . . 0.0 106.757 -175.94 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 8.6 ttm180 -138.18 139.57 26.01 Favored Pre-proline 0 CA--C 1.499 -0.982 0 N-CA-C 104.605 -2.368 . . . . 0.0 104.605 -179.907 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -72.89 116.06 4.58 Favored 'Trans proline' 0 N--CA 1.454 -0.843 0 C-N-CA 122.739 2.293 . . . . 0.0 108.824 174.713 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 3.0 tmtp? -70.22 81.49 0.53 Allowed 'General case' 0 C--N 1.358 0.97 0 C-N-CA 126.858 2.063 . . . . 0.0 111.029 -176.047 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 1.5 p30 -164.65 -50.06 0.03 OUTLIER 'General case' 0 N--CA 1.435 -1.176 0 N-CA-C 103.676 -2.713 . . . . 0.0 103.676 175.868 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 46.5 p -97.63 163.89 12.65 Favored 'General case' 0 N--CA 1.44 -0.968 0 C-N-CA 124.922 1.289 . . . . 0.0 108.01 178.135 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 4.8 m -125.92 46.18 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.849 0 N-CA-C 105.838 -1.912 . . . . 0.0 105.838 176.455 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -94.89 -154.06 30.66 Favored Glycine 0 C--N 1.356 1.656 0 N-CA-C 109.808 -1.317 . . . . 0.0 109.808 -175.64 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 80.4 ttt180 -78.9 126.76 31.12 Favored 'General case' 0 C--N 1.356 0.86 0 N-CA-C 108.142 -1.059 . . . . 0.0 108.142 -178.59 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -105.24 172.56 6.73 Favored 'General case' 0 CA--C 1.497 -1.061 0 C-N-CA 123.825 0.85 . . . . 0.0 110.377 -172.782 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 63.0 mttp -112.11 157.07 21.25 Favored 'General case' 0 CA--C 1.489 -1.403 0 N-CA-C 107.773 -1.195 . . . . 0.0 107.773 -170.717 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 15.7 pt-20 -151.21 159.73 44.23 Favored 'General case' 0 N--CA 1.437 -1.09 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 173.57 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -138.2 164.03 30.24 Favored 'General case' 0 N--CA 1.44 -0.935 0 N-CA-C 105.851 -1.907 . . . . 0.0 105.851 170.436 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 88.8 m -124.51 127.67 47.8 Favored 'General case' 0 CA--C 1.5 -0.947 0 N-CA-C 105.3 -2.111 . . . . 0.0 105.3 179.053 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 5.2 mp -117.27 135.93 23.29 Favored Pre-proline 0 N--CA 1.438 -1.034 0 N-CA-C 105.213 -2.143 . . . . 0.0 105.213 -172.111 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_exo -63.06 166.82 13.53 Favored 'Trans proline' 0 CA--C 1.509 -0.762 0 C-N-CA 123.54 2.826 . . . . 0.0 113.748 176.582 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -81.09 -16.82 73.62 Favored Glycine 0 C--N 1.353 1.473 0 C-N-CA 123.457 0.551 . . . . 0.0 113.249 -171.95 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 50.8 p-80 -83.83 -25.82 30.02 Favored 'General case' 0 C--N 1.357 0.901 0 CA-C-N 117.831 0.816 . . . . 0.0 109.999 179.899 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 92.4 mt -88.32 131.03 34.97 Favored 'General case' 0 CA--C 1.501 -0.922 0 N-CA-C 107.84 -1.17 . . . . 0.0 107.84 177.46 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 8.3 p-10 -112.95 8.35 18.51 Favored 'General case' 0 CA--C 1.503 -0.863 0 C-N-CA 124.666 1.186 . . . . 0.0 109.667 -174.421 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 32.9 p -146.75 160.92 41.64 Favored 'General case' 0 CA--C 1.499 -1.005 0 N-CA-C 106.484 -1.673 . . . . 0.0 106.484 -177.248 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 19.2 t80 -148.45 160.26 43.23 Favored 'General case' 0 CA--C 1.497 -1.093 0 N-CA-C 108.083 -1.08 . . . . 0.0 108.083 178.575 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 82.8 m -114.43 109.47 18.36 Favored 'General case' 0 N--CA 1.436 -1.14 0 N-CA-C 104.491 -2.411 . . . . 0.0 104.491 168.9 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 65.7 mt -82.94 137.79 20.41 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.902 0 N-CA-C 103.086 -2.931 . . . . 0.0 103.086 169.83 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 17.8 ptpt -147.84 160.62 42.56 Favored 'General case' 0 CA--C 1.495 -1.151 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 -177.709 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 89.82 52.67 2.56 Favored Glycine 0 CA--C 1.489 -1.555 0 N-CA-C 108.586 -1.806 . . . . 0.0 108.586 179.827 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 63.8 mt -120.47 170.63 9.2 Favored 'General case' 0 CA--C 1.498 -1.023 0 N-CA-C 107.377 -1.342 . . . . 0.0 107.377 -171.986 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 28.9 mtpp -101.59 153.75 37.7 Favored Pre-proline 0 N--CA 1.439 -1.012 0 N-CA-C 106.507 -1.664 . . . . 0.0 106.507 -179.775 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 70.6 Cg_endo -77.6 156.8 32.09 Favored 'Trans proline' 0 N--CA 1.452 -0.964 0 C-N-CA 122.936 2.424 . . . . 0.0 110.342 174.88 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 57.74 32.68 65.99 Favored Glycine 0 C--N 1.355 1.635 0 C-N-CA 126.904 2.192 . . . . 0.0 116.44 169.854 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 5.8 p -129.16 144.39 38.3 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.903 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 -177.009 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 3.5 p -95.4 135.49 29.31 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.918 0 N-CA-C 107.292 -1.373 . . . . 0.0 107.292 -179.693 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 94.8 m-85 -113.67 150.99 32.43 Favored 'General case' 0 CA--C 1.499 -1.011 0 N-CA-C 106.815 -1.55 . . . . 0.0 106.815 177.379 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -94.94 145.29 25.02 Favored 'General case' 0 CA--C 1.501 -0.928 0 N-CA-C 104.155 -2.535 . . . . 0.0 104.155 161.109 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -138.39 149.5 20.56 Favored Glycine 0 CA--C 1.487 -1.678 0 N-CA-C 108.599 -1.801 . . . . 0.0 108.599 -177.413 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 84.8 mt-30 -138.59 135.66 35.19 Favored 'General case' 0 CA--C 1.483 -1.608 0 N-CA-C 105.599 -2.0 . . . . 0.0 105.599 177.064 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 40.9 tp -116.72 99.36 7.07 Favored 'General case' 0 N--CA 1.435 -1.178 0 N-CA-C 103.787 -2.672 . . . . 0.0 103.787 179.075 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 33.0 mt -89.21 127.68 41.75 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.883 0 N-CA-C 104.762 -2.311 . . . . 0.0 104.762 177.702 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 13.3 p -112.03 115.98 29.8 Favored 'General case' 0 N--CA 1.434 -1.26 0 N-CA-C 106.565 -1.642 . . . . 0.0 106.565 -176.619 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 23.1 mm -90.68 138.63 19.13 Favored 'Isoleucine or valine' 0 CA--C 1.483 -1.603 0 N-CA-C 106.154 -1.795 . . . . 0.0 106.154 -167.468 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 36.2 mt-30 -101.24 153.6 19.48 Favored 'General case' 0 CA--C 1.494 -1.198 0 CA-C-N 113.851 -1.522 . . . . 0.0 107.569 -173.313 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 32.8 mt-30 -68.44 101.16 1.19 Allowed 'General case' 0 CA--C 1.5 -0.948 0 C-N-CA 124.939 1.295 . . . . 0.0 112.497 -166.165 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 85.7 m-85 52.99 39.99 30.38 Favored 'General case' 0 C--N 1.359 1.008 0 C-N-CA 127.296 2.238 . . . . 0.0 112.214 -179.825 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -149.64 -118.83 0.93 Allowed Glycine 0 C--N 1.354 1.545 0 N-CA-C 108.851 -1.7 . . . . 0.0 108.851 -175.294 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 64.4 m-70 -81.93 -175.68 5.73 Favored 'General case' 0 CA--C 1.496 -1.113 0 C-N-CA 124.757 1.223 . . . . 0.0 111.528 -167.858 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 40.1 mt-30 -134.0 137.47 44.77 Favored 'General case' 0 N--CA 1.436 -1.132 0 N-CA-C 103.536 -2.765 . . . . 0.0 103.536 171.595 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 16.7 tp10 -118.05 137.02 53.18 Favored 'General case' 0 CA--C 1.495 -1.146 0 N-CA-C 105.174 -2.158 . . . . 0.0 105.174 179.873 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 7.1 p -111.35 139.12 36.9 Favored 'Isoleucine or valine' 0 C--N 1.354 0.797 0 N-CA-C 107.618 -1.253 . . . . 0.0 107.618 -177.414 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 38.2 m -120.49 134.17 55.31 Favored 'General case' 0 N--CA 1.441 -0.886 0 N-CA-C 102.345 -3.206 . . . . 0.0 102.345 174.114 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 83.1 mtm180 -125.82 149.75 48.36 Favored 'General case' 0 CA--C 1.5 -0.954 0 CA-C-N 119.177 0.898 . . . . 0.0 109.479 -176.638 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 19.2 p90 -165.96 -176.59 3.85 Favored 'General case' 0 CA--C 1.501 -0.92 0 N-CA-C 107.382 -1.34 . . . . 0.0 107.382 -178.357 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 44.7 p30 -135.79 158.05 45.34 Favored 'General case' 0 N--CA 1.442 -0.858 0 N-CA-C 107.24 -1.393 . . . . 0.0 107.24 164.626 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 25.4 p90 -142.38 172.88 12.09 Favored 'General case' 0 CA--C 1.485 -1.53 0 N-CA-C 106.018 -1.845 . . . . 0.0 106.018 170.252 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 8.9 t -141.41 152.98 44.77 Favored 'General case' 0 CA--C 1.499 -0.996 0 N-CA-C 105.713 -1.958 . . . . 0.0 105.713 173.77 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 29.8 p -113.95 131.94 56.13 Favored 'General case' 0 N--CA 1.437 -1.104 0 N-CA-C 103.432 -2.803 . . . . 0.0 103.432 171.745 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 25.0 p -130.5 145.83 51.93 Favored 'General case' 0 CA--C 1.5 -0.968 0 N-CA-C 105.654 -1.98 . . . . 0.0 105.654 179.632 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 42.9 p . . . . . 0 C--O 1.26 1.65 0 N-CA-C 109.206 -0.664 . . . . 0.0 109.206 -177.575 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 65.2 m . . . . . 0 N--CA 1.49 1.553 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -160.97 178.99 36.71 Favored Glycine 0 C--N 1.351 1.386 0 N-CA-C 105.516 -3.034 . . . . 0.0 105.516 173.566 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 90.4 Cg_exo -61.17 134.27 51.51 Favored 'Trans proline' 0 CA--C 1.5 -1.177 0 C-N-CA 123.17 2.58 . . . . 0.0 112.255 -171.018 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 3.1 t -79.39 150.31 5.15 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.79 0 C-N-CA 126.313 1.845 . . . . 0.0 106.039 -176.442 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 54.5 mm-40 -100.1 89.46 4.04 Favored 'General case' 0 CA--C 1.485 -1.527 0 CA-C-O 122.776 1.274 . . . . 0.0 108.36 -170.262 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 2.3 p -104.06 127.24 58.42 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.136 0 CA-C-N 113.421 -1.718 . . . . 0.0 107.661 -166.879 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 59.2 m-85 -85.67 138.27 32.25 Favored 'General case' 0 CA--C 1.495 -1.135 0 C-N-CA 123.935 0.894 . . . . 0.0 110.444 -169.501 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 35.2 mt -131.82 62.21 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.438 -1.052 0 N-CA-C 100.615 -3.846 . . . . 0.0 100.615 163.057 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 88.2 m -111.76 100.31 8.84 Favored 'General case' 0 CA--C 1.498 -1.033 0 N-CA-C 104.941 -2.244 . . . . 0.0 104.941 -172.635 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 11.8 tp10 54.89 42.19 31.3 Favored 'General case' 0 C--N 1.358 0.975 0 C-N-CA 126.859 2.064 . . . . 0.0 111.138 -176.949 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 30.7 m -92.53 -55.21 0.25 Allowed Pre-proline 0 N--CA 1.442 -0.826 0 CA-C-O 113.992 -2.909 . . . . 0.0 109.936 -174.546 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_exo -71.46 87.47 0.78 Allowed 'Trans proline' 0 C--N 1.349 0.584 0 CA-C-N 126.435 3.334 . . . . 0.0 115.415 -164.664 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 11.1 p -159.73 82.11 0.73 Allowed 'General case' 0 CA--C 1.492 -1.268 0 N-CA-C 105.803 -1.925 . . . . 0.0 105.803 168.831 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 22.2 mp0 -156.02 157.52 31.32 Favored Pre-proline 0 N--CA 1.441 -0.92 0 N-CA-C 104.54 -2.393 . . . . 0.0 104.54 -176.405 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -80.01 -50.79 0.06 OUTLIER 'Trans proline' 0 N--CA 1.45 -1.056 0 C-N-CA 122.647 2.231 . . . . 0.0 111.75 172.861 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 36.6 m-20 -141.97 -12.39 0.85 Allowed 'General case' 0 N--CA 1.435 -1.191 0 C-N-CA 124.82 1.248 . . . . 0.0 110.228 -163.649 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 23.6 p -98.11 161.39 13.74 Favored 'General case' 0 CA--C 1.503 -0.846 0 O-C-N 120.739 -1.226 . . . . 0.0 107.701 -179.516 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 40.3 t-80 -151.52 104.26 2.91 Favored Pre-proline 0 N--CA 1.443 -0.816 0 CA-C-O 118.359 -0.829 . . . . 0.0 108.934 173.088 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -75.73 123.11 7.25 Favored 'Trans proline' 0 N--CA 1.452 -0.949 0 C-N-CA 123.199 2.599 . . . . 0.0 109.71 175.282 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 10.9 mt -111.6 136.56 47.35 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.947 0 N-CA-C 104.586 -2.375 . . . . 0.0 104.586 -178.639 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 35.7 mt-30 -140.3 146.93 39.17 Favored 'General case' 0 CA--C 1.494 -1.19 0 N-CA-C 104.668 -2.345 . . . . 0.0 104.668 179.387 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 42.7 p90 -147.48 169.63 19.14 Favored 'General case' 0 CA--C 1.499 -1.015 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 -174.072 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 8.1 m-80 -131.24 127.57 38.1 Favored 'General case' 0 CA--C 1.492 -1.252 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 179.624 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -92.26 175.78 3.11 Favored Pre-proline 0 N--CA 1.439 -0.993 0 C-N-CA 125.989 1.716 . . . . 0.0 108.946 -174.323 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_exo -63.16 159.58 38.45 Favored 'Trans proline' 0 CA--C 1.508 -0.823 0 C-N-CA 123.743 2.962 . . . . 0.0 112.297 171.095 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 35.9 mt-30 -81.57 -37.12 0.86 Allowed Pre-proline 0 N--CA 1.443 -0.795 0 CA-C-O 115.962 -1.971 . . . . 0.0 111.281 -177.414 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_exo -70.17 -8.26 23.16 Favored 'Trans proline' 0 CA--C 1.512 -0.625 0 CA-C-N 124.878 2.778 . . . . 0.0 112.905 169.526 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . 0.28 80.5 p 54.09 71.81 0.49 Allowed 'General case' 0 C--N 1.36 1.046 0 C-N-CA 127.609 2.363 . . . . 0.0 112.022 -177.254 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 49.8 t-80 -88.74 -10.57 47.85 Favored 'General case' 0 N--CA 1.441 -0.885 0 C-N-CA 124.473 1.109 . . . . 0.0 109.768 -176.329 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.408 HG21 ' CE1' ' A' ' 33' ' ' TYR . 84.7 mt -93.88 145.03 8.4 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.976 0 N-CA-C 105.434 -2.061 . . . . 0.0 105.434 -179.846 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 35.6 t -99.09 -86.78 0.36 Allowed 'General case' 0 N--CA 1.43 -1.445 0 N-CA-C 103.857 -2.646 . . . . 0.0 103.857 174.537 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 46.0 mtpt -89.16 165.94 14.15 Favored 'General case' 0 CA--C 1.492 -1.266 0 C-N-CA 124.854 1.262 . . . . 0.0 109.097 -168.359 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' TYR . . . . . 0.408 ' CE1' HG21 ' A' ' 30' ' ' ILE . 64.0 m-85 -125.63 142.34 51.56 Favored 'General case' 0 CA--C 1.495 -1.137 0 N-CA-C 104.547 -2.39 . . . . 0.0 104.547 164.641 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 54.7 mt -119.56 132.24 69.9 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.302 0 N-CA-C 101.141 -3.651 . . . . 0.0 101.141 168.796 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 3.0 mt -106.38 128.96 54.43 Favored 'General case' 0 CA--C 1.473 -2.017 0 N-CA-C 103.95 -2.611 . . . . 0.0 103.95 166.766 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 79.3 mtt180 -112.56 157.09 21.59 Favored 'General case' 0 N--CA 1.43 -1.442 0 N-CA-C 105.266 -2.124 . . . . 0.0 105.266 164.248 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 48.6 p90 -156.12 147.42 22.5 Favored 'General case' 0 N--CA 1.43 -1.44 0 N-CA-C 105.934 -1.876 . . . . 0.0 105.934 176.513 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 39.0 ptt180 -157.52 161.07 29.86 Favored Pre-proline 0 N--CA 1.438 -1.028 0 N-CA-C 105.41 -2.071 . . . . 0.0 105.41 170.189 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_exo -66.06 149.77 85.68 Favored 'Trans proline' 0 CA--C 1.503 -1.029 0 C-N-CA 123.367 2.711 . . . . 0.0 109.828 176.572 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 4.1 tmtp? -75.7 70.93 2.54 Favored 'General case' 0 C--N 1.358 0.947 0 C-N-CA 123.643 0.777 . . . . 0.0 109.587 175.731 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 30.4 m120 -158.67 -52.55 0.06 Allowed 'General case' 0 N--CA 1.437 -1.083 0 N-CA-C 103.671 -2.714 . . . . 0.0 103.671 -170.609 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 32.3 t -79.24 151.45 31.17 Favored 'General case' 0 CA--C 1.497 -1.096 0 CA-C-O 122.783 1.277 . . . . 0.0 110.064 -174.73 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 16.1 m -134.34 -0.54 1.24 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.894 0 CA-C-N 112.42 -2.173 . . . . 0.0 108.425 -174.514 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -98.2 -100.21 2.13 Favored Glycine 0 C--N 1.356 1.67 0 N-CA-C 109.355 -1.498 . . . . 0.0 109.355 -174.63 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 77.0 mtp85 -93.95 168.21 11.11 Favored 'General case' 0 CA--C 1.501 -0.908 0 C-N-CA 123.588 0.755 . . . . 0.0 109.559 -173.716 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 60.3 m95 -122.53 163.22 20.32 Favored 'General case' 0 N--CA 1.439 -0.996 0 N-CA-C 106.273 -1.751 . . . . 0.0 106.273 178.591 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -96.77 151.26 19.82 Favored 'General case' 0 CA--C 1.489 -1.392 0 N-CA-C 103.858 -2.645 . . . . 0.0 103.858 158.796 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 16.1 pt-20 -152.31 158.88 43.38 Favored 'General case' 0 CA--C 1.496 -1.12 0 CA-C-O 121.8 0.81 . . . . 0.0 109.559 -178.113 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -142.73 162.25 35.97 Favored 'General case' 0 CA--C 1.498 -1.036 0 N-CA-C 106.051 -1.833 . . . . 0.0 106.051 174.066 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 78.4 m -120.35 125.63 48.49 Favored 'General case' 0 CA--C 1.5 -0.945 0 N-CA-C 105.228 -2.138 . . . . 0.0 105.228 178.713 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 5.3 mp -109.43 133.3 20.87 Favored Pre-proline 0 N--CA 1.437 -1.107 0 N-CA-C 104.313 -2.476 . . . . 0.0 104.313 -177.929 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 65.3 Cg_exo -63.88 165.06 19.74 Favored 'Trans proline' 0 CA--C 1.507 -0.847 0 C-N-CA 123.393 2.729 . . . . 0.0 113.054 178.277 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -75.05 -18.04 80.2 Favored Glycine 0 C--N 1.351 1.403 0 N-CA-C 114.604 0.602 . . . . 0.0 114.604 -174.084 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 47.7 p-80 -83.71 -29.52 27.47 Favored 'General case' 0 C--N 1.356 0.864 0 CA-C-N 118.016 0.908 . . . . 0.0 109.826 179.832 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 89.6 mt -89.14 134.26 34.08 Favored 'General case' 0 CA--C 1.5 -0.972 0 N-CA-C 107.721 -1.215 . . . . 0.0 107.721 176.563 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 6.5 p-10 -123.53 25.01 8.4 Favored 'General case' 0 CA--C 1.498 -1.023 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 -177.541 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 33.9 p -146.79 163.22 36.72 Favored 'General case' 0 N--CA 1.439 -1.021 0 N-CA-C 107.59 -1.263 . . . . 0.0 107.59 -179.248 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 7.4 t80 -154.25 178.4 10.05 Favored 'General case' 0 N--CA 1.44 -0.936 0 N-CA-C 107.903 -1.147 . . . . 0.0 107.903 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 96.1 m -144.09 117.99 9.36 Favored 'General case' 0 N--CA 1.43 -1.44 0 N-CA-C 104.995 -2.224 . . . . 0.0 104.995 176.072 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 13.4 mm -87.22 144.38 9.4 Favored 'Isoleucine or valine' 0 C--N 1.354 0.768 0 N-CA-C 104.3 -2.481 . . . . 0.0 104.3 171.004 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 95.8 mttt -145.27 162.22 37.69 Favored 'General case' 0 CA--C 1.493 -1.225 0 N-CA-C 107.491 -1.3 . . . . 0.0 107.491 170.07 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 79.31 54.56 4.0 Favored Glycine 0 CA--C 1.488 -1.596 0 N-CA-C 108.968 -1.653 . . . . 0.0 108.968 175.249 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 85.3 mt -108.34 -153.87 0.52 Allowed 'General case' 0 CA--C 1.504 -0.799 0 N-CA-C 106.822 -1.547 . . . . 0.0 106.822 178.854 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 90.6 mttt -132.18 156.3 80.27 Favored Pre-proline 0 N--CA 1.44 -0.928 0 N-CA-C 105.74 -1.948 . . . . 0.0 105.74 -170.997 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_endo -74.09 135.78 21.44 Favored 'Trans proline' 0 N--CA 1.451 -0.993 0 C-N-CA 122.905 2.403 . . . . 0.0 110.45 173.202 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 57.25 49.74 70.09 Favored Glycine 0 C--N 1.355 1.612 0 C-N-CA 126.852 2.167 . . . . 0.0 115.823 170.417 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 27.8 t -118.13 133.58 64.49 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.102 0 N-CA-C 105.951 -1.87 . . . . 0.0 105.951 173.51 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 5.3 p -84.33 119.97 34.27 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.961 0 N-CA-C 105.48 -2.044 . . . . 0.0 105.48 164.947 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 83.0 m-85 -99.5 149.24 23.42 Favored 'General case' 0 CA--C 1.496 -1.13 0 C-N-CA 125.716 1.606 . . . . 0.0 107.354 -179.477 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 17.9 pt-20 -108.67 133.46 52.73 Favored 'General case' 0 CA--C 1.499 -0.984 0 N-CA-C 105.01 -2.219 . . . . 0.0 105.01 167.912 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -128.45 165.08 21.48 Favored Glycine 0 CA--C 1.484 -1.895 0 N-CA-C 107.688 -2.165 . . . . 0.0 107.688 -174.206 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 83.8 mt-30 -137.3 133.84 35.42 Favored 'General case' 0 CA--C 1.482 -1.667 0 N-CA-C 104.557 -2.386 . . . . 0.0 104.557 169.688 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 27.2 tp -110.54 90.77 3.42 Favored 'General case' 0 N--CA 1.435 -1.221 0 N-CA-C 103.335 -2.839 . . . . 0.0 103.335 174.383 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 13.2 mt -91.58 131.34 38.95 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.927 0 N-CA-C 105.492 -2.04 . . . . 0.0 105.492 -174.373 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 58.5 m -118.47 115.3 24.33 Favored 'General case' 0 N--CA 1.436 -1.164 0 N-CA-C 107.685 -1.228 . . . . 0.0 107.685 -173.998 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 1.7 mp -91.54 135.97 25.62 Favored 'Isoleucine or valine' 0 CA--C 1.499 -1.0 0 N-CA-C 105.163 -2.162 . . . . 0.0 105.163 -172.175 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 15.6 mp0 -99.17 122.07 41.88 Favored 'General case' 0 CA--C 1.498 -1.034 0 N-CA-C 102.582 -3.118 . . . . 0.0 102.582 170.174 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 16.7 tt0 -68.03 126.02 28.18 Favored 'General case' 0 N--CA 1.443 -0.789 0 C-N-CA 123.26 0.624 . . . . 0.0 111.629 -166.995 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 21.5 m-85 66.42 43.83 2.55 Favored 'General case' 0 C--N 1.357 0.902 0 C-N-CA 126.746 2.018 . . . . 0.0 111.912 179.787 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -171.95 -115.77 0.37 Allowed Glycine 0 N--CA 1.432 -1.587 0 N-CA-C 108.145 -1.982 . . . . 0.0 108.145 175.714 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 87.7 m-70 -84.71 178.53 7.63 Favored 'General case' 0 CA--C 1.498 -1.023 0 C-N-CA 125.182 1.393 . . . . 0.0 111.103 -169.302 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 5.3 pt20 -145.9 143.89 29.85 Favored 'General case' 0 N--CA 1.436 -1.138 0 N-CA-C 106.156 -1.794 . . . . 0.0 106.156 165.104 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 9.3 tm-20 -106.39 141.76 37.18 Favored 'General case' 0 N--CA 1.438 -1.064 0 N-CA-C 104.44 -2.43 . . . . 0.0 104.44 -177.351 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 3.2 p -121.96 120.43 61.43 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.804 0 N-CA-C 108.195 -1.039 . . . . 0.0 108.195 -179.467 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 83.9 m -97.15 129.09 44.57 Favored 'General case' 0 C--N 1.355 0.844 0 N-CA-C 102.622 -3.103 . . . . 0.0 102.622 169.822 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 55.3 ttt85 -115.17 137.66 51.77 Favored 'General case' 0 CA--C 1.498 -1.04 0 N-CA-C 106.358 -1.719 . . . . 0.0 106.358 175.45 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -150.86 176.76 10.77 Favored 'General case' 0 CA--C 1.494 -1.185 0 N-CA-C 107.657 -1.238 . . . . 0.0 107.657 -177.477 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 38.9 p-10 -139.39 151.25 46.16 Favored 'General case' 0 N--CA 1.438 -1.047 0 N-CA-C 106.0 -1.852 . . . . 0.0 106.0 171.21 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 18.5 p90 -144.43 170.51 15.89 Favored 'General case' 0 CA--C 1.489 -1.387 0 N-CA-C 105.801 -1.926 . . . . 0.0 105.801 176.433 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 55.2 m -122.19 142.98 49.86 Favored 'General case' 0 CA--C 1.5 -0.956 0 N-CA-C 105.564 -2.014 . . . . 0.0 105.564 -179.557 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 86.6 m -120.41 120.97 37.49 Favored 'General case' 0 CA--C 1.498 -1.056 0 N-CA-C 101.971 -3.344 . . . . 0.0 101.971 167.292 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 76.9 p -88.73 -168.46 2.2 Favored 'General case' 0 C--N 1.353 0.723 0 C-N-CA 123.654 0.781 . . . . 0.0 109.422 -169.527 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 32.3 t . . . . . 0 C--O 1.26 1.64 0 N-CA-C 106.768 -1.567 . . . . 0.0 106.768 -179.609 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 60.2 m . . . . . 0 N--CA 1.489 1.475 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 167.6 -162.79 36.59 Favored Glycine 0 N--CA 1.436 -1.36 0 N-CA-C 107.62 -2.192 . . . . 0.0 107.62 -179.931 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 79.4 Cg_exo -61.83 137.5 68.31 Favored 'Trans proline' 0 N--CA 1.444 -1.412 0 C-N-CA 123.359 2.706 . . . . 0.0 113.06 -177.389 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 3.5 t -77.37 152.53 5.51 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.915 0 C-N-CA 127.993 2.517 . . . . 0.0 107.006 -178.86 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 91.4 mt-10 -94.35 86.99 5.05 Favored 'General case' 0 CA--C 1.493 -1.23 0 CA-C-O 122.73 1.252 . . . . 0.0 108.721 -174.547 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.417 HG12 ' H ' ' A' ' 6' ' ' VAL . 2.1 p -88.98 154.32 3.18 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.077 0 N-CA-C 105.822 -1.918 . . . . 0.0 105.822 -171.293 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 36.8 t80 -146.57 66.06 1.18 Allowed 'General case' 0 N--CA 1.429 -1.497 0 N-CA-C 104.458 -2.423 . . . . 0.0 104.458 -148.199 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 61.2 mt -98.94 95.7 4.49 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.96 0 N-CA-C 104.166 -2.531 . . . . 0.0 104.166 176.118 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 14.7 t -157.66 -26.44 0.09 Allowed 'General case' 0 N--CA 1.442 -0.854 0 CA-C-N 113.756 -1.565 . . . . 0.0 110.149 -172.19 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 31.9 tt0 -100.96 2.38 40.65 Favored 'General case' 0 N--CA 1.438 -1.051 0 C-N-CA 125.661 1.585 . . . . 0.0 107.537 -176.238 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 20.5 p -134.61 73.55 67.43 Favored Pre-proline 0 C--N 1.358 0.976 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 -177.297 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -75.44 -52.5 0.1 Allowed 'Trans proline' 0 N--CA 1.453 -0.891 0 C-N-CA 122.585 2.19 . . . . 0.0 110.523 176.354 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 18.7 p -139.36 110.23 6.78 Favored 'General case' 0 N--CA 1.425 -1.686 0 N-CA-C 104.497 -2.409 . . . . 0.0 104.497 -172.979 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 29.0 mm100 -129.37 132.3 24.18 Favored Pre-proline 0 N--CA 1.438 -1.042 0 N-CA-C 101.657 -3.46 . . . . 0.0 101.657 168.486 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 64.1 Cg_endo -82.46 -27.38 2.25 Favored 'Trans proline' 0 CA--C 1.504 -1.003 0 C-N-CA 122.085 1.856 . . . . 0.0 112.052 -154.763 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 12.4 p-10 -120.75 -38.89 2.79 Favored 'General case' 0 CA--C 1.482 -1.654 0 C-N-CA 123.82 0.848 . . . . 0.0 109.198 -173.989 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 48.5 p -100.54 165.63 11.32 Favored 'General case' 0 N--CA 1.435 -1.22 0 N-CA-C 107.987 -1.116 . . . . 0.0 107.987 -174.956 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 63.7 t-80 -143.31 97.44 5.63 Favored Pre-proline 0 N--CA 1.435 -1.185 0 N-CA-C 104.501 -2.407 . . . . 0.0 104.501 162.434 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -71.18 133.83 23.76 Favored 'Trans proline' 0 N--CA 1.447 -1.258 0 C-N-CA 122.558 2.172 . . . . 0.0 110.167 172.061 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 14.7 mm -104.46 138.63 28.29 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.062 0 N-CA-C 102.928 -2.99 . . . . 0.0 102.928 176.664 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 73.1 mt-30 -128.31 149.66 50.41 Favored 'General case' 0 CA--C 1.493 -1.244 0 N-CA-C 103.909 -2.626 . . . . 0.0 103.909 172.609 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 49.1 p90 -149.49 167.69 25.54 Favored 'General case' 0 CA--C 1.491 -1.307 0 N-CA-C 107.947 -1.131 . . . . 0.0 107.947 -179.125 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 1.8 m120 -130.92 128.44 40.52 Favored 'General case' 0 CA--C 1.489 -1.374 0 N-CA-C 105.382 -2.081 . . . . 0.0 105.382 -179.751 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -87.02 143.79 35.5 Favored Pre-proline 0 N--CA 1.44 -0.927 0 CA-C-O 118.693 -0.67 . . . . 0.0 110.504 -170.622 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_endo -76.76 166.09 27.62 Favored 'Trans proline' 0 N--CA 1.452 -0.917 0 C-N-CA 122.716 2.277 . . . . 0.0 108.214 159.381 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 22.3 tt0 -129.73 84.44 61.19 Favored Pre-proline 0 N--CA 1.442 -0.861 0 N-CA-C 108.323 -0.991 . . . . 0.0 108.323 176.683 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 90.9 Cg_endo -82.31 -8.2 11.76 Favored 'Trans proline' 0 N--CA 1.453 -0.865 0 C-N-CA 123.148 2.565 . . . . 0.0 109.599 163.051 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 21.4 m 59.45 44.21 15.28 Favored 'General case' 0 C--N 1.36 1.028 0 C-N-CA 127.573 2.349 . . . . 0.0 111.222 -171.328 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 15.4 t-160 -140.57 -10.84 1.05 Allowed 'General case' 0 N--CA 1.438 -1.031 0 CA-C-N 113.947 -1.479 . . . . 0.0 108.92 -174.935 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 38.4 mt -111.11 130.7 64.09 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.094 0 N-CA-C 105.423 -2.066 . . . . 0.0 105.423 -173.408 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 32.0 t -112.91 -84.82 0.59 Allowed 'General case' 0 N--CA 1.433 -1.283 0 N-CA-C 107.806 -1.183 . . . . 0.0 107.806 -176.242 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 51.4 mtmt -87.68 168.87 12.62 Favored 'General case' 0 CA--C 1.485 -1.539 0 C-N-CA 124.009 0.924 . . . . 0.0 109.097 -161.313 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 86.8 m-85 -129.46 140.07 51.41 Favored 'General case' 0 CA--C 1.493 -1.238 0 N-CA-C 105.049 -2.204 . . . . 0.0 105.049 170.32 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 35.8 mt -117.24 131.08 71.0 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.203 0 N-CA-C 101.567 -3.494 . . . . 0.0 101.567 169.511 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 4.8 mt -106.65 128.68 54.37 Favored 'General case' 0 CA--C 1.473 -1.985 0 N-CA-C 104.389 -2.448 . . . . 0.0 104.389 168.182 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 65.5 mtt180 -113.97 157.97 21.75 Favored 'General case' 0 N--CA 1.431 -1.377 0 N-CA-C 105.644 -1.984 . . . . 0.0 105.644 167.082 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 36.0 p90 -147.07 130.41 16.63 Favored 'General case' 0 N--CA 1.432 -1.362 0 N-CA-C 104.359 -2.46 . . . . 0.0 104.359 174.16 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 20.0 ttp180 -122.94 138.78 30.2 Favored Pre-proline 0 CA--C 1.498 -1.046 0 N-CA-C 104.087 -2.56 . . . . 0.0 104.087 177.437 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 68.4 Cg_exo -66.26 130.14 23.3 Favored 'Trans proline' 0 CA--C 1.503 -1.037 0 CA-C-N 123.798 2.392 . . . . 0.0 109.122 169.395 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 39.9 ttmt -73.07 69.56 1.02 Allowed 'General case' 0 C--N 1.357 0.929 0 C-N-CA 124.716 1.206 . . . . 0.0 109.899 173.939 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 69.6 m-80 -160.65 -57.05 0.05 Allowed 'General case' 0 N--CA 1.434 -1.26 0 N-CA-C 102.18 -3.267 . . . . 0.0 102.18 -170.866 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 53.4 p -85.29 165.52 17.24 Favored 'General case' 0 N--CA 1.439 -1.021 0 C-N-CA 125.333 1.453 . . . . 0.0 109.109 179.565 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 19.2 m -113.73 -13.04 11.58 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.811 0 C-N-CA 124.254 1.022 . . . . 0.0 110.144 -172.31 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -175.81 38.61 0.1 Allowed Glycine 0 C--N 1.354 1.55 0 N-CA-C 110.359 -1.097 . . . . 0.0 110.359 -178.19 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -119.85 105.51 11.17 Favored 'General case' 0 CA--C 1.492 -1.257 0 N-CA-C 102.271 -3.233 . . . . 0.0 102.271 171.149 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -157.75 165.74 34.59 Favored 'General case' 0 CA--C 1.49 -1.33 0 CA-C-O 122.16 0.981 . . . . 0.0 112.161 -172.618 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 63.2 mttp -121.57 161.41 22.43 Favored 'General case' 0 CA--C 1.492 -1.257 0 CA-C-N 113.688 -1.596 . . . . 0.0 106.79 -169.777 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 15.8 pt-20 -151.92 160.71 43.43 Favored 'General case' 0 N--CA 1.435 -1.199 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 174.315 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -140.5 162.25 35.79 Favored 'General case' 0 CA--C 1.5 -0.961 0 N-CA-C 106.283 -1.747 . . . . 0.0 106.283 174.69 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 59.5 m -120.36 126.04 49.52 Favored 'General case' 0 CA--C 1.499 -0.982 0 N-CA-C 105.175 -2.157 . . . . 0.0 105.175 178.06 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 5.3 mp -112.7 135.94 21.57 Favored Pre-proline 0 N--CA 1.437 -1.098 0 N-CA-C 104.516 -2.401 . . . . 0.0 104.516 -177.346 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 63.2 Cg_exo -63.6 168.06 12.26 Favored 'Trans proline' 0 CA--C 1.51 -0.723 0 C-N-CA 123.45 2.766 . . . . 0.0 113.618 177.466 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -78.49 -20.01 72.65 Favored Glycine 0 C--N 1.351 1.383 0 C-N-CA 123.398 0.523 . . . . 0.0 113.26 -173.885 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 49.7 p-80 -84.27 -27.48 27.85 Favored 'General case' 0 C--N 1.355 0.836 0 CA-C-N 117.713 0.756 . . . . 0.0 110.022 -179.393 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 87.5 mt -88.52 130.64 35.18 Favored 'General case' 0 CA--C 1.5 -0.981 0 N-CA-C 107.541 -1.281 . . . . 0.0 107.541 177.264 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 7.6 p30 -118.88 13.05 13.05 Favored 'General case' 0 CA--C 1.501 -0.921 0 C-N-CA 124.113 0.965 . . . . 0.0 109.645 -173.311 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 46.9 p -142.93 166.6 24.19 Favored 'General case' 0 N--CA 1.44 -0.959 0 N-CA-C 107.282 -1.377 . . . . 0.0 107.282 179.169 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 9.9 t80 -154.87 176.74 12.1 Favored 'General case' 0 N--CA 1.44 -0.938 0 N-CA-C 107.788 -1.19 . . . . 0.0 107.788 -177.161 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 57.2 m -142.57 114.72 8.3 Favored 'General case' 0 N--CA 1.432 -1.367 0 N-CA-C 105.114 -2.18 . . . . 0.0 105.114 176.882 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 50.8 mt -98.84 98.09 6.73 Favored 'Isoleucine or valine' 0 C--N 1.36 1.044 0 N-CA-C 106.137 -1.801 . . . . 0.0 106.137 175.823 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 93.4 mttt -94.97 163.65 13.23 Favored 'General case' 0 CA--C 1.499 -0.988 0 CA-C-O 121.591 0.71 . . . . 0.0 109.341 178.453 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 84.03 49.51 4.73 Favored Glycine 0 CA--C 1.49 -1.471 0 N-CA-C 109.134 -1.586 . . . . 0.0 109.134 174.453 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 68.3 mt -121.63 162.73 20.16 Favored 'General case' 0 CA--C 1.497 -1.078 0 N-CA-C 106.171 -1.789 . . . . 0.0 106.171 -179.144 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -99.57 157.34 34.13 Favored Pre-proline 0 N--CA 1.44 -0.944 0 N-CA-C 107.257 -1.386 . . . . 0.0 107.257 -177.276 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -78.65 165.88 24.38 Favored 'Trans proline' 0 N--CA 1.451 -1.005 0 C-N-CA 123.074 2.516 . . . . 0.0 109.575 165.521 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 0.515 ' H ' ' HA ' ' A' ' 92' ' ' THR . . . 64.67 18.77 64.26 Favored Glycine 0 N--CA 1.43 -1.736 0 C-N-CA 127.223 2.344 . . . . 0.0 116.415 173.178 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 13.9 p -123.99 140.36 47.66 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.024 0 N-CA-C 107.942 -1.133 . . . . 0.0 107.942 -176.338 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 2.8 p -96.34 129.48 46.35 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.842 0 N-CA-C 107.391 -1.337 . . . . 0.0 107.391 178.671 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 82.6 m-85 -109.56 155.17 21.73 Favored 'General case' 0 N--CA 1.438 -1.04 0 C-N-CA 124.672 1.189 . . . . 0.0 108.436 177.375 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 19.3 tt0 -92.63 139.04 30.98 Favored 'General case' 0 N--CA 1.437 -1.108 0 N-CA-C 104.044 -2.576 . . . . 0.0 104.044 159.074 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -132.31 146.07 17.82 Favored Glycine 0 CA--C 1.49 -1.488 0 N-CA-C 107.575 -2.21 . . . . 0.0 107.575 171.679 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 32.4 mt-30 -138.57 136.02 35.6 Favored 'General case' 0 CA--C 1.479 -1.759 0 N-CA-C 106.321 -1.733 . . . . 0.0 106.321 177.834 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 45.2 tp -117.54 95.53 4.99 Favored 'General case' 0 N--CA 1.439 -1.011 0 N-CA-C 104.423 -2.436 . . . . 0.0 104.423 -178.281 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 12.5 mt -90.92 131.7 37.4 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.85 0 N-CA-C 105.167 -2.16 . . . . 0.0 105.167 -176.994 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 26.0 p -112.18 115.05 28.21 Favored 'General case' 0 N--CA 1.441 -0.882 0 N-CA-C 107.592 -1.262 . . . . 0.0 107.592 -176.257 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 5.8 mm -94.03 151.56 3.71 Favored 'Isoleucine or valine' 0 CA--C 1.49 -1.347 0 N-CA-C 106.282 -1.747 . . . . 0.0 106.282 -165.142 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' GLN . . . . . 0.522 HE21 ' HB2' ' A' ' 81' ' ' HIS . 15.6 mt-30 -119.1 145.66 45.74 Favored 'General case' 0 CA--C 1.49 -1.344 0 N-CA-C 105.154 -2.165 . . . . 0.0 105.154 176.879 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 36.1 mt-30 -77.27 35.31 0.17 Allowed 'General case' 0 C--N 1.356 0.856 0 C-N-CA 125.182 1.393 . . . . 0.0 112.917 179.322 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -138.54 13.33 2.76 Favored 'General case' 0 CA--C 1.499 -1.017 0 C-N-CA 124.754 1.222 . . . . 0.0 107.747 -179.436 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 92.51 -13.64 66.81 Favored Glycine 0 C--N 1.352 1.419 0 C-N-CA 124.298 0.952 . . . . 0.0 112.511 173.423 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' HIS . . . . . 0.522 ' HB2' HE21 ' A' ' 77' ' ' GLN . 65.4 m80 -80.74 161.99 24.31 Favored 'General case' 0 CA--C 1.502 -0.897 0 CA-C-N 118.045 0.922 . . . . 0.0 109.692 -174.81 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 80.7 mt-30 -145.45 137.34 25.44 Favored 'General case' 0 N--CA 1.437 -1.104 0 N-CA-C 104.606 -2.368 . . . . 0.0 104.606 -178.148 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 9.6 mp0 -118.36 131.37 56.31 Favored 'General case' 0 CA--C 1.494 -1.199 0 N-CA-C 104.074 -2.565 . . . . 0.0 104.074 173.155 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 5.6 p -106.91 132.72 53.52 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.864 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 -172.104 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 21.5 m -104.86 137.52 42.52 Favored 'General case' 0 N--CA 1.442 -0.873 0 N-CA-C 102.383 -3.192 . . . . 0.0 102.383 168.947 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 31.5 ptt-85 -134.38 145.95 49.44 Favored 'General case' 0 CA--C 1.496 -1.112 0 CA-C-O 121.588 0.708 . . . . 0.0 109.143 179.831 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 20.0 p90 -164.78 -178.9 5.52 Favored 'General case' 0 CA--C 1.499 -0.999 0 N-CA-C 106.376 -1.713 . . . . 0.0 106.376 -173.296 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -137.06 157.76 45.98 Favored 'General case' 0 N--CA 1.437 -1.094 0 N-CA-C 106.212 -1.773 . . . . 0.0 106.212 170.155 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 25.5 p90 -143.58 170.72 15.3 Favored 'General case' 0 CA--C 1.487 -1.453 0 N-CA-C 106.256 -1.757 . . . . 0.0 106.256 169.497 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 9.7 m -126.49 140.3 52.57 Favored 'General case' 0 CA--C 1.499 -1.001 0 N-CA-C 103.678 -2.712 . . . . 0.0 103.678 175.827 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 86.1 m -112.71 114.15 26.6 Favored 'General case' 0 CA--C 1.497 -1.09 0 N-CA-C 102.137 -3.283 . . . . 0.0 102.137 176.58 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 92' ' ' THR . . . . . 0.515 ' HA ' ' H ' ' A' ' 66' ' ' GLY . 23.7 p -125.21 168.5 13.38 Favored 'General case' 0 CA--C 1.5 -0.952 0 N-CA-C 106.438 -1.69 . . . . 0.0 106.438 -179.128 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 15.1 t . . . . . 0 C--O 1.258 1.546 0 N-CA-C 108.014 -1.106 . . . . 0.0 108.014 -178.399 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 23.3 t . . . . . 0 N--CA 1.482 1.171 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 169.4 174.62 37.96 Favored Glycine 0 C--N 1.349 1.286 0 N-CA-C 106.748 -2.541 . . . . 0.0 106.748 178.13 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 66.6 Cg_exo -60.1 138.86 84.44 Favored 'Trans proline' 0 N--CA 1.447 -1.214 0 C-N-CA 123.396 2.73 . . . . 0.0 113.493 -170.79 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 21.5 t -77.77 156.55 5.23 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.9 0 C-N-CA 128.277 2.631 . . . . 0.0 105.354 178.483 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 59.4 mm-40 -109.73 98.67 7.97 Favored 'General case' 0 CA--C 1.487 -1.478 0 N-CA-C 106.947 -1.501 . . . . 0.0 106.947 -174.442 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 2.2 p -123.27 139.3 50.38 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.108 0 N-CA-C 106.248 -1.76 . . . . 0.0 106.248 -169.163 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 75.1 m-85 -144.9 179.69 7.17 Favored 'General case' 0 CA--C 1.494 -1.184 0 N-CA-C 105.179 -2.156 . . . . 0.0 105.179 -172.403 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -135.92 127.89 45.27 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.094 0 N-CA-C 104.182 -2.525 . . . . 0.0 104.182 161.865 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 14.8 t -154.73 9.28 0.33 Allowed 'General case' 0 N--CA 1.437 -1.084 0 N-CA-C 107.274 -1.38 . . . . 0.0 107.274 -178.441 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 26.6 tt0 -83.05 -29.86 28.5 Favored 'General case' 0 C--N 1.359 0.98 0 O-C-N 121.102 -0.999 . . . . 0.0 111.097 -167.047 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 13.0 t -139.72 140.53 25.08 Favored Pre-proline 0 N--CA 1.442 -0.846 0 N-CA-C 104.41 -2.441 . . . . 0.0 104.41 175.178 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 69.7 Cg_endo -84.24 -20.25 4.24 Favored 'Trans proline' 0 N--CA 1.453 -0.882 0 C-N-CA 122.37 2.047 . . . . 0.0 110.729 178.88 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 47.6 m -158.0 113.71 2.75 Favored 'General case' 0 CA--C 1.495 -1.14 0 N-CA-C 105.762 -1.94 . . . . 0.0 105.762 -169.792 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 66.7 tp60 -157.03 119.08 2.14 Favored Pre-proline 0 N--CA 1.441 -0.899 0 N-CA-C 105.54 -2.022 . . . . 0.0 105.54 174.368 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -88.07 -20.72 1.78 Allowed 'Trans proline' 0 CA--C 1.505 -0.943 0 C-N-CA 122.262 1.975 . . . . 0.0 112.005 -167.282 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 5.8 p-10 -114.28 -39.46 3.86 Favored 'General case' 0 CA--C 1.491 -1.321 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 -164.701 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 66.5 m -104.31 154.33 19.95 Favored 'General case' 0 CA--C 1.494 -1.181 0 N-CA-C 106.599 -1.63 . . . . 0.0 106.599 176.285 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 18.3 t60 -139.95 89.58 11.24 Favored Pre-proline 0 N--CA 1.438 -1.033 0 N-CA-C 107.188 -1.412 . . . . 0.0 107.188 172.917 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -82.96 120.05 2.96 Favored 'Trans proline' 0 N--CA 1.447 -1.219 0 C-N-CA 123.11 2.54 . . . . 0.0 110.463 179.593 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.485 HD11 HD11 ' A' ' 35' ' ' LEU . 3.9 pt -104.85 173.84 1.35 Allowed 'Isoleucine or valine' 0 CA--C 1.497 -1.083 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 -177.486 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 2.4 pt20 -149.82 149.43 30.5 Favored 'General case' 0 N--CA 1.44 -0.967 0 N-CA-C 106.421 -1.696 . . . . 0.0 106.421 173.52 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 23.8 p90 -134.44 157.14 47.21 Favored 'General case' 0 CA--C 1.499 -0.983 0 N-CA-C 106.632 -1.618 . . . . 0.0 106.632 -177.808 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 59.8 t30 -99.71 -177.81 3.68 Favored 'General case' 0 CA--C 1.492 -1.272 0 N-CA-C 102.683 -3.08 . . . . 0.0 102.683 168.152 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -155.63 170.49 8.66 Favored Pre-proline 0 N--CA 1.438 -1.043 0 N-CA-C 106.334 -1.728 . . . . 0.0 106.334 176.325 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 63.5 Cg_exo -63.65 164.16 22.06 Favored 'Trans proline' 0 N--CA 1.456 -0.695 0 C-N-CA 123.267 2.645 . . . . 0.0 112.635 173.176 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 17.9 mp0 -80.48 -53.83 0.85 Allowed Pre-proline 0 N--CA 1.443 -0.818 0 CA-C-O 115.579 -2.153 . . . . 0.0 111.617 -167.919 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -74.03 172.26 16.29 Favored 'Trans proline' 0 CA--C 1.51 -0.699 0 CA-C-N 125.871 3.132 . . . . 0.0 109.95 174.221 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 22.8 t -83.79 87.01 7.07 Favored 'General case' 0 C--N 1.357 0.907 0 N-CA-C 107.237 -1.394 . . . . 0.0 107.237 178.563 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 3.6 t60 -112.56 -32.86 6.33 Favored 'General case' 0 N--CA 1.436 -1.145 0 N-CA-C 106.938 -1.504 . . . . 0.0 106.938 -177.084 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 1.8 mp -108.62 134.55 50.2 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.946 0 N-CA-C 103.315 -2.846 . . . . 0.0 103.315 -178.179 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 5.9 p -100.77 -82.01 0.46 Allowed 'General case' 0 N--CA 1.434 -1.26 0 N-CA-C 107.875 -1.158 . . . . 0.0 107.875 175.108 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 6.5 ttpm? -94.35 161.27 14.31 Favored 'General case' 0 CA--C 1.495 -1.136 0 C-N-CA 124.7 1.2 . . . . 0.0 108.029 -165.733 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 85.5 m-85 -125.9 138.14 53.77 Favored 'General case' 0 N--CA 1.437 -1.079 0 N-CA-C 105.111 -2.181 . . . . 0.0 105.111 171.733 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 34.3 mm -109.25 129.18 64.43 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.155 0 N-CA-C 101.03 -3.692 . . . . 0.0 101.03 165.831 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.485 HD11 HD11 ' A' ' 20' ' ' ILE . 3.8 mt -109.02 135.8 49.6 Favored 'General case' 0 CA--C 1.478 -1.796 0 N-CA-C 106.543 -1.651 . . . . 0.0 106.543 169.721 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 84.1 mtt180 -125.09 158.23 34.35 Favored 'General case' 0 N--CA 1.43 -1.446 0 N-CA-C 107.123 -1.436 . . . . 0.0 107.123 173.191 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 48.0 p90 -150.5 145.21 25.85 Favored 'General case' 0 N--CA 1.437 -1.091 0 N-CA-C 105.86 -1.904 . . . . 0.0 105.86 173.381 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 46.9 ttp180 -153.44 137.57 10.73 Favored Pre-proline 0 CA--C 1.498 -1.032 0 N-CA-C 105.324 -2.102 . . . . 0.0 105.324 -176.411 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -72.74 120.75 6.86 Favored 'Trans proline' 0 N--CA 1.451 -1.021 0 CA-C-N 123.485 2.28 . . . . 0.0 109.034 -177.369 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 58.5 tttm -73.48 65.06 0.89 Allowed 'General case' 0 C--N 1.358 0.962 0 C-N-CA 127.078 2.151 . . . . 0.0 110.554 177.514 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 6.4 t-20 -161.77 -53.0 0.04 OUTLIER 'General case' 0 N--CA 1.432 -1.358 0 N-CA-C 104.003 -2.592 . . . . 0.0 104.003 -169.735 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 50.3 m -88.36 166.0 14.57 Favored 'General case' 0 N--CA 1.438 -1.052 0 C-N-CA 124.431 1.092 . . . . 0.0 108.218 177.991 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 10.9 m -116.0 41.37 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.795 0 N-CA-C 106.938 -1.505 . . . . 0.0 106.938 -178.998 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -92.54 -156.38 32.72 Favored Glycine 0 C--N 1.354 1.559 0 N-CA-C 109.61 -1.396 . . . . 0.0 109.61 -177.494 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 39.6 mmt180 -101.87 172.2 7.07 Favored 'General case' 0 CA--C 1.499 -0.999 0 N-CA-C 107.324 -1.362 . . . . 0.0 107.324 -179.999 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 47.9 m95 -87.12 164.28 16.5 Favored 'General case' 0 N--CA 1.441 -0.88 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 -177.681 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 96.2 mttt -108.77 155.64 20.54 Favored 'General case' 0 CA--C 1.489 -1.366 0 N-CA-C 102.237 -3.246 . . . . 0.0 102.237 161.462 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -151.32 159.07 44.49 Favored 'General case' 0 CA--C 1.494 -1.209 0 CA-C-O 122.021 0.915 . . . . 0.0 109.794 -178.048 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -133.88 159.21 41.36 Favored 'General case' 0 N--CA 1.434 -1.241 0 N-CA-C 106.057 -1.831 . . . . 0.0 106.057 172.68 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 93.8 m -119.86 125.63 48.99 Favored 'General case' 0 CA--C 1.499 -1.006 0 N-CA-C 104.277 -2.49 . . . . 0.0 104.277 178.178 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 34.0 mt -123.79 122.79 26.35 Favored Pre-proline 0 N--CA 1.439 -0.984 0 N-CA-C 105.038 -2.208 . . . . 0.0 105.038 -171.602 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' PRO . . . . . 0.462 ' HB2' ' CE1' ' A' ' 54' ' ' HIS . 50.7 Cg_exo -67.25 169.21 15.78 Favored 'Trans proline' 0 CA--C 1.512 -0.612 0 C-N-CA 123.279 2.653 . . . . 0.0 111.301 175.757 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -86.71 83.21 1.6 Allowed Glycine 0 C--N 1.352 1.441 0 N-CA-C 110.121 -1.191 . . . . 0.0 110.121 -177.728 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' HIS . . . . . 0.462 ' CE1' ' HB2' ' A' ' 52' ' ' PRO . 0.5 OUTLIER -157.54 -44.11 0.07 Allowed 'General case' 0 CA--C 1.497 -1.079 0 N-CA-C 107.279 -1.378 . . . . 0.0 107.279 -179.795 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 92.2 mt -89.62 136.49 33.0 Favored 'General case' 0 CA--C 1.495 -1.148 0 N-CA-C 107.832 -1.173 . . . . 0.0 107.832 179.522 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 8.6 p30 -112.67 5.34 17.68 Favored 'General case' 0 N--CA 1.44 -0.926 0 C-N-CA 124.875 1.27 . . . . 0.0 109.119 -179.392 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 45.3 p -142.98 150.28 39.45 Favored 'General case' 0 CA--C 1.499 -1.012 0 N-CA-C 107.171 -1.418 . . . . 0.0 107.171 -178.519 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 7.5 t80 -126.36 174.08 8.85 Favored 'General case' 0 C--N 1.357 0.924 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 -179.087 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 88.0 m -138.74 109.44 6.64 Favored 'General case' 0 N--CA 1.43 -1.425 0 N-CA-C 104.618 -2.364 . . . . 0.0 104.618 172.205 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 28.3 mt -88.15 147.17 5.42 Favored 'Isoleucine or valine' 0 C--N 1.358 0.965 0 N-CA-C 104.271 -2.492 . . . . 0.0 104.271 171.447 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 94.0 mttt -141.08 162.65 34.97 Favored 'General case' 0 CA--C 1.5 -0.976 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 177.131 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 82.61 48.96 5.35 Favored Glycine 0 C--N 1.353 1.487 0 N-CA-C 109.838 -1.305 . . . . 0.0 109.838 173.758 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 58.0 mt -119.71 173.34 7.08 Favored 'General case' 0 CA--C 1.5 -0.958 0 N-CA-C 107.886 -1.153 . . . . 0.0 107.886 -173.654 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 67.8 mttm -110.36 157.15 38.96 Favored Pre-proline 0 N--CA 1.441 -0.876 0 N-CA-C 107.419 -1.326 . . . . 0.0 107.419 -176.113 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 67.5 Cg_endo -78.65 161.3 27.86 Favored 'Trans proline' 0 N--CA 1.451 -0.986 0 C-N-CA 123.168 2.579 . . . . 0.0 109.785 168.247 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 59.59 26.21 61.99 Favored Glycine 0 C--N 1.355 1.621 0 C-N-CA 127.261 2.363 . . . . 0.0 116.337 171.59 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 13.2 p -120.24 148.3 23.46 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.995 0 N-CA-C 106.837 -1.542 . . . . 0.0 106.837 -177.595 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 4.0 p -99.76 130.93 48.1 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.907 0 N-CA-C 106.626 -1.62 . . . . 0.0 106.626 176.137 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 93.5 m-85 -112.16 148.42 34.04 Favored 'General case' 0 CA--C 1.494 -1.189 0 N-CA-C 105.537 -2.023 . . . . 0.0 105.537 172.246 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -97.91 134.69 40.7 Favored 'General case' 0 CA--C 1.496 -1.11 0 N-CA-C 103.576 -2.75 . . . . 0.0 103.576 161.68 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -117.6 152.58 17.62 Favored Glycine 0 CA--C 1.486 -1.75 0 N-CA-C 106.065 -2.814 . . . . 0.0 106.065 -178.054 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 35.3 tt0 -145.64 130.1 17.82 Favored 'General case' 0 CA--C 1.48 -1.735 0 N-CA-C 106.623 -1.621 . . . . 0.0 106.623 -177.226 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 38.9 tp -118.14 99.8 7.11 Favored 'General case' 0 N--CA 1.437 -1.081 0 N-CA-C 104.151 -2.537 . . . . 0.0 104.151 -174.534 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 26.8 mt -91.99 131.56 38.75 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.865 0 N-CA-C 103.603 -2.74 . . . . 0.0 103.603 176.481 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 20.9 p -117.08 115.74 25.97 Favored 'General case' 0 N--CA 1.436 -1.166 0 N-CA-C 106.962 -1.495 . . . . 0.0 106.962 -177.33 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 1.7 mp -89.58 132.52 34.07 Favored 'Isoleucine or valine' 0 CA--C 1.483 -1.6 0 N-CA-C 102.543 -3.132 . . . . 0.0 102.543 -173.131 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 82.0 mt-30 -101.83 152.65 20.64 Favored 'General case' 0 CA--C 1.489 -1.393 0 N-CA-C 106.951 -1.5 . . . . 0.0 106.951 -174.97 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 11.8 tt0 -77.53 41.48 0.33 Allowed 'General case' 0 N--CA 1.443 -0.818 0 C-N-CA 125.858 1.663 . . . . 0.0 112.419 -179.668 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 8.5 t80 -151.78 16.7 0.68 Allowed 'General case' 0 N--CA 1.436 -1.128 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 178.315 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 86.99 -11.75 63.97 Favored Glycine 0 C--N 1.353 1.526 0 C-N-CA 123.73 0.681 . . . . 0.0 112.496 176.901 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 44.6 t-80 -78.65 160.38 27.56 Favored 'General case' 0 N--CA 1.441 -0.888 0 C-N-CA 124.68 1.192 . . . . 0.0 109.011 -176.767 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 83.2 mt-30 -136.22 136.2 39.71 Favored 'General case' 0 CA--C 1.491 -1.318 0 N-CA-C 104.579 -2.378 . . . . 0.0 104.579 175.14 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 16.8 tp10 -120.49 131.47 54.74 Favored 'General case' 0 CA--C 1.495 -1.171 0 N-CA-C 104.753 -2.314 . . . . 0.0 104.753 178.0 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 7.2 p -108.94 139.25 32.33 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.83 0 N-CA-C 107.561 -1.274 . . . . 0.0 107.561 -174.298 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 89.1 m -125.32 131.22 53.07 Favored 'General case' 0 N--CA 1.44 -0.953 0 N-CA-C 102.804 -3.036 . . . . 0.0 102.804 178.51 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 40.5 ttp180 -130.51 145.53 51.88 Favored 'General case' 0 C--N 1.356 0.882 0 CA-C-N 119.492 1.042 . . . . 0.0 109.031 178.459 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 17.8 p90 -156.35 -179.89 8.59 Favored 'General case' 0 CA--C 1.498 -1.026 0 N-CA-C 105.987 -1.857 . . . . 0.0 105.987 -171.245 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 1.6 p30 -141.05 157.72 44.93 Favored 'General case' 0 N--CA 1.442 -0.873 0 N-CA-C 108.117 -1.068 . . . . 0.0 108.117 169.153 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 21.8 p90 -144.66 170.71 15.56 Favored 'General case' 0 CA--C 1.493 -1.226 0 N-CA-C 106.921 -1.511 . . . . 0.0 106.921 173.597 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 24.7 p -117.51 138.6 51.78 Favored 'General case' 0 CA--C 1.501 -0.934 0 N-CA-C 106.175 -1.787 . . . . 0.0 106.175 171.491 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 56.0 m -108.07 113.49 26.69 Favored 'General case' 0 CA--C 1.495 -1.149 0 N-CA-C 103.009 -2.96 . . . . 0.0 103.009 172.076 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 15.0 t -161.86 165.36 27.85 Favored 'General case' 0 N--CA 1.436 -1.171 0 N-CA-C 104.731 -2.322 . . . . 0.0 104.731 -174.653 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 75.2 p . . . . . 0 C--O 1.261 1.687 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 173.587 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 70.1 m . . . . . 0 N--CA 1.488 1.456 0 CA-C-O 121.431 0.634 . . . . 0.0 110.88 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -178.29 104.07 0.18 Allowed Glycine 0 C--N 1.351 1.404 0 N-CA-C 108.593 -1.803 . . . . 0.0 108.593 176.544 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_exo -64.79 146.29 88.0 Favored 'Trans proline' 0 N--CA 1.442 -1.529 0 C-N-CA 123.157 2.571 . . . . 0.0 115.287 -161.042 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 4.6 m -83.0 169.28 1.6 Allowed 'Isoleucine or valine' 0 N--CA 1.432 -1.336 0 C-N-CA 126.641 1.977 . . . . 0.0 107.168 171.063 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 -101.81 100.35 10.67 Favored 'General case' 0 CA--C 1.495 -1.164 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 -176.678 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 4.2 p -107.77 137.62 38.16 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.138 0 N-CA-C 107.474 -1.306 . . . . 0.0 107.474 -174.016 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -145.19 133.48 21.71 Favored 'General case' 0 N--CA 1.433 -1.323 0 N-CA-C 106.975 -1.491 . . . . 0.0 106.975 -170.669 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 35.6 pt -89.13 162.27 2.57 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.295 0 N-CA-C 105.465 -2.05 . . . . 0.0 105.465 171.132 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 9.8 m -80.1 -105.84 0.02 OUTLIER 'General case' 0 C--N 1.354 0.769 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 -170.832 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 3.2 tm-20 -116.5 -87.74 0.6 Allowed 'General case' 0 CA--C 1.495 -1.156 0 N-CA-C 103.69 -2.707 . . . . 0.0 103.69 177.908 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 14.6 t -153.63 142.95 14.88 Favored Pre-proline 0 N--CA 1.438 -1.034 0 N-CA-C 101.136 -3.653 . . . . 0.0 101.136 162.452 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -77.97 -171.94 1.34 Allowed 'Trans proline' 0 N--CA 1.457 -0.674 0 C-N-CA 122.769 2.313 . . . . 0.0 109.48 179.667 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 11.5 t -114.36 36.2 3.86 Favored 'General case' 0 CA--C 1.499 -0.986 0 N-CA-C 106.221 -1.77 . . . . 0.0 106.221 173.82 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 37.2 mt-30 -125.37 101.65 30.88 Favored Pre-proline 0 N--CA 1.435 -1.21 0 CA-C-N 111.912 -2.404 . . . . 0.0 106.311 -176.808 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_exo -74.88 -11.36 21.7 Favored 'Trans proline' 0 CA--C 1.507 -0.83 0 C-N-CA 122.979 2.453 . . . . 0.0 110.722 177.293 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 8.6 p-10 -96.87 -30.81 12.92 Favored 'General case' 0 CA--C 1.486 -1.485 0 C-N-CA 125.508 1.523 . . . . 0.0 110.638 -172.783 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 22.9 t -119.54 156.71 29.78 Favored 'General case' 0 CA--C 1.498 -1.037 0 CA-C-O 122.223 1.011 . . . . 0.0 108.915 -172.47 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 9.0 t60 -140.39 98.75 7.26 Favored Pre-proline 0 N--CA 1.438 -1.056 0 N-CA-C 106.735 -1.58 . . . . 0.0 106.735 172.783 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -80.86 137.31 11.04 Favored 'Trans proline' 0 N--CA 1.447 -1.216 0 C-N-CA 123.019 2.479 . . . . 0.0 110.17 176.104 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 2.4 pt -118.64 172.77 5.59 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.07 0 N-CA-C 107.747 -1.205 . . . . 0.0 107.747 178.794 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' GLN . . . . . 0.448 ' HA ' ' HA ' ' A' ' 57' ' ' SER . 3.6 pt20 -150.79 158.34 44.03 Favored 'General case' 0 CA--C 1.492 -1.287 0 N-CA-C 105.706 -1.961 . . . . 0.0 105.706 168.947 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 43.7 p90 -142.97 164.49 29.94 Favored 'General case' 0 CA--C 1.493 -1.231 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 -175.409 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 81.1 m-20 -109.39 177.1 4.85 Favored 'General case' 0 CA--C 1.494 -1.2 0 N-CA-C 104.297 -2.482 . . . . 0.0 104.297 168.839 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -161.23 173.83 4.36 Favored Pre-proline 0 N--CA 1.435 -1.22 0 N-CA-C 104.788 -2.301 . . . . 0.0 104.788 -176.138 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.432 ' HD2' HD12 ' A' ' 30' ' ' ILE . 67.1 Cg_exo -63.1 153.49 73.55 Favored 'Trans proline' 0 N--CA 1.455 -0.742 0 C-N-CA 123.786 2.991 . . . . 0.0 112.758 175.563 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 26.1 tt0 -82.17 -40.36 0.93 Allowed Pre-proline 0 N--CA 1.443 -0.813 0 CA-C-O 115.574 -2.155 . . . . 0.0 112.071 -174.558 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_exo -69.49 -8.9 24.83 Favored 'Trans proline' 0 CA--C 1.512 -0.59 0 CA-C-N 125.674 3.062 . . . . 0.0 114.037 179.906 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 8.9 t 67.86 66.65 0.36 Allowed 'General case' 0 C--N 1.357 0.91 0 C-N-CA 126.107 1.763 . . . . 0.0 110.038 178.939 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 76.6 t60 -97.49 -2.27 42.33 Favored 'General case' 0 N--CA 1.441 -0.876 0 C-N-CA 124.517 1.127 . . . . 0.0 108.307 175.411 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.432 HD12 ' HD2' ' A' ' 25' ' ' PRO . 9.7 mt -111.16 135.8 49.21 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.071 0 N-CA-C 105.131 -2.174 . . . . 0.0 105.131 -179.669 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 4.6 p -98.13 -84.45 0.39 Allowed 'General case' 0 N--CA 1.428 -1.565 0 N-CA-C 106.518 -1.66 . . . . 0.0 106.518 178.282 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 52.7 mtmt -90.57 170.65 10.0 Favored 'General case' 0 CA--C 1.487 -1.448 0 C-N-CA 123.857 0.863 . . . . 0.0 109.086 -165.134 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 87.4 m-85 -132.43 140.05 48.28 Favored 'General case' 0 N--CA 1.436 -1.141 0 N-CA-C 103.837 -2.653 . . . . 0.0 103.837 167.568 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 41.8 mt -121.73 135.2 62.64 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.204 0 N-CA-C 101.632 -3.47 . . . . 0.0 101.632 173.66 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 4.5 mt -113.07 136.98 52.11 Favored 'General case' 0 CA--C 1.467 -2.233 0 N-CA-C 104.848 -2.278 . . . . 0.0 104.848 169.54 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 1.1 ptm180 -131.51 152.31 50.84 Favored 'General case' 0 N--CA 1.43 -1.472 0 N-CA-C 105.678 -1.971 . . . . 0.0 105.678 168.632 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 48.6 p90 -155.0 152.28 29.48 Favored 'General case' 0 N--CA 1.436 -1.158 0 N-CA-C 106.841 -1.54 . . . . 0.0 106.841 -175.034 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 36.4 ptt180 -158.14 157.37 29.18 Favored Pre-proline 0 CA--C 1.5 -0.949 0 N-CA-C 105.881 -1.896 . . . . 0.0 105.881 171.989 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_endo -76.43 124.33 7.65 Favored 'Trans proline' 0 CA--C 1.503 -1.067 0 C-N-CA 122.652 2.234 . . . . 0.0 108.968 -175.209 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 85.1 tttt -71.19 79.58 0.7 Allowed 'General case' 0 C--N 1.358 0.943 0 C-N-CA 126.296 1.839 . . . . 0.0 110.497 178.753 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 26.1 m120 -154.28 -69.57 0.13 Allowed 'General case' 0 N--CA 1.436 -1.167 0 N-CA-C 101.531 -3.507 . . . . 0.0 101.531 -176.313 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 55.1 m -96.79 167.03 11.35 Favored 'General case' 0 N--CA 1.44 -0.925 0 N-CA-C 106.746 -1.575 . . . . 0.0 106.746 171.55 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 2.6 m -132.82 62.59 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.439 -0.988 0 N-CA-C 105.285 -2.117 . . . . 0.0 105.285 179.892 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -93.1 -111.83 2.09 Favored Glycine 0 C--N 1.353 1.521 0 N-CA-C 108.838 -1.705 . . . . 0.0 108.838 -178.916 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 86.7 mtm180 -97.66 169.66 9.55 Favored 'General case' 0 CA--C 1.501 -0.92 0 N-CA-C 107.973 -1.121 . . . . 0.0 107.973 -179.367 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 70.6 m95 -112.16 167.17 10.62 Favored 'General case' 0 N--CA 1.44 -0.957 0 N-CA-C 107.615 -1.254 . . . . 0.0 107.615 178.53 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -114.51 152.89 30.97 Favored 'General case' 0 CA--C 1.487 -1.46 0 N-CA-C 102.537 -3.135 . . . . 0.0 102.537 163.245 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 16.2 pt-20 -152.35 159.04 43.51 Favored 'General case' 0 N--CA 1.437 -1.094 0 CA-C-O 121.749 0.785 . . . . 0.0 109.106 178.507 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -140.03 162.68 34.62 Favored 'General case' 0 CA--C 1.499 -0.998 0 N-CA-C 106.553 -1.647 . . . . 0.0 106.553 172.488 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 90.0 m -119.34 125.32 48.75 Favored 'General case' 0 CA--C 1.5 -0.969 0 N-CA-C 105.127 -2.175 . . . . 0.0 105.127 176.981 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 4.5 mp -109.03 133.64 20.65 Favored Pre-proline 0 N--CA 1.437 -1.117 0 N-CA-C 105.239 -2.134 . . . . 0.0 105.239 -175.928 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 68.7 Cg_exo -64.27 164.1 24.04 Favored 'Trans proline' 0 CA--C 1.508 -0.802 0 C-N-CA 123.312 2.675 . . . . 0.0 113.369 176.193 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -75.37 -16.63 80.5 Favored Glycine 0 C--N 1.352 1.418 0 C-N-CA 123.977 0.799 . . . . 0.0 114.497 -174.421 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 52.6 p-80 -83.52 -27.15 29.57 Favored 'General case' 0 C--N 1.357 0.903 0 CA-C-N 118.144 0.972 . . . . 0.0 110.105 -179.617 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 88.4 mt -88.65 131.18 35.1 Favored 'General case' 0 CA--C 1.501 -0.908 0 N-CA-C 107.945 -1.131 . . . . 0.0 107.945 177.161 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 8.5 p30 -114.17 7.87 16.73 Favored 'General case' 0 CA--C 1.504 -0.797 0 C-N-CA 124.521 1.128 . . . . 0.0 109.858 -174.753 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.448 ' HA ' ' HA ' ' A' ' 21' ' ' GLN . 36.9 p -139.23 160.49 39.68 Favored 'General case' 0 CA--C 1.497 -1.093 0 N-CA-C 107.163 -1.421 . . . . 0.0 107.163 -177.519 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 4.1 t80 -138.87 178.77 6.91 Favored 'General case' 0 C--N 1.36 1.064 0 CA-C-O 121.672 0.748 . . . . 0.0 109.171 175.729 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 89.4 m -144.49 103.62 3.97 Favored 'General case' 0 N--CA 1.432 -1.339 0 N-CA-C 103.689 -2.708 . . . . 0.0 103.689 -178.502 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 55.8 mt -95.37 106.51 18.33 Favored 'Isoleucine or valine' 0 C--N 1.358 0.969 0 N-CA-C 106.239 -1.763 . . . . 0.0 106.239 179.541 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 63.7 mttm -103.64 163.76 12.11 Favored 'General case' 0 CA--C 1.502 -0.897 0 CA-C-O 121.739 0.78 . . . . 0.0 109.542 178.814 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 90.85 45.5 4.2 Favored Glycine 0 CA--C 1.49 -1.474 0 N-CA-C 109.285 -1.526 . . . . 0.0 109.285 172.907 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 61.7 mt -119.92 176.67 5.3 Favored 'General case' 0 N--CA 1.44 -0.931 0 N-CA-C 106.909 -1.515 . . . . 0.0 106.909 -174.643 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -120.89 157.79 53.94 Favored Pre-proline 0 N--CA 1.44 -0.93 0 N-CA-C 106.704 -1.591 . . . . 0.0 106.704 -175.684 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 64.8 Cg_endo -78.63 164.54 25.76 Favored 'Trans proline' 0 N--CA 1.452 -0.956 0 C-N-CA 123.065 2.51 . . . . 0.0 110.559 170.252 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 0.585 ' H ' ' HA ' ' A' ' 92' ' ' THR . . . 60.94 25.2 63.76 Favored Glycine 0 N--CA 1.431 -1.679 0 C-N-CA 128.006 2.717 . . . . 0.0 116.124 171.256 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 8.5 p -130.54 146.83 33.42 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.15 0 N-CA-C 108.188 -1.041 . . . . 0.0 108.188 -176.124 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 4.2 p -95.88 133.66 36.23 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.907 0 N-CA-C 107.377 -1.342 . . . . 0.0 107.377 178.157 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 93.8 m-85 -112.9 149.48 33.12 Favored 'General case' 0 CA--C 1.498 -1.057 0 N-CA-C 106.161 -1.792 . . . . 0.0 106.161 174.299 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -101.1 140.0 36.01 Favored 'General case' 0 CA--C 1.497 -1.094 0 N-CA-C 104.561 -2.385 . . . . 0.0 104.561 164.827 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -137.15 148.98 20.08 Favored Glycine 0 CA--C 1.486 -1.723 0 N-CA-C 108.101 -2.0 . . . . 0.0 108.101 -175.035 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 84.5 mt-30 -138.79 135.77 34.97 Favored 'General case' 0 CA--C 1.484 -1.58 0 N-CA-C 105.585 -2.006 . . . . 0.0 105.585 178.477 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 46.0 tp -114.71 103.29 10.84 Favored 'General case' 0 N--CA 1.434 -1.271 0 N-CA-C 103.847 -2.649 . . . . 0.0 103.847 179.247 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 38.1 mt -91.94 122.02 42.99 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.898 0 N-CA-C 103.852 -2.647 . . . . 0.0 103.852 177.723 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 15.4 p -113.92 115.1 27.15 Favored 'General case' 0 N--CA 1.441 -0.884 0 N-CA-C 107.156 -1.424 . . . . 0.0 107.156 -175.316 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 1.8 mp -90.36 131.94 36.26 Favored 'Isoleucine or valine' 0 CA--C 1.482 -1.659 0 N-CA-C 104.805 -2.294 . . . . 0.0 104.805 -162.817 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 76.4 mt-30 -84.3 147.91 26.95 Favored 'General case' 0 CA--C 1.491 -1.298 0 N-CA-C 107.994 -1.113 . . . . 0.0 107.994 -178.882 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 20.2 tt0 -76.5 41.75 0.26 Allowed 'General case' 0 N--CA 1.442 -0.862 0 C-N-CA 126.331 1.852 . . . . 0.0 110.545 170.739 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 8.2 t80 -153.07 15.9 0.55 Allowed 'General case' 0 N--CA 1.434 -1.265 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 -176.528 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 89.25 -19.03 41.62 Favored Glycine 0 C--N 1.353 1.506 0 C-N-CA 123.72 0.676 . . . . 0.0 112.601 174.358 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 36.7 m170 -81.7 173.48 12.28 Favored 'General case' 0 CA--C 1.495 -1.153 0 C-N-CA 124.446 1.098 . . . . 0.0 109.274 -176.308 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 32.0 mt-30 -138.7 145.55 40.47 Favored 'General case' 0 CA--C 1.495 -1.154 0 N-CA-C 105.527 -2.027 . . . . 0.0 105.527 176.495 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -111.23 153.72 25.44 Favored 'General case' 0 CA--C 1.493 -1.215 0 N-CA-C 105.415 -2.068 . . . . 0.0 105.415 171.06 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 14.8 p -126.92 137.46 57.78 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.897 0 N-CA-C 106.523 -1.658 . . . . 0.0 106.523 173.325 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 91.4 m -127.08 131.01 50.98 Favored 'General case' 0 N--CA 1.438 -1.066 0 N-CA-C 101.973 -3.343 . . . . 0.0 101.973 179.055 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 88.8 mtt180 -127.08 148.92 50.13 Favored 'General case' 0 CA--C 1.495 -1.15 0 CA-C-N 118.804 0.729 . . . . 0.0 109.487 -173.154 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 19.6 p90 -164.82 178.26 7.32 Favored 'General case' 0 CA--C 1.502 -0.9 0 N-CA-C 108.156 -1.053 . . . . 0.0 108.156 -175.287 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 51.4 m-20 -132.52 154.06 50.33 Favored 'General case' 0 N--CA 1.442 -0.872 0 N-CA-C 105.507 -2.034 . . . . 0.0 105.507 168.743 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 20.9 p90 -142.5 166.84 23.57 Favored 'General case' 0 CA--C 1.488 -1.424 0 N-CA-C 107.41 -1.33 . . . . 0.0 107.41 169.708 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 25.0 p -120.02 141.65 49.53 Favored 'General case' 0 CA--C 1.5 -0.981 0 N-CA-C 106.21 -1.774 . . . . 0.0 106.21 174.919 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 45.4 m -115.74 120.16 38.39 Favored 'General case' 0 CA--C 1.493 -1.245 0 N-CA-C 102.137 -3.283 . . . . 0.0 102.137 171.706 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 92' ' ' THR . . . . . 0.585 ' HA ' ' H ' ' A' ' 66' ' ' GLY . 5.3 t -145.92 -66.95 0.29 Allowed 'General case' 0 N--CA 1.436 -1.132 0 N-CA-C 106.093 -1.817 . . . . 0.0 106.093 -175.626 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 93' ' ' SER . . . . . 0.436 ' H ' HG23 ' A' ' 92' ' ' THR . 19.8 m . . . . . 0 C--O 1.261 1.659 0 C-N-CA 125.505 1.522 . . . . 0.0 110.355 178.379 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 22.7 t . . . . . 0 N--CA 1.483 1.214 0 CA-C-O 121.259 0.552 . . . . 0.0 109.799 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 169.62 170.41 34.06 Favored Glycine 0 N--CA 1.436 -1.346 0 N-CA-C 106.717 -2.553 . . . . 0.0 106.717 176.699 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 22.8 Cg_exo -59.09 145.6 97.14 Favored 'Trans proline' 0 N--CA 1.448 -1.188 0 C-N-CA 123.058 2.505 . . . . 0.0 116.054 -164.598 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 48.9 t -79.17 158.96 4.63 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.94 0 C-N-CA 127.707 2.403 . . . . 0.0 106.991 179.575 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -103.86 106.3 16.76 Favored 'General case' 0 CA--C 1.494 -1.184 0 N-CA-C 104.853 -2.277 . . . . 0.0 104.853 175.052 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 2.1 p -130.4 141.64 45.77 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.1 0 N-CA-C 105.349 -2.093 . . . . 0.0 105.349 -169.632 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 1.8 p90 -154.0 149.23 27.0 Favored 'General case' 0 N--CA 1.438 -1.055 0 N-CA-C 105.933 -1.877 . . . . 0.0 105.933 -166.854 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 41.9 mt -109.06 119.76 59.18 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.059 0 N-CA-C 104.899 -2.26 . . . . 0.0 104.899 178.214 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 27.8 p -117.9 -176.8 3.12 Favored 'General case' 0 N--CA 1.442 -0.872 0 N-CA-C 106.937 -1.505 . . . . 0.0 106.937 -177.157 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 17.2 tt0 60.49 24.05 13.69 Favored 'General case' 0 C--N 1.359 0.986 0 C-N-CA 127.69 2.396 . . . . 0.0 112.925 173.367 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 9.6 t -125.06 94.53 43.62 Favored Pre-proline 0 C--N 1.352 0.689 0 N-CA-C 107.957 -1.127 . . . . 0.0 107.957 -176.113 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -78.37 -27.43 5.32 Favored 'Trans proline' 0 N--CA 1.455 -0.771 0 C-N-CA 122.442 2.095 . . . . 0.0 109.5 167.598 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 9.7 p 179.92 108.19 0.04 OUTLIER 'General case' 0 N--CA 1.438 -1.075 0 N-CA-C 104.89 -2.263 . . . . 0.0 104.89 178.306 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 39.1 mt-30 -146.44 103.58 4.01 Favored Pre-proline 0 N--CA 1.441 -0.908 0 N-CA-C 104.836 -2.283 . . . . 0.0 104.836 175.806 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_endo -83.19 -8.71 10.74 Favored 'Trans proline' 0 N--CA 1.454 -0.845 0 C-N-CA 123.273 2.649 . . . . 0.0 110.259 -177.501 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 12.3 p-10 -107.79 -42.09 4.82 Favored 'General case' 0 CA--C 1.492 -1.255 0 C-N-CA 124.725 1.21 . . . . 0.0 109.488 -169.069 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 32.8 t -117.06 157.02 26.55 Favored 'General case' 0 CA--C 1.496 -1.134 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 -172.558 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 23.7 m-70 -146.99 98.66 4.05 Favored Pre-proline 0 N--CA 1.437 -1.111 0 N-CA-C 106.516 -1.661 . . . . 0.0 106.516 169.235 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -76.59 100.03 1.35 Allowed 'Trans proline' 0 N--CA 1.447 -1.222 0 C-N-CA 123.654 2.902 . . . . 0.0 109.407 171.746 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.438 HG22 ' H ' ' A' ' 20' ' ' ILE . 13.4 tt -90.28 149.42 4.05 Favored 'Isoleucine or valine' 0 N--CA 1.408 -2.574 0 C-N-CA 128.834 2.854 . . . . 0.0 106.786 -177.41 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 57.3 mt-30 -141.03 151.06 43.76 Favored 'General case' 0 N--CA 1.434 -1.248 0 N-CA-C 104.225 -2.509 . . . . 0.0 104.225 175.724 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 34.0 p90 -138.98 156.82 46.93 Favored 'General case' 0 N--CA 1.437 -1.081 0 N-CA-C 107.794 -1.187 . . . . 0.0 107.794 -176.815 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 61.3 t30 -94.42 -173.65 3.12 Favored 'General case' 0 CA--C 1.49 -1.336 0 N-CA-C 103.531 -2.766 . . . . 0.0 103.531 169.898 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -155.97 169.21 10.81 Favored Pre-proline 0 N--CA 1.44 -0.96 0 N-CA-C 107.284 -1.376 . . . . 0.0 107.284 172.36 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 98.0 Cg_exo -64.39 167.34 15.05 Favored 'Trans proline' 0 CA--C 1.51 -0.683 0 C-N-CA 123.559 2.839 . . . . 0.0 112.447 170.686 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 71.4 tp60 -80.03 -42.68 1.44 Allowed Pre-proline 0 N--CA 1.444 -0.741 0 CA-C-O 115.586 -2.149 . . . . 0.0 112.026 -172.016 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_exo -66.78 152.72 79.98 Favored 'Trans proline' 0 CA--C 1.507 -0.864 0 CA-C-N 125.773 3.097 . . . . 0.0 112.171 177.936 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 27.2 p -99.58 58.01 1.04 Allowed 'General case' 0 C--N 1.353 0.754 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 179.739 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 76.3 t60 -106.21 -4.65 19.97 Favored 'General case' 0 N--CA 1.441 -0.92 0 C-N-CA 125.273 1.429 . . . . 0.0 107.595 175.67 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 41.8 mt -105.44 129.07 58.89 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.248 0 N-CA-C 105.037 -2.209 . . . . 0.0 105.037 178.167 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 5.2 p -104.36 -84.34 0.48 Allowed 'General case' 0 N--CA 1.43 -1.449 0 N-CA-C 107.459 -1.311 . . . . 0.0 107.459 -178.591 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 55.1 mtmt -89.7 168.83 11.81 Favored 'General case' 0 CA--C 1.488 -1.432 0 N-CA-C 108.544 -0.909 . . . . 0.0 108.544 -164.277 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 93.7 m-85 -129.79 138.34 51.0 Favored 'General case' 0 N--CA 1.434 -1.266 0 N-CA-C 103.861 -2.644 . . . . 0.0 103.861 168.297 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 57.3 mt -114.88 130.61 69.05 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.296 0 N-CA-C 101.01 -3.7 . . . . 0.0 101.01 169.885 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 3.1 mt -110.26 129.9 55.65 Favored 'General case' 0 CA--C 1.469 -2.144 0 N-CA-C 104.034 -2.58 . . . . 0.0 104.034 167.635 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 6.5 ptm180 -132.63 154.48 50.04 Favored 'General case' 0 N--CA 1.431 -1.399 0 N-CA-C 107.035 -1.468 . . . . 0.0 107.035 176.062 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 47.8 p90 -155.18 142.44 19.42 Favored 'General case' 0 N--CA 1.435 -1.176 0 N-CA-C 106.877 -1.527 . . . . 0.0 106.877 -173.328 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 30.7 ttp180 -139.54 140.88 26.61 Favored Pre-proline 0 CA--C 1.499 -1.017 0 N-CA-C 104.528 -2.397 . . . . 0.0 104.528 -177.777 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 26.7 Cg_endo -72.14 120.17 6.63 Favored 'Trans proline' 0 N--CA 1.452 -0.934 0 C-N-CA 122.827 2.351 . . . . 0.0 108.472 174.663 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 23.0 ttmm -68.06 85.2 0.24 Allowed 'General case' 0 C--N 1.359 1.005 0 C-N-CA 127.34 2.256 . . . . 0.0 109.733 -178.641 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 31.2 m120 -150.77 -72.41 0.17 Allowed 'General case' 0 N--CA 1.435 -1.209 0 N-CA-C 102.006 -3.331 . . . . 0.0 102.006 -178.075 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 53.7 p -105.55 172.1 6.98 Favored 'General case' 0 N--CA 1.441 -0.909 0 N-CA-C 107.374 -1.343 . . . . 0.0 107.374 174.61 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 4.0 m -116.21 52.27 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.863 0 N-CA-C 106.011 -1.848 . . . . 0.0 106.011 175.022 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -98.15 -129.08 6.27 Favored Glycine 0 C--N 1.355 1.597 0 N-CA-C 109.421 -1.472 . . . . 0.0 109.421 -176.031 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 17.5 ptm180 -80.09 160.06 25.89 Favored 'General case' 0 C--N 1.357 0.906 0 C-N-CA 123.942 0.897 . . . . 0.0 109.685 -176.925 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -162.49 169.91 19.56 Favored 'General case' 0 CA--C 1.493 -1.212 0 CA-C-O 121.445 0.64 . . . . 0.0 110.298 -171.217 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 95.6 mttt -111.06 155.89 22.12 Favored 'General case' 0 CA--C 1.488 -1.408 0 N-CA-C 107.485 -1.302 . . . . 0.0 107.485 -172.612 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 24.5 pt-20 -152.25 160.15 43.41 Favored 'General case' 0 N--CA 1.434 -1.27 0 N-CA-C 107.972 -1.121 . . . . 0.0 107.972 171.142 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -137.76 159.48 41.88 Favored 'General case' 0 N--CA 1.437 -1.102 0 N-CA-C 105.396 -2.075 . . . . 0.0 105.396 173.785 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 73.3 m -120.41 125.9 49.12 Favored 'General case' 0 CA--C 1.498 -1.036 0 N-CA-C 104.533 -2.395 . . . . 0.0 104.533 177.393 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 5.3 mp -114.73 136.03 22.43 Favored Pre-proline 0 N--CA 1.435 -1.188 0 N-CA-C 104.6 -2.37 . . . . 0.0 104.6 -174.255 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 62.0 Cg_exo -64.3 166.85 15.97 Favored 'Trans proline' 0 CA--C 1.508 -0.78 0 C-N-CA 123.528 2.818 . . . . 0.0 113.519 176.794 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -77.06 -19.23 77.63 Favored Glycine 0 C--N 1.353 1.507 0 C-N-CA 123.797 0.713 . . . . 0.0 114.242 -175.149 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 51.7 p-80 -83.23 -26.79 30.43 Favored 'General case' 0 C--N 1.355 0.838 0 CA-C-N 117.963 0.881 . . . . 0.0 109.788 -179.278 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 89.0 mt -88.84 132.92 34.45 Favored 'General case' 0 CA--C 1.501 -0.93 0 N-CA-C 107.37 -1.345 . . . . 0.0 107.37 175.407 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 7.8 p30 -121.33 15.0 11.31 Favored 'General case' 0 CA--C 1.5 -0.946 0 C-N-CA 124.19 0.996 . . . . 0.0 108.816 -175.501 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 32.9 p -144.73 155.47 43.57 Favored 'General case' 0 N--CA 1.438 -1.074 0 N-CA-C 106.928 -1.508 . . . . 0.0 106.928 -178.721 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 23.0 t80 -150.64 157.76 43.35 Favored 'General case' 0 CA--C 1.497 -1.093 0 N-CA-C 107.965 -1.124 . . . . 0.0 107.965 178.188 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 48.2 m -108.78 112.37 24.61 Favored 'General case' 0 CA--C 1.5 -0.945 0 N-CA-C 106.197 -1.779 . . . . 0.0 106.197 173.536 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 55.3 mt -97.19 91.83 2.76 Favored 'Isoleucine or valine' 0 C--N 1.359 0.982 0 N-CA-C 105.084 -2.191 . . . . 0.0 105.084 174.146 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.517 ' HD3' ' H ' ' A' ' 61' ' ' LYS . 0.3 OUTLIER -105.18 160.52 15.01 Favored 'General case' 0 CA--C 1.498 -1.022 0 N-CA-C 107.67 -1.233 . . . . 0.0 107.67 178.412 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 88.74 52.85 2.7 Favored Glycine 0 C--N 1.353 1.504 0 N-CA-C 108.75 -1.74 . . . . 0.0 108.75 179.796 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 60.7 mt -115.54 158.55 22.46 Favored 'General case' 0 CA--C 1.501 -0.91 0 N-CA-C 107.087 -1.449 . . . . 0.0 107.087 178.961 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 29.1 mtpp -95.35 155.71 38.48 Favored Pre-proline 0 N--CA 1.441 -0.925 0 N-CA-C 106.97 -1.492 . . . . 0.0 106.97 -178.442 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 69.0 Cg_endo -80.31 162.87 22.46 Favored 'Trans proline' 0 N--CA 1.454 -0.852 0 C-N-CA 122.988 2.459 . . . . 0.0 110.903 177.249 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 60.93 26.67 65.78 Favored Glycine 0 C--N 1.356 1.669 0 C-N-CA 127.819 2.628 . . . . 0.0 116.814 166.095 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 7.2 p -131.43 145.61 34.95 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.846 0 CA-C-N 117.701 0.75 . . . . 0.0 109.325 -173.211 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 2.9 p -90.46 127.29 43.05 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.863 0 N-CA-C 107.208 -1.405 . . . . 0.0 107.208 176.332 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 84.0 m-85 -107.3 147.77 29.85 Favored 'General case' 0 CA--C 1.498 -1.044 0 N-CA-C 106.814 -1.551 . . . . 0.0 106.814 172.842 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -95.87 143.98 26.61 Favored 'General case' 0 N--CA 1.439 -0.993 0 N-CA-C 105.132 -2.173 . . . . 0.0 105.132 160.918 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -133.42 155.13 21.56 Favored Glycine 0 CA--C 1.488 -1.637 0 N-CA-C 107.727 -2.149 . . . . 0.0 107.727 -178.962 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 32.0 mt-30 -143.13 138.25 29.68 Favored 'General case' 0 CA--C 1.482 -1.667 0 N-CA-C 105.959 -1.867 . . . . 0.0 105.959 176.345 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 42.8 tp -113.69 103.77 11.56 Favored 'General case' 0 N--CA 1.436 -1.175 0 N-CA-C 103.76 -2.682 . . . . 0.0 103.76 175.75 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 13.6 mt -98.19 128.45 49.63 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.786 0 N-CA-C 104.32 -2.474 . . . . 0.0 104.32 179.664 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 43.8 m -112.41 112.43 23.99 Favored 'General case' 0 N--CA 1.441 -0.923 0 N-CA-C 106.992 -1.484 . . . . 0.0 106.992 -175.189 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 1.7 mp -87.85 136.35 23.36 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.217 0 N-CA-C 104.712 -2.329 . . . . 0.0 104.712 -166.822 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 78.2 mt-30 -95.84 141.69 28.98 Favored 'General case' 0 N--CA 1.436 -1.154 0 N-CA-C 106.042 -1.836 . . . . 0.0 106.042 -179.068 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 7.8 tp-100 -69.04 117.02 10.16 Favored 'General case' 0 N--CA 1.441 -0.882 0 C-N-CA 124.129 0.972 . . . . 0.0 111.395 -170.554 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 31.9 m-85 58.09 45.39 17.81 Favored 'General case' 0 C--N 1.358 0.972 0 C-N-CA 127.325 2.25 . . . . 0.0 112.816 179.653 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -170.33 -114.46 0.31 Allowed Glycine 0 C--N 1.354 1.554 0 C-N-CA 118.663 -1.732 . . . . 0.0 109.704 174.847 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 52.2 m80 -83.24 -171.67 3.7 Favored 'General case' 0 CA--C 1.495 -1.165 0 C-N-CA 125.714 1.606 . . . . 0.0 110.425 -167.715 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -146.66 145.46 30.04 Favored 'General case' 0 N--CA 1.433 -1.281 0 N-CA-C 106.509 -1.663 . . . . 0.0 106.509 169.507 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -101.72 145.45 29.11 Favored 'General case' 0 N--CA 1.44 -0.957 0 N-CA-C 104.645 -2.354 . . . . 0.0 104.645 -179.907 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 6.6 p -124.99 137.96 55.86 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.775 0 N-CA-C 108.104 -1.073 . . . . 0.0 108.104 -177.569 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 61.0 m -125.85 137.13 53.74 Favored 'General case' 0 N--CA 1.439 -0.98 0 N-CA-C 103.232 -2.877 . . . . 0.0 103.232 175.922 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 54.6 ttp180 -130.15 144.6 51.45 Favored 'General case' 0 CA--C 1.502 -0.873 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 -179.309 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 23.6 p90 -156.48 -178.19 7.16 Favored 'General case' 0 CA--C 1.5 -0.962 0 N-CA-C 106.263 -1.754 . . . . 0.0 106.263 -178.216 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 47.7 p-10 -140.43 160.79 39.21 Favored 'General case' 0 N--CA 1.441 -0.877 0 N-CA-C 107.412 -1.329 . . . . 0.0 107.412 168.116 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 24.5 p90 -147.21 170.31 17.51 Favored 'General case' 0 CA--C 1.49 -1.365 0 N-CA-C 107.033 -1.469 . . . . 0.0 107.033 173.785 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 33.0 p -124.74 147.13 48.81 Favored 'General case' 0 CA--C 1.499 -0.994 0 N-CA-C 107.319 -1.363 . . . . 0.0 107.319 178.036 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 4.4 p -109.09 130.12 55.48 Favored 'General case' 0 N--CA 1.439 -1.012 0 N-CA-C 102.525 -3.139 . . . . 0.0 102.525 164.047 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 42.9 p -90.73 -179.17 5.46 Favored 'General case' 0 N--CA 1.444 -0.732 0 N-CA-C 106.931 -1.507 . . . . 0.0 106.931 179.54 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 31.5 t . . . . . 0 C--O 1.262 1.729 0 N-CA-C 105.186 -2.153 . . . . 0.0 105.186 176.695 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 68.0 m . . . . . 0 N--CA 1.484 1.275 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 167.75 -154.81 25.19 Favored Glycine 0 N--CA 1.435 -1.403 0 N-CA-C 105.795 -2.922 . . . . 0.0 105.795 -176.631 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_exo -61.65 139.45 81.11 Favored 'Trans proline' 0 N--CA 1.442 -1.527 0 C-N-CA 122.865 2.377 . . . . 0.0 113.694 -175.62 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 4.1 t -79.46 154.26 4.7 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.932 0 C-N-CA 127.202 2.201 . . . . 0.0 106.383 -179.14 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 55.6 mm-40 -101.43 96.11 6.93 Favored 'General case' 0 CA--C 1.49 -1.338 0 N-CA-C 107.643 -1.244 . . . . 0.0 107.643 -175.267 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 2.4 p -120.52 143.14 33.43 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.103 0 CA-C-N 113.459 -1.701 . . . . 0.0 107.802 -165.033 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -73.65 171.54 13.07 Favored 'General case' 0 N--CA 1.438 -1.036 0 C-N-CA 125.762 1.625 . . . . 0.0 112.494 -169.271 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.455 HG13 ' H ' ' A' ' 9' ' ' THR . 5.5 tp -89.7 -152.24 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.438 -1.048 0 C-N-CA 128.172 2.589 . . . . 0.0 106.285 175.18 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.493 ' HB ' ' H ' ' A' ' 90' ' ' THR . 4.3 t -72.46 92.2 1.44 Allowed 'General case' 0 N--CA 1.442 -0.848 0 C-N-CA 127.278 2.231 . . . . 0.0 108.85 172.541 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -85.99 0.02 54.34 Favored 'General case' 0 C--N 1.355 0.837 0 C-N-CA 124.617 1.167 . . . . 0.0 111.528 179.847 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 20.9 p -84.53 135.0 41.4 Favored Pre-proline 0 C--N 1.356 0.864 0 N-CA-C 107.958 -1.127 . . . . 0.0 107.958 177.181 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_endo -72.1 -69.85 0.02 OUTLIER 'Trans proline' 0 N--CA 1.45 -1.047 0 C-N-CA 122.998 2.465 . . . . 0.0 108.525 166.805 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 65.8 m -143.87 112.88 6.74 Favored 'General case' 0 N--CA 1.434 -1.232 0 N-CA-C 103.843 -2.651 . . . . 0.0 103.843 169.481 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 30.0 mm100 -140.16 113.66 7.53 Favored Pre-proline 0 N--CA 1.442 -0.836 0 N-CA-C 104.405 -2.442 . . . . 0.0 104.405 176.086 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 75.0 Cg_endo -82.63 -14.98 8.77 Favored 'Trans proline' 0 CA--C 1.504 -0.978 0 C-N-CA 123.024 2.483 . . . . 0.0 111.04 -169.408 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 4.7 p-10 -122.66 -36.11 2.96 Favored 'General case' 0 CA--C 1.486 -1.499 0 O-C-N 123.821 0.7 . . . . 0.0 110.744 -162.988 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 30.3 p -117.58 151.54 36.96 Favored 'General case' 0 CA--C 1.496 -1.127 0 CA-C-O 121.79 0.805 . . . . 0.0 108.896 -173.122 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 58.6 t-80 -145.77 106.37 4.28 Favored Pre-proline 0 N--CA 1.433 -1.28 0 N-CA-C 106.228 -1.767 . . . . 0.0 106.228 167.43 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -77.74 142.49 20.33 Favored 'Trans proline' 0 N--CA 1.447 -1.249 0 C-N-CA 122.578 2.186 . . . . 0.0 109.732 173.092 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 18.2 mm -102.9 140.09 22.1 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.919 0 N-CA-C 103.434 -2.802 . . . . 0.0 103.434 174.121 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 14.6 tm0? -130.32 138.04 50.24 Favored 'General case' 0 CA--C 1.498 -1.045 0 N-CA-C 102.801 -3.036 . . . . 0.0 102.801 176.5 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 49.5 p90 -140.64 166.38 24.9 Favored 'General case' 0 CA--C 1.497 -1.067 0 N-CA-C 106.913 -1.514 . . . . 0.0 106.913 -178.786 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 36.7 m-80 -136.91 132.42 34.46 Favored 'General case' 0 CA--C 1.488 -1.404 0 N-CA-C 105.469 -2.049 . . . . 0.0 105.469 177.198 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -104.0 167.61 9.79 Favored Pre-proline 0 N--CA 1.44 -0.972 0 C-N-CA 124.515 1.126 . . . . 0.0 109.378 -166.809 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_exo -66.23 158.48 54.62 Favored 'Trans proline' 0 CA--C 1.508 -0.78 0 C-N-CA 123.359 2.706 . . . . 0.0 111.926 171.207 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 24.4 tt0 -82.95 -45.12 0.88 Allowed Pre-proline 0 N--CA 1.443 -0.781 0 CA-C-O 115.54 -2.172 . . . . 0.0 111.691 -177.618 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 74.7 Cg_exo -68.57 164.55 32.53 Favored 'Trans proline' 0 CA--C 1.509 -0.77 0 CA-C-N 125.65 3.054 . . . . 0.0 112.717 -178.002 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 35.8 p -76.78 124.51 27.79 Favored 'General case' 0 C--N 1.355 0.847 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 179.323 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 64.2 t-80 -174.69 -42.78 0.01 OUTLIER 'General case' 0 CA--C 1.496 -1.098 0 N-CA-C 106.559 -1.645 . . . . 0.0 106.559 -171.192 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 36.1 mt -118.18 136.42 55.43 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.132 0 N-CA-C 106.331 -1.729 . . . . 0.0 106.331 -171.948 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 5.9 p -114.29 -85.39 0.6 Allowed 'General case' 0 N--CA 1.431 -1.399 0 N-CA-C 106.188 -1.782 . . . . 0.0 106.188 177.361 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 52.0 mtmt -86.03 167.48 14.98 Favored 'General case' 0 CA--C 1.485 -1.527 0 C-N-CA 124.799 1.239 . . . . 0.0 109.224 -164.387 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 81.4 m-85 -132.02 133.43 44.42 Favored 'General case' 0 CA--C 1.49 -1.362 0 N-CA-C 104.044 -2.576 . . . . 0.0 104.044 177.504 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 28.2 mt -122.41 127.87 75.24 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.326 0 N-CA-C 101.921 -3.363 . . . . 0.0 101.921 178.338 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 5.2 mt -110.51 133.46 53.27 Favored 'General case' 0 CA--C 1.475 -1.916 0 N-CA-C 106.151 -1.796 . . . . 0.0 106.151 177.531 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 2.4 mpt_? -112.45 155.46 24.21 Favored 'General case' 0 N--CA 1.432 -1.373 0 N-CA-C 104.62 -2.363 . . . . 0.0 104.62 166.961 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 47.8 p90 -155.32 150.73 27.15 Favored 'General case' 0 N--CA 1.438 -1.042 0 N-CA-C 107.729 -1.211 . . . . 0.0 107.729 170.196 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 11.2 ptp180 -150.88 148.87 24.0 Favored Pre-proline 0 CA--C 1.499 -0.982 0 N-CA-C 106.777 -1.564 . . . . 0.0 106.777 166.863 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -75.96 144.84 27.63 Favored 'Trans proline' 0 CA--C 1.503 -1.048 0 C-N-CA 122.763 2.309 . . . . 0.0 107.86 171.619 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -70.69 80.2 0.6 Allowed 'General case' 0 C--N 1.354 0.797 0 C-N-CA 125.085 1.354 . . . . 0.0 110.915 177.157 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 8.9 t-20 -161.97 -54.8 0.04 OUTLIER 'General case' 0 N--CA 1.431 -1.399 0 N-CA-C 102.917 -2.994 . . . . 0.0 102.917 -178.158 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 34.3 p -83.82 143.79 29.7 Favored 'General case' 0 N--CA 1.438 -1.065 0 N-CA-C 107.299 -1.371 . . . . 0.0 107.299 173.226 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 14.3 m -136.81 14.96 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.803 0 N-CA-C 106.677 -1.601 . . . . 0.0 106.677 177.614 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -101.44 -93.98 2.2 Favored Glycine 0 C--N 1.356 1.658 0 N-CA-C 108.043 -2.023 . . . . 0.0 108.043 -175.067 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 17.5 ptm180 -91.13 171.16 9.44 Favored 'General case' 0 CA--C 1.503 -0.864 0 N-CA-C 108.108 -1.071 . . . . 0.0 108.108 177.255 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -159.52 179.38 8.96 Favored 'General case' 0 CA--C 1.494 -1.192 0 N-CA-C 109.606 -0.516 . . . . 0.0 109.606 -178.657 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -110.04 152.63 25.7 Favored 'General case' 0 CA--C 1.489 -1.387 0 N-CA-C 106.755 -1.572 . . . . 0.0 106.755 -175.818 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -154.8 156.95 37.18 Favored 'General case' 0 N--CA 1.433 -1.284 0 N-CA-C 106.957 -1.497 . . . . 0.0 106.957 -178.953 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -146.05 164.03 33.4 Favored 'General case' 0 CA--C 1.502 -0.885 0 N-CA-C 107.793 -1.188 . . . . 0.0 107.793 175.13 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 96.9 m -120.98 126.57 50.29 Favored 'General case' 0 CA--C 1.502 -0.867 0 N-CA-C 105.542 -2.022 . . . . 0.0 105.542 178.382 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 5.0 mp -114.07 136.13 22.16 Favored Pre-proline 0 N--CA 1.439 -0.992 0 N-CA-C 105.296 -2.113 . . . . 0.0 105.296 -175.823 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_exo -63.06 165.66 16.22 Favored 'Trans proline' 0 CA--C 1.508 -0.81 0 C-N-CA 123.734 2.956 . . . . 0.0 113.799 176.823 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -82.2 -13.68 78.46 Favored Glycine 0 C--N 1.351 1.403 0 C-N-CA 123.507 0.575 . . . . 0.0 113.451 -171.682 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 50.5 p-80 -84.66 -27.16 27.29 Favored 'General case' 0 C--N 1.356 0.872 0 CA-C-N 117.945 0.872 . . . . 0.0 109.862 178.572 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 88.5 mt -88.52 130.39 35.24 Favored 'General case' 0 CA--C 1.498 -1.027 0 N-CA-C 108.536 -0.912 . . . . 0.0 108.536 178.678 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 8.4 p-10 -108.8 10.84 26.55 Favored 'General case' 0 N--CA 1.442 -0.845 0 C-N-CA 124.574 1.15 . . . . 0.0 109.921 -177.484 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 39.2 p -146.43 162.5 38.12 Favored 'General case' 0 N--CA 1.439 -1.003 0 N-CA-C 107.534 -1.284 . . . . 0.0 107.534 -178.598 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 10.7 t80 -140.21 174.63 10.33 Favored 'General case' 0 N--CA 1.444 -0.728 0 N-CA-C 107.122 -1.436 . . . . 0.0 107.122 -179.789 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 55.4 m -137.82 111.41 8.13 Favored 'General case' 0 N--CA 1.433 -1.317 0 N-CA-C 104.689 -2.337 . . . . 0.0 104.689 174.064 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 43.5 mt -91.43 138.72 19.09 Favored 'Isoleucine or valine' 0 C--N 1.358 0.95 0 N-CA-C 104.346 -2.464 . . . . 0.0 104.346 172.361 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 6.9 mtpm? -139.56 162.11 35.88 Favored 'General case' 0 CA--C 1.499 -0.994 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 -179.12 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 82.99 51.37 4.23 Favored Glycine 0 C--N 1.354 1.546 0 N-CA-C 109.429 -1.468 . . . . 0.0 109.429 176.862 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 80.5 mt -117.67 172.03 7.63 Favored 'General case' 0 CA--C 1.501 -0.932 0 N-CA-C 108.071 -1.085 . . . . 0.0 108.071 -170.869 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 10.4 mptt -102.97 151.21 38.37 Favored Pre-proline 0 N--CA 1.442 -0.828 0 N-CA-C 107.572 -1.27 . . . . 0.0 107.572 -172.479 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 64.2 Cg_exo -66.66 135.4 38.59 Favored 'Trans proline' 0 N--CA 1.453 -0.911 0 C-N-CA 123.62 2.88 . . . . 0.0 112.226 171.56 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 54.66 50.01 59.22 Favored Glycine 0 C--N 1.355 1.599 0 C-N-CA 127.256 2.36 . . . . 0.0 115.415 167.334 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 4.3 p -128.94 149.49 33.7 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.007 0 N-CA-C 107.597 -1.26 . . . . 0.0 107.597 178.871 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 7.6 p -95.23 135.5 29.11 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.959 0 N-CA-C 107.644 -1.243 . . . . 0.0 107.644 -178.256 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 83.6 m-85 -117.1 151.28 37.14 Favored 'General case' 0 CA--C 1.496 -1.121 0 N-CA-C 106.395 -1.706 . . . . 0.0 106.395 177.364 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -98.44 142.46 30.03 Favored 'General case' 0 CA--C 1.5 -0.97 0 N-CA-C 104.908 -2.256 . . . . 0.0 104.908 159.476 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -133.23 149.88 19.72 Favored Glycine 0 CA--C 1.49 -1.525 0 N-CA-C 107.693 -2.163 . . . . 0.0 107.693 179.938 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 33.7 mt-30 -136.49 136.24 39.25 Favored 'General case' 0 CA--C 1.484 -1.56 0 N-CA-C 106.581 -1.637 . . . . 0.0 106.581 176.173 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 15.0 tp -119.92 106.75 12.35 Favored 'General case' 0 CA--C 1.499 -1.007 0 N-CA-C 105.778 -1.934 . . . . 0.0 105.778 -176.851 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 5.9 mt -100.15 129.32 51.05 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.113 0 N-CA-C 105.036 -2.209 . . . . 0.0 105.036 -178.81 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 12.6 p -115.72 114.4 24.77 Favored 'General case' 0 N--CA 1.443 -0.823 0 N-CA-C 108.108 -1.071 . . . . 0.0 108.108 -176.418 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 1.7 mp -94.94 143.05 12.57 Favored 'Isoleucine or valine' 0 C--N 1.358 0.941 0 N-CA-C 106.045 -1.835 . . . . 0.0 106.045 -163.808 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 16.7 tt0 -102.3 140.95 35.9 Favored 'General case' 0 CA--C 1.498 -1.031 0 N-CA-C 105.116 -2.179 . . . . 0.0 105.116 171.342 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 75.4 mt-30 -67.19 115.21 6.61 Favored 'General case' 0 C--N 1.358 0.955 0 C-N-CA 123.319 0.648 . . . . 0.0 111.075 -176.038 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 58.4 m-85 60.12 40.03 18.84 Favored 'General case' 0 C--N 1.355 0.848 0 C-N-CA 126.523 1.929 . . . . 0.0 112.143 176.324 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -158.85 -118.61 0.53 Allowed Glycine 0 C--N 1.355 1.623 0 N-CA-C 108.779 -1.728 . . . . 0.0 108.779 -178.361 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 78.4 m-70 -82.84 179.98 7.61 Favored 'General case' 0 CA--C 1.501 -0.928 0 C-N-CA 124.657 1.183 . . . . 0.0 111.178 -168.38 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 13.7 pt20 -157.16 133.5 9.78 Favored 'General case' 0 N--CA 1.434 -1.258 0 N-CA-C 106.076 -1.824 . . . . 0.0 106.076 167.391 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 31.5 mm-40 -100.91 146.43 27.36 Favored 'General case' 0 CA--C 1.498 -1.031 0 N-CA-C 105.531 -2.026 . . . . 0.0 105.531 -178.231 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 7.6 p -122.3 141.55 42.27 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.721 0 N-CA-C 108.004 -1.109 . . . . 0.0 108.004 -174.444 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 23.2 m -125.79 145.45 50.21 Favored 'General case' 0 N--CA 1.442 -0.872 0 N-CA-C 104.398 -2.445 . . . . 0.0 104.398 -179.711 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 38.9 ttm180 -133.85 143.46 48.33 Favored 'General case' 0 CA--C 1.504 -0.81 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 173.32 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 28.9 p90 -155.67 175.68 13.6 Favored 'General case' 0 CA--C 1.5 -0.974 0 N-CA-C 106.905 -1.517 . . . . 0.0 106.905 -178.424 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 52.2 m-20 -133.47 153.86 51.28 Favored 'General case' 0 CA--C 1.504 -0.81 0 N-CA-C 106.018 -1.845 . . . . 0.0 106.018 170.334 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 17.1 p90 -151.28 175.64 12.01 Favored 'General case' 0 CA--C 1.493 -1.23 0 N-CA-C 106.678 -1.601 . . . . 0.0 106.678 173.222 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 90' ' ' THR . . . . . 0.493 ' H ' ' HB ' ' A' ' 9' ' ' THR . 31.4 p -122.6 147.02 46.9 Favored 'General case' 0 CA--C 1.504 -0.813 0 N-CA-C 107.533 -1.284 . . . . 0.0 107.533 174.276 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 94.3 m -99.52 121.65 41.47 Favored 'General case' 0 CA--C 1.496 -1.125 0 N-CA-C 102.721 -3.066 . . . . 0.0 102.721 165.583 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 2.3 m 68.13 -128.34 0.13 Allowed 'General case' 0 C--N 1.36 1.028 0 C-N-CA 126.573 1.949 . . . . 0.0 106.481 -165.346 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 26.8 p . . . . . 0 C--O 1.261 1.69 0 N-CA-C 106.168 -1.79 . . . . 0.0 106.168 174.124 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 24.1 t . . . . . 0 N--CA 1.48 1.037 0 N-CA-C 108.752 -0.833 . . . . 0.0 108.752 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -142.89 -147.74 4.82 Favored Glycine 0 C--N 1.352 1.439 0 N-CA-C 106.138 -2.785 . . . . 0.0 106.138 -176.917 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_exo -58.4 140.93 96.46 Favored 'Trans proline' 0 N--CA 1.445 -1.35 0 C-N-CA 123.749 2.966 . . . . 0.0 113.319 -175.783 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 7.3 t -79.0 155.31 4.83 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.892 0 C-N-CA 127.014 2.126 . . . . 0.0 106.569 -175.345 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 93.4 mt-10 -97.35 87.98 4.29 Favored 'General case' 0 CA--C 1.493 -1.224 0 CA-C-O 122.377 1.084 . . . . 0.0 108.181 -173.1 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 2.7 p -110.77 134.93 51.45 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.146 0 CA-C-N 114.319 -1.31 . . . . 0.0 107.868 -166.179 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 23.8 p90 -135.81 175.67 9.38 Favored 'General case' 0 N--CA 1.434 -1.246 0 N-CA-C 104.072 -2.566 . . . . 0.0 104.072 178.131 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 17.9 tt -112.74 123.53 68.5 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.952 0 N-CA-C 107.343 -1.355 . . . . 0.0 107.343 175.756 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 8.1 t -101.05 155.9 17.72 Favored 'General case' 0 N--CA 1.44 -0.931 0 N-CA-C 107.904 -1.147 . . . . 0.0 107.904 -177.209 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 58.17 37.46 26.29 Favored 'General case' 0 C--N 1.358 0.973 0 C-N-CA 127.465 2.306 . . . . 0.0 113.48 167.431 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 16.2 p -126.2 87.23 56.58 Favored Pre-proline 0 C--N 1.35 0.616 0 N-CA-C 109.217 -0.66 . . . . 0.0 109.217 178.47 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 68.6 Cg_endo -77.73 -25.8 7.5 Favored 'Trans proline' 0 N--CA 1.453 -0.861 0 C-N-CA 122.574 2.183 . . . . 0.0 109.512 162.369 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 9.1 p 172.18 109.98 0.01 OUTLIER 'General case' 0 N--CA 1.439 -1.002 0 N-CA-C 104.887 -2.264 . . . . 0.0 104.887 -179.975 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 92.1 mt-30 -151.56 105.61 2.9 Favored Pre-proline 0 N--CA 1.442 -0.834 0 N-CA-C 105.666 -1.976 . . . . 0.0 105.666 178.798 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -83.67 -14.14 7.93 Favored 'Trans proline' 0 CA--C 1.507 -0.84 0 C-N-CA 122.936 2.424 . . . . 0.0 110.917 -179.002 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 7.0 p-10 -104.18 -42.34 5.55 Favored 'General case' 0 CA--C 1.494 -1.199 0 O-C-N 123.716 0.635 . . . . 0.0 110.417 -165.72 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 10.9 p -120.1 143.98 47.86 Favored 'General case' 0 CA--C 1.488 -1.432 0 N-CA-C 107.98 -1.118 . . . . 0.0 107.98 -178.43 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' HIS . . . . . 0.515 ' CE1' HG22 ' A' ' 91' ' ' THR . 0.1 OUTLIER -135.12 92.75 17.8 Favored Pre-proline 0 N--CA 1.441 -0.905 0 N-CA-C 105.657 -1.979 . . . . 0.0 105.657 174.322 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_endo -74.9 127.87 11.11 Favored 'Trans proline' 0 N--CA 1.443 -1.447 0 C-N-CA 123.007 2.471 . . . . 0.0 109.442 170.492 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 28.3 mm -104.86 149.82 8.1 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.081 0 N-CA-C 104.231 -2.507 . . . . 0.0 104.231 -174.277 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 65.4 tt0 -140.24 142.84 35.77 Favored 'General case' 0 N--CA 1.438 -1.066 0 N-CA-C 104.205 -2.517 . . . . 0.0 104.205 168.587 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 37.8 p90 -136.27 164.2 28.63 Favored 'General case' 0 N--CA 1.439 -0.987 0 N-CA-C 106.226 -1.768 . . . . 0.0 106.226 -175.176 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 5.8 m120 -131.24 127.71 38.41 Favored 'General case' 0 CA--C 1.492 -1.286 0 N-CA-C 106.353 -1.721 . . . . 0.0 106.353 -179.948 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -84.61 161.77 52.67 Favored Pre-proline 0 N--CA 1.442 -0.857 0 C-N-CA 123.663 0.785 . . . . 0.0 110.541 -168.381 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_exo -67.23 172.72 9.62 Favored 'Trans proline' 0 CA--C 1.51 -0.717 0 C-N-CA 123.498 2.798 . . . . 0.0 112.295 170.766 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 1.4 tm0? -80.74 -46.99 1.23 Allowed Pre-proline 0 N--CA 1.443 -0.795 0 CA-C-O 115.569 -2.158 . . . . 0.0 110.429 -176.86 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 63.3 Cg_exo -68.25 164.78 31.02 Favored 'Trans proline' 0 CA--C 1.509 -0.75 0 CA-C-N 125.784 3.101 . . . . 0.0 112.086 176.999 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 22.6 t -88.07 85.88 7.03 Favored 'General case' 0 C--N 1.356 0.862 0 N-CA-C 106.412 -1.699 . . . . 0.0 106.412 176.258 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 59.9 t-80 -116.16 -28.85 6.45 Favored 'General case' 0 N--CA 1.437 -1.124 0 C-N-CA 125.585 1.554 . . . . 0.0 107.076 -175.01 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 42.6 mt -126.35 137.03 59.05 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.056 0 N-CA-C 106.916 -1.513 . . . . 0.0 106.916 -169.041 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 32.9 t -113.56 -85.72 0.59 Allowed 'General case' 0 N--CA 1.432 -1.348 0 N-CA-C 106.328 -1.731 . . . . 0.0 106.328 178.073 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 37.0 ttpt -88.43 160.67 17.44 Favored 'General case' 0 CA--C 1.493 -1.241 0 C-N-CA 125.859 1.664 . . . . 0.0 107.906 -165.04 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 92.8 m-85 -127.47 139.97 52.46 Favored 'General case' 0 CA--C 1.492 -1.28 0 N-CA-C 105.377 -2.083 . . . . 0.0 105.377 177.941 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 13.9 mt -124.95 131.09 73.03 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.151 0 N-CA-C 101.958 -3.349 . . . . 0.0 101.958 172.898 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 3.5 mt -109.23 127.55 54.34 Favored 'General case' 0 CA--C 1.475 -1.936 0 N-CA-C 104.975 -2.232 . . . . 0.0 104.975 174.303 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -116.63 158.33 23.91 Favored 'General case' 0 N--CA 1.434 -1.257 0 N-CA-C 104.636 -2.357 . . . . 0.0 104.636 174.375 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 48.4 p90 -157.29 142.29 16.94 Favored 'General case' 0 N--CA 1.437 -1.081 0 N-CA-C 107.018 -1.475 . . . . 0.0 107.018 175.079 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 13.4 ttm180 -131.68 125.2 20.35 Favored Pre-proline 0 CA--C 1.503 -0.853 0 N-CA-C 106.261 -1.755 . . . . 0.0 106.261 179.006 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 4.8 Cg_endo -73.35 118.93 5.72 Favored 'Trans proline' 0 N--CA 1.45 -1.066 0 CA-C-N 123.388 2.246 . . . . 0.0 109.033 168.969 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 32.3 mmmt -70.98 88.7 0.77 Allowed 'General case' 0 N--CA 1.44 -0.937 0 C-N-CA 125.644 1.578 . . . . 0.0 111.133 179.214 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 31.4 m120 -135.57 -68.02 0.52 Allowed 'General case' 0 N--CA 1.436 -1.148 0 N-CA-C 102.244 -3.243 . . . . 0.0 102.244 172.729 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 57.8 m -102.98 168.28 9.3 Favored 'General case' 0 N--CA 1.44 -0.945 0 N-CA-C 106.674 -1.602 . . . . 0.0 106.674 172.234 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 3.6 m -122.15 55.53 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.88 0 N-CA-C 105.752 -1.944 . . . . 0.0 105.752 177.581 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -104.01 -109.4 3.38 Favored Glycine 0 C--N 1.353 1.479 0 N-CA-C 107.78 -2.128 . . . . 0.0 107.78 -177.221 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 82.4 mtt85 -91.24 172.3 8.64 Favored 'General case' 0 CA--C 1.502 -0.883 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 -178.534 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -153.69 176.27 12.3 Favored 'General case' 0 N--CA 1.437 -1.097 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 -179.964 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 59.5 mttp -112.42 156.98 21.63 Favored 'General case' 0 CA--C 1.49 -1.356 0 N-CA-C 107.782 -1.192 . . . . 0.0 107.782 -174.767 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 1.1 pp20? -151.42 162.37 41.05 Favored 'General case' 0 N--CA 1.434 -1.24 0 N-CA-C 107.966 -1.124 . . . . 0.0 107.966 171.014 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -144.49 159.73 42.27 Favored 'General case' 0 CA--C 1.497 -1.062 0 N-CA-C 105.857 -1.905 . . . . 0.0 105.857 172.072 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 91.4 m -121.28 130.01 53.43 Favored 'General case' 0 CA--C 1.502 -0.896 0 N-CA-C 106.576 -1.638 . . . . 0.0 106.576 -173.892 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 4.1 mp -116.64 134.79 22.86 Favored Pre-proline 0 N--CA 1.438 -1.066 0 N-CA-C 105.386 -2.079 . . . . 0.0 105.386 -175.054 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 66.0 Cg_exo -62.88 164.55 18.71 Favored 'Trans proline' 0 N--CA 1.455 -0.736 0 C-N-CA 123.498 2.799 . . . . 0.0 113.351 174.954 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -81.88 -14.87 76.59 Favored Glycine 0 C--N 1.352 1.422 0 O-C-N 123.48 0.487 . . . . 0.0 113.297 -170.717 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 50.1 p-80 -83.87 -25.5 30.21 Favored 'General case' 0 C--N 1.356 0.852 0 CA-C-N 117.846 0.823 . . . . 0.0 109.828 179.173 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 89.9 mt -88.41 133.17 34.18 Favored 'General case' 0 CA--C 1.5 -0.959 0 N-CA-C 107.876 -1.157 . . . . 0.0 107.876 177.633 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 7.9 p30 -110.41 9.03 23.44 Favored 'General case' 0 CA--C 1.504 -0.821 0 C-N-CA 124.654 1.181 . . . . 0.0 109.802 -175.436 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 37.2 p -145.81 162.98 36.42 Favored 'General case' 0 N--CA 1.438 -1.051 0 N-CA-C 107.395 -1.335 . . . . 0.0 107.395 -177.477 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 8.3 t80 -141.8 174.94 10.11 Favored 'General case' 0 N--CA 1.441 -0.878 0 N-CA-C 108.009 -1.108 . . . . 0.0 108.009 179.765 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 89.6 m -135.45 109.98 8.54 Favored 'General case' 0 N--CA 1.432 -1.337 0 N-CA-C 104.19 -2.522 . . . . 0.0 104.19 171.202 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 58.3 mt -87.5 143.83 10.49 Favored 'Isoleucine or valine' 0 C--N 1.36 1.022 0 N-CA-C 103.943 -2.614 . . . . 0.0 103.943 169.977 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -147.07 160.58 42.24 Favored 'General case' 0 CA--C 1.498 -1.054 0 N-CA-C 108.054 -1.091 . . . . 0.0 108.054 173.865 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 86.83 51.83 3.3 Favored Glycine 0 C--N 1.353 1.484 0 N-CA-C 109.006 -1.638 . . . . 0.0 109.006 177.004 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 48.2 mt -112.1 175.29 5.49 Favored 'General case' 0 CA--C 1.502 -0.867 0 N-CA-C 107.013 -1.477 . . . . 0.0 107.013 -178.353 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 57.6 mttp -115.99 152.59 47.79 Favored Pre-proline 0 N--CA 1.444 -0.757 0 N-CA-C 106.526 -1.657 . . . . 0.0 106.526 -168.395 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_endo -79.5 155.36 24.59 Favored 'Trans proline' 0 N--CA 1.454 -0.835 0 C-N-CA 122.719 2.279 . . . . 0.0 110.838 175.883 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 59.01 29.8 65.76 Favored Glycine 0 C--N 1.354 1.566 0 C-N-CA 127.747 2.594 . . . . 0.0 116.883 167.288 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 9.0 p -127.4 148.24 32.14 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.847 0 N-CA-C 108.715 -0.846 . . . . 0.0 108.715 -177.581 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 6.7 p -92.8 124.17 45.14 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.765 0 N-CA-C 107.804 -1.184 . . . . 0.0 107.804 175.614 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 51.0 m-85 -101.48 150.41 23.07 Favored 'General case' 0 N--CA 1.439 -1.004 0 N-CA-C 107.629 -1.249 . . . . 0.0 107.629 173.403 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 12.4 tp10 -93.7 136.18 34.24 Favored 'General case' 0 CA--C 1.498 -1.044 0 N-CA-C 103.762 -2.681 . . . . 0.0 103.762 163.914 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -134.43 145.32 17.41 Favored Glycine 0 CA--C 1.488 -1.64 0 N-CA-C 107.547 -2.221 . . . . 0.0 107.547 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 35.2 mt-30 -140.75 136.81 32.9 Favored 'General case' 0 CA--C 1.485 -1.52 0 N-CA-C 105.718 -1.956 . . . . 0.0 105.718 -177.677 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 40.9 tp -115.01 98.21 6.67 Favored 'General case' 0 N--CA 1.437 -1.124 0 N-CA-C 103.453 -2.795 . . . . 0.0 103.453 179.297 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 39.7 mm -92.88 125.96 45.39 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.942 0 N-CA-C 103.704 -2.702 . . . . 0.0 103.704 -178.08 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 49.2 m -120.72 112.29 18.67 Favored 'General case' 0 N--CA 1.438 -1.069 0 N-CA-C 107.632 -1.247 . . . . 0.0 107.632 -169.261 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 39.3 mm -88.15 139.87 16.68 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.323 0 N-CA-C 106.894 -1.521 . . . . 0.0 106.894 -163.188 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 15.3 tt0 -101.93 132.34 47.8 Favored 'General case' 0 CA--C 1.495 -1.171 0 N-CA-C 104.953 -2.24 . . . . 0.0 104.953 178.776 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 17.8 tt0 -77.08 42.56 0.33 Allowed 'General case' 0 C--N 1.355 0.813 0 C-N-CA 125.339 1.456 . . . . 0.0 113.168 -177.761 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 61.6 m-85 -140.42 19.59 2.39 Favored 'General case' 0 N--CA 1.442 -0.872 0 N-CA-C 107.094 -1.447 . . . . 0.0 107.094 173.251 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 96.55 -21.57 44.95 Favored Glycine 0 C--N 1.354 1.582 0 C-N-CA 123.94 0.781 . . . . 0.0 111.395 174.598 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 77.9 m-70 -81.71 178.91 8.06 Favored 'General case' 0 CA--C 1.498 -1.032 0 C-N-CA 124.621 1.168 . . . . 0.0 109.508 -177.016 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 5.0 pt20 -159.02 163.53 36.32 Favored 'General case' 0 N--CA 1.439 -1.024 0 CA-C-O 122.027 0.917 . . . . 0.0 108.721 174.78 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 16.6 tp10 -117.37 154.2 31.73 Favored 'General case' 0 N--CA 1.437 -1.078 0 N-CA-C 105.631 -1.989 . . . . 0.0 105.631 179.604 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 1.9 p -126.0 134.31 66.84 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.86 0 N-CA-C 106.9 -1.519 . . . . 0.0 106.9 176.75 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 38.8 m -122.54 131.96 54.09 Favored 'General case' 0 N--CA 1.439 -0.996 0 N-CA-C 102.211 -3.255 . . . . 0.0 102.211 172.595 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 22.9 ttt180 -130.27 143.5 50.81 Favored 'General case' 0 CA--C 1.504 -0.803 0 CA-C-N 118.784 0.72 . . . . 0.0 109.444 -172.691 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 18.0 p90 -162.06 -177.18 5.6 Favored 'General case' 0 C--N 1.359 1.007 0 N-CA-C 106.829 -1.545 . . . . 0.0 106.829 -175.316 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 43.6 p-10 -136.63 160.91 37.38 Favored 'General case' 0 N--CA 1.442 -0.831 0 N-CA-C 106.018 -1.845 . . . . 0.0 106.018 168.836 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.413 ' CD1' ' CD2' ' A' ' 18' ' ' HIS . 22.3 p90 -143.61 164.82 29.32 Favored 'General case' 0 CA--C 1.488 -1.428 0 N-CA-C 107.254 -1.388 . . . . 0.0 107.254 170.065 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 22.8 p -117.88 137.96 52.45 Favored 'General case' 0 CA--C 1.499 -1.005 0 N-CA-C 106.337 -1.727 . . . . 0.0 106.337 177.433 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 91' ' ' THR . . . . . 0.515 HG22 ' CE1' ' A' ' 18' ' ' HIS . 7.0 p -107.97 128.77 54.93 Favored 'General case' 0 CA--C 1.5 -0.977 0 N-CA-C 103.061 -2.94 . . . . 0.0 103.061 172.788 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 15.1 t -158.41 152.21 23.6 Favored 'General case' 0 N--CA 1.437 -1.08 0 N-CA-C 105.944 -1.873 . . . . 0.0 105.944 -178.11 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 33.8 p . . . . . 0 C--O 1.26 1.625 0 N-CA-C 107.189 -1.411 . . . . 0.0 107.189 174.714 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 89.9 p . . . . . 0 N--CA 1.487 1.403 0 CA-C-O 121.467 0.651 . . . . 0.0 111.889 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 85.66 -157.81 31.63 Favored Glycine 0 C--N 1.355 1.588 0 N-CA-C 108.616 -1.793 . . . . 0.0 108.616 -178.911 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_exo -60.46 140.55 92.07 Favored 'Trans proline' 0 N--CA 1.443 -1.461 0 C-N-CA 123.137 2.558 . . . . 0.0 113.484 -177.385 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 7.6 t -78.57 149.77 5.58 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.947 0 C-N-CA 127.775 2.43 . . . . 0.0 105.461 179.112 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 90.0 mt-10 -103.71 94.29 5.37 Favored 'General case' 0 CA--C 1.493 -1.23 0 C-N-CA 123.849 0.86 . . . . 0.0 108.726 -168.282 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 2.5 p -121.83 142.47 38.0 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.983 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 -161.936 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 18.1 p90 -154.83 177.77 10.9 Favored 'General case' 0 N--CA 1.435 -1.192 0 N-CA-C 106.923 -1.51 . . . . 0.0 106.923 -168.158 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 19.4 tt -139.27 132.93 38.82 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.958 0 N-CA-C 102.662 -3.088 . . . . 0.0 102.662 160.314 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 12.3 p -127.29 125.72 41.38 Favored 'General case' 0 CA--C 1.502 -0.898 0 N-CA-C 108.093 -1.077 . . . . 0.0 108.093 -174.632 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 49.8 tt0 67.0 53.13 0.83 Allowed 'General case' 0 N--CA 1.442 -0.846 0 C-N-CA 126.679 1.992 . . . . 0.0 112.664 168.054 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 10.2 t -98.76 123.31 50.09 Favored Pre-proline 0 C--N 1.355 0.847 0 N-CA-C 104.458 -2.423 . . . . 0.0 104.458 166.146 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_endo -78.61 -41.94 0.23 Allowed 'Trans proline' 0 N--CA 1.453 -0.858 0 C-N-CA 122.145 1.897 . . . . 0.0 109.637 -179.858 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 8.8 p -179.8 130.72 0.1 Allowed 'General case' 0 N--CA 1.433 -1.306 0 N-CA-C 103.042 -2.947 . . . . 0.0 103.042 -178.309 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 25.4 tp60 -155.88 100.56 2.17 Favored Pre-proline 0 N--CA 1.437 -1.097 0 N-CA-C 105.069 -2.197 . . . . 0.0 105.069 179.729 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -82.94 -19.16 5.99 Favored 'Trans proline' 0 CA--C 1.502 -1.076 0 C-N-CA 122.884 2.39 . . . . 0.0 111.06 -169.053 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 1.7 p30 -103.2 -40.05 6.59 Favored 'General case' 0 CA--C 1.484 -1.596 0 O-C-N 124.09 0.869 . . . . 0.0 110.455 -166.593 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 73.1 m -116.18 156.7 26.03 Favored 'General case' 0 CA--C 1.497 -1.083 0 CA-C-O 121.871 0.843 . . . . 0.0 108.797 -178.532 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 21.1 t-80 -132.96 89.88 33.12 Favored Pre-proline 0 N--CA 1.438 -1.03 0 N-CA-C 106.167 -1.79 . . . . 0.0 106.167 169.414 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 65.5 Cg_endo -84.24 103.38 0.96 Allowed 'Trans proline' 0 N--CA 1.453 -0.871 0 C-N-CA 123.27 2.647 . . . . 0.0 110.449 -175.072 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.583 HD11 HD11 ' A' ' 35' ' ' LEU . 1.7 pt -94.39 168.29 1.53 Allowed 'Isoleucine or valine' 0 C--N 1.356 0.864 0 N-CA-C 109.925 -0.398 . . . . 0.0 109.925 -173.608 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 28.1 tt0 -144.35 147.83 33.95 Favored 'General case' 0 N--CA 1.438 -1.033 0 N-CA-C 104.974 -2.232 . . . . 0.0 104.974 169.97 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 40.9 p90 -129.81 156.6 44.08 Favored 'General case' 0 CA--C 1.496 -1.103 0 N-CA-C 106.859 -1.534 . . . . 0.0 106.859 177.535 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 8.2 t-20 -110.92 149.2 30.97 Favored 'General case' 0 CA--C 1.489 -1.373 0 N-CA-C 102.186 -3.265 . . . . 0.0 102.186 173.211 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -115.82 170.37 5.8 Favored Pre-proline 0 N--CA 1.441 -0.895 0 C-N-CA 124.161 0.984 . . . . 0.0 108.521 -166.369 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 94.8 Cg_exo -65.18 169.53 12.04 Favored 'Trans proline' 0 CA--C 1.511 -0.668 0 C-N-CA 123.613 2.875 . . . . 0.0 112.323 166.918 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 64.7 mt-30 -80.51 -56.1 0.7 Allowed Pre-proline 0 N--CA 1.442 -0.831 0 CA-C-O 115.505 -2.188 . . . . 0.0 112.454 -172.903 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -75.31 169.78 21.74 Favored 'Trans proline' 0 CA--C 1.511 -0.655 0 CA-C-N 125.923 3.151 . . . . 0.0 110.671 -177.073 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 67.3 m -87.09 86.16 7.28 Favored 'General case' 0 CA--C 1.502 -0.901 0 N-CA-C 106.708 -1.59 . . . . 0.0 106.708 175.975 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 11.9 t-160 -122.78 -26.05 4.54 Favored 'General case' 0 N--CA 1.436 -1.129 0 C-N-CA 124.972 1.309 . . . . 0.0 107.792 -171.673 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 1.7 mp -103.16 136.7 34.57 Favored 'Isoleucine or valine' 0 C--N 1.355 0.824 0 N-CA-C 103.885 -2.635 . . . . 0.0 103.885 -171.919 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 34.5 t -96.29 -85.99 0.33 Allowed 'General case' 0 N--CA 1.43 -1.468 0 N-CA-C 104.791 -2.3 . . . . 0.0 104.791 174.473 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 50.8 mtmt -90.67 170.97 9.7 Favored 'General case' 0 CA--C 1.493 -1.226 0 C-N-CA 123.884 0.874 . . . . 0.0 110.096 -168.01 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 96.4 m-85 -125.69 140.37 52.76 Favored 'General case' 0 CA--C 1.496 -1.101 0 N-CA-C 103.948 -2.612 . . . . 0.0 103.948 162.132 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 54.0 mt -120.9 127.85 75.99 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.12 0 N-CA-C 101.828 -3.397 . . . . 0.0 101.828 170.976 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.583 HD11 HD11 ' A' ' 20' ' ' ILE . 4.5 mt -106.91 137.15 45.52 Favored 'General case' 0 CA--C 1.476 -1.898 0 N-CA-C 105.384 -2.08 . . . . 0.0 105.384 171.611 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -131.83 156.02 46.78 Favored 'General case' 0 N--CA 1.434 -1.242 0 N-CA-C 106.878 -1.526 . . . . 0.0 106.878 166.258 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 49.4 p90 -155.27 145.76 22.07 Favored 'General case' 0 N--CA 1.435 -1.209 0 N-CA-C 106.517 -1.66 . . . . 0.0 106.517 -176.384 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 45.5 ttm-85 -135.87 140.67 34.15 Favored Pre-proline 0 N--CA 1.441 -0.88 0 N-CA-C 104.575 -2.38 . . . . 0.0 104.575 178.254 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -72.95 116.55 4.76 Favored 'Trans proline' 0 CA--C 1.504 -0.992 0 C-N-CA 122.735 2.29 . . . . 0.0 108.594 166.284 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 82.5 tttt -73.87 83.85 1.69 Allowed 'General case' 0 C--N 1.355 0.843 0 C-N-CA 125.537 1.535 . . . . 0.0 110.199 -174.252 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 33.1 m120 -147.51 -73.04 0.21 Allowed 'General case' 0 N--CA 1.435 -1.186 0 N-CA-C 102.354 -3.202 . . . . 0.0 102.354 -175.785 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 50.8 p -96.73 168.4 10.53 Favored 'General case' 0 N--CA 1.442 -0.867 0 N-CA-C 107.454 -1.313 . . . . 0.0 107.454 173.351 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 3.6 m -125.98 55.16 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.849 0 N-CA-C 105.821 -1.918 . . . . 0.0 105.821 177.192 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -93.19 -106.05 1.74 Allowed Glycine 0 C--N 1.355 1.611 0 N-CA-C 108.415 -1.874 . . . . 0.0 108.415 -177.247 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 5.6 mmp_? -105.12 170.01 8.12 Favored 'General case' 0 CA--C 1.499 -1.017 0 N-CA-C 107.042 -1.466 . . . . 0.0 107.042 176.729 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -151.23 173.01 14.95 Favored 'General case' 0 N--CA 1.436 -1.137 0 N-CA-C 108.728 -0.841 . . . . 0.0 108.728 -177.943 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 67.8 mttm -111.68 155.76 22.93 Favored 'General case' 0 CA--C 1.49 -1.357 0 N-CA-C 107.774 -1.195 . . . . 0.0 107.774 -172.13 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 15.4 pt-20 -151.49 160.67 43.6 Favored 'General case' 0 N--CA 1.435 -1.211 0 N-CA-C 108.247 -1.02 . . . . 0.0 108.247 172.565 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -137.37 156.76 47.84 Favored 'General case' 0 CA--C 1.497 -1.064 0 N-CA-C 105.938 -1.875 . . . . 0.0 105.938 171.532 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 95.2 m -117.85 123.29 45.52 Favored 'General case' 0 CA--C 1.499 -0.982 0 N-CA-C 104.134 -2.543 . . . . 0.0 104.134 176.398 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 65.9 mt -118.73 137.67 25.15 Favored Pre-proline 0 N--CA 1.437 -1.08 0 N-CA-C 105.984 -1.858 . . . . 0.0 105.984 -164.867 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 75.3 Cg_exo -65.05 163.87 27.08 Favored 'Trans proline' 0 N--CA 1.455 -0.749 0 C-N-CA 123.295 2.663 . . . . 0.0 113.545 176.491 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -78.68 -17.27 77.78 Favored Glycine 0 C--N 1.352 1.456 0 C-N-CA 124.042 0.83 . . . . 0.0 113.807 -174.87 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 54.3 p-80 -83.45 -23.81 32.09 Favored 'General case' 0 C--N 1.357 0.893 0 CA-C-N 117.936 0.868 . . . . 0.0 109.963 -179.602 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 80.8 mt -87.93 125.24 34.4 Favored 'General case' 0 CA--C 1.497 -1.093 0 N-CA-C 107.975 -1.12 . . . . 0.0 107.975 176.721 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 8.1 p30 -112.25 6.69 19.09 Favored 'General case' 0 N--CA 1.442 -0.848 0 C-N-CA 124.741 1.216 . . . . 0.0 109.783 -174.845 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 28.7 p -142.06 154.96 45.35 Favored 'General case' 0 CA--C 1.498 -1.043 0 N-CA-C 106.684 -1.598 . . . . 0.0 106.684 -177.977 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 10.8 t80 -133.84 171.33 14.3 Favored 'General case' 0 CA--C 1.502 -0.869 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 178.423 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 94.4 m -131.8 109.09 9.88 Favored 'General case' 0 N--CA 1.43 -1.433 0 N-CA-C 103.929 -2.619 . . . . 0.0 103.929 170.545 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 42.6 mt -84.09 139.48 17.54 Favored 'Isoleucine or valine' 0 C--N 1.358 0.969 0 N-CA-C 103.123 -2.917 . . . . 0.0 103.123 169.433 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 18.0 ptpt -147.74 160.05 43.14 Favored 'General case' 0 CA--C 1.497 -1.085 0 N-CA-C 109.068 -0.716 . . . . 0.0 109.068 -176.261 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 81.2 53.96 3.72 Favored Glycine 0 C--N 1.355 1.586 0 N-CA-C 108.816 -1.714 . . . . 0.0 108.816 -179.946 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 84.6 mt -117.14 172.6 7.17 Favored 'General case' 0 CA--C 1.496 -1.113 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 -173.019 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 65.7 tttp -124.43 139.56 33.26 Favored Pre-proline 0 N--CA 1.434 -1.259 0 N-CA-C 104.97 -2.233 . . . . 0.0 104.97 -175.342 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -74.9 163.97 34.4 Favored 'Trans proline' 0 N--CA 1.455 -0.789 0 C-N-CA 123.058 2.505 . . . . 0.0 110.089 174.98 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 62.63 44.07 98.07 Favored Glycine 0 N--CA 1.429 -1.824 0 C-N-CA 125.946 1.736 . . . . 0.0 112.756 -178.803 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 20.5 t -134.95 127.19 48.15 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.09 0 N-CA-C 104.325 -2.472 . . . . 0.0 104.325 173.078 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 4.4 p -83.8 116.72 28.21 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.928 0 N-CA-C 105.061 -2.2 . . . . 0.0 105.061 162.521 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 80.8 m-85 -97.64 147.04 24.72 Favored 'General case' 0 CA--C 1.495 -1.153 0 N-CA-C 105.817 -1.919 . . . . 0.0 105.817 178.71 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 14.6 pt-20 -95.37 140.76 29.79 Favored 'General case' 0 CA--C 1.501 -0.934 0 N-CA-C 105.168 -2.16 . . . . 0.0 105.168 164.288 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -134.33 151.89 20.45 Favored Glycine 0 CA--C 1.49 -1.521 0 N-CA-C 107.633 -2.187 . . . . 0.0 107.633 -178.972 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 31.9 mt-30 -143.65 135.71 26.67 Favored 'General case' 0 CA--C 1.488 -1.425 0 N-CA-C 105.699 -1.963 . . . . 0.0 105.699 179.171 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 15.4 tp -120.01 100.98 7.54 Favored 'General case' 0 CA--C 1.499 -0.983 0 N-CA-C 105.482 -2.044 . . . . 0.0 105.482 -177.453 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 18.7 mt -94.02 131.29 41.34 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.889 0 N-CA-C 105.072 -2.196 . . . . 0.0 105.072 178.143 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 23.3 p -108.38 125.87 52.22 Favored 'General case' 0 N--CA 1.44 -0.972 0 N-CA-C 106.088 -1.819 . . . . 0.0 106.088 173.163 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 1.7 mp -92.33 137.04 23.07 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.181 0 N-CA-C 103.427 -2.805 . . . . 0.0 103.427 -179.346 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 4.8 mp0 -92.25 153.48 19.23 Favored 'General case' 0 CA--C 1.497 -1.091 0 N-CA-C 107.032 -1.47 . . . . 0.0 107.032 177.701 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 9.0 tt0 -77.52 32.53 0.16 Allowed 'General case' 0 C--N 1.356 0.854 0 C-N-CA 125.5 1.52 . . . . 0.0 112.385 173.766 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 88.4 m-85 -143.9 14.26 1.7 Allowed 'General case' 0 CA--C 1.498 -1.027 0 C-N-CA 124.119 0.968 . . . . 0.0 108.687 -173.96 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 90.14 -17.94 50.91 Favored Glycine 0 C--N 1.35 1.357 0 C-N-CA 124.131 0.872 . . . . 0.0 112.433 173.835 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 78.4 m-70 -81.48 173.84 12.02 Favored 'General case' 0 CA--C 1.496 -1.109 0 C-N-CA 124.691 1.196 . . . . 0.0 109.17 -177.365 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 5.1 pt20 -155.03 142.41 19.56 Favored 'General case' 0 N--CA 1.438 -1.042 0 N-CA-C 107.778 -1.193 . . . . 0.0 107.778 171.715 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 67.7 mt-10 -108.24 140.22 41.8 Favored 'General case' 0 CA--C 1.496 -1.1 0 N-CA-C 105.191 -2.152 . . . . 0.0 105.191 178.97 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 3.3 p -117.81 137.39 51.9 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.823 0 N-CA-C 107.544 -1.28 . . . . 0.0 107.544 -175.377 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 24.9 m -117.33 140.57 49.4 Favored 'General case' 0 N--CA 1.441 -0.898 0 N-CA-C 104.015 -2.587 . . . . 0.0 104.015 174.84 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -126.46 153.88 44.46 Favored 'General case' 0 CA--C 1.498 -1.04 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 170.331 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 29.5 p90 -166.46 -179.1 4.77 Favored 'General case' 0 CA--C 1.5 -0.948 0 N-CA-C 106.888 -1.523 . . . . 0.0 106.888 -178.093 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 1.7 p30 -139.11 159.51 41.98 Favored 'General case' 0 N--CA 1.438 -1.038 0 N-CA-C 106.436 -1.691 . . . . 0.0 106.436 166.132 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 20.5 p90 -142.42 172.88 12.09 Favored 'General case' 0 CA--C 1.488 -1.411 0 N-CA-C 105.814 -1.921 . . . . 0.0 105.814 171.867 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 16.2 m -130.39 143.48 50.79 Favored 'General case' 0 CA--C 1.501 -0.915 0 N-CA-C 104.697 -2.334 . . . . 0.0 104.697 176.76 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 58.8 m -120.48 124.83 46.35 Favored 'General case' 0 N--CA 1.441 -0.918 0 N-CA-C 102.973 -2.973 . . . . 0.0 102.973 176.758 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 33.0 p -134.24 167.8 20.03 Favored 'General case' 0 C--N 1.357 0.894 0 N-CA-C 107.459 -1.311 . . . . 0.0 107.459 -177.738 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 56.8 p . . . . . 0 C--O 1.26 1.61 0 C-N-CA 124.431 1.092 . . . . 0.0 108.844 178.02 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 22.7 t . . . . . 0 N--CA 1.484 1.264 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -177.49 154.32 15.26 Favored Glycine 0 C--N 1.352 1.471 0 N-CA-C 107.82 -2.112 . . . . 0.0 107.82 175.663 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 70.7 Cg_exo -65.5 142.15 70.43 Favored 'Trans proline' 0 N--CA 1.444 -1.425 0 C-N-CA 122.257 1.971 . . . . 0.0 115.2 -169.913 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 12.9 t -78.29 154.36 5.1 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.807 0 C-N-CA 128.645 2.778 . . . . 0.0 104.776 168.287 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 57.8 mm-40 -109.35 99.88 9.06 Favored 'General case' 0 CA--C 1.488 -1.437 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 -172.249 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 2.4 p -119.23 141.29 39.86 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.012 0 N-CA-C 106.413 -1.699 . . . . 0.0 106.413 -172.087 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 15.4 p90 -142.69 162.24 35.99 Favored 'General case' 0 N--CA 1.436 -1.154 0 N-CA-C 107.078 -1.453 . . . . 0.0 107.078 -169.005 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 39.8 pt -94.98 157.92 3.01 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.365 0 N-CA-C 107.399 -1.334 . . . . 0.0 107.399 177.782 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 41.3 p -79.53 -169.37 1.89 Allowed 'General case' 0 C--N 1.354 0.8 0 C-N-CA 123.881 0.872 . . . . 0.0 111.167 -175.797 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -89.29 -11.38 43.64 Favored 'General case' 0 N--CA 1.443 -0.801 0 C-N-CA 125.136 1.374 . . . . 0.0 110.812 -170.701 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 5.0 t -114.17 94.98 37.14 Favored Pre-proline 0 N--CA 1.44 -0.952 0 N-CA-C 107.265 -1.383 . . . . 0.0 107.265 -177.478 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 93.7 Cg_endo -81.03 -9.36 12.94 Favored 'Trans proline' 0 N--CA 1.451 -0.977 0 C-N-CA 122.775 2.317 . . . . 0.0 109.649 167.072 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 49.2 m -95.17 76.8 3.47 Favored 'General case' 0 CA--C 1.493 -1.223 0 CA-C-O 123.391 1.567 . . . . 0.0 108.903 -177.502 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 80.7 mt-30 -156.34 99.38 2.12 Favored Pre-proline 0 N--CA 1.433 -1.306 0 N-CA-C 100.979 -3.711 . . . . 0.0 100.979 173.995 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_exo -76.66 -14.29 17.72 Favored 'Trans proline' 0 CA--C 1.509 -0.769 0 C-N-CA 122.494 2.13 . . . . 0.0 110.705 -178.258 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 13.8 p-10 -102.31 -45.36 5.13 Favored 'General case' 0 CA--C 1.492 -1.251 0 C-N-CA 125.132 1.373 . . . . 0.0 110.342 -168.033 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 73.5 m -110.85 158.16 19.02 Favored 'General case' 0 CA--C 1.493 -1.234 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 -176.219 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 18.7 t-160 -148.63 95.65 3.96 Favored Pre-proline 0 N--CA 1.44 -0.962 0 N-CA-C 107.651 -1.24 . . . . 0.0 107.651 165.575 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 70.2 Cg_endo -74.61 134.18 18.17 Favored 'Trans proline' 0 N--CA 1.446 -1.268 0 C-N-CA 122.903 2.402 . . . . 0.0 109.246 170.264 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 7.5 pt -116.08 168.39 7.77 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.047 0 N-CA-C 107.006 -1.479 . . . . 0.0 107.006 179.762 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 23.2 tt0 -148.9 147.7 28.98 Favored 'General case' 0 N--CA 1.438 -1.072 0 N-CA-C 105.068 -2.197 . . . . 0.0 105.068 172.27 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 39.5 p90 -131.5 160.95 33.7 Favored 'General case' 0 N--CA 1.438 -1.061 0 N-CA-C 107.069 -1.456 . . . . 0.0 107.069 -178.879 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 83.8 m-20 -103.92 -179.62 4.0 Favored 'General case' 0 CA--C 1.488 -1.407 0 N-CA-C 103.721 -2.696 . . . . 0.0 103.721 170.865 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -157.29 173.07 5.34 Favored Pre-proline 0 N--CA 1.44 -0.963 0 N-CA-C 106.696 -1.594 . . . . 0.0 106.696 177.317 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 79.8 Cg_exo -63.99 161.31 33.75 Favored 'Trans proline' 0 N--CA 1.455 -0.74 0 C-N-CA 123.761 2.974 . . . . 0.0 113.082 173.129 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 70.8 tp60 -82.71 -45.03 0.92 Allowed Pre-proline 0 N--CA 1.444 -0.746 0 CA-C-O 115.519 -2.181 . . . . 0.0 111.925 -175.375 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_exo -70.87 -15.51 32.92 Favored 'Trans proline' 0 CA--C 1.509 -0.727 0 CA-C-N 125.897 3.142 . . . . 0.0 113.342 -176.114 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 9.1 t 66.33 73.06 0.38 Allowed 'General case' 0 C--N 1.357 0.925 0 C-N-CA 126.153 1.781 . . . . 0.0 110.54 179.159 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 23.6 t-160 -97.55 -3.49 39.63 Favored 'General case' 0 N--CA 1.444 -0.752 0 C-N-CA 125.002 1.321 . . . . 0.0 107.976 174.311 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 33.5 mt -106.08 136.65 39.69 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.128 0 N-CA-C 104.516 -2.401 . . . . 0.0 104.516 -176.739 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 4.9 p -99.52 -85.01 0.4 Allowed 'General case' 0 N--CA 1.43 -1.442 0 N-CA-C 105.687 -1.968 . . . . 0.0 105.687 176.962 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 54.2 mtmt -89.76 167.39 12.91 Favored 'General case' 0 CA--C 1.488 -1.436 0 C-N-CA 123.423 0.689 . . . . 0.0 109.253 -164.992 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 93.8 m-85 -126.96 133.15 50.66 Favored 'General case' 0 CA--C 1.493 -1.239 0 N-CA-C 103.219 -2.882 . . . . 0.0 103.219 165.75 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.451 HD13 HD13 ' A' ' 76' ' ' ILE . 1.6 mp -107.6 136.26 43.48 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.195 1 N-CA-C 99.078 -4.416 . . . . 0.0 99.078 166.686 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 46.9 tp -119.72 137.08 54.15 Favored 'General case' 0 N--CA 1.397 -3.092 0 N-CA-C 101.36 -3.57 . . . . 0.0 101.36 172.664 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 14.9 ptp180 -133.94 155.3 50.17 Favored 'General case' 0 CA--C 1.488 -1.417 0 N-CA-C 107.072 -1.455 . . . . 0.0 107.072 174.168 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 47.0 p90 -152.67 139.13 18.59 Favored 'General case' 0 N--CA 1.43 -1.465 0 N-CA-C 105.778 -1.934 . . . . 0.0 105.778 -175.889 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 46.1 ttp85 -145.87 145.04 23.67 Favored Pre-proline 0 N--CA 1.442 -0.843 0 N-CA-C 104.871 -2.27 . . . . 0.0 104.871 -177.17 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 63.6 Cg_exo -64.21 122.8 10.89 Favored 'Trans proline' 0 CA--C 1.505 -0.975 0 C-N-CA 123.09 2.527 . . . . 0.0 111.06 174.7 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 49.9 tttp -71.95 75.65 0.91 Allowed 'General case' 0 C--N 1.358 0.956 0 C-N-CA 125.897 1.679 . . . . 0.0 110.449 176.475 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 29.8 m120 -151.35 -74.73 0.15 Allowed 'General case' 0 N--CA 1.435 -1.212 0 N-CA-C 102.407 -3.183 . . . . 0.0 102.407 -172.541 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 39.1 p -97.44 161.08 13.95 Favored 'General case' 0 C--N 1.356 0.88 0 N-CA-C 106.856 -1.535 . . . . 0.0 106.856 172.332 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 3.7 m -115.61 52.76 0.21 Allowed 'Isoleucine or valine' 0 CA--C 1.504 -0.81 0 N-CA-C 106.526 -1.657 . . . . 0.0 106.526 -179.236 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -88.59 -137.31 5.88 Favored Glycine 0 C--N 1.355 1.59 0 N-CA-C 109.722 -1.351 . . . . 0.0 109.722 -179.872 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 96.4 mtt-85 -85.05 155.78 21.38 Favored 'General case' 0 CA--C 1.499 -0.981 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 -177.596 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 49.0 m95 -105.19 159.33 15.95 Favored 'General case' 0 N--CA 1.436 -1.146 0 N-CA-C 107.552 -1.277 . . . . 0.0 107.552 -175.102 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 64.3 mttp -98.76 150.31 21.96 Favored 'General case' 0 CA--C 1.488 -1.416 0 N-CA-C 104.232 -2.507 . . . . 0.0 104.232 161.801 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -153.12 157.91 41.08 Favored 'General case' 0 CA--C 1.494 -1.173 0 CA-C-O 121.787 0.803 . . . . 0.0 108.867 -176.768 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -140.89 165.81 26.49 Favored 'General case' 0 N--CA 1.437 -1.114 0 N-CA-C 106.119 -1.808 . . . . 0.0 106.119 173.505 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 98.9 m -121.6 127.22 50.66 Favored 'General case' 0 CA--C 1.5 -0.952 0 N-CA-C 104.8 -2.296 . . . . 0.0 104.8 175.87 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 5.3 mp -114.97 134.35 22.51 Favored Pre-proline 0 N--CA 1.435 -1.203 0 N-CA-C 104.871 -2.27 . . . . 0.0 104.871 -176.014 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 68.7 Cg_exo -64.67 165.95 19.28 Favored 'Trans proline' 0 CA--C 1.508 -0.811 0 C-N-CA 123.354 2.703 . . . . 0.0 113.391 177.019 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -73.96 -20.57 79.71 Favored Glycine 0 C--N 1.351 1.376 0 C-N-CA 123.906 0.765 . . . . 0.0 114.141 -174.891 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 52.2 p-80 -83.56 -27.06 29.54 Favored 'General case' 0 C--N 1.354 0.793 0 CA-C-N 117.872 0.836 . . . . 0.0 110.243 -178.72 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 85.0 mt -88.65 126.25 35.21 Favored 'General case' 0 CA--C 1.501 -0.938 0 N-CA-C 107.894 -1.15 . . . . 0.0 107.894 177.283 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 7.8 p-10 -108.65 8.18 26.88 Favored 'General case' 0 CA--C 1.503 -0.843 0 C-N-CA 124.391 1.076 . . . . 0.0 110.634 -170.526 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 5.8 p -142.62 168.08 20.57 Favored 'General case' 0 CA--C 1.491 -1.297 0 N-CA-C 108.106 -1.072 . . . . 0.0 108.106 -177.802 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 8.5 t80 -139.6 175.86 9.22 Favored 'General case' 0 N--CA 1.441 -0.908 0 N-CA-C 107.81 -1.181 . . . . 0.0 107.81 174.365 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 99.3 m -140.05 112.2 7.65 Favored 'General case' 0 N--CA 1.435 -1.208 0 N-CA-C 104.924 -2.25 . . . . 0.0 104.924 178.573 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 17.3 mm -90.25 145.27 7.61 Favored 'Isoleucine or valine' 0 C--N 1.356 0.856 0 N-CA-C 105.013 -2.217 . . . . 0.0 105.013 171.261 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -149.83 161.58 41.97 Favored 'General case' 0 N--CA 1.438 -1.057 0 N-CA-C 107.841 -1.17 . . . . 0.0 107.841 167.662 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 85.88 52.3 3.34 Favored Glycine 0 C--N 1.354 1.543 0 N-CA-C 109.303 -1.519 . . . . 0.0 109.303 177.654 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 78.0 mt -115.18 165.62 12.73 Favored 'General case' 0 CA--C 1.5 -0.967 0 N-CA-C 108.142 -1.059 . . . . 0.0 108.142 -179.141 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt -103.58 154.93 37.53 Favored Pre-proline 0 N--CA 1.44 -0.952 0 N-CA-C 107.068 -1.456 . . . . 0.0 107.068 -176.068 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -76.96 152.52 31.91 Favored 'Trans proline' 0 N--CA 1.452 -0.966 0 C-N-CA 122.829 2.353 . . . . 0.0 111.127 -178.515 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 55.17 40.42 74.72 Favored Glycine 0 C--N 1.356 1.686 0 C-N-CA 127.567 2.508 . . . . 0.0 115.636 170.518 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 5.5 p -129.87 138.08 54.99 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.165 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 -177.169 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 3.2 p -91.76 127.59 43.96 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.884 0 C-N-CA 125.119 1.368 . . . . 0.0 107.681 -178.197 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 82.7 m-85 -107.71 153.24 23.23 Favored 'General case' 0 N--CA 1.438 -1.07 0 C-N-CA 125.12 1.368 . . . . 0.0 108.382 178.036 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 21.4 tp10 -97.55 136.51 37.85 Favored 'General case' 0 N--CA 1.434 -1.242 0 N-CA-C 104.027 -2.582 . . . . 0.0 104.027 165.354 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -131.0 144.11 15.58 Favored Glycine 0 CA--C 1.492 -1.36 0 N-CA-C 107.681 -2.168 . . . . 0.0 107.681 174.325 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 84.3 mt-30 -133.67 134.37 43.04 Favored 'General case' 0 CA--C 1.486 -1.485 0 N-CA-C 107.109 -1.441 . . . . 0.0 107.109 174.858 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 66.6 tp -109.97 101.46 10.28 Favored 'General case' 0 CA--C 1.502 -0.874 0 N-CA-C 104.499 -2.408 . . . . 0.0 104.499 178.493 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 32.4 mt -97.78 123.39 50.2 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.868 0 N-CA-C 104.102 -2.555 . . . . 0.0 104.102 -176.612 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 32.8 p -118.24 120.06 36.56 Favored 'General case' 0 CA--C 1.505 -0.769 0 N-CA-C 108.72 -0.844 . . . . 0.0 108.72 -172.25 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.451 HD13 HD13 ' A' ' 34' ' ' ILE . 1.8 mp -93.64 136.24 25.9 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.301 0 N-CA-C 104.581 -2.377 . . . . 0.0 104.581 -170.243 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 84.7 mt-30 -93.68 152.8 18.73 Favored 'General case' 0 CA--C 1.493 -1.224 0 N-CA-C 106.903 -1.517 . . . . 0.0 106.903 176.91 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 9.0 pt20 -69.14 99.56 1.15 Allowed 'General case' 0 N--CA 1.44 -0.926 0 C-N-CA 124.871 1.268 . . . . 0.0 111.458 -176.296 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 69.1 m-85 57.1 39.4 29.11 Favored 'General case' 0 C--N 1.358 0.946 0 C-N-CA 127.248 2.219 . . . . 0.0 112.16 -179.402 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -141.04 -124.32 2.02 Favored Glycine 0 C--N 1.357 1.708 0 N-CA-C 108.497 -1.841 . . . . 0.0 108.497 -177.4 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 59.1 m80 -83.82 -179.75 7.36 Favored 'General case' 0 CA--C 1.499 -1.019 0 C-N-CA 125.193 1.397 . . . . 0.0 110.302 -170.982 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 21.4 tt0 -139.26 119.15 13.31 Favored 'General case' 0 N--CA 1.434 -1.258 0 N-CA-C 104.781 -2.303 . . . . 0.0 104.781 175.993 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 88.0 mt-10 -99.11 154.23 18.28 Favored 'General case' 0 CA--C 1.499 -1.005 0 N-CA-C 107.37 -1.345 . . . . 0.0 107.37 -178.435 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 7.7 p -128.78 134.97 63.39 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.776 0 N-CA-C 107.598 -1.26 . . . . 0.0 107.598 175.082 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 95.2 m -119.84 137.0 54.26 Favored 'General case' 0 CA--C 1.498 -1.044 0 N-CA-C 102.623 -3.103 . . . . 0.0 102.623 175.098 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 83.0 mtm-85 -126.69 150.67 48.89 Favored 'General case' 0 CA--C 1.5 -0.964 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 -178.531 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 32.7 p90 -165.33 178.81 6.61 Favored 'General case' 0 CA--C 1.5 -0.98 0 N-CA-C 107.234 -1.395 . . . . 0.0 107.234 -177.993 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -139.43 157.85 45.14 Favored 'General case' 0 N--CA 1.441 -0.913 0 N-CA-C 106.441 -1.689 . . . . 0.0 106.441 169.472 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 24.0 p90 -144.83 175.59 10.08 Favored 'General case' 0 CA--C 1.488 -1.442 0 N-CA-C 105.271 -2.122 . . . . 0.0 105.271 172.375 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 8.9 t -143.9 154.94 43.86 Favored 'General case' 0 N--CA 1.44 -0.968 0 N-CA-C 105.439 -2.06 . . . . 0.0 105.439 173.631 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 54.8 p -121.95 138.93 54.23 Favored 'General case' 0 CA--C 1.497 -1.086 0 N-CA-C 104.242 -2.503 . . . . 0.0 104.242 177.144 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 12.3 t -165.89 172.9 11.08 Favored 'General case' 0 N--CA 1.44 -0.944 0 N-CA-C 105.134 -2.173 . . . . 0.0 105.134 -175.625 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 10.0 p . . . . . 0 C--O 1.261 1.678 0 N-CA-C 105.144 -2.169 . . . . 0.0 105.144 164.327 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 15.1 t . . . . . 0 N--CA 1.485 1.297 0 CA-C-O 121.381 0.61 . . . . 0.0 110.258 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 90.97 -150.5 20.57 Favored Glycine 0 C--N 1.353 1.518 0 N-CA-C 107.731 -2.148 . . . . 0.0 107.731 179.773 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -61.6 138.6 76.42 Favored 'Trans proline' 0 N--CA 1.441 -1.567 0 C-N-CA 123.115 2.543 . . . . 0.0 112.973 178.993 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 14.5 t -77.62 161.26 4.52 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.882 0 C-N-CA 129.005 2.922 . . . . 0.0 105.732 179.03 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 59.1 mm-40 -110.87 100.43 9.16 Favored 'General case' 0 CA--C 1.49 -1.361 0 N-CA-C 106.564 -1.643 . . . . 0.0 106.564 -179.449 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 1.5 p -120.85 141.17 42.48 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.041 0 N-CA-C 106.191 -1.781 . . . . 0.0 106.191 -169.531 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 30.6 p90 -153.32 172.61 16.77 Favored 'General case' 0 N--CA 1.434 -1.241 0 N-CA-C 107.015 -1.476 . . . . 0.0 107.015 -169.289 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 19.1 tt -146.72 136.28 16.87 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.177 0 N-CA-C 103.512 -2.773 . . . . 0.0 103.512 165.495 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 35.9 m -151.45 139.67 20.28 Favored 'General case' 0 CA--C 1.501 -0.917 0 N-CA-C 104.051 -2.574 . . . . 0.0 104.051 -175.796 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 29.6 tt0 67.65 59.4 0.48 Allowed 'General case' 0 CA--C 1.479 -1.78 0 C-N-CA 125.299 1.44 . . . . 0.0 108.878 162.186 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 66.0 m -85.12 136.47 38.18 Favored Pre-proline 0 N--CA 1.446 -0.657 0 N-CA-C 105.053 -2.202 . . . . 0.0 105.053 173.914 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 76.4 Cg_exo -75.97 45.63 1.55 Allowed 'Trans proline' 0 CA--C 1.519 -0.25 0 C-N-CA 123.342 2.695 . . . . 0.0 113.946 177.081 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 30.0 m 46.75 94.46 0.01 OUTLIER 'General case' 0 CA--C 1.499 -0.981 0 C-N-CA 128.203 2.601 . . . . 0.0 114.192 -174.375 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 82.4 mt-30 -137.59 108.64 8.57 Favored Pre-proline 0 N--CA 1.434 -1.255 0 N-CA-C 104.581 -2.377 . . . . 0.0 104.581 -172.906 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 66.5 Cg_endo -85.92 5.66 5.92 Favored 'Trans proline' 0 N--CA 1.454 -0.831 0 C-N-CA 123.611 2.874 . . . . 0.0 109.45 -177.886 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 5.8 p-10 -116.44 -35.95 4.13 Favored 'General case' 0 CA--C 1.491 -1.321 0 C-N-CA 124.328 1.051 . . . . 0.0 109.344 -172.581 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 30.3 p -130.22 151.95 50.18 Favored 'General case' 0 CA--C 1.499 -1.0 0 CA-C-O 122.151 0.977 . . . . 0.0 110.004 -175.42 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 35.7 m-70 -142.87 98.99 5.62 Favored Pre-proline 0 N--CA 1.438 -1.069 0 N-CA-C 107.145 -1.428 . . . . 0.0 107.145 175.668 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -79.1 114.04 3.3 Favored 'Trans proline' 0 N--CA 1.445 -1.339 0 C-N-CA 123.074 2.516 . . . . 0.0 110.178 175.953 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.53 HD11 HD11 ' A' ' 35' ' ' LEU . 3.9 pt -93.93 166.53 1.77 Allowed 'Isoleucine or valine' 0 CA--C 1.498 -1.05 0 N-CA-C 107.825 -1.176 . . . . 0.0 107.825 -178.251 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 17.6 mp0 -139.69 151.46 45.92 Favored 'General case' 0 CA--C 1.499 -1.002 0 N-CA-C 105.496 -2.038 . . . . 0.0 105.496 174.815 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 42.3 p90 -136.33 156.71 48.25 Favored 'General case' 0 CA--C 1.496 -1.113 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 175.666 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 83.2 m-20 -97.35 -175.71 3.3 Favored 'General case' 0 CA--C 1.486 -1.487 0 N-CA-C 104.31 -2.478 . . . . 0.0 104.31 171.29 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -157.59 173.79 4.65 Favored Pre-proline 0 N--CA 1.44 -0.93 0 N-CA-C 106.828 -1.545 . . . . 0.0 106.828 176.458 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_exo -63.96 162.52 28.78 Favored 'Trans proline' 0 CA--C 1.51 -0.724 0 C-N-CA 123.678 2.919 . . . . 0.0 112.209 169.169 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 1.2 tm0? -81.26 -60.09 0.43 Allowed Pre-proline 0 C--N 1.353 0.744 0 CA-C-O 115.705 -2.093 . . . . 0.0 110.671 -174.193 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_endo -75.42 174.43 12.81 Favored 'Trans proline' 0 CA--C 1.511 -0.645 0 CA-C-N 125.688 3.067 . . . . 0.0 110.161 -179.694 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 52.2 p -72.58 126.26 29.44 Favored 'General case' 0 C--N 1.357 0.919 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 177.787 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 3.2 t60 -160.9 -51.66 0.05 OUTLIER 'General case' 0 CA--C 1.493 -1.229 0 N-CA-C 106.566 -1.642 . . . . 0.0 106.566 -166.646 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 35.1 mt -111.81 132.64 59.87 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.1 0 N-CA-C 105.487 -2.042 . . . . 0.0 105.487 -174.154 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 30.0 t -102.77 -84.79 0.45 Allowed 'General case' 0 N--CA 1.431 -1.41 0 N-CA-C 107.586 -1.264 . . . . 0.0 107.586 -178.146 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 23.1 ttmm -91.42 149.51 21.68 Favored 'General case' 0 CA--C 1.493 -1.244 0 N-CA-C 106.829 -1.545 . . . . 0.0 106.829 -161.278 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 97.4 m-85 -117.49 128.84 55.38 Favored 'General case' 0 CA--C 1.496 -1.129 0 N-CA-C 104.725 -2.324 . . . . 0.0 104.725 168.785 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 60.9 mt -106.48 117.44 52.27 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.075 0 N-CA-C 102.188 -3.264 . . . . 0.0 102.188 169.604 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.53 HD11 HD11 ' A' ' 20' ' ' ILE . 0.9 OUTLIER -95.33 125.35 39.89 Favored 'General case' 0 CA--C 1.48 -1.745 0 N-CA-C 106.972 -1.492 . . . . 0.0 106.972 176.813 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 97.0 mtt180 -120.74 147.12 45.74 Favored 'General case' 0 CA--C 1.49 -1.333 0 N-CA-C 105.972 -1.862 . . . . 0.0 105.972 171.75 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 40.3 p90 -151.99 173.55 14.72 Favored 'General case' 0 CA--C 1.487 -1.479 0 N-CA-C 106.199 -1.778 . . . . 0.0 106.199 169.982 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 36.0 ptt180 -170.96 158.83 5.38 Favored Pre-proline 0 CA--C 1.499 -1.009 0 N-CA-C 106.284 -1.747 . . . . 0.0 106.284 177.004 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -74.51 140.86 27.44 Favored 'Trans proline' 0 N--CA 1.448 -1.181 0 C-N-CA 122.065 1.843 . . . . 0.0 107.839 168.062 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 57.7 tttp -71.18 78.42 0.7 Allowed 'General case' 0 C--N 1.355 0.806 0 C-N-CA 125.344 1.458 . . . . 0.0 110.784 179.947 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 20.9 m120 -161.11 -46.73 0.04 OUTLIER 'General case' 0 N--CA 1.438 -1.044 0 N-CA-C 104.966 -2.235 . . . . 0.0 104.966 -170.668 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 27.8 m -77.68 161.01 28.09 Favored 'General case' 0 C--N 1.359 0.995 0 C-N-CA 124.19 0.996 . . . . 0.0 110.503 -170.926 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 20.2 m -102.01 -26.93 3.4 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.879 0 C-N-CA 124.83 1.252 . . . . 0.0 109.887 -170.608 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -173.17 27.17 0.09 OUTLIER Glycine 0 CA--C 1.493 -1.339 0 N-CA-C 110.569 -1.012 . . . . 0.0 110.569 179.853 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 54.7 ttp180 -98.62 122.29 41.65 Favored 'General case' 0 CA--C 1.495 -1.15 0 N-CA-C 105.026 -2.213 . . . . 0.0 105.026 172.669 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 83.8 m95 -128.6 138.74 52.36 Favored 'General case' 0 CA--C 1.496 -1.123 0 N-CA-C 106.732 -1.581 . . . . 0.0 106.732 179.665 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 60.9 mttp -96.11 104.47 16.42 Favored 'General case' 0 CA--C 1.491 -1.307 0 N-CA-C 104.332 -2.47 . . . . 0.0 104.332 169.192 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 16.1 pt-20 -107.49 150.96 26.2 Favored 'General case' 0 CA--C 1.498 -1.055 0 CA-C-N 115.033 -0.985 . . . . 0.0 109.532 -176.475 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -136.74 154.51 50.56 Favored 'General case' 0 N--CA 1.438 -1.055 0 N-CA-C 105.917 -1.883 . . . . 0.0 105.917 178.089 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 92.4 m -121.71 125.1 45.82 Favored 'General case' 0 CA--C 1.501 -0.91 0 N-CA-C 104.292 -2.485 . . . . 0.0 104.292 178.317 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 63.6 mt -128.86 137.39 30.87 Favored Pre-proline 0 N--CA 1.44 -0.961 0 N-CA-C 105.154 -2.165 . . . . 0.0 105.154 -166.29 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -74.56 171.13 18.76 Favored 'Trans proline' 0 CA--C 1.508 -0.8 0 C-N-CA 123.44 2.76 . . . . 0.0 110.876 178.555 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -77.95 -11.96 84.88 Favored Glycine 0 C--N 1.352 1.463 0 C-N-CA 123.808 0.718 . . . . 0.0 114.117 -178.742 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 9.2 p-80 -83.01 -25.37 32.27 Favored 'General case' 0 C--N 1.357 0.931 0 CA-C-N 118.321 1.061 . . . . 0.0 110.236 -178.937 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 87.2 mt -89.09 128.26 35.74 Favored 'General case' 0 CA--C 1.501 -0.929 0 N-CA-C 107.316 -1.364 . . . . 0.0 107.316 173.412 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 8.4 p30 -112.91 1.05 15.32 Favored 'General case' 0 N--CA 1.443 -0.8 0 C-N-CA 124.762 1.225 . . . . 0.0 109.814 -173.146 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 25.7 p -145.71 160.18 42.09 Favored 'General case' 0 CA--C 1.498 -1.025 0 N-CA-C 106.331 -1.729 . . . . 0.0 106.331 -177.33 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 5.1 t80 -131.89 177.89 7.19 Favored 'General case' 0 C--N 1.358 0.942 0 CA-C-O 121.684 0.754 . . . . 0.0 109.366 178.808 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 97.7 m -133.72 105.78 7.01 Favored 'General case' 0 N--CA 1.431 -1.393 0 N-CA-C 103.302 -2.851 . . . . 0.0 103.302 171.613 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 59.5 mt -86.83 140.22 16.14 Favored 'Isoleucine or valine' 0 C--N 1.359 0.993 0 N-CA-C 103.938 -2.615 . . . . 0.0 103.938 171.326 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -147.26 160.46 42.47 Favored 'General case' 0 N--CA 1.438 -1.071 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 -176.866 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 84.42 52.6 3.51 Favored Glycine 0 C--N 1.354 1.565 0 N-CA-C 109.208 -1.557 . . . . 0.0 109.208 178.672 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 47.9 mt -114.9 168.59 9.77 Favored 'General case' 0 CA--C 1.501 -0.924 0 N-CA-C 107.591 -1.263 . . . . 0.0 107.591 -173.631 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -119.67 150.48 50.32 Favored Pre-proline 0 N--CA 1.442 -0.872 0 N-CA-C 106.775 -1.565 . . . . 0.0 106.775 -173.624 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -77.18 165.7 27.54 Favored 'Trans proline' 0 N--CA 1.454 -0.827 0 C-N-CA 123.129 2.552 . . . . 0.0 110.806 175.263 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 0.609 ' H ' ' HA ' ' A' ' 92' ' ' THR . . . 64.18 19.18 63.65 Favored Glycine 0 N--CA 1.429 -1.828 0 C-N-CA 128.209 2.814 . . . . 0.0 116.575 173.212 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 9.9 p -134.21 145.9 32.22 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.108 0 CA-C-N 118.636 1.218 . . . . 0.0 108.073 -174.713 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 7.3 p -90.33 128.2 42.38 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.959 0 N-CA-C 106.97 -1.492 . . . . 0.0 106.97 177.523 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 49.0 m-85 -101.0 137.33 39.51 Favored 'General case' 0 CA--C 1.493 -1.233 0 N-CA-C 105.575 -2.009 . . . . 0.0 105.575 174.3 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 18.9 pt-20 -112.35 158.63 19.55 Favored 'General case' 0 N--CA 1.437 -1.096 0 N-CA-C 105.956 -1.868 . . . . 0.0 105.956 173.044 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -169.57 -172.38 36.12 Favored Glycine 0 N--CA 1.415 -2.726 0 C-N-CA 120.578 -0.82 . . . . 0.0 114.879 175.447 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 32.0 mt-30 -148.24 139.88 23.71 Favored 'General case' 0 CA--C 1.486 -1.518 0 N-CA-C 105.997 -1.853 . . . . 0.0 105.997 -166.878 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 59.5 tp -116.47 96.41 5.51 Favored 'General case' 0 CA--C 1.499 -0.997 0 N-CA-C 104.015 -2.587 . . . . 0.0 104.015 174.958 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 27.3 mt -88.49 134.79 27.27 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.919 0 N-CA-C 104.05 -2.574 . . . . 0.0 104.05 -178.313 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 25.2 p -129.5 104.62 7.57 Favored 'General case' 0 N--CA 1.438 -1.066 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 -169.326 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 3.7 mp -93.51 136.42 25.31 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.312 0 N-CA-C 104.062 -2.57 . . . . 0.0 104.062 -167.07 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 80.5 mt-30 -88.24 177.29 6.92 Favored 'General case' 0 CA--C 1.496 -1.132 0 C-N-CA 123.712 0.805 . . . . 0.0 108.968 -171.304 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 35.3 mt-30 -71.52 96.04 1.47 Allowed 'General case' 0 CA--C 1.501 -0.921 0 C-N-CA 124.597 1.159 . . . . 0.0 109.459 176.46 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . 0.301 41.3 p90 47.65 33.0 2.76 Favored 'General case' 0 C--N 1.36 1.035 0 C-N-CA 128.126 2.57 . . . . 0.0 114.438 -174.815 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -125.29 -125.89 2.95 Favored Glycine 0 C--N 1.358 1.78 0 N-CA-C 109.456 -1.458 . . . . 0.0 109.456 -174.119 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 52.3 m80 -84.1 -178.02 6.83 Favored 'General case' 0 CA--C 1.498 -1.027 0 C-N-CA 125.614 1.566 . . . . 0.0 111.044 -167.818 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 35.7 mt-30 -125.29 146.25 49.64 Favored 'General case' 0 CA--C 1.494 -1.188 0 N-CA-C 103.459 -2.793 . . . . 0.0 103.459 167.806 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 54.6 mt-10 -138.14 121.48 17.06 Favored 'General case' 0 CA--C 1.492 -1.281 0 N-CA-C 105.372 -2.084 . . . . 0.0 105.372 -177.114 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 7.5 p -99.4 134.97 36.62 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.79 0 N-CA-C 108.151 -1.055 . . . . 0.0 108.151 -172.624 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 26.7 m -115.2 158.96 21.53 Favored 'General case' 0 N--CA 1.443 -0.802 0 N-CA-C 103.81 -2.663 . . . . 0.0 103.81 175.915 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 38.8 ptt180 -126.32 154.71 43.1 Favored 'General case' 0 CA--C 1.501 -0.915 0 CA-C-O 121.32 0.581 . . . . 0.0 109.8 178.126 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 29.4 p90 -157.45 165.43 35.69 Favored 'General case' 0 CA--C 1.502 -0.866 0 N-CA-C 107.274 -1.38 . . . . 0.0 107.274 173.486 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -145.57 156.82 43.93 Favored 'General case' 0 N--CA 1.441 -0.885 0 N-CA-C 106.314 -1.736 . . . . 0.0 106.314 159.997 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 27.4 p90 -146.37 168.23 21.62 Favored 'General case' 0 CA--C 1.492 -1.254 0 N-CA-C 106.404 -1.702 . . . . 0.0 106.404 171.046 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 26.6 p -110.86 140.36 45.39 Favored 'General case' 0 CA--C 1.5 -0.944 0 N-CA-C 106.957 -1.497 . . . . 0.0 106.957 178.668 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 89.7 m -116.45 109.14 16.91 Favored 'General case' 0 CA--C 1.489 -1.394 0 N-CA-C 102.106 -3.294 . . . . 0.0 102.106 174.037 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 92' ' ' THR . . . . . 0.609 ' HA ' ' H ' ' A' ' 66' ' ' GLY . 86.9 m -147.28 -55.69 0.24 Allowed 'General case' 0 CA--C 1.498 -1.034 0 N-CA-C 106.645 -1.613 . . . . 0.0 106.645 -171.686 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 8.9 t . . . . . 0 C--O 1.26 1.653 0 CA-C-O 118.078 -0.963 . . . . 0.0 110.049 -165.25 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 88.8 p . . . . . 0 N--CA 1.489 1.489 0 CA-C-O 121.348 0.594 . . . . 0.0 111.823 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 83.76 -149.25 25.46 Favored Glycine 0 C--N 1.355 1.635 0 N-CA-C 109.104 -1.598 . . . . 0.0 109.104 176.882 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_exo -61.55 136.12 61.15 Favored 'Trans proline' 0 N--CA 1.443 -1.472 0 C-N-CA 123.088 2.526 . . . . 0.0 113.624 -178.357 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 24.6 t -84.59 161.92 3.08 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.048 0 C-N-CA 129.202 3.001 . . . . 0.0 106.424 -178.196 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -108.38 108.9 20.06 Favored 'General case' 0 CA--C 1.496 -1.107 0 N-CA-C 105.876 -1.898 . . . . 0.0 105.876 175.927 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 1.5 p -129.3 142.04 45.01 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.894 0 N-CA-C 105.687 -1.968 . . . . 0.0 105.687 -170.101 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 33.1 p90 -155.51 171.04 20.58 Favored 'General case' 0 N--CA 1.438 -1.026 0 CA-C-O 121.876 0.846 . . . . 0.0 109.302 -162.184 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 14.5 tt -134.76 134.7 53.82 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.973 0 N-CA-C 102.014 -3.328 . . . . 0.0 102.014 162.742 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 93.6 m -146.62 128.39 15.29 Favored 'General case' 0 CA--C 1.504 -0.813 0 N-CA-C 106.702 -1.592 . . . . 0.0 106.702 -173.598 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 19.4 tt0 61.71 42.2 11.08 Favored 'General case' 0 C--N 1.358 0.974 0 C-N-CA 127.305 2.242 . . . . 0.0 113.202 165.936 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 99.7 m -87.6 122.9 70.24 Favored Pre-proline 0 N--CA 1.445 -0.694 0 N-CA-C 107.215 -1.402 . . . . 0.0 107.215 177.589 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 98.4 Cg_endo -85.06 80.27 2.15 Favored 'Trans proline' 0 N--CA 1.456 -0.717 0 C-N-CA 123.195 2.597 . . . . 0.0 110.947 -174.915 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . 0.264 80.7 p 51.1 99.38 0.01 OUTLIER 'General case' 0 C--N 1.357 0.913 0 C-N-CA 127.883 2.473 . . . . 0.0 115.547 174.007 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 99.6 mm-40 -129.56 102.81 17.99 Favored Pre-proline 0 N--CA 1.442 -0.831 0 N-CA-C 106.18 -1.785 . . . . 0.0 106.18 178.528 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_exo -74.66 -21.31 16.83 Favored 'Trans proline' 0 CA--C 1.506 -0.882 0 C-N-CA 123.2 2.6 . . . . 0.0 111.291 178.017 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 12.0 p-10 -102.46 -42.44 5.97 Favored 'General case' 0 CA--C 1.489 -1.368 0 C-N-CA 124.215 1.006 . . . . 0.0 111.029 -165.188 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 56.6 p -110.48 156.0 21.46 Favored 'General case' 0 CA--C 1.497 -1.06 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 -175.634 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 52.8 t-80 -131.57 98.72 17.8 Favored Pre-proline 0 N--CA 1.439 -0.989 0 N-CA-C 106.128 -1.804 . . . . 0.0 106.128 172.493 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -80.13 128.99 7.58 Favored 'Trans proline' 0 N--CA 1.451 -0.972 0 C-N-CA 123.26 2.64 . . . . 0.0 109.836 177.231 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 3.7 mp -111.9 149.04 14.67 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.183 0 N-CA-C 104.881 -2.266 . . . . 0.0 104.881 -179.62 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 31.2 mt-30 -138.7 152.94 48.44 Favored 'General case' 0 CA--C 1.497 -1.092 0 N-CA-C 104.578 -2.378 . . . . 0.0 104.578 164.57 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 37.2 p90 -136.02 158.5 44.26 Favored 'General case' 0 CA--C 1.501 -0.916 0 N-CA-C 107.065 -1.457 . . . . 0.0 107.065 -178.595 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 28.1 m120 -96.4 -176.92 3.78 Favored 'General case' 0 CA--C 1.488 -1.407 0 N-CA-C 103.934 -2.617 . . . . 0.0 103.934 169.045 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -157.35 171.85 6.91 Favored Pre-proline 0 N--CA 1.44 -0.933 0 N-CA-C 106.579 -1.637 . . . . 0.0 106.579 173.188 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 68.5 Cg_exo -63.74 154.46 69.28 Favored 'Trans proline' 0 CA--C 1.508 -0.814 0 C-N-CA 123.51 2.807 . . . . 0.0 112.842 174.59 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 24.0 tt0 -82.43 -41.93 0.94 Allowed Pre-proline 0 N--CA 1.443 -0.798 0 CA-C-O 115.697 -2.097 . . . . 0.0 112.031 -175.134 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_exo -71.71 -3.74 13.71 Favored 'Trans proline' 0 CA--C 1.514 -0.521 0 CA-C-N 125.574 3.026 . . . . 0.0 113.851 -179.867 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 10.3 t 71.0 75.93 0.19 Allowed 'General case' 0 C--N 1.357 0.903 0 C-N-CA 126.381 1.873 . . . . 0.0 108.812 -176.71 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 57.8 t-80 -90.95 -20.18 22.46 Favored 'General case' 0 N--CA 1.439 -0.977 0 C-N-CA 125.27 1.428 . . . . 0.0 108.455 179.969 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 22.9 mt -125.38 147.47 30.07 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.105 0 N-CA-C 105.396 -2.075 . . . . 0.0 105.396 -168.578 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 9.2 p -107.29 -84.13 0.53 Allowed 'General case' 0 N--CA 1.432 -1.328 0 N-CA-C 106.879 -1.526 . . . . 0.0 106.879 174.554 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 51.7 mtmt -89.2 167.57 12.98 Favored 'General case' 0 CA--C 1.486 -1.493 0 C-N-CA 124.683 1.193 . . . . 0.0 108.782 -165.274 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 90.4 m-85 -132.31 138.24 47.74 Favored 'General case' 0 CA--C 1.495 -1.142 0 N-CA-C 105.329 -2.1 . . . . 0.0 105.329 176.033 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 51.8 mt -118.42 131.55 70.85 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.111 0 N-CA-C 101.074 -3.676 . . . . 0.0 101.074 170.652 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 6.8 mt -111.01 128.13 55.75 Favored 'General case' 0 CA--C 1.477 -1.854 0 N-CA-C 104.739 -2.319 . . . . 0.0 104.739 170.104 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 3.2 mmm180 -107.51 160.11 15.91 Favored 'General case' 0 N--CA 1.432 -1.348 0 N-CA-C 104.737 -2.32 . . . . 0.0 104.737 171.077 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 48.5 p90 -159.18 152.82 22.89 Favored 'General case' 0 N--CA 1.437 -1.085 0 N-CA-C 107.801 -1.185 . . . . 0.0 107.801 171.093 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 13.1 ptp180 -154.61 158.05 32.2 Favored Pre-proline 0 CA--C 1.501 -0.932 0 N-CA-C 105.661 -1.978 . . . . 0.0 105.661 163.946 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' PRO . . . . . 0.433 ' HA ' ' HA ' ' A' ' 69' ' ' TYR . 37.9 Cg_endo -72.52 129.01 14.16 Favored 'Trans proline' 0 N--CA 1.451 -0.977 0 C-N-CA 122.637 2.225 . . . . 0.0 107.752 170.191 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 48.2 tttp -67.6 81.82 0.17 Allowed 'General case' 0 C--N 1.357 0.912 0 C-N-CA 127.781 2.433 . . . . 0.0 111.473 -170.761 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 4.7 t-20 -162.17 -51.05 0.04 OUTLIER 'General case' 0 N--CA 1.432 -1.335 0 N-CA-C 105.562 -2.014 . . . . 0.0 105.562 -173.607 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 37.9 p -80.63 155.7 26.72 Favored 'General case' 0 N--CA 1.438 -1.059 0 C-N-CA 124.567 1.147 . . . . 0.0 109.685 -176.891 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 17.3 m -130.44 10.67 2.14 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.811 0 C-N-CA 125.061 1.344 . . . . 0.0 107.888 -177.427 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -94.27 -113.18 2.45 Favored Glycine 0 C--N 1.356 1.694 0 N-CA-C 109.489 -1.444 . . . . 0.0 109.489 -174.534 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 85.6 mtm180 -92.66 175.95 6.63 Favored 'General case' 0 CA--C 1.503 -0.863 0 N-CA-C 108.191 -1.04 . . . . 0.0 108.191 -178.538 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -155.41 -178.41 7.25 Favored 'General case' 0 CA--C 1.495 -1.171 0 CA-C-O 121.221 0.534 . . . . 0.0 109.839 178.565 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 96.0 mttt -109.21 156.55 19.76 Favored 'General case' 0 CA--C 1.489 -1.396 0 N-CA-C 106.451 -1.685 . . . . 0.0 106.451 -176.724 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 1.1 pp20? -152.08 163.12 39.99 Favored 'General case' 0 N--CA 1.432 -1.363 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 176.252 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -139.97 160.79 39.14 Favored 'General case' 0 CA--C 1.495 -1.136 0 N-CA-C 105.663 -1.977 . . . . 0.0 105.663 169.596 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 77.6 m -120.62 125.96 49.07 Favored 'General case' 0 CA--C 1.499 -1.014 0 N-CA-C 104.732 -2.322 . . . . 0.0 104.732 176.446 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 4.9 mp -114.04 134.41 22.17 Favored Pre-proline 0 N--CA 1.435 -1.186 0 N-CA-C 104.84 -2.281 . . . . 0.0 104.84 -175.545 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 67.5 Cg_exo -63.89 167.6 13.62 Favored 'Trans proline' 0 CA--C 1.509 -0.761 0 C-N-CA 123.595 2.863 . . . . 0.0 113.406 177.227 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -77.75 -19.02 76.43 Favored Glycine 0 C--N 1.352 1.439 0 C-N-CA 123.583 0.611 . . . . 0.0 113.425 -173.488 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 50.9 p-80 -84.08 -27.88 27.95 Favored 'General case' 0 C--N 1.357 0.906 0 CA-C-N 117.757 0.779 . . . . 0.0 110.172 -179.471 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 86.4 mt -88.56 128.97 35.58 Favored 'General case' 0 CA--C 1.5 -0.943 0 N-CA-C 107.881 -1.155 . . . . 0.0 107.881 177.653 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 8.7 p30 -110.98 8.33 21.96 Favored 'General case' 0 CA--C 1.5 -0.946 0 C-N-CA 124.498 1.119 . . . . 0.0 110.543 -171.806 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 46.6 p -142.03 160.16 40.77 Favored 'General case' 0 N--CA 1.439 -0.988 0 N-CA-C 108.107 -1.071 . . . . 0.0 108.107 -175.713 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 12.3 t80 -143.63 176.72 9.0 Favored 'General case' 0 C--N 1.355 0.822 0 N-CA-C 107.328 -1.36 . . . . 0.0 107.328 176.953 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 97.6 m -147.06 116.96 7.2 Favored 'General case' 0 N--CA 1.429 -1.509 0 N-CA-C 104.851 -2.277 . . . . 0.0 104.851 176.101 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 79.7 mt -91.24 147.06 5.5 Favored 'Isoleucine or valine' 0 C--N 1.355 0.804 0 N-CA-C 103.555 -2.757 . . . . 0.0 103.555 169.364 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 67.6 mttm -140.38 166.37 24.89 Favored 'General case' 0 CA--C 1.5 -0.954 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 178.149 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 83.16 49.39 5.01 Favored Glycine 0 C--N 1.354 1.577 0 N-CA-C 109.211 -1.556 . . . . 0.0 109.211 174.787 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 63.9 mt -118.78 169.4 9.88 Favored 'General case' 0 CA--C 1.498 -1.023 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 -170.576 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -116.76 144.74 33.95 Favored Pre-proline 0 N--CA 1.439 -1.008 0 N-CA-C 105.679 -1.971 . . . . 0.0 105.679 -173.764 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -77.33 161.75 31.59 Favored 'Trans proline' 0 N--CA 1.452 -0.934 0 C-N-CA 122.788 2.325 . . . . 0.0 110.996 174.466 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 0.584 ' H ' ' HA ' ' A' ' 92' ' ' THR . . . 62.54 26.66 68.54 Favored Glycine 0 N--CA 1.428 -1.856 0 C-N-CA 127.617 2.532 . . . . 0.0 115.765 174.225 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 9.8 p -126.65 145.59 33.95 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.928 0 N-CA-C 107.596 -1.261 . . . . 0.0 107.596 179.408 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 4.2 p -92.61 135.75 26.7 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.824 0 N-CA-C 107.214 -1.402 . . . . 0.0 107.214 179.945 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 69' ' ' TYR . . . . . 0.433 ' HA ' ' HA ' ' A' ' 39' ' ' PRO . 91.1 m-85 -116.79 149.27 40.23 Favored 'General case' 0 CA--C 1.494 -1.193 0 N-CA-C 105.607 -1.997 . . . . 0.0 105.607 175.278 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -96.7 139.93 32.04 Favored 'General case' 0 CA--C 1.499 -1.009 0 N-CA-C 104.367 -2.457 . . . . 0.0 104.367 162.773 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -132.66 154.14 20.97 Favored Glycine 0 CA--C 1.483 -1.925 0 N-CA-C 106.951 -2.46 . . . . 0.0 106.951 179.849 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 29.2 tt0 -146.94 135.61 22.09 Favored 'General case' 0 CA--C 1.483 -1.627 0 N-CA-C 106.949 -1.5 . . . . 0.0 106.949 -178.625 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 21.8 tp -115.79 100.55 8.09 Favored 'General case' 0 N--CA 1.438 -1.074 0 N-CA-C 104.45 -2.426 . . . . 0.0 104.45 -177.355 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 21.2 mt -93.16 126.61 45.57 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.917 0 N-CA-C 104.032 -2.581 . . . . 0.0 104.032 177.572 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 74.2 m -117.98 111.32 18.8 Favored 'General case' 0 N--CA 1.436 -1.173 0 N-CA-C 107.746 -1.205 . . . . 0.0 107.746 -170.413 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 31.0 mm -91.22 144.01 10.05 Favored 'Isoleucine or valine' 0 CA--C 1.49 -1.365 0 N-CA-C 106.519 -1.66 . . . . 0.0 106.519 -165.799 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 17.1 tt0 -110.81 107.18 16.6 Favored 'General case' 0 CA--C 1.495 -1.135 0 N-CA-C 103.036 -2.95 . . . . 0.0 103.036 171.452 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 19.7 pt20 -67.25 138.46 56.91 Favored 'General case' 0 C--N 1.356 0.866 0 CA-C-O 121.232 0.539 . . . . 0.0 111.68 -167.148 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 55.0 m-85 68.05 32.15 5.14 Favored 'General case' 0 C--N 1.355 0.821 0 C-N-CA 126.695 1.998 . . . . 0.0 111.764 -176.1 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -174.97 -112.86 0.31 Allowed Glycine 0 C--N 1.355 1.613 0 C-N-CA 119.349 -1.405 . . . . 0.0 109.749 176.922 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 66.4 m80 -83.43 -178.73 7.15 Favored 'General case' 0 CA--C 1.5 -0.954 0 C-N-CA 125.242 1.417 . . . . 0.0 111.269 -164.595 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 5.9 pt20 -154.51 148.77 26.0 Favored 'General case' 0 N--CA 1.435 -1.216 0 N-CA-C 106.621 -1.622 . . . . 0.0 106.621 166.506 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 8.4 mp0 -109.81 155.93 21.0 Favored 'General case' 0 N--CA 1.437 -1.085 0 N-CA-C 104.869 -2.271 . . . . 0.0 104.869 -178.116 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 12.4 p -131.45 139.17 51.4 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.838 0 N-CA-C 107.772 -1.196 . . . . 0.0 107.772 -179.739 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 41.8 m -133.28 122.69 24.25 Favored 'General case' 0 N--CA 1.438 -1.074 0 N-CA-C 103.261 -2.866 . . . . 0.0 103.261 -178.669 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 52.8 ttt85 -119.75 144.15 47.42 Favored 'General case' 0 CA--C 1.504 -0.794 0 N-CA-C 108.174 -1.047 . . . . 0.0 108.174 -176.011 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 29.0 p90 -155.06 -179.59 8.21 Favored 'General case' 0 CA--C 1.499 -0.981 0 N-CA-C 107.547 -1.279 . . . . 0.0 107.547 -177.182 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -138.82 156.31 47.44 Favored 'General case' 0 N--CA 1.44 -0.961 0 N-CA-C 105.811 -1.922 . . . . 0.0 105.811 167.169 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 22.2 p90 -142.61 171.79 13.57 Favored 'General case' 0 CA--C 1.487 -1.477 0 N-CA-C 106.83 -1.544 . . . . 0.0 106.83 175.001 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 25.5 p -120.37 143.88 48.19 Favored 'General case' 0 CA--C 1.499 -0.993 0 N-CA-C 105.526 -2.027 . . . . 0.0 105.526 169.364 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 57.3 m -109.05 126.06 52.76 Favored 'General case' 0 CA--C 1.493 -1.244 0 N-CA-C 101.36 -3.57 . . . . 0.0 101.36 164.764 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 92' ' ' THR . . . . . 0.584 ' HA ' ' H ' ' A' ' 66' ' ' GLY . 12.4 t -146.01 172.46 13.35 Favored 'General case' 0 N--CA 1.435 -1.177 0 N-CA-C 105.264 -2.125 . . . . 0.0 105.264 -173.751 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 69.5 m . . . . . 0 C--O 1.26 1.629 0 N-CA-C 106.8 -1.556 . . . . 0.0 106.8 173.197 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 23.3 t . . . . . 0 N--CA 1.483 1.211 0 N-CA-C 109.581 -0.526 . . . . 0.0 109.581 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 166.66 176.83 38.07 Favored Glycine 0 N--CA 1.437 -1.285 0 N-CA-C 106.705 -2.558 . . . . 0.0 106.705 178.375 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 8.9 Cg_exo -55.42 148.57 51.36 Favored 'Trans proline' 0 N--CA 1.45 -1.078 0 C-N-CA 124.11 3.207 . . . . 0.0 116.463 -161.995 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 17.5 t -76.88 156.21 5.54 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.806 0 C-N-CA 128.29 2.636 . . . . 0.0 105.036 175.021 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 55.2 mt-10 -107.15 105.81 15.98 Favored 'General case' 0 CA--C 1.494 -1.18 0 N-CA-C 106.512 -1.662 . . . . 0.0 106.512 -176.478 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 1.7 p -127.49 141.83 45.26 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.981 0 N-CA-C 106.172 -1.788 . . . . 0.0 106.172 -169.808 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 21.2 p90 -156.67 170.79 21.61 Favored 'General case' 0 N--CA 1.436 -1.13 0 N-CA-C 106.95 -1.5 . . . . 0.0 106.95 -162.589 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.463 HG21 ' CE1' ' A' ' 18' ' ' HIS . 0.0 OUTLIER -129.21 120.04 50.36 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.661 0 N-CA-C 103.772 -2.677 . . . . 0.0 103.772 165.461 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 84.9 m -122.87 -21.89 5.43 Favored 'General case' 0 N--CA 1.443 -0.802 0 N-CA-C 106.663 -1.606 . . . . 0.0 106.663 176.912 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -104.38 7.3 35.59 Favored 'General case' 0 N--CA 1.438 -1.066 0 C-N-CA 125.08 1.352 . . . . 0.0 110.23 -168.026 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 30.6 m -108.87 100.35 39.2 Favored Pre-proline 0 C--N 1.36 1.027 0 N-CA-C 107.188 -1.412 . . . . 0.0 107.188 178.107 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -76.53 -80.26 0.01 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.884 0 C-N-CA 123.021 2.481 . . . . 0.0 109.727 170.186 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 10.7 p -140.02 108.23 5.79 Favored 'General case' 0 N--CA 1.433 -1.287 0 N-CA-C 104.617 -2.364 . . . . 0.0 104.617 -179.748 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 73.2 mt-30 -143.79 110.59 5.23 Favored Pre-proline 0 N--CA 1.438 -1.05 0 N-CA-C 104.166 -2.531 . . . . 0.0 104.166 -179.597 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -85.43 -19.1 3.72 Favored 'Trans proline' 0 CA--C 1.504 -0.987 0 C-N-CA 122.722 2.281 . . . . 0.0 111.267 -167.425 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 4.1 t30 -117.73 -33.67 4.45 Favored 'General case' 0 CA--C 1.487 -1.459 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 -170.849 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 67.8 m -103.63 152.12 22.14 Favored 'General case' 0 CA--C 1.495 -1.163 0 N-CA-C 107.092 -1.448 . . . . 0.0 107.092 178.854 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' HIS . . . . . 0.463 ' CE1' HG21 ' A' ' 8' ' ' ILE . 82.7 t60 -144.61 84.17 9.27 Favored Pre-proline 0 N--CA 1.437 -1.123 0 N-CA-C 106.559 -1.645 . . . . 0.0 106.559 174.651 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -81.75 123.19 4.13 Favored 'Trans proline' 0 N--CA 1.446 -1.294 0 C-N-CA 123.286 2.657 . . . . 0.0 109.765 179.882 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.577 HD11 HD11 ' A' ' 35' ' ' LEU . 3.4 pt -109.81 170.86 2.96 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.069 0 N-CA-C 108.466 -0.939 . . . . 0.0 108.466 -174.962 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 33.6 tt0 -145.92 148.03 32.38 Favored 'General case' 0 N--CA 1.437 -1.076 0 N-CA-C 105.459 -2.052 . . . . 0.0 105.459 172.247 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 19.6 p90 -130.75 158.04 41.18 Favored 'General case' 0 CA--C 1.499 -1.001 0 N-CA-C 106.27 -1.752 . . . . 0.0 106.27 179.491 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 89.6 m-20 -95.47 -179.46 4.77 Favored 'General case' 0 CA--C 1.488 -1.433 0 N-CA-C 103.647 -2.723 . . . . 0.0 103.647 168.89 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -160.08 165.37 17.9 Favored Pre-proline 0 N--CA 1.439 -0.982 0 N-CA-C 104.966 -2.235 . . . . 0.0 104.966 176.851 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -74.63 154.86 44.68 Favored 'Trans proline' 0 N--CA 1.453 -0.874 0 C-N-CA 122.546 2.164 . . . . 0.0 109.711 179.244 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 11.8 tp-100 -82.85 -43.41 0.9 Allowed Pre-proline 0 N--CA 1.443 -0.799 0 CA-C-O 115.924 -1.989 . . . . 0.0 111.219 -174.777 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 70.5 Cg_exo -67.89 167.94 20.09 Favored 'Trans proline' 0 CA--C 1.508 -0.778 0 CA-C-N 125.347 2.945 . . . . 0.0 111.976 174.213 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 34.8 p -72.94 123.18 22.94 Favored 'General case' 0 C--N 1.355 0.836 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 178.949 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 1.4 t60 -159.58 -51.54 0.06 Allowed 'General case' 0 CA--C 1.493 -1.248 0 N-CA-C 106.729 -1.582 . . . . 0.0 106.729 -169.83 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 48.9 mt -121.6 137.88 53.78 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.119 0 N-CA-C 106.425 -1.695 . . . . 0.0 106.425 -168.842 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 73.5 m -107.33 -82.26 0.55 Allowed 'General case' 0 N--CA 1.432 -1.345 0 C-N-CA 125.025 1.33 . . . . 0.0 108.131 179.953 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 35.0 ttpt -92.25 161.74 14.58 Favored 'General case' 0 CA--C 1.494 -1.196 0 C-N-CA 125.47 1.508 . . . . 0.0 107.731 -165.477 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 90.2 m-85 -128.92 137.01 51.17 Favored 'General case' 0 CA--C 1.497 -1.089 0 N-CA-C 104.686 -2.338 . . . . 0.0 104.686 173.367 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 62.0 mt -116.73 128.81 74.01 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.213 0 N-CA-C 101.611 -3.477 . . . . 0.0 101.611 171.725 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.577 HD11 HD11 ' A' ' 20' ' ' ILE . 3.1 mt -109.02 133.35 53.1 Favored 'General case' 0 CA--C 1.475 -1.908 0 N-CA-C 105.766 -1.939 . . . . 0.0 105.766 171.784 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 16.3 ptp180 -135.96 152.6 51.14 Favored 'General case' 0 N--CA 1.434 -1.259 0 N-CA-C 107.31 -1.367 . . . . 0.0 107.31 173.928 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 48.6 p90 -156.73 153.57 28.62 Favored 'General case' 0 N--CA 1.438 -1.039 0 N-CA-C 107.766 -1.198 . . . . 0.0 107.766 -172.736 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 10.6 ptp180 -149.02 155.78 40.38 Favored Pre-proline 0 CA--C 1.499 -0.988 0 N-CA-C 105.696 -1.964 . . . . 0.0 105.696 168.393 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -72.17 121.25 7.37 Favored 'Trans proline' 0 N--CA 1.452 -0.958 0 C-N-CA 122.876 2.384 . . . . 0.0 108.327 169.797 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 57.5 tttp -70.3 80.01 0.53 Allowed 'General case' 0 C--N 1.357 0.924 0 C-N-CA 126.918 2.087 . . . . 0.0 110.446 -178.182 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 29.9 m120 -155.4 -70.41 0.12 Allowed 'General case' 0 N--CA 1.435 -1.215 0 N-CA-C 102.046 -3.316 . . . . 0.0 102.046 -173.209 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 37.2 p -96.22 157.89 15.69 Favored 'General case' 0 N--CA 1.439 -0.993 0 N-CA-C 107.555 -1.276 . . . . 0.0 107.555 175.139 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 3.3 m -130.62 53.68 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.918 0 N-CA-C 105.789 -1.93 . . . . 0.0 105.789 178.24 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -94.61 -107.73 2.08 Favored Glycine 0 C--N 1.355 1.625 0 N-CA-C 108.017 -2.033 . . . . 0.0 108.017 -179.092 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 8.3 ptm180 -88.8 175.29 7.54 Favored 'General case' 0 CA--C 1.502 -0.874 0 N-CA-C 107.625 -1.25 . . . . 0.0 107.625 174.822 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -157.24 171.3 20.66 Favored 'General case' 0 CA--C 1.492 -1.262 0 CA-C-O 121.393 0.616 . . . . 0.0 110.191 175.199 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 64.9 mttp -109.45 152.29 25.59 Favored 'General case' 0 CA--C 1.486 -1.503 0 N-CA-C 107.469 -1.308 . . . . 0.0 107.469 -172.551 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -152.99 155.42 36.9 Favored 'General case' 0 N--CA 1.434 -1.252 0 N-CA-C 107.74 -1.208 . . . . 0.0 107.74 177.727 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -137.3 156.96 47.64 Favored 'General case' 0 N--CA 1.437 -1.107 0 N-CA-C 105.816 -1.92 . . . . 0.0 105.816 173.539 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 87.3 m -121.12 125.32 46.92 Favored 'General case' 0 CA--C 1.501 -0.93 0 N-CA-C 104.784 -2.302 . . . . 0.0 104.784 -179.585 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 58.5 mt -124.02 132.32 24.29 Favored Pre-proline 0 N--CA 1.439 -1.024 0 N-CA-C 105.039 -2.208 . . . . 0.0 105.039 -164.672 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo -77.95 172.51 15.47 Favored 'Trans proline' 0 N--CA 1.455 -0.794 0 C-N-CA 122.717 2.278 . . . . 0.0 110.558 -179.516 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -96.75 69.56 0.84 Allowed Glycine 0 C--N 1.353 1.486 0 N-CA-C 109.34 -1.504 . . . . 0.0 109.34 178.602 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' HIS . . . . . 0.646 ' HB2' HD13 ' A' ' 55' ' ' LEU . 27.3 m170 -120.55 -66.43 1.06 Allowed 'General case' 0 CA--C 1.499 -0.986 0 N-CA-C 103.265 -2.865 . . . . 0.0 103.265 174.357 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.647 HD22 ' H ' ' A' ' 55' ' ' LEU . 0.0 OUTLIER -89.69 164.08 14.85 Favored 'General case' 0 N--CA 1.43 -1.471 0 C-N-CA 129.17 2.988 . . . . 0.0 106.856 177.765 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 7.1 p30 -140.11 30.34 2.0 Favored 'General case' 0 N--CA 1.431 -1.399 0 N-CA-C 107.125 -1.435 . . . . 0.0 107.125 -177.567 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 36.5 p -139.8 149.12 43.13 Favored 'General case' 0 CA--C 1.501 -0.937 0 N-CA-C 106.809 -1.552 . . . . 0.0 106.809 177.321 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 10.3 t80 -128.37 175.99 8.06 Favored 'General case' 0 C--N 1.358 0.973 0 N-CA-C 107.92 -1.141 . . . . 0.0 107.92 179.764 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 97.7 m -138.5 109.25 6.65 Favored 'General case' 0 N--CA 1.432 -1.344 0 N-CA-C 104.081 -2.562 . . . . 0.0 104.081 173.113 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 27.4 mt -87.9 147.54 5.19 Favored 'Isoleucine or valine' 0 C--N 1.358 0.969 0 N-CA-C 103.427 -2.805 . . . . 0.0 103.427 169.696 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 8.7 ptpp? -150.1 162.83 39.66 Favored 'General case' 0 CA--C 1.497 -1.067 0 N-CA-C 108.169 -1.048 . . . . 0.0 108.169 179.366 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 83.63 51.03 4.21 Favored Glycine 0 C--N 1.354 1.575 0 N-CA-C 109.367 -1.493 . . . . 0.0 109.367 177.768 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 62.7 mt -120.34 177.44 5.03 Favored 'General case' 0 CA--C 1.5 -0.954 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 -171.59 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -122.79 152.88 63.1 Favored Pre-proline 0 N--CA 1.44 -0.952 0 N-CA-C 106.46 -1.681 . . . . 0.0 106.46 -175.765 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -79.72 163.74 23.59 Favored 'Trans proline' 0 N--CA 1.451 -0.992 0 C-N-CA 122.976 2.451 . . . . 0.0 110.62 175.312 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 0.578 ' H ' ' HA ' ' A' ' 92' ' ' THR . . . 58.64 26.16 59.57 Favored Glycine 0 C--N 1.356 1.657 0 C-N-CA 128.207 2.813 . . . . 0.0 116.28 171.966 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 8.6 p -126.41 147.5 31.24 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.977 0 N-CA-C 107.625 -1.25 . . . . 0.0 107.625 -176.988 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 5.1 p -96.02 138.14 22.2 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.945 0 N-CA-C 107.323 -1.362 . . . . 0.0 107.323 -178.114 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 88.6 m-85 -119.13 151.63 37.95 Favored 'General case' 0 N--CA 1.436 -1.157 0 N-CA-C 105.638 -1.986 . . . . 0.0 105.638 175.335 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -101.53 141.72 33.98 Favored 'General case' 0 CA--C 1.497 -1.095 0 N-CA-C 104.743 -2.317 . . . . 0.0 104.743 162.114 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -135.88 150.01 20.23 Favored Glycine 0 CA--C 1.488 -1.608 0 N-CA-C 107.701 -2.16 . . . . 0.0 107.701 -179.576 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 31.1 mt-30 -141.6 133.43 27.31 Favored 'General case' 0 CA--C 1.485 -1.545 0 N-CA-C 106.019 -1.845 . . . . 0.0 106.019 -177.628 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 23.2 tp -115.33 99.77 7.63 Favored 'General case' 0 N--CA 1.439 -1.01 0 N-CA-C 104.249 -2.5 . . . . 0.0 104.249 -178.339 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 11.7 mt -92.43 127.33 44.68 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.812 0 N-CA-C 104.502 -2.407 . . . . 0.0 104.502 179.767 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 10.3 p -114.98 111.66 21.49 Favored 'General case' 0 N--CA 1.436 -1.141 0 N-CA-C 107.593 -1.262 . . . . 0.0 107.593 -173.904 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 10.4 mm -94.79 150.81 3.96 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.298 0 N-CA-C 106.116 -1.809 . . . . 0.0 106.116 -167.195 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 6.4 pt20 -117.69 137.27 52.78 Favored 'General case' 0 CA--C 1.495 -1.155 0 N-CA-C 105.467 -2.049 . . . . 0.0 105.467 169.654 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 63.4 tp60 -69.02 117.89 11.23 Favored 'General case' 0 N--CA 1.441 -0.918 0 C-N-CA 124.107 0.963 . . . . 0.0 111.566 -167.019 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 36.1 m-85 59.09 49.95 8.73 Favored 'General case' 0 C--N 1.357 0.902 0 C-N-CA 126.971 2.108 . . . . 0.0 112.013 -177.918 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -158.72 -122.53 0.68 Allowed Glycine 0 N--CA 1.432 -1.623 0 N-CA-C 108.193 -1.963 . . . . 0.0 108.193 177.499 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 79.8 m-70 -86.58 177.87 7.25 Favored 'General case' 0 CA--C 1.498 -1.035 0 C-N-CA 125.34 1.456 . . . . 0.0 111.07 -169.479 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 26.6 mp0 -133.31 140.21 47.31 Favored 'General case' 0 N--CA 1.436 -1.173 0 N-CA-C 103.608 -2.738 . . . . 0.0 103.608 168.898 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 30.6 tt0 -119.25 137.73 53.47 Favored 'General case' 0 CA--C 1.496 -1.102 0 N-CA-C 103.948 -2.612 . . . . 0.0 103.948 177.915 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 6.3 p -117.1 136.01 55.63 Favored 'Isoleucine or valine' 0 C--N 1.354 0.775 0 N-CA-C 107.914 -1.143 . . . . 0.0 107.914 -177.065 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 63.6 m -116.73 140.15 49.75 Favored 'General case' 0 N--CA 1.441 -0.921 0 N-CA-C 103.067 -2.938 . . . . 0.0 103.067 173.464 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 79.2 mtt85 -128.09 152.05 48.46 Favored 'General case' 0 CA--C 1.5 -0.953 0 N-CA-C 109.195 -0.669 . . . . 0.0 109.195 177.331 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 30.7 p90 -163.81 175.79 10.13 Favored 'General case' 0 C--N 1.355 0.82 0 N-CA-C 107.796 -1.187 . . . . 0.0 107.796 -178.445 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 51.5 m-20 -133.53 154.11 51.1 Favored 'General case' 0 CA--C 1.502 -0.875 0 N-CA-C 105.715 -1.957 . . . . 0.0 105.715 169.553 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 22.1 p90 -142.94 169.36 17.72 Favored 'General case' 0 CA--C 1.487 -1.454 0 N-CA-C 107.765 -1.198 . . . . 0.0 107.765 171.095 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 27.5 p -121.89 143.26 49.54 Favored 'General case' 0 CA--C 1.501 -0.934 0 N-CA-C 105.733 -1.951 . . . . 0.0 105.733 170.754 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 45.1 m -114.02 125.63 54.21 Favored 'General case' 0 CA--C 1.497 -1.059 0 N-CA-C 102.499 -3.148 . . . . 0.0 102.499 170.953 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 92' ' ' THR . . . . . 0.578 ' HA ' ' H ' ' A' ' 66' ' ' GLY . 13.2 t -143.86 161.61 38.23 Favored 'General case' 0 N--CA 1.441 -0.907 0 N-CA-C 107.365 -1.346 . . . . 0.0 107.365 -171.523 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 50.8 p . . . . . 0 C--O 1.261 1.686 0 C-N-CA 124.837 1.255 . . . . 0.0 109.361 -179.103 . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 22.4 t . . . . . 0 N--CA 1.484 1.244 0 CA-C-O 121.64 0.733 . . . . 0.0 110.315 . . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -164.07 -169.66 27.9 Favored Glycine 0 N--CA 1.436 -1.355 0 N-CA-C 105.702 -2.959 . . . . 0.0 105.702 177.652 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_exo -60.34 132.22 42.61 Favored 'Trans proline' 0 N--CA 1.447 -1.264 0 C-N-CA 123.601 2.867 . . . . 0.0 111.125 -178.05 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 20.2 t -77.95 153.98 5.23 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.925 0 C-N-CA 127.095 2.158 . . . . 0.0 106.273 -172.792 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -96.12 85.67 4.07 Favored 'General case' 0 CA--C 1.49 -1.328 0 N-CA-C 107.377 -1.342 . . . . 0.0 107.377 -176.887 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.44 ' HA ' ' HA ' ' A' ' 22' ' ' TRP . 1.8 p -100.06 120.73 49.88 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.169 0 N-CA-C 106.484 -1.673 . . . . 0.0 106.484 -170.578 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 48.4 m-85 -94.57 96.38 9.41 Favored 'General case' 0 CA--C 1.495 -1.161 0 N-CA-C 106.923 -1.51 . . . . 0.0 106.923 -168.318 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 32.0 mm -103.04 96.36 4.57 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.264 0 N-CA-C 103.502 -2.777 . . . . 0.0 103.502 176.357 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 40.5 p -78.82 -32.79 46.39 Favored 'General case' 0 N--CA 1.442 -0.833 0 CA-C-N 114.501 -1.227 . . . . 0.0 108.567 178.501 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.473 ' HG3' ' H ' ' A' ' 90' ' ' THR . 25.8 tt0 67.35 54.05 0.73 Allowed 'General case' 0 C--N 1.358 0.956 0 C-N-CA 126.369 1.867 . . . . 0.0 109.726 175.608 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 2.2 p -152.07 81.45 5.67 Favored Pre-proline 0 N--CA 1.441 -0.885 0 N-CA-C 103.469 -2.789 . . . . 0.0 103.469 177.096 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -75.0 -39.24 1.26 Allowed 'Trans proline' 0 N--CA 1.453 -0.903 0 C-N-CA 122.183 1.922 . . . . 0.0 110.536 -176.595 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 23.1 m 60.92 29.21 18.88 Favored 'General case' 0 C--N 1.361 1.071 0 C-N-CA 127.323 2.249 . . . . 0.0 112.904 -179.767 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 83.5 mt-30 -150.23 141.0 14.45 Favored Pre-proline 0 N--CA 1.44 -0.969 0 N-CA-C 105.004 -2.221 . . . . 0.0 105.004 -175.69 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 64.6 Cg_endo -82.47 -29.14 1.55 Allowed 'Trans proline' 0 CA--C 1.506 -0.919 0 C-N-CA 122.584 2.19 . . . . 0.0 111.792 -161.648 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 1.9 m-80 -124.53 -20.22 5.19 Favored 'General case' 0 CA--C 1.491 -1.292 0 C-N-CA 124.128 0.971 . . . . 0.0 109.284 -169.016 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 5.7 p -108.52 134.91 50.64 Favored 'General case' 0 CA--C 1.495 -1.172 0 N-CA-C 107.714 -1.217 . . . . 0.0 107.714 -176.563 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 58.7 t-80 -122.8 98.2 43.15 Favored Pre-proline 0 N--CA 1.441 -0.906 0 N-CA-C 106.978 -1.49 . . . . 0.0 106.978 178.027 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 63.4 Cg_endo -80.05 127.15 6.72 Favored 'Trans proline' 0 N--CA 1.449 -1.107 0 C-N-CA 123.073 2.515 . . . . 0.0 109.873 177.635 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 2.1 pt -110.74 166.26 5.56 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.031 0 N-CA-C 107.153 -1.425 . . . . 0.0 107.153 174.365 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 32.3 mt-30 -138.51 160.09 40.45 Favored 'General case' 0 CA--C 1.497 -1.084 0 N-CA-C 105.286 -2.116 . . . . 0.0 105.286 167.68 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 22' ' ' TRP . . . . . 0.44 ' HA ' ' HA ' ' A' ' 6' ' ' VAL . 48.8 p90 -145.1 169.57 17.89 Favored 'General case' 0 CA--C 1.498 -1.054 0 N-CA-C 107.488 -1.301 . . . . 0.0 107.488 173.209 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 44.8 t30 -146.69 136.49 23.21 Favored 'General case' 0 CA--C 1.484 -1.575 0 N-CA-C 106.548 -1.649 . . . . 0.0 106.548 174.449 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -82.78 167.64 28.37 Favored Pre-proline 0 N--CA 1.439 -0.991 0 CA-C-N 112.793 -2.003 . . . . 0.0 111.681 -160.944 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 76.7 Cg_exo -66.16 176.29 4.04 Favored 'Trans proline' 0 N--CA 1.456 -0.68 0 C-N-CA 123.826 3.017 . . . . 0.0 111.752 165.107 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 1.3 tm0? -79.18 -46.04 1.68 Allowed Pre-proline 0 N--CA 1.443 -0.805 0 CA-C-O 115.544 -2.17 . . . . 0.0 110.496 -175.728 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 75.6 Cg_exo -66.53 148.0 83.02 Favored 'Trans proline' 0 CA--C 1.51 -0.721 0 CA-C-N 125.792 3.104 . . . . 0.0 111.969 177.147 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 69.6 m -100.85 63.19 1.03 Allowed 'General case' 0 CA--C 1.502 -0.889 0 N-CA-C 106.778 -1.564 . . . . 0.0 106.778 178.554 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 79.8 t60 -110.36 -1.59 17.09 Favored 'General case' 0 N--CA 1.44 -0.962 0 C-N-CA 125.322 1.449 . . . . 0.0 107.844 179.57 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 3.7 mp -100.16 126.28 53.71 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.115 0 N-CA-C 103.807 -2.664 . . . . 0.0 103.807 -177.639 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 60.5 m -95.43 -84.25 0.34 Allowed 'General case' 0 N--CA 1.431 -1.417 0 N-CA-C 106.153 -1.795 . . . . 0.0 106.153 177.232 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 53.7 mtmt -91.05 169.19 11.08 Favored 'General case' 0 CA--C 1.49 -1.358 0 C-N-CA 123.419 0.687 . . . . 0.0 109.24 -167.871 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 97.4 m-85 -126.87 133.82 50.62 Favored 'General case' 0 N--CA 1.435 -1.222 0 N-CA-C 103.048 -2.945 . . . . 0.0 103.048 164.108 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 51.1 mt -118.31 126.95 75.42 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.179 0 N-CA-C 102.398 -3.186 . . . . 0.0 102.398 173.804 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 7.0 mt -105.99 137.85 43.19 Favored 'General case' 0 CA--C 1.473 -2.003 0 N-CA-C 105.326 -2.101 . . . . 0.0 105.326 173.716 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -132.96 155.64 48.76 Favored 'General case' 0 N--CA 1.431 -1.422 0 N-CA-C 106.808 -1.553 . . . . 0.0 106.808 166.881 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 48.4 p90 -152.19 142.36 22.33 Favored 'General case' 0 N--CA 1.436 -1.132 0 N-CA-C 105.999 -1.852 . . . . 0.0 105.999 -177.352 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 45.4 ttm-85 -132.69 141.88 42.74 Favored Pre-proline 0 CA--C 1.5 -0.974 0 N-CA-C 103.991 -2.596 . . . . 0.0 103.991 179.578 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_endo -71.65 122.78 8.87 Favored 'Trans proline' 0 N--CA 1.452 -0.947 0 CA-C-N 123.683 2.351 . . . . 0.0 108.523 171.917 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 19.6 ttmm -71.58 63.92 0.43 Allowed 'General case' 0 C--N 1.358 0.963 0 C-N-CA 127.319 2.248 . . . . 0.0 111.767 -179.071 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 7.7 p30 -161.43 15.48 0.1 Allowed 'General case' 0 N--CA 1.438 -1.045 0 C-N-CA 125.292 1.437 . . . . 0.0 107.881 177.069 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 43.0 p -160.46 165.72 30.49 Favored 'General case' 0 N--CA 1.437 -1.102 0 N-CA-C 106.458 -1.682 . . . . 0.0 106.458 -175.897 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 4.9 m -137.73 40.73 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.845 0 N-CA-C 105.808 -1.923 . . . . 0.0 105.808 176.026 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -91.4 -114.92 1.92 Allowed Glycine 0 C--N 1.356 1.661 0 N-CA-C 109.071 -1.612 . . . . 0.0 109.071 -175.494 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 11.9 ptm180 -97.99 178.96 4.94 Favored 'General case' 0 CA--C 1.503 -0.861 0 N-CA-C 107.198 -1.408 . . . . 0.0 107.198 174.234 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -153.83 171.7 18.52 Favored 'General case' 0 N--CA 1.435 -1.206 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 176.363 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 96.7 mttt -110.34 157.13 19.84 Favored 'General case' 0 CA--C 1.489 -1.401 0 N-CA-C 107.291 -1.374 . . . . 0.0 107.291 -172.06 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 1.2 pp20? -150.64 160.62 43.7 Favored 'General case' 0 N--CA 1.437 -1.098 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 173.929 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -138.1 159.86 40.92 Favored 'General case' 0 N--CA 1.439 -0.98 0 N-CA-C 106.191 -1.781 . . . . 0.0 106.191 171.086 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 85.7 m -117.61 123.39 46.07 Favored 'General case' 0 CA--C 1.501 -0.933 0 N-CA-C 104.642 -2.355 . . . . 0.0 104.642 176.218 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 5.4 mp -112.8 133.59 21.9 Favored Pre-proline 0 N--CA 1.438 -1.063 0 N-CA-C 104.837 -2.283 . . . . 0.0 104.837 -174.076 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 64.3 Cg_exo -65.3 166.27 19.75 Favored 'Trans proline' 0 CA--C 1.509 -0.749 0 C-N-CA 123.185 2.59 . . . . 0.0 113.512 176.86 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -75.76 -19.18 79.23 Favored Glycine 0 C--N 1.353 1.491 0 C-N-CA 123.876 0.75 . . . . 0.0 114.245 -175.195 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 53.2 p-80 -83.05 -26.27 31.3 Favored 'General case' 0 C--N 1.356 0.851 0 CA-C-N 118.012 0.906 . . . . 0.0 109.835 -178.846 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 85.1 mt -88.58 128.92 35.58 Favored 'General case' 0 CA--C 1.5 -0.978 0 N-CA-C 107.441 -1.318 . . . . 0.0 107.441 175.605 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 8.0 p30 -117.46 10.61 13.62 Favored 'General case' 0 CA--C 1.502 -0.88 0 C-N-CA 124.083 0.953 . . . . 0.0 109.713 -173.313 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 29.1 p -142.17 161.35 38.24 Favored 'General case' 0 CA--C 1.498 -1.029 0 N-CA-C 106.537 -1.653 . . . . 0.0 106.537 179.291 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 11.1 t80 -140.56 162.2 35.93 Favored 'General case' 0 CA--C 1.499 -0.996 0 CA-C-O 121.849 0.833 . . . . 0.0 108.99 177.805 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 37.8 m -126.1 111.97 15.29 Favored 'General case' 0 N--CA 1.434 -1.243 0 N-CA-C 105.499 -2.037 . . . . 0.0 105.499 169.842 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 37.9 mt -84.75 140.71 15.64 Favored 'Isoleucine or valine' 0 C--N 1.357 0.897 0 N-CA-C 103.67 -2.715 . . . . 0.0 103.67 172.791 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 94.3 mttt -141.4 162.13 36.24 Favored 'General case' 0 CA--C 1.491 -1.3 0 CA-C-O 121.859 0.838 . . . . 0.0 108.881 -177.451 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 75.27 55.09 5.31 Favored Glycine 0 CA--C 1.489 -1.574 0 N-CA-C 108.937 -1.665 . . . . 0.0 108.937 176.63 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 62.3 mt -115.49 -174.22 2.48 Favored 'General case' 0 CA--C 1.5 -0.96 0 N-CA-C 107.547 -1.279 . . . . 0.0 107.547 -176.124 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 94.0 mttt -109.38 160.88 26.05 Favored Pre-proline 0 N--CA 1.441 -0.886 0 N-CA-C 106.091 -1.818 . . . . 0.0 106.091 -177.366 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -81.38 158.0 19.65 Favored 'Trans proline' 0 N--CA 1.45 -1.062 0 C-N-CA 122.764 2.309 . . . . 0.0 109.538 165.472 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 59.18 28.24 63.85 Favored Glycine 0 C--N 1.358 1.752 0 C-N-CA 126.947 2.213 . . . . 0.0 116.273 171.794 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 7.1 p -115.48 142.82 27.04 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.963 0 N-CA-C 107.803 -1.184 . . . . 0.0 107.803 -173.286 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 3.5 p -100.86 131.52 48.32 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.894 0 N-CA-C 106.423 -1.695 . . . . 0.0 106.423 173.594 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 90.0 m-85 -114.31 150.68 34.11 Favored 'General case' 0 N--CA 1.44 -0.946 0 N-CA-C 106.537 -1.653 . . . . 0.0 106.537 174.414 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -94.29 145.37 24.78 Favored 'General case' 0 CA--C 1.5 -0.961 0 N-CA-C 104.369 -2.456 . . . . 0.0 104.369 159.728 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -137.32 155.23 22.8 Favored Glycine 0 CA--C 1.485 -1.844 0 N-CA-C 108.192 -1.963 . . . . 0.0 108.192 -177.518 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 40.0 tt0 -151.34 135.13 16.43 Favored 'General case' 0 CA--C 1.485 -1.532 0 N-CA-C 106.478 -1.675 . . . . 0.0 106.478 -176.791 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 25.2 tp -123.87 97.86 5.55 Favored 'General case' 0 N--CA 1.434 -1.245 0 N-CA-C 104.556 -2.387 . . . . 0.0 104.556 -172.927 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 10.5 mt -91.83 138.63 19.39 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.853 0 N-CA-C 105.252 -2.129 . . . . 0.0 105.252 177.666 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 75.0 m -112.59 112.07 23.34 Favored 'General case' 0 N--CA 1.434 -1.233 0 N-CA-C 106.313 -1.736 . . . . 0.0 106.313 178.935 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 1.7 mp -89.49 134.17 29.47 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.217 0 N-CA-C 103.645 -2.724 . . . . 0.0 103.645 -173.058 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 79.0 mt-30 -99.37 160.13 14.5 Favored 'General case' 0 CA--C 1.494 -1.197 0 N-CA-C 106.704 -1.591 . . . . 0.0 106.704 -174.087 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 5.6 pt20 -69.09 110.27 4.43 Favored 'General case' 0 N--CA 1.441 -0.904 0 CA-C-O 121.982 0.896 . . . . 0.0 112.761 -170.947 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 75.6 m-85 53.95 40.86 32.04 Favored 'General case' 0 C--N 1.358 0.949 0 C-N-CA 127.834 2.454 . . . . 0.0 112.925 175.094 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -163.17 -114.94 0.32 Allowed Glycine 0 C--N 1.353 1.502 0 C-N-CA 119.324 -1.417 . . . . 0.0 109.808 -179.304 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 38.5 m170 -81.61 -175.85 5.75 Favored 'General case' 0 CA--C 1.498 -1.052 0 C-N-CA 125.05 1.34 . . . . 0.0 110.745 -167.324 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 4.8 pt20 -147.85 142.06 26.15 Favored 'General case' 0 N--CA 1.434 -1.238 0 N-CA-C 106.192 -1.781 . . . . 0.0 106.192 171.826 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 16.7 tp10 -110.7 139.46 45.97 Favored 'General case' 0 CA--C 1.496 -1.099 0 N-CA-C 105.823 -1.917 . . . . 0.0 105.823 -177.762 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 8.2 p -110.64 141.61 25.47 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.745 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 -174.48 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 36.2 m -130.15 129.24 43.22 Favored 'General case' 0 C--N 1.355 0.831 0 N-CA-C 102.832 -3.025 . . . . 0.0 102.832 175.67 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 18.7 ptp180 -134.71 154.48 51.54 Favored 'General case' 0 C--N 1.355 0.819 0 CA-C-N 119.912 1.233 . . . . 0.0 111.25 -176.256 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 18.7 p90 -165.26 -175.22 3.53 Favored 'General case' 0 C--N 1.359 1.0 0 N-CA-C 107.064 -1.458 . . . . 0.0 107.064 -169.517 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -140.15 159.46 42.14 Favored 'General case' 0 N--CA 1.443 -0.795 0 N-CA-C 107.029 -1.471 . . . . 0.0 107.029 166.735 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 20.7 p90 -144.83 169.23 18.43 Favored 'General case' 0 CA--C 1.492 -1.276 0 N-CA-C 107.723 -1.214 . . . . 0.0 107.723 174.103 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 90' ' ' THR . . . . . 0.473 ' H ' ' HG3' ' A' ' 10' ' ' GLU . 88.7 m -126.49 135.74 51.73 Favored 'General case' 0 CA--C 1.5 -0.971 0 N-CA-C 104.004 -2.591 . . . . 0.0 104.004 176.194 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 76.9 m -107.56 107.53 18.41 Favored 'General case' 0 CA--C 1.497 -1.064 0 N-CA-C 105.126 -2.176 . . . . 0.0 105.126 178.699 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 5.7 m 75.91 145.01 0.08 Allowed 'General case' 0 C--N 1.359 1.006 0 C-N-CA 127.213 2.205 . . . . 0.0 110.387 173.515 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 24.3 m . . . . . 0 C--O 1.259 1.604 0 C-N-CA 125.597 1.559 . . . . 0.0 109.785 -178.825 . . . . . . . . 0 0 . 1 . 022 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 22.8 t . . . . . 0 N--CA 1.481 1.108 0 N-CA-C 109.214 -0.662 . . . . 0.0 109.214 . . . . . . . . . 0 0 . 1 . 022 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -160.96 -153.52 7.02 Favored Glycine 0 C--N 1.352 1.462 0 N-CA-C 106.902 -2.479 . . . . 0.0 106.902 -176.832 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 74.8 Cg_exo -60.93 135.82 61.84 Favored 'Trans proline' 0 N--CA 1.445 -1.33 0 C-N-CA 123.401 2.734 . . . . 0.0 112.865 -176.638 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 32.1 t -79.12 157.46 4.75 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.06 0 C-N-CA 128.078 2.551 . . . . 0.0 107.348 -175.891 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 -105.48 102.26 11.74 Favored 'General case' 0 CA--C 1.491 -1.295 0 N-CA-C 105.197 -2.149 . . . . 0.0 105.197 176.78 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 1.7 p -117.46 134.66 60.33 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.114 0 N-CA-C 106.509 -1.663 . . . . 0.0 106.509 -166.762 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -121.04 170.34 9.62 Favored 'General case' 0 N--CA 1.434 -1.234 0 N-CA-C 106.975 -1.491 . . . . 0.0 106.975 -169.022 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 42.1 mm -118.82 152.56 21.06 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.903 0 N-CA-C 103.114 -2.921 . . . . 0.0 103.114 176.745 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 56.8 p -74.88 -176.45 2.9 Favored 'General case' 0 N--CA 1.446 -0.654 0 C-N-CA 124.688 1.195 . . . . 0.0 111.438 -171.325 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 22.3 pt-20 -102.49 24.41 10.44 Favored 'General case' 0 N--CA 1.44 -0.945 0 C-N-CA 124.898 1.279 . . . . 0.0 110.167 -169.605 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 25.7 p -83.58 120.93 76.14 Favored Pre-proline 0 C--N 1.357 0.897 0 N-CA-C 107.43 -1.322 . . . . 0.0 107.43 179.489 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_endo -77.99 -36.94 0.94 Allowed 'Trans proline' 0 CA--C 1.508 -0.817 0 C-N-CA 122.56 2.173 . . . . 0.0 110.535 -170.652 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 62.4 m -144.65 110.28 5.3 Favored 'General case' 0 CA--C 1.491 -1.303 0 N-CA-C 104.023 -2.584 . . . . 0.0 104.023 177.552 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 2.7 pm0 -98.36 153.79 37.88 Favored Pre-proline 0 N--CA 1.437 -1.082 0 N-CA-C 105.562 -2.014 . . . . 0.0 105.562 177.628 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -83.42 -76.09 0.0 OUTLIER 'Trans proline' 0 N--CA 1.45 -1.074 0 CA-C-N 122.764 2.023 . . . . 0.0 109.224 -177.326 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 58.1 m-20 -133.37 -6.14 2.96 Favored 'General case' 0 N--CA 1.434 -1.259 0 C-N-CA 127.256 2.223 . . . . 0.0 108.63 -171.965 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 70.9 m -92.57 154.64 18.29 Favored 'General case' 0 CA--C 1.496 -1.128 0 N-CA-C 105.793 -1.928 . . . . 0.0 105.793 174.777 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 10.8 t60 -147.3 90.72 5.23 Favored Pre-proline 0 N--CA 1.437 -1.099 0 N-CA-C 107.436 -1.32 . . . . 0.0 107.436 172.769 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -80.42 139.47 12.96 Favored 'Trans proline' 0 N--CA 1.446 -1.295 0 C-N-CA 122.705 2.27 . . . . 0.0 110.135 177.594 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.447 HD11 HD11 ' A' ' 35' ' ' LEU . 4.4 pt -122.49 175.24 5.83 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.055 0 N-CA-C 108.147 -1.057 . . . . 0.0 108.147 177.871 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 21' ' ' GLN . . . . . 0.425 ' HA ' ' HA ' ' A' ' 57' ' ' SER . 2.7 pt20 -151.31 155.23 38.31 Favored 'General case' 0 CA--C 1.498 -1.045 0 N-CA-C 105.733 -1.951 . . . . 0.0 105.733 176.27 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 33.5 p90 -142.31 162.52 35.26 Favored 'General case' 0 CA--C 1.501 -0.915 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 -175.872 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 61.8 t30 -98.94 -172.51 2.3 Favored 'General case' 0 CA--C 1.493 -1.222 0 N-CA-C 103.658 -2.719 . . . . 0.0 103.658 169.486 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -158.0 168.46 12.41 Favored Pre-proline 0 N--CA 1.44 -0.974 0 N-CA-C 106.471 -1.677 . . . . 0.0 106.471 168.694 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_exo -63.39 154.33 68.97 Favored 'Trans proline' 0 N--CA 1.454 -0.816 0 C-N-CA 123.244 2.63 . . . . 0.0 112.506 173.487 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 90.4 mm-40 -81.77 -35.51 0.75 Allowed Pre-proline 0 N--CA 1.443 -0.799 0 CA-C-O 115.148 -2.358 . . . . 0.0 114.208 -168.096 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_exo -70.83 -4.2 14.26 Favored 'Trans proline' 0 CA--C 1.512 -0.619 0 CA-C-N 126.1 3.214 . . . . 0.0 114.615 -177.809 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 8.7 t 68.38 59.55 0.41 Allowed 'General case' 0 C--N 1.359 0.986 0 C-N-CA 126.121 1.768 . . . . 0.0 108.886 -177.345 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 12.7 t-160 -94.41 -11.28 30.17 Favored 'General case' 0 N--CA 1.439 -0.991 0 C-N-CA 125.133 1.373 . . . . 0.0 108.034 -179.332 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 1.8 mp -111.56 137.36 44.46 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.949 0 N-CA-C 104.473 -2.417 . . . . 0.0 104.473 -175.099 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 62.2 m -100.06 -84.4 0.42 Allowed 'General case' 0 N--CA 1.432 -1.331 0 N-CA-C 106.823 -1.547 . . . . 0.0 106.823 171.093 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 55.4 mtmt -88.64 168.71 12.3 Favored 'General case' 0 CA--C 1.487 -1.457 0 C-N-CA 124.335 1.054 . . . . 0.0 109.447 -164.531 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 85.0 m-85 -130.26 135.0 47.65 Favored 'General case' 0 CA--C 1.495 -1.14 0 N-CA-C 103.978 -2.601 . . . . 0.0 103.978 170.252 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 42.0 mt -119.35 128.69 75.84 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.162 0 N-CA-C 101.913 -3.365 . . . . 0.0 101.913 174.515 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.447 HD11 HD11 ' A' ' 20' ' ' ILE . 4.2 mt -110.02 143.75 39.57 Favored 'General case' 0 CA--C 1.471 -2.084 0 N-CA-C 106.906 -1.516 . . . . 0.0 106.906 175.275 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 2.6 mpt_? -125.86 157.19 38.24 Favored 'General case' 0 N--CA 1.425 -1.705 0 N-CA-C 106.456 -1.683 . . . . 0.0 106.456 168.592 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 45.1 p90 -149.12 139.03 21.99 Favored 'General case' 0 N--CA 1.433 -1.321 0 N-CA-C 106.291 -1.744 . . . . 0.0 106.291 169.224 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 19.1 ttm180 -133.26 136.57 27.51 Favored Pre-proline 0 CA--C 1.495 -1.156 0 N-CA-C 104.206 -2.516 . . . . 0.0 104.206 179.103 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -71.0 114.72 3.99 Favored 'Trans proline' 0 N--CA 1.454 -0.846 0 CA-C-N 124.581 2.672 . . . . 0.0 108.495 175.02 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 54.4 tttp -70.89 72.26 0.55 Allowed 'General case' 0 C--N 1.359 0.992 0 C-N-CA 127.609 2.364 . . . . 0.0 111.467 -174.724 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 70.4 m-80 -154.05 -60.95 0.13 Allowed 'General case' 0 N--CA 1.434 -1.245 0 N-CA-C 101.532 -3.507 . . . . 0.0 101.532 -172.176 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 42.5 p -93.4 160.19 14.92 Favored 'General case' 0 N--CA 1.439 -0.99 0 C-N-CA 124.854 1.262 . . . . 0.0 107.65 173.175 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 5.9 m -126.33 44.87 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.842 0 N-CA-C 106.183 -1.784 . . . . 0.0 106.183 177.975 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -99.4 -128.54 6.27 Favored Glycine 0 C--N 1.355 1.593 0 N-CA-C 108.704 -1.759 . . . . 0.0 108.704 -177.547 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 83.9 mtt85 -84.51 168.18 15.67 Favored 'General case' 0 CA--C 1.502 -0.885 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 -179.072 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -151.83 173.26 14.99 Favored 'General case' 0 CA--C 1.494 -1.205 0 CA-C-O 121.506 0.669 . . . . 0.0 110.051 -172.981 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 36.9 mtmt -112.62 156.85 22.02 Favored 'General case' 0 CA--C 1.488 -1.427 0 N-CA-C 106.789 -1.56 . . . . 0.0 106.789 -173.001 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 16.3 pt-20 -152.28 160.66 43.31 Favored 'General case' 0 N--CA 1.436 -1.17 0 N-CA-C 108.666 -0.865 . . . . 0.0 108.666 178.698 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -140.19 163.02 33.87 Favored 'General case' 0 CA--C 1.498 -1.021 0 N-CA-C 107.102 -1.444 . . . . 0.0 107.102 171.434 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 90.5 m -121.31 126.23 48.98 Favored 'General case' 0 CA--C 1.501 -0.912 0 N-CA-C 104.691 -2.336 . . . . 0.0 104.691 175.344 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 5.2 mp -114.86 133.76 22.56 Favored Pre-proline 0 N--CA 1.437 -1.081 0 N-CA-C 105.121 -2.178 . . . . 0.0 105.121 -174.055 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_exo -64.09 165.59 18.89 Favored 'Trans proline' 0 CA--C 1.509 -0.759 0 C-N-CA 123.39 2.727 . . . . 0.0 113.812 177.127 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -77.71 -16.99 79.46 Favored Glycine 0 C--N 1.353 1.483 0 C-N-CA 123.869 0.747 . . . . 0.0 113.884 -172.887 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 51.8 p-80 -83.98 -24.98 30.37 Favored 'General case' 0 C--N 1.356 0.857 0 CA-C-N 117.975 0.887 . . . . 0.0 110.32 -179.643 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 88.2 mt -88.29 129.36 35.4 Favored 'General case' 0 CA--C 1.5 -0.955 0 N-CA-C 108.299 -1.0 . . . . 0.0 108.299 178.906 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 8.6 p30 -105.23 -1.09 25.77 Favored 'General case' 0 N--CA 1.442 -0.837 0 C-N-CA 124.909 1.284 . . . . 0.0 110.782 -173.918 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.425 ' HA ' ' HA ' ' A' ' 21' ' ' GLN . 30.5 p -139.42 159.29 42.5 Favored 'General case' 0 CA--C 1.497 -1.069 0 N-CA-C 107.575 -1.269 . . . . 0.0 107.575 -174.974 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 6.1 t80 -128.75 174.5 9.39 Favored 'General case' 0 C--N 1.36 1.055 0 N-CA-C 107.858 -1.164 . . . . 0.0 107.858 175.94 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 99.9 m -140.15 110.74 6.75 Favored 'General case' 0 N--CA 1.431 -1.406 0 N-CA-C 103.923 -2.621 . . . . 0.0 103.923 171.466 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 25.4 mt -87.5 148.74 4.39 Favored 'Isoleucine or valine' 0 C--N 1.358 0.958 0 N-CA-C 103.878 -2.638 . . . . 0.0 103.878 170.3 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 8.4 ptpp? -150.02 159.51 44.34 Favored 'General case' 0 CA--C 1.492 -1.255 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 178.18 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 78.94 54.87 3.98 Favored Glycine 0 C--N 1.355 1.591 0 N-CA-C 109.184 -1.566 . . . . 0.0 109.184 178.841 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 58.8 mt -116.11 -161.11 0.78 Allowed 'General case' 0 CA--C 1.502 -0.888 0 N-CA-C 106.84 -1.541 . . . . 0.0 106.84 -177.322 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 10.7 mptt -125.12 160.99 52.14 Favored Pre-proline 0 N--CA 1.442 -0.874 0 N-CA-C 105.684 -1.969 . . . . 0.0 105.684 -176.361 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -79.57 156.2 24.7 Favored 'Trans proline' 0 N--CA 1.452 -0.918 0 C-N-CA 123.035 2.49 . . . . 0.0 109.567 165.273 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 55.32 33.24 58.11 Favored Glycine 0 C--N 1.356 1.656 0 C-N-CA 127.514 2.483 . . . . 0.0 116.512 172.276 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 7.9 p -115.04 147.3 18.53 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.014 0 N-CA-C 107.282 -1.377 . . . . 0.0 107.282 -176.366 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 4.7 p -102.47 134.12 44.21 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.778 0 N-CA-C 106.636 -1.616 . . . . 0.0 106.636 174.577 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 81.8 m-85 -116.9 150.51 38.35 Favored 'General case' 0 N--CA 1.44 -0.936 0 N-CA-C 107.225 -1.398 . . . . 0.0 107.225 174.323 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 13.1 tp10 -95.95 128.88 43.23 Favored 'General case' 0 CA--C 1.492 -1.254 0 N-CA-C 102.089 -3.301 . . . . 0.0 102.089 165.821 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -125.91 140.83 12.43 Favored Glycine 0 CA--C 1.491 -1.468 0 N-CA-C 107.862 -2.095 . . . . 0.0 107.862 -179.205 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 28.7 tt0 -134.14 130.82 37.9 Favored 'General case' 0 CA--C 1.482 -1.64 0 N-CA-C 106.213 -1.773 . . . . 0.0 106.213 -178.496 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 43.2 tp -117.42 102.98 9.67 Favored 'General case' 0 N--CA 1.437 -1.09 0 N-CA-C 104.626 -2.361 . . . . 0.0 104.626 -176.516 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 11.9 mt -93.99 130.36 43.04 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.888 0 N-CA-C 104.287 -2.486 . . . . 0.0 104.287 174.878 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 25.2 p -112.75 114.11 26.52 Favored 'General case' 0 N--CA 1.438 -1.069 0 N-CA-C 106.683 -1.599 . . . . 0.0 106.683 -179.857 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 22.5 mm -90.03 142.0 13.54 Favored 'Isoleucine or valine' 0 CA--C 1.485 -1.529 0 N-CA-C 105.606 -1.998 . . . . 0.0 105.606 -167.985 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 78.0 mt-30 -104.57 152.42 22.44 Favored 'General case' 0 CA--C 1.493 -1.244 0 CA-C-N 114.548 -1.206 . . . . 0.0 107.904 -174.478 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 24.5 tt0 -77.49 35.09 0.18 Allowed 'General case' 0 C--N 1.355 0.841 0 C-N-CA 125.882 1.673 . . . . 0.0 113.41 -178.579 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 98.5 m-85 -143.63 11.74 1.67 Allowed 'General case' 0 CA--C 1.498 -1.057 0 N-CA-C 109.068 -0.715 . . . . 0.0 109.068 -175.719 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 88.91 -20.62 31.46 Favored Glycine 0 C--N 1.351 1.374 0 C-N-CA 124.097 0.856 . . . . 0.0 111.207 179.739 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 85.6 m-70 -81.04 173.9 12.14 Favored 'General case' 0 CA--C 1.496 -1.1 0 C-N-CA 125.362 1.465 . . . . 0.0 108.683 -178.673 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 5.4 pt20 -162.38 145.12 11.25 Favored 'General case' 0 N--CA 1.437 -1.117 0 N-CA-C 107.875 -1.157 . . . . 0.0 107.875 -176.102 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 48.0 mm-40 -110.21 147.89 32.9 Favored 'General case' 0 CA--C 1.496 -1.127 0 N-CA-C 106.351 -1.722 . . . . 0.0 106.351 179.237 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 8.7 p -118.74 143.0 31.02 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.746 0 N-CA-C 107.626 -1.249 . . . . 0.0 107.626 -175.773 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 28.1 m -131.72 131.94 43.47 Favored 'General case' 0 N--CA 1.441 -0.898 0 N-CA-C 103.275 -2.861 . . . . 0.0 103.275 179.748 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 88.2 mtm180 -125.46 148.47 48.83 Favored 'General case' 0 CA--C 1.501 -0.924 0 CA-C-N 119.011 0.823 . . . . 0.0 108.826 -179.699 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 23.0 p90 -163.38 179.82 7.07 Favored 'General case' 0 CA--C 1.501 -0.926 0 N-CA-C 106.804 -1.554 . . . . 0.0 106.804 -177.779 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 41.6 p30 -136.96 156.34 48.58 Favored 'General case' 0 N--CA 1.443 -0.824 0 N-CA-C 106.488 -1.671 . . . . 0.0 106.488 167.457 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 23.3 p90 -142.94 170.67 15.26 Favored 'General case' 0 CA--C 1.488 -1.439 0 N-CA-C 106.505 -1.665 . . . . 0.0 106.505 172.318 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 36.0 p -120.9 139.7 52.84 Favored 'General case' 0 CA--C 1.502 -0.897 0 N-CA-C 106.443 -1.688 . . . . 0.0 106.443 174.014 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 71.1 m -108.41 88.13 2.66 Favored 'General case' 0 CA--C 1.497 -1.094 0 N-CA-C 102.948 -2.982 . . . . 0.0 102.948 171.793 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 42.6 p -89.79 -178.42 5.5 Favored 'General case' 0 N--CA 1.443 -0.8 0 N-CA-C 106.998 -1.482 . . . . 0.0 106.998 178.977 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 22.7 t . . . . . 0 C--O 1.26 1.626 0 N-CA-C 104.923 -2.251 . . . . 0.0 104.923 175.385 . . . . . . . . 0 0 . 1 . 023 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 72.5 m . . . . . 0 N--CA 1.484 1.263 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 . . . . . . . . . 0 0 . 1 . 023 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -156.97 -143.1 3.57 Favored Glycine 0 C--N 1.352 1.421 0 N-CA-C 106.243 -2.743 . . . . 0.0 106.243 -175.666 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 77.5 Cg_exo -61.51 133.47 45.95 Favored 'Trans proline' 0 N--CA 1.446 -1.301 0 C-N-CA 122.742 2.295 . . . . 0.0 113.844 -171.579 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 38.6 t -85.71 161.78 2.96 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.085 0 C-N-CA 128.454 2.702 . . . . 0.0 107.513 -172.37 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -106.26 106.09 16.44 Favored 'General case' 0 CA--C 1.493 -1.249 0 N-CA-C 105.06 -2.2 . . . . 0.0 105.06 176.733 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 1.5 p -127.21 140.41 49.17 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.086 0 N-CA-C 104.958 -2.238 . . . . 0.0 104.958 -170.31 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 16.5 p90 -142.68 159.23 42.63 Favored 'General case' 0 N--CA 1.436 -1.169 0 N-CA-C 107.071 -1.455 . . . . 0.0 107.071 -166.674 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 38.2 pt -92.26 157.71 2.93 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.403 0 N-CA-C 107.09 -1.448 . . . . 0.0 107.09 176.885 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 25.2 p -75.96 -42.68 47.79 Favored 'General case' 0 CA--C 1.503 -0.848 0 C-N-CA 123.445 0.698 . . . . 0.0 112.204 -169.973 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 79.46 84.93 0.06 Allowed 'General case' 0 CA--C 1.496 -1.103 0 C-N-CA 126.714 2.005 . . . . 0.0 106.592 -175.324 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 15.9 p -113.02 142.61 27.61 Favored Pre-proline 0 N--CA 1.444 -0.737 0 N-CA-C 105.34 -2.096 . . . . 0.0 105.34 176.527 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -78.66 100.03 1.32 Allowed 'Trans proline' 0 N--CA 1.454 -0.797 0 C-N-CA 123.177 2.585 . . . . 0.0 109.921 177.494 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 20.1 m 73.25 122.17 0.04 OUTLIER 'General case' 0 C--N 1.359 1.003 0 C-N-CA 126.638 1.975 . . . . 0.0 111.119 179.159 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 5.6 pm0 -146.79 115.01 4.38 Favored Pre-proline 0 N--CA 1.44 -0.965 0 N-CA-C 106.54 -1.652 . . . . 0.0 106.54 -179.527 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_endo -84.2 -55.47 0.03 OUTLIER 'Trans proline' 0 CA--C 1.501 -1.152 0 C-N-CA 121.919 1.746 . . . . 0.0 110.906 -170.395 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 2.1 m-80 -118.87 -20.31 8.23 Favored 'General case' 0 CA--C 1.49 -1.328 0 C-N-CA 124.857 1.263 . . . . 0.0 109.242 -168.821 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 15.0 p -97.86 148.2 23.66 Favored 'General case' 0 CA--C 1.493 -1.235 0 N-CA-C 107.444 -1.317 . . . . 0.0 107.444 -177.514 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 28.1 t60 -150.54 97.04 3.33 Favored Pre-proline 0 N--CA 1.438 -1.053 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 170.403 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -80.06 139.5 13.56 Favored 'Trans proline' 0 N--CA 1.447 -1.24 0 C-N-CA 122.35 2.033 . . . . 0.0 110.408 178.759 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 18.7 mm -113.62 146.21 18.5 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.937 0 N-CA-C 104.429 -2.434 . . . . 0.0 104.429 -178.051 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 35.0 mt-30 -136.42 149.95 48.53 Favored 'General case' 0 CA--C 1.502 -0.879 0 N-CA-C 105.326 -2.101 . . . . 0.0 105.326 168.904 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 42.0 p90 -141.48 161.97 36.61 Favored 'General case' 0 CA--C 1.502 -0.873 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 -175.169 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 81.2 m-20 -100.98 -172.39 2.16 Favored 'General case' 0 CA--C 1.485 -1.543 0 N-CA-C 103.851 -2.648 . . . . 0.0 103.851 171.389 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -150.45 163.14 25.26 Favored Pre-proline 0 N--CA 1.444 -0.771 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 169.93 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 80.4 Cg_exo -67.32 170.16 13.98 Favored 'Trans proline' 0 N--CA 1.456 -0.704 0 C-N-CA 123.38 2.72 . . . . 0.0 112.319 169.682 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 24.0 mm100 -82.42 -56.01 0.53 Allowed Pre-proline 0 N--CA 1.442 -0.869 0 CA-C-O 115.578 -2.153 . . . . 0.0 113.644 -172.328 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 82.6 Cg_endo -75.77 170.04 21.0 Favored 'Trans proline' 0 CA--C 1.509 -0.773 0 CA-C-N 125.774 3.098 . . . . 0.0 111.085 -169.228 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 69.4 m -76.83 113.27 14.33 Favored 'General case' 0 CA--C 1.5 -0.955 0 N-CA-C 107.717 -1.216 . . . . 0.0 107.717 179.031 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 61.4 t-80 -167.59 -49.95 0.02 OUTLIER 'General case' 0 N--CA 1.435 -1.193 0 N-CA-C 105.441 -2.059 . . . . 0.0 105.441 -170.559 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 26.6 mt -105.69 126.62 60.99 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.145 0 N-CA-C 106.429 -1.693 . . . . 0.0 106.429 -176.668 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 74.3 m -116.35 -84.35 0.63 Allowed 'General case' 0 N--CA 1.433 -1.278 0 N-CA-C 107.828 -1.175 . . . . 0.0 107.828 -174.714 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 38.8 ttpt -89.27 156.43 18.75 Favored 'General case' 0 CA--C 1.493 -1.22 0 C-N-CA 126.197 1.799 . . . . 0.0 106.888 -164.641 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 90.7 m-85 -126.86 135.89 51.6 Favored 'General case' 0 CA--C 1.488 -1.417 0 N-CA-C 105.304 -2.11 . . . . 0.0 105.304 179.474 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 1.5 mp -112.65 135.69 51.26 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.231 0 N-CA-C 100.473 -3.899 . . . . 0.0 100.473 170.239 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 3.1 mt -106.49 124.78 50.11 Favored 'General case' 0 CA--C 1.479 -1.788 0 N-CA-C 104.676 -2.342 . . . . 0.0 104.676 166.436 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -106.58 154.01 21.51 Favored 'General case' 0 N--CA 1.431 -1.375 0 N-CA-C 104.483 -2.414 . . . . 0.0 104.483 170.771 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 48.2 p90 -154.79 141.64 19.11 Favored 'General case' 0 N--CA 1.433 -1.292 0 N-CA-C 106.344 -1.725 . . . . 0.0 106.344 168.171 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 5.3 ptp180 -133.74 153.99 80.34 Favored Pre-proline 0 CA--C 1.497 -1.064 0 N-CA-C 103.751 -2.685 . . . . 0.0 103.751 168.695 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 68.8 Cg_endo -75.22 164.8 32.26 Favored 'Trans proline' 0 CA--C 1.506 -0.921 0 C-N-CA 122.789 2.326 . . . . 0.0 106.765 164.711 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 5.5 ptmm? -64.92 93.8 0.12 Allowed 'General case' 0 C--N 1.352 0.678 0 CA-C-N 119.976 1.262 . . . . 0.0 113.048 176.658 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -128.3 -136.28 0.23 Allowed 'General case' 0 N--CA 1.44 -0.953 0 N-CA-C 104.974 -2.232 . . . . 0.0 104.974 167.427 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 42.4 m -97.17 -154.28 0.45 Allowed 'General case' 0 N--CA 1.44 -0.954 0 C-N-CA 125.607 1.563 . . . . 0.0 107.121 179.313 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 9.2 m -94.85 42.69 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.445 -0.711 0 C-N-CA 126.627 1.971 . . . . 0.0 107.284 176.322 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -90.19 -146.33 15.22 Favored Glycine 0 C--N 1.353 1.478 0 C-N-CA 124.184 0.897 . . . . 0.0 110.998 -171.947 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 17.1 tpt180 -75.95 135.2 40.05 Favored 'General case' 0 CA--C 1.502 -0.881 0 C-N-CA 124.267 1.027 . . . . 0.0 108.332 -177.01 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -146.95 174.65 11.32 Favored 'General case' 0 N--CA 1.434 -1.27 0 N-CA-C 109.395 -0.594 . . . . 0.0 109.395 -174.261 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 64.3 mttp -112.3 155.74 23.58 Favored 'General case' 0 CA--C 1.489 -1.403 0 N-CA-C 107.347 -1.353 . . . . 0.0 107.347 -171.482 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 15.4 pt-20 -150.68 158.89 44.68 Favored 'General case' 0 N--CA 1.433 -1.284 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 179.784 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -136.7 160.45 38.8 Favored 'General case' 0 CA--C 1.497 -1.065 0 N-CA-C 106.509 -1.663 . . . . 0.0 106.509 171.754 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 77.3 m -122.8 126.54 47.63 Favored 'General case' 0 CA--C 1.501 -0.924 0 N-CA-C 104.956 -2.238 . . . . 0.0 104.956 175.335 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 5.2 mp -117.56 135.33 23.22 Favored Pre-proline 0 N--CA 1.437 -1.099 0 N-CA-C 104.753 -2.314 . . . . 0.0 104.753 -177.26 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_exo -63.48 167.13 13.71 Favored 'Trans proline' 0 CA--C 1.51 -0.71 0 C-N-CA 123.558 2.839 . . . . 0.0 113.477 177.101 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -79.49 -18.84 72.7 Favored Glycine 0 C--N 1.352 1.464 0 C-N-CA 123.344 0.497 . . . . 0.0 113.363 -172.59 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 47.7 p-80 -84.18 -27.01 28.36 Favored 'General case' 0 C--N 1.354 0.794 0 CA-C-N 117.743 0.771 . . . . 0.0 109.968 179.774 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 88.5 mt -88.57 132.58 34.47 Favored 'General case' 0 CA--C 1.502 -0.893 0 N-CA-C 107.789 -1.189 . . . . 0.0 107.789 177.722 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 7.6 p-10 -114.98 9.88 16.16 Favored 'General case' 0 CA--C 1.502 -0.897 0 C-N-CA 124.287 1.035 . . . . 0.0 110.169 -171.669 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 53.4 p -144.55 165.81 26.92 Favored 'General case' 0 N--CA 1.44 -0.958 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 -175.267 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 11.2 t80 -151.98 174.72 13.3 Favored 'General case' 0 N--CA 1.441 -0.908 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 -179.162 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 87.7 m -139.1 113.13 8.63 Favored 'General case' 0 N--CA 1.431 -1.409 0 N-CA-C 105.078 -2.193 . . . . 0.0 105.078 172.775 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 54.2 mt -87.08 142.93 12.32 Favored 'Isoleucine or valine' 0 C--N 1.359 0.979 0 N-CA-C 104.217 -2.512 . . . . 0.0 104.217 172.604 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 60.7 mttp -141.41 162.42 35.53 Favored 'General case' 0 CA--C 1.495 -1.138 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 179.195 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 78.84 53.05 4.72 Favored Glycine 0 CA--C 1.488 -1.609 0 N-CA-C 109.094 -1.602 . . . . 0.0 109.094 174.949 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 78.7 mt -113.46 -166.06 1.05 Allowed 'General case' 0 CA--C 1.503 -0.855 0 N-CA-C 107.279 -1.378 . . . . 0.0 107.279 -176.589 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 11.0 mptt -132.29 148.67 70.63 Favored Pre-proline 0 N--CA 1.442 -0.859 0 N-CA-C 104.993 -2.225 . . . . 0.0 104.993 -177.517 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -78.97 162.54 26.28 Favored 'Trans proline' 0 N--CA 1.45 -1.055 0 C-N-CA 122.772 2.315 . . . . 0.0 109.761 173.772 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 0.536 ' H ' ' HA ' ' A' ' 92' ' ' THR . . . 63.63 24.0 67.55 Favored Glycine 0 N--CA 1.428 -1.851 0 C-N-CA 127.377 2.418 . . . . 0.0 116.063 172.886 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 9.6 p -129.7 143.13 42.02 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.02 0 N-CA-C 107.484 -1.302 . . . . 0.0 107.484 -178.037 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 11.5 p -95.65 127.56 47.58 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.011 0 CA-C-O 123.289 1.519 . . . . 0.0 107.571 178.258 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 87.3 m-85 -100.44 144.34 29.55 Favored 'General case' 0 N--CA 1.431 -1.41 0 N-CA-C 106.235 -1.765 . . . . 0.0 106.235 176.339 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 33.6 tp10 -90.57 132.66 35.59 Favored 'General case' 0 N--CA 1.439 -0.981 0 N-CA-C 104.205 -2.517 . . . . 0.0 104.205 163.064 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -129.3 152.43 19.5 Favored Glycine 0 CA--C 1.489 -1.547 0 N-CA-C 108.283 -1.927 . . . . 0.0 108.283 -179.136 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 85.4 mt-30 -138.19 137.8 37.95 Favored 'General case' 0 CA--C 1.485 -1.548 0 N-CA-C 106.347 -1.723 . . . . 0.0 106.347 174.849 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 62.7 tp -109.72 97.92 7.36 Favored 'General case' 0 CA--C 1.499 -1.014 0 N-CA-C 102.898 -3.001 . . . . 0.0 102.898 174.542 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 9.1 mt -94.86 124.61 47.43 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.054 0 N-CA-C 104.026 -2.583 . . . . 0.0 104.026 -174.21 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 74.6 m -112.89 108.9 18.02 Favored 'General case' 0 CA--C 1.5 -0.959 0 N-CA-C 107.826 -1.176 . . . . 0.0 107.826 -168.03 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 1.8 mp -93.17 136.9 23.76 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.226 0 N-CA-C 105.2 -2.148 . . . . 0.0 105.2 -167.241 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 14.0 tt0 -97.96 111.25 23.63 Favored 'General case' 0 N--CA 1.431 -1.377 0 N-CA-C 101.706 -3.442 . . . . 0.0 101.706 169.508 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 41.8 mt-30 -69.25 125.03 25.42 Favored 'General case' 0 CA--C 1.5 -0.975 0 CA-C-O 120.846 0.355 . . . . 0.0 110.218 -170.587 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 52.7 m-85 68.71 39.1 2.06 Favored 'General case' 0 C--N 1.356 0.872 0 C-N-CA 126.492 1.917 . . . . 0.0 110.996 -176.172 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -166.68 -116.22 0.35 Allowed Glycine 0 C--N 1.357 1.721 0 N-CA-C 109.288 -1.525 . . . . 0.0 109.288 179.144 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 29.3 m170 -82.51 -179.73 7.52 Favored 'General case' 0 CA--C 1.502 -0.874 0 C-N-CA 125.606 1.563 . . . . 0.0 111.259 -168.504 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 25.7 tt0 -147.44 123.58 10.81 Favored 'General case' 0 N--CA 1.436 -1.167 0 N-CA-C 105.591 -2.003 . . . . 0.0 105.591 170.686 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 47.8 mm-40 -104.68 160.63 14.81 Favored 'General case' 0 CA--C 1.501 -0.931 0 N-CA-C 106.243 -1.762 . . . . 0.0 106.243 176.558 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 10.9 p -135.84 138.55 47.53 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.842 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 -178.233 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 24.9 m -122.35 139.45 53.81 Favored 'General case' 0 N--CA 1.442 -0.833 0 N-CA-C 103.124 -2.917 . . . . 0.0 103.124 173.05 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 55.9 ttp180 -135.03 143.16 46.59 Favored 'General case' 0 CA--C 1.505 -0.77 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 -174.13 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 21.1 p90 -164.0 -175.81 4.22 Favored 'General case' 0 C--N 1.358 0.97 0 N-CA-C 106.891 -1.522 . . . . 0.0 106.891 -174.519 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 44.4 p-10 -136.5 158.34 44.67 Favored 'General case' 0 N--CA 1.442 -0.838 0 N-CA-C 107.093 -1.447 . . . . 0.0 107.093 166.748 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 25.2 p90 -143.75 164.12 31.37 Favored 'General case' 0 CA--C 1.486 -1.49 0 N-CA-C 106.821 -1.548 . . . . 0.0 106.821 169.769 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 43.8 m -118.42 137.77 52.92 Favored 'General case' 0 CA--C 1.498 -1.051 0 N-CA-C 105.336 -2.098 . . . . 0.0 105.336 179.186 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 61.3 m -115.75 115.67 26.73 Favored 'General case' 0 CA--C 1.493 -1.213 0 N-CA-C 101.866 -3.383 . . . . 0.0 101.866 174.722 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 92' ' ' THR . . . . . 0.536 ' HA ' ' H ' ' A' ' 66' ' ' GLY . 15.1 t -155.29 148.23 24.51 Favored 'General case' 0 N--CA 1.437 -1.103 0 N-CA-C 107.315 -1.365 . . . . 0.0 107.315 -174.227 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 67.7 m . . . . . 0 C--O 1.26 1.615 0 N-CA-C 106.467 -1.679 . . . . 0.0 106.467 175.214 . . . . . . . . 0 0 . 1 . 024 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 66.7 m . . . . . 0 N--CA 1.486 1.353 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 . . . . . . . . . 0 0 . 1 . 024 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 174.73 -160.73 30.05 Favored Glycine 0 C--N 1.35 1.308 0 N-CA-C 106.728 -2.549 . . . . 0.0 106.728 -178.313 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 29.8 Cg_exo -59.04 139.78 92.28 Favored 'Trans proline' 0 N--CA 1.446 -1.293 0 C-N-CA 123.649 2.899 . . . . 0.0 113.559 -175.168 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 41.9 t -79.83 160.15 4.28 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.996 0 C-N-CA 128.552 2.741 . . . . 0.0 106.282 -179.002 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 55.2 mt-10 -108.13 106.74 17.09 Favored 'General case' 0 CA--C 1.493 -1.215 0 N-CA-C 105.998 -1.853 . . . . 0.0 105.998 -179.638 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 1.5 p -124.18 140.07 48.66 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.914 0 N-CA-C 106.142 -1.799 . . . . 0.0 106.142 -172.367 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 16.5 p90 -146.09 165.18 29.85 Favored 'General case' 0 N--CA 1.438 -1.032 0 N-CA-C 105.968 -1.864 . . . . 0.0 105.968 -168.589 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 7.8 pt -110.51 113.99 45.8 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.557 0 N-CA-C 107.653 -1.24 . . . . 0.0 107.653 -178.515 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 9.4 t -121.92 170.42 9.82 Favored 'General case' 0 N--CA 1.445 -0.717 0 N-CA-C 107.028 -1.471 . . . . 0.0 107.028 -179.172 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 11.9 tp10 68.1 16.42 9.47 Favored 'General case' 0 C--N 1.36 1.035 0 C-N-CA 126.731 2.012 . . . . 0.0 112.863 171.657 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 5.7 t -143.75 94.59 5.96 Favored Pre-proline 0 N--CA 1.444 -0.73 0 N-CA-C 108.126 -1.065 . . . . 0.0 108.126 177.421 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -77.23 -32.63 2.98 Favored 'Trans proline' 0 N--CA 1.452 -0.95 0 C-N-CA 122.514 2.143 . . . . 0.0 109.453 162.062 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 12.3 p -168.03 109.41 0.58 Allowed 'General case' 0 N--CA 1.437 -1.111 0 N-CA-C 106.698 -1.593 . . . . 0.0 106.698 -179.438 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 90.5 mt-30 -151.65 114.72 3.02 Favored Pre-proline 0 C--N 1.353 0.729 0 N-CA-C 104.833 -2.284 . . . . 0.0 104.833 177.837 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -86.17 -21.76 2.41 Favored 'Trans proline' 0 CA--C 1.505 -0.952 0 C-N-CA 122.464 2.109 . . . . 0.0 111.372 -170.113 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 6.2 p-10 -104.37 -41.32 5.79 Favored 'General case' 0 CA--C 1.489 -1.369 0 C-N-CA 123.167 0.587 . . . . 0.0 109.622 -167.103 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 12.0 p -110.5 150.72 28.49 Favored 'General case' 0 CA--C 1.494 -1.202 0 N-CA-C 107.399 -1.334 . . . . 0.0 107.399 -179.095 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 7.7 t60 -143.37 93.61 6.37 Favored Pre-proline 0 N--CA 1.437 -1.087 0 N-CA-C 106.892 -1.522 . . . . 0.0 106.892 173.656 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -82.02 146.17 14.32 Favored 'Trans proline' 0 N--CA 1.445 -1.332 0 C-N-CA 123.436 2.757 . . . . 0.0 109.948 175.958 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.491 HD11 HD11 ' A' ' 35' ' ' LEU . 7.4 pt -126.3 173.44 12.04 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.985 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 178.217 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 49.2 tt0 -148.49 149.34 31.48 Favored 'General case' 0 N--CA 1.44 -0.95 0 N-CA-C 105.192 -2.151 . . . . 0.0 105.192 170.684 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 27.7 p90 -130.51 161.25 31.89 Favored 'General case' 0 N--CA 1.44 -0.959 0 N-CA-C 106.296 -1.742 . . . . 0.0 106.296 -179.696 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 61.1 t30 -96.61 -176.25 3.55 Favored 'General case' 0 CA--C 1.491 -1.327 0 N-CA-C 103.33 -2.841 . . . . 0.0 103.33 169.372 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -156.43 166.96 15.37 Favored Pre-proline 0 N--CA 1.44 -0.938 0 N-CA-C 106.621 -1.622 . . . . 0.0 106.621 172.888 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 99.6 Cg_exo -65.39 162.17 34.82 Favored 'Trans proline' 0 CA--C 1.508 -0.775 0 C-N-CA 123.486 2.791 . . . . 0.0 112.978 175.838 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 1.2 tm0? -82.08 -58.75 0.45 Allowed Pre-proline 0 N--CA 1.442 -0.845 0 CA-C-O 115.7 -2.095 . . . . 0.0 110.686 -177.46 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo -74.95 175.54 11.09 Favored 'Trans proline' 0 CA--C 1.51 -0.696 0 CA-C-N 125.67 3.061 . . . . 0.0 110.548 -177.168 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 44.2 p -69.18 124.5 23.98 Favored 'General case' 0 C--N 1.356 0.891 0 C-N-CA 123.824 0.85 . . . . 0.0 109.785 -178.239 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 22.2 t-80 -168.12 -42.82 0.02 OUTLIER 'General case' 0 CA--C 1.494 -1.199 0 N-CA-C 106.598 -1.63 . . . . 0.0 106.598 -170.747 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 33.4 mt -132.56 140.42 47.62 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.895 0 N-CA-C 107.68 -1.23 . . . . 0.0 107.68 -173.604 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 31.8 p -123.18 -71.22 0.73 Allowed 'General case' 0 C--N 1.359 0.985 0 C-N-CA 124.219 1.008 . . . . 0.0 109.536 172.875 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 44.6 mtpt -86.44 166.58 15.41 Favored 'General case' 0 CA--C 1.488 -1.439 0 C-N-CA 126.899 2.08 . . . . 0.0 107.219 -171.029 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 83.4 m-85 -134.31 148.61 50.79 Favored 'General case' 0 CA--C 1.493 -1.248 0 N-CA-C 104.855 -2.276 . . . . 0.0 104.855 175.369 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 4.4 mt -123.54 139.47 50.05 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.315 0 N-CA-C 101.402 -3.555 . . . . 0.0 101.402 171.361 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.491 HD11 HD11 ' A' ' 20' ' ' ILE . 12.0 mt -116.02 135.36 54.03 Favored 'General case' 0 CA--C 1.477 -1.852 0 N-CA-C 106.717 -1.586 . . . . 0.0 106.717 166.681 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 9.0 mpt_? -110.58 153.12 25.6 Favored 'General case' 0 N--CA 1.429 -1.48 0 N-CA-C 104.491 -2.411 . . . . 0.0 104.491 166.559 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 48.9 p90 -154.15 146.59 24.0 Favored 'General case' 0 N--CA 1.441 -0.905 0 N-CA-C 108.099 -1.075 . . . . 0.0 108.099 168.969 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 43.9 ttm-85 -142.08 143.9 29.75 Favored Pre-proline 0 CA--C 1.503 -0.844 0 N-CA-C 104.693 -2.336 . . . . 0.0 104.693 179.876 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -71.42 115.22 4.2 Favored 'Trans proline' 0 N--CA 1.454 -0.808 0 C-N-CA 122.878 2.386 . . . . 0.0 108.845 167.151 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 64.3 tttm -70.33 77.87 0.54 Allowed 'General case' 0 C--N 1.358 0.955 0 C-N-CA 126.979 2.112 . . . . 0.0 111.084 -177.179 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 68.7 m-80 -151.77 -73.26 0.15 Allowed 'General case' 0 N--CA 1.435 -1.218 0 N-CA-C 102.653 -3.091 . . . . 0.0 102.653 -173.436 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 60.8 m -96.5 168.38 10.58 Favored 'General case' 0 C--N 1.356 0.874 0 N-CA-C 107.19 -1.411 . . . . 0.0 107.19 175.028 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 2.6 m -130.91 62.27 0.3 Allowed 'Isoleucine or valine' 0 CA--C 1.501 -0.913 0 N-CA-C 105.436 -2.061 . . . . 0.0 105.436 179.759 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -93.18 -110.53 2.01 Favored Glycine 0 C--N 1.353 1.503 0 N-CA-C 107.969 -2.052 . . . . 0.0 107.969 -179.818 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 80.2 mtp180 -105.88 175.66 5.42 Favored 'General case' 0 CA--C 1.502 -0.884 0 N-CA-C 106.338 -1.727 . . . . 0.0 106.338 173.564 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -152.05 172.63 15.99 Favored 'General case' 0 CA--C 1.495 -1.168 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 -176.676 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 94.6 mttt -108.02 154.16 22.05 Favored 'General case' 0 CA--C 1.487 -1.456 0 N-CA-C 107.313 -1.366 . . . . 0.0 107.313 -173.984 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -152.19 153.03 33.01 Favored 'General case' 0 N--CA 1.431 -1.391 0 N-CA-C 107.542 -1.281 . . . . 0.0 107.542 -177.738 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -146.48 160.62 41.87 Favored 'General case' 0 CA--C 1.499 -1.018 0 N-CA-C 107.667 -1.235 . . . . 0.0 107.667 177.665 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 91.6 m -121.7 126.76 49.69 Favored 'General case' 0 CA--C 1.5 -0.956 0 N-CA-C 105.176 -2.157 . . . . 0.0 105.176 177.734 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 52.5 mt -117.58 136.92 23.75 Favored Pre-proline 0 N--CA 1.436 -1.164 0 N-CA-C 105.639 -1.985 . . . . 0.0 105.639 -166.635 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 76.1 Cg_exo -65.26 168.46 14.21 Favored 'Trans proline' 0 CA--C 1.51 -0.692 0 C-N-CA 123.214 2.609 . . . . 0.0 113.284 177.702 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -96.38 7.68 66.41 Favored Glycine 0 C--N 1.352 1.428 0 CA-C-O 118.951 -0.916 . . . . 0.0 113.013 -178.038 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 44.3 p-80 -83.93 -47.45 11.02 Favored 'General case' 0 C--N 1.362 1.146 0 CA-C-N 119.206 1.503 . . . . 0.0 109.186 178.869 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -87.95 165.76 14.99 Favored 'General case' 0 CA--C 1.489 -1.381 0 CA-C-O 122.934 1.35 . . . . 0.0 108.271 170.921 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 6.0 p-10 -140.54 24.53 2.25 Favored 'General case' 0 N--CA 1.424 -1.761 0 CA-C-N 112.974 -1.921 . . . . 0.0 106.987 -178.506 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 57.1 p -132.14 158.49 41.53 Favored 'General case' 0 CA--C 1.501 -0.91 0 N-CA-C 107.788 -1.19 . . . . 0.0 107.788 176.387 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 7.7 t80 -133.21 175.79 9.09 Favored 'General case' 0 C--N 1.359 1.002 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 175.463 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 93.3 m -142.4 110.84 6.1 Favored 'General case' 0 N--CA 1.431 -1.404 0 N-CA-C 104.409 -2.441 . . . . 0.0 104.409 173.985 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 26.3 mt -90.85 147.32 5.3 Favored 'Isoleucine or valine' 0 C--N 1.358 0.952 0 N-CA-C 104.293 -2.484 . . . . 0.0 104.293 172.443 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 67.3 mttm -142.46 164.62 29.63 Favored 'General case' 0 CA--C 1.5 -0.946 0 N-CA-C 108.717 -0.845 . . . . 0.0 108.717 177.549 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 82.02 50.01 5.07 Favored Glycine 0 C--N 1.356 1.663 0 C-N-CA 125.357 1.456 . . . . 0.0 109.562 175.153 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 49.5 mt -119.25 172.97 7.23 Favored 'General case' 0 CA--C 1.5 -0.97 0 N-CA-C 108.22 -1.03 . . . . 0.0 108.22 -170.998 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -114.61 160.91 31.38 Favored Pre-proline 0 N--CA 1.442 -0.872 0 N-CA-C 106.856 -1.535 . . . . 0.0 106.856 -176.937 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -79.75 163.12 23.88 Favored 'Trans proline' 0 N--CA 1.452 -0.944 0 C-N-CA 123.192 2.595 . . . . 0.0 109.83 166.131 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 60.9 24.65 62.92 Favored Glycine 0 C--N 1.355 1.638 0 C-N-CA 127.778 2.609 . . . . 0.0 116.496 172.1 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 7.7 p -118.9 146.14 23.94 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.063 0 N-CA-C 107.529 -1.286 . . . . 0.0 107.529 -174.56 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 4.2 p -100.31 129.9 50.36 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.906 0 N-CA-C 106.665 -1.606 . . . . 0.0 106.665 176.013 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 94.1 m-85 -113.44 150.01 33.38 Favored 'General case' 0 N--CA 1.439 -1.016 0 N-CA-C 105.923 -1.88 . . . . 0.0 105.923 173.508 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -100.61 144.58 29.42 Favored 'General case' 0 CA--C 1.496 -1.119 0 N-CA-C 104.327 -2.471 . . . . 0.0 104.327 162.546 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -126.99 157.76 20.74 Favored Glycine 0 CA--C 1.489 -1.584 0 N-CA-C 108.016 -2.034 . . . . 0.0 108.016 174.663 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 23.7 tt0 -142.7 131.48 22.76 Favored 'General case' 0 CA--C 1.482 -1.671 0 N-CA-C 106.004 -1.85 . . . . 0.0 106.004 176.53 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 39.8 tp -113.5 104.76 12.59 Favored 'General case' 0 N--CA 1.437 -1.112 0 N-CA-C 104.6 -2.371 . . . . 0.0 104.6 -174.878 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 21.8 mt -100.48 126.69 54.03 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.866 0 N-CA-C 103.192 -2.892 . . . . 0.0 103.192 -179.29 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 50.5 m -118.36 115.9 25.63 Favored 'General case' 0 N--CA 1.444 -0.74 0 CA-C-N 119.24 0.927 . . . . 0.0 109.154 -171.32 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 2.4 mp -104.3 141.11 20.55 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.982 0 N-CA-C 105.779 -1.934 . . . . 0.0 105.779 -162.824 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 77' ' ' GLN . . . . . 0.442 ' HB3' ' H ' ' A' ' 81' ' ' HIS . 66.2 tp60 -103.89 125.95 50.66 Favored 'General case' 0 CA--C 1.493 -1.25 0 N-CA-C 102.458 -3.164 . . . . 0.0 102.458 161.293 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 18.5 tt0 -68.35 117.89 10.72 Favored 'General case' 0 N--CA 1.443 -0.808 0 C-N-CA 123.036 0.534 . . . . 0.0 110.558 -170.428 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 24.8 m-85 64.44 53.96 1.58 Allowed 'General case' 0 C--N 1.358 0.957 0 C-N-CA 126.597 1.959 . . . . 0.0 110.686 -175.256 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -172.47 -110.86 0.25 Allowed Glycine 0 C--N 1.352 1.421 0 N-CA-C 109.021 -1.632 . . . . 0.0 109.021 -178.696 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 81' ' ' HIS . . . . . 0.442 ' H ' ' HB3' ' A' ' 77' ' ' GLN . 27.9 m170 -80.2 164.92 22.9 Favored 'General case' 0 CA--C 1.503 -0.861 0 C-N-CA 125.066 1.347 . . . . 0.0 111.436 -168.792 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 44.8 tt0 -151.0 111.27 4.15 Favored 'General case' 0 N--CA 1.435 -1.181 0 N-CA-C 105.539 -2.023 . . . . 0.0 105.539 169.806 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 17.2 tp10 -99.82 151.95 20.69 Favored 'General case' 0 N--CA 1.441 -0.901 0 N-CA-C 105.799 -1.926 . . . . 0.0 105.799 179.267 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 11.3 p -130.85 139.91 49.98 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.774 0 N-CA-C 107.324 -1.362 . . . . 0.0 107.324 177.849 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 85.8 m -138.51 133.85 33.17 Favored 'General case' 0 N--CA 1.441 -0.922 0 N-CA-C 102.901 -3.0 . . . . 0.0 102.901 -177.969 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 8.1 ptm180 -113.79 165.1 12.9 Favored 'General case' 0 C--N 1.357 0.915 0 CA-C-N 119.822 1.192 . . . . 0.0 109.667 174.506 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 43.0 p90 -163.99 174.6 11.2 Favored 'General case' 0 CA--C 1.5 -0.975 0 N-CA-C 106.919 -1.512 . . . . 0.0 106.919 177.163 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 1.4 p30 -143.97 156.55 44.45 Favored 'General case' 0 N--CA 1.441 -0.885 0 N-CA-C 106.965 -1.494 . . . . 0.0 106.965 166.459 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 6.6 p90 -148.36 173.27 13.23 Favored 'General case' 0 CA--C 1.488 -1.434 0 N-CA-C 107.661 -1.237 . . . . 0.0 107.661 -179.881 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 32.0 p -122.97 143.99 49.54 Favored 'General case' 0 CA--C 1.499 -0.99 0 N-CA-C 106.308 -1.738 . . . . 0.0 106.308 171.633 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 68.3 m -110.07 87.23 2.47 Favored 'General case' 0 CA--C 1.495 -1.137 0 N-CA-C 100.579 -3.86 . . . . 0.0 100.579 166.27 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 10.2 t -97.41 -50.88 4.36 Favored 'General case' 0 N--CA 1.441 -0.908 0 N-CA-C 108.293 -1.002 . . . . 0.0 108.293 -168.33 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 11.4 t . . . . . 0 C--O 1.26 1.638 0 C-N-CA 126.118 1.767 . . . . 0.0 110.256 -175.475 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.441 -0.984 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 95.9 Cg_exo -62.21 133.11 41.98 Favored 'Trans proline' 0 N--CA 1.445 -1.367 0 C-N-CA 123.592 2.861 . . . . 0.0 112.342 -178.504 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 4.3 t -80.98 155.33 4.26 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.924 0 C-N-CA 127.32 2.248 . . . . 0.0 107.424 -175.429 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 53.0 mt-10 -94.49 89.04 5.68 Favored 'General case' 0 CA--C 1.493 -1.25 0 C-N-CA 124.337 1.055 . . . . 0.0 108.426 -177.5 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 3.7 p -115.64 140.24 38.25 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.105 0 N-CA-C 105.497 -2.038 . . . . 0.0 105.497 -169.411 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 93.3 m-85 . . . . . 0 CA--C 1.493 -1.221 0 N-CA-C 107.28 -1.378 . . . . 0.0 107.28 -172.112 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_endo . . . . . 0 CA--C 1.509 -0.753 0 N-CA-C 110.003 -0.806 . . . . 0.0 110.003 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -91.16 -15.4 29.43 Favored 'General case' 0 CA--C 1.498 -1.041 0 C-N-CA 125.438 1.495 . . . . 0.0 108.222 177.663 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 50.1 m -102.58 149.96 23.89 Favored 'General case' 0 N--CA 1.437 -1.101 0 N-CA-C 107.094 -1.446 . . . . 0.0 107.094 175.425 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 60.0 t-80 -139.28 94.45 9.65 Favored Pre-proline 0 N--CA 1.442 -0.855 0 N-CA-C 107.526 -1.287 . . . . 0.0 107.526 175.729 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -78.21 101.36 1.46 Allowed 'Trans proline' 0 N--CA 1.447 -1.235 0 C-N-CA 123.144 2.562 . . . . 0.0 110.043 174.338 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 11.8 tt -90.58 156.69 3.01 Favored 'Isoleucine or valine' 0 N--CA 1.408 -2.532 0 C-N-CA 126.945 2.098 . . . . 0.0 106.042 176.308 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 25.4 tt0 -139.77 146.45 39.51 Favored 'General case' 0 N--CA 1.432 -1.334 0 N-CA-C 103.662 -2.718 . . . . 0.0 103.662 175.125 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 49.3 p90 -135.08 161.69 34.61 Favored 'General case' 0 N--CA 1.431 -1.379 0 N-CA-C 105.045 -2.205 . . . . 0.0 105.045 178.558 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 3.9 m120 -132.65 127.73 35.54 Favored 'General case' 0 CA--C 1.491 -1.325 0 N-CA-C 105.909 -1.886 . . . . 0.0 105.909 -178.884 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -81.18 159.99 66.59 Favored Pre-proline 0 N--CA 1.441 -0.901 0 C-N-CA 123.533 0.733 . . . . 0.0 111.254 -167.119 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_exo -67.29 173.87 7.99 Favored 'Trans proline' 0 N--CA 1.456 -0.718 0 C-N-CA 123.7 2.933 . . . . 0.0 111.738 166.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 49.4 tt0 -80.24 -42.38 1.37 Allowed Pre-proline 0 N--CA 1.444 -0.756 0 CA-C-O 115.63 -2.128 . . . . 0.0 111.522 -177.339 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 74.7 Cg_exo -66.59 148.13 82.93 Favored 'Trans proline' 0 CA--C 1.507 -0.849 0 CA-C-N 125.62 3.043 . . . . 0.0 112.061 177.039 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 24.6 p -98.99 58.52 1.13 Allowed 'General case' 0 C--N 1.355 0.844 0 N-CA-C 107.592 -1.262 . . . . 0.0 107.592 178.46 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 21.1 t-160 -104.38 -5.88 21.29 Favored 'General case' 0 N--CA 1.439 -1.001 0 C-N-CA 125.046 1.338 . . . . 0.0 107.784 178.104 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 56.7 mt -106.73 131.26 57.05 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.21 0 N-CA-C 105.2 -2.148 . . . . 0.0 105.2 178.498 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 75.2 m -104.01 -84.24 0.48 Allowed 'General case' 0 N--CA 1.43 -1.443 0 N-CA-C 106.203 -1.777 . . . . 0.0 106.203 -179.667 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 54.0 mtmt -88.9 167.26 13.37 Favored 'General case' 0 CA--C 1.492 -1.281 0 C-N-CA 123.687 0.795 . . . . 0.0 109.61 -168.801 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 90.0 m-85 -126.04 139.27 53.55 Favored 'General case' 0 N--CA 1.435 -1.196 0 N-CA-C 104.494 -2.41 . . . . 0.0 104.494 165.703 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 1.7 mp -115.03 136.34 52.05 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.132 1 N-CA-C 100.177 -4.009 . . . . 0.0 100.177 167.634 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 3.0 mt -111.53 133.63 53.67 Favored 'General case' 0 CA--C 1.472 -2.052 0 N-CA-C 103.837 -2.653 . . . . 0.0 103.837 164.588 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 16.7 ptp180 -128.73 154.84 45.94 Favored 'General case' 0 N--CA 1.432 -1.345 0 N-CA-C 106.301 -1.74 . . . . 0.0 106.301 169.107 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 48.3 p90 -153.44 144.53 22.94 Favored 'General case' 0 N--CA 1.436 -1.161 0 N-CA-C 106.987 -1.486 . . . . 0.0 106.987 -173.834 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 36.2 ttp180 -142.55 134.04 13.04 Favored Pre-proline 0 CA--C 1.497 -1.09 0 N-CA-C 104.783 -2.303 . . . . 0.0 104.783 -177.859 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 29.8 Cg_endo -72.31 116.71 4.81 Favored 'Trans proline' 0 CA--C 1.505 -0.947 0 C-N-CA 122.928 2.418 . . . . 0.0 108.156 178.364 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 5.5 tmtm? -69.86 85.02 0.49 Allowed 'General case' 0 C--N 1.359 1.011 0 C-N-CA 126.523 1.929 . . . . 0.0 110.242 -174.283 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 33.1 m120 -147.52 -67.78 0.25 Allowed 'General case' 0 N--CA 1.433 -1.286 0 N-CA-C 101.568 -3.493 . . . . 0.0 101.568 -178.71 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 50.8 p -103.28 170.27 8.06 Favored 'General case' 0 N--CA 1.441 -0.918 0 N-CA-C 107.072 -1.455 . . . . 0.0 107.072 171.617 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 3.7 m -119.82 53.42 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.841 0 N-CA-C 106.125 -1.806 . . . . 0.0 106.125 176.45 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -100.32 -131.55 7.41 Favored Glycine 0 C--N 1.356 1.641 0 N-CA-C 109.916 -1.273 . . . . 0.0 109.916 -175.452 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 56.1 ttp180 -79.78 148.51 31.42 Favored 'General case' 0 C--N 1.357 0.9 0 C-N-CA 124.727 1.211 . . . . 0.0 108.694 -175.026 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -148.5 169.86 19.32 Favored 'General case' 0 CA--C 1.494 -1.174 0 CA-C-O 121.468 0.651 . . . . 0.0 110.616 -171.952 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 62.3 mttp -112.3 159.07 19.01 Favored 'General case' 0 CA--C 1.491 -1.292 0 N-CA-C 107.774 -1.195 . . . . 0.0 107.774 -168.849 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 16.2 pt-20 -151.63 160.65 43.55 Favored 'General case' 0 N--CA 1.436 -1.141 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 172.287 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -137.38 163.69 30.42 Favored 'General case' 0 CA--C 1.501 -0.942 0 N-CA-C 106.063 -1.829 . . . . 0.0 106.063 171.68 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 89.4 m -120.41 125.25 47.49 Favored 'General case' 0 CA--C 1.501 -0.913 0 N-CA-C 104.957 -2.238 . . . . 0.0 104.957 175.992 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 5.3 mp -114.11 136.48 22.21 Favored Pre-proline 0 N--CA 1.437 -1.102 0 N-CA-C 105.196 -2.15 . . . . 0.0 105.196 -175.608 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_exo -64.19 163.72 25.09 Favored 'Trans proline' 0 CA--C 1.51 -0.723 0 C-N-CA 123.378 2.719 . . . . 0.0 113.774 176.624 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -76.26 -18.44 79.27 Favored Glycine 0 C--N 1.353 1.49 0 C-N-CA 124.149 0.881 . . . . 0.0 114.244 -174.03 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 52.4 p-80 -83.28 -25.17 31.82 Favored 'General case' 0 C--N 1.355 0.837 0 CA-C-N 117.951 0.876 . . . . 0.0 109.945 -179.044 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 89.0 mt -88.43 131.57 34.81 Favored 'General case' 0 CA--C 1.5 -0.955 0 N-CA-C 107.712 -1.218 . . . . 0.0 107.712 176.797 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 8.6 p-10 -113.74 8.82 17.59 Favored 'General case' 0 CA--C 1.502 -0.89 0 C-N-CA 124.457 1.103 . . . . 0.0 109.631 -174.916 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 33.5 p -146.39 157.73 43.81 Favored 'General case' 0 CA--C 1.498 -1.055 0 N-CA-C 106.633 -1.617 . . . . 0.0 106.633 -177.463 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 35.4 t80 -154.14 151.27 29.06 Favored 'General case' 0 CA--C 1.487 -1.444 0 N-CA-C 108.07 -1.085 . . . . 0.0 108.07 178.236 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 16.9 m -108.64 113.99 27.43 Favored 'General case' 0 N--CA 1.439 -0.979 0 N-CA-C 105.951 -1.87 . . . . 0.0 105.951 174.954 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 45.5 mt -91.95 102.28 13.39 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.89 0 N-CA-C 105.242 -2.132 . . . . 0.0 105.242 178.117 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 35.1 mtmm -106.48 162.32 13.82 Favored 'General case' 0 CA--C 1.497 -1.096 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 -175.785 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 79.93 52.51 4.61 Favored Glycine 0 C--N 1.351 1.365 0 N-CA-C 109.099 -1.6 . . . . 0.0 109.099 178.434 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 89.5 mt -118.12 173.12 6.97 Favored 'General case' 0 CA--C 1.498 -1.023 0 N-CA-C 106.87 -1.53 . . . . 0.0 106.87 -178.778 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 51.6 mtmt -98.14 147.28 32.87 Favored Pre-proline 0 N--CA 1.438 -1.063 0 N-CA-C 105.786 -1.931 . . . . 0.0 105.786 178.666 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -78.56 160.99 28.32 Favored 'Trans proline' 0 N--CA 1.452 -0.93 0 C-N-CA 123.043 2.496 . . . . 0.0 109.997 173.515 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 59.6 30.33 68.52 Favored Glycine 0 C--N 1.356 1.65 0 C-N-CA 126.626 2.06 . . . . 0.0 116.24 169.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 6.4 p -128.45 154.62 39.47 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.85 0 N-CA-C 107.813 -1.18 . . . . 0.0 107.813 -176.002 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 4.8 p -96.53 135.69 29.81 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.9 0 N-CA-C 106.769 -1.567 . . . . 0.0 106.769 175.554 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 81.9 m-85 -113.89 147.44 38.48 Favored 'General case' 0 CA--C 1.497 -1.078 0 N-CA-C 105.382 -2.081 . . . . 0.0 105.382 171.432 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 15.2 pt-20 -95.92 136.53 36.23 Favored 'General case' 0 CA--C 1.498 -1.027 0 N-CA-C 103.457 -2.794 . . . . 0.0 103.457 162.016 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -132.62 146.38 18.18 Favored Glycine 0 CA--C 1.485 -1.784 0 N-CA-C 107.679 -2.168 . . . . 0.0 107.679 -172.332 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 25.2 mt-30 -136.74 133.46 36.07 Favored 'General case' 0 CA--C 1.482 -1.65 0 N-CA-C 105.746 -1.946 . . . . 0.0 105.746 178.627 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 49.6 tp -112.63 100.1 8.45 Favored 'General case' 0 N--CA 1.437 -1.108 0 N-CA-C 103.393 -2.817 . . . . 0.0 103.393 179.535 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 21.7 mt -94.83 129.33 45.15 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.915 0 N-CA-C 104.696 -2.335 . . . . 0.0 104.696 -176.797 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 69.2 m -113.5 113.79 25.62 Favored 'General case' 0 CA--C 1.497 -1.092 0 N-CA-C 107.668 -1.234 . . . . 0.0 107.668 -175.276 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 18.5 mm -89.36 142.73 12.47 Favored 'Isoleucine or valine' 0 CA--C 1.49 -1.349 0 N-CA-C 105.514 -2.032 . . . . 0.0 105.514 -173.441 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 83.0 mt-30 -92.5 -175.62 4.04 Favored 'General case' 0 CA--C 1.502 -0.897 0 CA-C-N 114.766 -1.106 . . . . 0.0 109.203 -175.569 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 73.2 mt-30 -74.79 78.22 2.09 Favored 'General case' 0 N--CA 1.442 -0.863 0 C-N-CA 125.84 1.656 . . . . 0.0 112.347 -177.612 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 65.8 m-85 60.06 21.8 10.98 Favored 'General case' 0 C--N 1.358 0.977 0 C-N-CA 127.322 2.249 . . . . 0.0 112.777 178.623 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -119.28 -118.95 2.78 Favored Glycine 0 C--N 1.355 1.597 0 N-CA-C 108.695 -1.762 . . . . 0.0 108.695 -173.847 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' HIS . . . . . 0.551 ' CD2' ' H ' ' A' ' 82' ' ' GLN . 12.5 t-160 -81.34 -171.56 3.34 Favored 'General case' 0 CA--C 1.497 -1.065 0 C-N-CA 125.386 1.475 . . . . 0.0 108.902 -177.852 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . 0.551 ' H ' ' CD2' ' A' ' 81' ' ' HIS . 5.9 pt20 -144.66 146.48 32.27 Favored 'General case' 0 N--CA 1.434 -1.274 0 N-CA-C 106.067 -1.827 . . . . 0.0 106.067 170.127 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 46.9 mm-40 -105.19 156.22 18.31 Favored 'General case' 0 CA--C 1.494 -1.178 0 N-CA-C 105.897 -1.89 . . . . 0.0 105.897 179.735 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 7.4 p -129.51 135.76 60.83 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.924 0 N-CA-C 107.308 -1.367 . . . . 0.0 107.308 179.741 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 24.7 m -118.62 133.38 55.9 Favored 'General case' 0 N--CA 1.439 -1.001 0 N-CA-C 102.006 -3.331 . . . . 0.0 102.006 175.467 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 78.6 mtm180 -129.17 147.83 51.05 Favored 'General case' 0 CA--C 1.497 -1.081 0 CA-C-N 119.303 0.956 . . . . 0.0 109.187 -177.698 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 18.5 p90 -166.07 -176.1 3.61 Favored 'General case' 0 CA--C 1.498 -1.025 0 N-CA-C 106.826 -1.546 . . . . 0.0 106.826 -174.79 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -134.58 156.72 48.19 Favored 'General case' 0 N--CA 1.44 -0.962 0 N-CA-C 105.596 -2.001 . . . . 0.0 105.596 164.371 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 23.7 p90 -138.13 165.17 27.3 Favored 'General case' 0 CA--C 1.483 -1.629 0 N-CA-C 107.227 -1.397 . . . . 0.0 107.227 169.449 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 29.4 p -119.67 143.89 47.48 Favored 'General case' 0 N--CA 1.439 -1.004 0 N-CA-C 107.374 -1.343 . . . . 0.0 107.374 176.381 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 19.6 p -108.99 135.06 50.78 Favored 'General case' 0 N--CA 1.439 -1.012 0 N-CA-C 103.613 -2.736 . . . . 0.0 103.613 164.608 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 15.2 t -139.72 149.49 43.69 Favored 'General case' 0 N--CA 1.439 -1.005 0 N-CA-C 106.332 -1.729 . . . . 0.0 106.332 -173.742 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 35.4 t . . . . . 0 C--O 1.261 1.685 0 N-CA-C 105.396 -2.076 . . . . 0.0 105.396 177.99 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.442 -0.938 0 N-CA-C 109.136 -1.586 . . . . 0.0 109.136 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 64.4 Cg_exo -61.48 138.23 74.7 Favored 'Trans proline' 0 N--CA 1.442 -1.508 0 C-N-CA 123.241 2.628 . . . . 0.0 112.957 179.643 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 2.8 t -77.45 153.8 5.42 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.728 0 C-N-CA 127.785 2.434 . . . . 0.0 106.339 -178.527 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 48.7 mm-40 -99.03 88.76 4.05 Favored 'General case' 0 CA--C 1.488 -1.405 0 CA-C-O 122.829 1.3 . . . . 0.0 109.14 -170.133 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 2.4 p -105.66 128.01 60.12 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.07 0 CA-C-N 113.43 -1.714 . . . . 0.0 108.685 -164.376 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 27.5 p90 . . . . . 0 N--CA 1.44 -0.97 0 N-CA-C 106.703 -1.592 . . . . 0.0 106.703 -174.584 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 82.0 Cg_endo . . . . . 0 CA--C 1.505 -0.952 0 CA-C-O 117.82 -0.992 . . . . 0.0 111.544 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 4.1 t30 -124.95 -31.99 3.08 Favored 'General case' 0 CA--C 1.488 -1.42 0 CA-C-N 118.637 0.653 . . . . 0.0 109.78 -165.741 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 13.5 p -106.63 141.85 37.24 Favored 'General case' 0 CA--C 1.493 -1.238 0 N-CA-C 107.44 -1.319 . . . . 0.0 107.44 179.22 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 63.0 t60 -141.89 98.22 6.33 Favored Pre-proline 0 N--CA 1.439 -1.024 0 N-CA-C 107.603 -1.258 . . . . 0.0 107.603 176.531 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -78.32 139.11 16.37 Favored 'Trans proline' 0 N--CA 1.449 -1.092 0 C-N-CA 122.814 2.343 . . . . 0.0 110.785 -177.14 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 21.6 mm -106.87 136.27 42.4 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.958 0 N-CA-C 103.104 -2.924 . . . . 0.0 103.104 174.287 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 40.7 mt-30 -138.76 141.28 38.84 Favored 'General case' 0 CA--C 1.491 -1.318 0 N-CA-C 103.494 -2.78 . . . . 0.0 103.494 -178.048 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 46.1 p90 -148.77 167.23 26.14 Favored 'General case' 0 CA--C 1.498 -1.048 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 -170.609 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 9.5 m120 -131.19 129.53 41.82 Favored 'General case' 0 CA--C 1.492 -1.259 0 N-CA-C 107.441 -1.318 . . . . 0.0 107.441 178.868 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -94.71 170.58 7.85 Favored Pre-proline 0 N--CA 1.439 -0.999 0 C-N-CA 124.468 1.107 . . . . 0.0 109.879 -170.97 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 80.2 Cg_exo -66.06 164.13 28.77 Favored 'Trans proline' 0 CA--C 1.508 -0.807 0 C-N-CA 123.633 2.888 . . . . 0.0 112.222 168.929 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 17.4 mp0 -83.3 -57.34 0.43 Allowed Pre-proline 0 N--CA 1.442 -0.826 0 CA-C-O 115.844 -2.027 . . . . 0.0 110.402 -177.132 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -74.87 171.88 17.42 Favored 'Trans proline' 0 CA--C 1.509 -0.743 0 CA-C-N 125.499 3.0 . . . . 0.0 110.349 177.702 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 66.0 m -75.93 125.86 29.9 Favored 'General case' 0 CA--C 1.501 -0.933 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 -179.635 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 74.8 t60 -162.37 -49.89 0.04 OUTLIER 'General case' 0 N--CA 1.436 -1.17 0 N-CA-C 106.202 -1.777 . . . . 0.0 106.202 -172.813 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 54.0 mt -113.06 136.53 49.08 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.142 0 N-CA-C 105.203 -2.147 . . . . 0.0 105.203 -177.109 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 32.1 t -110.53 -87.5 0.52 Allowed 'General case' 0 N--CA 1.43 -1.474 0 N-CA-C 106.717 -1.586 . . . . 0.0 106.717 179.028 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 6.7 ttpm? -91.86 160.49 15.27 Favored 'General case' 0 CA--C 1.492 -1.262 0 C-N-CA 125.667 1.587 . . . . 0.0 107.649 -160.155 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 92.0 m-85 -125.58 138.91 53.96 Favored 'General case' 0 CA--C 1.494 -1.185 0 N-CA-C 106.277 -1.749 . . . . 0.0 106.277 176.072 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 53.5 mt -116.92 126.82 74.55 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.152 0 N-CA-C 102.592 -3.114 . . . . 0.0 102.592 168.483 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 5.0 mt -102.2 128.65 48.61 Favored 'General case' 0 CA--C 1.475 -1.912 0 N-CA-C 104.894 -2.261 . . . . 0.0 104.894 170.556 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 42.4 ttp85 -132.47 122.0 24.23 Favored 'General case' 0 N--CA 1.437 -1.115 0 N-CA-C 106.097 -1.816 . . . . 0.0 106.097 -178.71 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 42.3 p90 -138.06 151.1 47.52 Favored 'General case' 0 N--CA 1.444 -0.757 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 -169.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 33.2 ptt180 -155.92 164.47 21.25 Favored Pre-proline 0 CA--C 1.502 -0.897 0 N-CA-C 106.605 -1.628 . . . . 0.0 106.605 171.384 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . 0.416 ' HA ' ' HA ' ' A' ' 69' ' ' TYR . 37.7 Cg_endo -75.69 127.27 10.09 Favored 'Trans proline' 0 N--CA 1.452 -0.932 0 C-N-CA 122.344 2.029 . . . . 0.0 108.983 179.141 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 64.0 tttm -69.75 83.07 0.45 Allowed 'General case' 0 C--N 1.357 0.921 0 C-N-CA 127.349 2.259 . . . . 0.0 110.821 -177.588 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 29.1 m120 -145.9 -89.81 0.1 Allowed 'General case' 0 N--CA 1.437 -1.091 0 N-CA-C 105.054 -2.202 . . . . 0.0 105.054 -175.958 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 3.7 t -94.31 -164.95 1.23 Allowed 'General case' 0 C--N 1.355 0.819 0 C-N-CA 124.032 0.933 . . . . 0.0 108.924 -172.641 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 4.2 m -121.17 54.51 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.439 -1.003 0 N-CA-C 106.307 -1.738 . . . . 0.0 106.307 -176.648 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -89.8 -140.2 7.93 Favored Glycine 0 C--N 1.355 1.595 0 N-CA-C 110.281 -1.128 . . . . 0.0 110.281 -178.179 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -99.33 165.01 11.88 Favored 'General case' 0 CA--C 1.503 -0.831 0 N-CA-C 106.484 -1.672 . . . . 0.0 106.484 -178.332 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 47.3 m95 -112.34 156.73 21.98 Favored 'General case' 0 N--CA 1.441 -0.912 0 N-CA-C 108.071 -1.085 . . . . 0.0 108.071 -179.09 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 67.9 mttm -97.46 152.25 19.17 Favored 'General case' 0 CA--C 1.49 -1.352 0 N-CA-C 104.779 -2.304 . . . . 0.0 104.779 163.824 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -153.18 156.62 38.91 Favored 'General case' 0 CA--C 1.494 -1.191 0 N-CA-C 107.833 -1.173 . . . . 0.0 107.833 178.854 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -141.07 162.93 34.32 Favored 'General case' 0 CA--C 1.496 -1.132 0 N-CA-C 106.349 -1.723 . . . . 0.0 106.349 175.876 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 88.1 m -122.36 127.24 49.51 Favored 'General case' 0 CA--C 1.501 -0.933 0 N-CA-C 105.242 -2.133 . . . . 0.0 105.242 -179.705 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 4.8 mp -117.38 133.88 23.17 Favored Pre-proline 0 N--CA 1.437 -1.106 0 N-CA-C 104.613 -2.366 . . . . 0.0 104.613 -174.725 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_exo -63.32 166.19 15.6 Favored 'Trans proline' 0 CA--C 1.509 -0.742 0 C-N-CA 123.344 2.696 . . . . 0.0 113.616 176.677 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -81.14 -17.18 72.59 Favored Glycine 0 C--N 1.351 1.405 0 C-N-CA 123.557 0.598 . . . . 0.0 113.099 -172.073 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 52.2 p-80 -83.66 -24.8 31.19 Favored 'General case' 0 C--N 1.355 0.841 0 CA-C-N 117.889 0.845 . . . . 0.0 109.862 179.88 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 87.4 mt -88.18 130.67 34.99 Favored 'General case' 0 CA--C 1.501 -0.94 0 N-CA-C 107.645 -1.243 . . . . 0.0 107.645 177.139 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 8.1 p30 -110.15 7.95 23.59 Favored 'General case' 0 N--CA 1.441 -0.881 0 C-N-CA 124.708 1.203 . . . . 0.0 109.758 -174.937 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 42.1 p -146.5 167.03 24.69 Favored 'General case' 0 N--CA 1.439 -1.0 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 -178.14 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 9.3 t80 -153.29 178.37 9.84 Favored 'General case' 0 N--CA 1.439 -1.023 0 N-CA-C 107.1 -1.444 . . . . 0.0 107.1 -178.275 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 70.0 m -142.0 116.22 9.47 Favored 'General case' 0 N--CA 1.43 -1.459 0 N-CA-C 104.812 -2.292 . . . . 0.0 104.812 176.632 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 12.7 mm -85.75 140.18 16.3 Favored 'Isoleucine or valine' 0 C--N 1.358 0.964 0 N-CA-C 103.856 -2.646 . . . . 0.0 103.856 170.332 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 7.9 mtpm? -141.7 164.65 29.64 Favored 'General case' 0 CA--C 1.497 -1.063 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 178.938 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 85.86 49.49 4.28 Favored Glycine 0 CA--C 1.487 -1.669 0 N-CA-C 108.931 -1.668 . . . . 0.0 108.931 174.843 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 58.1 mt -118.77 170.15 9.24 Favored 'General case' 0 CA--C 1.497 -1.071 0 N-CA-C 108.528 -0.916 . . . . 0.0 108.528 -169.864 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 60.6 mtpt -110.46 155.16 42.51 Favored Pre-proline 0 N--CA 1.44 -0.929 0 N-CA-C 106.942 -1.503 . . . . 0.0 106.942 -176.478 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 63.9 Cg_endo -78.94 161.04 27.1 Favored 'Trans proline' 0 N--CA 1.452 -0.966 0 C-N-CA 122.91 2.407 . . . . 0.0 110.308 172.982 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . 0.438 ' H ' ' HA ' ' A' ' 92' ' ' THR . . . 59.47 26.27 61.8 Favored Glycine 0 C--N 1.355 1.586 0 C-N-CA 127.673 2.559 . . . . 0.0 116.378 171.29 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 10.7 p -121.77 147.45 25.76 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.992 0 N-CA-C 107.362 -1.348 . . . . 0.0 107.362 -177.203 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 4.0 p -96.73 129.15 47.19 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.951 0 N-CA-C 106.93 -1.507 . . . . 0.0 106.93 177.125 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . 0.416 ' HA ' ' HA ' ' A' ' 39' ' ' PRO . 93.4 m-85 -111.18 144.84 39.7 Favored 'General case' 0 CA--C 1.496 -1.113 0 N-CA-C 106.043 -1.836 . . . . 0.0 106.043 173.124 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -96.72 145.12 26.09 Favored 'General case' 0 CA--C 1.496 -1.128 0 N-CA-C 104.475 -2.417 . . . . 0.0 104.475 166.103 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -140.97 155.77 25.16 Favored Glycine 0 CA--C 1.486 -1.731 0 N-CA-C 108.624 -1.791 . . . . 0.0 108.624 -176.275 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 86.8 mt-30 -142.9 134.39 26.34 Favored 'General case' 0 CA--C 1.479 -1.782 0 N-CA-C 104.456 -2.424 . . . . 0.0 104.456 -179.333 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 35.6 tp -114.77 96.17 5.59 Favored 'General case' 0 N--CA 1.437 -1.102 0 N-CA-C 103.659 -2.719 . . . . 0.0 103.659 176.468 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 21.8 mt -88.76 135.37 25.92 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.048 0 N-CA-C 104.213 -2.514 . . . . 0.0 104.213 -177.275 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 14.2 p -124.96 112.14 16.24 Favored 'General case' 0 N--CA 1.435 -1.212 0 N-CA-C 107.777 -1.194 . . . . 0.0 107.777 -171.771 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 2.0 mp -93.48 134.84 29.87 Favored 'Isoleucine or valine' 0 CA--C 1.488 -1.41 0 N-CA-C 104.506 -2.405 . . . . 0.0 104.506 -165.703 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 74.4 mt-30 -92.66 149.9 21.04 Favored 'General case' 0 CA--C 1.493 -1.249 0 N-CA-C 106.522 -1.659 . . . . 0.0 106.522 -178.687 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 44.6 tt0 -70.46 105.71 3.16 Favored 'General case' 0 N--CA 1.441 -0.894 0 C-N-CA 123.44 0.696 . . . . 0.0 110.408 -177.997 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 31.6 m-85 59.94 41.03 18.29 Favored 'General case' 0 C--N 1.356 0.883 0 C-N-CA 127.094 2.157 . . . . 0.0 112.469 -178.626 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -149.94 -126.11 1.39 Allowed Glycine 0 C--N 1.358 1.752 0 N-CA-C 109.283 -1.527 . . . . 0.0 109.283 178.738 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 47.1 m80 -85.11 -176.26 6.1 Favored 'General case' 0 CA--C 1.497 -1.071 0 C-N-CA 126.107 1.763 . . . . 0.0 111.436 -165.555 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 70.1 mt-30 -130.42 144.47 51.41 Favored 'General case' 0 CA--C 1.496 -1.101 0 N-CA-C 103.975 -2.602 . . . . 0.0 103.975 168.659 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 57.3 mt-10 -131.28 131.32 43.77 Favored 'General case' 0 CA--C 1.491 -1.304 0 N-CA-C 105.312 -2.107 . . . . 0.0 105.312 179.721 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 12.4 p -104.48 134.82 44.78 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.799 0 N-CA-C 108.137 -1.06 . . . . 0.0 108.137 -174.914 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 40.0 m -109.11 131.71 54.81 Favored 'General case' 0 N--CA 1.44 -0.926 0 N-CA-C 101.831 -3.396 . . . . 0.0 101.831 171.403 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 87.5 mtt180 -123.75 149.01 46.11 Favored 'General case' 0 CA--C 1.494 -1.174 0 CA-C-N 119.491 1.041 . . . . 0.0 109.901 -177.92 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 14.8 p90 -163.25 -179.61 6.73 Favored 'General case' 0 CA--C 1.499 -0.988 0 N-CA-C 107.209 -1.404 . . . . 0.0 107.209 -179.149 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 9.3 p-10 -141.31 160.16 40.7 Favored 'General case' 0 N--CA 1.44 -0.963 0 N-CA-C 105.865 -1.902 . . . . 0.0 105.865 167.005 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 23.4 p90 -148.3 170.17 18.5 Favored 'General case' 0 CA--C 1.49 -1.358 0 N-CA-C 107.332 -1.358 . . . . 0.0 107.332 177.294 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 23.9 p -119.25 142.53 47.97 Favored 'General case' 0 CA--C 1.498 -1.024 0 N-CA-C 105.696 -1.965 . . . . 0.0 105.696 171.458 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 45.0 m -115.7 119.83 37.35 Favored 'General case' 0 CA--C 1.495 -1.143 0 N-CA-C 102.614 -3.106 . . . . 0.0 102.614 170.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . 0.438 ' HA ' ' H ' ' A' ' 66' ' ' GLY . 14.1 t -154.38 159.19 41.0 Favored 'General case' 0 N--CA 1.436 -1.144 0 N-CA-C 105.901 -1.888 . . . . 0.0 105.901 -173.205 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 9.4 t . . . . . 0 C--O 1.262 1.714 0 N-CA-C 106.356 -1.72 . . . . 0.0 106.356 175.042 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.438 -1.206 0 N-CA-C 106.767 -2.533 . . . . 0.0 106.767 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_exo -61.2 142.47 96.63 Favored 'Trans proline' 0 N--CA 1.446 -1.307 0 C-N-CA 122.837 2.358 . . . . 0.0 114.523 -171.68 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 4.4 t -76.27 154.29 5.89 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.83 0 C-N-CA 127.889 2.476 . . . . 0.0 106.608 -179.06 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 56.6 mm-40 -99.81 92.88 5.51 Favored 'General case' 0 CA--C 1.49 -1.357 0 N-CA-C 107.412 -1.329 . . . . 0.0 107.412 -177.613 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 1.3 p -108.1 131.32 58.82 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.067 0 CA-C-N 113.15 -1.841 . . . . 0.0 108.684 -164.512 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 40.0 m-85 . . . . . 0 CA--C 1.498 -1.027 0 N-CA-C 106.611 -1.626 . . . . 0.0 106.611 173.823 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 95.7 Cg_endo . . . . . 0 N--CA 1.452 -0.928 0 CA-C-O 118.115 -0.869 . . . . 0.0 110.596 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 48.5 m-20 -125.02 -20.92 4.8 Favored 'General case' 0 N--CA 1.434 -1.25 0 C-N-CA 123.617 0.767 . . . . 0.0 109.938 -171.791 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 19.4 m -103.8 142.0 35.13 Favored 'General case' 0 CA--C 1.494 -1.192 0 N-CA-C 106.993 -1.484 . . . . 0.0 106.993 178.677 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 61.6 t-80 -139.29 98.0 8.37 Favored Pre-proline 0 N--CA 1.434 -1.273 0 N-CA-C 105.513 -2.032 . . . . 0.0 105.513 176.819 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -80.55 148.86 18.45 Favored 'Trans proline' 0 N--CA 1.445 -1.327 0 C-N-CA 122.468 2.112 . . . . 0.0 109.403 174.315 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.414 HD11 HD11 ' A' ' 35' ' ' LEU . 5.0 pt -124.38 170.72 14.19 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.031 0 N-CA-C 107.525 -1.287 . . . . 0.0 107.525 172.324 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 32.5 mt-30 -139.04 161.17 38.04 Favored 'General case' 0 CA--C 1.501 -0.926 0 N-CA-C 105.161 -2.163 . . . . 0.0 105.161 167.884 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 49.5 p90 -148.56 169.39 20.41 Favored 'General case' 0 CA--C 1.497 -1.089 0 N-CA-C 108.136 -1.061 . . . . 0.0 108.136 175.679 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 20.8 m-80 -134.12 126.04 29.21 Favored 'General case' 0 CA--C 1.491 -1.308 0 N-CA-C 105.573 -2.01 . . . . 0.0 105.573 173.965 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -105.75 175.96 1.9 Allowed Pre-proline 0 N--CA 1.44 -0.969 0 C-N-CA 125.823 1.649 . . . . 0.0 107.647 -169.967 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_exo -61.6 144.86 97.92 Favored 'Trans proline' 0 N--CA 1.455 -0.766 0 C-N-CA 123.174 2.583 . . . . 0.0 113.151 176.488 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 22.0 tt0 -82.8 -39.98 0.83 Allowed Pre-proline 0 N--CA 1.443 -0.818 0 CA-C-O 115.564 -2.16 . . . . 0.0 112.726 -173.034 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 76.2 Cg_exo -72.18 4.65 3.15 Favored 'Trans proline' 0 C--N 1.349 0.561 0 CA-C-N 125.687 3.067 . . . . 0.0 114.679 -178.234 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 34.7 m 71.89 64.66 0.14 Allowed 'General case' 0 CA--C 1.499 -0.984 0 C-N-CA 126.464 1.905 . . . . 0.0 109.06 -178.432 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 55.9 t-80 -87.0 -28.11 22.83 Favored 'General case' 0 N--CA 1.44 -0.957 0 C-N-CA 125.127 1.371 . . . . 0.0 108.25 178.772 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 8.2 mm -119.29 147.61 22.76 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.15 0 N-CA-C 106.395 -1.706 . . . . 0.0 106.395 -170.959 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 74.5 m -99.35 -83.9 0.42 Allowed 'General case' 0 N--CA 1.43 -1.45 0 N-CA-C 106.406 -1.701 . . . . 0.0 106.406 175.896 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 45.5 mtpt -90.0 170.48 10.32 Favored 'General case' 0 CA--C 1.49 -1.349 0 C-N-CA 125.259 1.424 . . . . 0.0 109.198 -164.242 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 42.2 m-85 -131.39 145.4 51.8 Favored 'General case' 0 CA--C 1.498 -1.032 0 N-CA-C 104.589 -2.374 . . . . 0.0 104.589 166.624 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 33.1 mt -123.34 137.37 56.89 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.188 0 N-CA-C 101.792 -3.41 . . . . 0.0 101.792 170.248 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.414 HD11 HD11 ' A' ' 20' ' ' ILE . 4.7 mt -114.09 134.47 54.86 Favored 'General case' 0 CA--C 1.467 -2.214 0 N-CA-C 104.64 -2.356 . . . . 0.0 104.64 168.764 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 49.0 mtp180 -118.05 158.74 24.44 Favored 'General case' 0 N--CA 1.431 -1.417 0 N-CA-C 105.381 -2.081 . . . . 0.0 105.381 167.301 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 49.5 p90 -152.63 158.29 42.21 Favored 'General case' 0 N--CA 1.435 -1.21 0 N-CA-C 105.981 -1.859 . . . . 0.0 105.981 173.033 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 46.9 ttp180 -165.08 135.99 3.14 Favored Pre-proline 0 CA--C 1.497 -1.078 0 N-CA-C 104.783 -2.303 . . . . 0.0 104.783 -174.168 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -73.06 117.06 4.95 Favored 'Trans proline' 0 CA--C 1.505 -0.969 0 C-N-CA 122.766 2.311 . . . . 0.0 109.132 -176.829 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 37.9 ttpt -70.71 88.0 0.7 Allowed 'General case' 0 CA--C 1.499 -0.982 0 C-N-CA 126.414 1.886 . . . . 0.0 109.621 -179.939 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 -154.32 -58.55 0.12 Allowed 'General case' 0 N--CA 1.431 -1.401 0 N-CA-C 103.447 -2.797 . . . . 0.0 103.447 -178.521 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 6.4 t -107.32 -167.53 1.28 Allowed 'General case' 0 N--CA 1.439 -0.977 0 N-CA-C 105.228 -2.138 . . . . 0.0 105.228 169.376 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 2.7 m -134.84 63.44 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.44 -0.957 0 N-CA-C 104.823 -2.288 . . . . 0.0 104.823 179.18 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -91.23 -134.71 6.21 Favored Glycine 0 C--N 1.354 1.545 0 N-CA-C 109.819 -1.312 . . . . 0.0 109.819 -176.415 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -94.37 149.57 21.12 Favored 'General case' 0 CA--C 1.499 -1.003 0 N-CA-C 106.871 -1.529 . . . . 0.0 106.871 -176.498 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 64.2 m95 -93.84 151.42 19.61 Favored 'General case' 0 N--CA 1.439 -1.022 0 N-CA-C 107.703 -1.221 . . . . 0.0 107.703 178.825 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 61.9 mttp -96.99 152.32 18.84 Favored 'General case' 0 CA--C 1.488 -1.433 0 N-CA-C 104.105 -2.554 . . . . 0.0 104.105 161.073 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -152.69 155.44 37.27 Favored 'General case' 0 N--CA 1.435 -1.204 0 N-CA-C 108.23 -1.026 . . . . 0.0 108.23 -178.073 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -140.85 161.48 37.72 Favored 'General case' 0 CA--C 1.498 -1.028 0 N-CA-C 106.556 -1.646 . . . . 0.0 106.556 174.74 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 87.0 m -118.83 124.82 48.12 Favored 'General case' 0 CA--C 1.5 -0.954 0 N-CA-C 105.517 -2.031 . . . . 0.0 105.517 178.807 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 3.9 mp -106.13 134.37 19.8 Favored Pre-proline 0 N--CA 1.437 -1.099 0 N-CA-C 105.279 -2.119 . . . . 0.0 105.279 -177.468 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_exo -63.93 163.07 26.53 Favored 'Trans proline' 0 CA--C 1.507 -0.833 0 C-N-CA 123.491 2.794 . . . . 0.0 113.146 176.115 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -74.49 -17.14 79.82 Favored Glycine 0 C--N 1.351 1.41 0 C-N-CA 124.006 0.812 . . . . 0.0 114.477 -173.68 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 49.1 p-80 -84.04 -28.69 27.45 Favored 'General case' 0 C--N 1.355 0.826 0 CA-C-N 118.144 0.972 . . . . 0.0 110.22 -179.69 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 89.1 mt -88.74 130.83 35.26 Favored 'General case' 0 CA--C 1.5 -0.961 0 N-CA-C 107.94 -1.133 . . . . 0.0 107.94 178.07 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 7.7 p30 -117.1 11.37 14.18 Favored 'General case' 0 CA--C 1.503 -0.835 0 C-N-CA 124.225 1.01 . . . . 0.0 109.774 -173.563 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 28.1 p -141.02 159.83 41.38 Favored 'General case' 0 CA--C 1.497 -1.081 0 N-CA-C 106.583 -1.636 . . . . 0.0 106.583 179.427 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 7.9 t80 -135.65 172.95 12.27 Favored 'General case' 0 C--N 1.359 1.003 0 CA-C-O 121.829 0.823 . . . . 0.0 109.254 178.84 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 98.8 m -137.18 110.79 8.04 Favored 'General case' 0 N--CA 1.434 -1.257 0 N-CA-C 104.425 -2.435 . . . . 0.0 104.425 173.77 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 24.9 mt -89.28 143.39 11.27 Favored 'Isoleucine or valine' 0 C--N 1.358 0.945 0 N-CA-C 103.662 -2.718 . . . . 0.0 103.662 169.854 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -149.55 158.1 43.87 Favored 'General case' 0 CA--C 1.491 -1.302 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 -178.85 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 77.75 56.58 3.79 Favored Glycine 0 C--N 1.354 1.561 0 N-CA-C 108.984 -1.646 . . . . 0.0 108.984 -179.904 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 69.1 mt -117.08 -160.83 0.78 Allowed 'General case' 0 CA--C 1.5 -0.944 0 N-CA-C 106.584 -1.636 . . . . 0.0 106.584 -179.012 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -131.39 153.42 81.62 Favored Pre-proline 0 N--CA 1.443 -0.811 0 N-CA-C 106.067 -1.827 . . . . 0.0 106.067 -177.78 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 67.6 Cg_endo -79.4 162.45 25.12 Favored 'Trans proline' 0 N--CA 1.453 -0.886 0 C-N-CA 122.858 2.372 . . . . 0.0 109.925 171.893 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . 0.504 ' H ' ' HA ' ' A' ' 92' ' ' THR . . . 61.17 26.96 66.62 Favored Glycine 0 N--CA 1.431 -1.646 0 C-N-CA 127.27 2.367 . . . . 0.0 115.972 171.509 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 9.1 p -127.59 142.92 42.31 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.116 0 N-CA-C 108.28 -1.007 . . . . 0.0 108.28 -177.83 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 7.5 p -95.58 128.41 46.79 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.929 0 N-CA-C 107.463 -1.31 . . . . 0.0 107.463 177.029 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 91.5 m-85 -107.73 148.46 29.42 Favored 'General case' 0 CA--C 1.498 -1.039 0 N-CA-C 106.382 -1.71 . . . . 0.0 106.382 174.235 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -98.98 140.04 33.73 Favored 'General case' 0 CA--C 1.496 -1.121 0 N-CA-C 104.397 -2.445 . . . . 0.0 104.397 161.826 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -131.96 153.29 20.45 Favored Glycine 0 CA--C 1.484 -1.848 0 N-CA-C 107.688 -2.165 . . . . 0.0 107.688 -175.807 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 36.7 mt-30 -135.58 136.18 40.88 Favored 'General case' 0 CA--C 1.478 -1.791 0 N-CA-C 105.935 -1.876 . . . . 0.0 105.935 175.166 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 27.1 tp -114.39 103.31 10.94 Favored 'General case' 0 N--CA 1.438 -1.063 0 N-CA-C 104.179 -2.526 . . . . 0.0 104.179 176.456 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 24.4 mt -103.25 125.11 57.77 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.973 0 N-CA-C 104.068 -2.568 . . . . 0.0 104.068 -174.23 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 74.2 m -110.28 120.75 43.45 Favored 'General case' 0 CA--C 1.497 -1.091 0 N-CA-C 108.251 -1.018 . . . . 0.0 108.251 -175.653 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 1.8 mp -99.85 138.38 24.38 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.123 0 N-CA-C 104.647 -2.353 . . . . 0.0 104.647 -170.798 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 16.3 tt0 -105.09 127.84 53.07 Favored 'General case' 0 CA--C 1.494 -1.207 0 N-CA-C 102.02 -3.326 . . . . 0.0 102.02 170.692 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 63.5 tp60 -68.38 114.68 7.03 Favored 'General case' 0 C--N 1.355 0.825 0 C-N-CA 123.117 0.567 . . . . 0.0 111.163 -168.77 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 44.4 m-85 59.33 51.68 6.57 Favored 'General case' 0 C--N 1.358 0.936 0 C-N-CA 126.917 2.087 . . . . 0.0 111.703 -175.498 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -164.73 -117.29 0.4 Allowed Glycine 0 N--CA 1.434 -1.464 0 N-CA-C 108.503 -1.839 . . . . 0.0 108.503 178.042 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 24.0 t-80 -82.08 165.52 20.52 Favored 'General case' 0 N--CA 1.441 -0.919 0 C-N-CA 125.706 1.603 . . . . 0.0 110.795 -169.097 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 41.6 mt-30 -139.96 128.67 23.14 Favored 'General case' 0 CA--C 1.495 -1.151 0 N-CA-C 104.192 -2.521 . . . . 0.0 104.192 169.044 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -99.82 154.31 18.44 Favored 'General case' 0 CA--C 1.498 -1.033 0 N-CA-C 105.363 -2.088 . . . . 0.0 105.363 175.598 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 7.6 p -135.26 135.71 51.93 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.885 0 N-CA-C 107.929 -1.137 . . . . 0.0 107.929 177.533 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 48.6 m -122.01 141.5 51.28 Favored 'General case' 0 N--CA 1.44 -0.939 0 N-CA-C 103.143 -2.91 . . . . 0.0 103.143 175.742 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 32.2 ttm180 -131.72 139.42 49.0 Favored 'General case' 0 CA--C 1.502 -0.891 0 N-CA-C 107.805 -1.183 . . . . 0.0 107.805 170.346 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 8.2 p90 -146.25 179.58 7.41 Favored 'General case' 0 N--CA 1.439 -0.979 0 N-CA-C 105.807 -1.923 . . . . 0.0 105.807 177.985 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 52.9 m-20 -128.09 152.95 47.37 Favored 'General case' 0 CA--C 1.5 -0.96 0 N-CA-C 105.757 -1.942 . . . . 0.0 105.757 169.481 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 21.8 p90 -143.56 166.37 25.02 Favored 'General case' 0 CA--C 1.485 -1.548 0 N-CA-C 107.498 -1.297 . . . . 0.0 107.498 170.42 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 27.8 p -118.56 143.3 46.86 Favored 'General case' 0 CA--C 1.497 -1.082 0 N-CA-C 106.051 -1.833 . . . . 0.0 106.051 173.672 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 30.3 m -118.39 113.18 21.0 Favored 'General case' 0 CA--C 1.494 -1.185 0 N-CA-C 101.576 -3.49 . . . . 0.0 101.576 170.068 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . 0.504 ' HA ' ' H ' ' A' ' 66' ' ' GLY . 10.0 t -157.57 -37.37 0.07 Allowed 'General case' 0 N--CA 1.437 -1.088 0 N-CA-C 107.819 -1.178 . . . . 0.0 107.819 -169.088 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 89.4 p . . . . . 0 C--O 1.259 1.592 0 C-N-CA 126.962 2.105 . . . . 0.0 112.192 -174.66 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.436 -1.353 0 N-CA-C 107.075 -2.41 . . . . 0.0 107.075 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_exo -60.23 146.8 95.62 Favored 'Trans proline' 0 N--CA 1.446 -1.309 0 C-N-CA 123.151 2.567 . . . . 0.0 115.553 -169.676 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 6.7 t -77.42 153.12 5.44 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.773 0 C-N-CA 127.631 2.372 . . . . 0.0 105.424 174.309 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 94.7 mt-10 -100.27 95.26 6.67 Favored 'General case' 0 CA--C 1.494 -1.19 0 CA-C-O 121.885 0.85 . . . . 0.0 108.742 -170.621 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 1.8 p -115.3 136.05 53.32 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.999 0 C-N-CA 124.938 1.295 . . . . 0.0 108.365 -164.777 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 83.3 m-85 . . . . . 0 CA--C 1.498 -1.03 0 C-N-CA 125.063 1.345 . . . . 0.0 108.589 -179.14 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo . . . . . 0 N--CA 1.449 -1.089 0 CA-C-O 118.293 -0.794 . . . . 0.0 110.565 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -165.8 -39.22 0.03 OUTLIER 'General case' 0 CA--C 1.488 -1.412 0 O-C-N 123.711 0.632 . . . . 0.0 110.469 -174.854 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 15.5 p -126.42 138.22 53.51 Favored 'General case' 0 CA--C 1.489 -1.371 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 -169.078 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 67.7 t60 -117.56 113.75 38.34 Favored Pre-proline 0 N--CA 1.438 -1.027 0 CA-C-N 114.238 -1.346 . . . . 0.0 107.878 -175.377 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 62.5 Cg_endo -78.28 128.6 9.02 Favored 'Trans proline' 0 N--CA 1.45 -1.04 0 C-N-CA 122.949 2.433 . . . . 0.0 110.405 175.813 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 9.6 mm -105.92 136.08 41.65 Favored 'Isoleucine or valine' 0 C--N 1.354 0.792 0 N-CA-C 103.485 -2.783 . . . . 0.0 103.485 169.833 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 67.5 mt-30 -136.41 147.8 47.46 Favored 'General case' 0 CA--C 1.495 -1.148 0 N-CA-C 104.562 -2.384 . . . . 0.0 104.562 174.18 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 45.9 p90 -147.15 170.04 18.03 Favored 'General case' 0 CA--C 1.494 -1.186 0 N-CA-C 108.002 -1.11 . . . . 0.0 108.002 -175.673 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 26.6 m-80 -136.01 131.82 35.5 Favored 'General case' 0 CA--C 1.49 -1.354 0 N-CA-C 105.377 -2.083 . . . . 0.0 105.377 177.635 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -101.2 170.91 5.94 Favored Pre-proline 0 N--CA 1.439 -0.992 0 C-N-CA 124.541 1.136 . . . . 0.0 108.402 -172.651 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_exo -64.9 165.32 21.63 Favored 'Trans proline' 0 CA--C 1.51 -0.694 0 C-N-CA 123.701 2.934 . . . . 0.0 112.83 173.712 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 79.8 mt-30 -81.51 -55.61 0.62 Allowed Pre-proline 0 N--CA 1.442 -0.829 0 CA-C-O 115.612 -2.137 . . . . 0.0 112.042 -175.58 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_endo -75.29 173.56 14.3 Favored 'Trans proline' 0 CA--C 1.509 -0.726 0 CA-C-N 125.797 3.106 . . . . 0.0 110.431 -179.581 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 52.3 p -73.1 123.83 24.35 Favored 'General case' 0 C--N 1.355 0.845 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 179.014 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 58.7 t60 -160.85 -50.78 0.05 OUTLIER 'General case' 0 CA--C 1.492 -1.253 0 N-CA-C 106.639 -1.615 . . . . 0.0 106.639 -165.143 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 35.5 mt -116.7 140.3 39.73 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.169 0 N-CA-C 105.217 -2.142 . . . . 0.0 105.217 -175.625 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 72.8 m -106.06 -87.55 0.46 Allowed 'General case' 0 N--CA 1.429 -1.484 0 N-CA-C 105.916 -1.883 . . . . 0.0 105.916 178.605 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 53.9 mtmt -91.41 172.33 8.6 Favored 'General case' 0 CA--C 1.485 -1.547 0 C-N-CA 124.927 1.291 . . . . 0.0 108.235 -166.838 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 36.1 m-85 -131.5 151.91 51.17 Favored 'General case' 0 CA--C 1.496 -1.11 0 N-CA-C 105.071 -2.196 . . . . 0.0 105.071 169.164 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 24.6 mt -121.28 134.23 65.3 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.162 0 N-CA-C 101.939 -3.356 . . . . 0.0 101.939 164.941 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 6.5 mt -105.93 123.6 48.23 Favored 'General case' 0 CA--C 1.48 -1.748 0 N-CA-C 104.011 -2.589 . . . . 0.0 104.011 166.669 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 42.8 ttp85 -127.7 123.5 35.58 Favored 'General case' 0 N--CA 1.436 -1.128 0 N-CA-C 105.515 -2.032 . . . . 0.0 105.515 -179.094 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 41.6 p90 -136.86 150.29 48.19 Favored 'General case' 0 CA--C 1.503 -0.841 0 N-CA-C 107.681 -1.229 . . . . 0.0 107.681 -170.89 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 43.3 ptt85 -141.33 158.4 63.99 Favored Pre-proline 0 CA--C 1.499 -1.0 0 N-CA-C 105.754 -1.943 . . . . 0.0 105.754 168.713 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -72.3 164.96 34.04 Favored 'Trans proline' 0 N--CA 1.453 -0.856 0 C-N-CA 123.306 2.671 . . . . 0.0 107.811 162.45 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 5.4 ptmm? -63.66 88.02 0.04 OUTLIER 'General case' 0 C--N 1.357 0.914 0 CA-C-O 122.584 1.183 . . . . 0.0 112.592 172.402 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 31.5 m120 -130.39 -132.09 0.21 Allowed 'General case' 0 N--CA 1.44 -0.952 0 N-CA-C 104.593 -2.373 . . . . 0.0 104.593 176.302 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 57.0 p -99.44 174.24 6.37 Favored 'General case' 0 C--N 1.355 0.811 0 N-CA-C 107.671 -1.233 . . . . 0.0 107.671 176.388 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 9.5 m -100.6 41.63 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.354 0.772 0 C-N-CA 124.758 1.223 . . . . 0.0 108.142 179.128 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -85.13 -99.62 0.68 Allowed Glycine 0 C--N 1.355 1.587 0 N-CA-C 108.532 -1.827 . . . . 0.0 108.532 -179.618 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 96.3 mtm-85 -97.93 141.55 30.76 Favored 'General case' 0 CA--C 1.499 -1.012 0 N-CA-C 107.204 -1.406 . . . . 0.0 107.204 176.278 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 14.6 m95 -121.63 171.78 8.59 Favored 'General case' 0 N--CA 1.439 -1.014 0 N-CA-C 105.413 -2.069 . . . . 0.0 105.413 -177.366 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -101.72 150.27 23.3 Favored 'General case' 0 CA--C 1.486 -1.491 0 N-CA-C 105.072 -2.196 . . . . 0.0 105.072 169.167 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -153.96 158.18 40.27 Favored 'General case' 0 CA--C 1.495 -1.171 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 179.841 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -138.59 160.12 40.39 Favored 'General case' 0 N--CA 1.438 -1.068 0 N-CA-C 105.186 -2.153 . . . . 0.0 105.186 173.94 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 81.6 m -115.88 123.15 47.4 Favored 'General case' 0 CA--C 1.496 -1.12 0 N-CA-C 104.775 -2.306 . . . . 0.0 104.775 177.895 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 3.8 mm -101.18 135.59 19.88 Favored Pre-proline 0 N--CA 1.437 -1.095 0 N-CA-C 105.669 -1.975 . . . . 0.0 105.669 -176.349 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 95.4 Cg_exo -63.69 161.02 33.81 Favored 'Trans proline' 0 CA--C 1.508 -0.805 0 C-N-CA 123.354 2.703 . . . . 0.0 112.257 172.093 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -78.38 -18.25 76.39 Favored Glycine 0 C--N 1.352 1.448 0 C-N-CA 123.439 0.543 . . . . 0.0 113.491 -172.685 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 48.0 p-80 -83.78 -27.18 29.02 Favored 'General case' 0 C--N 1.355 0.838 0 CA-C-N 117.695 0.747 . . . . 0.0 109.923 179.737 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 88.3 mt -88.74 130.43 35.34 Favored 'General case' 0 CA--C 1.498 -1.043 0 N-CA-C 107.977 -1.119 . . . . 0.0 107.977 177.539 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 7.7 p30 -117.98 16.67 14.23 Favored 'General case' 0 CA--C 1.501 -0.929 0 C-N-CA 124.359 1.064 . . . . 0.0 108.935 -177.026 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 35.9 p -144.53 161.77 38.24 Favored 'General case' 0 N--CA 1.438 -1.039 0 N-CA-C 107.204 -1.406 . . . . 0.0 107.204 -179.796 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 12.0 t80 -152.83 178.65 9.42 Favored 'General case' 0 N--CA 1.438 -1.032 0 N-CA-C 106.955 -1.498 . . . . 0.0 106.955 179.687 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 80.8 m -144.34 115.59 7.98 Favored 'General case' 0 N--CA 1.426 -1.633 0 N-CA-C 103.752 -2.684 . . . . 0.0 103.752 174.421 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 53.9 mt -92.58 108.38 20.18 Favored 'Isoleucine or valine' 0 C--N 1.354 0.767 0 N-CA-C 105.236 -2.135 . . . . 0.0 105.236 175.906 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 10.0 mtmp? -108.23 163.74 12.91 Favored 'General case' 0 CA--C 1.498 -1.054 0 CA-C-O 121.547 0.689 . . . . 0.0 109.143 -175.531 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 80.37 50.67 5.28 Favored Glycine 0 CA--C 1.489 -1.552 0 N-CA-C 108.713 -1.755 . . . . 0.0 108.713 174.987 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 75.7 mt -121.72 163.81 18.45 Favored 'General case' 0 CA--C 1.498 -1.027 0 N-CA-C 106.954 -1.499 . . . . 0.0 106.954 -175.748 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 53.2 mtmt -98.78 147.83 33.73 Favored Pre-proline 0 N--CA 1.44 -0.926 0 N-CA-C 107.026 -1.472 . . . . 0.0 107.026 -177.096 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -76.58 162.66 32.82 Favored 'Trans proline' 0 N--CA 1.451 -1.025 0 C-N-CA 122.95 2.433 . . . . 0.0 109.85 169.832 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . 0.444 ' H ' ' HA ' ' A' ' 92' ' ' THR . . . 63.34 23.44 66.49 Favored Glycine 0 N--CA 1.428 -1.84 0 C-N-CA 127.417 2.437 . . . . 0.0 116.619 174.905 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 6.5 p -128.84 145.39 35.76 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.857 0 N-CA-C 107.966 -1.124 . . . . 0.0 107.966 -179.684 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 10.7 p -96.83 129.94 46.15 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.857 0 CA-C-O 123.187 1.47 . . . . 0.0 108.537 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 80.0 m-85 -104.65 145.11 30.79 Favored 'General case' 0 N--CA 1.432 -1.373 0 N-CA-C 106.435 -1.691 . . . . 0.0 106.435 176.563 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -91.02 133.1 35.58 Favored 'General case' 0 N--CA 1.442 -0.855 0 N-CA-C 105.336 -2.098 . . . . 0.0 105.336 159.502 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -130.26 158.69 22.51 Favored Glycine 0 C--N 1.355 1.61 0 N-CA-C 108.229 -1.948 . . . . 0.0 108.229 -179.897 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 32.0 mt-30 -149.77 138.57 20.96 Favored 'General case' 0 CA--C 1.484 -1.561 0 N-CA-C 105.422 -2.066 . . . . 0.0 105.422 -178.717 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 52.7 tp -117.47 98.21 6.28 Favored 'General case' 0 N--CA 1.437 -1.08 0 N-CA-C 104.846 -2.279 . . . . 0.0 104.846 179.436 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 48.0 mt -89.63 133.98 30.13 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.962 0 N-CA-C 104.558 -2.386 . . . . 0.0 104.558 -179.585 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 12.1 p -117.13 117.4 29.49 Favored 'General case' 0 N--CA 1.438 -1.075 0 N-CA-C 107.728 -1.212 . . . . 0.0 107.728 -178.427 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 2.6 mp -94.07 130.67 42.66 Favored 'Isoleucine or valine' 0 CA--C 1.487 -1.478 0 N-CA-C 103.455 -2.795 . . . . 0.0 103.455 -172.677 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 21.5 mt-30 -101.84 161.89 13.32 Favored 'General case' 0 CA--C 1.491 -1.295 0 CA-C-N 114.849 -1.069 . . . . 0.0 108.817 -169.845 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 14.4 pt20 -76.29 34.0 0.13 Allowed 'General case' 0 C--N 1.354 0.794 0 C-N-CA 126.537 1.935 . . . . 0.0 113.186 173.943 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 6.4 t80 -148.67 14.13 0.94 Allowed 'General case' 0 N--CA 1.437 -1.095 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 178.366 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 80.26 1.84 88.57 Favored Glycine 0 C--N 1.351 1.412 0 C-N-CA 123.897 0.761 . . . . 0.0 112.732 176.864 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 86.2 t60 -81.9 158.47 23.96 Favored 'General case' 0 N--CA 1.44 -0.953 0 N-CA-C 107.842 -1.17 . . . . 0.0 107.842 -178.918 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 71.7 mt-30 -138.33 110.29 7.24 Favored 'General case' 0 CA--C 1.491 -1.322 0 N-CA-C 102.854 -3.017 . . . . 0.0 102.854 178.976 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 16.8 tp10 -100.76 132.1 46.32 Favored 'General case' 0 CA--C 1.495 -1.153 0 N-CA-C 105.215 -2.143 . . . . 0.0 105.215 -179.94 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 6.6 p -109.25 134.94 49.69 Favored 'Isoleucine or valine' 0 C--N 1.355 0.818 0 N-CA-C 107.58 -1.267 . . . . 0.0 107.58 -174.061 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 90.8 m -110.66 138.61 46.83 Favored 'General case' 0 N--CA 1.44 -0.927 0 N-CA-C 102.477 -3.157 . . . . 0.0 102.477 171.272 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 16.7 ptm180 -129.67 152.39 49.23 Favored 'General case' 0 CA--C 1.499 -1.011 0 CA-C-N 118.84 0.745 . . . . 0.0 110.025 176.918 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 18.5 p90 -165.53 -177.95 4.67 Favored 'General case' 0 CA--C 1.5 -0.956 0 N-CA-C 106.323 -1.732 . . . . 0.0 106.323 -175.731 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 45.7 p-10 -134.22 158.16 44.42 Favored 'General case' 0 N--CA 1.44 -0.945 0 N-CA-C 106.286 -1.746 . . . . 0.0 106.286 166.608 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 24.3 p90 -143.1 164.61 29.67 Favored 'General case' 0 CA--C 1.482 -1.641 0 N-CA-C 106.785 -1.561 . . . . 0.0 106.785 170.838 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 38.4 p -113.73 141.61 47.05 Favored 'General case' 0 CA--C 1.498 -1.042 0 N-CA-C 105.919 -1.882 . . . . 0.0 105.919 172.749 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 97.5 m -109.57 112.84 25.16 Favored 'General case' 0 CA--C 1.491 -1.325 1 N-CA-C 100.189 -4.004 . . . . 0.0 100.189 168.041 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . 0.444 ' HA ' ' H ' ' A' ' 66' ' ' GLY . 11.9 t -159.24 149.79 19.49 Favored 'General case' 0 N--CA 1.437 -1.113 0 N-CA-C 105.375 -2.083 . . . . 0.0 105.375 -174.981 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 25.7 t . . . . . 0 C--O 1.261 1.708 0 N-CA-C 104.89 -2.263 . . . . 0.0 104.89 171.411 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.435 -1.383 0 N-CA-C 106.309 -2.716 . . . . 0.0 106.309 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 92.5 Cg_exo -62.37 138.14 69.46 Favored 'Trans proline' 0 N--CA 1.445 -1.356 0 C-N-CA 122.923 2.416 . . . . 0.0 112.973 -171.282 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 2.9 t -77.76 152.65 5.35 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.672 0 C-N-CA 126.443 1.897 . . . . 0.0 106.098 -179.805 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 52.7 mt-10 -96.16 91.34 5.87 Favored 'General case' 0 CA--C 1.494 -1.201 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 -173.335 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.409 ' HA ' ' HA ' ' A' ' 22' ' ' TRP . 2.1 p -110.22 129.43 65.27 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.075 0 N-CA-C 107.438 -1.319 . . . . 0.0 107.438 -164.967 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 75.6 m-85 . . . . . 0 CA--C 1.496 -1.109 0 N-CA-C 106.043 -1.836 . . . . 0.0 106.043 -175.035 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 98.7 Cg_endo . . . . . 0 N--CA 1.453 -0.874 0 CA-C-O 118.392 -0.753 . . . . 0.0 110.156 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 6.9 p-10 -102.79 -40.96 6.35 Favored 'General case' 0 CA--C 1.49 -1.356 0 C-N-CA 123.583 0.753 . . . . 0.0 109.61 -172.633 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 35.0 p -110.31 153.62 24.63 Favored 'General case' 0 CA--C 1.495 -1.154 0 N-CA-C 107.081 -1.452 . . . . 0.0 107.081 176.189 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 45.0 t-80 -136.85 98.83 10.47 Favored Pre-proline 0 N--CA 1.435 -1.224 0 N-CA-C 106.778 -1.564 . . . . 0.0 106.778 178.695 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -76.51 130.41 11.76 Favored 'Trans proline' 0 N--CA 1.447 -1.252 0 C-N-CA 122.76 2.307 . . . . 0.0 110.005 -177.441 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 14.5 mm -107.69 148.06 12.18 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.017 0 N-CA-C 103.088 -2.93 . . . . 0.0 103.088 176.127 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 4.4 pt20 -149.68 152.3 35.14 Favored 'General case' 0 CA--C 1.489 -1.377 0 N-CA-C 104.299 -2.482 . . . . 0.0 104.299 167.183 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' TRP . . . . . 0.409 ' HA ' ' HA ' ' A' ' 6' ' ' VAL . 44.6 p90 -147.15 166.98 25.31 Favored 'General case' 0 N--CA 1.436 -1.142 0 N-CA-C 106.595 -1.632 . . . . 0.0 106.595 -169.755 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 40.9 m-80 -138.81 132.5 30.68 Favored 'General case' 0 CA--C 1.49 -1.335 0 N-CA-C 107.487 -1.301 . . . . 0.0 107.487 -179.051 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -92.69 175.53 3.18 Favored Pre-proline 0 N--CA 1.44 -0.947 0 C-N-CA 125.696 1.599 . . . . 0.0 109.865 -167.122 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 78.6 Cg_exo -63.94 164.87 20.51 Favored 'Trans proline' 0 N--CA 1.455 -0.757 0 C-N-CA 123.672 2.914 . . . . 0.0 112.491 169.7 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 71.1 tp60 -80.92 -42.42 1.2 Allowed Pre-proline 0 N--CA 1.444 -0.759 0 CA-C-O 115.911 -1.995 . . . . 0.0 110.758 -175.799 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -70.02 -16.49 36.49 Favored 'Trans proline' 0 CA--C 1.512 -0.623 0 CA-C-N 125.382 2.958 . . . . 0.0 112.418 172.505 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 10.4 t 64.95 78.73 0.27 Allowed 'General case' 0 C--N 1.358 0.969 0 C-N-CA 126.545 1.938 . . . . 0.0 109.652 -176.799 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 20.1 t-160 -91.6 -6.68 51.9 Favored 'General case' 0 N--CA 1.442 -0.857 0 C-N-CA 124.755 1.222 . . . . 0.0 109.319 -177.466 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 84.5 mt -113.74 145.55 19.47 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.99 0 N-CA-C 104.736 -2.32 . . . . 0.0 104.736 -173.251 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 25.2 t -103.95 -87.49 0.43 Allowed 'General case' 0 N--CA 1.43 -1.464 0 N-CA-C 105.96 -1.867 . . . . 0.0 105.96 177.241 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 27.4 mtpp -89.58 167.45 12.94 Favored 'General case' 0 CA--C 1.486 -1.504 0 C-N-CA 125.693 1.597 . . . . 0.0 108.94 -163.546 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 90.9 m-85 -134.53 142.72 47.1 Favored 'General case' 0 CA--C 1.493 -1.244 0 N-CA-C 105.072 -2.196 . . . . 0.0 105.072 172.445 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 16.5 mt -123.04 134.45 66.13 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.178 0 N-CA-C 101.786 -3.413 . . . . 0.0 101.786 171.765 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 2.7 mt -110.8 131.48 55.02 Favored 'General case' 0 CA--C 1.473 -1.982 0 N-CA-C 105.715 -1.957 . . . . 0.0 105.715 173.416 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 2.2 mpt_? -115.65 157.72 23.8 Favored 'General case' 0 N--CA 1.428 -1.529 0 N-CA-C 104.981 -2.229 . . . . 0.0 104.981 172.506 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 37.5 p90 -151.01 136.26 17.64 Favored 'General case' 0 N--CA 1.432 -1.363 0 N-CA-C 105.695 -1.965 . . . . 0.0 105.695 171.204 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 15.3 ttp180 -137.39 135.79 19.81 Favored Pre-proline 0 CA--C 1.498 -1.038 0 N-CA-C 103.413 -2.81 . . . . 0.0 103.413 -178.716 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -77.33 155.15 32.48 Favored 'Trans proline' 0 CA--C 1.502 -1.086 0 CA-C-N 123.292 2.211 . . . . 0.0 108.686 179.563 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 70.8 mmtt -73.14 60.71 0.58 Allowed 'General case' 0 C--N 1.356 0.88 0 C-N-CA 125.704 1.601 . . . . 0.0 110.465 170.157 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 29.0 m120 -154.57 -56.93 0.11 Allowed 'General case' 0 N--CA 1.436 -1.17 0 N-CA-C 102.888 -3.004 . . . . 0.0 102.888 -173.163 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 34.8 m -85.31 160.75 19.75 Favored 'General case' 0 N--CA 1.44 -0.941 0 N-CA-C 108.374 -0.973 . . . . 0.0 108.374 178.181 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 17.4 m -131.69 -5.48 1.97 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.784 0 C-N-CA 124.522 1.129 . . . . 0.0 108.821 -173.827 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -142.85 -43.48 0.05 OUTLIER Glycine 0 C--N 1.356 1.644 0 N-CA-C 109.311 -1.516 . . . . 0.0 109.311 -172.656 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 79.7 ttt180 -80.92 126.16 31.02 Favored 'General case' 0 CA--C 1.502 -0.887 0 C-N-CA 124.183 0.993 . . . . 0.0 108.685 -176.89 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -155.97 -177.75 6.8 Favored 'General case' 0 CA--C 1.492 -1.269 0 CA-C-O 121.426 0.632 . . . . 0.0 109.825 -179.681 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 66.7 mttm -130.76 159.91 35.91 Favored 'General case' 0 N--CA 1.435 -1.211 0 N-CA-C 105.402 -2.074 . . . . 0.0 105.402 -175.698 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -149.44 159.84 43.95 Favored 'General case' 0 N--CA 1.434 -1.246 0 N-CA-C 107.691 -1.225 . . . . 0.0 107.691 175.947 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -141.29 157.97 44.51 Favored 'General case' 0 CA--C 1.496 -1.115 0 N-CA-C 106.398 -1.705 . . . . 0.0 106.398 170.999 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 89.0 m -118.84 127.06 53.16 Favored 'General case' 0 CA--C 1.5 -0.972 0 N-CA-C 105.954 -1.869 . . . . 0.0 105.954 -178.331 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 5.3 mp -114.39 133.91 22.38 Favored Pre-proline 0 N--CA 1.438 -1.072 0 N-CA-C 104.893 -2.262 . . . . 0.0 104.893 -175.695 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 62.6 Cg_exo -63.89 169.07 10.87 Favored 'Trans proline' 0 CA--C 1.508 -0.807 0 C-N-CA 123.387 2.724 . . . . 0.0 113.376 177.155 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -78.42 -19.74 73.39 Favored Glycine 0 C--N 1.351 1.398 0 C-N-CA 123.171 0.415 . . . . 0.0 113.559 -173.851 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 48.8 p-80 -83.84 -28.15 28.22 Favored 'General case' 0 C--N 1.356 0.887 0 CA-C-N 117.755 0.778 . . . . 0.0 109.962 -179.418 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 84.4 mt -88.77 130.49 35.35 Favored 'General case' 0 CA--C 1.501 -0.917 0 N-CA-C 107.723 -1.214 . . . . 0.0 107.723 177.162 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 8.0 p-10 -116.87 10.2 14.06 Favored 'General case' 0 CA--C 1.501 -0.912 0 C-N-CA 123.994 0.918 . . . . 0.0 110.098 -172.203 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 60.1 p -143.03 167.76 21.31 Favored 'General case' 0 N--CA 1.44 -0.942 0 N-CA-C 107.854 -1.165 . . . . 0.0 107.854 -178.631 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 8.3 t80 -155.48 178.27 10.42 Favored 'General case' 0 N--CA 1.441 -0.921 0 N-CA-C 108.023 -1.103 . . . . 0.0 108.023 -176.851 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 97.2 m -145.01 114.91 7.36 Favored 'General case' 0 N--CA 1.432 -1.34 0 N-CA-C 103.859 -2.645 . . . . 0.0 103.859 177.347 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 54.0 mt -97.02 96.68 5.59 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.822 0 N-CA-C 105.767 -1.938 . . . . 0.0 105.767 175.566 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.94 161.76 13.41 Favored 'General case' 0 CA--C 1.498 -1.031 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 -178.381 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 83.7 52.47 3.69 Favored Glycine 0 C--N 1.353 1.501 0 N-CA-C 108.866 -1.694 . . . . 0.0 108.866 177.637 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 76.3 mt -119.19 166.04 13.46 Favored 'General case' 0 CA--C 1.496 -1.11 0 N-CA-C 106.736 -1.579 . . . . 0.0 106.736 -179.51 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 61.1 mttp -97.66 156.59 35.91 Favored Pre-proline 0 N--CA 1.441 -0.898 0 N-CA-C 106.859 -1.534 . . . . 0.0 106.859 -175.666 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 66.2 Cg_endo -77.45 155.63 32.19 Favored 'Trans proline' 0 N--CA 1.451 -0.987 0 C-N-CA 122.808 2.339 . . . . 0.0 109.844 172.063 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 60.15 29.12 67.75 Favored Glycine 0 C--N 1.355 1.584 0 C-N-CA 126.674 2.083 . . . . 0.0 116.628 170.507 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 10.6 p -122.35 138.99 50.65 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.122 0 N-CA-C 107.747 -1.205 . . . . 0.0 107.747 179.472 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 2.4 p -97.74 134.99 33.83 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.818 0 N-CA-C 106.663 -1.606 . . . . 0.0 106.663 177.946 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 94.4 m-85 -114.23 154.4 27.98 Favored 'General case' 0 CA--C 1.502 -0.878 0 C-N-CA 124.97 1.308 . . . . 0.0 107.617 179.492 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -95.18 142.13 27.98 Favored 'General case' 0 CA--C 1.505 -0.787 0 N-CA-C 105.516 -2.031 . . . . 0.0 105.516 155.815 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -132.52 143.66 15.33 Favored Glycine 0 CA--C 1.487 -1.683 0 N-CA-C 107.565 -2.214 . . . . 0.0 107.565 -177.614 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 32.3 mt-30 -135.94 132.59 36.62 Favored 'General case' 0 CA--C 1.489 -1.375 0 N-CA-C 106.361 -1.718 . . . . 0.0 106.361 -178.189 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 47.2 tp -113.9 97.72 6.56 Favored 'General case' 0 N--CA 1.438 -1.042 0 N-CA-C 104.408 -2.441 . . . . 0.0 104.408 -176.757 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 1.8 mp -88.7 125.34 41.88 Favored 'Isoleucine or valine' 0 CA--C 1.499 -1.013 0 N-CA-C 103.585 -2.746 . . . . 0.0 103.585 -176.781 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 12.8 p -121.1 109.27 14.82 Favored 'General case' 0 N--CA 1.436 -1.129 0 N-CA-C 108.214 -1.032 . . . . 0.0 108.214 -170.405 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 29.7 mt -102.1 140.79 19.71 Favored 'Isoleucine or valine' 0 CA--C 1.487 -1.453 0 N-CA-C 105.787 -1.931 . . . . 0.0 105.787 -165.183 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 72.1 mt-30 -87.97 -178.86 6.1 Favored 'General case' 0 CA--C 1.505 -0.753 0 C-N-CA 123.49 0.716 . . . . 0.0 109.47 -177.374 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 85.2 mt-30 -74.3 84.03 1.91 Allowed 'General case' 0 C--N 1.357 0.928 0 C-N-CA 124.779 1.232 . . . . 0.0 110.753 175.465 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 82.6 m-85 58.5 28.38 16.88 Favored 'General case' 0 C--N 1.359 1.006 0 C-N-CA 126.75 2.02 . . . . 0.0 112.27 -177.682 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -112.53 -118.71 3.61 Favored Glycine 0 C--N 1.356 1.683 0 N-CA-C 108.88 -1.688 . . . . 0.0 108.88 -173.729 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 10.1 t-160 -80.9 169.11 17.96 Favored 'General case' 0 N--CA 1.441 -0.89 0 C-N-CA 125.005 1.322 . . . . 0.0 109.323 -174.761 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 22.3 tt0 -127.47 109.3 11.61 Favored 'General case' 0 N--CA 1.434 -1.229 0 N-CA-C 101.842 -3.392 . . . . 0.0 101.842 170.377 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 4.3 tm-20 -102.83 153.94 19.69 Favored 'General case' 0 CA--C 1.506 -0.748 0 N-CA-C 105.721 -1.955 . . . . 0.0 105.721 -171.938 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 4.4 p -127.94 128.89 69.54 Favored 'Isoleucine or valine' 0 C--N 1.354 0.771 0 N-CA-C 108.274 -1.01 . . . . 0.0 108.274 179.874 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 52.1 m -109.83 139.09 45.29 Favored 'General case' 0 N--CA 1.443 -0.807 0 N-CA-C 102.432 -3.173 . . . . 0.0 102.432 171.694 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 51.6 ttt85 -130.99 142.8 50.37 Favored 'General case' 0 CA--C 1.502 -0.866 0 N-CA-C 108.428 -0.953 . . . . 0.0 108.428 -179.076 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 15.7 p90 -157.07 -176.39 5.95 Favored 'General case' 0 N--CA 1.439 -1.003 0 N-CA-C 105.78 -1.933 . . . . 0.0 105.78 178.769 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 1.4 p30 -136.15 157.02 47.82 Favored 'General case' 0 N--CA 1.439 -0.999 0 N-CA-C 106.296 -1.742 . . . . 0.0 106.296 167.571 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 36.9 p90 -144.45 174.51 10.87 Favored 'General case' 0 CA--C 1.487 -1.469 0 N-CA-C 106.03 -1.841 . . . . 0.0 106.03 171.759 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 10.1 t -142.31 154.37 44.64 Favored 'General case' 0 N--CA 1.439 -0.988 0 N-CA-C 106.7 -1.592 . . . . 0.0 106.7 176.789 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 4.3 p -113.27 120.94 42.89 Favored 'General case' 0 N--CA 1.436 -1.16 0 N-CA-C 101.264 -3.606 . . . . 0.0 101.264 168.184 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 15.0 t -157.71 21.47 0.27 Allowed 'General case' 0 N--CA 1.442 -0.85 0 N-CA-C 106.451 -1.685 . . . . 0.0 106.451 -173.049 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 19.7 m . . . . . 0 C--O 1.26 1.611 0 C-N-CA 123.356 0.662 . . . . 0.0 109.671 -175.77 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.436 -1.317 0 N-CA-C 105.79 -2.924 . . . . 0.0 105.79 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 8.8 Cg_exo -54.61 146.05 55.89 Favored 'Trans proline' 0 N--CA 1.449 -1.133 0 C-N-CA 124.329 3.353 . . . . 0.0 114.898 -168.241 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 5.5 t -77.46 152.5 5.48 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.716 0 N-CA-C 105.436 -2.061 . . . . 0.0 105.436 -177.904 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 92.8 mt-10 -98.54 89.44 4.4 Favored 'General case' 0 CA--C 1.493 -1.234 0 CA-C-O 122.13 0.967 . . . . 0.0 108.666 -169.729 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 2.4 p -111.52 132.33 60.39 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.08 0 N-CA-C 106.979 -1.489 . . . . 0.0 106.979 -166.946 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 67.9 m-85 . . . . . 0 CA--C 1.498 -1.055 0 N-CA-C 106.125 -1.805 . . . . 0.0 106.125 -174.61 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo . . . . . 0 CA--C 1.504 -1.008 0 CA-C-O 118.738 -0.609 . . . . 0.0 110.97 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 1.9 p30 -100.16 -45.43 5.64 Favored 'General case' 0 CA--C 1.488 -1.417 0 C-N-CA 123.596 0.759 . . . . 0.0 109.985 -166.516 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 75.2 m -107.63 158.65 17.08 Favored 'General case' 0 CA--C 1.496 -1.106 0 N-CA-C 107.794 -1.187 . . . . 0.0 107.794 -179.346 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 11.7 t-160 -135.74 85.15 30.87 Favored Pre-proline 0 N--CA 1.438 -1.048 0 N-CA-C 105.593 -2.003 . . . . 0.0 105.593 172.884 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 64.7 Cg_endo -81.78 98.1 0.96 Allowed 'Trans proline' 0 N--CA 1.451 -0.987 0 C-N-CA 123.325 2.683 . . . . 0.0 110.156 -174.713 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.51 HD11 HD11 ' A' ' 35' ' ' LEU . 3.0 pt -97.6 173.21 1.0 Allowed 'Isoleucine or valine' 0 CA--C 1.499 -0.99 0 CA-C-O 121.181 0.515 . . . . 0.0 109.992 -173.497 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . 0.448 ' HA ' ' HA ' ' A' ' 57' ' ' SER . 1.9 pt20 -151.53 161.58 42.45 Favored 'General case' 0 CA--C 1.496 -1.099 0 N-CA-C 105.699 -1.963 . . . . 0.0 105.699 164.079 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 42.4 p90 -139.62 162.82 34.17 Favored 'General case' 0 CA--C 1.496 -1.122 0 N-CA-C 106.285 -1.746 . . . . 0.0 106.285 -177.679 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 3.1 m120 -127.94 124.48 37.43 Favored 'General case' 0 CA--C 1.491 -1.3 0 N-CA-C 106.183 -1.784 . . . . 0.0 106.183 -179.505 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -105.65 173.38 3.27 Favored Pre-proline 0 N--CA 1.439 -1.012 0 C-N-CA 125.536 1.535 . . . . 0.0 108.181 -169.71 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_exo -63.63 151.2 86.17 Favored 'Trans proline' 0 N--CA 1.455 -0.76 0 C-N-CA 123.732 2.955 . . . . 0.0 112.266 173.532 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 64.8 tt0 -82.05 -40.64 0.96 Allowed Pre-proline 0 N--CA 1.444 -0.76 0 CA-C-O 115.832 -2.033 . . . . 0.0 111.837 -174.742 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 77.1 Cg_exo -70.77 -3.52 12.85 Favored 'Trans proline' 0 CA--C 1.514 -0.481 0 CA-C-N 125.403 2.965 . . . . 0.0 113.818 177.175 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 10.0 t 71.33 78.08 0.17 Allowed 'General case' 0 C--N 1.358 0.937 0 C-N-CA 126.38 1.872 . . . . 0.0 109.252 -179.423 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 82.1 t60 -89.23 -30.15 18.73 Favored 'General case' 0 N--CA 1.441 -0.906 0 C-N-CA 124.696 1.198 . . . . 0.0 108.289 178.166 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 90.3 mt -108.83 146.41 14.52 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.107 0 N-CA-C 105.164 -2.162 . . . . 0.0 105.164 -171.204 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 32.9 t -102.69 -87.77 0.41 Allowed 'General case' 0 N--CA 1.428 -1.572 0 N-CA-C 104.531 -2.396 . . . . 0.0 104.531 176.891 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 50.3 mtpt -89.46 167.07 13.28 Favored 'General case' 0 CA--C 1.489 -1.4 0 C-N-CA 124.91 1.284 . . . . 0.0 108.85 -164.418 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 63.1 m-85 -132.09 142.62 49.58 Favored 'General case' 0 CA--C 1.497 -1.081 0 N-CA-C 105.035 -2.209 . . . . 0.0 105.035 170.987 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 53.7 mt -119.68 136.12 57.84 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.189 0 N-CA-C 101.156 -3.646 . . . . 0.0 101.156 170.503 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.51 HD11 HD11 ' A' ' 20' ' ' ILE . 5.9 mt -110.42 132.53 54.1 Favored 'General case' 0 CA--C 1.47 -2.132 0 N-CA-C 103.823 -2.658 . . . . 0.0 103.823 166.644 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 17.0 ptp180 -132.88 152.04 51.93 Favored 'General case' 0 CA--C 1.49 -1.363 0 N-CA-C 106.787 -1.561 . . . . 0.0 106.787 170.701 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 49.2 p90 -155.19 151.79 28.59 Favored 'General case' 0 N--CA 1.438 -1.04 0 N-CA-C 107.585 -1.265 . . . . 0.0 107.585 -171.22 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 2.8 ptt180 -155.68 153.5 26.31 Favored Pre-proline 0 CA--C 1.497 -1.062 0 N-CA-C 106.466 -1.679 . . . . 0.0 106.466 168.065 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -76.86 156.56 34.85 Favored 'Trans proline' 0 CA--C 1.501 -1.141 0 C-N-CA 122.547 2.165 . . . . 0.0 109.071 -178.231 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 71.4 mmtt -70.35 79.95 0.54 Allowed 'General case' 0 C--N 1.354 0.8 0 C-N-CA 125.065 1.346 . . . . 0.0 110.635 174.598 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 58.9 m-80 -152.01 -81.62 0.1 Allowed 'General case' 0 N--CA 1.437 -1.111 0 N-CA-C 103.43 -2.804 . . . . 0.0 103.43 -179.249 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 50.2 m -93.39 166.14 12.43 Favored 'General case' 0 CA--C 1.5 -0.978 0 C-N-CA 124.055 0.942 . . . . 0.0 108.531 -178.228 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 12.6 m -134.57 25.54 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.754 0 N-CA-C 106.623 -1.621 . . . . 0.0 106.623 178.167 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -89.72 -94.48 1.14 Allowed Glycine 0 C--N 1.356 1.681 0 N-CA-C 109.554 -1.418 . . . . 0.0 109.554 -174.797 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -95.5 166.29 11.93 Favored 'General case' 0 CA--C 1.5 -0.945 0 N-CA-C 107.584 -1.265 . . . . 0.0 107.584 179.418 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -158.29 173.87 16.03 Favored 'General case' 0 CA--C 1.493 -1.238 0 CA-C-O 121.17 0.509 . . . . 0.0 110.142 -177.7 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 8.6 mtpm? -106.53 155.07 19.98 Favored 'General case' 0 CA--C 1.484 -1.565 0 N-CA-C 106.877 -1.527 . . . . 0.0 106.877 -175.404 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 15.6 pt-20 -151.72 161.26 42.96 Favored 'General case' 0 N--CA 1.435 -1.193 0 CA-C-O 121.827 0.823 . . . . 0.0 109.064 173.699 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -138.66 162.39 34.77 Favored 'General case' 0 N--CA 1.44 -0.967 0 N-CA-C 105.765 -1.939 . . . . 0.0 105.765 170.275 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 77.8 m -121.64 126.56 49.32 Favored 'General case' 0 CA--C 1.502 -0.896 0 N-CA-C 105.389 -2.078 . . . . 0.0 105.389 178.233 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 4.2 mp -110.91 133.76 21.17 Favored Pre-proline 0 N--CA 1.436 -1.147 0 N-CA-C 105.12 -2.178 . . . . 0.0 105.12 -176.088 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_exo -63.85 165.15 19.46 Favored 'Trans proline' 0 CA--C 1.507 -0.828 0 C-N-CA 123.519 2.813 . . . . 0.0 113.187 176.743 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -76.52 -18.21 79.27 Favored Glycine 0 C--N 1.351 1.409 0 C-N-CA 123.627 0.632 . . . . 0.0 113.938 -173.933 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 49.8 p-80 -84.02 -28.45 27.66 Favored 'General case' 0 C--N 1.355 0.845 0 CA-C-N 117.992 0.896 . . . . 0.0 110.133 -179.826 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 88.0 mt -88.78 130.76 35.3 Favored 'General case' 0 CA--C 1.499 -0.991 0 N-CA-C 107.911 -1.144 . . . . 0.0 107.911 177.463 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 47.1 p-10 -117.78 12.44 13.89 Favored 'General case' 0 CA--C 1.502 -0.873 0 C-N-CA 123.879 0.872 . . . . 0.0 110.368 -174.887 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 0.448 ' HA ' ' HA ' ' A' ' 21' ' ' GLN . 58.0 p -136.8 161.57 35.61 Favored 'General case' 0 CA--C 1.498 -1.052 0 N-CA-C 107.795 -1.187 . . . . 0.0 107.795 -178.379 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 5.2 t80 -147.55 179.51 7.63 Favored 'General case' 0 C--N 1.357 0.933 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 177.198 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 80.2 m -144.92 112.4 6.16 Favored 'General case' 0 N--CA 1.433 -1.295 0 N-CA-C 104.178 -2.527 . . . . 0.0 104.178 174.002 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 50.6 mt -95.18 97.33 6.66 Favored 'Isoleucine or valine' 0 C--N 1.357 0.918 0 N-CA-C 105.333 -2.099 . . . . 0.0 105.333 174.763 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 22.6 pttp -103.82 159.81 15.32 Favored 'General case' 0 CA--C 1.501 -0.919 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 -176.489 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 87.75 51.69 3.17 Favored Glycine 0 C--N 1.354 1.579 0 N-CA-C 109.337 -1.505 . . . . 0.0 109.337 179.187 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 70.7 mt -119.78 171.11 8.63 Favored 'General case' 0 CA--C 1.504 -0.806 0 N-CA-C 107.398 -1.334 . . . . 0.0 107.398 -177.393 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 67.5 mttm -107.09 155.69 38.81 Favored Pre-proline 0 N--CA 1.442 -0.86 0 C-N-CA 124.984 1.313 . . . . 0.0 107.656 -172.338 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -75.82 151.53 36.03 Favored 'Trans proline' 0 N--CA 1.454 -0.853 0 C-N-CA 123.024 2.482 . . . . 0.0 110.811 177.054 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 56.05 36.55 67.95 Favored Glycine 0 C--N 1.355 1.605 0 C-N-CA 127.377 2.418 . . . . 0.0 116.06 169.623 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 9.8 p -124.11 143.56 36.98 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.998 0 N-CA-C 108.088 -1.078 . . . . 0.0 108.088 -177.498 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 7.7 p -98.61 128.4 50.19 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.96 0 N-CA-C 107.747 -1.205 . . . . 0.0 107.747 -179.543 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 68.8 m-85 -111.4 151.62 28.28 Favored 'General case' 0 CA--C 1.497 -1.082 0 C-N-CA 124.814 1.245 . . . . 0.0 108.809 -179.863 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 35.9 tp10 -93.61 137.04 33.28 Favored 'General case' 0 N--CA 1.44 -0.953 0 N-CA-C 104.578 -2.379 . . . . 0.0 104.578 160.017 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -135.33 156.62 22.75 Favored Glycine 0 CA--C 1.489 -1.553 0 N-CA-C 108.511 -1.836 . . . . 0.0 108.511 174.356 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 85.6 mt-30 -144.58 138.95 27.81 Favored 'General case' 0 CA--C 1.483 -1.598 0 N-CA-C 105.986 -1.857 . . . . 0.0 105.986 179.262 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 57.1 tp -115.73 97.32 6.05 Favored 'General case' 0 N--CA 1.435 -1.189 0 N-CA-C 103.892 -2.633 . . . . 0.0 103.892 178.248 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 9.4 mt -89.52 128.87 41.28 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.942 0 N-CA-C 105.356 -2.09 . . . . 0.0 105.356 -178.248 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 3.5 p -117.93 118.86 33.13 Favored 'General case' 0 N--CA 1.438 -1.058 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 -171.71 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 2.0 mp -94.08 131.68 40.31 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.222 0 N-CA-C 105.02 -2.215 . . . . 0.0 105.02 -173.149 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 19.4 mp0 -93.87 143.36 26.41 Favored 'General case' 0 CA--C 1.498 -1.033 0 N-CA-C 104.93 -2.248 . . . . 0.0 104.93 177.218 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 21.4 tt0 -69.12 112.4 5.7 Favored 'General case' 0 C--N 1.356 0.855 0 C-N-CA 123.858 0.863 . . . . 0.0 111.343 -172.585 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 33.7 m-85 56.32 44.81 24.07 Favored 'General case' 0 C--N 1.357 0.917 0 C-N-CA 126.983 2.113 . . . . 0.0 112.173 -179.007 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -156.73 -119.16 0.6 Allowed Glycine 0 CA--C 1.489 -1.577 0 N-CA-C 109.008 -1.637 . . . . 0.0 109.008 -177.98 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 69.2 m80 -82.68 176.77 9.09 Favored 'General case' 0 CA--C 1.501 -0.939 0 C-N-CA 124.9 1.28 . . . . 0.0 111.288 -166.477 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 22.8 tt0 -137.91 115.96 11.67 Favored 'General case' 0 N--CA 1.435 -1.197 0 N-CA-C 103.819 -2.66 . . . . 0.0 103.819 170.761 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 29.5 tt0 -104.77 147.97 27.12 Favored 'General case' 0 CA--C 1.5 -0.949 0 N-CA-C 106.089 -1.819 . . . . 0.0 106.089 -174.739 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 4.0 p -119.35 134.05 64.2 Favored 'Isoleucine or valine' 0 C--N 1.356 0.85 0 N-CA-C 107.796 -1.187 . . . . 0.0 107.796 178.272 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 65.1 m -110.93 138.44 47.33 Favored 'General case' 0 C--N 1.354 0.791 0 N-CA-C 102.518 -3.142 . . . . 0.0 102.518 168.326 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 27.8 ptt-85 -132.21 150.32 52.18 Favored 'General case' 0 CA--C 1.5 -0.971 0 N-CA-C 109.213 -0.662 . . . . 0.0 109.213 179.485 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 20.2 p90 -163.82 173.8 12.33 Favored 'General case' 0 N--CA 1.441 -0.901 0 N-CA-C 107.947 -1.131 . . . . 0.0 107.947 -174.874 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -125.62 146.05 49.88 Favored 'General case' 0 N--CA 1.438 -1.05 0 N-CA-C 103.816 -2.661 . . . . 0.0 103.816 173.628 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 28.5 p90 -139.51 168.1 20.59 Favored 'General case' 0 CA--C 1.485 -1.526 0 N-CA-C 107.572 -1.269 . . . . 0.0 107.572 167.882 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 60.6 m -130.44 141.93 50.51 Favored 'General case' 0 N--CA 1.44 -0.937 0 N-CA-C 104.832 -2.285 . . . . 0.0 104.832 176.795 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 23.9 p -111.6 136.94 50.11 Favored 'General case' 0 CA--C 1.501 -0.936 0 N-CA-C 103.851 -2.648 . . . . 0.0 103.851 170.486 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 10.5 t -146.22 156.7 43.57 Favored 'General case' 0 N--CA 1.44 -0.967 0 N-CA-C 106.716 -1.587 . . . . 0.0 106.716 -175.072 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 16.9 p . . . . . 0 C--O 1.261 1.684 0 CA-C-O 117.709 -1.139 . . . . 0.0 108.944 -178.336 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.44 -1.055 0 N-CA-C 106.913 -2.475 . . . . 0.0 106.913 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 79.3 Cg_exo -60.67 135.07 57.98 Favored 'Trans proline' 0 CA--C 1.497 -1.369 0 C-N-CA 123.388 2.725 . . . . 0.0 112.185 -173.359 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 16.1 t -84.07 155.24 3.67 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.017 0 C-N-CA 126.468 1.907 . . . . 0.0 106.167 -175.196 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 54.6 mt-10 -104.5 102.86 12.49 Favored 'General case' 0 CA--C 1.492 -1.273 0 N-CA-C 105.772 -1.936 . . . . 0.0 105.772 179.498 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 1.5 p -126.05 141.37 45.88 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.985 0 N-CA-C 105.623 -1.991 . . . . 0.0 105.623 -169.796 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 18.8 p90 . . . . . 0 N--CA 1.436 -1.144 0 N-CA-C 107.716 -1.216 . . . . 0.0 107.716 -162.728 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo . . . . . 0 CA--C 1.508 -0.822 0 CA-C-O 118.582 -0.674 . . . . 0.0 111.115 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 6.8 t-20 -135.78 -23.88 1.35 Allowed 'General case' 0 CA--C 1.495 -1.169 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 -168.709 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 23.0 p -97.64 156.19 16.64 Favored 'General case' 0 N--CA 1.439 -1.02 0 N-CA-C 107.605 -1.257 . . . . 0.0 107.605 177.483 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 79.8 t60 -139.44 86.43 14.28 Favored Pre-proline 0 N--CA 1.439 -1.011 0 N-CA-C 106.348 -1.723 . . . . 0.0 106.348 167.568 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -82.92 100.54 0.96 Allowed 'Trans proline' 0 N--CA 1.453 -0.887 0 C-N-CA 123.574 2.849 . . . . 0.0 110.369 -176.187 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.53 HD11 HD11 ' A' ' 35' ' ' LEU . 1.6 pt -94.38 166.59 1.77 Allowed 'Isoleucine or valine' 0 CA--C 1.501 -0.934 0 C-N-CA 122.715 0.406 . . . . 0.0 110.156 -173.609 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 48.0 tt0 -143.15 147.66 35.3 Favored 'General case' 0 N--CA 1.439 -0.995 0 N-CA-C 105.005 -2.22 . . . . 0.0 105.005 168.547 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 30.9 p90 -130.23 159.85 35.62 Favored 'General case' 0 CA--C 1.495 -1.167 0 N-CA-C 105.599 -2.0 . . . . 0.0 105.599 176.701 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 72.3 m-20 -130.83 132.7 45.38 Favored 'General case' 0 CA--C 1.488 -1.417 0 N-CA-C 104.997 -2.223 . . . . 0.0 104.997 171.837 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -85.77 164.36 40.01 Favored Pre-proline 0 N--CA 1.441 -0.908 0 C-N-CA 124.589 1.155 . . . . 0.0 110.675 -166.175 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_exo -67.23 -179.29 1.75 Allowed 'Trans proline' 0 N--CA 1.457 -0.675 0 C-N-CA 123.775 2.983 . . . . 0.0 112.548 169.072 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? -79.84 -50.85 1.19 Allowed Pre-proline 0 N--CA 1.443 -0.782 0 CA-C-O 115.02 -2.419 . . . . 0.0 111.157 -174.706 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -68.68 147.14 69.11 Favored 'Trans proline' 0 CA--C 1.508 -0.811 0 CA-C-N 126.305 3.288 . . . . 0.0 111.863 -173.056 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 29.4 p -99.0 58.59 1.14 Allowed 'General case' 0 C--N 1.355 0.83 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 -178.605 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 42.6 t60 -116.23 1.37 13.12 Favored 'General case' 0 N--CA 1.438 -1.043 0 C-N-CA 125.217 1.407 . . . . 0.0 107.425 175.857 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 31.2 mt -101.67 131.93 48.58 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.054 0 N-CA-C 104.263 -2.495 . . . . 0.0 104.263 171.017 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 4.4 p -110.52 -84.65 0.56 Allowed 'General case' 0 N--CA 1.432 -1.345 0 N-CA-C 107.028 -1.471 . . . . 0.0 107.028 179.515 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 53.2 mtmt -89.91 171.85 9.3 Favored 'General case' 0 CA--C 1.488 -1.439 0 C-N-CA 124.232 1.013 . . . . 0.0 108.785 -166.413 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 86.8 m-85 -129.34 147.66 51.19 Favored 'General case' 0 CA--C 1.496 -1.115 0 N-CA-C 105.362 -2.088 . . . . 0.0 105.362 168.435 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 61.9 mt -120.41 131.04 73.69 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.249 0 N-CA-C 101.207 -3.627 . . . . 0.0 101.207 165.683 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.53 HD11 HD11 ' A' ' 20' ' ' ILE . 2.9 mt -110.49 132.72 53.94 Favored 'General case' 0 CA--C 1.473 -1.997 0 N-CA-C 104.822 -2.288 . . . . 0.0 104.822 170.741 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -129.97 158.94 38.17 Favored 'General case' 0 CA--C 1.493 -1.241 0 N-CA-C 107.308 -1.367 . . . . 0.0 107.308 170.082 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 46.4 p90 -155.15 141.28 18.42 Favored 'General case' 0 N--CA 1.434 -1.232 0 N-CA-C 106.635 -1.617 . . . . 0.0 106.635 -177.908 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 27.0 ttp180 -137.89 142.65 36.94 Favored Pre-proline 0 CA--C 1.502 -0.902 0 N-CA-C 104.902 -2.258 . . . . 0.0 104.902 -179.359 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_exo -65.11 116.97 4.15 Favored 'Trans proline' 0 N--CA 1.455 -0.754 0 C-N-CA 123.024 2.482 . . . . 0.0 109.721 169.133 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 26.7 ttpp -71.96 83.87 0.96 Allowed 'General case' 0 C--N 1.359 0.993 0 C-N-CA 125.306 1.443 . . . . 0.0 110.096 179.933 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 33.1 m120 -150.58 -69.18 0.19 Allowed 'General case' 0 N--CA 1.434 -1.245 0 N-CA-C 102.321 -3.214 . . . . 0.0 102.321 -175.526 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 56.4 p -109.23 175.32 5.5 Favored 'General case' 0 N--CA 1.44 -0.97 0 N-CA-C 107.334 -1.358 . . . . 0.0 107.334 175.171 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 4.2 m -115.69 51.36 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.836 0 N-CA-C 106.241 -1.763 . . . . 0.0 106.241 176.009 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -94.81 -136.1 8.28 Favored Glycine 0 C--N 1.356 1.68 0 N-CA-C 109.739 -1.345 . . . . 0.0 109.739 -175.57 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 39.9 mmt180 -81.18 155.58 26.1 Favored 'General case' 0 CA--C 1.501 -0.939 0 C-N-CA 123.79 0.836 . . . . 0.0 109.108 -176.534 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -159.36 168.89 25.22 Favored 'General case' 0 CA--C 1.493 -1.225 0 CA-C-O 121.385 0.612 . . . . 0.0 109.832 -169.259 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -113.49 156.68 23.12 Favored 'General case' 0 CA--C 1.491 -1.293 0 N-CA-C 107.889 -1.152 . . . . 0.0 107.889 -169.975 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 23.5 pt-20 -151.37 161.27 43.0 Favored 'General case' 0 N--CA 1.435 -1.191 0 N-CA-C 107.765 -1.198 . . . . 0.0 107.765 172.125 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -139.62 164.71 29.2 Favored 'General case' 0 N--CA 1.438 -1.051 0 N-CA-C 105.603 -1.999 . . . . 0.0 105.603 171.222 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 88.8 m -118.51 122.65 43.21 Favored 'General case' 0 CA--C 1.498 -1.021 0 N-CA-C 104.333 -2.469 . . . . 0.0 104.333 176.056 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 3.7 mm -103.62 138.64 19.59 Favored Pre-proline 0 N--CA 1.438 -1.029 0 N-CA-C 105.808 -1.923 . . . . 0.0 105.808 -174.909 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_exo -63.91 161.15 34.11 Favored 'Trans proline' 0 N--CA 1.455 -0.784 0 C-N-CA 123.378 2.719 . . . . 0.0 112.562 170.817 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -78.22 -19.26 74.87 Favored Glycine 0 C--N 1.353 1.492 0 C-N-CA 123.843 0.735 . . . . 0.0 113.344 -172.485 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 50.3 p-80 -83.61 -24.97 31.24 Favored 'General case' 0 C--N 1.356 0.85 0 CA-C-N 117.68 0.74 . . . . 0.0 110.158 -178.802 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 88.7 mt -88.22 129.77 35.26 Favored 'General case' 0 CA--C 1.498 -1.024 0 N-CA-C 107.913 -1.143 . . . . 0.0 107.913 177.655 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 7.5 p30 -116.66 10.72 14.45 Favored 'General case' 0 CA--C 1.501 -0.93 0 C-N-CA 124.59 1.156 . . . . 0.0 109.662 -174.554 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 31.3 p -141.79 154.42 45.21 Favored 'General case' 0 N--CA 1.44 -0.974 0 N-CA-C 106.863 -1.532 . . . . 0.0 106.863 -179.237 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 9.8 t80 -137.55 170.7 15.62 Favored 'General case' 0 N--CA 1.441 -0.914 0 N-CA-C 107.91 -1.144 . . . . 0.0 107.91 178.606 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 89.2 m -133.93 110.01 9.42 Favored 'General case' 0 N--CA 1.429 -1.517 0 N-CA-C 104.424 -2.436 . . . . 0.0 104.424 172.773 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 45.2 mt -88.37 144.06 9.94 Favored 'Isoleucine or valine' 0 C--N 1.355 0.846 0 N-CA-C 103.663 -2.717 . . . . 0.0 103.663 172.051 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 56.7 mtmt -144.29 165.51 27.69 Favored 'General case' 0 CA--C 1.498 -1.04 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 175.929 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 88.7 48.3 3.97 Favored Glycine 0 CA--C 1.485 -1.832 0 N-CA-C 108.99 -1.644 . . . . 0.0 108.99 174.575 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 51.9 mt -120.79 171.22 8.76 Favored 'General case' 0 CA--C 1.498 -1.025 0 N-CA-C 107.604 -1.258 . . . . 0.0 107.604 -170.22 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt -113.66 150.87 44.0 Favored Pre-proline 0 N--CA 1.44 -0.93 0 N-CA-C 107.363 -1.347 . . . . 0.0 107.363 -174.247 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 78.5 Cg_exo -68.14 153.85 73.81 Favored 'Trans proline' 0 N--CA 1.453 -0.873 0 C-N-CA 123.37 2.714 . . . . 0.0 112.028 168.338 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . 0.603 ' H ' ' HA ' ' A' ' 92' ' ' THR . . . 58.95 30.28 66.29 Favored Glycine 0 N--CA 1.432 -1.604 0 C-N-CA 127.545 2.498 . . . . 0.0 116.478 170.37 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 4.9 p -126.92 142.13 44.27 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.029 0 N-CA-C 108.577 -0.898 . . . . 0.0 108.577 179.316 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 9.3 p -94.62 130.77 42.99 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.837 0 C-N-CA 124.641 1.176 . . . . 0.0 107.959 -178.816 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 88.8 m-85 -110.62 154.91 23.11 Favored 'General case' 0 N--CA 1.437 -1.085 0 C-N-CA 124.79 1.236 . . . . 0.0 108.011 177.854 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 15.3 tp10 -98.53 132.17 44.17 Favored 'General case' 0 N--CA 1.437 -1.099 0 N-CA-C 103.578 -2.749 . . . . 0.0 103.578 164.148 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -129.67 148.82 18.53 Favored Glycine 0 CA--C 1.489 -1.544 0 N-CA-C 107.667 -2.173 . . . . 0.0 107.667 175.786 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 34.6 mt-30 -141.47 137.05 31.86 Favored 'General case' 0 CA--C 1.484 -1.582 0 N-CA-C 106.549 -1.649 . . . . 0.0 106.549 178.4 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 27.6 tp -117.93 97.17 5.69 Favored 'General case' 0 N--CA 1.435 -1.202 0 N-CA-C 104.03 -2.581 . . . . 0.0 104.03 -178.721 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 20.3 mt -92.17 129.01 43.44 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.865 0 N-CA-C 104.947 -2.242 . . . . 0.0 104.947 -179.84 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 49.8 m -110.06 117.84 34.82 Favored 'General case' 0 CA--C 1.497 -1.061 0 N-CA-C 106.814 -1.55 . . . . 0.0 106.814 -175.784 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 1.7 mp -88.2 131.94 34.5 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.302 0 N-CA-C 104.348 -2.464 . . . . 0.0 104.348 -170.455 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 76.0 mt-30 -96.78 157.1 16.06 Favored 'General case' 0 N--CA 1.434 -1.269 0 N-CA-C 107.167 -1.42 . . . . 0.0 107.167 -176.787 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 32.3 mt-30 -69.48 118.2 12.06 Favored 'General case' 0 N--CA 1.438 -1.026 0 C-N-CA 123.919 0.888 . . . . 0.0 112.544 -168.503 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 49.0 m-85 61.68 35.58 16.93 Favored 'General case' 0 C--N 1.355 0.833 0 C-N-CA 127.117 2.167 . . . . 0.0 113.136 170.558 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 179.38 -93.31 0.09 OUTLIER Glycine 0 C--N 1.354 1.53 0 C-N-CA 118.294 -1.907 . . . . 0.0 111.416 177.73 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 74.1 m-70 -78.59 -178.74 6.03 Favored 'General case' 0 CA--C 1.498 -1.047 0 C-N-CA 124.797 1.239 . . . . 0.0 111.747 -163.602 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 4.4 pt20 -153.32 146.56 24.75 Favored 'General case' 0 N--CA 1.434 -1.245 0 N-CA-C 106.484 -1.672 . . . . 0.0 106.484 170.2 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 17.4 tp10 -104.87 146.28 29.22 Favored 'General case' 0 CA--C 1.496 -1.124 0 N-CA-C 105.575 -2.009 . . . . 0.0 105.575 179.855 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 3.0 p -117.76 131.59 70.06 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.824 0 N-CA-C 107.204 -1.406 . . . . 0.0 107.204 177.391 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 40.4 m -113.58 138.36 50.28 Favored 'General case' 0 N--CA 1.441 -0.9 0 N-CA-C 102.871 -3.011 . . . . 0.0 102.871 170.962 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 7.6 ptp85 -131.58 150.86 52.0 Favored 'General case' 0 CA--C 1.498 -1.025 0 CA-C-O 121.466 0.651 . . . . 0.0 109.594 178.86 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 30.0 p90 -164.2 178.2 7.77 Favored 'General case' 0 N--CA 1.44 -0.97 0 N-CA-C 106.959 -1.497 . . . . 0.0 106.959 -174.617 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 1.5 p30 -137.44 157.71 45.99 Favored 'General case' 0 N--CA 1.44 -0.928 0 N-CA-C 105.844 -1.91 . . . . 0.0 105.844 169.416 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 26.6 p90 -145.73 170.75 15.89 Favored 'General case' 0 CA--C 1.486 -1.497 0 N-CA-C 107.367 -1.346 . . . . 0.0 107.367 174.949 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 24.8 p -121.55 145.33 48.07 Favored 'General case' 0 CA--C 1.5 -0.954 0 N-CA-C 106.006 -1.85 . . . . 0.0 106.006 172.078 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 75.4 m -119.57 113.48 20.77 Favored 'General case' 0 CA--C 1.496 -1.111 0 N-CA-C 102.103 -3.295 . . . . 0.0 102.103 170.287 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . 0.603 ' HA ' ' H ' ' A' ' 66' ' ' GLY . 15.3 m -143.41 149.74 38.08 Favored 'General case' 0 C--N 1.356 0.87 0 N-CA-C 105.705 -1.961 . . . . 0.0 105.705 -171.934 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 8.7 t . . . . . 0 C--O 1.261 1.662 0 C-N-CA 124.632 1.173 . . . . 0.0 109.497 -176.01 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.439 -1.153 0 N-CA-C 106.077 -2.809 . . . . 0.0 106.077 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_exo -61.0 135.78 61.31 Favored 'Trans proline' 0 N--CA 1.445 -1.342 0 C-N-CA 123.3 2.666 . . . . 0.0 112.37 -173.176 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 8.4 t -78.57 154.05 5.0 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.88 0 C-N-CA 126.738 2.015 . . . . 0.0 106.214 -175.948 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -96.66 90.73 5.42 Favored 'General case' 0 CA--C 1.493 -1.242 0 N-CA-C 107.66 -1.237 . . . . 0.0 107.66 -175.04 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.425 ' HA ' ' HA ' ' A' ' 22' ' ' TRP . 2.6 p -114.33 133.92 58.89 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.175 0 N-CA-C 107.032 -1.47 . . . . 0.0 107.032 -166.86 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 75.3 m-85 . . . . . 0 N--CA 1.435 -1.188 0 N-CA-C 106.208 -1.775 . . . . 0.0 106.208 -173.776 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_endo . . . . . 0 N--CA 1.457 -0.644 0 N-CA-C 109.903 -0.845 . . . . 0.0 109.903 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 2.3 t30 -89.18 -14.44 36.06 Favored 'General case' 0 N--CA 1.439 -0.994 0 C-N-CA 126.088 1.755 . . . . 0.0 107.403 172.697 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 68.2 m -113.32 150.3 32.73 Favored 'General case' 0 CA--C 1.497 -1.093 0 CA-C-O 122.16 0.981 . . . . 0.0 108.803 175.784 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 26.0 t-80 -124.41 98.54 37.89 Favored Pre-proline 0 N--CA 1.439 -1.014 0 N-CA-C 105.343 -2.095 . . . . 0.0 105.343 166.901 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -74.72 115.2 4.22 Favored 'Trans proline' 0 N--CA 1.448 -1.177 0 C-N-CA 123.017 2.478 . . . . 0.0 108.635 170.492 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 11.1 tt -108.92 148.79 12.53 Favored 'Isoleucine or valine' 0 N--CA 1.406 -2.639 0 C-N-CA 127.053 2.141 . . . . 0.0 106.05 -178.521 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 23.5 tt0 -135.64 145.42 46.8 Favored 'General case' 0 N--CA 1.435 -1.189 0 N-CA-C 104.337 -2.468 . . . . 0.0 104.337 170.967 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' TRP . . . . . 0.425 ' HA ' ' HA ' ' A' ' 6' ' ' VAL . 49.1 p90 -135.46 165.56 25.22 Favored 'General case' 0 N--CA 1.438 -1.054 0 N-CA-C 105.337 -2.097 . . . . 0.0 105.337 175.211 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 39.6 m-80 -140.8 132.04 26.55 Favored 'General case' 0 CA--C 1.489 -1.368 0 N-CA-C 106.136 -1.802 . . . . 0.0 106.136 -179.708 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -96.85 168.59 10.09 Favored Pre-proline 0 N--CA 1.439 -1.006 0 CA-C-N 114.792 -1.095 . . . . 0.0 110.37 -163.797 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 81.1 Cg_exo -66.43 167.69 18.13 Favored 'Trans proline' 0 N--CA 1.456 -0.716 0 C-N-CA 123.821 3.014 . . . . 0.0 111.776 166.731 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 10.2 tm0? -81.95 -52.66 0.74 Allowed Pre-proline 0 N--CA 1.444 -0.774 0 CA-C-O 115.317 -2.278 . . . . 0.0 111.279 -175.232 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -71.26 166.01 30.61 Favored 'Trans proline' 0 CA--C 1.507 -0.829 0 CA-C-N 126.065 3.202 . . . . 0.0 112.45 -172.77 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 28.1 p -77.97 118.29 20.12 Favored 'General case' 0 C--N 1.358 0.94 0 N-CA-C 106.915 -1.513 . . . . 0.0 106.915 173.449 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 8.4 t-160 -169.73 -44.84 0.02 OUTLIER 'General case' 0 CA--C 1.497 -1.063 0 N-CA-C 107.214 -1.402 . . . . 0.0 107.214 -164.099 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 37.2 mt -112.2 137.36 45.27 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.014 0 N-CA-C 104.175 -2.528 . . . . 0.0 104.175 176.615 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 33.5 t -113.06 -87.29 0.56 Allowed 'General case' 0 N--CA 1.43 -1.437 0 N-CA-C 106.494 -1.669 . . . . 0.0 106.494 179.548 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 35.9 ttpt -89.18 163.31 15.48 Favored 'General case' 0 CA--C 1.491 -1.303 0 C-N-CA 125.686 1.594 . . . . 0.0 108.104 -159.202 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 90.6 m-85 -128.88 139.07 52.31 Favored 'General case' 0 CA--C 1.492 -1.257 0 N-CA-C 105.649 -1.982 . . . . 0.0 105.649 175.56 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 55.3 mt -119.42 131.09 73.04 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.121 0 N-CA-C 101.694 -3.447 . . . . 0.0 101.694 171.113 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 3.2 mt -110.47 135.63 50.85 Favored 'General case' 0 CA--C 1.473 -1.982 0 N-CA-C 105.02 -2.215 . . . . 0.0 105.02 171.899 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -131.35 156.51 45.39 Favored 'General case' 0 CA--C 1.493 -1.247 0 N-CA-C 106.889 -1.523 . . . . 0.0 106.889 167.555 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 49.6 p90 -154.18 145.47 22.96 Favored 'General case' 0 N--CA 1.434 -1.257 0 N-CA-C 106.757 -1.572 . . . . 0.0 106.757 -175.94 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 8.6 ttm180 -138.18 139.57 26.01 Favored Pre-proline 0 CA--C 1.499 -0.982 0 N-CA-C 104.605 -2.368 . . . . 0.0 104.605 -179.907 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -72.89 116.06 4.58 Favored 'Trans proline' 0 N--CA 1.454 -0.843 0 C-N-CA 122.739 2.293 . . . . 0.0 108.824 174.713 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 3.0 tmtp? -70.22 81.49 0.53 Allowed 'General case' 0 C--N 1.358 0.97 0 C-N-CA 126.858 2.063 . . . . 0.0 111.029 -176.047 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 1.5 p30 -164.65 -50.06 0.03 OUTLIER 'General case' 0 N--CA 1.435 -1.176 0 N-CA-C 103.676 -2.713 . . . . 0.0 103.676 175.868 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 46.5 p -97.63 163.89 12.65 Favored 'General case' 0 N--CA 1.44 -0.968 0 C-N-CA 124.922 1.289 . . . . 0.0 108.01 178.135 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 4.8 m -125.92 46.18 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.849 0 N-CA-C 105.838 -1.912 . . . . 0.0 105.838 176.455 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -94.89 -154.06 30.66 Favored Glycine 0 C--N 1.356 1.656 0 N-CA-C 109.808 -1.317 . . . . 0.0 109.808 -175.64 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 80.4 ttt180 -78.9 126.76 31.12 Favored 'General case' 0 C--N 1.356 0.86 0 N-CA-C 108.142 -1.059 . . . . 0.0 108.142 -178.59 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -105.24 172.56 6.73 Favored 'General case' 0 CA--C 1.497 -1.061 0 C-N-CA 123.825 0.85 . . . . 0.0 110.377 -172.782 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 63.0 mttp -112.11 157.07 21.25 Favored 'General case' 0 CA--C 1.489 -1.403 0 N-CA-C 107.773 -1.195 . . . . 0.0 107.773 -170.717 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 15.7 pt-20 -151.21 159.73 44.23 Favored 'General case' 0 N--CA 1.437 -1.09 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 173.57 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -138.2 164.03 30.24 Favored 'General case' 0 N--CA 1.44 -0.935 0 N-CA-C 105.851 -1.907 . . . . 0.0 105.851 170.436 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 88.8 m -124.51 127.67 47.8 Favored 'General case' 0 CA--C 1.5 -0.947 0 N-CA-C 105.3 -2.111 . . . . 0.0 105.3 179.053 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 5.2 mp -117.27 135.93 23.29 Favored Pre-proline 0 N--CA 1.438 -1.034 0 N-CA-C 105.213 -2.143 . . . . 0.0 105.213 -172.111 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_exo -63.06 166.82 13.53 Favored 'Trans proline' 0 CA--C 1.509 -0.762 0 C-N-CA 123.54 2.826 . . . . 0.0 113.748 176.582 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -81.09 -16.82 73.62 Favored Glycine 0 C--N 1.353 1.473 0 C-N-CA 123.457 0.551 . . . . 0.0 113.249 -171.95 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 50.8 p-80 -83.83 -25.82 30.02 Favored 'General case' 0 C--N 1.357 0.901 0 CA-C-N 117.831 0.816 . . . . 0.0 109.999 179.899 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 92.4 mt -88.32 131.03 34.97 Favored 'General case' 0 CA--C 1.501 -0.922 0 N-CA-C 107.84 -1.17 . . . . 0.0 107.84 177.46 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 8.3 p-10 -112.95 8.35 18.51 Favored 'General case' 0 CA--C 1.503 -0.863 0 C-N-CA 124.666 1.186 . . . . 0.0 109.667 -174.421 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 32.9 p -146.75 160.92 41.64 Favored 'General case' 0 CA--C 1.499 -1.005 0 N-CA-C 106.484 -1.673 . . . . 0.0 106.484 -177.248 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 19.2 t80 -148.45 160.26 43.23 Favored 'General case' 0 CA--C 1.497 -1.093 0 N-CA-C 108.083 -1.08 . . . . 0.0 108.083 178.575 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 82.8 m -114.43 109.47 18.36 Favored 'General case' 0 N--CA 1.436 -1.14 0 N-CA-C 104.491 -2.411 . . . . 0.0 104.491 168.9 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 65.7 mt -82.94 137.79 20.41 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.902 0 N-CA-C 103.086 -2.931 . . . . 0.0 103.086 169.83 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 17.8 ptpt -147.84 160.62 42.56 Favored 'General case' 0 CA--C 1.495 -1.151 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 -177.709 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 89.82 52.67 2.56 Favored Glycine 0 CA--C 1.489 -1.555 0 N-CA-C 108.586 -1.806 . . . . 0.0 108.586 179.827 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 63.8 mt -120.47 170.63 9.2 Favored 'General case' 0 CA--C 1.498 -1.023 0 N-CA-C 107.377 -1.342 . . . . 0.0 107.377 -171.986 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 28.9 mtpp -101.59 153.75 37.7 Favored Pre-proline 0 N--CA 1.439 -1.012 0 N-CA-C 106.507 -1.664 . . . . 0.0 106.507 -179.775 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 70.6 Cg_endo -77.6 156.8 32.09 Favored 'Trans proline' 0 N--CA 1.452 -0.964 0 C-N-CA 122.936 2.424 . . . . 0.0 110.342 174.88 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 57.74 32.68 65.99 Favored Glycine 0 C--N 1.355 1.635 0 C-N-CA 126.904 2.192 . . . . 0.0 116.44 169.854 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 5.8 p -129.16 144.39 38.3 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.903 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 -177.009 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 3.5 p -95.4 135.49 29.31 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.918 0 N-CA-C 107.292 -1.373 . . . . 0.0 107.292 -179.693 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 94.8 m-85 -113.67 150.99 32.43 Favored 'General case' 0 CA--C 1.499 -1.011 0 N-CA-C 106.815 -1.55 . . . . 0.0 106.815 177.379 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -94.94 145.29 25.02 Favored 'General case' 0 CA--C 1.501 -0.928 0 N-CA-C 104.155 -2.535 . . . . 0.0 104.155 161.109 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -138.39 149.5 20.56 Favored Glycine 0 CA--C 1.487 -1.678 0 N-CA-C 108.599 -1.801 . . . . 0.0 108.599 -177.413 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 26.2 mt-30 -138.59 135.66 35.19 Favored 'General case' 0 CA--C 1.483 -1.608 0 N-CA-C 105.599 -2.0 . . . . 0.0 105.599 177.064 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 40.9 tp -116.72 99.36 7.07 Favored 'General case' 0 N--CA 1.435 -1.178 0 N-CA-C 103.787 -2.672 . . . . 0.0 103.787 179.075 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 33.0 mt -89.21 127.68 41.75 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.883 0 N-CA-C 104.762 -2.311 . . . . 0.0 104.762 177.702 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 13.3 p -112.03 115.98 29.8 Favored 'General case' 0 N--CA 1.434 -1.26 0 N-CA-C 106.565 -1.642 . . . . 0.0 106.565 -176.619 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 23.1 mm -90.68 138.63 19.13 Favored 'Isoleucine or valine' 0 CA--C 1.483 -1.603 0 N-CA-C 106.154 -1.795 . . . . 0.0 106.154 -167.468 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 36.2 mt-30 -101.24 153.6 19.48 Favored 'General case' 0 CA--C 1.494 -1.198 0 CA-C-N 113.851 -1.522 . . . . 0.0 107.569 -173.313 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 32.8 mt-30 -68.44 101.16 1.19 Allowed 'General case' 0 CA--C 1.5 -0.948 0 C-N-CA 124.939 1.295 . . . . 0.0 112.497 -166.165 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 85.7 m-85 52.99 39.99 30.38 Favored 'General case' 0 C--N 1.359 1.008 0 C-N-CA 127.296 2.238 . . . . 0.0 112.214 -179.825 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -149.64 -118.83 0.93 Allowed Glycine 0 C--N 1.354 1.545 0 N-CA-C 108.851 -1.7 . . . . 0.0 108.851 -175.294 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 64.4 m-70 -81.93 -175.68 5.73 Favored 'General case' 0 CA--C 1.496 -1.113 0 C-N-CA 124.757 1.223 . . . . 0.0 111.528 -167.858 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 40.1 mt-30 -134.0 137.47 44.77 Favored 'General case' 0 N--CA 1.436 -1.132 0 N-CA-C 103.536 -2.765 . . . . 0.0 103.536 171.595 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 16.7 tp10 -118.05 137.02 53.18 Favored 'General case' 0 CA--C 1.495 -1.146 0 N-CA-C 105.174 -2.158 . . . . 0.0 105.174 179.873 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 7.1 p -111.35 139.12 36.9 Favored 'Isoleucine or valine' 0 C--N 1.354 0.797 0 N-CA-C 107.618 -1.253 . . . . 0.0 107.618 -177.414 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 38.2 m -120.49 134.17 55.31 Favored 'General case' 0 N--CA 1.441 -0.886 0 N-CA-C 102.345 -3.206 . . . . 0.0 102.345 174.114 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 83.1 mtm180 -125.82 149.75 48.36 Favored 'General case' 0 CA--C 1.5 -0.954 0 CA-C-N 119.177 0.898 . . . . 0.0 109.479 -176.638 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 19.2 p90 -165.96 -176.59 3.85 Favored 'General case' 0 CA--C 1.501 -0.92 0 N-CA-C 107.382 -1.34 . . . . 0.0 107.382 -178.357 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 44.7 p30 -135.79 158.05 45.34 Favored 'General case' 0 N--CA 1.442 -0.858 0 N-CA-C 107.24 -1.393 . . . . 0.0 107.24 164.626 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 25.4 p90 -142.38 172.88 12.09 Favored 'General case' 0 CA--C 1.485 -1.53 0 N-CA-C 106.018 -1.845 . . . . 0.0 106.018 170.252 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 8.9 t -141.41 152.98 44.77 Favored 'General case' 0 CA--C 1.499 -0.996 0 N-CA-C 105.713 -1.958 . . . . 0.0 105.713 173.77 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 29.8 p -113.95 131.94 56.13 Favored 'General case' 0 N--CA 1.437 -1.104 0 N-CA-C 103.432 -2.803 . . . . 0.0 103.432 171.745 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 25.0 p -130.5 145.83 51.93 Favored 'General case' 0 CA--C 1.5 -0.968 0 N-CA-C 105.654 -1.98 . . . . 0.0 105.654 179.632 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 42.9 p . . . . . 0 C--O 1.26 1.65 0 N-CA-C 109.206 -0.664 . . . . 0.0 109.206 -177.575 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.437 -1.249 0 N-CA-C 105.516 -3.034 . . . . 0.0 105.516 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 90.4 Cg_exo -61.17 134.27 51.51 Favored 'Trans proline' 0 CA--C 1.5 -1.177 0 C-N-CA 123.17 2.58 . . . . 0.0 112.255 -171.018 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 3.1 t -79.39 150.31 5.15 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.79 0 C-N-CA 126.313 1.845 . . . . 0.0 106.039 -176.442 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 54.5 mm-40 -100.1 89.46 4.04 Favored 'General case' 0 CA--C 1.485 -1.527 0 CA-C-O 122.776 1.274 . . . . 0.0 108.36 -170.262 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 2.3 p -104.06 127.24 58.42 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.136 0 CA-C-N 113.421 -1.718 . . . . 0.0 107.661 -166.879 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 59.2 m-85 . . . . . 0 CA--C 1.495 -1.135 0 C-N-CA 123.935 0.894 . . . . 0.0 110.444 -169.501 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo . . . . . 0 N--CA 1.45 -1.056 0 CA-C-O 119.004 -0.498 . . . . 0.0 111.75 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 36.6 m-20 -141.97 -12.39 0.85 Allowed 'General case' 0 N--CA 1.435 -1.191 0 C-N-CA 124.82 1.248 . . . . 0.0 110.228 -163.649 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 23.6 p -98.11 161.39 13.74 Favored 'General case' 0 CA--C 1.503 -0.846 0 O-C-N 120.739 -1.226 . . . . 0.0 107.701 -179.516 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 40.3 t-80 -151.52 104.26 2.91 Favored Pre-proline 0 N--CA 1.443 -0.816 0 CA-C-O 118.359 -0.829 . . . . 0.0 108.934 173.088 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -75.73 123.11 7.25 Favored 'Trans proline' 0 N--CA 1.452 -0.949 0 C-N-CA 123.199 2.599 . . . . 0.0 109.71 175.282 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 10.9 mt -111.6 136.56 47.35 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.947 0 N-CA-C 104.586 -2.375 . . . . 0.0 104.586 -178.639 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 35.7 mt-30 -140.3 146.93 39.17 Favored 'General case' 0 CA--C 1.494 -1.19 0 N-CA-C 104.668 -2.345 . . . . 0.0 104.668 179.387 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 42.7 p90 -147.48 169.63 19.14 Favored 'General case' 0 CA--C 1.499 -1.015 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 -174.072 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 5.7 m120 -131.24 127.57 38.1 Favored 'General case' 0 CA--C 1.492 -1.252 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 179.624 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -92.26 175.78 3.11 Favored Pre-proline 0 N--CA 1.439 -0.993 0 C-N-CA 125.989 1.716 . . . . 0.0 108.946 -174.323 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_exo -63.16 159.58 38.45 Favored 'Trans proline' 0 CA--C 1.508 -0.823 0 C-N-CA 123.743 2.962 . . . . 0.0 112.297 171.095 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 35.9 mt-30 -81.57 -37.12 0.86 Allowed Pre-proline 0 N--CA 1.443 -0.795 0 CA-C-O 115.962 -1.971 . . . . 0.0 111.281 -177.414 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_exo -70.17 -8.26 23.16 Favored 'Trans proline' 0 CA--C 1.512 -0.625 0 CA-C-N 124.878 2.778 . . . . 0.0 112.905 169.526 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . 0.28 80.5 p 54.09 71.81 0.49 Allowed 'General case' 0 C--N 1.36 1.046 0 C-N-CA 127.609 2.363 . . . . 0.0 112.022 -177.254 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 49.8 t-80 -88.74 -10.57 47.85 Favored 'General case' 0 N--CA 1.441 -0.885 0 C-N-CA 124.473 1.109 . . . . 0.0 109.768 -176.329 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.408 HG21 ' CE1' ' A' ' 33' ' ' TYR . 84.7 mt -93.88 145.03 8.4 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.976 0 N-CA-C 105.434 -2.061 . . . . 0.0 105.434 -179.846 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 35.6 t -99.09 -86.78 0.36 Allowed 'General case' 0 N--CA 1.43 -1.445 0 N-CA-C 103.857 -2.646 . . . . 0.0 103.857 174.537 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 46.0 mtpt -89.16 165.94 14.15 Favored 'General case' 0 CA--C 1.492 -1.266 0 C-N-CA 124.854 1.262 . . . . 0.0 109.097 -168.359 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . 0.408 ' CE1' HG21 ' A' ' 30' ' ' ILE . 64.0 m-85 -125.63 142.34 51.56 Favored 'General case' 0 CA--C 1.495 -1.137 0 N-CA-C 104.547 -2.39 . . . . 0.0 104.547 164.641 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 54.7 mt -119.56 132.24 69.9 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.302 0 N-CA-C 101.141 -3.651 . . . . 0.0 101.141 168.796 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 3.0 mt -106.38 128.96 54.43 Favored 'General case' 0 CA--C 1.473 -2.017 0 N-CA-C 103.95 -2.611 . . . . 0.0 103.95 166.766 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 79.3 mtt180 -112.56 157.09 21.59 Favored 'General case' 0 N--CA 1.43 -1.442 0 N-CA-C 105.266 -2.124 . . . . 0.0 105.266 164.248 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 48.6 p90 -156.12 147.42 22.5 Favored 'General case' 0 N--CA 1.43 -1.44 0 N-CA-C 105.934 -1.876 . . . . 0.0 105.934 176.513 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 39.0 ptt180 -157.52 161.07 29.86 Favored Pre-proline 0 N--CA 1.438 -1.028 0 N-CA-C 105.41 -2.071 . . . . 0.0 105.41 170.189 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_exo -66.06 149.77 85.68 Favored 'Trans proline' 0 CA--C 1.503 -1.029 0 C-N-CA 123.367 2.711 . . . . 0.0 109.828 176.572 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 4.1 tmtp? -75.7 70.93 2.54 Favored 'General case' 0 C--N 1.358 0.947 0 C-N-CA 123.643 0.777 . . . . 0.0 109.587 175.731 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 30.4 m120 -158.67 -52.55 0.06 Allowed 'General case' 0 N--CA 1.437 -1.083 0 N-CA-C 103.671 -2.714 . . . . 0.0 103.671 -170.609 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 32.3 t -79.24 151.45 31.17 Favored 'General case' 0 CA--C 1.497 -1.096 0 CA-C-O 122.783 1.277 . . . . 0.0 110.064 -174.73 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 16.1 m -134.34 -0.54 1.24 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.894 0 CA-C-N 112.42 -2.173 . . . . 0.0 108.425 -174.514 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -98.2 -100.21 2.13 Favored Glycine 0 C--N 1.356 1.67 0 N-CA-C 109.355 -1.498 . . . . 0.0 109.355 -174.63 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 77.0 mtp85 -93.95 168.21 11.11 Favored 'General case' 0 CA--C 1.501 -0.908 0 C-N-CA 123.588 0.755 . . . . 0.0 109.559 -173.716 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 60.3 m95 -122.53 163.22 20.32 Favored 'General case' 0 N--CA 1.439 -0.996 0 N-CA-C 106.273 -1.751 . . . . 0.0 106.273 178.591 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -96.77 151.26 19.82 Favored 'General case' 0 CA--C 1.489 -1.392 0 N-CA-C 103.858 -2.645 . . . . 0.0 103.858 158.796 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 16.1 pt-20 -152.31 158.88 43.38 Favored 'General case' 0 CA--C 1.496 -1.12 0 CA-C-O 121.8 0.81 . . . . 0.0 109.559 -178.113 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -142.73 162.25 35.97 Favored 'General case' 0 CA--C 1.498 -1.036 0 N-CA-C 106.051 -1.833 . . . . 0.0 106.051 174.066 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 78.4 m -120.35 125.63 48.49 Favored 'General case' 0 CA--C 1.5 -0.945 0 N-CA-C 105.228 -2.138 . . . . 0.0 105.228 178.713 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 5.3 mp -109.43 133.3 20.87 Favored Pre-proline 0 N--CA 1.437 -1.107 0 N-CA-C 104.313 -2.476 . . . . 0.0 104.313 -177.929 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 65.3 Cg_exo -63.88 165.06 19.74 Favored 'Trans proline' 0 CA--C 1.507 -0.847 0 C-N-CA 123.393 2.729 . . . . 0.0 113.054 178.277 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -75.05 -18.04 80.2 Favored Glycine 0 C--N 1.351 1.403 0 N-CA-C 114.604 0.602 . . . . 0.0 114.604 -174.084 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 47.7 p-80 -83.71 -29.52 27.47 Favored 'General case' 0 C--N 1.356 0.864 0 CA-C-N 118.016 0.908 . . . . 0.0 109.826 179.832 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 89.6 mt -89.14 134.26 34.08 Favored 'General case' 0 CA--C 1.5 -0.972 0 N-CA-C 107.721 -1.215 . . . . 0.0 107.721 176.563 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 6.5 p-10 -123.53 25.01 8.4 Favored 'General case' 0 CA--C 1.498 -1.023 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 -177.541 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 33.9 p -146.79 163.22 36.72 Favored 'General case' 0 N--CA 1.439 -1.021 0 N-CA-C 107.59 -1.263 . . . . 0.0 107.59 -179.248 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 7.4 t80 -154.25 178.4 10.05 Favored 'General case' 0 N--CA 1.44 -0.936 0 N-CA-C 107.903 -1.147 . . . . 0.0 107.903 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 96.1 m -144.09 117.99 9.36 Favored 'General case' 0 N--CA 1.43 -1.44 0 N-CA-C 104.995 -2.224 . . . . 0.0 104.995 176.072 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 13.4 mm -87.22 144.38 9.4 Favored 'Isoleucine or valine' 0 C--N 1.354 0.768 0 N-CA-C 104.3 -2.481 . . . . 0.0 104.3 171.004 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 95.8 mttt -145.27 162.22 37.69 Favored 'General case' 0 CA--C 1.493 -1.225 0 N-CA-C 107.491 -1.3 . . . . 0.0 107.491 170.07 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 79.31 54.56 4.0 Favored Glycine 0 CA--C 1.488 -1.596 0 N-CA-C 108.968 -1.653 . . . . 0.0 108.968 175.249 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 85.3 mt -108.34 -153.87 0.52 Allowed 'General case' 0 CA--C 1.504 -0.799 0 N-CA-C 106.822 -1.547 . . . . 0.0 106.822 178.854 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 90.6 mttt -132.18 156.3 80.27 Favored Pre-proline 0 N--CA 1.44 -0.928 0 N-CA-C 105.74 -1.948 . . . . 0.0 105.74 -170.997 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_endo -74.09 135.78 21.44 Favored 'Trans proline' 0 N--CA 1.451 -0.993 0 C-N-CA 122.905 2.403 . . . . 0.0 110.45 173.202 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 57.25 49.74 70.09 Favored Glycine 0 C--N 1.355 1.612 0 C-N-CA 126.852 2.167 . . . . 0.0 115.823 170.417 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 27.8 t -118.13 133.58 64.49 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.102 0 N-CA-C 105.951 -1.87 . . . . 0.0 105.951 173.51 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 5.3 p -84.33 119.97 34.27 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.961 0 N-CA-C 105.48 -2.044 . . . . 0.0 105.48 164.947 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 83.0 m-85 -99.5 149.24 23.42 Favored 'General case' 0 CA--C 1.496 -1.13 0 C-N-CA 125.716 1.606 . . . . 0.0 107.354 -179.477 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 17.9 pt-20 -108.67 133.46 52.73 Favored 'General case' 0 CA--C 1.499 -0.984 0 N-CA-C 105.01 -2.219 . . . . 0.0 105.01 167.912 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -128.45 165.08 21.48 Favored Glycine 0 CA--C 1.484 -1.895 0 N-CA-C 107.688 -2.165 . . . . 0.0 107.688 -174.206 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 83.8 mt-30 -137.3 133.84 35.42 Favored 'General case' 0 CA--C 1.482 -1.667 0 N-CA-C 104.557 -2.386 . . . . 0.0 104.557 169.688 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 27.2 tp -110.54 90.77 3.42 Favored 'General case' 0 N--CA 1.435 -1.221 0 N-CA-C 103.335 -2.839 . . . . 0.0 103.335 174.383 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 13.2 mt -91.58 131.34 38.95 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.927 0 N-CA-C 105.492 -2.04 . . . . 0.0 105.492 -174.373 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 58.5 m -118.47 115.3 24.33 Favored 'General case' 0 N--CA 1.436 -1.164 0 N-CA-C 107.685 -1.228 . . . . 0.0 107.685 -173.998 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 1.7 mp -91.54 135.97 25.62 Favored 'Isoleucine or valine' 0 CA--C 1.499 -1.0 0 N-CA-C 105.163 -2.162 . . . . 0.0 105.163 -172.175 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 15.6 mp0 -99.17 122.07 41.88 Favored 'General case' 0 CA--C 1.498 -1.034 0 N-CA-C 102.582 -3.118 . . . . 0.0 102.582 170.174 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 16.7 tt0 -68.03 126.02 28.18 Favored 'General case' 0 N--CA 1.443 -0.789 0 C-N-CA 123.26 0.624 . . . . 0.0 111.629 -166.995 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 21.5 m-85 66.42 43.83 2.55 Favored 'General case' 0 C--N 1.357 0.902 0 C-N-CA 126.746 2.018 . . . . 0.0 111.912 179.787 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -171.95 -115.77 0.37 Allowed Glycine 0 N--CA 1.432 -1.587 0 N-CA-C 108.145 -1.982 . . . . 0.0 108.145 175.714 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 87.7 m-70 -84.71 178.53 7.63 Favored 'General case' 0 CA--C 1.498 -1.023 0 C-N-CA 125.182 1.393 . . . . 0.0 111.103 -169.302 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 5.3 pt20 -145.9 143.89 29.85 Favored 'General case' 0 N--CA 1.436 -1.138 0 N-CA-C 106.156 -1.794 . . . . 0.0 106.156 165.104 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 9.3 tm-20 -106.39 141.76 37.18 Favored 'General case' 0 N--CA 1.438 -1.064 0 N-CA-C 104.44 -2.43 . . . . 0.0 104.44 -177.351 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 3.2 p -121.96 120.43 61.43 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.804 0 N-CA-C 108.195 -1.039 . . . . 0.0 108.195 -179.467 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 83.9 m -97.15 129.09 44.57 Favored 'General case' 0 C--N 1.355 0.844 0 N-CA-C 102.622 -3.103 . . . . 0.0 102.622 169.822 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 55.3 ttt85 -115.17 137.66 51.77 Favored 'General case' 0 CA--C 1.498 -1.04 0 N-CA-C 106.358 -1.719 . . . . 0.0 106.358 175.45 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -150.86 176.76 10.77 Favored 'General case' 0 CA--C 1.494 -1.185 0 N-CA-C 107.657 -1.238 . . . . 0.0 107.657 -177.477 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 38.9 p-10 -139.39 151.25 46.16 Favored 'General case' 0 N--CA 1.438 -1.047 0 N-CA-C 106.0 -1.852 . . . . 0.0 106.0 171.21 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 18.5 p90 -144.43 170.51 15.89 Favored 'General case' 0 CA--C 1.489 -1.387 0 N-CA-C 105.801 -1.926 . . . . 0.0 105.801 176.433 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 55.2 m -122.19 142.98 49.86 Favored 'General case' 0 CA--C 1.5 -0.956 0 N-CA-C 105.564 -2.014 . . . . 0.0 105.564 -179.557 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 86.6 m -120.41 120.97 37.49 Favored 'General case' 0 CA--C 1.498 -1.056 0 N-CA-C 101.971 -3.344 . . . . 0.0 101.971 167.292 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 76.9 p -88.73 -168.46 2.2 Favored 'General case' 0 C--N 1.353 0.723 0 C-N-CA 123.654 0.781 . . . . 0.0 109.422 -169.527 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 32.3 t . . . . . 0 C--O 1.26 1.64 0 N-CA-C 106.768 -1.567 . . . . 0.0 106.768 -179.609 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.436 -1.36 0 N-CA-C 107.62 -2.192 . . . . 0.0 107.62 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 79.4 Cg_exo -61.83 137.5 68.31 Favored 'Trans proline' 0 N--CA 1.444 -1.412 0 C-N-CA 123.359 2.706 . . . . 0.0 113.06 -177.389 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 3.5 t -77.37 152.53 5.51 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.915 0 C-N-CA 127.993 2.517 . . . . 0.0 107.006 -178.86 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 91.4 mt-10 -94.35 86.99 5.05 Favored 'General case' 0 CA--C 1.493 -1.23 0 CA-C-O 122.73 1.252 . . . . 0.0 108.721 -174.547 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.417 HG12 ' H ' ' A' ' 6' ' ' VAL . 2.1 p -88.98 154.32 3.18 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.077 0 N-CA-C 105.822 -1.918 . . . . 0.0 105.822 -171.293 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 36.8 t80 . . . . . 0 N--CA 1.429 -1.497 0 N-CA-C 104.458 -2.423 . . . . 0.0 104.458 -148.199 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 64.1 Cg_endo . . . . . 0 CA--C 1.504 -1.003 0 CA-C-O 118.494 -0.711 . . . . 0.0 112.052 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 1.4 p30 -120.75 -38.89 2.79 Favored 'General case' 0 CA--C 1.482 -1.654 0 C-N-CA 123.82 0.848 . . . . 0.0 109.198 -173.989 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 48.5 p -100.54 165.63 11.32 Favored 'General case' 0 N--CA 1.435 -1.22 0 N-CA-C 107.987 -1.116 . . . . 0.0 107.987 -174.956 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 63.7 t-80 -143.31 97.44 5.63 Favored Pre-proline 0 N--CA 1.435 -1.185 0 N-CA-C 104.501 -2.407 . . . . 0.0 104.501 162.434 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -71.18 133.83 23.76 Favored 'Trans proline' 0 N--CA 1.447 -1.258 0 C-N-CA 122.558 2.172 . . . . 0.0 110.167 172.061 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 14.7 mm -104.46 138.63 28.29 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.062 0 N-CA-C 102.928 -2.99 . . . . 0.0 102.928 176.664 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 73.1 mt-30 -128.31 149.66 50.41 Favored 'General case' 0 CA--C 1.493 -1.244 0 N-CA-C 103.909 -2.626 . . . . 0.0 103.909 172.609 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 49.1 p90 -149.49 167.69 25.54 Favored 'General case' 0 CA--C 1.491 -1.307 0 N-CA-C 107.947 -1.131 . . . . 0.0 107.947 -179.125 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 1.8 m120 -130.92 128.44 40.52 Favored 'General case' 0 CA--C 1.489 -1.374 0 N-CA-C 105.382 -2.081 . . . . 0.0 105.382 -179.751 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -87.02 143.79 35.5 Favored Pre-proline 0 N--CA 1.44 -0.927 0 CA-C-O 118.693 -0.67 . . . . 0.0 110.504 -170.622 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_endo -76.76 166.09 27.62 Favored 'Trans proline' 0 N--CA 1.452 -0.917 0 C-N-CA 122.716 2.277 . . . . 0.0 108.214 159.381 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 22.3 tt0 -129.73 84.44 61.19 Favored Pre-proline 0 N--CA 1.442 -0.861 0 N-CA-C 108.323 -0.991 . . . . 0.0 108.323 176.683 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 90.9 Cg_endo -82.31 -8.2 11.76 Favored 'Trans proline' 0 N--CA 1.453 -0.865 0 C-N-CA 123.148 2.565 . . . . 0.0 109.599 163.051 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 21.4 m 59.45 44.21 15.28 Favored 'General case' 0 C--N 1.36 1.028 0 C-N-CA 127.573 2.349 . . . . 0.0 111.222 -171.328 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 15.4 t-160 -140.57 -10.84 1.05 Allowed 'General case' 0 N--CA 1.438 -1.031 0 CA-C-N 113.947 -1.479 . . . . 0.0 108.92 -174.935 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 38.4 mt -111.11 130.7 64.09 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.094 0 N-CA-C 105.423 -2.066 . . . . 0.0 105.423 -173.408 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 32.0 t -112.91 -84.82 0.59 Allowed 'General case' 0 N--CA 1.433 -1.283 0 N-CA-C 107.806 -1.183 . . . . 0.0 107.806 -176.242 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 51.4 mtmt -87.68 168.87 12.62 Favored 'General case' 0 CA--C 1.485 -1.539 0 C-N-CA 124.009 0.924 . . . . 0.0 109.097 -161.313 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 86.8 m-85 -129.46 140.07 51.41 Favored 'General case' 0 CA--C 1.493 -1.238 0 N-CA-C 105.049 -2.204 . . . . 0.0 105.049 170.32 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 35.8 mt -117.24 131.08 71.0 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.203 0 N-CA-C 101.567 -3.494 . . . . 0.0 101.567 169.511 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 4.8 mt -106.65 128.68 54.37 Favored 'General case' 0 CA--C 1.473 -1.985 0 N-CA-C 104.389 -2.448 . . . . 0.0 104.389 168.182 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 65.5 mtt180 -113.97 157.97 21.75 Favored 'General case' 0 N--CA 1.431 -1.377 0 N-CA-C 105.644 -1.984 . . . . 0.0 105.644 167.082 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 36.0 p90 -147.07 130.41 16.63 Favored 'General case' 0 N--CA 1.432 -1.362 0 N-CA-C 104.359 -2.46 . . . . 0.0 104.359 174.16 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 20.0 ttp180 -122.94 138.78 30.2 Favored Pre-proline 0 CA--C 1.498 -1.046 0 N-CA-C 104.087 -2.56 . . . . 0.0 104.087 177.437 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 68.4 Cg_exo -66.26 130.14 23.3 Favored 'Trans proline' 0 CA--C 1.503 -1.037 0 CA-C-N 123.798 2.392 . . . . 0.0 109.122 169.395 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 39.9 ttmt -73.07 69.56 1.02 Allowed 'General case' 0 C--N 1.357 0.929 0 C-N-CA 124.716 1.206 . . . . 0.0 109.899 173.939 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 69.6 m-80 -160.65 -57.05 0.05 Allowed 'General case' 0 N--CA 1.434 -1.26 0 N-CA-C 102.18 -3.267 . . . . 0.0 102.18 -170.866 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 53.4 p -85.29 165.52 17.24 Favored 'General case' 0 N--CA 1.439 -1.021 0 C-N-CA 125.333 1.453 . . . . 0.0 109.109 179.565 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 19.2 m -113.73 -13.04 11.58 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.811 0 C-N-CA 124.254 1.022 . . . . 0.0 110.144 -172.31 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -175.81 38.61 0.1 Allowed Glycine 0 C--N 1.354 1.55 0 N-CA-C 110.359 -1.097 . . . . 0.0 110.359 -178.19 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -119.85 105.51 11.17 Favored 'General case' 0 CA--C 1.492 -1.257 0 N-CA-C 102.271 -3.233 . . . . 0.0 102.271 171.149 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -157.75 165.74 34.59 Favored 'General case' 0 CA--C 1.49 -1.33 0 CA-C-O 122.16 0.981 . . . . 0.0 112.161 -172.618 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 63.2 mttp -121.57 161.41 22.43 Favored 'General case' 0 CA--C 1.492 -1.257 0 CA-C-N 113.688 -1.596 . . . . 0.0 106.79 -169.777 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 15.8 pt-20 -151.92 160.71 43.43 Favored 'General case' 0 N--CA 1.435 -1.199 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 174.315 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -140.5 162.25 35.79 Favored 'General case' 0 CA--C 1.5 -0.961 0 N-CA-C 106.283 -1.747 . . . . 0.0 106.283 174.69 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 59.5 m -120.36 126.04 49.52 Favored 'General case' 0 CA--C 1.499 -0.982 0 N-CA-C 105.175 -2.157 . . . . 0.0 105.175 178.06 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 5.3 mp -112.7 135.94 21.57 Favored Pre-proline 0 N--CA 1.437 -1.098 0 N-CA-C 104.516 -2.401 . . . . 0.0 104.516 -177.346 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 63.2 Cg_exo -63.6 168.06 12.26 Favored 'Trans proline' 0 CA--C 1.51 -0.723 0 C-N-CA 123.45 2.766 . . . . 0.0 113.618 177.466 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -78.49 -20.01 72.65 Favored Glycine 0 C--N 1.351 1.383 0 C-N-CA 123.398 0.523 . . . . 0.0 113.26 -173.885 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 49.7 p-80 -84.27 -27.48 27.85 Favored 'General case' 0 C--N 1.355 0.836 0 CA-C-N 117.713 0.756 . . . . 0.0 110.022 -179.393 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 87.5 mt -88.52 130.64 35.18 Favored 'General case' 0 CA--C 1.5 -0.981 0 N-CA-C 107.541 -1.281 . . . . 0.0 107.541 177.264 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 7.6 p30 -118.88 13.05 13.05 Favored 'General case' 0 CA--C 1.501 -0.921 0 C-N-CA 124.113 0.965 . . . . 0.0 109.645 -173.311 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 46.9 p -142.93 166.6 24.19 Favored 'General case' 0 N--CA 1.44 -0.959 0 N-CA-C 107.282 -1.377 . . . . 0.0 107.282 179.169 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 9.9 t80 -154.87 176.74 12.1 Favored 'General case' 0 N--CA 1.44 -0.938 0 N-CA-C 107.788 -1.19 . . . . 0.0 107.788 -177.161 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 57.2 m -142.57 114.72 8.3 Favored 'General case' 0 N--CA 1.432 -1.367 0 N-CA-C 105.114 -2.18 . . . . 0.0 105.114 176.882 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 50.8 mt -98.84 98.09 6.73 Favored 'Isoleucine or valine' 0 C--N 1.36 1.044 0 N-CA-C 106.137 -1.801 . . . . 0.0 106.137 175.823 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 93.4 mttt -94.97 163.65 13.23 Favored 'General case' 0 CA--C 1.499 -0.988 0 CA-C-O 121.591 0.71 . . . . 0.0 109.341 178.453 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 84.03 49.51 4.73 Favored Glycine 0 CA--C 1.49 -1.471 0 N-CA-C 109.134 -1.586 . . . . 0.0 109.134 174.453 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 68.3 mt -121.63 162.73 20.16 Favored 'General case' 0 CA--C 1.497 -1.078 0 N-CA-C 106.171 -1.789 . . . . 0.0 106.171 -179.144 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -99.57 157.34 34.13 Favored Pre-proline 0 N--CA 1.44 -0.944 0 N-CA-C 107.257 -1.386 . . . . 0.0 107.257 -177.276 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -78.65 165.88 24.38 Favored 'Trans proline' 0 N--CA 1.451 -1.005 0 C-N-CA 123.074 2.516 . . . . 0.0 109.575 165.521 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . 0.515 ' H ' ' HA ' ' A' ' 92' ' ' THR . . . 64.67 18.77 64.26 Favored Glycine 0 N--CA 1.43 -1.736 0 C-N-CA 127.223 2.344 . . . . 0.0 116.415 173.178 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 13.9 p -123.99 140.36 47.66 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.024 0 N-CA-C 107.942 -1.133 . . . . 0.0 107.942 -176.338 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 2.8 p -96.34 129.48 46.35 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.842 0 N-CA-C 107.391 -1.337 . . . . 0.0 107.391 178.671 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 82.6 m-85 -109.56 155.17 21.73 Favored 'General case' 0 N--CA 1.438 -1.04 0 C-N-CA 124.672 1.189 . . . . 0.0 108.436 177.375 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 19.3 tt0 -92.63 139.04 30.98 Favored 'General case' 0 N--CA 1.437 -1.108 0 N-CA-C 104.044 -2.576 . . . . 0.0 104.044 159.074 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -132.31 146.07 17.82 Favored Glycine 0 CA--C 1.49 -1.488 0 N-CA-C 107.575 -2.21 . . . . 0.0 107.575 171.679 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 32.4 mt-30 -138.57 136.02 35.6 Favored 'General case' 0 CA--C 1.479 -1.759 0 N-CA-C 106.321 -1.733 . . . . 0.0 106.321 177.834 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 45.2 tp -117.54 95.53 4.99 Favored 'General case' 0 N--CA 1.439 -1.011 0 N-CA-C 104.423 -2.436 . . . . 0.0 104.423 -178.281 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 12.5 mt -90.92 131.7 37.4 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.85 0 N-CA-C 105.167 -2.16 . . . . 0.0 105.167 -176.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 26.0 p -112.18 115.05 28.21 Favored 'General case' 0 N--CA 1.441 -0.882 0 N-CA-C 107.592 -1.262 . . . . 0.0 107.592 -176.257 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 5.8 mm -94.03 151.56 3.71 Favored 'Isoleucine or valine' 0 CA--C 1.49 -1.347 0 N-CA-C 106.282 -1.747 . . . . 0.0 106.282 -165.142 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . 0.522 HE21 ' HB2' ' A' ' 81' ' ' HIS . 15.6 mt-30 -119.1 145.66 45.74 Favored 'General case' 0 CA--C 1.49 -1.344 0 N-CA-C 105.154 -2.165 . . . . 0.0 105.154 176.879 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 36.1 mt-30 -77.27 35.31 0.17 Allowed 'General case' 0 C--N 1.356 0.856 0 C-N-CA 125.182 1.393 . . . . 0.0 112.917 179.322 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -138.54 13.33 2.76 Favored 'General case' 0 CA--C 1.499 -1.017 0 C-N-CA 124.754 1.222 . . . . 0.0 107.747 -179.436 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 92.51 -13.64 66.81 Favored Glycine 0 C--N 1.352 1.419 0 C-N-CA 124.298 0.952 . . . . 0.0 112.511 173.423 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' HIS . . . . . 0.522 ' HB2' HE21 ' A' ' 77' ' ' GLN . 65.4 m80 -80.74 161.99 24.31 Favored 'General case' 0 CA--C 1.502 -0.897 0 CA-C-N 118.045 0.922 . . . . 0.0 109.692 -174.81 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 80.7 mt-30 -145.45 137.34 25.44 Favored 'General case' 0 N--CA 1.437 -1.104 0 N-CA-C 104.606 -2.368 . . . . 0.0 104.606 -178.148 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 9.6 mp0 -118.36 131.37 56.31 Favored 'General case' 0 CA--C 1.494 -1.199 0 N-CA-C 104.074 -2.565 . . . . 0.0 104.074 173.155 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 5.6 p -106.91 132.72 53.52 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.864 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 -172.104 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 21.5 m -104.86 137.52 42.52 Favored 'General case' 0 N--CA 1.442 -0.873 0 N-CA-C 102.383 -3.192 . . . . 0.0 102.383 168.947 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 31.5 ptt-85 -134.38 145.95 49.44 Favored 'General case' 0 CA--C 1.496 -1.112 0 CA-C-O 121.588 0.708 . . . . 0.0 109.143 179.831 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 20.0 p90 -164.78 -178.9 5.52 Favored 'General case' 0 CA--C 1.499 -0.999 0 N-CA-C 106.376 -1.713 . . . . 0.0 106.376 -173.296 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -137.06 157.76 45.98 Favored 'General case' 0 N--CA 1.437 -1.094 0 N-CA-C 106.212 -1.773 . . . . 0.0 106.212 170.155 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 25.5 p90 -143.58 170.72 15.3 Favored 'General case' 0 CA--C 1.487 -1.453 0 N-CA-C 106.256 -1.757 . . . . 0.0 106.256 169.497 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 9.7 m -126.49 140.3 52.57 Favored 'General case' 0 CA--C 1.499 -1.001 0 N-CA-C 103.678 -2.712 . . . . 0.0 103.678 175.827 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 86.1 m -112.71 114.15 26.6 Favored 'General case' 0 CA--C 1.497 -1.09 0 N-CA-C 102.137 -3.283 . . . . 0.0 102.137 176.58 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . 0.515 ' HA ' ' H ' ' A' ' 66' ' ' GLY . 23.7 p -125.21 168.5 13.38 Favored 'General case' 0 CA--C 1.5 -0.952 0 N-CA-C 106.438 -1.69 . . . . 0.0 106.438 -179.128 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 15.1 t . . . . . 0 C--O 1.258 1.546 0 N-CA-C 108.014 -1.106 . . . . 0.0 108.014 -178.399 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.437 -1.265 0 N-CA-C 106.748 -2.541 . . . . 0.0 106.748 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 66.6 Cg_exo -60.1 138.86 84.44 Favored 'Trans proline' 0 N--CA 1.447 -1.214 0 C-N-CA 123.396 2.73 . . . . 0.0 113.493 -170.79 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 21.5 t -77.77 156.55 5.23 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.9 0 C-N-CA 128.277 2.631 . . . . 0.0 105.354 178.483 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 59.4 mm-40 -109.73 98.67 7.97 Favored 'General case' 0 CA--C 1.487 -1.478 0 N-CA-C 106.947 -1.501 . . . . 0.0 106.947 -174.442 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 2.2 p -123.27 139.3 50.38 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.108 0 N-CA-C 106.248 -1.76 . . . . 0.0 106.248 -169.163 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 75.1 m-85 . . . . . 0 CA--C 1.494 -1.184 0 N-CA-C 105.179 -2.156 . . . . 0.0 105.179 -172.403 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo . . . . . 0 CA--C 1.505 -0.943 0 CA-C-O 118.206 -0.831 . . . . 0.0 112.005 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 5.8 p-10 -114.28 -39.46 3.86 Favored 'General case' 0 CA--C 1.491 -1.321 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 -164.701 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 66.5 m -104.31 154.33 19.95 Favored 'General case' 0 CA--C 1.494 -1.181 0 N-CA-C 106.599 -1.63 . . . . 0.0 106.599 176.285 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 37.0 t-80 -139.95 89.58 11.24 Favored Pre-proline 0 N--CA 1.438 -1.033 0 N-CA-C 107.188 -1.412 . . . . 0.0 107.188 172.917 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -82.96 120.05 2.96 Favored 'Trans proline' 0 N--CA 1.447 -1.219 0 C-N-CA 123.11 2.54 . . . . 0.0 110.463 179.593 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.485 HD11 HD11 ' A' ' 35' ' ' LEU . 3.9 pt -104.85 173.84 1.35 Allowed 'Isoleucine or valine' 0 CA--C 1.497 -1.083 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 -177.486 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 2.4 pt20 -149.82 149.43 30.5 Favored 'General case' 0 N--CA 1.44 -0.967 0 N-CA-C 106.421 -1.696 . . . . 0.0 106.421 173.52 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 23.8 p90 -134.44 157.14 47.21 Favored 'General case' 0 CA--C 1.499 -0.983 0 N-CA-C 106.632 -1.618 . . . . 0.0 106.632 -177.808 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 59.8 t30 -99.71 -177.81 3.68 Favored 'General case' 0 CA--C 1.492 -1.272 0 N-CA-C 102.683 -3.08 . . . . 0.0 102.683 168.152 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -155.63 170.49 8.66 Favored Pre-proline 0 N--CA 1.438 -1.043 0 N-CA-C 106.334 -1.728 . . . . 0.0 106.334 176.325 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 63.5 Cg_exo -63.65 164.16 22.06 Favored 'Trans proline' 0 N--CA 1.456 -0.695 0 C-N-CA 123.267 2.645 . . . . 0.0 112.635 173.176 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 17.9 mp0 -80.48 -53.83 0.85 Allowed Pre-proline 0 N--CA 1.443 -0.818 0 CA-C-O 115.579 -2.153 . . . . 0.0 111.617 -167.919 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -74.03 172.26 16.29 Favored 'Trans proline' 0 CA--C 1.51 -0.699 0 CA-C-N 125.871 3.132 . . . . 0.0 109.95 174.221 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 22.8 t -83.79 87.01 7.07 Favored 'General case' 0 C--N 1.357 0.907 0 N-CA-C 107.237 -1.394 . . . . 0.0 107.237 178.563 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 22.5 t-160 -112.56 -32.86 6.33 Favored 'General case' 0 N--CA 1.436 -1.145 0 N-CA-C 106.938 -1.504 . . . . 0.0 106.938 -177.084 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 1.8 mp -108.62 134.55 50.2 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.946 0 N-CA-C 103.315 -2.846 . . . . 0.0 103.315 -178.179 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 5.9 p -100.77 -82.01 0.46 Allowed 'General case' 0 N--CA 1.434 -1.26 0 N-CA-C 107.875 -1.158 . . . . 0.0 107.875 175.108 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 6.5 ttpm? -94.35 161.27 14.31 Favored 'General case' 0 CA--C 1.495 -1.136 0 C-N-CA 124.7 1.2 . . . . 0.0 108.029 -165.733 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 85.5 m-85 -125.9 138.14 53.77 Favored 'General case' 0 N--CA 1.437 -1.079 0 N-CA-C 105.111 -2.181 . . . . 0.0 105.111 171.733 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 34.3 mm -109.25 129.18 64.43 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.155 0 N-CA-C 101.03 -3.692 . . . . 0.0 101.03 165.831 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.485 HD11 HD11 ' A' ' 20' ' ' ILE . 3.8 mt -109.02 135.8 49.6 Favored 'General case' 0 CA--C 1.478 -1.796 0 N-CA-C 106.543 -1.651 . . . . 0.0 106.543 169.721 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 84.1 mtt180 -125.09 158.23 34.35 Favored 'General case' 0 N--CA 1.43 -1.446 0 N-CA-C 107.123 -1.436 . . . . 0.0 107.123 173.191 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 48.0 p90 -150.5 145.21 25.85 Favored 'General case' 0 N--CA 1.437 -1.091 0 N-CA-C 105.86 -1.904 . . . . 0.0 105.86 173.381 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 46.9 ttp180 -153.44 137.57 10.73 Favored Pre-proline 0 CA--C 1.498 -1.032 0 N-CA-C 105.324 -2.102 . . . . 0.0 105.324 -176.411 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -72.74 120.75 6.86 Favored 'Trans proline' 0 N--CA 1.451 -1.021 0 CA-C-N 123.485 2.28 . . . . 0.0 109.034 -177.369 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 58.5 tttm -73.48 65.06 0.89 Allowed 'General case' 0 C--N 1.358 0.962 0 C-N-CA 127.078 2.151 . . . . 0.0 110.554 177.514 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 6.4 t-20 -161.77 -53.0 0.04 OUTLIER 'General case' 0 N--CA 1.432 -1.358 0 N-CA-C 104.003 -2.592 . . . . 0.0 104.003 -169.735 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 50.3 m -88.36 166.0 14.57 Favored 'General case' 0 N--CA 1.438 -1.052 0 C-N-CA 124.431 1.092 . . . . 0.0 108.218 177.991 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 10.9 m -116.0 41.37 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.795 0 N-CA-C 106.938 -1.505 . . . . 0.0 106.938 -178.998 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -92.54 -156.38 32.72 Favored Glycine 0 C--N 1.354 1.559 0 N-CA-C 109.61 -1.396 . . . . 0.0 109.61 -177.494 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 39.6 mmt180 -101.87 172.2 7.07 Favored 'General case' 0 CA--C 1.499 -0.999 0 N-CA-C 107.324 -1.362 . . . . 0.0 107.324 -179.999 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 47.9 m95 -87.12 164.28 16.5 Favored 'General case' 0 N--CA 1.441 -0.88 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 -177.681 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 96.2 mttt -108.77 155.64 20.54 Favored 'General case' 0 CA--C 1.489 -1.366 0 N-CA-C 102.237 -3.246 . . . . 0.0 102.237 161.462 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -151.32 159.07 44.49 Favored 'General case' 0 CA--C 1.494 -1.209 0 CA-C-O 122.021 0.915 . . . . 0.0 109.794 -178.048 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -133.88 159.21 41.36 Favored 'General case' 0 N--CA 1.434 -1.241 0 N-CA-C 106.057 -1.831 . . . . 0.0 106.057 172.68 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 93.8 m -119.86 125.63 48.99 Favored 'General case' 0 CA--C 1.499 -1.006 0 N-CA-C 104.277 -2.49 . . . . 0.0 104.277 178.178 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 34.0 mt -123.79 122.79 26.35 Favored Pre-proline 0 N--CA 1.439 -0.984 0 N-CA-C 105.038 -2.208 . . . . 0.0 105.038 -171.602 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . 0.462 ' HB2' ' CE1' ' A' ' 54' ' ' HIS . 50.7 Cg_exo -67.25 169.21 15.78 Favored 'Trans proline' 0 CA--C 1.512 -0.612 0 C-N-CA 123.279 2.653 . . . . 0.0 111.301 175.757 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -86.71 83.21 1.6 Allowed Glycine 0 C--N 1.352 1.441 0 N-CA-C 110.121 -1.191 . . . . 0.0 110.121 -177.728 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . 0.462 ' CE1' ' HB2' ' A' ' 52' ' ' PRO . 0.5 OUTLIER -157.54 -44.11 0.07 Allowed 'General case' 0 CA--C 1.497 -1.079 0 N-CA-C 107.279 -1.378 . . . . 0.0 107.279 -179.795 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 92.2 mt -89.62 136.49 33.0 Favored 'General case' 0 CA--C 1.495 -1.148 0 N-CA-C 107.832 -1.173 . . . . 0.0 107.832 179.522 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 8.6 p30 -112.67 5.34 17.68 Favored 'General case' 0 N--CA 1.44 -0.926 0 C-N-CA 124.875 1.27 . . . . 0.0 109.119 -179.392 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 45.3 p -142.98 150.28 39.45 Favored 'General case' 0 CA--C 1.499 -1.012 0 N-CA-C 107.171 -1.418 . . . . 0.0 107.171 -178.519 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 7.5 t80 -126.36 174.08 8.85 Favored 'General case' 0 C--N 1.357 0.924 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 -179.087 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 88.0 m -138.74 109.44 6.64 Favored 'General case' 0 N--CA 1.43 -1.425 0 N-CA-C 104.618 -2.364 . . . . 0.0 104.618 172.205 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 28.3 mt -88.15 147.17 5.42 Favored 'Isoleucine or valine' 0 C--N 1.358 0.965 0 N-CA-C 104.271 -2.492 . . . . 0.0 104.271 171.447 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 94.0 mttt -141.08 162.65 34.97 Favored 'General case' 0 CA--C 1.5 -0.976 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 177.131 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 82.61 48.96 5.35 Favored Glycine 0 C--N 1.353 1.487 0 N-CA-C 109.838 -1.305 . . . . 0.0 109.838 173.758 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 58.0 mt -119.71 173.34 7.08 Favored 'General case' 0 CA--C 1.5 -0.958 0 N-CA-C 107.886 -1.153 . . . . 0.0 107.886 -173.654 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 67.8 mttm -110.36 157.15 38.96 Favored Pre-proline 0 N--CA 1.441 -0.876 0 N-CA-C 107.419 -1.326 . . . . 0.0 107.419 -176.113 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 67.5 Cg_endo -78.65 161.3 27.86 Favored 'Trans proline' 0 N--CA 1.451 -0.986 0 C-N-CA 123.168 2.579 . . . . 0.0 109.785 168.247 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 59.59 26.21 61.99 Favored Glycine 0 C--N 1.355 1.621 0 C-N-CA 127.261 2.363 . . . . 0.0 116.337 171.59 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 13.2 p -120.24 148.3 23.46 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.995 0 N-CA-C 106.837 -1.542 . . . . 0.0 106.837 -177.595 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 4.0 p -99.76 130.93 48.1 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.907 0 N-CA-C 106.626 -1.62 . . . . 0.0 106.626 176.137 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 93.5 m-85 -112.16 148.42 34.04 Favored 'General case' 0 CA--C 1.494 -1.189 0 N-CA-C 105.537 -2.023 . . . . 0.0 105.537 172.246 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -97.91 134.69 40.7 Favored 'General case' 0 CA--C 1.496 -1.11 0 N-CA-C 103.576 -2.75 . . . . 0.0 103.576 161.68 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -117.6 152.58 17.62 Favored Glycine 0 CA--C 1.486 -1.75 0 N-CA-C 106.065 -2.814 . . . . 0.0 106.065 -178.054 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 35.3 tt0 -145.64 130.1 17.82 Favored 'General case' 0 CA--C 1.48 -1.735 0 N-CA-C 106.623 -1.621 . . . . 0.0 106.623 -177.226 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 38.9 tp -118.14 99.8 7.11 Favored 'General case' 0 N--CA 1.437 -1.081 0 N-CA-C 104.151 -2.537 . . . . 0.0 104.151 -174.534 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 26.8 mt -91.99 131.56 38.75 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.865 0 N-CA-C 103.603 -2.74 . . . . 0.0 103.603 176.481 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 20.9 p -117.08 115.74 25.97 Favored 'General case' 0 N--CA 1.436 -1.166 0 N-CA-C 106.962 -1.495 . . . . 0.0 106.962 -177.33 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 1.7 mp -89.58 132.52 34.07 Favored 'Isoleucine or valine' 0 CA--C 1.483 -1.6 0 N-CA-C 102.543 -3.132 . . . . 0.0 102.543 -173.131 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 82.0 mt-30 -101.83 152.65 20.64 Favored 'General case' 0 CA--C 1.489 -1.393 0 N-CA-C 106.951 -1.5 . . . . 0.0 106.951 -174.97 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 11.8 tt0 -77.53 41.48 0.33 Allowed 'General case' 0 N--CA 1.443 -0.818 0 C-N-CA 125.858 1.663 . . . . 0.0 112.419 -179.668 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 8.5 t80 -151.78 16.7 0.68 Allowed 'General case' 0 N--CA 1.436 -1.128 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 178.315 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 86.99 -11.75 63.97 Favored Glycine 0 C--N 1.353 1.526 0 C-N-CA 123.73 0.681 . . . . 0.0 112.496 176.901 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 44.6 t-80 -78.65 160.38 27.56 Favored 'General case' 0 N--CA 1.441 -0.888 0 C-N-CA 124.68 1.192 . . . . 0.0 109.011 -176.767 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 83.2 mt-30 -136.22 136.2 39.71 Favored 'General case' 0 CA--C 1.491 -1.318 0 N-CA-C 104.579 -2.378 . . . . 0.0 104.579 175.14 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 16.8 tp10 -120.49 131.47 54.74 Favored 'General case' 0 CA--C 1.495 -1.171 0 N-CA-C 104.753 -2.314 . . . . 0.0 104.753 178.0 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 7.2 p -108.94 139.25 32.33 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.83 0 N-CA-C 107.561 -1.274 . . . . 0.0 107.561 -174.298 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 89.1 m -125.32 131.22 53.07 Favored 'General case' 0 N--CA 1.44 -0.953 0 N-CA-C 102.804 -3.036 . . . . 0.0 102.804 178.51 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 40.5 ttp180 -130.51 145.53 51.88 Favored 'General case' 0 C--N 1.356 0.882 0 CA-C-N 119.492 1.042 . . . . 0.0 109.031 178.459 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 17.8 p90 -156.35 -179.89 8.59 Favored 'General case' 0 CA--C 1.498 -1.026 0 N-CA-C 105.987 -1.857 . . . . 0.0 105.987 -171.245 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 1.6 p30 -141.05 157.72 44.93 Favored 'General case' 0 N--CA 1.442 -0.873 0 N-CA-C 108.117 -1.068 . . . . 0.0 108.117 169.153 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 21.8 p90 -144.66 170.71 15.56 Favored 'General case' 0 CA--C 1.493 -1.226 0 N-CA-C 106.921 -1.511 . . . . 0.0 106.921 173.597 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 24.7 p -117.51 138.6 51.78 Favored 'General case' 0 CA--C 1.501 -0.934 0 N-CA-C 106.175 -1.787 . . . . 0.0 106.175 171.491 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 56.0 m -108.07 113.49 26.69 Favored 'General case' 0 CA--C 1.495 -1.149 0 N-CA-C 103.009 -2.96 . . . . 0.0 103.009 172.076 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 15.0 t -161.86 165.36 27.85 Favored 'General case' 0 N--CA 1.436 -1.171 0 N-CA-C 104.731 -2.322 . . . . 0.0 104.731 -174.653 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 75.2 p . . . . . 0 C--O 1.261 1.687 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 173.587 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.438 -1.201 0 N-CA-C 108.593 -1.803 . . . . 0.0 108.593 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_exo -64.79 146.29 88.0 Favored 'Trans proline' 0 N--CA 1.442 -1.529 0 C-N-CA 123.157 2.571 . . . . 0.0 115.287 -161.042 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 4.6 m -83.0 169.28 1.6 Allowed 'Isoleucine or valine' 0 N--CA 1.432 -1.336 0 C-N-CA 126.641 1.977 . . . . 0.0 107.168 171.063 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 -101.81 100.35 10.67 Favored 'General case' 0 CA--C 1.495 -1.164 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 -176.678 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 4.2 p -107.77 137.62 38.16 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.138 0 N-CA-C 107.474 -1.306 . . . . 0.0 107.474 -174.016 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 1.6 t80 . . . . . 0 N--CA 1.433 -1.323 0 N-CA-C 106.975 -1.491 . . . . 0.0 106.975 -170.669 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_exo . . . . . 0 CA--C 1.507 -0.83 0 N-CA-C 110.722 -0.53 . . . . 0.0 110.722 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 1.9 p30 -96.87 -30.81 12.92 Favored 'General case' 0 CA--C 1.486 -1.485 0 C-N-CA 125.508 1.523 . . . . 0.0 110.638 -172.783 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 22.9 t -119.54 156.71 29.78 Favored 'General case' 0 CA--C 1.498 -1.037 0 CA-C-O 122.223 1.011 . . . . 0.0 108.915 -172.47 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 59.7 t-80 -140.39 98.75 7.26 Favored Pre-proline 0 N--CA 1.438 -1.056 0 N-CA-C 106.735 -1.58 . . . . 0.0 106.735 172.783 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -80.86 137.31 11.04 Favored 'Trans proline' 0 N--CA 1.447 -1.216 0 C-N-CA 123.019 2.479 . . . . 0.0 110.17 176.104 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 2.4 pt -118.64 172.77 5.59 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.07 0 N-CA-C 107.747 -1.205 . . . . 0.0 107.747 178.794 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . 0.448 ' HA ' ' HA ' ' A' ' 57' ' ' SER . 3.6 pt20 -150.79 158.34 44.03 Favored 'General case' 0 CA--C 1.492 -1.287 0 N-CA-C 105.706 -1.961 . . . . 0.0 105.706 168.947 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 43.7 p90 -142.97 164.49 29.94 Favored 'General case' 0 CA--C 1.493 -1.231 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 -175.409 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 81.1 m-20 -109.39 177.1 4.85 Favored 'General case' 0 CA--C 1.494 -1.2 0 N-CA-C 104.297 -2.482 . . . . 0.0 104.297 168.839 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -161.23 173.83 4.36 Favored Pre-proline 0 N--CA 1.435 -1.22 0 N-CA-C 104.788 -2.301 . . . . 0.0 104.788 -176.138 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . 0.432 ' HD2' HD12 ' A' ' 30' ' ' ILE . 67.1 Cg_exo -63.1 153.49 73.55 Favored 'Trans proline' 0 N--CA 1.455 -0.742 0 C-N-CA 123.786 2.991 . . . . 0.0 112.758 175.563 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 26.1 tt0 -82.17 -40.36 0.93 Allowed Pre-proline 0 N--CA 1.443 -0.813 0 CA-C-O 115.574 -2.155 . . . . 0.0 112.071 -174.558 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_exo -69.49 -8.9 24.83 Favored 'Trans proline' 0 CA--C 1.512 -0.59 0 CA-C-N 125.674 3.062 . . . . 0.0 114.037 179.906 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 8.9 t 67.86 66.65 0.36 Allowed 'General case' 0 C--N 1.357 0.91 0 C-N-CA 126.107 1.763 . . . . 0.0 110.038 178.939 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 76.6 t60 -97.49 -2.27 42.33 Favored 'General case' 0 N--CA 1.441 -0.876 0 C-N-CA 124.517 1.127 . . . . 0.0 108.307 175.411 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.432 HD12 ' HD2' ' A' ' 25' ' ' PRO . 9.7 mt -111.16 135.8 49.21 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.071 0 N-CA-C 105.131 -2.174 . . . . 0.0 105.131 -179.669 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 4.6 p -98.13 -84.45 0.39 Allowed 'General case' 0 N--CA 1.428 -1.565 0 N-CA-C 106.518 -1.66 . . . . 0.0 106.518 178.282 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 52.7 mtmt -90.57 170.65 10.0 Favored 'General case' 0 CA--C 1.487 -1.448 0 C-N-CA 123.857 0.863 . . . . 0.0 109.086 -165.134 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 87.4 m-85 -132.43 140.05 48.28 Favored 'General case' 0 N--CA 1.436 -1.141 0 N-CA-C 103.837 -2.653 . . . . 0.0 103.837 167.568 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 41.8 mt -121.73 135.2 62.64 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.204 0 N-CA-C 101.632 -3.47 . . . . 0.0 101.632 173.66 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 4.5 mt -113.07 136.98 52.11 Favored 'General case' 0 CA--C 1.467 -2.233 0 N-CA-C 104.848 -2.278 . . . . 0.0 104.848 169.54 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 1.1 ptm180 -131.51 152.31 50.84 Favored 'General case' 0 N--CA 1.43 -1.472 0 N-CA-C 105.678 -1.971 . . . . 0.0 105.678 168.632 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 48.6 p90 -155.0 152.28 29.48 Favored 'General case' 0 N--CA 1.436 -1.158 0 N-CA-C 106.841 -1.54 . . . . 0.0 106.841 -175.034 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 36.4 ptt180 -158.14 157.37 29.18 Favored Pre-proline 0 CA--C 1.5 -0.949 0 N-CA-C 105.881 -1.896 . . . . 0.0 105.881 171.989 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_endo -76.43 124.33 7.65 Favored 'Trans proline' 0 CA--C 1.503 -1.067 0 C-N-CA 122.652 2.234 . . . . 0.0 108.968 -175.209 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 85.1 tttt -71.19 79.58 0.7 Allowed 'General case' 0 C--N 1.358 0.943 0 C-N-CA 126.296 1.839 . . . . 0.0 110.497 178.753 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 67.7 m-80 -154.28 -69.57 0.13 Allowed 'General case' 0 N--CA 1.436 -1.167 0 N-CA-C 101.531 -3.507 . . . . 0.0 101.531 -176.313 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 55.1 m -96.79 167.03 11.35 Favored 'General case' 0 N--CA 1.44 -0.925 0 N-CA-C 106.746 -1.575 . . . . 0.0 106.746 171.55 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 2.6 m -132.82 62.59 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.439 -0.988 0 N-CA-C 105.285 -2.117 . . . . 0.0 105.285 179.892 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -93.1 -111.83 2.09 Favored Glycine 0 C--N 1.353 1.521 0 N-CA-C 108.838 -1.705 . . . . 0.0 108.838 -178.916 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 86.7 mtm180 -97.66 169.66 9.55 Favored 'General case' 0 CA--C 1.501 -0.92 0 N-CA-C 107.973 -1.121 . . . . 0.0 107.973 -179.367 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 70.6 m95 -112.16 167.17 10.62 Favored 'General case' 0 N--CA 1.44 -0.957 0 N-CA-C 107.615 -1.254 . . . . 0.0 107.615 178.53 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -114.51 152.89 30.97 Favored 'General case' 0 CA--C 1.487 -1.46 0 N-CA-C 102.537 -3.135 . . . . 0.0 102.537 163.245 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 16.2 pt-20 -152.35 159.04 43.51 Favored 'General case' 0 N--CA 1.437 -1.094 0 CA-C-O 121.749 0.785 . . . . 0.0 109.106 178.507 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -140.03 162.68 34.62 Favored 'General case' 0 CA--C 1.499 -0.998 0 N-CA-C 106.553 -1.647 . . . . 0.0 106.553 172.488 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 90.0 m -119.34 125.32 48.75 Favored 'General case' 0 CA--C 1.5 -0.969 0 N-CA-C 105.127 -2.175 . . . . 0.0 105.127 176.981 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 4.5 mp -109.03 133.64 20.65 Favored Pre-proline 0 N--CA 1.437 -1.117 0 N-CA-C 105.239 -2.134 . . . . 0.0 105.239 -175.928 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 68.7 Cg_exo -64.27 164.1 24.04 Favored 'Trans proline' 0 CA--C 1.508 -0.802 0 C-N-CA 123.312 2.675 . . . . 0.0 113.369 176.193 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -75.37 -16.63 80.5 Favored Glycine 0 C--N 1.352 1.418 0 C-N-CA 123.977 0.799 . . . . 0.0 114.497 -174.421 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 52.6 p-80 -83.52 -27.15 29.57 Favored 'General case' 0 C--N 1.357 0.903 0 CA-C-N 118.144 0.972 . . . . 0.0 110.105 -179.617 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 88.4 mt -88.65 131.18 35.1 Favored 'General case' 0 CA--C 1.501 -0.908 0 N-CA-C 107.945 -1.131 . . . . 0.0 107.945 177.161 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 8.5 p30 -114.17 7.87 16.73 Favored 'General case' 0 CA--C 1.504 -0.797 0 C-N-CA 124.521 1.128 . . . . 0.0 109.858 -174.753 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 0.448 ' HA ' ' HA ' ' A' ' 21' ' ' GLN . 36.9 p -139.23 160.49 39.68 Favored 'General case' 0 CA--C 1.497 -1.093 0 N-CA-C 107.163 -1.421 . . . . 0.0 107.163 -177.519 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 4.1 t80 -138.87 178.77 6.91 Favored 'General case' 0 C--N 1.36 1.064 0 CA-C-O 121.672 0.748 . . . . 0.0 109.171 175.729 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 89.4 m -144.49 103.62 3.97 Favored 'General case' 0 N--CA 1.432 -1.339 0 N-CA-C 103.689 -2.708 . . . . 0.0 103.689 -178.502 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 55.8 mt -95.37 106.51 18.33 Favored 'Isoleucine or valine' 0 C--N 1.358 0.969 0 N-CA-C 106.239 -1.763 . . . . 0.0 106.239 179.541 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 63.7 mttm -103.64 163.76 12.11 Favored 'General case' 0 CA--C 1.502 -0.897 0 CA-C-O 121.739 0.78 . . . . 0.0 109.542 178.814 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 90.85 45.5 4.2 Favored Glycine 0 CA--C 1.49 -1.474 0 N-CA-C 109.285 -1.526 . . . . 0.0 109.285 172.907 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 61.7 mt -119.92 176.67 5.3 Favored 'General case' 0 N--CA 1.44 -0.931 0 N-CA-C 106.909 -1.515 . . . . 0.0 106.909 -174.643 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -120.89 157.79 53.94 Favored Pre-proline 0 N--CA 1.44 -0.93 0 N-CA-C 106.704 -1.591 . . . . 0.0 106.704 -175.684 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 64.8 Cg_endo -78.63 164.54 25.76 Favored 'Trans proline' 0 N--CA 1.452 -0.956 0 C-N-CA 123.065 2.51 . . . . 0.0 110.559 170.252 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . 0.585 ' H ' ' HA ' ' A' ' 92' ' ' THR . . . 60.94 25.2 63.76 Favored Glycine 0 N--CA 1.431 -1.679 0 C-N-CA 128.006 2.717 . . . . 0.0 116.124 171.256 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 8.5 p -130.54 146.83 33.42 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.15 0 N-CA-C 108.188 -1.041 . . . . 0.0 108.188 -176.124 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 4.2 p -95.88 133.66 36.23 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.907 0 N-CA-C 107.377 -1.342 . . . . 0.0 107.377 178.157 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 93.8 m-85 -112.9 149.48 33.12 Favored 'General case' 0 CA--C 1.498 -1.057 0 N-CA-C 106.161 -1.792 . . . . 0.0 106.161 174.299 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -101.1 140.0 36.01 Favored 'General case' 0 CA--C 1.497 -1.094 0 N-CA-C 104.561 -2.385 . . . . 0.0 104.561 164.827 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -137.15 148.98 20.08 Favored Glycine 0 CA--C 1.486 -1.723 0 N-CA-C 108.101 -2.0 . . . . 0.0 108.101 -175.035 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 84.5 mt-30 -138.79 135.77 34.97 Favored 'General case' 0 CA--C 1.484 -1.58 0 N-CA-C 105.585 -2.006 . . . . 0.0 105.585 178.477 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 46.0 tp -114.71 103.29 10.84 Favored 'General case' 0 N--CA 1.434 -1.271 0 N-CA-C 103.847 -2.649 . . . . 0.0 103.847 179.247 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 38.1 mt -91.94 122.02 42.99 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.898 0 N-CA-C 103.852 -2.647 . . . . 0.0 103.852 177.723 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 15.4 p -113.92 115.1 27.15 Favored 'General case' 0 N--CA 1.441 -0.884 0 N-CA-C 107.156 -1.424 . . . . 0.0 107.156 -175.316 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 1.8 mp -90.36 131.94 36.26 Favored 'Isoleucine or valine' 0 CA--C 1.482 -1.659 0 N-CA-C 104.805 -2.294 . . . . 0.0 104.805 -162.817 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 76.4 mt-30 -84.3 147.91 26.95 Favored 'General case' 0 CA--C 1.491 -1.298 0 N-CA-C 107.994 -1.113 . . . . 0.0 107.994 -178.882 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 20.2 tt0 -76.5 41.75 0.26 Allowed 'General case' 0 N--CA 1.442 -0.862 0 C-N-CA 126.331 1.852 . . . . 0.0 110.545 170.739 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 8.2 t80 -153.07 15.9 0.55 Allowed 'General case' 0 N--CA 1.434 -1.265 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 -176.528 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 89.25 -19.03 41.62 Favored Glycine 0 C--N 1.353 1.506 0 C-N-CA 123.72 0.676 . . . . 0.0 112.601 174.358 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 36.7 m170 -81.7 173.48 12.28 Favored 'General case' 0 CA--C 1.495 -1.153 0 C-N-CA 124.446 1.098 . . . . 0.0 109.274 -176.308 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 77.1 mt-30 -138.7 145.55 40.47 Favored 'General case' 0 CA--C 1.495 -1.154 0 N-CA-C 105.527 -2.027 . . . . 0.0 105.527 176.495 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -111.23 153.72 25.44 Favored 'General case' 0 CA--C 1.493 -1.215 0 N-CA-C 105.415 -2.068 . . . . 0.0 105.415 171.06 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 14.8 p -126.92 137.46 57.78 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.897 0 N-CA-C 106.523 -1.658 . . . . 0.0 106.523 173.325 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 91.4 m -127.08 131.01 50.98 Favored 'General case' 0 N--CA 1.438 -1.066 0 N-CA-C 101.973 -3.343 . . . . 0.0 101.973 179.055 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 88.8 mtt180 -127.08 148.92 50.13 Favored 'General case' 0 CA--C 1.495 -1.15 0 CA-C-N 118.804 0.729 . . . . 0.0 109.487 -173.154 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 19.6 p90 -164.82 178.26 7.32 Favored 'General case' 0 CA--C 1.502 -0.9 0 N-CA-C 108.156 -1.053 . . . . 0.0 108.156 -175.287 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 51.4 m-20 -132.52 154.06 50.33 Favored 'General case' 0 N--CA 1.442 -0.872 0 N-CA-C 105.507 -2.034 . . . . 0.0 105.507 168.743 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 20.9 p90 -142.5 166.84 23.57 Favored 'General case' 0 CA--C 1.488 -1.424 0 N-CA-C 107.41 -1.33 . . . . 0.0 107.41 169.708 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 25.0 p -120.02 141.65 49.53 Favored 'General case' 0 CA--C 1.5 -0.981 0 N-CA-C 106.21 -1.774 . . . . 0.0 106.21 174.919 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 45.4 m -115.74 120.16 38.39 Favored 'General case' 0 CA--C 1.493 -1.245 0 N-CA-C 102.137 -3.283 . . . . 0.0 102.137 171.706 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . 0.585 ' HA ' ' H ' ' A' ' 66' ' ' GLY . 5.3 t -145.92 -66.95 0.29 Allowed 'General case' 0 N--CA 1.436 -1.132 0 N-CA-C 106.093 -1.817 . . . . 0.0 106.093 -175.626 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . 0.436 ' H ' HG23 ' A' ' 92' ' ' THR . 19.8 m . . . . . 0 C--O 1.261 1.659 0 C-N-CA 125.505 1.522 . . . . 0.0 110.355 178.379 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.436 -1.346 0 N-CA-C 106.717 -2.553 . . . . 0.0 106.717 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 22.8 Cg_exo -59.09 145.6 97.14 Favored 'Trans proline' 0 N--CA 1.448 -1.188 0 C-N-CA 123.058 2.505 . . . . 0.0 116.054 -164.598 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 48.9 t -79.17 158.96 4.63 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.94 0 C-N-CA 127.707 2.403 . . . . 0.0 106.991 179.575 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -103.86 106.3 16.76 Favored 'General case' 0 CA--C 1.494 -1.184 0 N-CA-C 104.853 -2.277 . . . . 0.0 104.853 175.052 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 2.1 p -130.4 141.64 45.77 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.1 0 N-CA-C 105.349 -2.093 . . . . 0.0 105.349 -169.632 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 1.8 p90 . . . . . 0 N--CA 1.438 -1.055 0 N-CA-C 105.933 -1.877 . . . . 0.0 105.933 -166.854 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_endo . . . . . 0 N--CA 1.454 -0.845 0 N-CA-C 110.259 -0.708 . . . . 0.0 110.259 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 1.3 p30 -107.79 -42.09 4.82 Favored 'General case' 0 CA--C 1.492 -1.255 0 C-N-CA 124.725 1.21 . . . . 0.0 109.488 -169.069 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 32.8 t -117.06 157.02 26.55 Favored 'General case' 0 CA--C 1.496 -1.134 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 -172.558 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 23.7 m-70 -146.99 98.66 4.05 Favored Pre-proline 0 N--CA 1.437 -1.111 0 N-CA-C 106.516 -1.661 . . . . 0.0 106.516 169.235 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -76.59 100.03 1.35 Allowed 'Trans proline' 0 N--CA 1.447 -1.222 0 C-N-CA 123.654 2.902 . . . . 0.0 109.407 171.746 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.438 HG22 ' H ' ' A' ' 20' ' ' ILE . 13.4 tt -90.28 149.42 4.05 Favored 'Isoleucine or valine' 0 N--CA 1.408 -2.574 0 C-N-CA 128.834 2.854 . . . . 0.0 106.786 -177.41 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 57.3 mt-30 -141.03 151.06 43.76 Favored 'General case' 0 N--CA 1.434 -1.248 0 N-CA-C 104.225 -2.509 . . . . 0.0 104.225 175.724 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 34.0 p90 -138.98 156.82 46.93 Favored 'General case' 0 N--CA 1.437 -1.081 0 N-CA-C 107.794 -1.187 . . . . 0.0 107.794 -176.815 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 61.3 t30 -94.42 -173.65 3.12 Favored 'General case' 0 CA--C 1.49 -1.336 0 N-CA-C 103.531 -2.766 . . . . 0.0 103.531 169.898 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -155.97 169.21 10.81 Favored Pre-proline 0 N--CA 1.44 -0.96 0 N-CA-C 107.284 -1.376 . . . . 0.0 107.284 172.36 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 98.0 Cg_exo -64.39 167.34 15.05 Favored 'Trans proline' 0 CA--C 1.51 -0.683 0 C-N-CA 123.559 2.839 . . . . 0.0 112.447 170.686 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 71.4 tp60 -80.03 -42.68 1.44 Allowed Pre-proline 0 N--CA 1.444 -0.741 0 CA-C-O 115.586 -2.149 . . . . 0.0 112.026 -172.016 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_exo -66.78 152.72 79.98 Favored 'Trans proline' 0 CA--C 1.507 -0.864 0 CA-C-N 125.773 3.097 . . . . 0.0 112.171 177.936 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 27.2 p -99.58 58.01 1.04 Allowed 'General case' 0 C--N 1.353 0.754 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 179.739 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 76.3 t60 -106.21 -4.65 19.97 Favored 'General case' 0 N--CA 1.441 -0.92 0 C-N-CA 125.273 1.429 . . . . 0.0 107.595 175.67 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 41.8 mt -105.44 129.07 58.89 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.248 0 N-CA-C 105.037 -2.209 . . . . 0.0 105.037 178.167 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 5.2 p -104.36 -84.34 0.48 Allowed 'General case' 0 N--CA 1.43 -1.449 0 N-CA-C 107.459 -1.311 . . . . 0.0 107.459 -178.591 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 55.1 mtmt -89.7 168.83 11.81 Favored 'General case' 0 CA--C 1.488 -1.432 0 N-CA-C 108.544 -0.909 . . . . 0.0 108.544 -164.277 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 93.7 m-85 -129.79 138.34 51.0 Favored 'General case' 0 N--CA 1.434 -1.266 0 N-CA-C 103.861 -2.644 . . . . 0.0 103.861 168.297 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 57.3 mt -114.88 130.61 69.05 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.296 0 N-CA-C 101.01 -3.7 . . . . 0.0 101.01 169.885 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 3.1 mt -110.26 129.9 55.65 Favored 'General case' 0 CA--C 1.469 -2.144 0 N-CA-C 104.034 -2.58 . . . . 0.0 104.034 167.635 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 6.5 ptm180 -132.63 154.48 50.04 Favored 'General case' 0 N--CA 1.431 -1.399 0 N-CA-C 107.035 -1.468 . . . . 0.0 107.035 176.062 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 47.8 p90 -155.18 142.44 19.42 Favored 'General case' 0 N--CA 1.435 -1.176 0 N-CA-C 106.877 -1.527 . . . . 0.0 106.877 -173.328 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 30.7 ttp180 -139.54 140.88 26.61 Favored Pre-proline 0 CA--C 1.499 -1.017 0 N-CA-C 104.528 -2.397 . . . . 0.0 104.528 -177.777 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 26.7 Cg_endo -72.14 120.17 6.63 Favored 'Trans proline' 0 N--CA 1.452 -0.934 0 C-N-CA 122.827 2.351 . . . . 0.0 108.472 174.663 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 23.0 ttmm -68.06 85.2 0.24 Allowed 'General case' 0 C--N 1.359 1.005 0 C-N-CA 127.34 2.256 . . . . 0.0 109.733 -178.641 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 31.2 m120 -150.77 -72.41 0.17 Allowed 'General case' 0 N--CA 1.435 -1.209 0 N-CA-C 102.006 -3.331 . . . . 0.0 102.006 -178.075 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 53.7 p -105.55 172.1 6.98 Favored 'General case' 0 N--CA 1.441 -0.909 0 N-CA-C 107.374 -1.343 . . . . 0.0 107.374 174.61 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 4.0 m -116.21 52.27 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.863 0 N-CA-C 106.011 -1.848 . . . . 0.0 106.011 175.022 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -98.15 -129.08 6.27 Favored Glycine 0 C--N 1.355 1.597 0 N-CA-C 109.421 -1.472 . . . . 0.0 109.421 -176.031 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 17.5 ptm180 -80.09 160.06 25.89 Favored 'General case' 0 C--N 1.357 0.906 0 C-N-CA 123.942 0.897 . . . . 0.0 109.685 -176.925 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -162.49 169.91 19.56 Favored 'General case' 0 CA--C 1.493 -1.212 0 CA-C-O 121.445 0.64 . . . . 0.0 110.298 -171.217 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 95.6 mttt -111.06 155.89 22.12 Favored 'General case' 0 CA--C 1.488 -1.408 0 N-CA-C 107.485 -1.302 . . . . 0.0 107.485 -172.612 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 24.5 pt-20 -152.25 160.15 43.41 Favored 'General case' 0 N--CA 1.434 -1.27 0 N-CA-C 107.972 -1.121 . . . . 0.0 107.972 171.142 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -137.76 159.48 41.88 Favored 'General case' 0 N--CA 1.437 -1.102 0 N-CA-C 105.396 -2.075 . . . . 0.0 105.396 173.785 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 73.3 m -120.41 125.9 49.12 Favored 'General case' 0 CA--C 1.498 -1.036 0 N-CA-C 104.533 -2.395 . . . . 0.0 104.533 177.393 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 5.3 mp -114.73 136.03 22.43 Favored Pre-proline 0 N--CA 1.435 -1.188 0 N-CA-C 104.6 -2.37 . . . . 0.0 104.6 -174.255 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 62.0 Cg_exo -64.3 166.85 15.97 Favored 'Trans proline' 0 CA--C 1.508 -0.78 0 C-N-CA 123.528 2.818 . . . . 0.0 113.519 176.794 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -77.06 -19.23 77.63 Favored Glycine 0 C--N 1.353 1.507 0 C-N-CA 123.797 0.713 . . . . 0.0 114.242 -175.149 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 51.7 p-80 -83.23 -26.79 30.43 Favored 'General case' 0 C--N 1.355 0.838 0 CA-C-N 117.963 0.881 . . . . 0.0 109.788 -179.278 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 89.0 mt -88.84 132.92 34.45 Favored 'General case' 0 CA--C 1.501 -0.93 0 N-CA-C 107.37 -1.345 . . . . 0.0 107.37 175.407 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 7.8 p30 -121.33 15.0 11.31 Favored 'General case' 0 CA--C 1.5 -0.946 0 C-N-CA 124.19 0.996 . . . . 0.0 108.816 -175.501 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 32.9 p -144.73 155.47 43.57 Favored 'General case' 0 N--CA 1.438 -1.074 0 N-CA-C 106.928 -1.508 . . . . 0.0 106.928 -178.721 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 23.0 t80 -150.64 157.76 43.35 Favored 'General case' 0 CA--C 1.497 -1.093 0 N-CA-C 107.965 -1.124 . . . . 0.0 107.965 178.188 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 48.2 m -108.78 112.37 24.61 Favored 'General case' 0 CA--C 1.5 -0.945 0 N-CA-C 106.197 -1.779 . . . . 0.0 106.197 173.536 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 55.3 mt -97.19 91.83 2.76 Favored 'Isoleucine or valine' 0 C--N 1.359 0.982 0 N-CA-C 105.084 -2.191 . . . . 0.0 105.084 174.146 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . 0.517 ' HD3' ' H ' ' A' ' 61' ' ' LYS . 0.3 OUTLIER -105.18 160.52 15.01 Favored 'General case' 0 CA--C 1.498 -1.022 0 N-CA-C 107.67 -1.233 . . . . 0.0 107.67 178.412 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 88.74 52.85 2.7 Favored Glycine 0 C--N 1.353 1.504 0 N-CA-C 108.75 -1.74 . . . . 0.0 108.75 179.796 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 60.7 mt -115.54 158.55 22.46 Favored 'General case' 0 CA--C 1.501 -0.91 0 N-CA-C 107.087 -1.449 . . . . 0.0 107.087 178.961 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 29.1 mtpp -95.35 155.71 38.48 Favored Pre-proline 0 N--CA 1.441 -0.925 0 N-CA-C 106.97 -1.492 . . . . 0.0 106.97 -178.442 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 69.0 Cg_endo -80.31 162.87 22.46 Favored 'Trans proline' 0 N--CA 1.454 -0.852 0 C-N-CA 122.988 2.459 . . . . 0.0 110.903 177.249 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 60.93 26.67 65.78 Favored Glycine 0 C--N 1.356 1.669 0 C-N-CA 127.819 2.628 . . . . 0.0 116.814 166.095 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 7.2 p -131.43 145.61 34.95 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.846 0 CA-C-N 117.701 0.75 . . . . 0.0 109.325 -173.211 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 2.9 p -90.46 127.29 43.05 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.863 0 N-CA-C 107.208 -1.405 . . . . 0.0 107.208 176.332 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 84.0 m-85 -107.3 147.77 29.85 Favored 'General case' 0 CA--C 1.498 -1.044 0 N-CA-C 106.814 -1.551 . . . . 0.0 106.814 172.842 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -95.87 143.98 26.61 Favored 'General case' 0 N--CA 1.439 -0.993 0 N-CA-C 105.132 -2.173 . . . . 0.0 105.132 160.918 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -133.42 155.13 21.56 Favored Glycine 0 CA--C 1.488 -1.637 0 N-CA-C 107.727 -2.149 . . . . 0.0 107.727 -178.962 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 32.0 mt-30 -143.13 138.25 29.68 Favored 'General case' 0 CA--C 1.482 -1.667 0 N-CA-C 105.959 -1.867 . . . . 0.0 105.959 176.345 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 42.8 tp -113.69 103.77 11.56 Favored 'General case' 0 N--CA 1.436 -1.175 0 N-CA-C 103.76 -2.682 . . . . 0.0 103.76 175.75 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 13.6 mt -98.19 128.45 49.63 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.786 0 N-CA-C 104.32 -2.474 . . . . 0.0 104.32 179.664 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 43.8 m -112.41 112.43 23.99 Favored 'General case' 0 N--CA 1.441 -0.923 0 N-CA-C 106.992 -1.484 . . . . 0.0 106.992 -175.189 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 1.7 mp -87.85 136.35 23.36 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.217 0 N-CA-C 104.712 -2.329 . . . . 0.0 104.712 -166.822 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 78.2 mt-30 -95.84 141.69 28.98 Favored 'General case' 0 N--CA 1.436 -1.154 0 N-CA-C 106.042 -1.836 . . . . 0.0 106.042 -179.068 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 7.8 tp-100 -69.04 117.02 10.16 Favored 'General case' 0 N--CA 1.441 -0.882 0 C-N-CA 124.129 0.972 . . . . 0.0 111.395 -170.554 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 31.9 m-85 58.09 45.39 17.81 Favored 'General case' 0 C--N 1.358 0.972 0 C-N-CA 127.325 2.25 . . . . 0.0 112.816 179.653 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -170.33 -114.46 0.31 Allowed Glycine 0 C--N 1.354 1.554 0 C-N-CA 118.663 -1.732 . . . . 0.0 109.704 174.847 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 52.2 m80 -83.24 -171.67 3.7 Favored 'General case' 0 CA--C 1.495 -1.165 0 C-N-CA 125.714 1.606 . . . . 0.0 110.425 -167.715 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -146.66 145.46 30.04 Favored 'General case' 0 N--CA 1.433 -1.281 0 N-CA-C 106.509 -1.663 . . . . 0.0 106.509 169.507 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -101.72 145.45 29.11 Favored 'General case' 0 N--CA 1.44 -0.957 0 N-CA-C 104.645 -2.354 . . . . 0.0 104.645 -179.907 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 6.6 p -124.99 137.96 55.86 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.775 0 N-CA-C 108.104 -1.073 . . . . 0.0 108.104 -177.569 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 61.0 m -125.85 137.13 53.74 Favored 'General case' 0 N--CA 1.439 -0.98 0 N-CA-C 103.232 -2.877 . . . . 0.0 103.232 175.922 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 54.6 ttp180 -130.15 144.6 51.45 Favored 'General case' 0 CA--C 1.502 -0.873 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 -179.309 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 23.6 p90 -156.48 -178.19 7.16 Favored 'General case' 0 CA--C 1.5 -0.962 0 N-CA-C 106.263 -1.754 . . . . 0.0 106.263 -178.216 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 47.7 p-10 -140.43 160.79 39.21 Favored 'General case' 0 N--CA 1.441 -0.877 0 N-CA-C 107.412 -1.329 . . . . 0.0 107.412 168.116 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 24.5 p90 -147.21 170.31 17.51 Favored 'General case' 0 CA--C 1.49 -1.365 0 N-CA-C 107.033 -1.469 . . . . 0.0 107.033 173.785 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 33.0 p -124.74 147.13 48.81 Favored 'General case' 0 CA--C 1.499 -0.994 0 N-CA-C 107.319 -1.363 . . . . 0.0 107.319 178.036 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 4.4 p -109.09 130.12 55.48 Favored 'General case' 0 N--CA 1.439 -1.012 0 N-CA-C 102.525 -3.139 . . . . 0.0 102.525 164.047 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 42.9 p -90.73 -179.17 5.46 Favored 'General case' 0 N--CA 1.444 -0.732 0 N-CA-C 106.931 -1.507 . . . . 0.0 106.931 179.54 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 31.5 t . . . . . 0 C--O 1.262 1.729 0 N-CA-C 105.186 -2.153 . . . . 0.0 105.186 176.695 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.435 -1.403 0 N-CA-C 105.795 -2.922 . . . . 0.0 105.795 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_exo -61.65 139.45 81.11 Favored 'Trans proline' 0 N--CA 1.442 -1.527 0 C-N-CA 122.865 2.377 . . . . 0.0 113.694 -175.62 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 4.1 t -79.46 154.26 4.7 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.932 0 C-N-CA 127.202 2.201 . . . . 0.0 106.383 -179.14 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 55.6 mm-40 -101.43 96.11 6.93 Favored 'General case' 0 CA--C 1.49 -1.338 0 N-CA-C 107.643 -1.244 . . . . 0.0 107.643 -175.267 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 2.4 p -120.52 143.14 33.43 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.103 0 CA-C-N 113.459 -1.701 . . . . 0.0 107.802 -165.033 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.438 -1.036 0 C-N-CA 125.762 1.625 . . . . 0.0 112.494 -169.271 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 75.0 Cg_endo . . . . . 0 CA--C 1.504 -0.978 0 CA-C-O 118.328 -0.78 . . . . 0.0 111.04 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 4.7 p-10 -122.66 -36.11 2.96 Favored 'General case' 0 CA--C 1.486 -1.499 0 O-C-N 123.821 0.7 . . . . 0.0 110.744 -162.988 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 30.3 p -117.58 151.54 36.96 Favored 'General case' 0 CA--C 1.496 -1.127 0 CA-C-O 121.79 0.805 . . . . 0.0 108.896 -173.122 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 81.0 t60 -145.77 106.37 4.28 Favored Pre-proline 0 N--CA 1.433 -1.28 0 N-CA-C 106.228 -1.767 . . . . 0.0 106.228 167.43 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -77.74 142.49 20.33 Favored 'Trans proline' 0 N--CA 1.447 -1.249 0 C-N-CA 122.578 2.186 . . . . 0.0 109.732 173.092 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 18.2 mm -102.9 140.09 22.1 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.919 0 N-CA-C 103.434 -2.802 . . . . 0.0 103.434 174.121 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 1.4 tm0? -130.32 138.04 50.24 Favored 'General case' 0 CA--C 1.498 -1.045 0 N-CA-C 102.801 -3.036 . . . . 0.0 102.801 176.5 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 49.5 p90 -140.64 166.38 24.9 Favored 'General case' 0 CA--C 1.497 -1.067 0 N-CA-C 106.913 -1.514 . . . . 0.0 106.913 -178.786 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 36.7 m-80 -136.91 132.42 34.46 Favored 'General case' 0 CA--C 1.488 -1.404 0 N-CA-C 105.469 -2.049 . . . . 0.0 105.469 177.198 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -104.0 167.61 9.79 Favored Pre-proline 0 N--CA 1.44 -0.972 0 C-N-CA 124.515 1.126 . . . . 0.0 109.378 -166.809 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_exo -66.23 158.48 54.62 Favored 'Trans proline' 0 CA--C 1.508 -0.78 0 C-N-CA 123.359 2.706 . . . . 0.0 111.926 171.207 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 24.4 tt0 -82.95 -45.12 0.88 Allowed Pre-proline 0 N--CA 1.443 -0.781 0 CA-C-O 115.54 -2.172 . . . . 0.0 111.691 -177.618 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 74.7 Cg_exo -68.57 164.55 32.53 Favored 'Trans proline' 0 CA--C 1.509 -0.77 0 CA-C-N 125.65 3.054 . . . . 0.0 112.717 -178.002 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 35.8 p -76.78 124.51 27.79 Favored 'General case' 0 C--N 1.355 0.847 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 179.323 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 64.2 t-80 -174.69 -42.78 0.01 OUTLIER 'General case' 0 CA--C 1.496 -1.098 0 N-CA-C 106.559 -1.645 . . . . 0.0 106.559 -171.192 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 36.1 mt -118.18 136.42 55.43 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.132 0 N-CA-C 106.331 -1.729 . . . . 0.0 106.331 -171.948 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 5.9 p -114.29 -85.39 0.6 Allowed 'General case' 0 N--CA 1.431 -1.399 0 N-CA-C 106.188 -1.782 . . . . 0.0 106.188 177.361 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 52.0 mtmt -86.03 167.48 14.98 Favored 'General case' 0 CA--C 1.485 -1.527 0 C-N-CA 124.799 1.239 . . . . 0.0 109.224 -164.387 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 81.4 m-85 -132.02 133.43 44.42 Favored 'General case' 0 CA--C 1.49 -1.362 0 N-CA-C 104.044 -2.576 . . . . 0.0 104.044 177.504 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 28.2 mt -122.41 127.87 75.24 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.326 0 N-CA-C 101.921 -3.363 . . . . 0.0 101.921 178.338 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 5.2 mt -110.51 133.46 53.27 Favored 'General case' 0 CA--C 1.475 -1.916 0 N-CA-C 106.151 -1.796 . . . . 0.0 106.151 177.531 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 2.4 mpt_? -112.45 155.46 24.21 Favored 'General case' 0 N--CA 1.432 -1.373 0 N-CA-C 104.62 -2.363 . . . . 0.0 104.62 166.961 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 47.8 p90 -155.32 150.73 27.15 Favored 'General case' 0 N--CA 1.438 -1.042 0 N-CA-C 107.729 -1.211 . . . . 0.0 107.729 170.196 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 11.2 ptp180 -150.88 148.87 24.0 Favored Pre-proline 0 CA--C 1.499 -0.982 0 N-CA-C 106.777 -1.564 . . . . 0.0 106.777 166.863 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -75.96 144.84 27.63 Favored 'Trans proline' 0 CA--C 1.503 -1.048 0 C-N-CA 122.763 2.309 . . . . 0.0 107.86 171.619 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -70.69 80.2 0.6 Allowed 'General case' 0 C--N 1.354 0.797 0 C-N-CA 125.085 1.354 . . . . 0.0 110.915 177.157 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 8.9 t-20 -161.97 -54.8 0.04 OUTLIER 'General case' 0 N--CA 1.431 -1.399 0 N-CA-C 102.917 -2.994 . . . . 0.0 102.917 -178.158 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 34.3 p -83.82 143.79 29.7 Favored 'General case' 0 N--CA 1.438 -1.065 0 N-CA-C 107.299 -1.371 . . . . 0.0 107.299 173.226 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 14.3 m -136.81 14.96 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.803 0 N-CA-C 106.677 -1.601 . . . . 0.0 106.677 177.614 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -101.44 -93.98 2.2 Favored Glycine 0 C--N 1.356 1.658 0 N-CA-C 108.043 -2.023 . . . . 0.0 108.043 -175.067 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 17.5 ptm180 -91.13 171.16 9.44 Favored 'General case' 0 CA--C 1.503 -0.864 0 N-CA-C 108.108 -1.071 . . . . 0.0 108.108 177.255 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -159.52 179.38 8.96 Favored 'General case' 0 CA--C 1.494 -1.192 0 N-CA-C 109.606 -0.516 . . . . 0.0 109.606 -178.657 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -110.04 152.63 25.7 Favored 'General case' 0 CA--C 1.489 -1.387 0 N-CA-C 106.755 -1.572 . . . . 0.0 106.755 -175.818 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -154.8 156.95 37.18 Favored 'General case' 0 N--CA 1.433 -1.284 0 N-CA-C 106.957 -1.497 . . . . 0.0 106.957 -178.953 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -146.05 164.03 33.4 Favored 'General case' 0 CA--C 1.502 -0.885 0 N-CA-C 107.793 -1.188 . . . . 0.0 107.793 175.13 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 96.9 m -120.98 126.57 50.29 Favored 'General case' 0 CA--C 1.502 -0.867 0 N-CA-C 105.542 -2.022 . . . . 0.0 105.542 178.382 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 5.0 mp -114.07 136.13 22.16 Favored Pre-proline 0 N--CA 1.439 -0.992 0 N-CA-C 105.296 -2.113 . . . . 0.0 105.296 -175.823 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_exo -63.06 165.66 16.22 Favored 'Trans proline' 0 CA--C 1.508 -0.81 0 C-N-CA 123.734 2.956 . . . . 0.0 113.799 176.823 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -82.2 -13.68 78.46 Favored Glycine 0 C--N 1.351 1.403 0 C-N-CA 123.507 0.575 . . . . 0.0 113.451 -171.682 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 50.5 p-80 -84.66 -27.16 27.29 Favored 'General case' 0 C--N 1.356 0.872 0 CA-C-N 117.945 0.872 . . . . 0.0 109.862 178.572 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 88.5 mt -88.52 130.39 35.24 Favored 'General case' 0 CA--C 1.498 -1.027 0 N-CA-C 108.536 -0.912 . . . . 0.0 108.536 178.678 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 8.4 p-10 -108.8 10.84 26.55 Favored 'General case' 0 N--CA 1.442 -0.845 0 C-N-CA 124.574 1.15 . . . . 0.0 109.921 -177.484 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 39.2 p -146.43 162.5 38.12 Favored 'General case' 0 N--CA 1.439 -1.003 0 N-CA-C 107.534 -1.284 . . . . 0.0 107.534 -178.598 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 10.7 t80 -140.21 174.63 10.33 Favored 'General case' 0 N--CA 1.444 -0.728 0 N-CA-C 107.122 -1.436 . . . . 0.0 107.122 -179.789 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 55.4 m -137.82 111.41 8.13 Favored 'General case' 0 N--CA 1.433 -1.317 0 N-CA-C 104.689 -2.337 . . . . 0.0 104.689 174.064 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 43.5 mt -91.43 138.72 19.09 Favored 'Isoleucine or valine' 0 C--N 1.358 0.95 0 N-CA-C 104.346 -2.464 . . . . 0.0 104.346 172.361 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 6.9 mtpm? -139.56 162.11 35.88 Favored 'General case' 0 CA--C 1.499 -0.994 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 -179.12 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 82.99 51.37 4.23 Favored Glycine 0 C--N 1.354 1.546 0 N-CA-C 109.429 -1.468 . . . . 0.0 109.429 176.862 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 80.5 mt -117.67 172.03 7.63 Favored 'General case' 0 CA--C 1.501 -0.932 0 N-CA-C 108.071 -1.085 . . . . 0.0 108.071 -170.869 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 10.4 mptt -102.97 151.21 38.37 Favored Pre-proline 0 N--CA 1.442 -0.828 0 N-CA-C 107.572 -1.27 . . . . 0.0 107.572 -172.479 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 64.2 Cg_exo -66.66 135.4 38.59 Favored 'Trans proline' 0 N--CA 1.453 -0.911 0 C-N-CA 123.62 2.88 . . . . 0.0 112.226 171.56 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 54.66 50.01 59.22 Favored Glycine 0 C--N 1.355 1.599 0 C-N-CA 127.256 2.36 . . . . 0.0 115.415 167.334 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 4.3 p -128.94 149.49 33.7 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.007 0 N-CA-C 107.597 -1.26 . . . . 0.0 107.597 178.871 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 7.6 p -95.23 135.5 29.11 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.959 0 N-CA-C 107.644 -1.243 . . . . 0.0 107.644 -178.256 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 83.6 m-85 -117.1 151.28 37.14 Favored 'General case' 0 CA--C 1.496 -1.121 0 N-CA-C 106.395 -1.706 . . . . 0.0 106.395 177.364 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -98.44 142.46 30.03 Favored 'General case' 0 CA--C 1.5 -0.97 0 N-CA-C 104.908 -2.256 . . . . 0.0 104.908 159.476 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -133.23 149.88 19.72 Favored Glycine 0 CA--C 1.49 -1.525 0 N-CA-C 107.693 -2.163 . . . . 0.0 107.693 179.938 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 33.7 mt-30 -136.49 136.24 39.25 Favored 'General case' 0 CA--C 1.484 -1.56 0 N-CA-C 106.581 -1.637 . . . . 0.0 106.581 176.173 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 15.0 tp -119.92 106.75 12.35 Favored 'General case' 0 CA--C 1.499 -1.007 0 N-CA-C 105.778 -1.934 . . . . 0.0 105.778 -176.851 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 5.9 mt -100.15 129.32 51.05 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.113 0 N-CA-C 105.036 -2.209 . . . . 0.0 105.036 -178.81 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 12.6 p -115.72 114.4 24.77 Favored 'General case' 0 N--CA 1.443 -0.823 0 N-CA-C 108.108 -1.071 . . . . 0.0 108.108 -176.418 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 1.7 mp -94.94 143.05 12.57 Favored 'Isoleucine or valine' 0 C--N 1.358 0.941 0 N-CA-C 106.045 -1.835 . . . . 0.0 106.045 -163.808 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 16.7 tt0 -102.3 140.95 35.9 Favored 'General case' 0 CA--C 1.498 -1.031 0 N-CA-C 105.116 -2.179 . . . . 0.0 105.116 171.342 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 75.4 mt-30 -67.19 115.21 6.61 Favored 'General case' 0 C--N 1.358 0.955 0 C-N-CA 123.319 0.648 . . . . 0.0 111.075 -176.038 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 58.4 m-85 60.12 40.03 18.84 Favored 'General case' 0 C--N 1.355 0.848 0 C-N-CA 126.523 1.929 . . . . 0.0 112.143 176.324 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -158.85 -118.61 0.53 Allowed Glycine 0 C--N 1.355 1.623 0 N-CA-C 108.779 -1.728 . . . . 0.0 108.779 -178.361 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 78.4 m-70 -82.84 179.98 7.61 Favored 'General case' 0 CA--C 1.501 -0.928 0 C-N-CA 124.657 1.183 . . . . 0.0 111.178 -168.38 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 10.9 pt20 -157.16 133.5 9.78 Favored 'General case' 0 N--CA 1.434 -1.258 0 N-CA-C 106.076 -1.824 . . . . 0.0 106.076 167.391 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 31.5 mm-40 -100.91 146.43 27.36 Favored 'General case' 0 CA--C 1.498 -1.031 0 N-CA-C 105.531 -2.026 . . . . 0.0 105.531 -178.231 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 7.6 p -122.3 141.55 42.27 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.721 0 N-CA-C 108.004 -1.109 . . . . 0.0 108.004 -174.444 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 23.2 m -125.79 145.45 50.21 Favored 'General case' 0 N--CA 1.442 -0.872 0 N-CA-C 104.398 -2.445 . . . . 0.0 104.398 -179.711 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 38.9 ttm180 -133.85 143.46 48.33 Favored 'General case' 0 CA--C 1.504 -0.81 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 173.32 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 28.9 p90 -155.67 175.68 13.6 Favored 'General case' 0 CA--C 1.5 -0.974 0 N-CA-C 106.905 -1.517 . . . . 0.0 106.905 -178.424 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 52.2 m-20 -133.47 153.86 51.28 Favored 'General case' 0 CA--C 1.504 -0.81 0 N-CA-C 106.018 -1.845 . . . . 0.0 106.018 170.334 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 17.1 p90 -151.28 175.64 12.01 Favored 'General case' 0 CA--C 1.493 -1.23 0 N-CA-C 106.678 -1.601 . . . . 0.0 106.678 173.222 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 31.4 p -122.6 147.02 46.9 Favored 'General case' 0 CA--C 1.504 -0.813 0 N-CA-C 107.533 -1.284 . . . . 0.0 107.533 174.276 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 94.3 m -99.52 121.65 41.47 Favored 'General case' 0 CA--C 1.496 -1.125 0 N-CA-C 102.721 -3.066 . . . . 0.0 102.721 165.583 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 2.3 m 68.13 -128.34 0.13 Allowed 'General case' 0 C--N 1.36 1.028 0 C-N-CA 126.573 1.949 . . . . 0.0 106.481 -165.346 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 26.8 p . . . . . 0 C--O 1.261 1.69 0 N-CA-C 106.168 -1.79 . . . . 0.0 106.168 174.124 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.438 -1.182 0 N-CA-C 106.138 -2.785 . . . . 0.0 106.138 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_exo -58.4 140.93 96.46 Favored 'Trans proline' 0 N--CA 1.445 -1.35 0 C-N-CA 123.749 2.966 . . . . 0.0 113.319 -175.783 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 7.3 t -79.0 155.31 4.83 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.892 0 C-N-CA 127.014 2.126 . . . . 0.0 106.569 -175.345 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 93.4 mt-10 -97.35 87.98 4.29 Favored 'General case' 0 CA--C 1.493 -1.224 0 CA-C-O 122.377 1.084 . . . . 0.0 108.181 -173.1 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 2.7 p -110.77 134.93 51.45 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.146 0 CA-C-N 114.319 -1.31 . . . . 0.0 107.868 -166.179 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 23.8 p90 . . . . . 0 N--CA 1.434 -1.246 0 N-CA-C 104.072 -2.566 . . . . 0.0 104.072 178.131 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo . . . . . 0 CA--C 1.507 -0.84 0 CA-C-O 118.19 -0.838 . . . . 0.0 110.917 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 7.0 p-10 -104.18 -42.34 5.55 Favored 'General case' 0 CA--C 1.494 -1.199 0 O-C-N 123.716 0.635 . . . . 0.0 110.417 -165.72 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 10.9 p -120.1 143.98 47.86 Favored 'General case' 0 CA--C 1.488 -1.432 0 N-CA-C 107.98 -1.118 . . . . 0.0 107.98 -178.43 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . 0.515 ' CE1' HG22 ' A' ' 91' ' ' THR . 0.1 OUTLIER -135.12 92.75 17.8 Favored Pre-proline 0 N--CA 1.441 -0.905 0 N-CA-C 105.657 -1.979 . . . . 0.0 105.657 174.322 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_endo -74.9 127.87 11.11 Favored 'Trans proline' 0 N--CA 1.443 -1.447 0 C-N-CA 123.007 2.471 . . . . 0.0 109.442 170.492 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 28.3 mm -104.86 149.82 8.1 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.081 0 N-CA-C 104.231 -2.507 . . . . 0.0 104.231 -174.277 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 65.4 tt0 -140.24 142.84 35.77 Favored 'General case' 0 N--CA 1.438 -1.066 0 N-CA-C 104.205 -2.517 . . . . 0.0 104.205 168.587 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 37.8 p90 -136.27 164.2 28.63 Favored 'General case' 0 N--CA 1.439 -0.987 0 N-CA-C 106.226 -1.768 . . . . 0.0 106.226 -175.176 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 5.8 m120 -131.24 127.71 38.41 Favored 'General case' 0 CA--C 1.492 -1.286 0 N-CA-C 106.353 -1.721 . . . . 0.0 106.353 -179.948 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -84.61 161.77 52.67 Favored Pre-proline 0 N--CA 1.442 -0.857 0 C-N-CA 123.663 0.785 . . . . 0.0 110.541 -168.381 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_exo -67.23 172.72 9.62 Favored 'Trans proline' 0 CA--C 1.51 -0.717 0 C-N-CA 123.498 2.798 . . . . 0.0 112.295 170.766 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 1.4 tm0? -80.74 -46.99 1.23 Allowed Pre-proline 0 N--CA 1.443 -0.795 0 CA-C-O 115.569 -2.158 . . . . 0.0 110.429 -176.86 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 63.3 Cg_exo -68.25 164.78 31.02 Favored 'Trans proline' 0 CA--C 1.509 -0.75 0 CA-C-N 125.784 3.101 . . . . 0.0 112.086 176.999 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 22.6 t -88.07 85.88 7.03 Favored 'General case' 0 C--N 1.356 0.862 0 N-CA-C 106.412 -1.699 . . . . 0.0 106.412 176.258 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 59.9 t-80 -116.16 -28.85 6.45 Favored 'General case' 0 N--CA 1.437 -1.124 0 C-N-CA 125.585 1.554 . . . . 0.0 107.076 -175.01 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 42.6 mt -126.35 137.03 59.05 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.056 0 N-CA-C 106.916 -1.513 . . . . 0.0 106.916 -169.041 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 32.9 t -113.56 -85.72 0.59 Allowed 'General case' 0 N--CA 1.432 -1.348 0 N-CA-C 106.328 -1.731 . . . . 0.0 106.328 178.073 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 37.0 ttpt -88.43 160.67 17.44 Favored 'General case' 0 CA--C 1.493 -1.241 0 C-N-CA 125.859 1.664 . . . . 0.0 107.906 -165.04 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 92.8 m-85 -127.47 139.97 52.46 Favored 'General case' 0 CA--C 1.492 -1.28 0 N-CA-C 105.377 -2.083 . . . . 0.0 105.377 177.941 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 13.9 mt -124.95 131.09 73.03 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.151 0 N-CA-C 101.958 -3.349 . . . . 0.0 101.958 172.898 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 3.5 mt -109.23 127.55 54.34 Favored 'General case' 0 CA--C 1.475 -1.936 0 N-CA-C 104.975 -2.232 . . . . 0.0 104.975 174.303 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -116.63 158.33 23.91 Favored 'General case' 0 N--CA 1.434 -1.257 0 N-CA-C 104.636 -2.357 . . . . 0.0 104.636 174.375 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 48.4 p90 -157.29 142.29 16.94 Favored 'General case' 0 N--CA 1.437 -1.081 0 N-CA-C 107.018 -1.475 . . . . 0.0 107.018 175.079 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 13.4 ttm180 -131.68 125.2 20.35 Favored Pre-proline 0 CA--C 1.503 -0.853 0 N-CA-C 106.261 -1.755 . . . . 0.0 106.261 179.006 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 4.8 Cg_endo -73.35 118.93 5.72 Favored 'Trans proline' 0 N--CA 1.45 -1.066 0 CA-C-N 123.388 2.246 . . . . 0.0 109.033 168.969 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 32.3 mmmt -70.98 88.7 0.77 Allowed 'General case' 0 N--CA 1.44 -0.937 0 C-N-CA 125.644 1.578 . . . . 0.0 111.133 179.214 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 70.5 m-80 -135.57 -68.02 0.52 Allowed 'General case' 0 N--CA 1.436 -1.148 0 N-CA-C 102.244 -3.243 . . . . 0.0 102.244 172.729 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 57.8 m -102.98 168.28 9.3 Favored 'General case' 0 N--CA 1.44 -0.945 0 N-CA-C 106.674 -1.602 . . . . 0.0 106.674 172.234 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 3.6 m -122.15 55.53 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.88 0 N-CA-C 105.752 -1.944 . . . . 0.0 105.752 177.581 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -104.01 -109.4 3.38 Favored Glycine 0 C--N 1.353 1.479 0 N-CA-C 107.78 -2.128 . . . . 0.0 107.78 -177.221 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 82.4 mtt85 -91.24 172.3 8.64 Favored 'General case' 0 CA--C 1.502 -0.883 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 -178.534 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -153.69 176.27 12.3 Favored 'General case' 0 N--CA 1.437 -1.097 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 -179.964 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 59.5 mttp -112.42 156.98 21.63 Favored 'General case' 0 CA--C 1.49 -1.356 0 N-CA-C 107.782 -1.192 . . . . 0.0 107.782 -174.767 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 1.1 pp20? -151.42 162.37 41.05 Favored 'General case' 0 N--CA 1.434 -1.24 0 N-CA-C 107.966 -1.124 . . . . 0.0 107.966 171.014 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -144.49 159.73 42.27 Favored 'General case' 0 CA--C 1.497 -1.062 0 N-CA-C 105.857 -1.905 . . . . 0.0 105.857 172.072 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 91.4 m -121.28 130.01 53.43 Favored 'General case' 0 CA--C 1.502 -0.896 0 N-CA-C 106.576 -1.638 . . . . 0.0 106.576 -173.892 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 4.1 mp -116.64 134.79 22.86 Favored Pre-proline 0 N--CA 1.438 -1.066 0 N-CA-C 105.386 -2.079 . . . . 0.0 105.386 -175.054 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 66.0 Cg_exo -62.88 164.55 18.71 Favored 'Trans proline' 0 N--CA 1.455 -0.736 0 C-N-CA 123.498 2.799 . . . . 0.0 113.351 174.954 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -81.88 -14.87 76.59 Favored Glycine 0 C--N 1.352 1.422 0 O-C-N 123.48 0.487 . . . . 0.0 113.297 -170.717 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 50.1 p-80 -83.87 -25.5 30.21 Favored 'General case' 0 C--N 1.356 0.852 0 CA-C-N 117.846 0.823 . . . . 0.0 109.828 179.173 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 89.9 mt -88.41 133.17 34.18 Favored 'General case' 0 CA--C 1.5 -0.959 0 N-CA-C 107.876 -1.157 . . . . 0.0 107.876 177.633 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 7.9 p30 -110.41 9.03 23.44 Favored 'General case' 0 CA--C 1.504 -0.821 0 C-N-CA 124.654 1.181 . . . . 0.0 109.802 -175.436 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 37.2 p -145.81 162.98 36.42 Favored 'General case' 0 N--CA 1.438 -1.051 0 N-CA-C 107.395 -1.335 . . . . 0.0 107.395 -177.477 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 8.3 t80 -141.8 174.94 10.11 Favored 'General case' 0 N--CA 1.441 -0.878 0 N-CA-C 108.009 -1.108 . . . . 0.0 108.009 179.765 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 89.6 m -135.45 109.98 8.54 Favored 'General case' 0 N--CA 1.432 -1.337 0 N-CA-C 104.19 -2.522 . . . . 0.0 104.19 171.202 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 58.3 mt -87.5 143.83 10.49 Favored 'Isoleucine or valine' 0 C--N 1.36 1.022 0 N-CA-C 103.943 -2.614 . . . . 0.0 103.943 169.977 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -147.07 160.58 42.24 Favored 'General case' 0 CA--C 1.498 -1.054 0 N-CA-C 108.054 -1.091 . . . . 0.0 108.054 173.865 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 86.83 51.83 3.3 Favored Glycine 0 C--N 1.353 1.484 0 N-CA-C 109.006 -1.638 . . . . 0.0 109.006 177.004 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 48.2 mt -112.1 175.29 5.49 Favored 'General case' 0 CA--C 1.502 -0.867 0 N-CA-C 107.013 -1.477 . . . . 0.0 107.013 -178.353 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 57.6 mttp -115.99 152.59 47.79 Favored Pre-proline 0 N--CA 1.444 -0.757 0 N-CA-C 106.526 -1.657 . . . . 0.0 106.526 -168.395 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_endo -79.5 155.36 24.59 Favored 'Trans proline' 0 N--CA 1.454 -0.835 0 C-N-CA 122.719 2.279 . . . . 0.0 110.838 175.883 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 59.01 29.8 65.76 Favored Glycine 0 C--N 1.354 1.566 0 C-N-CA 127.747 2.594 . . . . 0.0 116.883 167.288 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 9.0 p -127.4 148.24 32.14 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.847 0 N-CA-C 108.715 -0.846 . . . . 0.0 108.715 -177.581 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 6.7 p -92.8 124.17 45.14 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.765 0 N-CA-C 107.804 -1.184 . . . . 0.0 107.804 175.614 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 51.0 m-85 -101.48 150.41 23.07 Favored 'General case' 0 N--CA 1.439 -1.004 0 N-CA-C 107.629 -1.249 . . . . 0.0 107.629 173.403 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 12.4 tp10 -93.7 136.18 34.24 Favored 'General case' 0 CA--C 1.498 -1.044 0 N-CA-C 103.762 -2.681 . . . . 0.0 103.762 163.914 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -134.43 145.32 17.41 Favored Glycine 0 CA--C 1.488 -1.64 0 N-CA-C 107.547 -2.221 . . . . 0.0 107.547 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 35.2 mt-30 -140.75 136.81 32.9 Favored 'General case' 0 CA--C 1.485 -1.52 0 N-CA-C 105.718 -1.956 . . . . 0.0 105.718 -177.677 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 40.9 tp -115.01 98.21 6.67 Favored 'General case' 0 N--CA 1.437 -1.124 0 N-CA-C 103.453 -2.795 . . . . 0.0 103.453 179.297 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 39.7 mm -92.88 125.96 45.39 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.942 0 N-CA-C 103.704 -2.702 . . . . 0.0 103.704 -178.08 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 49.2 m -120.72 112.29 18.67 Favored 'General case' 0 N--CA 1.438 -1.069 0 N-CA-C 107.632 -1.247 . . . . 0.0 107.632 -169.261 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 39.3 mm -88.15 139.87 16.68 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.323 0 N-CA-C 106.894 -1.521 . . . . 0.0 106.894 -163.188 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 15.3 tt0 -101.93 132.34 47.8 Favored 'General case' 0 CA--C 1.495 -1.171 0 N-CA-C 104.953 -2.24 . . . . 0.0 104.953 178.776 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 17.8 tt0 -77.08 42.56 0.33 Allowed 'General case' 0 C--N 1.355 0.813 0 C-N-CA 125.339 1.456 . . . . 0.0 113.168 -177.761 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 61.6 m-85 -140.42 19.59 2.39 Favored 'General case' 0 N--CA 1.442 -0.872 0 N-CA-C 107.094 -1.447 . . . . 0.0 107.094 173.251 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 96.55 -21.57 44.95 Favored Glycine 0 C--N 1.354 1.582 0 C-N-CA 123.94 0.781 . . . . 0.0 111.395 174.598 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 77.9 m-70 -81.71 178.91 8.06 Favored 'General case' 0 CA--C 1.498 -1.032 0 C-N-CA 124.621 1.168 . . . . 0.0 109.508 -177.016 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 5.0 pt20 -159.02 163.53 36.32 Favored 'General case' 0 N--CA 1.439 -1.024 0 CA-C-O 122.027 0.917 . . . . 0.0 108.721 174.78 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 16.6 tp10 -117.37 154.2 31.73 Favored 'General case' 0 N--CA 1.437 -1.078 0 N-CA-C 105.631 -1.989 . . . . 0.0 105.631 179.604 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 1.9 p -126.0 134.31 66.84 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.86 0 N-CA-C 106.9 -1.519 . . . . 0.0 106.9 176.75 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 38.8 m -122.54 131.96 54.09 Favored 'General case' 0 N--CA 1.439 -0.996 0 N-CA-C 102.211 -3.255 . . . . 0.0 102.211 172.595 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 22.9 ttt180 -130.27 143.5 50.81 Favored 'General case' 0 CA--C 1.504 -0.803 0 CA-C-N 118.784 0.72 . . . . 0.0 109.444 -172.691 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 18.0 p90 -162.06 -177.18 5.6 Favored 'General case' 0 C--N 1.359 1.007 0 N-CA-C 106.829 -1.545 . . . . 0.0 106.829 -175.316 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 43.6 p-10 -136.63 160.91 37.38 Favored 'General case' 0 N--CA 1.442 -0.831 0 N-CA-C 106.018 -1.845 . . . . 0.0 106.018 168.836 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.413 ' CD1' ' CD2' ' A' ' 18' ' ' HIS . 22.3 p90 -143.61 164.82 29.32 Favored 'General case' 0 CA--C 1.488 -1.428 0 N-CA-C 107.254 -1.388 . . . . 0.0 107.254 170.065 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 22.8 p -117.88 137.96 52.45 Favored 'General case' 0 CA--C 1.499 -1.005 0 N-CA-C 106.337 -1.727 . . . . 0.0 106.337 177.433 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . 0.515 HG22 ' CE1' ' A' ' 18' ' ' HIS . 7.0 p -107.97 128.77 54.93 Favored 'General case' 0 CA--C 1.5 -0.977 0 N-CA-C 103.061 -2.94 . . . . 0.0 103.061 172.788 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 15.1 t -158.41 152.21 23.6 Favored 'General case' 0 N--CA 1.437 -1.08 0 N-CA-C 105.944 -1.873 . . . . 0.0 105.944 -178.11 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 33.8 p . . . . . 0 C--O 1.26 1.625 0 N-CA-C 107.189 -1.411 . . . . 0.0 107.189 174.714 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.443 -0.886 0 N-CA-C 108.616 -1.793 . . . . 0.0 108.616 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_exo -60.46 140.55 92.07 Favored 'Trans proline' 0 N--CA 1.443 -1.461 0 C-N-CA 123.137 2.558 . . . . 0.0 113.484 -177.385 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 7.6 t -78.57 149.77 5.58 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.947 0 C-N-CA 127.775 2.43 . . . . 0.0 105.461 179.112 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 90.0 mt-10 -103.71 94.29 5.37 Favored 'General case' 0 CA--C 1.493 -1.23 0 C-N-CA 123.849 0.86 . . . . 0.0 108.726 -168.282 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 2.5 p -121.83 142.47 38.0 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.983 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 -161.936 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 18.1 p90 . . . . . 0 N--CA 1.435 -1.192 0 N-CA-C 106.923 -1.51 . . . . 0.0 106.923 -168.158 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo . . . . . 0 CA--C 1.502 -1.076 0 CA-C-O 118.75 -0.604 . . . . 0.0 111.06 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 1.7 p30 -103.2 -40.05 6.59 Favored 'General case' 0 CA--C 1.484 -1.596 0 O-C-N 124.09 0.869 . . . . 0.0 110.455 -166.593 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 73.1 m -116.18 156.7 26.03 Favored 'General case' 0 CA--C 1.497 -1.083 0 CA-C-O 121.871 0.843 . . . . 0.0 108.797 -178.532 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 21.1 t-80 -132.96 89.88 33.12 Favored Pre-proline 0 N--CA 1.438 -1.03 0 N-CA-C 106.167 -1.79 . . . . 0.0 106.167 169.414 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 65.5 Cg_endo -84.24 103.38 0.96 Allowed 'Trans proline' 0 N--CA 1.453 -0.871 0 C-N-CA 123.27 2.647 . . . . 0.0 110.449 -175.072 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.583 HD11 HD11 ' A' ' 35' ' ' LEU . 1.7 pt -94.39 168.29 1.53 Allowed 'Isoleucine or valine' 0 C--N 1.356 0.864 0 N-CA-C 109.925 -0.398 . . . . 0.0 109.925 -173.608 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 28.1 tt0 -144.35 147.83 33.95 Favored 'General case' 0 N--CA 1.438 -1.033 0 N-CA-C 104.974 -2.232 . . . . 0.0 104.974 169.97 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 40.9 p90 -129.81 156.6 44.08 Favored 'General case' 0 CA--C 1.496 -1.103 0 N-CA-C 106.859 -1.534 . . . . 0.0 106.859 177.535 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 8.2 t-20 -110.92 149.2 30.97 Favored 'General case' 0 CA--C 1.489 -1.373 0 N-CA-C 102.186 -3.265 . . . . 0.0 102.186 173.211 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -115.82 170.37 5.8 Favored Pre-proline 0 N--CA 1.441 -0.895 0 C-N-CA 124.161 0.984 . . . . 0.0 108.521 -166.369 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 94.8 Cg_exo -65.18 169.53 12.04 Favored 'Trans proline' 0 CA--C 1.511 -0.668 0 C-N-CA 123.613 2.875 . . . . 0.0 112.323 166.918 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 64.7 mt-30 -80.51 -56.1 0.7 Allowed Pre-proline 0 N--CA 1.442 -0.831 0 CA-C-O 115.505 -2.188 . . . . 0.0 112.454 -172.903 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -75.31 169.78 21.74 Favored 'Trans proline' 0 CA--C 1.511 -0.655 0 CA-C-N 125.923 3.151 . . . . 0.0 110.671 -177.073 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 67.3 m -87.09 86.16 7.28 Favored 'General case' 0 CA--C 1.502 -0.901 0 N-CA-C 106.708 -1.59 . . . . 0.0 106.708 175.975 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 11.9 t-160 -122.78 -26.05 4.54 Favored 'General case' 0 N--CA 1.436 -1.129 0 C-N-CA 124.972 1.309 . . . . 0.0 107.792 -171.673 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 1.7 mp -103.16 136.7 34.57 Favored 'Isoleucine or valine' 0 C--N 1.355 0.824 0 N-CA-C 103.885 -2.635 . . . . 0.0 103.885 -171.919 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 34.5 t -96.29 -85.99 0.33 Allowed 'General case' 0 N--CA 1.43 -1.468 0 N-CA-C 104.791 -2.3 . . . . 0.0 104.791 174.473 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 50.8 mtmt -90.67 170.97 9.7 Favored 'General case' 0 CA--C 1.493 -1.226 0 C-N-CA 123.884 0.874 . . . . 0.0 110.096 -168.01 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 96.4 m-85 -125.69 140.37 52.76 Favored 'General case' 0 CA--C 1.496 -1.101 0 N-CA-C 103.948 -2.612 . . . . 0.0 103.948 162.132 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 54.0 mt -120.9 127.85 75.99 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.12 0 N-CA-C 101.828 -3.397 . . . . 0.0 101.828 170.976 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.583 HD11 HD11 ' A' ' 20' ' ' ILE . 4.5 mt -106.91 137.15 45.52 Favored 'General case' 0 CA--C 1.476 -1.898 0 N-CA-C 105.384 -2.08 . . . . 0.0 105.384 171.611 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -131.83 156.02 46.78 Favored 'General case' 0 N--CA 1.434 -1.242 0 N-CA-C 106.878 -1.526 . . . . 0.0 106.878 166.258 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 49.4 p90 -155.27 145.76 22.07 Favored 'General case' 0 N--CA 1.435 -1.209 0 N-CA-C 106.517 -1.66 . . . . 0.0 106.517 -176.384 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 45.5 ttm-85 -135.87 140.67 34.15 Favored Pre-proline 0 N--CA 1.441 -0.88 0 N-CA-C 104.575 -2.38 . . . . 0.0 104.575 178.254 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -72.95 116.55 4.76 Favored 'Trans proline' 0 CA--C 1.504 -0.992 0 C-N-CA 122.735 2.29 . . . . 0.0 108.594 166.284 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 82.5 tttt -73.87 83.85 1.69 Allowed 'General case' 0 C--N 1.355 0.843 0 C-N-CA 125.537 1.535 . . . . 0.0 110.199 -174.252 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 33.1 m120 -147.51 -73.04 0.21 Allowed 'General case' 0 N--CA 1.435 -1.186 0 N-CA-C 102.354 -3.202 . . . . 0.0 102.354 -175.785 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 50.8 p -96.73 168.4 10.53 Favored 'General case' 0 N--CA 1.442 -0.867 0 N-CA-C 107.454 -1.313 . . . . 0.0 107.454 173.351 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 3.6 m -125.98 55.16 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.849 0 N-CA-C 105.821 -1.918 . . . . 0.0 105.821 177.192 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -93.19 -106.05 1.74 Allowed Glycine 0 C--N 1.355 1.611 0 N-CA-C 108.415 -1.874 . . . . 0.0 108.415 -177.247 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 5.6 mmp_? -105.12 170.01 8.12 Favored 'General case' 0 CA--C 1.499 -1.017 0 N-CA-C 107.042 -1.466 . . . . 0.0 107.042 176.729 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -151.23 173.01 14.95 Favored 'General case' 0 N--CA 1.436 -1.137 0 N-CA-C 108.728 -0.841 . . . . 0.0 108.728 -177.943 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 67.8 mttm -111.68 155.76 22.93 Favored 'General case' 0 CA--C 1.49 -1.357 0 N-CA-C 107.774 -1.195 . . . . 0.0 107.774 -172.13 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 15.4 pt-20 -151.49 160.67 43.6 Favored 'General case' 0 N--CA 1.435 -1.211 0 N-CA-C 108.247 -1.02 . . . . 0.0 108.247 172.565 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -137.37 156.76 47.84 Favored 'General case' 0 CA--C 1.497 -1.064 0 N-CA-C 105.938 -1.875 . . . . 0.0 105.938 171.532 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 95.2 m -117.85 123.29 45.52 Favored 'General case' 0 CA--C 1.499 -0.982 0 N-CA-C 104.134 -2.543 . . . . 0.0 104.134 176.398 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 65.9 mt -118.73 137.67 25.15 Favored Pre-proline 0 N--CA 1.437 -1.08 0 N-CA-C 105.984 -1.858 . . . . 0.0 105.984 -164.867 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 75.3 Cg_exo -65.05 163.87 27.08 Favored 'Trans proline' 0 N--CA 1.455 -0.749 0 C-N-CA 123.295 2.663 . . . . 0.0 113.545 176.491 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -78.68 -17.27 77.78 Favored Glycine 0 C--N 1.352 1.456 0 C-N-CA 124.042 0.83 . . . . 0.0 113.807 -174.87 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 54.3 p-80 -83.45 -23.81 32.09 Favored 'General case' 0 C--N 1.357 0.893 0 CA-C-N 117.936 0.868 . . . . 0.0 109.963 -179.602 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 80.8 mt -87.93 125.24 34.4 Favored 'General case' 0 CA--C 1.497 -1.093 0 N-CA-C 107.975 -1.12 . . . . 0.0 107.975 176.721 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 8.1 p30 -112.25 6.69 19.09 Favored 'General case' 0 N--CA 1.442 -0.848 0 C-N-CA 124.741 1.216 . . . . 0.0 109.783 -174.845 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 28.7 p -142.06 154.96 45.35 Favored 'General case' 0 CA--C 1.498 -1.043 0 N-CA-C 106.684 -1.598 . . . . 0.0 106.684 -177.977 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 10.8 t80 -133.84 171.33 14.3 Favored 'General case' 0 CA--C 1.502 -0.869 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 178.423 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 94.4 m -131.8 109.09 9.88 Favored 'General case' 0 N--CA 1.43 -1.433 0 N-CA-C 103.929 -2.619 . . . . 0.0 103.929 170.545 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 42.6 mt -84.09 139.48 17.54 Favored 'Isoleucine or valine' 0 C--N 1.358 0.969 0 N-CA-C 103.123 -2.917 . . . . 0.0 103.123 169.433 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 18.0 ptpt -147.74 160.05 43.14 Favored 'General case' 0 CA--C 1.497 -1.085 0 N-CA-C 109.068 -0.716 . . . . 0.0 109.068 -176.261 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 81.2 53.96 3.72 Favored Glycine 0 C--N 1.355 1.586 0 N-CA-C 108.816 -1.714 . . . . 0.0 108.816 -179.946 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 84.6 mt -117.14 172.6 7.17 Favored 'General case' 0 CA--C 1.496 -1.113 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 -173.019 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 65.7 tttp -124.43 139.56 33.26 Favored Pre-proline 0 N--CA 1.434 -1.259 0 N-CA-C 104.97 -2.233 . . . . 0.0 104.97 -175.342 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -74.9 163.97 34.4 Favored 'Trans proline' 0 N--CA 1.455 -0.789 0 C-N-CA 123.058 2.505 . . . . 0.0 110.089 174.98 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 62.63 44.07 98.07 Favored Glycine 0 N--CA 1.429 -1.824 0 C-N-CA 125.946 1.736 . . . . 0.0 112.756 -178.803 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 20.5 t -134.95 127.19 48.15 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.09 0 N-CA-C 104.325 -2.472 . . . . 0.0 104.325 173.078 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 4.4 p -83.8 116.72 28.21 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.928 0 N-CA-C 105.061 -2.2 . . . . 0.0 105.061 162.521 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 80.8 m-85 -97.64 147.04 24.72 Favored 'General case' 0 CA--C 1.495 -1.153 0 N-CA-C 105.817 -1.919 . . . . 0.0 105.817 178.71 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 14.6 pt-20 -95.37 140.76 29.79 Favored 'General case' 0 CA--C 1.501 -0.934 0 N-CA-C 105.168 -2.16 . . . . 0.0 105.168 164.288 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -134.33 151.89 20.45 Favored Glycine 0 CA--C 1.49 -1.521 0 N-CA-C 107.633 -2.187 . . . . 0.0 107.633 -178.972 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 31.9 mt-30 -143.65 135.71 26.67 Favored 'General case' 0 CA--C 1.488 -1.425 0 N-CA-C 105.699 -1.963 . . . . 0.0 105.699 179.171 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 15.4 tp -120.01 100.98 7.54 Favored 'General case' 0 CA--C 1.499 -0.983 0 N-CA-C 105.482 -2.044 . . . . 0.0 105.482 -177.453 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 18.7 mt -94.02 131.29 41.34 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.889 0 N-CA-C 105.072 -2.196 . . . . 0.0 105.072 178.143 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 23.3 p -108.38 125.87 52.22 Favored 'General case' 0 N--CA 1.44 -0.972 0 N-CA-C 106.088 -1.819 . . . . 0.0 106.088 173.163 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 1.7 mp -92.33 137.04 23.07 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.181 0 N-CA-C 103.427 -2.805 . . . . 0.0 103.427 -179.346 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 4.8 mp0 -92.25 153.48 19.23 Favored 'General case' 0 CA--C 1.497 -1.091 0 N-CA-C 107.032 -1.47 . . . . 0.0 107.032 177.701 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 9.0 tt0 -77.52 32.53 0.16 Allowed 'General case' 0 C--N 1.356 0.854 0 C-N-CA 125.5 1.52 . . . . 0.0 112.385 173.766 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 88.4 m-85 -143.9 14.26 1.7 Allowed 'General case' 0 CA--C 1.498 -1.027 0 C-N-CA 124.119 0.968 . . . . 0.0 108.687 -173.96 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 90.14 -17.94 50.91 Favored Glycine 0 C--N 1.35 1.357 0 C-N-CA 124.131 0.872 . . . . 0.0 112.433 173.835 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 78.4 m-70 -81.48 173.84 12.02 Favored 'General case' 0 CA--C 1.496 -1.109 0 C-N-CA 124.691 1.196 . . . . 0.0 109.17 -177.365 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 5.1 pt20 -155.03 142.41 19.56 Favored 'General case' 0 N--CA 1.438 -1.042 0 N-CA-C 107.778 -1.193 . . . . 0.0 107.778 171.715 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 67.7 mt-10 -108.24 140.22 41.8 Favored 'General case' 0 CA--C 1.496 -1.1 0 N-CA-C 105.191 -2.152 . . . . 0.0 105.191 178.97 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 3.3 p -117.81 137.39 51.9 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.823 0 N-CA-C 107.544 -1.28 . . . . 0.0 107.544 -175.377 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 24.9 m -117.33 140.57 49.4 Favored 'General case' 0 N--CA 1.441 -0.898 0 N-CA-C 104.015 -2.587 . . . . 0.0 104.015 174.84 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -126.46 153.88 44.46 Favored 'General case' 0 CA--C 1.498 -1.04 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 170.331 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 29.5 p90 -166.46 -179.1 4.77 Favored 'General case' 0 CA--C 1.5 -0.948 0 N-CA-C 106.888 -1.523 . . . . 0.0 106.888 -178.093 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 1.7 p30 -139.11 159.51 41.98 Favored 'General case' 0 N--CA 1.438 -1.038 0 N-CA-C 106.436 -1.691 . . . . 0.0 106.436 166.132 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 20.5 p90 -142.42 172.88 12.09 Favored 'General case' 0 CA--C 1.488 -1.411 0 N-CA-C 105.814 -1.921 . . . . 0.0 105.814 171.867 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 16.2 m -130.39 143.48 50.79 Favored 'General case' 0 CA--C 1.501 -0.915 0 N-CA-C 104.697 -2.334 . . . . 0.0 104.697 176.76 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 58.8 m -120.48 124.83 46.35 Favored 'General case' 0 N--CA 1.441 -0.918 0 N-CA-C 102.973 -2.973 . . . . 0.0 102.973 176.758 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 33.0 p -134.24 167.8 20.03 Favored 'General case' 0 C--N 1.357 0.894 0 N-CA-C 107.459 -1.311 . . . . 0.0 107.459 -177.738 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 56.8 p . . . . . 0 C--O 1.26 1.61 0 C-N-CA 124.431 1.092 . . . . 0.0 108.844 178.02 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.437 -1.288 0 N-CA-C 107.82 -2.112 . . . . 0.0 107.82 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 70.7 Cg_exo -65.5 142.15 70.43 Favored 'Trans proline' 0 N--CA 1.444 -1.425 0 C-N-CA 122.257 1.971 . . . . 0.0 115.2 -169.913 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 12.9 t -78.29 154.36 5.1 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.807 0 C-N-CA 128.645 2.778 . . . . 0.0 104.776 168.287 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 57.8 mm-40 -109.35 99.88 9.06 Favored 'General case' 0 CA--C 1.488 -1.437 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 -172.249 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 2.4 p -119.23 141.29 39.86 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.012 0 N-CA-C 106.413 -1.699 . . . . 0.0 106.413 -172.087 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 15.4 p90 . . . . . 0 N--CA 1.436 -1.154 0 N-CA-C 107.078 -1.453 . . . . 0.0 107.078 -169.005 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_exo . . . . . 0 CA--C 1.509 -0.769 0 N-CA-C 110.705 -0.536 . . . . 0.0 110.705 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -102.31 -45.36 5.13 Favored 'General case' 0 CA--C 1.492 -1.251 0 C-N-CA 125.132 1.373 . . . . 0.0 110.342 -168.033 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 73.5 m -110.85 158.16 19.02 Favored 'General case' 0 CA--C 1.493 -1.234 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 -176.219 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 18.7 t-160 -148.63 95.65 3.96 Favored Pre-proline 0 N--CA 1.44 -0.962 0 N-CA-C 107.651 -1.24 . . . . 0.0 107.651 165.575 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 70.2 Cg_endo -74.61 134.18 18.17 Favored 'Trans proline' 0 N--CA 1.446 -1.268 0 C-N-CA 122.903 2.402 . . . . 0.0 109.246 170.264 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 7.5 pt -116.08 168.39 7.77 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.047 0 N-CA-C 107.006 -1.479 . . . . 0.0 107.006 179.762 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 23.2 tt0 -148.9 147.7 28.98 Favored 'General case' 0 N--CA 1.438 -1.072 0 N-CA-C 105.068 -2.197 . . . . 0.0 105.068 172.27 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 39.5 p90 -131.5 160.95 33.7 Favored 'General case' 0 N--CA 1.438 -1.061 0 N-CA-C 107.069 -1.456 . . . . 0.0 107.069 -178.879 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 83.8 m-20 -103.92 -179.62 4.0 Favored 'General case' 0 CA--C 1.488 -1.407 0 N-CA-C 103.721 -2.696 . . . . 0.0 103.721 170.865 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -157.29 173.07 5.34 Favored Pre-proline 0 N--CA 1.44 -0.963 0 N-CA-C 106.696 -1.594 . . . . 0.0 106.696 177.317 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 79.8 Cg_exo -63.99 161.31 33.75 Favored 'Trans proline' 0 N--CA 1.455 -0.74 0 C-N-CA 123.761 2.974 . . . . 0.0 113.082 173.129 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 70.8 tp60 -82.71 -45.03 0.92 Allowed Pre-proline 0 N--CA 1.444 -0.746 0 CA-C-O 115.519 -2.181 . . . . 0.0 111.925 -175.375 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_exo -70.87 -15.51 32.92 Favored 'Trans proline' 0 CA--C 1.509 -0.727 0 CA-C-N 125.897 3.142 . . . . 0.0 113.342 -176.114 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 9.1 t 66.33 73.06 0.38 Allowed 'General case' 0 C--N 1.357 0.925 0 C-N-CA 126.153 1.781 . . . . 0.0 110.54 179.159 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 23.6 t-160 -97.55 -3.49 39.63 Favored 'General case' 0 N--CA 1.444 -0.752 0 C-N-CA 125.002 1.321 . . . . 0.0 107.976 174.311 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 33.5 mt -106.08 136.65 39.69 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.128 0 N-CA-C 104.516 -2.401 . . . . 0.0 104.516 -176.739 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 4.9 p -99.52 -85.01 0.4 Allowed 'General case' 0 N--CA 1.43 -1.442 0 N-CA-C 105.687 -1.968 . . . . 0.0 105.687 176.962 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 54.2 mtmt -89.76 167.39 12.91 Favored 'General case' 0 CA--C 1.488 -1.436 0 C-N-CA 123.423 0.689 . . . . 0.0 109.253 -164.992 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 93.8 m-85 -126.96 133.15 50.66 Favored 'General case' 0 CA--C 1.493 -1.239 0 N-CA-C 103.219 -2.882 . . . . 0.0 103.219 165.75 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.451 HD13 HD13 ' A' ' 76' ' ' ILE . 1.6 mp -107.6 136.26 43.48 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.195 1 N-CA-C 99.078 -4.416 . . . . 0.0 99.078 166.686 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 46.9 tp -119.72 137.08 54.15 Favored 'General case' 0 N--CA 1.397 -3.092 0 N-CA-C 101.36 -3.57 . . . . 0.0 101.36 172.664 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 14.9 ptp180 -133.94 155.3 50.17 Favored 'General case' 0 CA--C 1.488 -1.417 0 N-CA-C 107.072 -1.455 . . . . 0.0 107.072 174.168 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 47.0 p90 -152.67 139.13 18.59 Favored 'General case' 0 N--CA 1.43 -1.465 0 N-CA-C 105.778 -1.934 . . . . 0.0 105.778 -175.889 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 46.1 ttp85 -145.87 145.04 23.67 Favored Pre-proline 0 N--CA 1.442 -0.843 0 N-CA-C 104.871 -2.27 . . . . 0.0 104.871 -177.17 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 63.6 Cg_exo -64.21 122.8 10.89 Favored 'Trans proline' 0 CA--C 1.505 -0.975 0 C-N-CA 123.09 2.527 . . . . 0.0 111.06 174.7 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 49.9 tttp -71.95 75.65 0.91 Allowed 'General case' 0 C--N 1.358 0.956 0 C-N-CA 125.897 1.679 . . . . 0.0 110.449 176.475 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 29.8 m120 -151.35 -74.73 0.15 Allowed 'General case' 0 N--CA 1.435 -1.212 0 N-CA-C 102.407 -3.183 . . . . 0.0 102.407 -172.541 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 39.1 p -97.44 161.08 13.95 Favored 'General case' 0 C--N 1.356 0.88 0 N-CA-C 106.856 -1.535 . . . . 0.0 106.856 172.332 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 3.7 m -115.61 52.76 0.21 Allowed 'Isoleucine or valine' 0 CA--C 1.504 -0.81 0 N-CA-C 106.526 -1.657 . . . . 0.0 106.526 -179.236 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -88.59 -137.31 5.88 Favored Glycine 0 C--N 1.355 1.59 0 N-CA-C 109.722 -1.351 . . . . 0.0 109.722 -179.872 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 96.4 mtt-85 -85.05 155.78 21.38 Favored 'General case' 0 CA--C 1.499 -0.981 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 -177.596 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 49.0 m95 -105.19 159.33 15.95 Favored 'General case' 0 N--CA 1.436 -1.146 0 N-CA-C 107.552 -1.277 . . . . 0.0 107.552 -175.102 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 64.3 mttp -98.76 150.31 21.96 Favored 'General case' 0 CA--C 1.488 -1.416 0 N-CA-C 104.232 -2.507 . . . . 0.0 104.232 161.801 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -153.12 157.91 41.08 Favored 'General case' 0 CA--C 1.494 -1.173 0 CA-C-O 121.787 0.803 . . . . 0.0 108.867 -176.768 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -140.89 165.81 26.49 Favored 'General case' 0 N--CA 1.437 -1.114 0 N-CA-C 106.119 -1.808 . . . . 0.0 106.119 173.505 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 98.9 m -121.6 127.22 50.66 Favored 'General case' 0 CA--C 1.5 -0.952 0 N-CA-C 104.8 -2.296 . . . . 0.0 104.8 175.87 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 5.3 mp -114.97 134.35 22.51 Favored Pre-proline 0 N--CA 1.435 -1.203 0 N-CA-C 104.871 -2.27 . . . . 0.0 104.871 -176.014 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 68.7 Cg_exo -64.67 165.95 19.28 Favored 'Trans proline' 0 CA--C 1.508 -0.811 0 C-N-CA 123.354 2.703 . . . . 0.0 113.391 177.019 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -73.96 -20.57 79.71 Favored Glycine 0 C--N 1.351 1.376 0 C-N-CA 123.906 0.765 . . . . 0.0 114.141 -174.891 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 52.2 p-80 -83.56 -27.06 29.54 Favored 'General case' 0 C--N 1.354 0.793 0 CA-C-N 117.872 0.836 . . . . 0.0 110.243 -178.72 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 85.0 mt -88.65 126.25 35.21 Favored 'General case' 0 CA--C 1.501 -0.938 0 N-CA-C 107.894 -1.15 . . . . 0.0 107.894 177.283 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 7.8 p-10 -108.65 8.18 26.88 Favored 'General case' 0 CA--C 1.503 -0.843 0 C-N-CA 124.391 1.076 . . . . 0.0 110.634 -170.526 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 5.8 p -142.62 168.08 20.57 Favored 'General case' 0 CA--C 1.491 -1.297 0 N-CA-C 108.106 -1.072 . . . . 0.0 108.106 -177.802 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 8.5 t80 -139.6 175.86 9.22 Favored 'General case' 0 N--CA 1.441 -0.908 0 N-CA-C 107.81 -1.181 . . . . 0.0 107.81 174.365 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 99.3 m -140.05 112.2 7.65 Favored 'General case' 0 N--CA 1.435 -1.208 0 N-CA-C 104.924 -2.25 . . . . 0.0 104.924 178.573 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 17.3 mm -90.25 145.27 7.61 Favored 'Isoleucine or valine' 0 C--N 1.356 0.856 0 N-CA-C 105.013 -2.217 . . . . 0.0 105.013 171.261 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -149.83 161.58 41.97 Favored 'General case' 0 N--CA 1.438 -1.057 0 N-CA-C 107.841 -1.17 . . . . 0.0 107.841 167.662 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 85.88 52.3 3.34 Favored Glycine 0 C--N 1.354 1.543 0 N-CA-C 109.303 -1.519 . . . . 0.0 109.303 177.654 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 78.0 mt -115.18 165.62 12.73 Favored 'General case' 0 CA--C 1.5 -0.967 0 N-CA-C 108.142 -1.059 . . . . 0.0 108.142 -179.141 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt -103.58 154.93 37.53 Favored Pre-proline 0 N--CA 1.44 -0.952 0 N-CA-C 107.068 -1.456 . . . . 0.0 107.068 -176.068 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -76.96 152.52 31.91 Favored 'Trans proline' 0 N--CA 1.452 -0.966 0 C-N-CA 122.829 2.353 . . . . 0.0 111.127 -178.515 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 55.17 40.42 74.72 Favored Glycine 0 C--N 1.356 1.686 0 C-N-CA 127.567 2.508 . . . . 0.0 115.636 170.518 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 5.5 p -129.87 138.08 54.99 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.165 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 -177.169 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 3.2 p -91.76 127.59 43.96 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.884 0 C-N-CA 125.119 1.368 . . . . 0.0 107.681 -178.197 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 82.7 m-85 -107.71 153.24 23.23 Favored 'General case' 0 N--CA 1.438 -1.07 0 C-N-CA 125.12 1.368 . . . . 0.0 108.382 178.036 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 21.4 tp10 -97.55 136.51 37.85 Favored 'General case' 0 N--CA 1.434 -1.242 0 N-CA-C 104.027 -2.582 . . . . 0.0 104.027 165.354 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -131.0 144.11 15.58 Favored Glycine 0 CA--C 1.492 -1.36 0 N-CA-C 107.681 -2.168 . . . . 0.0 107.681 174.325 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 25.9 mt-30 -133.67 134.37 43.04 Favored 'General case' 0 CA--C 1.486 -1.485 0 N-CA-C 107.109 -1.441 . . . . 0.0 107.109 174.858 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 66.6 tp -109.97 101.46 10.28 Favored 'General case' 0 CA--C 1.502 -0.874 0 N-CA-C 104.499 -2.408 . . . . 0.0 104.499 178.493 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 32.4 mt -97.78 123.39 50.2 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.868 0 N-CA-C 104.102 -2.555 . . . . 0.0 104.102 -176.612 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 32.8 p -118.24 120.06 36.56 Favored 'General case' 0 CA--C 1.505 -0.769 0 N-CA-C 108.72 -0.844 . . . . 0.0 108.72 -172.25 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.451 HD13 HD13 ' A' ' 34' ' ' ILE . 1.8 mp -93.64 136.24 25.9 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.301 0 N-CA-C 104.581 -2.377 . . . . 0.0 104.581 -170.243 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 84.7 mt-30 -93.68 152.8 18.73 Favored 'General case' 0 CA--C 1.493 -1.224 0 N-CA-C 106.903 -1.517 . . . . 0.0 106.903 176.91 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 9.0 pt20 -69.14 99.56 1.15 Allowed 'General case' 0 N--CA 1.44 -0.926 0 C-N-CA 124.871 1.268 . . . . 0.0 111.458 -176.296 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 69.1 m-85 57.1 39.4 29.11 Favored 'General case' 0 C--N 1.358 0.946 0 C-N-CA 127.248 2.219 . . . . 0.0 112.16 -179.402 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -141.04 -124.32 2.02 Favored Glycine 0 C--N 1.357 1.708 0 N-CA-C 108.497 -1.841 . . . . 0.0 108.497 -177.4 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 59.1 m80 -83.82 -179.75 7.36 Favored 'General case' 0 CA--C 1.499 -1.019 0 C-N-CA 125.193 1.397 . . . . 0.0 110.302 -170.982 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 21.4 tt0 -139.26 119.15 13.31 Favored 'General case' 0 N--CA 1.434 -1.258 0 N-CA-C 104.781 -2.303 . . . . 0.0 104.781 175.993 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 88.0 mt-10 -99.11 154.23 18.28 Favored 'General case' 0 CA--C 1.499 -1.005 0 N-CA-C 107.37 -1.345 . . . . 0.0 107.37 -178.435 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 7.7 p -128.78 134.97 63.39 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.776 0 N-CA-C 107.598 -1.26 . . . . 0.0 107.598 175.082 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 95.2 m -119.84 137.0 54.26 Favored 'General case' 0 CA--C 1.498 -1.044 0 N-CA-C 102.623 -3.103 . . . . 0.0 102.623 175.098 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 83.0 mtm-85 -126.69 150.67 48.89 Favored 'General case' 0 CA--C 1.5 -0.964 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 -178.531 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 32.7 p90 -165.33 178.81 6.61 Favored 'General case' 0 CA--C 1.5 -0.98 0 N-CA-C 107.234 -1.395 . . . . 0.0 107.234 -177.993 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -139.43 157.85 45.14 Favored 'General case' 0 N--CA 1.441 -0.913 0 N-CA-C 106.441 -1.689 . . . . 0.0 106.441 169.472 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 24.0 p90 -144.83 175.59 10.08 Favored 'General case' 0 CA--C 1.488 -1.442 0 N-CA-C 105.271 -2.122 . . . . 0.0 105.271 172.375 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 8.9 t -143.9 154.94 43.86 Favored 'General case' 0 N--CA 1.44 -0.968 0 N-CA-C 105.439 -2.06 . . . . 0.0 105.439 173.631 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 54.8 p -121.95 138.93 54.23 Favored 'General case' 0 CA--C 1.497 -1.086 0 N-CA-C 104.242 -2.503 . . . . 0.0 104.242 177.144 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 12.3 t -165.89 172.9 11.08 Favored 'General case' 0 N--CA 1.44 -0.944 0 N-CA-C 105.134 -2.173 . . . . 0.0 105.134 -175.625 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 10.0 p . . . . . 0 C--O 1.261 1.678 0 N-CA-C 105.144 -2.169 . . . . 0.0 105.144 164.327 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.441 -1.004 0 N-CA-C 107.731 -2.148 . . . . 0.0 107.731 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -61.6 138.6 76.42 Favored 'Trans proline' 0 N--CA 1.441 -1.567 0 C-N-CA 123.115 2.543 . . . . 0.0 112.973 178.993 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 14.5 t -77.62 161.26 4.52 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.882 0 C-N-CA 129.005 2.922 . . . . 0.0 105.732 179.03 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 59.1 mm-40 -110.87 100.43 9.16 Favored 'General case' 0 CA--C 1.49 -1.361 0 N-CA-C 106.564 -1.643 . . . . 0.0 106.564 -179.449 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 1.5 p -120.85 141.17 42.48 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.041 0 N-CA-C 106.191 -1.781 . . . . 0.0 106.191 -169.531 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 30.6 p90 . . . . . 0 N--CA 1.434 -1.241 0 N-CA-C 107.015 -1.476 . . . . 0.0 107.015 -169.289 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 66.5 Cg_endo . . . . . 0 N--CA 1.454 -0.831 0 N-CA-C 109.45 -1.019 . . . . 0.0 109.45 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 5.8 p-10 -116.44 -35.95 4.13 Favored 'General case' 0 CA--C 1.491 -1.321 0 C-N-CA 124.328 1.051 . . . . 0.0 109.344 -172.581 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 30.3 p -130.22 151.95 50.18 Favored 'General case' 0 CA--C 1.499 -1.0 0 CA-C-O 122.151 0.977 . . . . 0.0 110.004 -175.42 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 35.7 m-70 -142.87 98.99 5.62 Favored Pre-proline 0 N--CA 1.438 -1.069 0 N-CA-C 107.145 -1.428 . . . . 0.0 107.145 175.668 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -79.1 114.04 3.3 Favored 'Trans proline' 0 N--CA 1.445 -1.339 0 C-N-CA 123.074 2.516 . . . . 0.0 110.178 175.953 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.53 HD11 HD11 ' A' ' 35' ' ' LEU . 3.9 pt -93.93 166.53 1.77 Allowed 'Isoleucine or valine' 0 CA--C 1.498 -1.05 0 N-CA-C 107.825 -1.176 . . . . 0.0 107.825 -178.251 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 17.6 mp0 -139.69 151.46 45.92 Favored 'General case' 0 CA--C 1.499 -1.002 0 N-CA-C 105.496 -2.038 . . . . 0.0 105.496 174.815 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 42.3 p90 -136.33 156.71 48.25 Favored 'General case' 0 CA--C 1.496 -1.113 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 175.666 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 83.2 m-20 -97.35 -175.71 3.3 Favored 'General case' 0 CA--C 1.486 -1.487 0 N-CA-C 104.31 -2.478 . . . . 0.0 104.31 171.29 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -157.59 173.79 4.65 Favored Pre-proline 0 N--CA 1.44 -0.93 0 N-CA-C 106.828 -1.545 . . . . 0.0 106.828 176.458 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_exo -63.96 162.52 28.78 Favored 'Trans proline' 0 CA--C 1.51 -0.724 0 C-N-CA 123.678 2.919 . . . . 0.0 112.209 169.169 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 1.2 tm0? -81.26 -60.09 0.43 Allowed Pre-proline 0 C--N 1.353 0.744 0 CA-C-O 115.705 -2.093 . . . . 0.0 110.671 -174.193 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_endo -75.42 174.43 12.81 Favored 'Trans proline' 0 CA--C 1.511 -0.645 0 CA-C-N 125.688 3.067 . . . . 0.0 110.161 -179.694 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 52.2 p -72.58 126.26 29.44 Favored 'General case' 0 C--N 1.357 0.919 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 177.787 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 16.2 t-160 -160.9 -51.66 0.05 OUTLIER 'General case' 0 CA--C 1.493 -1.229 0 N-CA-C 106.566 -1.642 . . . . 0.0 106.566 -166.646 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 35.1 mt -111.81 132.64 59.87 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.1 0 N-CA-C 105.487 -2.042 . . . . 0.0 105.487 -174.154 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 30.0 t -102.77 -84.79 0.45 Allowed 'General case' 0 N--CA 1.431 -1.41 0 N-CA-C 107.586 -1.264 . . . . 0.0 107.586 -178.146 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 23.1 ttmm -91.42 149.51 21.68 Favored 'General case' 0 CA--C 1.493 -1.244 0 N-CA-C 106.829 -1.545 . . . . 0.0 106.829 -161.278 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 97.4 m-85 -117.49 128.84 55.38 Favored 'General case' 0 CA--C 1.496 -1.129 0 N-CA-C 104.725 -2.324 . . . . 0.0 104.725 168.785 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 60.9 mt -106.48 117.44 52.27 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.075 0 N-CA-C 102.188 -3.264 . . . . 0.0 102.188 169.604 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.53 HD11 HD11 ' A' ' 20' ' ' ILE . 0.9 OUTLIER -95.33 125.35 39.89 Favored 'General case' 0 CA--C 1.48 -1.745 0 N-CA-C 106.972 -1.492 . . . . 0.0 106.972 176.813 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 97.0 mtt180 -120.74 147.12 45.74 Favored 'General case' 0 CA--C 1.49 -1.333 0 N-CA-C 105.972 -1.862 . . . . 0.0 105.972 171.75 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 40.3 p90 -151.99 173.55 14.72 Favored 'General case' 0 CA--C 1.487 -1.479 0 N-CA-C 106.199 -1.778 . . . . 0.0 106.199 169.982 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 36.0 ptt180 -170.96 158.83 5.38 Favored Pre-proline 0 CA--C 1.499 -1.009 0 N-CA-C 106.284 -1.747 . . . . 0.0 106.284 177.004 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . 0.437 ' HB2' HD22 ' A' ' 41' ' ' ASN . 60.4 Cg_endo -74.51 140.86 27.44 Favored 'Trans proline' 0 N--CA 1.448 -1.181 0 C-N-CA 122.065 1.843 . . . . 0.0 107.839 168.062 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 57.7 tttp -71.18 78.42 0.7 Allowed 'General case' 0 C--N 1.355 0.806 0 C-N-CA 125.344 1.458 . . . . 0.0 110.784 179.947 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . 0.437 HD22 ' HB2' ' A' ' 39' ' ' PRO . 60.1 m-80 -161.11 -46.73 0.04 OUTLIER 'General case' 0 N--CA 1.438 -1.044 0 N-CA-C 104.966 -2.235 . . . . 0.0 104.966 -170.668 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 27.8 m -77.68 161.01 28.09 Favored 'General case' 0 C--N 1.359 0.995 0 C-N-CA 124.19 0.996 . . . . 0.0 110.503 -170.926 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 20.2 m -102.01 -26.93 3.4 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.879 0 C-N-CA 124.83 1.252 . . . . 0.0 109.887 -170.608 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -173.17 27.17 0.09 OUTLIER Glycine 0 CA--C 1.493 -1.339 0 N-CA-C 110.569 -1.012 . . . . 0.0 110.569 179.853 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 54.7 ttp180 -98.62 122.29 41.65 Favored 'General case' 0 CA--C 1.495 -1.15 0 N-CA-C 105.026 -2.213 . . . . 0.0 105.026 172.669 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 83.8 m95 -128.6 138.74 52.36 Favored 'General case' 0 CA--C 1.496 -1.123 0 N-CA-C 106.732 -1.581 . . . . 0.0 106.732 179.665 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 60.9 mttp -96.11 104.47 16.42 Favored 'General case' 0 CA--C 1.491 -1.307 0 N-CA-C 104.332 -2.47 . . . . 0.0 104.332 169.192 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 16.1 pt-20 -107.49 150.96 26.2 Favored 'General case' 0 CA--C 1.498 -1.055 0 CA-C-N 115.033 -0.985 . . . . 0.0 109.532 -176.475 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -136.74 154.51 50.56 Favored 'General case' 0 N--CA 1.438 -1.055 0 N-CA-C 105.917 -1.883 . . . . 0.0 105.917 178.089 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 92.4 m -121.71 125.1 45.82 Favored 'General case' 0 CA--C 1.501 -0.91 0 N-CA-C 104.292 -2.485 . . . . 0.0 104.292 178.317 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 63.6 mt -128.86 137.39 30.87 Favored Pre-proline 0 N--CA 1.44 -0.961 0 N-CA-C 105.154 -2.165 . . . . 0.0 105.154 -166.29 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -74.56 171.13 18.76 Favored 'Trans proline' 0 CA--C 1.508 -0.8 0 C-N-CA 123.44 2.76 . . . . 0.0 110.876 178.555 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -77.95 -11.96 84.88 Favored Glycine 0 C--N 1.352 1.463 0 C-N-CA 123.808 0.718 . . . . 0.0 114.117 -178.742 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 9.2 p-80 -83.01 -25.37 32.27 Favored 'General case' 0 C--N 1.357 0.931 0 CA-C-N 118.321 1.061 . . . . 0.0 110.236 -178.937 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 87.2 mt -89.09 128.26 35.74 Favored 'General case' 0 CA--C 1.501 -0.929 0 N-CA-C 107.316 -1.364 . . . . 0.0 107.316 173.412 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 8.4 p30 -112.91 1.05 15.32 Favored 'General case' 0 N--CA 1.443 -0.8 0 C-N-CA 124.762 1.225 . . . . 0.0 109.814 -173.146 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 25.7 p -145.71 160.18 42.09 Favored 'General case' 0 CA--C 1.498 -1.025 0 N-CA-C 106.331 -1.729 . . . . 0.0 106.331 -177.33 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 5.1 t80 -131.89 177.89 7.19 Favored 'General case' 0 C--N 1.358 0.942 0 CA-C-O 121.684 0.754 . . . . 0.0 109.366 178.808 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 97.7 m -133.72 105.78 7.01 Favored 'General case' 0 N--CA 1.431 -1.393 0 N-CA-C 103.302 -2.851 . . . . 0.0 103.302 171.613 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 59.5 mt -86.83 140.22 16.14 Favored 'Isoleucine or valine' 0 C--N 1.359 0.993 0 N-CA-C 103.938 -2.615 . . . . 0.0 103.938 171.326 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -147.26 160.46 42.47 Favored 'General case' 0 N--CA 1.438 -1.071 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 -176.866 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 84.42 52.6 3.51 Favored Glycine 0 C--N 1.354 1.565 0 N-CA-C 109.208 -1.557 . . . . 0.0 109.208 178.672 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 47.9 mt -114.9 168.59 9.77 Favored 'General case' 0 CA--C 1.501 -0.924 0 N-CA-C 107.591 -1.263 . . . . 0.0 107.591 -173.631 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -119.67 150.48 50.32 Favored Pre-proline 0 N--CA 1.442 -0.872 0 N-CA-C 106.775 -1.565 . . . . 0.0 106.775 -173.624 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -77.18 165.7 27.54 Favored 'Trans proline' 0 N--CA 1.454 -0.827 0 C-N-CA 123.129 2.552 . . . . 0.0 110.806 175.263 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . 0.609 ' H ' ' HA ' ' A' ' 92' ' ' THR . . . 64.18 19.18 63.65 Favored Glycine 0 N--CA 1.429 -1.828 0 C-N-CA 128.209 2.814 . . . . 0.0 116.575 173.212 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 9.9 p -134.21 145.9 32.22 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.108 0 CA-C-N 118.636 1.218 . . . . 0.0 108.073 -174.713 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 7.3 p -90.33 128.2 42.38 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.959 0 N-CA-C 106.97 -1.492 . . . . 0.0 106.97 177.523 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 49.0 m-85 -101.0 137.33 39.51 Favored 'General case' 0 CA--C 1.493 -1.233 0 N-CA-C 105.575 -2.009 . . . . 0.0 105.575 174.3 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 18.9 pt-20 -112.35 158.63 19.55 Favored 'General case' 0 N--CA 1.437 -1.096 0 N-CA-C 105.956 -1.868 . . . . 0.0 105.956 173.044 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -169.57 -172.38 36.12 Favored Glycine 0 N--CA 1.415 -2.726 0 C-N-CA 120.578 -0.82 . . . . 0.0 114.879 175.447 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 32.0 mt-30 -148.24 139.88 23.71 Favored 'General case' 0 CA--C 1.486 -1.518 0 N-CA-C 105.997 -1.853 . . . . 0.0 105.997 -166.878 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 59.5 tp -116.47 96.41 5.51 Favored 'General case' 0 CA--C 1.499 -0.997 0 N-CA-C 104.015 -2.587 . . . . 0.0 104.015 174.958 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 27.3 mt -88.49 134.79 27.27 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.919 0 N-CA-C 104.05 -2.574 . . . . 0.0 104.05 -178.313 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 25.2 p -129.5 104.62 7.57 Favored 'General case' 0 N--CA 1.438 -1.066 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 -169.326 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 3.7 mp -93.51 136.42 25.31 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.312 0 N-CA-C 104.062 -2.57 . . . . 0.0 104.062 -167.07 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 80.5 mt-30 -88.24 177.29 6.92 Favored 'General case' 0 CA--C 1.496 -1.132 0 C-N-CA 123.712 0.805 . . . . 0.0 108.968 -171.304 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 35.3 mt-30 -71.52 96.04 1.47 Allowed 'General case' 0 CA--C 1.501 -0.921 0 C-N-CA 124.597 1.159 . . . . 0.0 109.459 176.46 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . 0.301 41.3 p90 47.65 33.0 2.76 Favored 'General case' 0 C--N 1.36 1.035 0 C-N-CA 128.126 2.57 . . . . 0.0 114.438 -174.815 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -125.29 -125.89 2.95 Favored Glycine 0 C--N 1.358 1.78 0 N-CA-C 109.456 -1.458 . . . . 0.0 109.456 -174.119 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 52.3 m80 -84.1 -178.02 6.83 Favored 'General case' 0 CA--C 1.498 -1.027 0 C-N-CA 125.614 1.566 . . . . 0.0 111.044 -167.818 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 35.7 mt-30 -125.29 146.25 49.64 Favored 'General case' 0 CA--C 1.494 -1.188 0 N-CA-C 103.459 -2.793 . . . . 0.0 103.459 167.806 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 54.6 mt-10 -138.14 121.48 17.06 Favored 'General case' 0 CA--C 1.492 -1.281 0 N-CA-C 105.372 -2.084 . . . . 0.0 105.372 -177.114 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 7.5 p -99.4 134.97 36.62 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.79 0 N-CA-C 108.151 -1.055 . . . . 0.0 108.151 -172.624 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 26.7 m -115.2 158.96 21.53 Favored 'General case' 0 N--CA 1.443 -0.802 0 N-CA-C 103.81 -2.663 . . . . 0.0 103.81 175.915 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 38.8 ptt180 -126.32 154.71 43.1 Favored 'General case' 0 CA--C 1.501 -0.915 0 CA-C-O 121.32 0.581 . . . . 0.0 109.8 178.126 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 29.4 p90 -157.45 165.43 35.69 Favored 'General case' 0 CA--C 1.502 -0.866 0 N-CA-C 107.274 -1.38 . . . . 0.0 107.274 173.486 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -145.57 156.82 43.93 Favored 'General case' 0 N--CA 1.441 -0.885 0 N-CA-C 106.314 -1.736 . . . . 0.0 106.314 159.997 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 27.4 p90 -146.37 168.23 21.62 Favored 'General case' 0 CA--C 1.492 -1.254 0 N-CA-C 106.404 -1.702 . . . . 0.0 106.404 171.046 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 26.6 p -110.86 140.36 45.39 Favored 'General case' 0 CA--C 1.5 -0.944 0 N-CA-C 106.957 -1.497 . . . . 0.0 106.957 178.668 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 89.7 m -116.45 109.14 16.91 Favored 'General case' 0 CA--C 1.489 -1.394 0 N-CA-C 102.106 -3.294 . . . . 0.0 102.106 174.037 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . 0.609 ' HA ' ' H ' ' A' ' 66' ' ' GLY . 86.9 m -147.28 -55.69 0.24 Allowed 'General case' 0 CA--C 1.498 -1.034 0 N-CA-C 106.645 -1.613 . . . . 0.0 106.645 -171.686 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 8.9 t . . . . . 0 C--O 1.26 1.653 0 CA-C-O 118.078 -0.963 . . . . 0.0 110.049 -165.25 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.443 -0.847 0 N-CA-C 109.104 -1.598 . . . . 0.0 109.104 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_exo -61.55 136.12 61.15 Favored 'Trans proline' 0 N--CA 1.443 -1.472 0 C-N-CA 123.088 2.526 . . . . 0.0 113.624 -178.357 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 24.6 t -84.59 161.92 3.08 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.048 0 C-N-CA 129.202 3.001 . . . . 0.0 106.424 -178.196 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -108.38 108.9 20.06 Favored 'General case' 0 CA--C 1.496 -1.107 0 N-CA-C 105.876 -1.898 . . . . 0.0 105.876 175.927 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 1.5 p -129.3 142.04 45.01 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.894 0 N-CA-C 105.687 -1.968 . . . . 0.0 105.687 -170.101 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 33.1 p90 . . . . . 0 N--CA 1.438 -1.026 0 CA-C-O 121.876 0.846 . . . . 0.0 109.302 -162.184 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_exo . . . . . 0 CA--C 1.506 -0.882 0 CA-C-O 119.118 -0.451 . . . . 0.0 111.291 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 1.6 p30 -102.46 -42.44 5.97 Favored 'General case' 0 CA--C 1.489 -1.368 0 C-N-CA 124.215 1.006 . . . . 0.0 111.029 -165.188 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 56.6 p -110.48 156.0 21.46 Favored 'General case' 0 CA--C 1.497 -1.06 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 -175.634 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 86.3 t60 -131.57 98.72 17.8 Favored Pre-proline 0 N--CA 1.439 -0.989 0 N-CA-C 106.128 -1.804 . . . . 0.0 106.128 172.493 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -80.13 128.99 7.58 Favored 'Trans proline' 0 N--CA 1.451 -0.972 0 C-N-CA 123.26 2.64 . . . . 0.0 109.836 177.231 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 3.7 mp -111.9 149.04 14.67 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.183 0 N-CA-C 104.881 -2.266 . . . . 0.0 104.881 -179.62 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 31.2 mt-30 -138.7 152.94 48.44 Favored 'General case' 0 CA--C 1.497 -1.092 0 N-CA-C 104.578 -2.378 . . . . 0.0 104.578 164.57 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 37.2 p90 -136.02 158.5 44.26 Favored 'General case' 0 CA--C 1.501 -0.916 0 N-CA-C 107.065 -1.457 . . . . 0.0 107.065 -178.595 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 84.2 m-20 -96.4 -176.92 3.78 Favored 'General case' 0 CA--C 1.488 -1.407 0 N-CA-C 103.934 -2.617 . . . . 0.0 103.934 169.045 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -157.35 171.85 6.91 Favored Pre-proline 0 N--CA 1.44 -0.933 0 N-CA-C 106.579 -1.637 . . . . 0.0 106.579 173.188 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 68.5 Cg_exo -63.74 154.46 69.28 Favored 'Trans proline' 0 CA--C 1.508 -0.814 0 C-N-CA 123.51 2.807 . . . . 0.0 112.842 174.59 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 24.0 tt0 -82.43 -41.93 0.94 Allowed Pre-proline 0 N--CA 1.443 -0.798 0 CA-C-O 115.697 -2.097 . . . . 0.0 112.031 -175.134 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_exo -71.71 -3.74 13.71 Favored 'Trans proline' 0 CA--C 1.514 -0.521 0 CA-C-N 125.574 3.026 . . . . 0.0 113.851 -179.867 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 10.3 t 71.0 75.93 0.19 Allowed 'General case' 0 C--N 1.357 0.903 0 C-N-CA 126.381 1.873 . . . . 0.0 108.812 -176.71 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 57.8 t-80 -90.95 -20.18 22.46 Favored 'General case' 0 N--CA 1.439 -0.977 0 C-N-CA 125.27 1.428 . . . . 0.0 108.455 179.969 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 22.9 mt -125.38 147.47 30.07 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.105 0 N-CA-C 105.396 -2.075 . . . . 0.0 105.396 -168.578 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 9.2 p -107.29 -84.13 0.53 Allowed 'General case' 0 N--CA 1.432 -1.328 0 N-CA-C 106.879 -1.526 . . . . 0.0 106.879 174.554 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 51.7 mtmt -89.2 167.57 12.98 Favored 'General case' 0 CA--C 1.486 -1.493 0 C-N-CA 124.683 1.193 . . . . 0.0 108.782 -165.274 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 90.4 m-85 -132.31 138.24 47.74 Favored 'General case' 0 CA--C 1.495 -1.142 0 N-CA-C 105.329 -2.1 . . . . 0.0 105.329 176.033 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 51.8 mt -118.42 131.55 70.85 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.111 0 N-CA-C 101.074 -3.676 . . . . 0.0 101.074 170.652 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 6.8 mt -111.01 128.13 55.75 Favored 'General case' 0 CA--C 1.477 -1.854 0 N-CA-C 104.739 -2.319 . . . . 0.0 104.739 170.104 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 3.2 mmm180 -107.51 160.11 15.91 Favored 'General case' 0 N--CA 1.432 -1.348 0 N-CA-C 104.737 -2.32 . . . . 0.0 104.737 171.077 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 48.5 p90 -159.18 152.82 22.89 Favored 'General case' 0 N--CA 1.437 -1.085 0 N-CA-C 107.801 -1.185 . . . . 0.0 107.801 171.093 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 13.1 ptp180 -154.61 158.05 32.2 Favored Pre-proline 0 CA--C 1.501 -0.932 0 N-CA-C 105.661 -1.978 . . . . 0.0 105.661 163.946 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . 0.433 ' HA ' ' HA ' ' A' ' 69' ' ' TYR . 37.9 Cg_endo -72.52 129.01 14.16 Favored 'Trans proline' 0 N--CA 1.451 -0.977 0 C-N-CA 122.637 2.225 . . . . 0.0 107.752 170.191 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 48.2 tttp -67.6 81.82 0.17 Allowed 'General case' 0 C--N 1.357 0.912 0 C-N-CA 127.781 2.433 . . . . 0.0 111.473 -170.761 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 4.7 t-20 -162.17 -51.05 0.04 OUTLIER 'General case' 0 N--CA 1.432 -1.335 0 N-CA-C 105.562 -2.014 . . . . 0.0 105.562 -173.607 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 37.9 p -80.63 155.7 26.72 Favored 'General case' 0 N--CA 1.438 -1.059 0 C-N-CA 124.567 1.147 . . . . 0.0 109.685 -176.891 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 17.3 m -130.44 10.67 2.14 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.811 0 C-N-CA 125.061 1.344 . . . . 0.0 107.888 -177.427 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -94.27 -113.18 2.45 Favored Glycine 0 C--N 1.356 1.694 0 N-CA-C 109.489 -1.444 . . . . 0.0 109.489 -174.534 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 85.6 mtm180 -92.66 175.95 6.63 Favored 'General case' 0 CA--C 1.503 -0.863 0 N-CA-C 108.191 -1.04 . . . . 0.0 108.191 -178.538 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -155.41 -178.41 7.25 Favored 'General case' 0 CA--C 1.495 -1.171 0 CA-C-O 121.221 0.534 . . . . 0.0 109.839 178.565 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 96.0 mttt -109.21 156.55 19.76 Favored 'General case' 0 CA--C 1.489 -1.396 0 N-CA-C 106.451 -1.685 . . . . 0.0 106.451 -176.724 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 1.1 pp20? -152.08 163.12 39.99 Favored 'General case' 0 N--CA 1.432 -1.363 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 176.252 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -139.97 160.79 39.14 Favored 'General case' 0 CA--C 1.495 -1.136 0 N-CA-C 105.663 -1.977 . . . . 0.0 105.663 169.596 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 77.6 m -120.62 125.96 49.07 Favored 'General case' 0 CA--C 1.499 -1.014 0 N-CA-C 104.732 -2.322 . . . . 0.0 104.732 176.446 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 4.9 mp -114.04 134.41 22.17 Favored Pre-proline 0 N--CA 1.435 -1.186 0 N-CA-C 104.84 -2.281 . . . . 0.0 104.84 -175.545 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 67.5 Cg_exo -63.89 167.6 13.62 Favored 'Trans proline' 0 CA--C 1.509 -0.761 0 C-N-CA 123.595 2.863 . . . . 0.0 113.406 177.227 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -77.75 -19.02 76.43 Favored Glycine 0 C--N 1.352 1.439 0 C-N-CA 123.583 0.611 . . . . 0.0 113.425 -173.488 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 50.9 p-80 -84.08 -27.88 27.95 Favored 'General case' 0 C--N 1.357 0.906 0 CA-C-N 117.757 0.779 . . . . 0.0 110.172 -179.471 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 86.4 mt -88.56 128.97 35.58 Favored 'General case' 0 CA--C 1.5 -0.943 0 N-CA-C 107.881 -1.155 . . . . 0.0 107.881 177.653 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 8.7 p30 -110.98 8.33 21.96 Favored 'General case' 0 CA--C 1.5 -0.946 0 C-N-CA 124.498 1.119 . . . . 0.0 110.543 -171.806 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 46.6 p -142.03 160.16 40.77 Favored 'General case' 0 N--CA 1.439 -0.988 0 N-CA-C 108.107 -1.071 . . . . 0.0 108.107 -175.713 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 12.3 t80 -143.63 176.72 9.0 Favored 'General case' 0 C--N 1.355 0.822 0 N-CA-C 107.328 -1.36 . . . . 0.0 107.328 176.953 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 97.6 m -147.06 116.96 7.2 Favored 'General case' 0 N--CA 1.429 -1.509 0 N-CA-C 104.851 -2.277 . . . . 0.0 104.851 176.101 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 79.7 mt -91.24 147.06 5.5 Favored 'Isoleucine or valine' 0 C--N 1.355 0.804 0 N-CA-C 103.555 -2.757 . . . . 0.0 103.555 169.364 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 67.6 mttm -140.38 166.37 24.89 Favored 'General case' 0 CA--C 1.5 -0.954 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 178.149 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 83.16 49.39 5.01 Favored Glycine 0 C--N 1.354 1.577 0 N-CA-C 109.211 -1.556 . . . . 0.0 109.211 174.787 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 63.9 mt -118.78 169.4 9.88 Favored 'General case' 0 CA--C 1.498 -1.023 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 -170.576 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -116.76 144.74 33.95 Favored Pre-proline 0 N--CA 1.439 -1.008 0 N-CA-C 105.679 -1.971 . . . . 0.0 105.679 -173.764 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -77.33 161.75 31.59 Favored 'Trans proline' 0 N--CA 1.452 -0.934 0 C-N-CA 122.788 2.325 . . . . 0.0 110.996 174.466 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . 0.584 ' H ' ' HA ' ' A' ' 92' ' ' THR . . . 62.54 26.66 68.54 Favored Glycine 0 N--CA 1.428 -1.856 0 C-N-CA 127.617 2.532 . . . . 0.0 115.765 174.225 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 9.8 p -126.65 145.59 33.95 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.928 0 N-CA-C 107.596 -1.261 . . . . 0.0 107.596 179.408 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 4.2 p -92.61 135.75 26.7 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.824 0 N-CA-C 107.214 -1.402 . . . . 0.0 107.214 179.945 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . 0.433 ' HA ' ' HA ' ' A' ' 39' ' ' PRO . 91.1 m-85 -116.79 149.27 40.23 Favored 'General case' 0 CA--C 1.494 -1.193 0 N-CA-C 105.607 -1.997 . . . . 0.0 105.607 175.278 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -96.7 139.93 32.04 Favored 'General case' 0 CA--C 1.499 -1.009 0 N-CA-C 104.367 -2.457 . . . . 0.0 104.367 162.773 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -132.66 154.14 20.97 Favored Glycine 0 CA--C 1.483 -1.925 0 N-CA-C 106.951 -2.46 . . . . 0.0 106.951 179.849 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 29.2 tt0 -146.94 135.61 22.09 Favored 'General case' 0 CA--C 1.483 -1.627 0 N-CA-C 106.949 -1.5 . . . . 0.0 106.949 -178.625 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 21.8 tp -115.79 100.55 8.09 Favored 'General case' 0 N--CA 1.438 -1.074 0 N-CA-C 104.45 -2.426 . . . . 0.0 104.45 -177.355 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 21.2 mt -93.16 126.61 45.57 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.917 0 N-CA-C 104.032 -2.581 . . . . 0.0 104.032 177.572 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 74.2 m -117.98 111.32 18.8 Favored 'General case' 0 N--CA 1.436 -1.173 0 N-CA-C 107.746 -1.205 . . . . 0.0 107.746 -170.413 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 31.0 mm -91.22 144.01 10.05 Favored 'Isoleucine or valine' 0 CA--C 1.49 -1.365 0 N-CA-C 106.519 -1.66 . . . . 0.0 106.519 -165.799 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 17.1 tt0 -110.81 107.18 16.6 Favored 'General case' 0 CA--C 1.495 -1.135 0 N-CA-C 103.036 -2.95 . . . . 0.0 103.036 171.452 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 19.7 pt20 -67.25 138.46 56.91 Favored 'General case' 0 C--N 1.356 0.866 0 CA-C-O 121.232 0.539 . . . . 0.0 111.68 -167.148 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 55.0 m-85 68.05 32.15 5.14 Favored 'General case' 0 C--N 1.355 0.821 0 C-N-CA 126.695 1.998 . . . . 0.0 111.764 -176.1 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -174.97 -112.86 0.31 Allowed Glycine 0 C--N 1.355 1.613 0 C-N-CA 119.349 -1.405 . . . . 0.0 109.749 176.922 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 66.4 m80 -83.43 -178.73 7.15 Favored 'General case' 0 CA--C 1.5 -0.954 0 C-N-CA 125.242 1.417 . . . . 0.0 111.269 -164.595 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 5.9 pt20 -154.51 148.77 26.0 Favored 'General case' 0 N--CA 1.435 -1.216 0 N-CA-C 106.621 -1.622 . . . . 0.0 106.621 166.506 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 8.4 mp0 -109.81 155.93 21.0 Favored 'General case' 0 N--CA 1.437 -1.085 0 N-CA-C 104.869 -2.271 . . . . 0.0 104.869 -178.116 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 12.4 p -131.45 139.17 51.4 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.838 0 N-CA-C 107.772 -1.196 . . . . 0.0 107.772 -179.739 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 41.8 m -133.28 122.69 24.25 Favored 'General case' 0 N--CA 1.438 -1.074 0 N-CA-C 103.261 -2.866 . . . . 0.0 103.261 -178.669 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 52.8 ttt85 -119.75 144.15 47.42 Favored 'General case' 0 CA--C 1.504 -0.794 0 N-CA-C 108.174 -1.047 . . . . 0.0 108.174 -176.011 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 29.0 p90 -155.06 -179.59 8.21 Favored 'General case' 0 CA--C 1.499 -0.981 0 N-CA-C 107.547 -1.279 . . . . 0.0 107.547 -177.182 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -138.82 156.31 47.44 Favored 'General case' 0 N--CA 1.44 -0.961 0 N-CA-C 105.811 -1.922 . . . . 0.0 105.811 167.169 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 22.2 p90 -142.61 171.79 13.57 Favored 'General case' 0 CA--C 1.487 -1.477 0 N-CA-C 106.83 -1.544 . . . . 0.0 106.83 175.001 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 25.5 p -120.37 143.88 48.19 Favored 'General case' 0 CA--C 1.499 -0.993 0 N-CA-C 105.526 -2.027 . . . . 0.0 105.526 169.364 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 57.3 m -109.05 126.06 52.76 Favored 'General case' 0 CA--C 1.493 -1.244 0 N-CA-C 101.36 -3.57 . . . . 0.0 101.36 164.764 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . 0.584 ' HA ' ' H ' ' A' ' 66' ' ' GLY . 12.4 t -146.01 172.46 13.35 Favored 'General case' 0 N--CA 1.435 -1.177 0 N-CA-C 105.264 -2.125 . . . . 0.0 105.264 -173.751 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 69.5 m . . . . . 0 C--O 1.26 1.629 0 N-CA-C 106.8 -1.556 . . . . 0.0 106.8 173.197 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.437 -1.285 0 N-CA-C 106.705 -2.558 . . . . 0.0 106.705 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 8.9 Cg_exo -55.42 148.57 51.36 Favored 'Trans proline' 0 N--CA 1.45 -1.078 0 C-N-CA 124.11 3.207 . . . . 0.0 116.463 -161.995 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 17.5 t -76.88 156.21 5.54 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.806 0 C-N-CA 128.29 2.636 . . . . 0.0 105.036 175.021 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 55.2 mt-10 -107.15 105.81 15.98 Favored 'General case' 0 CA--C 1.494 -1.18 0 N-CA-C 106.512 -1.662 . . . . 0.0 106.512 -176.478 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 1.7 p -127.49 141.83 45.26 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.981 0 N-CA-C 106.172 -1.788 . . . . 0.0 106.172 -169.808 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 21.2 p90 . . . . . 0 N--CA 1.436 -1.13 0 N-CA-C 106.95 -1.5 . . . . 0.0 106.95 -162.589 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo . . . . . 0 CA--C 1.504 -0.987 0 CA-C-O 118.17 -0.846 . . . . 0.0 111.267 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 4.1 t30 -117.73 -33.67 4.45 Favored 'General case' 0 CA--C 1.487 -1.459 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 -170.849 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 67.8 m -103.63 152.12 22.14 Favored 'General case' 0 CA--C 1.495 -1.163 0 N-CA-C 107.092 -1.448 . . . . 0.0 107.092 178.854 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 82.7 t60 -144.61 84.17 9.27 Favored Pre-proline 0 N--CA 1.437 -1.123 0 N-CA-C 106.559 -1.645 . . . . 0.0 106.559 174.651 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -81.75 123.19 4.13 Favored 'Trans proline' 0 N--CA 1.446 -1.294 0 C-N-CA 123.286 2.657 . . . . 0.0 109.765 179.882 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.577 HD11 HD11 ' A' ' 35' ' ' LEU . 3.4 pt -109.81 170.86 2.96 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.069 0 N-CA-C 108.466 -0.939 . . . . 0.0 108.466 -174.962 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 33.6 tt0 -145.92 148.03 32.38 Favored 'General case' 0 N--CA 1.437 -1.076 0 N-CA-C 105.459 -2.052 . . . . 0.0 105.459 172.247 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 19.6 p90 -130.75 158.04 41.18 Favored 'General case' 0 CA--C 1.499 -1.001 0 N-CA-C 106.27 -1.752 . . . . 0.0 106.27 179.491 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 89.6 m-20 -95.47 -179.46 4.77 Favored 'General case' 0 CA--C 1.488 -1.433 0 N-CA-C 103.647 -2.723 . . . . 0.0 103.647 168.89 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -160.08 165.37 17.9 Favored Pre-proline 0 N--CA 1.439 -0.982 0 N-CA-C 104.966 -2.235 . . . . 0.0 104.966 176.851 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -74.63 154.86 44.68 Favored 'Trans proline' 0 N--CA 1.453 -0.874 0 C-N-CA 122.546 2.164 . . . . 0.0 109.711 179.244 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 11.8 tp-100 -82.85 -43.41 0.9 Allowed Pre-proline 0 N--CA 1.443 -0.799 0 CA-C-O 115.924 -1.989 . . . . 0.0 111.219 -174.777 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 70.5 Cg_exo -67.89 167.94 20.09 Favored 'Trans proline' 0 CA--C 1.508 -0.778 0 CA-C-N 125.347 2.945 . . . . 0.0 111.976 174.213 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 34.8 p -72.94 123.18 22.94 Favored 'General case' 0 C--N 1.355 0.836 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 178.949 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 20.0 t-160 -159.58 -51.54 0.06 Allowed 'General case' 0 CA--C 1.493 -1.248 0 N-CA-C 106.729 -1.582 . . . . 0.0 106.729 -169.83 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 48.9 mt -121.6 137.88 53.78 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.119 0 N-CA-C 106.425 -1.695 . . . . 0.0 106.425 -168.842 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 73.5 m -107.33 -82.26 0.55 Allowed 'General case' 0 N--CA 1.432 -1.345 0 C-N-CA 125.025 1.33 . . . . 0.0 108.131 179.953 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 35.0 ttpt -92.25 161.74 14.58 Favored 'General case' 0 CA--C 1.494 -1.196 0 C-N-CA 125.47 1.508 . . . . 0.0 107.731 -165.477 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 90.2 m-85 -128.92 137.01 51.17 Favored 'General case' 0 CA--C 1.497 -1.089 0 N-CA-C 104.686 -2.338 . . . . 0.0 104.686 173.367 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 62.0 mt -116.73 128.81 74.01 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.213 0 N-CA-C 101.611 -3.477 . . . . 0.0 101.611 171.725 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.577 HD11 HD11 ' A' ' 20' ' ' ILE . 3.1 mt -109.02 133.35 53.1 Favored 'General case' 0 CA--C 1.475 -1.908 0 N-CA-C 105.766 -1.939 . . . . 0.0 105.766 171.784 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 16.3 ptp180 -135.96 152.6 51.14 Favored 'General case' 0 N--CA 1.434 -1.259 0 N-CA-C 107.31 -1.367 . . . . 0.0 107.31 173.928 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 48.6 p90 -156.73 153.57 28.62 Favored 'General case' 0 N--CA 1.438 -1.039 0 N-CA-C 107.766 -1.198 . . . . 0.0 107.766 -172.736 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 10.6 ptp180 -149.02 155.78 40.38 Favored Pre-proline 0 CA--C 1.499 -0.988 0 N-CA-C 105.696 -1.964 . . . . 0.0 105.696 168.393 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -72.17 121.25 7.37 Favored 'Trans proline' 0 N--CA 1.452 -0.958 0 C-N-CA 122.876 2.384 . . . . 0.0 108.327 169.797 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 57.5 tttp -70.3 80.01 0.53 Allowed 'General case' 0 C--N 1.357 0.924 0 C-N-CA 126.918 2.087 . . . . 0.0 110.446 -178.182 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 29.9 m120 -155.4 -70.41 0.12 Allowed 'General case' 0 N--CA 1.435 -1.215 0 N-CA-C 102.046 -3.316 . . . . 0.0 102.046 -173.209 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 37.2 p -96.22 157.89 15.69 Favored 'General case' 0 N--CA 1.439 -0.993 0 N-CA-C 107.555 -1.276 . . . . 0.0 107.555 175.139 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 3.3 m -130.62 53.68 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.918 0 N-CA-C 105.789 -1.93 . . . . 0.0 105.789 178.24 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -94.61 -107.73 2.08 Favored Glycine 0 C--N 1.355 1.625 0 N-CA-C 108.017 -2.033 . . . . 0.0 108.017 -179.092 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 8.3 ptm180 -88.8 175.29 7.54 Favored 'General case' 0 CA--C 1.502 -0.874 0 N-CA-C 107.625 -1.25 . . . . 0.0 107.625 174.822 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -157.24 171.3 20.66 Favored 'General case' 0 CA--C 1.492 -1.262 0 CA-C-O 121.393 0.616 . . . . 0.0 110.191 175.199 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 64.9 mttp -109.45 152.29 25.59 Favored 'General case' 0 CA--C 1.486 -1.503 0 N-CA-C 107.469 -1.308 . . . . 0.0 107.469 -172.551 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -152.99 155.42 36.9 Favored 'General case' 0 N--CA 1.434 -1.252 0 N-CA-C 107.74 -1.208 . . . . 0.0 107.74 177.727 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -137.3 156.96 47.64 Favored 'General case' 0 N--CA 1.437 -1.107 0 N-CA-C 105.816 -1.92 . . . . 0.0 105.816 173.539 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 87.3 m -121.12 125.32 46.92 Favored 'General case' 0 CA--C 1.501 -0.93 0 N-CA-C 104.784 -2.302 . . . . 0.0 104.784 -179.585 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 58.5 mt -124.02 132.32 24.29 Favored Pre-proline 0 N--CA 1.439 -1.024 0 N-CA-C 105.039 -2.208 . . . . 0.0 105.039 -164.672 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo -77.95 172.51 15.47 Favored 'Trans proline' 0 N--CA 1.455 -0.794 0 C-N-CA 122.717 2.278 . . . . 0.0 110.558 -179.516 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -96.75 69.56 0.84 Allowed Glycine 0 C--N 1.353 1.486 0 N-CA-C 109.34 -1.504 . . . . 0.0 109.34 178.602 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . 0.646 ' HB2' HD13 ' A' ' 55' ' ' LEU . 27.3 m170 -120.55 -66.43 1.06 Allowed 'General case' 0 CA--C 1.499 -0.986 0 N-CA-C 103.265 -2.865 . . . . 0.0 103.265 174.357 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.647 HD22 ' H ' ' A' ' 55' ' ' LEU . 0.0 OUTLIER -89.69 164.08 14.85 Favored 'General case' 0 N--CA 1.43 -1.471 0 C-N-CA 129.17 2.988 . . . . 0.0 106.856 177.765 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 7.1 p30 -140.11 30.34 2.0 Favored 'General case' 0 N--CA 1.431 -1.399 0 N-CA-C 107.125 -1.435 . . . . 0.0 107.125 -177.567 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 36.5 p -139.8 149.12 43.13 Favored 'General case' 0 CA--C 1.501 -0.937 0 N-CA-C 106.809 -1.552 . . . . 0.0 106.809 177.321 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 10.3 t80 -128.37 175.99 8.06 Favored 'General case' 0 C--N 1.358 0.973 0 N-CA-C 107.92 -1.141 . . . . 0.0 107.92 179.764 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 97.7 m -138.5 109.25 6.65 Favored 'General case' 0 N--CA 1.432 -1.344 0 N-CA-C 104.081 -2.562 . . . . 0.0 104.081 173.113 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 27.4 mt -87.9 147.54 5.19 Favored 'Isoleucine or valine' 0 C--N 1.358 0.969 0 N-CA-C 103.427 -2.805 . . . . 0.0 103.427 169.696 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 8.7 ptpp? -150.1 162.83 39.66 Favored 'General case' 0 CA--C 1.497 -1.067 0 N-CA-C 108.169 -1.048 . . . . 0.0 108.169 179.366 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 83.63 51.03 4.21 Favored Glycine 0 C--N 1.354 1.575 0 N-CA-C 109.367 -1.493 . . . . 0.0 109.367 177.768 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 62.7 mt -120.34 177.44 5.03 Favored 'General case' 0 CA--C 1.5 -0.954 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 -171.59 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -122.79 152.88 63.1 Favored Pre-proline 0 N--CA 1.44 -0.952 0 N-CA-C 106.46 -1.681 . . . . 0.0 106.46 -175.765 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -79.72 163.74 23.59 Favored 'Trans proline' 0 N--CA 1.451 -0.992 0 C-N-CA 122.976 2.451 . . . . 0.0 110.62 175.312 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . 0.578 ' H ' ' HA ' ' A' ' 92' ' ' THR . . . 58.64 26.16 59.57 Favored Glycine 0 C--N 1.356 1.657 0 C-N-CA 128.207 2.813 . . . . 0.0 116.28 171.966 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 8.6 p -126.41 147.5 31.24 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.977 0 N-CA-C 107.625 -1.25 . . . . 0.0 107.625 -176.988 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 5.1 p -96.02 138.14 22.2 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.945 0 N-CA-C 107.323 -1.362 . . . . 0.0 107.323 -178.114 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 88.6 m-85 -119.13 151.63 37.95 Favored 'General case' 0 N--CA 1.436 -1.157 0 N-CA-C 105.638 -1.986 . . . . 0.0 105.638 175.335 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -101.53 141.72 33.98 Favored 'General case' 0 CA--C 1.497 -1.095 0 N-CA-C 104.743 -2.317 . . . . 0.0 104.743 162.114 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -135.88 150.01 20.23 Favored Glycine 0 CA--C 1.488 -1.608 0 N-CA-C 107.701 -2.16 . . . . 0.0 107.701 -179.576 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 31.1 mt-30 -141.6 133.43 27.31 Favored 'General case' 0 CA--C 1.485 -1.545 0 N-CA-C 106.019 -1.845 . . . . 0.0 106.019 -177.628 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 23.2 tp -115.33 99.77 7.63 Favored 'General case' 0 N--CA 1.439 -1.01 0 N-CA-C 104.249 -2.5 . . . . 0.0 104.249 -178.339 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 11.7 mt -92.43 127.33 44.68 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.812 0 N-CA-C 104.502 -2.407 . . . . 0.0 104.502 179.767 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 10.3 p -114.98 111.66 21.49 Favored 'General case' 0 N--CA 1.436 -1.141 0 N-CA-C 107.593 -1.262 . . . . 0.0 107.593 -173.904 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 10.4 mm -94.79 150.81 3.96 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.298 0 N-CA-C 106.116 -1.809 . . . . 0.0 106.116 -167.195 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 6.4 pt20 -117.69 137.27 52.78 Favored 'General case' 0 CA--C 1.495 -1.155 0 N-CA-C 105.467 -2.049 . . . . 0.0 105.467 169.654 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 63.4 tp60 -69.02 117.89 11.23 Favored 'General case' 0 N--CA 1.441 -0.918 0 C-N-CA 124.107 0.963 . . . . 0.0 111.566 -167.019 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 36.1 m-85 59.09 49.95 8.73 Favored 'General case' 0 C--N 1.357 0.902 0 C-N-CA 126.971 2.108 . . . . 0.0 112.013 -177.918 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -158.72 -122.53 0.68 Allowed Glycine 0 N--CA 1.432 -1.623 0 N-CA-C 108.193 -1.963 . . . . 0.0 108.193 177.499 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 79.8 m-70 -86.58 177.87 7.25 Favored 'General case' 0 CA--C 1.498 -1.035 0 C-N-CA 125.34 1.456 . . . . 0.0 111.07 -169.479 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 26.6 mp0 -133.31 140.21 47.31 Favored 'General case' 0 N--CA 1.436 -1.173 0 N-CA-C 103.608 -2.738 . . . . 0.0 103.608 168.898 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 30.6 tt0 -119.25 137.73 53.47 Favored 'General case' 0 CA--C 1.496 -1.102 0 N-CA-C 103.948 -2.612 . . . . 0.0 103.948 177.915 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 6.3 p -117.1 136.01 55.63 Favored 'Isoleucine or valine' 0 C--N 1.354 0.775 0 N-CA-C 107.914 -1.143 . . . . 0.0 107.914 -177.065 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 63.6 m -116.73 140.15 49.75 Favored 'General case' 0 N--CA 1.441 -0.921 0 N-CA-C 103.067 -2.938 . . . . 0.0 103.067 173.464 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 79.2 mtt85 -128.09 152.05 48.46 Favored 'General case' 0 CA--C 1.5 -0.953 0 N-CA-C 109.195 -0.669 . . . . 0.0 109.195 177.331 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 30.7 p90 -163.81 175.79 10.13 Favored 'General case' 0 C--N 1.355 0.82 0 N-CA-C 107.796 -1.187 . . . . 0.0 107.796 -178.445 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 51.5 m-20 -133.53 154.11 51.1 Favored 'General case' 0 CA--C 1.502 -0.875 0 N-CA-C 105.715 -1.957 . . . . 0.0 105.715 169.553 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 22.1 p90 -142.94 169.36 17.72 Favored 'General case' 0 CA--C 1.487 -1.454 0 N-CA-C 107.765 -1.198 . . . . 0.0 107.765 171.095 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 27.5 p -121.89 143.26 49.54 Favored 'General case' 0 CA--C 1.501 -0.934 0 N-CA-C 105.733 -1.951 . . . . 0.0 105.733 170.754 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 45.1 m -114.02 125.63 54.21 Favored 'General case' 0 CA--C 1.497 -1.059 0 N-CA-C 102.499 -3.148 . . . . 0.0 102.499 170.953 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . 0.578 ' HA ' ' H ' ' A' ' 66' ' ' GLY . 13.2 t -143.86 161.61 38.23 Favored 'General case' 0 N--CA 1.441 -0.907 0 N-CA-C 107.365 -1.346 . . . . 0.0 107.365 -171.523 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 50.8 p . . . . . 0 C--O 1.261 1.686 0 C-N-CA 124.837 1.255 . . . . 0.0 109.361 -179.103 . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.436 -1.355 0 N-CA-C 105.702 -2.959 . . . . 0.0 105.702 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_exo -60.34 132.22 42.61 Favored 'Trans proline' 0 N--CA 1.447 -1.264 0 C-N-CA 123.601 2.867 . . . . 0.0 111.125 -178.05 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 20.2 t -77.95 153.98 5.23 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.925 0 C-N-CA 127.095 2.158 . . . . 0.0 106.273 -172.792 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -96.12 85.67 4.07 Favored 'General case' 0 CA--C 1.49 -1.328 0 N-CA-C 107.377 -1.342 . . . . 0.0 107.377 -176.887 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.44 ' HA ' ' HA ' ' A' ' 22' ' ' TRP . 1.8 p -100.06 120.73 49.88 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.169 0 N-CA-C 106.484 -1.673 . . . . 0.0 106.484 -170.578 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 48.4 m-85 . . . . . 0 CA--C 1.495 -1.161 0 N-CA-C 106.923 -1.51 . . . . 0.0 106.923 -168.318 . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 64.6 Cg_endo . . . . . 0 CA--C 1.506 -0.919 0 CA-C-O 118.656 -0.643 . . . . 0.0 111.792 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 1.9 m-80 -124.53 -20.22 5.19 Favored 'General case' 0 CA--C 1.491 -1.292 0 C-N-CA 124.128 0.971 . . . . 0.0 109.284 -169.016 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 5.7 p -108.52 134.91 50.64 Favored 'General case' 0 CA--C 1.495 -1.172 0 N-CA-C 107.714 -1.217 . . . . 0.0 107.714 -176.563 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 58.7 t-80 -122.8 98.2 43.15 Favored Pre-proline 0 N--CA 1.441 -0.906 0 N-CA-C 106.978 -1.49 . . . . 0.0 106.978 178.027 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 63.4 Cg_endo -80.05 127.15 6.72 Favored 'Trans proline' 0 N--CA 1.449 -1.107 0 C-N-CA 123.073 2.515 . . . . 0.0 109.873 177.635 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 2.1 pt -110.74 166.26 5.56 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.031 0 N-CA-C 107.153 -1.425 . . . . 0.0 107.153 174.365 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 32.3 mt-30 -138.51 160.09 40.45 Favored 'General case' 0 CA--C 1.497 -1.084 0 N-CA-C 105.286 -2.116 . . . . 0.0 105.286 167.68 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 22' ' ' TRP . . . . . 0.44 ' HA ' ' HA ' ' A' ' 6' ' ' VAL . 48.8 p90 -145.1 169.57 17.89 Favored 'General case' 0 CA--C 1.498 -1.054 0 N-CA-C 107.488 -1.301 . . . . 0.0 107.488 173.209 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 44.8 t30 -146.69 136.49 23.21 Favored 'General case' 0 CA--C 1.484 -1.575 0 N-CA-C 106.548 -1.649 . . . . 0.0 106.548 174.449 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -82.78 167.64 28.37 Favored Pre-proline 0 N--CA 1.439 -0.991 0 CA-C-N 112.793 -2.003 . . . . 0.0 111.681 -160.944 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 76.7 Cg_exo -66.16 176.29 4.04 Favored 'Trans proline' 0 N--CA 1.456 -0.68 0 C-N-CA 123.826 3.017 . . . . 0.0 111.752 165.107 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 1.3 tm0? -79.18 -46.04 1.68 Allowed Pre-proline 0 N--CA 1.443 -0.805 0 CA-C-O 115.544 -2.17 . . . . 0.0 110.496 -175.728 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 75.6 Cg_exo -66.53 148.0 83.02 Favored 'Trans proline' 0 CA--C 1.51 -0.721 0 CA-C-N 125.792 3.104 . . . . 0.0 111.969 177.147 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 69.6 m -100.85 63.19 1.03 Allowed 'General case' 0 CA--C 1.502 -0.889 0 N-CA-C 106.778 -1.564 . . . . 0.0 106.778 178.554 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 79.8 t60 -110.36 -1.59 17.09 Favored 'General case' 0 N--CA 1.44 -0.962 0 C-N-CA 125.322 1.449 . . . . 0.0 107.844 179.57 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 3.7 mp -100.16 126.28 53.71 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.115 0 N-CA-C 103.807 -2.664 . . . . 0.0 103.807 -177.639 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 60.5 m -95.43 -84.25 0.34 Allowed 'General case' 0 N--CA 1.431 -1.417 0 N-CA-C 106.153 -1.795 . . . . 0.0 106.153 177.232 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 53.7 mtmt -91.05 169.19 11.08 Favored 'General case' 0 CA--C 1.49 -1.358 0 C-N-CA 123.419 0.687 . . . . 0.0 109.24 -167.871 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 97.4 m-85 -126.87 133.82 50.62 Favored 'General case' 0 N--CA 1.435 -1.222 0 N-CA-C 103.048 -2.945 . . . . 0.0 103.048 164.108 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 51.1 mt -118.31 126.95 75.42 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.179 0 N-CA-C 102.398 -3.186 . . . . 0.0 102.398 173.804 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 7.0 mt -105.99 137.85 43.19 Favored 'General case' 0 CA--C 1.473 -2.003 0 N-CA-C 105.326 -2.101 . . . . 0.0 105.326 173.716 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -132.96 155.64 48.76 Favored 'General case' 0 N--CA 1.431 -1.422 0 N-CA-C 106.808 -1.553 . . . . 0.0 106.808 166.881 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 48.4 p90 -152.19 142.36 22.33 Favored 'General case' 0 N--CA 1.436 -1.132 0 N-CA-C 105.999 -1.852 . . . . 0.0 105.999 -177.352 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 45.4 ttm-85 -132.69 141.88 42.74 Favored Pre-proline 0 CA--C 1.5 -0.974 0 N-CA-C 103.991 -2.596 . . . . 0.0 103.991 179.578 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_endo -71.65 122.78 8.87 Favored 'Trans proline' 0 N--CA 1.452 -0.947 0 CA-C-N 123.683 2.351 . . . . 0.0 108.523 171.917 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 19.6 ttmm -71.58 63.92 0.43 Allowed 'General case' 0 C--N 1.358 0.963 0 C-N-CA 127.319 2.248 . . . . 0.0 111.767 -179.071 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 7.7 p30 -161.43 15.48 0.1 Allowed 'General case' 0 N--CA 1.438 -1.045 0 C-N-CA 125.292 1.437 . . . . 0.0 107.881 177.069 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 43.0 p -160.46 165.72 30.49 Favored 'General case' 0 N--CA 1.437 -1.102 0 N-CA-C 106.458 -1.682 . . . . 0.0 106.458 -175.897 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 4.9 m -137.73 40.73 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.845 0 N-CA-C 105.808 -1.923 . . . . 0.0 105.808 176.026 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -91.4 -114.92 1.92 Allowed Glycine 0 C--N 1.356 1.661 0 N-CA-C 109.071 -1.612 . . . . 0.0 109.071 -175.494 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 11.9 ptm180 -97.99 178.96 4.94 Favored 'General case' 0 CA--C 1.503 -0.861 0 N-CA-C 107.198 -1.408 . . . . 0.0 107.198 174.234 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -153.83 171.7 18.52 Favored 'General case' 0 N--CA 1.435 -1.206 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 176.363 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 96.7 mttt -110.34 157.13 19.84 Favored 'General case' 0 CA--C 1.489 -1.401 0 N-CA-C 107.291 -1.374 . . . . 0.0 107.291 -172.06 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 1.2 pp20? -150.64 160.62 43.7 Favored 'General case' 0 N--CA 1.437 -1.098 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 173.929 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -138.1 159.86 40.92 Favored 'General case' 0 N--CA 1.439 -0.98 0 N-CA-C 106.191 -1.781 . . . . 0.0 106.191 171.086 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 85.7 m -117.61 123.39 46.07 Favored 'General case' 0 CA--C 1.501 -0.933 0 N-CA-C 104.642 -2.355 . . . . 0.0 104.642 176.218 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 5.4 mp -112.8 133.59 21.9 Favored Pre-proline 0 N--CA 1.438 -1.063 0 N-CA-C 104.837 -2.283 . . . . 0.0 104.837 -174.076 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 64.3 Cg_exo -65.3 166.27 19.75 Favored 'Trans proline' 0 CA--C 1.509 -0.749 0 C-N-CA 123.185 2.59 . . . . 0.0 113.512 176.86 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -75.76 -19.18 79.23 Favored Glycine 0 C--N 1.353 1.491 0 C-N-CA 123.876 0.75 . . . . 0.0 114.245 -175.195 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 53.2 p-80 -83.05 -26.27 31.3 Favored 'General case' 0 C--N 1.356 0.851 0 CA-C-N 118.012 0.906 . . . . 0.0 109.835 -178.846 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 85.1 mt -88.58 128.92 35.58 Favored 'General case' 0 CA--C 1.5 -0.978 0 N-CA-C 107.441 -1.318 . . . . 0.0 107.441 175.605 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 8.0 p30 -117.46 10.61 13.62 Favored 'General case' 0 CA--C 1.502 -0.88 0 C-N-CA 124.083 0.953 . . . . 0.0 109.713 -173.313 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 29.1 p -142.17 161.35 38.24 Favored 'General case' 0 CA--C 1.498 -1.029 0 N-CA-C 106.537 -1.653 . . . . 0.0 106.537 179.291 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 11.1 t80 -140.56 162.2 35.93 Favored 'General case' 0 CA--C 1.499 -0.996 0 CA-C-O 121.849 0.833 . . . . 0.0 108.99 177.805 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 37.8 m -126.1 111.97 15.29 Favored 'General case' 0 N--CA 1.434 -1.243 0 N-CA-C 105.499 -2.037 . . . . 0.0 105.499 169.842 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 37.9 mt -84.75 140.71 15.64 Favored 'Isoleucine or valine' 0 C--N 1.357 0.897 0 N-CA-C 103.67 -2.715 . . . . 0.0 103.67 172.791 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 94.3 mttt -141.4 162.13 36.24 Favored 'General case' 0 CA--C 1.491 -1.3 0 CA-C-O 121.859 0.838 . . . . 0.0 108.881 -177.451 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 75.27 55.09 5.31 Favored Glycine 0 CA--C 1.489 -1.574 0 N-CA-C 108.937 -1.665 . . . . 0.0 108.937 176.63 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 62.3 mt -115.49 -174.22 2.48 Favored 'General case' 0 CA--C 1.5 -0.96 0 N-CA-C 107.547 -1.279 . . . . 0.0 107.547 -176.124 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 94.0 mttt -109.38 160.88 26.05 Favored Pre-proline 0 N--CA 1.441 -0.886 0 N-CA-C 106.091 -1.818 . . . . 0.0 106.091 -177.366 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -81.38 158.0 19.65 Favored 'Trans proline' 0 N--CA 1.45 -1.062 0 C-N-CA 122.764 2.309 . . . . 0.0 109.538 165.472 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 59.18 28.24 63.85 Favored Glycine 0 C--N 1.358 1.752 0 C-N-CA 126.947 2.213 . . . . 0.0 116.273 171.794 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 7.1 p -115.48 142.82 27.04 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.963 0 N-CA-C 107.803 -1.184 . . . . 0.0 107.803 -173.286 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 3.5 p -100.86 131.52 48.32 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.894 0 N-CA-C 106.423 -1.695 . . . . 0.0 106.423 173.594 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 90.0 m-85 -114.31 150.68 34.11 Favored 'General case' 0 N--CA 1.44 -0.946 0 N-CA-C 106.537 -1.653 . . . . 0.0 106.537 174.414 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -94.29 145.37 24.78 Favored 'General case' 0 CA--C 1.5 -0.961 0 N-CA-C 104.369 -2.456 . . . . 0.0 104.369 159.728 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -137.32 155.23 22.8 Favored Glycine 0 CA--C 1.485 -1.844 0 N-CA-C 108.192 -1.963 . . . . 0.0 108.192 -177.518 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 27.5 tt0 -151.34 135.13 16.43 Favored 'General case' 0 CA--C 1.485 -1.532 0 N-CA-C 106.478 -1.675 . . . . 0.0 106.478 -176.791 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 25.2 tp -123.87 97.86 5.55 Favored 'General case' 0 N--CA 1.434 -1.245 0 N-CA-C 104.556 -2.387 . . . . 0.0 104.556 -172.927 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 10.5 mt -91.83 138.63 19.39 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.853 0 N-CA-C 105.252 -2.129 . . . . 0.0 105.252 177.666 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 75.0 m -112.59 112.07 23.34 Favored 'General case' 0 N--CA 1.434 -1.233 0 N-CA-C 106.313 -1.736 . . . . 0.0 106.313 178.935 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 1.7 mp -89.49 134.17 29.47 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.217 0 N-CA-C 103.645 -2.724 . . . . 0.0 103.645 -173.058 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 79.0 mt-30 -99.37 160.13 14.5 Favored 'General case' 0 CA--C 1.494 -1.197 0 N-CA-C 106.704 -1.591 . . . . 0.0 106.704 -174.087 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 5.6 pt20 -69.09 110.27 4.43 Favored 'General case' 0 N--CA 1.441 -0.904 0 CA-C-O 121.982 0.896 . . . . 0.0 112.761 -170.947 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 75.6 m-85 53.95 40.86 32.04 Favored 'General case' 0 C--N 1.358 0.949 0 C-N-CA 127.834 2.454 . . . . 0.0 112.925 175.094 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -163.17 -114.94 0.32 Allowed Glycine 0 C--N 1.353 1.502 0 C-N-CA 119.324 -1.417 . . . . 0.0 109.808 -179.304 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 38.5 m170 -81.61 -175.85 5.75 Favored 'General case' 0 CA--C 1.498 -1.052 0 C-N-CA 125.05 1.34 . . . . 0.0 110.745 -167.324 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 4.8 pt20 -147.85 142.06 26.15 Favored 'General case' 0 N--CA 1.434 -1.238 0 N-CA-C 106.192 -1.781 . . . . 0.0 106.192 171.826 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 16.7 tp10 -110.7 139.46 45.97 Favored 'General case' 0 CA--C 1.496 -1.099 0 N-CA-C 105.823 -1.917 . . . . 0.0 105.823 -177.762 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 8.2 p -110.64 141.61 25.47 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.745 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 -174.48 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 36.2 m -130.15 129.24 43.22 Favored 'General case' 0 C--N 1.355 0.831 0 N-CA-C 102.832 -3.025 . . . . 0.0 102.832 175.67 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 18.7 ptp180 -134.71 154.48 51.54 Favored 'General case' 0 C--N 1.355 0.819 0 CA-C-N 119.912 1.233 . . . . 0.0 111.25 -176.256 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 18.7 p90 -165.26 -175.22 3.53 Favored 'General case' 0 C--N 1.359 1.0 0 N-CA-C 107.064 -1.458 . . . . 0.0 107.064 -169.517 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -140.15 159.46 42.14 Favored 'General case' 0 N--CA 1.443 -0.795 0 N-CA-C 107.029 -1.471 . . . . 0.0 107.029 166.735 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 20.7 p90 -144.83 169.23 18.43 Favored 'General case' 0 CA--C 1.492 -1.276 0 N-CA-C 107.723 -1.214 . . . . 0.0 107.723 174.103 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 88.7 m -126.49 135.74 51.73 Favored 'General case' 0 CA--C 1.5 -0.971 0 N-CA-C 104.004 -2.591 . . . . 0.0 104.004 176.194 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 76.9 m -107.56 107.53 18.41 Favored 'General case' 0 CA--C 1.497 -1.064 0 N-CA-C 105.126 -2.176 . . . . 0.0 105.126 178.699 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 5.7 m 75.91 145.01 0.08 Allowed 'General case' 0 C--N 1.359 1.006 0 C-N-CA 127.213 2.205 . . . . 0.0 110.387 173.515 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 24.3 m . . . . . 0 C--O 1.259 1.604 0 C-N-CA 125.597 1.559 . . . . 0.0 109.785 -178.825 . . . . . . . . 0 0 . 1 . 022 nuclear nobuild core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.438 -1.227 0 N-CA-C 106.902 -2.479 . . . . 0.0 106.902 . . . . . . . . . 0 0 . 1 . 022 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 74.8 Cg_exo -60.93 135.82 61.84 Favored 'Trans proline' 0 N--CA 1.445 -1.33 0 C-N-CA 123.401 2.734 . . . . 0.0 112.865 -176.638 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 32.1 t -79.12 157.46 4.75 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.06 0 C-N-CA 128.078 2.551 . . . . 0.0 107.348 -175.891 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 -105.48 102.26 11.74 Favored 'General case' 0 CA--C 1.491 -1.295 0 N-CA-C 105.197 -2.149 . . . . 0.0 105.197 176.78 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 1.7 p -117.46 134.66 60.33 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.114 0 N-CA-C 106.509 -1.663 . . . . 0.0 106.509 -166.762 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 1.5 t80 . . . . . 0 N--CA 1.434 -1.234 0 N-CA-C 106.975 -1.491 . . . . 0.0 106.975 -169.022 . . . . . . . . 0 0 . 1 . 022 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo . . . . . 0 N--CA 1.45 -1.074 0 N-CA-C 109.224 -1.106 . . . . 0.0 109.224 . . . . . . . . . 0 0 . 1 . 022 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 58.1 m-20 -133.37 -6.14 2.96 Favored 'General case' 0 N--CA 1.434 -1.259 0 C-N-CA 127.256 2.223 . . . . 0.0 108.63 -171.965 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 70.9 m -92.57 154.64 18.29 Favored 'General case' 0 CA--C 1.496 -1.128 0 N-CA-C 105.793 -1.928 . . . . 0.0 105.793 174.777 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 46.7 t-80 -147.3 90.72 5.23 Favored Pre-proline 0 N--CA 1.437 -1.099 0 N-CA-C 107.436 -1.32 . . . . 0.0 107.436 172.769 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -80.42 139.47 12.96 Favored 'Trans proline' 0 N--CA 1.446 -1.295 0 C-N-CA 122.705 2.27 . . . . 0.0 110.135 177.594 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.447 HD11 HD11 ' A' ' 35' ' ' LEU . 4.4 pt -122.49 175.24 5.83 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.055 0 N-CA-C 108.147 -1.057 . . . . 0.0 108.147 177.871 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . 0.425 ' HA ' ' HA ' ' A' ' 57' ' ' SER . 2.7 pt20 -151.31 155.23 38.31 Favored 'General case' 0 CA--C 1.498 -1.045 0 N-CA-C 105.733 -1.951 . . . . 0.0 105.733 176.27 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 33.5 p90 -142.31 162.52 35.26 Favored 'General case' 0 CA--C 1.501 -0.915 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 -175.872 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 61.8 t30 -98.94 -172.51 2.3 Favored 'General case' 0 CA--C 1.493 -1.222 0 N-CA-C 103.658 -2.719 . . . . 0.0 103.658 169.486 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -158.0 168.46 12.41 Favored Pre-proline 0 N--CA 1.44 -0.974 0 N-CA-C 106.471 -1.677 . . . . 0.0 106.471 168.694 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_exo -63.39 154.33 68.97 Favored 'Trans proline' 0 N--CA 1.454 -0.816 0 C-N-CA 123.244 2.63 . . . . 0.0 112.506 173.487 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 90.4 mm-40 -81.77 -35.51 0.75 Allowed Pre-proline 0 N--CA 1.443 -0.799 0 CA-C-O 115.148 -2.358 . . . . 0.0 114.208 -168.096 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_exo -70.83 -4.2 14.26 Favored 'Trans proline' 0 CA--C 1.512 -0.619 0 CA-C-N 126.1 3.214 . . . . 0.0 114.615 -177.809 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 8.7 t 68.38 59.55 0.41 Allowed 'General case' 0 C--N 1.359 0.986 0 C-N-CA 126.121 1.768 . . . . 0.0 108.886 -177.345 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 12.7 t-160 -94.41 -11.28 30.17 Favored 'General case' 0 N--CA 1.439 -0.991 0 C-N-CA 125.133 1.373 . . . . 0.0 108.034 -179.332 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 1.8 mp -111.56 137.36 44.46 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.949 0 N-CA-C 104.473 -2.417 . . . . 0.0 104.473 -175.099 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 62.2 m -100.06 -84.4 0.42 Allowed 'General case' 0 N--CA 1.432 -1.331 0 N-CA-C 106.823 -1.547 . . . . 0.0 106.823 171.093 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 55.4 mtmt -88.64 168.71 12.3 Favored 'General case' 0 CA--C 1.487 -1.457 0 C-N-CA 124.335 1.054 . . . . 0.0 109.447 -164.531 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 85.0 m-85 -130.26 135.0 47.65 Favored 'General case' 0 CA--C 1.495 -1.14 0 N-CA-C 103.978 -2.601 . . . . 0.0 103.978 170.252 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 42.0 mt -119.35 128.69 75.84 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.162 0 N-CA-C 101.913 -3.365 . . . . 0.0 101.913 174.515 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.447 HD11 HD11 ' A' ' 20' ' ' ILE . 4.2 mt -110.02 143.75 39.57 Favored 'General case' 0 CA--C 1.471 -2.084 0 N-CA-C 106.906 -1.516 . . . . 0.0 106.906 175.275 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 2.6 mpt_? -125.86 157.19 38.24 Favored 'General case' 0 N--CA 1.425 -1.705 0 N-CA-C 106.456 -1.683 . . . . 0.0 106.456 168.592 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 45.1 p90 -149.12 139.03 21.99 Favored 'General case' 0 N--CA 1.433 -1.321 0 N-CA-C 106.291 -1.744 . . . . 0.0 106.291 169.224 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 19.1 ttm180 -133.26 136.57 27.51 Favored Pre-proline 0 CA--C 1.495 -1.156 0 N-CA-C 104.206 -2.516 . . . . 0.0 104.206 179.103 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -71.0 114.72 3.99 Favored 'Trans proline' 0 N--CA 1.454 -0.846 0 CA-C-N 124.581 2.672 . . . . 0.0 108.495 175.02 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 54.4 tttp -70.89 72.26 0.55 Allowed 'General case' 0 C--N 1.359 0.992 0 C-N-CA 127.609 2.364 . . . . 0.0 111.467 -174.724 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 70.4 m-80 -154.05 -60.95 0.13 Allowed 'General case' 0 N--CA 1.434 -1.245 0 N-CA-C 101.532 -3.507 . . . . 0.0 101.532 -172.176 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 42.5 p -93.4 160.19 14.92 Favored 'General case' 0 N--CA 1.439 -0.99 0 C-N-CA 124.854 1.262 . . . . 0.0 107.65 173.175 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 5.9 m -126.33 44.87 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.842 0 N-CA-C 106.183 -1.784 . . . . 0.0 106.183 177.975 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -99.4 -128.54 6.27 Favored Glycine 0 C--N 1.355 1.593 0 N-CA-C 108.704 -1.759 . . . . 0.0 108.704 -177.547 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 83.9 mtt85 -84.51 168.18 15.67 Favored 'General case' 0 CA--C 1.502 -0.885 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 -179.072 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -151.83 173.26 14.99 Favored 'General case' 0 CA--C 1.494 -1.205 0 CA-C-O 121.506 0.669 . . . . 0.0 110.051 -172.981 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 36.9 mtmt -112.62 156.85 22.02 Favored 'General case' 0 CA--C 1.488 -1.427 0 N-CA-C 106.789 -1.56 . . . . 0.0 106.789 -173.001 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 16.3 pt-20 -152.28 160.66 43.31 Favored 'General case' 0 N--CA 1.436 -1.17 0 N-CA-C 108.666 -0.865 . . . . 0.0 108.666 178.698 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -140.19 163.02 33.87 Favored 'General case' 0 CA--C 1.498 -1.021 0 N-CA-C 107.102 -1.444 . . . . 0.0 107.102 171.434 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 90.5 m -121.31 126.23 48.98 Favored 'General case' 0 CA--C 1.501 -0.912 0 N-CA-C 104.691 -2.336 . . . . 0.0 104.691 175.344 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 5.2 mp -114.86 133.76 22.56 Favored Pre-proline 0 N--CA 1.437 -1.081 0 N-CA-C 105.121 -2.178 . . . . 0.0 105.121 -174.055 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_exo -64.09 165.59 18.89 Favored 'Trans proline' 0 CA--C 1.509 -0.759 0 C-N-CA 123.39 2.727 . . . . 0.0 113.812 177.127 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -77.71 -16.99 79.46 Favored Glycine 0 C--N 1.353 1.483 0 C-N-CA 123.869 0.747 . . . . 0.0 113.884 -172.887 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 51.8 p-80 -83.98 -24.98 30.37 Favored 'General case' 0 C--N 1.356 0.857 0 CA-C-N 117.975 0.887 . . . . 0.0 110.32 -179.643 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 88.2 mt -88.29 129.36 35.4 Favored 'General case' 0 CA--C 1.5 -0.955 0 N-CA-C 108.299 -1.0 . . . . 0.0 108.299 178.906 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 8.6 p30 -105.23 -1.09 25.77 Favored 'General case' 0 N--CA 1.442 -0.837 0 C-N-CA 124.909 1.284 . . . . 0.0 110.782 -173.918 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 0.425 ' HA ' ' HA ' ' A' ' 21' ' ' GLN . 30.5 p -139.42 159.29 42.5 Favored 'General case' 0 CA--C 1.497 -1.069 0 N-CA-C 107.575 -1.269 . . . . 0.0 107.575 -174.974 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 6.1 t80 -128.75 174.5 9.39 Favored 'General case' 0 C--N 1.36 1.055 0 N-CA-C 107.858 -1.164 . . . . 0.0 107.858 175.94 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 99.9 m -140.15 110.74 6.75 Favored 'General case' 0 N--CA 1.431 -1.406 0 N-CA-C 103.923 -2.621 . . . . 0.0 103.923 171.466 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 25.4 mt -87.5 148.74 4.39 Favored 'Isoleucine or valine' 0 C--N 1.358 0.958 0 N-CA-C 103.878 -2.638 . . . . 0.0 103.878 170.3 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 8.4 ptpp? -150.02 159.51 44.34 Favored 'General case' 0 CA--C 1.492 -1.255 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 178.18 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 78.94 54.87 3.98 Favored Glycine 0 C--N 1.355 1.591 0 N-CA-C 109.184 -1.566 . . . . 0.0 109.184 178.841 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 58.8 mt -116.11 -161.11 0.78 Allowed 'General case' 0 CA--C 1.502 -0.888 0 N-CA-C 106.84 -1.541 . . . . 0.0 106.84 -177.322 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 10.7 mptt -125.12 160.99 52.14 Favored Pre-proline 0 N--CA 1.442 -0.874 0 N-CA-C 105.684 -1.969 . . . . 0.0 105.684 -176.361 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -79.57 156.2 24.7 Favored 'Trans proline' 0 N--CA 1.452 -0.918 0 C-N-CA 123.035 2.49 . . . . 0.0 109.567 165.273 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 55.32 33.24 58.11 Favored Glycine 0 C--N 1.356 1.656 0 C-N-CA 127.514 2.483 . . . . 0.0 116.512 172.276 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 7.9 p -115.04 147.3 18.53 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.014 0 N-CA-C 107.282 -1.377 . . . . 0.0 107.282 -176.366 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 4.7 p -102.47 134.12 44.21 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.778 0 N-CA-C 106.636 -1.616 . . . . 0.0 106.636 174.577 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 81.8 m-85 -116.9 150.51 38.35 Favored 'General case' 0 N--CA 1.44 -0.936 0 N-CA-C 107.225 -1.398 . . . . 0.0 107.225 174.323 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 13.1 tp10 -95.95 128.88 43.23 Favored 'General case' 0 CA--C 1.492 -1.254 0 N-CA-C 102.089 -3.301 . . . . 0.0 102.089 165.821 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -125.91 140.83 12.43 Favored Glycine 0 CA--C 1.491 -1.468 0 N-CA-C 107.862 -2.095 . . . . 0.0 107.862 -179.205 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 28.7 tt0 -134.14 130.82 37.9 Favored 'General case' 0 CA--C 1.482 -1.64 0 N-CA-C 106.213 -1.773 . . . . 0.0 106.213 -178.496 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 43.2 tp -117.42 102.98 9.67 Favored 'General case' 0 N--CA 1.437 -1.09 0 N-CA-C 104.626 -2.361 . . . . 0.0 104.626 -176.516 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 11.9 mt -93.99 130.36 43.04 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.888 0 N-CA-C 104.287 -2.486 . . . . 0.0 104.287 174.878 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 25.2 p -112.75 114.11 26.52 Favored 'General case' 0 N--CA 1.438 -1.069 0 N-CA-C 106.683 -1.599 . . . . 0.0 106.683 -179.857 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 22.5 mm -90.03 142.0 13.54 Favored 'Isoleucine or valine' 0 CA--C 1.485 -1.529 0 N-CA-C 105.606 -1.998 . . . . 0.0 105.606 -167.985 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 78.0 mt-30 -104.57 152.42 22.44 Favored 'General case' 0 CA--C 1.493 -1.244 0 CA-C-N 114.548 -1.206 . . . . 0.0 107.904 -174.478 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 24.5 tt0 -77.49 35.09 0.18 Allowed 'General case' 0 C--N 1.355 0.841 0 C-N-CA 125.882 1.673 . . . . 0.0 113.41 -178.579 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 98.5 m-85 -143.63 11.74 1.67 Allowed 'General case' 0 CA--C 1.498 -1.057 0 N-CA-C 109.068 -0.715 . . . . 0.0 109.068 -175.719 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 88.91 -20.62 31.46 Favored Glycine 0 C--N 1.351 1.374 0 C-N-CA 124.097 0.856 . . . . 0.0 111.207 179.739 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 85.6 m-70 -81.04 173.9 12.14 Favored 'General case' 0 CA--C 1.496 -1.1 0 C-N-CA 125.362 1.465 . . . . 0.0 108.683 -178.673 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 9.9 pt20 -162.38 145.12 11.25 Favored 'General case' 0 N--CA 1.437 -1.117 0 N-CA-C 107.875 -1.157 . . . . 0.0 107.875 -176.102 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 48.0 mm-40 -110.21 147.89 32.9 Favored 'General case' 0 CA--C 1.496 -1.127 0 N-CA-C 106.351 -1.722 . . . . 0.0 106.351 179.237 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 8.7 p -118.74 143.0 31.02 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.746 0 N-CA-C 107.626 -1.249 . . . . 0.0 107.626 -175.773 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 28.1 m -131.72 131.94 43.47 Favored 'General case' 0 N--CA 1.441 -0.898 0 N-CA-C 103.275 -2.861 . . . . 0.0 103.275 179.748 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 88.2 mtm180 -125.46 148.47 48.83 Favored 'General case' 0 CA--C 1.501 -0.924 0 CA-C-N 119.011 0.823 . . . . 0.0 108.826 -179.699 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 23.0 p90 -163.38 179.82 7.07 Favored 'General case' 0 CA--C 1.501 -0.926 0 N-CA-C 106.804 -1.554 . . . . 0.0 106.804 -177.779 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 41.6 p30 -136.96 156.34 48.58 Favored 'General case' 0 N--CA 1.443 -0.824 0 N-CA-C 106.488 -1.671 . . . . 0.0 106.488 167.457 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 23.3 p90 -142.94 170.67 15.26 Favored 'General case' 0 CA--C 1.488 -1.439 0 N-CA-C 106.505 -1.665 . . . . 0.0 106.505 172.318 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 36.0 p -120.9 139.7 52.84 Favored 'General case' 0 CA--C 1.502 -0.897 0 N-CA-C 106.443 -1.688 . . . . 0.0 106.443 174.014 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 71.1 m -108.41 88.13 2.66 Favored 'General case' 0 CA--C 1.497 -1.094 0 N-CA-C 102.948 -2.982 . . . . 0.0 102.948 171.793 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 42.6 p -89.79 -178.42 5.5 Favored 'General case' 0 N--CA 1.443 -0.8 0 N-CA-C 106.998 -1.482 . . . . 0.0 106.998 178.977 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 22.7 t . . . . . 0 C--O 1.26 1.626 0 N-CA-C 104.923 -2.251 . . . . 0.0 104.923 175.385 . . . . . . . . 0 0 . 1 . 023 nuclear nobuild core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.436 -1.313 0 N-CA-C 106.243 -2.743 . . . . 0.0 106.243 . . . . . . . . . 0 0 . 1 . 023 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 77.5 Cg_exo -61.51 133.47 45.95 Favored 'Trans proline' 0 N--CA 1.446 -1.301 0 C-N-CA 122.742 2.295 . . . . 0.0 113.844 -171.579 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 38.6 t -85.71 161.78 2.96 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.085 0 C-N-CA 128.454 2.702 . . . . 0.0 107.513 -172.37 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -106.26 106.09 16.44 Favored 'General case' 0 CA--C 1.493 -1.249 0 N-CA-C 105.06 -2.2 . . . . 0.0 105.06 176.733 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 1.5 p -127.21 140.41 49.17 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.086 0 N-CA-C 104.958 -2.238 . . . . 0.0 104.958 -170.31 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 16.5 p90 . . . . . 0 N--CA 1.436 -1.169 0 N-CA-C 107.071 -1.455 . . . . 0.0 107.071 -166.674 . . . . . . . . 0 0 . 1 . 023 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_endo . . . . . 0 CA--C 1.501 -1.152 0 N-CA-C 110.906 -0.459 . . . . 0.0 110.906 . . . . . . . . . 0 0 . 1 . 023 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 2.1 m-80 -118.87 -20.31 8.23 Favored 'General case' 0 CA--C 1.49 -1.328 0 C-N-CA 124.857 1.263 . . . . 0.0 109.242 -168.821 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 15.0 p -97.86 148.2 23.66 Favored 'General case' 0 CA--C 1.493 -1.235 0 N-CA-C 107.444 -1.317 . . . . 0.0 107.444 -177.514 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 28.1 t60 -150.54 97.04 3.33 Favored Pre-proline 0 N--CA 1.438 -1.053 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 170.403 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -80.06 139.5 13.56 Favored 'Trans proline' 0 N--CA 1.447 -1.24 0 C-N-CA 122.35 2.033 . . . . 0.0 110.408 178.759 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 18.7 mm -113.62 146.21 18.5 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.937 0 N-CA-C 104.429 -2.434 . . . . 0.0 104.429 -178.051 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 35.0 mt-30 -136.42 149.95 48.53 Favored 'General case' 0 CA--C 1.502 -0.879 0 N-CA-C 105.326 -2.101 . . . . 0.0 105.326 168.904 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 42.0 p90 -141.48 161.97 36.61 Favored 'General case' 0 CA--C 1.502 -0.873 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 -175.169 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 81.2 m-20 -100.98 -172.39 2.16 Favored 'General case' 0 CA--C 1.485 -1.543 0 N-CA-C 103.851 -2.648 . . . . 0.0 103.851 171.389 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -150.45 163.14 25.26 Favored Pre-proline 0 N--CA 1.444 -0.771 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 169.93 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 80.4 Cg_exo -67.32 170.16 13.98 Favored 'Trans proline' 0 N--CA 1.456 -0.704 0 C-N-CA 123.38 2.72 . . . . 0.0 112.319 169.682 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 24.0 mm100 -82.42 -56.01 0.53 Allowed Pre-proline 0 N--CA 1.442 -0.869 0 CA-C-O 115.578 -2.153 . . . . 0.0 113.644 -172.328 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 82.6 Cg_endo -75.77 170.04 21.0 Favored 'Trans proline' 0 CA--C 1.509 -0.773 0 CA-C-N 125.774 3.098 . . . . 0.0 111.085 -169.228 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 69.4 m -76.83 113.27 14.33 Favored 'General case' 0 CA--C 1.5 -0.955 0 N-CA-C 107.717 -1.216 . . . . 0.0 107.717 179.031 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 61.4 t-80 -167.59 -49.95 0.02 OUTLIER 'General case' 0 N--CA 1.435 -1.193 0 N-CA-C 105.441 -2.059 . . . . 0.0 105.441 -170.559 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 26.6 mt -105.69 126.62 60.99 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.145 0 N-CA-C 106.429 -1.693 . . . . 0.0 106.429 -176.668 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 74.3 m -116.35 -84.35 0.63 Allowed 'General case' 0 N--CA 1.433 -1.278 0 N-CA-C 107.828 -1.175 . . . . 0.0 107.828 -174.714 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 38.8 ttpt -89.27 156.43 18.75 Favored 'General case' 0 CA--C 1.493 -1.22 0 C-N-CA 126.197 1.799 . . . . 0.0 106.888 -164.641 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 90.7 m-85 -126.86 135.89 51.6 Favored 'General case' 0 CA--C 1.488 -1.417 0 N-CA-C 105.304 -2.11 . . . . 0.0 105.304 179.474 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 1.5 mp -112.65 135.69 51.26 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.231 0 N-CA-C 100.473 -3.899 . . . . 0.0 100.473 170.239 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 3.1 mt -106.49 124.78 50.11 Favored 'General case' 0 CA--C 1.479 -1.788 0 N-CA-C 104.676 -2.342 . . . . 0.0 104.676 166.436 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -106.58 154.01 21.51 Favored 'General case' 0 N--CA 1.431 -1.375 0 N-CA-C 104.483 -2.414 . . . . 0.0 104.483 170.771 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 48.2 p90 -154.79 141.64 19.11 Favored 'General case' 0 N--CA 1.433 -1.292 0 N-CA-C 106.344 -1.725 . . . . 0.0 106.344 168.171 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 5.3 ptp180 -133.74 153.99 80.34 Favored Pre-proline 0 CA--C 1.497 -1.064 0 N-CA-C 103.751 -2.685 . . . . 0.0 103.751 168.695 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 68.8 Cg_endo -75.22 164.8 32.26 Favored 'Trans proline' 0 CA--C 1.506 -0.921 0 C-N-CA 122.789 2.326 . . . . 0.0 106.765 164.711 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 5.5 ptmm? -64.92 93.8 0.12 Allowed 'General case' 0 C--N 1.352 0.678 0 CA-C-N 119.976 1.262 . . . . 0.0 113.048 176.658 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -128.3 -136.28 0.23 Allowed 'General case' 0 N--CA 1.44 -0.953 0 N-CA-C 104.974 -2.232 . . . . 0.0 104.974 167.427 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 42.4 m -97.17 -154.28 0.45 Allowed 'General case' 0 N--CA 1.44 -0.954 0 C-N-CA 125.607 1.563 . . . . 0.0 107.121 179.313 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 9.2 m -94.85 42.69 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.445 -0.711 0 C-N-CA 126.627 1.971 . . . . 0.0 107.284 176.322 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -90.19 -146.33 15.22 Favored Glycine 0 C--N 1.353 1.478 0 C-N-CA 124.184 0.897 . . . . 0.0 110.998 -171.947 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 17.1 tpt180 -75.95 135.2 40.05 Favored 'General case' 0 CA--C 1.502 -0.881 0 C-N-CA 124.267 1.027 . . . . 0.0 108.332 -177.01 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -146.95 174.65 11.32 Favored 'General case' 0 N--CA 1.434 -1.27 0 N-CA-C 109.395 -0.594 . . . . 0.0 109.395 -174.261 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 64.3 mttp -112.3 155.74 23.58 Favored 'General case' 0 CA--C 1.489 -1.403 0 N-CA-C 107.347 -1.353 . . . . 0.0 107.347 -171.482 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 15.4 pt-20 -150.68 158.89 44.68 Favored 'General case' 0 N--CA 1.433 -1.284 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 179.784 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -136.7 160.45 38.8 Favored 'General case' 0 CA--C 1.497 -1.065 0 N-CA-C 106.509 -1.663 . . . . 0.0 106.509 171.754 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 77.3 m -122.8 126.54 47.63 Favored 'General case' 0 CA--C 1.501 -0.924 0 N-CA-C 104.956 -2.238 . . . . 0.0 104.956 175.335 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 5.2 mp -117.56 135.33 23.22 Favored Pre-proline 0 N--CA 1.437 -1.099 0 N-CA-C 104.753 -2.314 . . . . 0.0 104.753 -177.26 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_exo -63.48 167.13 13.71 Favored 'Trans proline' 0 CA--C 1.51 -0.71 0 C-N-CA 123.558 2.839 . . . . 0.0 113.477 177.101 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -79.49 -18.84 72.7 Favored Glycine 0 C--N 1.352 1.464 0 C-N-CA 123.344 0.497 . . . . 0.0 113.363 -172.59 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 47.7 p-80 -84.18 -27.01 28.36 Favored 'General case' 0 C--N 1.354 0.794 0 CA-C-N 117.743 0.771 . . . . 0.0 109.968 179.774 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 88.5 mt -88.57 132.58 34.47 Favored 'General case' 0 CA--C 1.502 -0.893 0 N-CA-C 107.789 -1.189 . . . . 0.0 107.789 177.722 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 7.6 p-10 -114.98 9.88 16.16 Favored 'General case' 0 CA--C 1.502 -0.897 0 C-N-CA 124.287 1.035 . . . . 0.0 110.169 -171.669 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 53.4 p -144.55 165.81 26.92 Favored 'General case' 0 N--CA 1.44 -0.958 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 -175.267 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 11.2 t80 -151.98 174.72 13.3 Favored 'General case' 0 N--CA 1.441 -0.908 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 -179.162 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 87.7 m -139.1 113.13 8.63 Favored 'General case' 0 N--CA 1.431 -1.409 0 N-CA-C 105.078 -2.193 . . . . 0.0 105.078 172.775 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 54.2 mt -87.08 142.93 12.32 Favored 'Isoleucine or valine' 0 C--N 1.359 0.979 0 N-CA-C 104.217 -2.512 . . . . 0.0 104.217 172.604 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 60.7 mttp -141.41 162.42 35.53 Favored 'General case' 0 CA--C 1.495 -1.138 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 179.195 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 78.84 53.05 4.72 Favored Glycine 0 CA--C 1.488 -1.609 0 N-CA-C 109.094 -1.602 . . . . 0.0 109.094 174.949 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 78.7 mt -113.46 -166.06 1.05 Allowed 'General case' 0 CA--C 1.503 -0.855 0 N-CA-C 107.279 -1.378 . . . . 0.0 107.279 -176.589 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 11.0 mptt -132.29 148.67 70.63 Favored Pre-proline 0 N--CA 1.442 -0.859 0 N-CA-C 104.993 -2.225 . . . . 0.0 104.993 -177.517 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -78.97 162.54 26.28 Favored 'Trans proline' 0 N--CA 1.45 -1.055 0 C-N-CA 122.772 2.315 . . . . 0.0 109.761 173.772 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . 0.536 ' H ' ' HA ' ' A' ' 92' ' ' THR . . . 63.63 24.0 67.55 Favored Glycine 0 N--CA 1.428 -1.851 0 C-N-CA 127.377 2.418 . . . . 0.0 116.063 172.886 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 9.6 p -129.7 143.13 42.02 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.02 0 N-CA-C 107.484 -1.302 . . . . 0.0 107.484 -178.037 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 11.5 p -95.65 127.56 47.58 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.011 0 CA-C-O 123.289 1.519 . . . . 0.0 107.571 178.258 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 87.3 m-85 -100.44 144.34 29.55 Favored 'General case' 0 N--CA 1.431 -1.41 0 N-CA-C 106.235 -1.765 . . . . 0.0 106.235 176.339 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 33.6 tp10 -90.57 132.66 35.59 Favored 'General case' 0 N--CA 1.439 -0.981 0 N-CA-C 104.205 -2.517 . . . . 0.0 104.205 163.064 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -129.3 152.43 19.5 Favored Glycine 0 CA--C 1.489 -1.547 0 N-CA-C 108.283 -1.927 . . . . 0.0 108.283 -179.136 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 26.7 mt-30 -138.19 137.8 37.95 Favored 'General case' 0 CA--C 1.485 -1.548 0 N-CA-C 106.347 -1.723 . . . . 0.0 106.347 174.849 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 62.7 tp -109.72 97.92 7.36 Favored 'General case' 0 CA--C 1.499 -1.014 0 N-CA-C 102.898 -3.001 . . . . 0.0 102.898 174.542 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 9.1 mt -94.86 124.61 47.43 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.054 0 N-CA-C 104.026 -2.583 . . . . 0.0 104.026 -174.21 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 74.6 m -112.89 108.9 18.02 Favored 'General case' 0 CA--C 1.5 -0.959 0 N-CA-C 107.826 -1.176 . . . . 0.0 107.826 -168.03 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 1.8 mp -93.17 136.9 23.76 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.226 0 N-CA-C 105.2 -2.148 . . . . 0.0 105.2 -167.241 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 14.0 tt0 -97.96 111.25 23.63 Favored 'General case' 0 N--CA 1.431 -1.377 0 N-CA-C 101.706 -3.442 . . . . 0.0 101.706 169.508 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 41.8 mt-30 -69.25 125.03 25.42 Favored 'General case' 0 CA--C 1.5 -0.975 0 CA-C-O 120.846 0.355 . . . . 0.0 110.218 -170.587 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 52.7 m-85 68.71 39.1 2.06 Favored 'General case' 0 C--N 1.356 0.872 0 C-N-CA 126.492 1.917 . . . . 0.0 110.996 -176.172 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -166.68 -116.22 0.35 Allowed Glycine 0 C--N 1.357 1.721 0 N-CA-C 109.288 -1.525 . . . . 0.0 109.288 179.144 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 29.3 m170 -82.51 -179.73 7.52 Favored 'General case' 0 CA--C 1.502 -0.874 0 C-N-CA 125.606 1.563 . . . . 0.0 111.259 -168.504 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 25.7 tt0 -147.44 123.58 10.81 Favored 'General case' 0 N--CA 1.436 -1.167 0 N-CA-C 105.591 -2.003 . . . . 0.0 105.591 170.686 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 47.8 mm-40 -104.68 160.63 14.81 Favored 'General case' 0 CA--C 1.501 -0.931 0 N-CA-C 106.243 -1.762 . . . . 0.0 106.243 176.558 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 10.9 p -135.84 138.55 47.53 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.842 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 -178.233 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 24.9 m -122.35 139.45 53.81 Favored 'General case' 0 N--CA 1.442 -0.833 0 N-CA-C 103.124 -2.917 . . . . 0.0 103.124 173.05 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 55.9 ttp180 -135.03 143.16 46.59 Favored 'General case' 0 CA--C 1.505 -0.77 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 -174.13 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 21.1 p90 -164.0 -175.81 4.22 Favored 'General case' 0 C--N 1.358 0.97 0 N-CA-C 106.891 -1.522 . . . . 0.0 106.891 -174.519 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 44.4 p-10 -136.5 158.34 44.67 Favored 'General case' 0 N--CA 1.442 -0.838 0 N-CA-C 107.093 -1.447 . . . . 0.0 107.093 166.748 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 25.2 p90 -143.75 164.12 31.37 Favored 'General case' 0 CA--C 1.486 -1.49 0 N-CA-C 106.821 -1.548 . . . . 0.0 106.821 169.769 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 43.8 m -118.42 137.77 52.92 Favored 'General case' 0 CA--C 1.498 -1.051 0 N-CA-C 105.336 -2.098 . . . . 0.0 105.336 179.186 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 61.3 m -115.75 115.67 26.73 Favored 'General case' 0 CA--C 1.493 -1.213 0 N-CA-C 101.866 -3.383 . . . . 0.0 101.866 174.722 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . 0.536 ' HA ' ' H ' ' A' ' 66' ' ' GLY . 15.1 t -155.29 148.23 24.51 Favored 'General case' 0 N--CA 1.437 -1.103 0 N-CA-C 107.315 -1.365 . . . . 0.0 107.315 -174.227 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 67.7 m . . . . . 0 C--O 1.26 1.615 0 N-CA-C 106.467 -1.679 . . . . 0.0 106.467 175.214 . . . . . . . . 0 0 . 1 . 024 nuclear nobuild core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.438 -1.23 0 N-CA-C 106.728 -2.549 . . . . 0.0 106.728 . . . . . . . . . 0 0 . 1 . 024 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 29.8 Cg_exo -59.04 139.78 92.28 Favored 'Trans proline' 0 N--CA 1.446 -1.293 0 C-N-CA 123.649 2.899 . . . . 0.0 113.559 -175.168 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 41.9 t -79.83 160.15 4.28 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.996 0 C-N-CA 128.552 2.741 . . . . 0.0 106.282 -179.002 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 55.2 mt-10 -108.13 106.74 17.09 Favored 'General case' 0 CA--C 1.493 -1.215 0 N-CA-C 105.998 -1.853 . . . . 0.0 105.998 -179.638 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 1.5 p -124.18 140.07 48.66 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.914 0 N-CA-C 106.142 -1.799 . . . . 0.0 106.142 -172.367 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 16.5 p90 . . . . . 0 N--CA 1.438 -1.032 0 N-CA-C 105.968 -1.864 . . . . 0.0 105.968 -168.589 . . . . . . . . 0 0 . 1 . 024 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo . . . . . 0 CA--C 1.505 -0.952 0 CA-C-O 118.39 -0.754 . . . . 0.0 111.372 . . . . . . . . . 0 0 . 1 . 024 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 6.2 p-10 -104.37 -41.32 5.79 Favored 'General case' 0 CA--C 1.489 -1.369 0 C-N-CA 123.167 0.587 . . . . 0.0 109.622 -167.103 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 12.0 p -110.5 150.72 28.49 Favored 'General case' 0 CA--C 1.494 -1.202 0 N-CA-C 107.399 -1.334 . . . . 0.0 107.399 -179.095 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 58.6 t-80 -143.37 93.61 6.37 Favored Pre-proline 0 N--CA 1.437 -1.087 0 N-CA-C 106.892 -1.522 . . . . 0.0 106.892 173.656 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -82.02 146.17 14.32 Favored 'Trans proline' 0 N--CA 1.445 -1.332 0 C-N-CA 123.436 2.757 . . . . 0.0 109.948 175.958 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.491 HD11 HD11 ' A' ' 35' ' ' LEU . 7.4 pt -126.3 173.44 12.04 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.985 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 178.217 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 49.2 tt0 -148.49 149.34 31.48 Favored 'General case' 0 N--CA 1.44 -0.95 0 N-CA-C 105.192 -2.151 . . . . 0.0 105.192 170.684 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 27.7 p90 -130.51 161.25 31.89 Favored 'General case' 0 N--CA 1.44 -0.959 0 N-CA-C 106.296 -1.742 . . . . 0.0 106.296 -179.696 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 61.1 t30 -96.61 -176.25 3.55 Favored 'General case' 0 CA--C 1.491 -1.327 0 N-CA-C 103.33 -2.841 . . . . 0.0 103.33 169.372 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -156.43 166.96 15.37 Favored Pre-proline 0 N--CA 1.44 -0.938 0 N-CA-C 106.621 -1.622 . . . . 0.0 106.621 172.888 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 99.6 Cg_exo -65.39 162.17 34.82 Favored 'Trans proline' 0 CA--C 1.508 -0.775 0 C-N-CA 123.486 2.791 . . . . 0.0 112.978 175.838 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 1.2 tm0? -82.08 -58.75 0.45 Allowed Pre-proline 0 N--CA 1.442 -0.845 0 CA-C-O 115.7 -2.095 . . . . 0.0 110.686 -177.46 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo -74.95 175.54 11.09 Favored 'Trans proline' 0 CA--C 1.51 -0.696 0 CA-C-N 125.67 3.061 . . . . 0.0 110.548 -177.168 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 44.2 p -69.18 124.5 23.98 Favored 'General case' 0 C--N 1.356 0.891 0 C-N-CA 123.824 0.85 . . . . 0.0 109.785 -178.239 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 61.0 t60 -168.12 -42.82 0.02 OUTLIER 'General case' 0 CA--C 1.494 -1.199 0 N-CA-C 106.598 -1.63 . . . . 0.0 106.598 -170.747 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 33.4 mt -132.56 140.42 47.62 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.895 0 N-CA-C 107.68 -1.23 . . . . 0.0 107.68 -173.604 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 31.8 p -123.18 -71.22 0.73 Allowed 'General case' 0 C--N 1.359 0.985 0 C-N-CA 124.219 1.008 . . . . 0.0 109.536 172.875 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 44.6 mtpt -86.44 166.58 15.41 Favored 'General case' 0 CA--C 1.488 -1.439 0 C-N-CA 126.899 2.08 . . . . 0.0 107.219 -171.029 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 83.4 m-85 -134.31 148.61 50.79 Favored 'General case' 0 CA--C 1.493 -1.248 0 N-CA-C 104.855 -2.276 . . . . 0.0 104.855 175.369 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 4.4 mt -123.54 139.47 50.05 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.315 0 N-CA-C 101.402 -3.555 . . . . 0.0 101.402 171.361 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.491 HD11 HD11 ' A' ' 20' ' ' ILE . 12.0 mt -116.02 135.36 54.03 Favored 'General case' 0 CA--C 1.477 -1.852 0 N-CA-C 106.717 -1.586 . . . . 0.0 106.717 166.681 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 9.0 mpt_? -110.58 153.12 25.6 Favored 'General case' 0 N--CA 1.429 -1.48 0 N-CA-C 104.491 -2.411 . . . . 0.0 104.491 166.559 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 48.9 p90 -154.15 146.59 24.0 Favored 'General case' 0 N--CA 1.441 -0.905 0 N-CA-C 108.099 -1.075 . . . . 0.0 108.099 168.969 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 43.9 ttm-85 -142.08 143.9 29.75 Favored Pre-proline 0 CA--C 1.503 -0.844 0 N-CA-C 104.693 -2.336 . . . . 0.0 104.693 179.876 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -71.42 115.22 4.2 Favored 'Trans proline' 0 N--CA 1.454 -0.808 0 C-N-CA 122.878 2.386 . . . . 0.0 108.845 167.151 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 64.3 tttm -70.33 77.87 0.54 Allowed 'General case' 0 C--N 1.358 0.955 0 C-N-CA 126.979 2.112 . . . . 0.0 111.084 -177.179 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 68.7 m-80 -151.77 -73.26 0.15 Allowed 'General case' 0 N--CA 1.435 -1.218 0 N-CA-C 102.653 -3.091 . . . . 0.0 102.653 -173.436 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 60.8 m -96.5 168.38 10.58 Favored 'General case' 0 C--N 1.356 0.874 0 N-CA-C 107.19 -1.411 . . . . 0.0 107.19 175.028 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 2.6 m -130.91 62.27 0.3 Allowed 'Isoleucine or valine' 0 CA--C 1.501 -0.913 0 N-CA-C 105.436 -2.061 . . . . 0.0 105.436 179.759 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -93.18 -110.53 2.01 Favored Glycine 0 C--N 1.353 1.503 0 N-CA-C 107.969 -2.052 . . . . 0.0 107.969 -179.818 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 80.2 mtp180 -105.88 175.66 5.42 Favored 'General case' 0 CA--C 1.502 -0.884 0 N-CA-C 106.338 -1.727 . . . . 0.0 106.338 173.564 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -152.05 172.63 15.99 Favored 'General case' 0 CA--C 1.495 -1.168 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 -176.676 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 94.6 mttt -108.02 154.16 22.05 Favored 'General case' 0 CA--C 1.487 -1.456 0 N-CA-C 107.313 -1.366 . . . . 0.0 107.313 -173.984 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -152.19 153.03 33.01 Favored 'General case' 0 N--CA 1.431 -1.391 0 N-CA-C 107.542 -1.281 . . . . 0.0 107.542 -177.738 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -146.48 160.62 41.87 Favored 'General case' 0 CA--C 1.499 -1.018 0 N-CA-C 107.667 -1.235 . . . . 0.0 107.667 177.665 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 91.6 m -121.7 126.76 49.69 Favored 'General case' 0 CA--C 1.5 -0.956 0 N-CA-C 105.176 -2.157 . . . . 0.0 105.176 177.734 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 52.5 mt -117.58 136.92 23.75 Favored Pre-proline 0 N--CA 1.436 -1.164 0 N-CA-C 105.639 -1.985 . . . . 0.0 105.639 -166.635 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 76.1 Cg_exo -65.26 168.46 14.21 Favored 'Trans proline' 0 CA--C 1.51 -0.692 0 C-N-CA 123.214 2.609 . . . . 0.0 113.284 177.702 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -96.38 7.68 66.41 Favored Glycine 0 C--N 1.352 1.428 0 CA-C-O 118.951 -0.916 . . . . 0.0 113.013 -178.038 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 44.3 p-80 -83.93 -47.45 11.02 Favored 'General case' 0 C--N 1.362 1.146 0 CA-C-N 119.206 1.503 . . . . 0.0 109.186 178.869 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -87.95 165.76 14.99 Favored 'General case' 0 CA--C 1.489 -1.381 0 CA-C-O 122.934 1.35 . . . . 0.0 108.271 170.921 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 6.0 p-10 -140.54 24.53 2.25 Favored 'General case' 0 N--CA 1.424 -1.761 0 CA-C-N 112.974 -1.921 . . . . 0.0 106.987 -178.506 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 57.1 p -132.14 158.49 41.53 Favored 'General case' 0 CA--C 1.501 -0.91 0 N-CA-C 107.788 -1.19 . . . . 0.0 107.788 176.387 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 7.7 t80 -133.21 175.79 9.09 Favored 'General case' 0 C--N 1.359 1.002 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 175.463 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 93.3 m -142.4 110.84 6.1 Favored 'General case' 0 N--CA 1.431 -1.404 0 N-CA-C 104.409 -2.441 . . . . 0.0 104.409 173.985 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 26.3 mt -90.85 147.32 5.3 Favored 'Isoleucine or valine' 0 C--N 1.358 0.952 0 N-CA-C 104.293 -2.484 . . . . 0.0 104.293 172.443 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 67.3 mttm -142.46 164.62 29.63 Favored 'General case' 0 CA--C 1.5 -0.946 0 N-CA-C 108.717 -0.845 . . . . 0.0 108.717 177.549 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 82.02 50.01 5.07 Favored Glycine 0 C--N 1.356 1.663 0 C-N-CA 125.357 1.456 . . . . 0.0 109.562 175.153 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 49.5 mt -119.25 172.97 7.23 Favored 'General case' 0 CA--C 1.5 -0.97 0 N-CA-C 108.22 -1.03 . . . . 0.0 108.22 -170.998 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -114.61 160.91 31.38 Favored Pre-proline 0 N--CA 1.442 -0.872 0 N-CA-C 106.856 -1.535 . . . . 0.0 106.856 -176.937 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -79.75 163.12 23.88 Favored 'Trans proline' 0 N--CA 1.452 -0.944 0 C-N-CA 123.192 2.595 . . . . 0.0 109.83 166.131 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 60.9 24.65 62.92 Favored Glycine 0 C--N 1.355 1.638 0 C-N-CA 127.778 2.609 . . . . 0.0 116.496 172.1 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 7.7 p -118.9 146.14 23.94 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.063 0 N-CA-C 107.529 -1.286 . . . . 0.0 107.529 -174.56 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 4.2 p -100.31 129.9 50.36 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.906 0 N-CA-C 106.665 -1.606 . . . . 0.0 106.665 176.013 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 94.1 m-85 -113.44 150.01 33.38 Favored 'General case' 0 N--CA 1.439 -1.016 0 N-CA-C 105.923 -1.88 . . . . 0.0 105.923 173.508 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -100.61 144.58 29.42 Favored 'General case' 0 CA--C 1.496 -1.119 0 N-CA-C 104.327 -2.471 . . . . 0.0 104.327 162.546 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -126.99 157.76 20.74 Favored Glycine 0 CA--C 1.489 -1.584 0 N-CA-C 108.016 -2.034 . . . . 0.0 108.016 174.663 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 23.7 tt0 -142.7 131.48 22.76 Favored 'General case' 0 CA--C 1.482 -1.671 0 N-CA-C 106.004 -1.85 . . . . 0.0 106.004 176.53 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 39.8 tp -113.5 104.76 12.59 Favored 'General case' 0 N--CA 1.437 -1.112 0 N-CA-C 104.6 -2.371 . . . . 0.0 104.6 -174.878 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 21.8 mt -100.48 126.69 54.03 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.866 0 N-CA-C 103.192 -2.892 . . . . 0.0 103.192 -179.29 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 50.5 m -118.36 115.9 25.63 Favored 'General case' 0 N--CA 1.444 -0.74 0 CA-C-N 119.24 0.927 . . . . 0.0 109.154 -171.32 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 2.4 mp -104.3 141.11 20.55 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.982 0 N-CA-C 105.779 -1.934 . . . . 0.0 105.779 -162.824 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . 0.442 ' HB3' ' H ' ' A' ' 81' ' ' HIS . 12.0 tp-100 -103.89 125.95 50.66 Favored 'General case' 0 CA--C 1.493 -1.25 0 N-CA-C 102.458 -3.164 . . . . 0.0 102.458 161.293 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 18.5 tt0 -68.35 117.89 10.72 Favored 'General case' 0 N--CA 1.443 -0.808 0 C-N-CA 123.036 0.534 . . . . 0.0 110.558 -170.428 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 24.8 m-85 64.44 53.96 1.58 Allowed 'General case' 0 C--N 1.358 0.957 0 C-N-CA 126.597 1.959 . . . . 0.0 110.686 -175.256 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -172.47 -110.86 0.25 Allowed Glycine 0 C--N 1.352 1.421 0 N-CA-C 109.021 -1.632 . . . . 0.0 109.021 -178.696 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 81' ' ' HIS . . . . . 0.442 ' H ' ' HB3' ' A' ' 77' ' ' GLN . 27.9 m170 -80.2 164.92 22.9 Favored 'General case' 0 CA--C 1.503 -0.861 0 C-N-CA 125.066 1.347 . . . . 0.0 111.436 -168.792 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 44.8 tt0 -151.0 111.27 4.15 Favored 'General case' 0 N--CA 1.435 -1.181 0 N-CA-C 105.539 -2.023 . . . . 0.0 105.539 169.806 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 17.2 tp10 -99.82 151.95 20.69 Favored 'General case' 0 N--CA 1.441 -0.901 0 N-CA-C 105.799 -1.926 . . . . 0.0 105.799 179.267 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 11.3 p -130.85 139.91 49.98 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.774 0 N-CA-C 107.324 -1.362 . . . . 0.0 107.324 177.849 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 85.8 m -138.51 133.85 33.17 Favored 'General case' 0 N--CA 1.441 -0.922 0 N-CA-C 102.901 -3.0 . . . . 0.0 102.901 -177.969 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 8.1 ptm180 -113.79 165.1 12.9 Favored 'General case' 0 C--N 1.357 0.915 0 CA-C-N 119.822 1.192 . . . . 0.0 109.667 174.506 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 43.0 p90 -163.99 174.6 11.2 Favored 'General case' 0 CA--C 1.5 -0.975 0 N-CA-C 106.919 -1.512 . . . . 0.0 106.919 177.163 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 1.4 p30 -143.97 156.55 44.45 Favored 'General case' 0 N--CA 1.441 -0.885 0 N-CA-C 106.965 -1.494 . . . . 0.0 106.965 166.459 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 6.6 p90 -148.36 173.27 13.23 Favored 'General case' 0 CA--C 1.488 -1.434 0 N-CA-C 107.661 -1.237 . . . . 0.0 107.661 -179.881 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 32.0 p -122.97 143.99 49.54 Favored 'General case' 0 CA--C 1.499 -0.99 0 N-CA-C 106.308 -1.738 . . . . 0.0 106.308 171.633 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 68.3 m -110.07 87.23 2.47 Favored 'General case' 0 CA--C 1.495 -1.137 0 N-CA-C 100.579 -3.86 . . . . 0.0 100.579 166.27 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 10.2 t -97.41 -50.88 4.36 Favored 'General case' 0 N--CA 1.441 -0.908 0 N-CA-C 108.293 -1.002 . . . . 0.0 108.293 -168.33 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 11.4 t . . . . . 0 C--O 1.26 1.638 0 C-N-CA 126.118 1.767 . . . . 0.0 110.256 -175.475 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 17.0 t . . . . . 0 N--CA 1.484 1.258 0 CA-C-O 121.288 0.566 . . . . 0.0 110.538 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . 0.513 ' H ' ' HG3' ' A' ' 83' ' ' GLU . . . 100.89 -179.48 28.82 Favored Glycine 0 C--N 1.354 1.544 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 174.599 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 95.9 Cg_exo -62.21 133.11 41.98 Favored 'Trans proline' 0 N--CA 1.445 -1.367 0 C-N-CA 123.592 2.861 . . . . 0.0 112.342 -178.504 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 4.3 t -80.98 155.33 4.26 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.924 0 C-N-CA 127.32 2.248 . . . . 0.0 107.424 -175.429 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 53.0 mt-10 -94.49 89.04 5.68 Favored 'General case' 0 CA--C 1.493 -1.25 0 C-N-CA 124.337 1.055 . . . . 0.0 108.426 -177.5 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 3.7 p -115.64 140.24 38.25 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.105 0 N-CA-C 105.497 -2.038 . . . . 0.0 105.497 -169.411 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 93.3 m-85 -130.46 166.12 21.18 Favored 'General case' 0 CA--C 1.493 -1.221 0 N-CA-C 107.28 -1.378 . . . . 0.0 107.28 -172.112 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 58.6 mt -91.05 90.5 3.32 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.931 0 N-CA-C 104.596 -2.372 . . . . 0.0 104.596 176.798 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 24.8 p -106.41 154.85 20.23 Favored 'General case' 0 CA--C 1.5 -0.945 0 N-CA-C 105.204 -2.147 . . . . 0.0 105.204 175.736 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -169.15 82.66 0.13 Allowed 'General case' 0 N--CA 1.431 -1.419 0 N-CA-C 102.091 -3.3 . . . . 0.0 102.091 -178.009 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 45.8 p -80.81 166.69 37.62 Favored Pre-proline 0 N--CA 1.444 -0.755 0 CA-C-O 116.972 -1.49 . . . . 0.0 107.222 -178.256 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_exo -61.13 106.11 0.37 Allowed 'Trans proline' 0 CA--C 1.509 -0.774 0 C-N-CA 123.085 2.523 . . . . 0.0 113.82 -168.622 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 67.8 m -151.19 -163.92 1.88 Allowed 'General case' 0 N--CA 1.421 -1.925 0 N-CA-C 101.025 -3.694 . . . . 0.0 101.025 -174.619 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 37.4 mt-30 -83.38 157.36 65.15 Favored Pre-proline 0 N--CA 1.44 -0.967 0 C-N-CA 126.32 1.848 . . . . 0.0 107.801 178.411 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_endo -82.19 -5.61 12.0 Favored 'Trans proline' 0 CA--C 1.509 -0.753 0 C-N-CA 123.409 2.739 . . . . 0.0 110.003 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -91.16 -15.4 29.43 Favored 'General case' 0 CA--C 1.498 -1.041 0 C-N-CA 125.438 1.495 . . . . 0.0 108.222 177.663 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 50.1 m -102.58 149.96 23.89 Favored 'General case' 0 N--CA 1.437 -1.101 0 N-CA-C 107.094 -1.446 . . . . 0.0 107.094 175.425 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 60.0 t-80 -139.28 94.45 9.65 Favored Pre-proline 0 N--CA 1.442 -0.855 0 N-CA-C 107.526 -1.287 . . . . 0.0 107.526 175.729 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -78.21 101.36 1.46 Allowed 'Trans proline' 0 N--CA 1.447 -1.235 0 C-N-CA 123.144 2.562 . . . . 0.0 110.043 174.338 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 11.8 tt -90.58 156.69 3.01 Favored 'Isoleucine or valine' 0 N--CA 1.408 -2.532 0 C-N-CA 126.945 2.098 . . . . 0.0 106.042 176.308 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 25.4 tt0 -139.77 146.45 39.51 Favored 'General case' 0 N--CA 1.432 -1.334 0 N-CA-C 103.662 -2.718 . . . . 0.0 103.662 175.125 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 49.3 p90 -135.08 161.69 34.61 Favored 'General case' 0 N--CA 1.431 -1.379 0 N-CA-C 105.045 -2.205 . . . . 0.0 105.045 178.558 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 3.9 m120 -132.65 127.73 35.54 Favored 'General case' 0 CA--C 1.491 -1.325 0 N-CA-C 105.909 -1.886 . . . . 0.0 105.909 -178.884 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -81.18 159.99 66.59 Favored Pre-proline 0 N--CA 1.441 -0.901 0 C-N-CA 123.533 0.733 . . . . 0.0 111.254 -167.119 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_exo -67.29 173.87 7.99 Favored 'Trans proline' 0 N--CA 1.456 -0.718 0 C-N-CA 123.7 2.933 . . . . 0.0 111.738 166.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 49.4 tt0 -80.24 -42.38 1.37 Allowed Pre-proline 0 N--CA 1.444 -0.756 0 CA-C-O 115.63 -2.128 . . . . 0.0 111.522 -177.339 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 74.7 Cg_exo -66.59 148.13 82.93 Favored 'Trans proline' 0 CA--C 1.507 -0.849 0 CA-C-N 125.62 3.043 . . . . 0.0 112.061 177.039 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 24.6 p -98.99 58.52 1.13 Allowed 'General case' 0 C--N 1.355 0.844 0 N-CA-C 107.592 -1.262 . . . . 0.0 107.592 178.46 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 21.1 t-160 -104.38 -5.88 21.29 Favored 'General case' 0 N--CA 1.439 -1.001 0 C-N-CA 125.046 1.338 . . . . 0.0 107.784 178.104 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 56.7 mt -106.73 131.26 57.05 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.21 0 N-CA-C 105.2 -2.148 . . . . 0.0 105.2 178.498 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 75.2 m -104.01 -84.24 0.48 Allowed 'General case' 0 N--CA 1.43 -1.443 0 N-CA-C 106.203 -1.777 . . . . 0.0 106.203 -179.667 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 54.0 mtmt -88.9 167.26 13.37 Favored 'General case' 0 CA--C 1.492 -1.281 0 C-N-CA 123.687 0.795 . . . . 0.0 109.61 -168.801 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 90.0 m-85 -126.04 139.27 53.55 Favored 'General case' 0 N--CA 1.435 -1.196 0 N-CA-C 104.494 -2.41 . . . . 0.0 104.494 165.703 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 1.7 mp -115.03 136.34 52.05 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.132 1 N-CA-C 100.177 -4.009 . . . . 0.0 100.177 167.634 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 3.0 mt -111.53 133.63 53.67 Favored 'General case' 0 CA--C 1.472 -2.052 0 N-CA-C 103.837 -2.653 . . . . 0.0 103.837 164.588 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 16.7 ptp180 -128.73 154.84 45.94 Favored 'General case' 0 N--CA 1.432 -1.345 0 N-CA-C 106.301 -1.74 . . . . 0.0 106.301 169.107 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 48.3 p90 -153.44 144.53 22.94 Favored 'General case' 0 N--CA 1.436 -1.161 0 N-CA-C 106.987 -1.486 . . . . 0.0 106.987 -173.834 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 36.2 ttp180 -142.55 134.04 13.04 Favored Pre-proline 0 CA--C 1.497 -1.09 0 N-CA-C 104.783 -2.303 . . . . 0.0 104.783 -177.859 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 29.8 Cg_endo -72.31 116.71 4.81 Favored 'Trans proline' 0 CA--C 1.505 -0.947 0 C-N-CA 122.928 2.418 . . . . 0.0 108.156 178.364 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 5.5 tmtm? -69.86 85.02 0.49 Allowed 'General case' 0 C--N 1.359 1.011 0 C-N-CA 126.523 1.929 . . . . 0.0 110.242 -174.283 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 33.1 m120 -147.52 -67.78 0.25 Allowed 'General case' 0 N--CA 1.433 -1.286 0 N-CA-C 101.568 -3.493 . . . . 0.0 101.568 -178.71 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 50.8 p -103.28 170.27 8.06 Favored 'General case' 0 N--CA 1.441 -0.918 0 N-CA-C 107.072 -1.455 . . . . 0.0 107.072 171.617 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 3.7 m -119.82 53.42 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.841 0 N-CA-C 106.125 -1.806 . . . . 0.0 106.125 176.45 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -100.32 -131.55 7.41 Favored Glycine 0 C--N 1.356 1.641 0 N-CA-C 109.916 -1.273 . . . . 0.0 109.916 -175.452 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 56.1 ttp180 -79.78 148.51 31.42 Favored 'General case' 0 C--N 1.357 0.9 0 C-N-CA 124.727 1.211 . . . . 0.0 108.694 -175.026 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -148.5 169.86 19.32 Favored 'General case' 0 CA--C 1.494 -1.174 0 CA-C-O 121.468 0.651 . . . . 0.0 110.616 -171.952 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 62.3 mttp -112.3 159.07 19.01 Favored 'General case' 0 CA--C 1.491 -1.292 0 N-CA-C 107.774 -1.195 . . . . 0.0 107.774 -168.849 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 16.2 pt-20 -151.63 160.65 43.55 Favored 'General case' 0 N--CA 1.436 -1.141 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 172.287 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -137.38 163.69 30.42 Favored 'General case' 0 CA--C 1.501 -0.942 0 N-CA-C 106.063 -1.829 . . . . 0.0 106.063 171.68 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 89.4 m -120.41 125.25 47.49 Favored 'General case' 0 CA--C 1.501 -0.913 0 N-CA-C 104.957 -2.238 . . . . 0.0 104.957 175.992 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 5.3 mp -114.11 136.48 22.21 Favored Pre-proline 0 N--CA 1.437 -1.102 0 N-CA-C 105.196 -2.15 . . . . 0.0 105.196 -175.608 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_exo -64.19 163.72 25.09 Favored 'Trans proline' 0 CA--C 1.51 -0.723 0 C-N-CA 123.378 2.719 . . . . 0.0 113.774 176.624 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -76.26 -18.44 79.27 Favored Glycine 0 C--N 1.353 1.49 0 C-N-CA 124.149 0.881 . . . . 0.0 114.244 -174.03 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 52.4 p-80 -83.28 -25.17 31.82 Favored 'General case' 0 C--N 1.355 0.837 0 CA-C-N 117.951 0.876 . . . . 0.0 109.945 -179.044 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 89.0 mt -88.43 131.57 34.81 Favored 'General case' 0 CA--C 1.5 -0.955 0 N-CA-C 107.712 -1.218 . . . . 0.0 107.712 176.797 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 8.6 p-10 -113.74 8.82 17.59 Favored 'General case' 0 CA--C 1.502 -0.89 0 C-N-CA 124.457 1.103 . . . . 0.0 109.631 -174.916 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 33.5 p -146.39 157.73 43.81 Favored 'General case' 0 CA--C 1.498 -1.055 0 N-CA-C 106.633 -1.617 . . . . 0.0 106.633 -177.463 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 35.4 t80 -154.14 151.27 29.06 Favored 'General case' 0 CA--C 1.487 -1.444 0 N-CA-C 108.07 -1.085 . . . . 0.0 108.07 178.236 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 16.9 m -108.64 113.99 27.43 Favored 'General case' 0 N--CA 1.439 -0.979 0 N-CA-C 105.951 -1.87 . . . . 0.0 105.951 174.954 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 45.5 mt -91.95 102.28 13.39 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.89 0 N-CA-C 105.242 -2.132 . . . . 0.0 105.242 178.117 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 35.1 mtmm -106.48 162.32 13.82 Favored 'General case' 0 CA--C 1.497 -1.096 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 -175.785 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 79.93 52.51 4.61 Favored Glycine 0 C--N 1.351 1.365 0 N-CA-C 109.099 -1.6 . . . . 0.0 109.099 178.434 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 89.5 mt -118.12 173.12 6.97 Favored 'General case' 0 CA--C 1.498 -1.023 0 N-CA-C 106.87 -1.53 . . . . 0.0 106.87 -178.778 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 51.6 mtmt -98.14 147.28 32.87 Favored Pre-proline 0 N--CA 1.438 -1.063 0 N-CA-C 105.786 -1.931 . . . . 0.0 105.786 178.666 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -78.56 160.99 28.32 Favored 'Trans proline' 0 N--CA 1.452 -0.93 0 C-N-CA 123.043 2.496 . . . . 0.0 109.997 173.515 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 59.6 30.33 68.52 Favored Glycine 0 C--N 1.356 1.65 0 C-N-CA 126.626 2.06 . . . . 0.0 116.24 169.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 6.4 p -128.45 154.62 39.47 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.85 0 N-CA-C 107.813 -1.18 . . . . 0.0 107.813 -176.002 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 4.8 p -96.53 135.69 29.81 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.9 0 N-CA-C 106.769 -1.567 . . . . 0.0 106.769 175.554 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 81.9 m-85 -113.89 147.44 38.48 Favored 'General case' 0 CA--C 1.497 -1.078 0 N-CA-C 105.382 -2.081 . . . . 0.0 105.382 171.432 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 15.2 pt-20 -95.92 136.53 36.23 Favored 'General case' 0 CA--C 1.498 -1.027 0 N-CA-C 103.457 -2.794 . . . . 0.0 103.457 162.016 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -132.62 146.38 18.18 Favored Glycine 0 CA--C 1.485 -1.784 0 N-CA-C 107.679 -2.168 . . . . 0.0 107.679 -172.332 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 25.2 mt-30 -136.74 133.46 36.07 Favored 'General case' 0 CA--C 1.482 -1.65 0 N-CA-C 105.746 -1.946 . . . . 0.0 105.746 178.627 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 49.6 tp -112.63 100.1 8.45 Favored 'General case' 0 N--CA 1.437 -1.108 0 N-CA-C 103.393 -2.817 . . . . 0.0 103.393 179.535 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 21.7 mt -94.83 129.33 45.15 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.915 0 N-CA-C 104.696 -2.335 . . . . 0.0 104.696 -176.797 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 69.2 m -113.5 113.79 25.62 Favored 'General case' 0 CA--C 1.497 -1.092 0 N-CA-C 107.668 -1.234 . . . . 0.0 107.668 -175.276 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 18.5 mm -89.36 142.73 12.47 Favored 'Isoleucine or valine' 0 CA--C 1.49 -1.349 0 N-CA-C 105.514 -2.032 . . . . 0.0 105.514 -173.441 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 83.0 mt-30 -92.5 -175.62 4.04 Favored 'General case' 0 CA--C 1.502 -0.897 0 CA-C-N 114.766 -1.106 . . . . 0.0 109.203 -175.569 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 73.2 mt-30 -74.79 78.22 2.09 Favored 'General case' 0 N--CA 1.442 -0.863 0 C-N-CA 125.84 1.656 . . . . 0.0 112.347 -177.612 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 65.8 m-85 60.06 21.8 10.98 Favored 'General case' 0 C--N 1.358 0.977 0 C-N-CA 127.322 2.249 . . . . 0.0 112.777 178.623 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -119.28 -118.95 2.78 Favored Glycine 0 C--N 1.355 1.597 0 N-CA-C 108.695 -1.762 . . . . 0.0 108.695 -173.847 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . 0.551 ' CD2' ' H ' ' A' ' 82' ' ' GLN . 12.5 t-160 -81.34 -171.56 3.34 Favored 'General case' 0 CA--C 1.497 -1.065 0 C-N-CA 125.386 1.475 . . . . 0.0 108.902 -177.852 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . 0.551 ' H ' ' CD2' ' A' ' 81' ' ' HIS . 5.9 pt20 -144.66 146.48 32.27 Favored 'General case' 0 N--CA 1.434 -1.274 0 N-CA-C 106.067 -1.827 . . . . 0.0 106.067 170.127 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.513 ' HG3' ' H ' ' A' ' 2' ' ' GLY . 46.9 mm-40 -105.19 156.22 18.31 Favored 'General case' 0 CA--C 1.494 -1.178 0 N-CA-C 105.897 -1.89 . . . . 0.0 105.897 179.735 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 7.4 p -129.51 135.76 60.83 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.924 0 N-CA-C 107.308 -1.367 . . . . 0.0 107.308 179.741 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 24.7 m -118.62 133.38 55.9 Favored 'General case' 0 N--CA 1.439 -1.001 0 N-CA-C 102.006 -3.331 . . . . 0.0 102.006 175.467 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 78.6 mtm180 -129.17 147.83 51.05 Favored 'General case' 0 CA--C 1.497 -1.081 0 CA-C-N 119.303 0.956 . . . . 0.0 109.187 -177.698 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 18.5 p90 -166.07 -176.1 3.61 Favored 'General case' 0 CA--C 1.498 -1.025 0 N-CA-C 106.826 -1.546 . . . . 0.0 106.826 -174.79 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -134.58 156.72 48.19 Favored 'General case' 0 N--CA 1.44 -0.962 0 N-CA-C 105.596 -2.001 . . . . 0.0 105.596 164.371 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 23.7 p90 -138.13 165.17 27.3 Favored 'General case' 0 CA--C 1.483 -1.629 0 N-CA-C 107.227 -1.397 . . . . 0.0 107.227 169.449 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 29.4 p -119.67 143.89 47.48 Favored 'General case' 0 N--CA 1.439 -1.004 0 N-CA-C 107.374 -1.343 . . . . 0.0 107.374 176.381 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 19.6 p -108.99 135.06 50.78 Favored 'General case' 0 N--CA 1.439 -1.012 0 N-CA-C 103.613 -2.736 . . . . 0.0 103.613 164.608 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 15.2 t -139.72 149.49 43.69 Favored 'General case' 0 N--CA 1.439 -1.005 0 N-CA-C 106.332 -1.729 . . . . 0.0 106.332 -173.742 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 35.4 t . . . . . 0 C--O 1.261 1.685 0 N-CA-C 105.396 -2.076 . . . . 0.0 105.396 177.99 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 87.8 p . . . . . 0 N--CA 1.489 1.488 0 CA-C-O 121.46 0.648 . . . . 0.0 111.982 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 84.53 -151.16 26.34 Favored Glycine 0 C--N 1.356 1.671 0 N-CA-C 109.136 -1.586 . . . . 0.0 109.136 176.99 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 64.4 Cg_exo -61.48 138.23 74.7 Favored 'Trans proline' 0 N--CA 1.442 -1.508 0 C-N-CA 123.241 2.628 . . . . 0.0 112.957 179.643 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 2.8 t -77.45 153.8 5.42 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.728 0 C-N-CA 127.785 2.434 . . . . 0.0 106.339 -178.527 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 48.7 mm-40 -99.03 88.76 4.05 Favored 'General case' 0 CA--C 1.488 -1.405 0 CA-C-O 122.829 1.3 . . . . 0.0 109.14 -170.133 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 2.4 p -105.66 128.01 60.12 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.07 0 CA-C-N 113.43 -1.714 . . . . 0.0 108.685 -164.376 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 27.5 p90 -130.28 154.35 47.69 Favored 'General case' 0 N--CA 1.44 -0.97 0 N-CA-C 106.703 -1.592 . . . . 0.0 106.703 -174.584 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 40.6 mm -123.99 109.34 22.69 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.236 0 N-CA-C 105.276 -2.12 . . . . 0.0 105.276 -179.666 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 40.5 p -132.58 -152.43 0.5 Allowed 'General case' 0 N--CA 1.444 -0.739 0 N-CA-C 104.451 -2.426 . . . . 0.0 104.451 171.367 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 80.0 tt0 79.51 -18.89 0.47 Allowed 'General case' 0 C--N 1.362 1.149 0 C-N-CA 128.445 2.698 . . . . 0.0 112.35 169.551 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 14.9 p -139.99 109.46 7.07 Favored Pre-proline 0 N--CA 1.446 -0.653 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 -170.418 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -72.17 -31.53 11.87 Favored 'Trans proline' 0 N--CA 1.455 -0.77 0 C-N-CA 122.843 2.362 . . . . 0.0 110.697 164.696 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 11.9 p -169.02 119.47 0.72 Allowed 'General case' 0 N--CA 1.437 -1.076 0 N-CA-C 107.085 -1.45 . . . . 0.0 107.085 -176.12 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 23.9 mm100 -150.57 128.05 5.61 Favored Pre-proline 0 N--CA 1.443 -0.791 0 N-CA-C 104.834 -2.284 . . . . 0.0 104.834 170.418 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 82.0 Cg_endo -84.41 -16.17 5.99 Favored 'Trans proline' 0 CA--C 1.505 -0.952 0 C-N-CA 123.039 2.492 . . . . 0.0 111.544 -173.862 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 4.1 t30 -124.95 -31.99 3.08 Favored 'General case' 0 CA--C 1.488 -1.42 0 CA-C-N 118.637 0.653 . . . . 0.0 109.78 -165.741 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 13.5 p -106.63 141.85 37.24 Favored 'General case' 0 CA--C 1.493 -1.238 0 N-CA-C 107.44 -1.319 . . . . 0.0 107.44 179.22 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 63.0 t60 -141.89 98.22 6.33 Favored Pre-proline 0 N--CA 1.439 -1.024 0 N-CA-C 107.603 -1.258 . . . . 0.0 107.603 176.531 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -78.32 139.11 16.37 Favored 'Trans proline' 0 N--CA 1.449 -1.092 0 C-N-CA 122.814 2.343 . . . . 0.0 110.785 -177.14 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 21.6 mm -106.87 136.27 42.4 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.958 0 N-CA-C 103.104 -2.924 . . . . 0.0 103.104 174.287 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 40.7 mt-30 -138.76 141.28 38.84 Favored 'General case' 0 CA--C 1.491 -1.318 0 N-CA-C 103.494 -2.78 . . . . 0.0 103.494 -178.048 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 46.1 p90 -148.77 167.23 26.14 Favored 'General case' 0 CA--C 1.498 -1.048 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 -170.609 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 9.5 m120 -131.19 129.53 41.82 Favored 'General case' 0 CA--C 1.492 -1.259 0 N-CA-C 107.441 -1.318 . . . . 0.0 107.441 178.868 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -94.71 170.58 7.85 Favored Pre-proline 0 N--CA 1.439 -0.999 0 C-N-CA 124.468 1.107 . . . . 0.0 109.879 -170.97 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 80.2 Cg_exo -66.06 164.13 28.77 Favored 'Trans proline' 0 CA--C 1.508 -0.807 0 C-N-CA 123.633 2.888 . . . . 0.0 112.222 168.929 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 17.4 mp0 -83.3 -57.34 0.43 Allowed Pre-proline 0 N--CA 1.442 -0.826 0 CA-C-O 115.844 -2.027 . . . . 0.0 110.402 -177.132 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -74.87 171.88 17.42 Favored 'Trans proline' 0 CA--C 1.509 -0.743 0 CA-C-N 125.499 3.0 . . . . 0.0 110.349 177.702 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 66.0 m -75.93 125.86 29.9 Favored 'General case' 0 CA--C 1.501 -0.933 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 -179.635 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 74.8 t60 -162.37 -49.89 0.04 OUTLIER 'General case' 0 N--CA 1.436 -1.17 0 N-CA-C 106.202 -1.777 . . . . 0.0 106.202 -172.813 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 54.0 mt -113.06 136.53 49.08 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.142 0 N-CA-C 105.203 -2.147 . . . . 0.0 105.203 -177.109 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 32.1 t -110.53 -87.5 0.52 Allowed 'General case' 0 N--CA 1.43 -1.474 0 N-CA-C 106.717 -1.586 . . . . 0.0 106.717 179.028 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 6.7 ttpm? -91.86 160.49 15.27 Favored 'General case' 0 CA--C 1.492 -1.262 0 C-N-CA 125.667 1.587 . . . . 0.0 107.649 -160.155 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 92.0 m-85 -125.58 138.91 53.96 Favored 'General case' 0 CA--C 1.494 -1.185 0 N-CA-C 106.277 -1.749 . . . . 0.0 106.277 176.072 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 53.5 mt -116.92 126.82 74.55 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.152 0 N-CA-C 102.592 -3.114 . . . . 0.0 102.592 168.483 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 5.0 mt -102.2 128.65 48.61 Favored 'General case' 0 CA--C 1.475 -1.912 0 N-CA-C 104.894 -2.261 . . . . 0.0 104.894 170.556 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 42.4 ttp85 -132.47 122.0 24.23 Favored 'General case' 0 N--CA 1.437 -1.115 0 N-CA-C 106.097 -1.816 . . . . 0.0 106.097 -178.71 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 42.3 p90 -138.06 151.1 47.52 Favored 'General case' 0 N--CA 1.444 -0.757 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 -169.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 33.2 ptt180 -155.92 164.47 21.25 Favored Pre-proline 0 CA--C 1.502 -0.897 0 N-CA-C 106.605 -1.628 . . . . 0.0 106.605 171.384 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . 0.416 ' HA ' ' HA ' ' A' ' 69' ' ' TYR . 37.7 Cg_endo -75.69 127.27 10.09 Favored 'Trans proline' 0 N--CA 1.452 -0.932 0 C-N-CA 122.344 2.029 . . . . 0.0 108.983 179.141 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 64.0 tttm -69.75 83.07 0.45 Allowed 'General case' 0 C--N 1.357 0.921 0 C-N-CA 127.349 2.259 . . . . 0.0 110.821 -177.588 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 29.1 m120 -145.9 -89.81 0.1 Allowed 'General case' 0 N--CA 1.437 -1.091 0 N-CA-C 105.054 -2.202 . . . . 0.0 105.054 -175.958 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 3.7 t -94.31 -164.95 1.23 Allowed 'General case' 0 C--N 1.355 0.819 0 C-N-CA 124.032 0.933 . . . . 0.0 108.924 -172.641 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 4.2 m -121.17 54.51 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.439 -1.003 0 N-CA-C 106.307 -1.738 . . . . 0.0 106.307 -176.648 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -89.8 -140.2 7.93 Favored Glycine 0 C--N 1.355 1.595 0 N-CA-C 110.281 -1.128 . . . . 0.0 110.281 -178.179 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -99.33 165.01 11.88 Favored 'General case' 0 CA--C 1.503 -0.831 0 N-CA-C 106.484 -1.672 . . . . 0.0 106.484 -178.332 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 47.3 m95 -112.34 156.73 21.98 Favored 'General case' 0 N--CA 1.441 -0.912 0 N-CA-C 108.071 -1.085 . . . . 0.0 108.071 -179.09 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 67.9 mttm -97.46 152.25 19.17 Favored 'General case' 0 CA--C 1.49 -1.352 0 N-CA-C 104.779 -2.304 . . . . 0.0 104.779 163.824 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -153.18 156.62 38.91 Favored 'General case' 0 CA--C 1.494 -1.191 0 N-CA-C 107.833 -1.173 . . . . 0.0 107.833 178.854 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -141.07 162.93 34.32 Favored 'General case' 0 CA--C 1.496 -1.132 0 N-CA-C 106.349 -1.723 . . . . 0.0 106.349 175.876 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 88.1 m -122.36 127.24 49.51 Favored 'General case' 0 CA--C 1.501 -0.933 0 N-CA-C 105.242 -2.133 . . . . 0.0 105.242 -179.705 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 4.8 mp -117.38 133.88 23.17 Favored Pre-proline 0 N--CA 1.437 -1.106 0 N-CA-C 104.613 -2.366 . . . . 0.0 104.613 -174.725 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_exo -63.32 166.19 15.6 Favored 'Trans proline' 0 CA--C 1.509 -0.742 0 C-N-CA 123.344 2.696 . . . . 0.0 113.616 176.677 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -81.14 -17.18 72.59 Favored Glycine 0 C--N 1.351 1.405 0 C-N-CA 123.557 0.598 . . . . 0.0 113.099 -172.073 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 52.2 p-80 -83.66 -24.8 31.19 Favored 'General case' 0 C--N 1.355 0.841 0 CA-C-N 117.889 0.845 . . . . 0.0 109.862 179.88 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 87.4 mt -88.18 130.67 34.99 Favored 'General case' 0 CA--C 1.501 -0.94 0 N-CA-C 107.645 -1.243 . . . . 0.0 107.645 177.139 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 8.1 p30 -110.15 7.95 23.59 Favored 'General case' 0 N--CA 1.441 -0.881 0 C-N-CA 124.708 1.203 . . . . 0.0 109.758 -174.937 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 42.1 p -146.5 167.03 24.69 Favored 'General case' 0 N--CA 1.439 -1.0 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 -178.14 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 9.3 t80 -153.29 178.37 9.84 Favored 'General case' 0 N--CA 1.439 -1.023 0 N-CA-C 107.1 -1.444 . . . . 0.0 107.1 -178.275 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 70.0 m -142.0 116.22 9.47 Favored 'General case' 0 N--CA 1.43 -1.459 0 N-CA-C 104.812 -2.292 . . . . 0.0 104.812 176.632 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 12.7 mm -85.75 140.18 16.3 Favored 'Isoleucine or valine' 0 C--N 1.358 0.964 0 N-CA-C 103.856 -2.646 . . . . 0.0 103.856 170.332 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 7.9 mtpm? -141.7 164.65 29.64 Favored 'General case' 0 CA--C 1.497 -1.063 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 178.938 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 85.86 49.49 4.28 Favored Glycine 0 CA--C 1.487 -1.669 0 N-CA-C 108.931 -1.668 . . . . 0.0 108.931 174.843 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 58.1 mt -118.77 170.15 9.24 Favored 'General case' 0 CA--C 1.497 -1.071 0 N-CA-C 108.528 -0.916 . . . . 0.0 108.528 -169.864 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 60.6 mtpt -110.46 155.16 42.51 Favored Pre-proline 0 N--CA 1.44 -0.929 0 N-CA-C 106.942 -1.503 . . . . 0.0 106.942 -176.478 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 63.9 Cg_endo -78.94 161.04 27.1 Favored 'Trans proline' 0 N--CA 1.452 -0.966 0 C-N-CA 122.91 2.407 . . . . 0.0 110.308 172.982 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 0.438 ' H ' ' HA ' ' A' ' 92' ' ' THR . . . 59.47 26.27 61.8 Favored Glycine 0 C--N 1.355 1.586 0 C-N-CA 127.673 2.559 . . . . 0.0 116.378 171.29 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 10.7 p -121.77 147.45 25.76 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.992 0 N-CA-C 107.362 -1.348 . . . . 0.0 107.362 -177.203 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 4.0 p -96.73 129.15 47.19 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.951 0 N-CA-C 106.93 -1.507 . . . . 0.0 106.93 177.125 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . 0.416 ' HA ' ' HA ' ' A' ' 39' ' ' PRO . 93.4 m-85 -111.18 144.84 39.7 Favored 'General case' 0 CA--C 1.496 -1.113 0 N-CA-C 106.043 -1.836 . . . . 0.0 106.043 173.124 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -96.72 145.12 26.09 Favored 'General case' 0 CA--C 1.496 -1.128 0 N-CA-C 104.475 -2.417 . . . . 0.0 104.475 166.103 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -140.97 155.77 25.16 Favored Glycine 0 CA--C 1.486 -1.731 0 N-CA-C 108.624 -1.791 . . . . 0.0 108.624 -176.275 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 86.8 mt-30 -142.9 134.39 26.34 Favored 'General case' 0 CA--C 1.479 -1.782 0 N-CA-C 104.456 -2.424 . . . . 0.0 104.456 -179.333 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 35.6 tp -114.77 96.17 5.59 Favored 'General case' 0 N--CA 1.437 -1.102 0 N-CA-C 103.659 -2.719 . . . . 0.0 103.659 176.468 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 21.8 mt -88.76 135.37 25.92 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.048 0 N-CA-C 104.213 -2.514 . . . . 0.0 104.213 -177.275 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 14.2 p -124.96 112.14 16.24 Favored 'General case' 0 N--CA 1.435 -1.212 0 N-CA-C 107.777 -1.194 . . . . 0.0 107.777 -171.771 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 2.0 mp -93.48 134.84 29.87 Favored 'Isoleucine or valine' 0 CA--C 1.488 -1.41 0 N-CA-C 104.506 -2.405 . . . . 0.0 104.506 -165.703 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 74.4 mt-30 -92.66 149.9 21.04 Favored 'General case' 0 CA--C 1.493 -1.249 0 N-CA-C 106.522 -1.659 . . . . 0.0 106.522 -178.687 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 44.6 tt0 -70.46 105.71 3.16 Favored 'General case' 0 N--CA 1.441 -0.894 0 C-N-CA 123.44 0.696 . . . . 0.0 110.408 -177.997 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 31.6 m-85 59.94 41.03 18.29 Favored 'General case' 0 C--N 1.356 0.883 0 C-N-CA 127.094 2.157 . . . . 0.0 112.469 -178.626 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -149.94 -126.11 1.39 Allowed Glycine 0 C--N 1.358 1.752 0 N-CA-C 109.283 -1.527 . . . . 0.0 109.283 178.738 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 47.1 m80 -85.11 -176.26 6.1 Favored 'General case' 0 CA--C 1.497 -1.071 0 C-N-CA 126.107 1.763 . . . . 0.0 111.436 -165.555 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 70.1 mt-30 -130.42 144.47 51.41 Favored 'General case' 0 CA--C 1.496 -1.101 0 N-CA-C 103.975 -2.602 . . . . 0.0 103.975 168.659 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 57.3 mt-10 -131.28 131.32 43.77 Favored 'General case' 0 CA--C 1.491 -1.304 0 N-CA-C 105.312 -2.107 . . . . 0.0 105.312 179.721 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 12.4 p -104.48 134.82 44.78 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.799 0 N-CA-C 108.137 -1.06 . . . . 0.0 108.137 -174.914 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 40.0 m -109.11 131.71 54.81 Favored 'General case' 0 N--CA 1.44 -0.926 0 N-CA-C 101.831 -3.396 . . . . 0.0 101.831 171.403 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 87.5 mtt180 -123.75 149.01 46.11 Favored 'General case' 0 CA--C 1.494 -1.174 0 CA-C-N 119.491 1.041 . . . . 0.0 109.901 -177.92 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 14.8 p90 -163.25 -179.61 6.73 Favored 'General case' 0 CA--C 1.499 -0.988 0 N-CA-C 107.209 -1.404 . . . . 0.0 107.209 -179.149 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 9.3 p-10 -141.31 160.16 40.7 Favored 'General case' 0 N--CA 1.44 -0.963 0 N-CA-C 105.865 -1.902 . . . . 0.0 105.865 167.005 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 23.4 p90 -148.3 170.17 18.5 Favored 'General case' 0 CA--C 1.49 -1.358 0 N-CA-C 107.332 -1.358 . . . . 0.0 107.332 177.294 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 23.9 p -119.25 142.53 47.97 Favored 'General case' 0 CA--C 1.498 -1.024 0 N-CA-C 105.696 -1.965 . . . . 0.0 105.696 171.458 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 45.0 m -115.7 119.83 37.35 Favored 'General case' 0 CA--C 1.495 -1.143 0 N-CA-C 102.614 -3.106 . . . . 0.0 102.614 170.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . 0.438 ' HA ' ' H ' ' A' ' 66' ' ' GLY . 14.1 t -154.38 159.19 41.0 Favored 'General case' 0 N--CA 1.436 -1.144 0 N-CA-C 105.901 -1.888 . . . . 0.0 105.901 -173.205 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 9.4 t . . . . . 0 C--O 1.262 1.714 0 N-CA-C 106.356 -1.72 . . . . 0.0 106.356 175.042 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 18.7 t . . . . . 0 N--CA 1.483 1.192 0 N-CA-C 109.395 -0.595 . . . . 0.0 109.395 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 155.93 -161.62 30.8 Favored Glycine 0 C--N 1.351 1.382 0 N-CA-C 106.767 -2.533 . . . . 0.0 106.767 -178.324 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_exo -61.2 142.47 96.63 Favored 'Trans proline' 0 N--CA 1.446 -1.307 0 C-N-CA 122.837 2.358 . . . . 0.0 114.523 -171.68 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 4.4 t -76.27 154.29 5.89 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.83 0 C-N-CA 127.889 2.476 . . . . 0.0 106.608 -179.06 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 56.6 mm-40 -99.81 92.88 5.51 Favored 'General case' 0 CA--C 1.49 -1.357 0 N-CA-C 107.412 -1.329 . . . . 0.0 107.412 -177.613 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 1.3 p -108.1 131.32 58.82 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.067 0 CA-C-N 113.15 -1.841 . . . . 0.0 108.684 -164.512 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 40.0 m-85 -94.08 144.42 25.5 Favored 'General case' 0 CA--C 1.498 -1.027 0 N-CA-C 106.611 -1.626 . . . . 0.0 106.611 173.823 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 36.0 mm -114.56 96.26 4.49 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.235 0 N-CA-C 102.911 -2.996 . . . . 0.0 102.911 178.245 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 40.6 p -88.44 98.58 11.71 Favored 'General case' 0 N--CA 1.443 -0.805 0 CA-C-O 122.401 1.096 . . . . 0.0 109.776 -172.336 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 92.3 mt-10 -107.08 40.73 1.6 Allowed 'General case' 0 N--CA 1.443 -0.786 0 N-CA-C 105.874 -1.898 . . . . 0.0 105.874 173.595 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 48.3 m -85.74 -57.27 0.36 Allowed Pre-proline 0 N--CA 1.441 -0.913 0 CA-C-O 115.828 -2.034 . . . . 0.0 108.862 178.36 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_endo -74.69 171.8 17.5 Favored 'Trans proline' 0 CA--C 1.512 -0.596 0 CA-C-N 125.39 2.961 . . . . 0.0 110.381 177.242 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 73.3 m -123.15 103.24 8.43 Favored 'General case' 0 N--CA 1.433 -1.306 0 N-CA-C 106.107 -1.812 . . . . 0.0 106.107 -172.959 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 26.9 mp0 -140.71 134.22 14.91 Favored Pre-proline 0 N--CA 1.442 -0.831 0 N-CA-C 104.084 -2.562 . . . . 0.0 104.084 169.495 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 95.7 Cg_endo -81.91 -11.56 11.2 Favored 'Trans proline' 0 N--CA 1.452 -0.928 0 C-N-CA 123.012 2.475 . . . . 0.0 110.596 -175.762 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 48.5 m-20 -125.02 -20.92 4.8 Favored 'General case' 0 N--CA 1.434 -1.25 0 C-N-CA 123.617 0.767 . . . . 0.0 109.938 -171.791 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 19.4 m -103.8 142.0 35.13 Favored 'General case' 0 CA--C 1.494 -1.192 0 N-CA-C 106.993 -1.484 . . . . 0.0 106.993 178.677 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 61.6 t-80 -139.29 98.0 8.37 Favored Pre-proline 0 N--CA 1.434 -1.273 0 N-CA-C 105.513 -2.032 . . . . 0.0 105.513 176.819 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -80.55 148.86 18.45 Favored 'Trans proline' 0 N--CA 1.445 -1.327 0 C-N-CA 122.468 2.112 . . . . 0.0 109.403 174.315 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.414 HD11 HD11 ' A' ' 35' ' ' LEU . 5.0 pt -124.38 170.72 14.19 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.031 0 N-CA-C 107.525 -1.287 . . . . 0.0 107.525 172.324 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 32.5 mt-30 -139.04 161.17 38.04 Favored 'General case' 0 CA--C 1.501 -0.926 0 N-CA-C 105.161 -2.163 . . . . 0.0 105.161 167.884 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 49.5 p90 -148.56 169.39 20.41 Favored 'General case' 0 CA--C 1.497 -1.089 0 N-CA-C 108.136 -1.061 . . . . 0.0 108.136 175.679 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 20.8 m-80 -134.12 126.04 29.21 Favored 'General case' 0 CA--C 1.491 -1.308 0 N-CA-C 105.573 -2.01 . . . . 0.0 105.573 173.965 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -105.75 175.96 1.9 Allowed Pre-proline 0 N--CA 1.44 -0.969 0 C-N-CA 125.823 1.649 . . . . 0.0 107.647 -169.967 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_exo -61.6 144.86 97.92 Favored 'Trans proline' 0 N--CA 1.455 -0.766 0 C-N-CA 123.174 2.583 . . . . 0.0 113.151 176.488 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 22.0 tt0 -82.8 -39.98 0.83 Allowed Pre-proline 0 N--CA 1.443 -0.818 0 CA-C-O 115.564 -2.16 . . . . 0.0 112.726 -173.034 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 76.2 Cg_exo -72.18 4.65 3.15 Favored 'Trans proline' 0 C--N 1.349 0.561 0 CA-C-N 125.687 3.067 . . . . 0.0 114.679 -178.234 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 34.7 m 71.89 64.66 0.14 Allowed 'General case' 0 CA--C 1.499 -0.984 0 C-N-CA 126.464 1.905 . . . . 0.0 109.06 -178.432 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 55.9 t-80 -87.0 -28.11 22.83 Favored 'General case' 0 N--CA 1.44 -0.957 0 C-N-CA 125.127 1.371 . . . . 0.0 108.25 178.772 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 8.2 mm -119.29 147.61 22.76 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.15 0 N-CA-C 106.395 -1.706 . . . . 0.0 106.395 -170.959 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 74.5 m -99.35 -83.9 0.42 Allowed 'General case' 0 N--CA 1.43 -1.45 0 N-CA-C 106.406 -1.701 . . . . 0.0 106.406 175.896 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 45.5 mtpt -90.0 170.48 10.32 Favored 'General case' 0 CA--C 1.49 -1.349 0 C-N-CA 125.259 1.424 . . . . 0.0 109.198 -164.242 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 42.2 m-85 -131.39 145.4 51.8 Favored 'General case' 0 CA--C 1.498 -1.032 0 N-CA-C 104.589 -2.374 . . . . 0.0 104.589 166.624 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 33.1 mt -123.34 137.37 56.89 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.188 0 N-CA-C 101.792 -3.41 . . . . 0.0 101.792 170.248 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.414 HD11 HD11 ' A' ' 20' ' ' ILE . 4.7 mt -114.09 134.47 54.86 Favored 'General case' 0 CA--C 1.467 -2.214 0 N-CA-C 104.64 -2.356 . . . . 0.0 104.64 168.764 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 49.0 mtp180 -118.05 158.74 24.44 Favored 'General case' 0 N--CA 1.431 -1.417 0 N-CA-C 105.381 -2.081 . . . . 0.0 105.381 167.301 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 49.5 p90 -152.63 158.29 42.21 Favored 'General case' 0 N--CA 1.435 -1.21 0 N-CA-C 105.981 -1.859 . . . . 0.0 105.981 173.033 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 46.9 ttp180 -165.08 135.99 3.14 Favored Pre-proline 0 CA--C 1.497 -1.078 0 N-CA-C 104.783 -2.303 . . . . 0.0 104.783 -174.168 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -73.06 117.06 4.95 Favored 'Trans proline' 0 CA--C 1.505 -0.969 0 C-N-CA 122.766 2.311 . . . . 0.0 109.132 -176.829 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 37.9 ttpt -70.71 88.0 0.7 Allowed 'General case' 0 CA--C 1.499 -0.982 0 C-N-CA 126.414 1.886 . . . . 0.0 109.621 -179.939 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 -154.32 -58.55 0.12 Allowed 'General case' 0 N--CA 1.431 -1.401 0 N-CA-C 103.447 -2.797 . . . . 0.0 103.447 -178.521 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 6.4 t -107.32 -167.53 1.28 Allowed 'General case' 0 N--CA 1.439 -0.977 0 N-CA-C 105.228 -2.138 . . . . 0.0 105.228 169.376 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 2.7 m -134.84 63.44 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.44 -0.957 0 N-CA-C 104.823 -2.288 . . . . 0.0 104.823 179.18 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -91.23 -134.71 6.21 Favored Glycine 0 C--N 1.354 1.545 0 N-CA-C 109.819 -1.312 . . . . 0.0 109.819 -176.415 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -94.37 149.57 21.12 Favored 'General case' 0 CA--C 1.499 -1.003 0 N-CA-C 106.871 -1.529 . . . . 0.0 106.871 -176.498 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 64.2 m95 -93.84 151.42 19.61 Favored 'General case' 0 N--CA 1.439 -1.022 0 N-CA-C 107.703 -1.221 . . . . 0.0 107.703 178.825 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 61.9 mttp -96.99 152.32 18.84 Favored 'General case' 0 CA--C 1.488 -1.433 0 N-CA-C 104.105 -2.554 . . . . 0.0 104.105 161.073 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -152.69 155.44 37.27 Favored 'General case' 0 N--CA 1.435 -1.204 0 N-CA-C 108.23 -1.026 . . . . 0.0 108.23 -178.073 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -140.85 161.48 37.72 Favored 'General case' 0 CA--C 1.498 -1.028 0 N-CA-C 106.556 -1.646 . . . . 0.0 106.556 174.74 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 87.0 m -118.83 124.82 48.12 Favored 'General case' 0 CA--C 1.5 -0.954 0 N-CA-C 105.517 -2.031 . . . . 0.0 105.517 178.807 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 3.9 mp -106.13 134.37 19.8 Favored Pre-proline 0 N--CA 1.437 -1.099 0 N-CA-C 105.279 -2.119 . . . . 0.0 105.279 -177.468 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_exo -63.93 163.07 26.53 Favored 'Trans proline' 0 CA--C 1.507 -0.833 0 C-N-CA 123.491 2.794 . . . . 0.0 113.146 176.115 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -74.49 -17.14 79.82 Favored Glycine 0 C--N 1.351 1.41 0 C-N-CA 124.006 0.812 . . . . 0.0 114.477 -173.68 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 49.1 p-80 -84.04 -28.69 27.45 Favored 'General case' 0 C--N 1.355 0.826 0 CA-C-N 118.144 0.972 . . . . 0.0 110.22 -179.69 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 89.1 mt -88.74 130.83 35.26 Favored 'General case' 0 CA--C 1.5 -0.961 0 N-CA-C 107.94 -1.133 . . . . 0.0 107.94 178.07 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 7.7 p30 -117.1 11.37 14.18 Favored 'General case' 0 CA--C 1.503 -0.835 0 C-N-CA 124.225 1.01 . . . . 0.0 109.774 -173.563 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 28.1 p -141.02 159.83 41.38 Favored 'General case' 0 CA--C 1.497 -1.081 0 N-CA-C 106.583 -1.636 . . . . 0.0 106.583 179.427 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 7.9 t80 -135.65 172.95 12.27 Favored 'General case' 0 C--N 1.359 1.003 0 CA-C-O 121.829 0.823 . . . . 0.0 109.254 178.84 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 98.8 m -137.18 110.79 8.04 Favored 'General case' 0 N--CA 1.434 -1.257 0 N-CA-C 104.425 -2.435 . . . . 0.0 104.425 173.77 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 24.9 mt -89.28 143.39 11.27 Favored 'Isoleucine or valine' 0 C--N 1.358 0.945 0 N-CA-C 103.662 -2.718 . . . . 0.0 103.662 169.854 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -149.55 158.1 43.87 Favored 'General case' 0 CA--C 1.491 -1.302 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 -178.85 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 77.75 56.58 3.79 Favored Glycine 0 C--N 1.354 1.561 0 N-CA-C 108.984 -1.646 . . . . 0.0 108.984 -179.904 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 69.1 mt -117.08 -160.83 0.78 Allowed 'General case' 0 CA--C 1.5 -0.944 0 N-CA-C 106.584 -1.636 . . . . 0.0 106.584 -179.012 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -131.39 153.42 81.62 Favored Pre-proline 0 N--CA 1.443 -0.811 0 N-CA-C 106.067 -1.827 . . . . 0.0 106.067 -177.78 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 67.6 Cg_endo -79.4 162.45 25.12 Favored 'Trans proline' 0 N--CA 1.453 -0.886 0 C-N-CA 122.858 2.372 . . . . 0.0 109.925 171.893 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 0.504 ' H ' ' HA ' ' A' ' 92' ' ' THR . . . 61.17 26.96 66.62 Favored Glycine 0 N--CA 1.431 -1.646 0 C-N-CA 127.27 2.367 . . . . 0.0 115.972 171.509 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 9.1 p -127.59 142.92 42.31 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.116 0 N-CA-C 108.28 -1.007 . . . . 0.0 108.28 -177.83 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 7.5 p -95.58 128.41 46.79 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.929 0 N-CA-C 107.463 -1.31 . . . . 0.0 107.463 177.029 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 91.5 m-85 -107.73 148.46 29.42 Favored 'General case' 0 CA--C 1.498 -1.039 0 N-CA-C 106.382 -1.71 . . . . 0.0 106.382 174.235 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -98.98 140.04 33.73 Favored 'General case' 0 CA--C 1.496 -1.121 0 N-CA-C 104.397 -2.445 . . . . 0.0 104.397 161.826 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -131.96 153.29 20.45 Favored Glycine 0 CA--C 1.484 -1.848 0 N-CA-C 107.688 -2.165 . . . . 0.0 107.688 -175.807 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 36.7 mt-30 -135.58 136.18 40.88 Favored 'General case' 0 CA--C 1.478 -1.791 0 N-CA-C 105.935 -1.876 . . . . 0.0 105.935 175.166 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 27.1 tp -114.39 103.31 10.94 Favored 'General case' 0 N--CA 1.438 -1.063 0 N-CA-C 104.179 -2.526 . . . . 0.0 104.179 176.456 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 24.4 mt -103.25 125.11 57.77 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.973 0 N-CA-C 104.068 -2.568 . . . . 0.0 104.068 -174.23 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 74.2 m -110.28 120.75 43.45 Favored 'General case' 0 CA--C 1.497 -1.091 0 N-CA-C 108.251 -1.018 . . . . 0.0 108.251 -175.653 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 1.8 mp -99.85 138.38 24.38 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.123 0 N-CA-C 104.647 -2.353 . . . . 0.0 104.647 -170.798 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 16.3 tt0 -105.09 127.84 53.07 Favored 'General case' 0 CA--C 1.494 -1.207 0 N-CA-C 102.02 -3.326 . . . . 0.0 102.02 170.692 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 63.5 tp60 -68.38 114.68 7.03 Favored 'General case' 0 C--N 1.355 0.825 0 C-N-CA 123.117 0.567 . . . . 0.0 111.163 -168.77 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 44.4 m-85 59.33 51.68 6.57 Favored 'General case' 0 C--N 1.358 0.936 0 C-N-CA 126.917 2.087 . . . . 0.0 111.703 -175.498 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -164.73 -117.29 0.4 Allowed Glycine 0 N--CA 1.434 -1.464 0 N-CA-C 108.503 -1.839 . . . . 0.0 108.503 178.042 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 24.0 t-80 -82.08 165.52 20.52 Favored 'General case' 0 N--CA 1.441 -0.919 0 C-N-CA 125.706 1.603 . . . . 0.0 110.795 -169.097 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 41.6 mt-30 -139.96 128.67 23.14 Favored 'General case' 0 CA--C 1.495 -1.151 0 N-CA-C 104.192 -2.521 . . . . 0.0 104.192 169.044 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -99.82 154.31 18.44 Favored 'General case' 0 CA--C 1.498 -1.033 0 N-CA-C 105.363 -2.088 . . . . 0.0 105.363 175.598 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 7.6 p -135.26 135.71 51.93 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.885 0 N-CA-C 107.929 -1.137 . . . . 0.0 107.929 177.533 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 48.6 m -122.01 141.5 51.28 Favored 'General case' 0 N--CA 1.44 -0.939 0 N-CA-C 103.143 -2.91 . . . . 0.0 103.143 175.742 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 32.2 ttm180 -131.72 139.42 49.0 Favored 'General case' 0 CA--C 1.502 -0.891 0 N-CA-C 107.805 -1.183 . . . . 0.0 107.805 170.346 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 8.2 p90 -146.25 179.58 7.41 Favored 'General case' 0 N--CA 1.439 -0.979 0 N-CA-C 105.807 -1.923 . . . . 0.0 105.807 177.985 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 52.9 m-20 -128.09 152.95 47.37 Favored 'General case' 0 CA--C 1.5 -0.96 0 N-CA-C 105.757 -1.942 . . . . 0.0 105.757 169.481 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 21.8 p90 -143.56 166.37 25.02 Favored 'General case' 0 CA--C 1.485 -1.548 0 N-CA-C 107.498 -1.297 . . . . 0.0 107.498 170.42 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 27.8 p -118.56 143.3 46.86 Favored 'General case' 0 CA--C 1.497 -1.082 0 N-CA-C 106.051 -1.833 . . . . 0.0 106.051 173.672 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 30.3 m -118.39 113.18 21.0 Favored 'General case' 0 CA--C 1.494 -1.185 0 N-CA-C 101.576 -3.49 . . . . 0.0 101.576 170.068 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . 0.504 ' HA ' ' H ' ' A' ' 66' ' ' GLY . 10.0 t -157.57 -37.37 0.07 Allowed 'General case' 0 N--CA 1.437 -1.088 0 N-CA-C 107.819 -1.178 . . . . 0.0 107.819 -169.088 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 89.4 p . . . . . 0 C--O 1.259 1.592 0 C-N-CA 126.962 2.105 . . . . 0.0 112.192 -174.66 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 85.1 p . . . . . 0 N--CA 1.487 1.416 0 CA-C-O 121.632 0.729 . . . . 0.0 111.89 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 173.97 179.0 44.32 Favored Glycine 0 N--CA 1.436 -1.353 0 N-CA-C 107.075 -2.41 . . . . 0.0 107.075 178.825 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_exo -60.23 146.8 95.62 Favored 'Trans proline' 0 N--CA 1.446 -1.309 0 C-N-CA 123.151 2.567 . . . . 0.0 115.553 -169.676 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 6.7 t -77.42 153.12 5.44 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.773 0 C-N-CA 127.631 2.372 . . . . 0.0 105.424 174.309 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 94.7 mt-10 -100.27 95.26 6.67 Favored 'General case' 0 CA--C 1.494 -1.19 0 CA-C-O 121.885 0.85 . . . . 0.0 108.742 -170.621 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 1.8 p -115.3 136.05 53.32 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.999 0 C-N-CA 124.938 1.295 . . . . 0.0 108.365 -164.777 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 83.3 m-85 -86.74 148.78 25.28 Favored 'General case' 0 CA--C 1.498 -1.03 0 C-N-CA 125.063 1.345 . . . . 0.0 108.589 -179.14 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 45.2 mt -120.04 144.22 29.38 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.973 0 N-CA-C 102.826 -3.027 . . . . 0.0 102.826 179.377 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 24.9 p -126.89 99.89 5.93 Favored 'General case' 0 C--N 1.356 0.85 0 N-CA-C 105.897 -1.89 . . . . 0.0 105.897 176.209 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -106.73 34.22 3.53 Favored 'General case' 0 C--N 1.356 0.878 0 N-CA-C 108.025 -1.102 . . . . 0.0 108.025 177.284 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 33.1 p -89.45 157.96 46.52 Favored Pre-proline 0 N--CA 1.443 -0.817 0 N-CA-C 106.365 -1.717 . . . . 0.0 106.365 175.713 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 63.9 Cg_endo -78.36 84.04 2.1 Favored 'Trans proline' 0 N--CA 1.45 -1.042 0 C-N-CA 122.878 2.385 . . . . 0.0 109.178 169.306 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 63.0 m -157.54 32.29 0.27 Allowed 'General case' 0 CA--C 1.498 -1.048 0 CA-C-O 122.473 1.13 . . . . 0.0 110.514 -178.969 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 14.0 mp0 -138.39 86.85 16.17 Favored Pre-proline 0 CA--C 1.507 -0.692 0 CA-C-N 114.183 -1.371 . . . . 0.0 108.588 -178.894 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -86.9 -2.85 8.15 Favored 'Trans proline' 0 N--CA 1.449 -1.089 0 C-N-CA 122.478 2.119 . . . . 0.0 110.565 -177.578 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -165.8 -39.22 0.03 OUTLIER 'General case' 0 CA--C 1.488 -1.412 0 O-C-N 123.711 0.632 . . . . 0.0 110.469 -174.854 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 15.5 p -126.42 138.22 53.51 Favored 'General case' 0 CA--C 1.489 -1.371 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 -169.078 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 67.7 t60 -117.56 113.75 38.34 Favored Pre-proline 0 N--CA 1.438 -1.027 0 CA-C-N 114.238 -1.346 . . . . 0.0 107.878 -175.377 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 62.5 Cg_endo -78.28 128.6 9.02 Favored 'Trans proline' 0 N--CA 1.45 -1.04 0 C-N-CA 122.949 2.433 . . . . 0.0 110.405 175.813 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 9.6 mm -105.92 136.08 41.65 Favored 'Isoleucine or valine' 0 C--N 1.354 0.792 0 N-CA-C 103.485 -2.783 . . . . 0.0 103.485 169.833 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 67.5 mt-30 -136.41 147.8 47.46 Favored 'General case' 0 CA--C 1.495 -1.148 0 N-CA-C 104.562 -2.384 . . . . 0.0 104.562 174.18 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 45.9 p90 -147.15 170.04 18.03 Favored 'General case' 0 CA--C 1.494 -1.186 0 N-CA-C 108.002 -1.11 . . . . 0.0 108.002 -175.673 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 26.6 m-80 -136.01 131.82 35.5 Favored 'General case' 0 CA--C 1.49 -1.354 0 N-CA-C 105.377 -2.083 . . . . 0.0 105.377 177.635 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -101.2 170.91 5.94 Favored Pre-proline 0 N--CA 1.439 -0.992 0 C-N-CA 124.541 1.136 . . . . 0.0 108.402 -172.651 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_exo -64.9 165.32 21.63 Favored 'Trans proline' 0 CA--C 1.51 -0.694 0 C-N-CA 123.701 2.934 . . . . 0.0 112.83 173.712 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 79.8 mt-30 -81.51 -55.61 0.62 Allowed Pre-proline 0 N--CA 1.442 -0.829 0 CA-C-O 115.612 -2.137 . . . . 0.0 112.042 -175.58 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_endo -75.29 173.56 14.3 Favored 'Trans proline' 0 CA--C 1.509 -0.726 0 CA-C-N 125.797 3.106 . . . . 0.0 110.431 -179.581 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 52.3 p -73.1 123.83 24.35 Favored 'General case' 0 C--N 1.355 0.845 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 179.014 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 58.7 t60 -160.85 -50.78 0.05 OUTLIER 'General case' 0 CA--C 1.492 -1.253 0 N-CA-C 106.639 -1.615 . . . . 0.0 106.639 -165.143 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 35.5 mt -116.7 140.3 39.73 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.169 0 N-CA-C 105.217 -2.142 . . . . 0.0 105.217 -175.625 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 72.8 m -106.06 -87.55 0.46 Allowed 'General case' 0 N--CA 1.429 -1.484 0 N-CA-C 105.916 -1.883 . . . . 0.0 105.916 178.605 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 53.9 mtmt -91.41 172.33 8.6 Favored 'General case' 0 CA--C 1.485 -1.547 0 C-N-CA 124.927 1.291 . . . . 0.0 108.235 -166.838 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 36.1 m-85 -131.5 151.91 51.17 Favored 'General case' 0 CA--C 1.496 -1.11 0 N-CA-C 105.071 -2.196 . . . . 0.0 105.071 169.164 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 24.6 mt -121.28 134.23 65.3 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.162 0 N-CA-C 101.939 -3.356 . . . . 0.0 101.939 164.941 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 6.5 mt -105.93 123.6 48.23 Favored 'General case' 0 CA--C 1.48 -1.748 0 N-CA-C 104.011 -2.589 . . . . 0.0 104.011 166.669 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 42.8 ttp85 -127.7 123.5 35.58 Favored 'General case' 0 N--CA 1.436 -1.128 0 N-CA-C 105.515 -2.032 . . . . 0.0 105.515 -179.094 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 41.6 p90 -136.86 150.29 48.19 Favored 'General case' 0 CA--C 1.503 -0.841 0 N-CA-C 107.681 -1.229 . . . . 0.0 107.681 -170.89 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 43.3 ptt85 -141.33 158.4 63.99 Favored Pre-proline 0 CA--C 1.499 -1.0 0 N-CA-C 105.754 -1.943 . . . . 0.0 105.754 168.713 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -72.3 164.96 34.04 Favored 'Trans proline' 0 N--CA 1.453 -0.856 0 C-N-CA 123.306 2.671 . . . . 0.0 107.811 162.45 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 5.4 ptmm? -63.66 88.02 0.04 OUTLIER 'General case' 0 C--N 1.357 0.914 0 CA-C-O 122.584 1.183 . . . . 0.0 112.592 172.402 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 31.5 m120 -130.39 -132.09 0.21 Allowed 'General case' 0 N--CA 1.44 -0.952 0 N-CA-C 104.593 -2.373 . . . . 0.0 104.593 176.302 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 57.0 p -99.44 174.24 6.37 Favored 'General case' 0 C--N 1.355 0.811 0 N-CA-C 107.671 -1.233 . . . . 0.0 107.671 176.388 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 9.5 m -100.6 41.63 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.354 0.772 0 C-N-CA 124.758 1.223 . . . . 0.0 108.142 179.128 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -85.13 -99.62 0.68 Allowed Glycine 0 C--N 1.355 1.587 0 N-CA-C 108.532 -1.827 . . . . 0.0 108.532 -179.618 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 96.3 mtm-85 -97.93 141.55 30.76 Favored 'General case' 0 CA--C 1.499 -1.012 0 N-CA-C 107.204 -1.406 . . . . 0.0 107.204 176.278 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 14.6 m95 -121.63 171.78 8.59 Favored 'General case' 0 N--CA 1.439 -1.014 0 N-CA-C 105.413 -2.069 . . . . 0.0 105.413 -177.366 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -101.72 150.27 23.3 Favored 'General case' 0 CA--C 1.486 -1.491 0 N-CA-C 105.072 -2.196 . . . . 0.0 105.072 169.167 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -153.96 158.18 40.27 Favored 'General case' 0 CA--C 1.495 -1.171 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 179.841 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -138.59 160.12 40.39 Favored 'General case' 0 N--CA 1.438 -1.068 0 N-CA-C 105.186 -2.153 . . . . 0.0 105.186 173.94 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 81.6 m -115.88 123.15 47.4 Favored 'General case' 0 CA--C 1.496 -1.12 0 N-CA-C 104.775 -2.306 . . . . 0.0 104.775 177.895 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 3.8 mm -101.18 135.59 19.88 Favored Pre-proline 0 N--CA 1.437 -1.095 0 N-CA-C 105.669 -1.975 . . . . 0.0 105.669 -176.349 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 95.4 Cg_exo -63.69 161.02 33.81 Favored 'Trans proline' 0 CA--C 1.508 -0.805 0 C-N-CA 123.354 2.703 . . . . 0.0 112.257 172.093 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -78.38 -18.25 76.39 Favored Glycine 0 C--N 1.352 1.448 0 C-N-CA 123.439 0.543 . . . . 0.0 113.491 -172.685 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 48.0 p-80 -83.78 -27.18 29.02 Favored 'General case' 0 C--N 1.355 0.838 0 CA-C-N 117.695 0.747 . . . . 0.0 109.923 179.737 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 88.3 mt -88.74 130.43 35.34 Favored 'General case' 0 CA--C 1.498 -1.043 0 N-CA-C 107.977 -1.119 . . . . 0.0 107.977 177.539 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 7.7 p30 -117.98 16.67 14.23 Favored 'General case' 0 CA--C 1.501 -0.929 0 C-N-CA 124.359 1.064 . . . . 0.0 108.935 -177.026 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 35.9 p -144.53 161.77 38.24 Favored 'General case' 0 N--CA 1.438 -1.039 0 N-CA-C 107.204 -1.406 . . . . 0.0 107.204 -179.796 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 12.0 t80 -152.83 178.65 9.42 Favored 'General case' 0 N--CA 1.438 -1.032 0 N-CA-C 106.955 -1.498 . . . . 0.0 106.955 179.687 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 80.8 m -144.34 115.59 7.98 Favored 'General case' 0 N--CA 1.426 -1.633 0 N-CA-C 103.752 -2.684 . . . . 0.0 103.752 174.421 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 53.9 mt -92.58 108.38 20.18 Favored 'Isoleucine or valine' 0 C--N 1.354 0.767 0 N-CA-C 105.236 -2.135 . . . . 0.0 105.236 175.906 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 10.0 mtmp? -108.23 163.74 12.91 Favored 'General case' 0 CA--C 1.498 -1.054 0 CA-C-O 121.547 0.689 . . . . 0.0 109.143 -175.531 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 80.37 50.67 5.28 Favored Glycine 0 CA--C 1.489 -1.552 0 N-CA-C 108.713 -1.755 . . . . 0.0 108.713 174.987 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 75.7 mt -121.72 163.81 18.45 Favored 'General case' 0 CA--C 1.498 -1.027 0 N-CA-C 106.954 -1.499 . . . . 0.0 106.954 -175.748 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 53.2 mtmt -98.78 147.83 33.73 Favored Pre-proline 0 N--CA 1.44 -0.926 0 N-CA-C 107.026 -1.472 . . . . 0.0 107.026 -177.096 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -76.58 162.66 32.82 Favored 'Trans proline' 0 N--CA 1.451 -1.025 0 C-N-CA 122.95 2.433 . . . . 0.0 109.85 169.832 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 0.444 ' H ' ' HA ' ' A' ' 92' ' ' THR . . . 63.34 23.44 66.49 Favored Glycine 0 N--CA 1.428 -1.84 0 C-N-CA 127.417 2.437 . . . . 0.0 116.619 174.905 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 6.5 p -128.84 145.39 35.76 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.857 0 N-CA-C 107.966 -1.124 . . . . 0.0 107.966 -179.684 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 10.7 p -96.83 129.94 46.15 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.857 0 CA-C-O 123.187 1.47 . . . . 0.0 108.537 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 80.0 m-85 -104.65 145.11 30.79 Favored 'General case' 0 N--CA 1.432 -1.373 0 N-CA-C 106.435 -1.691 . . . . 0.0 106.435 176.563 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -91.02 133.1 35.58 Favored 'General case' 0 N--CA 1.442 -0.855 0 N-CA-C 105.336 -2.098 . . . . 0.0 105.336 159.502 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -130.26 158.69 22.51 Favored Glycine 0 C--N 1.355 1.61 0 N-CA-C 108.229 -1.948 . . . . 0.0 108.229 -179.897 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 32.0 mt-30 -149.77 138.57 20.96 Favored 'General case' 0 CA--C 1.484 -1.561 0 N-CA-C 105.422 -2.066 . . . . 0.0 105.422 -178.717 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 52.7 tp -117.47 98.21 6.28 Favored 'General case' 0 N--CA 1.437 -1.08 0 N-CA-C 104.846 -2.279 . . . . 0.0 104.846 179.436 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 48.0 mt -89.63 133.98 30.13 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.962 0 N-CA-C 104.558 -2.386 . . . . 0.0 104.558 -179.585 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 12.1 p -117.13 117.4 29.49 Favored 'General case' 0 N--CA 1.438 -1.075 0 N-CA-C 107.728 -1.212 . . . . 0.0 107.728 -178.427 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 2.6 mp -94.07 130.67 42.66 Favored 'Isoleucine or valine' 0 CA--C 1.487 -1.478 0 N-CA-C 103.455 -2.795 . . . . 0.0 103.455 -172.677 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 21.5 mt-30 -101.84 161.89 13.32 Favored 'General case' 0 CA--C 1.491 -1.295 0 CA-C-N 114.849 -1.069 . . . . 0.0 108.817 -169.845 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 14.4 pt20 -76.29 34.0 0.13 Allowed 'General case' 0 C--N 1.354 0.794 0 C-N-CA 126.537 1.935 . . . . 0.0 113.186 173.943 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 6.4 t80 -148.67 14.13 0.94 Allowed 'General case' 0 N--CA 1.437 -1.095 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 178.366 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 80.26 1.84 88.57 Favored Glycine 0 C--N 1.351 1.412 0 C-N-CA 123.897 0.761 . . . . 0.0 112.732 176.864 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 86.2 t60 -81.9 158.47 23.96 Favored 'General case' 0 N--CA 1.44 -0.953 0 N-CA-C 107.842 -1.17 . . . . 0.0 107.842 -178.918 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 71.7 mt-30 -138.33 110.29 7.24 Favored 'General case' 0 CA--C 1.491 -1.322 0 N-CA-C 102.854 -3.017 . . . . 0.0 102.854 178.976 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 16.8 tp10 -100.76 132.1 46.32 Favored 'General case' 0 CA--C 1.495 -1.153 0 N-CA-C 105.215 -2.143 . . . . 0.0 105.215 -179.94 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 6.6 p -109.25 134.94 49.69 Favored 'Isoleucine or valine' 0 C--N 1.355 0.818 0 N-CA-C 107.58 -1.267 . . . . 0.0 107.58 -174.061 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 90.8 m -110.66 138.61 46.83 Favored 'General case' 0 N--CA 1.44 -0.927 0 N-CA-C 102.477 -3.157 . . . . 0.0 102.477 171.272 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 16.7 ptm180 -129.67 152.39 49.23 Favored 'General case' 0 CA--C 1.499 -1.011 0 CA-C-N 118.84 0.745 . . . . 0.0 110.025 176.918 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 18.5 p90 -165.53 -177.95 4.67 Favored 'General case' 0 CA--C 1.5 -0.956 0 N-CA-C 106.323 -1.732 . . . . 0.0 106.323 -175.731 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 45.7 p-10 -134.22 158.16 44.42 Favored 'General case' 0 N--CA 1.44 -0.945 0 N-CA-C 106.286 -1.746 . . . . 0.0 106.286 166.608 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 24.3 p90 -143.1 164.61 29.67 Favored 'General case' 0 CA--C 1.482 -1.641 0 N-CA-C 106.785 -1.561 . . . . 0.0 106.785 170.838 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 38.4 p -113.73 141.61 47.05 Favored 'General case' 0 CA--C 1.498 -1.042 0 N-CA-C 105.919 -1.882 . . . . 0.0 105.919 172.749 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 97.5 m -109.57 112.84 25.16 Favored 'General case' 0 CA--C 1.491 -1.325 1 N-CA-C 100.189 -4.004 . . . . 0.0 100.189 168.041 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . 0.444 ' HA ' ' H ' ' A' ' 66' ' ' GLY . 11.9 t -159.24 149.79 19.49 Favored 'General case' 0 N--CA 1.437 -1.113 0 N-CA-C 105.375 -2.083 . . . . 0.0 105.375 -174.981 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 25.7 t . . . . . 0 C--O 1.261 1.708 0 N-CA-C 104.89 -2.263 . . . . 0.0 104.89 171.411 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 99.8 p . . . . . 0 N--CA 1.488 1.468 0 CA-C-O 121.471 0.653 . . . . 0.0 111.185 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -158.24 -168.6 20.72 Favored Glycine 0 N--CA 1.435 -1.383 0 N-CA-C 106.309 -2.716 . . . . 0.0 106.309 179.854 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 92.5 Cg_exo -62.37 138.14 69.46 Favored 'Trans proline' 0 N--CA 1.445 -1.356 0 C-N-CA 122.923 2.416 . . . . 0.0 112.973 -171.282 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 2.9 t -77.76 152.65 5.35 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.672 0 C-N-CA 126.443 1.897 . . . . 0.0 106.098 -179.805 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 52.7 mt-10 -96.16 91.34 5.87 Favored 'General case' 0 CA--C 1.494 -1.201 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 -173.335 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.409 ' HA ' ' HA ' ' A' ' 22' ' ' TRP . 2.1 p -110.22 129.43 65.27 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.075 0 N-CA-C 107.438 -1.319 . . . . 0.0 107.438 -164.967 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 75.6 m-85 -133.55 155.81 48.95 Favored 'General case' 0 CA--C 1.496 -1.109 0 N-CA-C 106.043 -1.836 . . . . 0.0 106.043 -175.035 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.429 HD12 ' HE1' ' A' ' 18' ' ' HIS . 50.3 mm -110.56 102.49 14.05 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.262 0 N-CA-C 105.689 -1.967 . . . . 0.0 105.689 -178.336 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 14.8 t -158.37 159.76 36.18 Favored 'General case' 0 N--CA 1.437 -1.079 0 N-CA-C 105.04 -2.207 . . . . 0.0 105.04 174.128 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 149.21 -64.91 0.0 OUTLIER 'General case' 0 CA--C 1.494 -1.19 0 N-CA-C 102.702 -3.073 . . . . 0.0 102.702 171.947 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 5.3 t -155.08 87.45 3.28 Favored Pre-proline 0 N--CA 1.439 -0.996 0 N-CA-C 105.504 -2.036 . . . . 0.0 105.504 175.919 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 70.0 Cg_endo -86.32 34.87 0.46 Allowed 'Trans proline' 0 N--CA 1.457 -0.625 0 C-N-CA 123.472 2.781 . . . . 0.0 110.281 174.547 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 68.6 m -122.62 42.41 3.18 Favored 'General case' 0 CA--C 1.499 -1.012 0 N-CA-C 106.781 -1.563 . . . . 0.0 106.781 178.535 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 99.1 mm-40 -136.47 113.15 10.17 Favored Pre-proline 0 N--CA 1.439 -0.997 0 CA-C-N 113.024 -1.898 . . . . 0.0 106.882 -175.094 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 98.7 Cg_endo -89.6 -7.41 4.8 Favored 'Trans proline' 0 N--CA 1.453 -0.874 0 C-N-CA 122.76 2.306 . . . . 0.0 110.156 175.347 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 6.9 p-10 -102.79 -40.96 6.35 Favored 'General case' 0 CA--C 1.49 -1.356 0 C-N-CA 123.583 0.753 . . . . 0.0 109.61 -172.633 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 35.0 p -110.31 153.62 24.63 Favored 'General case' 0 CA--C 1.495 -1.154 0 N-CA-C 107.081 -1.452 . . . . 0.0 107.081 176.189 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . 0.429 ' HE1' HD12 ' A' ' 8' ' ' ILE . 45.0 t-80 -136.85 98.83 10.47 Favored Pre-proline 0 N--CA 1.435 -1.224 0 N-CA-C 106.778 -1.564 . . . . 0.0 106.778 178.695 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -76.51 130.41 11.76 Favored 'Trans proline' 0 N--CA 1.447 -1.252 0 C-N-CA 122.76 2.307 . . . . 0.0 110.005 -177.441 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 14.5 mm -107.69 148.06 12.18 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.017 0 N-CA-C 103.088 -2.93 . . . . 0.0 103.088 176.127 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 4.4 pt20 -149.68 152.3 35.14 Favored 'General case' 0 CA--C 1.489 -1.377 0 N-CA-C 104.299 -2.482 . . . . 0.0 104.299 167.183 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' TRP . . . . . 0.409 ' HA ' ' HA ' ' A' ' 6' ' ' VAL . 44.6 p90 -147.15 166.98 25.31 Favored 'General case' 0 N--CA 1.436 -1.142 0 N-CA-C 106.595 -1.632 . . . . 0.0 106.595 -169.755 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 40.9 m-80 -138.81 132.5 30.68 Favored 'General case' 0 CA--C 1.49 -1.335 0 N-CA-C 107.487 -1.301 . . . . 0.0 107.487 -179.051 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -92.69 175.53 3.18 Favored Pre-proline 0 N--CA 1.44 -0.947 0 C-N-CA 125.696 1.599 . . . . 0.0 109.865 -167.122 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 78.6 Cg_exo -63.94 164.87 20.51 Favored 'Trans proline' 0 N--CA 1.455 -0.757 0 C-N-CA 123.672 2.914 . . . . 0.0 112.491 169.7 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 71.1 tp60 -80.92 -42.42 1.2 Allowed Pre-proline 0 N--CA 1.444 -0.759 0 CA-C-O 115.911 -1.995 . . . . 0.0 110.758 -175.799 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -70.02 -16.49 36.49 Favored 'Trans proline' 0 CA--C 1.512 -0.623 0 CA-C-N 125.382 2.958 . . . . 0.0 112.418 172.505 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 10.4 t 64.95 78.73 0.27 Allowed 'General case' 0 C--N 1.358 0.969 0 C-N-CA 126.545 1.938 . . . . 0.0 109.652 -176.799 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 20.1 t-160 -91.6 -6.68 51.9 Favored 'General case' 0 N--CA 1.442 -0.857 0 C-N-CA 124.755 1.222 . . . . 0.0 109.319 -177.466 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 84.5 mt -113.74 145.55 19.47 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.99 0 N-CA-C 104.736 -2.32 . . . . 0.0 104.736 -173.251 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 25.2 t -103.95 -87.49 0.43 Allowed 'General case' 0 N--CA 1.43 -1.464 0 N-CA-C 105.96 -1.867 . . . . 0.0 105.96 177.241 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 27.4 mtpp -89.58 167.45 12.94 Favored 'General case' 0 CA--C 1.486 -1.504 0 C-N-CA 125.693 1.597 . . . . 0.0 108.94 -163.546 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 90.9 m-85 -134.53 142.72 47.1 Favored 'General case' 0 CA--C 1.493 -1.244 0 N-CA-C 105.072 -2.196 . . . . 0.0 105.072 172.445 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 16.5 mt -123.04 134.45 66.13 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.178 0 N-CA-C 101.786 -3.413 . . . . 0.0 101.786 171.765 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 2.7 mt -110.8 131.48 55.02 Favored 'General case' 0 CA--C 1.473 -1.982 0 N-CA-C 105.715 -1.957 . . . . 0.0 105.715 173.416 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 2.2 mpt_? -115.65 157.72 23.8 Favored 'General case' 0 N--CA 1.428 -1.529 0 N-CA-C 104.981 -2.229 . . . . 0.0 104.981 172.506 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 37.5 p90 -151.01 136.26 17.64 Favored 'General case' 0 N--CA 1.432 -1.363 0 N-CA-C 105.695 -1.965 . . . . 0.0 105.695 171.204 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 15.3 ttp180 -137.39 135.79 19.81 Favored Pre-proline 0 CA--C 1.498 -1.038 0 N-CA-C 103.413 -2.81 . . . . 0.0 103.413 -178.716 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -77.33 155.15 32.48 Favored 'Trans proline' 0 CA--C 1.502 -1.086 0 CA-C-N 123.292 2.211 . . . . 0.0 108.686 179.563 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 70.8 mmtt -73.14 60.71 0.58 Allowed 'General case' 0 C--N 1.356 0.88 0 C-N-CA 125.704 1.601 . . . . 0.0 110.465 170.157 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 29.0 m120 -154.57 -56.93 0.11 Allowed 'General case' 0 N--CA 1.436 -1.17 0 N-CA-C 102.888 -3.004 . . . . 0.0 102.888 -173.163 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 34.8 m -85.31 160.75 19.75 Favored 'General case' 0 N--CA 1.44 -0.941 0 N-CA-C 108.374 -0.973 . . . . 0.0 108.374 178.181 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 17.4 m -131.69 -5.48 1.97 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.784 0 C-N-CA 124.522 1.129 . . . . 0.0 108.821 -173.827 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -142.85 -43.48 0.05 OUTLIER Glycine 0 C--N 1.356 1.644 0 N-CA-C 109.311 -1.516 . . . . 0.0 109.311 -172.656 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 79.7 ttt180 -80.92 126.16 31.02 Favored 'General case' 0 CA--C 1.502 -0.887 0 C-N-CA 124.183 0.993 . . . . 0.0 108.685 -176.89 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -155.97 -177.75 6.8 Favored 'General case' 0 CA--C 1.492 -1.269 0 CA-C-O 121.426 0.632 . . . . 0.0 109.825 -179.681 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 66.7 mttm -130.76 159.91 35.91 Favored 'General case' 0 N--CA 1.435 -1.211 0 N-CA-C 105.402 -2.074 . . . . 0.0 105.402 -175.698 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -149.44 159.84 43.95 Favored 'General case' 0 N--CA 1.434 -1.246 0 N-CA-C 107.691 -1.225 . . . . 0.0 107.691 175.947 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -141.29 157.97 44.51 Favored 'General case' 0 CA--C 1.496 -1.115 0 N-CA-C 106.398 -1.705 . . . . 0.0 106.398 170.999 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 89.0 m -118.84 127.06 53.16 Favored 'General case' 0 CA--C 1.5 -0.972 0 N-CA-C 105.954 -1.869 . . . . 0.0 105.954 -178.331 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 5.3 mp -114.39 133.91 22.38 Favored Pre-proline 0 N--CA 1.438 -1.072 0 N-CA-C 104.893 -2.262 . . . . 0.0 104.893 -175.695 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 62.6 Cg_exo -63.89 169.07 10.87 Favored 'Trans proline' 0 CA--C 1.508 -0.807 0 C-N-CA 123.387 2.724 . . . . 0.0 113.376 177.155 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -78.42 -19.74 73.39 Favored Glycine 0 C--N 1.351 1.398 0 C-N-CA 123.171 0.415 . . . . 0.0 113.559 -173.851 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 48.8 p-80 -83.84 -28.15 28.22 Favored 'General case' 0 C--N 1.356 0.887 0 CA-C-N 117.755 0.778 . . . . 0.0 109.962 -179.418 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 84.4 mt -88.77 130.49 35.35 Favored 'General case' 0 CA--C 1.501 -0.917 0 N-CA-C 107.723 -1.214 . . . . 0.0 107.723 177.162 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 8.0 p-10 -116.87 10.2 14.06 Favored 'General case' 0 CA--C 1.501 -0.912 0 C-N-CA 123.994 0.918 . . . . 0.0 110.098 -172.203 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 60.1 p -143.03 167.76 21.31 Favored 'General case' 0 N--CA 1.44 -0.942 0 N-CA-C 107.854 -1.165 . . . . 0.0 107.854 -178.631 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 8.3 t80 -155.48 178.27 10.42 Favored 'General case' 0 N--CA 1.441 -0.921 0 N-CA-C 108.023 -1.103 . . . . 0.0 108.023 -176.851 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 97.2 m -145.01 114.91 7.36 Favored 'General case' 0 N--CA 1.432 -1.34 0 N-CA-C 103.859 -2.645 . . . . 0.0 103.859 177.347 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 54.0 mt -97.02 96.68 5.59 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.822 0 N-CA-C 105.767 -1.938 . . . . 0.0 105.767 175.566 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.94 161.76 13.41 Favored 'General case' 0 CA--C 1.498 -1.031 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 -178.381 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 83.7 52.47 3.69 Favored Glycine 0 C--N 1.353 1.501 0 N-CA-C 108.866 -1.694 . . . . 0.0 108.866 177.637 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 76.3 mt -119.19 166.04 13.46 Favored 'General case' 0 CA--C 1.496 -1.11 0 N-CA-C 106.736 -1.579 . . . . 0.0 106.736 -179.51 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 61.1 mttp -97.66 156.59 35.91 Favored Pre-proline 0 N--CA 1.441 -0.898 0 N-CA-C 106.859 -1.534 . . . . 0.0 106.859 -175.666 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 66.2 Cg_endo -77.45 155.63 32.19 Favored 'Trans proline' 0 N--CA 1.451 -0.987 0 C-N-CA 122.808 2.339 . . . . 0.0 109.844 172.063 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 60.15 29.12 67.75 Favored Glycine 0 C--N 1.355 1.584 0 C-N-CA 126.674 2.083 . . . . 0.0 116.628 170.507 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 10.6 p -122.35 138.99 50.65 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.122 0 N-CA-C 107.747 -1.205 . . . . 0.0 107.747 179.472 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 2.4 p -97.74 134.99 33.83 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.818 0 N-CA-C 106.663 -1.606 . . . . 0.0 106.663 177.946 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 94.4 m-85 -114.23 154.4 27.98 Favored 'General case' 0 CA--C 1.502 -0.878 0 C-N-CA 124.97 1.308 . . . . 0.0 107.617 179.492 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -95.18 142.13 27.98 Favored 'General case' 0 CA--C 1.505 -0.787 0 N-CA-C 105.516 -2.031 . . . . 0.0 105.516 155.815 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -132.52 143.66 15.33 Favored Glycine 0 CA--C 1.487 -1.683 0 N-CA-C 107.565 -2.214 . . . . 0.0 107.565 -177.614 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 32.3 mt-30 -135.94 132.59 36.62 Favored 'General case' 0 CA--C 1.489 -1.375 0 N-CA-C 106.361 -1.718 . . . . 0.0 106.361 -178.189 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 47.2 tp -113.9 97.72 6.56 Favored 'General case' 0 N--CA 1.438 -1.042 0 N-CA-C 104.408 -2.441 . . . . 0.0 104.408 -176.757 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 1.8 mp -88.7 125.34 41.88 Favored 'Isoleucine or valine' 0 CA--C 1.499 -1.013 0 N-CA-C 103.585 -2.746 . . . . 0.0 103.585 -176.781 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 12.8 p -121.1 109.27 14.82 Favored 'General case' 0 N--CA 1.436 -1.129 0 N-CA-C 108.214 -1.032 . . . . 0.0 108.214 -170.405 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 29.7 mt -102.1 140.79 19.71 Favored 'Isoleucine or valine' 0 CA--C 1.487 -1.453 0 N-CA-C 105.787 -1.931 . . . . 0.0 105.787 -165.183 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 72.1 mt-30 -87.97 -178.86 6.1 Favored 'General case' 0 CA--C 1.505 -0.753 0 C-N-CA 123.49 0.716 . . . . 0.0 109.47 -177.374 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 85.2 mt-30 -74.3 84.03 1.91 Allowed 'General case' 0 C--N 1.357 0.928 0 C-N-CA 124.779 1.232 . . . . 0.0 110.753 175.465 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 82.6 m-85 58.5 28.38 16.88 Favored 'General case' 0 C--N 1.359 1.006 0 C-N-CA 126.75 2.02 . . . . 0.0 112.27 -177.682 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -112.53 -118.71 3.61 Favored Glycine 0 C--N 1.356 1.683 0 N-CA-C 108.88 -1.688 . . . . 0.0 108.88 -173.729 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 10.1 t-160 -80.9 169.11 17.96 Favored 'General case' 0 N--CA 1.441 -0.89 0 C-N-CA 125.005 1.322 . . . . 0.0 109.323 -174.761 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 22.3 tt0 -127.47 109.3 11.61 Favored 'General case' 0 N--CA 1.434 -1.229 0 N-CA-C 101.842 -3.392 . . . . 0.0 101.842 170.377 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 4.3 tm-20 -102.83 153.94 19.69 Favored 'General case' 0 CA--C 1.506 -0.748 0 N-CA-C 105.721 -1.955 . . . . 0.0 105.721 -171.938 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 4.4 p -127.94 128.89 69.54 Favored 'Isoleucine or valine' 0 C--N 1.354 0.771 0 N-CA-C 108.274 -1.01 . . . . 0.0 108.274 179.874 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 52.1 m -109.83 139.09 45.29 Favored 'General case' 0 N--CA 1.443 -0.807 0 N-CA-C 102.432 -3.173 . . . . 0.0 102.432 171.694 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 51.6 ttt85 -130.99 142.8 50.37 Favored 'General case' 0 CA--C 1.502 -0.866 0 N-CA-C 108.428 -0.953 . . . . 0.0 108.428 -179.076 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 15.7 p90 -157.07 -176.39 5.95 Favored 'General case' 0 N--CA 1.439 -1.003 0 N-CA-C 105.78 -1.933 . . . . 0.0 105.78 178.769 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 1.4 p30 -136.15 157.02 47.82 Favored 'General case' 0 N--CA 1.439 -0.999 0 N-CA-C 106.296 -1.742 . . . . 0.0 106.296 167.571 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 36.9 p90 -144.45 174.51 10.87 Favored 'General case' 0 CA--C 1.487 -1.469 0 N-CA-C 106.03 -1.841 . . . . 0.0 106.03 171.759 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 10.1 t -142.31 154.37 44.64 Favored 'General case' 0 N--CA 1.439 -0.988 0 N-CA-C 106.7 -1.592 . . . . 0.0 106.7 176.789 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 4.3 p -113.27 120.94 42.89 Favored 'General case' 0 N--CA 1.436 -1.16 0 N-CA-C 101.264 -3.606 . . . . 0.0 101.264 168.184 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 15.0 t -157.71 21.47 0.27 Allowed 'General case' 0 N--CA 1.442 -0.85 0 N-CA-C 106.451 -1.685 . . . . 0.0 106.451 -173.049 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 19.7 m . . . . . 0 C--O 1.26 1.611 0 C-N-CA 123.356 0.662 . . . . 0.0 109.671 -175.77 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 98.8 p . . . . . 0 N--CA 1.487 1.414 0 CA-C-O 121.639 0.733 . . . . 0.0 111.649 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 162.11 -171.4 38.0 Favored Glycine 0 N--CA 1.436 -1.317 0 N-CA-C 105.79 -2.924 . . . . 0.0 105.79 -179.253 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 8.8 Cg_exo -54.61 146.05 55.89 Favored 'Trans proline' 0 N--CA 1.449 -1.133 0 C-N-CA 124.329 3.353 . . . . 0.0 114.898 -168.241 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 5.5 t -77.46 152.5 5.48 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.716 0 N-CA-C 105.436 -2.061 . . . . 0.0 105.436 -177.904 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 92.8 mt-10 -98.54 89.44 4.4 Favored 'General case' 0 CA--C 1.493 -1.234 0 CA-C-O 122.13 0.967 . . . . 0.0 108.666 -169.729 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 2.4 p -111.52 132.33 60.39 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.08 0 N-CA-C 106.979 -1.489 . . . . 0.0 106.979 -166.946 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 67.9 m-85 -144.77 174.83 10.65 Favored 'General case' 0 CA--C 1.498 -1.055 0 N-CA-C 106.125 -1.805 . . . . 0.0 106.125 -174.61 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 19.3 tt -136.43 131.2 48.03 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.047 0 N-CA-C 103.275 -2.861 . . . . 0.0 103.275 159.951 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 15.1 t -143.63 10.92 1.64 Allowed 'General case' 0 N--CA 1.439 -0.995 0 N-CA-C 106.588 -1.634 . . . . 0.0 106.588 -177.733 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 6.8 mp0 -85.82 -69.74 0.64 Allowed 'General case' 0 CA--C 1.497 -1.084 0 N-CA-C 107.696 -1.224 . . . . 0.0 107.696 -175.25 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.428 HG21 HE21 ' A' ' 14' ' ' GLN . 43.4 p -101.98 130.1 25.08 Favored Pre-proline 0 N--CA 1.442 -0.869 0 N-CA-C 107.639 -1.245 . . . . 0.0 107.639 -175.734 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -81.37 -16.27 9.58 Favored 'Trans proline' 0 N--CA 1.453 -0.872 0 C-N-CA 122.863 2.376 . . . . 0.0 110.009 171.464 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 65.8 m -156.12 122.94 5.24 Favored 'General case' 0 N--CA 1.432 -1.344 0 N-CA-C 104.01 -2.589 . . . . 0.0 104.01 -177.594 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . 0.428 HE21 HG21 ' A' ' 11' ' ' THR . 7.5 tp-100 -157.43 111.36 1.86 Allowed Pre-proline 0 N--CA 1.437 -1.121 0 N-CA-C 105.834 -1.913 . . . . 0.0 105.834 171.695 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -83.46 -25.83 2.41 Favored 'Trans proline' 0 CA--C 1.504 -1.008 0 C-N-CA 122.213 1.942 . . . . 0.0 110.97 -169.567 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 1.9 p30 -100.16 -45.43 5.64 Favored 'General case' 0 CA--C 1.488 -1.417 0 C-N-CA 123.596 0.759 . . . . 0.0 109.985 -166.516 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 75.2 m -107.63 158.65 17.08 Favored 'General case' 0 CA--C 1.496 -1.106 0 N-CA-C 107.794 -1.187 . . . . 0.0 107.794 -179.346 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 11.7 t-160 -135.74 85.15 30.87 Favored Pre-proline 0 N--CA 1.438 -1.048 0 N-CA-C 105.593 -2.003 . . . . 0.0 105.593 172.884 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 64.7 Cg_endo -81.78 98.1 0.96 Allowed 'Trans proline' 0 N--CA 1.451 -0.987 0 C-N-CA 123.325 2.683 . . . . 0.0 110.156 -174.713 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.51 HD11 HD11 ' A' ' 35' ' ' LEU . 3.0 pt -97.6 173.21 1.0 Allowed 'Isoleucine or valine' 0 CA--C 1.499 -0.99 0 CA-C-O 121.181 0.515 . . . . 0.0 109.992 -173.497 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . 0.448 ' HA ' ' HA ' ' A' ' 57' ' ' SER . 1.9 pt20 -151.53 161.58 42.45 Favored 'General case' 0 CA--C 1.496 -1.099 0 N-CA-C 105.699 -1.963 . . . . 0.0 105.699 164.079 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 42.4 p90 -139.62 162.82 34.17 Favored 'General case' 0 CA--C 1.496 -1.122 0 N-CA-C 106.285 -1.746 . . . . 0.0 106.285 -177.679 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 3.1 m120 -127.94 124.48 37.43 Favored 'General case' 0 CA--C 1.491 -1.3 0 N-CA-C 106.183 -1.784 . . . . 0.0 106.183 -179.505 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -105.65 173.38 3.27 Favored Pre-proline 0 N--CA 1.439 -1.012 0 C-N-CA 125.536 1.535 . . . . 0.0 108.181 -169.71 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_exo -63.63 151.2 86.17 Favored 'Trans proline' 0 N--CA 1.455 -0.76 0 C-N-CA 123.732 2.955 . . . . 0.0 112.266 173.532 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 64.8 tt0 -82.05 -40.64 0.96 Allowed Pre-proline 0 N--CA 1.444 -0.76 0 CA-C-O 115.832 -2.033 . . . . 0.0 111.837 -174.742 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 77.1 Cg_exo -70.77 -3.52 12.85 Favored 'Trans proline' 0 CA--C 1.514 -0.481 0 CA-C-N 125.403 2.965 . . . . 0.0 113.818 177.175 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 10.0 t 71.33 78.08 0.17 Allowed 'General case' 0 C--N 1.358 0.937 0 C-N-CA 126.38 1.872 . . . . 0.0 109.252 -179.423 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 82.1 t60 -89.23 -30.15 18.73 Favored 'General case' 0 N--CA 1.441 -0.906 0 C-N-CA 124.696 1.198 . . . . 0.0 108.289 178.166 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 90.3 mt -108.83 146.41 14.52 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.107 0 N-CA-C 105.164 -2.162 . . . . 0.0 105.164 -171.204 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 32.9 t -102.69 -87.77 0.41 Allowed 'General case' 0 N--CA 1.428 -1.572 0 N-CA-C 104.531 -2.396 . . . . 0.0 104.531 176.891 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 50.3 mtpt -89.46 167.07 13.28 Favored 'General case' 0 CA--C 1.489 -1.4 0 C-N-CA 124.91 1.284 . . . . 0.0 108.85 -164.418 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 63.1 m-85 -132.09 142.62 49.58 Favored 'General case' 0 CA--C 1.497 -1.081 0 N-CA-C 105.035 -2.209 . . . . 0.0 105.035 170.987 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 53.7 mt -119.68 136.12 57.84 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.189 0 N-CA-C 101.156 -3.646 . . . . 0.0 101.156 170.503 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.51 HD11 HD11 ' A' ' 20' ' ' ILE . 5.9 mt -110.42 132.53 54.1 Favored 'General case' 0 CA--C 1.47 -2.132 0 N-CA-C 103.823 -2.658 . . . . 0.0 103.823 166.644 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 17.0 ptp180 -132.88 152.04 51.93 Favored 'General case' 0 CA--C 1.49 -1.363 0 N-CA-C 106.787 -1.561 . . . . 0.0 106.787 170.701 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 49.2 p90 -155.19 151.79 28.59 Favored 'General case' 0 N--CA 1.438 -1.04 0 N-CA-C 107.585 -1.265 . . . . 0.0 107.585 -171.22 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 2.8 ptt180 -155.68 153.5 26.31 Favored Pre-proline 0 CA--C 1.497 -1.062 0 N-CA-C 106.466 -1.679 . . . . 0.0 106.466 168.065 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -76.86 156.56 34.85 Favored 'Trans proline' 0 CA--C 1.501 -1.141 0 C-N-CA 122.547 2.165 . . . . 0.0 109.071 -178.231 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 71.4 mmtt -70.35 79.95 0.54 Allowed 'General case' 0 C--N 1.354 0.8 0 C-N-CA 125.065 1.346 . . . . 0.0 110.635 174.598 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 58.9 m-80 -152.01 -81.62 0.1 Allowed 'General case' 0 N--CA 1.437 -1.111 0 N-CA-C 103.43 -2.804 . . . . 0.0 103.43 -179.249 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 50.2 m -93.39 166.14 12.43 Favored 'General case' 0 CA--C 1.5 -0.978 0 C-N-CA 124.055 0.942 . . . . 0.0 108.531 -178.228 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 12.6 m -134.57 25.54 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.754 0 N-CA-C 106.623 -1.621 . . . . 0.0 106.623 178.167 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -89.72 -94.48 1.14 Allowed Glycine 0 C--N 1.356 1.681 0 N-CA-C 109.554 -1.418 . . . . 0.0 109.554 -174.797 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -95.5 166.29 11.93 Favored 'General case' 0 CA--C 1.5 -0.945 0 N-CA-C 107.584 -1.265 . . . . 0.0 107.584 179.418 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -158.29 173.87 16.03 Favored 'General case' 0 CA--C 1.493 -1.238 0 CA-C-O 121.17 0.509 . . . . 0.0 110.142 -177.7 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 8.6 mtpm? -106.53 155.07 19.98 Favored 'General case' 0 CA--C 1.484 -1.565 0 N-CA-C 106.877 -1.527 . . . . 0.0 106.877 -175.404 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 15.6 pt-20 -151.72 161.26 42.96 Favored 'General case' 0 N--CA 1.435 -1.193 0 CA-C-O 121.827 0.823 . . . . 0.0 109.064 173.699 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -138.66 162.39 34.77 Favored 'General case' 0 N--CA 1.44 -0.967 0 N-CA-C 105.765 -1.939 . . . . 0.0 105.765 170.275 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 77.8 m -121.64 126.56 49.32 Favored 'General case' 0 CA--C 1.502 -0.896 0 N-CA-C 105.389 -2.078 . . . . 0.0 105.389 178.233 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 4.2 mp -110.91 133.76 21.17 Favored Pre-proline 0 N--CA 1.436 -1.147 0 N-CA-C 105.12 -2.178 . . . . 0.0 105.12 -176.088 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_exo -63.85 165.15 19.46 Favored 'Trans proline' 0 CA--C 1.507 -0.828 0 C-N-CA 123.519 2.813 . . . . 0.0 113.187 176.743 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -76.52 -18.21 79.27 Favored Glycine 0 C--N 1.351 1.409 0 C-N-CA 123.627 0.632 . . . . 0.0 113.938 -173.933 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 49.8 p-80 -84.02 -28.45 27.66 Favored 'General case' 0 C--N 1.355 0.845 0 CA-C-N 117.992 0.896 . . . . 0.0 110.133 -179.826 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 88.0 mt -88.78 130.76 35.3 Favored 'General case' 0 CA--C 1.499 -0.991 0 N-CA-C 107.911 -1.144 . . . . 0.0 107.911 177.463 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 47.1 p-10 -117.78 12.44 13.89 Favored 'General case' 0 CA--C 1.502 -0.873 0 C-N-CA 123.879 0.872 . . . . 0.0 110.368 -174.887 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.448 ' HA ' ' HA ' ' A' ' 21' ' ' GLN . 58.0 p -136.8 161.57 35.61 Favored 'General case' 0 CA--C 1.498 -1.052 0 N-CA-C 107.795 -1.187 . . . . 0.0 107.795 -178.379 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 5.2 t80 -147.55 179.51 7.63 Favored 'General case' 0 C--N 1.357 0.933 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 177.198 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 80.2 m -144.92 112.4 6.16 Favored 'General case' 0 N--CA 1.433 -1.295 0 N-CA-C 104.178 -2.527 . . . . 0.0 104.178 174.002 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 50.6 mt -95.18 97.33 6.66 Favored 'Isoleucine or valine' 0 C--N 1.357 0.918 0 N-CA-C 105.333 -2.099 . . . . 0.0 105.333 174.763 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 22.6 pttp -103.82 159.81 15.32 Favored 'General case' 0 CA--C 1.501 -0.919 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 -176.489 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 87.75 51.69 3.17 Favored Glycine 0 C--N 1.354 1.579 0 N-CA-C 109.337 -1.505 . . . . 0.0 109.337 179.187 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 70.7 mt -119.78 171.11 8.63 Favored 'General case' 0 CA--C 1.504 -0.806 0 N-CA-C 107.398 -1.334 . . . . 0.0 107.398 -177.393 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 67.5 mttm -107.09 155.69 38.81 Favored Pre-proline 0 N--CA 1.442 -0.86 0 C-N-CA 124.984 1.313 . . . . 0.0 107.656 -172.338 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -75.82 151.53 36.03 Favored 'Trans proline' 0 N--CA 1.454 -0.853 0 C-N-CA 123.024 2.482 . . . . 0.0 110.811 177.054 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 56.05 36.55 67.95 Favored Glycine 0 C--N 1.355 1.605 0 C-N-CA 127.377 2.418 . . . . 0.0 116.06 169.623 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 9.8 p -124.11 143.56 36.98 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.998 0 N-CA-C 108.088 -1.078 . . . . 0.0 108.088 -177.498 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 7.7 p -98.61 128.4 50.19 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.96 0 N-CA-C 107.747 -1.205 . . . . 0.0 107.747 -179.543 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 68.8 m-85 -111.4 151.62 28.28 Favored 'General case' 0 CA--C 1.497 -1.082 0 C-N-CA 124.814 1.245 . . . . 0.0 108.809 -179.863 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 35.9 tp10 -93.61 137.04 33.28 Favored 'General case' 0 N--CA 1.44 -0.953 0 N-CA-C 104.578 -2.379 . . . . 0.0 104.578 160.017 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -135.33 156.62 22.75 Favored Glycine 0 CA--C 1.489 -1.553 0 N-CA-C 108.511 -1.836 . . . . 0.0 108.511 174.356 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 85.6 mt-30 -144.58 138.95 27.81 Favored 'General case' 0 CA--C 1.483 -1.598 0 N-CA-C 105.986 -1.857 . . . . 0.0 105.986 179.262 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 57.1 tp -115.73 97.32 6.05 Favored 'General case' 0 N--CA 1.435 -1.189 0 N-CA-C 103.892 -2.633 . . . . 0.0 103.892 178.248 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 9.4 mt -89.52 128.87 41.28 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.942 0 N-CA-C 105.356 -2.09 . . . . 0.0 105.356 -178.248 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 3.5 p -117.93 118.86 33.13 Favored 'General case' 0 N--CA 1.438 -1.058 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 -171.71 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 2.0 mp -94.08 131.68 40.31 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.222 0 N-CA-C 105.02 -2.215 . . . . 0.0 105.02 -173.149 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 19.4 mp0 -93.87 143.36 26.41 Favored 'General case' 0 CA--C 1.498 -1.033 0 N-CA-C 104.93 -2.248 . . . . 0.0 104.93 177.218 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 21.4 tt0 -69.12 112.4 5.7 Favored 'General case' 0 C--N 1.356 0.855 0 C-N-CA 123.858 0.863 . . . . 0.0 111.343 -172.585 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 33.7 m-85 56.32 44.81 24.07 Favored 'General case' 0 C--N 1.357 0.917 0 C-N-CA 126.983 2.113 . . . . 0.0 112.173 -179.007 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -156.73 -119.16 0.6 Allowed Glycine 0 CA--C 1.489 -1.577 0 N-CA-C 109.008 -1.637 . . . . 0.0 109.008 -177.98 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 69.2 m80 -82.68 176.77 9.09 Favored 'General case' 0 CA--C 1.501 -0.939 0 C-N-CA 124.9 1.28 . . . . 0.0 111.288 -166.477 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 22.8 tt0 -137.91 115.96 11.67 Favored 'General case' 0 N--CA 1.435 -1.197 0 N-CA-C 103.819 -2.66 . . . . 0.0 103.819 170.761 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 29.5 tt0 -104.77 147.97 27.12 Favored 'General case' 0 CA--C 1.5 -0.949 0 N-CA-C 106.089 -1.819 . . . . 0.0 106.089 -174.739 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 4.0 p -119.35 134.05 64.2 Favored 'Isoleucine or valine' 0 C--N 1.356 0.85 0 N-CA-C 107.796 -1.187 . . . . 0.0 107.796 178.272 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 65.1 m -110.93 138.44 47.33 Favored 'General case' 0 C--N 1.354 0.791 0 N-CA-C 102.518 -3.142 . . . . 0.0 102.518 168.326 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 27.8 ptt-85 -132.21 150.32 52.18 Favored 'General case' 0 CA--C 1.5 -0.971 0 N-CA-C 109.213 -0.662 . . . . 0.0 109.213 179.485 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 20.2 p90 -163.82 173.8 12.33 Favored 'General case' 0 N--CA 1.441 -0.901 0 N-CA-C 107.947 -1.131 . . . . 0.0 107.947 -174.874 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -125.62 146.05 49.88 Favored 'General case' 0 N--CA 1.438 -1.05 0 N-CA-C 103.816 -2.661 . . . . 0.0 103.816 173.628 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 28.5 p90 -139.51 168.1 20.59 Favored 'General case' 0 CA--C 1.485 -1.526 0 N-CA-C 107.572 -1.269 . . . . 0.0 107.572 167.882 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 60.6 m -130.44 141.93 50.51 Favored 'General case' 0 N--CA 1.44 -0.937 0 N-CA-C 104.832 -2.285 . . . . 0.0 104.832 176.795 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 23.9 p -111.6 136.94 50.11 Favored 'General case' 0 CA--C 1.501 -0.936 0 N-CA-C 103.851 -2.648 . . . . 0.0 103.851 170.486 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 10.5 t -146.22 156.7 43.57 Favored 'General case' 0 N--CA 1.44 -0.967 0 N-CA-C 106.716 -1.587 . . . . 0.0 106.716 -175.072 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 16.9 p . . . . . 0 C--O 1.261 1.684 0 CA-C-O 117.709 -1.139 . . . . 0.0 108.944 -178.336 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 72.2 m . . . . . 0 N--CA 1.486 1.355 0 N-CA-C 108.358 -0.978 . . . . 0.0 108.358 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -160.42 -179.92 35.51 Favored Glycine 0 C--N 1.352 1.434 0 N-CA-C 106.913 -2.475 . . . . 0.0 106.913 177.969 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 79.3 Cg_exo -60.67 135.07 57.98 Favored 'Trans proline' 0 CA--C 1.497 -1.369 0 C-N-CA 123.388 2.725 . . . . 0.0 112.185 -173.359 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 16.1 t -84.07 155.24 3.67 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.017 0 C-N-CA 126.468 1.907 . . . . 0.0 106.167 -175.196 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 54.6 mt-10 -104.5 102.86 12.49 Favored 'General case' 0 CA--C 1.492 -1.273 0 N-CA-C 105.772 -1.936 . . . . 0.0 105.772 179.498 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 1.5 p -126.05 141.37 45.88 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.985 0 N-CA-C 105.623 -1.991 . . . . 0.0 105.623 -169.796 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 18.8 p90 -161.69 170.3 19.93 Favored 'General case' 0 N--CA 1.436 -1.144 0 N-CA-C 107.716 -1.216 . . . . 0.0 107.716 -162.728 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.443 HG21 ' CE1' ' A' ' 18' ' ' HIS . 0.1 OUTLIER -124.19 133.49 69.17 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.823 0 N-CA-C 102.482 -3.155 . . . . 0.0 102.482 160.809 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 10.4 p -131.27 124.2 29.99 Favored 'General case' 0 CA--C 1.5 -0.964 0 N-CA-C 106.418 -1.697 . . . . 0.0 106.418 179.922 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 23.8 tt0 68.15 48.72 0.91 Allowed 'General case' 0 C--N 1.356 0.86 0 C-N-CA 126.44 1.896 . . . . 0.0 110.914 175.586 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 15.4 p -104.19 102.9 35.4 Favored Pre-proline 0 C--N 1.353 0.746 0 N-CA-C 106.113 -1.81 . . . . 0.0 106.113 172.175 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 31.0 Cg_endo -74.97 -69.02 0.02 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.768 0 C-N-CA 122.425 2.083 . . . . 0.0 110.607 -175.737 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 10.2 p -141.07 107.68 5.33 Favored 'General case' 0 N--CA 1.432 -1.349 0 N-CA-C 105.711 -1.959 . . . . 0.0 105.711 -179.742 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 91.3 mm-40 -120.83 105.74 40.25 Favored Pre-proline 0 N--CA 1.436 -1.145 0 N-CA-C 103.87 -2.641 . . . . 0.0 103.87 178.379 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -84.61 -25.48 1.97 Allowed 'Trans proline' 0 CA--C 1.508 -0.822 0 C-N-CA 122.289 1.993 . . . . 0.0 111.115 -167.426 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 6.8 t-20 -135.78 -23.88 1.35 Allowed 'General case' 0 CA--C 1.495 -1.169 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 -168.709 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 23.0 p -97.64 156.19 16.64 Favored 'General case' 0 N--CA 1.439 -1.02 0 N-CA-C 107.605 -1.257 . . . . 0.0 107.605 177.483 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . 0.443 ' CE1' HG21 ' A' ' 8' ' ' ILE . 79.8 t60 -139.44 86.43 14.28 Favored Pre-proline 0 N--CA 1.439 -1.011 0 N-CA-C 106.348 -1.723 . . . . 0.0 106.348 167.568 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -82.92 100.54 0.96 Allowed 'Trans proline' 0 N--CA 1.453 -0.887 0 C-N-CA 123.574 2.849 . . . . 0.0 110.369 -176.187 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.53 HD11 HD11 ' A' ' 35' ' ' LEU . 1.6 pt -94.38 166.59 1.77 Allowed 'Isoleucine or valine' 0 CA--C 1.501 -0.934 0 C-N-CA 122.715 0.406 . . . . 0.0 110.156 -173.609 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 48.0 tt0 -143.15 147.66 35.3 Favored 'General case' 0 N--CA 1.439 -0.995 0 N-CA-C 105.005 -2.22 . . . . 0.0 105.005 168.547 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 30.9 p90 -130.23 159.85 35.62 Favored 'General case' 0 CA--C 1.495 -1.167 0 N-CA-C 105.599 -2.0 . . . . 0.0 105.599 176.701 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 72.3 m-20 -130.83 132.7 45.38 Favored 'General case' 0 CA--C 1.488 -1.417 0 N-CA-C 104.997 -2.223 . . . . 0.0 104.997 171.837 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -85.77 164.36 40.01 Favored Pre-proline 0 N--CA 1.441 -0.908 0 C-N-CA 124.589 1.155 . . . . 0.0 110.675 -166.175 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_exo -67.23 -179.29 1.75 Allowed 'Trans proline' 0 N--CA 1.457 -0.675 0 C-N-CA 123.775 2.983 . . . . 0.0 112.548 169.072 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? -79.84 -50.85 1.19 Allowed Pre-proline 0 N--CA 1.443 -0.782 0 CA-C-O 115.02 -2.419 . . . . 0.0 111.157 -174.706 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -68.68 147.14 69.11 Favored 'Trans proline' 0 CA--C 1.508 -0.811 0 CA-C-N 126.305 3.288 . . . . 0.0 111.863 -173.056 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 29.4 p -99.0 58.59 1.14 Allowed 'General case' 0 C--N 1.355 0.83 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 -178.605 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 42.6 t60 -116.23 1.37 13.12 Favored 'General case' 0 N--CA 1.438 -1.043 0 C-N-CA 125.217 1.407 . . . . 0.0 107.425 175.857 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 31.2 mt -101.67 131.93 48.58 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.054 0 N-CA-C 104.263 -2.495 . . . . 0.0 104.263 171.017 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 4.4 p -110.52 -84.65 0.56 Allowed 'General case' 0 N--CA 1.432 -1.345 0 N-CA-C 107.028 -1.471 . . . . 0.0 107.028 179.515 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 53.2 mtmt -89.91 171.85 9.3 Favored 'General case' 0 CA--C 1.488 -1.439 0 C-N-CA 124.232 1.013 . . . . 0.0 108.785 -166.413 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 86.8 m-85 -129.34 147.66 51.19 Favored 'General case' 0 CA--C 1.496 -1.115 0 N-CA-C 105.362 -2.088 . . . . 0.0 105.362 168.435 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 61.9 mt -120.41 131.04 73.69 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.249 0 N-CA-C 101.207 -3.627 . . . . 0.0 101.207 165.683 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.53 HD11 HD11 ' A' ' 20' ' ' ILE . 2.9 mt -110.49 132.72 53.94 Favored 'General case' 0 CA--C 1.473 -1.997 0 N-CA-C 104.822 -2.288 . . . . 0.0 104.822 170.741 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -129.97 158.94 38.17 Favored 'General case' 0 CA--C 1.493 -1.241 0 N-CA-C 107.308 -1.367 . . . . 0.0 107.308 170.082 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 46.4 p90 -155.15 141.28 18.42 Favored 'General case' 0 N--CA 1.434 -1.232 0 N-CA-C 106.635 -1.617 . . . . 0.0 106.635 -177.908 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 27.0 ttp180 -137.89 142.65 36.94 Favored Pre-proline 0 CA--C 1.502 -0.902 0 N-CA-C 104.902 -2.258 . . . . 0.0 104.902 -179.359 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_exo -65.11 116.97 4.15 Favored 'Trans proline' 0 N--CA 1.455 -0.754 0 C-N-CA 123.024 2.482 . . . . 0.0 109.721 169.133 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 26.7 ttpp -71.96 83.87 0.96 Allowed 'General case' 0 C--N 1.359 0.993 0 C-N-CA 125.306 1.443 . . . . 0.0 110.096 179.933 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 33.1 m120 -150.58 -69.18 0.19 Allowed 'General case' 0 N--CA 1.434 -1.245 0 N-CA-C 102.321 -3.214 . . . . 0.0 102.321 -175.526 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 56.4 p -109.23 175.32 5.5 Favored 'General case' 0 N--CA 1.44 -0.97 0 N-CA-C 107.334 -1.358 . . . . 0.0 107.334 175.171 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 4.2 m -115.69 51.36 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.836 0 N-CA-C 106.241 -1.763 . . . . 0.0 106.241 176.009 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -94.81 -136.1 8.28 Favored Glycine 0 C--N 1.356 1.68 0 N-CA-C 109.739 -1.345 . . . . 0.0 109.739 -175.57 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 39.9 mmt180 -81.18 155.58 26.1 Favored 'General case' 0 CA--C 1.501 -0.939 0 C-N-CA 123.79 0.836 . . . . 0.0 109.108 -176.534 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -159.36 168.89 25.22 Favored 'General case' 0 CA--C 1.493 -1.225 0 CA-C-O 121.385 0.612 . . . . 0.0 109.832 -169.259 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -113.49 156.68 23.12 Favored 'General case' 0 CA--C 1.491 -1.293 0 N-CA-C 107.889 -1.152 . . . . 0.0 107.889 -169.975 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 23.5 pt-20 -151.37 161.27 43.0 Favored 'General case' 0 N--CA 1.435 -1.191 0 N-CA-C 107.765 -1.198 . . . . 0.0 107.765 172.125 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -139.62 164.71 29.2 Favored 'General case' 0 N--CA 1.438 -1.051 0 N-CA-C 105.603 -1.999 . . . . 0.0 105.603 171.222 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 88.8 m -118.51 122.65 43.21 Favored 'General case' 0 CA--C 1.498 -1.021 0 N-CA-C 104.333 -2.469 . . . . 0.0 104.333 176.056 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 3.7 mm -103.62 138.64 19.59 Favored Pre-proline 0 N--CA 1.438 -1.029 0 N-CA-C 105.808 -1.923 . . . . 0.0 105.808 -174.909 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_exo -63.91 161.15 34.11 Favored 'Trans proline' 0 N--CA 1.455 -0.784 0 C-N-CA 123.378 2.719 . . . . 0.0 112.562 170.817 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -78.22 -19.26 74.87 Favored Glycine 0 C--N 1.353 1.492 0 C-N-CA 123.843 0.735 . . . . 0.0 113.344 -172.485 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 50.3 p-80 -83.61 -24.97 31.24 Favored 'General case' 0 C--N 1.356 0.85 0 CA-C-N 117.68 0.74 . . . . 0.0 110.158 -178.802 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 88.7 mt -88.22 129.77 35.26 Favored 'General case' 0 CA--C 1.498 -1.024 0 N-CA-C 107.913 -1.143 . . . . 0.0 107.913 177.655 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 7.5 p30 -116.66 10.72 14.45 Favored 'General case' 0 CA--C 1.501 -0.93 0 C-N-CA 124.59 1.156 . . . . 0.0 109.662 -174.554 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 31.3 p -141.79 154.42 45.21 Favored 'General case' 0 N--CA 1.44 -0.974 0 N-CA-C 106.863 -1.532 . . . . 0.0 106.863 -179.237 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 9.8 t80 -137.55 170.7 15.62 Favored 'General case' 0 N--CA 1.441 -0.914 0 N-CA-C 107.91 -1.144 . . . . 0.0 107.91 178.606 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 89.2 m -133.93 110.01 9.42 Favored 'General case' 0 N--CA 1.429 -1.517 0 N-CA-C 104.424 -2.436 . . . . 0.0 104.424 172.773 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 45.2 mt -88.37 144.06 9.94 Favored 'Isoleucine or valine' 0 C--N 1.355 0.846 0 N-CA-C 103.663 -2.717 . . . . 0.0 103.663 172.051 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 56.7 mtmt -144.29 165.51 27.69 Favored 'General case' 0 CA--C 1.498 -1.04 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 175.929 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 88.7 48.3 3.97 Favored Glycine 0 CA--C 1.485 -1.832 0 N-CA-C 108.99 -1.644 . . . . 0.0 108.99 174.575 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 51.9 mt -120.79 171.22 8.76 Favored 'General case' 0 CA--C 1.498 -1.025 0 N-CA-C 107.604 -1.258 . . . . 0.0 107.604 -170.22 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt -113.66 150.87 44.0 Favored Pre-proline 0 N--CA 1.44 -0.93 0 N-CA-C 107.363 -1.347 . . . . 0.0 107.363 -174.247 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 78.5 Cg_exo -68.14 153.85 73.81 Favored 'Trans proline' 0 N--CA 1.453 -0.873 0 C-N-CA 123.37 2.714 . . . . 0.0 112.028 168.338 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 0.603 ' H ' ' HA ' ' A' ' 92' ' ' THR . . . 58.95 30.28 66.29 Favored Glycine 0 N--CA 1.432 -1.604 0 C-N-CA 127.545 2.498 . . . . 0.0 116.478 170.37 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 4.9 p -126.92 142.13 44.27 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.029 0 N-CA-C 108.577 -0.898 . . . . 0.0 108.577 179.316 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 9.3 p -94.62 130.77 42.99 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.837 0 C-N-CA 124.641 1.176 . . . . 0.0 107.959 -178.816 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 88.8 m-85 -110.62 154.91 23.11 Favored 'General case' 0 N--CA 1.437 -1.085 0 C-N-CA 124.79 1.236 . . . . 0.0 108.011 177.854 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 15.3 tp10 -98.53 132.17 44.17 Favored 'General case' 0 N--CA 1.437 -1.099 0 N-CA-C 103.578 -2.749 . . . . 0.0 103.578 164.148 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -129.67 148.82 18.53 Favored Glycine 0 CA--C 1.489 -1.544 0 N-CA-C 107.667 -2.173 . . . . 0.0 107.667 175.786 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 34.6 mt-30 -141.47 137.05 31.86 Favored 'General case' 0 CA--C 1.484 -1.582 0 N-CA-C 106.549 -1.649 . . . . 0.0 106.549 178.4 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 27.6 tp -117.93 97.17 5.69 Favored 'General case' 0 N--CA 1.435 -1.202 0 N-CA-C 104.03 -2.581 . . . . 0.0 104.03 -178.721 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 20.3 mt -92.17 129.01 43.44 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.865 0 N-CA-C 104.947 -2.242 . . . . 0.0 104.947 -179.84 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 49.8 m -110.06 117.84 34.82 Favored 'General case' 0 CA--C 1.497 -1.061 0 N-CA-C 106.814 -1.55 . . . . 0.0 106.814 -175.784 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 1.7 mp -88.2 131.94 34.5 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.302 0 N-CA-C 104.348 -2.464 . . . . 0.0 104.348 -170.455 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 76.0 mt-30 -96.78 157.1 16.06 Favored 'General case' 0 N--CA 1.434 -1.269 0 N-CA-C 107.167 -1.42 . . . . 0.0 107.167 -176.787 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 32.3 mt-30 -69.48 118.2 12.06 Favored 'General case' 0 N--CA 1.438 -1.026 0 C-N-CA 123.919 0.888 . . . . 0.0 112.544 -168.503 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 49.0 m-85 61.68 35.58 16.93 Favored 'General case' 0 C--N 1.355 0.833 0 C-N-CA 127.117 2.167 . . . . 0.0 113.136 170.558 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 179.38 -93.31 0.09 OUTLIER Glycine 0 C--N 1.354 1.53 0 C-N-CA 118.294 -1.907 . . . . 0.0 111.416 177.73 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 74.1 m-70 -78.59 -178.74 6.03 Favored 'General case' 0 CA--C 1.498 -1.047 0 C-N-CA 124.797 1.239 . . . . 0.0 111.747 -163.602 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 4.4 pt20 -153.32 146.56 24.75 Favored 'General case' 0 N--CA 1.434 -1.245 0 N-CA-C 106.484 -1.672 . . . . 0.0 106.484 170.2 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 17.4 tp10 -104.87 146.28 29.22 Favored 'General case' 0 CA--C 1.496 -1.124 0 N-CA-C 105.575 -2.009 . . . . 0.0 105.575 179.855 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 3.0 p -117.76 131.59 70.06 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.824 0 N-CA-C 107.204 -1.406 . . . . 0.0 107.204 177.391 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 40.4 m -113.58 138.36 50.28 Favored 'General case' 0 N--CA 1.441 -0.9 0 N-CA-C 102.871 -3.011 . . . . 0.0 102.871 170.962 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 7.6 ptp85 -131.58 150.86 52.0 Favored 'General case' 0 CA--C 1.498 -1.025 0 CA-C-O 121.466 0.651 . . . . 0.0 109.594 178.86 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 30.0 p90 -164.2 178.2 7.77 Favored 'General case' 0 N--CA 1.44 -0.97 0 N-CA-C 106.959 -1.497 . . . . 0.0 106.959 -174.617 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 1.5 p30 -137.44 157.71 45.99 Favored 'General case' 0 N--CA 1.44 -0.928 0 N-CA-C 105.844 -1.91 . . . . 0.0 105.844 169.416 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 26.6 p90 -145.73 170.75 15.89 Favored 'General case' 0 CA--C 1.486 -1.497 0 N-CA-C 107.367 -1.346 . . . . 0.0 107.367 174.949 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 24.8 p -121.55 145.33 48.07 Favored 'General case' 0 CA--C 1.5 -0.954 0 N-CA-C 106.006 -1.85 . . . . 0.0 106.006 172.078 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 75.4 m -119.57 113.48 20.77 Favored 'General case' 0 CA--C 1.496 -1.111 0 N-CA-C 102.103 -3.295 . . . . 0.0 102.103 170.287 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . 0.603 ' HA ' ' H ' ' A' ' 66' ' ' GLY . 15.3 m -143.41 149.74 38.08 Favored 'General case' 0 C--N 1.356 0.87 0 N-CA-C 105.705 -1.961 . . . . 0.0 105.705 -171.934 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 8.7 t . . . . . 0 C--O 1.261 1.662 0 C-N-CA 124.632 1.173 . . . . 0.0 109.497 -176.01 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 20.4 t . . . . . 0 N--CA 1.48 1.034 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -151.8 -173.18 21.28 Favored Glycine 0 C--N 1.351 1.393 0 N-CA-C 106.077 -2.809 . . . . 0.0 106.077 179.766 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_exo -61.0 135.78 61.31 Favored 'Trans proline' 0 N--CA 1.445 -1.342 0 C-N-CA 123.3 2.666 . . . . 0.0 112.37 -173.176 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 8.4 t -78.57 154.05 5.0 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.88 0 C-N-CA 126.738 2.015 . . . . 0.0 106.214 -175.948 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -96.66 90.73 5.42 Favored 'General case' 0 CA--C 1.493 -1.242 0 N-CA-C 107.66 -1.237 . . . . 0.0 107.66 -175.04 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.425 ' HA ' ' HA ' ' A' ' 22' ' ' TRP . 2.6 p -114.33 133.92 58.89 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.175 0 N-CA-C 107.032 -1.47 . . . . 0.0 107.032 -166.86 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 75.3 m-85 -134.07 173.4 11.62 Favored 'General case' 0 N--CA 1.435 -1.188 0 N-CA-C 106.208 -1.775 . . . . 0.0 106.208 -173.776 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 79.5 mt -98.92 141.72 16.03 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.021 0 N-CA-C 103.423 -2.806 . . . . 0.0 103.423 173.42 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 37.0 p -114.13 134.97 54.53 Favored 'General case' 0 CA--C 1.501 -0.916 0 N-CA-C 103.377 -2.823 . . . . 0.0 103.377 169.798 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 54.4 mt-10 -117.93 50.28 1.16 Allowed 'General case' 0 CA--C 1.495 -1.166 0 N-CA-C 104.54 -2.393 . . . . 0.0 104.54 -173.351 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 11.0 t -82.89 150.7 62.55 Favored Pre-proline 0 N--CA 1.44 -0.961 0 N-CA-C 105.677 -1.971 . . . . 0.0 105.677 175.531 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_exo -64.77 117.54 4.61 Favored 'Trans proline' 0 CA--C 1.507 -0.839 0 C-N-CA 122.544 2.163 . . . . 0.0 113.275 -171.617 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 5.7 t -154.49 -170.13 3.44 Favored 'General case' 0 N--CA 1.416 -2.156 0 N-CA-C 101.105 -3.665 . . . . 0.0 101.105 179.242 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 38.2 mt-30 -82.7 162.14 56.43 Favored Pre-proline 0 N--CA 1.442 -0.868 0 C-N-CA 126.6 1.96 . . . . 0.0 109.389 -174.971 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_endo -80.88 -2.58 11.89 Favored 'Trans proline' 0 N--CA 1.457 -0.644 0 C-N-CA 123.813 3.008 . . . . 0.0 109.903 165.419 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 2.3 t30 -89.18 -14.44 36.06 Favored 'General case' 0 N--CA 1.439 -0.994 0 C-N-CA 126.088 1.755 . . . . 0.0 107.403 172.697 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 68.2 m -113.32 150.3 32.73 Favored 'General case' 0 CA--C 1.497 -1.093 0 CA-C-O 122.16 0.981 . . . . 0.0 108.803 175.784 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 26.0 t-80 -124.41 98.54 37.89 Favored Pre-proline 0 N--CA 1.439 -1.014 0 N-CA-C 105.343 -2.095 . . . . 0.0 105.343 166.901 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -74.72 115.2 4.22 Favored 'Trans proline' 0 N--CA 1.448 -1.177 0 C-N-CA 123.017 2.478 . . . . 0.0 108.635 170.492 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 11.1 tt -108.92 148.79 12.53 Favored 'Isoleucine or valine' 0 N--CA 1.406 -2.639 0 C-N-CA 127.053 2.141 . . . . 0.0 106.05 -178.521 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 23.5 tt0 -135.64 145.42 46.8 Favored 'General case' 0 N--CA 1.435 -1.189 0 N-CA-C 104.337 -2.468 . . . . 0.0 104.337 170.967 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' TRP . . . . . 0.425 ' HA ' ' HA ' ' A' ' 6' ' ' VAL . 49.1 p90 -135.46 165.56 25.22 Favored 'General case' 0 N--CA 1.438 -1.054 0 N-CA-C 105.337 -2.097 . . . . 0.0 105.337 175.211 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 39.6 m-80 -140.8 132.04 26.55 Favored 'General case' 0 CA--C 1.489 -1.368 0 N-CA-C 106.136 -1.802 . . . . 0.0 106.136 -179.708 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -96.85 168.59 10.09 Favored Pre-proline 0 N--CA 1.439 -1.006 0 CA-C-N 114.792 -1.095 . . . . 0.0 110.37 -163.797 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 81.1 Cg_exo -66.43 167.69 18.13 Favored 'Trans proline' 0 N--CA 1.456 -0.716 0 C-N-CA 123.821 3.014 . . . . 0.0 111.776 166.731 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 10.2 tm0? -81.95 -52.66 0.74 Allowed Pre-proline 0 N--CA 1.444 -0.774 0 CA-C-O 115.317 -2.278 . . . . 0.0 111.279 -175.232 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -71.26 166.01 30.61 Favored 'Trans proline' 0 CA--C 1.507 -0.829 0 CA-C-N 126.065 3.202 . . . . 0.0 112.45 -172.77 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 28.1 p -77.97 118.29 20.12 Favored 'General case' 0 C--N 1.358 0.94 0 N-CA-C 106.915 -1.513 . . . . 0.0 106.915 173.449 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 8.4 t-160 -169.73 -44.84 0.02 OUTLIER 'General case' 0 CA--C 1.497 -1.063 0 N-CA-C 107.214 -1.402 . . . . 0.0 107.214 -164.099 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 37.2 mt -112.2 137.36 45.27 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.014 0 N-CA-C 104.175 -2.528 . . . . 0.0 104.175 176.615 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 33.5 t -113.06 -87.29 0.56 Allowed 'General case' 0 N--CA 1.43 -1.437 0 N-CA-C 106.494 -1.669 . . . . 0.0 106.494 179.548 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 35.9 ttpt -89.18 163.31 15.48 Favored 'General case' 0 CA--C 1.491 -1.303 0 C-N-CA 125.686 1.594 . . . . 0.0 108.104 -159.202 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 90.6 m-85 -128.88 139.07 52.31 Favored 'General case' 0 CA--C 1.492 -1.257 0 N-CA-C 105.649 -1.982 . . . . 0.0 105.649 175.56 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 55.3 mt -119.42 131.09 73.04 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.121 0 N-CA-C 101.694 -3.447 . . . . 0.0 101.694 171.113 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 3.2 mt -110.47 135.63 50.85 Favored 'General case' 0 CA--C 1.473 -1.982 0 N-CA-C 105.02 -2.215 . . . . 0.0 105.02 171.899 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -131.35 156.51 45.39 Favored 'General case' 0 CA--C 1.493 -1.247 0 N-CA-C 106.889 -1.523 . . . . 0.0 106.889 167.555 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 49.6 p90 -154.18 145.47 22.96 Favored 'General case' 0 N--CA 1.434 -1.257 0 N-CA-C 106.757 -1.572 . . . . 0.0 106.757 -175.94 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 8.6 ttm180 -138.18 139.57 26.01 Favored Pre-proline 0 CA--C 1.499 -0.982 0 N-CA-C 104.605 -2.368 . . . . 0.0 104.605 -179.907 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -72.89 116.06 4.58 Favored 'Trans proline' 0 N--CA 1.454 -0.843 0 C-N-CA 122.739 2.293 . . . . 0.0 108.824 174.713 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 3.0 tmtp? -70.22 81.49 0.53 Allowed 'General case' 0 C--N 1.358 0.97 0 C-N-CA 126.858 2.063 . . . . 0.0 111.029 -176.047 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 1.5 p30 -164.65 -50.06 0.03 OUTLIER 'General case' 0 N--CA 1.435 -1.176 0 N-CA-C 103.676 -2.713 . . . . 0.0 103.676 175.868 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 46.5 p -97.63 163.89 12.65 Favored 'General case' 0 N--CA 1.44 -0.968 0 C-N-CA 124.922 1.289 . . . . 0.0 108.01 178.135 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 4.8 m -125.92 46.18 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.849 0 N-CA-C 105.838 -1.912 . . . . 0.0 105.838 176.455 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -94.89 -154.06 30.66 Favored Glycine 0 C--N 1.356 1.656 0 N-CA-C 109.808 -1.317 . . . . 0.0 109.808 -175.64 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 80.4 ttt180 -78.9 126.76 31.12 Favored 'General case' 0 C--N 1.356 0.86 0 N-CA-C 108.142 -1.059 . . . . 0.0 108.142 -178.59 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -105.24 172.56 6.73 Favored 'General case' 0 CA--C 1.497 -1.061 0 C-N-CA 123.825 0.85 . . . . 0.0 110.377 -172.782 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 63.0 mttp -112.11 157.07 21.25 Favored 'General case' 0 CA--C 1.489 -1.403 0 N-CA-C 107.773 -1.195 . . . . 0.0 107.773 -170.717 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 15.7 pt-20 -151.21 159.73 44.23 Favored 'General case' 0 N--CA 1.437 -1.09 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 173.57 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -138.2 164.03 30.24 Favored 'General case' 0 N--CA 1.44 -0.935 0 N-CA-C 105.851 -1.907 . . . . 0.0 105.851 170.436 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 88.8 m -124.51 127.67 47.8 Favored 'General case' 0 CA--C 1.5 -0.947 0 N-CA-C 105.3 -2.111 . . . . 0.0 105.3 179.053 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 5.2 mp -117.27 135.93 23.29 Favored Pre-proline 0 N--CA 1.438 -1.034 0 N-CA-C 105.213 -2.143 . . . . 0.0 105.213 -172.111 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_exo -63.06 166.82 13.53 Favored 'Trans proline' 0 CA--C 1.509 -0.762 0 C-N-CA 123.54 2.826 . . . . 0.0 113.748 176.582 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -81.09 -16.82 73.62 Favored Glycine 0 C--N 1.353 1.473 0 C-N-CA 123.457 0.551 . . . . 0.0 113.249 -171.95 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 50.8 p-80 -83.83 -25.82 30.02 Favored 'General case' 0 C--N 1.357 0.901 0 CA-C-N 117.831 0.816 . . . . 0.0 109.999 179.899 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 92.4 mt -88.32 131.03 34.97 Favored 'General case' 0 CA--C 1.501 -0.922 0 N-CA-C 107.84 -1.17 . . . . 0.0 107.84 177.46 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 8.3 p-10 -112.95 8.35 18.51 Favored 'General case' 0 CA--C 1.503 -0.863 0 C-N-CA 124.666 1.186 . . . . 0.0 109.667 -174.421 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 32.9 p -146.75 160.92 41.64 Favored 'General case' 0 CA--C 1.499 -1.005 0 N-CA-C 106.484 -1.673 . . . . 0.0 106.484 -177.248 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 19.2 t80 -148.45 160.26 43.23 Favored 'General case' 0 CA--C 1.497 -1.093 0 N-CA-C 108.083 -1.08 . . . . 0.0 108.083 178.575 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 82.8 m -114.43 109.47 18.36 Favored 'General case' 0 N--CA 1.436 -1.14 0 N-CA-C 104.491 -2.411 . . . . 0.0 104.491 168.9 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 65.7 mt -82.94 137.79 20.41 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.902 0 N-CA-C 103.086 -2.931 . . . . 0.0 103.086 169.83 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 17.8 ptpt -147.84 160.62 42.56 Favored 'General case' 0 CA--C 1.495 -1.151 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 -177.709 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 89.82 52.67 2.56 Favored Glycine 0 CA--C 1.489 -1.555 0 N-CA-C 108.586 -1.806 . . . . 0.0 108.586 179.827 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 63.8 mt -120.47 170.63 9.2 Favored 'General case' 0 CA--C 1.498 -1.023 0 N-CA-C 107.377 -1.342 . . . . 0.0 107.377 -171.986 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 28.9 mtpp -101.59 153.75 37.7 Favored Pre-proline 0 N--CA 1.439 -1.012 0 N-CA-C 106.507 -1.664 . . . . 0.0 106.507 -179.775 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 70.6 Cg_endo -77.6 156.8 32.09 Favored 'Trans proline' 0 N--CA 1.452 -0.964 0 C-N-CA 122.936 2.424 . . . . 0.0 110.342 174.88 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 57.74 32.68 65.99 Favored Glycine 0 C--N 1.355 1.635 0 C-N-CA 126.904 2.192 . . . . 0.0 116.44 169.854 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 5.8 p -129.16 144.39 38.3 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.903 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 -177.009 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 3.5 p -95.4 135.49 29.31 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.918 0 N-CA-C 107.292 -1.373 . . . . 0.0 107.292 -179.693 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 94.8 m-85 -113.67 150.99 32.43 Favored 'General case' 0 CA--C 1.499 -1.011 0 N-CA-C 106.815 -1.55 . . . . 0.0 106.815 177.379 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -94.94 145.29 25.02 Favored 'General case' 0 CA--C 1.501 -0.928 0 N-CA-C 104.155 -2.535 . . . . 0.0 104.155 161.109 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -138.39 149.5 20.56 Favored Glycine 0 CA--C 1.487 -1.678 0 N-CA-C 108.599 -1.801 . . . . 0.0 108.599 -177.413 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 26.2 mt-30 -138.59 135.66 35.19 Favored 'General case' 0 CA--C 1.483 -1.608 0 N-CA-C 105.599 -2.0 . . . . 0.0 105.599 177.064 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 40.9 tp -116.72 99.36 7.07 Favored 'General case' 0 N--CA 1.435 -1.178 0 N-CA-C 103.787 -2.672 . . . . 0.0 103.787 179.075 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 33.0 mt -89.21 127.68 41.75 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.883 0 N-CA-C 104.762 -2.311 . . . . 0.0 104.762 177.702 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 13.3 p -112.03 115.98 29.8 Favored 'General case' 0 N--CA 1.434 -1.26 0 N-CA-C 106.565 -1.642 . . . . 0.0 106.565 -176.619 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 23.1 mm -90.68 138.63 19.13 Favored 'Isoleucine or valine' 0 CA--C 1.483 -1.603 0 N-CA-C 106.154 -1.795 . . . . 0.0 106.154 -167.468 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 36.2 mt-30 -101.24 153.6 19.48 Favored 'General case' 0 CA--C 1.494 -1.198 0 CA-C-N 113.851 -1.522 . . . . 0.0 107.569 -173.313 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 32.8 mt-30 -68.44 101.16 1.19 Allowed 'General case' 0 CA--C 1.5 -0.948 0 C-N-CA 124.939 1.295 . . . . 0.0 112.497 -166.165 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 85.7 m-85 52.99 39.99 30.38 Favored 'General case' 0 C--N 1.359 1.008 0 C-N-CA 127.296 2.238 . . . . 0.0 112.214 -179.825 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -149.64 -118.83 0.93 Allowed Glycine 0 C--N 1.354 1.545 0 N-CA-C 108.851 -1.7 . . . . 0.0 108.851 -175.294 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 64.4 m-70 -81.93 -175.68 5.73 Favored 'General case' 0 CA--C 1.496 -1.113 0 C-N-CA 124.757 1.223 . . . . 0.0 111.528 -167.858 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 40.1 mt-30 -134.0 137.47 44.77 Favored 'General case' 0 N--CA 1.436 -1.132 0 N-CA-C 103.536 -2.765 . . . . 0.0 103.536 171.595 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 16.7 tp10 -118.05 137.02 53.18 Favored 'General case' 0 CA--C 1.495 -1.146 0 N-CA-C 105.174 -2.158 . . . . 0.0 105.174 179.873 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 7.1 p -111.35 139.12 36.9 Favored 'Isoleucine or valine' 0 C--N 1.354 0.797 0 N-CA-C 107.618 -1.253 . . . . 0.0 107.618 -177.414 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 38.2 m -120.49 134.17 55.31 Favored 'General case' 0 N--CA 1.441 -0.886 0 N-CA-C 102.345 -3.206 . . . . 0.0 102.345 174.114 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 83.1 mtm180 -125.82 149.75 48.36 Favored 'General case' 0 CA--C 1.5 -0.954 0 CA-C-N 119.177 0.898 . . . . 0.0 109.479 -176.638 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 19.2 p90 -165.96 -176.59 3.85 Favored 'General case' 0 CA--C 1.501 -0.92 0 N-CA-C 107.382 -1.34 . . . . 0.0 107.382 -178.357 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 44.7 p30 -135.79 158.05 45.34 Favored 'General case' 0 N--CA 1.442 -0.858 0 N-CA-C 107.24 -1.393 . . . . 0.0 107.24 164.626 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 25.4 p90 -142.38 172.88 12.09 Favored 'General case' 0 CA--C 1.485 -1.53 0 N-CA-C 106.018 -1.845 . . . . 0.0 106.018 170.252 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 8.9 t -141.41 152.98 44.77 Favored 'General case' 0 CA--C 1.499 -0.996 0 N-CA-C 105.713 -1.958 . . . . 0.0 105.713 173.77 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 29.8 p -113.95 131.94 56.13 Favored 'General case' 0 N--CA 1.437 -1.104 0 N-CA-C 103.432 -2.803 . . . . 0.0 103.432 171.745 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 25.0 p -130.5 145.83 51.93 Favored 'General case' 0 CA--C 1.5 -0.968 0 N-CA-C 105.654 -1.98 . . . . 0.0 105.654 179.632 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 42.9 p . . . . . 0 C--O 1.26 1.65 0 N-CA-C 109.206 -0.664 . . . . 0.0 109.206 -177.575 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 65.2 m . . . . . 0 N--CA 1.49 1.553 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -160.97 178.99 36.71 Favored Glycine 0 C--N 1.351 1.386 0 N-CA-C 105.516 -3.034 . . . . 0.0 105.516 173.566 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 90.4 Cg_exo -61.17 134.27 51.51 Favored 'Trans proline' 0 CA--C 1.5 -1.177 0 C-N-CA 123.17 2.58 . . . . 0.0 112.255 -171.018 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 3.1 t -79.39 150.31 5.15 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.79 0 C-N-CA 126.313 1.845 . . . . 0.0 106.039 -176.442 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 54.5 mm-40 -100.1 89.46 4.04 Favored 'General case' 0 CA--C 1.485 -1.527 0 CA-C-O 122.776 1.274 . . . . 0.0 108.36 -170.262 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 2.3 p -104.06 127.24 58.42 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.136 0 CA-C-N 113.421 -1.718 . . . . 0.0 107.661 -166.879 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 59.2 m-85 -85.67 138.27 32.25 Favored 'General case' 0 CA--C 1.495 -1.135 0 C-N-CA 123.935 0.894 . . . . 0.0 110.444 -169.501 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 35.2 mt -131.82 62.21 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.438 -1.052 0 N-CA-C 100.615 -3.846 . . . . 0.0 100.615 163.057 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 88.2 m -111.76 100.31 8.84 Favored 'General case' 0 CA--C 1.498 -1.033 0 N-CA-C 104.941 -2.244 . . . . 0.0 104.941 -172.635 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 11.8 tp10 54.89 42.19 31.3 Favored 'General case' 0 C--N 1.358 0.975 0 C-N-CA 126.859 2.064 . . . . 0.0 111.138 -176.949 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 30.7 m -92.53 -55.21 0.25 Allowed Pre-proline 0 N--CA 1.442 -0.826 0 CA-C-O 113.992 -2.909 . . . . 0.0 109.936 -174.546 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_exo -71.46 87.47 0.78 Allowed 'Trans proline' 0 C--N 1.349 0.584 0 CA-C-N 126.435 3.334 . . . . 0.0 115.415 -164.664 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 11.1 p -159.73 82.11 0.73 Allowed 'General case' 0 CA--C 1.492 -1.268 0 N-CA-C 105.803 -1.925 . . . . 0.0 105.803 168.831 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 2.7 mp0 -156.02 157.52 31.32 Favored Pre-proline 0 N--CA 1.441 -0.92 0 N-CA-C 104.54 -2.393 . . . . 0.0 104.54 -176.405 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -80.01 -50.79 0.06 OUTLIER 'Trans proline' 0 N--CA 1.45 -1.056 0 C-N-CA 122.647 2.231 . . . . 0.0 111.75 172.861 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 36.6 m-20 -141.97 -12.39 0.85 Allowed 'General case' 0 N--CA 1.435 -1.191 0 C-N-CA 124.82 1.248 . . . . 0.0 110.228 -163.649 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 23.6 p -98.11 161.39 13.74 Favored 'General case' 0 CA--C 1.503 -0.846 0 O-C-N 120.739 -1.226 . . . . 0.0 107.701 -179.516 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 40.3 t-80 -151.52 104.26 2.91 Favored Pre-proline 0 N--CA 1.443 -0.816 0 CA-C-O 118.359 -0.829 . . . . 0.0 108.934 173.088 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -75.73 123.11 7.25 Favored 'Trans proline' 0 N--CA 1.452 -0.949 0 C-N-CA 123.199 2.599 . . . . 0.0 109.71 175.282 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 10.9 mt -111.6 136.56 47.35 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.947 0 N-CA-C 104.586 -2.375 . . . . 0.0 104.586 -178.639 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 35.7 mt-30 -140.3 146.93 39.17 Favored 'General case' 0 CA--C 1.494 -1.19 0 N-CA-C 104.668 -2.345 . . . . 0.0 104.668 179.387 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 42.7 p90 -147.48 169.63 19.14 Favored 'General case' 0 CA--C 1.499 -1.015 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 -174.072 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 5.7 m120 -131.24 127.57 38.1 Favored 'General case' 0 CA--C 1.492 -1.252 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 179.624 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -92.26 175.78 3.11 Favored Pre-proline 0 N--CA 1.439 -0.993 0 C-N-CA 125.989 1.716 . . . . 0.0 108.946 -174.323 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_exo -63.16 159.58 38.45 Favored 'Trans proline' 0 CA--C 1.508 -0.823 0 C-N-CA 123.743 2.962 . . . . 0.0 112.297 171.095 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 35.9 mt-30 -81.57 -37.12 0.86 Allowed Pre-proline 0 N--CA 1.443 -0.795 0 CA-C-O 115.962 -1.971 . . . . 0.0 111.281 -177.414 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_exo -70.17 -8.26 23.16 Favored 'Trans proline' 0 CA--C 1.512 -0.625 0 CA-C-N 124.878 2.778 . . . . 0.0 112.905 169.526 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . 0.28 80.5 p 54.09 71.81 0.49 Allowed 'General case' 0 C--N 1.36 1.046 0 C-N-CA 127.609 2.363 . . . . 0.0 112.022 -177.254 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 49.8 t-80 -88.74 -10.57 47.85 Favored 'General case' 0 N--CA 1.441 -0.885 0 C-N-CA 124.473 1.109 . . . . 0.0 109.768 -176.329 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.408 HG21 ' CE1' ' A' ' 33' ' ' TYR . 84.7 mt -93.88 145.03 8.4 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.976 0 N-CA-C 105.434 -2.061 . . . . 0.0 105.434 -179.846 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 35.6 t -99.09 -86.78 0.36 Allowed 'General case' 0 N--CA 1.43 -1.445 0 N-CA-C 103.857 -2.646 . . . . 0.0 103.857 174.537 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 46.0 mtpt -89.16 165.94 14.15 Favored 'General case' 0 CA--C 1.492 -1.266 0 C-N-CA 124.854 1.262 . . . . 0.0 109.097 -168.359 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . 0.408 ' CE1' HG21 ' A' ' 30' ' ' ILE . 64.0 m-85 -125.63 142.34 51.56 Favored 'General case' 0 CA--C 1.495 -1.137 0 N-CA-C 104.547 -2.39 . . . . 0.0 104.547 164.641 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 54.7 mt -119.56 132.24 69.9 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.302 0 N-CA-C 101.141 -3.651 . . . . 0.0 101.141 168.796 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 3.0 mt -106.38 128.96 54.43 Favored 'General case' 0 CA--C 1.473 -2.017 0 N-CA-C 103.95 -2.611 . . . . 0.0 103.95 166.766 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 79.3 mtt180 -112.56 157.09 21.59 Favored 'General case' 0 N--CA 1.43 -1.442 0 N-CA-C 105.266 -2.124 . . . . 0.0 105.266 164.248 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 48.6 p90 -156.12 147.42 22.5 Favored 'General case' 0 N--CA 1.43 -1.44 0 N-CA-C 105.934 -1.876 . . . . 0.0 105.934 176.513 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 39.0 ptt180 -157.52 161.07 29.86 Favored Pre-proline 0 N--CA 1.438 -1.028 0 N-CA-C 105.41 -2.071 . . . . 0.0 105.41 170.189 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_exo -66.06 149.77 85.68 Favored 'Trans proline' 0 CA--C 1.503 -1.029 0 C-N-CA 123.367 2.711 . . . . 0.0 109.828 176.572 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 4.1 tmtp? -75.7 70.93 2.54 Favored 'General case' 0 C--N 1.358 0.947 0 C-N-CA 123.643 0.777 . . . . 0.0 109.587 175.731 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 30.4 m120 -158.67 -52.55 0.06 Allowed 'General case' 0 N--CA 1.437 -1.083 0 N-CA-C 103.671 -2.714 . . . . 0.0 103.671 -170.609 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 32.3 t -79.24 151.45 31.17 Favored 'General case' 0 CA--C 1.497 -1.096 0 CA-C-O 122.783 1.277 . . . . 0.0 110.064 -174.73 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 16.1 m -134.34 -0.54 1.24 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.894 0 CA-C-N 112.42 -2.173 . . . . 0.0 108.425 -174.514 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -98.2 -100.21 2.13 Favored Glycine 0 C--N 1.356 1.67 0 N-CA-C 109.355 -1.498 . . . . 0.0 109.355 -174.63 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 77.0 mtp85 -93.95 168.21 11.11 Favored 'General case' 0 CA--C 1.501 -0.908 0 C-N-CA 123.588 0.755 . . . . 0.0 109.559 -173.716 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 60.3 m95 -122.53 163.22 20.32 Favored 'General case' 0 N--CA 1.439 -0.996 0 N-CA-C 106.273 -1.751 . . . . 0.0 106.273 178.591 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -96.77 151.26 19.82 Favored 'General case' 0 CA--C 1.489 -1.392 0 N-CA-C 103.858 -2.645 . . . . 0.0 103.858 158.796 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 16.1 pt-20 -152.31 158.88 43.38 Favored 'General case' 0 CA--C 1.496 -1.12 0 CA-C-O 121.8 0.81 . . . . 0.0 109.559 -178.113 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -142.73 162.25 35.97 Favored 'General case' 0 CA--C 1.498 -1.036 0 N-CA-C 106.051 -1.833 . . . . 0.0 106.051 174.066 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 78.4 m -120.35 125.63 48.49 Favored 'General case' 0 CA--C 1.5 -0.945 0 N-CA-C 105.228 -2.138 . . . . 0.0 105.228 178.713 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 5.3 mp -109.43 133.3 20.87 Favored Pre-proline 0 N--CA 1.437 -1.107 0 N-CA-C 104.313 -2.476 . . . . 0.0 104.313 -177.929 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 65.3 Cg_exo -63.88 165.06 19.74 Favored 'Trans proline' 0 CA--C 1.507 -0.847 0 C-N-CA 123.393 2.729 . . . . 0.0 113.054 178.277 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -75.05 -18.04 80.2 Favored Glycine 0 C--N 1.351 1.403 0 N-CA-C 114.604 0.602 . . . . 0.0 114.604 -174.084 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 47.7 p-80 -83.71 -29.52 27.47 Favored 'General case' 0 C--N 1.356 0.864 0 CA-C-N 118.016 0.908 . . . . 0.0 109.826 179.832 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 89.6 mt -89.14 134.26 34.08 Favored 'General case' 0 CA--C 1.5 -0.972 0 N-CA-C 107.721 -1.215 . . . . 0.0 107.721 176.563 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 6.5 p-10 -123.53 25.01 8.4 Favored 'General case' 0 CA--C 1.498 -1.023 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 -177.541 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 33.9 p -146.79 163.22 36.72 Favored 'General case' 0 N--CA 1.439 -1.021 0 N-CA-C 107.59 -1.263 . . . . 0.0 107.59 -179.248 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 7.4 t80 -154.25 178.4 10.05 Favored 'General case' 0 N--CA 1.44 -0.936 0 N-CA-C 107.903 -1.147 . . . . 0.0 107.903 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 96.1 m -144.09 117.99 9.36 Favored 'General case' 0 N--CA 1.43 -1.44 0 N-CA-C 104.995 -2.224 . . . . 0.0 104.995 176.072 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 13.4 mm -87.22 144.38 9.4 Favored 'Isoleucine or valine' 0 C--N 1.354 0.768 0 N-CA-C 104.3 -2.481 . . . . 0.0 104.3 171.004 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 95.8 mttt -145.27 162.22 37.69 Favored 'General case' 0 CA--C 1.493 -1.225 0 N-CA-C 107.491 -1.3 . . . . 0.0 107.491 170.07 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 79.31 54.56 4.0 Favored Glycine 0 CA--C 1.488 -1.596 0 N-CA-C 108.968 -1.653 . . . . 0.0 108.968 175.249 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 85.3 mt -108.34 -153.87 0.52 Allowed 'General case' 0 CA--C 1.504 -0.799 0 N-CA-C 106.822 -1.547 . . . . 0.0 106.822 178.854 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 90.6 mttt -132.18 156.3 80.27 Favored Pre-proline 0 N--CA 1.44 -0.928 0 N-CA-C 105.74 -1.948 . . . . 0.0 105.74 -170.997 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_endo -74.09 135.78 21.44 Favored 'Trans proline' 0 N--CA 1.451 -0.993 0 C-N-CA 122.905 2.403 . . . . 0.0 110.45 173.202 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 57.25 49.74 70.09 Favored Glycine 0 C--N 1.355 1.612 0 C-N-CA 126.852 2.167 . . . . 0.0 115.823 170.417 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 27.8 t -118.13 133.58 64.49 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.102 0 N-CA-C 105.951 -1.87 . . . . 0.0 105.951 173.51 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 5.3 p -84.33 119.97 34.27 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.961 0 N-CA-C 105.48 -2.044 . . . . 0.0 105.48 164.947 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 83.0 m-85 -99.5 149.24 23.42 Favored 'General case' 0 CA--C 1.496 -1.13 0 C-N-CA 125.716 1.606 . . . . 0.0 107.354 -179.477 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 17.9 pt-20 -108.67 133.46 52.73 Favored 'General case' 0 CA--C 1.499 -0.984 0 N-CA-C 105.01 -2.219 . . . . 0.0 105.01 167.912 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -128.45 165.08 21.48 Favored Glycine 0 CA--C 1.484 -1.895 0 N-CA-C 107.688 -2.165 . . . . 0.0 107.688 -174.206 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 83.8 mt-30 -137.3 133.84 35.42 Favored 'General case' 0 CA--C 1.482 -1.667 0 N-CA-C 104.557 -2.386 . . . . 0.0 104.557 169.688 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 27.2 tp -110.54 90.77 3.42 Favored 'General case' 0 N--CA 1.435 -1.221 0 N-CA-C 103.335 -2.839 . . . . 0.0 103.335 174.383 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 13.2 mt -91.58 131.34 38.95 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.927 0 N-CA-C 105.492 -2.04 . . . . 0.0 105.492 -174.373 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 58.5 m -118.47 115.3 24.33 Favored 'General case' 0 N--CA 1.436 -1.164 0 N-CA-C 107.685 -1.228 . . . . 0.0 107.685 -173.998 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 1.7 mp -91.54 135.97 25.62 Favored 'Isoleucine or valine' 0 CA--C 1.499 -1.0 0 N-CA-C 105.163 -2.162 . . . . 0.0 105.163 -172.175 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 15.6 mp0 -99.17 122.07 41.88 Favored 'General case' 0 CA--C 1.498 -1.034 0 N-CA-C 102.582 -3.118 . . . . 0.0 102.582 170.174 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 16.7 tt0 -68.03 126.02 28.18 Favored 'General case' 0 N--CA 1.443 -0.789 0 C-N-CA 123.26 0.624 . . . . 0.0 111.629 -166.995 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 21.5 m-85 66.42 43.83 2.55 Favored 'General case' 0 C--N 1.357 0.902 0 C-N-CA 126.746 2.018 . . . . 0.0 111.912 179.787 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -171.95 -115.77 0.37 Allowed Glycine 0 N--CA 1.432 -1.587 0 N-CA-C 108.145 -1.982 . . . . 0.0 108.145 175.714 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 87.7 m-70 -84.71 178.53 7.63 Favored 'General case' 0 CA--C 1.498 -1.023 0 C-N-CA 125.182 1.393 . . . . 0.0 111.103 -169.302 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 5.3 pt20 -145.9 143.89 29.85 Favored 'General case' 0 N--CA 1.436 -1.138 0 N-CA-C 106.156 -1.794 . . . . 0.0 106.156 165.104 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 9.3 tm-20 -106.39 141.76 37.18 Favored 'General case' 0 N--CA 1.438 -1.064 0 N-CA-C 104.44 -2.43 . . . . 0.0 104.44 -177.351 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 3.2 p -121.96 120.43 61.43 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.804 0 N-CA-C 108.195 -1.039 . . . . 0.0 108.195 -179.467 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 83.9 m -97.15 129.09 44.57 Favored 'General case' 0 C--N 1.355 0.844 0 N-CA-C 102.622 -3.103 . . . . 0.0 102.622 169.822 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 55.3 ttt85 -115.17 137.66 51.77 Favored 'General case' 0 CA--C 1.498 -1.04 0 N-CA-C 106.358 -1.719 . . . . 0.0 106.358 175.45 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -150.86 176.76 10.77 Favored 'General case' 0 CA--C 1.494 -1.185 0 N-CA-C 107.657 -1.238 . . . . 0.0 107.657 -177.477 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 38.9 p-10 -139.39 151.25 46.16 Favored 'General case' 0 N--CA 1.438 -1.047 0 N-CA-C 106.0 -1.852 . . . . 0.0 106.0 171.21 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 18.5 p90 -144.43 170.51 15.89 Favored 'General case' 0 CA--C 1.489 -1.387 0 N-CA-C 105.801 -1.926 . . . . 0.0 105.801 176.433 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 55.2 m -122.19 142.98 49.86 Favored 'General case' 0 CA--C 1.5 -0.956 0 N-CA-C 105.564 -2.014 . . . . 0.0 105.564 -179.557 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 86.6 m -120.41 120.97 37.49 Favored 'General case' 0 CA--C 1.498 -1.056 0 N-CA-C 101.971 -3.344 . . . . 0.0 101.971 167.292 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 76.9 p -88.73 -168.46 2.2 Favored 'General case' 0 C--N 1.353 0.723 0 C-N-CA 123.654 0.781 . . . . 0.0 109.422 -169.527 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 32.3 t . . . . . 0 C--O 1.26 1.64 0 N-CA-C 106.768 -1.567 . . . . 0.0 106.768 -179.609 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 60.2 m . . . . . 0 N--CA 1.489 1.475 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 167.6 -162.79 36.59 Favored Glycine 0 N--CA 1.436 -1.36 0 N-CA-C 107.62 -2.192 . . . . 0.0 107.62 -179.931 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 79.4 Cg_exo -61.83 137.5 68.31 Favored 'Trans proline' 0 N--CA 1.444 -1.412 0 C-N-CA 123.359 2.706 . . . . 0.0 113.06 -177.389 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 3.5 t -77.37 152.53 5.51 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.915 0 C-N-CA 127.993 2.517 . . . . 0.0 107.006 -178.86 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 91.4 mt-10 -94.35 86.99 5.05 Favored 'General case' 0 CA--C 1.493 -1.23 0 CA-C-O 122.73 1.252 . . . . 0.0 108.721 -174.547 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.417 HG12 ' H ' ' A' ' 6' ' ' VAL . 2.1 p -88.98 154.32 3.18 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.077 0 N-CA-C 105.822 -1.918 . . . . 0.0 105.822 -171.293 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 36.8 t80 -146.57 66.06 1.18 Allowed 'General case' 0 N--CA 1.429 -1.497 0 N-CA-C 104.458 -2.423 . . . . 0.0 104.458 -148.199 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 61.2 mt -98.94 95.7 4.49 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.96 0 N-CA-C 104.166 -2.531 . . . . 0.0 104.166 176.118 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 14.7 t -157.66 -26.44 0.09 Allowed 'General case' 0 N--CA 1.442 -0.854 0 CA-C-N 113.756 -1.565 . . . . 0.0 110.149 -172.19 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 31.9 tt0 -100.96 2.38 40.65 Favored 'General case' 0 N--CA 1.438 -1.051 0 C-N-CA 125.661 1.585 . . . . 0.0 107.537 -176.238 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 20.5 p -134.61 73.55 67.43 Favored Pre-proline 0 C--N 1.358 0.976 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 -177.297 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -75.44 -52.5 0.1 Allowed 'Trans proline' 0 N--CA 1.453 -0.891 0 C-N-CA 122.585 2.19 . . . . 0.0 110.523 176.354 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 18.7 p -139.36 110.23 6.78 Favored 'General case' 0 N--CA 1.425 -1.686 0 N-CA-C 104.497 -2.409 . . . . 0.0 104.497 -172.979 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 29.0 mm100 -129.37 132.3 24.18 Favored Pre-proline 0 N--CA 1.438 -1.042 0 N-CA-C 101.657 -3.46 . . . . 0.0 101.657 168.486 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 64.1 Cg_endo -82.46 -27.38 2.25 Favored 'Trans proline' 0 CA--C 1.504 -1.003 0 C-N-CA 122.085 1.856 . . . . 0.0 112.052 -154.763 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 1.4 p30 -120.75 -38.89 2.79 Favored 'General case' 0 CA--C 1.482 -1.654 0 C-N-CA 123.82 0.848 . . . . 0.0 109.198 -173.989 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 48.5 p -100.54 165.63 11.32 Favored 'General case' 0 N--CA 1.435 -1.22 0 N-CA-C 107.987 -1.116 . . . . 0.0 107.987 -174.956 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 63.7 t-80 -143.31 97.44 5.63 Favored Pre-proline 0 N--CA 1.435 -1.185 0 N-CA-C 104.501 -2.407 . . . . 0.0 104.501 162.434 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -71.18 133.83 23.76 Favored 'Trans proline' 0 N--CA 1.447 -1.258 0 C-N-CA 122.558 2.172 . . . . 0.0 110.167 172.061 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 14.7 mm -104.46 138.63 28.29 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.062 0 N-CA-C 102.928 -2.99 . . . . 0.0 102.928 176.664 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 73.1 mt-30 -128.31 149.66 50.41 Favored 'General case' 0 CA--C 1.493 -1.244 0 N-CA-C 103.909 -2.626 . . . . 0.0 103.909 172.609 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 49.1 p90 -149.49 167.69 25.54 Favored 'General case' 0 CA--C 1.491 -1.307 0 N-CA-C 107.947 -1.131 . . . . 0.0 107.947 -179.125 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 1.8 m120 -130.92 128.44 40.52 Favored 'General case' 0 CA--C 1.489 -1.374 0 N-CA-C 105.382 -2.081 . . . . 0.0 105.382 -179.751 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -87.02 143.79 35.5 Favored Pre-proline 0 N--CA 1.44 -0.927 0 CA-C-O 118.693 -0.67 . . . . 0.0 110.504 -170.622 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_endo -76.76 166.09 27.62 Favored 'Trans proline' 0 N--CA 1.452 -0.917 0 C-N-CA 122.716 2.277 . . . . 0.0 108.214 159.381 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 22.3 tt0 -129.73 84.44 61.19 Favored Pre-proline 0 N--CA 1.442 -0.861 0 N-CA-C 108.323 -0.991 . . . . 0.0 108.323 176.683 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 90.9 Cg_endo -82.31 -8.2 11.76 Favored 'Trans proline' 0 N--CA 1.453 -0.865 0 C-N-CA 123.148 2.565 . . . . 0.0 109.599 163.051 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 21.4 m 59.45 44.21 15.28 Favored 'General case' 0 C--N 1.36 1.028 0 C-N-CA 127.573 2.349 . . . . 0.0 111.222 -171.328 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 15.4 t-160 -140.57 -10.84 1.05 Allowed 'General case' 0 N--CA 1.438 -1.031 0 CA-C-N 113.947 -1.479 . . . . 0.0 108.92 -174.935 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 38.4 mt -111.11 130.7 64.09 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.094 0 N-CA-C 105.423 -2.066 . . . . 0.0 105.423 -173.408 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 32.0 t -112.91 -84.82 0.59 Allowed 'General case' 0 N--CA 1.433 -1.283 0 N-CA-C 107.806 -1.183 . . . . 0.0 107.806 -176.242 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 51.4 mtmt -87.68 168.87 12.62 Favored 'General case' 0 CA--C 1.485 -1.539 0 C-N-CA 124.009 0.924 . . . . 0.0 109.097 -161.313 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 86.8 m-85 -129.46 140.07 51.41 Favored 'General case' 0 CA--C 1.493 -1.238 0 N-CA-C 105.049 -2.204 . . . . 0.0 105.049 170.32 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 35.8 mt -117.24 131.08 71.0 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.203 0 N-CA-C 101.567 -3.494 . . . . 0.0 101.567 169.511 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 4.8 mt -106.65 128.68 54.37 Favored 'General case' 0 CA--C 1.473 -1.985 0 N-CA-C 104.389 -2.448 . . . . 0.0 104.389 168.182 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 65.5 mtt180 -113.97 157.97 21.75 Favored 'General case' 0 N--CA 1.431 -1.377 0 N-CA-C 105.644 -1.984 . . . . 0.0 105.644 167.082 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 36.0 p90 -147.07 130.41 16.63 Favored 'General case' 0 N--CA 1.432 -1.362 0 N-CA-C 104.359 -2.46 . . . . 0.0 104.359 174.16 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 20.0 ttp180 -122.94 138.78 30.2 Favored Pre-proline 0 CA--C 1.498 -1.046 0 N-CA-C 104.087 -2.56 . . . . 0.0 104.087 177.437 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 68.4 Cg_exo -66.26 130.14 23.3 Favored 'Trans proline' 0 CA--C 1.503 -1.037 0 CA-C-N 123.798 2.392 . . . . 0.0 109.122 169.395 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 39.9 ttmt -73.07 69.56 1.02 Allowed 'General case' 0 C--N 1.357 0.929 0 C-N-CA 124.716 1.206 . . . . 0.0 109.899 173.939 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 69.6 m-80 -160.65 -57.05 0.05 Allowed 'General case' 0 N--CA 1.434 -1.26 0 N-CA-C 102.18 -3.267 . . . . 0.0 102.18 -170.866 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 53.4 p -85.29 165.52 17.24 Favored 'General case' 0 N--CA 1.439 -1.021 0 C-N-CA 125.333 1.453 . . . . 0.0 109.109 179.565 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 19.2 m -113.73 -13.04 11.58 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.811 0 C-N-CA 124.254 1.022 . . . . 0.0 110.144 -172.31 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -175.81 38.61 0.1 Allowed Glycine 0 C--N 1.354 1.55 0 N-CA-C 110.359 -1.097 . . . . 0.0 110.359 -178.19 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -119.85 105.51 11.17 Favored 'General case' 0 CA--C 1.492 -1.257 0 N-CA-C 102.271 -3.233 . . . . 0.0 102.271 171.149 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -157.75 165.74 34.59 Favored 'General case' 0 CA--C 1.49 -1.33 0 CA-C-O 122.16 0.981 . . . . 0.0 112.161 -172.618 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 63.2 mttp -121.57 161.41 22.43 Favored 'General case' 0 CA--C 1.492 -1.257 0 CA-C-N 113.688 -1.596 . . . . 0.0 106.79 -169.777 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 15.8 pt-20 -151.92 160.71 43.43 Favored 'General case' 0 N--CA 1.435 -1.199 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 174.315 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -140.5 162.25 35.79 Favored 'General case' 0 CA--C 1.5 -0.961 0 N-CA-C 106.283 -1.747 . . . . 0.0 106.283 174.69 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 59.5 m -120.36 126.04 49.52 Favored 'General case' 0 CA--C 1.499 -0.982 0 N-CA-C 105.175 -2.157 . . . . 0.0 105.175 178.06 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 5.3 mp -112.7 135.94 21.57 Favored Pre-proline 0 N--CA 1.437 -1.098 0 N-CA-C 104.516 -2.401 . . . . 0.0 104.516 -177.346 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 63.2 Cg_exo -63.6 168.06 12.26 Favored 'Trans proline' 0 CA--C 1.51 -0.723 0 C-N-CA 123.45 2.766 . . . . 0.0 113.618 177.466 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -78.49 -20.01 72.65 Favored Glycine 0 C--N 1.351 1.383 0 C-N-CA 123.398 0.523 . . . . 0.0 113.26 -173.885 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 49.7 p-80 -84.27 -27.48 27.85 Favored 'General case' 0 C--N 1.355 0.836 0 CA-C-N 117.713 0.756 . . . . 0.0 110.022 -179.393 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 87.5 mt -88.52 130.64 35.18 Favored 'General case' 0 CA--C 1.5 -0.981 0 N-CA-C 107.541 -1.281 . . . . 0.0 107.541 177.264 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 7.6 p30 -118.88 13.05 13.05 Favored 'General case' 0 CA--C 1.501 -0.921 0 C-N-CA 124.113 0.965 . . . . 0.0 109.645 -173.311 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 46.9 p -142.93 166.6 24.19 Favored 'General case' 0 N--CA 1.44 -0.959 0 N-CA-C 107.282 -1.377 . . . . 0.0 107.282 179.169 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 9.9 t80 -154.87 176.74 12.1 Favored 'General case' 0 N--CA 1.44 -0.938 0 N-CA-C 107.788 -1.19 . . . . 0.0 107.788 -177.161 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 57.2 m -142.57 114.72 8.3 Favored 'General case' 0 N--CA 1.432 -1.367 0 N-CA-C 105.114 -2.18 . . . . 0.0 105.114 176.882 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 50.8 mt -98.84 98.09 6.73 Favored 'Isoleucine or valine' 0 C--N 1.36 1.044 0 N-CA-C 106.137 -1.801 . . . . 0.0 106.137 175.823 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 93.4 mttt -94.97 163.65 13.23 Favored 'General case' 0 CA--C 1.499 -0.988 0 CA-C-O 121.591 0.71 . . . . 0.0 109.341 178.453 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 84.03 49.51 4.73 Favored Glycine 0 CA--C 1.49 -1.471 0 N-CA-C 109.134 -1.586 . . . . 0.0 109.134 174.453 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 68.3 mt -121.63 162.73 20.16 Favored 'General case' 0 CA--C 1.497 -1.078 0 N-CA-C 106.171 -1.789 . . . . 0.0 106.171 -179.144 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -99.57 157.34 34.13 Favored Pre-proline 0 N--CA 1.44 -0.944 0 N-CA-C 107.257 -1.386 . . . . 0.0 107.257 -177.276 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -78.65 165.88 24.38 Favored 'Trans proline' 0 N--CA 1.451 -1.005 0 C-N-CA 123.074 2.516 . . . . 0.0 109.575 165.521 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 0.515 ' H ' ' HA ' ' A' ' 92' ' ' THR . . . 64.67 18.77 64.26 Favored Glycine 0 N--CA 1.43 -1.736 0 C-N-CA 127.223 2.344 . . . . 0.0 116.415 173.178 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 13.9 p -123.99 140.36 47.66 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.024 0 N-CA-C 107.942 -1.133 . . . . 0.0 107.942 -176.338 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 2.8 p -96.34 129.48 46.35 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.842 0 N-CA-C 107.391 -1.337 . . . . 0.0 107.391 178.671 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 82.6 m-85 -109.56 155.17 21.73 Favored 'General case' 0 N--CA 1.438 -1.04 0 C-N-CA 124.672 1.189 . . . . 0.0 108.436 177.375 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 19.3 tt0 -92.63 139.04 30.98 Favored 'General case' 0 N--CA 1.437 -1.108 0 N-CA-C 104.044 -2.576 . . . . 0.0 104.044 159.074 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -132.31 146.07 17.82 Favored Glycine 0 CA--C 1.49 -1.488 0 N-CA-C 107.575 -2.21 . . . . 0.0 107.575 171.679 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 32.4 mt-30 -138.57 136.02 35.6 Favored 'General case' 0 CA--C 1.479 -1.759 0 N-CA-C 106.321 -1.733 . . . . 0.0 106.321 177.834 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 45.2 tp -117.54 95.53 4.99 Favored 'General case' 0 N--CA 1.439 -1.011 0 N-CA-C 104.423 -2.436 . . . . 0.0 104.423 -178.281 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 12.5 mt -90.92 131.7 37.4 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.85 0 N-CA-C 105.167 -2.16 . . . . 0.0 105.167 -176.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 26.0 p -112.18 115.05 28.21 Favored 'General case' 0 N--CA 1.441 -0.882 0 N-CA-C 107.592 -1.262 . . . . 0.0 107.592 -176.257 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 5.8 mm -94.03 151.56 3.71 Favored 'Isoleucine or valine' 0 CA--C 1.49 -1.347 0 N-CA-C 106.282 -1.747 . . . . 0.0 106.282 -165.142 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . 0.522 HE21 ' HB2' ' A' ' 81' ' ' HIS . 15.6 mt-30 -119.1 145.66 45.74 Favored 'General case' 0 CA--C 1.49 -1.344 0 N-CA-C 105.154 -2.165 . . . . 0.0 105.154 176.879 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 36.1 mt-30 -77.27 35.31 0.17 Allowed 'General case' 0 C--N 1.356 0.856 0 C-N-CA 125.182 1.393 . . . . 0.0 112.917 179.322 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -138.54 13.33 2.76 Favored 'General case' 0 CA--C 1.499 -1.017 0 C-N-CA 124.754 1.222 . . . . 0.0 107.747 -179.436 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 92.51 -13.64 66.81 Favored Glycine 0 C--N 1.352 1.419 0 C-N-CA 124.298 0.952 . . . . 0.0 112.511 173.423 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . 0.522 ' HB2' HE21 ' A' ' 77' ' ' GLN . 65.4 m80 -80.74 161.99 24.31 Favored 'General case' 0 CA--C 1.502 -0.897 0 CA-C-N 118.045 0.922 . . . . 0.0 109.692 -174.81 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 80.7 mt-30 -145.45 137.34 25.44 Favored 'General case' 0 N--CA 1.437 -1.104 0 N-CA-C 104.606 -2.368 . . . . 0.0 104.606 -178.148 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 9.6 mp0 -118.36 131.37 56.31 Favored 'General case' 0 CA--C 1.494 -1.199 0 N-CA-C 104.074 -2.565 . . . . 0.0 104.074 173.155 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 5.6 p -106.91 132.72 53.52 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.864 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 -172.104 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 21.5 m -104.86 137.52 42.52 Favored 'General case' 0 N--CA 1.442 -0.873 0 N-CA-C 102.383 -3.192 . . . . 0.0 102.383 168.947 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 31.5 ptt-85 -134.38 145.95 49.44 Favored 'General case' 0 CA--C 1.496 -1.112 0 CA-C-O 121.588 0.708 . . . . 0.0 109.143 179.831 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 20.0 p90 -164.78 -178.9 5.52 Favored 'General case' 0 CA--C 1.499 -0.999 0 N-CA-C 106.376 -1.713 . . . . 0.0 106.376 -173.296 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -137.06 157.76 45.98 Favored 'General case' 0 N--CA 1.437 -1.094 0 N-CA-C 106.212 -1.773 . . . . 0.0 106.212 170.155 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 25.5 p90 -143.58 170.72 15.3 Favored 'General case' 0 CA--C 1.487 -1.453 0 N-CA-C 106.256 -1.757 . . . . 0.0 106.256 169.497 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 9.7 m -126.49 140.3 52.57 Favored 'General case' 0 CA--C 1.499 -1.001 0 N-CA-C 103.678 -2.712 . . . . 0.0 103.678 175.827 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 86.1 m -112.71 114.15 26.6 Favored 'General case' 0 CA--C 1.497 -1.09 0 N-CA-C 102.137 -3.283 . . . . 0.0 102.137 176.58 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . 0.515 ' HA ' ' H ' ' A' ' 66' ' ' GLY . 23.7 p -125.21 168.5 13.38 Favored 'General case' 0 CA--C 1.5 -0.952 0 N-CA-C 106.438 -1.69 . . . . 0.0 106.438 -179.128 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 15.1 t . . . . . 0 C--O 1.258 1.546 0 N-CA-C 108.014 -1.106 . . . . 0.0 108.014 -178.399 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 23.3 t . . . . . 0 N--CA 1.482 1.171 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 169.4 174.62 37.96 Favored Glycine 0 C--N 1.349 1.286 0 N-CA-C 106.748 -2.541 . . . . 0.0 106.748 178.13 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 66.6 Cg_exo -60.1 138.86 84.44 Favored 'Trans proline' 0 N--CA 1.447 -1.214 0 C-N-CA 123.396 2.73 . . . . 0.0 113.493 -170.79 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 21.5 t -77.77 156.55 5.23 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.9 0 C-N-CA 128.277 2.631 . . . . 0.0 105.354 178.483 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 59.4 mm-40 -109.73 98.67 7.97 Favored 'General case' 0 CA--C 1.487 -1.478 0 N-CA-C 106.947 -1.501 . . . . 0.0 106.947 -174.442 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 2.2 p -123.27 139.3 50.38 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.108 0 N-CA-C 106.248 -1.76 . . . . 0.0 106.248 -169.163 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 75.1 m-85 -144.9 179.69 7.17 Favored 'General case' 0 CA--C 1.494 -1.184 0 N-CA-C 105.179 -2.156 . . . . 0.0 105.179 -172.403 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -135.92 127.89 45.27 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.094 0 N-CA-C 104.182 -2.525 . . . . 0.0 104.182 161.865 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 14.8 t -154.73 9.28 0.33 Allowed 'General case' 0 N--CA 1.437 -1.084 0 N-CA-C 107.274 -1.38 . . . . 0.0 107.274 -178.441 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 26.6 tt0 -83.05 -29.86 28.5 Favored 'General case' 0 C--N 1.359 0.98 0 O-C-N 121.102 -0.999 . . . . 0.0 111.097 -167.047 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 13.0 t -139.72 140.53 25.08 Favored Pre-proline 0 N--CA 1.442 -0.846 0 N-CA-C 104.41 -2.441 . . . . 0.0 104.41 175.178 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 69.7 Cg_endo -84.24 -20.25 4.24 Favored 'Trans proline' 0 N--CA 1.453 -0.882 0 C-N-CA 122.37 2.047 . . . . 0.0 110.729 178.88 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 47.6 m -158.0 113.71 2.75 Favored 'General case' 0 CA--C 1.495 -1.14 0 N-CA-C 105.762 -1.94 . . . . 0.0 105.762 -169.792 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 66.7 tp60 -157.03 119.08 2.14 Favored Pre-proline 0 N--CA 1.441 -0.899 0 N-CA-C 105.54 -2.022 . . . . 0.0 105.54 174.368 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -88.07 -20.72 1.78 Allowed 'Trans proline' 0 CA--C 1.505 -0.943 0 C-N-CA 122.262 1.975 . . . . 0.0 112.005 -167.282 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 5.8 p-10 -114.28 -39.46 3.86 Favored 'General case' 0 CA--C 1.491 -1.321 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 -164.701 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 66.5 m -104.31 154.33 19.95 Favored 'General case' 0 CA--C 1.494 -1.181 0 N-CA-C 106.599 -1.63 . . . . 0.0 106.599 176.285 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 37.0 t-80 -139.95 89.58 11.24 Favored Pre-proline 0 N--CA 1.438 -1.033 0 N-CA-C 107.188 -1.412 . . . . 0.0 107.188 172.917 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -82.96 120.05 2.96 Favored 'Trans proline' 0 N--CA 1.447 -1.219 0 C-N-CA 123.11 2.54 . . . . 0.0 110.463 179.593 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.485 HD11 HD11 ' A' ' 35' ' ' LEU . 3.9 pt -104.85 173.84 1.35 Allowed 'Isoleucine or valine' 0 CA--C 1.497 -1.083 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 -177.486 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 2.4 pt20 -149.82 149.43 30.5 Favored 'General case' 0 N--CA 1.44 -0.967 0 N-CA-C 106.421 -1.696 . . . . 0.0 106.421 173.52 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 23.8 p90 -134.44 157.14 47.21 Favored 'General case' 0 CA--C 1.499 -0.983 0 N-CA-C 106.632 -1.618 . . . . 0.0 106.632 -177.808 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 59.8 t30 -99.71 -177.81 3.68 Favored 'General case' 0 CA--C 1.492 -1.272 0 N-CA-C 102.683 -3.08 . . . . 0.0 102.683 168.152 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -155.63 170.49 8.66 Favored Pre-proline 0 N--CA 1.438 -1.043 0 N-CA-C 106.334 -1.728 . . . . 0.0 106.334 176.325 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 63.5 Cg_exo -63.65 164.16 22.06 Favored 'Trans proline' 0 N--CA 1.456 -0.695 0 C-N-CA 123.267 2.645 . . . . 0.0 112.635 173.176 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 17.9 mp0 -80.48 -53.83 0.85 Allowed Pre-proline 0 N--CA 1.443 -0.818 0 CA-C-O 115.579 -2.153 . . . . 0.0 111.617 -167.919 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -74.03 172.26 16.29 Favored 'Trans proline' 0 CA--C 1.51 -0.699 0 CA-C-N 125.871 3.132 . . . . 0.0 109.95 174.221 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 22.8 t -83.79 87.01 7.07 Favored 'General case' 0 C--N 1.357 0.907 0 N-CA-C 107.237 -1.394 . . . . 0.0 107.237 178.563 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 22.5 t-160 -112.56 -32.86 6.33 Favored 'General case' 0 N--CA 1.436 -1.145 0 N-CA-C 106.938 -1.504 . . . . 0.0 106.938 -177.084 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 1.8 mp -108.62 134.55 50.2 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.946 0 N-CA-C 103.315 -2.846 . . . . 0.0 103.315 -178.179 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 5.9 p -100.77 -82.01 0.46 Allowed 'General case' 0 N--CA 1.434 -1.26 0 N-CA-C 107.875 -1.158 . . . . 0.0 107.875 175.108 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 6.5 ttpm? -94.35 161.27 14.31 Favored 'General case' 0 CA--C 1.495 -1.136 0 C-N-CA 124.7 1.2 . . . . 0.0 108.029 -165.733 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 85.5 m-85 -125.9 138.14 53.77 Favored 'General case' 0 N--CA 1.437 -1.079 0 N-CA-C 105.111 -2.181 . . . . 0.0 105.111 171.733 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 34.3 mm -109.25 129.18 64.43 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.155 0 N-CA-C 101.03 -3.692 . . . . 0.0 101.03 165.831 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.485 HD11 HD11 ' A' ' 20' ' ' ILE . 3.8 mt -109.02 135.8 49.6 Favored 'General case' 0 CA--C 1.478 -1.796 0 N-CA-C 106.543 -1.651 . . . . 0.0 106.543 169.721 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 84.1 mtt180 -125.09 158.23 34.35 Favored 'General case' 0 N--CA 1.43 -1.446 0 N-CA-C 107.123 -1.436 . . . . 0.0 107.123 173.191 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 48.0 p90 -150.5 145.21 25.85 Favored 'General case' 0 N--CA 1.437 -1.091 0 N-CA-C 105.86 -1.904 . . . . 0.0 105.86 173.381 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 46.9 ttp180 -153.44 137.57 10.73 Favored Pre-proline 0 CA--C 1.498 -1.032 0 N-CA-C 105.324 -2.102 . . . . 0.0 105.324 -176.411 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -72.74 120.75 6.86 Favored 'Trans proline' 0 N--CA 1.451 -1.021 0 CA-C-N 123.485 2.28 . . . . 0.0 109.034 -177.369 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 58.5 tttm -73.48 65.06 0.89 Allowed 'General case' 0 C--N 1.358 0.962 0 C-N-CA 127.078 2.151 . . . . 0.0 110.554 177.514 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 6.4 t-20 -161.77 -53.0 0.04 OUTLIER 'General case' 0 N--CA 1.432 -1.358 0 N-CA-C 104.003 -2.592 . . . . 0.0 104.003 -169.735 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 50.3 m -88.36 166.0 14.57 Favored 'General case' 0 N--CA 1.438 -1.052 0 C-N-CA 124.431 1.092 . . . . 0.0 108.218 177.991 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 10.9 m -116.0 41.37 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.795 0 N-CA-C 106.938 -1.505 . . . . 0.0 106.938 -178.998 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -92.54 -156.38 32.72 Favored Glycine 0 C--N 1.354 1.559 0 N-CA-C 109.61 -1.396 . . . . 0.0 109.61 -177.494 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 39.6 mmt180 -101.87 172.2 7.07 Favored 'General case' 0 CA--C 1.499 -0.999 0 N-CA-C 107.324 -1.362 . . . . 0.0 107.324 -179.999 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 47.9 m95 -87.12 164.28 16.5 Favored 'General case' 0 N--CA 1.441 -0.88 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 -177.681 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 96.2 mttt -108.77 155.64 20.54 Favored 'General case' 0 CA--C 1.489 -1.366 0 N-CA-C 102.237 -3.246 . . . . 0.0 102.237 161.462 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -151.32 159.07 44.49 Favored 'General case' 0 CA--C 1.494 -1.209 0 CA-C-O 122.021 0.915 . . . . 0.0 109.794 -178.048 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -133.88 159.21 41.36 Favored 'General case' 0 N--CA 1.434 -1.241 0 N-CA-C 106.057 -1.831 . . . . 0.0 106.057 172.68 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 93.8 m -119.86 125.63 48.99 Favored 'General case' 0 CA--C 1.499 -1.006 0 N-CA-C 104.277 -2.49 . . . . 0.0 104.277 178.178 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 34.0 mt -123.79 122.79 26.35 Favored Pre-proline 0 N--CA 1.439 -0.984 0 N-CA-C 105.038 -2.208 . . . . 0.0 105.038 -171.602 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . 0.462 ' HB2' ' CE1' ' A' ' 54' ' ' HIS . 50.7 Cg_exo -67.25 169.21 15.78 Favored 'Trans proline' 0 CA--C 1.512 -0.612 0 C-N-CA 123.279 2.653 . . . . 0.0 111.301 175.757 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -86.71 83.21 1.6 Allowed Glycine 0 C--N 1.352 1.441 0 N-CA-C 110.121 -1.191 . . . . 0.0 110.121 -177.728 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . 0.462 ' CE1' ' HB2' ' A' ' 52' ' ' PRO . 0.5 OUTLIER -157.54 -44.11 0.07 Allowed 'General case' 0 CA--C 1.497 -1.079 0 N-CA-C 107.279 -1.378 . . . . 0.0 107.279 -179.795 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 92.2 mt -89.62 136.49 33.0 Favored 'General case' 0 CA--C 1.495 -1.148 0 N-CA-C 107.832 -1.173 . . . . 0.0 107.832 179.522 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 8.6 p30 -112.67 5.34 17.68 Favored 'General case' 0 N--CA 1.44 -0.926 0 C-N-CA 124.875 1.27 . . . . 0.0 109.119 -179.392 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 45.3 p -142.98 150.28 39.45 Favored 'General case' 0 CA--C 1.499 -1.012 0 N-CA-C 107.171 -1.418 . . . . 0.0 107.171 -178.519 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 7.5 t80 -126.36 174.08 8.85 Favored 'General case' 0 C--N 1.357 0.924 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 -179.087 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 88.0 m -138.74 109.44 6.64 Favored 'General case' 0 N--CA 1.43 -1.425 0 N-CA-C 104.618 -2.364 . . . . 0.0 104.618 172.205 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 28.3 mt -88.15 147.17 5.42 Favored 'Isoleucine or valine' 0 C--N 1.358 0.965 0 N-CA-C 104.271 -2.492 . . . . 0.0 104.271 171.447 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 94.0 mttt -141.08 162.65 34.97 Favored 'General case' 0 CA--C 1.5 -0.976 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 177.131 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 82.61 48.96 5.35 Favored Glycine 0 C--N 1.353 1.487 0 N-CA-C 109.838 -1.305 . . . . 0.0 109.838 173.758 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 58.0 mt -119.71 173.34 7.08 Favored 'General case' 0 CA--C 1.5 -0.958 0 N-CA-C 107.886 -1.153 . . . . 0.0 107.886 -173.654 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 67.8 mttm -110.36 157.15 38.96 Favored Pre-proline 0 N--CA 1.441 -0.876 0 N-CA-C 107.419 -1.326 . . . . 0.0 107.419 -176.113 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 67.5 Cg_endo -78.65 161.3 27.86 Favored 'Trans proline' 0 N--CA 1.451 -0.986 0 C-N-CA 123.168 2.579 . . . . 0.0 109.785 168.247 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 59.59 26.21 61.99 Favored Glycine 0 C--N 1.355 1.621 0 C-N-CA 127.261 2.363 . . . . 0.0 116.337 171.59 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 13.2 p -120.24 148.3 23.46 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.995 0 N-CA-C 106.837 -1.542 . . . . 0.0 106.837 -177.595 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 4.0 p -99.76 130.93 48.1 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.907 0 N-CA-C 106.626 -1.62 . . . . 0.0 106.626 176.137 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 93.5 m-85 -112.16 148.42 34.04 Favored 'General case' 0 CA--C 1.494 -1.189 0 N-CA-C 105.537 -2.023 . . . . 0.0 105.537 172.246 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -97.91 134.69 40.7 Favored 'General case' 0 CA--C 1.496 -1.11 0 N-CA-C 103.576 -2.75 . . . . 0.0 103.576 161.68 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -117.6 152.58 17.62 Favored Glycine 0 CA--C 1.486 -1.75 0 N-CA-C 106.065 -2.814 . . . . 0.0 106.065 -178.054 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 35.3 tt0 -145.64 130.1 17.82 Favored 'General case' 0 CA--C 1.48 -1.735 0 N-CA-C 106.623 -1.621 . . . . 0.0 106.623 -177.226 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 38.9 tp -118.14 99.8 7.11 Favored 'General case' 0 N--CA 1.437 -1.081 0 N-CA-C 104.151 -2.537 . . . . 0.0 104.151 -174.534 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 26.8 mt -91.99 131.56 38.75 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.865 0 N-CA-C 103.603 -2.74 . . . . 0.0 103.603 176.481 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 20.9 p -117.08 115.74 25.97 Favored 'General case' 0 N--CA 1.436 -1.166 0 N-CA-C 106.962 -1.495 . . . . 0.0 106.962 -177.33 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 1.7 mp -89.58 132.52 34.07 Favored 'Isoleucine or valine' 0 CA--C 1.483 -1.6 0 N-CA-C 102.543 -3.132 . . . . 0.0 102.543 -173.131 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 82.0 mt-30 -101.83 152.65 20.64 Favored 'General case' 0 CA--C 1.489 -1.393 0 N-CA-C 106.951 -1.5 . . . . 0.0 106.951 -174.97 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 11.8 tt0 -77.53 41.48 0.33 Allowed 'General case' 0 N--CA 1.443 -0.818 0 C-N-CA 125.858 1.663 . . . . 0.0 112.419 -179.668 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 8.5 t80 -151.78 16.7 0.68 Allowed 'General case' 0 N--CA 1.436 -1.128 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 178.315 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 86.99 -11.75 63.97 Favored Glycine 0 C--N 1.353 1.526 0 C-N-CA 123.73 0.681 . . . . 0.0 112.496 176.901 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 44.6 t-80 -78.65 160.38 27.56 Favored 'General case' 0 N--CA 1.441 -0.888 0 C-N-CA 124.68 1.192 . . . . 0.0 109.011 -176.767 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 83.2 mt-30 -136.22 136.2 39.71 Favored 'General case' 0 CA--C 1.491 -1.318 0 N-CA-C 104.579 -2.378 . . . . 0.0 104.579 175.14 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 16.8 tp10 -120.49 131.47 54.74 Favored 'General case' 0 CA--C 1.495 -1.171 0 N-CA-C 104.753 -2.314 . . . . 0.0 104.753 178.0 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 7.2 p -108.94 139.25 32.33 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.83 0 N-CA-C 107.561 -1.274 . . . . 0.0 107.561 -174.298 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 89.1 m -125.32 131.22 53.07 Favored 'General case' 0 N--CA 1.44 -0.953 0 N-CA-C 102.804 -3.036 . . . . 0.0 102.804 178.51 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 40.5 ttp180 -130.51 145.53 51.88 Favored 'General case' 0 C--N 1.356 0.882 0 CA-C-N 119.492 1.042 . . . . 0.0 109.031 178.459 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 17.8 p90 -156.35 -179.89 8.59 Favored 'General case' 0 CA--C 1.498 -1.026 0 N-CA-C 105.987 -1.857 . . . . 0.0 105.987 -171.245 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 1.6 p30 -141.05 157.72 44.93 Favored 'General case' 0 N--CA 1.442 -0.873 0 N-CA-C 108.117 -1.068 . . . . 0.0 108.117 169.153 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 21.8 p90 -144.66 170.71 15.56 Favored 'General case' 0 CA--C 1.493 -1.226 0 N-CA-C 106.921 -1.511 . . . . 0.0 106.921 173.597 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 24.7 p -117.51 138.6 51.78 Favored 'General case' 0 CA--C 1.501 -0.934 0 N-CA-C 106.175 -1.787 . . . . 0.0 106.175 171.491 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 56.0 m -108.07 113.49 26.69 Favored 'General case' 0 CA--C 1.495 -1.149 0 N-CA-C 103.009 -2.96 . . . . 0.0 103.009 172.076 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 15.0 t -161.86 165.36 27.85 Favored 'General case' 0 N--CA 1.436 -1.171 0 N-CA-C 104.731 -2.322 . . . . 0.0 104.731 -174.653 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 75.2 p . . . . . 0 C--O 1.261 1.687 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 173.587 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 70.1 m . . . . . 0 N--CA 1.488 1.456 0 CA-C-O 121.431 0.634 . . . . 0.0 110.88 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -178.29 104.07 0.18 Allowed Glycine 0 C--N 1.351 1.404 0 N-CA-C 108.593 -1.803 . . . . 0.0 108.593 176.544 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_exo -64.79 146.29 88.0 Favored 'Trans proline' 0 N--CA 1.442 -1.529 0 C-N-CA 123.157 2.571 . . . . 0.0 115.287 -161.042 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 4.6 m -83.0 169.28 1.6 Allowed 'Isoleucine or valine' 0 N--CA 1.432 -1.336 0 C-N-CA 126.641 1.977 . . . . 0.0 107.168 171.063 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 -101.81 100.35 10.67 Favored 'General case' 0 CA--C 1.495 -1.164 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 -176.678 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 4.2 p -107.77 137.62 38.16 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.138 0 N-CA-C 107.474 -1.306 . . . . 0.0 107.474 -174.016 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -145.19 133.48 21.71 Favored 'General case' 0 N--CA 1.433 -1.323 0 N-CA-C 106.975 -1.491 . . . . 0.0 106.975 -170.669 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 35.6 pt -89.13 162.27 2.57 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.295 0 N-CA-C 105.465 -2.05 . . . . 0.0 105.465 171.132 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 9.8 m -80.1 -105.84 0.02 OUTLIER 'General case' 0 C--N 1.354 0.769 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 -170.832 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 3.2 tm-20 -116.5 -87.74 0.6 Allowed 'General case' 0 CA--C 1.495 -1.156 0 N-CA-C 103.69 -2.707 . . . . 0.0 103.69 177.908 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 14.6 t -153.63 142.95 14.88 Favored Pre-proline 0 N--CA 1.438 -1.034 0 N-CA-C 101.136 -3.653 . . . . 0.0 101.136 162.452 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -77.97 -171.94 1.34 Allowed 'Trans proline' 0 N--CA 1.457 -0.674 0 C-N-CA 122.769 2.313 . . . . 0.0 109.48 179.667 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 11.5 t -114.36 36.2 3.86 Favored 'General case' 0 CA--C 1.499 -0.986 0 N-CA-C 106.221 -1.77 . . . . 0.0 106.221 173.82 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 37.2 mt-30 -125.37 101.65 30.88 Favored Pre-proline 0 N--CA 1.435 -1.21 0 CA-C-N 111.912 -2.404 . . . . 0.0 106.311 -176.808 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_exo -74.88 -11.36 21.7 Favored 'Trans proline' 0 CA--C 1.507 -0.83 0 C-N-CA 122.979 2.453 . . . . 0.0 110.722 177.293 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 1.9 p30 -96.87 -30.81 12.92 Favored 'General case' 0 CA--C 1.486 -1.485 0 C-N-CA 125.508 1.523 . . . . 0.0 110.638 -172.783 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 22.9 t -119.54 156.71 29.78 Favored 'General case' 0 CA--C 1.498 -1.037 0 CA-C-O 122.223 1.011 . . . . 0.0 108.915 -172.47 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 59.7 t-80 -140.39 98.75 7.26 Favored Pre-proline 0 N--CA 1.438 -1.056 0 N-CA-C 106.735 -1.58 . . . . 0.0 106.735 172.783 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -80.86 137.31 11.04 Favored 'Trans proline' 0 N--CA 1.447 -1.216 0 C-N-CA 123.019 2.479 . . . . 0.0 110.17 176.104 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 2.4 pt -118.64 172.77 5.59 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.07 0 N-CA-C 107.747 -1.205 . . . . 0.0 107.747 178.794 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . 0.448 ' HA ' ' HA ' ' A' ' 57' ' ' SER . 3.6 pt20 -150.79 158.34 44.03 Favored 'General case' 0 CA--C 1.492 -1.287 0 N-CA-C 105.706 -1.961 . . . . 0.0 105.706 168.947 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 43.7 p90 -142.97 164.49 29.94 Favored 'General case' 0 CA--C 1.493 -1.231 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 -175.409 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 81.1 m-20 -109.39 177.1 4.85 Favored 'General case' 0 CA--C 1.494 -1.2 0 N-CA-C 104.297 -2.482 . . . . 0.0 104.297 168.839 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -161.23 173.83 4.36 Favored Pre-proline 0 N--CA 1.435 -1.22 0 N-CA-C 104.788 -2.301 . . . . 0.0 104.788 -176.138 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.432 ' HD2' HD12 ' A' ' 30' ' ' ILE . 67.1 Cg_exo -63.1 153.49 73.55 Favored 'Trans proline' 0 N--CA 1.455 -0.742 0 C-N-CA 123.786 2.991 . . . . 0.0 112.758 175.563 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 26.1 tt0 -82.17 -40.36 0.93 Allowed Pre-proline 0 N--CA 1.443 -0.813 0 CA-C-O 115.574 -2.155 . . . . 0.0 112.071 -174.558 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_exo -69.49 -8.9 24.83 Favored 'Trans proline' 0 CA--C 1.512 -0.59 0 CA-C-N 125.674 3.062 . . . . 0.0 114.037 179.906 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 8.9 t 67.86 66.65 0.36 Allowed 'General case' 0 C--N 1.357 0.91 0 C-N-CA 126.107 1.763 . . . . 0.0 110.038 178.939 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 76.6 t60 -97.49 -2.27 42.33 Favored 'General case' 0 N--CA 1.441 -0.876 0 C-N-CA 124.517 1.127 . . . . 0.0 108.307 175.411 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.432 HD12 ' HD2' ' A' ' 25' ' ' PRO . 9.7 mt -111.16 135.8 49.21 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.071 0 N-CA-C 105.131 -2.174 . . . . 0.0 105.131 -179.669 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 4.6 p -98.13 -84.45 0.39 Allowed 'General case' 0 N--CA 1.428 -1.565 0 N-CA-C 106.518 -1.66 . . . . 0.0 106.518 178.282 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 52.7 mtmt -90.57 170.65 10.0 Favored 'General case' 0 CA--C 1.487 -1.448 0 C-N-CA 123.857 0.863 . . . . 0.0 109.086 -165.134 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 87.4 m-85 -132.43 140.05 48.28 Favored 'General case' 0 N--CA 1.436 -1.141 0 N-CA-C 103.837 -2.653 . . . . 0.0 103.837 167.568 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 41.8 mt -121.73 135.2 62.64 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.204 0 N-CA-C 101.632 -3.47 . . . . 0.0 101.632 173.66 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 4.5 mt -113.07 136.98 52.11 Favored 'General case' 0 CA--C 1.467 -2.233 0 N-CA-C 104.848 -2.278 . . . . 0.0 104.848 169.54 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 1.1 ptm180 -131.51 152.31 50.84 Favored 'General case' 0 N--CA 1.43 -1.472 0 N-CA-C 105.678 -1.971 . . . . 0.0 105.678 168.632 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 48.6 p90 -155.0 152.28 29.48 Favored 'General case' 0 N--CA 1.436 -1.158 0 N-CA-C 106.841 -1.54 . . . . 0.0 106.841 -175.034 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 36.4 ptt180 -158.14 157.37 29.18 Favored Pre-proline 0 CA--C 1.5 -0.949 0 N-CA-C 105.881 -1.896 . . . . 0.0 105.881 171.989 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_endo -76.43 124.33 7.65 Favored 'Trans proline' 0 CA--C 1.503 -1.067 0 C-N-CA 122.652 2.234 . . . . 0.0 108.968 -175.209 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 85.1 tttt -71.19 79.58 0.7 Allowed 'General case' 0 C--N 1.358 0.943 0 C-N-CA 126.296 1.839 . . . . 0.0 110.497 178.753 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 67.7 m-80 -154.28 -69.57 0.13 Allowed 'General case' 0 N--CA 1.436 -1.167 0 N-CA-C 101.531 -3.507 . . . . 0.0 101.531 -176.313 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 55.1 m -96.79 167.03 11.35 Favored 'General case' 0 N--CA 1.44 -0.925 0 N-CA-C 106.746 -1.575 . . . . 0.0 106.746 171.55 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 2.6 m -132.82 62.59 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.439 -0.988 0 N-CA-C 105.285 -2.117 . . . . 0.0 105.285 179.892 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -93.1 -111.83 2.09 Favored Glycine 0 C--N 1.353 1.521 0 N-CA-C 108.838 -1.705 . . . . 0.0 108.838 -178.916 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 86.7 mtm180 -97.66 169.66 9.55 Favored 'General case' 0 CA--C 1.501 -0.92 0 N-CA-C 107.973 -1.121 . . . . 0.0 107.973 -179.367 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 70.6 m95 -112.16 167.17 10.62 Favored 'General case' 0 N--CA 1.44 -0.957 0 N-CA-C 107.615 -1.254 . . . . 0.0 107.615 178.53 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -114.51 152.89 30.97 Favored 'General case' 0 CA--C 1.487 -1.46 0 N-CA-C 102.537 -3.135 . . . . 0.0 102.537 163.245 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 16.2 pt-20 -152.35 159.04 43.51 Favored 'General case' 0 N--CA 1.437 -1.094 0 CA-C-O 121.749 0.785 . . . . 0.0 109.106 178.507 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -140.03 162.68 34.62 Favored 'General case' 0 CA--C 1.499 -0.998 0 N-CA-C 106.553 -1.647 . . . . 0.0 106.553 172.488 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 90.0 m -119.34 125.32 48.75 Favored 'General case' 0 CA--C 1.5 -0.969 0 N-CA-C 105.127 -2.175 . . . . 0.0 105.127 176.981 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 4.5 mp -109.03 133.64 20.65 Favored Pre-proline 0 N--CA 1.437 -1.117 0 N-CA-C 105.239 -2.134 . . . . 0.0 105.239 -175.928 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 68.7 Cg_exo -64.27 164.1 24.04 Favored 'Trans proline' 0 CA--C 1.508 -0.802 0 C-N-CA 123.312 2.675 . . . . 0.0 113.369 176.193 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -75.37 -16.63 80.5 Favored Glycine 0 C--N 1.352 1.418 0 C-N-CA 123.977 0.799 . . . . 0.0 114.497 -174.421 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 52.6 p-80 -83.52 -27.15 29.57 Favored 'General case' 0 C--N 1.357 0.903 0 CA-C-N 118.144 0.972 . . . . 0.0 110.105 -179.617 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 88.4 mt -88.65 131.18 35.1 Favored 'General case' 0 CA--C 1.501 -0.908 0 N-CA-C 107.945 -1.131 . . . . 0.0 107.945 177.161 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 8.5 p30 -114.17 7.87 16.73 Favored 'General case' 0 CA--C 1.504 -0.797 0 C-N-CA 124.521 1.128 . . . . 0.0 109.858 -174.753 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.448 ' HA ' ' HA ' ' A' ' 21' ' ' GLN . 36.9 p -139.23 160.49 39.68 Favored 'General case' 0 CA--C 1.497 -1.093 0 N-CA-C 107.163 -1.421 . . . . 0.0 107.163 -177.519 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 4.1 t80 -138.87 178.77 6.91 Favored 'General case' 0 C--N 1.36 1.064 0 CA-C-O 121.672 0.748 . . . . 0.0 109.171 175.729 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 89.4 m -144.49 103.62 3.97 Favored 'General case' 0 N--CA 1.432 -1.339 0 N-CA-C 103.689 -2.708 . . . . 0.0 103.689 -178.502 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 55.8 mt -95.37 106.51 18.33 Favored 'Isoleucine or valine' 0 C--N 1.358 0.969 0 N-CA-C 106.239 -1.763 . . . . 0.0 106.239 179.541 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 63.7 mttm -103.64 163.76 12.11 Favored 'General case' 0 CA--C 1.502 -0.897 0 CA-C-O 121.739 0.78 . . . . 0.0 109.542 178.814 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 90.85 45.5 4.2 Favored Glycine 0 CA--C 1.49 -1.474 0 N-CA-C 109.285 -1.526 . . . . 0.0 109.285 172.907 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 61.7 mt -119.92 176.67 5.3 Favored 'General case' 0 N--CA 1.44 -0.931 0 N-CA-C 106.909 -1.515 . . . . 0.0 106.909 -174.643 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -120.89 157.79 53.94 Favored Pre-proline 0 N--CA 1.44 -0.93 0 N-CA-C 106.704 -1.591 . . . . 0.0 106.704 -175.684 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 64.8 Cg_endo -78.63 164.54 25.76 Favored 'Trans proline' 0 N--CA 1.452 -0.956 0 C-N-CA 123.065 2.51 . . . . 0.0 110.559 170.252 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 0.585 ' H ' ' HA ' ' A' ' 92' ' ' THR . . . 60.94 25.2 63.76 Favored Glycine 0 N--CA 1.431 -1.679 0 C-N-CA 128.006 2.717 . . . . 0.0 116.124 171.256 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 8.5 p -130.54 146.83 33.42 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.15 0 N-CA-C 108.188 -1.041 . . . . 0.0 108.188 -176.124 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 4.2 p -95.88 133.66 36.23 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.907 0 N-CA-C 107.377 -1.342 . . . . 0.0 107.377 178.157 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 93.8 m-85 -112.9 149.48 33.12 Favored 'General case' 0 CA--C 1.498 -1.057 0 N-CA-C 106.161 -1.792 . . . . 0.0 106.161 174.299 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -101.1 140.0 36.01 Favored 'General case' 0 CA--C 1.497 -1.094 0 N-CA-C 104.561 -2.385 . . . . 0.0 104.561 164.827 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -137.15 148.98 20.08 Favored Glycine 0 CA--C 1.486 -1.723 0 N-CA-C 108.101 -2.0 . . . . 0.0 108.101 -175.035 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 84.5 mt-30 -138.79 135.77 34.97 Favored 'General case' 0 CA--C 1.484 -1.58 0 N-CA-C 105.585 -2.006 . . . . 0.0 105.585 178.477 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 46.0 tp -114.71 103.29 10.84 Favored 'General case' 0 N--CA 1.434 -1.271 0 N-CA-C 103.847 -2.649 . . . . 0.0 103.847 179.247 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 38.1 mt -91.94 122.02 42.99 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.898 0 N-CA-C 103.852 -2.647 . . . . 0.0 103.852 177.723 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 15.4 p -113.92 115.1 27.15 Favored 'General case' 0 N--CA 1.441 -0.884 0 N-CA-C 107.156 -1.424 . . . . 0.0 107.156 -175.316 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 1.8 mp -90.36 131.94 36.26 Favored 'Isoleucine or valine' 0 CA--C 1.482 -1.659 0 N-CA-C 104.805 -2.294 . . . . 0.0 104.805 -162.817 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 76.4 mt-30 -84.3 147.91 26.95 Favored 'General case' 0 CA--C 1.491 -1.298 0 N-CA-C 107.994 -1.113 . . . . 0.0 107.994 -178.882 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 20.2 tt0 -76.5 41.75 0.26 Allowed 'General case' 0 N--CA 1.442 -0.862 0 C-N-CA 126.331 1.852 . . . . 0.0 110.545 170.739 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 8.2 t80 -153.07 15.9 0.55 Allowed 'General case' 0 N--CA 1.434 -1.265 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 -176.528 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 89.25 -19.03 41.62 Favored Glycine 0 C--N 1.353 1.506 0 C-N-CA 123.72 0.676 . . . . 0.0 112.601 174.358 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 36.7 m170 -81.7 173.48 12.28 Favored 'General case' 0 CA--C 1.495 -1.153 0 C-N-CA 124.446 1.098 . . . . 0.0 109.274 -176.308 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 77.1 mt-30 -138.7 145.55 40.47 Favored 'General case' 0 CA--C 1.495 -1.154 0 N-CA-C 105.527 -2.027 . . . . 0.0 105.527 176.495 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -111.23 153.72 25.44 Favored 'General case' 0 CA--C 1.493 -1.215 0 N-CA-C 105.415 -2.068 . . . . 0.0 105.415 171.06 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 14.8 p -126.92 137.46 57.78 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.897 0 N-CA-C 106.523 -1.658 . . . . 0.0 106.523 173.325 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 91.4 m -127.08 131.01 50.98 Favored 'General case' 0 N--CA 1.438 -1.066 0 N-CA-C 101.973 -3.343 . . . . 0.0 101.973 179.055 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 88.8 mtt180 -127.08 148.92 50.13 Favored 'General case' 0 CA--C 1.495 -1.15 0 CA-C-N 118.804 0.729 . . . . 0.0 109.487 -173.154 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 19.6 p90 -164.82 178.26 7.32 Favored 'General case' 0 CA--C 1.502 -0.9 0 N-CA-C 108.156 -1.053 . . . . 0.0 108.156 -175.287 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 51.4 m-20 -132.52 154.06 50.33 Favored 'General case' 0 N--CA 1.442 -0.872 0 N-CA-C 105.507 -2.034 . . . . 0.0 105.507 168.743 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 20.9 p90 -142.5 166.84 23.57 Favored 'General case' 0 CA--C 1.488 -1.424 0 N-CA-C 107.41 -1.33 . . . . 0.0 107.41 169.708 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 25.0 p -120.02 141.65 49.53 Favored 'General case' 0 CA--C 1.5 -0.981 0 N-CA-C 106.21 -1.774 . . . . 0.0 106.21 174.919 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 45.4 m -115.74 120.16 38.39 Favored 'General case' 0 CA--C 1.493 -1.245 0 N-CA-C 102.137 -3.283 . . . . 0.0 102.137 171.706 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . 0.585 ' HA ' ' H ' ' A' ' 66' ' ' GLY . 5.3 t -145.92 -66.95 0.29 Allowed 'General case' 0 N--CA 1.436 -1.132 0 N-CA-C 106.093 -1.817 . . . . 0.0 106.093 -175.626 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . 0.436 ' H ' HG23 ' A' ' 92' ' ' THR . 19.8 m . . . . . 0 C--O 1.261 1.659 0 C-N-CA 125.505 1.522 . . . . 0.0 110.355 178.379 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 22.7 t . . . . . 0 N--CA 1.483 1.214 0 CA-C-O 121.259 0.552 . . . . 0.0 109.799 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 169.62 170.41 34.06 Favored Glycine 0 N--CA 1.436 -1.346 0 N-CA-C 106.717 -2.553 . . . . 0.0 106.717 176.699 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 22.8 Cg_exo -59.09 145.6 97.14 Favored 'Trans proline' 0 N--CA 1.448 -1.188 0 C-N-CA 123.058 2.505 . . . . 0.0 116.054 -164.598 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 48.9 t -79.17 158.96 4.63 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.94 0 C-N-CA 127.707 2.403 . . . . 0.0 106.991 179.575 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -103.86 106.3 16.76 Favored 'General case' 0 CA--C 1.494 -1.184 0 N-CA-C 104.853 -2.277 . . . . 0.0 104.853 175.052 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 2.1 p -130.4 141.64 45.77 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.1 0 N-CA-C 105.349 -2.093 . . . . 0.0 105.349 -169.632 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 1.8 p90 -154.0 149.23 27.0 Favored 'General case' 0 N--CA 1.438 -1.055 0 N-CA-C 105.933 -1.877 . . . . 0.0 105.933 -166.854 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 41.9 mt -109.06 119.76 59.18 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.059 0 N-CA-C 104.899 -2.26 . . . . 0.0 104.899 178.214 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 27.8 p -117.9 -176.8 3.12 Favored 'General case' 0 N--CA 1.442 -0.872 0 N-CA-C 106.937 -1.505 . . . . 0.0 106.937 -177.157 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 17.2 tt0 60.49 24.05 13.69 Favored 'General case' 0 C--N 1.359 0.986 0 C-N-CA 127.69 2.396 . . . . 0.0 112.925 173.367 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 9.6 t -125.06 94.53 43.62 Favored Pre-proline 0 C--N 1.352 0.689 0 N-CA-C 107.957 -1.127 . . . . 0.0 107.957 -176.113 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -78.37 -27.43 5.32 Favored 'Trans proline' 0 N--CA 1.455 -0.771 0 C-N-CA 122.442 2.095 . . . . 0.0 109.5 167.598 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 9.7 p 179.92 108.19 0.04 OUTLIER 'General case' 0 N--CA 1.438 -1.075 0 N-CA-C 104.89 -2.263 . . . . 0.0 104.89 178.306 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 39.1 mt-30 -146.44 103.58 4.01 Favored Pre-proline 0 N--CA 1.441 -0.908 0 N-CA-C 104.836 -2.283 . . . . 0.0 104.836 175.806 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_endo -83.19 -8.71 10.74 Favored 'Trans proline' 0 N--CA 1.454 -0.845 0 C-N-CA 123.273 2.649 . . . . 0.0 110.259 -177.501 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 1.3 p30 -107.79 -42.09 4.82 Favored 'General case' 0 CA--C 1.492 -1.255 0 C-N-CA 124.725 1.21 . . . . 0.0 109.488 -169.069 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 32.8 t -117.06 157.02 26.55 Favored 'General case' 0 CA--C 1.496 -1.134 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 -172.558 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 23.7 m-70 -146.99 98.66 4.05 Favored Pre-proline 0 N--CA 1.437 -1.111 0 N-CA-C 106.516 -1.661 . . . . 0.0 106.516 169.235 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -76.59 100.03 1.35 Allowed 'Trans proline' 0 N--CA 1.447 -1.222 0 C-N-CA 123.654 2.902 . . . . 0.0 109.407 171.746 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.438 HG22 ' H ' ' A' ' 20' ' ' ILE . 13.4 tt -90.28 149.42 4.05 Favored 'Isoleucine or valine' 0 N--CA 1.408 -2.574 0 C-N-CA 128.834 2.854 . . . . 0.0 106.786 -177.41 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 57.3 mt-30 -141.03 151.06 43.76 Favored 'General case' 0 N--CA 1.434 -1.248 0 N-CA-C 104.225 -2.509 . . . . 0.0 104.225 175.724 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 34.0 p90 -138.98 156.82 46.93 Favored 'General case' 0 N--CA 1.437 -1.081 0 N-CA-C 107.794 -1.187 . . . . 0.0 107.794 -176.815 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 61.3 t30 -94.42 -173.65 3.12 Favored 'General case' 0 CA--C 1.49 -1.336 0 N-CA-C 103.531 -2.766 . . . . 0.0 103.531 169.898 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -155.97 169.21 10.81 Favored Pre-proline 0 N--CA 1.44 -0.96 0 N-CA-C 107.284 -1.376 . . . . 0.0 107.284 172.36 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 98.0 Cg_exo -64.39 167.34 15.05 Favored 'Trans proline' 0 CA--C 1.51 -0.683 0 C-N-CA 123.559 2.839 . . . . 0.0 112.447 170.686 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 71.4 tp60 -80.03 -42.68 1.44 Allowed Pre-proline 0 N--CA 1.444 -0.741 0 CA-C-O 115.586 -2.149 . . . . 0.0 112.026 -172.016 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_exo -66.78 152.72 79.98 Favored 'Trans proline' 0 CA--C 1.507 -0.864 0 CA-C-N 125.773 3.097 . . . . 0.0 112.171 177.936 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 27.2 p -99.58 58.01 1.04 Allowed 'General case' 0 C--N 1.353 0.754 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 179.739 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 76.3 t60 -106.21 -4.65 19.97 Favored 'General case' 0 N--CA 1.441 -0.92 0 C-N-CA 125.273 1.429 . . . . 0.0 107.595 175.67 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 41.8 mt -105.44 129.07 58.89 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.248 0 N-CA-C 105.037 -2.209 . . . . 0.0 105.037 178.167 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 5.2 p -104.36 -84.34 0.48 Allowed 'General case' 0 N--CA 1.43 -1.449 0 N-CA-C 107.459 -1.311 . . . . 0.0 107.459 -178.591 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 55.1 mtmt -89.7 168.83 11.81 Favored 'General case' 0 CA--C 1.488 -1.432 0 N-CA-C 108.544 -0.909 . . . . 0.0 108.544 -164.277 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 93.7 m-85 -129.79 138.34 51.0 Favored 'General case' 0 N--CA 1.434 -1.266 0 N-CA-C 103.861 -2.644 . . . . 0.0 103.861 168.297 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 57.3 mt -114.88 130.61 69.05 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.296 0 N-CA-C 101.01 -3.7 . . . . 0.0 101.01 169.885 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 3.1 mt -110.26 129.9 55.65 Favored 'General case' 0 CA--C 1.469 -2.144 0 N-CA-C 104.034 -2.58 . . . . 0.0 104.034 167.635 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 6.5 ptm180 -132.63 154.48 50.04 Favored 'General case' 0 N--CA 1.431 -1.399 0 N-CA-C 107.035 -1.468 . . . . 0.0 107.035 176.062 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 47.8 p90 -155.18 142.44 19.42 Favored 'General case' 0 N--CA 1.435 -1.176 0 N-CA-C 106.877 -1.527 . . . . 0.0 106.877 -173.328 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 30.7 ttp180 -139.54 140.88 26.61 Favored Pre-proline 0 CA--C 1.499 -1.017 0 N-CA-C 104.528 -2.397 . . . . 0.0 104.528 -177.777 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 26.7 Cg_endo -72.14 120.17 6.63 Favored 'Trans proline' 0 N--CA 1.452 -0.934 0 C-N-CA 122.827 2.351 . . . . 0.0 108.472 174.663 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 23.0 ttmm -68.06 85.2 0.24 Allowed 'General case' 0 C--N 1.359 1.005 0 C-N-CA 127.34 2.256 . . . . 0.0 109.733 -178.641 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 31.2 m120 -150.77 -72.41 0.17 Allowed 'General case' 0 N--CA 1.435 -1.209 0 N-CA-C 102.006 -3.331 . . . . 0.0 102.006 -178.075 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 53.7 p -105.55 172.1 6.98 Favored 'General case' 0 N--CA 1.441 -0.909 0 N-CA-C 107.374 -1.343 . . . . 0.0 107.374 174.61 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 4.0 m -116.21 52.27 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.863 0 N-CA-C 106.011 -1.848 . . . . 0.0 106.011 175.022 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -98.15 -129.08 6.27 Favored Glycine 0 C--N 1.355 1.597 0 N-CA-C 109.421 -1.472 . . . . 0.0 109.421 -176.031 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 17.5 ptm180 -80.09 160.06 25.89 Favored 'General case' 0 C--N 1.357 0.906 0 C-N-CA 123.942 0.897 . . . . 0.0 109.685 -176.925 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -162.49 169.91 19.56 Favored 'General case' 0 CA--C 1.493 -1.212 0 CA-C-O 121.445 0.64 . . . . 0.0 110.298 -171.217 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 95.6 mttt -111.06 155.89 22.12 Favored 'General case' 0 CA--C 1.488 -1.408 0 N-CA-C 107.485 -1.302 . . . . 0.0 107.485 -172.612 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 24.5 pt-20 -152.25 160.15 43.41 Favored 'General case' 0 N--CA 1.434 -1.27 0 N-CA-C 107.972 -1.121 . . . . 0.0 107.972 171.142 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -137.76 159.48 41.88 Favored 'General case' 0 N--CA 1.437 -1.102 0 N-CA-C 105.396 -2.075 . . . . 0.0 105.396 173.785 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 73.3 m -120.41 125.9 49.12 Favored 'General case' 0 CA--C 1.498 -1.036 0 N-CA-C 104.533 -2.395 . . . . 0.0 104.533 177.393 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 5.3 mp -114.73 136.03 22.43 Favored Pre-proline 0 N--CA 1.435 -1.188 0 N-CA-C 104.6 -2.37 . . . . 0.0 104.6 -174.255 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 62.0 Cg_exo -64.3 166.85 15.97 Favored 'Trans proline' 0 CA--C 1.508 -0.78 0 C-N-CA 123.528 2.818 . . . . 0.0 113.519 176.794 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -77.06 -19.23 77.63 Favored Glycine 0 C--N 1.353 1.507 0 C-N-CA 123.797 0.713 . . . . 0.0 114.242 -175.149 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 51.7 p-80 -83.23 -26.79 30.43 Favored 'General case' 0 C--N 1.355 0.838 0 CA-C-N 117.963 0.881 . . . . 0.0 109.788 -179.278 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 89.0 mt -88.84 132.92 34.45 Favored 'General case' 0 CA--C 1.501 -0.93 0 N-CA-C 107.37 -1.345 . . . . 0.0 107.37 175.407 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 7.8 p30 -121.33 15.0 11.31 Favored 'General case' 0 CA--C 1.5 -0.946 0 C-N-CA 124.19 0.996 . . . . 0.0 108.816 -175.501 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 32.9 p -144.73 155.47 43.57 Favored 'General case' 0 N--CA 1.438 -1.074 0 N-CA-C 106.928 -1.508 . . . . 0.0 106.928 -178.721 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 23.0 t80 -150.64 157.76 43.35 Favored 'General case' 0 CA--C 1.497 -1.093 0 N-CA-C 107.965 -1.124 . . . . 0.0 107.965 178.188 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 48.2 m -108.78 112.37 24.61 Favored 'General case' 0 CA--C 1.5 -0.945 0 N-CA-C 106.197 -1.779 . . . . 0.0 106.197 173.536 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 55.3 mt -97.19 91.83 2.76 Favored 'Isoleucine or valine' 0 C--N 1.359 0.982 0 N-CA-C 105.084 -2.191 . . . . 0.0 105.084 174.146 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.517 ' HD3' ' H ' ' A' ' 61' ' ' LYS . 0.3 OUTLIER -105.18 160.52 15.01 Favored 'General case' 0 CA--C 1.498 -1.022 0 N-CA-C 107.67 -1.233 . . . . 0.0 107.67 178.412 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 88.74 52.85 2.7 Favored Glycine 0 C--N 1.353 1.504 0 N-CA-C 108.75 -1.74 . . . . 0.0 108.75 179.796 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 60.7 mt -115.54 158.55 22.46 Favored 'General case' 0 CA--C 1.501 -0.91 0 N-CA-C 107.087 -1.449 . . . . 0.0 107.087 178.961 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 29.1 mtpp -95.35 155.71 38.48 Favored Pre-proline 0 N--CA 1.441 -0.925 0 N-CA-C 106.97 -1.492 . . . . 0.0 106.97 -178.442 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 69.0 Cg_endo -80.31 162.87 22.46 Favored 'Trans proline' 0 N--CA 1.454 -0.852 0 C-N-CA 122.988 2.459 . . . . 0.0 110.903 177.249 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 60.93 26.67 65.78 Favored Glycine 0 C--N 1.356 1.669 0 C-N-CA 127.819 2.628 . . . . 0.0 116.814 166.095 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 7.2 p -131.43 145.61 34.95 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.846 0 CA-C-N 117.701 0.75 . . . . 0.0 109.325 -173.211 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 2.9 p -90.46 127.29 43.05 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.863 0 N-CA-C 107.208 -1.405 . . . . 0.0 107.208 176.332 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 84.0 m-85 -107.3 147.77 29.85 Favored 'General case' 0 CA--C 1.498 -1.044 0 N-CA-C 106.814 -1.551 . . . . 0.0 106.814 172.842 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -95.87 143.98 26.61 Favored 'General case' 0 N--CA 1.439 -0.993 0 N-CA-C 105.132 -2.173 . . . . 0.0 105.132 160.918 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -133.42 155.13 21.56 Favored Glycine 0 CA--C 1.488 -1.637 0 N-CA-C 107.727 -2.149 . . . . 0.0 107.727 -178.962 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 32.0 mt-30 -143.13 138.25 29.68 Favored 'General case' 0 CA--C 1.482 -1.667 0 N-CA-C 105.959 -1.867 . . . . 0.0 105.959 176.345 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 42.8 tp -113.69 103.77 11.56 Favored 'General case' 0 N--CA 1.436 -1.175 0 N-CA-C 103.76 -2.682 . . . . 0.0 103.76 175.75 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 13.6 mt -98.19 128.45 49.63 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.786 0 N-CA-C 104.32 -2.474 . . . . 0.0 104.32 179.664 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 43.8 m -112.41 112.43 23.99 Favored 'General case' 0 N--CA 1.441 -0.923 0 N-CA-C 106.992 -1.484 . . . . 0.0 106.992 -175.189 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 1.7 mp -87.85 136.35 23.36 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.217 0 N-CA-C 104.712 -2.329 . . . . 0.0 104.712 -166.822 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 78.2 mt-30 -95.84 141.69 28.98 Favored 'General case' 0 N--CA 1.436 -1.154 0 N-CA-C 106.042 -1.836 . . . . 0.0 106.042 -179.068 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 7.8 tp-100 -69.04 117.02 10.16 Favored 'General case' 0 N--CA 1.441 -0.882 0 C-N-CA 124.129 0.972 . . . . 0.0 111.395 -170.554 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 31.9 m-85 58.09 45.39 17.81 Favored 'General case' 0 C--N 1.358 0.972 0 C-N-CA 127.325 2.25 . . . . 0.0 112.816 179.653 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -170.33 -114.46 0.31 Allowed Glycine 0 C--N 1.354 1.554 0 C-N-CA 118.663 -1.732 . . . . 0.0 109.704 174.847 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 52.2 m80 -83.24 -171.67 3.7 Favored 'General case' 0 CA--C 1.495 -1.165 0 C-N-CA 125.714 1.606 . . . . 0.0 110.425 -167.715 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -146.66 145.46 30.04 Favored 'General case' 0 N--CA 1.433 -1.281 0 N-CA-C 106.509 -1.663 . . . . 0.0 106.509 169.507 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -101.72 145.45 29.11 Favored 'General case' 0 N--CA 1.44 -0.957 0 N-CA-C 104.645 -2.354 . . . . 0.0 104.645 -179.907 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 6.6 p -124.99 137.96 55.86 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.775 0 N-CA-C 108.104 -1.073 . . . . 0.0 108.104 -177.569 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 61.0 m -125.85 137.13 53.74 Favored 'General case' 0 N--CA 1.439 -0.98 0 N-CA-C 103.232 -2.877 . . . . 0.0 103.232 175.922 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 54.6 ttp180 -130.15 144.6 51.45 Favored 'General case' 0 CA--C 1.502 -0.873 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 -179.309 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 23.6 p90 -156.48 -178.19 7.16 Favored 'General case' 0 CA--C 1.5 -0.962 0 N-CA-C 106.263 -1.754 . . . . 0.0 106.263 -178.216 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 47.7 p-10 -140.43 160.79 39.21 Favored 'General case' 0 N--CA 1.441 -0.877 0 N-CA-C 107.412 -1.329 . . . . 0.0 107.412 168.116 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 24.5 p90 -147.21 170.31 17.51 Favored 'General case' 0 CA--C 1.49 -1.365 0 N-CA-C 107.033 -1.469 . . . . 0.0 107.033 173.785 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 33.0 p -124.74 147.13 48.81 Favored 'General case' 0 CA--C 1.499 -0.994 0 N-CA-C 107.319 -1.363 . . . . 0.0 107.319 178.036 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 4.4 p -109.09 130.12 55.48 Favored 'General case' 0 N--CA 1.439 -1.012 0 N-CA-C 102.525 -3.139 . . . . 0.0 102.525 164.047 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 42.9 p -90.73 -179.17 5.46 Favored 'General case' 0 N--CA 1.444 -0.732 0 N-CA-C 106.931 -1.507 . . . . 0.0 106.931 179.54 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 31.5 t . . . . . 0 C--O 1.262 1.729 0 N-CA-C 105.186 -2.153 . . . . 0.0 105.186 176.695 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 68.0 m . . . . . 0 N--CA 1.484 1.275 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 167.75 -154.81 25.19 Favored Glycine 0 N--CA 1.435 -1.403 0 N-CA-C 105.795 -2.922 . . . . 0.0 105.795 -176.631 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_exo -61.65 139.45 81.11 Favored 'Trans proline' 0 N--CA 1.442 -1.527 0 C-N-CA 122.865 2.377 . . . . 0.0 113.694 -175.62 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 4.1 t -79.46 154.26 4.7 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.932 0 C-N-CA 127.202 2.201 . . . . 0.0 106.383 -179.14 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 55.6 mm-40 -101.43 96.11 6.93 Favored 'General case' 0 CA--C 1.49 -1.338 0 N-CA-C 107.643 -1.244 . . . . 0.0 107.643 -175.267 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 2.4 p -120.52 143.14 33.43 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.103 0 CA-C-N 113.459 -1.701 . . . . 0.0 107.802 -165.033 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -73.65 171.54 13.07 Favored 'General case' 0 N--CA 1.438 -1.036 0 C-N-CA 125.762 1.625 . . . . 0.0 112.494 -169.271 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.455 HG13 ' H ' ' A' ' 9' ' ' THR . 5.5 tp -89.7 -152.24 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.438 -1.048 0 C-N-CA 128.172 2.589 . . . . 0.0 106.285 175.18 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.493 ' HB ' ' H ' ' A' ' 90' ' ' THR . 4.3 t -72.46 92.2 1.44 Allowed 'General case' 0 N--CA 1.442 -0.848 0 C-N-CA 127.278 2.231 . . . . 0.0 108.85 172.541 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -85.99 0.02 54.34 Favored 'General case' 0 C--N 1.355 0.837 0 C-N-CA 124.617 1.167 . . . . 0.0 111.528 179.847 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 20.9 p -84.53 135.0 41.4 Favored Pre-proline 0 C--N 1.356 0.864 0 N-CA-C 107.958 -1.127 . . . . 0.0 107.958 177.181 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_endo -72.1 -69.85 0.02 OUTLIER 'Trans proline' 0 N--CA 1.45 -1.047 0 C-N-CA 122.998 2.465 . . . . 0.0 108.525 166.805 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 65.8 m -143.87 112.88 6.74 Favored 'General case' 0 N--CA 1.434 -1.232 0 N-CA-C 103.843 -2.651 . . . . 0.0 103.843 169.481 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 30.0 mm100 -140.16 113.66 7.53 Favored Pre-proline 0 N--CA 1.442 -0.836 0 N-CA-C 104.405 -2.442 . . . . 0.0 104.405 176.086 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 75.0 Cg_endo -82.63 -14.98 8.77 Favored 'Trans proline' 0 CA--C 1.504 -0.978 0 C-N-CA 123.024 2.483 . . . . 0.0 111.04 -169.408 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 4.7 p-10 -122.66 -36.11 2.96 Favored 'General case' 0 CA--C 1.486 -1.499 0 O-C-N 123.821 0.7 . . . . 0.0 110.744 -162.988 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 30.3 p -117.58 151.54 36.96 Favored 'General case' 0 CA--C 1.496 -1.127 0 CA-C-O 121.79 0.805 . . . . 0.0 108.896 -173.122 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . 0.481 ' HE1' ' HA ' ' A' ' 9' ' ' THR . 81.0 t60 -145.77 106.37 4.28 Favored Pre-proline 0 N--CA 1.433 -1.28 0 N-CA-C 106.228 -1.767 . . . . 0.0 106.228 167.43 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -77.74 142.49 20.33 Favored 'Trans proline' 0 N--CA 1.447 -1.249 0 C-N-CA 122.578 2.186 . . . . 0.0 109.732 173.092 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 18.2 mm -102.9 140.09 22.1 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.919 0 N-CA-C 103.434 -2.802 . . . . 0.0 103.434 174.121 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 1.4 tm0? -130.32 138.04 50.24 Favored 'General case' 0 CA--C 1.498 -1.045 0 N-CA-C 102.801 -3.036 . . . . 0.0 102.801 176.5 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 49.5 p90 -140.64 166.38 24.9 Favored 'General case' 0 CA--C 1.497 -1.067 0 N-CA-C 106.913 -1.514 . . . . 0.0 106.913 -178.786 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 36.7 m-80 -136.91 132.42 34.46 Favored 'General case' 0 CA--C 1.488 -1.404 0 N-CA-C 105.469 -2.049 . . . . 0.0 105.469 177.198 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -104.0 167.61 9.79 Favored Pre-proline 0 N--CA 1.44 -0.972 0 C-N-CA 124.515 1.126 . . . . 0.0 109.378 -166.809 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_exo -66.23 158.48 54.62 Favored 'Trans proline' 0 CA--C 1.508 -0.78 0 C-N-CA 123.359 2.706 . . . . 0.0 111.926 171.207 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 24.4 tt0 -82.95 -45.12 0.88 Allowed Pre-proline 0 N--CA 1.443 -0.781 0 CA-C-O 115.54 -2.172 . . . . 0.0 111.691 -177.618 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 74.7 Cg_exo -68.57 164.55 32.53 Favored 'Trans proline' 0 CA--C 1.509 -0.77 0 CA-C-N 125.65 3.054 . . . . 0.0 112.717 -178.002 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 35.8 p -76.78 124.51 27.79 Favored 'General case' 0 C--N 1.355 0.847 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 179.323 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 64.2 t-80 -174.69 -42.78 0.01 OUTLIER 'General case' 0 CA--C 1.496 -1.098 0 N-CA-C 106.559 -1.645 . . . . 0.0 106.559 -171.192 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 36.1 mt -118.18 136.42 55.43 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.132 0 N-CA-C 106.331 -1.729 . . . . 0.0 106.331 -171.948 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 5.9 p -114.29 -85.39 0.6 Allowed 'General case' 0 N--CA 1.431 -1.399 0 N-CA-C 106.188 -1.782 . . . . 0.0 106.188 177.361 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 52.0 mtmt -86.03 167.48 14.98 Favored 'General case' 0 CA--C 1.485 -1.527 0 C-N-CA 124.799 1.239 . . . . 0.0 109.224 -164.387 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 81.4 m-85 -132.02 133.43 44.42 Favored 'General case' 0 CA--C 1.49 -1.362 0 N-CA-C 104.044 -2.576 . . . . 0.0 104.044 177.504 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 28.2 mt -122.41 127.87 75.24 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.326 0 N-CA-C 101.921 -3.363 . . . . 0.0 101.921 178.338 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 5.2 mt -110.51 133.46 53.27 Favored 'General case' 0 CA--C 1.475 -1.916 0 N-CA-C 106.151 -1.796 . . . . 0.0 106.151 177.531 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 2.4 mpt_? -112.45 155.46 24.21 Favored 'General case' 0 N--CA 1.432 -1.373 0 N-CA-C 104.62 -2.363 . . . . 0.0 104.62 166.961 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 47.8 p90 -155.32 150.73 27.15 Favored 'General case' 0 N--CA 1.438 -1.042 0 N-CA-C 107.729 -1.211 . . . . 0.0 107.729 170.196 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 11.2 ptp180 -150.88 148.87 24.0 Favored Pre-proline 0 CA--C 1.499 -0.982 0 N-CA-C 106.777 -1.564 . . . . 0.0 106.777 166.863 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -75.96 144.84 27.63 Favored 'Trans proline' 0 CA--C 1.503 -1.048 0 C-N-CA 122.763 2.309 . . . . 0.0 107.86 171.619 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -70.69 80.2 0.6 Allowed 'General case' 0 C--N 1.354 0.797 0 C-N-CA 125.085 1.354 . . . . 0.0 110.915 177.157 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 8.9 t-20 -161.97 -54.8 0.04 OUTLIER 'General case' 0 N--CA 1.431 -1.399 0 N-CA-C 102.917 -2.994 . . . . 0.0 102.917 -178.158 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 34.3 p -83.82 143.79 29.7 Favored 'General case' 0 N--CA 1.438 -1.065 0 N-CA-C 107.299 -1.371 . . . . 0.0 107.299 173.226 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 14.3 m -136.81 14.96 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.803 0 N-CA-C 106.677 -1.601 . . . . 0.0 106.677 177.614 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -101.44 -93.98 2.2 Favored Glycine 0 C--N 1.356 1.658 0 N-CA-C 108.043 -2.023 . . . . 0.0 108.043 -175.067 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 17.5 ptm180 -91.13 171.16 9.44 Favored 'General case' 0 CA--C 1.503 -0.864 0 N-CA-C 108.108 -1.071 . . . . 0.0 108.108 177.255 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -159.52 179.38 8.96 Favored 'General case' 0 CA--C 1.494 -1.192 0 N-CA-C 109.606 -0.516 . . . . 0.0 109.606 -178.657 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -110.04 152.63 25.7 Favored 'General case' 0 CA--C 1.489 -1.387 0 N-CA-C 106.755 -1.572 . . . . 0.0 106.755 -175.818 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -154.8 156.95 37.18 Favored 'General case' 0 N--CA 1.433 -1.284 0 N-CA-C 106.957 -1.497 . . . . 0.0 106.957 -178.953 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -146.05 164.03 33.4 Favored 'General case' 0 CA--C 1.502 -0.885 0 N-CA-C 107.793 -1.188 . . . . 0.0 107.793 175.13 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 96.9 m -120.98 126.57 50.29 Favored 'General case' 0 CA--C 1.502 -0.867 0 N-CA-C 105.542 -2.022 . . . . 0.0 105.542 178.382 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 5.0 mp -114.07 136.13 22.16 Favored Pre-proline 0 N--CA 1.439 -0.992 0 N-CA-C 105.296 -2.113 . . . . 0.0 105.296 -175.823 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_exo -63.06 165.66 16.22 Favored 'Trans proline' 0 CA--C 1.508 -0.81 0 C-N-CA 123.734 2.956 . . . . 0.0 113.799 176.823 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -82.2 -13.68 78.46 Favored Glycine 0 C--N 1.351 1.403 0 C-N-CA 123.507 0.575 . . . . 0.0 113.451 -171.682 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 50.5 p-80 -84.66 -27.16 27.29 Favored 'General case' 0 C--N 1.356 0.872 0 CA-C-N 117.945 0.872 . . . . 0.0 109.862 178.572 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 88.5 mt -88.52 130.39 35.24 Favored 'General case' 0 CA--C 1.498 -1.027 0 N-CA-C 108.536 -0.912 . . . . 0.0 108.536 178.678 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 8.4 p-10 -108.8 10.84 26.55 Favored 'General case' 0 N--CA 1.442 -0.845 0 C-N-CA 124.574 1.15 . . . . 0.0 109.921 -177.484 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 39.2 p -146.43 162.5 38.12 Favored 'General case' 0 N--CA 1.439 -1.003 0 N-CA-C 107.534 -1.284 . . . . 0.0 107.534 -178.598 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 10.7 t80 -140.21 174.63 10.33 Favored 'General case' 0 N--CA 1.444 -0.728 0 N-CA-C 107.122 -1.436 . . . . 0.0 107.122 -179.789 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 55.4 m -137.82 111.41 8.13 Favored 'General case' 0 N--CA 1.433 -1.317 0 N-CA-C 104.689 -2.337 . . . . 0.0 104.689 174.064 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 43.5 mt -91.43 138.72 19.09 Favored 'Isoleucine or valine' 0 C--N 1.358 0.95 0 N-CA-C 104.346 -2.464 . . . . 0.0 104.346 172.361 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 6.9 mtpm? -139.56 162.11 35.88 Favored 'General case' 0 CA--C 1.499 -0.994 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 -179.12 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 82.99 51.37 4.23 Favored Glycine 0 C--N 1.354 1.546 0 N-CA-C 109.429 -1.468 . . . . 0.0 109.429 176.862 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 80.5 mt -117.67 172.03 7.63 Favored 'General case' 0 CA--C 1.501 -0.932 0 N-CA-C 108.071 -1.085 . . . . 0.0 108.071 -170.869 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 10.4 mptt -102.97 151.21 38.37 Favored Pre-proline 0 N--CA 1.442 -0.828 0 N-CA-C 107.572 -1.27 . . . . 0.0 107.572 -172.479 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 64.2 Cg_exo -66.66 135.4 38.59 Favored 'Trans proline' 0 N--CA 1.453 -0.911 0 C-N-CA 123.62 2.88 . . . . 0.0 112.226 171.56 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 54.66 50.01 59.22 Favored Glycine 0 C--N 1.355 1.599 0 C-N-CA 127.256 2.36 . . . . 0.0 115.415 167.334 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 4.3 p -128.94 149.49 33.7 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.007 0 N-CA-C 107.597 -1.26 . . . . 0.0 107.597 178.871 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 7.6 p -95.23 135.5 29.11 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.959 0 N-CA-C 107.644 -1.243 . . . . 0.0 107.644 -178.256 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 83.6 m-85 -117.1 151.28 37.14 Favored 'General case' 0 CA--C 1.496 -1.121 0 N-CA-C 106.395 -1.706 . . . . 0.0 106.395 177.364 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -98.44 142.46 30.03 Favored 'General case' 0 CA--C 1.5 -0.97 0 N-CA-C 104.908 -2.256 . . . . 0.0 104.908 159.476 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -133.23 149.88 19.72 Favored Glycine 0 CA--C 1.49 -1.525 0 N-CA-C 107.693 -2.163 . . . . 0.0 107.693 179.938 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 33.7 mt-30 -136.49 136.24 39.25 Favored 'General case' 0 CA--C 1.484 -1.56 0 N-CA-C 106.581 -1.637 . . . . 0.0 106.581 176.173 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 15.0 tp -119.92 106.75 12.35 Favored 'General case' 0 CA--C 1.499 -1.007 0 N-CA-C 105.778 -1.934 . . . . 0.0 105.778 -176.851 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 5.9 mt -100.15 129.32 51.05 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.113 0 N-CA-C 105.036 -2.209 . . . . 0.0 105.036 -178.81 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 12.6 p -115.72 114.4 24.77 Favored 'General case' 0 N--CA 1.443 -0.823 0 N-CA-C 108.108 -1.071 . . . . 0.0 108.108 -176.418 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 1.7 mp -94.94 143.05 12.57 Favored 'Isoleucine or valine' 0 C--N 1.358 0.941 0 N-CA-C 106.045 -1.835 . . . . 0.0 106.045 -163.808 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 16.7 tt0 -102.3 140.95 35.9 Favored 'General case' 0 CA--C 1.498 -1.031 0 N-CA-C 105.116 -2.179 . . . . 0.0 105.116 171.342 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 75.4 mt-30 -67.19 115.21 6.61 Favored 'General case' 0 C--N 1.358 0.955 0 C-N-CA 123.319 0.648 . . . . 0.0 111.075 -176.038 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 58.4 m-85 60.12 40.03 18.84 Favored 'General case' 0 C--N 1.355 0.848 0 C-N-CA 126.523 1.929 . . . . 0.0 112.143 176.324 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -158.85 -118.61 0.53 Allowed Glycine 0 C--N 1.355 1.623 0 N-CA-C 108.779 -1.728 . . . . 0.0 108.779 -178.361 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 78.4 m-70 -82.84 179.98 7.61 Favored 'General case' 0 CA--C 1.501 -0.928 0 C-N-CA 124.657 1.183 . . . . 0.0 111.178 -168.38 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 10.9 pt20 -157.16 133.5 9.78 Favored 'General case' 0 N--CA 1.434 -1.258 0 N-CA-C 106.076 -1.824 . . . . 0.0 106.076 167.391 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 31.5 mm-40 -100.91 146.43 27.36 Favored 'General case' 0 CA--C 1.498 -1.031 0 N-CA-C 105.531 -2.026 . . . . 0.0 105.531 -178.231 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 7.6 p -122.3 141.55 42.27 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.721 0 N-CA-C 108.004 -1.109 . . . . 0.0 108.004 -174.444 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 23.2 m -125.79 145.45 50.21 Favored 'General case' 0 N--CA 1.442 -0.872 0 N-CA-C 104.398 -2.445 . . . . 0.0 104.398 -179.711 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 38.9 ttm180 -133.85 143.46 48.33 Favored 'General case' 0 CA--C 1.504 -0.81 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 173.32 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 28.9 p90 -155.67 175.68 13.6 Favored 'General case' 0 CA--C 1.5 -0.974 0 N-CA-C 106.905 -1.517 . . . . 0.0 106.905 -178.424 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 52.2 m-20 -133.47 153.86 51.28 Favored 'General case' 0 CA--C 1.504 -0.81 0 N-CA-C 106.018 -1.845 . . . . 0.0 106.018 170.334 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 17.1 p90 -151.28 175.64 12.01 Favored 'General case' 0 CA--C 1.493 -1.23 0 N-CA-C 106.678 -1.601 . . . . 0.0 106.678 173.222 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . 0.493 ' H ' ' HB ' ' A' ' 9' ' ' THR . 31.4 p -122.6 147.02 46.9 Favored 'General case' 0 CA--C 1.504 -0.813 0 N-CA-C 107.533 -1.284 . . . . 0.0 107.533 174.276 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 94.3 m -99.52 121.65 41.47 Favored 'General case' 0 CA--C 1.496 -1.125 0 N-CA-C 102.721 -3.066 . . . . 0.0 102.721 165.583 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 2.3 m 68.13 -128.34 0.13 Allowed 'General case' 0 C--N 1.36 1.028 0 C-N-CA 126.573 1.949 . . . . 0.0 106.481 -165.346 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 26.8 p . . . . . 0 C--O 1.261 1.69 0 N-CA-C 106.168 -1.79 . . . . 0.0 106.168 174.124 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 24.1 t . . . . . 0 N--CA 1.48 1.037 0 N-CA-C 108.752 -0.833 . . . . 0.0 108.752 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -142.89 -147.74 4.82 Favored Glycine 0 C--N 1.352 1.439 0 N-CA-C 106.138 -2.785 . . . . 0.0 106.138 -176.917 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_exo -58.4 140.93 96.46 Favored 'Trans proline' 0 N--CA 1.445 -1.35 0 C-N-CA 123.749 2.966 . . . . 0.0 113.319 -175.783 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 7.3 t -79.0 155.31 4.83 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.892 0 C-N-CA 127.014 2.126 . . . . 0.0 106.569 -175.345 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 93.4 mt-10 -97.35 87.98 4.29 Favored 'General case' 0 CA--C 1.493 -1.224 0 CA-C-O 122.377 1.084 . . . . 0.0 108.181 -173.1 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 2.7 p -110.77 134.93 51.45 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.146 0 CA-C-N 114.319 -1.31 . . . . 0.0 107.868 -166.179 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 23.8 p90 -135.81 175.67 9.38 Favored 'General case' 0 N--CA 1.434 -1.246 0 N-CA-C 104.072 -2.566 . . . . 0.0 104.072 178.131 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 17.9 tt -112.74 123.53 68.5 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.952 0 N-CA-C 107.343 -1.355 . . . . 0.0 107.343 175.756 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 8.1 t -101.05 155.9 17.72 Favored 'General case' 0 N--CA 1.44 -0.931 0 N-CA-C 107.904 -1.147 . . . . 0.0 107.904 -177.209 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 58.17 37.46 26.29 Favored 'General case' 0 C--N 1.358 0.973 0 C-N-CA 127.465 2.306 . . . . 0.0 113.48 167.431 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 16.2 p -126.2 87.23 56.58 Favored Pre-proline 0 C--N 1.35 0.616 0 N-CA-C 109.217 -0.66 . . . . 0.0 109.217 178.47 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 68.6 Cg_endo -77.73 -25.8 7.5 Favored 'Trans proline' 0 N--CA 1.453 -0.861 0 C-N-CA 122.574 2.183 . . . . 0.0 109.512 162.369 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 9.1 p 172.18 109.98 0.01 OUTLIER 'General case' 0 N--CA 1.439 -1.002 0 N-CA-C 104.887 -2.264 . . . . 0.0 104.887 -179.975 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 92.1 mt-30 -151.56 105.61 2.9 Favored Pre-proline 0 N--CA 1.442 -0.834 0 N-CA-C 105.666 -1.976 . . . . 0.0 105.666 178.798 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -83.67 -14.14 7.93 Favored 'Trans proline' 0 CA--C 1.507 -0.84 0 C-N-CA 122.936 2.424 . . . . 0.0 110.917 -179.002 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 7.0 p-10 -104.18 -42.34 5.55 Favored 'General case' 0 CA--C 1.494 -1.199 0 O-C-N 123.716 0.635 . . . . 0.0 110.417 -165.72 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 10.9 p -120.1 143.98 47.86 Favored 'General case' 0 CA--C 1.488 -1.432 0 N-CA-C 107.98 -1.118 . . . . 0.0 107.98 -178.43 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . 0.515 ' CE1' HG22 ' A' ' 91' ' ' THR . 0.1 OUTLIER -135.12 92.75 17.8 Favored Pre-proline 0 N--CA 1.441 -0.905 0 N-CA-C 105.657 -1.979 . . . . 0.0 105.657 174.322 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_endo -74.9 127.87 11.11 Favored 'Trans proline' 0 N--CA 1.443 -1.447 0 C-N-CA 123.007 2.471 . . . . 0.0 109.442 170.492 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 28.3 mm -104.86 149.82 8.1 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.081 0 N-CA-C 104.231 -2.507 . . . . 0.0 104.231 -174.277 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 65.4 tt0 -140.24 142.84 35.77 Favored 'General case' 0 N--CA 1.438 -1.066 0 N-CA-C 104.205 -2.517 . . . . 0.0 104.205 168.587 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 37.8 p90 -136.27 164.2 28.63 Favored 'General case' 0 N--CA 1.439 -0.987 0 N-CA-C 106.226 -1.768 . . . . 0.0 106.226 -175.176 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 5.8 m120 -131.24 127.71 38.41 Favored 'General case' 0 CA--C 1.492 -1.286 0 N-CA-C 106.353 -1.721 . . . . 0.0 106.353 -179.948 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -84.61 161.77 52.67 Favored Pre-proline 0 N--CA 1.442 -0.857 0 C-N-CA 123.663 0.785 . . . . 0.0 110.541 -168.381 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_exo -67.23 172.72 9.62 Favored 'Trans proline' 0 CA--C 1.51 -0.717 0 C-N-CA 123.498 2.798 . . . . 0.0 112.295 170.766 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 1.4 tm0? -80.74 -46.99 1.23 Allowed Pre-proline 0 N--CA 1.443 -0.795 0 CA-C-O 115.569 -2.158 . . . . 0.0 110.429 -176.86 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 63.3 Cg_exo -68.25 164.78 31.02 Favored 'Trans proline' 0 CA--C 1.509 -0.75 0 CA-C-N 125.784 3.101 . . . . 0.0 112.086 176.999 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 22.6 t -88.07 85.88 7.03 Favored 'General case' 0 C--N 1.356 0.862 0 N-CA-C 106.412 -1.699 . . . . 0.0 106.412 176.258 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 59.9 t-80 -116.16 -28.85 6.45 Favored 'General case' 0 N--CA 1.437 -1.124 0 C-N-CA 125.585 1.554 . . . . 0.0 107.076 -175.01 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 42.6 mt -126.35 137.03 59.05 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.056 0 N-CA-C 106.916 -1.513 . . . . 0.0 106.916 -169.041 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 32.9 t -113.56 -85.72 0.59 Allowed 'General case' 0 N--CA 1.432 -1.348 0 N-CA-C 106.328 -1.731 . . . . 0.0 106.328 178.073 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 37.0 ttpt -88.43 160.67 17.44 Favored 'General case' 0 CA--C 1.493 -1.241 0 C-N-CA 125.859 1.664 . . . . 0.0 107.906 -165.04 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 92.8 m-85 -127.47 139.97 52.46 Favored 'General case' 0 CA--C 1.492 -1.28 0 N-CA-C 105.377 -2.083 . . . . 0.0 105.377 177.941 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 13.9 mt -124.95 131.09 73.03 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.151 0 N-CA-C 101.958 -3.349 . . . . 0.0 101.958 172.898 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 3.5 mt -109.23 127.55 54.34 Favored 'General case' 0 CA--C 1.475 -1.936 0 N-CA-C 104.975 -2.232 . . . . 0.0 104.975 174.303 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -116.63 158.33 23.91 Favored 'General case' 0 N--CA 1.434 -1.257 0 N-CA-C 104.636 -2.357 . . . . 0.0 104.636 174.375 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 48.4 p90 -157.29 142.29 16.94 Favored 'General case' 0 N--CA 1.437 -1.081 0 N-CA-C 107.018 -1.475 . . . . 0.0 107.018 175.079 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 13.4 ttm180 -131.68 125.2 20.35 Favored Pre-proline 0 CA--C 1.503 -0.853 0 N-CA-C 106.261 -1.755 . . . . 0.0 106.261 179.006 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 4.8 Cg_endo -73.35 118.93 5.72 Favored 'Trans proline' 0 N--CA 1.45 -1.066 0 CA-C-N 123.388 2.246 . . . . 0.0 109.033 168.969 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 32.3 mmmt -70.98 88.7 0.77 Allowed 'General case' 0 N--CA 1.44 -0.937 0 C-N-CA 125.644 1.578 . . . . 0.0 111.133 179.214 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 70.5 m-80 -135.57 -68.02 0.52 Allowed 'General case' 0 N--CA 1.436 -1.148 0 N-CA-C 102.244 -3.243 . . . . 0.0 102.244 172.729 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 57.8 m -102.98 168.28 9.3 Favored 'General case' 0 N--CA 1.44 -0.945 0 N-CA-C 106.674 -1.602 . . . . 0.0 106.674 172.234 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 3.6 m -122.15 55.53 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.88 0 N-CA-C 105.752 -1.944 . . . . 0.0 105.752 177.581 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -104.01 -109.4 3.38 Favored Glycine 0 C--N 1.353 1.479 0 N-CA-C 107.78 -2.128 . . . . 0.0 107.78 -177.221 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 82.4 mtt85 -91.24 172.3 8.64 Favored 'General case' 0 CA--C 1.502 -0.883 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 -178.534 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -153.69 176.27 12.3 Favored 'General case' 0 N--CA 1.437 -1.097 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 -179.964 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 59.5 mttp -112.42 156.98 21.63 Favored 'General case' 0 CA--C 1.49 -1.356 0 N-CA-C 107.782 -1.192 . . . . 0.0 107.782 -174.767 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 1.1 pp20? -151.42 162.37 41.05 Favored 'General case' 0 N--CA 1.434 -1.24 0 N-CA-C 107.966 -1.124 . . . . 0.0 107.966 171.014 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -144.49 159.73 42.27 Favored 'General case' 0 CA--C 1.497 -1.062 0 N-CA-C 105.857 -1.905 . . . . 0.0 105.857 172.072 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 91.4 m -121.28 130.01 53.43 Favored 'General case' 0 CA--C 1.502 -0.896 0 N-CA-C 106.576 -1.638 . . . . 0.0 106.576 -173.892 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 4.1 mp -116.64 134.79 22.86 Favored Pre-proline 0 N--CA 1.438 -1.066 0 N-CA-C 105.386 -2.079 . . . . 0.0 105.386 -175.054 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 66.0 Cg_exo -62.88 164.55 18.71 Favored 'Trans proline' 0 N--CA 1.455 -0.736 0 C-N-CA 123.498 2.799 . . . . 0.0 113.351 174.954 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -81.88 -14.87 76.59 Favored Glycine 0 C--N 1.352 1.422 0 O-C-N 123.48 0.487 . . . . 0.0 113.297 -170.717 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 50.1 p-80 -83.87 -25.5 30.21 Favored 'General case' 0 C--N 1.356 0.852 0 CA-C-N 117.846 0.823 . . . . 0.0 109.828 179.173 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 89.9 mt -88.41 133.17 34.18 Favored 'General case' 0 CA--C 1.5 -0.959 0 N-CA-C 107.876 -1.157 . . . . 0.0 107.876 177.633 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 7.9 p30 -110.41 9.03 23.44 Favored 'General case' 0 CA--C 1.504 -0.821 0 C-N-CA 124.654 1.181 . . . . 0.0 109.802 -175.436 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 37.2 p -145.81 162.98 36.42 Favored 'General case' 0 N--CA 1.438 -1.051 0 N-CA-C 107.395 -1.335 . . . . 0.0 107.395 -177.477 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 8.3 t80 -141.8 174.94 10.11 Favored 'General case' 0 N--CA 1.441 -0.878 0 N-CA-C 108.009 -1.108 . . . . 0.0 108.009 179.765 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 89.6 m -135.45 109.98 8.54 Favored 'General case' 0 N--CA 1.432 -1.337 0 N-CA-C 104.19 -2.522 . . . . 0.0 104.19 171.202 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 58.3 mt -87.5 143.83 10.49 Favored 'Isoleucine or valine' 0 C--N 1.36 1.022 0 N-CA-C 103.943 -2.614 . . . . 0.0 103.943 169.977 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -147.07 160.58 42.24 Favored 'General case' 0 CA--C 1.498 -1.054 0 N-CA-C 108.054 -1.091 . . . . 0.0 108.054 173.865 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 86.83 51.83 3.3 Favored Glycine 0 C--N 1.353 1.484 0 N-CA-C 109.006 -1.638 . . . . 0.0 109.006 177.004 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 48.2 mt -112.1 175.29 5.49 Favored 'General case' 0 CA--C 1.502 -0.867 0 N-CA-C 107.013 -1.477 . . . . 0.0 107.013 -178.353 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 57.6 mttp -115.99 152.59 47.79 Favored Pre-proline 0 N--CA 1.444 -0.757 0 N-CA-C 106.526 -1.657 . . . . 0.0 106.526 -168.395 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_endo -79.5 155.36 24.59 Favored 'Trans proline' 0 N--CA 1.454 -0.835 0 C-N-CA 122.719 2.279 . . . . 0.0 110.838 175.883 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 59.01 29.8 65.76 Favored Glycine 0 C--N 1.354 1.566 0 C-N-CA 127.747 2.594 . . . . 0.0 116.883 167.288 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 9.0 p -127.4 148.24 32.14 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.847 0 N-CA-C 108.715 -0.846 . . . . 0.0 108.715 -177.581 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 6.7 p -92.8 124.17 45.14 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.765 0 N-CA-C 107.804 -1.184 . . . . 0.0 107.804 175.614 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 51.0 m-85 -101.48 150.41 23.07 Favored 'General case' 0 N--CA 1.439 -1.004 0 N-CA-C 107.629 -1.249 . . . . 0.0 107.629 173.403 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 12.4 tp10 -93.7 136.18 34.24 Favored 'General case' 0 CA--C 1.498 -1.044 0 N-CA-C 103.762 -2.681 . . . . 0.0 103.762 163.914 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -134.43 145.32 17.41 Favored Glycine 0 CA--C 1.488 -1.64 0 N-CA-C 107.547 -2.221 . . . . 0.0 107.547 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 35.2 mt-30 -140.75 136.81 32.9 Favored 'General case' 0 CA--C 1.485 -1.52 0 N-CA-C 105.718 -1.956 . . . . 0.0 105.718 -177.677 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 40.9 tp -115.01 98.21 6.67 Favored 'General case' 0 N--CA 1.437 -1.124 0 N-CA-C 103.453 -2.795 . . . . 0.0 103.453 179.297 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 39.7 mm -92.88 125.96 45.39 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.942 0 N-CA-C 103.704 -2.702 . . . . 0.0 103.704 -178.08 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 49.2 m -120.72 112.29 18.67 Favored 'General case' 0 N--CA 1.438 -1.069 0 N-CA-C 107.632 -1.247 . . . . 0.0 107.632 -169.261 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 39.3 mm -88.15 139.87 16.68 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.323 0 N-CA-C 106.894 -1.521 . . . . 0.0 106.894 -163.188 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 15.3 tt0 -101.93 132.34 47.8 Favored 'General case' 0 CA--C 1.495 -1.171 0 N-CA-C 104.953 -2.24 . . . . 0.0 104.953 178.776 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 17.8 tt0 -77.08 42.56 0.33 Allowed 'General case' 0 C--N 1.355 0.813 0 C-N-CA 125.339 1.456 . . . . 0.0 113.168 -177.761 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 61.6 m-85 -140.42 19.59 2.39 Favored 'General case' 0 N--CA 1.442 -0.872 0 N-CA-C 107.094 -1.447 . . . . 0.0 107.094 173.251 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 96.55 -21.57 44.95 Favored Glycine 0 C--N 1.354 1.582 0 C-N-CA 123.94 0.781 . . . . 0.0 111.395 174.598 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 77.9 m-70 -81.71 178.91 8.06 Favored 'General case' 0 CA--C 1.498 -1.032 0 C-N-CA 124.621 1.168 . . . . 0.0 109.508 -177.016 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 5.0 pt20 -159.02 163.53 36.32 Favored 'General case' 0 N--CA 1.439 -1.024 0 CA-C-O 122.027 0.917 . . . . 0.0 108.721 174.78 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 16.6 tp10 -117.37 154.2 31.73 Favored 'General case' 0 N--CA 1.437 -1.078 0 N-CA-C 105.631 -1.989 . . . . 0.0 105.631 179.604 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 1.9 p -126.0 134.31 66.84 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.86 0 N-CA-C 106.9 -1.519 . . . . 0.0 106.9 176.75 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 38.8 m -122.54 131.96 54.09 Favored 'General case' 0 N--CA 1.439 -0.996 0 N-CA-C 102.211 -3.255 . . . . 0.0 102.211 172.595 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 22.9 ttt180 -130.27 143.5 50.81 Favored 'General case' 0 CA--C 1.504 -0.803 0 CA-C-N 118.784 0.72 . . . . 0.0 109.444 -172.691 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 18.0 p90 -162.06 -177.18 5.6 Favored 'General case' 0 C--N 1.359 1.007 0 N-CA-C 106.829 -1.545 . . . . 0.0 106.829 -175.316 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 43.6 p-10 -136.63 160.91 37.38 Favored 'General case' 0 N--CA 1.442 -0.831 0 N-CA-C 106.018 -1.845 . . . . 0.0 106.018 168.836 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.413 ' CD1' ' CD2' ' A' ' 18' ' ' HIS . 22.3 p90 -143.61 164.82 29.32 Favored 'General case' 0 CA--C 1.488 -1.428 0 N-CA-C 107.254 -1.388 . . . . 0.0 107.254 170.065 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 22.8 p -117.88 137.96 52.45 Favored 'General case' 0 CA--C 1.499 -1.005 0 N-CA-C 106.337 -1.727 . . . . 0.0 106.337 177.433 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . 0.515 HG22 ' CE1' ' A' ' 18' ' ' HIS . 7.0 p -107.97 128.77 54.93 Favored 'General case' 0 CA--C 1.5 -0.977 0 N-CA-C 103.061 -2.94 . . . . 0.0 103.061 172.788 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 15.1 t -158.41 152.21 23.6 Favored 'General case' 0 N--CA 1.437 -1.08 0 N-CA-C 105.944 -1.873 . . . . 0.0 105.944 -178.11 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 33.8 p . . . . . 0 C--O 1.26 1.625 0 N-CA-C 107.189 -1.411 . . . . 0.0 107.189 174.714 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 89.9 p . . . . . 0 N--CA 1.487 1.403 0 CA-C-O 121.467 0.651 . . . . 0.0 111.889 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 85.66 -157.81 31.63 Favored Glycine 0 C--N 1.355 1.588 0 N-CA-C 108.616 -1.793 . . . . 0.0 108.616 -178.911 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_exo -60.46 140.55 92.07 Favored 'Trans proline' 0 N--CA 1.443 -1.461 0 C-N-CA 123.137 2.558 . . . . 0.0 113.484 -177.385 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 7.6 t -78.57 149.77 5.58 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.947 0 C-N-CA 127.775 2.43 . . . . 0.0 105.461 179.112 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 90.0 mt-10 -103.71 94.29 5.37 Favored 'General case' 0 CA--C 1.493 -1.23 0 C-N-CA 123.849 0.86 . . . . 0.0 108.726 -168.282 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 2.5 p -121.83 142.47 38.0 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.983 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 -161.936 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 18.1 p90 -154.83 177.77 10.9 Favored 'General case' 0 N--CA 1.435 -1.192 0 N-CA-C 106.923 -1.51 . . . . 0.0 106.923 -168.158 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 19.4 tt -139.27 132.93 38.82 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.958 0 N-CA-C 102.662 -3.088 . . . . 0.0 102.662 160.314 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 12.3 p -127.29 125.72 41.38 Favored 'General case' 0 CA--C 1.502 -0.898 0 N-CA-C 108.093 -1.077 . . . . 0.0 108.093 -174.632 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 49.8 tt0 67.0 53.13 0.83 Allowed 'General case' 0 N--CA 1.442 -0.846 0 C-N-CA 126.679 1.992 . . . . 0.0 112.664 168.054 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 10.2 t -98.76 123.31 50.09 Favored Pre-proline 0 C--N 1.355 0.847 0 N-CA-C 104.458 -2.423 . . . . 0.0 104.458 166.146 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_endo -78.61 -41.94 0.23 Allowed 'Trans proline' 0 N--CA 1.453 -0.858 0 C-N-CA 122.145 1.897 . . . . 0.0 109.637 -179.858 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 8.8 p -179.8 130.72 0.1 Allowed 'General case' 0 N--CA 1.433 -1.306 0 N-CA-C 103.042 -2.947 . . . . 0.0 103.042 -178.309 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 25.4 tp60 -155.88 100.56 2.17 Favored Pre-proline 0 N--CA 1.437 -1.097 0 N-CA-C 105.069 -2.197 . . . . 0.0 105.069 179.729 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -82.94 -19.16 5.99 Favored 'Trans proline' 0 CA--C 1.502 -1.076 0 C-N-CA 122.884 2.39 . . . . 0.0 111.06 -169.053 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 1.7 p30 -103.2 -40.05 6.59 Favored 'General case' 0 CA--C 1.484 -1.596 0 O-C-N 124.09 0.869 . . . . 0.0 110.455 -166.593 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 73.1 m -116.18 156.7 26.03 Favored 'General case' 0 CA--C 1.497 -1.083 0 CA-C-O 121.871 0.843 . . . . 0.0 108.797 -178.532 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 21.1 t-80 -132.96 89.88 33.12 Favored Pre-proline 0 N--CA 1.438 -1.03 0 N-CA-C 106.167 -1.79 . . . . 0.0 106.167 169.414 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 65.5 Cg_endo -84.24 103.38 0.96 Allowed 'Trans proline' 0 N--CA 1.453 -0.871 0 C-N-CA 123.27 2.647 . . . . 0.0 110.449 -175.072 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.583 HD11 HD11 ' A' ' 35' ' ' LEU . 1.7 pt -94.39 168.29 1.53 Allowed 'Isoleucine or valine' 0 C--N 1.356 0.864 0 N-CA-C 109.925 -0.398 . . . . 0.0 109.925 -173.608 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 28.1 tt0 -144.35 147.83 33.95 Favored 'General case' 0 N--CA 1.438 -1.033 0 N-CA-C 104.974 -2.232 . . . . 0.0 104.974 169.97 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 40.9 p90 -129.81 156.6 44.08 Favored 'General case' 0 CA--C 1.496 -1.103 0 N-CA-C 106.859 -1.534 . . . . 0.0 106.859 177.535 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 8.2 t-20 -110.92 149.2 30.97 Favored 'General case' 0 CA--C 1.489 -1.373 0 N-CA-C 102.186 -3.265 . . . . 0.0 102.186 173.211 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -115.82 170.37 5.8 Favored Pre-proline 0 N--CA 1.441 -0.895 0 C-N-CA 124.161 0.984 . . . . 0.0 108.521 -166.369 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 94.8 Cg_exo -65.18 169.53 12.04 Favored 'Trans proline' 0 CA--C 1.511 -0.668 0 C-N-CA 123.613 2.875 . . . . 0.0 112.323 166.918 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 64.7 mt-30 -80.51 -56.1 0.7 Allowed Pre-proline 0 N--CA 1.442 -0.831 0 CA-C-O 115.505 -2.188 . . . . 0.0 112.454 -172.903 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -75.31 169.78 21.74 Favored 'Trans proline' 0 CA--C 1.511 -0.655 0 CA-C-N 125.923 3.151 . . . . 0.0 110.671 -177.073 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 67.3 m -87.09 86.16 7.28 Favored 'General case' 0 CA--C 1.502 -0.901 0 N-CA-C 106.708 -1.59 . . . . 0.0 106.708 175.975 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 11.9 t-160 -122.78 -26.05 4.54 Favored 'General case' 0 N--CA 1.436 -1.129 0 C-N-CA 124.972 1.309 . . . . 0.0 107.792 -171.673 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 1.7 mp -103.16 136.7 34.57 Favored 'Isoleucine or valine' 0 C--N 1.355 0.824 0 N-CA-C 103.885 -2.635 . . . . 0.0 103.885 -171.919 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 34.5 t -96.29 -85.99 0.33 Allowed 'General case' 0 N--CA 1.43 -1.468 0 N-CA-C 104.791 -2.3 . . . . 0.0 104.791 174.473 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 50.8 mtmt -90.67 170.97 9.7 Favored 'General case' 0 CA--C 1.493 -1.226 0 C-N-CA 123.884 0.874 . . . . 0.0 110.096 -168.01 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 96.4 m-85 -125.69 140.37 52.76 Favored 'General case' 0 CA--C 1.496 -1.101 0 N-CA-C 103.948 -2.612 . . . . 0.0 103.948 162.132 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 54.0 mt -120.9 127.85 75.99 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.12 0 N-CA-C 101.828 -3.397 . . . . 0.0 101.828 170.976 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.583 HD11 HD11 ' A' ' 20' ' ' ILE . 4.5 mt -106.91 137.15 45.52 Favored 'General case' 0 CA--C 1.476 -1.898 0 N-CA-C 105.384 -2.08 . . . . 0.0 105.384 171.611 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -131.83 156.02 46.78 Favored 'General case' 0 N--CA 1.434 -1.242 0 N-CA-C 106.878 -1.526 . . . . 0.0 106.878 166.258 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 49.4 p90 -155.27 145.76 22.07 Favored 'General case' 0 N--CA 1.435 -1.209 0 N-CA-C 106.517 -1.66 . . . . 0.0 106.517 -176.384 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 45.5 ttm-85 -135.87 140.67 34.15 Favored Pre-proline 0 N--CA 1.441 -0.88 0 N-CA-C 104.575 -2.38 . . . . 0.0 104.575 178.254 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -72.95 116.55 4.76 Favored 'Trans proline' 0 CA--C 1.504 -0.992 0 C-N-CA 122.735 2.29 . . . . 0.0 108.594 166.284 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 82.5 tttt -73.87 83.85 1.69 Allowed 'General case' 0 C--N 1.355 0.843 0 C-N-CA 125.537 1.535 . . . . 0.0 110.199 -174.252 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 33.1 m120 -147.51 -73.04 0.21 Allowed 'General case' 0 N--CA 1.435 -1.186 0 N-CA-C 102.354 -3.202 . . . . 0.0 102.354 -175.785 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 50.8 p -96.73 168.4 10.53 Favored 'General case' 0 N--CA 1.442 -0.867 0 N-CA-C 107.454 -1.313 . . . . 0.0 107.454 173.351 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 3.6 m -125.98 55.16 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.849 0 N-CA-C 105.821 -1.918 . . . . 0.0 105.821 177.192 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -93.19 -106.05 1.74 Allowed Glycine 0 C--N 1.355 1.611 0 N-CA-C 108.415 -1.874 . . . . 0.0 108.415 -177.247 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 5.6 mmp_? -105.12 170.01 8.12 Favored 'General case' 0 CA--C 1.499 -1.017 0 N-CA-C 107.042 -1.466 . . . . 0.0 107.042 176.729 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -151.23 173.01 14.95 Favored 'General case' 0 N--CA 1.436 -1.137 0 N-CA-C 108.728 -0.841 . . . . 0.0 108.728 -177.943 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 67.8 mttm -111.68 155.76 22.93 Favored 'General case' 0 CA--C 1.49 -1.357 0 N-CA-C 107.774 -1.195 . . . . 0.0 107.774 -172.13 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 15.4 pt-20 -151.49 160.67 43.6 Favored 'General case' 0 N--CA 1.435 -1.211 0 N-CA-C 108.247 -1.02 . . . . 0.0 108.247 172.565 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -137.37 156.76 47.84 Favored 'General case' 0 CA--C 1.497 -1.064 0 N-CA-C 105.938 -1.875 . . . . 0.0 105.938 171.532 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 95.2 m -117.85 123.29 45.52 Favored 'General case' 0 CA--C 1.499 -0.982 0 N-CA-C 104.134 -2.543 . . . . 0.0 104.134 176.398 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 65.9 mt -118.73 137.67 25.15 Favored Pre-proline 0 N--CA 1.437 -1.08 0 N-CA-C 105.984 -1.858 . . . . 0.0 105.984 -164.867 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 75.3 Cg_exo -65.05 163.87 27.08 Favored 'Trans proline' 0 N--CA 1.455 -0.749 0 C-N-CA 123.295 2.663 . . . . 0.0 113.545 176.491 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -78.68 -17.27 77.78 Favored Glycine 0 C--N 1.352 1.456 0 C-N-CA 124.042 0.83 . . . . 0.0 113.807 -174.87 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 54.3 p-80 -83.45 -23.81 32.09 Favored 'General case' 0 C--N 1.357 0.893 0 CA-C-N 117.936 0.868 . . . . 0.0 109.963 -179.602 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 80.8 mt -87.93 125.24 34.4 Favored 'General case' 0 CA--C 1.497 -1.093 0 N-CA-C 107.975 -1.12 . . . . 0.0 107.975 176.721 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 8.1 p30 -112.25 6.69 19.09 Favored 'General case' 0 N--CA 1.442 -0.848 0 C-N-CA 124.741 1.216 . . . . 0.0 109.783 -174.845 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 28.7 p -142.06 154.96 45.35 Favored 'General case' 0 CA--C 1.498 -1.043 0 N-CA-C 106.684 -1.598 . . . . 0.0 106.684 -177.977 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 10.8 t80 -133.84 171.33 14.3 Favored 'General case' 0 CA--C 1.502 -0.869 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 178.423 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 94.4 m -131.8 109.09 9.88 Favored 'General case' 0 N--CA 1.43 -1.433 0 N-CA-C 103.929 -2.619 . . . . 0.0 103.929 170.545 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 42.6 mt -84.09 139.48 17.54 Favored 'Isoleucine or valine' 0 C--N 1.358 0.969 0 N-CA-C 103.123 -2.917 . . . . 0.0 103.123 169.433 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 18.0 ptpt -147.74 160.05 43.14 Favored 'General case' 0 CA--C 1.497 -1.085 0 N-CA-C 109.068 -0.716 . . . . 0.0 109.068 -176.261 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 81.2 53.96 3.72 Favored Glycine 0 C--N 1.355 1.586 0 N-CA-C 108.816 -1.714 . . . . 0.0 108.816 -179.946 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 84.6 mt -117.14 172.6 7.17 Favored 'General case' 0 CA--C 1.496 -1.113 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 -173.019 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 65.7 tttp -124.43 139.56 33.26 Favored Pre-proline 0 N--CA 1.434 -1.259 0 N-CA-C 104.97 -2.233 . . . . 0.0 104.97 -175.342 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -74.9 163.97 34.4 Favored 'Trans proline' 0 N--CA 1.455 -0.789 0 C-N-CA 123.058 2.505 . . . . 0.0 110.089 174.98 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 62.63 44.07 98.07 Favored Glycine 0 N--CA 1.429 -1.824 0 C-N-CA 125.946 1.736 . . . . 0.0 112.756 -178.803 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 20.5 t -134.95 127.19 48.15 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.09 0 N-CA-C 104.325 -2.472 . . . . 0.0 104.325 173.078 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 4.4 p -83.8 116.72 28.21 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.928 0 N-CA-C 105.061 -2.2 . . . . 0.0 105.061 162.521 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 80.8 m-85 -97.64 147.04 24.72 Favored 'General case' 0 CA--C 1.495 -1.153 0 N-CA-C 105.817 -1.919 . . . . 0.0 105.817 178.71 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 14.6 pt-20 -95.37 140.76 29.79 Favored 'General case' 0 CA--C 1.501 -0.934 0 N-CA-C 105.168 -2.16 . . . . 0.0 105.168 164.288 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -134.33 151.89 20.45 Favored Glycine 0 CA--C 1.49 -1.521 0 N-CA-C 107.633 -2.187 . . . . 0.0 107.633 -178.972 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 31.9 mt-30 -143.65 135.71 26.67 Favored 'General case' 0 CA--C 1.488 -1.425 0 N-CA-C 105.699 -1.963 . . . . 0.0 105.699 179.171 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 15.4 tp -120.01 100.98 7.54 Favored 'General case' 0 CA--C 1.499 -0.983 0 N-CA-C 105.482 -2.044 . . . . 0.0 105.482 -177.453 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 18.7 mt -94.02 131.29 41.34 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.889 0 N-CA-C 105.072 -2.196 . . . . 0.0 105.072 178.143 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 23.3 p -108.38 125.87 52.22 Favored 'General case' 0 N--CA 1.44 -0.972 0 N-CA-C 106.088 -1.819 . . . . 0.0 106.088 173.163 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 1.7 mp -92.33 137.04 23.07 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.181 0 N-CA-C 103.427 -2.805 . . . . 0.0 103.427 -179.346 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 4.8 mp0 -92.25 153.48 19.23 Favored 'General case' 0 CA--C 1.497 -1.091 0 N-CA-C 107.032 -1.47 . . . . 0.0 107.032 177.701 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 9.0 tt0 -77.52 32.53 0.16 Allowed 'General case' 0 C--N 1.356 0.854 0 C-N-CA 125.5 1.52 . . . . 0.0 112.385 173.766 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 88.4 m-85 -143.9 14.26 1.7 Allowed 'General case' 0 CA--C 1.498 -1.027 0 C-N-CA 124.119 0.968 . . . . 0.0 108.687 -173.96 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 90.14 -17.94 50.91 Favored Glycine 0 C--N 1.35 1.357 0 C-N-CA 124.131 0.872 . . . . 0.0 112.433 173.835 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 78.4 m-70 -81.48 173.84 12.02 Favored 'General case' 0 CA--C 1.496 -1.109 0 C-N-CA 124.691 1.196 . . . . 0.0 109.17 -177.365 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 5.1 pt20 -155.03 142.41 19.56 Favored 'General case' 0 N--CA 1.438 -1.042 0 N-CA-C 107.778 -1.193 . . . . 0.0 107.778 171.715 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 67.7 mt-10 -108.24 140.22 41.8 Favored 'General case' 0 CA--C 1.496 -1.1 0 N-CA-C 105.191 -2.152 . . . . 0.0 105.191 178.97 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 3.3 p -117.81 137.39 51.9 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.823 0 N-CA-C 107.544 -1.28 . . . . 0.0 107.544 -175.377 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 24.9 m -117.33 140.57 49.4 Favored 'General case' 0 N--CA 1.441 -0.898 0 N-CA-C 104.015 -2.587 . . . . 0.0 104.015 174.84 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -126.46 153.88 44.46 Favored 'General case' 0 CA--C 1.498 -1.04 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 170.331 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 29.5 p90 -166.46 -179.1 4.77 Favored 'General case' 0 CA--C 1.5 -0.948 0 N-CA-C 106.888 -1.523 . . . . 0.0 106.888 -178.093 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 1.7 p30 -139.11 159.51 41.98 Favored 'General case' 0 N--CA 1.438 -1.038 0 N-CA-C 106.436 -1.691 . . . . 0.0 106.436 166.132 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 20.5 p90 -142.42 172.88 12.09 Favored 'General case' 0 CA--C 1.488 -1.411 0 N-CA-C 105.814 -1.921 . . . . 0.0 105.814 171.867 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 16.2 m -130.39 143.48 50.79 Favored 'General case' 0 CA--C 1.501 -0.915 0 N-CA-C 104.697 -2.334 . . . . 0.0 104.697 176.76 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 58.8 m -120.48 124.83 46.35 Favored 'General case' 0 N--CA 1.441 -0.918 0 N-CA-C 102.973 -2.973 . . . . 0.0 102.973 176.758 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 33.0 p -134.24 167.8 20.03 Favored 'General case' 0 C--N 1.357 0.894 0 N-CA-C 107.459 -1.311 . . . . 0.0 107.459 -177.738 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 56.8 p . . . . . 0 C--O 1.26 1.61 0 C-N-CA 124.431 1.092 . . . . 0.0 108.844 178.02 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 22.7 t . . . . . 0 N--CA 1.484 1.264 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -177.49 154.32 15.26 Favored Glycine 0 C--N 1.352 1.471 0 N-CA-C 107.82 -2.112 . . . . 0.0 107.82 175.663 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 70.7 Cg_exo -65.5 142.15 70.43 Favored 'Trans proline' 0 N--CA 1.444 -1.425 0 C-N-CA 122.257 1.971 . . . . 0.0 115.2 -169.913 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 12.9 t -78.29 154.36 5.1 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.807 0 C-N-CA 128.645 2.778 . . . . 0.0 104.776 168.287 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 57.8 mm-40 -109.35 99.88 9.06 Favored 'General case' 0 CA--C 1.488 -1.437 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 -172.249 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 2.4 p -119.23 141.29 39.86 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.012 0 N-CA-C 106.413 -1.699 . . . . 0.0 106.413 -172.087 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 15.4 p90 -142.69 162.24 35.99 Favored 'General case' 0 N--CA 1.436 -1.154 0 N-CA-C 107.078 -1.453 . . . . 0.0 107.078 -169.005 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 39.8 pt -94.98 157.92 3.01 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.365 0 N-CA-C 107.399 -1.334 . . . . 0.0 107.399 177.782 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 41.3 p -79.53 -169.37 1.89 Allowed 'General case' 0 C--N 1.354 0.8 0 C-N-CA 123.881 0.872 . . . . 0.0 111.167 -175.797 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -89.29 -11.38 43.64 Favored 'General case' 0 N--CA 1.443 -0.801 0 C-N-CA 125.136 1.374 . . . . 0.0 110.812 -170.701 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 5.0 t -114.17 94.98 37.14 Favored Pre-proline 0 N--CA 1.44 -0.952 0 N-CA-C 107.265 -1.383 . . . . 0.0 107.265 -177.478 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 93.7 Cg_endo -81.03 -9.36 12.94 Favored 'Trans proline' 0 N--CA 1.451 -0.977 0 C-N-CA 122.775 2.317 . . . . 0.0 109.649 167.072 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 49.2 m -95.17 76.8 3.47 Favored 'General case' 0 CA--C 1.493 -1.223 0 CA-C-O 123.391 1.567 . . . . 0.0 108.903 -177.502 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 80.7 mt-30 -156.34 99.38 2.12 Favored Pre-proline 0 N--CA 1.433 -1.306 0 N-CA-C 100.979 -3.711 . . . . 0.0 100.979 173.995 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_exo -76.66 -14.29 17.72 Favored 'Trans proline' 0 CA--C 1.509 -0.769 0 C-N-CA 122.494 2.13 . . . . 0.0 110.705 -178.258 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -102.31 -45.36 5.13 Favored 'General case' 0 CA--C 1.492 -1.251 0 C-N-CA 125.132 1.373 . . . . 0.0 110.342 -168.033 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 73.5 m -110.85 158.16 19.02 Favored 'General case' 0 CA--C 1.493 -1.234 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 -176.219 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 18.7 t-160 -148.63 95.65 3.96 Favored Pre-proline 0 N--CA 1.44 -0.962 0 N-CA-C 107.651 -1.24 . . . . 0.0 107.651 165.575 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 70.2 Cg_endo -74.61 134.18 18.17 Favored 'Trans proline' 0 N--CA 1.446 -1.268 0 C-N-CA 122.903 2.402 . . . . 0.0 109.246 170.264 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 7.5 pt -116.08 168.39 7.77 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.047 0 N-CA-C 107.006 -1.479 . . . . 0.0 107.006 179.762 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 23.2 tt0 -148.9 147.7 28.98 Favored 'General case' 0 N--CA 1.438 -1.072 0 N-CA-C 105.068 -2.197 . . . . 0.0 105.068 172.27 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 39.5 p90 -131.5 160.95 33.7 Favored 'General case' 0 N--CA 1.438 -1.061 0 N-CA-C 107.069 -1.456 . . . . 0.0 107.069 -178.879 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 83.8 m-20 -103.92 -179.62 4.0 Favored 'General case' 0 CA--C 1.488 -1.407 0 N-CA-C 103.721 -2.696 . . . . 0.0 103.721 170.865 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -157.29 173.07 5.34 Favored Pre-proline 0 N--CA 1.44 -0.963 0 N-CA-C 106.696 -1.594 . . . . 0.0 106.696 177.317 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 79.8 Cg_exo -63.99 161.31 33.75 Favored 'Trans proline' 0 N--CA 1.455 -0.74 0 C-N-CA 123.761 2.974 . . . . 0.0 113.082 173.129 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 70.8 tp60 -82.71 -45.03 0.92 Allowed Pre-proline 0 N--CA 1.444 -0.746 0 CA-C-O 115.519 -2.181 . . . . 0.0 111.925 -175.375 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_exo -70.87 -15.51 32.92 Favored 'Trans proline' 0 CA--C 1.509 -0.727 0 CA-C-N 125.897 3.142 . . . . 0.0 113.342 -176.114 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 9.1 t 66.33 73.06 0.38 Allowed 'General case' 0 C--N 1.357 0.925 0 C-N-CA 126.153 1.781 . . . . 0.0 110.54 179.159 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 23.6 t-160 -97.55 -3.49 39.63 Favored 'General case' 0 N--CA 1.444 -0.752 0 C-N-CA 125.002 1.321 . . . . 0.0 107.976 174.311 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 33.5 mt -106.08 136.65 39.69 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.128 0 N-CA-C 104.516 -2.401 . . . . 0.0 104.516 -176.739 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 4.9 p -99.52 -85.01 0.4 Allowed 'General case' 0 N--CA 1.43 -1.442 0 N-CA-C 105.687 -1.968 . . . . 0.0 105.687 176.962 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 54.2 mtmt -89.76 167.39 12.91 Favored 'General case' 0 CA--C 1.488 -1.436 0 C-N-CA 123.423 0.689 . . . . 0.0 109.253 -164.992 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 93.8 m-85 -126.96 133.15 50.66 Favored 'General case' 0 CA--C 1.493 -1.239 0 N-CA-C 103.219 -2.882 . . . . 0.0 103.219 165.75 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.451 HD13 HD13 ' A' ' 76' ' ' ILE . 1.6 mp -107.6 136.26 43.48 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.195 1 N-CA-C 99.078 -4.416 . . . . 0.0 99.078 166.686 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 46.9 tp -119.72 137.08 54.15 Favored 'General case' 0 N--CA 1.397 -3.092 0 N-CA-C 101.36 -3.57 . . . . 0.0 101.36 172.664 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 14.9 ptp180 -133.94 155.3 50.17 Favored 'General case' 0 CA--C 1.488 -1.417 0 N-CA-C 107.072 -1.455 . . . . 0.0 107.072 174.168 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 47.0 p90 -152.67 139.13 18.59 Favored 'General case' 0 N--CA 1.43 -1.465 0 N-CA-C 105.778 -1.934 . . . . 0.0 105.778 -175.889 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 46.1 ttp85 -145.87 145.04 23.67 Favored Pre-proline 0 N--CA 1.442 -0.843 0 N-CA-C 104.871 -2.27 . . . . 0.0 104.871 -177.17 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 63.6 Cg_exo -64.21 122.8 10.89 Favored 'Trans proline' 0 CA--C 1.505 -0.975 0 C-N-CA 123.09 2.527 . . . . 0.0 111.06 174.7 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 49.9 tttp -71.95 75.65 0.91 Allowed 'General case' 0 C--N 1.358 0.956 0 C-N-CA 125.897 1.679 . . . . 0.0 110.449 176.475 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 29.8 m120 -151.35 -74.73 0.15 Allowed 'General case' 0 N--CA 1.435 -1.212 0 N-CA-C 102.407 -3.183 . . . . 0.0 102.407 -172.541 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 39.1 p -97.44 161.08 13.95 Favored 'General case' 0 C--N 1.356 0.88 0 N-CA-C 106.856 -1.535 . . . . 0.0 106.856 172.332 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 3.7 m -115.61 52.76 0.21 Allowed 'Isoleucine or valine' 0 CA--C 1.504 -0.81 0 N-CA-C 106.526 -1.657 . . . . 0.0 106.526 -179.236 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -88.59 -137.31 5.88 Favored Glycine 0 C--N 1.355 1.59 0 N-CA-C 109.722 -1.351 . . . . 0.0 109.722 -179.872 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 96.4 mtt-85 -85.05 155.78 21.38 Favored 'General case' 0 CA--C 1.499 -0.981 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 -177.596 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 49.0 m95 -105.19 159.33 15.95 Favored 'General case' 0 N--CA 1.436 -1.146 0 N-CA-C 107.552 -1.277 . . . . 0.0 107.552 -175.102 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 64.3 mttp -98.76 150.31 21.96 Favored 'General case' 0 CA--C 1.488 -1.416 0 N-CA-C 104.232 -2.507 . . . . 0.0 104.232 161.801 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -153.12 157.91 41.08 Favored 'General case' 0 CA--C 1.494 -1.173 0 CA-C-O 121.787 0.803 . . . . 0.0 108.867 -176.768 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -140.89 165.81 26.49 Favored 'General case' 0 N--CA 1.437 -1.114 0 N-CA-C 106.119 -1.808 . . . . 0.0 106.119 173.505 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 98.9 m -121.6 127.22 50.66 Favored 'General case' 0 CA--C 1.5 -0.952 0 N-CA-C 104.8 -2.296 . . . . 0.0 104.8 175.87 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 5.3 mp -114.97 134.35 22.51 Favored Pre-proline 0 N--CA 1.435 -1.203 0 N-CA-C 104.871 -2.27 . . . . 0.0 104.871 -176.014 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 68.7 Cg_exo -64.67 165.95 19.28 Favored 'Trans proline' 0 CA--C 1.508 -0.811 0 C-N-CA 123.354 2.703 . . . . 0.0 113.391 177.019 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -73.96 -20.57 79.71 Favored Glycine 0 C--N 1.351 1.376 0 C-N-CA 123.906 0.765 . . . . 0.0 114.141 -174.891 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 52.2 p-80 -83.56 -27.06 29.54 Favored 'General case' 0 C--N 1.354 0.793 0 CA-C-N 117.872 0.836 . . . . 0.0 110.243 -178.72 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 85.0 mt -88.65 126.25 35.21 Favored 'General case' 0 CA--C 1.501 -0.938 0 N-CA-C 107.894 -1.15 . . . . 0.0 107.894 177.283 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 7.8 p-10 -108.65 8.18 26.88 Favored 'General case' 0 CA--C 1.503 -0.843 0 C-N-CA 124.391 1.076 . . . . 0.0 110.634 -170.526 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 5.8 p -142.62 168.08 20.57 Favored 'General case' 0 CA--C 1.491 -1.297 0 N-CA-C 108.106 -1.072 . . . . 0.0 108.106 -177.802 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 8.5 t80 -139.6 175.86 9.22 Favored 'General case' 0 N--CA 1.441 -0.908 0 N-CA-C 107.81 -1.181 . . . . 0.0 107.81 174.365 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 99.3 m -140.05 112.2 7.65 Favored 'General case' 0 N--CA 1.435 -1.208 0 N-CA-C 104.924 -2.25 . . . . 0.0 104.924 178.573 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 17.3 mm -90.25 145.27 7.61 Favored 'Isoleucine or valine' 0 C--N 1.356 0.856 0 N-CA-C 105.013 -2.217 . . . . 0.0 105.013 171.261 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -149.83 161.58 41.97 Favored 'General case' 0 N--CA 1.438 -1.057 0 N-CA-C 107.841 -1.17 . . . . 0.0 107.841 167.662 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 85.88 52.3 3.34 Favored Glycine 0 C--N 1.354 1.543 0 N-CA-C 109.303 -1.519 . . . . 0.0 109.303 177.654 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 78.0 mt -115.18 165.62 12.73 Favored 'General case' 0 CA--C 1.5 -0.967 0 N-CA-C 108.142 -1.059 . . . . 0.0 108.142 -179.141 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt -103.58 154.93 37.53 Favored Pre-proline 0 N--CA 1.44 -0.952 0 N-CA-C 107.068 -1.456 . . . . 0.0 107.068 -176.068 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -76.96 152.52 31.91 Favored 'Trans proline' 0 N--CA 1.452 -0.966 0 C-N-CA 122.829 2.353 . . . . 0.0 111.127 -178.515 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 55.17 40.42 74.72 Favored Glycine 0 C--N 1.356 1.686 0 C-N-CA 127.567 2.508 . . . . 0.0 115.636 170.518 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 5.5 p -129.87 138.08 54.99 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.165 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 -177.169 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 3.2 p -91.76 127.59 43.96 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.884 0 C-N-CA 125.119 1.368 . . . . 0.0 107.681 -178.197 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 82.7 m-85 -107.71 153.24 23.23 Favored 'General case' 0 N--CA 1.438 -1.07 0 C-N-CA 125.12 1.368 . . . . 0.0 108.382 178.036 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 21.4 tp10 -97.55 136.51 37.85 Favored 'General case' 0 N--CA 1.434 -1.242 0 N-CA-C 104.027 -2.582 . . . . 0.0 104.027 165.354 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -131.0 144.11 15.58 Favored Glycine 0 CA--C 1.492 -1.36 0 N-CA-C 107.681 -2.168 . . . . 0.0 107.681 174.325 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 25.9 mt-30 -133.67 134.37 43.04 Favored 'General case' 0 CA--C 1.486 -1.485 0 N-CA-C 107.109 -1.441 . . . . 0.0 107.109 174.858 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 66.6 tp -109.97 101.46 10.28 Favored 'General case' 0 CA--C 1.502 -0.874 0 N-CA-C 104.499 -2.408 . . . . 0.0 104.499 178.493 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 32.4 mt -97.78 123.39 50.2 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.868 0 N-CA-C 104.102 -2.555 . . . . 0.0 104.102 -176.612 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 32.8 p -118.24 120.06 36.56 Favored 'General case' 0 CA--C 1.505 -0.769 0 N-CA-C 108.72 -0.844 . . . . 0.0 108.72 -172.25 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.451 HD13 HD13 ' A' ' 34' ' ' ILE . 1.8 mp -93.64 136.24 25.9 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.301 0 N-CA-C 104.581 -2.377 . . . . 0.0 104.581 -170.243 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 84.7 mt-30 -93.68 152.8 18.73 Favored 'General case' 0 CA--C 1.493 -1.224 0 N-CA-C 106.903 -1.517 . . . . 0.0 106.903 176.91 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 9.0 pt20 -69.14 99.56 1.15 Allowed 'General case' 0 N--CA 1.44 -0.926 0 C-N-CA 124.871 1.268 . . . . 0.0 111.458 -176.296 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 69.1 m-85 57.1 39.4 29.11 Favored 'General case' 0 C--N 1.358 0.946 0 C-N-CA 127.248 2.219 . . . . 0.0 112.16 -179.402 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -141.04 -124.32 2.02 Favored Glycine 0 C--N 1.357 1.708 0 N-CA-C 108.497 -1.841 . . . . 0.0 108.497 -177.4 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 59.1 m80 -83.82 -179.75 7.36 Favored 'General case' 0 CA--C 1.499 -1.019 0 C-N-CA 125.193 1.397 . . . . 0.0 110.302 -170.982 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 21.4 tt0 -139.26 119.15 13.31 Favored 'General case' 0 N--CA 1.434 -1.258 0 N-CA-C 104.781 -2.303 . . . . 0.0 104.781 175.993 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 88.0 mt-10 -99.11 154.23 18.28 Favored 'General case' 0 CA--C 1.499 -1.005 0 N-CA-C 107.37 -1.345 . . . . 0.0 107.37 -178.435 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 7.7 p -128.78 134.97 63.39 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.776 0 N-CA-C 107.598 -1.26 . . . . 0.0 107.598 175.082 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 95.2 m -119.84 137.0 54.26 Favored 'General case' 0 CA--C 1.498 -1.044 0 N-CA-C 102.623 -3.103 . . . . 0.0 102.623 175.098 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 83.0 mtm-85 -126.69 150.67 48.89 Favored 'General case' 0 CA--C 1.5 -0.964 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 -178.531 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 32.7 p90 -165.33 178.81 6.61 Favored 'General case' 0 CA--C 1.5 -0.98 0 N-CA-C 107.234 -1.395 . . . . 0.0 107.234 -177.993 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -139.43 157.85 45.14 Favored 'General case' 0 N--CA 1.441 -0.913 0 N-CA-C 106.441 -1.689 . . . . 0.0 106.441 169.472 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 24.0 p90 -144.83 175.59 10.08 Favored 'General case' 0 CA--C 1.488 -1.442 0 N-CA-C 105.271 -2.122 . . . . 0.0 105.271 172.375 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 8.9 t -143.9 154.94 43.86 Favored 'General case' 0 N--CA 1.44 -0.968 0 N-CA-C 105.439 -2.06 . . . . 0.0 105.439 173.631 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 54.8 p -121.95 138.93 54.23 Favored 'General case' 0 CA--C 1.497 -1.086 0 N-CA-C 104.242 -2.503 . . . . 0.0 104.242 177.144 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 12.3 t -165.89 172.9 11.08 Favored 'General case' 0 N--CA 1.44 -0.944 0 N-CA-C 105.134 -2.173 . . . . 0.0 105.134 -175.625 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 10.0 p . . . . . 0 C--O 1.261 1.678 0 N-CA-C 105.144 -2.169 . . . . 0.0 105.144 164.327 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 15.1 t . . . . . 0 N--CA 1.485 1.297 0 CA-C-O 121.381 0.61 . . . . 0.0 110.258 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 90.97 -150.5 20.57 Favored Glycine 0 C--N 1.353 1.518 0 N-CA-C 107.731 -2.148 . . . . 0.0 107.731 179.773 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -61.6 138.6 76.42 Favored 'Trans proline' 0 N--CA 1.441 -1.567 0 C-N-CA 123.115 2.543 . . . . 0.0 112.973 178.993 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 14.5 t -77.62 161.26 4.52 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.882 0 C-N-CA 129.005 2.922 . . . . 0.0 105.732 179.03 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 59.1 mm-40 -110.87 100.43 9.16 Favored 'General case' 0 CA--C 1.49 -1.361 0 N-CA-C 106.564 -1.643 . . . . 0.0 106.564 -179.449 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 1.5 p -120.85 141.17 42.48 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.041 0 N-CA-C 106.191 -1.781 . . . . 0.0 106.191 -169.531 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 30.6 p90 -153.32 172.61 16.77 Favored 'General case' 0 N--CA 1.434 -1.241 0 N-CA-C 107.015 -1.476 . . . . 0.0 107.015 -169.289 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 19.1 tt -146.72 136.28 16.87 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.177 0 N-CA-C 103.512 -2.773 . . . . 0.0 103.512 165.495 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 35.9 m -151.45 139.67 20.28 Favored 'General case' 0 CA--C 1.501 -0.917 0 N-CA-C 104.051 -2.574 . . . . 0.0 104.051 -175.796 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 29.6 tt0 67.65 59.4 0.48 Allowed 'General case' 0 CA--C 1.479 -1.78 0 C-N-CA 125.299 1.44 . . . . 0.0 108.878 162.186 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 66.0 m -85.12 136.47 38.18 Favored Pre-proline 0 N--CA 1.446 -0.657 0 N-CA-C 105.053 -2.202 . . . . 0.0 105.053 173.914 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 76.4 Cg_exo -75.97 45.63 1.55 Allowed 'Trans proline' 0 CA--C 1.519 -0.25 0 C-N-CA 123.342 2.695 . . . . 0.0 113.946 177.081 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 30.0 m 46.75 94.46 0.01 OUTLIER 'General case' 0 CA--C 1.499 -0.981 0 C-N-CA 128.203 2.601 . . . . 0.0 114.192 -174.375 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 34.9 mt-30 -137.59 108.64 8.57 Favored Pre-proline 0 N--CA 1.434 -1.255 0 N-CA-C 104.581 -2.377 . . . . 0.0 104.581 -172.906 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 66.5 Cg_endo -85.92 5.66 5.92 Favored 'Trans proline' 0 N--CA 1.454 -0.831 0 C-N-CA 123.611 2.874 . . . . 0.0 109.45 -177.886 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 5.8 p-10 -116.44 -35.95 4.13 Favored 'General case' 0 CA--C 1.491 -1.321 0 C-N-CA 124.328 1.051 . . . . 0.0 109.344 -172.581 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 30.3 p -130.22 151.95 50.18 Favored 'General case' 0 CA--C 1.499 -1.0 0 CA-C-O 122.151 0.977 . . . . 0.0 110.004 -175.42 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 35.7 m-70 -142.87 98.99 5.62 Favored Pre-proline 0 N--CA 1.438 -1.069 0 N-CA-C 107.145 -1.428 . . . . 0.0 107.145 175.668 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -79.1 114.04 3.3 Favored 'Trans proline' 0 N--CA 1.445 -1.339 0 C-N-CA 123.074 2.516 . . . . 0.0 110.178 175.953 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.53 HD11 HD11 ' A' ' 35' ' ' LEU . 3.9 pt -93.93 166.53 1.77 Allowed 'Isoleucine or valine' 0 CA--C 1.498 -1.05 0 N-CA-C 107.825 -1.176 . . . . 0.0 107.825 -178.251 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 17.6 mp0 -139.69 151.46 45.92 Favored 'General case' 0 CA--C 1.499 -1.002 0 N-CA-C 105.496 -2.038 . . . . 0.0 105.496 174.815 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 42.3 p90 -136.33 156.71 48.25 Favored 'General case' 0 CA--C 1.496 -1.113 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 175.666 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 83.2 m-20 -97.35 -175.71 3.3 Favored 'General case' 0 CA--C 1.486 -1.487 0 N-CA-C 104.31 -2.478 . . . . 0.0 104.31 171.29 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -157.59 173.79 4.65 Favored Pre-proline 0 N--CA 1.44 -0.93 0 N-CA-C 106.828 -1.545 . . . . 0.0 106.828 176.458 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_exo -63.96 162.52 28.78 Favored 'Trans proline' 0 CA--C 1.51 -0.724 0 C-N-CA 123.678 2.919 . . . . 0.0 112.209 169.169 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 1.2 tm0? -81.26 -60.09 0.43 Allowed Pre-proline 0 C--N 1.353 0.744 0 CA-C-O 115.705 -2.093 . . . . 0.0 110.671 -174.193 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_endo -75.42 174.43 12.81 Favored 'Trans proline' 0 CA--C 1.511 -0.645 0 CA-C-N 125.688 3.067 . . . . 0.0 110.161 -179.694 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 52.2 p -72.58 126.26 29.44 Favored 'General case' 0 C--N 1.357 0.919 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 177.787 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 16.2 t-160 -160.9 -51.66 0.05 OUTLIER 'General case' 0 CA--C 1.493 -1.229 0 N-CA-C 106.566 -1.642 . . . . 0.0 106.566 -166.646 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 35.1 mt -111.81 132.64 59.87 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.1 0 N-CA-C 105.487 -2.042 . . . . 0.0 105.487 -174.154 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 30.0 t -102.77 -84.79 0.45 Allowed 'General case' 0 N--CA 1.431 -1.41 0 N-CA-C 107.586 -1.264 . . . . 0.0 107.586 -178.146 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 23.1 ttmm -91.42 149.51 21.68 Favored 'General case' 0 CA--C 1.493 -1.244 0 N-CA-C 106.829 -1.545 . . . . 0.0 106.829 -161.278 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 97.4 m-85 -117.49 128.84 55.38 Favored 'General case' 0 CA--C 1.496 -1.129 0 N-CA-C 104.725 -2.324 . . . . 0.0 104.725 168.785 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 60.9 mt -106.48 117.44 52.27 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.075 0 N-CA-C 102.188 -3.264 . . . . 0.0 102.188 169.604 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.53 HD11 HD11 ' A' ' 20' ' ' ILE . 0.9 OUTLIER -95.33 125.35 39.89 Favored 'General case' 0 CA--C 1.48 -1.745 0 N-CA-C 106.972 -1.492 . . . . 0.0 106.972 176.813 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 97.0 mtt180 -120.74 147.12 45.74 Favored 'General case' 0 CA--C 1.49 -1.333 0 N-CA-C 105.972 -1.862 . . . . 0.0 105.972 171.75 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 40.3 p90 -151.99 173.55 14.72 Favored 'General case' 0 CA--C 1.487 -1.479 0 N-CA-C 106.199 -1.778 . . . . 0.0 106.199 169.982 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 36.0 ptt180 -170.96 158.83 5.38 Favored Pre-proline 0 CA--C 1.499 -1.009 0 N-CA-C 106.284 -1.747 . . . . 0.0 106.284 177.004 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . 0.437 ' HB2' HD22 ' A' ' 41' ' ' ASN . 60.4 Cg_endo -74.51 140.86 27.44 Favored 'Trans proline' 0 N--CA 1.448 -1.181 0 C-N-CA 122.065 1.843 . . . . 0.0 107.839 168.062 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 57.7 tttp -71.18 78.42 0.7 Allowed 'General case' 0 C--N 1.355 0.806 0 C-N-CA 125.344 1.458 . . . . 0.0 110.784 179.947 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . 0.437 HD22 ' HB2' ' A' ' 39' ' ' PRO . 60.1 m-80 -161.11 -46.73 0.04 OUTLIER 'General case' 0 N--CA 1.438 -1.044 0 N-CA-C 104.966 -2.235 . . . . 0.0 104.966 -170.668 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 27.8 m -77.68 161.01 28.09 Favored 'General case' 0 C--N 1.359 0.995 0 C-N-CA 124.19 0.996 . . . . 0.0 110.503 -170.926 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 20.2 m -102.01 -26.93 3.4 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.879 0 C-N-CA 124.83 1.252 . . . . 0.0 109.887 -170.608 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -173.17 27.17 0.09 OUTLIER Glycine 0 CA--C 1.493 -1.339 0 N-CA-C 110.569 -1.012 . . . . 0.0 110.569 179.853 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 54.7 ttp180 -98.62 122.29 41.65 Favored 'General case' 0 CA--C 1.495 -1.15 0 N-CA-C 105.026 -2.213 . . . . 0.0 105.026 172.669 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 83.8 m95 -128.6 138.74 52.36 Favored 'General case' 0 CA--C 1.496 -1.123 0 N-CA-C 106.732 -1.581 . . . . 0.0 106.732 179.665 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 60.9 mttp -96.11 104.47 16.42 Favored 'General case' 0 CA--C 1.491 -1.307 0 N-CA-C 104.332 -2.47 . . . . 0.0 104.332 169.192 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 16.1 pt-20 -107.49 150.96 26.2 Favored 'General case' 0 CA--C 1.498 -1.055 0 CA-C-N 115.033 -0.985 . . . . 0.0 109.532 -176.475 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -136.74 154.51 50.56 Favored 'General case' 0 N--CA 1.438 -1.055 0 N-CA-C 105.917 -1.883 . . . . 0.0 105.917 178.089 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 92.4 m -121.71 125.1 45.82 Favored 'General case' 0 CA--C 1.501 -0.91 0 N-CA-C 104.292 -2.485 . . . . 0.0 104.292 178.317 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 63.6 mt -128.86 137.39 30.87 Favored Pre-proline 0 N--CA 1.44 -0.961 0 N-CA-C 105.154 -2.165 . . . . 0.0 105.154 -166.29 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -74.56 171.13 18.76 Favored 'Trans proline' 0 CA--C 1.508 -0.8 0 C-N-CA 123.44 2.76 . . . . 0.0 110.876 178.555 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -77.95 -11.96 84.88 Favored Glycine 0 C--N 1.352 1.463 0 C-N-CA 123.808 0.718 . . . . 0.0 114.117 -178.742 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 9.2 p-80 -83.01 -25.37 32.27 Favored 'General case' 0 C--N 1.357 0.931 0 CA-C-N 118.321 1.061 . . . . 0.0 110.236 -178.937 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 87.2 mt -89.09 128.26 35.74 Favored 'General case' 0 CA--C 1.501 -0.929 0 N-CA-C 107.316 -1.364 . . . . 0.0 107.316 173.412 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 8.4 p30 -112.91 1.05 15.32 Favored 'General case' 0 N--CA 1.443 -0.8 0 C-N-CA 124.762 1.225 . . . . 0.0 109.814 -173.146 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 25.7 p -145.71 160.18 42.09 Favored 'General case' 0 CA--C 1.498 -1.025 0 N-CA-C 106.331 -1.729 . . . . 0.0 106.331 -177.33 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 5.1 t80 -131.89 177.89 7.19 Favored 'General case' 0 C--N 1.358 0.942 0 CA-C-O 121.684 0.754 . . . . 0.0 109.366 178.808 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 97.7 m -133.72 105.78 7.01 Favored 'General case' 0 N--CA 1.431 -1.393 0 N-CA-C 103.302 -2.851 . . . . 0.0 103.302 171.613 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 59.5 mt -86.83 140.22 16.14 Favored 'Isoleucine or valine' 0 C--N 1.359 0.993 0 N-CA-C 103.938 -2.615 . . . . 0.0 103.938 171.326 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -147.26 160.46 42.47 Favored 'General case' 0 N--CA 1.438 -1.071 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 -176.866 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 84.42 52.6 3.51 Favored Glycine 0 C--N 1.354 1.565 0 N-CA-C 109.208 -1.557 . . . . 0.0 109.208 178.672 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 47.9 mt -114.9 168.59 9.77 Favored 'General case' 0 CA--C 1.501 -0.924 0 N-CA-C 107.591 -1.263 . . . . 0.0 107.591 -173.631 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -119.67 150.48 50.32 Favored Pre-proline 0 N--CA 1.442 -0.872 0 N-CA-C 106.775 -1.565 . . . . 0.0 106.775 -173.624 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -77.18 165.7 27.54 Favored 'Trans proline' 0 N--CA 1.454 -0.827 0 C-N-CA 123.129 2.552 . . . . 0.0 110.806 175.263 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 0.609 ' H ' ' HA ' ' A' ' 92' ' ' THR . . . 64.18 19.18 63.65 Favored Glycine 0 N--CA 1.429 -1.828 0 C-N-CA 128.209 2.814 . . . . 0.0 116.575 173.212 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 9.9 p -134.21 145.9 32.22 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.108 0 CA-C-N 118.636 1.218 . . . . 0.0 108.073 -174.713 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 7.3 p -90.33 128.2 42.38 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.959 0 N-CA-C 106.97 -1.492 . . . . 0.0 106.97 177.523 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 49.0 m-85 -101.0 137.33 39.51 Favored 'General case' 0 CA--C 1.493 -1.233 0 N-CA-C 105.575 -2.009 . . . . 0.0 105.575 174.3 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 18.9 pt-20 -112.35 158.63 19.55 Favored 'General case' 0 N--CA 1.437 -1.096 0 N-CA-C 105.956 -1.868 . . . . 0.0 105.956 173.044 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -169.57 -172.38 36.12 Favored Glycine 0 N--CA 1.415 -2.726 0 C-N-CA 120.578 -0.82 . . . . 0.0 114.879 175.447 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 32.0 mt-30 -148.24 139.88 23.71 Favored 'General case' 0 CA--C 1.486 -1.518 0 N-CA-C 105.997 -1.853 . . . . 0.0 105.997 -166.878 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 59.5 tp -116.47 96.41 5.51 Favored 'General case' 0 CA--C 1.499 -0.997 0 N-CA-C 104.015 -2.587 . . . . 0.0 104.015 174.958 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 27.3 mt -88.49 134.79 27.27 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.919 0 N-CA-C 104.05 -2.574 . . . . 0.0 104.05 -178.313 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 25.2 p -129.5 104.62 7.57 Favored 'General case' 0 N--CA 1.438 -1.066 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 -169.326 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 3.7 mp -93.51 136.42 25.31 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.312 0 N-CA-C 104.062 -2.57 . . . . 0.0 104.062 -167.07 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 80.5 mt-30 -88.24 177.29 6.92 Favored 'General case' 0 CA--C 1.496 -1.132 0 C-N-CA 123.712 0.805 . . . . 0.0 108.968 -171.304 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 35.3 mt-30 -71.52 96.04 1.47 Allowed 'General case' 0 CA--C 1.501 -0.921 0 C-N-CA 124.597 1.159 . . . . 0.0 109.459 176.46 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . 0.301 41.3 p90 47.65 33.0 2.76 Favored 'General case' 0 C--N 1.36 1.035 0 C-N-CA 128.126 2.57 . . . . 0.0 114.438 -174.815 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -125.29 -125.89 2.95 Favored Glycine 0 C--N 1.358 1.78 0 N-CA-C 109.456 -1.458 . . . . 0.0 109.456 -174.119 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 52.3 m80 -84.1 -178.02 6.83 Favored 'General case' 0 CA--C 1.498 -1.027 0 C-N-CA 125.614 1.566 . . . . 0.0 111.044 -167.818 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 35.7 mt-30 -125.29 146.25 49.64 Favored 'General case' 0 CA--C 1.494 -1.188 0 N-CA-C 103.459 -2.793 . . . . 0.0 103.459 167.806 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 54.6 mt-10 -138.14 121.48 17.06 Favored 'General case' 0 CA--C 1.492 -1.281 0 N-CA-C 105.372 -2.084 . . . . 0.0 105.372 -177.114 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 7.5 p -99.4 134.97 36.62 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.79 0 N-CA-C 108.151 -1.055 . . . . 0.0 108.151 -172.624 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 26.7 m -115.2 158.96 21.53 Favored 'General case' 0 N--CA 1.443 -0.802 0 N-CA-C 103.81 -2.663 . . . . 0.0 103.81 175.915 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 38.8 ptt180 -126.32 154.71 43.1 Favored 'General case' 0 CA--C 1.501 -0.915 0 CA-C-O 121.32 0.581 . . . . 0.0 109.8 178.126 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 29.4 p90 -157.45 165.43 35.69 Favored 'General case' 0 CA--C 1.502 -0.866 0 N-CA-C 107.274 -1.38 . . . . 0.0 107.274 173.486 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -145.57 156.82 43.93 Favored 'General case' 0 N--CA 1.441 -0.885 0 N-CA-C 106.314 -1.736 . . . . 0.0 106.314 159.997 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 27.4 p90 -146.37 168.23 21.62 Favored 'General case' 0 CA--C 1.492 -1.254 0 N-CA-C 106.404 -1.702 . . . . 0.0 106.404 171.046 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 26.6 p -110.86 140.36 45.39 Favored 'General case' 0 CA--C 1.5 -0.944 0 N-CA-C 106.957 -1.497 . . . . 0.0 106.957 178.668 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 89.7 m -116.45 109.14 16.91 Favored 'General case' 0 CA--C 1.489 -1.394 0 N-CA-C 102.106 -3.294 . . . . 0.0 102.106 174.037 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . 0.609 ' HA ' ' H ' ' A' ' 66' ' ' GLY . 86.9 m -147.28 -55.69 0.24 Allowed 'General case' 0 CA--C 1.498 -1.034 0 N-CA-C 106.645 -1.613 . . . . 0.0 106.645 -171.686 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 8.9 t . . . . . 0 C--O 1.26 1.653 0 CA-C-O 118.078 -0.963 . . . . 0.0 110.049 -165.25 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 88.8 p . . . . . 0 N--CA 1.489 1.489 0 CA-C-O 121.348 0.594 . . . . 0.0 111.823 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 83.76 -149.25 25.46 Favored Glycine 0 C--N 1.355 1.635 0 N-CA-C 109.104 -1.598 . . . . 0.0 109.104 176.882 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_exo -61.55 136.12 61.15 Favored 'Trans proline' 0 N--CA 1.443 -1.472 0 C-N-CA 123.088 2.526 . . . . 0.0 113.624 -178.357 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 24.6 t -84.59 161.92 3.08 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.048 0 C-N-CA 129.202 3.001 . . . . 0.0 106.424 -178.196 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -108.38 108.9 20.06 Favored 'General case' 0 CA--C 1.496 -1.107 0 N-CA-C 105.876 -1.898 . . . . 0.0 105.876 175.927 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 1.5 p -129.3 142.04 45.01 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.894 0 N-CA-C 105.687 -1.968 . . . . 0.0 105.687 -170.101 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 33.1 p90 -155.51 171.04 20.58 Favored 'General case' 0 N--CA 1.438 -1.026 0 CA-C-O 121.876 0.846 . . . . 0.0 109.302 -162.184 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 14.5 tt -134.76 134.7 53.82 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.973 0 N-CA-C 102.014 -3.328 . . . . 0.0 102.014 162.742 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 93.6 m -146.62 128.39 15.29 Favored 'General case' 0 CA--C 1.504 -0.813 0 N-CA-C 106.702 -1.592 . . . . 0.0 106.702 -173.598 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 19.4 tt0 61.71 42.2 11.08 Favored 'General case' 0 C--N 1.358 0.974 0 C-N-CA 127.305 2.242 . . . . 0.0 113.202 165.936 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 99.7 m -87.6 122.9 70.24 Favored Pre-proline 0 N--CA 1.445 -0.694 0 N-CA-C 107.215 -1.402 . . . . 0.0 107.215 177.589 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 98.4 Cg_endo -85.06 80.27 2.15 Favored 'Trans proline' 0 N--CA 1.456 -0.717 0 C-N-CA 123.195 2.597 . . . . 0.0 110.947 -174.915 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . 0.264 80.7 p 51.1 99.38 0.01 OUTLIER 'General case' 0 C--N 1.357 0.913 0 C-N-CA 127.883 2.473 . . . . 0.0 115.547 174.007 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 99.6 mm-40 -129.56 102.81 17.99 Favored Pre-proline 0 N--CA 1.442 -0.831 0 N-CA-C 106.18 -1.785 . . . . 0.0 106.18 178.528 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_exo -74.66 -21.31 16.83 Favored 'Trans proline' 0 CA--C 1.506 -0.882 0 C-N-CA 123.2 2.6 . . . . 0.0 111.291 178.017 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 1.6 p30 -102.46 -42.44 5.97 Favored 'General case' 0 CA--C 1.489 -1.368 0 C-N-CA 124.215 1.006 . . . . 0.0 111.029 -165.188 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 56.6 p -110.48 156.0 21.46 Favored 'General case' 0 CA--C 1.497 -1.06 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 -175.634 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 86.3 t60 -131.57 98.72 17.8 Favored Pre-proline 0 N--CA 1.439 -0.989 0 N-CA-C 106.128 -1.804 . . . . 0.0 106.128 172.493 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -80.13 128.99 7.58 Favored 'Trans proline' 0 N--CA 1.451 -0.972 0 C-N-CA 123.26 2.64 . . . . 0.0 109.836 177.231 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 3.7 mp -111.9 149.04 14.67 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.183 0 N-CA-C 104.881 -2.266 . . . . 0.0 104.881 -179.62 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 31.2 mt-30 -138.7 152.94 48.44 Favored 'General case' 0 CA--C 1.497 -1.092 0 N-CA-C 104.578 -2.378 . . . . 0.0 104.578 164.57 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 37.2 p90 -136.02 158.5 44.26 Favored 'General case' 0 CA--C 1.501 -0.916 0 N-CA-C 107.065 -1.457 . . . . 0.0 107.065 -178.595 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 84.2 m-20 -96.4 -176.92 3.78 Favored 'General case' 0 CA--C 1.488 -1.407 0 N-CA-C 103.934 -2.617 . . . . 0.0 103.934 169.045 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -157.35 171.85 6.91 Favored Pre-proline 0 N--CA 1.44 -0.933 0 N-CA-C 106.579 -1.637 . . . . 0.0 106.579 173.188 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 68.5 Cg_exo -63.74 154.46 69.28 Favored 'Trans proline' 0 CA--C 1.508 -0.814 0 C-N-CA 123.51 2.807 . . . . 0.0 112.842 174.59 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 24.0 tt0 -82.43 -41.93 0.94 Allowed Pre-proline 0 N--CA 1.443 -0.798 0 CA-C-O 115.697 -2.097 . . . . 0.0 112.031 -175.134 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_exo -71.71 -3.74 13.71 Favored 'Trans proline' 0 CA--C 1.514 -0.521 0 CA-C-N 125.574 3.026 . . . . 0.0 113.851 -179.867 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 10.3 t 71.0 75.93 0.19 Allowed 'General case' 0 C--N 1.357 0.903 0 C-N-CA 126.381 1.873 . . . . 0.0 108.812 -176.71 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 57.8 t-80 -90.95 -20.18 22.46 Favored 'General case' 0 N--CA 1.439 -0.977 0 C-N-CA 125.27 1.428 . . . . 0.0 108.455 179.969 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 22.9 mt -125.38 147.47 30.07 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.105 0 N-CA-C 105.396 -2.075 . . . . 0.0 105.396 -168.578 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 9.2 p -107.29 -84.13 0.53 Allowed 'General case' 0 N--CA 1.432 -1.328 0 N-CA-C 106.879 -1.526 . . . . 0.0 106.879 174.554 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 51.7 mtmt -89.2 167.57 12.98 Favored 'General case' 0 CA--C 1.486 -1.493 0 C-N-CA 124.683 1.193 . . . . 0.0 108.782 -165.274 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 90.4 m-85 -132.31 138.24 47.74 Favored 'General case' 0 CA--C 1.495 -1.142 0 N-CA-C 105.329 -2.1 . . . . 0.0 105.329 176.033 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 51.8 mt -118.42 131.55 70.85 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.111 0 N-CA-C 101.074 -3.676 . . . . 0.0 101.074 170.652 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 6.8 mt -111.01 128.13 55.75 Favored 'General case' 0 CA--C 1.477 -1.854 0 N-CA-C 104.739 -2.319 . . . . 0.0 104.739 170.104 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 3.2 mmm180 -107.51 160.11 15.91 Favored 'General case' 0 N--CA 1.432 -1.348 0 N-CA-C 104.737 -2.32 . . . . 0.0 104.737 171.077 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 48.5 p90 -159.18 152.82 22.89 Favored 'General case' 0 N--CA 1.437 -1.085 0 N-CA-C 107.801 -1.185 . . . . 0.0 107.801 171.093 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 13.1 ptp180 -154.61 158.05 32.2 Favored Pre-proline 0 CA--C 1.501 -0.932 0 N-CA-C 105.661 -1.978 . . . . 0.0 105.661 163.946 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . 0.433 ' HA ' ' HA ' ' A' ' 69' ' ' TYR . 37.9 Cg_endo -72.52 129.01 14.16 Favored 'Trans proline' 0 N--CA 1.451 -0.977 0 C-N-CA 122.637 2.225 . . . . 0.0 107.752 170.191 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 48.2 tttp -67.6 81.82 0.17 Allowed 'General case' 0 C--N 1.357 0.912 0 C-N-CA 127.781 2.433 . . . . 0.0 111.473 -170.761 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 4.7 t-20 -162.17 -51.05 0.04 OUTLIER 'General case' 0 N--CA 1.432 -1.335 0 N-CA-C 105.562 -2.014 . . . . 0.0 105.562 -173.607 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 37.9 p -80.63 155.7 26.72 Favored 'General case' 0 N--CA 1.438 -1.059 0 C-N-CA 124.567 1.147 . . . . 0.0 109.685 -176.891 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 17.3 m -130.44 10.67 2.14 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.811 0 C-N-CA 125.061 1.344 . . . . 0.0 107.888 -177.427 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -94.27 -113.18 2.45 Favored Glycine 0 C--N 1.356 1.694 0 N-CA-C 109.489 -1.444 . . . . 0.0 109.489 -174.534 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 85.6 mtm180 -92.66 175.95 6.63 Favored 'General case' 0 CA--C 1.503 -0.863 0 N-CA-C 108.191 -1.04 . . . . 0.0 108.191 -178.538 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -155.41 -178.41 7.25 Favored 'General case' 0 CA--C 1.495 -1.171 0 CA-C-O 121.221 0.534 . . . . 0.0 109.839 178.565 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 96.0 mttt -109.21 156.55 19.76 Favored 'General case' 0 CA--C 1.489 -1.396 0 N-CA-C 106.451 -1.685 . . . . 0.0 106.451 -176.724 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 1.1 pp20? -152.08 163.12 39.99 Favored 'General case' 0 N--CA 1.432 -1.363 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 176.252 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -139.97 160.79 39.14 Favored 'General case' 0 CA--C 1.495 -1.136 0 N-CA-C 105.663 -1.977 . . . . 0.0 105.663 169.596 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 77.6 m -120.62 125.96 49.07 Favored 'General case' 0 CA--C 1.499 -1.014 0 N-CA-C 104.732 -2.322 . . . . 0.0 104.732 176.446 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 4.9 mp -114.04 134.41 22.17 Favored Pre-proline 0 N--CA 1.435 -1.186 0 N-CA-C 104.84 -2.281 . . . . 0.0 104.84 -175.545 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 67.5 Cg_exo -63.89 167.6 13.62 Favored 'Trans proline' 0 CA--C 1.509 -0.761 0 C-N-CA 123.595 2.863 . . . . 0.0 113.406 177.227 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -77.75 -19.02 76.43 Favored Glycine 0 C--N 1.352 1.439 0 C-N-CA 123.583 0.611 . . . . 0.0 113.425 -173.488 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 50.9 p-80 -84.08 -27.88 27.95 Favored 'General case' 0 C--N 1.357 0.906 0 CA-C-N 117.757 0.779 . . . . 0.0 110.172 -179.471 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 86.4 mt -88.56 128.97 35.58 Favored 'General case' 0 CA--C 1.5 -0.943 0 N-CA-C 107.881 -1.155 . . . . 0.0 107.881 177.653 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 8.7 p30 -110.98 8.33 21.96 Favored 'General case' 0 CA--C 1.5 -0.946 0 C-N-CA 124.498 1.119 . . . . 0.0 110.543 -171.806 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 46.6 p -142.03 160.16 40.77 Favored 'General case' 0 N--CA 1.439 -0.988 0 N-CA-C 108.107 -1.071 . . . . 0.0 108.107 -175.713 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 12.3 t80 -143.63 176.72 9.0 Favored 'General case' 0 C--N 1.355 0.822 0 N-CA-C 107.328 -1.36 . . . . 0.0 107.328 176.953 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 97.6 m -147.06 116.96 7.2 Favored 'General case' 0 N--CA 1.429 -1.509 0 N-CA-C 104.851 -2.277 . . . . 0.0 104.851 176.101 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 79.7 mt -91.24 147.06 5.5 Favored 'Isoleucine or valine' 0 C--N 1.355 0.804 0 N-CA-C 103.555 -2.757 . . . . 0.0 103.555 169.364 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 67.6 mttm -140.38 166.37 24.89 Favored 'General case' 0 CA--C 1.5 -0.954 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 178.149 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 83.16 49.39 5.01 Favored Glycine 0 C--N 1.354 1.577 0 N-CA-C 109.211 -1.556 . . . . 0.0 109.211 174.787 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 63.9 mt -118.78 169.4 9.88 Favored 'General case' 0 CA--C 1.498 -1.023 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 -170.576 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -116.76 144.74 33.95 Favored Pre-proline 0 N--CA 1.439 -1.008 0 N-CA-C 105.679 -1.971 . . . . 0.0 105.679 -173.764 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -77.33 161.75 31.59 Favored 'Trans proline' 0 N--CA 1.452 -0.934 0 C-N-CA 122.788 2.325 . . . . 0.0 110.996 174.466 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 0.584 ' H ' ' HA ' ' A' ' 92' ' ' THR . . . 62.54 26.66 68.54 Favored Glycine 0 N--CA 1.428 -1.856 0 C-N-CA 127.617 2.532 . . . . 0.0 115.765 174.225 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 9.8 p -126.65 145.59 33.95 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.928 0 N-CA-C 107.596 -1.261 . . . . 0.0 107.596 179.408 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 4.2 p -92.61 135.75 26.7 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.824 0 N-CA-C 107.214 -1.402 . . . . 0.0 107.214 179.945 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . 0.433 ' HA ' ' HA ' ' A' ' 39' ' ' PRO . 91.1 m-85 -116.79 149.27 40.23 Favored 'General case' 0 CA--C 1.494 -1.193 0 N-CA-C 105.607 -1.997 . . . . 0.0 105.607 175.278 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -96.7 139.93 32.04 Favored 'General case' 0 CA--C 1.499 -1.009 0 N-CA-C 104.367 -2.457 . . . . 0.0 104.367 162.773 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -132.66 154.14 20.97 Favored Glycine 0 CA--C 1.483 -1.925 0 N-CA-C 106.951 -2.46 . . . . 0.0 106.951 179.849 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 29.2 tt0 -146.94 135.61 22.09 Favored 'General case' 0 CA--C 1.483 -1.627 0 N-CA-C 106.949 -1.5 . . . . 0.0 106.949 -178.625 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 21.8 tp -115.79 100.55 8.09 Favored 'General case' 0 N--CA 1.438 -1.074 0 N-CA-C 104.45 -2.426 . . . . 0.0 104.45 -177.355 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 21.2 mt -93.16 126.61 45.57 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.917 0 N-CA-C 104.032 -2.581 . . . . 0.0 104.032 177.572 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 74.2 m -117.98 111.32 18.8 Favored 'General case' 0 N--CA 1.436 -1.173 0 N-CA-C 107.746 -1.205 . . . . 0.0 107.746 -170.413 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 31.0 mm -91.22 144.01 10.05 Favored 'Isoleucine or valine' 0 CA--C 1.49 -1.365 0 N-CA-C 106.519 -1.66 . . . . 0.0 106.519 -165.799 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 17.1 tt0 -110.81 107.18 16.6 Favored 'General case' 0 CA--C 1.495 -1.135 0 N-CA-C 103.036 -2.95 . . . . 0.0 103.036 171.452 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 19.7 pt20 -67.25 138.46 56.91 Favored 'General case' 0 C--N 1.356 0.866 0 CA-C-O 121.232 0.539 . . . . 0.0 111.68 -167.148 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 55.0 m-85 68.05 32.15 5.14 Favored 'General case' 0 C--N 1.355 0.821 0 C-N-CA 126.695 1.998 . . . . 0.0 111.764 -176.1 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -174.97 -112.86 0.31 Allowed Glycine 0 C--N 1.355 1.613 0 C-N-CA 119.349 -1.405 . . . . 0.0 109.749 176.922 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 66.4 m80 -83.43 -178.73 7.15 Favored 'General case' 0 CA--C 1.5 -0.954 0 C-N-CA 125.242 1.417 . . . . 0.0 111.269 -164.595 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 5.9 pt20 -154.51 148.77 26.0 Favored 'General case' 0 N--CA 1.435 -1.216 0 N-CA-C 106.621 -1.622 . . . . 0.0 106.621 166.506 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 8.4 mp0 -109.81 155.93 21.0 Favored 'General case' 0 N--CA 1.437 -1.085 0 N-CA-C 104.869 -2.271 . . . . 0.0 104.869 -178.116 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 12.4 p -131.45 139.17 51.4 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.838 0 N-CA-C 107.772 -1.196 . . . . 0.0 107.772 -179.739 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 41.8 m -133.28 122.69 24.25 Favored 'General case' 0 N--CA 1.438 -1.074 0 N-CA-C 103.261 -2.866 . . . . 0.0 103.261 -178.669 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 52.8 ttt85 -119.75 144.15 47.42 Favored 'General case' 0 CA--C 1.504 -0.794 0 N-CA-C 108.174 -1.047 . . . . 0.0 108.174 -176.011 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 29.0 p90 -155.06 -179.59 8.21 Favored 'General case' 0 CA--C 1.499 -0.981 0 N-CA-C 107.547 -1.279 . . . . 0.0 107.547 -177.182 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -138.82 156.31 47.44 Favored 'General case' 0 N--CA 1.44 -0.961 0 N-CA-C 105.811 -1.922 . . . . 0.0 105.811 167.169 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 22.2 p90 -142.61 171.79 13.57 Favored 'General case' 0 CA--C 1.487 -1.477 0 N-CA-C 106.83 -1.544 . . . . 0.0 106.83 175.001 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 25.5 p -120.37 143.88 48.19 Favored 'General case' 0 CA--C 1.499 -0.993 0 N-CA-C 105.526 -2.027 . . . . 0.0 105.526 169.364 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 57.3 m -109.05 126.06 52.76 Favored 'General case' 0 CA--C 1.493 -1.244 0 N-CA-C 101.36 -3.57 . . . . 0.0 101.36 164.764 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . 0.584 ' HA ' ' H ' ' A' ' 66' ' ' GLY . 12.4 t -146.01 172.46 13.35 Favored 'General case' 0 N--CA 1.435 -1.177 0 N-CA-C 105.264 -2.125 . . . . 0.0 105.264 -173.751 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 69.5 m . . . . . 0 C--O 1.26 1.629 0 N-CA-C 106.8 -1.556 . . . . 0.0 106.8 173.197 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 23.3 t . . . . . 0 N--CA 1.483 1.211 0 N-CA-C 109.581 -0.526 . . . . 0.0 109.581 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 166.66 176.83 38.07 Favored Glycine 0 N--CA 1.437 -1.285 0 N-CA-C 106.705 -2.558 . . . . 0.0 106.705 178.375 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 8.9 Cg_exo -55.42 148.57 51.36 Favored 'Trans proline' 0 N--CA 1.45 -1.078 0 C-N-CA 124.11 3.207 . . . . 0.0 116.463 -161.995 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 17.5 t -76.88 156.21 5.54 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.806 0 C-N-CA 128.29 2.636 . . . . 0.0 105.036 175.021 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 55.2 mt-10 -107.15 105.81 15.98 Favored 'General case' 0 CA--C 1.494 -1.18 0 N-CA-C 106.512 -1.662 . . . . 0.0 106.512 -176.478 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 1.7 p -127.49 141.83 45.26 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.981 0 N-CA-C 106.172 -1.788 . . . . 0.0 106.172 -169.808 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 21.2 p90 -156.67 170.79 21.61 Favored 'General case' 0 N--CA 1.436 -1.13 0 N-CA-C 106.95 -1.5 . . . . 0.0 106.95 -162.589 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.463 HG21 ' CE1' ' A' ' 18' ' ' HIS . 0.0 OUTLIER -129.21 120.04 50.36 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.661 0 N-CA-C 103.772 -2.677 . . . . 0.0 103.772 165.461 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 84.9 m -122.87 -21.89 5.43 Favored 'General case' 0 N--CA 1.443 -0.802 0 N-CA-C 106.663 -1.606 . . . . 0.0 106.663 176.912 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -104.38 7.3 35.59 Favored 'General case' 0 N--CA 1.438 -1.066 0 C-N-CA 125.08 1.352 . . . . 0.0 110.23 -168.026 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 30.6 m -108.87 100.35 39.2 Favored Pre-proline 0 C--N 1.36 1.027 0 N-CA-C 107.188 -1.412 . . . . 0.0 107.188 178.107 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -76.53 -80.26 0.01 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.884 0 C-N-CA 123.021 2.481 . . . . 0.0 109.727 170.186 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 10.7 p -140.02 108.23 5.79 Favored 'General case' 0 N--CA 1.433 -1.287 0 N-CA-C 104.617 -2.364 . . . . 0.0 104.617 -179.748 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 73.2 mt-30 -143.79 110.59 5.23 Favored Pre-proline 0 N--CA 1.438 -1.05 0 N-CA-C 104.166 -2.531 . . . . 0.0 104.166 -179.597 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -85.43 -19.1 3.72 Favored 'Trans proline' 0 CA--C 1.504 -0.987 0 C-N-CA 122.722 2.281 . . . . 0.0 111.267 -167.425 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 4.1 t30 -117.73 -33.67 4.45 Favored 'General case' 0 CA--C 1.487 -1.459 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 -170.849 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 67.8 m -103.63 152.12 22.14 Favored 'General case' 0 CA--C 1.495 -1.163 0 N-CA-C 107.092 -1.448 . . . . 0.0 107.092 178.854 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . 0.463 ' CE1' HG21 ' A' ' 8' ' ' ILE . 82.7 t60 -144.61 84.17 9.27 Favored Pre-proline 0 N--CA 1.437 -1.123 0 N-CA-C 106.559 -1.645 . . . . 0.0 106.559 174.651 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -81.75 123.19 4.13 Favored 'Trans proline' 0 N--CA 1.446 -1.294 0 C-N-CA 123.286 2.657 . . . . 0.0 109.765 179.882 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.577 HD11 HD11 ' A' ' 35' ' ' LEU . 3.4 pt -109.81 170.86 2.96 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.069 0 N-CA-C 108.466 -0.939 . . . . 0.0 108.466 -174.962 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 33.6 tt0 -145.92 148.03 32.38 Favored 'General case' 0 N--CA 1.437 -1.076 0 N-CA-C 105.459 -2.052 . . . . 0.0 105.459 172.247 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 19.6 p90 -130.75 158.04 41.18 Favored 'General case' 0 CA--C 1.499 -1.001 0 N-CA-C 106.27 -1.752 . . . . 0.0 106.27 179.491 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 89.6 m-20 -95.47 -179.46 4.77 Favored 'General case' 0 CA--C 1.488 -1.433 0 N-CA-C 103.647 -2.723 . . . . 0.0 103.647 168.89 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -160.08 165.37 17.9 Favored Pre-proline 0 N--CA 1.439 -0.982 0 N-CA-C 104.966 -2.235 . . . . 0.0 104.966 176.851 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -74.63 154.86 44.68 Favored 'Trans proline' 0 N--CA 1.453 -0.874 0 C-N-CA 122.546 2.164 . . . . 0.0 109.711 179.244 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 11.8 tp-100 -82.85 -43.41 0.9 Allowed Pre-proline 0 N--CA 1.443 -0.799 0 CA-C-O 115.924 -1.989 . . . . 0.0 111.219 -174.777 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 70.5 Cg_exo -67.89 167.94 20.09 Favored 'Trans proline' 0 CA--C 1.508 -0.778 0 CA-C-N 125.347 2.945 . . . . 0.0 111.976 174.213 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 34.8 p -72.94 123.18 22.94 Favored 'General case' 0 C--N 1.355 0.836 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 178.949 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 20.0 t-160 -159.58 -51.54 0.06 Allowed 'General case' 0 CA--C 1.493 -1.248 0 N-CA-C 106.729 -1.582 . . . . 0.0 106.729 -169.83 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 48.9 mt -121.6 137.88 53.78 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.119 0 N-CA-C 106.425 -1.695 . . . . 0.0 106.425 -168.842 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 73.5 m -107.33 -82.26 0.55 Allowed 'General case' 0 N--CA 1.432 -1.345 0 C-N-CA 125.025 1.33 . . . . 0.0 108.131 179.953 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 35.0 ttpt -92.25 161.74 14.58 Favored 'General case' 0 CA--C 1.494 -1.196 0 C-N-CA 125.47 1.508 . . . . 0.0 107.731 -165.477 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 90.2 m-85 -128.92 137.01 51.17 Favored 'General case' 0 CA--C 1.497 -1.089 0 N-CA-C 104.686 -2.338 . . . . 0.0 104.686 173.367 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 62.0 mt -116.73 128.81 74.01 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.213 0 N-CA-C 101.611 -3.477 . . . . 0.0 101.611 171.725 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.577 HD11 HD11 ' A' ' 20' ' ' ILE . 3.1 mt -109.02 133.35 53.1 Favored 'General case' 0 CA--C 1.475 -1.908 0 N-CA-C 105.766 -1.939 . . . . 0.0 105.766 171.784 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 16.3 ptp180 -135.96 152.6 51.14 Favored 'General case' 0 N--CA 1.434 -1.259 0 N-CA-C 107.31 -1.367 . . . . 0.0 107.31 173.928 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 48.6 p90 -156.73 153.57 28.62 Favored 'General case' 0 N--CA 1.438 -1.039 0 N-CA-C 107.766 -1.198 . . . . 0.0 107.766 -172.736 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 10.6 ptp180 -149.02 155.78 40.38 Favored Pre-proline 0 CA--C 1.499 -0.988 0 N-CA-C 105.696 -1.964 . . . . 0.0 105.696 168.393 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -72.17 121.25 7.37 Favored 'Trans proline' 0 N--CA 1.452 -0.958 0 C-N-CA 122.876 2.384 . . . . 0.0 108.327 169.797 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 57.5 tttp -70.3 80.01 0.53 Allowed 'General case' 0 C--N 1.357 0.924 0 C-N-CA 126.918 2.087 . . . . 0.0 110.446 -178.182 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 29.9 m120 -155.4 -70.41 0.12 Allowed 'General case' 0 N--CA 1.435 -1.215 0 N-CA-C 102.046 -3.316 . . . . 0.0 102.046 -173.209 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 37.2 p -96.22 157.89 15.69 Favored 'General case' 0 N--CA 1.439 -0.993 0 N-CA-C 107.555 -1.276 . . . . 0.0 107.555 175.139 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 3.3 m -130.62 53.68 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.918 0 N-CA-C 105.789 -1.93 . . . . 0.0 105.789 178.24 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -94.61 -107.73 2.08 Favored Glycine 0 C--N 1.355 1.625 0 N-CA-C 108.017 -2.033 . . . . 0.0 108.017 -179.092 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 8.3 ptm180 -88.8 175.29 7.54 Favored 'General case' 0 CA--C 1.502 -0.874 0 N-CA-C 107.625 -1.25 . . . . 0.0 107.625 174.822 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -157.24 171.3 20.66 Favored 'General case' 0 CA--C 1.492 -1.262 0 CA-C-O 121.393 0.616 . . . . 0.0 110.191 175.199 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 64.9 mttp -109.45 152.29 25.59 Favored 'General case' 0 CA--C 1.486 -1.503 0 N-CA-C 107.469 -1.308 . . . . 0.0 107.469 -172.551 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -152.99 155.42 36.9 Favored 'General case' 0 N--CA 1.434 -1.252 0 N-CA-C 107.74 -1.208 . . . . 0.0 107.74 177.727 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -137.3 156.96 47.64 Favored 'General case' 0 N--CA 1.437 -1.107 0 N-CA-C 105.816 -1.92 . . . . 0.0 105.816 173.539 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 87.3 m -121.12 125.32 46.92 Favored 'General case' 0 CA--C 1.501 -0.93 0 N-CA-C 104.784 -2.302 . . . . 0.0 104.784 -179.585 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 58.5 mt -124.02 132.32 24.29 Favored Pre-proline 0 N--CA 1.439 -1.024 0 N-CA-C 105.039 -2.208 . . . . 0.0 105.039 -164.672 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo -77.95 172.51 15.47 Favored 'Trans proline' 0 N--CA 1.455 -0.794 0 C-N-CA 122.717 2.278 . . . . 0.0 110.558 -179.516 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -96.75 69.56 0.84 Allowed Glycine 0 C--N 1.353 1.486 0 N-CA-C 109.34 -1.504 . . . . 0.0 109.34 178.602 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . 0.646 ' HB2' HD13 ' A' ' 55' ' ' LEU . 27.3 m170 -120.55 -66.43 1.06 Allowed 'General case' 0 CA--C 1.499 -0.986 0 N-CA-C 103.265 -2.865 . . . . 0.0 103.265 174.357 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.647 HD22 ' H ' ' A' ' 55' ' ' LEU . 0.0 OUTLIER -89.69 164.08 14.85 Favored 'General case' 0 N--CA 1.43 -1.471 0 C-N-CA 129.17 2.988 . . . . 0.0 106.856 177.765 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 7.1 p30 -140.11 30.34 2.0 Favored 'General case' 0 N--CA 1.431 -1.399 0 N-CA-C 107.125 -1.435 . . . . 0.0 107.125 -177.567 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 36.5 p -139.8 149.12 43.13 Favored 'General case' 0 CA--C 1.501 -0.937 0 N-CA-C 106.809 -1.552 . . . . 0.0 106.809 177.321 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 10.3 t80 -128.37 175.99 8.06 Favored 'General case' 0 C--N 1.358 0.973 0 N-CA-C 107.92 -1.141 . . . . 0.0 107.92 179.764 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 97.7 m -138.5 109.25 6.65 Favored 'General case' 0 N--CA 1.432 -1.344 0 N-CA-C 104.081 -2.562 . . . . 0.0 104.081 173.113 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 27.4 mt -87.9 147.54 5.19 Favored 'Isoleucine or valine' 0 C--N 1.358 0.969 0 N-CA-C 103.427 -2.805 . . . . 0.0 103.427 169.696 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 8.7 ptpp? -150.1 162.83 39.66 Favored 'General case' 0 CA--C 1.497 -1.067 0 N-CA-C 108.169 -1.048 . . . . 0.0 108.169 179.366 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 83.63 51.03 4.21 Favored Glycine 0 C--N 1.354 1.575 0 N-CA-C 109.367 -1.493 . . . . 0.0 109.367 177.768 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 62.7 mt -120.34 177.44 5.03 Favored 'General case' 0 CA--C 1.5 -0.954 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 -171.59 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -122.79 152.88 63.1 Favored Pre-proline 0 N--CA 1.44 -0.952 0 N-CA-C 106.46 -1.681 . . . . 0.0 106.46 -175.765 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -79.72 163.74 23.59 Favored 'Trans proline' 0 N--CA 1.451 -0.992 0 C-N-CA 122.976 2.451 . . . . 0.0 110.62 175.312 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 0.578 ' H ' ' HA ' ' A' ' 92' ' ' THR . . . 58.64 26.16 59.57 Favored Glycine 0 C--N 1.356 1.657 0 C-N-CA 128.207 2.813 . . . . 0.0 116.28 171.966 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 8.6 p -126.41 147.5 31.24 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.977 0 N-CA-C 107.625 -1.25 . . . . 0.0 107.625 -176.988 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 5.1 p -96.02 138.14 22.2 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.945 0 N-CA-C 107.323 -1.362 . . . . 0.0 107.323 -178.114 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 88.6 m-85 -119.13 151.63 37.95 Favored 'General case' 0 N--CA 1.436 -1.157 0 N-CA-C 105.638 -1.986 . . . . 0.0 105.638 175.335 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -101.53 141.72 33.98 Favored 'General case' 0 CA--C 1.497 -1.095 0 N-CA-C 104.743 -2.317 . . . . 0.0 104.743 162.114 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -135.88 150.01 20.23 Favored Glycine 0 CA--C 1.488 -1.608 0 N-CA-C 107.701 -2.16 . . . . 0.0 107.701 -179.576 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 31.1 mt-30 -141.6 133.43 27.31 Favored 'General case' 0 CA--C 1.485 -1.545 0 N-CA-C 106.019 -1.845 . . . . 0.0 106.019 -177.628 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 23.2 tp -115.33 99.77 7.63 Favored 'General case' 0 N--CA 1.439 -1.01 0 N-CA-C 104.249 -2.5 . . . . 0.0 104.249 -178.339 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 11.7 mt -92.43 127.33 44.68 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.812 0 N-CA-C 104.502 -2.407 . . . . 0.0 104.502 179.767 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 10.3 p -114.98 111.66 21.49 Favored 'General case' 0 N--CA 1.436 -1.141 0 N-CA-C 107.593 -1.262 . . . . 0.0 107.593 -173.904 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 10.4 mm -94.79 150.81 3.96 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.298 0 N-CA-C 106.116 -1.809 . . . . 0.0 106.116 -167.195 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 6.4 pt20 -117.69 137.27 52.78 Favored 'General case' 0 CA--C 1.495 -1.155 0 N-CA-C 105.467 -2.049 . . . . 0.0 105.467 169.654 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 63.4 tp60 -69.02 117.89 11.23 Favored 'General case' 0 N--CA 1.441 -0.918 0 C-N-CA 124.107 0.963 . . . . 0.0 111.566 -167.019 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 36.1 m-85 59.09 49.95 8.73 Favored 'General case' 0 C--N 1.357 0.902 0 C-N-CA 126.971 2.108 . . . . 0.0 112.013 -177.918 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -158.72 -122.53 0.68 Allowed Glycine 0 N--CA 1.432 -1.623 0 N-CA-C 108.193 -1.963 . . . . 0.0 108.193 177.499 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 79.8 m-70 -86.58 177.87 7.25 Favored 'General case' 0 CA--C 1.498 -1.035 0 C-N-CA 125.34 1.456 . . . . 0.0 111.07 -169.479 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 26.6 mp0 -133.31 140.21 47.31 Favored 'General case' 0 N--CA 1.436 -1.173 0 N-CA-C 103.608 -2.738 . . . . 0.0 103.608 168.898 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 30.6 tt0 -119.25 137.73 53.47 Favored 'General case' 0 CA--C 1.496 -1.102 0 N-CA-C 103.948 -2.612 . . . . 0.0 103.948 177.915 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 6.3 p -117.1 136.01 55.63 Favored 'Isoleucine or valine' 0 C--N 1.354 0.775 0 N-CA-C 107.914 -1.143 . . . . 0.0 107.914 -177.065 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 63.6 m -116.73 140.15 49.75 Favored 'General case' 0 N--CA 1.441 -0.921 0 N-CA-C 103.067 -2.938 . . . . 0.0 103.067 173.464 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 79.2 mtt85 -128.09 152.05 48.46 Favored 'General case' 0 CA--C 1.5 -0.953 0 N-CA-C 109.195 -0.669 . . . . 0.0 109.195 177.331 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 30.7 p90 -163.81 175.79 10.13 Favored 'General case' 0 C--N 1.355 0.82 0 N-CA-C 107.796 -1.187 . . . . 0.0 107.796 -178.445 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 51.5 m-20 -133.53 154.11 51.1 Favored 'General case' 0 CA--C 1.502 -0.875 0 N-CA-C 105.715 -1.957 . . . . 0.0 105.715 169.553 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 22.1 p90 -142.94 169.36 17.72 Favored 'General case' 0 CA--C 1.487 -1.454 0 N-CA-C 107.765 -1.198 . . . . 0.0 107.765 171.095 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 27.5 p -121.89 143.26 49.54 Favored 'General case' 0 CA--C 1.501 -0.934 0 N-CA-C 105.733 -1.951 . . . . 0.0 105.733 170.754 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 45.1 m -114.02 125.63 54.21 Favored 'General case' 0 CA--C 1.497 -1.059 0 N-CA-C 102.499 -3.148 . . . . 0.0 102.499 170.953 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . 0.578 ' HA ' ' H ' ' A' ' 66' ' ' GLY . 13.2 t -143.86 161.61 38.23 Favored 'General case' 0 N--CA 1.441 -0.907 0 N-CA-C 107.365 -1.346 . . . . 0.0 107.365 -171.523 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 50.8 p . . . . . 0 C--O 1.261 1.686 0 C-N-CA 124.837 1.255 . . . . 0.0 109.361 -179.103 . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 22.4 t . . . . . 0 N--CA 1.484 1.244 0 CA-C-O 121.64 0.733 . . . . 0.0 110.315 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -164.07 -169.66 27.9 Favored Glycine 0 N--CA 1.436 -1.355 0 N-CA-C 105.702 -2.959 . . . . 0.0 105.702 177.652 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_exo -60.34 132.22 42.61 Favored 'Trans proline' 0 N--CA 1.447 -1.264 0 C-N-CA 123.601 2.867 . . . . 0.0 111.125 -178.05 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 20.2 t -77.95 153.98 5.23 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.925 0 C-N-CA 127.095 2.158 . . . . 0.0 106.273 -172.792 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -96.12 85.67 4.07 Favored 'General case' 0 CA--C 1.49 -1.328 0 N-CA-C 107.377 -1.342 . . . . 0.0 107.377 -176.887 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.44 ' HA ' ' HA ' ' A' ' 22' ' ' TRP . 1.8 p -100.06 120.73 49.88 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.169 0 N-CA-C 106.484 -1.673 . . . . 0.0 106.484 -170.578 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 48.4 m-85 -94.57 96.38 9.41 Favored 'General case' 0 CA--C 1.495 -1.161 0 N-CA-C 106.923 -1.51 . . . . 0.0 106.923 -168.318 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 32.0 mm -103.04 96.36 4.57 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.264 0 N-CA-C 103.502 -2.777 . . . . 0.0 103.502 176.357 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 40.5 p -78.82 -32.79 46.39 Favored 'General case' 0 N--CA 1.442 -0.833 0 CA-C-N 114.501 -1.227 . . . . 0.0 108.567 178.501 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.473 ' HG3' ' H ' ' A' ' 90' ' ' THR . 25.8 tt0 67.35 54.05 0.73 Allowed 'General case' 0 C--N 1.358 0.956 0 C-N-CA 126.369 1.867 . . . . 0.0 109.726 175.608 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 2.2 p -152.07 81.45 5.67 Favored Pre-proline 0 N--CA 1.441 -0.885 0 N-CA-C 103.469 -2.789 . . . . 0.0 103.469 177.096 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -75.0 -39.24 1.26 Allowed 'Trans proline' 0 N--CA 1.453 -0.903 0 C-N-CA 122.183 1.922 . . . . 0.0 110.536 -176.595 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 23.1 m 60.92 29.21 18.88 Favored 'General case' 0 C--N 1.361 1.071 0 C-N-CA 127.323 2.249 . . . . 0.0 112.904 -179.767 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 83.5 mt-30 -150.23 141.0 14.45 Favored Pre-proline 0 N--CA 1.44 -0.969 0 N-CA-C 105.004 -2.221 . . . . 0.0 105.004 -175.69 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 64.6 Cg_endo -82.47 -29.14 1.55 Allowed 'Trans proline' 0 CA--C 1.506 -0.919 0 C-N-CA 122.584 2.19 . . . . 0.0 111.792 -161.648 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 1.9 m-80 -124.53 -20.22 5.19 Favored 'General case' 0 CA--C 1.491 -1.292 0 C-N-CA 124.128 0.971 . . . . 0.0 109.284 -169.016 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 5.7 p -108.52 134.91 50.64 Favored 'General case' 0 CA--C 1.495 -1.172 0 N-CA-C 107.714 -1.217 . . . . 0.0 107.714 -176.563 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 58.7 t-80 -122.8 98.2 43.15 Favored Pre-proline 0 N--CA 1.441 -0.906 0 N-CA-C 106.978 -1.49 . . . . 0.0 106.978 178.027 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 63.4 Cg_endo -80.05 127.15 6.72 Favored 'Trans proline' 0 N--CA 1.449 -1.107 0 C-N-CA 123.073 2.515 . . . . 0.0 109.873 177.635 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 2.1 pt -110.74 166.26 5.56 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.031 0 N-CA-C 107.153 -1.425 . . . . 0.0 107.153 174.365 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 32.3 mt-30 -138.51 160.09 40.45 Favored 'General case' 0 CA--C 1.497 -1.084 0 N-CA-C 105.286 -2.116 . . . . 0.0 105.286 167.68 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 22' ' ' TRP . . . . . 0.44 ' HA ' ' HA ' ' A' ' 6' ' ' VAL . 48.8 p90 -145.1 169.57 17.89 Favored 'General case' 0 CA--C 1.498 -1.054 0 N-CA-C 107.488 -1.301 . . . . 0.0 107.488 173.209 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 44.8 t30 -146.69 136.49 23.21 Favored 'General case' 0 CA--C 1.484 -1.575 0 N-CA-C 106.548 -1.649 . . . . 0.0 106.548 174.449 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -82.78 167.64 28.37 Favored Pre-proline 0 N--CA 1.439 -0.991 0 CA-C-N 112.793 -2.003 . . . . 0.0 111.681 -160.944 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 76.7 Cg_exo -66.16 176.29 4.04 Favored 'Trans proline' 0 N--CA 1.456 -0.68 0 C-N-CA 123.826 3.017 . . . . 0.0 111.752 165.107 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 1.3 tm0? -79.18 -46.04 1.68 Allowed Pre-proline 0 N--CA 1.443 -0.805 0 CA-C-O 115.544 -2.17 . . . . 0.0 110.496 -175.728 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 75.6 Cg_exo -66.53 148.0 83.02 Favored 'Trans proline' 0 CA--C 1.51 -0.721 0 CA-C-N 125.792 3.104 . . . . 0.0 111.969 177.147 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 69.6 m -100.85 63.19 1.03 Allowed 'General case' 0 CA--C 1.502 -0.889 0 N-CA-C 106.778 -1.564 . . . . 0.0 106.778 178.554 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 79.8 t60 -110.36 -1.59 17.09 Favored 'General case' 0 N--CA 1.44 -0.962 0 C-N-CA 125.322 1.449 . . . . 0.0 107.844 179.57 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 3.7 mp -100.16 126.28 53.71 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.115 0 N-CA-C 103.807 -2.664 . . . . 0.0 103.807 -177.639 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 60.5 m -95.43 -84.25 0.34 Allowed 'General case' 0 N--CA 1.431 -1.417 0 N-CA-C 106.153 -1.795 . . . . 0.0 106.153 177.232 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 53.7 mtmt -91.05 169.19 11.08 Favored 'General case' 0 CA--C 1.49 -1.358 0 C-N-CA 123.419 0.687 . . . . 0.0 109.24 -167.871 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 97.4 m-85 -126.87 133.82 50.62 Favored 'General case' 0 N--CA 1.435 -1.222 0 N-CA-C 103.048 -2.945 . . . . 0.0 103.048 164.108 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 51.1 mt -118.31 126.95 75.42 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.179 0 N-CA-C 102.398 -3.186 . . . . 0.0 102.398 173.804 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 7.0 mt -105.99 137.85 43.19 Favored 'General case' 0 CA--C 1.473 -2.003 0 N-CA-C 105.326 -2.101 . . . . 0.0 105.326 173.716 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -132.96 155.64 48.76 Favored 'General case' 0 N--CA 1.431 -1.422 0 N-CA-C 106.808 -1.553 . . . . 0.0 106.808 166.881 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 48.4 p90 -152.19 142.36 22.33 Favored 'General case' 0 N--CA 1.436 -1.132 0 N-CA-C 105.999 -1.852 . . . . 0.0 105.999 -177.352 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 45.4 ttm-85 -132.69 141.88 42.74 Favored Pre-proline 0 CA--C 1.5 -0.974 0 N-CA-C 103.991 -2.596 . . . . 0.0 103.991 179.578 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_endo -71.65 122.78 8.87 Favored 'Trans proline' 0 N--CA 1.452 -0.947 0 CA-C-N 123.683 2.351 . . . . 0.0 108.523 171.917 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 19.6 ttmm -71.58 63.92 0.43 Allowed 'General case' 0 C--N 1.358 0.963 0 C-N-CA 127.319 2.248 . . . . 0.0 111.767 -179.071 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 7.7 p30 -161.43 15.48 0.1 Allowed 'General case' 0 N--CA 1.438 -1.045 0 C-N-CA 125.292 1.437 . . . . 0.0 107.881 177.069 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 43.0 p -160.46 165.72 30.49 Favored 'General case' 0 N--CA 1.437 -1.102 0 N-CA-C 106.458 -1.682 . . . . 0.0 106.458 -175.897 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 4.9 m -137.73 40.73 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.845 0 N-CA-C 105.808 -1.923 . . . . 0.0 105.808 176.026 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -91.4 -114.92 1.92 Allowed Glycine 0 C--N 1.356 1.661 0 N-CA-C 109.071 -1.612 . . . . 0.0 109.071 -175.494 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 11.9 ptm180 -97.99 178.96 4.94 Favored 'General case' 0 CA--C 1.503 -0.861 0 N-CA-C 107.198 -1.408 . . . . 0.0 107.198 174.234 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -153.83 171.7 18.52 Favored 'General case' 0 N--CA 1.435 -1.206 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 176.363 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 96.7 mttt -110.34 157.13 19.84 Favored 'General case' 0 CA--C 1.489 -1.401 0 N-CA-C 107.291 -1.374 . . . . 0.0 107.291 -172.06 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 1.2 pp20? -150.64 160.62 43.7 Favored 'General case' 0 N--CA 1.437 -1.098 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 173.929 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -138.1 159.86 40.92 Favored 'General case' 0 N--CA 1.439 -0.98 0 N-CA-C 106.191 -1.781 . . . . 0.0 106.191 171.086 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 85.7 m -117.61 123.39 46.07 Favored 'General case' 0 CA--C 1.501 -0.933 0 N-CA-C 104.642 -2.355 . . . . 0.0 104.642 176.218 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 5.4 mp -112.8 133.59 21.9 Favored Pre-proline 0 N--CA 1.438 -1.063 0 N-CA-C 104.837 -2.283 . . . . 0.0 104.837 -174.076 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 64.3 Cg_exo -65.3 166.27 19.75 Favored 'Trans proline' 0 CA--C 1.509 -0.749 0 C-N-CA 123.185 2.59 . . . . 0.0 113.512 176.86 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -75.76 -19.18 79.23 Favored Glycine 0 C--N 1.353 1.491 0 C-N-CA 123.876 0.75 . . . . 0.0 114.245 -175.195 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 53.2 p-80 -83.05 -26.27 31.3 Favored 'General case' 0 C--N 1.356 0.851 0 CA-C-N 118.012 0.906 . . . . 0.0 109.835 -178.846 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 85.1 mt -88.58 128.92 35.58 Favored 'General case' 0 CA--C 1.5 -0.978 0 N-CA-C 107.441 -1.318 . . . . 0.0 107.441 175.605 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 8.0 p30 -117.46 10.61 13.62 Favored 'General case' 0 CA--C 1.502 -0.88 0 C-N-CA 124.083 0.953 . . . . 0.0 109.713 -173.313 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 29.1 p -142.17 161.35 38.24 Favored 'General case' 0 CA--C 1.498 -1.029 0 N-CA-C 106.537 -1.653 . . . . 0.0 106.537 179.291 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 11.1 t80 -140.56 162.2 35.93 Favored 'General case' 0 CA--C 1.499 -0.996 0 CA-C-O 121.849 0.833 . . . . 0.0 108.99 177.805 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 37.8 m -126.1 111.97 15.29 Favored 'General case' 0 N--CA 1.434 -1.243 0 N-CA-C 105.499 -2.037 . . . . 0.0 105.499 169.842 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 37.9 mt -84.75 140.71 15.64 Favored 'Isoleucine or valine' 0 C--N 1.357 0.897 0 N-CA-C 103.67 -2.715 . . . . 0.0 103.67 172.791 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 94.3 mttt -141.4 162.13 36.24 Favored 'General case' 0 CA--C 1.491 -1.3 0 CA-C-O 121.859 0.838 . . . . 0.0 108.881 -177.451 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 75.27 55.09 5.31 Favored Glycine 0 CA--C 1.489 -1.574 0 N-CA-C 108.937 -1.665 . . . . 0.0 108.937 176.63 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 62.3 mt -115.49 -174.22 2.48 Favored 'General case' 0 CA--C 1.5 -0.96 0 N-CA-C 107.547 -1.279 . . . . 0.0 107.547 -176.124 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 94.0 mttt -109.38 160.88 26.05 Favored Pre-proline 0 N--CA 1.441 -0.886 0 N-CA-C 106.091 -1.818 . . . . 0.0 106.091 -177.366 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -81.38 158.0 19.65 Favored 'Trans proline' 0 N--CA 1.45 -1.062 0 C-N-CA 122.764 2.309 . . . . 0.0 109.538 165.472 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 59.18 28.24 63.85 Favored Glycine 0 C--N 1.358 1.752 0 C-N-CA 126.947 2.213 . . . . 0.0 116.273 171.794 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 7.1 p -115.48 142.82 27.04 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.963 0 N-CA-C 107.803 -1.184 . . . . 0.0 107.803 -173.286 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 3.5 p -100.86 131.52 48.32 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.894 0 N-CA-C 106.423 -1.695 . . . . 0.0 106.423 173.594 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 90.0 m-85 -114.31 150.68 34.11 Favored 'General case' 0 N--CA 1.44 -0.946 0 N-CA-C 106.537 -1.653 . . . . 0.0 106.537 174.414 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -94.29 145.37 24.78 Favored 'General case' 0 CA--C 1.5 -0.961 0 N-CA-C 104.369 -2.456 . . . . 0.0 104.369 159.728 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -137.32 155.23 22.8 Favored Glycine 0 CA--C 1.485 -1.844 0 N-CA-C 108.192 -1.963 . . . . 0.0 108.192 -177.518 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 27.5 tt0 -151.34 135.13 16.43 Favored 'General case' 0 CA--C 1.485 -1.532 0 N-CA-C 106.478 -1.675 . . . . 0.0 106.478 -176.791 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 25.2 tp -123.87 97.86 5.55 Favored 'General case' 0 N--CA 1.434 -1.245 0 N-CA-C 104.556 -2.387 . . . . 0.0 104.556 -172.927 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 10.5 mt -91.83 138.63 19.39 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.853 0 N-CA-C 105.252 -2.129 . . . . 0.0 105.252 177.666 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 75.0 m -112.59 112.07 23.34 Favored 'General case' 0 N--CA 1.434 -1.233 0 N-CA-C 106.313 -1.736 . . . . 0.0 106.313 178.935 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 1.7 mp -89.49 134.17 29.47 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.217 0 N-CA-C 103.645 -2.724 . . . . 0.0 103.645 -173.058 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 79.0 mt-30 -99.37 160.13 14.5 Favored 'General case' 0 CA--C 1.494 -1.197 0 N-CA-C 106.704 -1.591 . . . . 0.0 106.704 -174.087 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 5.6 pt20 -69.09 110.27 4.43 Favored 'General case' 0 N--CA 1.441 -0.904 0 CA-C-O 121.982 0.896 . . . . 0.0 112.761 -170.947 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 75.6 m-85 53.95 40.86 32.04 Favored 'General case' 0 C--N 1.358 0.949 0 C-N-CA 127.834 2.454 . . . . 0.0 112.925 175.094 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -163.17 -114.94 0.32 Allowed Glycine 0 C--N 1.353 1.502 0 C-N-CA 119.324 -1.417 . . . . 0.0 109.808 -179.304 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 38.5 m170 -81.61 -175.85 5.75 Favored 'General case' 0 CA--C 1.498 -1.052 0 C-N-CA 125.05 1.34 . . . . 0.0 110.745 -167.324 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 4.8 pt20 -147.85 142.06 26.15 Favored 'General case' 0 N--CA 1.434 -1.238 0 N-CA-C 106.192 -1.781 . . . . 0.0 106.192 171.826 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 16.7 tp10 -110.7 139.46 45.97 Favored 'General case' 0 CA--C 1.496 -1.099 0 N-CA-C 105.823 -1.917 . . . . 0.0 105.823 -177.762 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 8.2 p -110.64 141.61 25.47 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.745 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 -174.48 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 36.2 m -130.15 129.24 43.22 Favored 'General case' 0 C--N 1.355 0.831 0 N-CA-C 102.832 -3.025 . . . . 0.0 102.832 175.67 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 18.7 ptp180 -134.71 154.48 51.54 Favored 'General case' 0 C--N 1.355 0.819 0 CA-C-N 119.912 1.233 . . . . 0.0 111.25 -176.256 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 18.7 p90 -165.26 -175.22 3.53 Favored 'General case' 0 C--N 1.359 1.0 0 N-CA-C 107.064 -1.458 . . . . 0.0 107.064 -169.517 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -140.15 159.46 42.14 Favored 'General case' 0 N--CA 1.443 -0.795 0 N-CA-C 107.029 -1.471 . . . . 0.0 107.029 166.735 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 20.7 p90 -144.83 169.23 18.43 Favored 'General case' 0 CA--C 1.492 -1.276 0 N-CA-C 107.723 -1.214 . . . . 0.0 107.723 174.103 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . 0.473 ' H ' ' HG3' ' A' ' 10' ' ' GLU . 88.7 m -126.49 135.74 51.73 Favored 'General case' 0 CA--C 1.5 -0.971 0 N-CA-C 104.004 -2.591 . . . . 0.0 104.004 176.194 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 76.9 m -107.56 107.53 18.41 Favored 'General case' 0 CA--C 1.497 -1.064 0 N-CA-C 105.126 -2.176 . . . . 0.0 105.126 178.699 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 5.7 m 75.91 145.01 0.08 Allowed 'General case' 0 C--N 1.359 1.006 0 C-N-CA 127.213 2.205 . . . . 0.0 110.387 173.515 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 24.3 m . . . . . 0 C--O 1.259 1.604 0 C-N-CA 125.597 1.559 . . . . 0.0 109.785 -178.825 . . . . . . . . 0 0 . 1 . 022 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 22.8 t . . . . . 0 N--CA 1.481 1.108 0 N-CA-C 109.214 -0.662 . . . . 0.0 109.214 . . . . . . . . . 0 0 . 1 . 022 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -160.96 -153.52 7.02 Favored Glycine 0 C--N 1.352 1.462 0 N-CA-C 106.902 -2.479 . . . . 0.0 106.902 -176.832 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 74.8 Cg_exo -60.93 135.82 61.84 Favored 'Trans proline' 0 N--CA 1.445 -1.33 0 C-N-CA 123.401 2.734 . . . . 0.0 112.865 -176.638 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 32.1 t -79.12 157.46 4.75 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.06 0 C-N-CA 128.078 2.551 . . . . 0.0 107.348 -175.891 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 -105.48 102.26 11.74 Favored 'General case' 0 CA--C 1.491 -1.295 0 N-CA-C 105.197 -2.149 . . . . 0.0 105.197 176.78 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 1.7 p -117.46 134.66 60.33 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.114 0 N-CA-C 106.509 -1.663 . . . . 0.0 106.509 -166.762 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -121.04 170.34 9.62 Favored 'General case' 0 N--CA 1.434 -1.234 0 N-CA-C 106.975 -1.491 . . . . 0.0 106.975 -169.022 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.497 HD12 ' HE1' ' A' ' 18' ' ' HIS . 42.1 mm -118.82 152.56 21.06 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.903 0 N-CA-C 103.114 -2.921 . . . . 0.0 103.114 176.745 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 56.8 p -74.88 -176.45 2.9 Favored 'General case' 0 N--CA 1.446 -0.654 0 C-N-CA 124.688 1.195 . . . . 0.0 111.438 -171.325 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 22.3 pt-20 -102.49 24.41 10.44 Favored 'General case' 0 N--CA 1.44 -0.945 0 C-N-CA 124.898 1.279 . . . . 0.0 110.167 -169.605 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 25.7 p -83.58 120.93 76.14 Favored Pre-proline 0 C--N 1.357 0.897 0 N-CA-C 107.43 -1.322 . . . . 0.0 107.43 179.489 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_endo -77.99 -36.94 0.94 Allowed 'Trans proline' 0 CA--C 1.508 -0.817 0 C-N-CA 122.56 2.173 . . . . 0.0 110.535 -170.652 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 62.4 m -144.65 110.28 5.3 Favored 'General case' 0 CA--C 1.491 -1.303 0 N-CA-C 104.023 -2.584 . . . . 0.0 104.023 177.552 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 2.7 pm0 -98.36 153.79 37.88 Favored Pre-proline 0 N--CA 1.437 -1.082 0 N-CA-C 105.562 -2.014 . . . . 0.0 105.562 177.628 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -83.42 -76.09 0.0 OUTLIER 'Trans proline' 0 N--CA 1.45 -1.074 0 CA-C-N 122.764 2.023 . . . . 0.0 109.224 -177.326 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 58.1 m-20 -133.37 -6.14 2.96 Favored 'General case' 0 N--CA 1.434 -1.259 0 C-N-CA 127.256 2.223 . . . . 0.0 108.63 -171.965 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 70.9 m -92.57 154.64 18.29 Favored 'General case' 0 CA--C 1.496 -1.128 0 N-CA-C 105.793 -1.928 . . . . 0.0 105.793 174.777 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . 0.497 ' HE1' HD12 ' A' ' 8' ' ' ILE . 46.7 t-80 -147.3 90.72 5.23 Favored Pre-proline 0 N--CA 1.437 -1.099 0 N-CA-C 107.436 -1.32 . . . . 0.0 107.436 172.769 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -80.42 139.47 12.96 Favored 'Trans proline' 0 N--CA 1.446 -1.295 0 C-N-CA 122.705 2.27 . . . . 0.0 110.135 177.594 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.447 HD11 HD11 ' A' ' 35' ' ' LEU . 4.4 pt -122.49 175.24 5.83 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.055 0 N-CA-C 108.147 -1.057 . . . . 0.0 108.147 177.871 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . 0.425 ' HA ' ' HA ' ' A' ' 57' ' ' SER . 2.7 pt20 -151.31 155.23 38.31 Favored 'General case' 0 CA--C 1.498 -1.045 0 N-CA-C 105.733 -1.951 . . . . 0.0 105.733 176.27 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 33.5 p90 -142.31 162.52 35.26 Favored 'General case' 0 CA--C 1.501 -0.915 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 -175.872 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 61.8 t30 -98.94 -172.51 2.3 Favored 'General case' 0 CA--C 1.493 -1.222 0 N-CA-C 103.658 -2.719 . . . . 0.0 103.658 169.486 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -158.0 168.46 12.41 Favored Pre-proline 0 N--CA 1.44 -0.974 0 N-CA-C 106.471 -1.677 . . . . 0.0 106.471 168.694 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_exo -63.39 154.33 68.97 Favored 'Trans proline' 0 N--CA 1.454 -0.816 0 C-N-CA 123.244 2.63 . . . . 0.0 112.506 173.487 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 90.4 mm-40 -81.77 -35.51 0.75 Allowed Pre-proline 0 N--CA 1.443 -0.799 0 CA-C-O 115.148 -2.358 . . . . 0.0 114.208 -168.096 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_exo -70.83 -4.2 14.26 Favored 'Trans proline' 0 CA--C 1.512 -0.619 0 CA-C-N 126.1 3.214 . . . . 0.0 114.615 -177.809 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 8.7 t 68.38 59.55 0.41 Allowed 'General case' 0 C--N 1.359 0.986 0 C-N-CA 126.121 1.768 . . . . 0.0 108.886 -177.345 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 12.7 t-160 -94.41 -11.28 30.17 Favored 'General case' 0 N--CA 1.439 -0.991 0 C-N-CA 125.133 1.373 . . . . 0.0 108.034 -179.332 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 1.8 mp -111.56 137.36 44.46 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.949 0 N-CA-C 104.473 -2.417 . . . . 0.0 104.473 -175.099 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 62.2 m -100.06 -84.4 0.42 Allowed 'General case' 0 N--CA 1.432 -1.331 0 N-CA-C 106.823 -1.547 . . . . 0.0 106.823 171.093 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 55.4 mtmt -88.64 168.71 12.3 Favored 'General case' 0 CA--C 1.487 -1.457 0 C-N-CA 124.335 1.054 . . . . 0.0 109.447 -164.531 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 85.0 m-85 -130.26 135.0 47.65 Favored 'General case' 0 CA--C 1.495 -1.14 0 N-CA-C 103.978 -2.601 . . . . 0.0 103.978 170.252 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 42.0 mt -119.35 128.69 75.84 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.162 0 N-CA-C 101.913 -3.365 . . . . 0.0 101.913 174.515 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.447 HD11 HD11 ' A' ' 20' ' ' ILE . 4.2 mt -110.02 143.75 39.57 Favored 'General case' 0 CA--C 1.471 -2.084 0 N-CA-C 106.906 -1.516 . . . . 0.0 106.906 175.275 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 2.6 mpt_? -125.86 157.19 38.24 Favored 'General case' 0 N--CA 1.425 -1.705 0 N-CA-C 106.456 -1.683 . . . . 0.0 106.456 168.592 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 45.1 p90 -149.12 139.03 21.99 Favored 'General case' 0 N--CA 1.433 -1.321 0 N-CA-C 106.291 -1.744 . . . . 0.0 106.291 169.224 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 19.1 ttm180 -133.26 136.57 27.51 Favored Pre-proline 0 CA--C 1.495 -1.156 0 N-CA-C 104.206 -2.516 . . . . 0.0 104.206 179.103 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -71.0 114.72 3.99 Favored 'Trans proline' 0 N--CA 1.454 -0.846 0 CA-C-N 124.581 2.672 . . . . 0.0 108.495 175.02 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 54.4 tttp -70.89 72.26 0.55 Allowed 'General case' 0 C--N 1.359 0.992 0 C-N-CA 127.609 2.364 . . . . 0.0 111.467 -174.724 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 70.4 m-80 -154.05 -60.95 0.13 Allowed 'General case' 0 N--CA 1.434 -1.245 0 N-CA-C 101.532 -3.507 . . . . 0.0 101.532 -172.176 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 42.5 p -93.4 160.19 14.92 Favored 'General case' 0 N--CA 1.439 -0.99 0 C-N-CA 124.854 1.262 . . . . 0.0 107.65 173.175 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 5.9 m -126.33 44.87 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.842 0 N-CA-C 106.183 -1.784 . . . . 0.0 106.183 177.975 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -99.4 -128.54 6.27 Favored Glycine 0 C--N 1.355 1.593 0 N-CA-C 108.704 -1.759 . . . . 0.0 108.704 -177.547 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 83.9 mtt85 -84.51 168.18 15.67 Favored 'General case' 0 CA--C 1.502 -0.885 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 -179.072 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -151.83 173.26 14.99 Favored 'General case' 0 CA--C 1.494 -1.205 0 CA-C-O 121.506 0.669 . . . . 0.0 110.051 -172.981 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 36.9 mtmt -112.62 156.85 22.02 Favored 'General case' 0 CA--C 1.488 -1.427 0 N-CA-C 106.789 -1.56 . . . . 0.0 106.789 -173.001 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 16.3 pt-20 -152.28 160.66 43.31 Favored 'General case' 0 N--CA 1.436 -1.17 0 N-CA-C 108.666 -0.865 . . . . 0.0 108.666 178.698 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -140.19 163.02 33.87 Favored 'General case' 0 CA--C 1.498 -1.021 0 N-CA-C 107.102 -1.444 . . . . 0.0 107.102 171.434 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 90.5 m -121.31 126.23 48.98 Favored 'General case' 0 CA--C 1.501 -0.912 0 N-CA-C 104.691 -2.336 . . . . 0.0 104.691 175.344 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 5.2 mp -114.86 133.76 22.56 Favored Pre-proline 0 N--CA 1.437 -1.081 0 N-CA-C 105.121 -2.178 . . . . 0.0 105.121 -174.055 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_exo -64.09 165.59 18.89 Favored 'Trans proline' 0 CA--C 1.509 -0.759 0 C-N-CA 123.39 2.727 . . . . 0.0 113.812 177.127 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -77.71 -16.99 79.46 Favored Glycine 0 C--N 1.353 1.483 0 C-N-CA 123.869 0.747 . . . . 0.0 113.884 -172.887 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 51.8 p-80 -83.98 -24.98 30.37 Favored 'General case' 0 C--N 1.356 0.857 0 CA-C-N 117.975 0.887 . . . . 0.0 110.32 -179.643 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 88.2 mt -88.29 129.36 35.4 Favored 'General case' 0 CA--C 1.5 -0.955 0 N-CA-C 108.299 -1.0 . . . . 0.0 108.299 178.906 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 8.6 p30 -105.23 -1.09 25.77 Favored 'General case' 0 N--CA 1.442 -0.837 0 C-N-CA 124.909 1.284 . . . . 0.0 110.782 -173.918 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.425 ' HA ' ' HA ' ' A' ' 21' ' ' GLN . 30.5 p -139.42 159.29 42.5 Favored 'General case' 0 CA--C 1.497 -1.069 0 N-CA-C 107.575 -1.269 . . . . 0.0 107.575 -174.974 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 6.1 t80 -128.75 174.5 9.39 Favored 'General case' 0 C--N 1.36 1.055 0 N-CA-C 107.858 -1.164 . . . . 0.0 107.858 175.94 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 99.9 m -140.15 110.74 6.75 Favored 'General case' 0 N--CA 1.431 -1.406 0 N-CA-C 103.923 -2.621 . . . . 0.0 103.923 171.466 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 25.4 mt -87.5 148.74 4.39 Favored 'Isoleucine or valine' 0 C--N 1.358 0.958 0 N-CA-C 103.878 -2.638 . . . . 0.0 103.878 170.3 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 8.4 ptpp? -150.02 159.51 44.34 Favored 'General case' 0 CA--C 1.492 -1.255 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 178.18 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 78.94 54.87 3.98 Favored Glycine 0 C--N 1.355 1.591 0 N-CA-C 109.184 -1.566 . . . . 0.0 109.184 178.841 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 58.8 mt -116.11 -161.11 0.78 Allowed 'General case' 0 CA--C 1.502 -0.888 0 N-CA-C 106.84 -1.541 . . . . 0.0 106.84 -177.322 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 10.7 mptt -125.12 160.99 52.14 Favored Pre-proline 0 N--CA 1.442 -0.874 0 N-CA-C 105.684 -1.969 . . . . 0.0 105.684 -176.361 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -79.57 156.2 24.7 Favored 'Trans proline' 0 N--CA 1.452 -0.918 0 C-N-CA 123.035 2.49 . . . . 0.0 109.567 165.273 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 55.32 33.24 58.11 Favored Glycine 0 C--N 1.356 1.656 0 C-N-CA 127.514 2.483 . . . . 0.0 116.512 172.276 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 7.9 p -115.04 147.3 18.53 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.014 0 N-CA-C 107.282 -1.377 . . . . 0.0 107.282 -176.366 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 4.7 p -102.47 134.12 44.21 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.778 0 N-CA-C 106.636 -1.616 . . . . 0.0 106.636 174.577 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 81.8 m-85 -116.9 150.51 38.35 Favored 'General case' 0 N--CA 1.44 -0.936 0 N-CA-C 107.225 -1.398 . . . . 0.0 107.225 174.323 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 13.1 tp10 -95.95 128.88 43.23 Favored 'General case' 0 CA--C 1.492 -1.254 0 N-CA-C 102.089 -3.301 . . . . 0.0 102.089 165.821 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -125.91 140.83 12.43 Favored Glycine 0 CA--C 1.491 -1.468 0 N-CA-C 107.862 -2.095 . . . . 0.0 107.862 -179.205 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 28.7 tt0 -134.14 130.82 37.9 Favored 'General case' 0 CA--C 1.482 -1.64 0 N-CA-C 106.213 -1.773 . . . . 0.0 106.213 -178.496 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 43.2 tp -117.42 102.98 9.67 Favored 'General case' 0 N--CA 1.437 -1.09 0 N-CA-C 104.626 -2.361 . . . . 0.0 104.626 -176.516 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 11.9 mt -93.99 130.36 43.04 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.888 0 N-CA-C 104.287 -2.486 . . . . 0.0 104.287 174.878 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 25.2 p -112.75 114.11 26.52 Favored 'General case' 0 N--CA 1.438 -1.069 0 N-CA-C 106.683 -1.599 . . . . 0.0 106.683 -179.857 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 22.5 mm -90.03 142.0 13.54 Favored 'Isoleucine or valine' 0 CA--C 1.485 -1.529 0 N-CA-C 105.606 -1.998 . . . . 0.0 105.606 -167.985 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 78.0 mt-30 -104.57 152.42 22.44 Favored 'General case' 0 CA--C 1.493 -1.244 0 CA-C-N 114.548 -1.206 . . . . 0.0 107.904 -174.478 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 24.5 tt0 -77.49 35.09 0.18 Allowed 'General case' 0 C--N 1.355 0.841 0 C-N-CA 125.882 1.673 . . . . 0.0 113.41 -178.579 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 98.5 m-85 -143.63 11.74 1.67 Allowed 'General case' 0 CA--C 1.498 -1.057 0 N-CA-C 109.068 -0.715 . . . . 0.0 109.068 -175.719 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 88.91 -20.62 31.46 Favored Glycine 0 C--N 1.351 1.374 0 C-N-CA 124.097 0.856 . . . . 0.0 111.207 179.739 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 85.6 m-70 -81.04 173.9 12.14 Favored 'General case' 0 CA--C 1.496 -1.1 0 C-N-CA 125.362 1.465 . . . . 0.0 108.683 -178.673 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 9.9 pt20 -162.38 145.12 11.25 Favored 'General case' 0 N--CA 1.437 -1.117 0 N-CA-C 107.875 -1.157 . . . . 0.0 107.875 -176.102 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 48.0 mm-40 -110.21 147.89 32.9 Favored 'General case' 0 CA--C 1.496 -1.127 0 N-CA-C 106.351 -1.722 . . . . 0.0 106.351 179.237 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 8.7 p -118.74 143.0 31.02 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.746 0 N-CA-C 107.626 -1.249 . . . . 0.0 107.626 -175.773 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 28.1 m -131.72 131.94 43.47 Favored 'General case' 0 N--CA 1.441 -0.898 0 N-CA-C 103.275 -2.861 . . . . 0.0 103.275 179.748 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 88.2 mtm180 -125.46 148.47 48.83 Favored 'General case' 0 CA--C 1.501 -0.924 0 CA-C-N 119.011 0.823 . . . . 0.0 108.826 -179.699 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 23.0 p90 -163.38 179.82 7.07 Favored 'General case' 0 CA--C 1.501 -0.926 0 N-CA-C 106.804 -1.554 . . . . 0.0 106.804 -177.779 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 41.6 p30 -136.96 156.34 48.58 Favored 'General case' 0 N--CA 1.443 -0.824 0 N-CA-C 106.488 -1.671 . . . . 0.0 106.488 167.457 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 23.3 p90 -142.94 170.67 15.26 Favored 'General case' 0 CA--C 1.488 -1.439 0 N-CA-C 106.505 -1.665 . . . . 0.0 106.505 172.318 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 36.0 p -120.9 139.7 52.84 Favored 'General case' 0 CA--C 1.502 -0.897 0 N-CA-C 106.443 -1.688 . . . . 0.0 106.443 174.014 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 71.1 m -108.41 88.13 2.66 Favored 'General case' 0 CA--C 1.497 -1.094 0 N-CA-C 102.948 -2.982 . . . . 0.0 102.948 171.793 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 42.6 p -89.79 -178.42 5.5 Favored 'General case' 0 N--CA 1.443 -0.8 0 N-CA-C 106.998 -1.482 . . . . 0.0 106.998 178.977 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 22.7 t . . . . . 0 C--O 1.26 1.626 0 N-CA-C 104.923 -2.251 . . . . 0.0 104.923 175.385 . . . . . . . . 0 0 . 1 . 023 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 72.5 m . . . . . 0 N--CA 1.484 1.263 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 . . . . . . . . . 0 0 . 1 . 023 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -156.97 -143.1 3.57 Favored Glycine 0 C--N 1.352 1.421 0 N-CA-C 106.243 -2.743 . . . . 0.0 106.243 -175.666 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 77.5 Cg_exo -61.51 133.47 45.95 Favored 'Trans proline' 0 N--CA 1.446 -1.301 0 C-N-CA 122.742 2.295 . . . . 0.0 113.844 -171.579 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 38.6 t -85.71 161.78 2.96 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.085 0 C-N-CA 128.454 2.702 . . . . 0.0 107.513 -172.37 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -106.26 106.09 16.44 Favored 'General case' 0 CA--C 1.493 -1.249 0 N-CA-C 105.06 -2.2 . . . . 0.0 105.06 176.733 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 1.5 p -127.21 140.41 49.17 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.086 0 N-CA-C 104.958 -2.238 . . . . 0.0 104.958 -170.31 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 16.5 p90 -142.68 159.23 42.63 Favored 'General case' 0 N--CA 1.436 -1.169 0 N-CA-C 107.071 -1.455 . . . . 0.0 107.071 -166.674 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 38.2 pt -92.26 157.71 2.93 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.403 0 N-CA-C 107.09 -1.448 . . . . 0.0 107.09 176.885 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 25.2 p -75.96 -42.68 47.79 Favored 'General case' 0 CA--C 1.503 -0.848 0 C-N-CA 123.445 0.698 . . . . 0.0 112.204 -169.973 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 79.46 84.93 0.06 Allowed 'General case' 0 CA--C 1.496 -1.103 0 C-N-CA 126.714 2.005 . . . . 0.0 106.592 -175.324 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 15.9 p -113.02 142.61 27.61 Favored Pre-proline 0 N--CA 1.444 -0.737 0 N-CA-C 105.34 -2.096 . . . . 0.0 105.34 176.527 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -78.66 100.03 1.32 Allowed 'Trans proline' 0 N--CA 1.454 -0.797 0 C-N-CA 123.177 2.585 . . . . 0.0 109.921 177.494 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 20.1 m 73.25 122.17 0.04 OUTLIER 'General case' 0 C--N 1.359 1.003 0 C-N-CA 126.638 1.975 . . . . 0.0 111.119 179.159 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 5.6 pm0 -146.79 115.01 4.38 Favored Pre-proline 0 N--CA 1.44 -0.965 0 N-CA-C 106.54 -1.652 . . . . 0.0 106.54 -179.527 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_endo -84.2 -55.47 0.03 OUTLIER 'Trans proline' 0 CA--C 1.501 -1.152 0 C-N-CA 121.919 1.746 . . . . 0.0 110.906 -170.395 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 2.1 m-80 -118.87 -20.31 8.23 Favored 'General case' 0 CA--C 1.49 -1.328 0 C-N-CA 124.857 1.263 . . . . 0.0 109.242 -168.821 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 15.0 p -97.86 148.2 23.66 Favored 'General case' 0 CA--C 1.493 -1.235 0 N-CA-C 107.444 -1.317 . . . . 0.0 107.444 -177.514 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 28.1 t60 -150.54 97.04 3.33 Favored Pre-proline 0 N--CA 1.438 -1.053 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 170.403 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -80.06 139.5 13.56 Favored 'Trans proline' 0 N--CA 1.447 -1.24 0 C-N-CA 122.35 2.033 . . . . 0.0 110.408 178.759 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 18.7 mm -113.62 146.21 18.5 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.937 0 N-CA-C 104.429 -2.434 . . . . 0.0 104.429 -178.051 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 35.0 mt-30 -136.42 149.95 48.53 Favored 'General case' 0 CA--C 1.502 -0.879 0 N-CA-C 105.326 -2.101 . . . . 0.0 105.326 168.904 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 42.0 p90 -141.48 161.97 36.61 Favored 'General case' 0 CA--C 1.502 -0.873 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 -175.169 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 81.2 m-20 -100.98 -172.39 2.16 Favored 'General case' 0 CA--C 1.485 -1.543 0 N-CA-C 103.851 -2.648 . . . . 0.0 103.851 171.389 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -150.45 163.14 25.26 Favored Pre-proline 0 N--CA 1.444 -0.771 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 169.93 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 80.4 Cg_exo -67.32 170.16 13.98 Favored 'Trans proline' 0 N--CA 1.456 -0.704 0 C-N-CA 123.38 2.72 . . . . 0.0 112.319 169.682 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 24.0 mm100 -82.42 -56.01 0.53 Allowed Pre-proline 0 N--CA 1.442 -0.869 0 CA-C-O 115.578 -2.153 . . . . 0.0 113.644 -172.328 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 82.6 Cg_endo -75.77 170.04 21.0 Favored 'Trans proline' 0 CA--C 1.509 -0.773 0 CA-C-N 125.774 3.098 . . . . 0.0 111.085 -169.228 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 69.4 m -76.83 113.27 14.33 Favored 'General case' 0 CA--C 1.5 -0.955 0 N-CA-C 107.717 -1.216 . . . . 0.0 107.717 179.031 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 61.4 t-80 -167.59 -49.95 0.02 OUTLIER 'General case' 0 N--CA 1.435 -1.193 0 N-CA-C 105.441 -2.059 . . . . 0.0 105.441 -170.559 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 26.6 mt -105.69 126.62 60.99 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.145 0 N-CA-C 106.429 -1.693 . . . . 0.0 106.429 -176.668 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 74.3 m -116.35 -84.35 0.63 Allowed 'General case' 0 N--CA 1.433 -1.278 0 N-CA-C 107.828 -1.175 . . . . 0.0 107.828 -174.714 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 38.8 ttpt -89.27 156.43 18.75 Favored 'General case' 0 CA--C 1.493 -1.22 0 C-N-CA 126.197 1.799 . . . . 0.0 106.888 -164.641 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 90.7 m-85 -126.86 135.89 51.6 Favored 'General case' 0 CA--C 1.488 -1.417 0 N-CA-C 105.304 -2.11 . . . . 0.0 105.304 179.474 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 1.5 mp -112.65 135.69 51.26 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.231 0 N-CA-C 100.473 -3.899 . . . . 0.0 100.473 170.239 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 3.1 mt -106.49 124.78 50.11 Favored 'General case' 0 CA--C 1.479 -1.788 0 N-CA-C 104.676 -2.342 . . . . 0.0 104.676 166.436 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -106.58 154.01 21.51 Favored 'General case' 0 N--CA 1.431 -1.375 0 N-CA-C 104.483 -2.414 . . . . 0.0 104.483 170.771 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 48.2 p90 -154.79 141.64 19.11 Favored 'General case' 0 N--CA 1.433 -1.292 0 N-CA-C 106.344 -1.725 . . . . 0.0 106.344 168.171 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 5.3 ptp180 -133.74 153.99 80.34 Favored Pre-proline 0 CA--C 1.497 -1.064 0 N-CA-C 103.751 -2.685 . . . . 0.0 103.751 168.695 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 68.8 Cg_endo -75.22 164.8 32.26 Favored 'Trans proline' 0 CA--C 1.506 -0.921 0 C-N-CA 122.789 2.326 . . . . 0.0 106.765 164.711 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 5.5 ptmm? -64.92 93.8 0.12 Allowed 'General case' 0 C--N 1.352 0.678 0 CA-C-N 119.976 1.262 . . . . 0.0 113.048 176.658 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -128.3 -136.28 0.23 Allowed 'General case' 0 N--CA 1.44 -0.953 0 N-CA-C 104.974 -2.232 . . . . 0.0 104.974 167.427 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 42.4 m -97.17 -154.28 0.45 Allowed 'General case' 0 N--CA 1.44 -0.954 0 C-N-CA 125.607 1.563 . . . . 0.0 107.121 179.313 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 9.2 m -94.85 42.69 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.445 -0.711 0 C-N-CA 126.627 1.971 . . . . 0.0 107.284 176.322 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -90.19 -146.33 15.22 Favored Glycine 0 C--N 1.353 1.478 0 C-N-CA 124.184 0.897 . . . . 0.0 110.998 -171.947 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 17.1 tpt180 -75.95 135.2 40.05 Favored 'General case' 0 CA--C 1.502 -0.881 0 C-N-CA 124.267 1.027 . . . . 0.0 108.332 -177.01 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -146.95 174.65 11.32 Favored 'General case' 0 N--CA 1.434 -1.27 0 N-CA-C 109.395 -0.594 . . . . 0.0 109.395 -174.261 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 64.3 mttp -112.3 155.74 23.58 Favored 'General case' 0 CA--C 1.489 -1.403 0 N-CA-C 107.347 -1.353 . . . . 0.0 107.347 -171.482 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 15.4 pt-20 -150.68 158.89 44.68 Favored 'General case' 0 N--CA 1.433 -1.284 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 179.784 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -136.7 160.45 38.8 Favored 'General case' 0 CA--C 1.497 -1.065 0 N-CA-C 106.509 -1.663 . . . . 0.0 106.509 171.754 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 77.3 m -122.8 126.54 47.63 Favored 'General case' 0 CA--C 1.501 -0.924 0 N-CA-C 104.956 -2.238 . . . . 0.0 104.956 175.335 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 5.2 mp -117.56 135.33 23.22 Favored Pre-proline 0 N--CA 1.437 -1.099 0 N-CA-C 104.753 -2.314 . . . . 0.0 104.753 -177.26 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_exo -63.48 167.13 13.71 Favored 'Trans proline' 0 CA--C 1.51 -0.71 0 C-N-CA 123.558 2.839 . . . . 0.0 113.477 177.101 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -79.49 -18.84 72.7 Favored Glycine 0 C--N 1.352 1.464 0 C-N-CA 123.344 0.497 . . . . 0.0 113.363 -172.59 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 47.7 p-80 -84.18 -27.01 28.36 Favored 'General case' 0 C--N 1.354 0.794 0 CA-C-N 117.743 0.771 . . . . 0.0 109.968 179.774 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 88.5 mt -88.57 132.58 34.47 Favored 'General case' 0 CA--C 1.502 -0.893 0 N-CA-C 107.789 -1.189 . . . . 0.0 107.789 177.722 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 7.6 p-10 -114.98 9.88 16.16 Favored 'General case' 0 CA--C 1.502 -0.897 0 C-N-CA 124.287 1.035 . . . . 0.0 110.169 -171.669 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 53.4 p -144.55 165.81 26.92 Favored 'General case' 0 N--CA 1.44 -0.958 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 -175.267 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 11.2 t80 -151.98 174.72 13.3 Favored 'General case' 0 N--CA 1.441 -0.908 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 -179.162 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 87.7 m -139.1 113.13 8.63 Favored 'General case' 0 N--CA 1.431 -1.409 0 N-CA-C 105.078 -2.193 . . . . 0.0 105.078 172.775 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 54.2 mt -87.08 142.93 12.32 Favored 'Isoleucine or valine' 0 C--N 1.359 0.979 0 N-CA-C 104.217 -2.512 . . . . 0.0 104.217 172.604 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 60.7 mttp -141.41 162.42 35.53 Favored 'General case' 0 CA--C 1.495 -1.138 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 179.195 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 78.84 53.05 4.72 Favored Glycine 0 CA--C 1.488 -1.609 0 N-CA-C 109.094 -1.602 . . . . 0.0 109.094 174.949 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 78.7 mt -113.46 -166.06 1.05 Allowed 'General case' 0 CA--C 1.503 -0.855 0 N-CA-C 107.279 -1.378 . . . . 0.0 107.279 -176.589 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 11.0 mptt -132.29 148.67 70.63 Favored Pre-proline 0 N--CA 1.442 -0.859 0 N-CA-C 104.993 -2.225 . . . . 0.0 104.993 -177.517 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -78.97 162.54 26.28 Favored 'Trans proline' 0 N--CA 1.45 -1.055 0 C-N-CA 122.772 2.315 . . . . 0.0 109.761 173.772 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 0.536 ' H ' ' HA ' ' A' ' 92' ' ' THR . . . 63.63 24.0 67.55 Favored Glycine 0 N--CA 1.428 -1.851 0 C-N-CA 127.377 2.418 . . . . 0.0 116.063 172.886 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 9.6 p -129.7 143.13 42.02 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.02 0 N-CA-C 107.484 -1.302 . . . . 0.0 107.484 -178.037 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 11.5 p -95.65 127.56 47.58 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.011 0 CA-C-O 123.289 1.519 . . . . 0.0 107.571 178.258 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 87.3 m-85 -100.44 144.34 29.55 Favored 'General case' 0 N--CA 1.431 -1.41 0 N-CA-C 106.235 -1.765 . . . . 0.0 106.235 176.339 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 33.6 tp10 -90.57 132.66 35.59 Favored 'General case' 0 N--CA 1.439 -0.981 0 N-CA-C 104.205 -2.517 . . . . 0.0 104.205 163.064 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -129.3 152.43 19.5 Favored Glycine 0 CA--C 1.489 -1.547 0 N-CA-C 108.283 -1.927 . . . . 0.0 108.283 -179.136 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 26.7 mt-30 -138.19 137.8 37.95 Favored 'General case' 0 CA--C 1.485 -1.548 0 N-CA-C 106.347 -1.723 . . . . 0.0 106.347 174.849 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 62.7 tp -109.72 97.92 7.36 Favored 'General case' 0 CA--C 1.499 -1.014 0 N-CA-C 102.898 -3.001 . . . . 0.0 102.898 174.542 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 9.1 mt -94.86 124.61 47.43 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.054 0 N-CA-C 104.026 -2.583 . . . . 0.0 104.026 -174.21 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 74.6 m -112.89 108.9 18.02 Favored 'General case' 0 CA--C 1.5 -0.959 0 N-CA-C 107.826 -1.176 . . . . 0.0 107.826 -168.03 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 1.8 mp -93.17 136.9 23.76 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.226 0 N-CA-C 105.2 -2.148 . . . . 0.0 105.2 -167.241 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 14.0 tt0 -97.96 111.25 23.63 Favored 'General case' 0 N--CA 1.431 -1.377 0 N-CA-C 101.706 -3.442 . . . . 0.0 101.706 169.508 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 41.8 mt-30 -69.25 125.03 25.42 Favored 'General case' 0 CA--C 1.5 -0.975 0 CA-C-O 120.846 0.355 . . . . 0.0 110.218 -170.587 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 52.7 m-85 68.71 39.1 2.06 Favored 'General case' 0 C--N 1.356 0.872 0 C-N-CA 126.492 1.917 . . . . 0.0 110.996 -176.172 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -166.68 -116.22 0.35 Allowed Glycine 0 C--N 1.357 1.721 0 N-CA-C 109.288 -1.525 . . . . 0.0 109.288 179.144 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 29.3 m170 -82.51 -179.73 7.52 Favored 'General case' 0 CA--C 1.502 -0.874 0 C-N-CA 125.606 1.563 . . . . 0.0 111.259 -168.504 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 25.7 tt0 -147.44 123.58 10.81 Favored 'General case' 0 N--CA 1.436 -1.167 0 N-CA-C 105.591 -2.003 . . . . 0.0 105.591 170.686 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 47.8 mm-40 -104.68 160.63 14.81 Favored 'General case' 0 CA--C 1.501 -0.931 0 N-CA-C 106.243 -1.762 . . . . 0.0 106.243 176.558 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 10.9 p -135.84 138.55 47.53 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.842 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 -178.233 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 24.9 m -122.35 139.45 53.81 Favored 'General case' 0 N--CA 1.442 -0.833 0 N-CA-C 103.124 -2.917 . . . . 0.0 103.124 173.05 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 55.9 ttp180 -135.03 143.16 46.59 Favored 'General case' 0 CA--C 1.505 -0.77 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 -174.13 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 21.1 p90 -164.0 -175.81 4.22 Favored 'General case' 0 C--N 1.358 0.97 0 N-CA-C 106.891 -1.522 . . . . 0.0 106.891 -174.519 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 44.4 p-10 -136.5 158.34 44.67 Favored 'General case' 0 N--CA 1.442 -0.838 0 N-CA-C 107.093 -1.447 . . . . 0.0 107.093 166.748 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 25.2 p90 -143.75 164.12 31.37 Favored 'General case' 0 CA--C 1.486 -1.49 0 N-CA-C 106.821 -1.548 . . . . 0.0 106.821 169.769 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 43.8 m -118.42 137.77 52.92 Favored 'General case' 0 CA--C 1.498 -1.051 0 N-CA-C 105.336 -2.098 . . . . 0.0 105.336 179.186 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 61.3 m -115.75 115.67 26.73 Favored 'General case' 0 CA--C 1.493 -1.213 0 N-CA-C 101.866 -3.383 . . . . 0.0 101.866 174.722 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . 0.536 ' HA ' ' H ' ' A' ' 66' ' ' GLY . 15.1 t -155.29 148.23 24.51 Favored 'General case' 0 N--CA 1.437 -1.103 0 N-CA-C 107.315 -1.365 . . . . 0.0 107.315 -174.227 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 67.7 m . . . . . 0 C--O 1.26 1.615 0 N-CA-C 106.467 -1.679 . . . . 0.0 106.467 175.214 . . . . . . . . 0 0 . 1 . 024 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 66.7 m . . . . . 0 N--CA 1.486 1.353 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 . . . . . . . . . 0 0 . 1 . 024 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 174.73 -160.73 30.05 Favored Glycine 0 C--N 1.35 1.308 0 N-CA-C 106.728 -2.549 . . . . 0.0 106.728 -178.313 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 29.8 Cg_exo -59.04 139.78 92.28 Favored 'Trans proline' 0 N--CA 1.446 -1.293 0 C-N-CA 123.649 2.899 . . . . 0.0 113.559 -175.168 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 41.9 t -79.83 160.15 4.28 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.996 0 C-N-CA 128.552 2.741 . . . . 0.0 106.282 -179.002 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 55.2 mt-10 -108.13 106.74 17.09 Favored 'General case' 0 CA--C 1.493 -1.215 0 N-CA-C 105.998 -1.853 . . . . 0.0 105.998 -179.638 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 1.5 p -124.18 140.07 48.66 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.914 0 N-CA-C 106.142 -1.799 . . . . 0.0 106.142 -172.367 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 16.5 p90 -146.09 165.18 29.85 Favored 'General case' 0 N--CA 1.438 -1.032 0 N-CA-C 105.968 -1.864 . . . . 0.0 105.968 -168.589 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 7.8 pt -110.51 113.99 45.8 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.557 0 N-CA-C 107.653 -1.24 . . . . 0.0 107.653 -178.515 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 9.4 t -121.92 170.42 9.82 Favored 'General case' 0 N--CA 1.445 -0.717 0 N-CA-C 107.028 -1.471 . . . . 0.0 107.028 -179.172 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 11.9 tp10 68.1 16.42 9.47 Favored 'General case' 0 C--N 1.36 1.035 0 C-N-CA 126.731 2.012 . . . . 0.0 112.863 171.657 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 5.7 t -143.75 94.59 5.96 Favored Pre-proline 0 N--CA 1.444 -0.73 0 N-CA-C 108.126 -1.065 . . . . 0.0 108.126 177.421 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -77.23 -32.63 2.98 Favored 'Trans proline' 0 N--CA 1.452 -0.95 0 C-N-CA 122.514 2.143 . . . . 0.0 109.453 162.062 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 12.3 p -168.03 109.41 0.58 Allowed 'General case' 0 N--CA 1.437 -1.111 0 N-CA-C 106.698 -1.593 . . . . 0.0 106.698 -179.438 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 90.5 mt-30 -151.65 114.72 3.02 Favored Pre-proline 0 C--N 1.353 0.729 0 N-CA-C 104.833 -2.284 . . . . 0.0 104.833 177.837 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -86.17 -21.76 2.41 Favored 'Trans proline' 0 CA--C 1.505 -0.952 0 C-N-CA 122.464 2.109 . . . . 0.0 111.372 -170.113 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 6.2 p-10 -104.37 -41.32 5.79 Favored 'General case' 0 CA--C 1.489 -1.369 0 C-N-CA 123.167 0.587 . . . . 0.0 109.622 -167.103 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 12.0 p -110.5 150.72 28.49 Favored 'General case' 0 CA--C 1.494 -1.202 0 N-CA-C 107.399 -1.334 . . . . 0.0 107.399 -179.095 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 58.6 t-80 -143.37 93.61 6.37 Favored Pre-proline 0 N--CA 1.437 -1.087 0 N-CA-C 106.892 -1.522 . . . . 0.0 106.892 173.656 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -82.02 146.17 14.32 Favored 'Trans proline' 0 N--CA 1.445 -1.332 0 C-N-CA 123.436 2.757 . . . . 0.0 109.948 175.958 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.491 HD11 HD11 ' A' ' 35' ' ' LEU . 7.4 pt -126.3 173.44 12.04 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.985 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 178.217 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 49.2 tt0 -148.49 149.34 31.48 Favored 'General case' 0 N--CA 1.44 -0.95 0 N-CA-C 105.192 -2.151 . . . . 0.0 105.192 170.684 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 27.7 p90 -130.51 161.25 31.89 Favored 'General case' 0 N--CA 1.44 -0.959 0 N-CA-C 106.296 -1.742 . . . . 0.0 106.296 -179.696 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 61.1 t30 -96.61 -176.25 3.55 Favored 'General case' 0 CA--C 1.491 -1.327 0 N-CA-C 103.33 -2.841 . . . . 0.0 103.33 169.372 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -156.43 166.96 15.37 Favored Pre-proline 0 N--CA 1.44 -0.938 0 N-CA-C 106.621 -1.622 . . . . 0.0 106.621 172.888 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 99.6 Cg_exo -65.39 162.17 34.82 Favored 'Trans proline' 0 CA--C 1.508 -0.775 0 C-N-CA 123.486 2.791 . . . . 0.0 112.978 175.838 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 1.2 tm0? -82.08 -58.75 0.45 Allowed Pre-proline 0 N--CA 1.442 -0.845 0 CA-C-O 115.7 -2.095 . . . . 0.0 110.686 -177.46 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo -74.95 175.54 11.09 Favored 'Trans proline' 0 CA--C 1.51 -0.696 0 CA-C-N 125.67 3.061 . . . . 0.0 110.548 -177.168 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 44.2 p -69.18 124.5 23.98 Favored 'General case' 0 C--N 1.356 0.891 0 C-N-CA 123.824 0.85 . . . . 0.0 109.785 -178.239 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 61.0 t60 -168.12 -42.82 0.02 OUTLIER 'General case' 0 CA--C 1.494 -1.199 0 N-CA-C 106.598 -1.63 . . . . 0.0 106.598 -170.747 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 33.4 mt -132.56 140.42 47.62 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.895 0 N-CA-C 107.68 -1.23 . . . . 0.0 107.68 -173.604 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 31.8 p -123.18 -71.22 0.73 Allowed 'General case' 0 C--N 1.359 0.985 0 C-N-CA 124.219 1.008 . . . . 0.0 109.536 172.875 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 44.6 mtpt -86.44 166.58 15.41 Favored 'General case' 0 CA--C 1.488 -1.439 0 C-N-CA 126.899 2.08 . . . . 0.0 107.219 -171.029 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 83.4 m-85 -134.31 148.61 50.79 Favored 'General case' 0 CA--C 1.493 -1.248 0 N-CA-C 104.855 -2.276 . . . . 0.0 104.855 175.369 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 4.4 mt -123.54 139.47 50.05 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.315 0 N-CA-C 101.402 -3.555 . . . . 0.0 101.402 171.361 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.491 HD11 HD11 ' A' ' 20' ' ' ILE . 12.0 mt -116.02 135.36 54.03 Favored 'General case' 0 CA--C 1.477 -1.852 0 N-CA-C 106.717 -1.586 . . . . 0.0 106.717 166.681 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 9.0 mpt_? -110.58 153.12 25.6 Favored 'General case' 0 N--CA 1.429 -1.48 0 N-CA-C 104.491 -2.411 . . . . 0.0 104.491 166.559 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 48.9 p90 -154.15 146.59 24.0 Favored 'General case' 0 N--CA 1.441 -0.905 0 N-CA-C 108.099 -1.075 . . . . 0.0 108.099 168.969 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 43.9 ttm-85 -142.08 143.9 29.75 Favored Pre-proline 0 CA--C 1.503 -0.844 0 N-CA-C 104.693 -2.336 . . . . 0.0 104.693 179.876 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -71.42 115.22 4.2 Favored 'Trans proline' 0 N--CA 1.454 -0.808 0 C-N-CA 122.878 2.386 . . . . 0.0 108.845 167.151 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 64.3 tttm -70.33 77.87 0.54 Allowed 'General case' 0 C--N 1.358 0.955 0 C-N-CA 126.979 2.112 . . . . 0.0 111.084 -177.179 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 68.7 m-80 -151.77 -73.26 0.15 Allowed 'General case' 0 N--CA 1.435 -1.218 0 N-CA-C 102.653 -3.091 . . . . 0.0 102.653 -173.436 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 60.8 m -96.5 168.38 10.58 Favored 'General case' 0 C--N 1.356 0.874 0 N-CA-C 107.19 -1.411 . . . . 0.0 107.19 175.028 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 2.6 m -130.91 62.27 0.3 Allowed 'Isoleucine or valine' 0 CA--C 1.501 -0.913 0 N-CA-C 105.436 -2.061 . . . . 0.0 105.436 179.759 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -93.18 -110.53 2.01 Favored Glycine 0 C--N 1.353 1.503 0 N-CA-C 107.969 -2.052 . . . . 0.0 107.969 -179.818 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 80.2 mtp180 -105.88 175.66 5.42 Favored 'General case' 0 CA--C 1.502 -0.884 0 N-CA-C 106.338 -1.727 . . . . 0.0 106.338 173.564 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -152.05 172.63 15.99 Favored 'General case' 0 CA--C 1.495 -1.168 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 -176.676 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 94.6 mttt -108.02 154.16 22.05 Favored 'General case' 0 CA--C 1.487 -1.456 0 N-CA-C 107.313 -1.366 . . . . 0.0 107.313 -173.984 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -152.19 153.03 33.01 Favored 'General case' 0 N--CA 1.431 -1.391 0 N-CA-C 107.542 -1.281 . . . . 0.0 107.542 -177.738 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -146.48 160.62 41.87 Favored 'General case' 0 CA--C 1.499 -1.018 0 N-CA-C 107.667 -1.235 . . . . 0.0 107.667 177.665 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 91.6 m -121.7 126.76 49.69 Favored 'General case' 0 CA--C 1.5 -0.956 0 N-CA-C 105.176 -2.157 . . . . 0.0 105.176 177.734 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 52.5 mt -117.58 136.92 23.75 Favored Pre-proline 0 N--CA 1.436 -1.164 0 N-CA-C 105.639 -1.985 . . . . 0.0 105.639 -166.635 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 76.1 Cg_exo -65.26 168.46 14.21 Favored 'Trans proline' 0 CA--C 1.51 -0.692 0 C-N-CA 123.214 2.609 . . . . 0.0 113.284 177.702 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -96.38 7.68 66.41 Favored Glycine 0 C--N 1.352 1.428 0 CA-C-O 118.951 -0.916 . . . . 0.0 113.013 -178.038 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 44.3 p-80 -83.93 -47.45 11.02 Favored 'General case' 0 C--N 1.362 1.146 0 CA-C-N 119.206 1.503 . . . . 0.0 109.186 178.869 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -87.95 165.76 14.99 Favored 'General case' 0 CA--C 1.489 -1.381 0 CA-C-O 122.934 1.35 . . . . 0.0 108.271 170.921 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 6.0 p-10 -140.54 24.53 2.25 Favored 'General case' 0 N--CA 1.424 -1.761 0 CA-C-N 112.974 -1.921 . . . . 0.0 106.987 -178.506 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 57.1 p -132.14 158.49 41.53 Favored 'General case' 0 CA--C 1.501 -0.91 0 N-CA-C 107.788 -1.19 . . . . 0.0 107.788 176.387 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 7.7 t80 -133.21 175.79 9.09 Favored 'General case' 0 C--N 1.359 1.002 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 175.463 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 93.3 m -142.4 110.84 6.1 Favored 'General case' 0 N--CA 1.431 -1.404 0 N-CA-C 104.409 -2.441 . . . . 0.0 104.409 173.985 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 26.3 mt -90.85 147.32 5.3 Favored 'Isoleucine or valine' 0 C--N 1.358 0.952 0 N-CA-C 104.293 -2.484 . . . . 0.0 104.293 172.443 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 67.3 mttm -142.46 164.62 29.63 Favored 'General case' 0 CA--C 1.5 -0.946 0 N-CA-C 108.717 -0.845 . . . . 0.0 108.717 177.549 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 82.02 50.01 5.07 Favored Glycine 0 C--N 1.356 1.663 0 C-N-CA 125.357 1.456 . . . . 0.0 109.562 175.153 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 49.5 mt -119.25 172.97 7.23 Favored 'General case' 0 CA--C 1.5 -0.97 0 N-CA-C 108.22 -1.03 . . . . 0.0 108.22 -170.998 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -114.61 160.91 31.38 Favored Pre-proline 0 N--CA 1.442 -0.872 0 N-CA-C 106.856 -1.535 . . . . 0.0 106.856 -176.937 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -79.75 163.12 23.88 Favored 'Trans proline' 0 N--CA 1.452 -0.944 0 C-N-CA 123.192 2.595 . . . . 0.0 109.83 166.131 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 60.9 24.65 62.92 Favored Glycine 0 C--N 1.355 1.638 0 C-N-CA 127.778 2.609 . . . . 0.0 116.496 172.1 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 7.7 p -118.9 146.14 23.94 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.063 0 N-CA-C 107.529 -1.286 . . . . 0.0 107.529 -174.56 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 4.2 p -100.31 129.9 50.36 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.906 0 N-CA-C 106.665 -1.606 . . . . 0.0 106.665 176.013 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 94.1 m-85 -113.44 150.01 33.38 Favored 'General case' 0 N--CA 1.439 -1.016 0 N-CA-C 105.923 -1.88 . . . . 0.0 105.923 173.508 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -100.61 144.58 29.42 Favored 'General case' 0 CA--C 1.496 -1.119 0 N-CA-C 104.327 -2.471 . . . . 0.0 104.327 162.546 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -126.99 157.76 20.74 Favored Glycine 0 CA--C 1.489 -1.584 0 N-CA-C 108.016 -2.034 . . . . 0.0 108.016 174.663 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 23.7 tt0 -142.7 131.48 22.76 Favored 'General case' 0 CA--C 1.482 -1.671 0 N-CA-C 106.004 -1.85 . . . . 0.0 106.004 176.53 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 39.8 tp -113.5 104.76 12.59 Favored 'General case' 0 N--CA 1.437 -1.112 0 N-CA-C 104.6 -2.371 . . . . 0.0 104.6 -174.878 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 21.8 mt -100.48 126.69 54.03 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.866 0 N-CA-C 103.192 -2.892 . . . . 0.0 103.192 -179.29 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 50.5 m -118.36 115.9 25.63 Favored 'General case' 0 N--CA 1.444 -0.74 0 CA-C-N 119.24 0.927 . . . . 0.0 109.154 -171.32 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 2.4 mp -104.3 141.11 20.55 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.982 0 N-CA-C 105.779 -1.934 . . . . 0.0 105.779 -162.824 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . 0.442 ' HB3' ' H ' ' A' ' 81' ' ' HIS . 12.0 tp-100 -103.89 125.95 50.66 Favored 'General case' 0 CA--C 1.493 -1.25 0 N-CA-C 102.458 -3.164 . . . . 0.0 102.458 161.293 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 18.5 tt0 -68.35 117.89 10.72 Favored 'General case' 0 N--CA 1.443 -0.808 0 C-N-CA 123.036 0.534 . . . . 0.0 110.558 -170.428 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 24.8 m-85 64.44 53.96 1.58 Allowed 'General case' 0 C--N 1.358 0.957 0 C-N-CA 126.597 1.959 . . . . 0.0 110.686 -175.256 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -172.47 -110.86 0.25 Allowed Glycine 0 C--N 1.352 1.421 0 N-CA-C 109.021 -1.632 . . . . 0.0 109.021 -178.696 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . 0.442 ' H ' ' HB3' ' A' ' 77' ' ' GLN . 27.9 m170 -80.2 164.92 22.9 Favored 'General case' 0 CA--C 1.503 -0.861 0 C-N-CA 125.066 1.347 . . . . 0.0 111.436 -168.792 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 44.8 tt0 -151.0 111.27 4.15 Favored 'General case' 0 N--CA 1.435 -1.181 0 N-CA-C 105.539 -2.023 . . . . 0.0 105.539 169.806 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 17.2 tp10 -99.82 151.95 20.69 Favored 'General case' 0 N--CA 1.441 -0.901 0 N-CA-C 105.799 -1.926 . . . . 0.0 105.799 179.267 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 11.3 p -130.85 139.91 49.98 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.774 0 N-CA-C 107.324 -1.362 . . . . 0.0 107.324 177.849 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 85.8 m -138.51 133.85 33.17 Favored 'General case' 0 N--CA 1.441 -0.922 0 N-CA-C 102.901 -3.0 . . . . 0.0 102.901 -177.969 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 8.1 ptm180 -113.79 165.1 12.9 Favored 'General case' 0 C--N 1.357 0.915 0 CA-C-N 119.822 1.192 . . . . 0.0 109.667 174.506 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 43.0 p90 -163.99 174.6 11.2 Favored 'General case' 0 CA--C 1.5 -0.975 0 N-CA-C 106.919 -1.512 . . . . 0.0 106.919 177.163 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 1.4 p30 -143.97 156.55 44.45 Favored 'General case' 0 N--CA 1.441 -0.885 0 N-CA-C 106.965 -1.494 . . . . 0.0 106.965 166.459 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 6.6 p90 -148.36 173.27 13.23 Favored 'General case' 0 CA--C 1.488 -1.434 0 N-CA-C 107.661 -1.237 . . . . 0.0 107.661 -179.881 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 32.0 p -122.97 143.99 49.54 Favored 'General case' 0 CA--C 1.499 -0.99 0 N-CA-C 106.308 -1.738 . . . . 0.0 106.308 171.633 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 68.3 m -110.07 87.23 2.47 Favored 'General case' 0 CA--C 1.495 -1.137 0 N-CA-C 100.579 -3.86 . . . . 0.0 100.579 166.27 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 10.2 t -97.41 -50.88 4.36 Favored 'General case' 0 N--CA 1.441 -0.908 0 N-CA-C 108.293 -1.002 . . . . 0.0 108.293 -168.33 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 11.4 t . . . . . 0 C--O 1.26 1.638 0 C-N-CA 126.118 1.767 . . . . 0.0 110.256 -175.475 . . . . . . . . 0 0 . 1 stop_ save_